data_2rsv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rsv _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -101.54 108.44 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -35.8 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.508 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 150.34 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mt -103.25 142.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 11.8 pt -116.76 143.44 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 p -102.33 141.76 34.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.137 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 10.3 m-20 -83.03 -144.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.88 56.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 109.698 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.46 35.6 26.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.571 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -139.33 -8.46 1.3 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.36 177.75 9.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.157 0.503 . . . . 0.0 111.692 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -155.25 92.73 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.904 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 9.2 m95 -96.64 144.83 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.408 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.35 125.81 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.852 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.32 131.81 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.0 -121.04 4.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.86 154.61 44.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.709 0.29 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.32 175.19 7.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.516 2.144 . . . . 0.0 112.335 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 pt -141.61 30.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -85.19 124.08 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -146.29 153.3 40.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.44 135.93 36.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.05 137.67 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -124.39 151.18 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.6 ttp -89.81 52.83 2.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -149.47 148.23 29.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.41 34.74 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.43 176.33 7.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.72 134.93 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t 63.42 125.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.38 -52.74 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.3 -133.94 52.09 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.65 29.71 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -105.68 31.98 4.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.82 99.3 9.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.04 42.5 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.709 2.273 . . . . 0.0 112.66 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -149.93 150.28 31.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 110.779 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.02 146.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 128' ' ' PHE . 7.5 p -131.95 131.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.599 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -105.39 121.09 43.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.215 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.12 152.02 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.422 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -140.71 136.26 16.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.68 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 112.375 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.3 t 62.28 122.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -171.51 159.9 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.88 75.0 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.82 -75.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.46 -61.91 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.48 -33.18 72.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.58 -31.93 72.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.3 p -75.07 -41.61 58.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.8 -38.48 64.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.24 -51.68 62.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -56.78 -51.81 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 198' ' ' TYR . 19.6 t80 -64.27 -29.79 70.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.57 -50.7 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.262 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -25.38 64.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -87.67 -47.43 8.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.84 19.41 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 114.12 38.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.467 0.175 . . . . 0.0 110.649 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.25 -26.19 7.93 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.503 2.136 . . . . 0.0 112.636 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.4 -40.44 57.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -79.33 -43.43 23.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.25 -52.87 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -42.28 64.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -43.23 67.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.964 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -53.89 37.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt -56.66 -34.23 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -74.88 -27.7 60.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 m -71.62 -38.53 70.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -6.53 19.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.983 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.19 27.66 16.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 mt -51.83 -32.52 32.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.1 tttt 46.74 40.91 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.658 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 25.1 t80 -176.86 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.347 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 167' ' ' TYR . 13.4 tp 59.96 158.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.725 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 164' ' ' ILE . . . -110.66 32.98 6.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.624 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.428 HG21 ' CE2' ' A' ' 167' ' ' TYR . 23.3 t -112.6 126.6 28.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.529 0.204 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.69 161.8 23.63 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.305 2.003 . . . . 0.0 112.025 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 115.43 27.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.06 131.95 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 9.3 m95 -109.89 -40.91 4.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -175.03 46.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.762 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -135.4 162.0 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.82 174.49 24.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.84 150.61 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.064 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 121.85 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.42 127.86 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -138.29 126.16 22.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.97 20.84 4.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.68 62.07 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.792 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -96.13 129.86 43.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.784 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.64 118.77 30.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.084 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -101.42 122.56 43.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -106.51 130.89 54.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CE1' ' HA3' ' A' ' 117' ' ' GLY . 25.3 p90 -140.27 168.62 19.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.104 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -142.73 138.96 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 130' ' ' ILE . 1.5 mp -94.09 141.8 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.09 164.21 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.658 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.83 -69.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.09 -78.24 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 184' ' ' LEU . 1.4 m-85 64.19 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.916 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -117.8 -101.66 2.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.615 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.8 t -102.02 166.33 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.856 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 13.1 p30 -97.95 161.68 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -58.53 -25.14 62.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.56 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -37.95 68.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.82 70.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 138' ' ' LEU . 14.1 mt -76.35 -26.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 149' ' ' PHE . 36.3 t80 -56.21 -44.74 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.09 -30.35 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.24 -14.09 62.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.511 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -94.6 -1.0 54.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.248 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 92.56 44.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.962 0.505 . . . . 0.0 110.395 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.75 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.591 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -170.72 121.46 0.58 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.918 0.39 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 254' ' ' TRP . 8.6 m-85 -61.33 177.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.6 t -113.41 160.69 18.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.788 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -36.95 74.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -70.69 -48.8 52.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.7 p -58.69 -56.2 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.168 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.35 -53.5 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.54 -45.67 84.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -65.67 -52.9 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.81 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.53 -34.06 76.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.743 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.1 m -58.83 -46.41 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.8 -43.81 98.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -34.02 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.838 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.96 -36.62 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.149 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.4 mt -55.35 -44.12 75.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -26.44 68.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.458 HG12 ' HA3' ' A' ' 109' ' ' GLY . 5.0 mt -72.74 -46.55 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.3 mt -59.85 -27.29 66.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.961 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -30.37 60.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 110' ' ' VAL . 91.1 t80 -77.15 -56.09 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 41.6 pt -55.13 -29.35 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -42.37 90.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -16.87 61.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 89' ' ' ARG . 0.6 OUTLIER -98.11 2.24 48.41 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.177 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 74.75 40.25 0.39 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.941 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -138.01 127.28 24.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.695 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.9 m -142.26 169.34 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.391 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 67.54 43.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.46 -17.17 52.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.678 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.73 82.31 0.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.0 110.993 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.04 108.49 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.005 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -149.32 -176.5 5.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -84.69 -0.26 52.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.417 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.63 5.72 12.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.324 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -125.12 -11.07 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.328 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.9 mt -108.32 125.62 51.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.949 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 134' ' ' PHE . 1.2 mt -129.58 154.53 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.354 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.401 HD21 ' HB ' ' A' ' 193' ' ' VAL . 6.1 mt -100.07 149.2 23.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.8 133.37 55.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -75.25 -66.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.808 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -22.75 41.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.836 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.87 80.94 41.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 101.74 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.565 2.177 . . . . 0.0 112.199 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -177.5 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 107' ' ' TYR . 8.6 mp0 -108.22 164.03 12.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 194' ' ' TYR . 10.8 p -132.05 147.79 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.484 ' N ' HG23 ' A' ' 193' ' ' VAL . 1.4 m-85 -123.14 156.73 34.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.709 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 26.1 tp -107.28 115.93 31.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.696 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.4 m -86.86 179.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.254 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.47 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 26.3 m-85 -145.47 -57.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -58.43 -23.69 54.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.696 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.56 33.87 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -131.08 -90.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.053 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.16 118.87 8.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.752 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -94.82 47.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -127.75 -52.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.722 0.296 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.406 ' CD1' HG12 ' A' ' 271' ' ' VAL . 2.1 tt -179.09 38.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.53 63.03 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.504 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 262' ' ' GLU . 30.3 m-85 76.34 29.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.745 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.0 m -83.72 145.2 28.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.2 t -59.24 141.28 54.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mt -61.01 -37.22 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -43.88 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.44 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -72.9 -32.0 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.17 12.84 29.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.298 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 55.79 28.7 53.12 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.79 110.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.56 151.88 0.1 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.79 154.86 8.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.531 2.154 . . . . 0.0 112.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.3 t -100.55 123.57 44.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 mtm105 -144.87 -50.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -17.66 60.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.31 -33.65 66.01 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.544 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.39 -33.12 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.66 -31.59 36.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.841 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.52 -40.91 93.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.21 -41.29 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.033 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 54.5 tp -70.37 -39.71 74.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.36 -45.86 94.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.545 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.41 ' HA ' HD11 ' A' ' 252' ' ' ILE . 43.6 m-85 -78.61 -25.62 45.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.83 -41.41 82.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -48.19 81.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 249' ' ' TYR . 2.4 mp -65.77 -31.72 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.295 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.415 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -70.4 -43.61 69.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.011 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 15.1 m0 -82.23 -42.91 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.08 -36.82 82.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.159 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.27 -21.43 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.32 88.94 0.27 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 8.6 m170 62.41 144.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.456 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.15 165.77 33.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 41.3 Cg_endo -67.99 64.41 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.43 2.087 . . . . 0.0 112.607 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.478 ' CD1' ' C ' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -178.9 -40.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.888 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -113.11 25.35 11.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.356 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -58.54 6.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.7 m120 -129.1 -25.87 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.327 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 41.9 mt 74.33 11.11 4.19 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -85.12 -15.83 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.597 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.472 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 4.4 m-20 -133.89 74.72 68.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.411 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 49.1 Cg_exo -56.04 -16.12 15.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.882 2.388 . . . . 0.0 112.982 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -49.99 -50.44 47.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.476 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.9 p90 -84.13 -27.05 28.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.383 . . . . 0.0 110.785 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 270' ' ' TYR . 18.3 t -60.69 -35.49 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.55 -44.15 44.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.22 -47.62 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -64.4 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -46.76 78.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.6 mt -68.65 -34.7 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -50.72 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -61.89 -37.06 83.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -54.58 -29.33 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -116.75 22.28 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -136.23 40.3 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 27.9 mt -49.26 -40.05 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.5 64.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -35.98 66.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.7 pp -80.02 -41.58 25.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 15.0 ttm -63.0 -32.98 74.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.762 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.27 -32.59 33.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -82.79 -27.15 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.289 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.6 m -93.55 -41.28 9.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.349 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -107.57 160.39 26.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.13 167.66 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.63 37.93 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -113.09 33.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 60.72 30.33 19.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -80.09 -50.77 1.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 295' ' ' LYS . 42.2 Cg_exo -56.86 -162.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.515 2.144 . . . . 0.0 112.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.39 -45.64 1.13 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -44.64 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 29.6 mm -77.24 -46.76 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.055 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.87 -49.57 10.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.411 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 323' ' ' ILE . 0.8 OUTLIER -58.87 -40.35 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.414 ' CE2' HD21 ' A' ' 320' ' ' LEU . 14.5 t80 -69.88 -42.62 73.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.417 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.1 mtp -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.317 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.03 -50.35 74.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 73.6 m -57.48 -37.79 73.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 31.6 t -72.3 -24.75 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -31.9 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.376 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.48 -12.98 23.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 317' ' ' TYR . 52.7 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.777 0.24 . . . . 0.0 112.422 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 1.5 tp 63.2 32.28 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 3.2 m-85 -66.05 -42.08 89.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -58.5 -32.91 69.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -77.4 -47.45 19.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.414 HD21 ' CE2' ' A' ' 302' ' ' TYR . 61.6 mt -55.19 -43.02 74.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -58.55 -37.82 76.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.02 -33.36 73.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 301' ' ' LYS . 64.9 mt -61.38 -49.43 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 302' ' ' TYR . 12.2 mt -80.51 -23.63 39.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.317 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.3 tt -82.44 -35.15 27.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -68.76 -42.51 77.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.21 -26.52 56.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.556 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 28.1 mt -53.84 -29.7 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.21 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.245 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.8 pt -97.51 24.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.33 40.74 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.632 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.9 t -89.62 178.51 6.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 151.89 30.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.51 89.48 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.77 0.319 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.12 114.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.85 -26.43 5.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -76.17 134.54 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.001 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.9 mt -105.28 145.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.415 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 25.2 pt -119.5 154.49 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.263 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 68.4 p -97.93 141.27 31.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.0 -162.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.94 -41.95 34.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 109.775 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.35 -2.21 33.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.653 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 86.96 27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -72.79 177.41 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.141 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.77 79.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.873 0.368 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -73.19 128.65 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.94 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -91.9 119.18 31.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.62 150.39 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.45 -116.28 2.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.03 158.85 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.733 0.302 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 56.2 Cg_endo -70.48 155.1 64.25 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.559 2.173 . . . . 0.0 112.373 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.2 pt -145.63 31.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.9 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.43 106.92 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 70.6 m-85 -131.37 171.33 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.978 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 151.41 23.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.43 153.28 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -146.79 140.8 26.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.6 ttp -85.17 57.39 4.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -59.83 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 m 59.39 31.95 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 m -139.83 -66.83 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -176.45 134.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.97 167.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 -31.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.19 -116.36 3.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -160.87 31.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -138.66 -77.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.89 77.56 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.54 48.87 2.92 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.715 2.276 . . . . 0.0 112.716 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.69 170.14 19.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.1 146.04 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.21 118.78 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.228 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.18 121.94 44.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.14 151.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -141.21 122.25 8.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.19 96.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.336 2.024 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.75 178.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.89 79.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -135.98 32.06 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.26 -178.52 28.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.38 10.99 3.43 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.791 2.327 . . . . 0.0 112.97 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.96 -32.96 72.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.983 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.43 -39.21 92.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.1 p -69.72 -32.05 70.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 198' ' ' TYR . 11.7 tp10 -75.79 -40.5 55.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.46 -42.54 92.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -62.08 -51.7 66.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.1 -40.05 84.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 3.0 m-85 -56.32 -60.06 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.357 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.07 -17.65 63.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -75.87 -47.53 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.97 -25.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -88.74 23.63 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -76.73 138.54 66.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.536 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.22 -27.8 58.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.513 2.142 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -79.45 -47.36 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.5 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 96' ' ' ILE . 64.6 mt -55.84 -45.68 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -48.65 -38.24 20.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -35.15 63.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.452 HD12 HG21 ' A' ' 100' ' ' ILE . 40.9 mm -66.55 -41.46 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -74.92 -27.6 60.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.59 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.2 p -84.37 -28.47 26.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.351 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -107.11 -7.23 16.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.844 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm 58.7 21.83 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.802 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -54.69 -41.56 70.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.986 0.422 . . . . 0.0 110.755 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt 52.35 27.08 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.562 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -177.57 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.691 0.281 . . . . 0.0 111.381 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 167' ' ' TYR . 14.1 tp 69.92 -65.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.824 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.92 1.55 10.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.98 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.4 t -89.8 138.65 27.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.83 153.22 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.24 115.62 28.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.22 121.78 36.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -103.86 -40.67 6.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.05 -176.78 46.48 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.66 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -132.58 178.71 6.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -163.36 173.24 39.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.06 159.92 40.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.726 0.298 . . . . 0.0 110.746 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -144.32 119.43 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.023 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.71 124.62 49.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.15 126.2 22.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.0 t30 55.43 20.83 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.422 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.57 -3.55 61.26 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.903 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -96.14 129.09 43.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -89.07 140.78 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -125.75 123.56 39.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -102.56 125.13 49.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.441 ' CE1' ' HA3' ' A' ' 117' ' ' GLY . 23.9 p90 -140.43 162.47 35.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.5 ttm -131.41 147.18 52.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 130' ' ' ILE . 9.1 mm -98.73 119.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.9 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.54 171.94 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -71.28 145.88 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 134.17 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' A' ' 196' ' ' VAL . 72.9 m-85 -110.17 154.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.722 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -85.39 -107.84 0.69 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.368 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 m -111.24 118.71 36.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.831 0.348 . . . . 0.0 110.672 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -51.22 160.98 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -66.53 -21.7 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.679 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -65.24 -44.7 87.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.027 0.441 . . . . 0.0 109.813 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.88 66.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.191 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.81 -25.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -62.41 -49.03 77.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.521 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.85 -31.11 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.75 -25.43 67.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -108.95 10.4 26.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 81.01 52.71 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.047 0.451 . . . . 0.0 110.454 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 23.6 mtpt 61.14 19.66 10.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.588 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -136.15 -175.56 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.045 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -137.13 -172.71 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.01 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.0 m -119.12 149.74 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -30.57 65.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -34.83 62.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -48.38 35.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CB ' ' A' ' 251' ' ' MET . 59.4 t -60.08 -54.19 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 16.5 mt -58.87 -49.7 76.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -59.86 -51.27 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.91 -33.42 71.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.519 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -45.57 90.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.69 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.74 -45.78 92.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.75 -48.79 79.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.781 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.18 -40.21 88.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.4 mt -58.07 -33.47 69.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.21 -32.7 72.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.788 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.74 -44.54 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.45 -40.44 71.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.67 -38.46 91.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.067 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.424 ' CE2' HD22 ' A' ' 108' ' ' LEU . 80.5 t80 -66.56 -52.05 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 175' ' ' HIS . 38.0 pt -62.37 -27.16 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.427 ' CE1' HG12 ' A' ' 174' ' ' VAL . 0.8 OUTLIER -80.71 -34.48 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -16.75 62.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.676 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 2.44 49.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 12.9 mt-10 78.09 43.48 0.09 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.851 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.3 122.21 15.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.465 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 18.8 m -121.92 142.8 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.209 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.505 ' CE1' ' CD1' ' A' ' 198' ' ' TYR . 0.5 OUTLIER 177.74 82.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.82 79.57 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.07 22.46 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.649 0.261 . . . . 0.0 111.143 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.1 91.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 171.69 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -76.86 -6.31 51.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.538 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.71 1.79 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -123.87 -9.61 7.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.102 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 193' ' ' VAL . 9.6 mt -108.63 128.83 55.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 134' ' ' PHE . 1.4 mt -135.46 149.15 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.756 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.52 147.83 25.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.281 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -65.8 125.75 26.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -94.95 -42.81 8.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -30.25 66.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.467 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -141.22 69.24 27.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.432 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.51 108.3 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.5 -45.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.082 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -149.62 -166.52 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 111.205 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -109.91 148.24 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.85 156.93 26.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.351 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.14 115.84 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 134' ' ' PHE . 13.1 m -118.5 145.93 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.15 100.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.252 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.505 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 2.9 m-85 -86.65 -20.27 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 65.21 14.64 59.71 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -146.61 -66.35 0.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 44.38 87.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -131.0 149.01 52.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -95.82 82.82 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.465 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 41.5 p90 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.612 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 m 61.29 162.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 225' ' ' ILE . 3.7 tp -130.13 15.87 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 227' ' ' PHE . 43.8 tt0 -74.55 -34.82 63.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 226' ' ' GLU . 73.0 m-85 -157.59 30.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.0 t -76.11 132.62 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 172.25 10.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -53.6 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -42.26 90.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.26 -32.79 74.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.216 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.5 -36.53 84.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.67 12.98 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.31 31.45 59.55 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.801 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.6 113.28 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.05 154.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.78 158.68 56.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.578 2.186 . . . . 0.0 112.254 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 18.9 m -67.22 113.09 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -134.59 -57.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -87.58 -24.87 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.6 -32.11 64.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.563 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -38.12 74.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 57.9 mt -80.6 -33.48 35.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.57 -37.81 79.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.44 -39.67 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.36 -45.43 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.42 92.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 25.4 m-85 -78.81 -25.7 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.67 -43.25 84.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.279 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.404 ' CB ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.17 -49.62 76.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.019 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.6 mt -63.99 -28.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -80.12 -40.19 27.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 36.2 m0 -82.29 -30.85 30.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.9 mt -79.79 -44.04 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.297 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.05 0.62 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.449 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.71 97.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.5 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 64.07 154.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.473 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -137.77 171.28 8.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.56 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 45.3 Cg_endo -68.89 61.73 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.411 2.074 . . . . 0.0 112.633 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 262' ' ' GLU . 1.6 p90 178.12 -37.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -98.09 22.23 9.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.437 179.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.82 -55.83 6.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -132.22 -26.41 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.482 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 66.0 mt 71.93 12.27 6.11 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.208 0.528 . . . . 0.0 109.69 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -84.77 -14.43 48.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -134.92 101.24 11.61 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.52 19.27 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.724 2.283 . . . . 0.0 112.724 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -45.67 17.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -82.09 -26.46 33.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 11.3 t -61.72 -44.22 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -71.47 -44.34 64.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -66.51 -41.25 89.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 278' ' ' TYR . 75.5 m -63.17 -40.5 97.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.419 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -61.98 -45.91 91.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.044 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.5 mt -70.88 -46.08 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -59.59 -51.61 69.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 274' ' ' SER . 16.3 m-85 -60.43 -31.87 70.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -59.43 -33.26 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.407 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.19 23.07 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.868 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -139.16 37.91 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.489 HD11 ' CB ' ' A' ' 303' ' ' MET . 7.0 mm -47.09 -43.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -47.74 36.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.073 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.7 -33.61 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 tt -64.33 -43.63 94.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 3.5 mmt -65.48 -32.52 74.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.984 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.75 -27.03 31.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.139 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -54.84 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.34 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 68.2 m -76.42 -41.22 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.52 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.84 158.71 34.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 177.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.612 2.208 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -108.01 -66.24 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -59.69 -35.12 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -60.27 143.52 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -63.8 148.86 94.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.11 158.83 55.23 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -94.2 20.84 45.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.568 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.35 9.2 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.526 0.203 . . . . 0.0 111.402 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 34.2 mm -79.52 -40.76 21.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.77 32.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.312 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -59.85 -39.77 86.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.63 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 306' ' ' VAL . 70.4 t80 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.489 ' CB ' HD11 ' A' ' 282' ' ' ILE . 1.4 mtp -64.73 -45.72 85.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.595 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.13 -51.89 67.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.846 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.7 p -58.07 -53.59 56.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 302' ' ' TYR . 61.1 t -56.32 -24.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.154 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -43.1 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.78 -11.98 60.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.689 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--O 1.232 0.148 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.222 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.784 0.244 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.8 tp -140.13 17.64 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -60.07 -31.63 70.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.75 -46.48 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.779 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.49 -40.2 90.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.421 HD23 ' CE1' ' A' ' 302' ' ' TYR . 34.6 mt -55.55 -48.15 75.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 7.7 ttm105 -57.46 -34.56 69.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -38.52 71.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.5 mt -57.07 -47.91 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -79.78 -22.0 43.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.462 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.68 -40.49 20.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.688 0.28 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.92 -39.42 90.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.94 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -60.32 -26.34 63.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.5 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.413 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 69.9 mt -48.44 -27.99 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -81.28 -31.08 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.73 -26.35 65.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.297 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.97 22.75 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.455 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 53.25 45.69 64.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.738 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.7 t -118.33 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.57 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.959 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.79 133.85 51.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.67 127.1 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.98 22.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -58.87 139.84 56.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.421 HG22 HD13 ' A' ' 28' ' ' ILE . 21.7 mm -100.34 136.39 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.2 pt -117.89 154.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.088 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 3.1 t -101.81 136.94 40.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -93.77 -164.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -41.37 43.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -75.25 -6.63 50.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.429 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 4.2 tttp 89.59 27.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.6 OUTLIER -75.16 178.36 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.154 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.63 79.6 1.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.39 . . . . 0.0 110.591 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' HB2' HG13 ' A' ' 29' ' ' ILE . 80.5 m95 -76.51 136.73 39.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.952 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.88 129.14 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.95 128.54 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.7 -122.58 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.57 154.42 37.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 61.4 Cg_endo -73.1 105.49 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.615 2.21 . . . . 0.0 112.362 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -98.54 -28.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.558 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -111.83 137.53 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 44.2 m-85 -143.74 172.22 13.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.804 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.65 158.26 35.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.45 152.37 43.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.48 156.79 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.4 ptp -97.47 26.42 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.29 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 p -134.45 35.74 3.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.6 30.91 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -131.26 179.07 6.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -99.13 29.89 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t 68.3 -68.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.51 179.03 21.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.559 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -92.54 48.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.38 -69.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.27 139.32 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.93 -4.74 13.51 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.667 2.245 . . . . 0.0 112.816 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 11.8 m -149.65 157.11 42.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.27 144.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.39 121.11 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -98.07 116.19 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.07 139.32 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.309 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 136.52 15.96 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.686 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.51 96.6 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.389 2.059 . . . . 0.0 112.317 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 t 179.63 177.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.24 -42.58 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.12 95.28 2.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.05 -147.98 5.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.488 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.16 -23.09 39.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.528 2.152 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.1 -33.2 71.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.915 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -42.14 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.8 p -70.88 -30.15 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -75.02 -42.31 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.2 -51.49 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -59.54 -46.21 89.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 198' ' ' TYR . 12.2 t80 -54.67 -50.68 67.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 24.7 m-85 -59.81 -41.48 91.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.415 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -79.95 -17.79 52.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -47.41 69.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.486 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 171' ' ' HIS . . . -145.03 -32.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -53.86 -21.8 8.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -51.34 125.26 25.53 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 -25.4 15.34 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.491 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.4 -44.01 92.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.131 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.28 -43.13 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.282 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 mt -58.42 -48.34 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -52.28 -39.53 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.043 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.33 -29.2 59.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -76.62 -43.98 36.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mt -65.85 -37.47 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.023 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.8 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -82.02 -36.99 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.433 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.71 -2.5 24.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.4 mttm 59.51 31.34 20.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -49.39 -30.88 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.68 -55.6 0.51 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.026 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CD1' ' OE1' ' A' ' 192' ' ' GLN . 6.8 t80 -150.68 139.8 21.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.979 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.72 162.19 19.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.61 19.14 42.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.97 125.25 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 149.13 37.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.369 2.046 . . . . 0.0 112.262 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.4 115.88 25.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -86.9 129.61 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.721 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.7 m95 -107.58 -40.91 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.77 -174.66 46.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.1 p -132.86 169.0 17.39 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -158.96 175.84 35.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.977 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.83 150.83 36.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -141.17 141.61 34.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.61 136.07 54.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -138.27 126.27 22.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.29 18.59 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.322 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 10.39 54.72 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.861 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -96.21 159.37 14.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 110.711 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.5 m -111.34 123.11 49.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 124' ' ' LYS . 12.9 m-85 -122.12 136.5 54.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.793 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -117.95 125.12 49.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.806 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.437 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 29.5 p90 -133.16 165.84 23.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.417 ' HE1' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -134.65 144.77 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.53 111.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.2 173.06 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.141 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.35 127.69 32.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -55.65 176.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 184' ' ' LEU . 54.9 m-85 -147.42 175.82 10.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.663 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.21 -81.67 1.6 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.461 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.6 t -149.58 130.51 14.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.837 0.351 . . . . 0.0 110.582 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.16 165.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.713 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 138' ' ' LEU . 2.8 mt -77.34 -14.07 59.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -33.25 29.86 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.05 0.453 . . . . 0.0 109.932 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -75.83 -31.3 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.824 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.427 ' CG2' ' CE1' ' A' ' 149' ' ' PHE . 12.2 mt -68.93 -26.74 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.412 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 24.1 t80 -71.17 -43.92 66.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -29.9 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.4 67.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.219 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.32 21.03 9.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.039 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 79.41 47.92 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 10.2 tttt 64.7 18.2 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.25 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 13.7 mtp85 -138.01 -170.67 2.84 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.002 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE1' ' CG2' ' A' ' 141' ' ' ILE . 0.2 OUTLIER -137.55 -166.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.675 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 m -129.35 151.7 49.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -62.22 -30.7 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -30.99 62.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -51.24 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CG ' ' A' ' 251' ' ' MET . 21.9 t -60.33 -48.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.58 -43.87 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.727 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -68.47 -54.5 16.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.19 -42.47 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -55.58 -42.47 74.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.418 ' CD1' ' HG ' ' A' ' 325' ' ' LEU . 10.8 mt -60.02 -49.72 76.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.589 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 21.4 mmt-85 -60.72 -42.0 96.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.19 -36.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.0 mt -60.23 -39.71 87.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.535 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -34.61 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.7 mt -74.54 -42.87 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.34 -32.24 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -73.66 -32.79 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.578 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -70.91 -49.89 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -63.23 -27.71 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.423 ' CD2' HG13 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -72.8 -40.47 65.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 -14.77 62.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 57.5 m-70 -101.42 2.86 39.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.152 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 76.34 43.37 0.15 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 111.0 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.99 129.08 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 169' ' ' HIS . 28.9 m -142.2 169.44 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.1 m170 65.23 48.83 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.39 -10.86 54.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.897 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 76.08 69.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.984 0.421 . . . . 0.0 111.026 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.4 mp -73.97 98.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -144.38 -179.55 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.936 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.32 -0.61 46.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.436 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.29 -3.38 18.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 110.833 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -126.16 -2.15 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 193' ' ' VAL . 9.4 mt -108.36 113.56 26.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.997 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 134' ' ' PHE . 1.0 OUTLIER -122.82 144.71 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.45 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 193' ' ' VAL . 1.3 mt -90.48 149.0 22.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.349 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 9.9 m-20 -67.89 126.18 28.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -86.9 -60.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.406 ' HB2' ' NH1' ' A' ' 133' ' ' ARG . 10.4 mmtt -63.79 -30.83 71.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -130.34 71.71 82.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.2 97.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.551 2.167 . . . . 0.0 112.057 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.19 -53.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 107' ' ' TYR . 1.4 mt-30 -150.86 -177.42 5.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -110.0 141.28 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.681 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.449 ' N ' HG23 ' A' ' 193' ' ' VAL . 3.3 m-85 -106.97 153.8 22.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.125 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.6 tp -105.99 116.14 31.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 m -88.57 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 198' ' ' TYR . 1.2 t70 63.76 129.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 30.1 m-85 -162.56 -44.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -55.89 -25.81 46.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.704 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.07 33.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 111.096 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.59 -110.29 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.19 119.38 8.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.809 0.337 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.66 49.49 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.417 ' CE2' ' NH2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.2 p -154.39 -46.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.409 HG12 HG11 ' A' ' 271' ' ' VAL . 1.2 tt -174.56 36.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 265' ' ' LEU . 7.5 pt-20 -95.99 62.85 2.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 12.6 t80 70.98 31.97 2.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 41.7 p -100.15 179.75 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 160.16 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.29 -40.29 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -78.13 -28.65 48.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.18 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -58.07 -39.79 79.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -97.02 -5.63 37.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 83.58 -2.7 86.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.718 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.23 157.77 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.807 0.336 . . . . 0.0 111.167 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -164.99 78.33 1.34 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.45 10.66 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.73 2.287 . . . . 0.0 112.878 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.0 p -153.61 163.24 40.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.417 ' NH2' ' CE2' ' A' ' 204' ' ' TYR . 0.0 OUTLIER -113.88 -11.83 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.94 -13.48 61.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.315 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.36 -25.93 55.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.607 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -31.86 62.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.977 0.418 . . . . 0.0 110.838 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.58 -30.45 36.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.39 -32.56 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 29.3 mt -69.59 -37.55 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.186 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 40.7 tp -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.83 -41.75 94.23 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.34 -29.03 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -37.18 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.404 ' CG ' HG12 ' A' ' 154' ' ' VAL . 1.8 mtt -68.35 -39.7 81.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 7.4 mm -62.25 -39.32 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -80.27 -34.97 36.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -76.41 -48.12 20.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.414 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.46 -36.21 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.55 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.39 -13.92 22.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.573 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.55 94.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.261 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.0 146.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 110.653 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.467 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.91 166.15 29.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.212 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.01 62.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.953 2.435 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.467 ' CH2' ' CD2' ' A' ' 259' ' ' LEU . 0.7 OUTLIER -178.54 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.448 ' HB2' ' CD1' ' A' ' 261' ' ' TRP . 1.8 tt0 -108.94 18.22 20.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.069 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -66.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.82 -27.34 3.07 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.428 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 226' ' ' GLU . 19.8 mt 77.18 7.94 2.91 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -16.42 61.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.468 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 33.4 t70 -145.06 91.19 5.99 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.71 -7.28 17.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.685 2.256 . . . . 0.0 112.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.84 -50.11 69.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 110.965 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 5.5 p90 -83.88 -26.22 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 25.9 t -60.38 -40.85 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -48.67 23.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.975 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -61.6 -35.16 77.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.071 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 m -72.09 -33.7 68.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -70.2 -49.73 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.046 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.4 mm -61.15 -36.59 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -75.54 -52.12 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -55.4 -35.09 64.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -29.69 65.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 22.68 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.94 43.57 2.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 18.7 mt -55.48 -37.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.18 64.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 5.4 t -71.12 -42.79 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 282' ' ' ILE . 1.5 pp -65.23 -31.46 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.79 0.329 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mmt -66.81 -49.36 66.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -68.68 -31.4 70.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.247 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -53.76 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.102 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.0 m -66.15 -41.16 90.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.155 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.0 146.19 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 -166.86 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.51 45.28 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -45.73 19.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -149.87 167.15 27.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -86.78 156.57 55.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.86 118.41 5.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.593 2.195 . . . . 0.0 112.192 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -157.69 -49.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.67 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 303' ' ' MET . 19.0 mm -79.43 -41.69 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.227 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.57 -42.36 7.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.869 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -67.23 -38.71 85.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 110.58 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 11.0 t80 -70.5 -44.52 67.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 47.2 mmm -68.73 -31.93 71.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.84 -43.07 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.328 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 5.5 p -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 79.5 t -79.45 -24.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -36.68 23.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.738 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.1 -27.89 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.54 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.124 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.871 0.28 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.06 29.23 3.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 166' ' ' GLU . 4.1 m-85 -66.53 -29.7 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -40.53 67.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -42.76 48.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 39.3 mt -58.27 -41.38 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -57.28 -47.36 81.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -39.13 80.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.37 -46.42 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.055 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.99 -50.36 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -53.73 -49.89 67.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -56.29 -42.35 77.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.995 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.94 -29.71 65.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.75 -35.02 79.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.2 66.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.247 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.49 32.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.1 70.14 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.85 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.61 101.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 39.23 3.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.44 70.1 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.812 0.339 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.0 t -129.44 117.36 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.71 30.0 27.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -132.54 139.1 47.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.734 0.302 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 35.2 mt -103.71 140.09 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 128' ' ' PHE . 30.7 pt -119.86 154.55 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.6 p -95.65 136.92 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB3' ' CD1' ' A' ' 37' ' ' TRP . 21.7 p-10 -94.54 -148.29 0.27 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.985 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -85.67 -37.91 18.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.242 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.39 2.34 32.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.856 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.2 mmpt? 83.08 15.47 0.34 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -63.15 169.89 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 76.13 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.018 0.437 . . . . 0.0 110.619 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 31' ' ' ASP . 44.5 m95 -67.11 142.67 57.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.787 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -105.46 132.66 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.931 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.8 130.02 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.56 -106.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.858 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 2.3 mt -121.99 162.25 38.18 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 38.4 Cg_endo -66.78 140.38 55.58 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.666 2.244 . . . . 0.0 112.29 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.5 pt -142.57 30.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.686 0.279 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.7 mm -135.63 127.4 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 14.2 m-85 -146.43 145.8 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -71.82 136.55 47.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.352 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.55 157.22 23.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.507 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 145.99 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.673 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ptm -98.2 40.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.8 t30 58.72 35.86 24.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -65.8 -67.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.43 -170.14 1.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -76.65 -38.82 53.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.85 131.84 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.32 -29.1 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.094 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.88 65.41 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -179.25 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 110.767 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 76.07 1.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.94 89.95 21.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.88 42.36 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.871 2.381 . . . . 0.0 112.807 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.71 157.13 42.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.754 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.05 144.9 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.444 ' HB ' HG13 ' A' ' 130' ' ' ILE . 11.2 p -127.41 129.82 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.316 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -94.7 117.48 30.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.199 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.2 125.31 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 111.55 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -141.16 146.98 45.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 114.89 3.85 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -60.2 124.16 19.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.12 -73.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -79.36 -32.79 43.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.14 48.42 3.57 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.783 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 38.5 Cg_endo -67.7 -51.36 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.266 1.977 . . . . 0.0 111.643 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.93 -21.44 51.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.821 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.78 -33.9 50.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.441 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 t -74.68 -35.36 62.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.817 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -73.1 -35.29 66.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.67 -36.2 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -63.97 -47.98 78.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HB2' ' CE1' ' A' ' 173' ' ' TYR . 10.2 t80 -72.0 -35.7 69.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.85 -50.47 72.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -74.98 -17.47 60.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.44 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -47.73 14.64 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.36 -19.64 4.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.61 21.4 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 113.25 35.08 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.57 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.76 -29.55 3.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 0.0 112.749 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -71.93 -39.38 69.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.83 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -67.53 -49.78 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -29.66 61.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -38.16 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -71.14 -42.69 68.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.025 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' LYS . 60.6 mt -69.68 -36.43 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.84 60.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 p -84.37 -30.28 25.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.342 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -4.16 17.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 100' ' ' ILE . 3.0 mtmp? 56.59 30.91 18.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.531 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.7 mt -45.56 -84.65 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.16 -62.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.755 0.312 . . . . 0.0 110.984 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -169.13 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tp 75.34 146.44 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . -86.76 10.23 68.56 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.995 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.97 115.45 44.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.783 0.291 . . . . 0.0 110.939 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 141.07 8.42 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.484 2.123 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 122.26 26.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.42 131.36 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.4 -40.99 3.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.618 0.247 . . . . 0.0 111.551 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.75 171.64 38.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.804 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.66 164.48 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.603 0.239 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -162.01 179.75 37.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.979 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.45 159.68 42.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.715 0.293 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -144.53 141.65 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.957 0.408 . . . . 0.0 111.108 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.41 129.24 54.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 126.35 22.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.921 0.391 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 55.47 20.9 3.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.72 -0.18 64.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.85 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -96.23 151.15 19.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.759 0.314 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.6 p -101.26 127.33 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.203 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -113.57 147.9 37.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.34 125.17 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.77 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 20.7 p90 -135.29 162.45 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -144.94 140.26 28.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.026 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.444 HG13 ' HB ' ' A' ' 70' ' ' VAL . 2.7 mp -99.11 129.82 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -133.31 173.06 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -55.75 138.19 48.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 170.46 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -145.73 157.5 43.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.98 -74.69 1.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.5 p -148.53 135.1 19.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.82 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -57.31 152.48 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.24 -23.19 46.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.75 -38.56 91.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.154 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -36.48 81.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -73.85 -25.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.714 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 254' ' ' TRP . 13.1 t80 -76.42 -51.89 10.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.32 -29.99 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.58 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.45 63.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.21 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -96.16 19.77 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.002 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 80.97 48.01 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt 63.37 19.19 11.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.302 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.413 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 20.7 mtp180 -131.91 -178.58 4.95 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -139.06 -167.81 2.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.688 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.08 144.46 47.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.45 -31.27 63.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -74.93 -43.91 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.416 HG21 ' CE1' ' A' ' 149' ' ' PHE . 58.6 m -58.45 -51.82 68.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.22 -46.0 88.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.3 -48.29 73.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -41.97 95.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.32 -38.98 75.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -59.43 -34.55 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.8 -46.77 62.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.466 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -61.32 -44.72 96.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.85 -42.18 94.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.698 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.52 -35.93 66.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -36.93 79.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.603 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.54 -38.71 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.17 -48.22 80.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.821 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -31.09 72.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -72.2 -47.91 47.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.829 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.47 -27.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.6 -33.43 58.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.357 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -15.86 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -102.39 3.11 37.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.867 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 74.17 45.24 0.21 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.891 0.377 . . . . 0.0 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -133.08 124.9 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.416 HG13 ' CE1' ' A' ' 204' ' ' TYR . 28.3 m -132.2 165.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.067 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.37 -51.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.237 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.09 24.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.605 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.67 -80.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.584 0.23 . . . . 0.0 110.795 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.0 mt 44.57 95.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.99 174.84 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -77.09 -1.0 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.8 t -111.97 1.94 16.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 0.0 110.551 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -123.4 -12.07 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.194 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 4.5 mt -108.36 125.19 51.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.908 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.86 156.55 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 111.351 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.31 149.84 22.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.05 129.68 40.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.942 0.401 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -73.07 -60.21 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -61.01 -20.84 62.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.534 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -136.52 78.23 44.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.54 80.46 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.534 2.156 . . . . 0.0 112.14 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.36 37.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.06 143.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 183' ' ' LEU . 4.0 p -109.95 147.99 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.162 0.506 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 8.4 m-85 -126.12 156.89 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.652 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.42 HD22 ' CE1' ' A' ' 198' ' ' TYR . 39.5 tp -104.01 115.9 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.659 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.76 142.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.1 t70 55.77 84.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.42 ' CE1' HD22 ' A' ' 195' ' ' LEU . 3.5 m-30 -59.05 -21.05 58.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.119 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.49 9.06 68.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.758 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.61 -58.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.734 0.302 . . . . 0.0 110.818 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 43.93 76.24 0.09 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -116.72 148.97 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -103.1 69.71 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.416 ' CE1' HG13 ' A' ' 174' ' ' VAL . 17.0 p90 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 -67.22 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -159.19 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 271' ' ' VAL . 5.4 mm-40 -159.48 26.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 227' ' ' PHE . 37.7 t80 -95.07 24.32 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.622 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -76.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.993 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.7 t -157.86 163.51 37.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.908 0.385 . . . . 0.0 110.952 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.39 -30.51 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -64.29 -39.47 93.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -67.49 -29.64 69.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.72 -25.48 61.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -88.92 12.87 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.475 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.98 28.13 72.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.642 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 129.29 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.691 0.282 . . . . 0.0 111.027 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.413 ' CB ' ' HD3' ' A' ' 238' ' ' PRO . . . -76.98 -54.29 1.6 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 52.0 Cg_exo -54.39 88.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.449 2.099 . . . . 0.0 112.194 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.19 80.77 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -101.8 -24.81 14.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -17.76 41.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.236 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -61.63 -30.31 74.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.78 -36.79 58.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 110.972 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.74 -35.0 33.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -57.3 -43.71 83.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.9 -42.1 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.1 -30.85 70.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.814 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.36 67.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.366 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.416 ' CZ ' ' HE2' ' A' ' 275' ' ' LYS . 34.5 m-85 -78.55 -26.17 45.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.297 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.283 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -51.07 65.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.6 mt -63.73 -33.53 62.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.02 -33.74 38.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 30.8 m0 -82.28 -48.74 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.415 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -70.93 -36.82 72.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.598 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.14 0.53 51.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.772 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 57.75 94.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.519 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 45.8 m80 63.52 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.468 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -132.97 168.52 17.53 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 59.2 Cg_endo -72.61 60.0 3.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.527 2.151 . . . . 0.0 112.534 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 1.3 p90 178.15 -39.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.9 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -107.45 20.35 19.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.47 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.22 -62.29 1.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.2 t-20 -128.57 -26.46 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.283 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 27.9 mt 75.53 10.2 3.5 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.08 0.466 . . . . 0.0 109.756 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -80.91 -16.45 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.11 81.81 37.69 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.89 -14.77 29.11 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.791 2.328 . . . . 0.0 112.534 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.85 -50.45 45.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.254 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 6.0 p90 -84.04 -26.85 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.767 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 39.5 t -60.62 -39.02 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.229 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -73.1 -45.28 58.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.94 -42.73 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.6 t -60.74 -46.17 91.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -58.75 -51.61 69.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 14.0 mt -53.12 -37.66 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.534 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.02 7.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.328 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 285' ' ' LEU . 9.8 m-85 -57.91 -36.98 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.62 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 0.0 110.695 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.35 28.12 7.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.403 ' HB3' ' CB ' ' A' ' 284' ' ' SER . 4.1 m120 -136.13 45.1 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 282' ' ' ILE . 18.8 mt -50.43 -36.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.238 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 281' ' ' ASN . 0.3 OUTLIER -78.92 -42.25 27.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.96 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 278' ' ' TYR . 3.0 pp -68.7 -28.47 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.743 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.66 -51.62 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -24.82 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.336 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -48.3 11.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 111.179 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.8 m -83.16 -41.25 18.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -104.18 153.45 38.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 -170.0 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.562 2.175 . . . . 0.0 112.349 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.05 -43.69 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.13 94.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.08 69.52 0.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 96.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.24 -34.42 21.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.261 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.83 78.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.935 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -57.1 14.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 27.1 mm -69.04 -35.31 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -52.21 -46.09 65.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -61.24 -37.47 83.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 324' ' ' LEU . 46.4 t80 -71.3 -36.17 71.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.428 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 0.6 OUTLIER -69.67 -38.06 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.587 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.53 -49.4 76.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.604 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.39 -39.69 84.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.712 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.417 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 22.5 t -73.82 -24.37 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.261 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -79.67 -43.16 23.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.32 -14.4 61.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 6.7 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.853 0.272 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 24.8 mt -108.95 31.41 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -61.64 -31.45 71.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -38.79 92.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -76.62 -44.33 34.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 84.4 mt -54.67 -42.18 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.54 -33.32 69.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.44 -32.84 58.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -61.16 -46.96 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.421 HD13 ' CE2' ' A' ' 302' ' ' TYR . 41.0 mt -81.17 -23.81 37.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.384 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.53 -44.39 15.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.184 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.85 -29.11 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -75.36 -26.45 65.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.746 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -51.65 -35.22 41.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -29.95 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.27 -30.58 71.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 14.5 pt -97.97 28.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.265 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.35 91.71 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.614 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 m -137.5 164.85 27.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -154.61 154.12 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.54 91.0 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t 64.56 110.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.239 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.13 -21.65 42.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.896 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -95.18 147.48 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.09 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mt -113.88 142.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 128' ' ' PHE . 24.9 pt -118.34 154.41 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.419 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 9.4 p -95.88 141.55 29.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.922 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -161.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.18 -39.91 24.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -78.8 -2.82 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.654 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 1.6 tttt 88.51 29.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 30' ' ' THR . 7.2 tttp -77.13 176.41 8.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.365 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 79.07 1.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.442 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 130' ' ' ILE . 44.0 m95 -74.53 134.75 42.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.09 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -102.42 127.02 49.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -77.7 117.64 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.23 -105.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.53 159.42 52.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.05 151.97 67.62 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.174 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -145.68 30.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.167 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.544 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 7.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.74 113.51 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 9.3 m-85 -135.93 172.29 13.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -78.11 158.78 28.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.04 137.96 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.201 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -143.38 157.77 44.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.41 ' HE3' ' CZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -96.82 46.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -82.81 128.52 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 p -115.86 -39.04 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -93.03 -66.71 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.29 173.06 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.27 144.79 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.45 155.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.62 82.88 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.473 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.2 30.67 20.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.12 31.38 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.61 48.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.07 45.69 1.95 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.572 2.181 . . . . 0.0 112.713 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.8 148.21 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.46 144.89 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.45 119.94 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 118.15 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.398 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.1 135.78 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.336 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.2 143.37 30.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.674 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.58 117.61 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.421 2.08 . . . . 0.0 112.307 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -71.58 109.78 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -157.32 -75.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -76.39 -27.65 56.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.33 46.12 4.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.878 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 43.6 Cg_endo -70.14 -53.19 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.234 1.956 . . . . 0.0 111.651 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 tp -71.37 -23.92 61.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.71 -29.2 62.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.68 -39.69 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.86 -32.51 74.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.28 -45.61 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.669 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -57.49 -40.07 77.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CG ' ' HB1' ' A' ' 201' ' ' ALA . 64.3 t80 -72.16 -36.88 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -70.6 -41.19 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.32 -35.95 81.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.17 14.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.797 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.64 -49.58 4.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.61 2.82 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -55.93 121.14 38.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.52 0.2 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.27 -26.94 21.65 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.36 2.04 . . . . 0.0 112.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -79.34 -43.61 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -51.63 51.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.022 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.3 mt -57.12 -52.42 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.134 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.76 -31.96 7.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.97 -46.45 29.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.4 mm -56.04 -37.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -74.99 -27.76 60.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.1 m -74.61 -38.78 62.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.442 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -107.27 -3.5 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 55.44 24.88 7.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.0 mt -52.22 -39.55 60.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt 50.54 41.21 25.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.52 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -177.38 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 167' ' ' TYR . 13.6 tp 60.87 155.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.622 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 164' ' ' ILE . . . -83.87 -3.81 89.07 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.1 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.98 114.3 40.7 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.685 0.242 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.64 151.87 4.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.391 2.061 . . . . 0.0 112.371 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.3 115.49 19.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -92.9 126.03 37.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.0 m95 -103.45 -40.82 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.76 -178.29 45.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.558 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -135.57 159.47 41.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -145.45 -177.78 20.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.931 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 159.84 41.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -136.47 137.5 40.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -118.05 125.54 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 126.14 22.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.09 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.38 21.33 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.491 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.3 57.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.985 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -96.2 159.41 14.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.5 m -114.51 124.09 51.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.0 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.27 140.41 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -121.54 127.94 51.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.598 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 23.5 p90 -140.2 161.09 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.251 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ttm -128.05 142.36 51.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.37 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.419 HD13 ' CE3' ' A' ' 37' ' ' TRP . 19.5 mt -118.62 111.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.413 . . . . 0.0 111.336 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -125.46 173.27 9.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.34 132.5 20.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.99 143.16 55.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 42.6 m-85 -111.34 179.91 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.76 -98.63 2.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.553 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.6 p -125.85 128.18 47.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 11.9 p30 -56.25 164.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -69.16 -21.36 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.549 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -35.04 44.11 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.901 0.382 . . . . 0.0 110.429 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -77.83 -25.58 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.356 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.42 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 44.6 mt -73.94 -27.52 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.975 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -57.15 -45.65 83.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.695 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -27.99 60.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.31 -26.2 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 3.2 m-80 -92.79 5.64 50.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.332 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 90.11 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.128 0.49 . . . . 0.0 110.671 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.07 16.33 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.722 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -161.39 116.35 2.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 1.8 m-85 -57.34 174.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -106.8 158.44 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -32.45 69.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -71.68 -47.78 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -58.28 -55.19 38.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.315 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -54.91 -52.69 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.392 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 52.5 mt -56.52 -46.85 80.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.272 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -52.03 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.8 -44.25 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.2 p -54.66 -45.02 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.733 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.05 -43.75 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.358 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -44.51 97.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.477 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.91 -33.48 63.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.676 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.9 -38.63 86.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.537 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -32.91 71.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.332 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 109' ' ' GLY . 18.7 mt -78.21 -35.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.376 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 15.9 mt -58.15 -48.17 81.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.577 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -31.68 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.431 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 85.1 t80 -64.1 -42.97 96.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.487 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 36.0 pt -81.13 -27.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.243 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.41 -29.57 57.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.81 -17.03 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.423 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -106.87 8.45 30.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.688 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 68.88 49.16 0.69 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.27 138.85 46.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.405 HG12 ' CD1' ' A' ' 204' ' ' TYR . 14.4 m -130.68 169.31 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.487 ' CD2' ' CD1' ' A' ' 168' ' ' ILE . 1.5 p80 -154.11 -44.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 111.279 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.31 52.79 49.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.625 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.42 -85.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.59 0.233 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 mt 45.99 91.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -147.11 170.96 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.821 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.36 -1.99 29.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.647 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.19 -0.99 17.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.426 . . . . 0.0 110.435 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -121.5 -8.31 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.351 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.44 ' HB3' HG22 ' A' ' 193' ' ' VAL . 8.5 mt -108.43 115.34 29.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.279 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -122.11 146.43 47.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.211 -178.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 193' ' ' VAL . 31.0 mt -86.39 148.9 25.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.18 124.42 23.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.88 -53.82 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -59.66 -30.14 68.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -143.39 79.14 14.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.641 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.72 108.23 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.634 2.222 . . . . 0.0 112.224 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -56.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -167.74 2.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -110.02 147.39 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 32.1 m-85 -113.22 156.89 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.139 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 175' ' ' HIS . 43.0 tp -104.05 115.83 31.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 m -122.17 165.83 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.51 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.658 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -98.59 -50.66 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 90.64 -47.52 3.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.135 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.04 34.87 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.489 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.438 ' HB1' ' CG ' ' A' ' 86' ' ' PHE . . . -77.93 59.65 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -137.06 149.09 47.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.025 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -59.82 101.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.405 ' CD1' HG12 ' A' ' 174' ' ' VAL . 42.1 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.11 176.81 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.466 ' O ' HG12 ' A' ' 225' ' ' ILE . 16.9 tt -93.14 13.83 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -92.46 25.03 3.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.798 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 226' ' ' GLU . 0.4 OUTLIER 174.94 -28.15 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 16.7 p -81.15 161.72 23.94 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -167.84 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 30.2 mt -73.75 -55.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.3 -31.18 65.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.86 -28.38 61.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -61.56 -51.44 68.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -91.74 12.92 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.421 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.21 15.35 58.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.818 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.5 t -64.38 141.48 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.22 162.64 0.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 -164.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 12.2 p -139.56 104.16 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -158.0 -53.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -28.2 61.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.4 -33.64 66.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -56.56 -30.42 63.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.64 -36.56 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.89 -35.3 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 12.0 mt -62.87 -41.52 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.19 -50.61 67.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.81 -27.95 51.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.458 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.93 -33.19 45.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 0.0 110.79 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.414 ' HB3' ' CE3' ' A' ' 254' ' ' TRP . 69.2 m -53.15 -51.63 61.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.046 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -30.58 64.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.624 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 252' ' ' ILE . 20.8 mm -69.18 -44.24 80.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.994 0.426 . . . . 0.0 110.737 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.03 -27.18 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.108 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 2.9 m0 -81.59 -54.38 5.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.38 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 43.9 mt -70.32 -35.13 73.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.528 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.4 ' OG1' ' CE1' ' A' ' 290' ' ' PHE . 0.3 OUTLIER -96.25 -13.92 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.538 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.9 97.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.184 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.0 141.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.654 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.477 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -116.64 159.25 41.12 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 14.3 Cg_exo -69.04 59.49 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.839 2.359 . . . . 0.0 112.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 3.3 p90 179.13 -38.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.241 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.409 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.1 tt0 -95.99 24.67 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.076 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.59 -57.39 3.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.816 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -125.95 -29.96 3.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 73.49 11.67 4.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -15.61 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.449 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 1.8 m-20 -132.94 103.96 12.88 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.5 17.4 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.722 2.282 . . . . 0.0 112.826 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -79.99 -50.1 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -77.42 -26.04 51.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 5.2 t -60.69 -45.75 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -47.69 25.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -39.16 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -72.74 -39.63 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -49.91 75.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 5.1 mt -63.97 -44.65 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -52.04 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.8 m-85 -59.03 -33.94 71.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -59.18 -31.14 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 23.65 11.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -147.79 45.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 18.5 mt -54.84 -41.24 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.08 67.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -41.52 61.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 1.0 OUTLIER -70.77 -38.33 73.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.5 ttm -67.53 -33.09 74.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -75.56 -37.69 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.44 25.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.043 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.38 -34.39 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.004 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 8.9 m-85 -127.9 79.91 72.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.969 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 111.4 3.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.554 2.169 . . . . 0.0 112.359 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -128.54 -46.37 1.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -173.84 -62.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -177.01 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.13 127.88 59.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.12 -168.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.77 -89.91 1.5 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.428 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -125.6 -39.97 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 111.037 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 303' ' ' MET . 35.3 mm -54.87 -41.43 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.4 -30.57 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.5 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.25 -42.26 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 11.3 t80 -67.57 -37.72 83.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 62.9 mmm -71.77 -30.0 65.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.96 -50.34 68.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -41.65 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 27.8 t -69.93 -24.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.106 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -80.43 -29.94 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.64 -11.91 20.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.584 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.292 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.17 -23.87 19.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -53.92 -30.28 45.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.97 -36.58 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.9 -37.3 67.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 55.5 mt -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -59.34 -46.62 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -40.71 82.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 18.6 mt -58.06 -46.81 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.68 -51.63 15.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.28 -49.87 68.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.32 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -58.78 -39.97 82.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.001 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.12 -31.93 70.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.585 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 15.5 mt -63.02 -41.73 99.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.55 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.75 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.0 pt -101.45 27.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.188 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.04 28.08 52.81 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.583 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 18.1 t -102.33 156.79 17.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -174.61 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.67 100.42 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 64.75 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.495 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.43 -25.44 22.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.975 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -83.39 136.13 34.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.196 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 mm -100.42 144.27 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -119.76 151.3 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -95.81 141.4 29.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.806 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.08 -163.53 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.099 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -41.0 35.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 109.792 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -76.69 -5.01 46.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.531 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 89.65 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.9 mttp -77.21 -177.66 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.207 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -132.76 81.78 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 110.697 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -75.26 136.93 40.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.932 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -94.1 118.68 31.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -72.73 144.17 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.91 -117.42 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.787 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.1 mt -113.27 164.61 15.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 111.021 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 33.9 Cg_endo -64.6 141.86 74.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.598 2.199 . . . . 0.0 112.251 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 pt -153.76 79.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.565 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.647 0.26 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.59 130.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -146.46 150.15 35.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.75 158.8 35.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.342 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.39 50.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.0 111.38 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -149.14 132.0 16.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.9 mtp -83.62 57.01 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.95 -177.67 5.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.0 p -175.65 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.4 p -79.28 -66.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.21 -69.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -161.21 160.38 29.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.58 139.95 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.061 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.89 -123.61 4.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.35 31.05 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.86 42.04 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.16 92.34 10.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.14 49.97 3.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.633 2.222 . . . . 0.0 112.753 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 59.6 m -149.86 148.19 28.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.51 144.96 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG11 ' O ' ' A' ' 70' ' ' VAL . 3.8 p -132.17 122.39 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.878 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -96.95 116.33 29.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.682 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.3 t -113.13 133.8 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.39 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.17 150.65 59.41 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.728 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.07 101.21 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.277 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 m 60.36 173.43 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.04 151.41 43.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.31 -55.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.58 0.22 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.07 -36.09 64.32 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.352 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.17 -39.83 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.63 -40.44 91.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.8 p -68.64 -31.8 71.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 38.3 tt0 -73.82 -47.66 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.46 -48.08 81.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -45.03 92.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.443 ' CE2' ' CB ' ' A' ' 90' ' ' ALA . 16.7 t80 -71.91 -44.74 63.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 83' ' ' GLU . 4.3 m-85 -57.07 -29.8 63.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.493 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -80.0 -45.57 18.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.074 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -87.39 -47.62 8.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 86' ' ' PHE . . . -81.34 -46.47 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.782 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.71 33.17 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.593 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -72.03 123.73 89.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.605 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.58 -25.34 79.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.398 2.065 . . . . 0.0 112.249 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.39 -36.01 39.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.6 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.2 mt -56.7 -56.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.304 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -37.95 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -74.47 -43.84 54.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.32 -51.91 65.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.31 -37.1 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -27.65 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 64.6 m -83.48 -30.92 26.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.23 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -105.95 -4.36 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.43 28.42 15.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.6 mt -48.93 -39.41 26.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.213 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER 75.41 -1.75 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.62 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 75.6 t80 174.19 162.46 0.19 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 110.461 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.412 ' N ' ' CG ' ' A' ' 107' ' ' TYR . 11.7 tp -147.42 -66.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 130.65 -14.65 5.52 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.7 126.86 88.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.612 0.206 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.49 148.23 20.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.483 2.122 . . . . 0.0 112.193 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 115.57 22.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.046 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 39.1 t80 -97.48 125.05 41.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -100.82 -40.7 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.86 -176.53 46.36 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.625 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -134.88 154.53 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -137.67 171.07 23.42 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.84 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mt -142.39 157.25 44.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.702 0.287 . . . . 0.0 110.623 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -145.96 141.56 27.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -115.92 125.33 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 126.27 22.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 60.44 17.05 6.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.51 -6.35 59.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.872 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -96.17 129.57 43.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.9 t -92.38 130.94 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.03 151.48 29.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.93 125.65 35.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.452 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 31.0 p90 -133.56 163.76 28.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.1 ttm -127.98 140.74 51.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -120.77 111.69 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.44 . . . . 0.0 111.549 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -123.42 173.43 8.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.718 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.85 138.28 48.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.025 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.421 ' HD3' ' CG ' ' A' ' 187' ' ' TYR . 52.1 ttt180 -68.89 154.6 41.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -119.32 161.84 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.2 -73.91 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 m -146.56 138.25 24.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.01 152.45 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -70.95 -41.73 70.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -65.55 -26.96 68.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.83 -29.77 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 46.8 t80 -54.24 -47.66 71.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.835 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.05 -25.57 68.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.715 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.73 -19.25 59.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 4.1 m-80 -91.0 5.59 48.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.233 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 90.55 43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.268 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.6 tttt 62.04 18.7 10.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 1.4 ptt85 -165.49 126.21 1.88 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.3 158.53 30.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.07 160.51 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -28.9 68.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 45.5 p -68.01 -44.07 77.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.87 -54.03 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.291 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 74.5 mt -61.78 -45.3 94.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -58.58 -44.0 89.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.33 -37.17 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.795 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.6 m -58.25 -41.41 84.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.422 ' CD1' ' HG ' ' A' ' 325' ' ' LEU . 12.7 mt -70.71 -43.79 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.77 88.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.3 mt -71.29 -33.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.56 -40.21 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.46 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -36.29 80.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.0 mt -73.65 -40.24 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 mt -56.22 -33.06 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.69 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 -29.34 59.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.408 ' CD2' HD22 ' A' ' 108' ' ' LEU . 81.3 t80 -72.02 -52.51 16.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 48.4 pt -64.75 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -40.16 88.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.326 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.02 -12.31 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.75 4.49 25.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.943 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 66.17 46.92 1.97 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.875 0.369 . . . . 0.0 110.706 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -135.34 120.11 18.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.58 169.08 16.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.008 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 12.6 p-80 -149.82 -52.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.95 37.52 83.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.3 -81.22 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.4 mp 47.4 93.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 174.84 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.019 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -78.23 -3.96 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.3 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.6 t -108.54 0.32 20.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.642 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -125.33 -9.55 6.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.326 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 54.9 mt -108.28 117.66 34.73 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.67 161.45 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.921 0.391 . . . . 0.0 111.492 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.0 mt -92.8 149.82 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.07 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.81 129.91 41.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.421 ' CG ' ' HD3' ' A' ' 133' ' ' ARG . 60.4 t80 -71.77 -62.81 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.591 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -19.95 63.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.653 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -134.34 76.8 61.65 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 78.04 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.437 2.091 . . . . 0.0 111.963 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -179.62 36.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.8 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 107' ' ' TYR . 1.0 OUTLIER -174.12 145.79 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.264 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 183' ' ' LEU . 2.4 p -109.98 147.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 110.888 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 10.8 m-85 -126.25 157.59 37.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 175' ' ' HIS . 34.0 tp -103.12 115.79 31.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.889 0.376 . . . . 0.0 110.607 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.77 141.32 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.182 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 57.54 106.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 175' ' ' HIS . 3.4 m-30 -75.48 -24.09 56.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.76 -24.7 24.92 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.553 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mp -150.78 -44.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 111.04 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 45.93 87.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.095 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 203' ' ' ARG . 30.5 t80 -143.84 148.77 35.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 202' ' ' TYR . 15.2 mtm105 -74.11 98.49 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.359 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.0 p -59.61 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 225' ' ' ILE . 2.3 tp -163.9 27.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.196 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.24 -35.36 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -152.23 32.34 0.53 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.705 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 39.9 p -65.54 128.74 37.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.021 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.6 m -89.88 146.57 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -57.81 -35.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.71 -30.53 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -75.3 -39.2 59.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -44.3 92.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -92.83 0.57 57.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.87 7.9 62.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.945 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.2 127.87 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.65 154.27 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.21 -166.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.55 2.167 . . . . 0.0 112.255 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -96.96 28.46 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -90.86 -53.02 4.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -25.44 62.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.873 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -65.05 -37.76 94.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -40.59 89.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.0 -35.93 81.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -62.95 -42.55 99.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.2 -39.9 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.76 -39.54 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.77 -44.93 96.55 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.379 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.63 -25.7 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.91 -43.33 86.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.252 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -50.1 74.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 mt -64.19 -26.55 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.401 ' OE1' ' CD1' ' A' ' 254' ' ' TRP . 12.4 tm0? -71.07 -45.2 64.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.401 ' CD1' ' OE1' ' A' ' 253' ' ' GLN . 18.5 m0 -82.19 -41.09 20.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.0 mt -67.04 -39.21 86.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -0.57 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.404 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 57.49 96.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 55.6 m80 62.54 144.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 260' ' ' PRO . 0.1 OUTLIER -122.35 164.65 24.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.466 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.93 63.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.421 2.08 . . . . 0.0 112.519 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 7.6 p90 176.41 -38.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.108 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.9 tt0 -95.55 18.47 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.289 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -55.93 15.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 93.6 m-20 -126.99 -27.36 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.6 mt 70.67 12.4 7.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -85.19 -15.3 44.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.175 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 2.1 m-20 -132.56 100.52 14.95 Favored Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.93 15.02 2.05 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.616 2.211 . . . . 0.0 112.857 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -78.54 -49.77 12.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.471 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.1 p90 -77.13 -26.47 53.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 12.5 t -60.71 -37.53 76.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -75.52 -44.94 41.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.068 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.15 -49.67 63.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.235 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.9 m -58.58 -41.98 86.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -62.35 -41.5 98.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.144 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.3 mt -75.1 -29.09 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.01 16.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.449 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -69.98 -40.13 75.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.388 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -52.58 -27.52 17.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.02 15.33 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.21 45.76 2.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 285' ' ' LEU . 21.1 mt -51.7 -36.5 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.336 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.13 63.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.574 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 9.9 t -68.37 -40.36 81.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.34 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.5 pp -76.01 -28.41 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.331 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 4.0 mmt -67.61 -38.42 83.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.751 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -82.7 -31.58 28.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -82.66 -51.59 7.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.07 -41.13 67.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -115.68 151.97 46.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.009 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 131.89 17.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.629 2.219 . . . . 0.0 112.281 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.02 43.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -107.13 -55.91 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -162.1 -176.45 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 60.82 87.16 0.14 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.59 144.16 44.04 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.608 2.205 . . . . 0.0 112.377 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -96.86 -18.08 30.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.709 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.14 10.61 6.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.362 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 43.3 mm -79.41 -46.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.13 -45.27 11.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.446 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -59.63 -42.76 93.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.52 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -70.17 -36.79 74.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.612 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.407 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 1.6 mtp -67.39 -42.47 83.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.579 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.48 -48.39 80.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -37.78 80.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.692 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 40.6 t -71.08 -25.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -43.12 15.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 110.217 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -14.31 62.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.545 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.462 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.231 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.465 -0.197 0 CA-C-O 120.736 0.223 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 1.4 pp -155.41 30.55 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.041 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -57.53 -37.05 72.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.22 -40.69 94.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.741 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.62 -42.88 99.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 79.4 mt -56.18 -45.38 79.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -56.34 -46.45 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.38 91.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 97.2 mt -53.07 -42.22 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 61.1 mt -81.06 -51.51 8.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.089 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.422 ' HG ' ' CD1' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -56.03 -49.77 72.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.43 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.91 -46.16 71.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.71 -28.13 56.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.16 -24.74 64.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.715 0.293 . . . . 0.0 111.071 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 1.2 mmtm -69.76 -33.47 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.02 -18.85 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.143 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.52 -34.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -122.07 -24.44 2.25 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.279 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 3.0 t 71.43 65.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 74.61 103.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 164.02 26.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.834 0.35 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 110.6 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.93 -27.61 6.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.495 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 135.19 51.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mt -100.66 143.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.423 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 18.4 pt -119.7 154.99 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.4 m -94.98 135.45 36.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -160.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.248 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.1 -38.74 51.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.73 3.66 28.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.235 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.9 mttp 76.03 32.43 0.63 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.5 mtpp -77.34 171.87 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.065 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -111.88 73.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.49 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.7 145.87 55.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -100.8 132.39 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.9 123.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.07 -127.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.551 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.27 159.39 70.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.85 128.2 18.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.167 . . . . 0.0 112.299 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -109.72 -30.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.439 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.349 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.61 114.8 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -146.32 158.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.934 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.66 163.69 27.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.57 157.51 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -149.29 154.01 38.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 43.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.955 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 60.2 -175.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t 60.47 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.56 68.88 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 59.7 -174.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.7 p -86.06 85.13 7.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t 68.95 -67.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.197 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.24 -156.12 21.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.7 -30.03 8.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.36 53.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.1 113.55 31.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.55 25.85 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.93 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.68 148.34 29.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.959 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 HG12 ' CG ' ' A' ' 133' ' ' ARG . 27.5 m -129.63 156.89 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.19 122.88 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -106.4 121.93 45.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.16 146.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.22 136.75 16.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.731 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.33 89.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.364 2.043 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 59.61 172.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.7 81.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.04 -29.34 6.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.15 -165.9 22.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.65 29.29 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.936 2.424 . . . . 0.0 112.808 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.91 -31.88 51.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -67.01 -42.46 84.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.4 t -69.17 -28.62 66.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.956 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -40.4 69.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.65 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.69 -44.54 93.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.04 92.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.46 -43.04 95.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 4.4 m-85 -60.07 -44.41 94.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -79.83 -17.6 52.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.382 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -65.35 -47.8 75.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.784 0.326 . . . . 0.0 111.046 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.68 33.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.255 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -119.44 -10.68 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 163.84 0.44 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.696 0.284 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.44 -19.39 43.59 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.614 2.209 . . . . 0.0 112.493 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -75.62 -39.74 57.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -79.34 -42.09 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.36 -48.78 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -70.2 -49.58 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.174 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -58.15 -51.7 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.08 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.41 -35.72 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.009 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -75.07 -27.84 60.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.29 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -82.38 -37.76 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.468 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -104.8 -1.2 26.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 58.33 31.24 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.763 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.2 mt -51.28 -26.84 7.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.215 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.0 tttt 58.2 94.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.408 ' CE1' ' OH ' ' A' ' 194' ' ' TYR . 2.1 t80 63.87 132.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.4 tp -125.54 163.71 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.6 10.05 66.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.923 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.2 t -92.74 123.43 61.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.757 0.278 . . . . 0.0 111.065 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 146.38 49.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.075 . . . . 0.0 112.248 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -89.34 119.83 30.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -74.93 123.65 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.81 -40.61 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.47 46.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.704 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.52 163.39 34.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -164.66 -174.98 35.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -145.5 159.84 42.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -133.38 141.7 48.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.33 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 126.34 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.63 18.46 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.53 20.67 36.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.626 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 0.3 OUTLIER -121.13 128.94 53.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.17 130.87 37.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 124' ' ' LYS . 9.8 m-85 -120.26 143.46 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 133.14 52.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 11.3 p90 -137.88 163.68 30.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ttm -129.46 136.33 49.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.516 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.6 mt -109.2 119.27 58.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.42 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -134.01 173.23 11.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.795 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.74 145.24 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.208 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -73.4 160.64 31.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CD2' HD13 ' A' ' 184' ' ' LEU . 92.5 m-85 -132.3 154.92 49.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.98 -99.31 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.342 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.58 125.28 47.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -53.5 158.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.938 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.455 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 0.6 OUTLIER -63.79 -21.66 66.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -61.53 -40.5 94.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 0.0 109.981 178.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 138' ' ' LEU . 3.1 mt -73.13 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -67.37 -49.02 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.57 -28.58 59.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.873 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.19 -23.63 66.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.8 m-20 -98.75 20.89 12.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 81.77 48.66 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.243 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt 63.37 18.97 11.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.311 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 -176.16 4.52 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.421 ' CE1' HG23 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -128.14 -176.0 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.26 135.33 53.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.829 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -26.57 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -42.44 64.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.3 p -74.83 -35.58 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.745 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.4 t -57.68 -53.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 52.7 mt -63.87 -44.31 93.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.777 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -62.17 -45.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.692 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.15 -37.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.737 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.1 m -56.55 -37.33 70.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.96 -46.77 41.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.07 -46.19 90.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 mt -66.54 -34.43 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.757 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.03 -36.76 77.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.98 -40.1 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.04 -42.02 84.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.653 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.69 -45.11 95.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.26 -53.01 62.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 175' ' ' HIS . 36.3 pt -66.99 -27.17 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.21 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.408 ' CD2' ' OH ' ' A' ' 204' ' ' TYR . 8.2 t-160 -78.07 -36.5 48.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.645 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -16.98 62.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -94.57 -1.03 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 75.85 37.71 0.38 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.16 116.03 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.444 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 15.9 m -112.04 141.82 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.266 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 198' ' ' TYR . 0.8 OUTLIER -179.36 66.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.645 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -63.1 79.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.661 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -106.35 26.83 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.3 mp -59.76 103.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.022 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 170.14 16.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.895 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -77.3 -3.35 39.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.282 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.8 t -112.62 2.26 16.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.658 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -126.53 -5.41 6.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.098 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.484 ' HB3' HG22 ' A' ' 193' ' ' VAL . 10.9 mt -108.44 127.55 54.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.402 HD13 ' CD2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -136.94 150.08 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.908 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 141' ' ' ILE . 13.8 mt -86.67 149.41 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.256 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.5 OUTLIER -67.49 127.99 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.746 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.459 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 23.9 t80 -86.47 -43.67 12.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.544 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -20.73 62.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -149.6 71.0 9.76 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.616 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.06 91.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.735 2.29 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.45 31.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.57 155.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.014 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 183' ' ' LEU . 3.7 p -109.94 148.16 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 5.3 m-85 -119.66 156.9 29.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 35.9 tp -106.9 115.8 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.2 m -115.95 141.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.371 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.45 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.023 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 175' ' ' HIS . 5.2 m-85 -90.22 -19.18 24.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.39 23.29 73.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.373 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 mp -156.32 -68.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 45.67 88.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -137.4 149.11 46.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.998 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.4 81.19 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.713 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.444 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 13.3 p90 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.421 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.789 -0.125 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 67.0 m 61.74 -90.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.623 0.212 . . . . 0.0 110.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 225' ' ' ILE . 5.9 tp -179.15 35.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.53 -45.19 13.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -157.57 35.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 118.48 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 176.29 8.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mt -61.83 -31.77 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -74.49 -41.6 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -27.69 66.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -94.79 -17.33 22.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.207 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.32 24.93 10.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.4 t -89.36 145.18 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.515 ' CB ' ' HD3' ' A' ' 238' ' ' PRO . . . -119.08 -61.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 50.3 Cg_exo -55.89 107.33 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.223 1.949 . . . . 0.0 112.299 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.23 -52.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 77.44 -2.82 2.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.768 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -89.55 -23.1 22.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.72 0.295 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.5 -49.74 70.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.701 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.11 -33.44 73.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.55 -33.06 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.15 -38.79 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 17.4 mt -63.59 -43.95 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.25 -33.51 75.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.511 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.11 -41.83 99.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -78.52 -25.69 45.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 3.6 m -56.74 -39.99 74.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.372 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -48.81 62.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.249 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.33 -33.45 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.398 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -80.03 -42.7 23.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 0.0 110.928 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.4 m0 -74.1 -24.27 59.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.37 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.47 -35.86 10.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.59 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 m -96.2 -14.25 22.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.82 92.27 0.41 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 38.4 m80 61.52 153.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.337 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.456 ' CD1' ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -125.21 162.63 42.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.509 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 49.1 Cg_endo -68.65 62.13 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 112.424 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 6.8 p90 176.42 -38.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.2 tm-20 -94.26 18.93 10.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.155 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.19 -55.54 13.65 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.5 -28.72 2.26 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.444 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 48.0 mt 73.51 10.73 4.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -79.08 -15.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.215 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.473 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.4 m-20 -135.94 101.26 10.54 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.04 16.45 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.674 2.249 . . . . 0.0 112.873 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -79.52 -49.78 11.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.8 p90 -75.83 -29.33 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 6.9 t -62.16 -36.44 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -75.47 -49.3 19.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.19 -35.53 78.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 53.8 m -67.23 -46.14 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.176 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.36 -40.92 96.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 12.2 mt -68.24 -35.03 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -81.18 -50.17 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.4 m-85 -58.36 -40.36 82.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.49 -35.44 63.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.744 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -102.83 16.57 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.143 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.93 46.63 1.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.855 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 282' ' ' ILE . 18.6 mt -53.42 -35.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.92 -26.22 60.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.217 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 29.5 t -72.98 -42.55 63.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 3.2 pp -77.49 -30.79 53.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.14 -38.65 88.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.639 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -29.79 28.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -82.87 -53.48 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 65.3 m -74.12 -41.19 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.05 152.12 44.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.832 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.57 -46.31 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 54.88 27.83 9.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.43 -31.82 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -106.6 -75.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.021 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.45 110.26 9.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 176.46 6.66 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.378 2.052 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.26 4.85 38.21 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.826 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.06 14.94 5.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 111.297 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.44 -43.69 23.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.738 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.91 48.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -38.58 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -71.25 -45.52 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.429 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 1.3 mtp -61.38 -41.81 97.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -45.52 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 33.2 m -62.26 -29.6 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.441 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 84.3 t -79.39 -24.0 12.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.343 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 -35.98 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 10.6 tp -110.64 -29.99 7.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.276 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 CA-C-O 120.8 0.25 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.62 0.23 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.358 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -60.72 -30.14 69.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -39.46 78.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -82.08 -35.98 28.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 59.2 mt -57.53 -50.73 72.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -56.08 -45.48 79.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.147 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -40.75 79.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 18.1 mt -58.35 -47.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.69 -50.85 22.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.011 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -49.84 65.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.382 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -55.11 -39.33 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.7 71.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.73 -38.87 87.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -61.2 -27.07 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.81 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.9 pt -117.93 20.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.538 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 49.9 43.35 39.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.752 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.1 m -97.95 36.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.05 144.06 45.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.37 114.48 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 m -59.12 145.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.76 -25.29 28.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -112.5 133.56 54.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.012 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mt -100.38 147.86 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.411 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 46.6 pt -116.77 154.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 111.457 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -97.64 141.61 30.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.743 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.34 -162.66 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -36.3 32.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -84.95 5.06 30.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.299 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 11.5 mmtm 79.63 31.36 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.884 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' THR . 9.7 mttp -75.14 177.0 6.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.957 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 80.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.513 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.1 137.64 36.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.976 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -93.86 119.81 33.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.09 149.6 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.03 -146.37 6.8 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 159.19 31.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.26 168.24 18.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.57 2.18 . . . . 0.0 112.332 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -137.6 79.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.479 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.4 mt -82.27 104.57 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -143.6 162.82 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.49 158.41 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.03 159.05 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.6 159.64 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.96 41.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.71 82.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 t -114.96 -38.23 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.1 t -127.6 -172.78 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.73 -49.34 75.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 156.84 45.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.68 99.82 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.17 -105.77 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 53.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -165.58 38.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.67 142.75 94.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.038 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.73 8.79 4.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.692 2.261 . . . . 0.0 113.023 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.2 m -149.69 148.24 29.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.94 144.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.27 128.2 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.298 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.72 120.63 39.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.22 152.07 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.939 0.399 . . . . 0.0 111.421 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -135.85 126.24 16.64 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.56 87.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.478 2.119 . . . . 0.0 112.428 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t 48.97 33.29 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.275 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -89.89 161.73 15.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -155.42 145.22 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.04 -75.4 0.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -44.59 1.98 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.593 2.195 . . . . 0.0 112.263 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.89 -37.78 47.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -58.52 -29.39 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.012 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.1 p -75.77 -28.55 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.71 -42.81 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.71 -32.75 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -71.03 -51.78 23.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.403 ' CE2' ' OH ' ' A' ' 198' ' ' TYR . 73.5 t80 -67.0 -40.81 87.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.946 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 3.4 m-30 -57.13 -45.12 83.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.89 -17.67 52.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -47.6 19.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.97 -29.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -71.41 3.46 3.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -52.57 159.54 1.65 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.745 0.307 . . . . 0.0 110.932 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.22 -32.82 12.32 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.478 2.119 . . . . 0.0 112.288 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.57 -30.02 41.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -75.89 -54.04 7.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.399 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.71 -53.23 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.359 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -51.35 -35.66 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.205 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -36.09 78.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -77.08 -42.49 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.51 -33.17 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -27.67 60.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.1 m -72.6 -36.77 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -5.42 19.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.34 29.68 19.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.886 0.374 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.7 mt -50.89 -33.52 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.237 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 76.83 -55.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 138.67 50.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 tp -120.62 -66.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.98 -9.83 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.98 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.35 131.05 66.66 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.709 0.255 . . . . 0.0 111.175 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.13 147.56 26.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.273 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -87.33 115.51 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -88.31 126.46 35.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -105.74 -40.72 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.96 -174.62 46.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.623 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -136.58 162.76 32.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -142.46 174.43 23.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.824 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.2 mt -148.08 159.83 43.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.64 122.1 11.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.028 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.85 118.47 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.22 126.32 22.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.23 20.58 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.527 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.36 -1.3 60.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.94 129.0 43.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.762 0.315 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t -96.22 123.05 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.25 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -106.71 121.28 44.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.488 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -106.35 125.08 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 12.4 p90 -139.81 158.76 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -128.05 147.21 50.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.647 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 mt -121.34 112.73 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.97 173.41 7.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.169 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.19 148.74 4.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HG2' ' CD2' ' A' ' 187' ' ' TYR . 1.9 tpt180 -65.38 155.69 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -128.58 160.01 33.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.29 -110.29 2.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.555 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 p -107.98 125.79 51.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.762 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' HA ' HD21 ' A' ' 184' ' ' LEU . 10.1 m-20 -58.65 160.34 5.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.813 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 1.2 mm? -65.77 -24.35 66.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 180' ' ' ALA . 1.2 mt-30 -63.71 -44.29 94.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 110.15 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -60.71 -30.68 70.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.26 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.1 mt -72.87 -25.2 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.762 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.433 ' CE2' ' HA ' ' A' ' 147' ' ' LYS . 76.7 t80 -67.75 -48.85 65.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.619 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.59 -27.96 58.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.741 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.02 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 77.7 m-20 -97.51 -1.8 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.263 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 88.7 45.34 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.166 0.507 . . . . 0.0 110.345 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 51.7 mttt 61.33 20.91 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.396 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -135.11 107.86 7.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.421 ' CE1' ' HA ' ' A' ' 142' ' ' TYR . 2.0 m-85 -77.93 -172.93 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -116.9 150.37 38.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -29.4 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -73.81 -43.75 57.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -61.3 -52.04 66.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -54.84 -54.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.0 mt -62.47 -47.87 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -43.12 93.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.68 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.1 -35.27 76.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.32 -42.24 81.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.06 -43.19 71.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.726 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -64.27 -49.27 72.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.36 -36.23 76.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.54 -36.03 77.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -35.86 74.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.78 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.0 mt -76.89 -37.3 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.39 -41.85 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.15 -30.96 68.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.696 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -70.93 -53.35 15.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.426 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 12.1 pt -66.67 -27.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.21 -32.85 61.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.92 -16.96 62.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.58 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -100.47 3.2 42.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 67.71 42.44 2.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 0.3 OUTLIER -131.64 127.48 37.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.06 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 204' ' ' TYR . 3.7 m -113.57 169.21 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.066 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.447 ' HB3' ' CG ' ' A' ' 198' ' ' TYR . 18.7 p-80 -147.42 -50.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.42 52.83 38.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.646 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.58 28.98 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.253 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.82 106.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.719 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -153.55 -177.76 6.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -81.7 -0.08 41.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.293 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 p -109.11 1.23 20.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.44 -6.65 4.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.519 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 193' ' ' VAL . 17.9 mt -108.59 127.98 54.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 137' ' ' ASP . 0.7 OUTLIER -134.97 156.82 48.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.164 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.9 mt -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.307 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.456 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.3 OUTLIER -67.26 130.32 42.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 133' ' ' ARG . 6.1 t80 -75.01 -54.41 7.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -21.3 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.506 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -135.89 73.68 59.32 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 102.0 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.526 2.151 . . . . 0.0 112.147 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -177.44 -35.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -176.77 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 183' ' ' LEU . 3.5 p -132.56 148.12 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.456 ' CE1' ' ND2' ' A' ' 186' ' ' ASN . 6.3 m-85 -121.06 156.94 31.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.142 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 175' ' ' HIS . 60.4 tp -106.62 115.88 30.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.34 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.1 m -106.64 143.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.266 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.58 104.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.447 ' CG ' ' HB3' ' A' ' 175' ' ' HIS . 5.8 m-30 -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 88.98 -50.66 3.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.398 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 200' ' ' LEU . 2.9 mm? -118.61 -38.72 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.665 0.269 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 44.37 82.09 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -118.86 148.96 42.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.416 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 11.0 mtp180 -102.39 70.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.687 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.419 ' CE1' HG13 ' A' ' 174' ' ' VAL . 43.6 p90 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.26 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -147.47 146.3 29.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 6.9 tp -68.01 -11.13 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -52.47 -36.75 55.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.408 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 62.9 m-85 -157.42 33.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.25 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.0 t -66.53 139.92 57.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.786 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.6 131.83 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.6 mt -59.31 -58.85 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -44.19 97.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.07 -45.18 83.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.22 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -61.82 -27.84 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -90.07 -0.1 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.393 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.16 87.2 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.002 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -54.13 107.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 111.183 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.56 165.94 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.24 148.08 88.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.46 109.7 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.25 -47.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -67.21 -30.41 70.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.61 91.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.16 -32.68 66.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 317' ' ' TYR . 84.0 mt -80.57 -37.4 31.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -61.71 -37.72 85.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 6.1 mt -61.93 -49.28 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.8 -40.73 95.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.97 92.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -78.67 -25.88 44.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.15 -39.97 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -50.0 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.761 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.96 -30.56 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.05 -39.94 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -82.23 -25.8 33.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.381 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.22 -44.68 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.223 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.23 0.61 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 65.36 100.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.3 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 3.8 p80 55.67 165.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -135.38 168.46 17.5 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.507 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 43.2 Cg_endo -68.33 63.33 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.379 2.053 . . . . 0.0 112.457 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 270' ' ' TYR . 3.8 p90 175.19 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.013 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -95.21 19.78 10.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.47 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -57.67 4.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 87.0 m-20 -126.91 -26.02 3.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.343 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 48.4 mt 71.3 12.41 6.72 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.106 0.479 . . . . 0.0 109.822 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -12.89 49.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.196 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -124.06 79.63 58.42 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.92 -11.12 29.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.767 2.311 . . . . 0.0 112.597 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -47.65 22.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.069 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -75.3 -26.15 58.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.884 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 77.8 t -57.78 -35.22 50.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.591 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -75.59 -41.69 53.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -40.48 82.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.079 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 67.1 m -75.44 -29.93 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -73.54 -45.9 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.069 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.02 -38.57 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -65.12 -52.0 57.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.425 ' CG ' HD13 ' A' ' 285' ' ' LEU . 13.0 m-85 -62.05 -35.12 77.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -29.28 63.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -118.9 24.0 11.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -140.34 42.52 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.465 HD13 ' CB ' ' A' ' 303' ' ' MET . 6.4 mm -47.6 -41.07 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.39 63.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.97 68.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' A' ' 278' ' ' TYR . 5.0 tt -64.76 -51.16 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.707 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.734 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.4 -26.54 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -82.76 -52.87 6.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.075 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.92 -41.17 37.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.57 87.38 7.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.41 76.2 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.441 2.094 . . . . 0.0 112.253 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -172.42 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.24 58.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.66 -68.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -152.27 101.19 2.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.224 1.95 . . . . 0.0 111.975 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -174.86 28.82 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.595 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 68.16 7.01 5.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.502 0.191 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 303' ' ' MET . 24.3 mm -79.8 -45.7 22.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 110.963 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.51 -46.74 9.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -43.06 89.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.768 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.452 ' CE2' ' CD1' ' A' ' 324' ' ' LEU . 18.4 t80 -70.56 -46.47 63.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.465 ' CB ' HD13 ' A' ' 282' ' ' ILE . 62.6 mmm -66.06 -37.71 86.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.748 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -42.36 98.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.564 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 42.2 m -67.65 -31.74 71.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.41 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 66.3 t -79.35 -24.4 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.195 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.33 -40.74 58.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.11 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.79 -27.11 12.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 305' ' ' THR . 1.6 mp . . . . . 0 N--CA 1.462 0.159 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.888 0.287 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.01 41.24 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CE2' HD21 ' A' ' 244' ' ' LEU . 11.3 m-85 -59.16 -30.09 67.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.75 -47.91 83.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.67 -35.01 79.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.976 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 57.9 mt -59.57 -42.12 91.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -63.12 -36.39 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.97 73.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.8 mt -66.26 -49.24 77.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.254 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 302' ' ' TYR . 5.8 mt -76.2 -24.54 54.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.261 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.64 -44.75 15.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -59.47 -37.1 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.37 76.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.53 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 13.2 mt -59.98 -41.2 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -27.69 61.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.14 -26.29 62.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.31 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 27.7 pt -106.3 -27.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.21 7.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -65.45 0.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.829 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.91 108.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.08 89.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.84 143.64 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.82 26.36 69.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.1 170.53 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.7 mm -126.28 126.26 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.228 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 36.3 pt -116.87 154.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 t -95.56 141.48 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.916 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -160.81 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.04 -39.12 26.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.156 0.503 . . . . 0.0 109.895 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -84.42 2.83 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 7.4 mttt 86.08 30.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.47 178.62 5.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -130.63 80.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 130' ' ' ILE . 44.2 m95 -78.19 144.93 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.004 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -97.28 148.22 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.58 127.64 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.81 -143.13 12.23 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.54 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.47 152.55 39.34 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.45 165.96 2.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.294 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.3 pt -154.42 29.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.393 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 97.9 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.56 83.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.068 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 49.5 m-85 -119.93 172.1 7.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.4 165.88 19.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.75 150.22 52.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.89 157.06 46.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.416 ' HE2' ' CH2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -101.5 57.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.978 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.92 94.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.25 -172.16 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -75.65 -38.88 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.74 -68.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -155.48 161.86 40.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.76 114.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.96 -69.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -119.06 32.03 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.72 87.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.62 80.9 0.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.11 49.55 3.17 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.708 2.272 . . . . 0.0 112.642 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.2 m -149.79 148.23 28.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.96 144.98 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.071 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.94 129.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.54 124.09 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 50' ' ' CYS . 2.6 t -113.15 139.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -141.15 144.0 33.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.705 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.92 109.09 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.484 2.122 . . . . 0.0 112.289 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 t -57.83 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.21 -49.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -167.46 110.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.5 39.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.563 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 -0.77 10.93 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.634 2.222 . . . . 0.0 112.729 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.91 -41.97 92.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -48.92 73.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -75.08 -36.47 61.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.63 -53.04 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.71 -35.6 80.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.437 ' CD1' ' CD2' ' A' ' 173' ' ' TYR . 51.1 t80 -65.15 -37.97 89.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 4.0 m-85 -55.87 -53.33 58.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -17.35 53.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.605 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.31 -47.56 12.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . . . -128.19 -24.11 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -90.6 23.05 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -70.91 130.08 88.84 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.81 -24.72 76.95 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.459 2.106 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.43 -35.8 39.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.965 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -79.38 -50.24 11.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 91' ' ' ALA . 48.8 mt -62.58 -57.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -50.18 -55.33 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.359 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -31.37 63.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -77.32 -49.71 14.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.04 -23.26 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.876 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -27.36 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.626 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.9 p -77.98 -11.05 59.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.358 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 78.18 13.87 1.55 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -83.36 -14.53 52.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.449 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.28 -51.46 2.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.14 -56.55 0.58 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CG ' ' NE2' ' A' ' 192' ' ' GLN . 41.1 t80 -145.33 145.03 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tp -126.12 -43.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 95.41 -7.69 68.89 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.741 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.04 136.64 61.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.72 0.26 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.61 143.46 99.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.457 2.105 . . . . 0.0 112.239 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -84.96 115.65 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -89.03 126.76 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -103.48 -40.63 6.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.01 -178.37 45.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.614 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.1 t -132.62 161.15 34.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.64 0.257 . . . . 0.0 110.523 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.44 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.05 170.65 30.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.802 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -137.91 159.14 42.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.77 125.16 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.019 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 130.78 46.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -138.2 126.29 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.13 17.15 6.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.41 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.94 -11.42 55.97 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.922 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -96.09 129.03 43.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 t -93.45 131.67 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -113.0 151.01 31.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -116.56 132.22 56.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 17.1 p90 -141.24 159.89 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 ttm -128.17 145.74 50.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.422 HD12 ' CE3' ' A' ' 37' ' ' TRP . 16.3 mt -120.2 111.54 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -123.49 173.3 8.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.69 134.52 24.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 145.52 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 48.6 m-85 -109.27 166.38 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.28 -100.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.503 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 m -125.41 127.61 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.67 159.56 3.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -65.65 -20.16 66.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.492 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -51.09 -32.74 23.34 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 121.062 0.458 . . . . 0.0 110.335 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -30.89 51.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.132 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.415 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 30.6 mt -76.69 -25.16 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 147' ' ' LYS . 12.1 t80 -77.88 -45.32 24.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.552 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -29.59 62.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.31 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.67 9.06 43.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.018 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 79.24 49.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.143 0.497 . . . . 0.0 110.02 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 258' ' ' HIS . 0.1 OUTLIER 62.55 21.4 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.132 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -120.74 161.1 22.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -146.41 143.39 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 144.39 37.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -56.4 -26.35 52.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -73.85 -41.95 61.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -45.72 91.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.21 -54.09 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.251 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.32 -48.13 79.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.31 -50.71 70.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.644 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 138' ' ' LEU . 18.4 mt -61.52 -41.01 96.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -55.62 -41.26 73.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.67 -49.2 76.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.427 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -47.24 86.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.763 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.99 -37.61 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.14 -37.8 75.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.94 -31.96 70.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.4 mt -74.42 -45.54 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.02 -45.37 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.788 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 25.3 t80 -75.22 -48.99 20.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 27.0 pt -74.04 -38.8 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.422 ' CG ' HG13 ' A' ' 174' ' ' VAL . 18.2 t-80 -68.73 -25.18 64.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -98.0 -1.34 42.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.306 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.26 -58.38 1.9 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.717 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 204' ' ' TYR . 0.5 OUTLIER 168.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.473 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.437 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 64.9 m-85 -159.51 126.37 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 0.0 110.996 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.454 HG12 ' CD2' ' A' ' 204' ' ' TYR . 30.4 m -132.55 147.5 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.433 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 37.7 t60 77.79 47.07 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -58.81 -18.41 39.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.861 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 t70 74.52 97.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.838 0.351 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.32 114.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.048 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -148.02 179.44 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -83.72 0.75 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -115.21 2.16 14.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.476 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -125.51 -7.49 6.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 9.6 mt -108.29 113.61 26.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.113 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -119.04 148.0 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.191 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 40.5 mt -86.69 148.53 25.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.212 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.72 127.48 31.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.58 -41.5 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.777 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -77.24 -23.64 51.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.822 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.09 61.67 12.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.57 114.86 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.651 2.234 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -177.49 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.405 ' NE2' ' CG ' ' A' ' 107' ' ' TYR . 3.2 mt-30 -131.2 177.26 7.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.08 147.33 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 3.6 m-85 -113.62 150.6 32.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 30.1 tp -104.14 117.61 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.2 m -92.17 -179.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.57 93.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -117.72 -49.82 2.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.706 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.06 52.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.86 3.61 37.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.473 0.178 . . . . 0.0 111.421 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' VAL . . . -92.5 -109.61 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.409 ' CZ ' ' O ' ' A' ' 237' ' ' ALA . 46.0 t80 -146.32 118.13 8.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 110.435 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -90.25 77.79 6.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.317 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.454 ' CD2' HG12 ' A' ' 174' ' ' VAL . 8.3 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.183 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -158.49 133.9 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.406 ' CD1' HG11 ' A' ' 271' ' ' VAL . 7.1 tp -65.63 -13.41 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.443 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.95 -51.03 25.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.742 0.306 . . . . 0.0 111.348 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -145.56 31.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.224 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.9 t -56.87 116.52 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.319 . . . . 0.0 110.947 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 t -57.47 163.31 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mt -60.76 -37.73 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.34 -31.32 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.06 -36.5 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.22 -32.16 73.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -92.2 12.95 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.263 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.39 24.07 55.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.611 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 28.8 t -67.87 136.42 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.419 ' CB ' ' CD ' ' A' ' 238' ' ' PRO . . . -68.98 -62.45 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 237' ' ' ALA . 21.5 Cg_endo -61.2 125.6 17.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.508 2.138 . . . . 0.0 112.353 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.95 121.16 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -127.51 -44.25 1.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -8.21 55.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.51 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.61 -49.71 71.35 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.36 -34.44 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.374 . . . . 0.0 111.054 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.03 -33.42 51.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.03 -37.28 87.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 6.1 mt -65.29 -45.76 92.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.0 -37.23 84.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.87 -43.78 97.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.52 -25.65 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 0.0 111.16 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 254' ' ' TRP . 6.0 m -56.65 -38.41 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.279 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -48.96 56.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.086 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 5.0 mt -59.59 -51.74 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.178 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.55 -28.61 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.406 ' CG ' ' O ' ' A' ' 250' ' ' CYS . 20.7 m0 -82.35 -28.49 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.267 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 82.8 mt -86.75 -41.68 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 15.0 t -96.23 0.56 51.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.498 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.8 97.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.499 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.416 ' CE1' ' HG2' ' A' ' 147' ' ' LYS . 5.1 m-70 64.16 166.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 260' ' ' PRO . 0.2 OUTLIER -132.29 162.44 56.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.7 Cg_endo -67.44 64.19 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.361 2.041 . . . . 0.0 112.433 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.547 ' HA ' ' CD1' ' A' ' 270' ' ' TYR . 2.3 p90 177.19 -36.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.169 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.6 tt0 -88.14 10.71 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.536 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.89 -48.13 82.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.9 t-20 -130.54 -29.22 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.387 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 85.9 mt 71.97 11.64 6.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -14.37 54.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.418 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.446 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -136.89 87.4 19.56 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.104 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.01 -10.61 21.17 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.68 2.253 . . . . 0.0 112.484 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -49.81 -50.22 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.331 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.547 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.4 p90 -81.12 -26.17 36.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 50.5 t -61.62 -40.89 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.044 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -75.55 -45.06 40.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.06 -46.97 84.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 59.1 m -58.56 -43.59 89.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -41.7 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.47 -28.98 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.376 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -81.36 -52.17 7.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.608 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.421 ' CD1' HD12 ' A' ' 285' ' ' LEU . 4.9 m-85 -64.0 -40.57 96.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.642 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -26.57 11.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -113.83 17.76 17.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.34 35.57 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.403 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 20.5 mt -47.24 -48.61 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.53 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.78 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.196 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 278' ' ' TYR . 0.8 OUTLIER -68.57 -37.82 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.424 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -40.22 94.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.725 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -23.3 42.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -82.66 -54.03 5.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.205 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.3 m -79.25 -41.21 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.415 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.29 149.75 39.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -48.65 20.73 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.526 2.151 . . . . 0.0 112.267 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.46 31.1 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -30.84 23.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -170.58 119.59 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm 59.44 97.75 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 -167.47 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.253 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.16 11.49 69.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.878 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 71.0 10.41 6.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.686 0.243 . . . . 0.0 111.341 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 299' ' ' ILE . 37.4 mm -79.59 -45.79 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.788 0.328 . . . . 0.0 110.824 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.86 -43.32 8.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -60.24 -43.99 95.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.533 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 43.2 t80 -68.53 -39.41 81.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.403 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.6 mtp -68.43 -37.29 80.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.342 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.04 -50.22 74.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 2.2 p -59.08 -41.26 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 18.0 t -65.19 -24.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.121 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -77.24 -39.77 47.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.222 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -17.41 56.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.091 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.704 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.824 0.26 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 17.7 tp -118.84 -1.26 11.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.398 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -57.58 -32.37 67.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.857 0.361 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.0 -37.63 87.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -46.04 63.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 36.3 mt -54.87 -45.59 74.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -32.41 65.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -38.19 45.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.81 -44.49 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.211 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 38.4 mt -75.4 -49.94 17.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -49.84 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -53.4 -39.44 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -26.56 70.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 17.1 mt -65.2 -40.5 94.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -74.46 -27.28 60.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.86 -27.42 68.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.46 -28.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.62 5.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 33.6 t -90.9 152.64 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.72 91.7 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.72 145.9 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.49 123.56 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.95 -27.2 7.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.592 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -82.45 143.07 31.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.6 mt -100.43 142.42 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 30.8 pt -113.7 154.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 62.2 m -95.51 140.98 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -97.16 -162.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.109 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.94 -42.12 40.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 109.811 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.36 -0.05 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.5 mtpt 84.61 29.04 0.06 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 30' ' ' THR . 6.0 mttt -74.49 -179.86 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -128.32 79.63 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.807 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' CZ3' ' HE3' ' A' ' 56' ' ' MET . 31.0 m95 -74.78 143.24 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.756 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 126.6 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.87 147.18 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.98 -151.77 19.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.706 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.01 157.47 54.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 111.018 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' A' ' 52' ' ' TYR . 24.5 Cg_exo -63.27 144.74 92.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.596 2.197 . . . . 0.0 112.282 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.1 pt -142.22 -42.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.222 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.547 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.99 112.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.305 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 42' ' ' PRO . 13.7 m-85 -126.57 169.56 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.49 158.15 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.619 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.07 150.91 40.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.349 . . . . 0.0 111.338 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -137.77 157.57 46.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.418 ' HE3' ' CZ3' ' A' ' 37' ' ' TRP . 2.9 mmt -97.06 30.8 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.51 104.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -137.77 -65.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -103.69 -178.19 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.97 -34.58 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -142.94 159.23 42.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -89.88 160.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.51 46.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.538 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -163.66 -45.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -143.61 67.85 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.74 80.09 13.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.82 48.27 2.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.748 2.299 . . . . 0.0 112.699 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.2 m -149.81 153.31 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.15 144.85 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.044 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 124.81 39.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -104.4 123.38 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.499 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 t -113.07 135.17 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.466 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.21 150.62 59.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.579 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.51 118.87 5.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.495 2.13 . . . . 0.0 112.209 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -55.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t0 61.58 98.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.02 94.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.06 151.33 20.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.28 35.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.486 2.124 . . . . 0.0 112.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.77 -37.64 88.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.7 -41.31 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 p -72.84 -32.22 65.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.03 -40.73 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.808 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.51 -51.65 67.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -57.72 -43.75 85.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.6 t80 -63.67 -31.61 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.411 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 3.3 m-85 -71.65 -60.29 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.66 -17.89 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.375 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -47.37 60.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.23 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.91 -37.41 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.871 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -54.99 -21.21 11.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 123.12 8.55 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.993 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.92 -25.64 12.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.556 2.171 . . . . 0.0 112.466 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.91 -35.92 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -79.4 -39.76 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.42 -57.61 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.191 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -32.15 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.178 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -76.15 -32.93 59.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -77.16 -38.21 52.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.2 mt -69.69 -37.5 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.13 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -74.94 -27.78 60.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.254 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.6 p -84.36 -34.02 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.335 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -2.24 24.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 58.61 31.05 20.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.637 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -51.59 -25.64 7.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tptp 78.52 -55.6 0.47 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 108' ' ' LEU . 19.9 t80 -152.79 163.51 39.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 3.4 tp -139.85 -168.02 2.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.38 28.4 2.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.92 136.49 19.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.588 0.232 . . . . 0.0 110.985 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.48 151.82 66.1 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.608 2.206 . . . . 0.0 112.291 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.8 115.53 23.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -92.5 115.35 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -92.84 -40.46 10.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.745 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.17 -175.98 46.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.405 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.6 t -137.92 165.89 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.666 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.44 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.34 177.2 28.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.583 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 mp -147.83 159.86 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -141.89 141.74 33.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -111.41 130.29 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -138.23 126.26 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.79 23.86 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.9 10.66 61.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.819 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.15 159.2 15.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.17 122.19 46.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -114.23 141.43 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -126.9 126.72 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.44 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 35.1 p90 -136.26 161.73 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -128.06 145.83 50.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.9 mt -121.52 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -132.36 173.29 11.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.8 139.58 26.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.081 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -71.84 151.5 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -115.48 167.4 10.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.39 -64.07 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 p -154.33 156.71 37.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.77 153.25 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.78 -25.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.734 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 11.2 tt0 -70.33 -44.37 68.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -60.77 -28.53 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.5 mt -74.56 -28.33 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 t80 -57.28 -46.28 83.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.58 -25.97 67.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.078 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.09 -17.36 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.475 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.2 m120 -94.95 -3.04 49.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 98.78 43.15 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.043 0.537 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 59.79 20.35 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 5.8 mtp180 -169.89 128.04 0.9 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.928 0.394 . . . . 0.0 111.141 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -81.26 -175.45 5.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -115.76 169.34 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -57.91 -29.9 65.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.6 m -60.84 -55.31 34.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.9 t -56.75 -52.37 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 23.3 mt -59.27 -41.27 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -64.82 -44.38 90.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.67 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.73 -32.73 70.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.733 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 t -62.85 -41.18 99.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.36 -33.67 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -70.56 -49.49 47.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.3 mt -61.32 -41.9 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.971 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.26 -40.9 91.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.69 -32.92 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.526 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 10.6 mt -79.74 -40.18 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.707 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 22.9 mt -55.85 -38.76 70.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.85 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -32.67 74.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD1' HD23 ' A' ' 108' ' ' LEU . 80.3 t80 -74.09 -52.51 12.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.778 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 169' ' ' HIS . 8.0 pt -67.66 -27.16 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.271 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.414 ' CE1' HD12 ' A' ' 168' ' ' ILE . 1.3 m-70 -80.33 -32.29 37.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.595 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.97 -17.01 62.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -104.36 5.98 34.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.024 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 73.52 46.28 0.22 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.385 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.453 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.1 m-85 -137.06 129.12 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.3 m -112.17 164.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.491 ' CD2' ' CE1' ' A' ' 198' ' ' TYR . 12.5 t-80 -120.01 -66.02 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.28 43.93 93.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -162.84 36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.905 0.383 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.8 mt -74.7 114.24 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -177.92 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.054 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -80.07 -2.57 44.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.594 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.6 t -106.37 0.05 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.107 0.479 . . . . 0.0 110.57 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.76 -11.24 7.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.074 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 18.4 mt -108.32 113.77 27.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.616 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 1.7 mt -116.99 168.38 10.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.856 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' A' ' 193' ' ' VAL . 49.9 mt -106.56 149.48 27.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.95 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 0.3 OUTLIER -89.51 142.96 27.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 109.941 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.1 -26.7 5.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -25.23 37.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 174.2 -58.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.425 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.496 ' HB2' ' CB ' ' A' ' 186' ' ' ASN . 96.0 Cg_exo -37.45 -60.43 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.026 2.484 . . . . 0.0 113.538 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 0.5 OUTLIER 82.32 -4.45 1.43 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.51 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -89.57 -166.88 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 185' ' ' LEU . 2.0 p -109.93 145.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 7.8 m-85 -124.38 156.95 36.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.857 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 175' ' ' HIS . 14.9 tp -105.4 115.93 31.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.625 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.97 170.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.2 t70 56.17 88.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.1 m-85 -81.8 -33.88 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.624 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 63.5 14.47 54.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.797 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.26 -49.69 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 46.81 87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.16 135.82 53.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 15.3 ttp-105 -103.49 50.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 69.1 p -150.97 -176.46 5.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 225' ' ' ILE . 2.0 tp -148.45 27.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -102.45 -28.25 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -148.93 30.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.3 m -68.65 122.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.4 t -69.88 169.56 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.46 -32.07 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -33.51 60.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -74.0 -31.66 63.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -25.55 65.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 12.87 16.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.321 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.21 69.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.81 152.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.34 . . . . 0.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.03 109.41 16.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.29 177.44 4.54 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.384 2.056 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.6 m -150.55 -59.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -47.27 1.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -59.2 -29.67 67.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -64.99 -49.66 61.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.6 -42.03 71.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.916 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.24 -31.69 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -39.88 78.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 9.2 mt -66.7 -35.97 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.3 tp -70.8 -38.84 73.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.93 -35.77 92.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.54 -25.8 45.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 111.022 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 10.4 m -65.02 -32.92 74.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.035 0.445 . . . . 0.0 110.468 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -52.69 64.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.055 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 4.1 mp -68.32 -28.67 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -41.84 55.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 111.473 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.403 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 40.8 m0 -82.27 -24.89 34.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.788 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.16 -37.37 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 m -96.12 -12.68 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.421 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 75.04 87.8 0.25 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.5 m170 64.98 158.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.476 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.4 OUTLIER -132.63 160.34 68.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 37.5 Cg_endo -65.92 66.06 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.549 2.166 . . . . 0.0 112.85 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.476 ' CH2' ' CD2' ' A' ' 259' ' ' LEU . 5.7 p90 178.34 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.288 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -98.53 21.99 10.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.214 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -56.09 9.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 69.4 m-20 -125.96 -27.09 3.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 69.2 mt 70.19 12.74 7.7 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.02 -14.83 43.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.118 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.449 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.9 m-20 -134.33 98.32 14.03 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.03 17.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.698 2.265 . . . . 0.0 112.83 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -80.09 -46.95 15.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.7 p90 -79.27 -26.73 42.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 26.7 t -61.43 -37.79 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.189 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -75.51 -45.54 37.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.237 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -67.19 -37.91 84.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.1 m -68.3 -43.41 77.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -52.42 64.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.1 mt -60.38 -33.27 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.561 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -81.05 -49.57 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.23 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -62.8 -36.78 84.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -54.2 -29.63 46.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.877 0.37 . . . . 0.0 110.645 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.0 19.52 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -136.39 41.58 2.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.816 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 282' ' ' ILE . 23.5 mt -53.17 -38.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.7 64.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -40.76 85.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.028 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 3.6 pp -75.54 -28.43 59.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -45.09 91.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.93 -27.4 33.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.373 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -82.76 -33.06 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.691 0.281 . . . . 0.0 111.334 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.4 m -93.7 -41.24 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.55 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.21 154.69 37.48 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.63 151.67 18.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.714 2.276 . . . . 0.0 112.327 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.13 -35.68 13.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -71.66 -46.36 59.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -68.15 149.15 49.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.05 147.68 88.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.98 166.91 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.624 2.216 . . . . 0.0 112.156 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -104.99 25.14 26.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.577 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 68.53 13.6 8.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.689 0.28 . . . . 0.0 111.301 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.25 -45.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.527 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.63 -43.78 17.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.287 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -41.71 88.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.392 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.46 -43.17 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.514 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.413 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 3.8 mtp -61.04 -41.28 96.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.597 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.11 -50.35 74.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.685 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 41.9 m -58.45 -33.58 69.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.451 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 71.1 t -79.37 -24.46 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.8 -38.61 21.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.683 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 7.7 mt -107.48 -28.34 9.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.497 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 111.144 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.268 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.0 mt -103.08 31.22 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -68.48 -29.63 68.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -46.54 85.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -73.83 -43.64 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 61.8 mt -56.49 -40.57 75.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.0 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.84 -38.02 76.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.96 -48.27 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.78 -21.29 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.482 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.53 -49.69 10.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.15 -37.31 74.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.98 -27.82 57.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.542 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.79 -39.08 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -30.14 69.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.01 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 12.0 pt -105.77 -29.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.202 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.46 27.25 3.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -114.49 34.04 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -71.81 89.78 1.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 89.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -101.9 114.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.65 -25.99 11.37 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.04 147.39 29.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.29 135.84 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 13.4 pt -119.84 148.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -95.55 141.46 29.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 35' ' ' LYS . 4.1 t70 -83.41 -142.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.27 56.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.1 34.6 24.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.901 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -152.85 19.06 0.6 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' A' ' 37' ' ' TRP . 2.0 mmtt -163.94 175.1 10.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.445 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -151.24 90.44 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 7.3 m95 -94.87 139.96 30.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.209 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -93.14 135.0 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -87.39 138.78 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.67 -118.65 4.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.551 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.4 154.59 47.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.948 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.59 170.69 5.28 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.544 2.163 . . . . 0.0 112.275 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.5 pt -143.9 36.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.562 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 mt -114.68 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -146.35 172.06 14.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.955 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.33 156.33 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.67 142.41 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.06 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.41 159.72 38.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.1 mtm -99.31 38.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.62 87.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -64.13 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -175.08 -51.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -111.14 -46.55 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.45 178.98 4.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.98 122.64 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.42 -151.56 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.574 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.63 31.34 5.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 80.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.54 137.01 19.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.27 33.25 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.842 2.361 . . . . 0.0 112.775 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.82 148.25 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.86 144.87 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 7.4 p -134.89 132.94 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.557 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -109.37 120.78 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 t -113.19 149.07 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.363 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -133.2 149.86 73.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.679 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 80.32 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.168 . . . . 0.0 112.388 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.1 t 57.04 -168.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 61.39 165.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -124.29 130.81 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.78 -111.45 0.26 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.05 -36.62 85.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -45.72 74.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -45.79 72.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 p -58.63 -44.17 89.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.67 -38.83 80.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.98 -46.57 70.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -56.34 -40.82 75.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.5 t80 -79.66 -29.88 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.422 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 2.1 m-85 -67.71 -52.67 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.434 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -19.61 59.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.437 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -66.33 -47.52 73.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.674 0.273 . . . . 0.0 111.298 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.1 -35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -59.28 -16.99 24.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 125.01 26.88 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.517 0.199 . . . . 0.0 110.84 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.87 -24.89 14.46 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.488 2.125 . . . . 0.0 112.614 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -44.46 91.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.43 -43.77 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.0 mt -54.83 -57.6 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.409 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.45 -40.77 62.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.153 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -57.0 -39.65 75.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -77.32 -44.53 29.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.6 mt -62.7 -38.8 82.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.63 60.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.414 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -80.52 -36.93 32.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.495 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -105.42 -3.34 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 mttt 58.33 29.31 17.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.857 0.36 . . . . 0.0 110.724 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.9 mt -47.76 -40.41 20.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.206 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 4.0 tmtp? 69.07 7.81 6.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 68.6 t80 174.62 161.83 0.2 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.751 0.31 . . . . 0.0 110.498 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.422 HD21 ' CG ' ' A' ' 167' ' ' TYR . 9.3 tp -153.56 -60.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.07 -0.26 21.02 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.044 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.33 136.17 43.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.78 0.29 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.41 143.05 95.11 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.313 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 115.68 26.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -90.42 134.47 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -111.97 -40.83 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.86 -174.5 46.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.824 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.2 t -136.86 153.19 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -131.48 168.29 22.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.28 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.3 mt -147.93 134.47 19.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 0.0 110.748 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -139.32 135.74 34.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -108.24 135.63 49.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 126.3 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.85 18.3 5.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.38 57.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.895 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -96.04 129.02 43.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.819 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.8 130.31 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.72 136.38 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.25 125.12 52.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.467 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 12.9 p90 -134.73 159.35 41.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.709 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ttm -128.06 141.92 51.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.3 mt -111.94 111.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.04 173.41 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.73 136.91 21.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.94 172.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.235 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.4 ' CE2' HG12 ' A' ' 196' ' ' VAL . 31.5 m-85 -150.17 162.06 41.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.645 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.6 -84.53 1.58 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.449 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 m -149.68 127.36 11.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.823 0.344 . . . . 0.0 110.719 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.43 ' HA ' HD21 ' A' ' 184' ' ' LEU . 4.9 m-20 -49.0 159.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -69.29 -21.31 63.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.41 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 1.7 pt20 -51.9 -34.13 39.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.379 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -29.63 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.652 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.92 -29.82 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.571 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -59.58 -50.03 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.04 -27.48 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.07 66.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.366 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 3.2 m-80 -97.9 14.96 25.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 87.5 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.95 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.453 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.7 123.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 7.4 m-85 -59.58 -174.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 m -119.14 153.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.571 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -54.75 -27.3 40.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.88 -42.39 57.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -44.3 53.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.243 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -53.92 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.43 -46.93 85.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.966 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -52.85 56.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.992 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.5 -40.1 85.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.8 p -59.18 -36.8 75.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.94 -44.12 77.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.16 95.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.0 mt -64.3 -36.99 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.58 -38.59 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.49 -41.22 93.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.1 mt -74.89 -41.94 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.2 mt -56.88 -40.51 76.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 317' ' ' TYR . 10.6 tt0 -64.96 -37.9 89.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.422 ' CG ' HD21 ' A' ' 108' ' ' LEU . 89.9 t80 -66.41 -53.44 35.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 169' ' ' HIS . 5.3 pt -65.48 -27.04 40.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.408 ' N ' HG13 ' A' ' 168' ' ' ILE . 14.8 m-70 -76.48 -39.84 52.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.498 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.91 -12.32 61.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.62 4.25 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.765 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 70.69 47.09 0.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 126.74 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 27.2 m -133.01 169.27 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -162.37 -47.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.16 59.67 8.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.44 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.77 29.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.3 mt -64.54 105.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.438 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 14.1 tptm -149.84 168.33 24.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -69.39 0.03 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.065 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 -4.07 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.571 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -124.96 -5.77 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.356 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 193' ' ' VAL . 12.6 mt -108.22 113.51 26.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.244 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 137' ' ' ASP . 0.2 OUTLIER -121.14 149.75 42.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -178.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 193' ' ' VAL . 10.3 mt -90.36 149.19 22.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.65 130.54 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.687 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -66.77 -67.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -21.3 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -119.56 67.28 10.17 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.83 97.31 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.1 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -172.5 -38.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.213 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -116.15 174.36 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 183' ' ' LEU . 7.9 p -133.05 136.56 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 3.4 m-85 -106.91 156.88 18.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.2 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.06 115.87 31.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.565 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.4 HG12 ' CE2' ' A' ' 134' ' ' PHE . 27.8 m -115.37 156.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 56.04 93.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.496 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 5.0 m-85 -79.27 -12.87 59.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 57.01 25.2 53.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.5 -62.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.703 0.287 . . . . 0.0 111.014 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 43.88 82.91 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -142.08 149.01 39.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -82.79 94.34 7.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 35.4 p90 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.725 -0.15 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -91.34 -46.95 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.2 tp -178.11 38.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.197 0.523 . . . . 0.0 110.522 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -94.66 64.85 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.269 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 262' ' ' GLU . 53.3 m-85 75.29 32.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -72.78 153.89 40.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.3 m -95.88 157.49 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.66 -30.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -48.73 55.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.42 74.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.58 -26.1 61.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.83 12.82 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.375 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.52 59.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.591 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 124.85 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 111.041 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.15 118.91 33.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -51.97 101.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.403 2.069 . . . . 0.0 112.298 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.8 m -60.68 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.11 -51.51 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -62.78 -23.91 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.49 -49.55 72.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.692 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 -31.04 63.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 30.6 mt -72.18 -36.09 69.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.67 -29.89 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 42.0 mt -72.39 -42.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.412 HD22 ' CZ ' ' A' ' 302' ' ' TYR . 41.5 tp -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.15 97.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.314 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.5 -25.88 45.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -34.57 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.108 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -49.43 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.32 -30.26 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.41 ' OE1' ' CD1' ' A' ' 254' ' ' TRP . 17.6 tm0? -80.04 -37.4 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.4 m0 -82.22 -39.35 23.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.06 -45.39 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.076 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.4 p -96.14 0.55 51.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.41 97.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.475 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 m80 65.0 155.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -134.52 172.54 7.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.474 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 61.5 Cg_endo -73.49 58.11 3.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.373 2.049 . . . . 0.0 112.589 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 3.1 p90 -180.0 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.306 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -99.04 20.62 13.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 178.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -55.12 23.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.948 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.1 OUTLIER -127.68 -25.27 3.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.452 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 53.5 mt 69.34 12.74 8.41 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -88.25 -15.48 35.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.083 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 4.0 t0 -135.12 97.46 13.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 20.73 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.625 2.216 . . . . 0.0 112.944 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -44.85 22.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.789 0.328 . . . . 0.0 110.764 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.0 p90 -83.87 -26.62 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.015 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 16.3 t -61.76 -37.06 77.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -72.11 -44.36 63.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.35 -37.37 77.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.069 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.3 p -72.01 -38.12 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.253 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.53 85.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 28.7 mm -70.29 -29.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.408 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -48.74 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.6 m-85 -67.33 -40.56 85.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -50.68 -27.79 7.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.839 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -118.3 22.84 11.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.11 44.04 2.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.987 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 22.7 mt -53.32 -38.24 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.01 64.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -40.69 86.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 4.2 pp -76.44 -28.34 56.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -37.93 85.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.501 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.84 -31.09 28.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -82.68 -49.6 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.093 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 53.4 m -72.06 -41.33 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.47 134.87 22.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.95 165.3 32.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.68 -29.43 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -38.34 75.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -74.49 -177.35 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.25 142.33 25.75 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.55 142.02 61.15 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -99.1 24.35 32.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.624 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 64.16 17.1 10.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.714 0.292 . . . . 0.0 111.193 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.54 -51.99 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.5 -41.91 14.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.307 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -41.77 96.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.419 ' CE1' HG22 ' A' ' 306' ' ' VAL . 50.3 t80 -72.05 -44.41 63.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.808 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.424 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 1.9 mtp -58.26 -39.76 80.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.662 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -65.76 -43.76 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 0.7 OUTLIER -65.95 -34.54 78.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 302' ' ' TYR . 67.9 t -78.75 -24.39 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.98 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.058 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 pp -102.17 -24.7 13.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 305' ' ' THR . 1.1 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.162 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.779 0.241 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 tp -98.74 29.01 3.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.41 ' CG ' ' HG3' ' A' ' 166' ' ' GLU . 63.1 m-85 -62.66 -30.02 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.52 -45.57 79.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -45.18 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.13 -50.25 71.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -50.96 64.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -54.43 -42.35 70.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.6 mt -54.22 -46.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.19 -37.26 28.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -49.75 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -54.09 -43.57 70.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.035 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.12 67.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.19 -24.74 63.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.719 0.295 . . . . 0.0 111.051 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 18.8 mttm -76.38 -33.94 58.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.37 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.93 -18.72 55.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.039 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.07 -34.77 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -116.23 -25.0 3.66 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.347 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 5.4 t 69.71 72.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.84 125.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.85 138.74 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.29 113.05 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.75 13.83 15.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.3 161.13 14.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.39 131.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.46 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 9.3 pt -119.84 125.55 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.767 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 t -95.55 141.31 29.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 13.7 m-20 -90.4 -161.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.57 63.06 0.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.9 31.3 18.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.214 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.8 -33.58 8.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.641 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.87 -158.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.28 93.04 1.94 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.737 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -78.08 155.26 30.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.4 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -100.16 117.78 35.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -73.01 143.49 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.06 -111.07 2.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.598 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.5 mt -96.11 154.37 38.86 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.704 0.288 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -65.73 -27.35 52.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.324 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt 42.48 31.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.728 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.49 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.641 0.257 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mt -129.15 137.61 56.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 0.0 111.325 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' A' ' 42' ' ' PRO . 62.4 m-85 -146.43 167.87 22.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.09 149.55 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.95 146.92 45.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 152.23 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtp -96.48 37.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.31 30.12 19.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.95 179.46 6.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.02 171.87 12.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.16 174.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 t -81.41 157.36 25.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.3 130.87 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.15 -90.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.574 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -99.14 30.52 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.05 -44.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.61 88.66 2.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.92 80.91 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.71 148.19 28.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.808 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.68 155.37 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -148.13 126.95 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 116.22 28.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.682 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.46 137.63 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.69 147.22 63.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.46 83.5 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.89 -63.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.243 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -46.48 131.28 11.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -140.36 80.08 1.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.52 -76.17 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.45 -28.18 32.67 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.616 2.211 . . . . 0.0 112.299 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 tp -73.08 -33.27 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -30.62 70.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 p -76.13 -37.98 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 59.8 tt0 -74.41 -39.11 62.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.5 -52.47 63.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 11.3 t80 -71.03 -45.83 63.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.993 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 83' ' ' GLU . 5.7 m-85 -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.461 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.43 -48.04 36.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.645 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -87.75 -47.52 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.701 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 86' ' ' PHE . . . -77.49 -50.23 13.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.886 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.51 32.32 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.708 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.04 125.91 89.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.48 -28.2 84.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.44 2.094 . . . . 0.0 112.444 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.35 -32.89 43.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.176 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -79.22 -52.65 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.286 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.71 -52.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.228 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.6 -50.6 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -64.66 -42.58 95.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -58.53 -54.2 49.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.93 -36.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -75.11 -27.81 59.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.316 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -78.78 -38.74 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.499 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.71 -2.42 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.335 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.12 30.44 18.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 110.643 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.1 mt -50.15 -31.12 12.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.92 -56.62 0.54 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.29 151.46 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.682 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.92 -66.88 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.09 -14.37 3.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.11 125.29 77.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.629 0.215 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.31 152.76 7.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 112.249 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -80.19 115.48 19.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.421 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 13.3 t80 -93.24 115.76 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -91.8 -40.98 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.224 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.79 -174.63 46.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.76 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 p -131.03 158.05 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.02 179.45 20.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.353 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.99 158.85 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.961 0.41 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.62 114.61 11.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.602 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -91.4 142.26 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 123' ' ' GLY . 4.0 tttt -130.57 157.53 42.46 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.98 51.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.632 0.253 . . . . 0.0 111.428 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 121' ' ' LYS . . . 144.2 -18.27 2.11 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.897 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -126.4 142.96 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.68 138.29 46.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.477 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 126' ' ' TYR . 2.7 m-85 -125.7 134.64 51.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.959 0.409 . . . . 0.0 111.334 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -124.13 138.26 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.467 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.46 ' CZ ' ' HB ' ' A' ' 29' ' ' ILE . 23.2 p90 -147.03 168.73 20.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.275 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -136.67 146.44 45.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.6 mm -96.0 135.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -143.49 165.28 27.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.69 130.09 41.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.443 ' CD ' ' CD2' ' A' ' 187' ' ' TYR . 3.6 ttt-85 -57.73 143.06 43.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -113.14 166.89 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.79 -83.2 1.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -133.92 127.01 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 3.0 m-20 -55.35 155.75 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.08 -23.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -65.43 -42.91 91.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.134 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -61.5 -29.89 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.4 mt -75.39 -28.54 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 10.3 t80 -59.53 -49.37 78.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -28.01 67.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.24 -23.1 65.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.326 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 5.7 m-20 -96.4 15.63 20.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.166 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 88.71 46.4 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.52 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.2 19.45 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 33.3 mtt180 -147.14 -179.09 6.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 153' ' ' THR . 0.1 OUTLIER -132.84 144.59 50.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 p -81.91 155.38 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.36 68.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -71.8 -36.06 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 149' ' ' PHE . 1.7 m -72.75 -42.26 64.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.05 -54.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.219 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 71.8 mt -54.89 -47.15 74.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.665 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.17 -41.17 90.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.0 m -54.56 -42.4 70.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.49 -39.61 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -64.97 -46.34 81.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.726 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.85 -34.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.765 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.3 mt -62.34 -35.89 80.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.668 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.17 -42.26 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.9 mt -71.41 -34.78 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.75 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.77 -39.05 79.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.68 -37.23 79.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -66.78 -54.85 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.713 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 43.5 pt -63.12 -27.28 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -77.9 -38.35 45.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.459 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -10.9 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.981 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.51 4.8 26.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.821 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 71.5 48.93 0.31 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -139.68 139.05 36.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 12.3 m -137.92 169.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 1.4 p80 -147.13 -54.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.28 31.98 68.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.376 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -136.74 81.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.3 mt -115.61 117.85 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -159.42 -176.6 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -80.78 1.91 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.479 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.08 1.4 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 110.329 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -124.82 -12.94 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.287 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 5.5 mt -108.48 123.32 48.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.98 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -127.9 160.96 30.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.4 mt -95.04 149.34 21.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.022 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.7 132.58 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.443 ' CD2' ' CD ' ' A' ' 133' ' ' ARG . 22.3 t80 -68.58 -61.83 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.418 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -63.15 -18.51 63.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.24 75.26 74.87 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.55 89.92 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.536 2.157 . . . . 0.0 112.066 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.95 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.107 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.54 149.86 23.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 2.9 p -112.45 147.99 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.124 0.488 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 24.7 m-85 -126.47 157.32 38.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.974 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.405 HD23 ' CE1' ' A' ' 198' ' ' TYR . 26.2 tp -103.32 115.83 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 5.2 t -103.56 137.38 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.134 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.16 130.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.724 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.5 m-85 -103.02 7.95 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.195 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 80.99 -55.25 4.78 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.17 -32.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.579 0.228 . . . . 0.0 111.53 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.29 94.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.746 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.29 149.06 49.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.82 78.18 2.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.768 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.455 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 42.2 p90 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.3 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -169.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 225' ' ' ILE . 20.3 tt -139.13 31.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.031 0.443 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -94.63 21.88 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.709 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 179' ' ' LYS . 0.5 OUTLIER 168.58 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.638 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.2 p -60.01 150.14 30.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -177.71 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.96 -35.43 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -29.89 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.07 77.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -33.57 76.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -86.12 4.4 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.393 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.84 -2.33 83.71 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.884 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 t -63.77 133.73 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.844 0.354 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.4 150.13 89.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.92 -35.01 36.97 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.518 2.146 . . . . 0.0 112.234 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.429 ' HA ' ' CD2' ' A' ' 204' ' ' TYR . 21.1 t 67.62 -69.62 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.6 ttp-105 -166.18 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -71.73 -32.77 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.5 96.25 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.31 -43.34 91.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.24 -38.51 91.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.8 -31.02 69.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 7.0 mt -75.9 -42.38 39.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.77 -46.27 87.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.684 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.77 -25.42 44.12 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.88 -31.53 45.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.414 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 97.2 m -54.22 -48.73 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -30.54 71.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.28 -45.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.201 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -27.37 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.512 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.414 ' CZ3' ' HB3' ' A' ' 250' ' ' CYS . 17.2 m0 -76.99 -32.66 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.434 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.15 -35.51 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 m -96.27 0.59 51.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.599 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.35 96.29 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.332 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 33.4 m80 61.74 154.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.469 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -121.68 164.26 25.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.823 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 60.0 Cg_endo -72.62 57.64 3.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.641 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 5.8 p90 179.35 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -92.47 13.44 19.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -59.4 5.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 4.6 m-80 -129.95 -26.17 2.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.417 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 83.6 mt 72.75 11.19 5.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -16.22 49.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.222 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -132.16 99.97 15.9 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.791 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.95 12.07 2.78 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -49.98 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.9 p90 -79.92 -26.23 40.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 15.1 t -60.67 -45.73 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.37 -31.96 62.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.039 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.13 -47.79 33.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.174 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB3' ' CE2' ' A' ' 278' ' ' TYR . 1.5 m -66.84 -35.99 81.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -64.77 -49.62 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.201 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.7 mt -66.91 -30.14 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.307 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -52.05 7.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 285' ' ' LEU . 10.7 m-85 -56.68 -31.96 64.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -27.86 65.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.66 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -130.07 30.29 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -150.19 38.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 282' ' ' ILE . 21.2 mt -52.98 -49.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.03 -49.6 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.3 p -65.33 -31.6 72.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.277 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 278' ' ' TYR . 1.4 tt -68.7 -38.42 80.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.488 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 290' ' ' PHE . 0.0 OUTLIER -65.42 -38.16 89.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.809 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -25.68 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -82.75 -54.9 4.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.403 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -41.3 78.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 286' ' ' MET . 19.4 m-85 -102.26 152.74 38.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -51.03 -61.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.663 2.242 . . . . 0.0 112.462 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -146.53 -45.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.013 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 63.62 56.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -65.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.744 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -62.42 -56.55 29.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 295' ' ' LYS . 18.6 Cg_endo -60.08 -164.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.4 2.066 . . . . 0.0 112.235 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 135.14 37.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.543 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -33.86 18.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.495 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' A' ' 303' ' ' MET . 20.2 mm -74.68 -46.61 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.27 -45.69 17.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -61.71 -38.82 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.489 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -70.05 -43.36 71.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.873 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 299' ' ' ILE . 4.5 mtp -65.51 -37.2 86.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -51.38 70.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.617 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 p -60.96 -34.72 75.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 39.6 t -73.36 -24.66 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.191 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -76.67 -31.89 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.4 mt -104.33 -10.9 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.065 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 N--CA 1.466 -0.119 0 CA-C-O 120.765 0.236 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.87 53.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -56.04 -32.81 64.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -63.27 -34.34 77.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.82 -44.38 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.27 -45.43 80.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -58.45 -47.56 83.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -39.42 81.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.12 -44.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.28 -48.21 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 -49.86 75.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -58.52 -40.36 82.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.77 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.08 -29.29 59.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.399 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.01 -39.47 93.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -30.72 69.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 331' ' ' ILE . 16.1 pt -106.59 27.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.18 38.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.6 164.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -176.76 37.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.814 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.31 85.13 4.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t 65.03 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 25.8 71.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.593 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.77 137.56 41.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.18 141.29 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.7 pt -119.91 154.61 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.151 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.2 m -95.49 139.47 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.675 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 17.0 p-10 -98.3 -149.81 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.0 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -38.09 18.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.402 . . . . 0.0 110.324 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.99 -0.12 33.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.837 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER 85.02 16.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.289 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.77 173.52 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.69 78.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 110.532 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.46 128.56 37.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -88.21 124.02 33.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.53 122.65 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.14 -121.56 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.52 164.56 17.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.07 118.43 5.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.542 2.161 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 pt -107.02 30.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 6.4 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.69 104.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 23.3 m-85 -129.55 163.59 25.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.4 mt -73.29 165.91 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.5 152.46 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.273 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -136.34 159.74 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.29 29.85 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 t30 58.97 -168.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t 61.56 45.27 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -169.03 126.33 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.988 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.39 116.11 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m 60.75 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.24 -57.36 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -151.37 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.551 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 m -100.84 37.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.02 30.67 5.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.72 119.55 72.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -87.5 30.17 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.797 2.331 . . . . 0.0 112.927 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.76 148.13 28.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.12 153.88 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.67 134.59 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -121.58 116.76 25.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.68 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 t -113.37 149.54 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 136.19 20.03 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.93 82.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.514 2.143 . . . . 0.0 112.355 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 53.62 29.67 9.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.9 120.77 33.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.61 41.52 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.1 -79.09 1.43 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.09 -43.41 2.4 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.538 2.159 . . . . 0.0 112.35 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.9 tp -60.13 -30.1 69.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.46 -32.3 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.7 p -77.76 -31.7 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -68.33 -46.58 69.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.01 -45.82 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -60.35 -29.67 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 2.5 m-85 -65.9 -60.3 2.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -17.84 64.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.773 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -18.99 60.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.59 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -62.22 -15.28 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -47.95 130.2 11.88 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.0 -24.32 19.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -79.32 -33.2 43.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.4 -42.51 25.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.8 mt -65.72 -55.26 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -50.76 -31.94 18.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -34.67 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.28 -46.06 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 104' ' ' LYS . 41.5 mm -64.48 -36.52 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.238 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -75.01 -27.72 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -76.65 -38.8 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.342 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -105.46 -3.73 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.254 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 100' ' ' ILE . 16.7 tttt 60.09 30.9 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 mt -49.93 -32.08 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.253 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -55.91 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.98 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.408 ' OH ' ' CE1' ' A' ' 194' ' ' TYR . 30.2 t80 -142.21 138.59 31.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.758 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 167' ' ' TYR . 13.2 tp -114.68 -66.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 132.46 -7.21 5.3 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.822 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.7 t -71.66 136.0 83.38 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.666 0.233 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.5 142.58 80.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.59 2.193 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.97 121.72 26.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -98.7 131.36 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -110.39 -40.83 4.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.065 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.97 -174.58 46.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.655 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -132.97 164.05 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -149.24 174.65 28.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.275 -0.965 . . . . 0.0 113.168 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 mt -145.23 145.15 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.716 0.293 . . . . 0.0 110.741 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -121.81 135.8 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -113.65 121.44 44.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -138.2 126.24 22.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 55.93 20.6 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.364 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.98 -4.99 61.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.903 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -96.04 129.08 43.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 110.776 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.4 t -100.44 122.99 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -105.81 143.59 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.755 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 129.27 54.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.462 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 11.2 p90 -141.52 159.24 42.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 tmm? -128.13 147.59 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.2 mt -123.32 112.76 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 111.377 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -121.96 173.3 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.94 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.99 149.66 2.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -87.51 168.09 13.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.429 ' CG ' ' HB2' ' A' ' 184' ' ' LEU . 80.6 m-85 -141.46 160.82 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.808 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.77 -94.57 0.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.96 130.69 55.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.418 ' HA ' HD22 ' A' ' 184' ' ' LEU . 6.0 m-20 -57.67 159.83 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.4 -31.01 68.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.585 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 2.0 mm100 -59.44 -45.14 92.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.387 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.49 70.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.378 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.9 mt -80.17 -26.94 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 16.3 t80 -66.88 -50.84 61.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -29.31 68.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.572 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.5 -24.7 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.084 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.1 m-80 -94.47 15.66 17.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 86.84 45.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.14 19.71 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.326 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 23.9 mtm180 -145.17 -175.63 4.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.93 171.17 14.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 m -97.08 157.64 15.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -72.54 -42.62 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -60.75 -43.63 97.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.89 -49.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 33.2 mt -60.52 -47.28 86.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.958 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -59.83 -46.78 88.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.6 mt -69.97 -43.54 71.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.2 p -54.4 -34.42 61.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.71 -41.41 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -45.74 77.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.688 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.4 mt -63.65 -34.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.762 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.38 -40.19 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -38.27 84.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.52 -39.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 47.7 mt -59.11 -45.07 91.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.591 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HG2' ' CG ' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -66.7 -33.95 76.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.658 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.421 ' CD2' HD21 ' A' ' 108' ' ' LEU . 60.6 t80 -65.51 -51.85 57.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.618 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.0 pt -72.28 -27.28 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.415 ' CE1' HG11 ' A' ' 174' ' ' VAL . 1.5 m-70 -76.16 -32.48 59.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -16.93 62.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -101.38 3.61 40.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.818 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 78.08 45.36 0.07 Allowed 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -134.31 142.31 47.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.507 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 204' ' ' TYR . 28.9 m -142.22 138.88 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.138 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.91 -67.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 81.31 36.54 20.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.626 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.87 -89.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.96 -0.141 . . . . 0.0 110.919 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.0 mp 41.38 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.832 0.349 . . . . 0.0 111.718 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 24.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.297 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . 65.96 9.86 6.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.65 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.8 p -113.63 1.48 14.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -134.71 4.76 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.146 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 1.9 mt -108.48 117.71 34.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.719 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -126.78 146.66 50.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.347 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 192' ' ' GLN . 21.9 mt -89.84 149.66 22.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.84 128.01 34.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.446 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 19.7 t80 -71.0 -58.82 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -21.6 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.603 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -129.24 71.08 82.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 86.25 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.52 2.147 . . . . 0.0 112.126 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -177.98 37.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -178.15 172.37 1.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.388 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.409 ' HB ' ' CD2' ' A' ' 185' ' ' LEU . 2.1 p -132.64 147.63 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.391 . . . . 0.0 110.693 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 22.6 m-85 -127.27 156.88 41.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.986 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.8 tp -103.93 115.83 31.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.649 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.6 m -107.41 179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.32 108.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.709 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.39 28.18 8.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.74 41.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.966 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.63 11.67 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 110.947 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -100.24 68.38 1.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.239 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -126.21 149.37 49.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.253 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -54.26 96.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.428 ' CD1' HG22 ' A' ' 174' ' ' VAL . 44.6 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -140.96 -178.34 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.431 ' O ' HG12 ' A' ' 225' ' ' ILE . 8.7 tt -133.74 10.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.347 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.405 ' O ' ' CD2' ' A' ' 227' ' ' PHE . 27.4 tt0 -67.74 -13.67 62.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.313 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 226' ' ' GLU . 8.5 m-85 -165.14 29.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.68 130.45 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.54 -47.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.236 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.0 mt -57.03 -59.27 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.153 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.65 -28.18 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.17 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -57.4 -27.61 62.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.299 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.53 1.87 38.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.341 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.52 21.1 40.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.686 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.4 t -80.51 158.5 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.72 130.65 63.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.44 74.51 3.68 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 204' ' ' TYR . 0.6 OUTLIER -77.39 73.31 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.003 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 73.25 -57.62 0.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.334 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -58.94 -28.49 66.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -80.21 -33.97 30.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.528 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.9 -44.65 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.88 -44.4 86.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.299 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.28 -29.32 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 73.0 mt -76.02 -37.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 41.8 tp -66.44 -36.28 82.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.709 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.23 -28.02 72.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.41 -25.93 46.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 62.7 m -66.62 -32.84 74.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.011 0.434 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.24 -52.59 64.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.174 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.17 -38.55 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.625 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.71 -39.95 94.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.219 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -82.28 -32.34 29.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.9 mt -83.58 -37.37 23.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 111.475 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.9 m -96.21 -9.25 30.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.499 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.1 94.35 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.444 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 18.8 m80 62.28 150.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.429 HD21 ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -111.24 158.49 35.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.69 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 45.2 Cg_endo -68.32 61.94 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.557 2.171 . . . . 0.0 112.413 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.548 ' HA ' ' CD1' ' A' ' 270' ' ' TYR . 4.8 p90 175.64 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.463 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.9 tt0 -88.61 10.91 18.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.34 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.3 -47.61 81.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -131.97 -28.32 1.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.399 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.5 mt 71.55 11.29 6.52 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -16.25 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.278 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -131.23 100.75 16.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.94 13.38 2.36 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.638 2.225 . . . . 0.0 112.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -73.73 -46.66 44.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.5 p90 -83.92 -26.44 29.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 28.7 t -63.03 -39.59 85.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.092 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -52.62 10.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.312 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 75.2 m -56.21 -40.22 73.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.331 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.6 -44.67 93.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 27.9 mm -71.1 -33.08 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.734 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -81.08 -52.17 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -61.99 -35.42 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.024 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -26.5 42.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.359 . . . . 0.0 110.751 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -118.28 20.6 13.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -142.52 45.34 1.62 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.083 0.468 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.427 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 26.7 mt -50.45 -40.17 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.65 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.174 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.96 -38.37 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 1.1 pp -74.01 -39.69 63.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.421 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 8.5 mtt -69.0 -44.29 73.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -39.02 92.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.91 -24.87 32.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.889 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 75.9 m -92.02 -41.35 10.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.66 0.267 . . . . 0.0 111.713 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.74 155.27 58.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.45 179.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.634 2.223 . . . . 0.0 112.278 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -111.25 67.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.67 88.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.9 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 61.41 153.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -93.26 121.7 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.15 -61.91 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.54 -24.53 30.26 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.02 -64.37 0.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 25.8 mm -72.96 -43.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.51 -42.16 10.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.506 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.49 93.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.41 ' CD2' HD21 ' A' ' 320' ' ' LEU . 25.6 t80 -69.51 -40.07 77.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.427 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.9 mtp -68.31 -38.6 81.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.68 -45.36 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.98 -32.88 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.389 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 36.5 t -77.24 -24.88 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -37.72 42.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.164 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.53 -14.54 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.363 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.894 0.289 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.27 -22.28 41.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.086 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.405 ' CG ' ' HG2' ' A' ' 166' ' ' GLU . 34.0 m-85 -52.84 -39.43 62.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 111.047 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.63 -36.48 78.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.0 -45.89 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 302' ' ' TYR . 35.9 mt -56.47 -38.24 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.032 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -43.62 88.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.34 -35.54 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 302' ' ' TYR . 70.9 mt -58.35 -47.12 88.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.025 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 47.4 mt -73.64 -51.63 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -49.71 73.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.53 -39.89 74.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -28.14 72.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.05 -32.52 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -66.88 -30.2 70.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.87 -18.89 55.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.532 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.8 84.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 111.333 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 127.23 -33.9 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.704 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.38 101.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.6 mttm 61.71 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.82 115.79 18.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.892 0.377 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.19 110.49 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.82 25.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.554 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -55.62 177.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.41 131.31 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 28.9 pt -118.41 154.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.1 t -95.54 138.49 33.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.977 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.2 -160.92 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -77.18 -43.8 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 109.967 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.84 -2.2 35.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER 87.31 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 30' ' ' THR . 11.4 mtpt -74.13 178.19 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.64 77.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.405 ' HB2' HG13 ' A' ' 29' ' ' ILE . 67.2 m95 -72.75 141.76 48.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 127.88 46.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.974 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.7 t -92.83 158.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.046 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 -125.13 2.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.81 164.03 37.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.28 -180.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.544 2.162 . . . . 0.0 112.387 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -157.37 -43.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.215 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.503 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 1.9 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.947 0.403 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.07 115.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 15.4 m-85 -140.17 165.2 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.97 156.71 39.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.15 159.39 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.075 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.12 155.63 40.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.3 ptm -101.07 38.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.92 111.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -175.22 3.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 p -64.93 -45.45 85.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -179.04 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.24 -175.68 5.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.47 146.29 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.02 -89.37 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -89.45 -30.35 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.98 53.26 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.48 96.31 41.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.52 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.691 2.261 . . . . 0.0 113.025 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.1 m -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.33 158.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.34 129.9 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -111.1 123.61 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.451 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 t -113.13 141.69 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.472 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.38 133.79 24.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.605 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HA ' ' CE2' ' A' ' 126' ' ' TYR . 37.1 Cg_endo -65.59 88.12 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.439 2.093 . . . . 0.0 112.326 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m 54.44 -171.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 60.42 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -135.36 -178.22 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.18 -82.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.43 -41.64 6.31 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.62 2.213 . . . . 0.0 112.374 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.46 -30.64 71.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -32.72 72.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -78.37 -43.34 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.6 tt0 -64.07 -46.36 84.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.6 -51.15 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -51.9 66.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 198' ' ' TYR . 15.5 t80 -63.99 -33.73 76.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 83' ' ' GLU . 3.4 m-85 -72.47 -46.23 55.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -27.17 65.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.7 -47.45 8.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 171' ' ' HIS . . . -103.06 -33.68 9.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.96 26.87 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.9 133.74 65.36 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.33 -32.84 89.95 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -37.11 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.157 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -58.01 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.3 mt -53.27 -49.38 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.407 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.56 -43.34 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 111.089 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -28.6 64.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -51.06 11.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.2 -37.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.257 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -74.86 -27.8 60.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.402 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.4 p -82.15 -38.77 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.527 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -1.63 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.456 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 32.84 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 mt -83.2 58.94 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.58 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.92 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.653 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.18 122.05 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.91 0.386 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.86 159.77 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.47 17.09 57.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.86 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.19 127.12 43.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.594 0.197 . . . . 0.0 111.072 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.05 141.15 48.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.281 1.987 . . . . 0.0 112.283 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.47 115.43 22.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -96.88 127.63 43.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.706 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 7.2 m95 -103.04 -40.81 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -177.68 46.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.595 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -135.32 161.79 34.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.607 0.241 . . . . 0.0 110.545 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -153.79 -179.42 29.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.647 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.32 159.83 42.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.037 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -132.11 141.7 49.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.831 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.43 125.29 47.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 126.2 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 51.89 23.82 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.89 21.24 40.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.58 159.33 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.769 0.318 . . . . 0.0 110.71 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m -112.74 120.5 41.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 74' ' ' PRO . 22.1 m-85 -118.18 121.34 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.788 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -107.77 129.28 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.54 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 24.0 p90 -140.04 160.3 40.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 111.235 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -128.16 140.03 52.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 mt -110.63 111.82 37.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.453 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -127.82 173.22 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.27 141.68 45.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -73.81 161.92 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.96 170.38 14.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.97 -52.16 1.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.6 m -157.93 171.89 19.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -98.82 153.73 18.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 2.2 mm? -60.03 -33.47 72.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -61.73 -46.52 89.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.848 0.356 . . . . 0.0 110.282 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -58.71 -28.57 65.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 149' ' ' PHE . 35.1 mt -75.32 -26.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -58.13 -47.65 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.683 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.28 -26.74 68.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.791 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.85 -20.93 61.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 17.0 m120 -94.57 4.19 54.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 85.32 45.86 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.043 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 19.77 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.273 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -162.99 117.43 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 153' ' ' THR . 1.4 m-85 -63.56 -172.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.43 158.08 29.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.738 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -34.1 73.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -74.71 -37.74 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 149' ' ' PHE . 1.7 m -73.7 -40.75 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.04 -44.51 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 22.9 mt -58.33 -54.26 49.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -56.99 -46.99 81.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.0 mt -65.76 -38.41 88.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -56.87 -34.11 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.708 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 9.7 mt -73.31 -45.5 55.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -61.73 -45.07 95.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.791 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -65.83 -33.04 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.932 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.706 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -40.62 91.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.94 -42.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.12 -43.77 74.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.973 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HG3' ' CD1' ' A' ' 317' ' ' TYR . 2.1 tt0 -66.0 -37.3 85.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.799 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.82 -54.66 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.1 pt -59.01 -27.6 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.174 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.42 ' CE1' HG13 ' A' ' 174' ' ' VAL . 2.2 m80 -69.05 -44.17 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.19 -14.45 61.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -99.03 2.87 46.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 72.89 43.05 0.44 Allowed 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.094 0.473 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.402 ' CD1' ' HB2' ' A' ' 201' ' ' ALA . 0.7 OUTLIER -140.88 110.38 6.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 204' ' ' TYR . 19.3 m -131.16 139.48 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.619 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.417 ' CD2' ' O ' ' A' ' 198' ' ' TYR . 2.0 t60 -175.76 160.26 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.534 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -109.43 71.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 30.98 2.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.74 94.49 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.872 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.65 24.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.27 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . 68.2 8.21 6.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.806 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -110.48 0.24 17.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -141.65 7.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.9 OUTLIER -108.66 114.45 28.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.048 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.75 148.16 48.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 192' ' ' GLN . 6.6 mt -95.03 149.25 21.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.949 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.512 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 1.0 OUTLIER -89.38 132.37 35.0 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.111 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -122.21 -31.38 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -24.29 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.796 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 190' ' ' PRO . 0.7 OUTLIER -166.16 -57.86 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.772 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 189' ' ' ASN . 24.3 Cg_exo -61.25 -133.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.306 2.004 . . . . 0.0 112.376 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 186' ' ' ASN . 0.2 OUTLIER 171.92 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.247 -0.283 . . . . 0.0 111.72 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 1.2 mt-30 -85.95 -169.13 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.475 ' HB ' ' CD2' ' A' ' 185' ' ' LEU . 3.5 p -109.58 147.94 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 11.0 m-85 -129.5 151.42 50.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.035 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.415 HD23 ' CZ ' ' A' ' 198' ' ' TYR . 14.2 tp -104.04 115.97 31.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.508 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.3 131.88 60.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 20.0 t0 62.61 124.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 86' ' ' PHE . 10.1 m-85 -105.45 14.85 28.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.201 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 83.08 -55.28 5.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.626 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mp -139.18 -42.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.649 0.261 . . . . 0.0 111.17 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.402 ' HB2' ' CD1' ' A' ' 173' ' ' TYR . . . 64.17 101.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.688 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 44.4 t80 -115.73 148.99 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.983 0.42 . . . . 0.0 111.017 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -95.57 78.21 3.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.43 ' CD1' HG12 ' A' ' 174' ' ' VAL . 7.8 p90 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.524 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.79 65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.916 0.388 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.63 -18.46 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -59.92 -30.86 69.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.246 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -149.25 34.87 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.305 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.6 t -81.51 116.83 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.303 . . . . 0.0 110.899 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 m -64.85 153.43 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.62 -30.45 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 -40.28 74.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.88 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.53 -25.52 64.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.4 7.56 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 78.56 23.42 64.96 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.714 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.72 128.19 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 202' ' ' TYR . . . -82.7 -53.71 0.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 40.6 Cg_exo -56.88 94.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.466 2.111 . . . . 0.0 112.225 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 m -106.48 120.07 40.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.405 ' HG3' ' CD2' ' A' ' 204' ' ' TYR . 7.8 mtm105 -125.61 -47.8 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.44 -14.12 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.52 -49.68 71.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.692 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.53 -38.99 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 57.8 mt -74.44 -42.55 58.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.79 -35.13 72.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 11.7 mt -70.18 -44.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 23.8 tp -59.43 -41.47 89.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.763 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -60.57 -31.37 74.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.177 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -78.33 -25.72 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 67.2 m -68.03 -32.92 73.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.7 mmm -58.54 -53.48 57.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.198 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.93 -39.86 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -59.28 -40.15 85.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -82.43 -46.17 13.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.89 -25.87 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.8 m -104.5 0.67 29.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.3 88.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.374 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.5 m170 62.9 163.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -131.45 164.26 43.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.713 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.72 62.54 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.419 2.079 . . . . 0.0 112.407 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 4.0 p90 177.24 -37.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.154 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.3 tt0 -91.88 12.58 21.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.316 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.76 -53.76 54.25 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.3 m-20 -131.38 -29.1 1.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.367 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 54.6 mt 73.89 9.87 4.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -77.02 -16.03 59.42 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.161 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.46 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.7 m-20 -136.21 99.89 10.79 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.799 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.12 16.63 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.647 2.231 . . . . 0.0 112.768 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -79.95 -44.93 19.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.347 . . . . 0.0 110.775 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 3.4 p90 -80.55 -26.21 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 27.6 t -62.96 -38.08 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.261 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -75.65 -47.32 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.114 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -52.17 62.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.33 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.6 m -55.52 -39.44 70.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.361 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.56 -44.88 96.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.356 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.5 mt -70.71 -31.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.595 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -81.06 -45.5 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 0.0 111.466 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.456 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.2 m-85 -70.85 -34.13 71.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.54 -31.39 62.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.365 . . . . 0.0 110.667 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.31 16.87 23.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.952 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -139.73 44.45 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.753 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 30.5 mt -50.58 -39.1 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.89 -27.85 61.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -38.36 27.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 1.6 pp -73.25 -39.36 65.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.437 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 10.6 mtt -71.16 -38.28 72.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.2 -41.22 97.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -24.81 33.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.3 m -89.78 -41.16 12.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.575 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.17 150.76 37.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.89 178.88 4.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.209 . . . . 0.0 112.291 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.87 30.66 4.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -88.57 -32.2 18.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -134.86 169.64 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.82 138.82 19.9 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.51 121.24 9.14 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.317 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -147.98 -54.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -62.93 -61.57 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.91 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 18.0 mm -76.02 -43.34 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.07 -47.92 17.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.517 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -59.31 -37.74 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 323' ' ' ILE . 85.6 t80 -72.11 -40.68 67.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.761 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.437 ' HG3' ' HE1' ' A' ' 286' ' ' MET . 2.5 mtp -68.3 -41.06 81.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.632 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.4 -47.55 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 3.3 p -60.64 -36.52 78.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 26.1 t -74.89 -24.72 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.022 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -30.94 54.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.52 -8.77 18.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.727 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.191 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 CA-C-O 120.828 0.262 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.17 25.73 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.413 ' CD1' ' HG3' ' A' ' 166' ' ' GLU . 86.7 m-85 -64.75 -34.19 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.35 -30.9 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.05 -46.01 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 62.1 mt -57.88 -48.86 78.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -30.64 66.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.05 -41.34 35.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 302' ' ' TYR . 17.4 mt -54.62 -41.38 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.8 -49.8 17.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.08 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.02 -49.92 75.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.192 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -58.51 -42.27 87.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.01 56.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.456 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.67 -28.76 70.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.732 0.301 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 4.0 mtmt -67.7 -28.54 67.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -18.69 55.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.4 pp -114.12 16.95 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 108.27 43.22 1.29 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.251 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 17.7 m 58.76 177.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.218 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.64 145.79 32.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.35 162.68 11.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.12 120.75 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.16 -24.78 29.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.6 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.16 153.52 14.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mt -123.05 140.11 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 25.8 pt -119.64 154.67 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 6.7 p -95.38 141.33 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.21 -161.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.64 -37.4 36.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -83.2 4.5 26.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.3 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 77.19 30.0 0.55 Allowed 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.4 mtpp -76.17 175.82 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.032 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.32 77.34 1.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 0.0 110.678 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -71.89 128.3 35.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.972 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -86.42 127.97 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.05 125.21 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.42 -125.6 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.555 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.76 156.92 49.26 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.99 131.35 19.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.586 2.191 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.85 -36.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.555 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.878 0.37 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 23.4 mm -96.86 122.97 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -145.91 168.28 21.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -82.26 154.81 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.35 157.79 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.23 154.86 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.56 51.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 60.51 101.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.99 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -121.81 179.43 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 144.49 32.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 67.5 -72.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.11 -169.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.89 94.48 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.0 -91.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.532 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.94 30.44 4.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.33 65.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.7 94.48 48.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.76 36.46 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.286 2.657 . . . . 0.0 112.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.72 148.24 29.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.57 144.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.059 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.4 123.62 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -105.44 124.22 49.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -113.96 141.62 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.07 150.62 59.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.66 86.0 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.517 2.145 . . . . 0.0 112.215 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.6 -71.5 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -161.37 99.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -110.55 -26.26 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.6 -154.65 7.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.597 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.27 24.84 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.301 2.667 . . . . 0.0 112.687 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.77 -42.29 92.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.14 -44.11 95.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -67.22 -34.34 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.34 -42.91 74.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -57.57 -52.08 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -46.07 78.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 201' ' ' ALA . 12.2 t80 -70.54 -30.74 67.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -67.56 -46.98 71.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.083 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -79.88 -17.61 52.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.552 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -47.64 60.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.757 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 -34.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.401 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -53.95 -20.8 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -47.46 138.29 8.76 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.659 0.266 . . . . 0.0 111.035 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.7 -18.31 47.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.496 2.131 . . . . 0.0 112.393 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.34 -35.9 40.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -79.3 -45.77 19.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.406 HG12 ' CZ ' ' A' ' 167' ' ' TYR . 62.2 mt -61.05 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -55.45 -33.68 63.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -38.98 63.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -68.95 -42.07 77.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 104' ' ' LYS . 27.3 mt -65.51 -37.5 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.042 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.79 60.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.4 m -80.97 -37.73 28.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.514 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.43 -3.51 20.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.43 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 59.96 31.85 20.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 110.657 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.2 mt -52.4 -28.45 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mttm 76.33 -56.13 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -145.79 154.27 41.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.435 HD23 ' CD1' ' A' ' 167' ' ' TYR . 1.5 tp -127.55 -72.88 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 127.31 1.03 6.77 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.007 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.5 t -76.2 128.5 82.64 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.843 0.321 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.81 143.0 9.79 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -84.25 116.88 23.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.709 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -111.99 -40.68 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.94 -175.95 46.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.95 162.1 35.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.675 0.274 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.15 -175.05 21.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.65 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -145.26 158.9 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -131.84 133.85 45.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -107.79 122.6 47.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 126.22 22.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 57.73 19.51 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.275 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.29 -0.15 61.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.897 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 129.09 47.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -96.14 131.62 42.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.63 148.88 39.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -111.4 125.27 53.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 10.8 p90 -132.24 160.23 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.5 ttm -128.12 142.64 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.767 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 mt -116.24 116.76 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.299 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -128.88 173.16 10.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.36 144.57 20.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.049 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.18 179.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 196' ' ' VAL . 49.5 m-85 -151.69 145.47 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.73 -107.87 0.82 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -113.4 130.25 56.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -57.76 155.91 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.04 -23.14 65.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.733 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -68.61 -42.0 78.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.904 0.383 . . . . 0.0 110.409 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -62.8 -35.36 79.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.039 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.28 -28.52 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.481 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 254' ' ' TRP . 48.4 t80 -61.16 -52.43 64.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.8 -30.42 56.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.96 -16.44 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -87.81 -2.93 58.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.135 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 95.74 41.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.063 0.545 . . . . 0.0 110.327 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 61.53 19.13 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.541 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -167.04 125.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.129 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.78 -176.88 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.9 p -113.95 -176.91 3.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -71.8 -33.9 68.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -65.9 -48.08 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.3 p -63.44 -40.22 96.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.78 -53.82 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.21 -46.91 82.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -52.8 61.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.28 -37.01 83.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 38.5 m -58.13 -37.94 75.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.0 mt -67.58 -48.01 68.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.676 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.91 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.9 mt -62.75 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.706 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.84 -35.08 79.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.602 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.62 -38.3 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.4 mt -74.54 -42.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 169' ' ' HIS . 6.9 mt -56.29 -43.13 78.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 32.1 tt0 -66.93 -32.78 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.435 ' CD1' HD23 ' A' ' 108' ' ' LEU . 88.9 t80 -68.22 -50.32 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 26.0 pt -73.41 -27.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.413 ' CD2' HG12 ' A' ' 174' ' ' VAL . 3.6 m-70 -68.46 -32.37 72.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.299 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.98 -17.1 62.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.51 4.74 38.94 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 77.1 5.34 3.25 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.488 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 203' ' ' ARG . 4.6 m-85 -94.24 132.77 38.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.723 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.413 HG12 ' CD2' ' A' ' 169' ' ' HIS . 30.4 m -142.37 139.06 29.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.071 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.447 ' CD2' ' CD1' ' A' ' 168' ' ' ILE . 3.0 p80 -115.67 -40.91 3.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.346 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 59.32 19.11 45.55 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.632 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.07 61.35 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.51 102.56 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.657 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 6.2 mtmm -146.68 -175.48 4.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.687 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -84.75 3.08 39.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.6 p -106.15 -2.82 22.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.05 -2.89 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.351 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.1 mt -108.32 122.68 47.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -131.64 160.63 34.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.76 0.314 . . . . 0.0 110.999 -178.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.5 147.08 23.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 111.194 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.406 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 0.2 OUTLIER -60.98 131.64 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -78.12 -53.72 7.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.77 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.843 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.15 71.81 18.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.969 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.65 101.91 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.16 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -178.0 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -113.24 159.11 19.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.21 148.29 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.99 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 13.0 m-85 -125.95 157.63 37.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.008 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 34.3 tp -103.32 115.97 31.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' A' ' 184' ' ' LEU . 2.3 t -118.18 157.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 54.52 103.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -97.91 -64.31 1.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 95.31 -37.66 3.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.021 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mp -128.74 22.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 86' ' ' PHE . . . -78.39 60.97 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.166 0.508 . . . . 0.0 110.536 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -124.33 149.03 47.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.193 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -55.49 97.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.968 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 47.6 p90 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 179.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 -63.28 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.65 -44.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 271' ' ' VAL . 14.3 mm-40 -159.26 27.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.404 ' CE2' ' HD3' ' A' ' 179' ' ' LYS . 2.7 t80 -94.63 23.8 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 -72.85 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.998 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.99 150.32 5.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.347 . . . . 0.0 111.035 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.23 -31.57 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.5 -31.46 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.22 -30.24 63.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -75.66 -29.33 59.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.08 12.91 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.461 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.45 26.31 74.38 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.534 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.63 144.63 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -58.17 145.13 74.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.83 -36.28 18.86 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.414 2.076 . . . . 0.0 112.23 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.6 m 59.55 33.77 22.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -56.14 0.65 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.555 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -21.76 56.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.145 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -59.03 -32.1 70.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.68 -29.23 45.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.418 ' CD1' ' CD1' ' A' ' 320' ' ' LEU . 18.8 mt -73.84 -29.77 62.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.011 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.3 -31.98 62.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.1 -38.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.92 -31.23 62.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.64 -47.69 80.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.422 ' CE2' ' HE2' ' A' ' 275' ' ' LYS . 51.3 m-85 -78.49 -25.88 45.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 -41.44 70.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.139 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -48.63 80.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.864 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.37 -28.48 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.037 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -80.1 -36.86 34.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.475 ' CD1' ' CE1' ' A' ' 142' ' ' TYR . 20.8 m0 -82.38 -29.89 30.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.426 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.426 HD13 ' CZ ' ' A' ' 290' ' ' PHE . 30.2 mt -67.21 -47.09 71.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.392 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.1 t -98.71 -23.35 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.327 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.429 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 101.79 14.99 27.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.817 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 166.62 170.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.453 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -133.6 159.56 72.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.7 Cg_exo -68.33 59.97 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.748 2.299 . . . . 0.0 112.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 16.2 p90 177.34 -42.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.106 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -95.63 17.2 15.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.529 179.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -58.33 -51.61 69.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.5 t-20 -130.51 -25.92 2.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 77.2 mt 70.03 13.7 7.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.239 0.543 . . . . 0.0 109.611 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -89.81 -14.99 33.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.253 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.477 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 0.5 OUTLIER -134.98 88.61 26.47 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.93 -8.09 22.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.614 2.209 . . . . 0.0 112.664 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -54.56 -50.07 68.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.751 0.31 . . . . 0.0 111.189 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 5.7 p90 -81.73 -26.18 34.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.612 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 59.4 t -60.06 -44.33 94.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.473 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -68.89 -42.27 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -36.55 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.1 m -65.61 -43.67 88.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.422 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.9 OUTLIER -62.93 -44.58 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.69 -29.68 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.435 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -49.82 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.403 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 13.2 m-85 -64.5 -39.94 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.468 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -26.33 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.28 19.07 15.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -143.81 49.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 16.6 mt -54.11 -35.22 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.348 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.82 -29.79 62.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 111.067 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.9 pp -73.9 -29.69 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.4 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 4.9 mmt -64.85 -47.47 77.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.01 -20.93 44.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -82.7 -50.86 8.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.694 0.283 . . . . 0.0 111.399 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.87 -41.13 30.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.334 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 255' ' ' LEU . 12.6 m-85 -104.63 98.92 16.04 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.084 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.92 84.72 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.474 2.116 . . . . 0.0 112.046 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.6 97.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.642 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 56.18 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -161.84 -51.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -151.16 104.74 2.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 -49.1 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.367 2.045 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.62 30.22 0.03 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.39 7.92 6.29 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.737 0.268 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 303' ' ' MET . 28.8 mm -79.57 -46.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.4 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.25 -35.81 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.523 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.48 -41.49 80.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 11.5 t80 -72.11 -34.32 68.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.567 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 65.3 mmm -71.78 -48.22 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.28 -41.41 75.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.1 m -64.44 -42.19 96.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 110.539 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 41.2 t -69.55 -24.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.144 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -71.65 -37.29 70.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 73.7 mt -97.53 -13.53 21.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.607 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.952 0.313 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.427 HD22 ' CD1' ' A' ' 317' ' ' TYR . 5.3 tt -127.93 -74.86 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.427 ' CD1' HD22 ' A' ' 316' ' ' LEU . 35.2 m-85 -70.68 -38.03 73.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.84 -46.58 84.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.066 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -73.33 -45.94 52.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 52.1 mt -58.76 -51.84 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.66 -42.03 70.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -62.36 -46.76 87.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.9 mt -51.03 -47.28 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 52.6 mt -71.54 -48.88 45.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.025 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.31 -49.97 72.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.372 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -39.09 79.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.805 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.01 -33.25 68.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.98 -38.6 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.42 -30.78 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -30.86 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.17 26.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.83 25.94 38.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.728 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 m -91.92 158.34 16.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 179.12 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.7 102.27 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.53 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.89 -28.82 12.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.51 149.51 49.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.864 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mt -117.61 136.85 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.439 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 30.0 pt -111.67 154.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -95.3 141.38 28.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -160.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.094 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.21 -42.97 29.77 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.073 0.463 . . . . 0.0 109.971 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -82.22 2.14 33.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.707 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 23.5 tttp 87.6 28.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -69.51 176.52 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.231 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -127.86 78.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.898 0.38 . . . . 0.0 110.589 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' CE2' ' HE3' ' A' ' 56' ' ' MET . 34.7 m95 -76.39 131.39 39.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -92.43 124.38 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.4 t -75.45 142.34 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -134.58 8.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.74 161.82 22.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.43 173.69 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.521 2.147 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.5 pt -160.08 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.71 118.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -146.37 171.97 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.29 156.91 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.62 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.46 159.61 41.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.058 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.403 ' HE3' ' CE2' ' A' ' 37' ' ' TRP . 2.9 mmt -118.68 72.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 64.43 -77.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 59.15 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -80.13 60.76 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.59 148.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 m 59.48 170.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -118.1 -53.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.45 -169.94 30.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.528 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 t -103.59 39.99 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -156.37 82.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.97 137.61 26.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -87.99 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.985 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 77.2 m -149.7 148.29 29.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.74 144.88 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 8.0 p -131.57 124.38 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.55 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.41 144.3 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.15 140.7 21.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.36 109.31 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.507 2.138 . . . . 0.0 112.314 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.71 178.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -87.17 -171.25 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.84 113.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.4 -168.12 30.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.416 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 -44.49 46.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 112.251 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.6 tp -70.12 -30.08 67.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.01 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -60.87 -36.78 80.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.2 p -70.63 -36.66 73.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -70.73 -48.4 54.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.26 -43.07 87.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -49.9 75.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' CD2' ' A' ' 198' ' ' TYR . 29.8 t80 -70.43 -39.63 74.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CE2' ' HE2' ' A' ' 129' ' ' MET . 2.6 m-85 -54.86 -42.97 72.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -77.26 -17.78 58.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.372 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -82.64 -26.77 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.378 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.88 -44.62 0.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.664 0.268 . . . . 0.0 111.719 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.04 -11.63 49.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.778 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -47.22 133.62 9.39 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.527 0.203 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.3 -30.57 26.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.538 2.159 . . . . 0.0 112.632 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -31.33 42.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.58 -40.56 66.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.3 -57.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -53.49 -27.15 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.301 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -73.96 -55.99 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.03 -47.24 78.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 104' ' ' LYS . 36.3 mm -56.9 -43.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -75.17 -27.64 59.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.1 m -78.79 -38.81 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.612 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -4.72 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.459 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 100' ' ' ILE . 6.8 mttm 59.64 26.96 16.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.24 -47.13 72.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.22 36.18 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -176.84 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.4 tp 71.96 -63.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.34 12.46 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.823 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.405 ' CG1' ' HD2' ' A' ' 111' ' ' PRO . 24.0 t -81.08 138.97 49.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.56 0.219 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD2' ' CG1' ' A' ' 110' ' ' VAL . 84.6 Cg_exo -46.42 146.38 5.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 112.399 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 115.52 23.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.289 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.2 127.85 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.565 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -112.33 -40.89 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.82 174.9 41.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.606 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.92 173.33 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.417 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -156.94 178.0 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.764 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.93 159.87 43.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.876 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 116.57 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.69 124.38 36.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.26 126.29 22.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.4 t30 59.67 17.27 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.535 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.44 56.57 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.916 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 129.03 43.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.819 0.342 . . . . 0.0 110.682 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.3 t -91.15 124.32 35.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.044 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.73 147.74 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -125.1 125.13 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.45 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 16.5 p90 -138.28 163.11 32.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.411 ' HE2' ' CE2' ' A' ' 87' ' ' TYR . 9.4 tmm? -128.1 148.62 50.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.709 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.8 mt -123.39 112.74 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.249 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -123.08 173.27 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -54.19 142.67 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.089 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.455 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -80.26 156.31 26.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -120.36 155.42 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.06 -80.14 1.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -131.65 131.19 42.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -58.87 159.78 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.12 -23.91 66.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.754 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -64.27 -42.05 96.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -64.02 -29.7 70.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.298 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.4 HG23 ' CE1' ' A' ' 149' ' ' PHE . 12.0 mt -81.5 -29.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 254' ' ' TRP . 18.2 t80 -70.92 -48.89 51.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.806 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.38 -29.81 65.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.44 -24.75 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 3.2 m-80 -95.2 16.16 17.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.14 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 84.04 46.94 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.153 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.67 20.12 11.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.249 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.13 176.8 8.38 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' CE1' HG23 ' A' ' 141' ' ' ILE . 0.2 OUTLIER -135.93 -169.3 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.65 145.2 43.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -30.43 65.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -71.18 -36.43 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.17 -41.12 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.3 t -55.91 -54.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 61.5 mt -64.18 -37.23 86.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.47 -44.71 74.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.4 mt -71.04 -47.81 56.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 p -53.38 -37.61 62.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.411 ' CD1' ' HG ' ' A' ' 325' ' ' LEU . 1.7 mt -68.17 -48.13 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.665 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -38.4 82.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.9 mt -68.57 -37.39 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.1 mt -60.8 -36.96 80.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.488 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -37.94 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.496 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.18 -39.0 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.32 -43.08 92.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.607 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.0 -34.9 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.592 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -67.84 -52.49 36.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.1 pt -67.19 -29.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.995 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -75.09 -34.23 61.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.418 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.95 -16.89 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.44 40.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 77.49 43.9 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.69 140.34 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 31.0 m -126.07 138.92 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 45.6 t-80 -159.48 92.48 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.897 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -93.64 38.61 3.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.284 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 t0 -97.39 34.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.39 114.46 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 227' ' ' PHE . 0.4 OUTLIER -160.38 -179.12 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -80.21 -2.09 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.412 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.4 m -107.28 -0.62 22.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -127.5 -5.21 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 13.0 mt -108.49 118.69 37.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.062 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.07 156.68 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 192' ' ' GLN . 6.5 mt -99.11 149.65 22.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 191' ' ' ASP . 14.0 m-20 -73.47 135.63 44.11 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.836 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.455 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 9.0 t80 -71.48 -68.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 -15.13 23.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.746 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.576 ' CB ' ' CD ' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -76.5 -168.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 189' ' ' ASN . 39.9 Cg_exo -39.85 -27.38 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.563 2.175 . . . . 0.0 113.913 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 1.1 t70 88.08 5.03 0.25 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.653 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -72.82 -167.58 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 183' ' ' LEU . 2.5 p -109.96 147.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.163 0.506 . . . . 0.0 111.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 15.7 m-85 -131.41 157.25 43.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.559 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 58.0 tp -103.62 115.79 31.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.679 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.67 -175.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.85 98.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.628 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.503 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 13.1 m-85 -109.87 30.53 6.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -53.72 -24.67 26.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.254 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -114.15 -4.27 13.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.538 0.209 . . . . 0.0 111.064 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -77.12 59.39 1.71 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 110.689 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.49 149.05 52.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -53.11 93.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.067 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.406 ' CE1' HG13 ' A' ' 174' ' ' VAL . 42.3 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -59.95 -176.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 0.0 110.772 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 225' ' ' ILE . 7.3 tt -101.11 -21.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.71 -22.96 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 63.1 m-85 -142.53 30.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.322 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.4 t -85.6 146.59 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.95 159.0 19.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.5 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.49 -42.98 82.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.29 66.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.196 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.84 -25.56 63.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.318 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -96.33 0.12 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.45 58.57 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.706 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.73 122.59 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.83 158.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 -171.23 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.6 2.2 . . . . 0.0 112.299 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.06 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -73.95 -54.18 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -83.36 -16.89 44.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.84 92.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.61 -28.79 65.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.309 . . . . 0.0 110.95 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 70.3 mt -76.6 -34.81 58.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -32.35 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 13.4 mt -66.65 -44.81 89.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.02 -36.56 83.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.32 91.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 275' ' ' LYS . 38.6 m-85 -78.58 -25.69 45.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.297 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -39.06 72.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.03 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -50.04 69.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.74 -29.21 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.981 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.447 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -68.92 -47.55 65.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.447 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 16.2 m0 -82.34 -26.88 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.405 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.05 -49.34 65.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.386 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 13.1 t -101.53 -11.48 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 92.75 108.07 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.306 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 25.8 p80 48.18 -175.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.447 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -135.02 154.61 79.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.422 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 48.8 Cg_endo -68.77 61.62 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.098 . . . . 0.0 112.166 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.563 ' HA ' ' CD1' ' A' ' 270' ' ' TYR . 8.4 p90 177.45 -36.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.419 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -89.26 14.44 11.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.535 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.11 -42.12 97.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -129.33 -29.33 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.277 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 87.7 mt 69.59 13.65 8.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -88.19 -14.94 37.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.361 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.0 94.73 14.16 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 -4.43 15.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.545 2.163 . . . . 0.0 112.643 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -53.21 -49.95 65.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.2 p90 -83.6 -26.07 30.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.008 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 61.4 t -59.84 -44.38 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -75.51 -36.88 60.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.296 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.84 -43.24 80.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.285 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -36.57 84.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.416 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -66.4 -50.33 63.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.212 -179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.93 -28.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.352 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -52.13 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.184 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' CD1' ' A' ' 285' ' ' LEU . 4.4 m-85 -57.99 -37.03 73.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.77 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -55.52 -26.99 46.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 28.63 5.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.74 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -146.64 41.58 1.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 4.2 mm -53.73 -45.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -70.36 -39.55 74.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -70.94 -29.54 65.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 278' ' ' TYR . 5.3 tt -67.38 -50.89 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 3.1 mmt -62.03 -36.82 82.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -19.96 61.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -46.48 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 4.7 m -93.69 -41.18 9.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.383 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.11 107.28 43.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.66 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.454 2.102 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.59 -25.18 38.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.2 -49.88 70.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.69 104.86 17.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -66.36 139.35 96.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.17 -174.09 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.541 2.161 . . . . 0.0 112.26 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 138.77 -43.05 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.322 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -70.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.656 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 303' ' ' MET . 19.8 mm -79.57 -49.72 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.993 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.62 -31.31 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -76.68 -36.46 57.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.42 ' CE1' HG22 ' A' ' 306' ' ' VAL . 17.9 t80 -76.15 -34.3 59.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 56.5 mmm -74.16 -42.13 60.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.11 -40.74 96.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 1.7 p -66.8 -36.05 81.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 302' ' ' TYR . 74.4 t -79.64 -24.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -32.93 41.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.22 -25.24 10.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.853 0.272 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.39 22.99 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.06 -35.84 81.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.16 -37.05 84.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -77.33 -45.43 26.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 302' ' ' TYR . 56.4 mt -51.04 -43.25 60.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -57.62 -35.74 70.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -35.45 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.86 -51.49 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.36 -48.9 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -54.76 -49.94 69.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.363 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.6 -40.28 86.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.14 65.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 47.1 mt -61.08 -34.96 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -59.74 -31.47 69.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.24 48.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.4 pp -143.77 84.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.412 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.29 -42.69 1.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.724 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 t 65.31 87.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 61.0 156.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -75.53 153.44 37.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t 66.02 104.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.62 37.16 31.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.623 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -136.34 152.13 50.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -116.98 139.21 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.7 pt -119.74 154.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 34.6 m -95.55 141.33 29.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.996 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.77 -160.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.03 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.4 ttm -77.67 -41.69 37.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.86 0.15 36.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.589 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 3.1 mttp 87.24 27.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -70.34 179.25 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.06 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.16 79.59 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.445 ' HB2' HG13 ' A' ' 29' ' ' ILE . 69.6 m95 -73.49 137.66 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.907 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.66 134.49 34.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.89 143.72 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.02 -130.64 7.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.51 159.13 30.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.57 111.18 2.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.533 2.155 . . . . 0.0 112.063 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.4 pt -106.43 -37.9 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 3.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.37 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 3.6 mp -98.9 136.68 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.387 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 50' ' ' CYS . 19.6 m-85 -140.45 170.3 16.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.663 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.22 152.45 42.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.08 153.93 45.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.318 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -143.8 150.45 38.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.789 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 mtm -99.45 45.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m120 59.84 -177.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 m 61.28 45.15 9.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -163.51 -43.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 69.93 -66.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -87.62 86.97 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.48 88.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.85 36.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.3 p -147.55 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -155.44 80.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.21 71.58 3.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 86.28 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.83 148.13 29.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -128.27 153.47 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.048 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 p -142.79 119.37 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -103.65 117.42 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 128' ' ' PHE . 11.8 t -118.95 152.05 21.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -139.08 135.77 17.69 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.636 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 83.4 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.303 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.23 -171.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.09 156.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -78.99 177.6 8.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.47 -162.87 29.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.23 32.78 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.708 2.272 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -60.61 -30.84 70.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.41 -37.15 86.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.019 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -33.13 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.7 -40.9 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -76.91 -37.62 55.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -59.56 -40.3 86.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 173' ' ' TYR . 8.5 t80 -82.83 -29.81 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 111' ' ' PRO . 2.1 m-85 -64.4 -51.91 60.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.122 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.59 -17.3 61.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.434 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.67 -47.51 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 -22.61 6.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.5 23.8 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -73.16 113.18 19.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.37 -33.31 36.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.454 2.102 . . . . 0.0 112.591 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.68 -39.01 77.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.32 -47.27 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.314 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -57.58 -57.54 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.44 62.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -64.39 -47.42 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.406 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -60.3 -55.05 38.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.254 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.0 mt -56.33 -36.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -74.96 -27.7 60.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.8 m -81.75 -36.61 28.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -2.54 26.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.81 30.77 20.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.676 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.7 mt -49.57 -31.7 11.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.54 -55.57 0.52 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.83 129.11 13.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.895 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 167' ' ' TYR . 12.4 tp -99.22 -66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.74 9.5 6.91 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.064 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.8 138.78 27.76 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.826 0.313 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 71.9 Cg_exo -50.8 151.41 11.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.525 2.15 . . . . 0.0 112.406 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.08 115.58 27.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -99.78 126.96 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.562 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -105.95 -40.87 5.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 111.028 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 -174.72 46.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.597 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 p -134.86 159.42 41.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -138.59 173.37 22.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.828 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.04 158.07 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.3 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -145.83 138.61 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.74 123.84 48.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.678 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -138.26 126.23 22.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.22 22.68 2.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.414 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.11 3.51 63.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.719 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -96.08 128.92 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.5 m -89.39 125.82 35.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.09 125.9 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.76 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.91 125.21 51.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.455 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 14.6 p90 -140.31 165.72 26.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 111.407 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.89 147.14 52.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -123.28 111.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 111.4 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.66 173.46 9.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.975 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.98 144.82 3.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -88.42 -25.56 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.3 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.405 ' CD2' HD11 ' A' ' 184' ' ' LEU . 80.7 m-85 65.08 178.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.02 -108.15 1.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.59 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -107.02 127.85 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' HD21 ' A' ' 184' ' ' LEU . 1.3 p30 -58.26 157.65 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -23.6 65.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -41.03 96.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.97 0.414 . . . . 0.0 110.084 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -34.99 79.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.405 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.35 -25.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.664 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 11.9 t80 -67.71 -53.62 26.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -29.46 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.706 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.27 -20.29 62.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.311 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 2.0 m-20 -98.93 18.17 17.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 86.18 47.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 63.0 19.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.474 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -147.21 -173.97 4.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -169.11 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.9 t -113.25 150.24 32.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -59.25 -31.49 69.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -40.98 60.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 p -65.47 -43.3 90.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.88 -52.31 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.993 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.11 -48.04 80.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -59.91 -50.4 73.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.68 -40.26 87.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -56.03 -40.93 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.9 -48.04 78.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -47.42 85.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 27.1 mt -66.59 -35.09 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.8 mt -58.79 -39.87 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.759 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.47 -32.03 72.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.4 mt -77.11 -43.33 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.929 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 75.3 mt -58.52 -39.33 79.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -71.15 -31.39 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.672 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.425 ' CE2' HD21 ' A' ' 108' ' ' LEU . 73.3 t80 -73.93 -54.74 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.2 pt -60.11 -30.11 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.25 -37.28 74.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 110.36 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -16.89 62.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.565 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -101.68 6.12 41.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.965 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 77.88 46.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.07 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.51 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 47.2 m-85 -141.54 119.42 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.584 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.93 164.19 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.675 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.06 50.23 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.43 -18.18 49.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.866 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 69.1 79.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 110.846 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.06 115.36 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -155.94 172.87 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.824 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -76.81 -2.76 34.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.549 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.22 2.1 16.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.844 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -127.95 -6.76 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.363 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.523 ' HB3' HG21 ' A' ' 193' ' ' VAL . 11.0 mt -108.63 127.51 54.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.946 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.436 HD21 ' HA ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -134.49 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.123 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.82 149.47 24.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.43 130.31 42.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -82.76 -50.79 8.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -21.07 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -148.3 77.78 9.68 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.74 88.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.78 35.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 174.84 149.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -109.97 147.95 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.104 0.478 . . . . 0.0 111.025 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 4.6 m-85 -117.09 156.86 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -105.63 115.86 30.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.2 162.11 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.107 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.28 70.91 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -73.23 -60.39 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 92.51 -33.55 4.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.361 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.08 21.29 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.021 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -83.35 59.15 4.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.06 0.457 . . . . 0.0 110.615 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.81 149.33 50.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.133 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -58.6 99.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 54.4 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.495 -179.696 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.5 m -92.6 -71.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.424 HD12 ' HB ' ' A' ' 271' ' ' VAL . 1.9 tp -176.74 30.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -102.75 67.57 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.346 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 226' ' ' GLU . 34.3 m-85 72.26 41.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.645 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -102.34 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.785 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -79.99 145.9 32.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.13 -30.8 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.01 -31.31 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.27 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -61.9 -25.61 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -85.01 5.96 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.512 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.28 -2.26 85.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.903 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.97 178.76 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.771 0.319 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.22 132.02 9.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.99 -24.18 31.19 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.356 2.038 . . . . 0.0 112.409 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.7 t 61.65 35.67 16.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -179.57 -76.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -72.21 -15.84 61.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.374 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.57 92.71 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -26.99 46.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.959 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 29.1 mt -78.23 -34.05 49.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.074 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -39.87 85.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 11.2 mt -65.01 -34.88 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.6 tp -77.93 -36.17 49.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.28 -29.02 73.85 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.62 -27.55 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 26.9 m -60.6 -45.83 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -51.14 29.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.663 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.67 -51.44 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.573 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.7 -36.04 69.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -82.38 -49.92 9.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.05 -36.28 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.522 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.5 m -96.12 -15.38 22.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 68.96 94.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.313 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.7 m80 62.93 140.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.396 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.469 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -122.49 168.84 10.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 55.2 Cg_endo -70.04 59.95 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.45 2.1 . . . . 0.0 112.72 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 2.4 p90 177.92 -41.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.6 OUTLIER -95.35 17.68 13.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.346 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.21 -57.34 11.83 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 57.2 t30 -129.12 -26.27 2.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.335 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 66.0 mt 70.96 11.95 7.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -85.23 -16.5 40.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.163 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.7 OUTLIER -133.13 100.43 14.22 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.734 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.15 19.2 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.74 2.293 . . . . 0.0 112.86 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -77.95 -46.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.9 p90 -83.76 -26.71 29.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 18.3 t -65.62 -45.2 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.218 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.42 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -39.9 64.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 47.9 m -66.61 -38.29 86.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.159 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -51.14 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.42 -37.34 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -81.18 -50.5 9.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.2 m-85 -59.43 -40.89 88.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -51.7 -29.43 18.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.04 25.68 9.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -137.6 41.83 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 282' ' ' ILE . 28.4 mt -49.58 -39.91 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.84 -34.64 64.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.988 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.47 -43.27 63.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 3.5 pp -71.33 -33.2 69.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.408 ' HE3' ' HB ' ' A' ' 299' ' ' ILE . 0.8 OUTLIER -61.99 -50.93 70.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.2 -27.85 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -32.89 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 111.237 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 60.8 m -93.71 -41.18 9.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.467 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -94.0 144.66 28.47 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.738 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 176.45 6.81 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.489 2.126 . . . . 0.0 112.285 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -98.62 30.45 3.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -41.15 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -131.67 150.11 52.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 143.19 74.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.53 137.49 25.38 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.478 2.119 . . . . 0.0 112.293 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.93 -41.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.56 -67.87 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.408 ' HB ' ' HE3' ' A' ' 286' ' ' MET . 29.1 mm -75.66 -41.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -47.23 -45.97 23.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.332 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -61.76 -35.65 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.585 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 306' ' ' VAL . 21.1 t80 -73.81 -35.88 64.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.721 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.4 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.2 mtp -70.3 -45.26 66.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.35 77.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 1.9 m -62.27 -33.53 74.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 302' ' ' TYR . 91.0 t -79.64 -23.96 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.64 -34.01 25.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.649 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.73 -30.45 6.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.268 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.313 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 317' ' ' TYR . 50.3 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.691 0.205 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.5 tp 74.86 57.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 15.5 m-85 -70.34 -30.9 67.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -58.55 -47.59 83.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -46.75 72.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 53.7 mt -55.64 -40.7 72.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -46.59 86.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -40.25 90.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 67.4 mt -57.85 -42.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -51.55 9.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 -49.92 75.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.48 -38.99 86.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.974 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.89 -27.92 65.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.31 -38.03 87.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -29.89 70.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.52 77.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.0 pt -99.59 24.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.257 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.36 26.55 37.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.658 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.29 164.56 24.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 146.01 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -127.69 129.48 47.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.877 0.37 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.66 128.16 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.18 57.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.572 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.92 153.3 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mt -115.22 137.15 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.414 HD11 ' CE1' ' A' ' 128' ' ' PHE . 48.8 pt -119.85 154.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.18 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.2 p -95.57 141.57 28.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.743 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.62 -162.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -37.52 27.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.5 -1.81 43.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 6.4 mttp 86.12 29.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' THR . 5.2 mttp -78.23 177.62 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.188 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -129.3 80.44 1.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -77.46 131.41 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -89.9 118.24 29.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.9 t -89.55 141.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -107.19 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.31 165.87 26.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.37 178.03 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.64 2.227 . . . . 0.0 112.285 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.3 pt -156.08 30.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.069 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.409 0.147 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.413 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 53.3 mt -142.4 135.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 29.3 m-85 -143.4 156.31 44.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.483 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.85 157.5 34.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.26 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -140.79 159.72 41.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.4 ptp -101.01 37.85 1.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t30 59.99 30.58 20.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -85.19 -72.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 m -117.18 144.77 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.46 160.86 30.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m 60.5 95.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.83 47.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.05 -27.35 3.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.86 38.13 4.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.63 -59.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 52.63 74.35 0.79 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.144 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.57 -27.29 13.09 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.596 2.198 . . . . 0.0 112.618 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.2 m -149.86 165.31 32.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.41 152.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 130' ' ' ILE . 7.7 p -142.2 141.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -111.01 123.88 51.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.23 136.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.531 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.13 120.6 8.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.685 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.91 91.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.526 2.151 . . . . 0.0 112.472 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p 49.72 83.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.76 118.29 27.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.3 -85.52 0.12 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.36 -49.06 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.552 2.168 . . . . 0.0 112.306 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 tp -76.12 -31.1 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -68.59 -31.19 70.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.412 HG23 ' CD2' ' A' ' 202' ' ' TYR . 1.0 OUTLIER -71.28 -45.42 63.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.68 -42.21 74.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.78 -48.48 72.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.743 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.67 -39.67 92.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE1' ' HG2' ' A' ' 111' ' ' PRO . 2.6 m-85 -57.34 -53.9 52.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -75.31 -17.64 60.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.379 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -83.1 -47.46 11.63 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.89 -23.88 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.92 25.28 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 111.669 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -73.32 131.08 83.38 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.651 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.26 -29.01 89.21 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.488 2.125 . . . . 0.0 112.381 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.33 -31.96 43.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -49.96 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.94 -46.48 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -51.8 -48.35 63.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.179 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -38.96 92.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -53.22 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 46.6 mt -64.37 -26.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -75.12 -27.55 59.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -39.21 35.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.88 11.81 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER 70.37 2.03 3.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 167' ' ' TYR . 4.5 mt 44.71 28.39 0.33 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.388 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 48.8 36.61 8.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.8 t80 71.34 114.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.757 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.432 HD22 ' CZ ' ' A' ' 167' ' ' TYR . 6.3 tp -101.79 125.53 48.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.38 20.72 42.1 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.753 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -78.17 133.42 64.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.534 0.207 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.437 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -51.02 145.64 24.42 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.638 2.225 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 126.23 32.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.14 134.07 43.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -111.52 -40.7 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -176.31 46.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.91 155.01 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -134.53 175.49 20.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.044 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.91 154.71 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -145.81 141.74 28.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.34 126.66 50.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HE3' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.26 126.39 22.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.15 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 56.33 19.89 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.31 9.26 58.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.836 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -96.07 159.3 15.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.525 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 83.2 p -112.58 118.45 35.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.078 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.431 ' CE2' ' HE3' ' A' ' 121' ' ' LYS . 13.0 m-85 -110.44 129.07 55.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.668 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.23 125.08 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.711 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.444 ' CE1' ' HA3' ' A' ' 117' ' ' GLY . 23.7 p90 -134.53 159.59 40.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -130.02 141.7 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.453 ' CG1' ' HB ' ' A' ' 70' ' ' VAL . 5.5 mt -110.16 125.24 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.76 173.35 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.868 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.94 137.39 39.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.12 -25.61 27.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.42 ' CE2' HG12 ' A' ' 196' ' ' VAL . 59.8 m-85 64.71 -170.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -107.41 -104.28 2.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.665 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 m -97.14 157.71 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.413 ' HA ' HD23 ' A' ' 184' ' ' LEU . 1.2 m-20 -92.81 157.0 16.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -63.71 -30.14 71.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 5.2 pt20 -57.28 -42.81 82.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.668 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -64.65 -25.92 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.5 mt -72.63 -28.95 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.0 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -58.04 -46.26 85.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.18 -31.27 65.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.91 -21.45 65.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.409 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -93.95 -0.22 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 90.9 43.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 61.54 19.97 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.488 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -162.1 107.87 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -58.27 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.9 m -111.79 161.63 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.69 -31.55 72.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -70.99 -50.39 34.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -59.19 -50.66 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.16 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -52.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.318 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.52 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.258 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -46.03 90.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.07 -35.35 76.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.8 p -57.91 -36.37 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.5 -47.23 50.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -49.52 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.77 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.08 -37.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.96 -36.47 74.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -38.04 84.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.79 -38.47 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 61.5 mt -58.16 -48.22 80.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.411 ' HG2' ' CE2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -68.12 -38.93 82.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.432 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 90.6 t80 -59.7 -41.42 90.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 28.2 pt -81.67 -27.19 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.112 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -75.93 -29.99 58.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.425 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.77 -17.1 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.22 6.24 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 72.04 47.16 0.31 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.886 0.374 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.405 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 11.1 m-85 -132.05 132.83 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 204' ' ' TYR . 29.3 m -128.99 169.31 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 168' ' ' ILE . 11.4 p-80 -151.68 -51.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.83 53.12 44.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.66 30.17 5.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.104 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.29 105.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.026 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.26 29.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 139' ' ' GLN . . . 67.11 11.05 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.87 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 m -117.13 5.97 12.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -138.49 2.89 2.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.594 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.526 ' HB3' HG23 ' A' ' 193' ' ' VAL . 5.3 mt -109.59 130.2 55.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.098 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 137' ' ' ASP . 1.1 mt -137.53 147.54 45.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.094 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.403 ' CD2' ' HB ' ' A' ' 193' ' ' VAL . 24.8 mt -86.47 145.87 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 111.528 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 125.87 25.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.83 -49.46 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -58.1 -24.4 58.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.659 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.35 81.14 2.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.15 109.73 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.584 2.189 . . . . 0.0 112.291 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -144.55 -45.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -157.86 -167.7 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.526 HG23 ' HB3' ' A' ' 183' ' ' LEU . 7.6 p -109.75 148.1 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 9.2 m-85 -119.21 156.96 28.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.388 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.455 ' CD2' ' CD2' ' A' ' 175' ' ' HIS . 18.3 tp -106.61 115.77 30.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.428 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG12 ' CE2' ' A' ' 134' ' ' PHE . 30.5 m -126.95 167.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.296 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.7 t70 53.65 57.68 5.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.007 0.432 . . . . 0.0 110.707 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -59.68 -51.55 69.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.071 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.81 -35.83 4.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.94 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.56 31.65 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.503 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -71.82 59.44 0.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.76 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.412 ' CD2' HG23 ' A' ' 82' ' ' THR . 14.0 p90 -138.48 148.97 44.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.064 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.405 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 19.4 mtm105 -56.52 101.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.408 ' CD1' HG11 ' A' ' 174' ' ' VAL . 46.0 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.172 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.5 p -87.87 178.09 6.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.405 HG12 ' CG1' ' A' ' 271' ' ' VAL . 2.7 tt -116.16 -26.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -24.62 4.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.472 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.406 ' CG ' HG21 ' A' ' 246' ' ' ILE . 11.1 m-85 -144.41 38.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.07 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.2 t -83.99 138.9 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.8 t -91.8 148.29 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.34 -51.16 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.188 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.83 -43.91 86.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -72.39 -28.11 62.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.233 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -68.71 -28.04 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.64 12.86 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.44 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.08 23.29 63.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.747 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.81 119.52 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 110.94 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.437 ' CB ' ' HD3' ' A' ' 238' ' ' PRO . . . -57.67 -57.4 25.66 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 52.2 Cg_exo -52.43 89.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.407 2.072 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 t -138.14 160.99 37.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -178.79 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.118 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.41 -42.76 93.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.569 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -35.21 73.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.5 mt -80.5 -34.49 35.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.98 -39.37 89.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.717 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.406 HG21 ' CG ' ' A' ' 227' ' ' PHE . 8.5 mt -62.9 -47.93 90.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.4 tp -64.79 -33.94 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.397 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.3 95.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.416 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 34.0 m-85 -78.57 -25.84 45.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.88 -34.45 65.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.583 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -46.57 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -63.57 -38.63 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 259' ' ' LEU . 1.5 pp0? -75.17 -31.06 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -82.38 -40.71 20.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.99 -31.19 56.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.98 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.3 m -103.07 0.51 32.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.412 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.71 95.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.519 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 61.12 161.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.472 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -133.0 168.74 16.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.865 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.6 Cg_exo -68.44 59.14 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.863 2.375 . . . . 0.0 112.515 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 2.0 p90 179.15 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.445 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 4.1 tt0 -84.48 5.63 26.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.23 -54.1 49.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.4 m120 -130.05 -27.53 2.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 78.5 mt 71.26 12.62 6.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.27 -15.38 38.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.468 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -130.03 92.16 37.35 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.18 -4.12 13.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.883 2.389 . . . . 0.0 112.662 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -55.34 -50.34 69.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.277 . . . . 0.0 111.079 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.7 p90 -84.09 -26.03 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 40.8 t -62.49 -43.04 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.298 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -75.52 -40.81 56.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -48.08 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -45.31 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.185 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.416 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -58.74 -42.87 89.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 17.3 mt -72.56 -29.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.497 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -75.41 -52.1 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.428 ' CG ' HD11 ' A' ' 285' ' ' LEU . 29.8 m-85 -60.47 -39.46 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -26.18 66.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.948 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -120.2 23.78 10.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.66 53.43 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.074 0.464 . . . . 0.0 110.744 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 303' ' ' MET . 2.6 mm -48.52 -41.79 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.339 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -64.26 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.513 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.2 p -70.38 -31.98 69.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.428 HD11 ' CG ' ' A' ' 278' ' ' TYR . 1.2 tt -66.41 -51.4 57.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.14 -34.63 76.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -82.79 -33.34 27.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.313 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -54.85 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.467 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 85.7 m -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.286 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 290' ' ' PHE . 3.7 m-85 -108.36 146.29 33.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 -172.42 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.43 30.87 3.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 -35.28 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.68 91.66 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.79 108.02 1.06 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.23 127.21 23.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.468 2.112 . . . . 0.0 112.256 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -124.1 -40.51 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -47.5 85.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 303' ' ' MET . 19.2 mm -76.79 -48.74 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.32 -44.72 8.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.615 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.22 97.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.382 . . . . 0.0 110.814 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.421 ' CE2' HD11 ' A' ' 324' ' ' LEU . 18.5 t80 -69.59 -43.5 72.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.018 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.517 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 69.1 mmm -66.54 -39.02 88.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.764 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.83 -40.36 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.273 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -32.34 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 14.0 t -71.91 -24.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.096 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -75.7 -37.45 59.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.71 -12.49 22.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.968 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.85 0.271 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.87 42.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.411 ' CE2' ' HG2' ' A' ' 166' ' ' GLU . 20.1 m-85 -57.06 -36.16 70.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.021 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -69.2 -33.88 74.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.74 -47.42 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.409 HD22 ' CE2' ' A' ' 302' ' ' TYR . 25.9 mt -53.29 -44.37 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -59.15 -32.65 70.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.97 -30.47 55.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.98 -50.01 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.343 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 302' ' ' TYR . 8.4 mt -79.96 -26.65 39.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.58 -48.89 10.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.733 0.301 . . . . 0.0 111.107 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.76 -34.29 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.6 56.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.583 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 29.4 mt -57.23 -32.55 66.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -70.08 -29.62 66.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.63 63.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.8 -28.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.215 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.11 22.92 5.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m -97.67 164.52 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -138.63 111.85 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.81 92.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.957 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 58.1 m -60.97 168.59 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.791 0.329 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 6.6 t -155.75 150.0 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -72.28 139.12 27.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.2 m 60.51 -177.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.5 p -75.47 -31.35 60.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 133.95 68.14 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.453 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt -117.39 91.08 36.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.679 0.276 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.67 157.98 3.18 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.396 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -77.57 -64.83 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 t 69.1 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -148.03 157.08 43.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.42 -37.53 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.0 140.33 43.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -101.32 -39.16 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.4 30.88 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 161.31 24.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.448 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.37 88.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -144.64 -64.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.2 m 68.25 -68.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m 59.99 172.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.97 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.82 -50.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -79.67 110.1 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.91 -45.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -169.32 103.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mt -69.64 -179.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.19 166.94 22.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.41 -32.65 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -88.4 -78.63 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 72' ' ' VAL . 6.5 m-85 -121.41 98.28 5.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.97 -168.59 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.146 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -101.54 108.44 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -35.8 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.508 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 150.34 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mt -103.25 142.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 11.8 pt -116.76 143.44 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 p -102.33 141.76 34.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.137 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 10.3 m-20 -83.03 -144.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.88 56.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 109.698 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.46 35.6 26.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.571 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -139.33 -8.46 1.3 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.36 177.75 9.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.157 0.503 . . . . 0.0 111.692 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -155.25 92.73 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.904 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 9.2 m95 -96.64 144.83 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.408 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.35 125.81 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.852 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.32 131.81 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.0 -121.04 4.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.86 154.61 44.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.709 0.29 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.32 175.19 7.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.516 2.144 . . . . 0.0 112.335 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 pt -141.61 30.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.48 115.7 2.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -110.77 158.87 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.53 -94.72 0.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.473 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.6 52.31 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -121.2 -69.13 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.01 -92.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.576 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.61 91.65 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -85.19 124.08 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -146.29 153.3 40.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.44 135.93 36.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.05 137.67 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -124.39 151.18 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.6 ttp -89.81 52.83 2.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -149.47 148.23 29.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.41 34.74 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.43 176.33 7.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.72 134.93 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t 63.42 125.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.38 -52.74 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.3 -133.94 52.09 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.65 29.71 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -105.68 31.98 4.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.82 99.3 9.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.04 42.5 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.709 2.273 . . . . 0.0 112.66 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -149.93 150.28 31.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 110.779 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.02 146.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 128' ' ' PHE . 7.5 p -131.95 131.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.599 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -105.39 121.09 43.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.215 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' A' ' 23' ' ' PHE . 2.8 t -113.12 152.02 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -140.71 136.26 16.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.68 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 112.375 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.3 t 62.28 122.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -171.51 159.9 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.88 75.0 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.82 -75.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.46 -61.91 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.48 -33.18 72.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.58 -31.93 72.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.3 p -75.07 -41.61 58.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.8 -38.48 64.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.24 -51.68 62.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -56.78 -51.81 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 198' ' ' TYR . 19.6 t80 -64.27 -29.79 70.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.57 -50.7 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.262 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -25.38 64.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -87.67 -47.43 8.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.84 19.41 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 114.12 38.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.467 0.175 . . . . 0.0 110.649 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.25 -26.19 7.93 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.503 2.136 . . . . 0.0 112.636 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.4 -40.44 57.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -79.33 -43.43 23.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.25 -52.87 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -42.28 64.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -43.23 67.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.964 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -53.89 37.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt -56.66 -34.23 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -74.88 -27.7 60.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 m -71.62 -38.53 70.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -6.53 19.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.983 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.19 27.66 16.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 mt -51.83 -32.52 32.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.1 tttt 46.74 40.91 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.658 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 25.1 t80 -176.86 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.347 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 167' ' ' TYR . 13.4 tp 59.96 158.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.725 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 164' ' ' ILE . . . -110.66 32.98 6.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.624 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.428 HG21 ' CE2' ' A' ' 167' ' ' TYR . 23.3 t -112.6 126.6 28.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.529 0.204 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.69 161.8 23.63 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.305 2.003 . . . . 0.0 112.025 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 115.43 27.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.06 131.95 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 9.3 m95 -109.89 -40.91 4.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -175.03 46.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.762 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -135.4 162.0 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.82 174.49 24.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.84 150.61 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.064 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 121.85 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.42 127.86 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -138.29 126.16 22.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.97 20.84 4.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.68 62.07 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.792 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -96.13 129.86 43.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.784 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.64 118.77 30.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.084 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -101.42 122.56 43.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -106.51 130.89 54.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CE1' ' HA3' ' A' ' 117' ' ' GLY . 25.3 p90 -140.27 168.62 19.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.104 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -142.73 138.96 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 130' ' ' ILE . 1.5 mp -94.09 141.8 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.09 164.21 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.658 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.83 -69.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.09 -78.24 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 184' ' ' LEU . 1.4 m-85 64.19 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.916 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -117.8 -101.66 2.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.615 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.8 t -102.02 166.33 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.856 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 13.1 p30 -97.95 161.68 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -58.53 -25.14 62.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.56 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -37.95 68.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.82 70.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 138' ' ' LEU . 14.1 mt -76.35 -26.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 149' ' ' PHE . 36.3 t80 -56.21 -44.74 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.09 -30.35 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.24 -14.09 62.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.511 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -94.6 -1.0 54.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.248 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 92.56 44.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.962 0.505 . . . . 0.0 110.395 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.75 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.591 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -170.72 121.46 0.58 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.918 0.39 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 254' ' ' TRP . 8.6 m-85 -61.33 177.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.6 t -113.41 160.69 18.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.788 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -36.95 74.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -70.69 -48.8 52.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.7 p -58.69 -56.2 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.168 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.35 -53.5 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.54 -45.67 84.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -65.67 -52.9 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.81 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.53 -34.06 76.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.743 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.1 m -58.83 -46.41 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.8 -43.81 98.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -34.02 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.838 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.96 -36.62 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.149 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.4 mt -55.35 -44.12 75.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -26.44 68.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.458 HG12 ' HA3' ' A' ' 109' ' ' GLY . 5.0 mt -72.74 -46.55 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.3 mt -59.85 -27.29 66.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.961 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -30.37 60.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 110' ' ' VAL . 91.1 t80 -77.15 -56.09 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 41.6 pt -55.13 -29.35 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -42.37 90.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -16.87 61.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 89' ' ' ARG . 0.6 OUTLIER -98.11 2.24 48.41 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.177 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 74.75 40.25 0.39 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.941 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -138.01 127.28 24.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.695 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.9 m -142.26 169.34 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.391 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 67.54 43.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.46 -17.17 52.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.678 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.73 82.31 0.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.0 110.993 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.04 108.49 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.005 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -149.32 -176.5 5.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -84.69 -0.26 52.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.417 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.63 5.72 12.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.324 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -125.12 -11.07 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.328 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.9 mt -108.32 125.62 51.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.949 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 134' ' ' PHE . 1.2 mt -129.58 154.53 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.354 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.401 HD21 ' HB ' ' A' ' 193' ' ' VAL . 6.1 mt -100.07 149.2 23.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.8 133.37 55.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -75.25 -66.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.808 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -22.75 41.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.836 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.87 80.94 41.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 101.74 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.565 2.177 . . . . 0.0 112.199 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -177.5 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 107' ' ' TYR . 8.6 mp0 -108.22 164.03 12.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 194' ' ' TYR . 10.8 p -132.05 147.79 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.484 ' N ' HG23 ' A' ' 193' ' ' VAL . 1.4 m-85 -123.14 156.73 34.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.709 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 26.1 tp -107.28 115.93 31.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.696 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.4 m -86.86 179.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.254 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.47 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 26.3 m-85 -145.47 -57.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -58.43 -23.69 54.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.696 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.56 33.87 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -131.08 -90.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.053 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.16 118.87 8.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.752 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -94.82 47.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.44 94.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.4 m 58.52 163.91 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.96 -167.66 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.543 2.162 . . . . 0.0 112.329 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -106.12 -46.0 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.76 77.15 0.39 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.91 125.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -37.99 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -76.4 126.41 30.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -67.42 -54.47 20.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.68 154.17 42.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -145.28 -56.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.56 54.02 3.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -155.74 102.91 2.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.46 71.37 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.376 2.05 . . . . 0.0 112.249 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -149.68 -46.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -31.11 66.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.94 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 19.7 t -102.11 -68.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 56.89 36.09 27.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.0 111.58 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 59.49 -149.29 40.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -127.75 -52.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.722 0.296 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.406 ' CD1' HG12 ' A' ' 271' ' ' VAL . 2.1 tt -179.09 38.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.53 63.03 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.504 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 262' ' ' GLU . 30.3 m-85 76.34 29.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.745 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.0 m -83.72 145.2 28.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.2 t -59.24 141.28 54.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mt -61.01 -37.22 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -43.88 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.44 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -72.9 -32.0 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.17 12.84 29.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.298 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 55.79 28.7 53.12 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.79 110.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.56 151.88 0.1 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.79 154.86 8.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.531 2.154 . . . . 0.0 112.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.3 t -100.55 123.57 44.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 mtm105 -144.87 -50.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -17.66 60.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.31 -33.65 66.01 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.544 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.39 -33.12 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.66 -31.59 36.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.841 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.52 -40.91 93.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.21 -41.29 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.033 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 54.5 tp -70.37 -39.71 74.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.36 -45.86 94.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.545 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.41 ' HA ' HD11 ' A' ' 252' ' ' ILE . 43.6 m-85 -78.61 -25.62 45.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.83 -41.41 82.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -48.19 81.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 249' ' ' TYR . 2.4 mp -65.77 -31.72 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.295 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.415 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -70.4 -43.61 69.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.011 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 15.1 m0 -82.23 -42.91 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.08 -36.82 82.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.159 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.27 -21.43 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.32 88.94 0.27 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 8.6 m170 62.41 144.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.456 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.15 165.77 33.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 41.3 Cg_endo -67.99 64.41 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.43 2.087 . . . . 0.0 112.607 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.478 ' CD1' ' C ' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -178.9 -40.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.888 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -113.11 25.35 11.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.356 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -58.54 6.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.7 m120 -129.1 -25.87 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.327 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 41.9 mt 74.33 11.11 4.19 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -85.12 -15.83 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.597 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.472 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 4.4 m-20 -133.89 74.72 68.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.411 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 49.1 Cg_exo -56.04 -16.12 15.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.882 2.388 . . . . 0.0 112.982 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -49.99 -50.44 47.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.476 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.9 p90 -84.13 -27.05 28.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.383 . . . . 0.0 110.785 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 270' ' ' TYR . 18.3 t -60.69 -35.49 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.55 -44.15 44.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.22 -47.62 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -64.4 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -46.76 78.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.6 mt -68.65 -34.7 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -50.72 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -61.89 -37.06 83.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -54.58 -29.33 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -116.75 22.28 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -136.23 40.3 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 27.9 mt -49.26 -40.05 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.5 64.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -35.98 66.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.7 pp -80.02 -41.58 25.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 15.0 ttm -63.0 -32.98 74.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.762 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.27 -32.59 33.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -82.79 -27.15 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.289 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.6 m -93.55 -41.28 9.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.349 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -107.57 160.39 26.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.13 167.66 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.63 37.93 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -113.09 33.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 60.72 30.33 19.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -80.09 -50.77 1.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 295' ' ' LYS . 42.2 Cg_exo -56.86 -162.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.515 2.144 . . . . 0.0 112.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.39 -45.64 1.13 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -44.64 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 29.6 mm -77.24 -46.76 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.055 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.87 -49.57 10.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.411 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 323' ' ' ILE . 0.8 OUTLIER -58.87 -40.35 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.414 ' CE2' HD21 ' A' ' 320' ' ' LEU . 14.5 t80 -69.88 -42.62 73.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.417 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.1 mtp -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.317 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.03 -50.35 74.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 73.6 m -57.48 -37.79 73.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 31.6 t -72.3 -24.75 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -31.9 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.376 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.48 -12.98 23.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.95 87.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -170.84 -43.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.37 23.95 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.0 m -117.18 -8.96 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.359 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.78 -71.42 0.1 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.835 0.35 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.64 138.63 82.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 317' ' ' TYR . 52.7 Cg_exo -54.86 -23.64 35.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.512 2.141 . . . . 0.0 112.422 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 1.5 tp 63.2 32.28 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 3.2 m-85 -66.05 -42.08 89.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -58.5 -32.91 69.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -77.4 -47.45 19.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.414 HD21 ' CE2' ' A' ' 302' ' ' TYR . 61.6 mt -55.19 -43.02 74.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -58.55 -37.82 76.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.02 -33.36 73.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 301' ' ' LYS . 64.9 mt -61.38 -49.43 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 302' ' ' TYR . 12.2 mt -80.51 -23.63 39.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.317 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.3 tt -82.44 -35.15 27.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -68.76 -42.51 77.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.21 -26.52 56.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.556 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 28.1 mt -53.84 -29.7 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.21 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.245 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.8 pt -97.51 24.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.33 40.74 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.632 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.9 t -89.62 178.51 6.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 151.89 30.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.51 89.48 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -115.68 -66.04 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 174.26 40.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -121.22 146.04 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 341' ' ' LEU . 10.3 mt -110.68 -12.21 14.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.17 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 1.8 t0 64.02 20.03 12.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.697 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 339' ' ' LEU . 14.9 mt -98.53 29.08 3.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 m -64.8 -44.19 90.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 16.4 m 42.12 61.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.636 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 21.4 t 66.37 91.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.91 35.2 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.67 118.52 36.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 142.98 -96.9 0.19 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.467 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 113.03 28.6 3.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.2 tp -171.41 85.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.86 137.5 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.13 -61.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 60.26 159.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 59.0 p -70.76 104.25 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 3.9 tt -160.65 53.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.025 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 43.0 p -129.72 86.49 2.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.63 165.03 12.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -75.91 110.27 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 65.6 mtp85 -95.66 172.04 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.73 177.35 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -151.6 -69.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.58 -174.81 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.32 131.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.54 120.53 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -92.78 178.68 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.3 m -91.53 -32.29 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.11 155.3 31.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.58 130.64 7.17 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.45 51.78 3.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.5 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -105.48 -28.91 5.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 9.3 p -170.01 144.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -173.34 -48.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -166.31 120.26 1.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.7 t -120.64 88.18 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -75.76 178.05 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.08 118.94 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.2 m -92.72 -51.16 5.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -93.86 162.17 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.7 p -150.86 130.5 13.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.66 119.18 38.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.16 105.41 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.844 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.91 97.26 9.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -160.52 179.12 8.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -150.04 31.2 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 9.8 pt -145.16 142.03 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.29 -49.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.4 m -73.91 145.13 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -93.0 48.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 58.0 m -140.0 -66.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 60.17 105.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 17.7 p -86.43 -178.61 6.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.82 111.46 5.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -140.58 162.53 35.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 14.4 mtp85 60.57 -177.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.07 116.55 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -75.26 94.81 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.9 mttt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.907 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 23.5 p -108.2 154.58 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.1 m 60.59 -179.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -129.6 167.37 21.49 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.79 -54.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.1 m 60.4 81.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 119.55 145.04 7.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm -62.57 134.29 95.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.598 0.237 . . . . 0.0 110.781 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.18 166.39 1.05 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.392 2.062 . . . . 0.0 112.364 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.28 164.21 38.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.49 138.62 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -62.53 109.51 1.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.77 33.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.07 -40.92 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -107.71 89.58 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.66 -173.33 2.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.18 28.13 3.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 60.1 94.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -109.34 -31.7 7.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.4 m -96.5 170.76 8.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -105.98 -34.1 7.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.0 145.73 32.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -141.12 160.31 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -92.21 86.53 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -159.0 113.74 2.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 mt 60.32 109.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.98 119.42 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -50.03 75.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.985 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.1 80.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 3.3 m-85 -59.44 96.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.05 -169.57 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.12 114.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.85 -26.43 5.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -76.17 134.54 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.001 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.9 mt -105.28 145.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.415 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 25.2 pt -119.5 154.49 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.263 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 68.4 p -97.93 141.27 31.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.0 -162.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.94 -41.95 34.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 109.775 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.35 -2.21 33.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.653 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 86.96 27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -72.79 177.41 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.141 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.77 79.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.873 0.368 . . . . 0.0 110.597 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -73.19 128.65 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.94 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -91.9 119.18 31.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 23' ' ' PHE . 21.4 t -73.62 150.39 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.45 -116.28 2.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.03 158.85 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.733 0.302 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 56.2 Cg_endo -70.48 155.1 64.25 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.559 2.173 . . . . 0.0 112.373 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.2 pt -145.63 31.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.65 -42.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 62.9 169.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.74 165.97 41.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.04 34.68 4.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.79 82.33 1.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.86 112.62 2.1 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.9 m -91.2 59.99 4.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.43 106.92 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 23' ' ' PHE . 70.6 m-85 -131.37 171.33 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.978 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 151.41 23.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.43 153.28 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -146.79 140.8 26.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.6 ttp -85.17 57.39 4.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -59.83 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 m 59.39 31.95 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 m -139.83 -66.83 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -176.45 134.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.97 167.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 -31.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.19 -116.36 3.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -160.87 31.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -138.66 -77.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.89 77.56 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.54 48.87 2.92 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.715 2.276 . . . . 0.0 112.716 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.69 170.14 19.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.1 146.04 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.21 118.78 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.228 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.18 121.94 44.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 2.8 t -113.14 151.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -141.21 122.25 8.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.19 96.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.336 2.024 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.75 178.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.89 79.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -135.98 32.06 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.26 -178.52 28.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.38 10.99 3.43 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.791 2.327 . . . . 0.0 112.97 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.96 -32.96 72.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.983 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.43 -39.21 92.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.1 p -69.72 -32.05 70.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 198' ' ' TYR . 11.7 tp10 -75.79 -40.5 55.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.46 -42.54 92.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -62.08 -51.7 66.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.1 -40.05 84.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 3.0 m-85 -56.32 -60.06 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.357 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.07 -17.65 63.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -75.87 -47.53 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.97 -25.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -88.74 23.63 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -76.73 138.54 66.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.536 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.22 -27.8 58.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.513 2.142 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -79.45 -47.36 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.5 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 96' ' ' ILE . 64.6 mt -55.84 -45.68 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -48.65 -38.24 20.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -35.15 63.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.452 HD12 HG21 ' A' ' 100' ' ' ILE . 40.9 mm -66.55 -41.46 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -74.92 -27.6 60.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.59 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.2 p -84.37 -28.47 26.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.351 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -107.11 -7.23 16.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.844 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm 58.7 21.83 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.802 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -54.69 -41.56 70.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.986 0.422 . . . . 0.0 110.755 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt 52.35 27.08 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.562 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -177.57 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.691 0.281 . . . . 0.0 111.381 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 167' ' ' TYR . 14.1 tp 69.92 -65.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.824 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.92 1.55 10.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.98 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.4 t -89.8 138.65 27.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.83 153.22 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.24 115.62 28.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.22 121.78 36.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -103.86 -40.67 6.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.05 -176.78 46.48 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.66 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -132.58 178.71 6.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -163.36 173.24 39.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.06 159.92 40.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.726 0.298 . . . . 0.0 110.746 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -144.32 119.43 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.023 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.71 124.62 49.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.15 126.2 22.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.0 t30 55.43 20.83 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.422 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.57 -3.55 61.26 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.903 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -96.14 129.09 43.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -89.07 140.78 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -125.75 123.56 39.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -102.56 125.13 49.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.992 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.441 ' CE1' ' HA3' ' A' ' 117' ' ' GLY . 23.9 p90 -140.43 162.47 35.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.5 ttm -131.41 147.18 52.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 130' ' ' ILE . 9.1 mm -98.73 119.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.9 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.54 171.94 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -71.28 145.88 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 134.17 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' A' ' 196' ' ' VAL . 72.9 m-85 -110.17 154.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.722 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -85.39 -107.84 0.69 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.368 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 m -111.24 118.71 36.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.831 0.348 . . . . 0.0 110.672 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -51.22 160.98 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -66.53 -21.7 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.679 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -65.24 -44.7 87.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.027 0.441 . . . . 0.0 109.813 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.88 66.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.191 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.81 -25.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -62.41 -49.03 77.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.521 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.85 -31.11 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.75 -25.43 67.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -108.95 10.4 26.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 81.01 52.71 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.047 0.451 . . . . 0.0 110.454 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 23.6 mtpt 61.14 19.66 10.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.588 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -136.15 -175.56 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.045 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -137.13 -172.71 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.01 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.0 m -119.12 149.74 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -30.57 65.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -34.83 62.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -48.38 35.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CB ' ' A' ' 251' ' ' MET . 59.4 t -60.08 -54.19 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 16.5 mt -58.87 -49.7 76.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -59.86 -51.27 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.91 -33.42 71.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.519 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -45.57 90.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.69 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.74 -45.78 92.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.75 -48.79 79.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.781 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.18 -40.21 88.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.4 mt -58.07 -33.47 69.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.21 -32.7 72.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.788 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.74 -44.54 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.45 -40.44 71.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.67 -38.46 91.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.067 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.424 ' CE2' HD22 ' A' ' 108' ' ' LEU . 80.5 t80 -66.56 -52.05 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 175' ' ' HIS . 38.0 pt -62.37 -27.16 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.427 ' CE1' HG12 ' A' ' 174' ' ' VAL . 0.8 OUTLIER -80.71 -34.48 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -16.75 62.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.676 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 2.44 49.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 12.9 mt-10 78.09 43.48 0.09 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.851 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.3 122.21 15.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.465 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 18.8 m -121.92 142.8 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.209 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.505 ' CE1' ' CD1' ' A' ' 198' ' ' TYR . 0.5 OUTLIER 177.74 82.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.82 79.57 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.07 22.46 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.649 0.261 . . . . 0.0 111.143 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.1 91.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 171.69 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -76.86 -6.31 51.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.538 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.71 1.79 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -123.87 -9.61 7.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.102 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 193' ' ' VAL . 9.6 mt -108.63 128.83 55.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 134' ' ' PHE . 1.4 mt -135.46 149.15 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.756 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.52 147.83 25.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.281 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -65.8 125.75 26.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -94.95 -42.81 8.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -30.25 66.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.467 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -141.22 69.24 27.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.432 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.51 108.3 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.5 -45.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.082 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 339' ' ' LEU . 40.6 mt-30 -149.62 -166.52 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 111.205 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -109.91 148.24 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.85 156.93 26.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.351 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.14 115.84 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 134' ' ' PHE . 13.1 m -118.5 145.93 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.15 100.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.252 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.505 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 2.9 m-85 -86.65 -20.27 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 65.21 14.64 59.71 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -146.61 -66.35 0.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 44.38 87.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -131.0 149.01 52.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -95.82 82.82 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.465 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 41.5 p90 -44.87 -29.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.612 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.5 t -103.54 88.98 1.94 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.01 -167.11 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.633 2.222 . . . . 0.0 112.284 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.66 30.52 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.34 99.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.513 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.46 138.95 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.0 111.06 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.64 27.49 5.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 56.48 78.17 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.047 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -158.82 83.92 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 131.01 16.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.96 91.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.86 79.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.97 107.22 40.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.85 97.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.558 2.172 . . . . 0.0 112.469 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -127.12 30.31 5.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 61.14 35.01 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 62.1 m 63.22 121.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.405 ' CD2' ' HA ' ' A' ' 238' ' ' PRO . 0.7 OUTLIER -62.51 -44.48 96.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -119.26 103.36 9.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.63 -168.44 0.61 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 m 61.29 162.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 225' ' ' ILE . 3.7 tp -130.13 15.87 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 227' ' ' PHE . 43.8 tt0 -74.55 -34.82 63.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 226' ' ' GLU . 73.0 m-85 -157.59 30.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.0 t -76.11 132.62 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 172.25 10.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -53.6 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -42.26 90.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.26 -32.79 74.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.216 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.5 -36.53 84.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.67 12.98 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.31 31.45 59.55 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.801 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.6 113.28 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.05 154.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 221' ' ' HIS . 48.5 Cg_endo -68.78 158.68 56.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.578 2.186 . . . . 0.0 112.254 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 18.9 m -67.22 113.09 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -134.59 -57.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -87.58 -24.87 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.6 -32.11 64.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.563 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -38.12 74.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 57.9 mt -80.6 -33.48 35.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.57 -37.81 79.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.44 -39.67 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.36 -45.43 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.42 92.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 25.4 m-85 -78.81 -25.7 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.67 -43.25 84.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.279 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.404 ' CB ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.17 -49.62 76.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.019 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.6 mt -63.99 -28.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -80.12 -40.19 27.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 36.2 m0 -82.29 -30.85 30.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.9 mt -79.79 -44.04 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.297 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.05 0.62 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.449 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.71 97.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.5 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 64.07 154.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.473 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -137.77 171.28 8.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.56 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 45.3 Cg_endo -68.89 61.73 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.411 2.074 . . . . 0.0 112.633 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 262' ' ' GLU . 1.6 p90 178.12 -37.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -98.09 22.23 9.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.437 179.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.82 -55.83 6.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -132.22 -26.41 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.482 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 66.0 mt 71.93 12.27 6.11 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.208 0.528 . . . . 0.0 109.69 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -84.77 -14.43 48.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -134.92 101.24 11.61 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.52 19.27 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.724 2.283 . . . . 0.0 112.724 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -45.67 17.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -82.09 -26.46 33.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 11.3 t -61.72 -44.22 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -71.47 -44.34 64.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -66.51 -41.25 89.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 278' ' ' TYR . 75.5 m -63.17 -40.5 97.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.419 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -61.98 -45.91 91.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.044 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.5 mt -70.88 -46.08 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -59.59 -51.61 69.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 274' ' ' SER . 16.3 m-85 -60.43 -31.87 70.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -59.43 -33.26 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.407 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.19 23.07 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.868 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -139.16 37.91 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.489 HD11 ' CB ' ' A' ' 303' ' ' MET . 7.0 mm -47.09 -43.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -47.74 36.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.073 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.7 -33.61 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 tt -64.33 -43.63 94.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 3.5 mmt -65.48 -32.52 74.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.984 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.75 -27.03 31.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.139 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -54.84 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.34 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 68.2 m -76.42 -41.22 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.52 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.84 158.71 34.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 177.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.612 2.208 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -108.01 -66.24 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -59.69 -35.12 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -60.27 143.52 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -63.8 148.86 94.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.11 158.83 55.23 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -94.2 20.84 45.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.568 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.35 9.2 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.526 0.203 . . . . 0.0 111.402 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 34.2 mm -79.52 -40.76 21.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.77 32.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.312 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -59.85 -39.77 86.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.63 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 306' ' ' VAL . 70.4 t80 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.489 ' CB ' HD11 ' A' ' 282' ' ' ILE . 1.4 mtp -64.73 -45.72 85.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.595 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.13 -51.89 67.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.846 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.7 p -58.07 -53.59 56.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 302' ' ' TYR . 61.1 t -56.32 -24.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.154 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -43.1 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.78 -11.98 60.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.689 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.85 131.7 18.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.222 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.13 165.86 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.789 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.95 30.9 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.5 t -128.42 -44.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.49 -75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 9.2 tptt 58.9 64.51 3.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.47 88.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.345 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.8 tp -140.13 17.64 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -60.07 -31.63 70.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.75 -46.48 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.779 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.49 -40.2 90.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.421 HD23 ' CE1' ' A' ' 302' ' ' TYR . 34.6 mt -55.55 -48.15 75.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 7.7 ttm105 -57.46 -34.56 69.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -38.52 71.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.5 mt -57.07 -47.91 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -79.78 -22.0 43.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.462 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.68 -40.49 20.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.688 0.28 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.92 -39.42 90.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.94 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -60.32 -26.34 63.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.5 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.413 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 69.9 mt -48.44 -27.99 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -81.28 -31.08 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.73 -26.35 65.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.297 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.97 22.75 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.455 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 53.25 45.69 64.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.738 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.7 t -118.33 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.57 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.959 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.79 133.85 51.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -164.89 -60.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -176.89 35.33 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.546 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 136.43 33.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.445 ' O ' HD11 ' A' ' 341' ' ' LEU . 0.2 OUTLIER 179.17 -24.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.69 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -51.96 -23.57 5.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 339' ' ' LEU . 1.0 OUTLIER 70.88 10.95 7.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.282 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.6 t 56.69 86.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.808 0.337 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 344' ' ' VAL . 5.6 m -152.16 88.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 35.4 m 43.31 31.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.587 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.09 -44.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -60.35 -31.44 70.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 82.02 46.5 6.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.519 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -83.08 58.74 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.75 -33.11 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.02 157.78 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 59.49 78.53 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.12 -179.44 7.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.4 t -110.66 108.83 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.63 134.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 60.9 p -127.52 -46.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 162.77 22.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.85 19.98 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.65 -74.7 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 178.67 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.22 78.84 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.88 -173.58 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 1.3 pt -98.39 30.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -117.21 31.58 6.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -146.46 145.17 30.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.96 -67.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -118.14 -176.67 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.777 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -128.23 86.59 57.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.03 -38.85 6.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.574 2.183 . . . . 0.0 112.24 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 70.6 137.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 10.1 m -130.5 104.16 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.31 118.21 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.72 -69.59 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.956 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 3.8 m -93.23 147.77 22.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -118.85 -66.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -164.01 157.01 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -58.87 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.11 136.51 42.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.08 -62.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.68 89.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -45.46 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -81.69 176.34 9.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.961 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.52 -38.55 71.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 58.02 -171.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.055 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 8.0 mt 69.47 -64.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.93 40.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 1.4 m -117.96 -39.9 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -75.21 90.06 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.7 p -147.28 31.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.18 137.66 19.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 43.9 p -97.87 -176.64 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.8 146.99 4.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 -55.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -161.27 102.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.4 139.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.9 127.44 55.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.942 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 57.8 p -62.54 132.52 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 17.8 m -145.71 132.66 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -109.74 122.8 6.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.545 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 4.2 p -79.72 95.83 6.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.2 t -71.15 -54.41 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 92.13 -62.27 2.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.41 148.04 39.32 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.71 116.78 4.84 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.537 2.158 . . . . 0.0 112.34 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.87 123.98 26.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 m -111.71 179.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -105.13 87.74 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.19 88.27 7.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.04 70.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.61 127.21 54.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 123.96 34.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.059 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.71 130.96 50.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.507 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.58 78.78 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 126.83 29.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.9 t -97.71 107.88 20.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -102.18 120.41 40.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.7 92.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.038 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -110.17 160.16 16.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -125.99 113.46 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -104.38 31.03 4.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.57 -176.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.32 123.85 29.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.95 -40.19 87.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -139.4 -80.31 0.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 8.4 m-85 -126.29 134.01 51.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.849 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.44 -178.37 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.67 127.1 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.98 22.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -58.87 139.84 56.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG22 HD13 ' A' ' 28' ' ' ILE . 21.7 mm -100.34 136.39 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.2 pt -117.89 154.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.088 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 3.1 t -101.81 136.94 40.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -93.77 -164.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -41.37 43.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -75.25 -6.63 50.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.429 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 4.2 tttp 89.59 27.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.6 OUTLIER -75.16 178.36 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.154 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.63 79.6 1.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.39 . . . . 0.0 110.591 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' HB2' HG13 ' A' ' 29' ' ' ILE . 80.5 m95 -76.51 136.73 39.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.952 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.88 129.14 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.95 128.54 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.7 -122.58 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.57 154.42 37.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 61.4 Cg_endo -73.1 105.49 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.615 2.21 . . . . 0.0 112.362 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -98.54 -28.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.99 -100.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.558 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.75 78.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.841 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.95 28.82 5.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.89 -42.79 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.507 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -56.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 110.936 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.34 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -160.39 90.67 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -111.83 137.53 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 23' ' ' PHE . 44.2 m-85 -143.74 172.22 13.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.804 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.65 158.26 35.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.45 152.37 43.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.48 156.79 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.4 ptp -97.47 26.42 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.29 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 p -134.45 35.74 3.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.6 30.91 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -131.26 179.07 6.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -99.13 29.89 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t 68.3 -68.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.51 179.03 21.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.559 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -92.54 48.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.38 -69.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.27 139.32 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.93 -4.74 13.51 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.667 2.245 . . . . 0.0 112.816 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 11.8 m -149.65 157.11 42.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.27 144.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.39 121.11 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -98.07 116.19 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 11.9 t -113.07 139.32 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.309 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 136.52 15.96 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.686 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.51 96.6 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.389 2.059 . . . . 0.0 112.317 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 t 179.63 177.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.24 -42.58 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.12 95.28 2.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.05 -147.98 5.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.488 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.16 -23.09 39.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.528 2.152 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.1 -33.2 71.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.915 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -42.14 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.8 p -70.88 -30.15 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -75.02 -42.31 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.2 -51.49 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -59.54 -46.21 89.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 198' ' ' TYR . 12.2 t80 -54.67 -50.68 67.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 24.7 m-85 -59.81 -41.48 91.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.415 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -79.95 -17.79 52.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -47.41 69.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.486 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 171' ' ' HIS . . . -145.03 -32.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -53.86 -21.8 8.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -51.34 125.26 25.53 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 -25.4 15.34 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.491 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.4 -44.01 92.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.131 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.28 -43.13 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.282 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 mt -58.42 -48.34 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -52.28 -39.53 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.043 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.33 -29.2 59.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -76.62 -43.98 36.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mt -65.85 -37.47 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.023 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.8 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -82.02 -36.99 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.433 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.71 -2.5 24.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.4 mttm 59.51 31.34 20.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -49.39 -30.88 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.68 -55.6 0.51 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.026 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CD1' ' OE1' ' A' ' 192' ' ' GLN . 6.8 t80 -150.68 139.8 21.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.979 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.72 162.19 19.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.61 19.14 42.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.97 125.25 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 149.13 37.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.369 2.046 . . . . 0.0 112.262 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.4 115.88 25.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -86.9 129.61 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.721 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.7 m95 -107.58 -40.91 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.77 -174.66 46.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.1 p -132.86 169.0 17.39 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -158.96 175.84 35.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.977 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.83 150.83 36.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -141.17 141.61 34.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.61 136.07 54.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -138.27 126.27 22.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.29 18.59 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.322 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 10.39 54.72 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.861 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -96.21 159.37 14.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 110.711 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.5 m -111.34 123.11 49.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 124' ' ' LYS . 12.9 m-85 -122.12 136.5 54.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.793 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -117.95 125.12 49.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.806 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.437 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 29.5 p90 -133.16 165.84 23.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.417 ' HE1' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -134.65 144.77 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.53 111.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.2 173.06 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.141 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.35 127.69 32.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -55.65 176.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 184' ' ' LEU . 54.9 m-85 -147.42 175.82 10.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.663 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.21 -81.67 1.6 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.461 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.6 t -149.58 130.51 14.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.837 0.351 . . . . 0.0 110.582 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.16 165.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.713 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 138' ' ' LEU . 2.8 mt -77.34 -14.07 59.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -33.25 29.86 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.05 0.453 . . . . 0.0 109.932 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -75.83 -31.3 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.824 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.427 ' CG2' ' CE1' ' A' ' 149' ' ' PHE . 12.2 mt -68.93 -26.74 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.412 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 24.1 t80 -71.17 -43.92 66.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -29.9 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.4 67.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.219 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.32 21.03 9.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.039 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 79.41 47.92 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 10.2 tttt 64.7 18.2 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.25 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 13.7 mtp85 -138.01 -170.67 2.84 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.002 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE1' ' CG2' ' A' ' 141' ' ' ILE . 0.2 OUTLIER -137.55 -166.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.675 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 m -129.35 151.7 49.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -62.22 -30.7 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -30.99 62.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -51.24 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CG ' ' A' ' 251' ' ' MET . 21.9 t -60.33 -48.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.58 -43.87 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.727 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -68.47 -54.5 16.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.19 -42.47 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -55.58 -42.47 74.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.418 ' CD1' ' HG ' ' A' ' 325' ' ' LEU . 10.8 mt -60.02 -49.72 76.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.589 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 21.4 mmt-85 -60.72 -42.0 96.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.19 -36.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.0 mt -60.23 -39.71 87.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.535 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -34.61 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 9.7 mt -74.54 -42.87 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.34 -32.24 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -73.66 -32.79 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.578 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -70.91 -49.89 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -63.23 -27.71 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.423 ' CD2' HG13 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -72.8 -40.47 65.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 -14.77 62.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 57.5 m-70 -101.42 2.86 39.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.152 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 76.34 43.37 0.15 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 111.0 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.99 129.08 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 169' ' ' HIS . 28.9 m -142.2 169.44 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.1 m170 65.23 48.83 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.39 -10.86 54.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.897 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 76.08 69.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.984 0.421 . . . . 0.0 111.026 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.4 mp -73.97 98.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -144.38 -179.55 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.936 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.32 -0.61 46.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.436 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.29 -3.38 18.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 110.833 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -126.16 -2.15 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 193' ' ' VAL . 9.4 mt -108.36 113.56 26.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.997 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 134' ' ' PHE . 1.0 OUTLIER -122.82 144.71 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.45 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 193' ' ' VAL . 1.3 mt -90.48 149.0 22.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.349 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 9.9 m-20 -67.89 126.18 28.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -86.9 -60.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.406 ' HB2' ' NH1' ' A' ' 133' ' ' ARG . 10.4 mmtt -63.79 -30.83 71.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -130.34 71.71 82.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.2 97.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.551 2.167 . . . . 0.0 112.057 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.19 -53.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 107' ' ' TYR . 1.4 mt-30 -150.86 -177.42 5.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -110.0 141.28 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.681 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.449 ' N ' HG23 ' A' ' 193' ' ' VAL . 3.3 m-85 -106.97 153.8 22.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.125 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.6 tp -105.99 116.14 31.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 m -88.57 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 198' ' ' TYR . 1.2 t70 63.76 129.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 30.1 m-85 -162.56 -44.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -55.89 -25.81 46.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.704 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.07 33.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 111.096 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.59 -110.29 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.19 119.38 8.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.809 0.337 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.66 49.49 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.417 ' CE2' ' NH2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER 54.74 83.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.5 t 63.93 133.41 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.806 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.39 -31.82 10.92 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.502 2.134 . . . . 0.0 112.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -121.61 -65.84 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.66 -41.88 1.84 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.465 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.05 -42.9 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -95.35 151.84 18.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 -26.18 9.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.05 174.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -68.05 -175.78 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.24 -47.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.966 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.0 174.54 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.016 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.86 166.12 16.1 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.56 71.35 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.501 2.134 . . . . 0.0 112.288 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.68 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -59.9 2.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 18.2 m 63.57 135.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -60.63 3.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -153.73 -58.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.91 -159.68 1.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.2 p -154.39 -46.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.409 HG12 HG11 ' A' ' 271' ' ' VAL . 1.2 tt -174.56 36.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 265' ' ' LEU . 7.5 pt-20 -95.99 62.85 2.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 12.6 t80 70.98 31.97 2.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 41.7 p -100.15 179.75 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 160.16 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.29 -40.29 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -78.13 -28.65 48.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.18 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -58.07 -39.79 79.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -97.02 -5.63 37.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 83.58 -2.7 86.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.718 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.23 157.77 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.807 0.336 . . . . 0.0 111.167 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -164.99 78.33 1.34 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.45 10.66 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.73 2.287 . . . . 0.0 112.878 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.0 p -153.61 163.24 40.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.417 ' NH2' ' CE2' ' A' ' 204' ' ' TYR . 0.0 OUTLIER -113.88 -11.83 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.94 -13.48 61.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.315 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.36 -25.93 55.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.607 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -31.86 62.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.977 0.418 . . . . 0.0 110.838 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.58 -30.45 36.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.39 -32.56 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 29.3 mt -69.59 -37.55 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.186 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 40.7 tp -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.83 -41.75 94.23 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.34 -29.03 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -37.18 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.404 ' CG ' HG12 ' A' ' 154' ' ' VAL . 1.8 mtt -68.35 -39.7 81.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 7.4 mm -62.25 -39.32 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -80.27 -34.97 36.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -76.41 -48.12 20.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.414 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.46 -36.21 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.55 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.39 -13.92 22.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.573 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.55 94.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.261 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.0 146.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 110.653 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.467 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.91 166.15 29.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.212 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.01 62.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.953 2.435 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.467 ' CH2' ' CD2' ' A' ' 259' ' ' LEU . 0.7 OUTLIER -178.54 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.448 ' HB2' ' CD1' ' A' ' 261' ' ' TRP . 1.8 tt0 -108.94 18.22 20.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.069 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -66.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.82 -27.34 3.07 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.428 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 226' ' ' GLU . 19.8 mt 77.18 7.94 2.91 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -16.42 61.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.468 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 33.4 t70 -145.06 91.19 5.99 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.71 -7.28 17.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.685 2.256 . . . . 0.0 112.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.84 -50.11 69.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 110.965 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 5.5 p90 -83.88 -26.22 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 25.9 t -60.38 -40.85 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -48.67 23.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.975 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -61.6 -35.16 77.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.071 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 m -72.09 -33.7 68.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -70.2 -49.73 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.046 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.4 mm -61.15 -36.59 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -75.54 -52.12 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -55.4 -35.09 64.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -29.69 65.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 22.68 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.94 43.57 2.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 18.7 mt -55.48 -37.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.18 64.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 5.4 t -71.12 -42.79 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 282' ' ' ILE . 1.5 pp -65.23 -31.46 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.79 0.329 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mmt -66.81 -49.36 66.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -68.68 -31.4 70.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.247 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -53.76 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.102 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.0 m -66.15 -41.16 90.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.155 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.0 146.19 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 -166.86 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.51 45.28 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -45.73 19.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -149.87 167.15 27.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -86.78 156.57 55.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.86 118.41 5.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.593 2.195 . . . . 0.0 112.192 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -157.69 -49.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.67 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 303' ' ' MET . 19.0 mm -79.43 -41.69 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.227 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.57 -42.36 7.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.869 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -67.23 -38.71 85.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 110.58 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 11.0 t80 -70.5 -44.52 67.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 47.2 mmm -68.73 -31.93 71.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.84 -43.07 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.328 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 5.5 p -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 79.5 t -79.45 -24.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -36.68 23.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.738 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.1 -27.89 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.54 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER 47.6 -167.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.124 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -106.79 54.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 56.94 25.9 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 4.4 m 56.19 25.66 9.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -54.04 7.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -136.51 155.42 76.97 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.691 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.72 132.15 29.8 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.464 2.11 . . . . 0.0 112.223 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.06 29.23 3.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 166' ' ' GLU . 4.1 m-85 -66.53 -29.7 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -40.53 67.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -42.76 48.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 39.3 mt -58.27 -41.38 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -57.28 -47.36 81.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -39.13 80.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.37 -46.42 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.055 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.99 -50.36 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -53.73 -49.89 67.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -56.29 -42.35 77.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.995 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.94 -29.71 65.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.75 -35.02 79.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.2 66.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.247 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.49 32.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.1 70.14 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.85 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.61 101.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 39.23 3.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.44 70.1 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.9 -44.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 174.94 39.05 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.342 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -79.88 121.19 25.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.63 -9.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.204 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 341' ' ' LEU . 5.6 m-20 -60.5 -30.74 69.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 340' ' ' ASP . 1.1 mt 70.81 -52.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 18.3 t 65.89 101.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.401 HG12 HG12 ' A' ' 141' ' ' ILE . 19.0 m -130.19 -44.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 30.2 t -111.9 -46.51 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.121 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.79 150.87 28.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -157.41 -55.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.9 62.44 0.29 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.463 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -132.26 53.64 0.8 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mt -130.97 83.16 2.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -160.45 -71.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.851 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -151.41 155.33 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 85.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.75 123.24 44.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 29.3 mt 63.8 158.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.099 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 19.4 m 61.12 163.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -125.38 134.41 52.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.58 50.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.78 93.64 4.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 155.73 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -131.64 93.54 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -160.37 153.39 21.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.4 mp -106.53 -55.1 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -167.24 106.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.32 129.66 18.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 149.66 43.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -88.16 136.05 33.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.12 86.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.74 111.0 2.9 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.558 2.172 . . . . 0.0 112.271 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -120.52 179.88 16.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 11.1 p -171.34 -44.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.085 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.39 -53.36 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.26 32.81 20.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 15.7 p -138.99 -65.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.54 136.56 43.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -178.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.9 m 61.24 171.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -82.78 -64.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.5 m -110.8 -66.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -143.62 -57.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 44.9 m -99.04 -61.38 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -153.03 -58.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.28 126.91 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -150.26 110.91 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 20.1 mt -107.03 31.03 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.67 169.15 11.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -65.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -126.81 -53.92 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.37 171.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -152.77 160.32 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.2 m -90.1 169.5 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 64.15 39.26 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -101.72 -34.42 9.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -109.23 158.47 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.809 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.43 -47.1 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -94.35 131.97 39.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.1 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.901 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 1.3 m 60.38 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 8.1 m -169.51 132.81 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -138.62 -44.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.3 m -70.12 -40.25 74.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -150.28 127.08 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 177.8 98.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -178.57 -61.61 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.253 . . . . 0.0 110.934 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 47.5 Cg_endo -68.59 117.53 5.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.498 2.132 . . . . 0.0 112.294 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.8 ttt-85 -164.73 149.19 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.78 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.03 149.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -70.59 164.72 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -175.56 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.0 121.45 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.18 156.77 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.962 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.95 -175.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.028 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.99 139.02 6.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.533 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.07 30.14 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -61.02 115.13 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.9 m -143.57 92.83 2.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.21 105.45 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.78 169.11 4.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 -178.65 3.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -137.94 86.4 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.28 140.06 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.25 97.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.2 157.22 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.063 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -125.69 -57.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -96.42 -60.12 1.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CD2' ' CG2' ' A' ' 29' ' ' ILE . 10.2 p90 -166.04 107.09 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . . . -134.1 -53.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.0 t -129.44 117.36 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.71 30.0 27.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -132.54 139.1 47.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.734 0.302 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 35.2 mt -103.71 140.09 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 128' ' ' PHE . 30.7 pt -119.86 154.55 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.6 p -95.65 136.92 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HB3' ' CD1' ' A' ' 37' ' ' TRP . 21.7 p-10 -94.54 -148.29 0.27 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.985 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -85.67 -37.91 18.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.242 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.39 2.34 32.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.856 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.2 mmpt? 83.08 15.47 0.34 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -63.15 169.89 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 76.13 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.018 0.437 . . . . 0.0 110.619 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 31' ' ' ASP . 44.5 m95 -67.11 142.67 57.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.787 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -105.46 132.66 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.931 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.8 130.02 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.56 -106.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.858 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 2.3 mt -121.99 162.25 38.18 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 38.4 Cg_endo -66.78 140.38 55.58 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.666 2.244 . . . . 0.0 112.29 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.5 pt -142.57 30.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.75 141.58 3.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -115.89 144.02 44.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.69 93.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.26 -66.07 2.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.436 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.45 -76.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.79 0.328 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 52' ' ' TYR . . . -109.71 -79.35 1.08 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 78.34 -55.71 0.48 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 111.177 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.7 mm -135.63 127.4 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.428 ' CE2' ' HA3' ' A' ' 49' ' ' GLY . 14.2 m-85 -146.43 145.8 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -71.82 136.55 47.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.352 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.55 157.22 23.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.507 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 145.99 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.673 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ptm -98.2 40.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.8 t30 58.72 35.86 24.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -65.8 -67.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.43 -170.14 1.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -76.65 -38.82 53.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.85 131.84 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.32 -29.1 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.094 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.88 65.41 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -179.25 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 110.767 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 76.07 1.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.94 89.95 21.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.88 42.36 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.871 2.381 . . . . 0.0 112.807 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.71 157.13 42.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.754 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.05 144.9 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.444 ' HB ' HG13 ' A' ' 130' ' ' ILE . 11.2 p -127.41 129.82 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.316 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -94.7 117.48 30.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.199 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.2 125.31 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 111.55 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -141.16 146.98 45.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 114.89 3.85 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -60.2 124.16 19.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.12 -73.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -79.36 -32.79 43.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.14 48.42 3.57 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.783 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 38.5 Cg_endo -67.7 -51.36 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.266 1.977 . . . . 0.0 111.643 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.93 -21.44 51.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.821 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.78 -33.9 50.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.441 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 t -74.68 -35.36 62.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.817 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -73.1 -35.29 66.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.67 -36.2 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -63.97 -47.98 78.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HB2' ' CE1' ' A' ' 173' ' ' TYR . 10.2 t80 -72.0 -35.7 69.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.85 -50.47 72.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -74.98 -17.47 60.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.44 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -47.73 14.64 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.36 -19.64 4.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.61 21.4 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 113.25 35.08 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.57 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.76 -29.55 3.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 0.0 112.749 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -71.93 -39.38 69.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.83 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -67.53 -49.78 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -29.66 61.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -38.16 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -71.14 -42.69 68.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.025 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 104' ' ' LYS . 60.6 mt -69.68 -36.43 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.84 60.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 p -84.37 -30.28 25.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.342 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -4.16 17.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 100' ' ' ILE . 3.0 mtmp? 56.59 30.91 18.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.531 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.7 mt -45.56 -84.65 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.16 -62.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.755 0.312 . . . . 0.0 110.984 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -169.13 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tp 75.34 146.44 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . -86.76 10.23 68.56 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.995 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.97 115.45 44.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.783 0.291 . . . . 0.0 110.939 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 141.07 8.42 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.484 2.123 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 122.26 26.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.42 131.36 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.4 -40.99 3.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.618 0.247 . . . . 0.0 111.551 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.75 171.64 38.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.804 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.66 164.48 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.603 0.239 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -162.01 179.75 37.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.979 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.45 159.68 42.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.715 0.293 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -144.53 141.65 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.957 0.408 . . . . 0.0 111.108 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.41 129.24 54.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 126.35 22.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.921 0.391 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 55.47 20.9 3.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.72 -0.18 64.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.85 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -96.23 151.15 19.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.759 0.314 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.6 p -101.26 127.33 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.203 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -113.57 147.9 37.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.34 125.17 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.77 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 20.7 p90 -135.29 162.45 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -144.94 140.26 28.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.026 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.444 HG13 ' HB ' ' A' ' 70' ' ' VAL . 2.7 mp -99.11 129.82 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -133.31 173.06 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -55.75 138.19 48.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 170.46 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -145.73 157.5 43.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.98 -74.69 1.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.5 p -148.53 135.1 19.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.82 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -57.31 152.48 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.24 -23.19 46.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.75 -38.56 91.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.154 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -36.48 81.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -73.85 -25.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.714 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 254' ' ' TRP . 13.1 t80 -76.42 -51.89 10.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.32 -29.99 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.58 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.45 63.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.21 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -96.16 19.77 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.002 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 80.97 48.01 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt 63.37 19.19 11.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.302 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.413 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 20.7 mtp180 -131.91 -178.58 4.95 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -139.06 -167.81 2.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.688 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.08 144.46 47.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.45 -31.27 63.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -74.93 -43.91 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.416 HG21 ' CE1' ' A' ' 149' ' ' PHE . 58.6 m -58.45 -51.82 68.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.22 -46.0 88.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.3 -48.29 73.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -41.97 95.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.32 -38.98 75.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -59.43 -34.55 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.8 -46.77 62.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.466 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -61.32 -44.72 96.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.85 -42.18 94.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.698 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.52 -35.93 66.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -36.93 79.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.603 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.54 -38.71 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.17 -48.22 80.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.821 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -31.09 72.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -72.2 -47.91 47.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.829 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.47 -27.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.6 -33.43 58.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.357 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -15.86 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -102.39 3.11 37.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.867 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 74.17 45.24 0.21 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.891 0.377 . . . . 0.0 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -133.08 124.9 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.416 HG13 ' CE1' ' A' ' 204' ' ' TYR . 28.3 m -132.2 165.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.067 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.37 -51.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.237 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.09 24.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.605 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.67 -80.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.584 0.23 . . . . 0.0 110.795 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.0 mt 44.57 95.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.99 174.84 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -77.09 -1.0 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.8 t -111.97 1.94 16.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 0.0 110.551 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -123.4 -12.07 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.194 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 4.5 mt -108.36 125.19 51.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.908 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.86 156.55 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 111.351 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.31 149.84 22.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.05 129.68 40.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.942 0.401 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -73.07 -60.21 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -61.01 -20.84 62.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.534 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -136.52 78.23 44.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.54 80.46 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.534 2.156 . . . . 0.0 112.14 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.36 37.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.06 143.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 183' ' ' LEU . 4.0 p -109.95 147.99 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.162 0.506 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 8.4 m-85 -126.12 156.89 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.652 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.42 HD22 ' CE1' ' A' ' 198' ' ' TYR . 39.5 tp -104.01 115.9 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.659 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.76 142.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.1 t70 55.77 84.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.42 ' CE1' HD22 ' A' ' 195' ' ' LEU . 3.5 m-30 -59.05 -21.05 58.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.119 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.49 9.06 68.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.758 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.61 -58.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.734 0.302 . . . . 0.0 110.818 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 43.93 76.24 0.09 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -116.72 148.97 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -103.1 69.71 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.416 ' CE1' HG13 ' A' ' 174' ' ' VAL . 17.0 p90 -50.12 -43.16 51.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.11 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.91 -34.68 46.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.575 2.183 . . . . 0.0 112.277 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.23 34.63 4.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.44 -90.17 1.82 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.425 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 24.2 t -66.0 -29.78 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 63.74 34.72 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -77.21 166.66 22.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.44 -66.12 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.25 145.19 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -62.95 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.04 96.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -163.24 72.78 1.94 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 100.84 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.568 2.178 . . . . 0.0 112.282 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.47 -70.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -56.63 10.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 76.9 m 60.76 94.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.808 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 45.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.27 92.97 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 90.62 -134.11 12.16 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.505 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 -67.22 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -159.19 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 271' ' ' VAL . 5.4 mm-40 -159.48 26.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 227' ' ' PHE . 37.7 t80 -95.07 24.32 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.622 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -76.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.993 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.7 t -157.86 163.51 37.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.908 0.385 . . . . 0.0 110.952 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.39 -30.51 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -64.29 -39.47 93.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -67.49 -29.64 69.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.72 -25.48 61.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -88.92 12.87 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.475 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.98 28.13 72.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.642 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 129.29 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.691 0.282 . . . . 0.0 111.027 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.413 ' CB ' ' HD3' ' A' ' 238' ' ' PRO . . . -76.98 -54.29 1.6 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 52.0 Cg_exo -54.39 88.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.449 2.099 . . . . 0.0 112.194 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.19 80.77 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -101.8 -24.81 14.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -17.76 41.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.236 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -61.63 -30.31 74.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.78 -36.79 58.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 110.972 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.74 -35.0 33.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -57.3 -43.71 83.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.9 -42.1 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.1 -30.85 70.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.814 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.36 67.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.366 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.416 ' CZ ' ' HE2' ' A' ' 275' ' ' LYS . 34.5 m-85 -78.55 -26.17 45.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.297 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.283 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -51.07 65.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.6 mt -63.73 -33.53 62.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.02 -33.74 38.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 30.8 m0 -82.28 -48.74 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.415 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -70.93 -36.82 72.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.598 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.14 0.53 51.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.772 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 57.75 94.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.519 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 45.8 m80 63.52 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.468 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -132.97 168.52 17.53 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 59.2 Cg_endo -72.61 60.0 3.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.527 2.151 . . . . 0.0 112.534 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 1.3 p90 178.15 -39.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.9 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -107.45 20.35 19.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.47 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.22 -62.29 1.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.2 t-20 -128.57 -26.46 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.283 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 27.9 mt 75.53 10.2 3.5 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.08 0.466 . . . . 0.0 109.756 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -80.91 -16.45 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.11 81.81 37.69 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.89 -14.77 29.11 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.791 2.328 . . . . 0.0 112.534 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.85 -50.45 45.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.254 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 6.0 p90 -84.04 -26.85 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.767 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 39.5 t -60.62 -39.02 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.229 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -73.1 -45.28 58.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.94 -42.73 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.6 t -60.74 -46.17 91.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -58.75 -51.61 69.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 14.0 mt -53.12 -37.66 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.534 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.02 7.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.328 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 285' ' ' LEU . 9.8 m-85 -57.91 -36.98 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.62 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 0.0 110.695 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.35 28.12 7.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.403 ' HB3' ' CB ' ' A' ' 284' ' ' SER . 4.1 m120 -136.13 45.1 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 282' ' ' ILE . 18.8 mt -50.43 -36.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.238 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 281' ' ' ASN . 0.3 OUTLIER -78.92 -42.25 27.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.96 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 278' ' ' TYR . 3.0 pp -68.7 -28.47 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.743 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.66 -51.62 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -24.82 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.336 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -48.3 11.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 111.179 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.8 m -83.16 -41.25 18.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -104.18 153.45 38.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 -170.0 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.562 2.175 . . . . 0.0 112.349 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.05 -43.69 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.13 94.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.08 69.52 0.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 96.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.24 -34.42 21.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.261 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.83 78.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.935 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -57.1 14.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 27.1 mm -69.04 -35.31 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -52.21 -46.09 65.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -61.24 -37.47 83.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 324' ' ' LEU . 46.4 t80 -71.3 -36.17 71.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.428 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 0.6 OUTLIER -69.67 -38.06 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.587 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.53 -49.4 76.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.604 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.39 -39.69 84.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.712 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.417 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 22.5 t -73.82 -24.37 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.261 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -79.67 -43.16 23.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.32 -14.4 61.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 6.7 mt -52.56 93.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.74 -171.02 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.016 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.55 79.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 3.8 m 57.77 22.09 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 53.22 97.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -85.87 127.39 62.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.2 95.0 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.372 2.048 . . . . 0.0 112.38 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 24.8 mt -108.95 31.41 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -61.64 -31.45 71.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -38.79 92.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -76.62 -44.33 34.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 84.4 mt -54.67 -42.18 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.54 -33.32 69.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.44 -32.84 58.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 60.1 mt -61.16 -46.96 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.421 HD13 ' CE2' ' A' ' 302' ' ' TYR . 41.0 mt -81.17 -23.81 37.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.384 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.53 -44.39 15.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.184 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.85 -29.11 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -75.36 -26.45 65.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.746 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 40.9 mt -51.65 -35.22 41.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -29.95 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.27 -30.58 71.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 14.5 pt -97.97 28.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.265 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.35 91.71 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.614 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 m -137.5 164.85 27.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -154.61 154.12 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.54 91.0 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -118.69 35.73 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.85 46.89 21.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 126.01 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.74 16.4 20.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.255 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 3.9 t70 56.51 33.54 22.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.039 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.47 62.2 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.688 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 67.5 m -58.85 -51.85 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 344' ' ' VAL . 5.3 p 42.76 68.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.608 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 34.5 m 43.69 41.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.698 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 59.67 -176.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.36 -63.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 168.1 89.68 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -123.19 -40.05 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.51 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -41.44 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -143.87 172.99 12.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -170.88 106.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -97.74 166.19 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 60.4 p -130.48 151.72 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.2 pp -77.81 161.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.191 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 1.9 t -164.62 73.06 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -39.24 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -91.76 91.28 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.45 134.6 35.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 132.04 55.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.83 109.52 16.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -105.71 164.16 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.89 95.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.37 -35.36 6.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -128.56 103.52 7.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 60.3 m -118.64 -57.5 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 -53.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 60.21 101.48 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.3 -26.81 35.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.432 2.088 . . . . 0.0 112.26 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -102.11 75.27 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 24.8 m -85.89 145.85 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 111.173 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -177.03 -40.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -99.87 34.29 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 62.9 p -136.03 31.66 2.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.79 174.07 7.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -94.0 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.7 t 61.07 83.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -141.59 158.99 43.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.41 104.51 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.92 -55.94 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.72 156.69 22.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -65.73 131.69 46.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -141.04 138.99 34.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 60.07 87.69 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 26.4 mt -112.18 -35.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 118.53 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.6 m -124.15 121.67 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -118.18 104.89 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 24.7 m -152.52 -46.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.15 175.46 7.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 9.3 t -116.8 159.71 21.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.66 146.97 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -85.92 178.95 7.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -137.67 150.59 47.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.83 120.13 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 65.19 -77.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.929 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 2.7 m -147.85 169.23 20.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 12.0 p -151.03 141.63 22.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -169.8 150.64 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 4.1 p -76.42 131.37 39.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.1 169.39 24.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.71 174.49 50.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt 62.4 148.94 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.0 151.45 20.67 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 112.217 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -104.12 130.98 51.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.987 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.8 137.97 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.04 -35.15 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -178.46 139.18 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.091 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.99 -71.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.97 95.42 4.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.804 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.15 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.2 67.52 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -40.81 35.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 61.6 154.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.0 m -161.01 152.39 19.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -86.87 107.42 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.65 133.46 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -137.98 117.82 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mmt-85 -155.42 139.62 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -165.36 -66.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 mt -155.28 168.08 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.19 86.3 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -66.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' CE2' ' CG2' ' A' ' 29' ' ' ILE . 26.2 p90 -130.67 119.73 22.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.92 119.18 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.308 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t 64.56 110.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.239 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.13 -21.65 42.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.896 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -95.18 147.48 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.09 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mt -113.88 142.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' CG2' ' CE2' ' A' ' 23' ' ' PHE . 24.9 pt -118.34 154.41 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.419 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 9.4 p -95.88 141.55 29.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.922 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -161.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.18 -39.91 24.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -78.8 -2.82 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.654 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 1.6 tttt 88.51 29.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 30' ' ' THR . 7.2 tttp -77.13 176.41 8.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.365 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 79.07 1.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.442 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 130' ' ' ILE . 44.0 m95 -74.53 134.75 42.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.09 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -102.42 127.02 49.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -77.7 117.64 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.23 -105.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.53 159.42 52.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.05 151.97 67.62 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.174 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -145.68 30.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.167 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.75 163.24 32.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.544 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -172.0 83.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.42 49.91 1.01 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.59 -63.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -129.92 -57.15 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.95 -100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.424 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 7.7 m -134.53 80.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.743 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.74 113.51 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 9.3 m-85 -135.93 172.29 13.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -78.11 158.78 28.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.04 137.96 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.201 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -143.38 157.77 44.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.41 ' HE3' ' CZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -96.82 46.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -82.81 128.52 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 p -115.86 -39.04 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -93.03 -66.71 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.29 173.06 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.27 144.79 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.45 155.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.62 82.88 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.473 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.2 30.67 20.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.12 31.38 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.61 48.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.07 45.69 1.95 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.572 2.181 . . . . 0.0 112.713 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.8 148.21 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.46 144.89 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.45 119.94 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 118.15 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.398 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 2.8 t -113.1 135.78 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.336 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.2 143.37 30.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.674 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.58 117.61 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.421 2.08 . . . . 0.0 112.307 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -71.58 109.78 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -157.32 -75.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -76.39 -27.65 56.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.33 46.12 4.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.878 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 43.6 Cg_endo -70.14 -53.19 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.234 1.956 . . . . 0.0 111.651 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 tp -71.37 -23.92 61.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.71 -29.2 62.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.68 -39.69 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.86 -32.51 74.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.28 -45.61 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.669 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -57.49 -40.07 77.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CG ' ' HB1' ' A' ' 201' ' ' ALA . 64.3 t80 -72.16 -36.88 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -70.6 -41.19 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.32 -35.95 81.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.17 14.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.797 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.64 -49.58 4.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.61 2.82 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -55.93 121.14 38.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.52 0.2 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.27 -26.94 21.65 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.36 2.04 . . . . 0.0 112.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -79.34 -43.61 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -51.63 51.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.022 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.3 mt -57.12 -52.42 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.134 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.76 -31.96 7.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.97 -46.45 29.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.4 mm -56.04 -37.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -74.99 -27.76 60.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.1 m -74.61 -38.78 62.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.442 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -107.27 -3.5 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 55.44 24.88 7.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.0 mt -52.22 -39.55 60.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt 50.54 41.21 25.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.52 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -177.38 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.45 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 167' ' ' TYR . 13.6 tp 60.87 155.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.622 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 164' ' ' ILE . . . -83.87 -3.81 89.07 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.1 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.98 114.3 40.7 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.685 0.242 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.64 151.87 4.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.391 2.061 . . . . 0.0 112.371 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.3 115.49 19.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -92.9 126.03 37.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.0 m95 -103.45 -40.82 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.76 -178.29 45.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.558 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -135.57 159.47 41.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -145.45 -177.78 20.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.931 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 159.84 41.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -136.47 137.5 40.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -118.05 125.54 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 126.14 22.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.09 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.38 21.33 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.491 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.3 57.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.985 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -96.2 159.41 14.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.5 m -114.51 124.09 51.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.0 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.27 140.41 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -121.54 127.94 51.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.598 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 23.5 p90 -140.2 161.09 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.251 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ttm -128.05 142.36 51.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.37 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.419 HD13 ' CE3' ' A' ' 37' ' ' TRP . 19.5 mt -118.62 111.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.413 . . . . 0.0 111.336 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -125.46 173.27 9.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.34 132.5 20.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.99 143.16 55.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 42.6 m-85 -111.34 179.91 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.76 -98.63 2.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.553 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.6 p -125.85 128.18 47.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 11.9 p30 -56.25 164.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -69.16 -21.36 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.549 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -35.04 44.11 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.901 0.382 . . . . 0.0 110.429 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -77.83 -25.58 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.356 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.42 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 44.6 mt -73.94 -27.52 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.975 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -57.15 -45.65 83.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.695 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -27.99 60.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.31 -26.2 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 3.2 m-80 -92.79 5.64 50.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.332 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 90.11 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.128 0.49 . . . . 0.0 110.671 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.07 16.33 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.722 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -161.39 116.35 2.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 1.8 m-85 -57.34 174.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -106.8 158.44 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -32.45 69.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -71.68 -47.78 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -58.28 -55.19 38.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.315 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -54.91 -52.69 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.392 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 52.5 mt -56.52 -46.85 80.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.272 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -52.03 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.8 -44.25 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.2 p -54.66 -45.02 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.733 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.05 -43.75 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.358 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -44.51 97.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.477 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.91 -33.48 63.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.676 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.9 -38.63 86.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.537 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -32.91 71.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.332 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 109' ' ' GLY . 18.7 mt -78.21 -35.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.376 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 15.9 mt -58.15 -48.17 81.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.577 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -31.68 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.431 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 85.1 t80 -64.1 -42.97 96.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.487 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 36.0 pt -81.13 -27.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.243 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.41 -29.57 57.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.81 -17.03 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.423 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -106.87 8.45 30.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.688 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 68.88 49.16 0.69 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.27 138.85 46.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.405 HG12 ' CD1' ' A' ' 204' ' ' TYR . 14.4 m -130.68 169.31 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.487 ' CD2' ' CD1' ' A' ' 168' ' ' ILE . 1.5 p80 -154.11 -44.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 111.279 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.31 52.79 49.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.625 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.42 -85.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.59 0.233 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 mt 45.99 91.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -147.11 170.96 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.821 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.36 -1.99 29.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.647 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.19 -0.99 17.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.426 . . . . 0.0 110.435 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -121.5 -8.31 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.351 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.44 ' HB3' HG22 ' A' ' 193' ' ' VAL . 8.5 mt -108.43 115.34 29.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.279 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -122.11 146.43 47.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.211 -178.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 193' ' ' VAL . 31.0 mt -86.39 148.9 25.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.18 124.42 23.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.88 -53.82 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -59.66 -30.14 68.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -143.39 79.14 14.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.641 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.72 108.23 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.634 2.222 . . . . 0.0 112.224 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -56.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -167.74 2.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -110.02 147.39 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 32.1 m-85 -113.22 156.89 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.139 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 175' ' ' HIS . 43.0 tp -104.05 115.83 31.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 m -122.17 165.83 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.51 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.658 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -98.59 -50.66 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 90.64 -47.52 3.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.135 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.04 34.87 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.489 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.438 ' HB1' ' CG ' ' A' ' 86' ' ' PHE . . . -77.93 59.65 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -137.06 149.09 47.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.025 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -59.82 101.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 206' ' ' PRO . 42.1 p90 -59.51 -28.04 66.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 13.6 t 61.42 95.98 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.018 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.426 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 52.4 Cg_exo -52.47 -177.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.521 2.148 . . . . 0.0 112.217 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -111.27 -31.88 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.34 -44.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.63 172.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -114.52 31.3 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -69.73 158.62 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.42 32.64 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.0 108.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.974 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.07 -68.57 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.719 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 59.23 161.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' A' ' 217' ' ' PRO . 0.1 OUTLIER -165.15 -64.59 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 216' ' ' ASP . 69.3 Cg_endo -74.34 -168.04 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.415 2.076 . . . . 0.0 112.183 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.82 -40.24 7.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -170.68 43.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.24 134.69 0.43 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 217' ' ' PRO . 0.5 OUTLIER -164.91 -49.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.984 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.98 31.56 2.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.991 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.47 -106.02 2.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.587 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.11 176.81 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.466 ' O ' HG12 ' A' ' 225' ' ' ILE . 16.9 tt -93.14 13.83 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -92.46 25.03 3.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.798 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 226' ' ' GLU . 0.4 OUTLIER 174.94 -28.15 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 16.7 p -81.15 161.72 23.94 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -167.84 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 30.2 mt -73.75 -55.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.3 -31.18 65.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.86 -28.38 61.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -61.56 -51.44 68.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -91.74 12.92 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.421 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.21 15.35 58.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.818 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.5 t -64.38 141.48 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.22 162.64 0.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 -164.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 12.2 p -139.56 104.16 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -158.0 -53.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -28.2 61.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.4 -33.64 66.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -56.56 -30.42 63.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.64 -36.56 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.89 -35.3 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 12.0 mt -62.87 -41.52 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.19 -50.61 67.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.81 -27.95 51.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.458 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.93 -33.19 45.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 0.0 110.79 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.414 ' HB3' ' CE3' ' A' ' 254' ' ' TRP . 69.2 m -53.15 -51.63 61.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.046 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -30.58 64.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.624 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 252' ' ' ILE . 20.8 mm -69.18 -44.24 80.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.994 0.426 . . . . 0.0 110.737 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.03 -27.18 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.108 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 2.9 m0 -81.59 -54.38 5.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.38 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 43.9 mt -70.32 -35.13 73.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.528 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.4 ' OG1' ' CE1' ' A' ' 290' ' ' PHE . 0.3 OUTLIER -96.25 -13.92 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.538 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.9 97.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.184 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.0 141.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.654 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.477 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -116.64 159.25 41.12 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 14.3 Cg_exo -69.04 59.49 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.839 2.359 . . . . 0.0 112.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 3.3 p90 179.13 -38.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.241 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.409 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.1 tt0 -95.99 24.67 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.076 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.59 -57.39 3.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.816 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -125.95 -29.96 3.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 73.49 11.67 4.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -15.61 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.449 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 1.8 m-20 -132.94 103.96 12.88 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.5 17.4 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.722 2.282 . . . . 0.0 112.826 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -79.99 -50.1 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -77.42 -26.04 51.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 5.2 t -60.69 -45.75 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -47.69 25.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -39.16 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -72.74 -39.63 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -49.91 75.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 5.1 mt -63.97 -44.65 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -52.04 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.8 m-85 -59.03 -33.94 71.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -59.18 -31.14 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 23.65 11.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -147.79 45.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 18.5 mt -54.84 -41.24 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.08 67.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -41.52 61.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 1.0 OUTLIER -70.77 -38.33 73.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.5 ttm -67.53 -33.09 74.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -75.56 -37.69 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.44 25.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.043 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.38 -34.39 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.004 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 8.9 m-85 -127.9 79.91 72.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.969 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 111.4 3.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.554 2.169 . . . . 0.0 112.359 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -128.54 -46.37 1.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -173.84 -62.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -177.01 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.13 127.88 59.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.12 -168.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.77 -89.91 1.5 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.428 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -125.6 -39.97 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 111.037 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 303' ' ' MET . 35.3 mm -54.87 -41.43 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.4 -30.57 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.5 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.25 -42.26 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 11.3 t80 -67.57 -37.72 83.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 62.9 mmm -71.77 -30.0 65.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.96 -50.34 68.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -41.65 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 27.8 t -69.93 -24.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.106 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -80.43 -29.94 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.64 -11.91 20.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.584 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -54.63 91.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.86 -160.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.57 29.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 p -95.94 -33.94 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.7 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.44 -163.33 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.479 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 12.3 mmtm -151.54 -66.98 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 60.8 Cg_endo -72.3 64.01 3.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.31 2.006 . . . . 0.0 112.217 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.17 -23.87 19.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -53.92 -30.28 45.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.97 -36.58 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.9 -37.3 67.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 55.5 mt -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -59.34 -46.62 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -40.71 82.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 18.6 mt -58.06 -46.81 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.68 -51.63 15.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.28 -49.87 68.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.32 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -58.78 -39.97 82.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.001 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.12 -31.93 70.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.585 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 15.5 mt -63.02 -41.73 99.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.55 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.75 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.0 pt -101.45 27.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.188 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.04 28.08 52.81 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.583 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 18.1 t -102.33 156.79 17.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -174.61 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.67 100.42 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.4 -26.42 10.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.71 1.83 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.426 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.6 148.02 28.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.865 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 58.2 mt -91.78 12.75 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.318 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.85 25.3 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.797 0.332 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.404 ' HB3' HD12 ' A' ' 141' ' ' ILE . 34.8 mt -72.71 -43.08 63.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.4 68.33 0.61 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.72 30.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.09 -36.78 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.45 142.28 37.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -78.43 -38.87 40.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 123.27 -139.01 11.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 176.83 107.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.446 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.59 86.55 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -72.84 93.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.3 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.74 103.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 1.4 m -116.62 31.65 6.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 354' ' ' ILE . 0.2 OUTLIER -142.06 31.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.179 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 68.4 p -71.96 -34.24 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -115.4 111.16 20.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.1 146.61 24.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.87 -41.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -130.8 131.04 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -128.53 150.78 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -123.29 27.84 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.48 146.94 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.025 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 60.24 177.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.41 109.09 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.832 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -72.4 -28.5 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.045 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -58.3 -68.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.31 93.74 19.69 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.73 -59.81 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -160.49 -152.0 6.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.544 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.32 105.23 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.138 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 59.8 31.11 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -105.21 133.79 49.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.5 p -108.83 -46.1 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.24 -178.17 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.6 175.12 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.0 m 60.3 162.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -78.23 146.17 35.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 76.5 p -72.76 -59.55 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.23 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 7.9 m -107.14 122.38 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.65 127.31 55.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -150.41 -49.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.36 115.37 23.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.44 138.48 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -139.05 120.83 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -90.81 137.95 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 39.61 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.47 163.81 12.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 60.35 170.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.9 m 60.26 31.44 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.62 -59.28 3.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.1 -43.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.01 150.39 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 7.4 p 179.53 -34.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -173.78 90.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 13.3 tttt . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.928 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.569 -0.212 . . . . 0.0 112.569 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 1.4 m -65.36 135.9 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 69.6 m -137.82 92.71 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -88.17 170.38 39.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.505 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 23.5 p -162.05 111.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.68 172.61 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -178.34 -95.86 0.1 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.0 131.64 23.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.62 0.248 . . . . 0.0 110.778 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.59 151.37 46.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.508 2.139 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -138.21 177.21 8.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.01 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -134.65 97.47 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.66 33.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 173.5 12.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -107.73 88.86 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.35 30.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.39 -178.15 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.36 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.889 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.13 113.8 12.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 t -161.39 110.72 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.003 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.78 23.29 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.96 -168.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.836 0.35 . . . . 0.0 111.221 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 155.73 42.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -135.59 31.34 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -75.56 -67.62 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mp -111.62 162.55 15.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.828 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.09 137.51 9.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.59 156.02 38.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -178.02 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.437 ' CZ ' HG23 ' A' ' 29' ' ' ILE . 5.3 t80 -93.13 44.38 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -177.5 145.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 64.75 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.495 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.43 -25.44 22.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.975 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -83.39 136.13 34.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.196 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.0 mm -100.42 144.27 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.718 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.437 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 34.1 pt -119.76 151.3 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -95.81 141.4 29.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.806 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.08 -163.53 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.099 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -41.0 35.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 109.792 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -76.69 -5.01 46.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.531 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 89.65 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.9 mttp -77.21 -177.66 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.207 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -132.76 81.78 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 110.697 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -75.26 136.93 40.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.932 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -94.1 118.68 31.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -72.73 144.17 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.91 -117.42 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.787 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.1 mt -113.27 164.61 15.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 111.021 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 33.9 Cg_endo -64.6 141.86 74.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.598 2.199 . . . . 0.0 112.251 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.0 pt -153.76 79.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.28 97.23 0.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.565 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 59.62 96.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 68.12 1.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.81 -97.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.592 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -81.6 -69.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA2' ' CE2' ' A' ' 52' ' ' TYR . . . -170.33 -102.51 0.16 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.472 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 79.09 -56.1 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.647 0.26 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.59 130.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.424 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 9.1 m-85 -146.46 150.15 35.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.75 158.8 35.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.342 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.39 50.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.0 111.38 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -149.14 132.0 16.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.9 mtp -83.62 57.01 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.95 -177.67 5.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.0 p -175.65 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.4 p -79.28 -66.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.21 -69.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -161.21 160.38 29.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.58 139.95 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.061 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.89 -123.61 4.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.35 31.05 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.86 42.04 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.16 92.34 10.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.14 49.97 3.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.633 2.222 . . . . 0.0 112.753 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 59.6 m -149.86 148.19 28.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.51 144.96 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG11 ' O ' ' A' ' 70' ' ' VAL . 3.8 p -132.17 122.39 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.878 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -96.95 116.33 29.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.682 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.3 t -113.13 133.8 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.39 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.17 150.65 59.41 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.728 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.07 101.21 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.277 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 m 60.36 173.43 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.04 151.41 43.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.31 -55.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.58 0.22 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.07 -36.09 64.32 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.352 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.17 -39.83 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.63 -40.44 91.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.8 p -68.64 -31.8 71.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 38.3 tt0 -73.82 -47.66 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.46 -48.08 81.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -45.03 92.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.443 ' CE2' ' CB ' ' A' ' 90' ' ' ALA . 16.7 t80 -71.91 -44.74 63.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 83' ' ' GLU . 4.3 m-85 -57.07 -29.8 63.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.493 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -80.0 -45.57 18.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.074 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -87.39 -47.62 8.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 86' ' ' PHE . . . -81.34 -46.47 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.782 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.71 33.17 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.593 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -72.03 123.73 89.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.605 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.58 -25.34 79.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.398 2.065 . . . . 0.0 112.249 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.39 -36.01 39.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.6 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.2 mt -56.7 -56.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.304 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -37.95 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -74.47 -43.84 54.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.32 -51.91 65.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.31 -37.1 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -27.65 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 64.6 m -83.48 -30.92 26.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.23 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -105.95 -4.36 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.43 28.42 15.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.6 mt -48.93 -39.41 26.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.213 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER 75.41 -1.75 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.62 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 75.6 t80 174.19 162.46 0.19 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 110.461 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' N ' ' CG ' ' A' ' 107' ' ' TYR . 11.7 tp -147.42 -66.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 130.65 -14.65 5.52 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.7 126.86 88.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.612 0.206 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.49 148.23 20.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.483 2.122 . . . . 0.0 112.193 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 115.57 22.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.046 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 39.1 t80 -97.48 125.05 41.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -100.82 -40.7 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.86 -176.53 46.36 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.625 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -134.88 154.53 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -137.67 171.07 23.42 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.84 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mt -142.39 157.25 44.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.702 0.287 . . . . 0.0 110.623 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -145.96 141.56 27.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -115.92 125.33 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 126.27 22.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 60.44 17.05 6.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.51 -6.35 59.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.872 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -96.17 129.57 43.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.9 t -92.38 130.94 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.03 151.48 29.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.93 125.65 35.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.452 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 31.0 p90 -133.56 163.76 28.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.1 ttm -127.98 140.74 51.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -120.77 111.69 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.44 . . . . 0.0 111.549 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -123.42 173.43 8.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.718 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.85 138.28 48.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.025 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.421 ' HD3' ' CG ' ' A' ' 187' ' ' TYR . 52.1 ttt180 -68.89 154.6 41.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -119.32 161.84 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.2 -73.91 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 m -146.56 138.25 24.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.01 152.45 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -70.95 -41.73 70.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -65.55 -26.96 68.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.83 -29.77 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 46.8 t80 -54.24 -47.66 71.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.835 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.05 -25.57 68.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.715 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.73 -19.25 59.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 4.1 m-80 -91.0 5.59 48.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.233 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 90.55 43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.268 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.6 tttt 62.04 18.7 10.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 1.4 ptt85 -165.49 126.21 1.88 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.3 158.53 30.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.07 160.51 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -28.9 68.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 45.5 p -68.01 -44.07 77.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.87 -54.03 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.291 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 74.5 mt -61.78 -45.3 94.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -58.58 -44.0 89.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.33 -37.17 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.795 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.6 m -58.25 -41.41 84.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.422 ' CD1' ' HG ' ' A' ' 325' ' ' LEU . 12.7 mt -70.71 -43.79 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.77 88.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.3 mt -71.29 -33.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.56 -40.21 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.46 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -36.29 80.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.0 mt -73.65 -40.24 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 21.3 mt -56.22 -33.06 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.69 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 -29.34 59.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.408 ' CD2' HD22 ' A' ' 108' ' ' LEU . 81.3 t80 -72.02 -52.51 16.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 48.4 pt -64.75 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -40.16 88.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.326 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.02 -12.31 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.75 4.49 25.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.943 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 66.17 46.92 1.97 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.875 0.369 . . . . 0.0 110.706 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -135.34 120.11 18.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.58 169.08 16.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.008 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 12.6 p-80 -149.82 -52.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.95 37.52 83.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.3 -81.22 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.4 mp 47.4 93.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 174.84 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.019 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -78.23 -3.96 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.3 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.6 t -108.54 0.32 20.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.642 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -125.33 -9.55 6.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.326 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 54.9 mt -108.28 117.66 34.73 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.67 161.45 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.921 0.391 . . . . 0.0 111.492 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.0 mt -92.8 149.82 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.07 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.81 129.91 41.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.421 ' CG ' ' HD3' ' A' ' 133' ' ' ARG . 60.4 t80 -71.77 -62.81 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.591 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -19.95 63.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.653 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -134.34 76.8 61.65 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 78.04 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.437 2.091 . . . . 0.0 111.963 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -179.62 36.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.8 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 107' ' ' TYR . 1.0 OUTLIER -174.12 145.79 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.264 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 183' ' ' LEU . 2.4 p -109.98 147.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 110.888 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 10.8 m-85 -126.25 157.59 37.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 175' ' ' HIS . 34.0 tp -103.12 115.79 31.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.889 0.376 . . . . 0.0 110.607 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.77 141.32 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.182 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 57.54 106.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 175' ' ' HIS . 3.4 m-30 -75.48 -24.09 56.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.76 -24.7 24.92 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.553 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mp -150.78 -44.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 111.04 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 45.93 87.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.095 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 203' ' ' ARG . 30.5 t80 -143.84 148.77 35.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 202' ' ' TYR . 15.2 mtm105 -74.11 98.49 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -50.59 -26.28 5.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.4 p -98.23 97.68 4.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.24 -52.75 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.414 2.076 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -144.07 30.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.8 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.12 133.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -144.54 33.19 1.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 155.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.94 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.22 159.75 19.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 213' ' ' TYR . 0.7 OUTLIER -147.74 -45.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt 60.13 46.24 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 110.829 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -161.46 139.08 9.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.41 106.34 0.64 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.97 -32.75 96.02 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.459 2.106 . . . . 0.0 112.178 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -161.72 30.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.3 ttt85 60.77 68.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -72.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 63.5 m170 57.16 96.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -112.45 135.01 53.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 69.34 145.1 0.19 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.0 p -59.61 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 225' ' ' ILE . 2.3 tp -163.9 27.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.196 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.24 -35.36 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -152.23 32.34 0.53 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.705 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 39.9 p -65.54 128.74 37.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.021 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.6 m -89.88 146.57 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -57.81 -35.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.71 -30.53 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -75.3 -39.2 59.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -44.3 92.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -92.83 0.57 57.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.87 7.9 62.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.945 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.2 127.87 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.65 154.27 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.21 -166.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.55 2.167 . . . . 0.0 112.255 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -96.96 28.46 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -90.86 -53.02 4.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -25.44 62.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.873 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -65.05 -37.76 94.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -40.59 89.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.0 -35.93 81.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -62.95 -42.55 99.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.2 -39.9 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.76 -39.54 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.77 -44.93 96.55 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.379 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.63 -25.7 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.91 -43.33 86.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.252 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -50.1 74.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 mt -64.19 -26.55 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.401 ' OE1' ' CD1' ' A' ' 254' ' ' TRP . 12.4 tm0? -71.07 -45.2 64.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.401 ' CD1' ' OE1' ' A' ' 253' ' ' GLN . 18.5 m0 -82.19 -41.09 20.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.0 mt -67.04 -39.21 86.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -0.57 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.404 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 57.49 96.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 55.6 m80 62.54 144.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 260' ' ' PRO . 0.1 OUTLIER -122.35 164.65 24.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.466 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.93 63.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.421 2.08 . . . . 0.0 112.519 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 7.6 p90 176.41 -38.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.108 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.9 tt0 -95.55 18.47 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.289 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -55.93 15.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 93.6 m-20 -126.99 -27.36 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.6 mt 70.67 12.4 7.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -85.19 -15.3 44.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.175 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 2.1 m-20 -132.56 100.52 14.95 Favored Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.93 15.02 2.05 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.616 2.211 . . . . 0.0 112.857 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -78.54 -49.77 12.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.471 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.1 p90 -77.13 -26.47 53.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 12.5 t -60.71 -37.53 76.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -75.52 -44.94 41.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.068 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.15 -49.67 63.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.235 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.9 m -58.58 -41.98 86.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -62.35 -41.5 98.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.144 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.3 mt -75.1 -29.09 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.01 16.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.449 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -69.98 -40.13 75.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.388 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -52.58 -27.52 17.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.02 15.33 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.21 45.76 2.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 285' ' ' LEU . 21.1 mt -51.7 -36.5 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.336 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.13 63.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.574 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 9.9 t -68.37 -40.36 81.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.34 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.5 pp -76.01 -28.41 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.331 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 4.0 mmt -67.61 -38.42 83.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.751 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -82.7 -31.58 28.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -82.66 -51.59 7.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.07 -41.13 67.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -115.68 151.97 46.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.009 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 131.89 17.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.629 2.219 . . . . 0.0 112.281 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.02 43.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -107.13 -55.91 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -162.1 -176.45 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 60.82 87.16 0.14 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.59 144.16 44.04 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.608 2.205 . . . . 0.0 112.377 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -96.86 -18.08 30.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.709 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.14 10.61 6.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.362 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 43.3 mm -79.41 -46.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.13 -45.27 11.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.446 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -59.63 -42.76 93.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.52 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -70.17 -36.79 74.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.612 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.407 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 1.6 mtp -67.39 -42.47 83.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.579 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.48 -48.39 80.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -37.78 80.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.692 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 40.6 t -71.08 -25.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -43.12 15.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 110.217 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -14.31 62.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.545 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 8.7 mt -47.35 114.09 0.81 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.231 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.51 144.53 51.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.759 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -93.3 46.33 1.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.3 m -157.65 -47.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -176.33 116.2 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -176.73 72.15 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 132.24 20.02 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 112.23 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 1.4 pp -155.41 30.55 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.041 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -57.53 -37.05 72.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.22 -40.69 94.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.741 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.62 -42.88 99.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 79.4 mt -56.18 -45.38 79.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -56.34 -46.45 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.38 91.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 97.2 mt -53.07 -42.22 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 61.1 mt -81.06 -51.51 8.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.089 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.422 ' HG ' ' CD1' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -56.03 -49.77 72.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.43 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.91 -46.16 71.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.71 -28.13 56.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.16 -24.74 64.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.715 0.293 . . . . 0.0 111.071 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 1.2 mmtm -69.76 -33.47 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.02 -18.85 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.143 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.52 -34.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -122.07 -24.44 2.25 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.279 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 3.0 t 71.43 65.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 74.61 103.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 164.02 26.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -176.37 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -91.55 46.55 2.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.54 137.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 70.2 mt -100.5 -3.56 30.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 63.39 17.62 10.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.676 0.274 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.49 -61.44 1.83 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.7 t 77.89 -55.28 0.51 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.156 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.4 t 58.31 73.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.065 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.0 p -61.35 -28.48 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -106.34 81.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.62 -44.28 28.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 141.76 -94.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -127.01 -162.63 11.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.41 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 tt -127.76 158.9 36.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -66.2 115.25 5.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.12 54.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -99.05 31.43 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 28.2 p -115.77 177.78 4.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 9.6 mt 59.64 75.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.0 m -149.51 136.3 19.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 80.72 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -130.68 88.66 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.0 56.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -166.08 93.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -125.49 -50.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -66.86 117.48 9.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.99 117.68 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -87.37 -46.75 9.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.09 170.16 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.951 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.2 m -126.78 129.52 48.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 60.43 96.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.31 125.6 33.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.84 124.34 15.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.418 2.078 . . . . 0.0 112.21 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.29 -71.02 0.94 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.539 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.15 145.18 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.135 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -131.37 154.18 48.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.59 86.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 76.2 p -120.03 136.76 54.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.42 -176.64 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 60.06 89.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.2 p -103.64 132.81 49.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.29 108.14 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.0 m -127.83 75.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -171.82 -176.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.784 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 33.6 p -99.9 177.54 5.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.49 91.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.02 132.87 43.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -133.66 179.57 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 30.1 mt 63.54 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 60.25 31.95 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.0 p -133.5 104.18 6.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 159.73 37.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 28.7 t -162.91 89.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.47 166.3 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 m -147.12 81.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.963 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -74.78 123.61 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -149.91 -51.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -71.44 166.88 20.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.2 m -139.98 117.97 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -108.11 -61.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 6.3 m -88.61 -53.47 4.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 75.6 m -137.61 118.51 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -124.3 36.29 2.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.82 155.6 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 2.5 m -96.82 39.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -177.12 -121.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mtm -169.54 73.7 0.69 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.83 -25.46 27.33 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.539 2.159 . . . . 0.0 112.344 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -60.6 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.048 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.26 145.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -146.38 -47.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.6 -169.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.4 -48.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.43 129.78 54.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.04 -44.64 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.02 167.06 42.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -164.8 95.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 151.63 49.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -106.35 -66.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 m -142.94 -173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 173.8 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -154.67 -49.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -131.43 127.59 37.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -105.24 30.66 5.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -133.35 -178.66 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.43 -70.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -97.6 177.7 5.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.44 -51.69 2.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' CE2' HG23 ' A' ' 29' ' ' ILE . 3.6 m-85 -62.69 113.91 3.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.83 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.85 -171.57 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.051 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 110.6 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.93 -27.61 6.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.495 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 135.19 51.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mt -100.66 143.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.424 HG23 ' CE2' ' A' ' 23' ' ' PHE . 18.4 pt -119.7 154.99 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.4 m -94.98 135.45 36.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -160.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.248 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.1 -38.74 51.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.73 3.66 28.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.235 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.9 mttp 76.03 32.43 0.63 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.5 mtpp -77.34 171.87 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.065 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -111.88 73.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.49 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.7 145.87 55.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -100.8 132.39 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.9 123.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.07 -127.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.551 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.27 159.39 70.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.85 128.2 18.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.167 . . . . 0.0 112.299 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -109.72 -30.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.48 42.57 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.439 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.1 99.98 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 -101.12 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.571 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.93 73.75 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CE1' ' NZ ' ' A' ' 71' ' ' LYS . 93.7 m-85 -101.98 -37.72 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.97 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.37 -72.8 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -122.69 73.98 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.961 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.61 114.8 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 59.0 m-85 -146.32 158.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.66 163.69 27.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.57 157.51 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -149.29 154.01 38.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 43.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.955 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 60.2 -175.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t 60.47 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.56 68.88 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 59.7 -174.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.7 p -86.06 85.13 7.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t 68.95 -67.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.197 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.24 -156.12 21.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.7 -30.03 8.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.36 53.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.1 113.55 31.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.55 25.85 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.93 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.68 148.34 29.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.959 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 HG12 ' CG ' ' A' ' 133' ' ' ARG . 27.5 m -129.63 156.89 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.19 122.88 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' NZ ' ' CE1' ' A' ' 48' ' ' PHE . 2.4 mttm -106.4 121.93 45.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 3.3 t -113.16 146.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.22 136.75 16.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.731 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.33 89.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.364 2.043 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 59.61 172.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.7 81.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.04 -29.34 6.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.15 -165.9 22.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.65 29.29 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.936 2.424 . . . . 0.0 112.808 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.91 -31.88 51.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -67.01 -42.46 84.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.4 t -69.17 -28.62 66.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.956 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -40.4 69.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.65 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.69 -44.54 93.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.04 92.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.46 -43.04 95.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 4.4 m-85 -60.07 -44.41 94.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -79.83 -17.6 52.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.382 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -65.35 -47.8 75.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.784 0.326 . . . . 0.0 111.046 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.68 33.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.255 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -119.44 -10.68 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 163.84 0.44 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.696 0.284 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.44 -19.39 43.59 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.614 2.209 . . . . 0.0 112.493 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -75.62 -39.74 57.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -79.34 -42.09 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.36 -48.78 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -70.2 -49.58 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.174 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -58.15 -51.7 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.08 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.41 -35.72 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.009 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -75.07 -27.84 60.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.29 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -82.38 -37.76 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.468 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -104.8 -1.2 26.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 58.33 31.24 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.763 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.2 mt -51.28 -26.84 7.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.215 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.0 tttt 58.2 94.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.408 ' CE1' ' OH ' ' A' ' 194' ' ' TYR . 2.1 t80 63.87 132.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.4 tp -125.54 163.71 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.6 10.05 66.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.923 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.2 t -92.74 123.43 61.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.757 0.278 . . . . 0.0 111.065 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 146.38 49.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.075 . . . . 0.0 112.248 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -89.34 119.83 30.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -74.93 123.65 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.81 -40.61 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.47 46.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.704 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.52 163.39 34.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -164.66 -174.98 35.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -145.5 159.84 42.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -133.38 141.7 48.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.33 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 126.34 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.63 18.46 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.53 20.67 36.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.626 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 0.3 OUTLIER -121.13 128.94 53.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.17 130.87 37.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 124' ' ' LYS . 9.8 m-85 -120.26 143.46 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 133.14 52.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 11.3 p90 -137.88 163.68 30.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ttm -129.46 136.33 49.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.516 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.6 mt -109.2 119.27 58.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.42 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -134.01 173.23 11.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.795 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.74 145.24 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.208 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -73.4 160.64 31.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CD2' HD13 ' A' ' 184' ' ' LEU . 92.5 m-85 -132.3 154.92 49.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.98 -99.31 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.342 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.58 125.28 47.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -53.5 158.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.938 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.455 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 0.6 OUTLIER -63.79 -21.66 66.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -61.53 -40.5 94.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 0.0 109.981 178.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 138' ' ' LEU . 3.1 mt -73.13 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -67.37 -49.02 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.57 -28.58 59.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.873 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.19 -23.63 66.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.8 m-20 -98.75 20.89 12.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 81.77 48.66 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.243 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt 63.37 18.97 11.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.311 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 -176.16 4.52 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.421 ' CE1' HG23 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -128.14 -176.0 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.26 135.33 53.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.829 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -26.57 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -42.44 64.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.3 p -74.83 -35.58 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.745 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.4 t -57.68 -53.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.971 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 52.7 mt -63.87 -44.31 93.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.777 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -62.17 -45.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.692 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.15 -37.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.737 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.1 m -56.55 -37.33 70.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.96 -46.77 41.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.07 -46.19 90.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 mt -66.54 -34.43 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.757 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.03 -36.76 77.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.98 -40.1 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.04 -42.02 84.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.653 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.69 -45.11 95.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.26 -53.01 62.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 175' ' ' HIS . 36.3 pt -66.99 -27.17 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.21 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.408 ' CD2' ' OH ' ' A' ' 204' ' ' TYR . 8.2 t-160 -78.07 -36.5 48.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.645 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -16.98 62.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -94.57 -1.03 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 75.85 37.71 0.38 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.16 116.03 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.444 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 15.9 m -112.04 141.82 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.266 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 198' ' ' TYR . 0.8 OUTLIER -179.36 66.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.645 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -63.1 79.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.661 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -106.35 26.83 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.3 mp -59.76 103.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.022 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 170.14 16.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.895 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -77.3 -3.35 39.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.282 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.8 t -112.62 2.26 16.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.658 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -126.53 -5.41 6.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.098 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.484 ' HB3' HG22 ' A' ' 193' ' ' VAL . 10.9 mt -108.44 127.55 54.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.402 HD13 ' CD2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -136.94 150.08 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.908 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 141' ' ' ILE . 13.8 mt -86.67 149.41 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.256 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.5 OUTLIER -67.49 127.99 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.746 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.459 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 23.9 t80 -86.47 -43.67 12.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.544 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -20.73 62.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -149.6 71.0 9.76 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.616 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.06 91.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.735 2.29 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.45 31.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.57 155.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.014 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 183' ' ' LEU . 3.7 p -109.94 148.16 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 5.3 m-85 -119.66 156.9 29.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 35.9 tp -106.9 115.8 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.2 m -115.95 141.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.371 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.45 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.023 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 175' ' ' HIS . 5.2 m-85 -90.22 -19.18 24.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.39 23.29 73.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.373 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 mp -156.32 -68.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 45.67 88.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -137.4 149.11 46.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.998 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.4 81.19 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.713 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.444 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 13.3 p90 -46.17 -40.44 11.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.421 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.64 106.77 0.7 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 152.62 21.36 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.493 2.128 . . . . 0.0 112.335 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -35.35 5.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.39 29.47 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.42 141.49 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.31 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -97.16 33.6 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.93 158.17 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -130.02 135.34 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.424 ' CZ ' HG12 ' A' ' 236' ' ' VAL . 1.4 t80 61.38 96.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -87.41 -60.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 58.95 96.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -175.09 96.06 0.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.17 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -159.64 -45.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -31.45 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 64.9 m 60.57 -178.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.53 34.95 2.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.74 -178.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.974 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.25 -9.0 17.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.789 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 67.0 m 61.74 -90.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.623 0.212 . . . . 0.0 110.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 225' ' ' ILE . 5.9 tp -179.15 35.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.53 -45.19 13.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -157.57 35.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 118.48 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 176.29 8.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mt -61.83 -31.77 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -74.49 -41.6 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -27.69 66.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -94.79 -17.33 22.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.207 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.32 24.93 10.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.424 HG12 ' CZ ' ' A' ' 213' ' ' TYR . 22.4 t -89.36 145.18 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.515 ' CB ' ' HD3' ' A' ' 238' ' ' PRO . . . -119.08 -61.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 50.3 Cg_exo -55.89 107.33 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.223 1.949 . . . . 0.0 112.299 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.23 -52.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 77.44 -2.82 2.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.768 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -89.55 -23.1 22.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.72 0.295 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.5 -49.74 70.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.701 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.11 -33.44 73.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.55 -33.06 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.15 -38.79 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 17.4 mt -63.59 -43.95 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.25 -33.51 75.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.511 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.11 -41.83 99.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -78.52 -25.69 45.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 3.6 m -56.74 -39.99 74.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.372 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -48.81 62.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.249 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.33 -33.45 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.398 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -80.03 -42.7 23.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 0.0 110.928 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.4 m0 -74.1 -24.27 59.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.37 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.47 -35.86 10.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.59 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 m -96.2 -14.25 22.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.82 92.27 0.41 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 38.4 m80 61.52 153.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.337 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.456 ' CD1' ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -125.21 162.63 42.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.509 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 49.1 Cg_endo -68.65 62.13 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 112.424 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 6.8 p90 176.42 -38.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.2 tm-20 -94.26 18.93 10.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.155 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.19 -55.54 13.65 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.5 -28.72 2.26 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.444 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 48.0 mt 73.51 10.73 4.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -79.08 -15.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.215 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.473 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.4 m-20 -135.94 101.26 10.54 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.04 16.45 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.674 2.249 . . . . 0.0 112.873 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -79.52 -49.78 11.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.8 p90 -75.83 -29.33 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 6.9 t -62.16 -36.44 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -75.47 -49.3 19.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.19 -35.53 78.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 53.8 m -67.23 -46.14 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.176 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.36 -40.92 96.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 12.2 mt -68.24 -35.03 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -81.18 -50.17 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.4 m-85 -58.36 -40.36 82.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.49 -35.44 63.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.744 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -102.83 16.57 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.143 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.93 46.63 1.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.855 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 282' ' ' ILE . 18.6 mt -53.42 -35.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.92 -26.22 60.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.217 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 29.5 t -72.98 -42.55 63.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 3.2 pp -77.49 -30.79 53.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.14 -38.65 88.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.639 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -29.79 28.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -82.87 -53.48 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 65.3 m -74.12 -41.19 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.05 152.12 44.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.832 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.57 -46.31 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 54.88 27.83 9.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.43 -31.82 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -106.6 -75.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.021 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.45 110.26 9.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 176.46 6.66 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.378 2.052 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.26 4.85 38.21 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.826 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.06 14.94 5.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 111.297 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.44 -43.69 23.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.738 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -49.75 -43.91 48.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -38.58 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -71.25 -45.52 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.429 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 1.3 mtp -61.38 -41.81 97.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -45.52 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 33.2 m -62.26 -29.6 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.441 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 84.3 t -79.39 -24.0 12.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.343 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 -35.98 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 10.6 tp -110.64 -29.99 7.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.276 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER 52.36 178.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -158.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.81 59.15 3.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.7 p 65.5 44.82 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.749 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -100.79 148.5 24.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 315' ' ' PRO . 0.0 OUTLIER -81.46 -48.55 1.02 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 314' ' ' LYS . 85.8 Cg_endo -82.01 77.38 3.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.358 2.039 . . . . 0.0 112.639 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.62 0.23 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.358 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -60.72 -30.14 69.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -39.46 78.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -82.08 -35.98 28.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 59.2 mt -57.53 -50.73 72.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -56.08 -45.48 79.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.147 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -40.75 79.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 18.1 mt -58.35 -47.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.69 -50.85 22.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.011 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -49.84 65.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.382 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -55.11 -39.33 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.7 71.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.73 -38.87 87.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -61.2 -27.07 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.81 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.9 pt -117.93 20.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.538 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 49.9 43.35 39.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.752 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.1 m -97.95 36.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.05 144.06 45.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.37 114.48 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -167.65 42.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 114.94 28.86 2.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.565 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -126.64 134.37 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.84 -26.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.36 -22.81 8.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.645 0.26 . . . . 0.0 111.528 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 1.2 mp 74.63 24.8 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.763 0.316 . . . . 0.0 111.077 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 32.5 t 54.99 33.1 19.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.259 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.8 m -79.52 -25.33 12.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.35 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 t 67.67 86.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.52 146.38 28.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.13 -59.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 145.34 -44.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.446 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 165.79 -117.36 0.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.35 119.18 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -132.78 -46.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.62 87.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -89.19 -31.56 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 40.6 p -76.03 165.88 24.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 20.0 pt -114.76 -36.07 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 77.8 p -80.23 131.59 35.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -127.01 160.74 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.15 -69.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.05 -179.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.89 89.41 3.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -115.28 -51.71 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.51 127.98 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.56 153.68 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -143.08 77.61 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 59.97 31.31 20.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 99.3 p -113.22 168.95 9.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -140.4 177.42 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.78 88.84 14.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.48 136.04 48.05 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.552 2.168 . . . . 0.0 112.347 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -92.89 -125.88 3.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.7 147.58 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -150.76 37.93 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 61.32 178.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.3 m -150.56 -62.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.9 103.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -145.07 108.27 4.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.2 m -160.8 50.47 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 60.47 105.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 1.5 m -86.01 169.91 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -76.07 94.35 3.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 8.4 t -81.57 126.43 31.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.49 144.86 31.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -96.81 166.72 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 60.61 178.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.82 126.22 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.51 151.55 41.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.2 p -109.96 89.1 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.66 92.85 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.9 p -117.37 -177.63 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -60.38 144.65 50.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 14.0 p -114.94 -62.94 1.53 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.939 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 61.25 154.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.76 93.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -104.11 124.73 49.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.32 81.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.139 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.14 33.19 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 22.4 t 60.59 -170.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.8 m -123.96 134.82 53.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -156.38 -54.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.27 143.27 31.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.8 m -162.01 110.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -179.86 36.23 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 1.5 mpp? -76.51 -60.92 0.83 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 59.2 Cg_endo -72.31 162.84 40.44 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.153 . . . . 0.0 112.35 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -119.5 -66.39 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.67 -40.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.174 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.39 110.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 85.37 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.67 -174.14 2.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -90.14 108.65 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.86 -31.15 12.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.76 161.39 10.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.12 132.79 25.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.859 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -87.6 95.69 10.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 p -171.42 -178.03 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 t -160.86 139.25 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.0 -44.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -69.56 140.77 53.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.18 31.29 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -131.74 147.69 52.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.52 173.57 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.26 177.7 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.32 -67.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 61.32 90.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 2.9 m-85 -80.58 104.57 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.6 -179.9 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 m -59.12 145.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.76 -25.29 28.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -112.5 133.56 54.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.012 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mt -100.38 147.86 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.412 HG22 ' CE2' ' A' ' 23' ' ' PHE . 46.6 pt -116.77 154.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 111.457 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -97.64 141.61 30.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.743 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.34 -162.66 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -36.3 32.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -84.95 5.06 30.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.299 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 11.5 mmtm 79.63 31.36 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.884 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' THR . 9.7 mttp -75.14 177.0 6.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.957 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 80.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.513 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.1 137.64 36.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.976 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -93.86 119.81 33.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.09 149.6 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.03 -146.37 6.8 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 159.19 31.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.26 168.24 18.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.57 2.18 . . . . 0.0 112.332 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -137.6 79.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.12 -173.62 23.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.479 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.85 105.28 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.758 0.313 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.04 58.56 1.98 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.456 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.44 -107.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.545 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -164.75 -45.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.52 -95.19 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.1 m -132.45 66.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.4 mt -82.27 104.57 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 23' ' ' PHE . 18.8 m-85 -143.6 162.82 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.49 158.41 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.03 159.05 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.6 159.64 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.96 41.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.71 82.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 t -114.96 -38.23 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.1 t -127.6 -172.78 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.73 -49.34 75.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 156.84 45.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.68 99.82 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.17 -105.77 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 53.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -165.58 38.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.67 142.75 94.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.038 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.73 8.79 4.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.692 2.261 . . . . 0.0 113.023 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.2 m -149.69 148.24 29.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.94 144.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.27 128.2 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.298 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.72 120.63 39.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.421 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 3.1 t -113.22 152.07 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.939 0.399 . . . . 0.0 111.421 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -135.85 126.24 16.64 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.56 87.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.478 2.119 . . . . 0.0 112.428 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t 48.97 33.29 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.275 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -89.89 161.73 15.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -155.42 145.22 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.04 -75.4 0.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -44.59 1.98 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.593 2.195 . . . . 0.0 112.263 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.89 -37.78 47.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -58.52 -29.39 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.012 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.1 p -75.77 -28.55 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.71 -42.81 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.71 -32.75 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -71.03 -51.78 23.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.403 ' CE2' ' OH ' ' A' ' 198' ' ' TYR . 73.5 t80 -67.0 -40.81 87.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.946 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 3.4 m-30 -57.13 -45.12 83.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.89 -17.67 52.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -47.6 19.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.97 -29.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -71.41 3.46 3.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -52.57 159.54 1.65 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.745 0.307 . . . . 0.0 110.932 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.22 -32.82 12.32 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.478 2.119 . . . . 0.0 112.288 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.57 -30.02 41.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -75.89 -54.04 7.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.399 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.71 -53.23 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.359 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -51.35 -35.66 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.205 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -36.09 78.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -77.08 -42.49 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.7 mt -65.51 -33.17 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -27.67 60.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.1 m -72.6 -36.77 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -5.42 19.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.34 29.68 19.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.886 0.374 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.7 mt -50.89 -33.52 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.237 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 76.83 -55.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 138.67 50.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 tp -120.62 -66.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.98 -9.83 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.98 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.35 131.05 66.66 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.709 0.255 . . . . 0.0 111.175 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.13 147.56 26.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.273 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -87.33 115.51 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -88.31 126.46 35.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -105.74 -40.72 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.96 -174.62 46.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.623 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -136.58 162.76 32.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -142.46 174.43 23.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.824 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.2 mt -148.08 159.83 43.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.64 122.1 11.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.028 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.85 118.47 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.22 126.32 22.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.23 20.58 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.527 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.36 -1.3 60.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.94 129.0 43.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.762 0.315 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t -96.22 123.05 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.25 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -106.71 121.28 44.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.488 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -106.35 125.08 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 12.4 p90 -139.81 158.76 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -128.05 147.21 50.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.647 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 mt -121.34 112.73 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.97 173.41 7.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.169 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.19 148.74 4.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HG2' ' CD2' ' A' ' 187' ' ' TYR . 1.9 tpt180 -65.38 155.69 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -128.58 160.01 33.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.29 -110.29 2.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.555 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 p -107.98 125.79 51.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.762 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' HA ' HD21 ' A' ' 184' ' ' LEU . 10.1 m-20 -58.65 160.34 5.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.813 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 1.2 mm? -65.77 -24.35 66.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 180' ' ' ALA . 1.2 mt-30 -63.71 -44.29 94.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 110.15 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -60.71 -30.68 70.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.26 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.1 mt -72.87 -25.2 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.762 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.433 ' CE2' ' HA ' ' A' ' 147' ' ' LYS . 76.7 t80 -67.75 -48.85 65.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.619 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.59 -27.96 58.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.741 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.02 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 77.7 m-20 -97.51 -1.8 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.263 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 88.7 45.34 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.166 0.507 . . . . 0.0 110.345 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 51.7 mttt 61.33 20.91 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.396 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -135.11 107.86 7.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.421 ' CE1' ' HA ' ' A' ' 142' ' ' TYR . 2.0 m-85 -77.93 -172.93 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -116.9 150.37 38.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -29.4 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -73.81 -43.75 57.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -61.3 -52.04 66.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -54.84 -54.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.0 mt -62.47 -47.87 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -43.12 93.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.68 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.1 -35.27 76.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.32 -42.24 81.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.06 -43.19 71.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.726 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -64.27 -49.27 72.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.36 -36.23 76.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.54 -36.03 77.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -35.86 74.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.78 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.0 mt -76.89 -37.3 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.39 -41.85 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.15 -30.96 68.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.696 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -70.93 -53.35 15.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.426 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 12.1 pt -66.67 -27.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.21 -32.85 61.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.92 -16.96 62.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.58 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -100.47 3.2 42.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 67.71 42.44 2.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 0.3 OUTLIER -131.64 127.48 37.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.06 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 204' ' ' TYR . 3.7 m -113.57 169.21 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.066 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.447 ' HB3' ' CG ' ' A' ' 198' ' ' TYR . 18.7 p-80 -147.42 -50.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.42 52.83 38.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.646 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.58 28.98 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.253 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.82 106.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.719 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -153.55 -177.76 6.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -81.7 -0.08 41.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.293 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 p -109.11 1.23 20.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.44 -6.65 4.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.519 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 193' ' ' VAL . 17.9 mt -108.59 127.98 54.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 137' ' ' ASP . 0.7 OUTLIER -134.97 156.82 48.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.164 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.9 mt -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.307 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.456 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.3 OUTLIER -67.26 130.32 42.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 133' ' ' ARG . 6.1 t80 -75.01 -54.41 7.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -21.3 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.506 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -135.89 73.68 59.32 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 102.0 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.526 2.151 . . . . 0.0 112.147 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -177.44 -35.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -176.77 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 183' ' ' LEU . 3.5 p -132.56 148.12 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.456 ' CE1' ' ND2' ' A' ' 186' ' ' ASN . 6.3 m-85 -121.06 156.94 31.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.142 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 175' ' ' HIS . 60.4 tp -106.62 115.88 30.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.34 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.1 m -106.64 143.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.266 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.58 104.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.447 ' CG ' ' HB3' ' A' ' 175' ' ' HIS . 5.8 m-30 -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 88.98 -50.66 3.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.398 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 200' ' ' LEU . 2.9 mm? -118.61 -38.72 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.665 0.269 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 44.37 82.09 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.252 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -118.86 148.96 42.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.416 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 11.0 mtp180 -102.39 70.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.687 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.424 ' CE2' ' HD3' ' A' ' 206' ' ' PRO . 43.6 p90 -50.85 -48.36 60.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.26 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 77.3 m 58.0 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 204' ' ' TYR . 53.7 Cg_exo -52.15 106.43 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.519 2.146 . . . . 0.0 112.305 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -141.44 83.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 109.58 81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.37 31.15 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.0 -35.97 7.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -87.39 -171.22 3.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -142.44 140.51 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.439 ' CE1' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER 60.12 89.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.739 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -127.45 33.3 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -50.61 174.64 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.418 ' CB ' ' CD ' ' A' ' 217' ' ' PRO . 0.3 OUTLIER -178.92 -61.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 216' ' ' ASP . 48.6 Cg_endo -68.78 178.57 3.85 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.41 2.073 . . . . 0.0 112.255 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.38 -41.47 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 40.01 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -37.86 74.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -80.0 -64.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.59 -168.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.814 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.24 -112.45 2.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -147.47 146.3 29.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 6.9 tp -68.01 -11.13 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -52.47 -36.75 55.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.408 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 62.9 m-85 -157.42 33.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.25 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.0 t -66.53 139.92 57.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.786 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.6 131.83 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.6 mt -59.31 -58.85 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -44.19 97.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.07 -45.18 83.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.22 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -61.82 -27.84 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -90.07 -0.1 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.393 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.16 87.2 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.002 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.439 HG21 ' CE1' ' A' ' 213' ' ' TYR . 21.2 t -54.13 107.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.56 165.94 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.24 148.08 88.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.46 109.7 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.25 -47.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -67.21 -30.41 70.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.61 91.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.16 -32.68 66.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 317' ' ' TYR . 84.0 mt -80.57 -37.4 31.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -61.71 -37.72 85.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 6.1 mt -61.93 -49.28 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.8 -40.73 95.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.97 92.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -78.67 -25.88 44.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.15 -39.97 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -50.0 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.761 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.96 -30.56 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.05 -39.94 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -82.23 -25.8 33.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.381 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.22 -44.68 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.223 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.23 0.61 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 65.36 100.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.3 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 3.8 p80 55.67 165.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -135.38 168.46 17.5 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.507 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 43.2 Cg_endo -68.33 63.33 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.379 2.053 . . . . 0.0 112.457 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 270' ' ' TYR . 3.8 p90 175.19 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.013 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -95.21 19.78 10.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.47 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -57.67 4.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 87.0 m-20 -126.91 -26.02 3.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.343 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 48.4 mt 71.3 12.41 6.72 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.106 0.479 . . . . 0.0 109.822 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -12.89 49.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.196 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -124.06 79.63 58.42 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.92 -11.12 29.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.767 2.311 . . . . 0.0 112.597 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -47.65 22.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.069 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -75.3 -26.15 58.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.884 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 77.8 t -57.78 -35.22 50.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.591 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -75.59 -41.69 53.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -40.48 82.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.079 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 67.1 m -75.44 -29.93 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -73.54 -45.9 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.069 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.02 -38.57 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -65.12 -52.0 57.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.425 ' CG ' HD13 ' A' ' 285' ' ' LEU . 13.0 m-85 -62.05 -35.12 77.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -29.28 63.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -118.9 24.0 11.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -140.34 42.52 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.465 HD13 ' CB ' ' A' ' 303' ' ' MET . 6.4 mm -47.6 -41.07 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.39 63.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.97 68.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' A' ' 278' ' ' TYR . 5.0 tt -64.76 -51.16 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.707 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.734 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.4 -26.54 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -82.76 -52.87 6.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.075 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.92 -41.17 37.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.57 87.38 7.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.41 76.2 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.441 2.094 . . . . 0.0 112.253 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -172.42 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.24 58.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.66 -68.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -152.27 101.19 2.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.224 1.95 . . . . 0.0 111.975 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -174.86 28.82 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.595 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 68.16 7.01 5.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.502 0.191 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 303' ' ' MET . 24.3 mm -79.8 -45.7 22.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 110.963 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.51 -46.74 9.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -43.06 89.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.768 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.452 ' CE2' ' CD1' ' A' ' 324' ' ' LEU . 18.4 t80 -70.56 -46.47 63.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.465 ' CB ' HD13 ' A' ' 282' ' ' ILE . 62.6 mmm -66.06 -37.71 86.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.748 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -42.36 98.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.564 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 42.2 m -67.65 -31.74 71.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.41 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 66.3 t -79.35 -24.4 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.195 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.33 -40.74 58.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.11 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 310' ' ' ASP . 0.1 OUTLIER -102.79 -27.11 12.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 305' ' ' THR . 1.6 mp 57.23 -82.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 308' ' ' LEU . 12.6 m-20 -166.89 39.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.966 0.413 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.3 t80 61.24 39.99 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m 60.4 31.52 20.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.36 101.86 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.65 139.61 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.31 179.06 6.2 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.596 2.197 . . . . 0.0 112.308 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.01 41.24 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CE2' HD21 ' A' ' 244' ' ' LEU . 11.3 m-85 -59.16 -30.09 67.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.75 -47.91 83.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.67 -35.01 79.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.976 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 57.9 mt -59.57 -42.12 91.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -63.12 -36.39 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.97 73.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 20.8 mt -66.26 -49.24 77.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.254 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 302' ' ' TYR . 5.8 mt -76.2 -24.54 54.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.261 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.64 -44.75 15.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -59.47 -37.1 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.37 76.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.53 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 13.2 mt -59.98 -41.2 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -27.69 61.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.14 -26.29 62.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.31 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 27.7 pt -106.3 -27.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.221 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.21 7.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -65.45 0.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.829 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.91 108.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.08 89.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.64 100.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 132.66 -45.45 1.13 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.44 -175.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.307 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 11.3 mt -104.21 9.9 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.429 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.39 28.02 10.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.692 0.282 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 32.8 mt -61.06 -33.1 72.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.2 t 61.1 98.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.862 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.0 m -147.27 86.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.126 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 18.5 t -92.67 46.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.29 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 62.57 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.81 104.18 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.73 164.32 13.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.02 -144.24 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.584 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.06 157.1 37.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.8 129.47 15.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -103.06 179.79 4.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -158.29 149.99 21.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 1.1 m -140.95 137.61 33.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 19.0 tt -83.6 114.67 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 43.8 p -143.81 31.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -102.76 151.69 22.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -83.31 167.18 17.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -170.0 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -157.46 133.07 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -157.76 165.44 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.6 145.5 55.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.8 pt -146.18 144.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -115.42 -75.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.84 176.0 7.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.8 t -98.48 86.49 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.32 84.57 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -109.1 158.65 33.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.94 -175.0 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.227 . . . . 0.0 112.228 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 87.54 61.05 1.57 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.475 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.06 -46.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.51 113.93 27.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -83.1 77.94 9.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.1 t -123.54 79.67 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -138.46 168.04 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 60.33 83.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.5 m 60.64 31.19 20.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.34 149.66 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.6 p -141.19 -46.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.95 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 4.6 m 67.74 39.71 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.89 -48.53 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 59.15 177.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -140.14 105.86 5.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.71 62.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.005 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -123.27 -41.1 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.7 m 63.09 106.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.1 ttm105 -91.46 125.43 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 4.1 p -157.17 82.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.58 160.08 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.8 t -82.77 133.75 35.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.58 -46.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.69 -42.87 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.985 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 61.73 152.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.67 159.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -140.1 -48.29 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.0 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.894 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 6.8 p -82.85 -61.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.3 m -93.94 93.71 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -172.64 120.93 0.84 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.5 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -68.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.8 p -73.98 168.45 19.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 111.12 52.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -178.87 -60.97 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 1' ' ' MET . 37.3 Cg_endo -65.85 78.13 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.391 2.061 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -94.29 173.69 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.95 -43.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -146.35 141.37 27.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -173.7 -70.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.69 127.88 48.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.04 159.21 5.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.51 -50.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.19 123.65 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -71.17 -42.4 69.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.78 7.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.09 82.49 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.9 p -95.7 -28.63 14.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 63.3 160.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -125.27 149.7 47.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -119.18 -58.2 1.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -164.13 -58.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mt 60.46 31.68 20.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.89 77.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.26 -70.25 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -152.73 -66.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' A' ' 72' ' ' VAL . 5.4 m-85 -117.44 152.06 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.31 -176.0 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.147 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.84 143.64 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.82 26.36 69.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.1 170.53 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.7 mm -126.28 126.26 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.228 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 36.3 pt -116.87 154.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 t -95.56 141.48 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.916 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -160.81 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.04 -39.12 26.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.156 0.503 . . . . 0.0 109.895 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -84.42 2.83 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 7.4 mttt 86.08 30.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.47 178.62 5.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -130.63 80.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 130' ' ' ILE . 44.2 m95 -78.19 144.93 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.004 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -97.28 148.22 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.58 127.64 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.81 -143.13 12.23 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.54 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.47 152.55 39.34 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.45 165.96 2.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.294 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.3 pt -154.42 29.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.48 -163.69 24.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.393 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.17 171.25 9.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.95 68.38 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.531 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.17 28.03 0.89 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.55 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -138.82 -56.06 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.81 -103.25 0.16 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 97.9 m -143.76 84.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.56 83.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.068 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 49.5 m-85 -119.93 172.1 7.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.4 165.88 19.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.75 150.22 52.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.89 157.06 46.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.416 ' HE2' ' CH2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -101.5 57.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.978 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.92 94.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.25 -172.16 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -75.65 -38.88 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.74 -68.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -155.48 161.86 40.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.76 114.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.96 -69.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -119.06 32.03 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.72 87.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.62 80.9 0.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.11 49.55 3.17 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.708 2.272 . . . . 0.0 112.642 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.2 m -149.79 148.23 28.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.96 144.98 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.071 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.94 129.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.54 124.09 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 50' ' ' CYS . 2.6 t -113.15 139.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -141.15 144.0 33.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.705 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.92 109.09 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.484 2.122 . . . . 0.0 112.289 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 t -57.83 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.21 -49.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -167.46 110.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.5 39.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.563 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 -0.77 10.93 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.634 2.222 . . . . 0.0 112.729 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.91 -41.97 92.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -48.92 73.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -75.08 -36.47 61.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.63 -53.04 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.71 -35.6 80.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.437 ' CD1' ' CD2' ' A' ' 173' ' ' TYR . 51.1 t80 -65.15 -37.97 89.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 4.0 m-85 -55.87 -53.33 58.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -17.35 53.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.605 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.31 -47.56 12.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . . . -128.19 -24.11 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -90.6 23.05 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -70.91 130.08 88.84 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.81 -24.72 76.95 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.459 2.106 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.43 -35.8 39.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.965 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -79.38 -50.24 11.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 91' ' ' ALA . 48.8 mt -62.58 -57.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -50.18 -55.33 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.359 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -31.37 63.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -77.32 -49.71 14.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.04 -23.26 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.876 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -27.36 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.626 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.9 p -77.98 -11.05 59.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.358 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 78.18 13.87 1.55 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -83.36 -14.53 52.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.449 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.28 -51.46 2.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.14 -56.55 0.58 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CG ' ' NE2' ' A' ' 192' ' ' GLN . 41.1 t80 -145.33 145.03 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tp -126.12 -43.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 95.41 -7.69 68.89 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.741 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.04 136.64 61.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.72 0.26 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.61 143.46 99.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.457 2.105 . . . . 0.0 112.239 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -84.96 115.65 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -89.03 126.76 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -103.48 -40.63 6.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.01 -178.37 45.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.614 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.1 t -132.62 161.15 34.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.64 0.257 . . . . 0.0 110.523 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.44 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.05 170.65 30.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.802 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -137.91 159.14 42.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.77 125.16 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.019 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 130.78 46.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -138.2 126.29 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.13 17.15 6.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.41 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.94 -11.42 55.97 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.922 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -96.09 129.03 43.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 t -93.45 131.67 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -113.0 151.01 31.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -116.56 132.22 56.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 17.1 p90 -141.24 159.89 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 ttm -128.17 145.74 50.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.422 HD12 ' CE3' ' A' ' 37' ' ' TRP . 16.3 mt -120.2 111.54 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -123.49 173.3 8.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.69 134.52 24.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 145.52 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 48.6 m-85 -109.27 166.38 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.28 -100.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.503 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 m -125.41 127.61 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.67 159.56 3.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -65.65 -20.16 66.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.492 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -51.09 -32.74 23.34 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 121.062 0.458 . . . . 0.0 110.335 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -30.89 51.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.132 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.415 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 30.6 mt -76.69 -25.16 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 147' ' ' LYS . 12.1 t80 -77.88 -45.32 24.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.552 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -29.59 62.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.31 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.67 9.06 43.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.018 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 79.24 49.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.143 0.497 . . . . 0.0 110.02 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 258' ' ' HIS . 0.1 OUTLIER 62.55 21.4 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.132 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -120.74 161.1 22.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -146.41 143.39 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 144.39 37.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -56.4 -26.35 52.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -73.85 -41.95 61.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -45.72 91.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.21 -54.09 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.251 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.32 -48.13 79.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.31 -50.71 70.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.644 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 138' ' ' LEU . 18.4 mt -61.52 -41.01 96.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -55.62 -41.26 73.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.67 -49.2 76.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.427 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -47.24 86.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.763 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.99 -37.61 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.14 -37.8 75.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.94 -31.96 70.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.4 mt -74.42 -45.54 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.02 -45.37 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.788 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 25.3 t80 -75.22 -48.99 20.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 27.0 pt -74.04 -38.8 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.422 ' CG ' HG13 ' A' ' 174' ' ' VAL . 18.2 t-80 -68.73 -25.18 64.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -98.0 -1.34 42.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.306 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.26 -58.38 1.9 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.717 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 204' ' ' TYR . 0.5 OUTLIER 168.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.473 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.437 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 64.9 m-85 -159.51 126.37 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 0.0 110.996 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.454 HG12 ' CD2' ' A' ' 204' ' ' TYR . 30.4 m -132.55 147.5 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.433 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 37.7 t60 77.79 47.07 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -58.81 -18.41 39.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.861 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 t70 74.52 97.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.838 0.351 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.32 114.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.048 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -148.02 179.44 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -83.72 0.75 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -115.21 2.16 14.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.476 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -125.51 -7.49 6.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 9.6 mt -108.29 113.61 26.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.113 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -119.04 148.0 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.191 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 40.5 mt -86.69 148.53 25.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.212 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.72 127.48 31.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.58 -41.5 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.777 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -77.24 -23.64 51.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.822 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.09 61.67 12.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.57 114.86 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.651 2.234 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -177.49 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.405 ' NE2' ' CG ' ' A' ' 107' ' ' TYR . 3.2 mt-30 -131.2 177.26 7.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.08 147.33 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 3.6 m-85 -113.62 150.6 32.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 30.1 tp -104.14 117.61 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.2 m -92.17 -179.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.57 93.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -117.72 -49.82 2.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.706 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.06 52.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.86 3.61 37.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.473 0.178 . . . . 0.0 111.421 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' VAL . . . -92.5 -109.61 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.409 ' CZ ' ' O ' ' A' ' 237' ' ' ALA . 46.0 t80 -146.32 118.13 8.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 110.435 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.408 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 12.9 ptt180 -90.25 77.79 6.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.317 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.454 ' CD2' HG12 ' A' ' 174' ' ' VAL . 8.3 p90 -72.2 1.14 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.183 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.9 OUTLIER -42.59 -48.66 13.1 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 205' ' ' CYS . 22.9 Cg_exo -64.85 159.68 44.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.606 2.204 . . . . 0.0 112.37 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -87.45 -37.3 17.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.734 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.32 79.23 0.13 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 210' ' ' HIS . 27.2 t -66.78 -53.23 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 0.0 110.983 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.418 ' CD2' HG12 ' A' ' 209' ' ' VAL . 28.4 m-70 -108.65 149.06 29.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.824 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 61.07 90.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.1 -65.29 1.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -82.84 148.15 27.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -131.94 -68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.71 39.58 17.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.766 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -100.45 97.32 6.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.9 82.63 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.426 2.084 . . . . 0.0 112.285 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -142.78 37.56 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 61.93 47.33 6.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 5.5 t -79.66 -51.04 9.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.67 82.88 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -101.93 -35.68 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.71 -75.06 1.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.545 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -158.49 133.9 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.406 ' CD1' HG11 ' A' ' 271' ' ' VAL . 7.1 tp -65.63 -13.41 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.443 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.95 -51.03 25.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.742 0.306 . . . . 0.0 111.348 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -145.56 31.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.224 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.9 t -56.87 116.52 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.319 . . . . 0.0 110.947 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 t -57.47 163.31 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mt -60.76 -37.73 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.34 -31.32 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.06 -36.5 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.22 -32.16 73.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -92.2 12.95 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.263 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.39 24.07 55.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.611 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 28.8 t -67.87 136.42 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.419 ' CB ' ' CD ' ' A' ' 238' ' ' PRO . . . -68.98 -62.45 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 237' ' ' ALA . 21.5 Cg_endo -61.2 125.6 17.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.508 2.138 . . . . 0.0 112.353 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.95 121.16 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -127.51 -44.25 1.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -8.21 55.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.51 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.61 -49.71 71.35 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.36 -34.44 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.374 . . . . 0.0 111.054 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.03 -33.42 51.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.03 -37.28 87.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 6.1 mt -65.29 -45.76 92.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.0 -37.23 84.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.87 -43.78 97.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -78.52 -25.65 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 0.0 111.16 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 254' ' ' TRP . 6.0 m -56.65 -38.41 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.279 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -48.96 56.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.086 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 5.0 mt -59.59 -51.74 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.178 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.55 -28.61 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.406 ' CG ' ' O ' ' A' ' 250' ' ' CYS . 20.7 m0 -82.35 -28.49 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.267 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 82.8 mt -86.75 -41.68 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 15.0 t -96.23 0.56 51.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.498 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.8 97.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.499 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.416 ' CE1' ' HG2' ' A' ' 147' ' ' LYS . 5.1 m-70 64.16 166.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 260' ' ' PRO . 0.2 OUTLIER -132.29 162.44 56.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.7 Cg_endo -67.44 64.19 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.361 2.041 . . . . 0.0 112.433 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.547 ' HA ' ' CD1' ' A' ' 270' ' ' TYR . 2.3 p90 177.19 -36.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.169 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.6 tt0 -88.14 10.71 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.536 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.89 -48.13 82.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.9 t-20 -130.54 -29.22 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.387 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 85.9 mt 71.97 11.64 6.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -14.37 54.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.418 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.446 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -136.89 87.4 19.56 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.104 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.01 -10.61 21.17 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.68 2.253 . . . . 0.0 112.484 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -49.81 -50.22 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.331 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.547 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.4 p90 -81.12 -26.17 36.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 50.5 t -61.62 -40.89 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.044 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -75.55 -45.06 40.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.06 -46.97 84.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 59.1 m -58.56 -43.59 89.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -41.7 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.3 mt -77.47 -28.98 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.376 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -81.36 -52.17 7.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.608 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.421 ' CD1' HD12 ' A' ' 285' ' ' LEU . 4.9 m-85 -64.0 -40.57 96.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.642 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -26.57 11.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -113.83 17.76 17.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.34 35.57 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.403 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 20.5 mt -47.24 -48.61 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.53 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.78 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.196 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 278' ' ' TYR . 0.8 OUTLIER -68.57 -37.82 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.424 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -40.22 94.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.725 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -23.3 42.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -82.66 -54.03 5.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.205 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.3 m -79.25 -41.21 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.415 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.29 149.75 39.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -48.65 20.73 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.526 2.151 . . . . 0.0 112.267 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.46 31.1 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -30.84 23.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -170.58 119.59 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm 59.44 97.75 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 -167.47 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.253 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.16 11.49 69.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.878 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 71.0 10.41 6.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.686 0.243 . . . . 0.0 111.341 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 299' ' ' ILE . 37.4 mm -79.59 -45.79 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.788 0.328 . . . . 0.0 110.824 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.86 -43.32 8.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -60.24 -43.99 95.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.533 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 43.2 t80 -68.53 -39.41 81.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.403 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.6 mtp -68.43 -37.29 80.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.342 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.04 -50.22 74.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 2.2 p -59.08 -41.26 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 18.0 t -65.19 -24.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.121 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -77.24 -39.77 47.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.222 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -17.41 56.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.091 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.8 OUTLIER -69.59 115.43 8.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.704 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -141.71 -48.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.184 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -166.03 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.272 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 25.1 p -84.79 8.22 17.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -126.77 36.17 4.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.408 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 6.4 mtpp -59.05 -60.99 8.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.8 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 73.4 Cg_endo -74.73 60.62 5.26 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.541 2.161 . . . . 0.0 112.274 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 17.7 tp -118.84 -1.26 11.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.398 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -57.58 -32.37 67.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.857 0.361 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.0 -37.63 87.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -46.04 63.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 36.3 mt -54.87 -45.59 74.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -32.41 65.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -38.19 45.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.81 -44.49 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.211 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 38.4 mt -75.4 -49.94 17.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -49.84 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.361 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -53.4 -39.44 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -26.56 70.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 17.1 mt -65.2 -40.5 94.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -74.46 -27.28 60.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.86 -27.42 68.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.46 -28.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.62 5.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 33.6 t -90.9 152.64 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.72 91.7 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.72 145.9 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.43 32.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.49 0.46 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -82.3 157.83 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.422 ' HB2' ' HG ' ' A' ' 341' ' ' LEU . 2.3 mt -97.4 16.18 20.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.96 39.94 29.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.207 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.422 ' HG ' ' HB2' ' A' ' 339' ' ' LEU . 66.5 mt -83.94 -43.19 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.1 m 58.35 96.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.001 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 5.6 m -149.67 71.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 18.4 t 60.22 60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 59.86 166.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -124.5 -46.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -76.63 153.92 43.08 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 109.58 -158.33 14.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.2 mt -139.21 -47.84 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 153.88 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -92.41 -48.29 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.046 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.2 tttt 60.12 30.92 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 6.8 m -161.53 31.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.972 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -143.2 112.7 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 85.45 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 63.92 -78.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.026 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 -44.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.965 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -176.38 -64.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 140.04 29.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.83 -43.77 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.12 146.04 50.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.821 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.2 tt -109.67 141.85 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -129.83 112.23 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.13 109.41 5.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 4.0 m -73.31 150.02 42.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -70.24 92.63 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -89.32 152.06 47.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.27 136.34 31.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.312 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -178.14 53.51 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.526 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.74 -31.38 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.128 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -100.25 161.27 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 60.29 -179.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.8 p -128.8 121.37 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -76.57 -52.85 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.966 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.16 145.18 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.04 177.97 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -157.53 98.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 3.4 m 60.0 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -158.26 103.85 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 p -96.35 155.19 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -145.71 -47.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -114.67 151.42 33.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -157.4 108.58 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.503 HG23 HD13 ' A' ' 384' ' ' ILE . 0.0 OUTLIER -169.68 124.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -118.5 -41.17 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 81.4 p -81.73 123.84 29.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -135.16 174.06 11.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 30.0 m 60.75 95.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 60.35 -176.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.35 36.01 20.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.66 90.86 5.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -171.04 125.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.89 133.69 51.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.35 157.71 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 -47.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 71.3 m -60.31 164.35 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.03 -179.67 5.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 117.38 -160.87 13.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.4 m -127.14 -64.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 69.2 m -126.7 136.31 52.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -169.82 59.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.505 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 60.22 90.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.245 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.35 167.28 24.36 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.512 2.141 . . . . 0.0 112.295 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -119.21 107.97 14.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.5 116.01 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.4 tttp 59.9 88.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 -52.71 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.74 -68.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -106.91 160.29 15.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.84 150.38 25.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.29 -132.32 4.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.55 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -85.01 120.09 26.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -105.12 103.57 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.9 p -104.22 170.33 7.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.8 p -80.32 -69.31 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.9 30.78 20.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.091 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -148.45 153.07 38.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 60.15 68.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.1 107.94 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -138.28 -46.45 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.29 166.98 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -86.05 -77.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CE2' ' CG2' ' A' ' 29' ' ' ILE . 5.9 m-85 -115.01 75.95 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.09 -169.66 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.49 123.56 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.95 -27.2 7.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.592 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -82.45 143.07 31.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.6 mt -100.43 142.42 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' CG2' ' CE2' ' A' ' 23' ' ' PHE . 30.8 pt -113.7 154.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 62.2 m -95.51 140.98 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -97.16 -162.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.109 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.94 -42.12 40.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 109.811 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.36 -0.05 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.5 mtpt 84.61 29.04 0.06 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 30' ' ' THR . 6.0 mttt -74.49 -179.86 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -128.32 79.63 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.807 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' CZ3' ' HE3' ' A' ' 56' ' ' MET . 31.0 m95 -74.78 143.24 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.756 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 126.6 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.87 147.18 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.98 -151.77 19.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.706 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.01 157.47 54.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 111.018 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' A' ' 52' ' ' TYR . 24.5 Cg_exo -63.27 144.74 92.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.596 2.197 . . . . 0.0 112.282 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.1 pt -142.22 -42.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.222 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.3 -104.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.547 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -71.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.56 -70.12 0.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.531 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -66.69 2.28 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -96.19 42.06 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.83 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.73 87.99 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.429 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.23 57.98 4.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 110.813 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.99 112.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.305 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 42' ' ' PRO . 13.7 m-85 -126.57 169.56 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.49 158.15 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.619 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.07 150.91 40.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.349 . . . . 0.0 111.338 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -137.77 157.57 46.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.418 ' HE3' ' CZ3' ' A' ' 37' ' ' TRP . 2.9 mmt -97.06 30.8 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.51 104.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -137.77 -65.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -103.69 -178.19 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.97 -34.58 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -142.94 159.23 42.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -89.88 160.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.51 46.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.538 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -163.66 -45.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -143.61 67.85 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.74 80.09 13.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.82 48.27 2.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.748 2.299 . . . . 0.0 112.699 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.2 m -149.81 153.31 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.15 144.85 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.044 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 124.81 39.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -104.4 123.38 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.499 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 ' CE1' ' A' ' 23' ' ' PHE . 5.0 t -113.07 135.17 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.466 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.21 150.62 59.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.579 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.51 118.87 5.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.495 2.13 . . . . 0.0 112.209 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -55.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t0 61.58 98.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.02 94.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.06 151.33 20.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.28 35.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.486 2.124 . . . . 0.0 112.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.77 -37.64 88.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.7 -41.31 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 p -72.84 -32.22 65.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.03 -40.73 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.808 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.51 -51.65 67.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -57.72 -43.75 85.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.6 t80 -63.67 -31.61 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.411 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 3.3 m-85 -71.65 -60.29 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.66 -17.89 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.375 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -47.37 60.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.23 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.91 -37.41 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.871 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -54.99 -21.21 11.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 123.12 8.55 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.993 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.92 -25.64 12.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.556 2.171 . . . . 0.0 112.466 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.91 -35.92 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -79.4 -39.76 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.0 mt -65.42 -57.61 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.191 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -32.15 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.178 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -76.15 -32.93 59.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -77.16 -38.21 52.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.2 mt -69.69 -37.5 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.13 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -74.94 -27.78 60.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.254 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.6 p -84.36 -34.02 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.335 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -2.24 24.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 58.61 31.05 20.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.637 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -51.59 -25.64 7.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tptp 78.52 -55.6 0.47 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 108' ' ' LEU . 19.9 t80 -152.79 163.51 39.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 107' ' ' TYR . 3.4 tp -139.85 -168.02 2.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.38 28.4 2.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.92 136.49 19.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.588 0.232 . . . . 0.0 110.985 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.48 151.82 66.1 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.608 2.206 . . . . 0.0 112.291 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.8 115.53 23.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -92.5 115.35 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -92.84 -40.46 10.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.745 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.17 -175.98 46.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.405 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.6 t -137.92 165.89 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.666 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.44 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.34 177.2 28.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.583 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 mp -147.83 159.86 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -141.89 141.74 33.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -111.41 130.29 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -138.23 126.26 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.79 23.86 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.9 10.66 61.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.819 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.15 159.2 15.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.17 122.19 46.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -114.23 141.43 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -126.9 126.72 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.44 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 35.1 p90 -136.26 161.73 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -128.06 145.83 50.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.9 mt -121.52 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -132.36 173.29 11.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.8 139.58 26.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.081 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -71.84 151.5 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -115.48 167.4 10.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.39 -64.07 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 p -154.33 156.71 37.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.77 153.25 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.78 -25.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.734 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 11.2 tt0 -70.33 -44.37 68.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -60.77 -28.53 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.5 mt -74.56 -28.33 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 t80 -57.28 -46.28 83.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.58 -25.97 67.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.078 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.09 -17.36 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.475 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.2 m120 -94.95 -3.04 49.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 98.78 43.15 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.043 0.537 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 59.79 20.35 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 5.8 mtp180 -169.89 128.04 0.9 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.928 0.394 . . . . 0.0 111.141 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -81.26 -175.45 5.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -115.76 169.34 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -57.91 -29.9 65.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.6 m -60.84 -55.31 34.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.9 t -56.75 -52.37 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 23.3 mt -59.27 -41.27 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -64.82 -44.38 90.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.67 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.73 -32.73 70.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.733 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 t -62.85 -41.18 99.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.36 -33.67 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -70.56 -49.49 47.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.3 mt -61.32 -41.9 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.971 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.26 -40.9 91.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.69 -32.92 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.526 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 10.6 mt -79.74 -40.18 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.707 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 22.9 mt -55.85 -38.76 70.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.85 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -32.67 74.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD1' HD23 ' A' ' 108' ' ' LEU . 80.3 t80 -74.09 -52.51 12.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.778 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 169' ' ' HIS . 8.0 pt -67.66 -27.16 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.271 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.414 ' CE1' HD12 ' A' ' 168' ' ' ILE . 1.3 m-70 -80.33 -32.29 37.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.595 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.97 -17.01 62.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -104.36 5.98 34.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.024 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 73.52 46.28 0.22 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.385 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.453 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.1 m-85 -137.06 129.12 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.3 m -112.17 164.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.491 ' CD2' ' CE1' ' A' ' 198' ' ' TYR . 12.5 t-80 -120.01 -66.02 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.28 43.93 93.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -162.84 36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.905 0.383 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.8 mt -74.7 114.24 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -177.92 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.054 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -80.07 -2.57 44.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.594 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.6 t -106.37 0.05 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.107 0.479 . . . . 0.0 110.57 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.76 -11.24 7.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.074 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 18.4 mt -108.32 113.77 27.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.616 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 1.7 mt -116.99 168.38 10.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.856 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' A' ' 193' ' ' VAL . 49.9 mt -106.56 149.48 27.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.95 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 0.3 OUTLIER -89.51 142.96 27.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 109.941 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.1 -26.7 5.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -25.23 37.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 174.2 -58.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.425 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.496 ' HB2' ' CB ' ' A' ' 186' ' ' ASN . 96.0 Cg_exo -37.45 -60.43 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.026 2.484 . . . . 0.0 113.538 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 0.5 OUTLIER 82.32 -4.45 1.43 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.51 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -89.57 -166.88 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 185' ' ' LEU . 2.0 p -109.93 145.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 7.8 m-85 -124.38 156.95 36.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.857 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 175' ' ' HIS . 14.9 tp -105.4 115.93 31.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.625 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.97 170.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.2 t70 56.17 88.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.1 m-85 -81.8 -33.88 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.624 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 63.5 14.47 54.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.797 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.26 -49.69 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 46.81 87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.16 135.82 53.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 15.3 ttp-105 -103.49 50.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 52.77 24.88 3.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 52.65 89.17 0.1 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.08 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.48 -38.27 63.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.562 2.175 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.1 86.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.36 52.91 0.61 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t 61.31 93.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.79 0.329 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -74.08 77.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -135.08 76.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.5 157.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -166.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt 58.13 93.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -73.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -177.71 83.43 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.92 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.541 2.161 . . . . 0.0 112.267 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.89 -60.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -124.16 30.99 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 16.1 m 59.24 -177.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -113.43 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.75 144.81 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -95.82 36.06 4.02 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.485 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 69.1 p -150.97 -176.46 5.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 225' ' ' ILE . 2.0 tp -148.45 27.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -102.45 -28.25 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -148.93 30.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.3 m -68.65 122.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.4 t -69.88 169.56 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.46 -32.07 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -33.51 60.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -74.0 -31.66 63.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -25.55 65.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 12.87 16.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.321 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.21 69.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.81 152.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.34 . . . . 0.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.03 109.41 16.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.29 177.44 4.54 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.384 2.056 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.6 m -150.55 -59.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -47.27 1.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -59.2 -29.67 67.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -64.99 -49.66 61.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.6 -42.03 71.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.916 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.24 -31.69 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -39.88 78.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 9.2 mt -66.7 -35.97 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.3 tp -70.8 -38.84 73.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.93 -35.77 92.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.54 -25.8 45.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 111.022 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 10.4 m -65.02 -32.92 74.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.035 0.445 . . . . 0.0 110.468 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -52.69 64.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.055 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 4.1 mp -68.32 -28.67 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -41.84 55.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 111.473 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.403 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 40.8 m0 -82.27 -24.89 34.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.788 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.16 -37.37 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 m -96.12 -12.68 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.421 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 75.04 87.8 0.25 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.5 m170 64.98 158.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.476 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.4 OUTLIER -132.63 160.34 68.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 37.5 Cg_endo -65.92 66.06 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.549 2.166 . . . . 0.0 112.85 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.476 ' CH2' ' CD2' ' A' ' 259' ' ' LEU . 5.7 p90 178.34 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.288 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -98.53 21.99 10.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.214 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -56.09 9.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 69.4 m-20 -125.96 -27.09 3.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 69.2 mt 70.19 12.74 7.7 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.02 -14.83 43.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.118 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.449 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.9 m-20 -134.33 98.32 14.03 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.03 17.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.698 2.265 . . . . 0.0 112.83 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -80.09 -46.95 15.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.7 p90 -79.27 -26.73 42.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 26.7 t -61.43 -37.79 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.189 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -75.51 -45.54 37.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.237 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -67.19 -37.91 84.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.1 m -68.3 -43.41 77.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -52.42 64.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.1 mt -60.38 -33.27 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.561 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -81.05 -49.57 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.23 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -62.8 -36.78 84.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -54.2 -29.63 46.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.877 0.37 . . . . 0.0 110.645 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.0 19.52 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -136.39 41.58 2.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.816 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 282' ' ' ILE . 23.5 mt -53.17 -38.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.7 64.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -40.76 85.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.028 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 3.6 pp -75.54 -28.43 59.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -45.09 91.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.93 -27.4 33.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.373 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -82.76 -33.06 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.691 0.281 . . . . 0.0 111.334 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.4 m -93.7 -41.24 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.55 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.21 154.69 37.48 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.63 151.67 18.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.714 2.276 . . . . 0.0 112.327 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.13 -35.68 13.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -71.66 -46.36 59.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -68.15 149.15 49.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.05 147.68 88.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.98 166.91 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.624 2.216 . . . . 0.0 112.156 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -104.99 25.14 26.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.577 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 68.53 13.6 8.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.689 0.28 . . . . 0.0 111.301 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.25 -45.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.527 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.63 -43.78 17.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.287 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -41.71 88.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.392 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.46 -43.17 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.514 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.413 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 3.8 mtp -61.04 -41.28 96.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.597 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.11 -50.35 74.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.685 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 41.9 m -58.45 -33.58 69.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.451 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 71.1 t -79.37 -24.46 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.8 -38.61 21.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.683 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 7.7 mt -107.48 -28.34 9.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.497 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.9 OUTLIER 48.99 -167.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 111.144 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.32 174.95 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.968 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -92.86 -64.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.45 29.24 6.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -148.17 85.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 315' ' ' PRO . 2.5 mmmp? -59.37 -58.77 17.03 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 38.1 Cg_endo -66.21 91.09 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.412 2.074 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.0 mt -103.08 31.22 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -68.48 -29.63 68.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -46.54 85.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -73.83 -43.64 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 61.8 mt -56.49 -40.57 75.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.0 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.84 -38.02 76.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.96 -48.27 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.78 -21.29 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.482 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.53 -49.69 10.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.15 -37.31 74.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.98 -27.82 57.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.542 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.79 -39.08 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -30.14 69.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.01 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 12.0 pt -105.77 -29.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.202 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.46 27.25 3.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -114.49 34.04 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -71.81 89.78 1.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 89.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.93 -31.25 7.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.2 27.35 4.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 157.24 37.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.32 23.62 9.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.026 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 4.2 t70 60.75 28.38 18.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.43 76.3 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.998 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 35.8 p -69.73 -28.2 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.703 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.6 t 64.55 90.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.89 30.77 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.95 129.36 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.78 151.74 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.66 -91.27 2.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 148.93 -110.81 0.5 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 tp -114.76 99.72 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.914 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -151.06 101.95 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -127.15 -57.24 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -134.71 123.36 23.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 65.3 p -139.68 -60.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 5.3 pt -72.34 78.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.05 144.84 24.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -82.14 149.37 28.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -81.57 85.03 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 141.52 57.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 32.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.6 99.8 6.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.49 158.99 28.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.2 mm -95.0 144.6 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.79 31.87 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.1 31.21 4.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.0 m -108.94 113.36 26.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.11 34.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' A' ' 368' ' ' PRO . 0.9 OUTLIER -75.98 -52.91 2.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 367' ' ' GLU . 52.0 Cg_exo -52.59 98.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.578 2.186 . . . . 0.0 112.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -75.22 178.03 47.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.464 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.11 149.08 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -77.85 -28.85 50.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.61 -63.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.97 173.73 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -141.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.0 155.89 23.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -34.1 9.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -133.94 138.33 45.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.03 127.24 5.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -129.31 130.19 45.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.4 t -151.36 158.87 44.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -150.73 154.08 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -162.93 -61.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -165.28 -44.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.02 170.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -170.84 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 43.7 p -140.91 -174.1 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -84.7 126.57 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 13.9 m -91.05 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.44 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.5 114.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -152.01 -55.7 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 159.0 24.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 161.71 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.3 m -93.42 -31.63 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -92.38 81.99 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 96.0 p -151.65 166.79 30.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 24.0 t -110.41 157.6 19.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 67.69 103.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 85.1 p -74.22 98.75 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 12.2 t -146.16 -49.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -72.1 -28.48 68.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.22 157.31 56.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.3 158.75 56.38 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.522 2.148 . . . . 0.0 112.333 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.11 97.93 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t 62.43 117.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -54.34 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.09 -74.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -172.32 -46.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.67 35.47 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.93 69.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.41 43.29 1.69 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -155.04 174.73 14.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -167.01 177.83 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -113.7 102.46 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 t -113.16 149.94 32.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.66 -58.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -33.71 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -67.34 116.33 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -98.01 150.4 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.36 20.69 10.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 52.1 87.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 0.0 111.256 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 60.81 -165.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.813 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 63.71 99.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 3.6 m-30 -59.53 92.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -171.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -101.9 114.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.65 -25.99 11.37 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.04 147.39 29.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.29 135.84 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 13.4 pt -119.84 148.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -95.55 141.46 29.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 35' ' ' LYS . 4.1 t70 -83.41 -142.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.27 56.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.1 34.6 24.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.901 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -152.85 19.06 0.6 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' A' ' 37' ' ' TRP . 2.0 mmtt -163.94 175.1 10.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.445 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -151.24 90.44 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 7.3 m95 -94.87 139.96 30.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.209 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -93.14 135.0 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 23' ' ' PHE . 19.5 t -87.39 138.78 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.67 -118.65 4.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.551 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.4 154.59 47.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.948 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.59 170.69 5.28 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.544 2.163 . . . . 0.0 112.275 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.5 pt -143.9 36.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.34 148.62 7.11 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.562 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -109.12 134.46 51.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.21 -121.91 0.95 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.501 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.07 66.32 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.454 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -104.41 -51.37 3.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.29 -88.38 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.97 94.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 mt -114.68 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 23' ' ' PHE . 19.5 m-85 -146.35 172.06 14.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.33 156.33 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.67 142.41 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.06 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.41 159.72 38.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.1 mtm -99.31 38.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.62 87.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -64.13 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -175.08 -51.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -111.14 -46.55 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.45 178.98 4.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.98 122.64 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.42 -151.56 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.574 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.63 31.34 5.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 80.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.54 137.01 19.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.27 33.25 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.842 2.361 . . . . 0.0 112.775 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.82 148.25 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.86 144.87 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 7.4 p -134.89 132.94 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.557 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -109.37 120.78 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 14.7 t -113.19 149.07 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.363 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -133.2 149.86 73.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.679 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 80.32 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.168 . . . . 0.0 112.388 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.1 t 57.04 -168.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 61.39 165.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -124.29 130.81 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.78 -111.45 0.26 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.05 -36.62 85.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -45.72 74.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -45.79 72.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 p -58.63 -44.17 89.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.67 -38.83 80.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.98 -46.57 70.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -56.34 -40.82 75.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.5 t80 -79.66 -29.88 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.422 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 2.1 m-85 -67.71 -52.67 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.434 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -19.61 59.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.437 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -66.33 -47.52 73.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.674 0.273 . . . . 0.0 111.298 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.1 -35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -59.28 -16.99 24.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 125.01 26.88 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.517 0.199 . . . . 0.0 110.84 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.87 -24.89 14.46 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.488 2.125 . . . . 0.0 112.614 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -44.46 91.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.43 -43.77 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.0 mt -54.83 -57.6 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.409 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.45 -40.77 62.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.153 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -57.0 -39.65 75.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -77.32 -44.53 29.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.6 mt -62.7 -38.8 82.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.63 60.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.414 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -80.52 -36.93 32.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.495 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -105.42 -3.34 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 mttt 58.33 29.31 17.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.857 0.36 . . . . 0.0 110.724 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.9 mt -47.76 -40.41 20.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.206 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 4.0 tmtp? 69.07 7.81 6.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 68.6 t80 174.62 161.83 0.2 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.751 0.31 . . . . 0.0 110.498 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.422 HD21 ' CG ' ' A' ' 167' ' ' TYR . 9.3 tp -153.56 -60.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.07 -0.26 21.02 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.044 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.33 136.17 43.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.78 0.29 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.41 143.05 95.11 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.313 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 115.68 26.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -90.42 134.47 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -111.97 -40.83 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.86 -174.5 46.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.824 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.2 t -136.86 153.19 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -131.48 168.29 22.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.28 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.3 mt -147.93 134.47 19.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 0.0 110.748 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -139.32 135.74 34.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -108.24 135.63 49.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 126.3 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.85 18.3 5.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.38 57.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.895 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -96.04 129.02 43.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.819 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.8 130.31 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.72 136.38 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.25 125.12 52.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.467 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 12.9 p90 -134.73 159.35 41.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.709 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ttm -128.06 141.92 51.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.3 mt -111.94 111.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.04 173.41 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.73 136.91 21.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.94 172.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.235 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.4 ' CE2' HG12 ' A' ' 196' ' ' VAL . 31.5 m-85 -150.17 162.06 41.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.645 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.6 -84.53 1.58 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.449 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 m -149.68 127.36 11.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.823 0.344 . . . . 0.0 110.719 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' HA ' HD21 ' A' ' 184' ' ' LEU . 4.9 m-20 -49.0 159.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -69.29 -21.31 63.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.41 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 1.7 pt20 -51.9 -34.13 39.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.379 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -29.63 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.652 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.92 -29.82 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.571 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -59.58 -50.03 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.04 -27.48 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.07 66.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.366 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 3.2 m-80 -97.9 14.96 25.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 87.5 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.95 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.453 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.7 123.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 7.4 m-85 -59.58 -174.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 m -119.14 153.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.571 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -54.75 -27.3 40.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.88 -42.39 57.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -44.3 53.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.243 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -53.92 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.091 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.43 -46.93 85.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.966 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -52.85 56.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.992 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.5 -40.1 85.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.8 p -59.18 -36.8 75.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.94 -44.12 77.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.16 95.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.0 mt -64.3 -36.99 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.58 -38.59 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.49 -41.22 93.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.1 mt -74.89 -41.94 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.2 mt -56.88 -40.51 76.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 317' ' ' TYR . 10.6 tt0 -64.96 -37.9 89.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.422 ' CG ' HD21 ' A' ' 108' ' ' LEU . 89.9 t80 -66.41 -53.44 35.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 169' ' ' HIS . 5.3 pt -65.48 -27.04 40.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.408 ' N ' HG13 ' A' ' 168' ' ' ILE . 14.8 m-70 -76.48 -39.84 52.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.498 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.91 -12.32 61.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.62 4.25 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.765 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 70.69 47.09 0.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 126.74 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 27.2 m -133.01 169.27 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -162.37 -47.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.16 59.67 8.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.44 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.77 29.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.3 mt -64.54 105.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.438 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 14.1 tptm -149.84 168.33 24.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -69.39 0.03 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.065 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 -4.07 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.571 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -124.96 -5.77 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.356 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 193' ' ' VAL . 12.6 mt -108.22 113.51 26.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.244 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 137' ' ' ASP . 0.2 OUTLIER -121.14 149.75 42.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -178.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 193' ' ' VAL . 10.3 mt -90.36 149.19 22.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.65 130.54 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.687 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -66.77 -67.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -21.3 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -119.56 67.28 10.17 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.83 97.31 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.1 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -172.5 -38.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.213 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -116.15 174.36 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 183' ' ' LEU . 7.9 p -133.05 136.56 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 3.4 m-85 -106.91 156.88 18.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.2 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.06 115.87 31.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.565 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.4 HG12 ' CE2' ' A' ' 134' ' ' PHE . 27.8 m -115.37 156.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 56.04 93.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.496 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 5.0 m-85 -79.27 -12.87 59.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 57.01 25.2 53.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 221' ' ' HIS . 0.2 OUTLIER -176.5 -62.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.703 0.287 . . . . 0.0 111.014 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 43.88 82.91 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -142.08 149.01 39.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -82.79 94.34 7.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 35.4 p90 -48.24 -46.32 35.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.66 87.72 6.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.979 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.0 -38.51 69.61 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.559 2.173 . . . . 0.0 112.266 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -173.07 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.92 -55.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.472 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.0 t 69.04 -67.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -160.71 -50.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.969 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -127.11 -179.05 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -120.75 -41.68 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.98 153.39 17.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -60.68 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 60.67 40.98 15.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.88 86.15 24.36 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.31 133.0 21.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.554 2.169 . . . . 0.0 112.325 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -177.68 -44.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -99.42 -22.2 15.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 19.6 m 61.67 30.87 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CD2' HD23 ' A' ' 200' ' ' LEU . 7.7 t60 58.96 46.46 13.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.976 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 221' ' ' HIS . 54.3 m-20 65.94 -68.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -49.79 150.42 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.725 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -91.34 -46.95 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.2 tp -178.11 38.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.197 0.523 . . . . 0.0 110.522 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -94.66 64.85 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.269 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 262' ' ' GLU . 53.3 m-85 75.29 32.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -72.78 153.89 40.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.3 m -95.88 157.49 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.66 -30.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -48.73 55.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.42 74.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.58 -26.1 61.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.83 12.82 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.375 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.52 59.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.591 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 124.85 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 111.041 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.15 118.91 33.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -51.97 101.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.403 2.069 . . . . 0.0 112.298 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.8 m -60.68 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.11 -51.51 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -62.78 -23.91 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.49 -49.55 72.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.692 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 -31.04 63.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 30.6 mt -72.18 -36.09 69.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.67 -29.89 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 42.0 mt -72.39 -42.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.412 HD22 ' CZ ' ' A' ' 302' ' ' TYR . 41.5 tp -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.15 97.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.314 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.5 -25.88 45.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -34.57 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.108 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -49.43 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.32 -30.26 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.41 ' OE1' ' CD1' ' A' ' 254' ' ' TRP . 17.6 tm0? -80.04 -37.4 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.4 m0 -82.22 -39.35 23.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.06 -45.39 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.076 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 10.4 p -96.14 0.55 51.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.41 97.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.475 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 m80 65.0 155.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -134.52 172.54 7.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.474 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 61.5 Cg_endo -73.49 58.11 3.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.373 2.049 . . . . 0.0 112.589 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 3.1 p90 -180.0 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.306 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -99.04 20.62 13.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 178.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -55.12 23.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.948 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.1 OUTLIER -127.68 -25.27 3.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.452 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 53.5 mt 69.34 12.74 8.41 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -88.25 -15.48 35.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.083 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 4.0 t0 -135.12 97.46 13.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 20.73 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.625 2.216 . . . . 0.0 112.944 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -44.85 22.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.789 0.328 . . . . 0.0 110.764 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.0 p90 -83.87 -26.62 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.015 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 16.3 t -61.76 -37.06 77.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -72.11 -44.36 63.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.35 -37.37 77.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.069 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.3 p -72.01 -38.12 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.253 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.53 85.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.14 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 28.7 mm -70.29 -29.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.408 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -48.74 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.6 m-85 -67.33 -40.56 85.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -50.68 -27.79 7.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.839 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -118.3 22.84 11.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.11 44.04 2.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.987 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 22.7 mt -53.32 -38.24 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.01 64.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -40.69 86.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 4.2 pp -76.44 -28.34 56.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -37.93 85.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.501 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.84 -31.09 28.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -82.68 -49.6 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.093 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 53.4 m -72.06 -41.33 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.47 134.87 22.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.95 165.3 32.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.68 -29.43 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -38.34 75.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -74.49 -177.35 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.25 142.33 25.75 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.55 142.02 61.15 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -99.1 24.35 32.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.624 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 64.16 17.1 10.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.714 0.292 . . . . 0.0 111.193 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.54 -51.99 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.5 -41.91 14.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.307 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -41.77 96.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.419 ' CE1' HG22 ' A' ' 306' ' ' VAL . 50.3 t80 -72.05 -44.41 63.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.808 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.424 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 1.9 mtp -58.26 -39.76 80.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.662 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -65.76 -43.76 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 0.7 OUTLIER -65.95 -34.54 78.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' A' ' 302' ' ' TYR . 67.9 t -78.75 -24.39 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.98 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.058 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 310' ' ' ASP . 3.6 pp -102.17 -24.7 13.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 305' ' ' THR . 1.1 mp 58.41 -80.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.162 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 308' ' ' LEU . 0.4 OUTLIER -145.42 170.99 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.794 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -87.33 -33.55 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.1 p -114.46 27.29 9.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.47 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.62 165.45 15.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.84 108.25 2.05 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.279 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 11.2 tp -98.74 29.01 3.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.41 ' CG ' ' HG3' ' A' ' 166' ' ' GLU . 63.1 m-85 -62.66 -30.02 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.52 -45.57 79.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -45.18 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.13 -50.25 71.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -50.96 64.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -54.43 -42.35 70.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.6 mt -54.22 -46.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.19 -37.26 28.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -49.75 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -54.09 -43.57 70.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.035 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.12 67.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.19 -24.74 63.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.719 0.295 . . . . 0.0 111.051 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 18.8 mttm -76.38 -33.94 58.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.37 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.93 -18.72 55.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.039 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.07 -34.77 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -116.23 -25.0 3.66 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.347 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 5.4 t 69.71 72.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.84 125.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.85 138.74 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.38 38.52 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.26 54.57 26.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.26 116.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.0 31.2 3.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.93 27.76 13.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 19.8 mt -98.49 35.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.823 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 11.2 m -59.67 -52.8 63.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.5 m 42.31 58.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.662 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.8 m 41.62 77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.797 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 84.07 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -158.89 155.16 27.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.71 168.05 12.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 173.54 -125.53 1.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 62.8 mt 60.68 97.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -109.79 -47.08 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -135.12 -177.25 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -146.5 -55.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.0 -62.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.9 pp -133.05 176.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.7 m -136.13 105.85 6.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.57 114.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -76.97 -177.69 4.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 61.41 172.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 -47.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -93.31 151.57 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -89.34 156.39 18.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.4 mt -59.93 90.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -161.78 31.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.46 121.9 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.6 t -137.29 -46.27 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt 63.26 95.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -125.22 139.72 34.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.53 84.48 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.431 2.087 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -141.85 -44.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.574 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 21.5 t 66.1 90.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.92 156.14 34.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.72 -54.99 2.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 39.8 p -88.69 170.03 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -154.63 -66.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 375' ' ' TRP . 0.0 OUTLIER -118.57 -165.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.0 p -175.81 171.68 2.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -116.87 -59.0 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.26 -177.93 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.06 85.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.67 123.02 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.81 134.51 39.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.46 79.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -151.73 69.29 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 8.7 tp -134.46 145.45 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.039 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 46.21 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.0 p -89.3 128.27 35.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -126.44 -44.97 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.0 m -105.17 148.22 27.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 390' ' ' THR . 0.0 OUTLIER -178.46 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.2 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' A' ' 389' ' ' ARG . 4.1 t -94.8 -40.88 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -174.47 137.05 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -87.0 -53.19 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 148.99 51.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.51 157.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 60.81 33.53 20.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.556 -0.217 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 4.3 m -154.03 -62.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 49.3 m -83.97 113.78 21.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.29 41.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.523 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.99 130.2 53.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.72 142.06 27.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 136.34 44.39 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.522 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt -111.05 165.94 11.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.24 -34.01 22.81 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -161.7 129.89 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.68 31.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 147.26 25.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.11 176.89 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.28 121.11 3.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.49 169.18 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.85 -31.31 11.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.33 -160.75 12.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.53 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -119.77 -44.62 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.87 159.8 42.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 t -143.51 128.0 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -168.53 150.69 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.18 165.21 9.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.14 -47.57 5.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.1 115.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 62.42 117.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.1 100.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.28 -57.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -179.84 6.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -131.5 -54.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 3.9 m-85 -76.08 97.16 3.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.01 -176.72 3.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.29 113.05 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.75 13.83 15.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.3 161.13 14.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.39 131.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.46 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 9.3 pt -119.84 125.55 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.767 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 t -95.55 141.31 29.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 13.7 m-20 -90.4 -161.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.57 63.06 0.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.9 31.3 18.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.214 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.8 -33.58 8.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.641 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.87 -158.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.28 93.04 1.94 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.737 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -78.08 155.26 30.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.4 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -100.16 117.78 35.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -73.01 143.49 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.06 -111.07 2.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.598 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.5 mt -96.11 154.37 38.86 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.704 0.288 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -65.73 -27.35 52.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.324 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt 42.48 31.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.728 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -179.11 111.81 0.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.77 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.12 -65.69 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.28 -103.7 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.537 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -68.88 -30.49 69.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.7 -85.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.437 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 78.18 -55.3 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.257 . . . . 0.0 111.2 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mt -129.15 137.61 56.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 0.0 111.325 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 62.4 m-85 -146.43 167.87 22.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.09 149.55 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.95 146.92 45.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 152.23 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtp -96.48 37.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.31 30.12 19.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.95 179.46 6.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.02 171.87 12.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.16 174.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 t -81.41 157.36 25.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.3 130.87 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.15 -90.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.574 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -99.14 30.52 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.05 -44.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.61 88.66 2.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.92 80.91 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.71 148.19 28.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.808 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.68 155.37 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -148.13 126.95 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 116.22 28.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.682 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.46 137.63 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.69 147.22 63.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.46 83.5 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.89 -63.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.243 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -46.48 131.28 11.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -140.36 80.08 1.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.52 -76.17 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.45 -28.18 32.67 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.616 2.211 . . . . 0.0 112.299 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 tp -73.08 -33.27 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -30.62 70.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 p -76.13 -37.98 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 59.8 tt0 -74.41 -39.11 62.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.5 -52.47 63.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 11.3 t80 -71.03 -45.83 63.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.993 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 83' ' ' GLU . 5.7 m-85 -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.461 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.43 -48.04 36.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.645 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -87.75 -47.52 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.701 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 86' ' ' PHE . . . -77.49 -50.23 13.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.886 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.51 32.32 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.708 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.04 125.91 89.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.48 -28.2 84.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.44 2.094 . . . . 0.0 112.444 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.35 -32.89 43.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.176 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -79.22 -52.65 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.286 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.71 -52.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.228 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.6 -50.6 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -64.66 -42.58 95.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -58.53 -54.2 49.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.93 -36.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -75.11 -27.81 59.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.316 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -78.78 -38.74 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.499 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.71 -2.42 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.335 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.12 30.44 18.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 110.643 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.1 mt -50.15 -31.12 12.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.92 -56.62 0.54 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.29 151.46 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.682 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.92 -66.88 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.09 -14.37 3.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.908 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.11 125.29 77.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.629 0.215 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.31 152.76 7.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 112.249 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -80.19 115.48 19.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.421 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 13.3 t80 -93.24 115.76 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -91.8 -40.98 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.224 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.79 -174.63 46.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.76 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 p -131.03 158.05 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.02 179.45 20.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.353 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.99 158.85 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.961 0.41 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.62 114.61 11.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.602 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -91.4 142.26 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 123' ' ' GLY . 4.0 tttt -130.57 157.53 42.46 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.98 51.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.632 0.253 . . . . 0.0 111.428 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 121' ' ' LYS . . . 144.2 -18.27 2.11 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.897 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -126.4 142.96 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.68 138.29 46.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.477 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 126' ' ' TYR . 2.7 m-85 -125.7 134.64 51.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.959 0.409 . . . . 0.0 111.334 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -124.13 138.26 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.467 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.46 ' CZ ' ' HB ' ' A' ' 29' ' ' ILE . 23.2 p90 -147.03 168.73 20.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.275 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -136.67 146.44 45.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.6 mm -96.0 135.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -143.49 165.28 27.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.69 130.09 41.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.443 ' CD ' ' CD2' ' A' ' 187' ' ' TYR . 3.6 ttt-85 -57.73 143.06 43.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -113.14 166.89 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.79 -83.2 1.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -133.92 127.01 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 3.0 m-20 -55.35 155.75 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.08 -23.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -65.43 -42.91 91.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.134 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -61.5 -29.89 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.4 mt -75.39 -28.54 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 10.3 t80 -59.53 -49.37 78.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -28.01 67.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.24 -23.1 65.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.326 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 5.7 m-20 -96.4 15.63 20.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.166 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 88.71 46.4 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.52 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.2 19.45 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 33.3 mtt180 -147.14 -179.09 6.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 153' ' ' THR . 0.1 OUTLIER -132.84 144.59 50.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 p -81.91 155.38 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.36 68.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -71.8 -36.06 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 149' ' ' PHE . 1.7 m -72.75 -42.26 64.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.05 -54.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.219 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 71.8 mt -54.89 -47.15 74.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.665 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.17 -41.17 90.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.0 m -54.56 -42.4 70.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.49 -39.61 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -64.97 -46.34 81.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.726 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.85 -34.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.765 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.3 mt -62.34 -35.89 80.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.668 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.17 -42.26 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.9 mt -71.41 -34.78 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.75 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.77 -39.05 79.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.68 -37.23 79.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -66.78 -54.85 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.713 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 43.5 pt -63.12 -27.28 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -77.9 -38.35 45.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.459 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -10.9 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.981 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.51 4.8 26.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.821 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 71.5 48.93 0.31 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -139.68 139.05 36.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 204' ' ' TYR . 12.3 m -137.92 169.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 1.4 p80 -147.13 -54.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.28 31.98 68.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.376 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -136.74 81.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.3 mt -115.61 117.85 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -159.42 -176.6 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -80.78 1.91 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.479 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.08 1.4 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 110.329 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -124.82 -12.94 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.287 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 5.5 mt -108.48 123.32 48.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.98 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -127.9 160.96 30.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.4 mt -95.04 149.34 21.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.022 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.7 132.58 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.443 ' CD2' ' CD ' ' A' ' 133' ' ' ARG . 22.3 t80 -68.58 -61.83 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.418 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -63.15 -18.51 63.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.24 75.26 74.87 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.55 89.92 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.536 2.157 . . . . 0.0 112.066 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.95 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.107 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.54 149.86 23.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 2.9 p -112.45 147.99 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.124 0.488 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 24.7 m-85 -126.47 157.32 38.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.974 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.405 HD23 ' CE1' ' A' ' 198' ' ' TYR . 26.2 tp -103.32 115.83 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 5.2 t -103.56 137.38 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.134 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.16 130.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.724 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.5 m-85 -103.02 7.95 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.195 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 80.99 -55.25 4.78 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.17 -32.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.579 0.228 . . . . 0.0 111.53 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.29 94.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.746 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.29 149.06 49.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.82 78.18 2.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.768 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.455 ' CD1' ' CG1' ' A' ' 174' ' ' VAL . 42.2 p90 -46.5 -46.59 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.3 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 48.8 t -74.12 127.02 88.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 -171.45 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.478 2.119 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.29 -43.14 17.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.16 -75.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.68 114.01 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.173 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.31 -69.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -177.66 132.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -175.38 4.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 216' ' ' ASP . 2.7 t80 -107.94 -77.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? 44.35 92.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.772 0.32 . . . . 0.0 111.537 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 61.24 117.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.044 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 213' ' ' TYR . 1.0 OUTLIER -169.31 82.53 0.66 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.66 84.92 0.62 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.551 2.167 . . . . 0.0 112.288 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.78 23.63 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.5 56.92 6.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.965 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.17 -66.23 1.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -98.57 34.61 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -67.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.771 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 58.83 -133.39 52.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.704 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -169.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 225' ' ' ILE . 20.3 tt -139.13 31.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.031 0.443 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -94.63 21.88 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.709 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 179' ' ' LYS . 0.5 OUTLIER 168.58 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.638 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.2 p -60.01 150.14 30.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -177.71 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.96 -35.43 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -29.89 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.07 77.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -33.57 76.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -86.12 4.4 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.393 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.84 -2.33 83.71 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.884 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 t -63.77 133.73 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.844 0.354 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.4 150.13 89.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.92 -35.01 36.97 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.518 2.146 . . . . 0.0 112.234 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.429 ' HA ' ' CD2' ' A' ' 204' ' ' TYR . 21.1 t 67.62 -69.62 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.6 ttp-105 -166.18 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -71.73 -32.77 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.5 96.25 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.31 -43.34 91.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.24 -38.51 91.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.8 -31.02 69.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 7.0 mt -75.9 -42.38 39.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.77 -46.27 87.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.684 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.77 -25.42 44.12 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.88 -31.53 45.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.414 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 97.2 m -54.22 -48.73 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -30.54 71.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.28 -45.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.201 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -27.37 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.512 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.414 ' CZ3' ' HB3' ' A' ' 250' ' ' CYS . 17.2 m0 -76.99 -32.66 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.434 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.15 -35.51 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 m -96.27 0.59 51.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.599 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.35 96.29 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.332 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 33.4 m80 61.74 154.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.469 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -121.68 164.26 25.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.823 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 60.0 Cg_endo -72.62 57.64 3.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.641 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 5.8 p90 179.35 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -92.47 13.44 19.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -59.4 5.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 4.6 m-80 -129.95 -26.17 2.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.417 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 83.6 mt 72.75 11.19 5.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -16.22 49.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.222 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -132.16 99.97 15.9 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.791 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.95 12.07 2.78 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -49.98 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.9 p90 -79.92 -26.23 40.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 15.1 t -60.67 -45.73 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.37 -31.96 62.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.039 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.13 -47.79 33.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.174 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB3' ' CE2' ' A' ' 278' ' ' TYR . 1.5 m -66.84 -35.99 81.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -64.77 -49.62 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.201 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.7 mt -66.91 -30.14 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.307 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -52.05 7.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 285' ' ' LEU . 10.7 m-85 -56.68 -31.96 64.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -27.86 65.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.66 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -130.07 30.29 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -150.19 38.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 282' ' ' ILE . 21.2 mt -52.98 -49.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.03 -49.6 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.3 p -65.33 -31.6 72.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.277 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 278' ' ' TYR . 1.4 tt -68.7 -38.42 80.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.488 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 290' ' ' PHE . 0.0 OUTLIER -65.42 -38.16 89.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.809 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -25.68 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -82.75 -54.9 4.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.403 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -41.3 78.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 286' ' ' MET . 19.4 m-85 -102.26 152.74 38.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -51.03 -61.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.663 2.242 . . . . 0.0 112.462 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -146.53 -45.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.013 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 63.62 56.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -65.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.744 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -62.42 -56.55 29.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 295' ' ' LYS . 18.6 Cg_endo -60.08 -164.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.4 2.066 . . . . 0.0 112.235 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 135.14 37.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.543 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -33.86 18.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.495 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' A' ' 303' ' ' MET . 20.2 mm -74.68 -46.61 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.27 -45.69 17.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -61.71 -38.82 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.489 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -70.05 -43.36 71.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.873 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 299' ' ' ILE . 4.5 mtp -65.51 -37.2 86.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -51.38 70.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.617 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 p -60.96 -34.72 75.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 39.6 t -73.36 -24.66 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.191 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -76.67 -31.89 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.4 mt -104.33 -10.9 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -53.12 136.09 36.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.065 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.37 162.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.25 20.77 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 3.5 m -164.99 -49.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 110.805 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 -170.08 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 165.13 14.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.05 142.27 27.83 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.627 2.218 . . . . 0.0 112.262 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.87 53.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -56.04 -32.81 64.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -63.27 -34.34 77.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.82 -44.38 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.27 -45.43 80.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -58.45 -47.56 83.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -39.42 81.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.12 -44.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.28 -48.21 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 -49.86 75.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -58.52 -40.36 82.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.77 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.08 -29.29 59.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.399 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.01 -39.47 93.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -30.72 69.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 331' ' ' ILE . 16.1 pt -106.59 27.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.18 38.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.6 164.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -176.76 37.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.814 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.31 85.13 4.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -109.14 -29.22 8.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 137.04 43.46 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.2 -177.22 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.457 ' HB2' ' HG ' ' A' ' 341' ' ' LEU . 12.9 mt -113.14 -9.99 13.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.415 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.03 29.86 0.76 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 339' ' ' LEU . 0.4 OUTLIER -139.01 68.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.804 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.4 t 66.35 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 6.2 m -149.67 83.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.39 174.76 10.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -137.79 -50.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 76.08 169.58 28.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -152.81 -175.58 24.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.16 31.3 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -104.73 106.03 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.79 90.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.51 107.25 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 2.6 p -151.54 35.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 27.2 mm 59.85 105.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 63.4 p -94.78 -34.43 12.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.17 144.49 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -138.1 -60.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.746 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.93 132.45 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -96.95 168.55 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -168.7 -49.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.77 94.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.7 tp -149.41 138.62 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.37 -47.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -105.36 141.74 36.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.7 p -171.68 -57.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -96.77 -32.1 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.72 124.4 81.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.16 -169.21 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.435 2.09 . . . . 0.0 112.372 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -153.33 160.49 29.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.507 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.44 92.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.84 114.32 28.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.97 -32.64 9.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.4 p -71.86 179.92 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 62.92 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 62.48 118.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.983 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.8 t -94.08 47.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -157.35 103.12 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.7 m 61.15 163.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -83.46 139.56 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 7.1 p -143.93 76.73 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -125.86 -44.8 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 134.0 35.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -119.76 149.85 41.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.71 -48.56 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 60.05 31.18 20.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.67 94.26 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.07 133.61 51.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.6 m -139.22 94.12 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.36 103.39 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.56 -46.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.44 162.59 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.32 132.08 10.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.69 -179.65 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.76 122.95 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.197 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -93.2 84.02 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.869 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 64.5 m -60.8 138.13 58.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.5 m -86.38 132.63 33.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -166.69 174.36 42.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.3 m -106.61 163.7 12.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 29.1 t -118.15 95.14 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 147.96 64.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.88 111.7 13.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.55 101.8 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.476 2.117 . . . . 0.0 112.321 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -85.76 176.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.59 59.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.68 -70.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.6 165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.88 31.96 6.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.039 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.02 29.84 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.06 36.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.97 -116.47 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 133.31 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.897 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -129.74 153.02 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.988 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -153.61 127.77 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.35 84.63 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.61 89.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -165.52 138.77 4.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -86.8 157.35 19.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -145.87 123.37 11.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tt -136.5 129.96 31.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.01 -53.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -132.49 164.35 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -64.85 -72.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' CE2' ' CG2' ' A' ' 29' ' ' ILE . 52.8 p90 -154.47 120.03 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -171.67 138.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.108 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t 65.03 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 25.8 71.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.593 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.77 137.56 41.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.18 141.29 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.469 ' CG2' ' CE2' ' A' ' 23' ' ' PHE . 48.7 pt -119.91 154.61 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.2 m -95.49 139.47 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.675 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 17.0 p-10 -98.3 -149.81 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.0 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -38.09 18.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.402 . . . . 0.0 110.324 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.99 -0.12 33.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.837 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER 85.02 16.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.289 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.77 173.52 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.69 78.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 110.532 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.46 128.56 37.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -88.21 124.02 33.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.53 122.65 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.14 -121.56 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.52 164.56 17.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.07 118.43 5.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.542 2.161 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 pt -107.02 30.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.68 137.57 2.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -59.11 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.19 108.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.76 -48.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -152.08 -64.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 -75.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.482 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 6.4 m -136.93 80.61 1.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.69 104.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 23.3 m-85 -129.55 163.59 25.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.4 mt -73.29 165.91 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.5 152.46 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.273 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -136.34 159.74 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.29 29.85 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 t30 58.97 -168.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t 61.56 45.27 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -169.03 126.33 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.988 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.39 116.11 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m 60.75 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.24 -57.36 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -151.37 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.551 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 m -100.84 37.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.02 30.67 5.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.72 119.55 72.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -87.5 30.17 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.797 2.331 . . . . 0.0 112.927 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.76 148.13 28.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -119.12 153.88 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.67 134.59 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -121.58 116.76 25.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.68 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 t -113.37 149.54 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 136.19 20.03 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.93 82.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.514 2.143 . . . . 0.0 112.355 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 53.62 29.67 9.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.9 120.77 33.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.61 41.52 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.1 -79.09 1.43 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.09 -43.41 2.4 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.538 2.159 . . . . 0.0 112.35 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.9 tp -60.13 -30.1 69.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.46 -32.3 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.7 p -77.76 -31.7 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -68.33 -46.58 69.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.01 -45.82 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -60.35 -29.67 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 2.5 m-85 -65.9 -60.3 2.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -17.84 64.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.773 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -18.99 60.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.59 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -62.22 -15.28 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -47.95 130.2 11.88 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.0 -24.32 19.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -79.32 -33.2 43.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.4 -42.51 25.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.8 mt -65.72 -55.26 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -50.76 -31.94 18.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -34.67 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.28 -46.06 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 104' ' ' LYS . 41.5 mm -64.48 -36.52 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.238 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -75.01 -27.72 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -76.65 -38.8 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.342 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -105.46 -3.73 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.254 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 100' ' ' ILE . 16.7 tttt 60.09 30.9 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 mt -49.93 -32.08 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.253 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -55.91 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.98 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.408 ' OH ' ' CE1' ' A' ' 194' ' ' TYR . 30.2 t80 -142.21 138.59 31.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.758 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 167' ' ' TYR . 13.2 tp -114.68 -66.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 132.46 -7.21 5.3 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.822 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.7 t -71.66 136.0 83.38 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.666 0.233 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.5 142.58 80.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.59 2.193 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.97 121.72 26.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -98.7 131.36 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -110.39 -40.83 4.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.065 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.97 -174.58 46.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.655 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -132.97 164.05 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -149.24 174.65 28.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.275 -0.965 . . . . 0.0 113.168 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 mt -145.23 145.15 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.716 0.293 . . . . 0.0 110.741 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -121.81 135.8 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -113.65 121.44 44.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -138.2 126.24 22.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 55.93 20.6 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.364 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.98 -4.99 61.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.903 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -96.04 129.08 43.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 110.776 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.4 t -100.44 122.99 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -105.81 143.59 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.755 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 129.27 54.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.462 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 11.2 p90 -141.52 159.24 42.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 tmm? -128.13 147.59 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.2 mt -123.32 112.76 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 111.377 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -121.96 173.3 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.94 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.99 149.66 2.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -87.51 168.09 13.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.429 ' CG ' ' HB2' ' A' ' 184' ' ' LEU . 80.6 m-85 -141.46 160.82 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.808 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.77 -94.57 0.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.96 130.69 55.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.418 ' HA ' HD22 ' A' ' 184' ' ' LEU . 6.0 m-20 -57.67 159.83 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.4 -31.01 68.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.585 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 2.0 mm100 -59.44 -45.14 92.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.387 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.49 70.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.378 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.9 mt -80.17 -26.94 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 16.3 t80 -66.88 -50.84 61.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -29.31 68.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.572 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.5 -24.7 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.084 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.1 m-80 -94.47 15.66 17.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 86.84 45.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.14 19.71 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.326 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 23.9 mtm180 -145.17 -175.63 4.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.93 171.17 14.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.4 m -97.08 157.64 15.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -72.54 -42.62 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -60.75 -43.63 97.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.89 -49.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 33.2 mt -60.52 -47.28 86.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.958 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -59.83 -46.78 88.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.6 mt -69.97 -43.54 71.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.2 p -54.4 -34.42 61.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.71 -41.41 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -45.74 77.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.688 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.4 mt -63.65 -34.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.762 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.38 -40.19 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -38.27 84.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.52 -39.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 47.7 mt -59.11 -45.07 91.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.591 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HG2' ' CG ' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -66.7 -33.95 76.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.658 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.421 ' CD2' HD21 ' A' ' 108' ' ' LEU . 60.6 t80 -65.51 -51.85 57.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.618 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.0 pt -72.28 -27.28 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.415 ' CE1' HG11 ' A' ' 174' ' ' VAL . 1.5 m-70 -76.16 -32.48 59.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -16.93 62.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -101.38 3.61 40.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.818 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 78.08 45.36 0.07 Allowed 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.088 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -134.31 142.31 47.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.507 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 204' ' ' TYR . 28.9 m -142.22 138.88 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.138 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.91 -67.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 81.31 36.54 20.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.626 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.87 -89.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.96 -0.141 . . . . 0.0 110.919 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.0 mp 41.38 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.832 0.349 . . . . 0.0 111.718 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 24.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.297 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . 65.96 9.86 6.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.65 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.8 p -113.63 1.48 14.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -134.71 4.76 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.146 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 1.9 mt -108.48 117.71 34.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.719 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -126.78 146.66 50.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.347 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 192' ' ' GLN . 21.9 mt -89.84 149.66 22.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.84 128.01 34.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.446 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 19.7 t80 -71.0 -58.82 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -21.6 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.603 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -129.24 71.08 82.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 86.25 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.52 2.147 . . . . 0.0 112.126 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -177.98 37.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -178.15 172.37 1.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.388 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.409 ' HB ' ' CD2' ' A' ' 185' ' ' LEU . 2.1 p -132.64 147.63 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.391 . . . . 0.0 110.693 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 22.6 m-85 -127.27 156.88 41.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.986 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.8 tp -103.93 115.83 31.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.649 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.6 m -107.41 179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.32 108.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.709 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.39 28.18 8.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.74 41.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.966 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.63 11.67 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 110.947 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -100.24 68.38 1.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.239 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -126.21 149.37 49.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.253 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -54.26 96.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.444 ' CE2' ' HD3' ' A' ' 206' ' ' PRO . 44.6 p90 -60.39 -47.94 83.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 107.32 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.945 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 204' ' ' TYR . 72.5 Cg_endo -78.8 -47.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.336 2.024 . . . . 0.0 112.303 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 176.99 -37.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 102.28 23.14 9.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 9.7 m -149.45 97.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.298 . . . . 0.0 111.048 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 26.6 m170 62.36 -80.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -168.59 156.38 7.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.932 0.396 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -148.65 131.55 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 171.44 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.91 66.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.54 -43.69 93.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -104.23 121.87 46.02 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.49 -10.94 26.14 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.554 2.169 . . . . 0.0 112.894 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -93.28 5.43 51.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.582 0.23 . . . . 0.0 111.218 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 53.91 24.3 4.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.745 0.307 . . . . 0.0 110.981 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 1.8 t -163.8 128.76 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.35 87.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -150.47 179.69 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -122.55 -38.81 0.57 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -140.96 -178.34 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.431 ' O ' HG12 ' A' ' 225' ' ' ILE . 8.7 tt -133.74 10.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.347 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.405 ' O ' ' CD2' ' A' ' 227' ' ' PHE . 27.4 tt0 -67.74 -13.67 62.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.313 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 226' ' ' GLU . 8.5 m-85 -165.14 29.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.68 130.45 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.54 -47.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.236 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.0 mt -57.03 -59.27 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.153 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.65 -28.18 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.17 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -57.4 -27.61 62.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.299 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.53 1.87 38.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.341 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.52 21.1 40.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.686 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.4 t -80.51 158.5 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.72 130.65 63.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.44 74.51 3.68 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 204' ' ' TYR . 0.6 OUTLIER -77.39 73.31 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.003 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 73.25 -57.62 0.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.334 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -58.94 -28.49 66.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -80.21 -33.97 30.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.528 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.9 -44.65 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.88 -44.4 86.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.299 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.28 -29.32 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 73.0 mt -76.02 -37.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 41.8 tp -66.44 -36.28 82.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.709 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.23 -28.02 72.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.41 -25.93 46.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 62.7 m -66.62 -32.84 74.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.011 0.434 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.24 -52.59 64.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.174 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.17 -38.55 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.625 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.71 -39.95 94.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.219 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -82.28 -32.34 29.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.9 mt -83.58 -37.37 23.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 111.475 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.9 m -96.21 -9.25 30.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.499 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.1 94.35 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.444 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 18.8 m80 62.28 150.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.429 HD21 ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -111.24 158.49 35.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.69 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 45.2 Cg_endo -68.32 61.94 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.557 2.171 . . . . 0.0 112.413 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.548 ' HA ' ' CD1' ' A' ' 270' ' ' TYR . 4.8 p90 175.64 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.463 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.9 tt0 -88.61 10.91 18.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.34 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.3 -47.61 81.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -131.97 -28.32 1.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.399 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.5 mt 71.55 11.29 6.52 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -16.25 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.278 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -131.23 100.75 16.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.94 13.38 2.36 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.638 2.225 . . . . 0.0 112.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -73.73 -46.66 44.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.5 p90 -83.92 -26.44 29.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 28.7 t -63.03 -39.59 85.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.092 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -52.62 10.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.312 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 75.2 m -56.21 -40.22 73.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.331 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.6 -44.67 93.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 27.9 mm -71.1 -33.08 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.734 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -81.08 -52.17 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -61.99 -35.42 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.024 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -26.5 42.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.359 . . . . 0.0 110.751 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -118.28 20.6 13.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -142.52 45.34 1.62 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.083 0.468 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.427 ' CD1' ' CB ' ' A' ' 303' ' ' MET . 26.7 mt -50.45 -40.17 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.65 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.174 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.96 -38.37 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 1.1 pp -74.01 -39.69 63.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.421 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 8.5 mtt -69.0 -44.29 73.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -39.02 92.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.91 -24.87 32.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.889 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 75.9 m -92.02 -41.35 10.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.66 0.267 . . . . 0.0 111.713 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.74 155.27 58.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.45 179.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.634 2.223 . . . . 0.0 112.278 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -111.25 67.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.67 88.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.9 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 61.41 153.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -93.26 121.7 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.15 -61.91 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.54 -24.53 30.26 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.02 -64.37 0.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 25.8 mm -72.96 -43.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.51 -42.16 10.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.506 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.49 93.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.41 ' CD2' HD21 ' A' ' 320' ' ' LEU . 25.6 t80 -69.51 -40.07 77.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.427 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.9 mtp -68.31 -38.6 81.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.68 -45.36 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.98 -32.88 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.389 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 36.5 t -77.24 -24.88 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -37.72 42.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.164 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.53 -14.54 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.363 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -51.27 96.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.9 88.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.24 30.43 20.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.95 -32.99 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.923 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.17 104.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.405 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 9.0 mttm -58.88 -60.54 10.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 59.4 Cg_endo -71.84 62.27 3.1 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.464 2.109 . . . . 0.0 112.384 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.27 -22.28 41.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.086 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.405 ' CG ' ' HG2' ' A' ' 166' ' ' GLU . 34.0 m-85 -52.84 -39.43 62.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 111.047 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.63 -36.48 78.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.0 -45.89 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 302' ' ' TYR . 35.9 mt -56.47 -38.24 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.032 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -43.62 88.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.34 -35.54 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 302' ' ' TYR . 70.9 mt -58.35 -47.12 88.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.025 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 47.4 mt -73.64 -51.63 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -49.71 73.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.53 -39.89 74.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -28.14 72.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.05 -32.52 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -66.88 -30.2 70.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.87 -18.89 55.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.532 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.8 84.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 111.333 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 127.23 -33.9 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.704 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.38 101.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.6 mttm 61.71 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.82 115.79 18.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -170.21 37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -152.54 -43.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -106.86 132.24 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 192' ' ' GLN . 27.3 mt -96.91 -4.41 40.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.359 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 62.12 19.55 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.769 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.29 48.3 1.31 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 110.637 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.997 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.3 28.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 21.9 t 58.38 75.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.96 82.9 4.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.75 89.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.817 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -136.39 48.63 0.91 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.519 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -82.33 128.28 8.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.33 174.78 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 0.0 110.846 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -107.34 128.04 54.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -158.27 -47.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.63 169.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.7 t -101.83 160.87 14.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.8 pt -66.85 153.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 9.5 t -162.83 152.99 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.85 105.66 1.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -130.41 36.18 3.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 61.15 105.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -118.57 102.48 8.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -95.13 -179.02 4.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -130.65 -172.88 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.07 102.82 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.54 164.43 30.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 89.11 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 -42.1 2.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.99 53.43 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.94 133.31 21.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.777 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.41 -172.05 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.487 2.125 . . . . 0.0 112.377 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 170.55 -142.33 7.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.06 179.08 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.0 66.27 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.38 104.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.5 t -156.34 170.39 22.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -162.25 140.95 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -47.29 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.81 163.85 20.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -108.96 -26.83 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.4 m 64.16 83.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -155.31 90.11 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -63.46 1.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -79.73 172.21 14.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.02 127.98 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.39 -43.31 12.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.77 108.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -61.79 137.99 58.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.65 88.09 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.12 -67.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 -174.09 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.42 -60.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 m -132.3 125.17 30.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.48 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.966 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -99.08 -36.76 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 108.36 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.26 143.22 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 94.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 45.8 t -140.01 -60.69 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.332 . . . . 0.0 110.937 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.76 85.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 128.71 -172.87 19.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.5 m -128.07 101.66 6.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.7 m -112.21 154.3 25.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 176.15 -87.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 104.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.582 0.23 . . . . 0.0 110.851 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.85 165.7 27.01 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.405 2.07 . . . . 0.0 112.24 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -120.24 -67.14 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.82 147.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.163 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -116.89 -39.08 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 34.09 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.68 152.64 51.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -138.28 22.61 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.37 100.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.277 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.78 93.33 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.588 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -164.92 123.12 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.11 91.55 6.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.928 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -62.89 93.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -91.99 144.85 25.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.21 138.21 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.018 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -149.26 127.62 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -74.86 -178.37 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.7 175.98 9.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.39 77.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.58 -167.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.057 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -106.55 -53.09 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.0 -72.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' CZ ' HG23 ' A' ' 72' ' ' VAL . 6.5 m-85 -118.27 108.11 14.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.83 -178.83 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.19 110.49 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.82 25.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.554 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -55.62 177.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.41 131.31 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 28.9 pt -118.41 154.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.1 t -95.54 138.49 33.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.977 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.2 -160.92 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -77.18 -43.8 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 109.967 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.84 -2.2 35.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER 87.31 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 30' ' ' THR . 11.4 mtpt -74.13 178.19 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.64 77.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.405 ' HB2' HG13 ' A' ' 29' ' ' ILE . 67.2 m95 -72.75 141.76 48.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 127.88 46.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.974 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.7 t -92.83 158.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.046 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 -125.13 2.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.81 164.03 37.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.28 -180.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.544 2.162 . . . . 0.0 112.387 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -157.37 -43.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.215 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.89 177.21 24.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -108.11 44.61 1.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -72.69 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.6 -152.19 28.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.543 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.93 32.37 1.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.41 -103.66 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 1.9 m -142.48 71.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.07 115.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 15.4 m-85 -140.17 165.2 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.97 156.71 39.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.15 159.39 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.075 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.12 155.63 40.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.3 ptm -101.07 38.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.92 111.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -175.22 3.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 p -64.93 -45.45 85.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -179.04 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.24 -175.68 5.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.47 146.29 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.02 -89.37 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -89.45 -30.35 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.98 53.26 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.48 96.31 41.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.52 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.691 2.261 . . . . 0.0 113.025 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.1 m -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.33 158.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.34 129.9 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -111.1 123.61 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.451 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 18.0 t -113.13 141.69 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.472 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.38 133.79 24.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.605 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HA ' ' CE2' ' A' ' 126' ' ' TYR . 37.1 Cg_endo -65.59 88.12 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.439 2.093 . . . . 0.0 112.326 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m 54.44 -171.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 60.42 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -135.36 -178.22 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.18 -82.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.43 -41.64 6.31 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.62 2.213 . . . . 0.0 112.374 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.46 -30.64 71.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -32.72 72.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -78.37 -43.34 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.6 tt0 -64.07 -46.36 84.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.6 -51.15 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -51.9 66.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 198' ' ' TYR . 15.5 t80 -63.99 -33.73 76.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 83' ' ' GLU . 3.4 m-85 -72.47 -46.23 55.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -27.17 65.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.7 -47.45 8.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 171' ' ' HIS . . . -103.06 -33.68 9.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.96 26.87 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.9 133.74 65.36 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.33 -32.84 89.95 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -37.11 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.157 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -58.01 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.3 mt -53.27 -49.38 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.407 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.56 -43.34 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 111.089 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -28.6 64.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -51.06 11.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.2 -37.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.257 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -74.86 -27.8 60.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.402 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.4 p -82.15 -38.77 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.527 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -1.63 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.456 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 32.84 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 mt -83.2 58.94 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.58 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.92 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.653 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.18 122.05 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.91 0.386 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.86 159.77 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.47 17.09 57.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.86 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.19 127.12 43.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.594 0.197 . . . . 0.0 111.072 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.05 141.15 48.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.281 1.987 . . . . 0.0 112.283 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.47 115.43 22.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -96.88 127.63 43.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.706 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 7.2 m95 -103.04 -40.81 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -177.68 46.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.595 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -135.32 161.79 34.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.607 0.241 . . . . 0.0 110.545 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -153.79 -179.42 29.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.647 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.32 159.83 42.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.037 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -132.11 141.7 49.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.831 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.43 125.29 47.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 126.2 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 51.89 23.82 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.89 21.24 40.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.58 159.33 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.769 0.318 . . . . 0.0 110.71 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m -112.74 120.5 41.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 74' ' ' PRO . 22.1 m-85 -118.18 121.34 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.788 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -107.77 129.28 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.54 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 24.0 p90 -140.04 160.3 40.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 111.235 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -128.16 140.03 52.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 mt -110.63 111.82 37.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.453 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -127.82 173.22 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.27 141.68 45.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -73.81 161.92 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.96 170.38 14.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.97 -52.16 1.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.6 m -157.93 171.89 19.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -98.82 153.73 18.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 180' ' ' ALA . 2.2 mm? -60.03 -33.47 72.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -61.73 -46.52 89.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.848 0.356 . . . . 0.0 110.282 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -58.71 -28.57 65.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 149' ' ' PHE . 35.1 mt -75.32 -26.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -58.13 -47.65 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.683 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.28 -26.74 68.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.791 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.85 -20.93 61.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 17.0 m120 -94.57 4.19 54.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 85.32 45.86 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.043 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 19.77 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.273 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -162.99 117.43 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 153' ' ' THR . 1.4 m-85 -63.56 -172.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.43 158.08 29.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.738 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -34.1 73.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -74.71 -37.74 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 149' ' ' PHE . 1.7 m -73.7 -40.75 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.04 -44.51 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 22.9 mt -58.33 -54.26 49.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -56.99 -46.99 81.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.0 mt -65.76 -38.41 88.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -56.87 -34.11 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.708 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 9.7 mt -73.31 -45.5 55.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -61.73 -45.07 95.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.791 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -65.83 -33.04 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.932 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.706 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -40.62 91.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 mt -67.94 -42.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.12 -43.77 74.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.973 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HG3' ' CD1' ' A' ' 317' ' ' TYR . 2.1 tt0 -66.0 -37.3 85.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.799 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.82 -54.66 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.1 pt -59.01 -27.6 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.174 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.42 ' CE1' HG13 ' A' ' 174' ' ' VAL . 2.2 m80 -69.05 -44.17 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.19 -14.45 61.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -99.03 2.87 46.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 72.89 43.05 0.44 Allowed 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.094 0.473 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.402 ' CD1' ' HB2' ' A' ' 201' ' ' ALA . 0.7 OUTLIER -140.88 110.38 6.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 204' ' ' TYR . 19.3 m -131.16 139.48 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.619 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.417 ' CD2' ' O ' ' A' ' 198' ' ' TYR . 2.0 t60 -175.76 160.26 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.534 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -109.43 71.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 30.98 2.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.74 94.49 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.872 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.65 24.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.27 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . 68.2 8.21 6.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.806 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -110.48 0.24 17.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -141.65 7.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.9 OUTLIER -108.66 114.45 28.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.048 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.75 148.16 48.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 192' ' ' GLN . 6.6 mt -95.03 149.25 21.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.949 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.512 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 1.0 OUTLIER -89.38 132.37 35.0 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.111 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -122.21 -31.38 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -24.29 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.796 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 190' ' ' PRO . 0.7 OUTLIER -166.16 -57.86 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.772 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 189' ' ' ASN . 24.3 Cg_exo -61.25 -133.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.306 2.004 . . . . 0.0 112.376 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 186' ' ' ASN . 0.2 OUTLIER 171.92 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.247 -0.283 . . . . 0.0 111.72 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 1.2 mt-30 -85.95 -169.13 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.475 ' HB ' ' CD2' ' A' ' 185' ' ' LEU . 3.5 p -109.58 147.94 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 11.0 m-85 -129.5 151.42 50.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.035 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.415 HD23 ' CZ ' ' A' ' 198' ' ' TYR . 14.2 tp -104.04 115.97 31.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.508 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.3 131.88 60.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 20.0 t0 62.61 124.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 86' ' ' PHE . 10.1 m-85 -105.45 14.85 28.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.201 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 83.08 -55.28 5.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.626 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mp -139.18 -42.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.649 0.261 . . . . 0.0 111.17 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.402 ' HB2' ' CD1' ' A' ' 173' ' ' TYR . . . 64.17 101.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.688 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 44.4 t80 -115.73 148.99 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.983 0.42 . . . . 0.0 111.017 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -95.57 78.21 3.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.43 ' CD1' HG12 ' A' ' 174' ' ' VAL . 7.8 p90 -44.53 -34.47 2.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.524 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.84 136.48 85.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.78 171.14 18.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.445 2.097 . . . . 0.0 112.262 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.95 -40.45 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.84 44.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.93 -61.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -112.86 135.25 53.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.985 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -102.4 37.86 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.9 -168.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 215' ' ' GLU . 1.1 p90 -98.36 -177.87 3.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -54.04 4.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 213' ' ' TYR . 7.3 tt0 62.94 102.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.407 ' N ' ' HD3' ' A' ' 217' ' ' PRO . 4.3 t0 57.98 62.99 4.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 216' ' ' ASP . 32.1 Cg_exo -58.2 -59.81 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.49 2.127 . . . . 0.0 112.147 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.22 -46.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.851 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -169.54 69.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 98.6 m 60.02 165.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -133.79 -54.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.45 143.98 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -100.96 -134.07 8.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.567 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.79 65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.916 0.388 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.63 -18.46 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -59.92 -30.86 69.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.246 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -149.25 34.87 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.305 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 12.6 t -81.51 116.83 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.303 . . . . 0.0 110.899 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 m -64.85 153.43 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.62 -30.45 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 -40.28 74.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.88 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.53 -25.52 64.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.4 7.56 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 78.56 23.42 64.96 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.714 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.72 128.19 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 202' ' ' TYR . . . -82.7 -53.71 0.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 40.6 Cg_exo -56.88 94.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.466 2.111 . . . . 0.0 112.225 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 m -106.48 120.07 40.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.405 ' HG3' ' CD2' ' A' ' 204' ' ' TYR . 7.8 mtm105 -125.61 -47.8 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.44 -14.12 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.52 -49.68 71.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.692 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.53 -38.99 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 57.8 mt -74.44 -42.55 58.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.79 -35.13 72.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 11.7 mt -70.18 -44.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 23.8 tp -59.43 -41.47 89.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.763 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -60.57 -31.37 74.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.177 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -78.33 -25.72 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 67.2 m -68.03 -32.92 73.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.7 mmm -58.54 -53.48 57.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.198 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.93 -39.86 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -59.28 -40.15 85.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -82.43 -46.17 13.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.89 -25.87 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.8 m -104.5 0.67 29.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.3 88.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.374 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.5 m170 62.9 163.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -131.45 164.26 43.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.713 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.72 62.54 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.419 2.079 . . . . 0.0 112.407 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 4.0 p90 177.24 -37.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.154 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.3 tt0 -91.88 12.58 21.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.316 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.76 -53.76 54.25 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.3 m-20 -131.38 -29.1 1.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.367 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 54.6 mt 73.89 9.87 4.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -77.02 -16.03 59.42 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.161 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.46 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.7 m-20 -136.21 99.89 10.79 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.799 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.12 16.63 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.647 2.231 . . . . 0.0 112.768 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -79.95 -44.93 19.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.347 . . . . 0.0 110.775 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 3.4 p90 -80.55 -26.21 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 27.6 t -62.96 -38.08 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.261 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -75.65 -47.32 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.114 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -52.17 62.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.33 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.6 m -55.52 -39.44 70.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.361 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.56 -44.88 96.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.356 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.5 mt -70.71 -31.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.595 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -81.06 -45.5 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 0.0 111.466 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.456 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.2 m-85 -70.85 -34.13 71.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.54 -31.39 62.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.365 . . . . 0.0 110.667 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.31 16.87 23.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.952 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -139.73 44.45 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.753 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 30.5 mt -50.58 -39.1 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.89 -27.85 61.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -38.36 27.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 1.6 pp -73.25 -39.36 65.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.437 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 10.6 mtt -71.16 -38.28 72.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.2 -41.22 97.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -24.81 33.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.3 m -89.78 -41.16 12.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.575 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.17 150.76 37.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.89 178.88 4.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.209 . . . . 0.0 112.291 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.87 30.66 4.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -88.57 -32.2 18.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -134.86 169.64 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.82 138.82 19.9 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.51 121.24 9.14 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.317 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -147.98 -54.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -62.93 -61.57 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.91 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 18.0 mm -76.02 -43.34 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.07 -47.92 17.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.517 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -59.31 -37.74 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 323' ' ' ILE . 85.6 t80 -72.11 -40.68 67.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.761 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.437 ' HG3' ' HE1' ' A' ' 286' ' ' MET . 2.5 mtp -68.3 -41.06 81.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.632 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.4 -47.55 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 3.3 p -60.64 -36.52 78.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 26.1 t -74.89 -24.72 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.022 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -30.94 54.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.52 -8.77 18.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.727 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -47.44 157.71 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.191 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 178.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 16.1 t80 77.56 -56.05 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.5 t -108.53 -39.47 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.77 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.46 112.81 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.41 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 0.0 OUTLIER -73.33 -61.28 1.48 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 58.1 Cg_endo -71.32 111.88 3.2 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.113 . . . . 0.0 112.39 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.17 25.73 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.413 ' CD1' ' HG3' ' A' ' 166' ' ' GLU . 86.7 m-85 -64.75 -34.19 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.35 -30.9 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.05 -46.01 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 62.1 mt -57.88 -48.86 78.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -30.64 66.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.05 -41.34 35.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 302' ' ' TYR . 17.4 mt -54.62 -41.38 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.8 -49.8 17.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.08 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.02 -49.92 75.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.192 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -58.51 -42.27 87.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.01 56.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.456 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.67 -28.76 70.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.732 0.301 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 4.0 mtmt -67.7 -28.54 67.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -18.69 55.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.4 pp -114.12 16.95 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 108.27 43.22 1.29 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.251 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 17.7 m 58.76 177.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.218 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.64 145.79 32.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.35 162.68 11.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.52 -65.6 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -148.2 28.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.88 140.33 32.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 28.25 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 62.89 28.83 16.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.208 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 8.0 mt -99.86 40.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.741 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 11.0 p -61.41 -38.68 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.3 m 41.82 76.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.677 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 12.6 m -135.14 -47.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.99 157.64 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.83 139.72 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 161.42 -94.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 93.13 -157.87 23.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.75 143.1 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.91 92.63 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.07 -163.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.51 18.97 9.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.4 m 56.08 101.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.7 tt -178.33 -43.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 20.9 p -131.13 70.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.49 139.06 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 9.2 tttt 61.12 156.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -146.32 102.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.3 134.61 52.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.967 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -159.99 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -156.33 151.12 26.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 22.5 mm -138.05 96.84 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.83 176.35 7.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.74 151.93 20.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.23 -29.36 7.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.67 167.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.039 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -107.12 87.15 2.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.33 62.12 3.46 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 0.0 112.3 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -136.36 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.7 55.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 111.007 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.06 134.0 48.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -171.38 -65.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.7 m -112.5 142.47 45.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.0 153.76 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -108.24 126.27 52.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.41 -175.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -142.16 135.08 28.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 2.7 p -131.83 159.86 37.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.43 175.2 6.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.955 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.5 p -130.58 136.6 49.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 146.86 29.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -105.06 97.06 6.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.54 -170.21 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.073 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.59 -28.97 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -159.5 104.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 1.6 p -100.71 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -109.17 -68.62 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 10.8 t 60.75 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.88 118.11 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.3 t -115.46 -38.94 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -106.97 131.02 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -81.4 -178.29 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.01 115.3 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.7 m -82.4 137.09 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -107.05 142.86 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.92 77.35 1.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.0 p -145.41 175.98 9.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 116.9 150.31 9.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.75 -35.65 26.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.8 t -145.07 -54.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -146.89 -170.92 15.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.409 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt -118.16 136.61 23.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.16 -45.42 41.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -96.14 -172.89 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 p -172.04 -41.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.45 71.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.67 153.57 38.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.35 -52.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -119.56 122.78 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.89 -43.71 4.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.73 50.99 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.499 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 130.99 38.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 154.01 37.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -152.55 160.28 43.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -140.29 35.2 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.07 33.43 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -94.66 115.08 27.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.22 91.5 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -157.11 167.04 31.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -129.43 -62.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.85 80.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.42 85.91 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -123.55 -74.98 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' CZ ' HG22 ' A' ' 29' ' ' ILE . 3.8 m-85 -82.53 113.6 20.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 177.62 7.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.12 120.75 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.16 -24.78 29.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.6 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.16 153.52 14.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mt -123.05 140.11 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 25.8 pt -119.64 154.67 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 6.7 p -95.38 141.33 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.21 -161.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.64 -37.4 36.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -83.2 4.5 26.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.3 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 77.19 30.0 0.55 Allowed 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.4 mtpp -76.17 175.82 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.032 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.32 77.34 1.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 0.0 110.678 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -71.89 128.3 35.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.972 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -86.42 127.97 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.05 125.21 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.42 -125.6 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.555 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.76 156.92 49.26 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.99 131.35 19.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.586 2.191 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.85 -36.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.9 101.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -105.58 -44.19 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.803 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.28 -42.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.9 94.12 1.68 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.422 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.9 -65.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.23 -85.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -149.47 87.44 1.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 23.4 mm -96.86 122.97 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 61.2 m-85 -145.91 168.28 21.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -82.26 154.81 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.35 157.79 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.23 154.86 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.56 51.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 60.51 101.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.99 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -121.81 179.43 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 144.49 32.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 67.5 -72.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.11 -169.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.89 94.48 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.0 -91.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.532 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.94 30.44 4.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.33 65.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.7 94.48 48.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.76 36.46 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.286 2.657 . . . . 0.0 112.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.72 148.24 29.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.57 144.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.059 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.4 123.62 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -105.44 124.22 49.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -113.96 141.62 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.07 150.62 59.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.66 86.0 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.517 2.145 . . . . 0.0 112.215 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.6 -71.5 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -161.37 99.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -110.55 -26.26 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.6 -154.65 7.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.597 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.27 24.84 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.301 2.667 . . . . 0.0 112.687 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.77 -42.29 92.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.14 -44.11 95.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -67.22 -34.34 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.34 -42.91 74.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -57.57 -52.08 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -46.07 78.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 201' ' ' ALA . 12.2 t80 -70.54 -30.74 67.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -67.56 -46.98 71.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.083 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -79.88 -17.61 52.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.552 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -47.64 60.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.757 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 -34.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.401 ' CB ' ' HA ' ' A' ' 87' ' ' TYR . . . -53.95 -20.8 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -47.46 138.29 8.76 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.659 0.266 . . . . 0.0 111.035 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.7 -18.31 47.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.496 2.131 . . . . 0.0 112.393 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.34 -35.9 40.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -79.3 -45.77 19.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG12 ' CZ ' ' A' ' 167' ' ' TYR . 62.2 mt -61.05 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -55.45 -33.68 63.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -38.98 63.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -68.95 -42.07 77.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.406 ' O ' ' N ' ' A' ' 104' ' ' LYS . 27.3 mt -65.51 -37.5 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.042 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.79 60.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.4 m -80.97 -37.73 28.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.514 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.43 -3.51 20.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.43 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 59.96 31.85 20.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 110.657 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.2 mt -52.4 -28.45 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mttm 76.33 -56.13 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -145.79 154.27 41.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.435 HD23 ' CD1' ' A' ' 167' ' ' TYR . 1.5 tp -127.55 -72.88 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 127.31 1.03 6.77 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.007 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.5 t -76.2 128.5 82.64 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.843 0.321 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.81 143.0 9.79 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -84.25 116.88 23.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.709 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -111.99 -40.68 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.94 -175.95 46.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.95 162.1 35.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.675 0.274 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.15 -175.05 21.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.65 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -145.26 158.9 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -131.84 133.85 45.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -107.79 122.6 47.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 126.22 22.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 57.73 19.51 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.275 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.29 -0.15 61.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.897 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 129.09 47.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -96.14 131.62 42.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.63 148.88 39.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -111.4 125.27 53.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 10.8 p90 -132.24 160.23 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.5 ttm -128.12 142.64 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.767 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 mt -116.24 116.76 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.299 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -128.88 173.16 10.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.36 144.57 20.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.049 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.18 179.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 196' ' ' VAL . 49.5 m-85 -151.69 145.47 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.73 -107.87 0.82 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -113.4 130.25 56.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -57.76 155.91 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.04 -23.14 65.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.733 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -68.61 -42.0 78.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.904 0.383 . . . . 0.0 110.409 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -62.8 -35.36 79.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.039 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.28 -28.52 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.481 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 254' ' ' TRP . 48.4 t80 -61.16 -52.43 64.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.8 -30.42 56.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.96 -16.44 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -87.81 -2.93 58.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.135 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 95.74 41.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.063 0.545 . . . . 0.0 110.327 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 61.53 19.13 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.541 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -167.04 125.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.129 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.78 -176.88 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.9 p -113.95 -176.91 3.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -71.8 -33.9 68.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -65.9 -48.08 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.3 p -63.44 -40.22 96.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.78 -53.82 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.21 -46.91 82.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -52.8 61.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.28 -37.01 83.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 38.5 m -58.13 -37.94 75.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.0 mt -67.58 -48.01 68.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.676 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.91 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.9 mt -62.75 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.706 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.84 -35.08 79.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.602 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.62 -38.3 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.4 mt -74.54 -42.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 169' ' ' HIS . 6.9 mt -56.29 -43.13 78.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 32.1 tt0 -66.93 -32.78 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.435 ' CD1' HD23 ' A' ' 108' ' ' LEU . 88.9 t80 -68.22 -50.32 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 26.0 pt -73.41 -27.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.413 ' CD2' HG12 ' A' ' 174' ' ' VAL . 3.6 m-70 -68.46 -32.37 72.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.299 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.98 -17.1 62.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.51 4.74 38.94 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 77.1 5.34 3.25 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.488 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 203' ' ' ARG . 4.6 m-85 -94.24 132.77 38.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.723 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.413 HG12 ' CD2' ' A' ' 169' ' ' HIS . 30.4 m -142.37 139.06 29.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.071 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.447 ' CD2' ' CD1' ' A' ' 168' ' ' ILE . 3.0 p80 -115.67 -40.91 3.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.346 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 59.32 19.11 45.55 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.632 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.07 61.35 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.51 102.56 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.657 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 6.2 mtmm -146.68 -175.48 4.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.687 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -84.75 3.08 39.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.6 p -106.15 -2.82 22.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.05 -2.89 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.351 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.1 mt -108.32 122.68 47.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -131.64 160.63 34.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.76 0.314 . . . . 0.0 110.999 -178.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.5 147.08 23.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 111.194 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.406 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 0.2 OUTLIER -60.98 131.64 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -78.12 -53.72 7.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.77 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.843 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.15 71.81 18.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.969 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.65 101.91 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.16 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -178.0 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -113.24 159.11 19.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.21 148.29 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.99 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 13.0 m-85 -125.95 157.63 37.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.008 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 34.3 tp -103.32 115.97 31.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' A' ' 184' ' ' LEU . 2.3 t -118.18 157.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 54.52 103.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -97.91 -64.31 1.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 95.31 -37.66 3.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.021 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mp -128.74 22.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 86' ' ' PHE . . . -78.39 60.97 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.166 0.508 . . . . 0.0 110.536 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -124.33 149.03 47.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.193 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -55.49 97.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.968 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -57.73 -29.76 65.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.76 75.29 78.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.79 -62.99 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.587 2.191 . . . . 0.0 112.414 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.88 90.47 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.62 -44.79 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.397 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.78 83.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.07 167.37 10.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.61 -30.99 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -129.86 -72.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -174.62 -178.34 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -98.93 -66.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.41 53.69 2.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -145.3 154.82 54.02 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.08 172.37 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.632 2.221 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.32 -55.19 0.48 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -10.78 60.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 56.7 m -52.57 134.24 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.07 87.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.72 163.43 15.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.05 -92.97 1.11 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.521 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 -63.28 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.65 -44.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 271' ' ' VAL . 14.3 mm-40 -159.26 27.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.404 ' CE2' ' HD3' ' A' ' 179' ' ' LYS . 2.7 t80 -94.63 23.8 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 -72.85 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.998 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.99 150.32 5.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.347 . . . . 0.0 111.035 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.23 -31.57 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.5 -31.46 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.22 -30.24 63.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -75.66 -29.33 59.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.08 12.91 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.461 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.45 26.31 74.38 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.534 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.63 144.63 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -58.17 145.13 74.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.83 -36.28 18.86 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.414 2.076 . . . . 0.0 112.23 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.6 m 59.55 33.77 22.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -56.14 0.65 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.555 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -21.76 56.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.145 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -59.03 -32.1 70.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.68 -29.23 45.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.418 ' CD1' ' CD1' ' A' ' 320' ' ' LEU . 18.8 mt -73.84 -29.77 62.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.011 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.3 -31.98 62.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.1 -38.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.92 -31.23 62.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.64 -47.69 80.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.422 ' CE2' ' HE2' ' A' ' 275' ' ' LYS . 51.3 m-85 -78.49 -25.88 45.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 -41.44 70.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.139 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -48.63 80.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.864 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.37 -28.48 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.037 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -80.1 -36.86 34.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.475 ' CD1' ' CE1' ' A' ' 142' ' ' TYR . 20.8 m0 -82.38 -29.89 30.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.426 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.426 HD13 ' CZ ' ' A' ' 290' ' ' PHE . 30.2 mt -67.21 -47.09 71.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.392 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.1 t -98.71 -23.35 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.327 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.429 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 101.79 14.99 27.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.817 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 166.62 170.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.453 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -133.6 159.56 72.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.7 Cg_exo -68.33 59.97 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.748 2.299 . . . . 0.0 112.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 16.2 p90 177.34 -42.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.106 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -95.63 17.2 15.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.529 179.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -58.33 -51.61 69.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.5 t-20 -130.51 -25.92 2.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 77.2 mt 70.03 13.7 7.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.239 0.543 . . . . 0.0 109.611 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -89.81 -14.99 33.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.253 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.477 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 0.5 OUTLIER -134.98 88.61 26.47 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.93 -8.09 22.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.614 2.209 . . . . 0.0 112.664 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -54.56 -50.07 68.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.751 0.31 . . . . 0.0 111.189 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 5.7 p90 -81.73 -26.18 34.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.612 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 59.4 t -60.06 -44.33 94.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.473 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -68.89 -42.27 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -36.55 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.1 m -65.61 -43.67 88.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.422 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.9 OUTLIER -62.93 -44.58 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.69 -29.68 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.435 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -49.82 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.403 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 13.2 m-85 -64.5 -39.94 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.468 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -26.33 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.28 19.07 15.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -143.81 49.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 16.6 mt -54.11 -35.22 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.348 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.82 -29.79 62.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 111.067 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.9 pp -73.9 -29.69 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.4 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 4.9 mmt -64.85 -47.47 77.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.01 -20.93 44.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -82.7 -50.86 8.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.694 0.283 . . . . 0.0 111.399 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.87 -41.13 30.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.334 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 255' ' ' LEU . 12.6 m-85 -104.63 98.92 16.04 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.084 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.92 84.72 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.474 2.116 . . . . 0.0 112.046 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.6 97.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.642 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 56.18 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -161.84 -51.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -151.16 104.74 2.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 -49.1 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.367 2.045 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.62 30.22 0.03 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.39 7.92 6.29 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.737 0.268 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 303' ' ' MET . 28.8 mm -79.57 -46.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.4 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.25 -35.81 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.523 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -68.48 -41.49 80.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 320' ' ' LEU . 11.5 t80 -72.11 -34.32 68.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.567 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 65.3 mmm -71.78 -48.22 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.28 -41.41 75.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.1 m -64.44 -42.19 96.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 110.539 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 41.2 t -69.55 -24.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.144 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -71.65 -37.29 70.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 73.7 mt -97.53 -13.53 21.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.607 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -63.16 120.46 11.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.91 -175.59 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.39 -19.65 56.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 16.6 p -95.57 30.68 2.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -141.3 113.26 7.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.854 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 315' ' ' PRO . 15.3 mttp -64.97 -56.45 20.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.285 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 40.1 Cg_endo -67.13 113.24 2.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.34 2.027 . . . . 0.0 112.567 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.427 HD22 ' CD1' ' A' ' 317' ' ' TYR . 5.3 tt -127.93 -74.86 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.427 ' CD1' HD22 ' A' ' 316' ' ' LEU . 35.2 m-85 -70.68 -38.03 73.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.84 -46.58 84.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.066 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -73.33 -45.94 52.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 302' ' ' TYR . 52.1 mt -58.76 -51.84 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.66 -42.03 70.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -62.36 -46.76 87.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.9 mt -51.03 -47.28 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 52.6 mt -71.54 -48.88 45.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.025 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.31 -49.97 72.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.372 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -39.09 79.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.805 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.01 -33.25 68.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.98 -38.6 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.42 -30.78 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -30.86 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.17 26.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.83 25.94 38.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.728 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 m -91.92 158.34 16.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 179.12 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.7 102.27 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.02 -28.5 12.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 163.99 -28.79 0.23 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.457 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -96.21 157.09 16.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.73 32.53 2.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 62.9 23.22 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.028 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.14 77.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.957 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 84.2 p -67.96 -25.53 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.6 t 71.73 95.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m -87.16 -35.01 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.72 131.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.44 174.2 8.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 156.79 -169.39 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 162.23 -159.58 31.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.2 tt -127.28 138.49 53.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -96.33 129.63 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -138.59 129.23 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -65.98 178.73 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 61.0 p -121.27 -45.12 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 3.8 tt -122.04 147.86 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.21 -70.63 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -159.81 129.88 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 -67.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 57.24 94.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.74 178.13 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -127.29 178.96 5.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.66 119.13 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 3.2 mt -83.66 105.11 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.27 114.51 23.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -131.88 31.27 4.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.3 m -150.06 125.62 10.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -79.95 100.06 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -111.9 155.42 43.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.15 155.51 8.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.315 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.86 -45.13 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.27 138.17 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -86.71 95.4 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -91.93 -71.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.9 m -148.18 114.71 5.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.81 175.02 7.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 60.81 168.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 107.45 19.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -159.85 165.45 32.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 3.5 t -160.85 59.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.46 134.59 11.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.827 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.62 140.84 40.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.42 133.3 38.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.34 36.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -88.8 -67.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 23.6 mt 59.84 94.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.1 112.44 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.94 -59.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 60.2 104.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.1 m -124.97 38.59 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -112.16 144.93 40.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 177.28 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.77 -167.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.01 37.55 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.07 43.07 11.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.46 123.56 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 60.16 36.11 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 6.0 tttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.928 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 3.2 m -64.8 161.54 17.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.813 0.339 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.2 m -103.97 176.99 4.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -78.15 -35.26 34.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 9.8 m 60.87 94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.5 t -130.34 -48.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -128.03 -46.33 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.427 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mtp -154.81 145.25 15.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.13 156.84 9.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.457 2.105 . . . . 0.0 112.255 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 60.45 110.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.45 94.4 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -81.7 145.59 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.95 -51.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.052 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.63 -68.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 60.73 98.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.24 114.9 16.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.35 -166.96 24.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.553 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.68 99.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -84.6 124.25 31.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -150.17 -52.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.97 87.74 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.6 79.72 6.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -160.35 138.3 9.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.58 -175.33 5.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -107.29 118.25 36.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mt -94.25 170.46 9.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.4 -70.4 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.04 111.51 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -73.74 -31.49 63.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' CE2' ' CG2' ' A' ' 29' ' ' ILE . 23.2 m-85 -75.65 63.81 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.731 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.16 -176.56 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.211 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.53 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.89 -28.82 12.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.51 149.51 49.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.864 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mt -117.61 136.85 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.45 ' CG2' ' CE2' ' A' ' 23' ' ' PHE . 30.0 pt -111.67 154.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -95.3 141.38 28.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -160.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.094 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.21 -42.97 29.77 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.073 0.463 . . . . 0.0 109.971 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -82.22 2.14 33.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.707 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 23.5 tttp 87.6 28.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -69.51 176.52 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.231 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -127.86 78.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.898 0.38 . . . . 0.0 110.589 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' CE2' ' HE3' ' A' ' 56' ' ' MET . 34.7 m95 -76.39 131.39 39.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -92.43 124.38 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.4 t -75.45 142.34 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -134.58 8.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.74 161.82 22.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.43 173.69 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.521 2.147 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.5 pt -160.08 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.04 -131.92 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -158.73 113.1 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.19 -69.43 2.81 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.54 141.34 2.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -96.84 -48.98 5.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.23 -96.67 2.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.71 79.63 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.71 118.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 23' ' ' PHE . 22.4 m-85 -146.37 171.97 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.29 156.91 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.62 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.46 159.61 41.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.058 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.403 ' HE3' ' CE2' ' A' ' 37' ' ' TRP . 2.9 mmt -118.68 72.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 64.43 -77.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 59.15 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -80.13 60.76 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.59 148.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 m 59.48 170.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -118.1 -53.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.45 -169.94 30.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.528 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 t -103.59 39.99 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -156.37 82.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.97 137.61 26.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -87.99 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.985 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 77.2 m -149.7 148.29 29.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.74 144.88 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 8.0 p -131.57 124.38 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.55 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.407 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 4.7 t -113.41 144.3 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.15 140.7 21.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.36 109.31 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.507 2.138 . . . . 0.0 112.314 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.71 178.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -87.17 -171.25 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.84 113.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.4 -168.12 30.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.416 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 -44.49 46.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 112.251 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.6 tp -70.12 -30.08 67.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.01 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -60.87 -36.78 80.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.2 p -70.63 -36.66 73.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -70.73 -48.4 54.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.26 -43.07 87.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -49.9 75.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' CD2' ' A' ' 198' ' ' TYR . 29.8 t80 -70.43 -39.63 74.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CE2' ' HE2' ' A' ' 129' ' ' MET . 2.6 m-85 -54.86 -42.97 72.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -77.26 -17.78 58.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.372 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -82.64 -26.77 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.378 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.88 -44.62 0.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.664 0.268 . . . . 0.0 111.719 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.04 -11.63 49.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.778 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -47.22 133.62 9.39 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.527 0.203 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.3 -30.57 26.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.538 2.159 . . . . 0.0 112.632 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -31.33 42.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.58 -40.56 66.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.3 -57.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -53.49 -27.15 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.301 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -73.96 -55.99 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.03 -47.24 78.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 104' ' ' LYS . 36.3 mm -56.9 -43.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -75.17 -27.64 59.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.1 m -78.79 -38.81 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.612 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -4.72 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.459 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 100' ' ' ILE . 6.8 mttm 59.64 26.96 16.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.24 -47.13 72.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.22 36.18 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -176.84 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.4 tp 71.96 -63.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.34 12.46 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.823 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.405 ' CG1' ' HD2' ' A' ' 111' ' ' PRO . 24.0 t -81.08 138.97 49.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.56 0.219 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD2' ' CG1' ' A' ' 110' ' ' VAL . 84.6 Cg_exo -46.42 146.38 5.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 112.399 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 115.52 23.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.289 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.2 127.85 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.565 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -112.33 -40.89 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.82 174.9 41.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.606 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.92 173.33 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.417 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -156.94 178.0 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.764 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.93 159.87 43.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.876 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 116.57 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.69 124.38 36.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.26 126.29 22.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.4 t30 59.67 17.27 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.535 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.44 56.57 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.916 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 129.03 43.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.819 0.342 . . . . 0.0 110.682 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.3 t -91.15 124.32 35.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.044 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.73 147.74 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -125.1 125.13 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.45 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 16.5 p90 -138.28 163.11 32.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.411 ' HE2' ' CE2' ' A' ' 87' ' ' TYR . 9.4 tmm? -128.1 148.62 50.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.709 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.8 mt -123.39 112.74 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.249 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -123.08 173.27 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -54.19 142.67 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.089 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.455 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -80.26 156.31 26.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -120.36 155.42 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.06 -80.14 1.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -131.65 131.19 42.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -58.87 159.78 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.12 -23.91 66.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.754 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -64.27 -42.05 96.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -64.02 -29.7 70.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.298 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.4 HG23 ' CE1' ' A' ' 149' ' ' PHE . 12.0 mt -81.5 -29.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 254' ' ' TRP . 18.2 t80 -70.92 -48.89 51.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.806 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.38 -29.81 65.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.44 -24.75 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 3.2 m-80 -95.2 16.16 17.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.14 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 84.04 46.94 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.153 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.67 20.12 11.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.249 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.13 176.8 8.38 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' CE1' HG23 ' A' ' 141' ' ' ILE . 0.2 OUTLIER -135.93 -169.3 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.65 145.2 43.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -30.43 65.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -71.18 -36.43 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.17 -41.12 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.3 t -55.91 -54.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 61.5 mt -64.18 -37.23 86.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.47 -44.71 74.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.4 mt -71.04 -47.81 56.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 p -53.38 -37.61 62.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.411 ' CD1' ' HG ' ' A' ' 325' ' ' LEU . 1.7 mt -68.17 -48.13 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.665 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -38.4 82.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.9 mt -68.57 -37.39 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.1 mt -60.8 -36.96 80.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.488 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -37.94 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.496 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.18 -39.0 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.32 -43.08 92.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.607 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.0 -34.9 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.592 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -67.84 -52.49 36.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.1 pt -67.19 -29.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.995 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -75.09 -34.23 61.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.418 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.95 -16.89 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.44 40.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 77.49 43.9 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.69 140.34 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 31.0 m -126.07 138.92 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 45.6 t-80 -159.48 92.48 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.897 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -93.64 38.61 3.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.284 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 t0 -97.39 34.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.39 114.46 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 227' ' ' PHE . 0.4 OUTLIER -160.38 -179.12 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 139' ' ' GLN . . . -80.21 -2.09 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.412 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.4 m -107.28 -0.62 22.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -127.5 -5.21 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 13.0 mt -108.49 118.69 37.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.062 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.07 156.68 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' A' ' 192' ' ' GLN . 6.5 mt -99.11 149.65 22.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 191' ' ' ASP . 14.0 m-20 -73.47 135.63 44.11 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.836 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.455 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 9.0 t80 -71.48 -68.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 -15.13 23.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.746 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.576 ' CB ' ' CD ' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -76.5 -168.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 189' ' ' ASN . 39.9 Cg_exo -39.85 -27.38 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.563 2.175 . . . . 0.0 113.913 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 1.1 t70 88.08 5.03 0.25 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.653 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -72.82 -167.58 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 183' ' ' LEU . 2.5 p -109.96 147.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.163 0.506 . . . . 0.0 111.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 15.7 m-85 -131.41 157.25 43.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.559 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 58.0 tp -103.62 115.79 31.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.679 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.67 -175.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.85 98.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.628 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.503 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 13.1 m-85 -109.87 30.53 6.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -53.72 -24.67 26.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.254 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -114.15 -4.27 13.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.538 0.209 . . . . 0.0 111.064 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -77.12 59.39 1.71 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 110.689 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.49 149.05 52.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -53.11 93.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.067 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.406 ' CE1' HG13 ' A' ' 174' ' ' VAL . 42.3 p90 -60.0 -35.82 75.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.3 m 63.39 125.97 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.38 170.49 19.12 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.312 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -129.14 -55.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -80.33 -51.45 4.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.55 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 18.2 t 69.06 -66.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.24 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -112.18 30.78 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -121.37 146.11 47.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 147.75 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 61.09 160.15 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -172.23 35.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.026 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.48 81.31 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' CB ' ' HD3' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -97.34 -56.61 0.19 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.198 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 216' ' ' ASP . 54.4 Cg_exo -52.24 -173.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.508 2.139 . . . . 0.0 112.347 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.17 70.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.96 47.58 17.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.006 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.52 89.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -69.45 -55.93 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.64 -70.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.018 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -58.95 171.96 4.45 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.687 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -59.95 -176.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 0.0 110.772 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 225' ' ' ILE . 7.3 tt -101.11 -21.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.71 -22.96 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 63.1 m-85 -142.53 30.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.322 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.4 t -85.6 146.59 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.95 159.0 19.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.5 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.49 -42.98 82.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.29 66.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.196 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.84 -25.56 63.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.318 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -96.33 0.12 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' A' ' 217' ' ' PRO . . . 89.44 -15.45 58.57 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.706 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.73 122.59 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.83 158.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 -171.23 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.6 2.2 . . . . 0.0 112.299 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.06 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -73.95 -54.18 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -83.36 -16.89 44.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.84 92.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.61 -28.79 65.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.309 . . . . 0.0 110.95 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 70.3 mt -76.6 -34.81 58.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -32.35 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 13.4 mt -66.65 -44.81 89.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.02 -36.56 83.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.32 91.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 275' ' ' LYS . 38.6 m-85 -78.58 -25.69 45.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.297 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -39.06 72.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.03 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -50.04 69.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.74 -29.21 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.981 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.447 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -68.92 -47.55 65.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.447 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 16.2 m0 -82.34 -26.88 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.405 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.05 -49.34 65.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.386 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 13.1 t -101.53 -11.48 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 92.75 108.07 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.306 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 25.8 p80 48.18 -175.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.447 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -135.02 154.61 79.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.422 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 48.8 Cg_endo -68.77 61.62 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.098 . . . . 0.0 112.166 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.563 ' HA ' ' CD1' ' A' ' 270' ' ' TYR . 8.4 p90 177.45 -36.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.419 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -89.26 14.44 11.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.535 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.11 -42.12 97.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -129.33 -29.33 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.277 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 87.7 mt 69.59 13.65 8.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -88.19 -14.94 37.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.361 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.0 94.73 14.16 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 -4.43 15.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.545 2.163 . . . . 0.0 112.643 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -53.21 -49.95 65.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.2 p90 -83.6 -26.07 30.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.008 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 61.4 t -59.84 -44.38 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -75.51 -36.88 60.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.296 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.84 -43.24 80.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.285 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -36.57 84.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.416 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -66.4 -50.33 63.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.212 -179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.93 -28.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.352 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -52.13 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.184 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' CD1' ' A' ' 285' ' ' LEU . 4.4 m-85 -57.99 -37.03 73.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.77 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -55.52 -26.99 46.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 28.63 5.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.74 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -146.64 41.58 1.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 4.2 mm -53.73 -45.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -70.36 -39.55 74.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -70.94 -29.54 65.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 278' ' ' TYR . 5.3 tt -67.38 -50.89 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 3.1 mmt -62.03 -36.82 82.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -19.96 61.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -46.48 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 4.7 m -93.69 -41.18 9.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.383 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.11 107.28 43.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.66 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.454 2.102 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.59 -25.18 38.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.2 -49.88 70.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.69 104.86 17.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -66.36 139.35 96.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.17 -174.09 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.541 2.161 . . . . 0.0 112.26 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 138.77 -43.05 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.322 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -70.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.656 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 303' ' ' MET . 19.8 mm -79.57 -49.72 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.993 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.62 -31.31 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -76.68 -36.46 57.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.42 ' CE1' HG22 ' A' ' 306' ' ' VAL . 17.9 t80 -76.15 -34.3 59.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 56.5 mmm -74.16 -42.13 60.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.11 -40.74 96.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 1.7 p -66.8 -36.05 81.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 302' ' ' TYR . 74.4 t -79.64 -24.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -32.93 41.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.22 -25.24 10.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER 47.78 -165.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.119 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.05 39.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.89 29.72 19.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.82 30.75 20.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -88.17 -40.79 13.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.57 166.27 16.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.771 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.46 129.31 22.25 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.13 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.39 22.99 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.06 -35.84 81.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.16 -37.05 84.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -77.33 -45.43 26.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 302' ' ' TYR . 56.4 mt -51.04 -43.25 60.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -57.62 -35.74 70.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -35.45 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.86 -51.49 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.36 -48.9 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -54.76 -49.94 69.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.363 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.6 -40.28 86.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.14 65.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 47.1 mt -61.08 -34.96 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -59.74 -31.47 69.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.24 48.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.4 pp -143.77 84.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.412 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.29 -42.69 1.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.724 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 t 65.31 87.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 61.0 156.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -75.53 153.44 37.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -107.49 -28.76 9.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.77 42.07 0.23 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.382 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -168.92 160.49 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 5.6 mt -91.19 10.48 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.333 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 2.3 t70 58.29 21.57 8.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.159 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 27.2 mt -71.39 -73.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 110.563 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.3 m 77.16 -54.55 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.9 t 70.1 30.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.016 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 18.6 t 59.79 36.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 62.26 149.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.95 -169.5 3.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 110.24 78.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.415 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 81.71 71.9 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.3 mp -122.25 105.38 10.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.335 . . . . 0.0 110.928 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -64.0 94.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.95 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.85 8.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -72.43 173.02 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.0 m -159.12 83.51 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 355' ' ' THR . 1.7 pp -109.17 -28.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 354' ' ' ILE . 9.4 t 50.55 175.33 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.456 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.51 160.19 4.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.979 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 174.13 14.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -135.69 157.54 46.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -128.56 -52.77 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -97.01 133.66 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -115.21 106.97 14.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -179.51 -36.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.78 -58.47 3.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.257 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -87.42 143.34 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.8 m -97.54 166.9 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.68 168.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 155.57 36.22 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.4 130.88 24.86 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.581 2.187 . . . . 0.0 112.255 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 140.79 174.85 14.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 151.04 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 111.175 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.32 99.33 3.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 60.47 88.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.1 m -84.58 -37.57 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.65 98.75 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -63.81 170.5 3.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 18.8 p -162.53 162.03 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -106.42 -179.73 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 1.7 t -145.94 -47.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -113.28 -58.97 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.3 t -84.93 150.91 24.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.9 115.08 8.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.42 100.62 7.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -115.51 159.99 20.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 17.5 mt -130.75 134.08 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -177.5 5.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 81.0 p -83.47 146.36 28.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 125.47 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.2 m 60.52 89.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.04 133.94 54.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 42.7 m -62.5 114.5 3.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -95.89 152.17 18.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 117.23 6.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 147.68 47.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 20.6 t -112.64 127.63 69.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -98.46 28.72 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.043 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 13.3 p 58.62 32.3 22.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.6 t -82.74 89.05 6.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -138.89 -87.92 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.3 176.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 62.4 m -107.28 149.96 27.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -175.85 -135.25 2.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.57 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.5 139.32 14.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.654 0.264 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.58 133.93 48.28 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.517 2.145 . . . . 0.0 112.22 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 124.77 23.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.17 155.97 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 30.54 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.25 153.73 18.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 60.68 -173.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -151.12 111.91 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.6 118.33 26.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.02 -68.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.457 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.03 -169.83 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.7 132.29 21.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t 60.48 32.09 20.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.6 p -87.78 -66.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.57 92.23 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -157.79 88.17 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -106.1 -33.01 8.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -74.46 -176.77 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -127.15 88.27 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.26 -61.91 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.18 -171.6 3.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 62.67 75.66 0.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 29' ' ' ILE . 50.2 p90 -65.59 127.86 33.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -166.76 122.73 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t 66.02 104.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.62 37.16 31.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.623 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -136.34 152.13 50.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -116.98 139.21 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.7 pt -119.74 154.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 34.6 m -95.55 141.33 29.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.996 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.77 -160.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.03 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.4 ttm -77.67 -41.69 37.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.86 0.15 36.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.589 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 3.1 mttp 87.24 27.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -70.34 179.25 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.06 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.16 79.59 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.445 ' HB2' HG13 ' A' ' 29' ' ' ILE . 69.6 m95 -73.49 137.66 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.907 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.66 134.49 34.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.89 143.72 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.02 -130.64 7.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.51 159.13 30.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.57 111.18 2.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.533 2.155 . . . . 0.0 112.063 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.4 pt -106.43 -37.9 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.43 179.03 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -171.75 -42.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.9 97.06 1.72 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.37 -152.71 7.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.64 32.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 -98.08 0.15 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 3.6 p -179.01 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 3.6 mp -98.9 136.68 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.387 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 50' ' ' CYS . 19.6 m-85 -140.45 170.3 16.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.663 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.22 152.45 42.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.08 153.93 45.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.318 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -143.8 150.45 38.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.789 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 mtm -99.45 45.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m120 59.84 -177.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 m 61.28 45.15 9.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -163.51 -43.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 69.93 -66.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -87.62 86.97 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.48 88.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.85 36.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.3 p -147.55 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -155.44 80.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.21 71.58 3.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 86.28 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.83 148.13 29.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -128.27 153.47 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.048 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 p -142.79 119.37 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -103.65 117.42 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 128' ' ' PHE . 11.8 t -118.95 152.05 21.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -139.08 135.77 17.69 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.636 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 83.4 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.303 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.23 -171.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.09 156.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -78.99 177.6 8.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.47 -162.87 29.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.23 32.78 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.708 2.272 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -60.61 -30.84 70.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.41 -37.15 86.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.019 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -33.13 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.7 -40.9 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -76.91 -37.62 55.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -59.56 -40.3 86.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 173' ' ' TYR . 8.5 t80 -82.83 -29.81 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 111' ' ' PRO . 2.1 m-85 -64.4 -51.91 60.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.122 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.59 -17.3 61.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.434 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.67 -47.51 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 -22.61 6.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.5 23.8 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -73.16 113.18 19.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.37 -33.31 36.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.454 2.102 . . . . 0.0 112.591 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.68 -39.01 77.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.32 -47.27 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.314 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -57.58 -57.54 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.44 62.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -64.39 -47.42 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.406 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -60.3 -55.05 38.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.254 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.0 mt -56.33 -36.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -74.96 -27.7 60.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.8 m -81.75 -36.61 28.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -2.54 26.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.81 30.77 20.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.676 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.7 mt -49.57 -31.7 11.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.54 -55.57 0.52 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.83 129.11 13.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.895 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 167' ' ' TYR . 12.4 tp -99.22 -66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.74 9.5 6.91 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.064 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.8 138.78 27.76 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.826 0.313 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 71.9 Cg_exo -50.8 151.41 11.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.525 2.15 . . . . 0.0 112.406 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.08 115.58 27.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -99.78 126.96 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.562 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -105.95 -40.87 5.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 111.028 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 -174.72 46.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.597 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 p -134.86 159.42 41.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -138.59 173.37 22.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.828 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.04 158.07 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.3 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -145.83 138.61 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.74 123.84 48.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.678 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -138.26 126.23 22.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.22 22.68 2.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.414 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.11 3.51 63.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.719 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -96.08 128.92 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.5 m -89.39 125.82 35.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.09 125.9 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.76 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.91 125.21 51.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.455 ' CZ ' ' HA3' ' A' ' 117' ' ' GLY . 14.6 p90 -140.31 165.72 26.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 111.407 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.89 147.14 52.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -123.28 111.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 111.4 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.66 173.46 9.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.975 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.98 144.82 3.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -88.42 -25.56 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.3 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.405 ' CD2' HD11 ' A' ' 184' ' ' LEU . 80.7 m-85 65.08 178.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.02 -108.15 1.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.59 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -107.02 127.85 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' HD21 ' A' ' 184' ' ' LEU . 1.3 p30 -58.26 157.65 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -23.6 65.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -41.03 96.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.97 0.414 . . . . 0.0 110.084 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -34.99 79.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.405 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.35 -25.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.664 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 11.9 t80 -67.71 -53.62 26.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -29.46 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.706 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.27 -20.29 62.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.311 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 2.0 m-20 -98.93 18.17 17.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 86.18 47.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 63.0 19.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.474 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -147.21 -173.97 4.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -169.11 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.9 t -113.25 150.24 32.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -59.25 -31.49 69.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -40.98 60.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.6 p -65.47 -43.3 90.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.88 -52.31 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.993 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.11 -48.04 80.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -59.91 -50.4 73.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.68 -40.26 87.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -56.03 -40.93 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.9 -48.04 78.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -47.42 85.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 27.1 mt -66.59 -35.09 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.8 mt -58.79 -39.87 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.759 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.47 -32.03 72.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.4 mt -77.11 -43.33 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.929 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 75.3 mt -58.52 -39.33 79.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -71.15 -31.39 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.672 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.425 ' CE2' HD21 ' A' ' 108' ' ' LEU . 73.3 t80 -73.93 -54.74 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.2 pt -60.11 -30.11 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.25 -37.28 74.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 110.36 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -16.89 62.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.565 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -101.68 6.12 41.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.965 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 77.88 46.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.07 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.51 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 47.2 m-85 -141.54 119.42 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.584 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.93 164.19 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.675 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.06 50.23 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.43 -18.18 49.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.866 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 69.1 79.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 110.846 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.06 115.36 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -155.94 172.87 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.824 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -76.81 -2.76 34.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.549 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.22 2.1 16.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.844 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -127.95 -6.76 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.363 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.523 ' HB3' HG21 ' A' ' 193' ' ' VAL . 11.0 mt -108.63 127.51 54.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.946 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.436 HD21 ' HA ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -134.49 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.123 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.82 149.47 24.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.43 130.31 42.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -82.76 -50.79 8.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -21.07 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -148.3 77.78 9.68 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.74 88.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.78 35.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 174.84 149.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -109.97 147.95 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.104 0.478 . . . . 0.0 111.025 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 4.6 m-85 -117.09 156.86 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -105.63 115.86 30.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.2 162.11 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.107 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.28 70.91 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -73.23 -60.39 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 92.51 -33.55 4.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.361 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.08 21.29 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.021 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -83.35 59.15 4.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.06 0.457 . . . . 0.0 110.615 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.81 149.33 50.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.133 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -58.6 99.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 205' ' ' CYS . 54.4 p90 -54.9 -47.79 73.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.411 ' N ' ' CD2' ' A' ' 204' ' ' TYR . 8.9 p -67.13 134.64 93.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.203 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.38 -72.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.477 2.118 . . . . 0.0 112.243 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -142.73 -71.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.74 -89.22 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.8 t 60.33 159.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -152.47 -51.59 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -129.07 36.44 4.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -116.52 -48.54 2.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.418 ' C ' ' HG2' ' A' ' 214' ' ' LYS . 0.6 OUTLIER -71.86 -152.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.751 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 213' ' ' TYR . 19.4 ptmt 45.09 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.002 0.43 . . . . 0.0 111.231 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 76.24 87.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.62 89.75 0.29 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.806 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.53 141.92 32.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.518 2.145 . . . . 0.0 112.42 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -132.23 -70.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 30.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 1.7 m 56.49 103.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.987 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -72.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.33 164.22 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.003 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.24 110.55 3.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.5 m -92.6 -71.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.424 HD12 ' HB ' ' A' ' 271' ' ' VAL . 1.9 tp -176.74 30.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -102.75 67.57 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.346 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 226' ' ' GLU . 34.3 m-85 72.26 41.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.645 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -102.34 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.785 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -79.99 145.9 32.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.13 -30.8 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.01 -31.31 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.27 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -61.9 -25.61 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -85.01 5.96 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.512 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.28 -2.26 85.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.903 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.97 178.76 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.771 0.319 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.22 132.02 9.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.99 -24.18 31.19 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.356 2.038 . . . . 0.0 112.409 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.7 t 61.65 35.67 16.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -179.57 -76.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -72.21 -15.84 61.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.374 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.57 92.71 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -26.99 46.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.959 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 29.1 mt -78.23 -34.05 49.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.074 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -39.87 85.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 11.2 mt -65.01 -34.88 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.6 tp -77.93 -36.17 49.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.28 -29.02 73.85 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.62 -27.55 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 26.9 m -60.6 -45.83 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -51.14 29.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.663 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.67 -51.44 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.573 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.7 -36.04 69.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -82.38 -49.92 9.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.05 -36.28 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.522 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.5 m -96.12 -15.38 22.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 68.96 94.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.313 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.7 m80 62.93 140.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.396 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.469 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -122.49 168.84 10.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 55.2 Cg_endo -70.04 59.95 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.45 2.1 . . . . 0.0 112.72 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 2.4 p90 177.92 -41.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.6 OUTLIER -95.35 17.68 13.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.346 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.21 -57.34 11.83 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 57.2 t30 -129.12 -26.27 2.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.335 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 66.0 mt 70.96 11.95 7.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -85.23 -16.5 40.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.163 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.7 OUTLIER -133.13 100.43 14.22 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.734 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.15 19.2 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.74 2.293 . . . . 0.0 112.86 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -77.95 -46.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.9 p90 -83.76 -26.71 29.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 18.3 t -65.62 -45.2 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.218 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.42 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -39.9 64.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 47.9 m -66.61 -38.29 86.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.159 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -51.14 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.42 -37.34 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -81.18 -50.5 9.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.2 m-85 -59.43 -40.89 88.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -51.7 -29.43 18.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.04 25.68 9.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -137.6 41.83 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 282' ' ' ILE . 28.4 mt -49.58 -39.91 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.84 -34.64 64.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.988 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.47 -43.27 63.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 3.5 pp -71.33 -33.2 69.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.408 ' HE3' ' HB ' ' A' ' 299' ' ' ILE . 0.8 OUTLIER -61.99 -50.93 70.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.2 -27.85 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -32.89 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 111.237 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 60.8 m -93.71 -41.18 9.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.467 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -94.0 144.66 28.47 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.738 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 176.45 6.81 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.489 2.126 . . . . 0.0 112.285 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -98.62 30.45 3.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -41.15 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -131.67 150.11 52.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 143.19 74.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.53 137.49 25.38 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.478 2.119 . . . . 0.0 112.293 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.93 -41.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.56 -67.87 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.408 ' HB ' ' HE3' ' A' ' 286' ' ' MET . 29.1 mm -75.66 -41.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -47.23 -45.97 23.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.332 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -61.76 -35.65 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.585 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 306' ' ' VAL . 21.1 t80 -73.81 -35.88 64.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.721 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.4 ' CB ' ' CD1' ' A' ' 282' ' ' ILE . 2.2 mtp -70.3 -45.26 66.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.35 77.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 1.9 m -62.27 -33.53 74.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 302' ' ' TYR . 91.0 t -79.64 -23.96 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.64 -34.01 25.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.649 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.73 -30.45 6.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.268 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 305' ' ' THR . 0.5 OUTLIER 44.87 -165.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.313 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.79 160.32 30.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.76 84.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 28.5 m -159.49 73.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -152.01 -173.54 4.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.8 0.49 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 317' ' ' TYR . 50.3 Cg_exo -53.69 -21.86 21.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.613 2.209 . . . . 0.0 112.443 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.5 tp 74.86 57.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 15.5 m-85 -70.34 -30.9 67.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -58.55 -47.59 83.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -46.75 72.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 53.7 mt -55.64 -40.7 72.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -46.59 86.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -40.25 90.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 67.4 mt -57.85 -42.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -51.55 9.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 -49.92 75.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.48 -38.99 86.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.974 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.89 -27.92 65.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.31 -38.03 87.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -29.89 70.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.52 77.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.0 pt -99.59 24.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.257 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.36 26.55 37.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.658 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.29 164.56 24.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 146.01 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -127.69 129.48 47.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.62 -55.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -159.58 27.22 0.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -93.69 146.6 23.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.811 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.31 0.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.107 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.3 -20.46 65.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 70.85 8.73 6.64 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 7.1 m 73.23 -56.07 0.66 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.772 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.4 t 76.28 -54.27 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.369 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 6.3 m -151.72 31.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.229 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -37.57 16.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -87.28 146.38 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 155.04 -85.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -109.73 151.32 17.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.27 -71.31 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.26 98.83 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.0 166.03 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -165.96 -62.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.7 m -144.76 118.28 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 1.3 tt -71.27 -41.52 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.028 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 4.4 t -160.05 106.03 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -90.06 159.99 16.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -145.1 125.31 13.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.83 87.79 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.82 30.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 62.74 -79.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.002 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -69.34 112.47 5.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 17.3 tt -89.81 70.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.61 178.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 59.99 91.93 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 32.2 t -123.75 159.74 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -136.87 163.62 30.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -132.31 136.89 28.81 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.33 91.7 1.04 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.484 2.123 . . . . 0.0 112.339 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 135.98 49.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.576 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 15.1 t -130.2 29.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.766 0.317 . . . . 0.0 111.111 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.74 145.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.83 150.91 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 170.39 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -120.29 -41.75 2.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 7.0 m0 61.43 31.6 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.4 t -82.94 146.89 28.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.17 172.75 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.802 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 43.6 p -94.02 166.74 12.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.07 96.81 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.94 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 6.5 t -73.77 123.44 24.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -87.82 -40.05 14.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 60.21 100.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -144.35 167.35 22.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.59 153.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.94 -49.47 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 38.4 m -77.4 126.1 30.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -145.59 -56.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.2 m -97.16 142.97 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -166.82 114.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 p -147.47 168.18 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.96 -51.22 4.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.09 167.5 19.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -126.09 130.46 51.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.88 105.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.159 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.01 114.94 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.842 -179.978 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 10.2 t 60.52 32.11 20.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.963 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -118.35 -51.11 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 161.57 112.53 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 71.3 m -154.12 -52.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 14.5 m -79.49 -171.31 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 157.34 -166.34 33.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.421 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 81.42 9.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 0.0 110.973 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.99 55.56 5.66 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.615 2.21 . . . . 0.0 112.521 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.62 123.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t 63.74 139.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -82.77 83.56 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.62 15.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.02 78.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -166.69 118.75 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.55 86.77 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.33 -46.55 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 91.79 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -126.07 94.93 4.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.4 -175.48 5.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 152.15 38.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.23 97.66 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -159.61 149.2 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.42 100.78 12.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.98 31.74 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 126.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -104.36 -41.32 5.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.09 -51.53 66.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.973 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 7.4 m-85 -121.14 113.63 20.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.95 -178.38 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.66 128.16 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.18 57.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.572 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.92 153.3 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mt -115.22 137.15 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.418 HG21 ' CE2' ' A' ' 23' ' ' PHE . 48.8 pt -119.85 154.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.18 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.2 p -95.57 141.57 28.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.743 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.62 -162.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -37.52 27.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.5 -1.81 43.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 6.4 mttp 86.12 29.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' THR . 5.2 mttp -78.23 177.62 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.188 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -129.3 80.44 1.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -77.46 131.41 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -89.9 118.24 29.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.9 t -89.55 141.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -107.19 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.31 165.87 26.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.37 178.03 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.64 2.227 . . . . 0.0 112.285 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.3 pt -156.08 30.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.069 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.06 93.73 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 61.34 106.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.82 155.9 15.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.46 -86.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.84 61.95 1.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.67 113.22 3.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.335 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 40.6 t -177.78 -89.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.409 0.147 . . . . 0.0 110.882 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.413 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 53.3 mt -142.4 135.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 29.3 m-85 -143.4 156.31 44.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.483 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.85 157.5 34.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.26 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -140.79 159.72 41.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.4 ptp -101.01 37.85 1.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t30 59.99 30.58 20.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -85.19 -72.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 m -117.18 144.77 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.46 160.86 30.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m 60.5 95.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.83 47.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.05 -27.35 3.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.86 38.13 4.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.63 -59.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 52.63 74.35 0.79 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.144 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.57 -27.29 13.09 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.596 2.198 . . . . 0.0 112.618 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.2 m -149.86 165.31 32.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.41 152.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 130' ' ' ILE . 7.7 p -142.2 141.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -111.01 123.88 51.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.23 136.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.531 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.13 120.6 8.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.685 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.91 91.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.526 2.151 . . . . 0.0 112.472 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p 49.72 83.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.76 118.29 27.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.3 -85.52 0.12 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.36 -49.06 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.552 2.168 . . . . 0.0 112.306 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 tp -76.12 -31.1 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -68.59 -31.19 70.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.412 HG23 ' CD2' ' A' ' 202' ' ' TYR . 1.0 OUTLIER -71.28 -45.42 63.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.68 -42.21 74.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.78 -48.48 72.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.743 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.67 -39.67 92.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE1' ' HG2' ' A' ' 111' ' ' PRO . 2.6 m-85 -57.34 -53.9 52.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -75.31 -17.64 60.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.379 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -83.1 -47.46 11.63 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.89 -23.88 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.92 25.28 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 111.669 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -73.32 131.08 83.38 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.651 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.26 -29.01 89.21 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.488 2.125 . . . . 0.0 112.381 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.33 -31.96 43.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -49.96 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.94 -46.48 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -51.8 -48.35 63.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.179 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -38.96 92.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -53.22 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 46.6 mt -64.37 -26.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -75.12 -27.55 59.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -39.21 35.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.88 11.81 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER 70.37 2.03 3.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 167' ' ' TYR . 4.5 mt 44.71 28.39 0.33 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.388 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 48.8 36.61 8.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.8 t80 71.34 114.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.757 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.432 HD22 ' CZ ' ' A' ' 167' ' ' TYR . 6.3 tp -101.79 125.53 48.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.38 20.72 42.1 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.753 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.7 t -78.17 133.42 64.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.534 0.207 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.437 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -51.02 145.64 24.42 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.638 2.225 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 126.23 32.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.14 134.07 43.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -111.52 -40.7 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -176.31 46.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.91 155.01 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -134.53 175.49 20.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.044 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.91 154.71 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -145.81 141.74 28.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.34 126.66 50.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HE3' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.26 126.39 22.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.15 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 56.33 19.89 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.31 9.26 58.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.836 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -96.07 159.3 15.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.525 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 83.2 p -112.58 118.45 35.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.078 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.431 ' CE2' ' HE3' ' A' ' 121' ' ' LYS . 13.0 m-85 -110.44 129.07 55.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.668 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.23 125.08 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.711 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.444 ' CE1' ' HA3' ' A' ' 117' ' ' GLY . 23.7 p90 -134.53 159.59 40.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -130.02 141.7 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.453 ' CG1' ' HB ' ' A' ' 70' ' ' VAL . 5.5 mt -110.16 125.24 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.76 173.35 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.868 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.94 137.39 39.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.12 -25.61 27.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.42 ' CE2' HG12 ' A' ' 196' ' ' VAL . 59.8 m-85 64.71 -170.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -107.41 -104.28 2.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.665 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 m -97.14 157.71 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.413 ' HA ' HD23 ' A' ' 184' ' ' LEU . 1.2 m-20 -92.81 157.0 16.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -63.71 -30.14 71.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 5.2 pt20 -57.28 -42.81 82.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.668 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -64.65 -25.92 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.5 mt -72.63 -28.95 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.0 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -58.04 -46.26 85.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.18 -31.27 65.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.91 -21.45 65.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.409 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -93.95 -0.22 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 145' ' ' ASN . . . 90.9 43.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 61.54 19.97 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.488 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -162.1 107.87 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -58.27 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.9 m -111.79 161.63 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.69 -31.55 72.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -70.99 -50.39 34.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -59.19 -50.66 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.16 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -52.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.318 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.52 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.258 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -46.03 90.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.07 -35.35 76.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.8 p -57.91 -36.37 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.5 -47.23 50.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -49.52 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.77 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.08 -37.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.96 -36.47 74.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -38.04 84.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.79 -38.47 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 61.5 mt -58.16 -48.22 80.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.411 ' HG2' ' CE2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -68.12 -38.93 82.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.432 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 90.6 t80 -59.7 -41.42 90.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 28.2 pt -81.67 -27.19 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.112 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -75.93 -29.99 58.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.425 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.77 -17.1 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.22 6.24 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 72.04 47.16 0.31 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.886 0.374 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.405 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 11.1 m-85 -132.05 132.83 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 204' ' ' TYR . 29.3 m -128.99 169.31 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 168' ' ' ILE . 11.4 p-80 -151.68 -51.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.83 53.12 44.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.66 30.17 5.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.104 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 mt -87.29 105.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.026 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.26 29.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 139' ' ' GLN . . . 67.11 11.05 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.87 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 m -117.13 5.97 12.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -138.49 2.89 2.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.594 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.526 ' HB3' HG23 ' A' ' 193' ' ' VAL . 5.3 mt -109.59 130.2 55.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.098 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 137' ' ' ASP . 1.1 mt -137.53 147.54 45.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.094 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.403 ' CD2' ' HB ' ' A' ' 193' ' ' VAL . 24.8 mt -86.47 145.87 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 111.528 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 125.87 25.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.83 -49.46 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -58.1 -24.4 58.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.659 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.35 81.14 2.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.15 109.73 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.584 2.189 . . . . 0.0 112.291 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -144.55 -45.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -157.86 -167.7 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.526 HG23 ' HB3' ' A' ' 183' ' ' LEU . 7.6 p -109.75 148.1 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 9.2 m-85 -119.21 156.96 28.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.388 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.455 ' CD2' ' CD2' ' A' ' 175' ' ' HIS . 18.3 tp -106.61 115.77 30.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.428 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG12 ' CE2' ' A' ' 134' ' ' PHE . 30.5 m -126.95 167.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.296 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.7 t70 53.65 57.68 5.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.007 0.432 . . . . 0.0 110.707 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -59.68 -51.55 69.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.071 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.81 -35.83 4.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.94 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.56 31.65 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.503 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -71.82 59.44 0.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.76 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.412 ' CD2' HG23 ' A' ' 82' ' ' THR . 14.0 p90 -138.48 148.97 44.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.064 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.405 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 19.4 mtm105 -56.52 101.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.408 ' CD1' HG11 ' A' ' 174' ' ' VAL . 46.0 p90 -58.68 -23.41 59.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.172 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 15.4 t -104.68 103.29 39.49 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.943 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -52.1 176.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.439 2.093 . . . . 0.0 112.398 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.92 -34.81 3.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.85 14.53 58.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.062 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.6 171.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -137.82 -50.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -66.65 140.43 57.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.05 155.88 26.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.63 147.87 31.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.27 94.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.62 106.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -171.46 84.97 0.48 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 94.54 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.586 2.191 . . . . 0.0 112.337 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 20.84 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 53.71 47.25 24.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.084 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 58.0 m -91.71 -38.45 12.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -64.91 -45.97 83.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.47 172.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 122.51 -164.12 15.65 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.5 p -87.87 178.09 6.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.405 HG12 ' CG1' ' A' ' 271' ' ' VAL . 2.7 tt -116.16 -26.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -24.62 4.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.472 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.406 ' CG ' HG21 ' A' ' 246' ' ' ILE . 11.1 m-85 -144.41 38.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.07 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.2 t -83.99 138.9 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.8 t -91.8 148.29 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.34 -51.16 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.188 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.83 -43.91 86.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -72.39 -28.11 62.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.233 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -68.71 -28.04 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.64 12.86 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.44 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.08 23.29 63.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.747 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.81 119.52 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 110.94 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.437 ' CB ' ' HD3' ' A' ' 238' ' ' PRO . . . -57.67 -57.4 25.66 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 237' ' ' ALA . 52.2 Cg_exo -52.43 89.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.407 2.072 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 t -138.14 160.99 37.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -178.79 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.118 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.41 -42.76 93.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.569 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -35.21 73.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.5 mt -80.5 -34.49 35.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.98 -39.37 89.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.717 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.406 HG21 ' CG ' ' A' ' 227' ' ' PHE . 8.5 mt -62.9 -47.93 90.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.4 tp -64.79 -33.94 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.397 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.3 95.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.416 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 34.0 m-85 -78.57 -25.84 45.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.88 -34.45 65.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.583 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -46.57 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -63.57 -38.63 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 259' ' ' LEU . 1.5 pp0? -75.17 -31.06 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -82.38 -40.71 20.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.99 -31.19 56.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.98 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.3 m -103.07 0.51 32.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.412 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.71 95.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.519 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 61.12 161.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.472 ' CD2' ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -133.0 168.74 16.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.865 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.6 Cg_exo -68.44 59.14 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.863 2.375 . . . . 0.0 112.515 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 2.0 p90 179.15 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.445 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 4.1 tt0 -84.48 5.63 26.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.23 -54.1 49.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.4 m120 -130.05 -27.53 2.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 78.5 mt 71.26 12.62 6.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.27 -15.38 38.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.468 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -130.03 92.16 37.35 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.18 -4.12 13.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.883 2.389 . . . . 0.0 112.662 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -55.34 -50.34 69.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.277 . . . . 0.0 111.079 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.7 p90 -84.09 -26.03 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 40.8 t -62.49 -43.04 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.298 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -75.52 -40.81 56.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -48.08 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -45.31 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.185 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.416 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -58.74 -42.87 89.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 17.3 mt -72.56 -29.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.497 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -75.41 -52.1 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.428 ' CG ' HD11 ' A' ' 285' ' ' LEU . 29.8 m-85 -60.47 -39.46 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -26.18 66.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.948 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -120.2 23.78 10.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.66 53.43 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.074 0.464 . . . . 0.0 110.744 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 303' ' ' MET . 2.6 mm -48.52 -41.79 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.339 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -64.26 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.513 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.2 p -70.38 -31.98 69.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.428 HD11 ' CG ' ' A' ' 278' ' ' TYR . 1.2 tt -66.41 -51.4 57.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.14 -34.63 76.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -82.79 -33.34 27.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.313 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -54.85 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.467 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 85.7 m -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.286 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 290' ' ' PHE . 3.7 m-85 -108.36 146.29 33.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 -172.42 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.43 30.87 3.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 -35.28 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.68 91.66 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.79 108.02 1.06 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.23 127.21 23.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.468 2.112 . . . . 0.0 112.256 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -124.1 -40.51 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -47.5 85.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 303' ' ' MET . 19.2 mm -76.79 -48.74 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.32 -44.72 8.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.615 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.22 97.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.382 . . . . 0.0 110.814 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.421 ' CE2' HD11 ' A' ' 324' ' ' LEU . 18.5 t80 -69.59 -43.5 72.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.018 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.517 ' HG2' ' O ' ' A' ' 299' ' ' ILE . 69.1 mmm -66.54 -39.02 88.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.764 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.83 -40.36 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.273 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -32.34 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 14.0 t -71.91 -24.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.096 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -75.7 -37.45 59.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.71 -12.49 22.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -52.86 140.86 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.968 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.58 -58.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.72 -48.49 15.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.45 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.3 -58.39 7.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 179.84 -67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -117.85 156.47 49.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.15 -178.19 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.276 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.87 42.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.411 ' CE2' ' HG2' ' A' ' 166' ' ' GLU . 20.1 m-85 -57.06 -36.16 70.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.021 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -69.2 -33.88 74.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.74 -47.42 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.409 HD22 ' CE2' ' A' ' 302' ' ' TYR . 25.9 mt -53.29 -44.37 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -59.15 -32.65 70.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.97 -30.47 55.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.98 -50.01 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.343 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 302' ' ' TYR . 8.4 mt -79.96 -26.65 39.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.58 -48.89 10.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.733 0.301 . . . . 0.0 111.107 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.76 -34.29 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.6 56.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.583 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . . . . . . . . . 29.4 mt -57.23 -32.55 66.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -70.08 -29.62 66.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.63 63.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.8 -28.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.215 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.11 22.92 5.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m -97.67 164.52 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -138.63 111.85 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.81 92.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.97 -74.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.957 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -134.4 22.94 3.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.692 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.81 135.62 41.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.709 0.29 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.407 ' O ' HD13 ' A' ' 341' ' ' LEU . 0.2 OUTLIER 177.76 -15.31 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.53 -24.49 8.22 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.653 0.263 . . . . 0.0 111.542 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 339' ' ' LEU . 0.9 OUTLIER 67.75 12.29 8.78 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.419 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.1 m 51.46 83.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.888 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 15.2 m -151.74 88.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 14.6 m -83.6 56.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.57 31.65 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -143.54 85.52 1.84 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.12 73.48 1.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 137.52 102.41 0.6 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.408 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -109.91 -30.45 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -92.84 132.79 36.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -149.18 176.97 10.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -177.88 3.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 4.4 t -150.82 80.69 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.74 151.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.066 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 1.3 t -120.03 -41.93 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -104.68 116.74 32.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -31.84 15.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.66 176.9 8.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.67 93.92 5.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.97 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.37 145.74 32.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.41 96.67 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.43 131.84 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 31.42 5.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.52 74.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 30.9 t -110.4 -28.93 8.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 63.44 116.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -107.48 99.67 29.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.71 -49.02 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.475 2.117 . . . . 0.0 112.358 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 100.38 -160.53 19.1 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 16.9 m -152.25 149.37 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.132 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 44.83 39.34 3.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.395 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.71 116.65 33.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 4.9 m 60.19 83.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -112.67 135.44 53.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -144.31 165.53 27.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.12 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -85.36 -49.18 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 17.6 m 60.71 95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -168.48 162.45 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 67.4 p -77.52 122.19 24.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 93.68 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.33 95.61 3.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -160.7 174.88 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 3.5 tp -119.74 114.74 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.39 144.59 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.95 95.15 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.44 80.65 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.778 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 37.0 m 61.11 179.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.3 ttm-85 -159.29 -48.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.2 t -160.24 -45.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -69.69 116.23 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -34.09 64.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -128.33 104.51 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.57 126.58 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -147.97 -49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 8.7 mttm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.917 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 40' ' ' GLY . 17.9 t -101.54 108.44 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -35.8 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.508 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 150.34 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG12 ' CG ' ' A' ' 38' ' ' LYS . 18.6 mt -103.25 142.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 11.8 pt -116.76 143.44 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 36' ' ' GLU . 11.8 p -102.33 141.76 34.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.137 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 10.3 m-20 -83.03 -144.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.88 56.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 109.698 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.46 35.6 26.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.571 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -139.33 -8.46 1.3 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.36 177.75 9.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.157 0.503 . . . . 0.0 111.692 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' HG22 ' A' ' 30' ' ' THR . 7.7 mt-10 -155.25 92.73 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 9.2 m95 -96.64 144.83 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.408 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -89.35 125.81 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.852 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.32 131.81 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -106.0 -121.04 4.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.477 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.86 154.61 44.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.709 0.29 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.32 175.19 7.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.516 2.144 . . . . 0.0 112.335 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 pt -141.61 30.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -85.19 124.08 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.605 ' O ' HG12 ' A' ' 70' ' ' VAL . 68.5 m-85 -146.29 153.3 40.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.44 135.93 36.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.05 137.67 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.624 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 25.3 t0 -124.39 151.18 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.6 ttp -89.81 52.83 2.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -149.47 148.23 29.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.41 34.74 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.43 176.33 7.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.72 134.93 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t 63.42 125.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.38 -52.74 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.3 -133.94 52.09 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.65 29.71 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -105.68 31.98 4.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . -137.82 99.3 9.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.04 42.5 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.709 2.273 . . . . 0.0 112.66 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -149.93 150.28 31.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 110.779 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 131' ' ' MET . 15.8 m -122.02 146.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.855 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 52' ' ' TYR . 7.5 p -131.95 131.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.599 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -105.39 121.09 43.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.215 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 128' ' ' PHE . 2.8 t -113.12 152.02 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -140.71 136.26 16.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.68 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 112.375 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.3 t 62.28 122.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -171.51 159.9 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.88 75.0 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 82' ' ' THR . . . 179.82 -75.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.46 -61.91 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.64 ' HG ' HD23 ' A' ' 84' ' ' LEU . 6.3 tp -60.48 -33.18 72.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.58 -31.93 72.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 78' ' ' GLY . 22.3 p -75.07 -41.61 58.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.8 -38.48 64.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.5 mm? -64.24 -51.68 62.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -56.78 -51.81 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 198' ' ' TYR . 19.6 t80 -64.27 -29.79 70.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.2 m-85 -69.57 -50.7 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -25.38 64.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -87.67 -47.43 8.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -88.84 19.41 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' CD ' ' HB2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -77.59 114.12 38.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.467 0.175 . . . . 0.0 110.649 179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.25 -26.19 7.93 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.503 2.136 . . . . 0.0 112.636 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.402 ' HB2' ' CD ' ' A' ' 92' ' ' LYS . 8.2 mm-40 -75.4 -40.44 57.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -79.33 -43.43 23.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 51.2 mt -61.25 -52.87 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -42.28 64.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -43.23 67.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.964 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -53.89 37.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 96' ' ' ILE . 40.2 mt -56.66 -34.23 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -74.88 -27.7 60.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 m -71.62 -38.53 70.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -6.53 19.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.983 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.19 27.66 16.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.45 ' CD1' HD13 ' A' ' 108' ' ' LEU . 59.7 mt -51.83 -32.52 32.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.1 tttt 46.74 40.91 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.658 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 25.1 t80 -176.86 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.347 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 96' ' ' ILE . 13.4 tp 59.96 158.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.725 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 164' ' ' ILE . . . -110.66 32.98 6.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.624 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.879 HG21 ' CE2' ' A' ' 167' ' ' TYR . 23.3 t -112.6 126.6 28.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.529 0.204 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.69 161.8 23.63 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.305 2.003 . . . . 0.0 112.025 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 115.43 27.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.06 131.95 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 9.3 m95 -109.89 -40.91 4.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -175.03 46.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.762 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -135.4 162.0 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.82 174.49 24.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.5 mt -147.84 150.61 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.064 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 121.85 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.42 127.86 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -138.29 126.16 22.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.97 20.84 4.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.68 62.07 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.792 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -96.13 129.86 43.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.784 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.64 118.77 30.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.084 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.454 ' O ' HD23 ' A' ' 118' ' ' LEU . 10.0 m-85 -101.42 122.56 43.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -106.51 130.89 54.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.442 ' CZ ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 p90 -140.27 168.62 19.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.104 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.681 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.8 tmm? -142.73 138.96 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 130' ' ' ILE . 1.5 mp -94.09 141.8 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -122.09 164.21 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.658 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.83 -69.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -148.09 -78.24 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 184' ' ' LEU . 1.4 m-85 64.19 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.916 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -117.8 -101.66 2.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.615 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.8 t -102.02 166.33 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.856 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.583 ' HB3' HD22 ' A' ' 184' ' ' LEU . 13.1 p30 -97.95 161.68 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.962 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -58.53 -25.14 62.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.56 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.56 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -55.46 -37.95 68.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.82 70.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 185' ' ' LEU . 14.1 mt -76.35 -26.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.424 ' HA ' ' CE1' ' A' ' 149' ' ' PHE . 36.3 t80 -56.21 -44.74 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.09 -30.35 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.24 -14.09 62.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.511 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -94.6 -1.0 54.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.248 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 92.56 44.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.962 0.505 . . . . 0.0 110.395 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.75 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.591 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -170.72 121.46 0.58 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.918 0.39 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 254' ' ' TRP . 8.6 m-85 -61.33 177.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.521 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.6 t -113.41 160.69 18.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.788 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -36.95 74.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -70.69 -48.8 52.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.7 p -58.69 -56.2 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.168 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.556 HG21 ' HG ' ' A' ' 255' ' ' LEU . 48.9 t -54.35 -53.5 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 155' ' ' LEU . 15.2 mt -57.54 -45.67 84.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.993 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -65.67 -52.9 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.81 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' A' ' 193' ' ' VAL . 5.7 mt -62.53 -34.06 76.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.743 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.562 ' HB3' HD13 ' A' ' 324' ' ' LEU . 34.1 m -58.83 -46.41 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 325' ' ' LEU . 86.2 mt -61.8 -43.81 98.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -34.02 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.838 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.4 mt -78.96 -36.62 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.149 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.593 HD13 ' HA ' ' A' ' 321' ' ' ARG . 3.4 mt -55.35 -44.12 75.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -26.44 68.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.453 HG12 ' HA3' ' A' ' 109' ' ' GLY . 5.0 mt -72.74 -46.55 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 243' ' ' ASP . 28.3 mt -59.85 -27.29 66.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -30.37 60.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.879 ' CE2' HG21 ' A' ' 110' ' ' VAL . 91.1 t80 -77.15 -56.09 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.436 HG21 ' CE1' ' A' ' 198' ' ' TYR . 41.6 pt -55.13 -29.35 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -42.37 90.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -16.87 61.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 89' ' ' ARG . 0.6 OUTLIER -98.11 2.24 48.41 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.177 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 74.75 40.25 0.39 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.941 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -138.01 127.28 24.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.695 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 202' ' ' TYR . 14.9 m -142.26 169.34 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.391 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.682 ' NE2' HG23 ' A' ' 228' ' ' THR . 1.9 t-160 67.54 43.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.46 -17.17 52.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.678 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.73 82.31 0.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.0 110.993 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.689 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mp -82.04 108.49 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 8.2 tttt -149.32 -176.5 5.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -84.69 -0.26 52.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.417 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.63 5.72 12.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.324 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.759 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.1 m-80 -125.12 -11.07 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.328 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.9 mt -108.32 125.62 51.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.949 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.754 HD23 ' C ' ' A' ' 183' ' ' LEU . 1.2 mt -129.58 154.53 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.354 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 1.058 HD11 HD11 ' A' ' 141' ' ' ILE . 6.1 mt -100.07 149.2 23.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.8 133.37 55.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 133' ' ' ARG . 23.5 t80 -75.25 -66.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.808 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -22.75 41.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.836 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.87 80.94 41.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 101.74 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.565 2.177 . . . . 0.0 112.199 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -177.5 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.417 ' HB3' ' CE2' ' A' ' 107' ' ' TYR . 8.6 mp0 -108.22 164.03 12.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.78 HG21 HD21 ' A' ' 138' ' ' LEU . 10.8 p -132.05 147.79 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 1.4 m-85 -123.14 156.73 34.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.709 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 178' ' ' ILE . 26.1 tp -107.28 115.93 31.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.696 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 182' ' ' ASN . 12.4 m -86.86 179.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.254 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.47 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 26.3 m-85 -145.47 -57.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -58.43 -23.69 54.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.696 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.56 33.87 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 175' ' ' HIS . . . -131.08 -90.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.053 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -146.16 118.87 8.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.752 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -94.82 47.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 225' ' ' ILE . 1.3 t -127.75 -52.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.722 0.296 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.619 HG12 HG11 ' A' ' 271' ' ' VAL . 2.1 tt -179.09 38.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.53 63.03 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.504 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.428 ' CE1' ' HG3' ' A' ' 262' ' ' GLU . 30.3 m-85 76.34 29.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.745 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 ' NE2' ' A' ' 175' ' ' HIS . 31.0 m -83.72 145.2 28.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 8.2 t -59.24 141.28 54.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mt -61.01 -37.22 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -43.88 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -59.12 -30.44 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.9 -32.0 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.729 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -96.17 12.84 29.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.298 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 55.79 28.7 53.12 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.5 t -90.79 110.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.56 151.88 0.1 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.79 154.86 8.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.531 2.154 . . . . 0.0 112.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 174' ' ' VAL . 1.3 t -100.55 123.57 44.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 mtm105 -144.87 -50.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -17.66 60.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.31 -33.65 66.01 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.544 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.759 ' HB3' HD22 ' A' ' 165' ' ' LEU . 2.8 m-20 -60.39 -33.12 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.639 HD21 ' CE1' ' A' ' 317' ' ' TYR . 10.4 mt -80.66 -31.59 36.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.841 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.52 -40.91 93.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 243' ' ' ASP . 5.2 mt -61.21 -41.29 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.033 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.437 HD23 ' OH ' ' A' ' 302' ' ' TYR . 54.5 tp -70.37 -39.71 74.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -59.36 -45.86 94.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.545 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -78.61 -25.62 45.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.458 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.83 -41.41 82.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.411 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.0 -48.19 81.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.4 mp -65.77 -31.72 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.295 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.425 ' CB ' HD11 ' A' ' 259' ' ' LEU . 2.6 tm0? -70.4 -43.61 69.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.011 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 15.1 m0 -82.23 -42.91 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.556 ' HG ' HG21 ' A' ' 154' ' ' VAL . 25.5 mt -67.08 -36.82 82.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.27 -21.43 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.32 88.94 0.27 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 62.41 144.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.873 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.15 165.77 33.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 41.3 Cg_endo -67.99 64.41 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.43 2.087 . . . . 0.0 112.607 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.873 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -178.9 -40.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.888 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -113.11 25.35 11.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.356 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -58.54 6.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.7 m120 -129.1 -25.87 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.327 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.574 HD22 HG23 ' A' ' 225' ' ' ILE . 41.9 mt 74.33 11.11 4.19 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -85.12 -15.83 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.597 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.472 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 4.4 m-20 -133.89 74.72 68.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 49.1 Cg_exo -56.04 -16.12 15.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.882 2.388 . . . . 0.0 112.982 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -49.99 -50.44 47.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.476 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.9 p90 -84.13 -27.05 28.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.383 . . . . 0.0 110.785 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 225' ' ' ILE . 18.3 t -60.69 -35.49 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.55 -44.15 44.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.22 -47.62 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -64.4 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -46.76 78.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.6 mt -68.65 -34.7 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -50.72 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -61.89 -37.06 83.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -54.58 -29.33 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -116.75 22.28 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -136.23 40.3 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.734 HD13 ' CB ' ' A' ' 303' ' ' MET . 27.9 mt -49.26 -40.05 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.5 64.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -35.98 66.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 286' ' ' MET . 2.7 pp -80.02 -41.58 25.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 15.0 ttm -63.0 -32.98 74.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.762 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.27 -32.59 33.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -82.79 -27.15 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.289 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.6 m -93.55 -41.28 9.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.349 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -107.57 160.39 26.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.13 167.66 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.63 37.93 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -113.09 33.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 60.72 30.33 19.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -80.09 -50.77 1.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 295' ' ' LYS . 42.2 Cg_exo -56.86 -162.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.515 2.144 . . . . 0.0 112.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.39 -45.64 1.13 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -44.64 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 303' ' ' MET . 29.6 mm -77.24 -46.76 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.055 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.723 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -44.87 -49.57 10.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.526 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.8 OUTLIER -58.87 -40.35 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.663 ' O ' HG23 ' A' ' 306' ' ' VAL . 14.5 t80 -69.88 -42.62 73.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.1 mtp -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.317 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.03 -50.35 74.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.556 HG23 HD23 ' A' ' 316' ' ' LEU . 73.6 m -57.48 -37.79 73.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 302' ' ' TYR . 31.6 t -72.3 -24.75 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -31.9 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.376 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.48 -12.98 23.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.694 ' O ' HD21 ' A' ' 309' ' ' LEU . 52.7 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.777 0.24 . . . . 0.0 112.422 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 305' ' ' THR . 1.5 tp 63.2 32.28 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.639 ' CE1' HD21 ' A' ' 244' ' ' LEU . 3.2 m-85 -66.05 -42.08 89.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -58.5 -32.91 69.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -77.4 -47.45 19.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.778 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.6 mt -55.19 -43.02 74.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.593 ' HA ' HD13 ' A' ' 162' ' ' LEU . 1.8 ttt180 -58.55 -37.82 76.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.02 -33.36 73.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 320' ' ' LEU . 64.9 mt -61.38 -49.43 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 302' ' ' TYR . 12.2 mt -80.51 -23.63 39.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.317 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.868 ' HA ' HD11 ' A' ' 159' ' ' LEU . 7.3 tt -82.44 -35.15 27.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.905 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -68.76 -42.51 77.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.21 -26.52 56.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.556 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.697 HD11 ' CD1' ' A' ' 159' ' ' LEU . 28.1 mt -53.84 -29.7 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.21 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.245 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.8 pt -97.51 24.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.33 40.74 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.632 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.9 t -89.62 178.51 6.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 151.89 30.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.51 89.48 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.77 0.319 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.12 114.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.85 -26.43 5.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -76.17 134.54 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.001 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 36' ' ' GLU . 37.9 mt -105.28 145.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.764 HD12 ' CE1' ' A' ' 128' ' ' PHE . 25.2 pt -119.5 154.49 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.263 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 68.4 p -97.93 141.27 31.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.0 -162.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.94 -41.95 34.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 109.775 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.35 -2.21 33.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.653 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 86.96 27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -72.79 177.41 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.141 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 28' ' ' ILE . 31.0 mt-10 -128.77 79.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.873 0.368 . . . . 0.0 110.597 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 80.4 m95 -73.19 128.65 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.94 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -91.9 119.18 31.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.62 150.39 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.45 -116.28 2.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 41' ' ' LEU . 4.0 mm? -105.03 158.85 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.733 0.302 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 56.2 Cg_endo -70.48 155.1 64.25 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.559 2.173 . . . . 0.0 112.373 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 HG22 ' A' ' 51' ' ' ILE . 7.2 pt -145.63 31.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.9 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.465 HG22 HG13 ' A' ' 43' ' ' ILE . 2.2 mt -85.43 106.92 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 70.6 m-85 -131.37 171.33 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.978 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 151.41 23.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.43 153.28 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.672 ' CB ' HG13 ' A' ' 62' ' ' VAL . 28.5 t70 -146.79 140.8 26.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.6 ttp -85.17 57.39 4.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -59.83 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 m 59.39 31.95 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 m -139.83 -66.83 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -176.45 134.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.97 167.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.672 HG13 ' CB ' ' A' ' 55' ' ' ASP . 33.0 t -105.92 -31.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.19 -116.36 3.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -160.87 31.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -138.66 -77.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.89 77.56 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.54 48.87 2.92 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.715 2.276 . . . . 0.0 112.716 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.69 170.14 19.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 131' ' ' MET . 15.6 m -143.1 146.04 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 130' ' ' ILE . 11.5 p -139.21 118.78 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CG ' HG12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -105.18 121.94 44.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.685 HG22 ' CB ' ' A' ' 128' ' ' PHE . 2.8 t -113.14 151.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' HG3' HD22 ' A' ' 80' ' ' LEU . 11.5 mt-10 -141.21 122.25 8.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.19 96.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.336 2.024 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.75 178.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.89 79.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -135.98 32.06 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.26 -178.52 28.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.38 10.99 3.43 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.791 2.327 . . . . 0.0 112.97 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.428 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.5 tp -60.96 -32.96 72.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.43 -39.21 92.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 72.1 p -69.72 -32.05 70.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 198' ' ' TYR . 11.7 tp10 -75.79 -40.5 55.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.6 mm? -65.46 -42.54 92.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -62.08 -51.7 66.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 168' ' ' ILE . 16.7 t80 -59.1 -40.05 84.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.967 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.0 m-85 -56.32 -60.06 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.357 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.07 -17.65 63.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -75.87 -47.53 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.97 -25.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.967 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -88.74 23.63 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -76.73 138.54 66.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.536 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.22 -27.8 58.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.513 2.142 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -79.45 -47.36 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.5 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.6 mt -55.84 -45.68 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -48.65 -38.24 20.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -74.2 -35.15 63.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.672 HG23 ' H ' ' A' ' 106' ' ' LYS . 40.9 mm -66.55 -41.46 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -74.92 -27.6 60.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.59 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' LYS . 25.2 p -84.37 -28.47 26.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.351 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.4 ' CB ' ' HG ' ' A' ' 105' ' ' LEU . 2.5 mmt180 -107.11 -7.23 16.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.844 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm 58.7 21.83 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.802 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 108' ' ' LEU . 41.8 mt -54.69 -41.56 70.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.986 0.422 . . . . 0.0 110.755 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.672 ' H ' HG23 ' A' ' 100' ' ' ILE . 11.5 mtpt 52.35 27.08 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.562 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -177.57 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.691 0.281 . . . . 0.0 111.381 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 105' ' ' LEU . 14.1 tp 69.92 -65.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.824 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.92 1.55 10.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.98 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.524 HG23 ' HG ' ' A' ' 108' ' ' LEU . 22.4 t -89.8 138.65 27.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 111.069 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.83 153.22 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.24 115.62 28.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.22 121.78 36.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -103.86 -40.67 6.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.05 -176.78 46.48 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.66 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -132.58 178.71 6.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -163.36 173.24 39.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.423 HD23 ' HG2' ' A' ' 127' ' ' ARG . 1.1 mt -137.06 159.92 40.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.726 0.298 . . . . 0.0 110.746 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -144.32 119.43 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.023 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.71 124.62 49.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.15 126.2 22.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.0 t30 55.43 20.83 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.422 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.57 -3.55 61.26 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.903 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -96.14 129.09 43.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -89.07 140.78 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -125.75 123.56 39.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.423 ' HG2' HD23 ' A' ' 118' ' ' LEU . 10.7 mtp85 -102.56 125.13 49.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.764 ' CE1' HD12 ' A' ' 29' ' ' ILE . 23.9 p90 -140.43 162.47 35.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.626 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -131.41 147.18 52.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 70' ' ' VAL . 9.1 mm -98.73 119.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.9 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -120.54 171.94 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.081 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -71.28 145.88 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -64.32 134.17 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.577 ' CE2' HG11 ' A' ' 196' ' ' VAL . 72.9 m-85 -110.17 154.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.722 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -85.39 -107.84 0.69 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.368 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 m -111.24 118.71 36.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.831 0.348 . . . . 0.0 110.672 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -51.22 160.98 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.658 HD13 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -66.53 -21.7 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.679 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.769 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -65.24 -44.7 87.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.027 0.441 . . . . 0.0 109.813 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.88 66.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.191 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.658 HD12 HD13 ' A' ' 138' ' ' LEU . 13.8 mt -74.81 -25.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -62.41 -49.03 77.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.521 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.85 -31.11 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.75 -25.43 67.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.587 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -108.95 10.4 26.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.01 52.71 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.047 0.451 . . . . 0.0 110.454 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 23.6 mtpt 61.14 19.66 10.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.588 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -136.15 -175.56 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.045 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -137.13 -172.71 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.01 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.0 m -119.12 149.74 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -57.82 -30.57 65.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.432 ' HB3' HD12 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -74.89 -34.83 62.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -48.38 35.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG21 ' HG ' ' A' ' 255' ' ' LEU . 59.4 t -60.08 -54.19 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 16.5 mt -58.87 -49.7 76.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -59.86 -51.27 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 193' ' ' VAL . 15.4 mt -59.91 -33.42 71.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.519 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 247' ' ' LEU . 0.1 OUTLIER -58.99 -45.57 90.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.69 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 325' ' ' LEU . 58.2 mt -61.74 -45.78 92.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.75 -48.79 79.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.781 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HG12 ' A' ' 178' ' ' ILE . 11.9 mt -65.18 -40.21 88.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 324' ' ' LEU . 7.4 mt -58.07 -33.47 69.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.21 -32.7 72.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.788 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.74 -44.54 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 178' ' ' ILE . 72.2 mt -55.45 -40.44 71.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.67 -38.46 91.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.067 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.672 ' CE2' HD21 ' A' ' 108' ' ' LEU . 80.5 t80 -66.56 -52.05 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 175' ' ' HIS . 38.0 pt -62.37 -27.16 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -80.71 -34.48 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -16.75 62.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.676 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 2.44 49.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.428 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 12.9 mt-10 78.09 43.48 0.09 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.851 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.3 122.21 15.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.846 HG13 ' CD1' ' A' ' 204' ' ' TYR . 18.8 m -121.92 142.8 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.209 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.505 ' CE1' ' CD1' ' A' ' 198' ' ' TYR . 0.5 OUTLIER 177.74 82.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.82 79.57 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.817 ' OD1' HD21 ' A' ' 195' ' ' LEU . 17.1 p-10 -103.07 22.46 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.649 0.261 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.622 HG12 HG21 ' A' ' 161' ' ' ILE . 3.0 mp -64.1 91.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 171.69 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.769 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.86 -6.31 51.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.538 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.71 1.79 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -123.87 -9.61 7.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.102 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.63 128.83 55.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.4 mt -135.46 149.15 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.756 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 193' ' ' VAL . 50.2 mt -86.52 147.83 25.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.281 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -65.8 125.75 26.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -94.95 -42.81 8.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -30.25 66.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.467 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -141.22 69.24 27.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.432 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.51 108.3 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.5 -45.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.082 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -149.62 -166.52 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 111.205 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.9 p -109.91 148.24 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 14.4 m-85 -116.85 156.93 26.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.351 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.817 HD21 ' OD1' ' A' ' 177' ' ' ASP . 22.3 tp -109.14 115.84 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 134' ' ' PHE . 13.1 m -118.5 145.93 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.15 100.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.252 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.505 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 2.9 m-85 -86.65 -20.27 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 65.21 14.64 59.71 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -146.61 -66.35 0.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.38 87.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.295 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -131.0 149.01 52.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -95.82 82.82 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.846 ' CD1' HG13 ' A' ' 174' ' ' VAL . 41.5 p90 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.612 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 226' ' ' GLU . 2.0 m 61.29 162.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.894 HG23 HD22 ' A' ' 265' ' ' LEU . 3.7 tp -130.13 15.87 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.499 ' HA ' HD21 ' A' ' 265' ' ' LEU . 43.8 tt0 -74.55 -34.82 63.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 226' ' ' GLU . 73.0 m-85 -157.59 30.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -76.11 132.62 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 172.25 10.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -53.6 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -42.26 90.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.26 -32.79 74.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.216 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.5 -36.53 84.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.724 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -101.67 12.98 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.392 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.31 31.45 59.55 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.801 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.7 t -90.6 113.28 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.106 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.05 154.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.78 158.68 56.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.578 2.186 . . . . 0.0 112.254 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.57 ' O ' HG11 ' A' ' 174' ' ' VAL . 18.9 m -67.22 113.09 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -134.59 -57.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -87.58 -24.87 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.6 -32.11 64.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.563 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -38.12 74.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.444 HD12 ' CD1' ' A' ' 309' ' ' LEU . 57.9 mt -80.6 -33.48 35.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.57 -37.81 79.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.44 -39.67 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.875 HD23 ' OH ' ' A' ' 302' ' ' TYR . 49.6 tp -64.36 -45.43 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.42 92.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.439 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 25.4 m-85 -78.81 -25.7 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.67 -43.25 84.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.279 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.41 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.17 -49.62 76.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.019 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.538 HD11 ' SD ' ' A' ' 303' ' ' MET . 3.6 mt -63.99 -28.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.364 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.2 tm0? -80.12 -40.19 27.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.002 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 36.2 m0 -82.29 -30.85 30.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.439 ' HG ' HG21 ' A' ' 154' ' ' VAL . 28.9 mt -79.79 -44.04 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.05 0.62 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.449 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.71 97.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.5 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 64.07 154.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 1.008 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -137.77 171.28 8.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.56 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 45.3 Cg_endo -68.89 61.73 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.411 2.074 . . . . 0.0 112.633 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 1.008 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.6 p90 178.12 -37.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -98.09 22.23 9.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.437 179.205 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.82 -55.83 6.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -132.22 -26.41 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.482 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.894 HD22 HG23 ' A' ' 225' ' ' ILE . 66.0 mt 71.93 12.27 6.11 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.208 0.528 . . . . 0.0 109.69 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -84.77 -14.43 48.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.456 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -134.92 101.24 11.61 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.52 19.27 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.724 2.283 . . . . 0.0 112.724 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -45.67 17.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -82.09 -26.46 33.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.617 HG11 ' CD1' ' A' ' 225' ' ' ILE . 11.3 t -61.72 -44.22 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -71.47 -44.34 64.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -66.51 -41.25 89.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 278' ' ' TYR . 75.5 m -63.17 -40.5 97.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -61.98 -45.91 91.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.044 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.5 mt -70.88 -46.08 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -59.59 -51.61 69.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.834 ' CD1' HD12 ' A' ' 285' ' ' LEU . 16.3 m-85 -60.43 -31.87 70.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -59.43 -33.26 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.407 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.19 23.07 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.868 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -139.16 37.91 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.609 HG21 ' CG ' ' A' ' 304' ' ' GLU . 7.0 mm -47.09 -43.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -47.74 36.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.073 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.7 -33.61 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.2 tt -64.33 -43.63 94.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 3.5 mmt -65.48 -32.52 74.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.984 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.75 -27.03 31.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.139 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -54.84 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.34 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 252' ' ' ILE . 68.2 m -76.42 -41.22 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.52 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.84 158.71 34.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 177.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.612 2.208 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -108.01 -66.24 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -59.69 -35.12 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -60.27 143.52 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -63.8 148.86 94.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.11 158.83 55.23 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -94.2 20.84 45.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.568 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.35 9.2 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.526 0.203 . . . . 0.0 111.402 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.704 HG22 ' CG ' ' A' ' 303' ' ' MET . 34.2 mm -79.52 -40.76 21.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.446 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -48.04 -45.77 32.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.312 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -59.85 -39.77 86.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.63 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.875 ' OH ' HD23 ' A' ' 247' ' ' LEU . 70.4 t80 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.704 ' CG ' HG22 ' A' ' 299' ' ' ILE . 1.4 mtp -64.73 -45.72 85.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.595 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.609 ' CG ' HG21 ' A' ' 282' ' ' ILE . 2.1 mt-10 -58.13 -51.89 67.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.846 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.7 p -58.07 -53.59 56.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 302' ' ' TYR . 61.1 t -56.32 -24.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.154 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -43.1 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.78 -11.98 60.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.689 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' A' ' 244' ' ' LEU . 15.9 mt . . . . . 0 C--O 1.232 0.148 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.222 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.784 0.244 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.8 tp -140.13 17.64 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -60.07 -31.63 70.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.75 -46.48 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.779 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.49 -40.2 90.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.906 ' HA ' HD12 ' A' ' 323' ' ' ILE . 34.6 mt -55.55 -48.15 75.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.476 ' HG2' HD22 ' A' ' 159' ' ' LEU . 7.7 ttm105 -57.46 -34.56 69.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.876 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -38.52 71.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 320' ' ' LEU . 37.5 mt -57.07 -47.91 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 158' ' ' SER . 30.6 mt -79.78 -22.0 43.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.462 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 325' ' ' LEU . 7.2 tt -82.68 -40.49 20.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.688 0.28 . . . . 0.0 111.109 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.92 -39.42 90.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.94 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -60.32 -26.34 63.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.5 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 69.9 mt -48.44 -27.99 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -81.28 -31.08 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.73 -26.35 65.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.297 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 151' ' ' ARG . 10.6 pt -106.97 22.75 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 53.25 45.69 64.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.738 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.7 t -118.33 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.57 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.959 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.79 133.85 51.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.67 127.1 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.98 22.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -58.87 139.84 56.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' A' ' 38' ' ' LYS . 21.7 mm -100.34 136.39 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.2 pt -117.89 154.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.088 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 3.1 t -101.81 136.94 40.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -93.77 -164.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -41.37 43.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -75.25 -6.63 50.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.429 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 4.2 tttp 89.59 27.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -75.16 178.36 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.154 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.63 79.6 1.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.39 . . . . 0.0 110.591 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.452 ' HB2' HG13 ' A' ' 29' ' ' ILE . 80.5 m95 -76.51 136.73 39.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.952 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -96.88 129.14 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.95 128.54 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.7 -122.58 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 53' ' ' LEU . 3.9 mm? -100.57 154.42 37.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 61.4 Cg_endo -73.1 105.49 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.615 2.21 . . . . 0.0 112.362 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -98.54 -28.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.558 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -111.83 137.53 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 44.2 m-85 -143.74 172.22 13.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.804 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 66' ' ' ALA . 25.2 mt -69.65 158.26 35.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.68 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -124.45 152.37 43.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.48 156.79 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.4 ptp -97.47 26.42 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.29 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 p -134.45 35.74 3.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.6 30.91 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -131.26 179.07 6.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -99.13 29.89 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' A' ' 38' ' ' LYS . 24.0 t 68.3 -68.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.51 179.03 21.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.559 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -92.54 48.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.482 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -158.38 -69.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.695 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . 63.27 139.32 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.93 -4.74 13.51 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.667 2.245 . . . . 0.0 112.816 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 11.8 m -149.65 157.11 42.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.564 HG13 ' CB ' ' A' ' 133' ' ' ARG . 29.7 m -120.27 144.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 HD13 ' A' ' 130' ' ' ILE . 11.4 p -119.39 121.11 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -98.07 116.19 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.496 HG22 ' CB ' ' A' ' 128' ' ' PHE . 11.9 t -113.07 139.32 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.309 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 136.52 15.96 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.686 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.51 96.6 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.389 2.059 . . . . 0.0 112.317 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 t 179.63 177.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.24 -42.58 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.12 95.28 2.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.05 -147.98 5.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.488 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.16 -23.09 39.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.528 2.152 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.545 HD23 ' HG3' ' A' ' 127' ' ' ARG . 8.4 tp -60.1 -33.2 71.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -42.14 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.8 p -70.88 -30.15 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -75.02 -42.31 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.3 mm? -59.2 -51.49 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -59.54 -46.21 89.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 198' ' ' TYR . 12.2 t80 -54.67 -50.68 67.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.674 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 24.7 m-85 -59.81 -41.48 91.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.415 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -79.95 -17.79 52.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -47.41 69.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.486 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB1' ' CE1' ' A' ' 171' ' ' HIS . . . -145.03 -32.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -53.86 -21.8 8.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -51.34 125.26 25.53 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 -25.4 15.34 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.491 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.4 -44.01 92.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.131 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.28 -43.13 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.282 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.753 HG22 HD11 ' A' ' 100' ' ' ILE . 30.2 mt -58.42 -48.34 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -52.28 -39.53 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.043 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -75.33 -29.2 59.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -76.62 -43.98 36.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.753 HD11 HG22 ' A' ' 96' ' ' ILE . 34.5 mt -65.85 -37.47 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.8 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' LYS . 16.6 p -82.02 -36.99 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.433 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.71 -2.5 24.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.4 mttm 59.51 31.34 20.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 100' ' ' ILE . 11.7 mt -49.39 -30.88 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.68 -55.6 0.51 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.026 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CD1' ' OE1' ' A' ' 192' ' ' GLN . 6.8 t80 -150.68 139.8 21.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.979 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' A' ' 167' ' ' TYR . 9.5 tp -119.72 162.19 19.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.61 19.14 42.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.97 125.25 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 149.13 37.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.369 2.046 . . . . 0.0 112.262 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.4 115.88 25.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -86.9 129.61 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.721 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 114' ' ' TRP . 6.7 m95 -107.58 -40.91 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.77 -174.66 46.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.1 p -132.86 169.0 17.39 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -158.96 175.84 35.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.977 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.83 150.83 36.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -141.17 141.61 34.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.61 136.07 54.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -138.27 126.27 22.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.29 18.59 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.322 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 10.39 54.72 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.861 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -96.21 159.37 14.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 110.711 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.5 m -111.34 123.11 49.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.492 ' O ' HD23 ' A' ' 118' ' ' LEU . 12.9 m-85 -122.12 136.5 54.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.793 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.545 ' HG3' HD23 ' A' ' 80' ' ' LEU . 15.5 tpt180 -117.95 125.12 49.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.806 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CB ' HG22 ' A' ' 72' ' ' VAL . 29.5 p90 -133.16 165.84 23.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.454 ' HB2' HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -134.65 144.77 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 70' ' ' VAL . 7.2 mm -101.53 111.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.2 173.06 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.141 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.35 127.69 32.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.564 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.65 176.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 184' ' ' LEU . 54.9 m-85 -147.42 175.82 10.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.663 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.21 -81.67 1.6 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.461 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.6 t -149.58 130.51 14.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.837 0.351 . . . . 0.0 110.582 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.16 165.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.713 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.693 HD22 HD12 ' A' ' 141' ' ' ILE . 2.8 mt -77.34 -14.07 59.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.675 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.43 -33.25 29.86 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.05 0.453 . . . . 0.0 109.932 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -75.83 -31.3 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.824 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.693 HD12 HD22 ' A' ' 138' ' ' LEU . 12.2 mt -68.93 -26.74 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 24.1 t80 -71.17 -43.92 66.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -29.9 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.4 67.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.219 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-20 -96.32 21.03 9.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.039 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.41 47.92 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 10.2 tttt 64.7 18.2 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.25 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 13.7 mtp85 -138.01 -170.67 2.84 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.002 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.2 OUTLIER -137.55 -166.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.675 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 m -129.35 151.7 49.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -62.22 -30.7 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -30.99 62.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -51.24 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 150' ' ' SER . 21.9 t -60.33 -48.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.3 mt -59.58 -43.87 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.727 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -68.47 -54.5 16.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.19 -42.47 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.695 ' OG ' HD11 ' A' ' 247' ' ' LEU . 16.1 m -55.58 -42.47 74.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.8 mt -60.02 -49.72 76.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.589 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 21.4 mmt-85 -60.72 -42.0 96.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.817 ' HA ' HD12 ' A' ' 164' ' ' ILE . 17.8 mt -65.19 -36.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.642 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.0 mt -60.23 -39.71 87.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.535 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -34.61 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 161' ' ' ILE . 9.7 mt -74.54 -42.87 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 243' ' ' ASP . 11.4 mt -54.34 -32.24 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.802 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' CD2' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -73.66 -32.79 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.578 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.619 ' CD2' HD21 ' A' ' 108' ' ' LEU . 57.1 t80 -70.91 -49.89 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 165' ' ' LEU . 34.2 pt -63.23 -27.71 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.529 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -72.8 -40.47 65.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 -14.77 62.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.644 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 57.5 m-70 -101.42 2.86 39.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.152 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 76.34 43.37 0.15 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 111.0 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.99 129.08 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.877 HG21 ' HG3' ' A' ' 240' ' ' ARG . 28.9 m -142.2 169.44 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.1 m170 65.23 48.83 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.39 -10.86 54.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.897 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 76.08 69.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.984 0.421 . . . . 0.0 111.026 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.661 HD11 HD21 ' A' ' 165' ' ' LEU . 2.4 mp -73.97 98.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 183' ' ' LEU . 23.6 mttp -144.38 -179.55 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.675 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -82.32 -0.61 46.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.436 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.29 -3.38 18.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 110.833 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.577 ' O ' HG22 ' A' ' 196' ' ' VAL . 35.2 m-20 -126.16 -2.15 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 179' ' ' LYS . 9.4 mt -108.36 113.56 26.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.997 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.813 ' C ' HG23 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -122.82 144.71 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.45 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.851 HD23 ' HB ' ' A' ' 193' ' ' VAL . 1.3 mt -90.48 149.0 22.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.349 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 9.9 m-20 -67.89 126.18 28.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -86.9 -60.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.417 ' HB2' ' NH1' ' A' ' 133' ' ' ARG . 10.4 mmtt -63.79 -30.83 71.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -130.34 71.71 82.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.2 97.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.551 2.167 . . . . 0.0 112.057 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.19 -53.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 107' ' ' TYR . 1.4 mt-30 -150.86 -177.42 5.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 185' ' ' LEU . 7.4 p -110.0 141.28 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.681 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.409 ' CE1' ' OD1' ' A' ' 186' ' ' ASN . 3.3 m-85 -106.97 153.8 22.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.125 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.6 tp -105.99 116.14 31.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 182' ' ' ASN . 7.6 m -88.57 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 198' ' ' TYR . 1.2 t70 63.76 129.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.425 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 30.1 m-85 -162.56 -44.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -55.89 -25.81 46.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.704 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.07 33.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 111.096 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.59 -110.29 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.19 119.38 8.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.809 0.337 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.66 49.49 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.417 ' CE2' ' NH2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.2 p -154.39 -46.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.769 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tt -174.56 36.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HA ' HD13 ' A' ' 265' ' ' LEU . 7.5 pt-20 -95.99 62.85 2.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 226' ' ' GLU . 12.6 t80 70.98 31.97 2.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 41.7 p -100.15 179.75 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 160.16 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.29 -40.29 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -78.13 -28.65 48.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.18 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -58.07 -39.79 79.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -97.02 -5.63 37.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 83.58 -2.7 86.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.718 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.23 157.77 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.807 0.336 . . . . 0.0 111.167 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -164.99 78.33 1.34 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.45 10.66 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.73 2.287 . . . . 0.0 112.878 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.0 p -153.61 163.24 40.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.877 ' HG3' HG21 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -113.88 -11.83 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.94 -13.48 61.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.315 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.36 -25.93 55.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.607 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.663 ' HB3' HD22 ' A' ' 165' ' ' LEU . 0.8 OUTLIER -55.69 -31.86 62.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.977 0.418 . . . . 0.0 110.838 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 320' ' ' LEU . 21.3 mt -80.58 -30.45 36.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.39 -32.56 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 29.3 mt -69.59 -37.55 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.186 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.739 HD23 ' OH ' ' A' ' 302' ' ' TYR . 40.7 tp -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.83 -41.75 94.23 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.34 -29.03 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -37.18 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.593 ' SD ' HD12 ' A' ' 299' ' ' ILE . 1.8 mtt -68.35 -39.7 81.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.716 HG22 HD23 ' A' ' 259' ' ' LEU . 7.4 mm -62.25 -39.32 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.15 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.836 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.8 tm0? -80.27 -34.97 36.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -76.41 -48.12 20.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.414 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.46 -36.21 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.55 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -96.39 -13.92 22.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.573 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.55 94.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.261 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.0 146.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 110.653 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.924 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.91 166.15 29.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.212 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.01 62.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.953 2.435 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.924 ' CH2' HD22 ' A' ' 259' ' ' LEU . 0.7 OUTLIER -178.54 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 261' ' ' TRP . 1.8 tt0 -108.94 18.22 20.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.069 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -66.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.82 -27.34 3.07 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.428 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 225' ' ' ILE . 19.8 mt 77.18 7.94 2.91 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -16.42 61.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.47 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 33.4 t70 -145.06 91.19 5.99 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 38.5 Cg_endo -66.71 -7.28 17.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.685 2.256 . . . . 0.0 112.841 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.84 -50.11 69.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 110.965 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.47 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 5.5 p90 -83.88 -26.22 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.769 ' CG1' HD11 ' A' ' 225' ' ' ILE . 25.9 t -60.38 -40.85 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -48.67 23.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.975 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -61.6 -35.16 77.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.071 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 m -72.09 -33.7 68.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -70.2 -49.73 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.046 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.4 mm -61.15 -36.59 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -75.54 -52.12 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -55.4 -35.09 64.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -29.69 65.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 22.68 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -137.94 43.57 2.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.7 mt -55.48 -37.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.18 64.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 5.4 t -71.12 -42.79 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.5 pp -65.23 -31.46 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.79 0.329 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mmt -66.81 -49.36 66.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -68.68 -31.4 70.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.247 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -53.76 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.102 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.466 ' O ' HG23 ' A' ' 256' ' ' THR . 81.0 m -66.15 -41.16 90.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.155 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.0 146.19 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 -166.86 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.51 45.28 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -45.73 19.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -149.87 167.15 27.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -86.78 156.57 55.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.86 118.41 5.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.593 2.195 . . . . 0.0 112.192 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -157.69 -49.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.67 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.69 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.0 mm -79.43 -41.69 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.227 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.57 -42.36 7.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.869 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -67.23 -38.71 85.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 110.58 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.739 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.0 t80 -70.5 -44.52 67.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.716 ' CB ' HD13 ' A' ' 282' ' ' ILE . 47.2 mmm -68.73 -31.93 71.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.84 -43.07 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.328 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.881 ' O ' HD12 ' A' ' 309' ' ' LEU . 5.5 p -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 302' ' ' TYR . 79.5 t -79.45 -24.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -36.68 23.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.738 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.1 -27.89 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.54 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.124 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.871 0.28 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.06 29.23 3.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 166' ' ' GLU . 4.1 m-85 -66.53 -29.7 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -40.53 67.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -42.76 48.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.878 ' HA ' HD12 ' A' ' 323' ' ' ILE . 39.3 mt -58.27 -41.38 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.458 ' CG ' HD22 ' A' ' 159' ' ' LEU . 15.0 ttp180 -57.28 -47.36 81.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -39.13 80.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 320' ' ' LEU . 52.0 mt -57.37 -46.42 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.055 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 155' ' ' LEU . 37.4 mt -75.99 -50.36 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.611 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -53.73 -49.89 67.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -56.29 -42.35 77.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.995 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.94 -29.71 65.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 155' ' ' LEU . 19.7 mt -64.75 -35.02 79.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.2 66.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.247 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.49 32.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.1 70.14 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.85 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.61 101.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 39.23 3.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 325' ' ' LEU . 6.5 p-10 -90.44 70.1 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' O ' HG12 ' A' ' 39' ' ' VAL . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.812 0.339 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 41' ' ' LEU . 15.0 t -129.44 117.36 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.71 30.0 27.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -132.54 139.1 47.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.734 0.302 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.641 HG21 ' HB3' ' A' ' 36' ' ' GLU . 35.2 mt -103.71 140.09 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.928 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.7 pt -119.86 154.55 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.6 p -95.65 136.92 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 37' ' ' TRP . 21.7 p-10 -94.54 -148.29 0.27 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.985 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -85.67 -37.91 18.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.242 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.39 2.34 32.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.856 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.2 mmpt? 83.08 15.47 0.34 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -63.15 169.89 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -118.21 76.13 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.018 0.437 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 31' ' ' ASP . 44.5 m95 -67.11 142.67 57.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.787 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 62' ' ' VAL . 23.2 mttm -105.46 132.66 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 24' ' ' ALA . 17.0 t -89.8 130.02 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.429 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -77.56 -106.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.858 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.638 ' HA ' HG22 ' A' ' 25' ' ' VAL . 2.3 mt -121.99 162.25 38.18 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 38.4 Cg_endo -66.78 140.38 55.58 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.666 2.244 . . . . 0.0 112.29 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.694 HG13 HG22 ' A' ' 51' ' ' ILE . 6.5 pt -142.57 30.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.742 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.686 0.279 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 50' ' ' CYS . 19.7 mm -135.63 127.4 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.361 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 70' ' ' VAL . 14.2 m-85 -146.43 145.8 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' H ' ' A' ' 41' ' ' LEU . 81.0 mt -71.82 136.55 47.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.352 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -114.55 157.22 23.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.507 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 145.99 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.673 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ptm -98.2 40.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.8 t30 58.72 35.86 24.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -65.8 -67.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.43 -170.14 1.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -76.65 -38.82 53.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.85 131.84 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 47.7 t -74.32 -29.1 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.88 65.41 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -179.25 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 110.767 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 76.07 1.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -114.94 89.95 21.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.88 42.36 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.871 2.381 . . . . 0.0 112.807 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -149.71 157.13 42.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.733 HG13 ' HG2' ' A' ' 133' ' ' ARG . 4.8 m -132.05 144.9 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 52' ' ' TYR . 11.2 p -127.41 129.82 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.316 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -94.7 117.48 30.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.199 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.2 125.31 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 111.55 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -141.16 146.98 45.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 114.89 3.85 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -60.2 124.16 19.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.12 -73.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -79.36 -32.79 43.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.14 48.42 3.57 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.783 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' THR . 38.5 Cg_endo -67.7 -51.36 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.266 1.977 . . . . 0.0 111.643 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.1 tp -77.93 -21.44 51.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.821 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.78 -33.9 50.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.441 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 79' ' ' PRO . 1.8 t -74.68 -35.36 62.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -73.1 -35.29 66.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 mm? -72.67 -36.2 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -63.97 -47.98 78.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 10.2 t80 -72.0 -35.7 69.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.727 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 1.7 m-85 -56.85 -50.47 72.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -74.98 -17.47 60.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.44 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -47.73 14.64 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -126.36 -19.64 4.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.727 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -92.61 21.4 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 113.25 35.08 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.57 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.76 -29.55 3.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 0.0 112.749 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -71.93 -39.38 69.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.83 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' A' ' 100' ' ' ILE . 50.1 mt -67.53 -49.78 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -29.66 61.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -78.8 -38.16 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -71.14 -42.69 68.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.025 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.6 mt -69.68 -36.43 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.84 60.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 98' ' ' LYS . 35.8 p -84.37 -30.28 25.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.342 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -4.16 17.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 100' ' ' ILE . 3.0 mtmp? 56.59 30.91 18.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.531 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.606 ' HB2' HG23 ' A' ' 100' ' ' ILE . 78.7 mt -45.56 -84.65 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.593 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER 175.16 -62.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.755 0.312 . . . . 0.0 110.984 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -169.13 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 108' ' ' LEU . 4.2 tp 75.34 146.44 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.76 10.23 68.56 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.995 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.97 115.45 44.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.783 0.291 . . . . 0.0 110.939 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 141.07 8.42 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.484 2.123 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 122.26 26.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.42 131.36 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.4 -40.99 3.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.618 0.247 . . . . 0.0 111.551 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.75 171.64 38.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.804 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -132.66 164.48 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.603 0.239 . . . . 0.0 110.643 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -162.01 179.75 37.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.979 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.45 159.68 42.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.715 0.293 . . . . 0.0 110.77 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -144.53 141.65 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.957 0.408 . . . . 0.0 111.108 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.41 129.24 54.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 126.35 22.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.921 0.391 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 55.47 20.9 3.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.72 -0.18 64.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.85 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -96.23 151.15 19.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.759 0.314 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.6 p -101.26 127.33 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.203 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.831 ' O ' HD23 ' A' ' 118' ' ' LEU . 21.6 m-85 -113.57 147.9 37.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.635 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -124.34 125.17 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.77 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.928 ' CE1' HD12 ' A' ' 29' ' ' ILE . 20.7 p90 -135.29 162.45 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.503 ' HG3' HD11 ' A' ' 84' ' ' LEU . 16.0 tmm? -144.94 140.26 28.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.026 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.453 HG13 ' HB ' ' A' ' 70' ' ' VAL . 2.7 mp -99.11 129.82 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -133.31 173.06 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -55.75 138.19 48.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.733 ' HG2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -62.85 170.46 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -145.73 157.5 43.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.98 -74.69 1.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.5 p -148.53 135.1 19.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.82 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -57.31 152.48 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.841 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -57.24 -23.19 46.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.8 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 45.3 tt0 -63.75 -38.56 91.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.154 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -36.48 81.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.841 HD12 ' HA ' ' A' ' 138' ' ' LEU . 8.8 mt -73.85 -25.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.714 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 254' ' ' TRP . 13.1 t80 -76.42 -51.89 10.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.32 -29.99 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.58 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.45 63.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.21 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -96.16 19.77 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.002 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 80.97 48.01 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt 63.37 19.19 11.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.302 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 20.7 mtp180 -131.91 -178.58 4.95 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.868 ' CE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -139.06 -167.81 2.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.688 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.08 144.46 47.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.45 -31.27 63.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 331' ' ' ILE . 3.2 mtmt -74.93 -43.91 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.868 HG21 ' CE1' ' A' ' 149' ' ' PHE . 58.6 m -58.45 -51.82 68.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.22 -46.0 88.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.438 HD22 ' OE2' ' A' ' 298' ' ' GLU . 40.9 mt -65.3 -48.29 73.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -41.97 95.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.677 HD22 HG11 ' A' ' 193' ' ' VAL . 23.7 mt -70.32 -38.98 75.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 324' ' ' LEU . 91.6 p -59.43 -34.55 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.787 HD12 HD11 ' A' ' 328' ' ' LEU . 13.0 mt -70.8 -46.77 62.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.466 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -61.32 -44.72 96.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.7 mt -64.85 -42.18 94.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.698 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 158' ' ' SER . 2.8 mt -55.52 -35.93 66.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -36.93 79.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.603 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 161' ' ' ILE . 5.1 mt -79.54 -38.71 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 162' ' ' LEU . 89.6 mt -58.17 -48.22 80.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -31.09 72.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -72.2 -47.91 47.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.829 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.47 -27.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -76.6 -33.43 58.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.357 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -15.86 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -102.39 3.11 37.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.867 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 74.17 45.24 0.21 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.891 0.377 . . . . 0.0 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -133.08 124.9 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 204' ' ' TYR . 28.3 m -132.2 165.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.067 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.585 ' O ' HD22 ' A' ' 200' ' ' LEU . 10.4 p-80 -150.37 -51.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.237 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.09 24.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.605 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.67 -80.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.584 0.23 . . . . 0.0 110.795 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.0 mt 44.57 95.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 183' ' ' LEU . 5.6 tttt -147.99 174.84 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.8 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -77.09 -1.0 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.593 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.8 t -111.97 1.94 16.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 0.0 110.551 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -123.4 -12.07 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.194 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 179' ' ' LYS . 4.5 mt -108.36 125.19 51.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.908 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 196' ' ' VAL . 0.9 OUTLIER -130.86 156.55 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 111.351 -178.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 141' ' ' ILE . 27.3 mt -90.31 149.84 22.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.05 129.68 40.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.942 0.401 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -73.07 -60.21 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -61.01 -20.84 62.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.534 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -136.52 78.23 44.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.54 80.46 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.534 2.156 . . . . 0.0 112.14 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.36 37.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.06 143.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 157' ' ' LEU . 4.0 p -109.95 147.99 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.162 0.506 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 8.4 m-85 -126.12 156.89 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.652 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 183' ' ' LEU . 39.5 tp -104.01 115.9 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.659 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.77 HG21 HD11 ' A' ' 184' ' ' LEU . 30.9 m -113.76 142.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.1 t70 55.77 84.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -59.05 -21.05 58.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.119 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.713 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 71.49 9.06 68.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.758 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.6 OUTLIER -153.61 -58.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.734 0.302 . . . . 0.0 110.818 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.533 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 43.93 76.24 0.09 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -116.72 148.97 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -103.1 69.71 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.697 ' CD1' HG13 ' A' ' 174' ' ' VAL . 17.0 p90 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 -67.22 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.76 HD13 ' HG2' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -159.19 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.76 ' HG2' HD13 ' A' ' 225' ' ' ILE . 5.4 mm-40 -159.48 26.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 227' ' ' PHE . 37.7 t80 -95.07 24.32 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.622 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -142.43 -76.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.993 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.522 ' H ' HG23 ' A' ' 228' ' ' THR . 7.7 t -157.86 163.51 37.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.908 0.385 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.39 -30.51 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.628 ' OD1' HG21 ' A' ' 236' ' ' VAL . 19.3 t70 -64.29 -39.47 93.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -67.49 -29.64 69.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.72 -25.48 61.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -88.92 12.87 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.475 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.98 28.13 72.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.642 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.628 HG21 ' OD1' ' A' ' 231' ' ' ASP . 22.0 t -88.44 129.29 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.691 0.282 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -76.98 -54.29 1.6 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.0 Cg_exo -54.39 88.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.449 2.099 . . . . 0.0 112.194 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.19 80.77 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -101.8 -24.81 14.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -17.76 41.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.236 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 246' ' ' ILE . . . -61.63 -30.31 74.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.78 -36.79 58.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 110.972 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.58 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 62.2 mt -80.74 -35.0 33.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -57.3 -43.71 83.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 242' ' ' GLY . 3.3 mt -59.9 -42.1 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.804 HD23 ' OH ' ' A' ' 302' ' ' TYR . 30.7 tp -61.1 -30.85 70.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -70.69 -37.36 67.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.366 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.412 ' CZ ' ' HE2' ' A' ' 275' ' ' LYS . 34.5 m-85 -78.55 -26.17 45.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.297 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.283 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.583 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -64.4 -51.07 65.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.189 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.6 mt -63.73 -33.53 62.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -80.02 -33.74 38.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 30.8 m0 -82.28 -48.74 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.415 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -70.93 -36.82 72.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.598 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 289' ' ' CYS . 0.5 OUTLIER -96.14 0.53 51.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.772 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 57.75 94.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.519 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 45.8 m80 63.52 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -132.97 168.52 17.53 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 59.2 Cg_endo -72.61 60.0 3.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.527 2.151 . . . . 0.0 112.534 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.3 p90 178.15 -39.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.9 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -107.45 20.35 19.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.47 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.22 -62.29 1.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -128.57 -26.46 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.283 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 27.9 mt 75.53 10.2 3.5 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.08 0.466 . . . . 0.0 109.756 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -80.91 -16.45 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.11 81.81 37.69 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 33.4 Cg_exo -59.89 -14.77 29.11 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.791 2.328 . . . . 0.0 112.534 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.85 -50.45 45.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.254 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 6.0 p90 -84.04 -26.85 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.767 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 225' ' ' ILE . 39.5 t -60.62 -39.02 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.229 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -73.1 -45.28 58.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 276' ' ' ILE . 19.8 t70 -69.94 -42.73 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.6 t -60.74 -46.17 91.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 279' ' ' ARG . 0.0 OUTLIER -58.75 -51.61 69.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 273' ' ' ASP . 14.0 mt -53.12 -37.66 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.534 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.02 7.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.328 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 285' ' ' LEU . 9.8 m-85 -57.91 -36.98 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 275' ' ' LYS . 0.0 OUTLIER -55.77 -30.62 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 0.0 110.695 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.35 28.12 7.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 284' ' ' SER . 4.1 m120 -136.13 45.1 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.682 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.8 mt -50.43 -36.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.238 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 281' ' ' ASN . 0.3 OUTLIER -78.92 -42.25 27.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.96 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 285' ' ' LEU . 3.0 pp -68.7 -28.47 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.743 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.434 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.9 mmt -72.66 -51.62 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -24.82 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.336 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -48.3 11.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 111.179 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.501 ' HB3' HG21 ' A' ' 256' ' ' THR . 96.8 m -83.16 -41.25 18.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -104.18 153.45 38.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 -170.0 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.562 2.175 . . . . 0.0 112.349 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.05 -43.69 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.13 94.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.08 69.52 0.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 96.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.24 -34.42 21.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.261 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.83 78.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.935 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.438 ' OE2' HD22 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.83 -57.1 14.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.874 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.583 HD12 ' SD ' ' A' ' 251' ' ' MET . 27.1 mm -69.04 -35.31 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.434 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -52.21 -46.09 65.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -61.24 -37.47 83.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.859 ' O ' HG23 ' A' ' 306' ' ' VAL . 46.4 t80 -71.3 -36.17 71.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.682 ' CB ' HD13 ' A' ' 282' ' ' ILE . 0.6 OUTLIER -69.67 -38.06 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.587 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.53 -49.4 76.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.604 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.468 HG21 HD11 ' A' ' 323' ' ' ILE . 0.6 OUTLIER -59.39 -39.69 84.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.712 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 302' ' ' TYR . 22.5 t -73.82 -24.37 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.261 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -79.67 -43.16 23.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.32 -14.4 61.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.814 HD12 ' HA ' ' A' ' 306' ' ' VAL . 6.7 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.853 0.272 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 24.8 mt -108.95 31.41 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.58 ' CZ ' HD21 ' A' ' 244' ' ' LEU . 15.0 m-85 -61.64 -31.45 71.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -38.79 92.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -76.62 -44.33 34.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.764 ' HA ' HD12 ' A' ' 323' ' ' ILE . 84.4 mt -54.67 -42.18 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.525 ' HG2' HD22 ' A' ' 159' ' ' LEU . 3.4 tmt_? -58.54 -33.32 69.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.44 -32.84 58.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 320' ' ' LEU . 60.1 mt -61.16 -46.96 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.66 HD13 ' OG ' ' A' ' 158' ' ' SER . 41.0 mt -81.17 -23.81 37.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.384 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.613 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.53 -44.39 15.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.184 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.85 -29.11 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -75.36 -26.45 65.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.746 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.787 HD11 HD12 ' A' ' 159' ' ' LEU . 40.9 mt -51.65 -35.22 41.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -29.95 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.27 -30.58 71.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.7 HD12 ' HG2' ' A' ' 152' ' ' LYS . 14.5 pt -97.97 28.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.265 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.35 91.71 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.614 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 m -137.5 164.85 27.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -154.61 154.12 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.54 91.0 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 64.56 110.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.239 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.13 -21.65 42.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.896 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -95.18 147.48 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.09 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 36' ' ' GLU . 17.9 mt -113.88 142.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.896 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 24.9 pt -118.34 154.41 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.419 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 9.4 p -95.88 141.55 29.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.922 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -161.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.18 -39.91 24.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -78.8 -2.82 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.654 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 1.6 tttt 88.51 29.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' THR . 7.2 tttp -77.13 176.41 8.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.365 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB2' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -127.71 79.07 1.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.442 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.407 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.0 m95 -74.53 134.75 42.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.09 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -102.42 127.02 49.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -77.7 117.64 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -63.23 -105.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -122.53 159.42 52.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.868 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.526 ' HD2' HD23 ' A' ' 41' ' ' LEU . 55.6 Cg_endo -70.05 151.97 67.62 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.174 . . . . 0.0 112.334 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -145.68 30.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.167 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.544 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 7.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.431 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.4 mp -93.74 113.51 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.052 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 9.3 m-85 -135.93 172.29 13.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -78.11 158.78 28.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.04 137.96 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.201 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -143.38 157.77 44.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 46.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -82.81 128.52 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 p -115.86 -39.04 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -93.03 -66.71 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.29 173.06 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.27 144.79 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 63' ' ' GLY . 21.5 t -66.45 155.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -175.62 82.88 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.473 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.2 30.67 20.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.12 31.38 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.61 48.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.07 45.69 1.95 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.572 2.181 . . . . 0.0 112.713 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.8 148.21 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.46 144.89 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.7 p -125.45 119.94 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 118.15 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.398 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' A' ' 128' ' ' PHE . 2.8 t -113.1 135.78 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.336 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.2 143.37 30.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.674 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.58 117.61 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.421 2.08 . . . . 0.0 112.307 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -71.58 109.78 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -157.32 -75.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -76.39 -27.65 56.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.33 46.12 4.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.878 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 43.6 Cg_endo -70.14 -53.19 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.234 1.956 . . . . 0.0 111.651 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 tp -71.37 -23.92 61.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.71 -29.2 62.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.68 -39.69 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.86 -32.51 74.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -69.28 -45.61 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.669 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -57.49 -40.07 77.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.599 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 64.3 t80 -72.16 -36.88 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -70.6 -41.19 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.32 -35.95 81.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.17 14.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.797 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -99.64 -49.58 4.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.847 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -76.61 2.82 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -55.93 121.14 38.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.52 0.2 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.27 -26.94 21.65 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.36 2.04 . . . . 0.0 112.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -79.34 -43.61 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -51.63 51.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.022 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.847 HD11 ' HA ' ' A' ' 91' ' ' ALA . 45.3 mt -57.12 -52.42 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.134 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.76 -31.96 7.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.97 -46.45 29.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.62 ' CG1' HG22 ' A' ' 96' ' ' ILE . 47.4 mm -56.04 -37.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -74.99 -27.76 60.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.1 m -74.61 -38.78 62.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.442 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -107.27 -3.5 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 55.44 24.88 7.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 108' ' ' LEU . 6.0 mt -52.22 -39.55 60.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.567 ' H ' HG23 ' A' ' 100' ' ' ILE . 7.7 ttmt 50.54 41.21 25.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 192' ' ' GLN . 36.7 t80 -177.38 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 105' ' ' LEU . 13.6 tp 60.87 155.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.622 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 164' ' ' ILE . . . -83.87 -3.81 89.07 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.1 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' A' ' 167' ' ' TYR . 43.2 t -77.98 114.3 40.7 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.685 0.242 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.64 151.87 4.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.391 2.061 . . . . 0.0 112.371 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.3 115.49 19.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -92.9 126.03 37.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.454 ' N ' ' CD1' ' A' ' 114' ' ' TRP . 6.0 m95 -103.45 -40.82 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.76 -178.29 45.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.558 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 84' ' ' LEU . 2.6 p -135.57 159.47 41.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -145.45 -177.78 20.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.931 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 159.84 41.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -136.47 137.5 40.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 15.7 p-10 -118.05 125.54 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -138.23 126.14 22.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.09 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.38 21.33 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.491 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.3 57.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.985 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.4 mmtp -96.2 159.41 14.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.5 m -114.51 124.09 51.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.0 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.27 140.41 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -121.54 127.94 51.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.598 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.896 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.5 p90 -140.2 161.09 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.251 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.694 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.3 ttm -128.05 142.36 51.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 29' ' ' ILE . 19.5 mt -118.62 111.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.413 . . . . 0.0 111.336 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -125.46 173.27 9.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.34 132.5 20.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.99 143.16 55.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CD2' HD12 ' A' ' 184' ' ' LEU . 42.6 m-85 -111.34 179.91 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.76 -98.63 2.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.553 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.6 p -125.85 128.18 47.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.703 ' HB3' HD22 ' A' ' 184' ' ' LEU . 11.9 p30 -56.25 164.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.851 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -69.16 -21.36 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.549 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.638 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.91 -35.04 44.11 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.901 0.382 . . . . 0.0 110.429 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -77.83 -25.58 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.356 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 138' ' ' LEU . 44.6 mt -73.94 -27.52 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.975 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -57.15 -45.65 83.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.695 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -27.99 60.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.31 -26.2 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -92.79 5.64 50.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.332 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.11 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.128 0.49 . . . . 0.0 110.671 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.07 16.33 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.722 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 145' ' ' ASN . 7.2 ptm180 -161.39 116.35 2.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 1.8 m-85 -57.34 174.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -106.8 158.44 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.626 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -59.2 -32.45 69.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -71.68 -47.78 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -58.28 -55.19 38.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.315 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.781 HG11 ' HB3' ' A' ' 251' ' ' MET . 61.7 t -54.91 -52.69 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.392 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.5 mt -56.52 -46.85 80.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.272 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -52.03 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.8 -44.25 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.604 ' OG ' HD13 ' A' ' 324' ' ' LEU . 27.2 p -54.66 -45.02 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.733 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 321' ' ' ARG . 10.4 mt -63.05 -43.75 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.358 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -44.51 97.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.477 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.91 -33.48 63.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.676 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 165' ' ' LEU . 10.6 mt -60.9 -38.63 86.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.537 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -32.91 71.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.332 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.416 ' CD1' ' HA3' ' A' ' 109' ' ' GLY . 18.7 mt -78.21 -35.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.376 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 162' ' ' LEU . 15.9 mt -58.15 -48.17 81.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.577 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -31.68 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 110' ' ' VAL . 85.1 t80 -64.1 -42.97 96.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -81.13 -27.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.243 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.41 -29.57 57.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.81 -17.03 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.423 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -106.87 8.45 30.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.688 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 68.88 49.16 0.69 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.27 138.85 46.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 239' ' ' SER . 14.4 m -130.68 169.31 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.497 ' CD2' HD21 ' A' ' 195' ' ' LEU . 6.0 p-80 -154.11 -44.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 111.279 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.31 52.79 49.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.625 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.42 -85.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.59 0.233 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 mt 45.99 91.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 183' ' ' LEU . 19.1 tttt -147.11 170.96 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.821 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -76.36 -1.99 29.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.647 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.19 -0.99 17.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.426 . . . . 0.0 110.435 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -121.5 -8.31 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.351 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.847 ' C ' HD23 ' A' ' 184' ' ' LEU . 8.5 mt -108.43 115.34 29.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.279 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.11 146.43 47.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.211 -178.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 141' ' ' ILE . 31.0 mt -86.39 148.9 25.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.18 124.42 23.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.88 -53.82 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -59.66 -30.14 68.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -143.39 79.14 14.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.641 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.72 108.23 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.634 2.222 . . . . 0.0 112.224 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -56.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -149.94 -167.74 2.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.851 HG21 HD21 ' A' ' 138' ' ' LEU . 6.3 p -110.02 147.39 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 32.1 m-85 -113.22 156.89 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.139 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 175' ' ' HIS . 43.0 tp -104.05 115.83 31.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' A' ' 134' ' ' PHE . 14.9 m -122.17 165.83 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.51 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.658 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.555 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 9.0 m-85 -98.59 -50.66 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 90.64 -47.52 3.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.135 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.04 34.87 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.489 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.599 ' HB1' ' CD1' ' A' ' 86' ' ' PHE . . . -77.93 59.65 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -137.06 149.09 47.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.025 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -59.82 101.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.1 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 179.86 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 228' ' ' THR . 0.6 OUTLIER -135.11 176.81 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.019 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 265' ' ' LEU . 16.9 tt -93.14 13.83 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -92.46 25.03 3.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.798 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 226' ' ' GLU . 0.4 OUTLIER 174.94 -28.15 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 224' ' ' THR . 16.7 p -81.15 161.72 23.94 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -167.84 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 276' ' ' ILE . 30.2 mt -73.75 -55.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.3 -31.18 65.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.86 -28.38 61.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.404 ' CE1' ' HB ' ' A' ' 225' ' ' ILE . 15.6 t60 -61.56 -51.44 68.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.016 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 236' ' ' VAL . 17.0 m-80 -91.74 12.92 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.421 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.21 15.35 58.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.818 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 234' ' ' ASN . 14.5 t -64.38 141.48 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.22 162.64 0.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 -164.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.682 ' O ' HG11 ' A' ' 174' ' ' VAL . 12.2 p -139.56 104.16 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -158.0 -53.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -28.2 61.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.4 -33.64 66.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 246' ' ' ILE . 34.3 m-20 -56.56 -30.42 63.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.77 HD13 HD11 ' A' ' 320' ' ' LEU . 52.4 mt -80.64 -36.56 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.89 -35.3 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 243' ' ' ASP . 12.0 mt -62.87 -41.52 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.876 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.3 tp -64.19 -50.61 67.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.717 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.81 -27.95 51.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.458 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.93 -33.19 45.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 0.0 110.79 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.429 ' HB3' ' CE3' ' A' ' 254' ' ' TRP . 69.2 m -53.15 -51.63 61.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.046 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.781 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -57.37 -30.58 64.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.624 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.653 HG22 HD23 ' A' ' 259' ' ' LEU . 20.8 mm -69.18 -44.24 80.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.994 0.426 . . . . 0.0 110.737 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.705 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.4 tm0? -80.03 -27.18 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.108 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 2.9 m0 -81.59 -54.38 5.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.38 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 151' ' ' ARG . 43.9 mt -70.32 -35.13 73.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.528 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.25 -13.92 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.538 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.9 97.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.184 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 253' ' ' GLN . 0.1 OUTLIER 66.0 141.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.654 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.966 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -116.64 159.25 41.12 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 14.3 Cg_exo -69.04 59.49 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.839 2.359 . . . . 0.0 112.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.966 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.3 p90 179.13 -38.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.241 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.409 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.1 tt0 -95.99 24.67 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.076 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.59 -57.39 3.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.816 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -125.95 -29.96 3.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.717 HD11 ' CG2' ' A' ' 225' ' ' ILE . 0.3 OUTLIER 73.49 11.67 4.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -15.61 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.449 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.462 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 1.8 m-20 -132.94 103.96 12.88 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.5 17.4 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.722 2.282 . . . . 0.0 112.826 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -79.99 -50.1 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -77.42 -26.04 51.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 5.2 t -60.69 -45.75 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -47.69 25.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -39.16 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -72.74 -39.63 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -49.91 75.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.436 HG13 HD11 ' A' ' 230' ' ' ILE . 5.1 mt -63.97 -44.65 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -52.04 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.8 m-85 -59.03 -33.94 71.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -59.18 -31.14 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 23.65 11.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -147.79 45.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.784 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.5 mt -54.84 -41.24 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.08 67.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -41.52 61.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 282' ' ' ILE . 1.0 OUTLIER -70.77 -38.33 73.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 2.5 ttm -67.53 -33.09 74.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -75.56 -37.69 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.44 25.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.043 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.38 -34.39 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.004 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 8.9 m-85 -127.9 79.91 72.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.969 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 111.4 3.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.554 2.169 . . . . 0.0 112.359 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -128.54 -46.37 1.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -173.84 -62.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -177.01 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.13 127.88 59.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 53.1 Cg_exo -55.12 -168.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.77 -89.91 1.5 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.428 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -125.6 -39.97 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 111.037 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.722 HG22 ' CG ' ' A' ' 303' ' ' MET . 35.3 mm -54.87 -41.43 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -44.4 -30.57 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.5 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.25 -42.26 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.876 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.3 t80 -67.57 -37.72 83.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.784 ' CB ' HD13 ' A' ' 282' ' ' ILE . 62.9 mmm -71.77 -30.0 65.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.96 -50.34 68.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -41.65 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 302' ' ' TYR . 27.8 t -69.93 -24.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.106 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -80.43 -29.94 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.64 -11.91 20.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.584 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.832 ' HG ' HD22 ' A' ' 316' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.292 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.832 HD22 ' HG ' ' A' ' 309' ' ' LEU . 4.0 mp -92.17 -23.87 19.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.513 ' CD2' HD21 ' A' ' 244' ' ' LEU . 76.0 m-85 -53.92 -30.28 45.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.97 -36.58 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.9 -37.3 67.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.92 ' HA ' HD12 ' A' ' 323' ' ' ILE . 55.5 mt -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.57 ' HG3' HD22 ' A' ' 159' ' ' LEU . 1.5 ttm-85 -59.34 -46.62 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -40.71 82.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.92 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.6 mt -58.06 -46.81 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.604 HD13 ' OG ' ' A' ' 158' ' ' SER . 40.8 mt -73.68 -51.63 15.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.984 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.28 -49.87 68.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.32 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -58.78 -39.97 82.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.001 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.12 -31.93 70.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.585 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.5 mt -63.02 -41.73 99.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.55 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.75 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.0 pt -101.45 27.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.188 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.04 28.08 52.81 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.583 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 18.1 t -102.33 156.79 17.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -174.61 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.67 100.42 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' C ' HG23 ' A' ' 25' ' ' VAL . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 41' ' ' LEU . 1.0 OUTLIER 64.75 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.495 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.43 -25.44 22.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.975 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -83.39 136.13 34.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.196 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 38' ' ' LYS . 11.0 mm -100.42 144.27 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.718 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 128' ' ' PHE . 34.1 pt -119.76 151.3 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -95.81 141.4 29.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.806 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.08 -163.53 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.099 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -41.0 35.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 109.792 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -76.69 -5.01 46.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.531 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 89.65 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.9 mttp -77.21 -177.66 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.207 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.8 mm-40 -132.76 81.78 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 110.697 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -75.26 136.93 40.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.932 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' HD12 ' A' ' 28' ' ' ILE . 3.4 mttm -94.1 118.68 31.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -72.73 144.17 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.91 -117.42 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.787 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.677 ' HA ' HG22 ' A' ' 25' ' ' VAL . 3.1 mt -113.27 164.61 15.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 111.021 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 33.9 Cg_endo -64.6 141.86 74.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.598 2.199 . . . . 0.0 112.251 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 ' HG ' ' A' ' 53' ' ' LEU . 13.0 pt -153.76 79.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.565 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.879 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.647 0.26 . . . . 0.0 111.118 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 50' ' ' CYS . 3.9 mp -141.59 130.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 m-85 -146.46 150.15 35.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 41' ' ' LEU . 24.4 mt -70.75 158.8 35.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.342 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.583 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -132.69 154.39 50.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.0 111.38 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -149.14 132.0 16.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.9 mtp -83.62 57.01 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.95 -177.67 5.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.0 p -175.65 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.4 p -79.28 -66.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.21 -69.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -161.21 160.38 29.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.425 HG23 ' HD3' ' A' ' 38' ' ' LYS . 21.5 t -90.58 139.95 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.061 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.89 -123.61 4.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.35 31.05 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.86 42.04 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.583 ' HB1' ' O ' ' A' ' 54' ' ' ALA . . . -109.16 92.34 10.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.001 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.14 49.97 3.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.633 2.222 . . . . 0.0 112.753 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 59.6 m -149.86 148.19 28.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 133' ' ' ARG . 16.5 m -124.51 144.96 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 3.8 p -132.17 122.39 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.878 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -96.95 116.33 29.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.682 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 128' ' ' PHE . 9.3 t -113.13 133.8 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.39 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.17 150.65 59.41 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.728 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.07 101.21 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.277 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 m 60.36 173.43 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.04 151.41 43.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.31 -55.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' THR . . . 163.44 -68.58 0.22 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.464 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.07 -36.09 64.32 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.352 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.17 -39.83 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.63 -40.44 91.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 21.8 p -68.64 -31.8 71.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 38.3 tt0 -73.82 -47.66 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.7 mm? -58.46 -48.08 81.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -45.03 92.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.443 ' CE2' ' CB ' ' A' ' 90' ' ' ALA . 16.7 t80 -71.91 -44.74 63.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.718 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -57.07 -29.8 63.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.493 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -80.0 -45.57 18.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.074 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -87.39 -47.62 8.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 86' ' ' PHE . . . -81.34 -46.47 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.782 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -94.71 33.17 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.593 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -72.03 123.73 89.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.605 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.58 -25.34 79.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.398 2.065 . . . . 0.0 112.249 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.39 -36.01 39.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.6 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 60.2 mt -56.7 -56.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.304 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -37.95 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -74.47 -43.84 54.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.32 -51.91 65.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' A' ' 105' ' ' LEU . 66.8 mt -60.31 -37.1 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -27.65 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 64.6 m -83.48 -30.92 26.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.23 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HD3' HD21 ' A' ' 105' ' ' LEU . 3.5 ttt-85 -105.95 -4.36 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.018 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.43 28.42 15.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 100' ' ' ILE . 66.6 mt -48.93 -39.41 26.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER 75.41 -1.75 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.62 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 75.6 t80 174.19 162.46 0.19 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 110.461 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.7 tp -147.42 -66.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 130.65 -14.65 5.52 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.7 126.86 88.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.612 0.206 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.49 148.23 20.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.483 2.122 . . . . 0.0 112.193 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -83.99 115.57 22.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.046 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 39.1 t80 -97.48 125.05 41.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -100.82 -40.7 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.86 -176.53 46.36 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.625 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -134.88 154.53 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -137.67 171.07 23.42 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.84 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 127' ' ' ARG . 5.9 mt -142.39 157.25 44.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.702 0.287 . . . . 0.0 110.623 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -145.96 141.56 27.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -115.92 125.33 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 126.27 22.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 60.44 17.05 6.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.51 -6.35 59.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.872 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -96.17 129.57 43.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.9 t -92.38 130.94 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.03 151.48 29.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.748 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -129.93 125.65 35.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.631 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 29' ' ' ILE . 31.0 p90 -133.56 163.76 28.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.665 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.1 ttm -127.98 140.74 51.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.033 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 29' ' ' ILE . 13.7 mt -120.77 111.69 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.44 . . . . 0.0 111.549 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -123.42 173.43 8.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.718 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 15.7 t0 -55.85 138.28 48.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HG3' HG13 ' A' ' 69' ' ' VAL . 52.1 ttt180 -68.89 154.6 41.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.5 ' CD2' HD12 ' A' ' 184' ' ' LEU . 73.3 m-85 -119.32 161.84 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.2 -73.91 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 m -146.56 138.25 24.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.556 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -60.01 152.45 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.715 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 30.3 tp60 -70.95 -41.73 70.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -65.55 -26.96 68.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 138' ' ' LEU . 29.1 mt -75.83 -29.77 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 46.8 t80 -54.24 -47.66 71.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.835 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.05 -25.57 68.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.715 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.73 -19.25 59.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 4.1 m-80 -91.0 5.59 48.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.233 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.55 43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.268 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.6 tttt 62.04 18.7 10.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 1.4 ptt85 -165.49 126.21 1.88 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.3 158.53 30.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -93.07 160.51 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -28.9 68.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 45.5 p -68.01 -44.07 77.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.733 HG21 ' HG ' ' A' ' 255' ' ' LEU . 47.7 t -57.87 -54.03 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.291 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.733 ' HB3' HD21 ' A' ' 328' ' ' LEU . 74.5 mt -61.78 -45.3 94.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.622 ' OE1' HD13 ' A' ' 328' ' ' LEU . 8.8 tp60 -58.58 -44.0 89.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.668 HD22 HG11 ' A' ' 193' ' ' VAL . 42.6 mt -73.33 -37.17 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.6 m -58.25 -41.41 84.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 325' ' ' LEU . 12.7 mt -70.71 -43.79 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.77 88.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' LEU . 7.3 mt -71.29 -33.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.2 mt -64.56 -40.21 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -36.29 80.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.0 mt -73.65 -40.24 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' A' ' 162' ' ' LEU . 21.3 mt -56.22 -33.06 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.69 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 -29.34 59.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -72.02 -52.51 16.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.615 HG21 ' OH ' ' A' ' 198' ' ' TYR . 48.4 pt -64.75 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -40.16 88.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.326 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.02 -12.31 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.75 4.49 25.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.943 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 66.17 46.92 1.97 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.875 0.369 . . . . 0.0 110.706 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -135.34 120.11 18.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 204' ' ' TYR . 3.0 m -124.58 169.08 16.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.008 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 3.8 p80 -149.82 -52.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 68.95 37.52 83.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.53 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.3 -81.22 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 183' ' ' LEU . 2.4 mp 47.4 93.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.399 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 174.84 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.019 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -78.23 -3.96 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.3 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.6 t -108.54 0.32 20.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.642 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -125.33 -9.55 6.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.326 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.872 ' C ' HD23 ' A' ' 184' ' ' LEU . 54.9 mt -108.28 117.66 34.73 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.872 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.67 161.45 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.921 0.391 . . . . 0.0 111.492 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.0 mt -92.8 149.82 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.07 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.81 129.91 41.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.416 ' CG ' ' HD3' ' A' ' 133' ' ' ARG . 60.4 t80 -71.77 -62.81 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.591 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -19.95 63.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.653 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -134.34 76.8 61.65 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 78.04 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.437 2.091 . . . . 0.0 111.963 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -179.62 36.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.8 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 107' ' ' TYR . 0.5 OUTLIER -174.12 145.79 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.264 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.668 HG11 HD22 ' A' ' 157' ' ' LEU . 2.4 p -109.98 147.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 110.888 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 10.8 m-85 -126.25 157.59 37.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 34.0 tp -103.12 115.79 31.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.889 0.376 . . . . 0.0 110.607 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.77 141.32 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.182 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 57.54 106.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.615 ' OH ' HG21 ' A' ' 168' ' ' ILE . 3.4 m-30 -75.48 -24.09 56.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.658 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 93.76 -24.7 24.92 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.553 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 199' ' ' GLY . 5.0 mp -150.78 -44.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 45.93 87.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.095 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.574 ' O ' HG22 ' A' ' 174' ' ' VAL . 30.5 t80 -143.84 148.77 35.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 202' ' ' TYR . 15.2 mtm105 -74.11 98.49 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 174' ' ' VAL . 43.0 p90 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.0 p -59.61 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.3 tp -163.9 27.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.196 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.24 -35.36 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -152.23 32.34 0.53 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.705 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 39.9 p -65.54 128.74 37.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.021 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.6 m -89.88 146.57 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.834 HD11 ' HG3' ' A' ' 275' ' ' LYS . 3.0 mp -57.81 -35.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.71 -30.53 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -75.3 -39.2 59.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -44.3 92.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -92.83 0.57 57.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.87 7.9 62.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.945 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.2 127.87 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.65 154.27 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.21 -166.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.55 2.167 . . . . 0.0 112.255 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -96.96 28.46 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -90.86 -53.02 4.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -25.44 62.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.873 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -65.05 -37.76 94.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.05 -40.59 89.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.489 HD12 HD11 ' A' ' 309' ' ' LEU . 48.7 mt -67.0 -35.93 81.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.784 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -62.95 -42.55 99.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.9 mt -65.2 -39.9 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.499 HD23 ' OH ' ' A' ' 302' ' ' TYR . 32.5 tp -65.76 -39.54 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.77 -44.93 96.55 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.379 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.63 -25.7 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.91 -43.33 86.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.252 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.678 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.28 -50.1 74.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 mt -64.19 -26.55 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.66 ' HB2' HD11 ' A' ' 259' ' ' LEU . 12.4 tm0? -71.07 -45.2 64.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.401 ' CD1' ' OE1' ' A' ' 253' ' ' GLN . 18.5 m0 -82.19 -41.09 20.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.733 ' HG ' HG21 ' A' ' 154' ' ' VAL . 21.0 mt -67.04 -39.21 86.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -0.57 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 57.49 96.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 55.6 m80 62.54 144.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -122.35 164.65 24.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.466 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.93 63.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.421 2.08 . . . . 0.0 112.519 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.838 ' CH2' HD22 ' A' ' 259' ' ' LEU . 7.6 p90 176.41 -38.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.108 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.9 tt0 -95.55 18.47 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.289 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -55.93 15.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 93.6 m-20 -126.99 -27.36 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.6 mt 70.67 12.4 7.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -85.19 -15.3 44.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.175 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.46 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 2.1 m-20 -132.56 100.52 14.95 Favored Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.93 15.02 2.05 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.616 2.211 . . . . 0.0 112.857 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -78.54 -49.77 12.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.1 p90 -77.13 -26.47 53.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 225' ' ' ILE . 12.5 t -60.71 -37.53 76.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.56 ' NH1' HD11 ' A' ' 276' ' ' ILE . 12.3 ttt-85 -75.52 -44.94 41.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.068 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.15 -49.67 63.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.235 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.9 m -58.58 -41.98 86.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.834 ' HG3' HD11 ' A' ' 230' ' ' ILE . 10.8 tptt -62.35 -41.5 98.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.144 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.56 HD11 ' NH1' ' A' ' 272' ' ' ARG . 11.3 mt -75.1 -29.09 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.01 16.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -69.98 -40.13 75.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.388 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -52.58 -27.52 17.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.02 15.33 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.21 45.76 2.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.708 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.1 mt -51.7 -36.5 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.336 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.13 63.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.574 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 9.9 t -68.37 -40.36 81.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.34 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.5 pp -76.01 -28.41 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.331 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 4.0 mmt -67.61 -38.42 83.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.751 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -82.7 -31.58 28.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -82.66 -51.59 7.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.07 -41.13 67.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -115.68 151.97 46.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.009 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 131.89 17.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.629 2.219 . . . . 0.0 112.281 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.02 43.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -107.13 -55.91 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -162.1 -176.45 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 60.82 87.16 0.14 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.59 144.16 44.04 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.608 2.205 . . . . 0.0 112.377 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.453 ' O ' HD11 ' A' ' 155' ' ' LEU . . . -96.86 -18.08 30.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.709 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.14 10.61 6.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.362 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.538 HG22 ' CG ' ' A' ' 303' ' ' MET . 43.3 mm -79.41 -46.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.13 -45.27 11.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.446 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.575 ' HB2' HG23 ' A' ' 323' ' ' ILE . 69.1 mttt -59.63 -42.76 93.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.52 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 306' ' ' VAL . 72.7 t80 -70.17 -36.79 74.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.612 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.708 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.6 mtp -67.39 -42.47 83.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.579 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.48 -48.39 80.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -37.78 80.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.692 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 302' ' ' TYR . 40.6 t -71.08 -25.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -43.12 15.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 110.217 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -14.31 62.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.545 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 306' ' ' VAL . 8.7 mt . . . . . 0 N--CA 1.462 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.231 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.465 -0.197 0 CA-C-O 120.736 0.223 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' A' ' 320' ' ' LEU . 1.4 pp -155.41 30.55 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.041 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -57.53 -37.05 72.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.22 -40.69 94.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.741 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.62 -42.88 99.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.562 ' HG ' HD12 ' A' ' 316' ' ' LEU . 79.4 mt -56.18 -45.38 79.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -56.34 -46.45 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.38 91.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 301' ' ' LYS . 97.2 mt -53.07 -42.22 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 155' ' ' LEU . 61.1 mt -81.06 -51.51 8.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.089 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -56.03 -49.77 72.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.43 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.91 -46.16 71.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.71 -28.13 56.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 155' ' ' LEU . 7.2 mt -69.16 -24.74 64.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.715 0.293 . . . . 0.0 111.071 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 1.2 mmtm -69.76 -33.47 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.02 -18.85 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.143 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.52 -34.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -122.07 -24.44 2.25 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.279 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 3.0 t 71.43 65.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 74.61 103.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 164.02 26.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.834 0.35 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 110.6 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.93 -27.61 6.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.495 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 135.19 51.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 36' ' ' GLU . 15.7 mt -100.66 143.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.897 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 18.4 pt -119.7 154.99 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 34' ' ' LYS . 1.4 m -94.98 135.45 36.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -160.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.248 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.1 -38.74 51.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.73 3.66 28.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.235 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.9 mttp 76.03 32.43 0.63 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.5 mtpp -77.34 171.87 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.065 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 28' ' ' ILE . 22.3 mt-10 -111.88 73.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.49 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HB2' HG13 ' A' ' 29' ' ' ILE . 26.7 m95 -66.7 145.87 55.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.959 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -100.8 132.39 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 29' ' ' ILE . 25.4 t -88.9 123.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 62' ' ' VAL . . . -75.07 -127.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.551 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.27 159.39 70.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.85 128.2 18.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.167 . . . . 0.0 112.299 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -109.72 -30.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.439 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.349 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.415 HD12 ' HG2' ' A' ' 71' ' ' LYS . 21.5 mm -87.61 114.8 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -146.32 158.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.934 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 69' ' ' VAL . 69.0 mt -72.66 163.69 27.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -136.57 157.51 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.733 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.8 t70 -149.29 154.01 38.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 43.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.955 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 60.2 -175.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t 60.47 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.56 68.88 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 59.7 -174.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.7 p -86.06 85.13 7.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 55' ' ' ASP . 20.0 t 68.95 -67.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.24 -156.12 21.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.7 -30.03 8.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.36 53.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.1 113.55 31.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.55 25.85 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.93 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.68 148.34 29.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.959 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 53' ' ' LEU . 27.5 m -129.63 156.89 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.6 p -140.19 122.88 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HG2' HD12 ' A' ' 51' ' ' ILE . 2.4 mttm -106.4 121.93 45.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' A' ' 128' ' ' PHE . 3.3 t -113.16 146.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.22 136.75 16.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.731 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.33 89.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.364 2.043 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 59.61 172.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.7 81.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.04 -29.34 6.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.15 -165.9 22.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.65 29.29 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.936 2.424 . . . . 0.0 112.808 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.543 HD23 ' HD3' ' A' ' 127' ' ' ARG . 12.3 tp -77.91 -31.88 51.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -67.01 -42.46 84.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 201' ' ' ALA . 11.4 t -69.17 -28.62 66.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.956 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -40.4 69.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.65 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.1 mm? -63.69 -44.54 93.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.04 92.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.46 -43.04 95.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.892 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.4 m-85 -60.07 -44.41 94.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -79.83 -17.6 52.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.382 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -65.35 -47.8 75.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.784 0.326 . . . . 0.0 111.046 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.68 33.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.255 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -119.44 -10.68 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 163.84 0.44 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.696 0.284 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.44 -19.39 43.59 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.614 2.209 . . . . 0.0 112.493 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -75.62 -39.74 57.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -79.34 -42.09 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.486 HD12 ' HB ' ' A' ' 110' ' ' VAL . 28.0 mm -58.36 -48.78 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -70.2 -49.58 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.174 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -58.15 -51.7 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.08 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 108' ' ' LEU . 27.9 mt -61.41 -35.72 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -75.07 -27.84 60.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.29 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -82.38 -37.76 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.468 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -104.8 -1.2 26.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 58.33 31.24 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.763 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HB2' HG23 ' A' ' 100' ' ' ILE . 51.2 mt -51.28 -26.84 7.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.215 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.0 tttt 58.2 94.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.1 t80 63.87 132.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 100' ' ' ILE . 11.4 tp -125.54 163.71 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.6 10.05 66.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.923 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.579 HG21 ' CD2' ' A' ' 167' ' ' TYR . 23.2 t -92.74 123.43 61.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.757 0.278 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 146.38 49.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.075 . . . . 0.0 112.248 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -89.34 119.83 30.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -74.93 123.65 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.81 -40.61 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.47 46.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.704 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -145.52 163.39 34.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.66 -174.98 35.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.707 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -145.5 159.84 42.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -133.38 141.7 48.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.33 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 126.34 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.63 18.46 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.53 20.67 36.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.626 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 0.3 OUTLIER -121.13 128.94 53.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.17 130.87 37.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 124' ' ' LYS . 9.8 m-85 -120.26 143.46 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.543 ' HD3' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -107.04 133.14 52.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.897 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.3 p90 -137.88 163.68 30.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.687 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.7 ttm -129.46 136.33 49.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.423 HG21 ' CZ3' ' A' ' 37' ' ' TRP . 17.6 mt -109.2 119.27 58.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.42 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -134.01 173.23 11.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.795 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.74 145.24 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.208 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -73.4 160.64 31.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 184' ' ' LEU . 92.5 m-85 -132.3 154.92 49.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.98 -99.31 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.342 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.58 125.28 47.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.6 p30 -53.5 158.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -63.79 -21.66 66.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.724 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -61.53 -40.5 94.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 0.0 109.981 178.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 138' ' ' LEU . 3.1 mt -73.13 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -67.37 -49.02 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.57 -28.58 59.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.873 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.19 -23.63 66.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -98.75 20.89 12.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.77 48.66 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.243 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt 63.37 18.97 11.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.311 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 -176.16 4.52 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.452 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -128.14 -176.0 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.908 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -117.26 135.33 53.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.829 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.768 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -57.48 -26.57 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -42.44 64.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.3 p -74.83 -35.58 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.745 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 150' ' ' SER . 42.4 t -57.68 -53.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.971 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.669 HD23 HD22 ' A' ' 324' ' ' LEU . 52.7 mt -63.87 -44.31 93.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.777 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -62.17 -45.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.692 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 193' ' ' VAL . 13.6 mt -70.15 -37.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.737 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.1 m -56.55 -37.33 70.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 328' ' ' LEU . 11.4 mt -73.96 -46.77 41.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.07 -46.19 90.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 178' ' ' ILE . 11.4 mt -66.54 -34.43 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.757 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.6 mt -60.03 -36.76 77.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.98 -40.1 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.56 HD21 HD11 ' A' ' 178' ' ' ILE . 82.3 mt -58.04 -42.02 84.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.653 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.69 -45.11 95.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CD2' HG21 ' A' ' 110' ' ' VAL . 60.8 t80 -60.26 -53.01 62.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.3 pt -66.99 -27.17 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.408 ' CD2' ' OH ' ' A' ' 204' ' ' TYR . 8.2 t-160 -78.07 -36.5 48.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.645 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -16.98 62.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -94.57 -1.03 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 75.85 37.71 0.38 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.16 116.03 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.726 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.9 m -112.04 141.82 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.266 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 198' ' ' TYR . 0.8 OUTLIER -179.36 66.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.645 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.641 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -63.1 79.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.661 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -106.35 26.83 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 183' ' ' LEU . 3.3 mp -59.76 103.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.022 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -143.4 170.14 16.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.895 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -77.3 -3.35 39.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.282 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.8 t -112.62 2.26 16.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.658 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -126.53 -5.41 6.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.098 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 184' ' ' LEU . 10.9 mt -108.44 127.55 54.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -136.94 150.08 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.908 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 193' ' ' VAL . 13.8 mt -86.67 149.41 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.256 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.49 127.99 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.746 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.459 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 23.9 t80 -86.47 -43.67 12.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.544 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -20.73 62.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -149.6 71.0 9.76 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.616 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.06 91.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.735 2.29 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.45 31.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.57 155.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.014 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 138' ' ' LEU . 3.7 p -109.94 148.16 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 5.3 m-85 -119.66 156.9 29.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 35.9 tp -106.9 115.8 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 184' ' ' LEU . 24.2 m -115.95 141.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.371 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.45 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.023 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 175' ' ' HIS . 5.2 m-85 -90.22 -19.18 24.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.39 23.29 73.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.373 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 mp -156.32 -68.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 45.67 88.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -137.4 149.11 46.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.998 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.4 81.19 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.713 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.726 ' CD1' HG13 ' A' ' 174' ' ' VAL . 13.3 p90 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.421 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.789 -0.125 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 225' ' ' ILE . 67.0 m 61.74 -90.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.623 0.212 . . . . 0.0 110.77 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.567 HD11 ' CG1' ' A' ' 271' ' ' VAL . 5.9 tp -179.15 35.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.53 -45.19 13.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -157.57 35.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 118.48 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 176.29 8.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 276' ' ' ILE . 3.6 mt -61.83 -31.77 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -74.49 -41.6 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -27.69 66.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -94.79 -17.33 22.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.207 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.32 24.93 10.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.4 t -89.36 145.18 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -119.08 -61.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 50.3 Cg_exo -55.89 107.33 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.223 1.949 . . . . 0.0 112.299 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.23 -52.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 77.44 -2.82 2.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.768 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -89.55 -23.1 22.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.72 0.295 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.5 -49.74 70.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.701 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.11 -33.44 73.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 320' ' ' LEU . 25.8 mt -80.55 -33.06 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.15 -38.79 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 176' ' ' GLY . 17.4 mt -63.59 -43.95 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.25 -33.51 75.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.511 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.11 -41.83 99.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 252' ' ' ILE . 61.2 m-85 -78.52 -25.69 45.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 111.342 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 3.6 m -56.74 -39.99 74.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.372 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.476 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -68.87 -48.81 62.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.249 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 285' ' ' LEU . 6.1 mt -57.33 -33.45 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.398 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.566 ' HB2' HD21 ' A' ' 259' ' ' LEU . 7.9 tt0 -80.03 -42.7 23.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 0.0 110.928 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.4 m0 -74.1 -24.27 59.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.37 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 151' ' ' ARG . 5.3 mt -96.47 -35.86 10.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.59 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 m -96.2 -14.25 22.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.82 92.27 0.41 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 38.4 m80 61.52 153.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.337 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.882 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -125.21 162.63 42.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.509 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.65 62.13 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 112.424 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.882 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 6.8 p90 176.42 -38.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.468 ' HA ' HD21 ' A' ' 265' ' ' LEU . 1.2 tm-20 -94.26 18.93 10.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.155 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.19 -55.54 13.65 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.5 -28.72 2.26 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.444 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 225' ' ' ILE . 48.0 mt 73.51 10.73 4.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -79.08 -15.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.215 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.473 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.4 m-20 -135.94 101.26 10.54 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.04 16.45 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.674 2.249 . . . . 0.0 112.873 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -79.52 -49.78 11.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.8 p90 -75.83 -29.33 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.567 ' CG1' HD11 ' A' ' 225' ' ' ILE . 6.9 t -62.16 -36.44 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -75.47 -49.3 19.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.19 -35.53 78.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 53.8 m -67.23 -46.14 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.176 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.36 -40.92 96.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 230' ' ' ILE . 12.2 mt -68.24 -35.03 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -81.18 -50.17 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.4 m-85 -58.36 -40.36 82.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.49 -35.44 63.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.744 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -102.83 16.57 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.143 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.93 46.63 1.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.855 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.74 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.6 mt -53.42 -35.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.92 -26.22 60.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.217 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 29.5 t -72.98 -42.55 63.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.502 HD13 HD13 ' A' ' 252' ' ' ILE . 3.2 pp -77.49 -30.79 53.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 7.2 mmt -66.14 -38.65 88.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.639 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -29.79 28.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -82.87 -53.48 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 65.3 m -74.12 -41.19 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 286' ' ' MET . 50.4 m-85 -112.05 152.12 44.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.832 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.57 -46.31 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 54.88 27.83 9.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.43 -31.82 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -106.6 -75.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.021 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.45 110.26 9.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 176.46 6.66 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.378 2.052 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.26 4.85 38.21 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.826 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.06 14.94 5.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 111.297 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.476 HD12 ' SD ' ' A' ' 251' ' ' MET . 30.2 mm -79.44 -43.69 23.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.738 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -49.75 -43.91 48.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.212 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HD2' HG23 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -60.46 -38.58 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.777 ' HA ' HD13 ' A' ' 323' ' ' ILE . 11.2 t80 -71.25 -45.52 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.74 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.3 mtp -61.38 -41.81 97.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -45.52 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.691 ' O ' HD12 ' A' ' 309' ' ' LEU . 33.2 m -62.26 -29.6 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.566 ' HA ' HD12 ' A' ' 309' ' ' LEU . 84.3 t -79.39 -24.0 12.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.343 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 -35.98 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 10.6 tp -110.64 -29.99 7.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.276 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 1.143 HD21 HD22 ' A' ' 316' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 CA-C-O 120.8 0.25 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 1.143 HD22 HD21 ' A' ' 309' ' ' LEU . 0.5 OUTLIER -91.62 0.23 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.358 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 244' ' ' LEU . 72.9 m-85 -60.72 -30.14 69.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.132 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -39.46 78.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -82.08 -35.98 28.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 323' ' ' ILE . 59.2 mt -57.53 -50.73 72.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.056 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.422 ' HA ' HD21 ' A' ' 159' ' ' LEU . 8.4 ptm180 -56.08 -45.48 79.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.147 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -40.75 79.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.1 mt -58.35 -47.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.669 HD22 HD23 ' A' ' 155' ' ' LEU . 72.4 mt -72.69 -50.85 22.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.011 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -53.01 -49.84 65.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.382 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 -39.33 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.7 71.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 325' ' ' LEU . 13.4 mt -66.73 -38.87 87.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.936 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -61.2 -27.07 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.81 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.9 pt -117.93 20.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.538 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 49.9 43.35 39.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.752 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.1 m -97.95 36.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.05 144.06 45.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.37 114.48 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HA2' ' A' ' 40' ' ' GLY . 3.4 m -59.12 145.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.76 -25.29 28.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -112.5 133.56 54.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.012 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mt -100.38 147.86 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.925 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 46.6 pt -116.77 154.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 111.457 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -97.64 141.61 30.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.743 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.34 -162.66 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -36.3 32.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -84.95 5.06 30.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.299 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 11.5 mmtm 79.63 31.36 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.884 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' THR . 9.7 mttp -75.14 177.0 6.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.957 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 80.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.513 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 91.6 m95 -80.1 137.64 36.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.976 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -93.86 119.81 33.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.09 149.6 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -125.03 -146.37 6.8 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.579 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 159.19 31.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.26 168.24 18.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.57 2.18 . . . . 0.0 112.332 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -137.6 79.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.479 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 13.1 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 71' ' ' LYS . 8.4 mt -82.27 104.57 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -143.6 162.82 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 8.0 mt -78.49 158.41 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -139.03 159.05 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.6 159.64 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.96 41.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.71 82.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 t -114.96 -38.23 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.1 t -127.6 -172.78 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.73 -49.34 75.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 156.84 45.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.68 99.82 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.17 -105.77 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 53.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -165.58 38.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -68.67 142.75 94.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.73 8.79 4.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.692 2.261 . . . . 0.0 113.023 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.2 m -149.69 148.24 29.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.873 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.2 m -120.94 144.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 130' ' ' ILE . 8.9 p -127.27 128.2 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.298 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.72 120.63 39.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.662 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.763 HG22 ' CB ' ' A' ' 128' ' ' PHE . 3.1 t -113.22 152.07 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.939 0.399 . . . . 0.0 111.421 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HB3' ' CB ' ' A' ' 76' ' ' ASP . 7.1 mt-10 -135.85 126.24 16.64 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.56 87.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.478 2.119 . . . . 0.0 112.428 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t 48.97 33.29 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.275 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 2.1 t70 -89.89 161.73 15.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -155.42 145.22 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.82 ' O ' HG23 ' A' ' 82' ' ' THR . . . 135.04 -75.4 0.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -44.59 1.98 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.593 2.195 . . . . 0.0 112.263 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.425 ' HG ' HD23 ' A' ' 84' ' ' LEU . 5.1 tp -77.89 -37.78 47.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -58.52 -29.39 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.012 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 78' ' ' GLY . 67.1 p -75.77 -28.55 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.71 -42.81 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.886 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.4 mm? -68.71 -32.75 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -71.03 -51.78 23.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 73.5 t80 -67.0 -40.81 87.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.946 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.94 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-30 -57.13 -45.12 83.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 73.6 mt-30 -79.89 -17.67 52.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -47.6 19.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.97 -29.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -71.41 3.46 3.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 11.1 mtpt -52.57 159.54 1.65 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.745 0.307 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.22 -32.82 12.32 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.478 2.119 . . . . 0.0 112.288 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.57 -30.02 41.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -75.89 -54.04 7.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.399 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 100' ' ' ILE . 70.5 mt -57.71 -53.23 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.359 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -51.35 -35.66 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.205 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -36.09 78.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -77.08 -42.49 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.7 mt -65.51 -33.17 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -27.67 60.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.1 m -72.6 -36.77 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -5.42 19.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.34 29.68 19.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.886 0.374 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 100' ' ' ILE . 21.7 mt -50.89 -33.52 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.237 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 76.83 -55.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 138.67 50.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.493 HD21 ' CD1' ' A' ' 167' ' ' TYR . 11.0 tp -120.62 -66.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 131.98 -9.83 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.98 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.35 131.05 66.66 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.709 0.255 . . . . 0.0 111.175 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.13 147.56 26.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.273 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -87.33 115.51 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -88.31 126.46 35.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -105.74 -40.72 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.96 -174.62 46.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.623 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -136.58 162.76 32.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -142.46 174.43 23.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.824 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 127' ' ' ARG . 32.2 mt -148.08 159.83 43.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 110.945 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.64 122.1 11.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.028 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.85 118.47 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.22 126.32 22.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.23 20.58 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.527 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.36 -1.3 60.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.94 129.0 43.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.762 0.315 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t -96.22 123.05 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.25 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -106.71 121.28 44.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.488 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.687 ' HA ' HD23 ' A' ' 118' ' ' LEU . 43.5 mtp85 -106.35 125.08 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.4 p90 -139.81 158.76 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.886 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.4 tmm? -128.05 147.21 50.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.647 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.447 HG12 HG23 ' A' ' 70' ' ' VAL . 20.5 mt -121.34 112.73 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.102 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.97 173.41 7.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.169 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.19 148.74 4.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.873 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.9 tpt180 -65.38 155.69 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -128.58 160.01 33.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.29 -110.29 2.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.555 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 p -107.98 125.79 51.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.762 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.743 ' OD1' HD22 ' A' ' 184' ' ' LEU . 10.1 m-20 -58.65 160.34 5.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.813 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.792 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -65.77 -24.35 66.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.591 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 1.2 mt-30 -63.71 -44.29 94.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 110.15 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -60.71 -30.68 70.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.26 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 138' ' ' LEU . 40.1 mt -72.87 -25.2 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.762 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 147' ' ' LYS . 76.7 t80 -67.75 -48.85 65.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.619 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.59 -27.96 58.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.741 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.02 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 77.7 m-20 -97.51 -1.8 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.263 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.7 45.34 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.166 0.507 . . . . 0.0 110.345 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 51.7 mttt 61.33 20.91 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.396 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -135.11 107.86 7.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 142' ' ' TYR . 2.0 m-85 -77.93 -172.93 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 154' ' ' VAL . 23.0 t -116.9 150.37 38.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -60.43 -29.4 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.648 ' HG2' HD12 ' A' ' 331' ' ' ILE . 17.3 mtmt -73.81 -43.75 57.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -61.3 -52.04 66.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.43 HG21 ' HG ' ' A' ' 255' ' ' LEU . 46.1 t -54.84 -54.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 328' ' ' LEU . 49.0 mt -62.47 -47.87 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.52 -43.12 93.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.68 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.645 HD22 HG11 ' A' ' 193' ' ' VAL . 22.4 mt -69.1 -35.27 76.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.591 ' OG ' HD21 ' A' ' 247' ' ' LEU . 0.5 OUTLIER -57.32 -42.24 81.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 325' ' ' LEU . 90.5 mt -70.06 -43.19 71.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.726 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -64.27 -49.27 72.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 164' ' ' ILE . 14.2 mt -66.36 -36.23 76.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.54 -36.03 77.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -35.86 74.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.78 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 161' ' ' ILE . 7.0 mt -76.89 -37.3 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.39 -41.85 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.15 -30.96 68.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.696 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.493 ' CD1' HD21 ' A' ' 108' ' ' LEU . 48.5 t80 -70.93 -53.35 15.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.467 HD11 ' CE1' ' A' ' 175' ' ' HIS . 12.1 pt -66.67 -27.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.407 ' N ' HG13 ' A' ' 168' ' ' ILE . 12.3 m170 -75.21 -32.85 61.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.92 -16.96 62.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.58 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -100.47 3.2 42.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 67.71 42.44 2.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.422 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 0.3 OUTLIER -131.64 127.48 37.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.06 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.795 HG11 ' HB3' ' A' ' 239' ' ' SER . 3.7 m -113.57 169.21 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.066 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.709 ' CD2' HD21 ' A' ' 195' ' ' LEU . 18.7 p-80 -147.42 -50.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 53.42 52.83 38.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.646 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.58 28.98 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.253 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.82 106.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.719 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.497 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -153.55 -177.76 6.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.591 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -81.7 -0.08 41.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.293 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 p -109.11 1.23 20.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.44 -6.65 4.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.519 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 184' ' ' LEU . 17.9 mt -108.59 127.98 54.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -134.97 156.82 48.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.164 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.9 mt -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.307 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.26 130.32 42.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 133' ' ' ARG . 6.1 t80 -75.01 -54.41 7.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -21.3 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.506 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -135.89 73.68 59.32 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 102.0 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.526 2.151 . . . . 0.0 112.147 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -177.44 -35.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -176.77 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -132.56 148.12 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 6.3 m-85 -121.06 156.94 31.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.142 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.709 HD21 ' CD2' ' A' ' 175' ' ' HIS . 60.4 tp -106.62 115.88 30.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.34 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 184' ' ' LEU . 11.1 m -106.64 143.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.58 104.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 175' ' ' HIS . 5.8 m-30 -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.697 ' C ' HD22 ' A' ' 200' ' ' LEU . . . 88.98 -50.66 3.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.398 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 199' ' ' GLY . 2.9 mm? -118.61 -38.72 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.665 0.269 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.37 82.09 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.252 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -118.86 148.96 42.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.422 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 11.0 mtp180 -102.39 70.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.687 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.781 ' CD1' HG13 ' A' ' 174' ' ' VAL . 43.6 p90 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.26 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 200' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -147.47 146.3 29.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.892 HG23 HD22 ' A' ' 265' ' ' LEU . 6.9 tp -68.01 -11.13 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.804 ' HG3' HD11 ' A' ' 265' ' ' LEU . 1.0 OUTLIER -52.47 -36.75 55.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.408 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 62.9 m-85 -157.42 33.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.25 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.727 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -66.53 139.92 57.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.786 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 0.3 OUTLIER -84.6 131.83 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 275' ' ' LYS . 2.6 mt -59.31 -58.85 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.61 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -62.41 -44.19 97.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -57.07 -45.18 83.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -61.82 -27.84 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.632 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.6 t-20 -90.07 -0.1 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.393 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.16 87.2 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.002 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 234' ' ' ASN . 21.2 t -54.13 107.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.56 165.94 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.718 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 36.1 Cg_endo -65.24 148.08 88.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.795 ' HB3' HG11 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -59.46 109.7 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.25 -47.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -67.21 -30.41 70.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.61 91.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.82 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 m-20 -57.16 -32.68 66.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 110.982 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.764 HD21 ' CE2' ' A' ' 317' ' ' TYR . 84.0 mt -80.57 -37.4 31.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -61.71 -37.72 85.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -61.93 -49.28 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.667 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.5 tp -64.8 -40.73 95.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.97 92.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -78.67 -25.88 44.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.15 -39.97 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -50.0 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.761 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.96 -30.56 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.3 tt0 -80.05 -39.94 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.07 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -82.23 -25.8 33.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.381 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 154' ' ' VAL . 16.6 mt -91.22 -44.68 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.223 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.23 0.61 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 65.36 100.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.3 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 3.8 p80 55.67 165.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.888 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -135.38 168.46 17.5 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.507 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 43.2 Cg_endo -68.33 63.33 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.379 2.053 . . . . 0.0 112.457 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.888 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 3.8 p90 175.19 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.013 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -95.21 19.78 10.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.47 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -57.67 4.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 87.0 m-20 -126.91 -26.02 3.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.343 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.892 HD22 HG23 ' A' ' 225' ' ' ILE . 48.4 mt 71.3 12.41 6.72 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.106 0.479 . . . . 0.0 109.822 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -12.89 49.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.196 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 271' ' ' VAL . 29.4 m-20 -124.06 79.63 58.42 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.92 -11.12 29.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.767 2.311 . . . . 0.0 112.597 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -47.65 22.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.069 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -75.3 -26.15 58.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.884 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 261' ' ' TRP . 77.8 t -57.78 -35.22 50.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.591 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -75.59 -41.69 53.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -40.48 82.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.079 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 67.1 m -75.44 -29.93 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.807 ' HB3' HD11 ' A' ' 230' ' ' ILE . 11.6 mmtp -73.54 -45.9 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.069 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.02 -38.57 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -65.12 -52.0 57.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.524 ' CG ' HD12 ' A' ' 285' ' ' LEU . 13.0 m-85 -62.05 -35.12 77.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.444 ' HD3' HD12 ' A' ' 230' ' ' ILE . 0.4 OUTLIER -57.33 -29.28 63.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -118.9 24.0 11.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -140.34 42.52 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 303' ' ' MET . 6.4 mm -47.6 -41.07 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.39 63.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.97 68.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.524 HD12 ' CG ' ' A' ' 278' ' ' TYR . 5.0 tt -64.76 -51.16 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.707 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.574 ' HG3' ' HB2' ' A' ' 300' ' ' ALA . 10.4 mmt -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.734 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.4 -26.54 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -82.76 -52.87 6.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.075 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.92 -41.17 37.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.57 87.38 7.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.41 76.2 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.441 2.094 . . . . 0.0 112.253 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -172.42 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.24 58.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.66 -68.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 296' ' ' PRO . 1.4 mtpp -152.27 101.19 2.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 19.1 Cg_endo -60.2 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.224 1.95 . . . . 0.0 111.975 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -174.86 28.82 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.595 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 68.16 7.01 5.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.502 0.191 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.662 HG22 ' CG ' ' A' ' 303' ' ' MET . 24.3 mm -79.8 -45.7 22.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 110.963 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 286' ' ' MET . . . -44.51 -46.74 9.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.585 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -43.06 89.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.768 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.879 ' CE2' HD11 ' A' ' 324' ' ' LEU . 18.4 t80 -70.56 -46.47 63.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.662 ' CG ' HG22 ' A' ' 299' ' ' ILE . 62.6 mmm -66.06 -37.71 86.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.748 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -42.36 98.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.564 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 42.2 m -67.65 -31.74 71.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 309' ' ' LEU . 66.3 t -79.35 -24.4 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.195 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.33 -40.74 58.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.11 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.79 -27.11 12.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.6 mp . . . . . 0 N--CA 1.462 0.159 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.888 0.287 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 319' ' ' ASN . 0.9 OUTLIER -151.01 41.24 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.764 ' CE2' HD21 ' A' ' 244' ' ' LEU . 11.3 m-85 -59.16 -30.09 67.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.75 -47.91 83.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.894 ' HB2' HD22 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -63.67 -35.01 79.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.976 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.922 ' HA ' HD12 ' A' ' 323' ' ' ILE . 57.9 mt -59.57 -42.12 91.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -63.12 -36.39 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.97 73.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 320' ' ' LEU . 20.8 mt -66.26 -49.24 77.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.879 HD11 ' CE2' ' A' ' 302' ' ' TYR . 5.8 mt -76.2 -24.54 54.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.261 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.768 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.6 tt -82.64 -44.75 15.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -59.47 -37.1 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.37 76.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.53 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 159' ' ' LEU . 13.2 mt -59.98 -41.2 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -27.69 61.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.14 -26.29 62.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.31 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.648 HD12 ' HG2' ' A' ' 152' ' ' LYS . 27.7 pt -106.3 -27.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.221 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.21 7.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -65.45 0.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.829 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.91 108.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.442 ' OD2' HD12 ' A' ' 328' ' ' LEU . 5.8 m-20 -70.08 89.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.84 143.64 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.82 26.36 69.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.548 ' O ' HD13 ' A' ' 28' ' ' ILE . 14.8 mm-40 -92.1 170.53 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.548 HD13 ' O ' ' A' ' 27' ' ' GLU . 26.7 mm -126.28 126.26 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.228 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.962 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 36.3 pt -116.87 154.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 t -95.56 141.48 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.916 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -160.81 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.04 -39.12 26.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.156 0.503 . . . . 0.0 109.895 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -84.42 2.83 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 7.4 mttt 86.08 30.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.47 178.62 5.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -130.63 80.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.2 m95 -78.19 144.93 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.004 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG2' HD13 ' A' ' 28' ' ' ILE . 11.5 mtpp -97.28 148.22 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.58 127.64 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.81 -143.13 12.23 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.54 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.47 152.55 39.34 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.45 165.96 2.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.294 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.769 HG13 HG22 ' A' ' 51' ' ' ILE . 14.3 pt -154.42 29.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.393 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 97.9 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.769 HG22 HG13 ' A' ' 43' ' ' ILE . 28.9 mm -92.56 83.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -119.93 172.1 7.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.4 165.88 19.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -130.75 150.22 52.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.417 ' CB ' HG22 ' A' ' 62' ' ' VAL . 26.1 t0 -139.89 157.06 46.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.5 57.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.92 94.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.25 -172.16 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -75.65 -38.88 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.74 -68.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -155.48 161.86 40.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 66' ' ' ALA . 21.6 t -74.76 114.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.96 -69.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -119.06 32.03 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.72 87.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -167.62 80.9 0.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.11 49.55 3.17 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.708 2.272 . . . . 0.0 112.642 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.2 m -149.79 148.23 28.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 43' ' ' ILE . 16.9 m -122.96 144.98 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 130' ' ' ILE . 8.0 p -132.94 129.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.156 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.54 124.09 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.665 HG22 ' CB ' ' A' ' 128' ' ' PHE . 2.6 t -113.15 139.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -141.15 144.0 33.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.705 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.92 109.09 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.484 2.122 . . . . 0.0 112.289 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 t -57.83 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.21 -49.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -167.46 110.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.5 39.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.563 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HG3' HD12 ' A' ' 200' ' ' LEU . 71.6 Cg_endo -77.14 -0.77 10.93 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.634 2.222 . . . . 0.0 112.729 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.91 -41.97 92.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -48.92 73.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.502 HG22 ' HA2' ' A' ' 199' ' ' GLY . 6.6 m -75.08 -36.47 61.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.63 -53.04 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HG3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -62.71 -35.6 80.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.871 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 51.1 t80 -65.15 -37.97 89.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.941 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.0 m-85 -55.87 -53.33 58.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -17.35 53.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.605 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.31 -47.56 12.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -128.19 -24.11 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -90.6 23.05 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -70.91 130.08 88.84 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.81 -24.72 76.95 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.459 2.106 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.43 -35.8 39.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.965 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -79.38 -50.24 11.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 91' ' ' ALA . 48.8 mt -62.58 -57.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -50.18 -55.33 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.359 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -31.37 63.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -77.32 -49.71 14.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 106' ' ' LYS . 22.2 mt -75.04 -23.26 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.876 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -27.36 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.626 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.9 p -77.98 -11.05 59.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.358 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 78.18 13.87 1.55 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -83.36 -14.53 52.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.449 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 105' ' ' LEU . 5.0 mt -111.28 -51.46 2.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 100' ' ' ILE . 1.0 OUTLIER 76.14 -56.55 0.58 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CG ' ' NE2' ' A' ' 192' ' ' GLN . 41.1 t80 -145.33 145.03 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 167' ' ' TYR . 11.1 tp -126.12 -43.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 95.41 -7.69 68.89 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.741 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' HG ' ' A' ' 108' ' ' LEU . 35.6 t -78.04 136.64 61.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.72 0.26 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 110' ' ' VAL . 20.1 Cg_endo -60.61 143.46 99.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.457 2.105 . . . . 0.0 112.239 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -84.96 115.65 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.455 ' CE1' HD21 ' A' ' 84' ' ' LEU . 40.0 t80 -89.03 126.76 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -103.48 -40.63 6.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.01 -178.37 45.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.614 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.1 t -132.62 161.15 34.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.64 0.257 . . . . 0.0 110.523 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.05 170.65 30.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.802 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 127' ' ' ARG . 1.8 mt -137.91 159.14 42.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.782 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.77 125.16 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.019 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 130.78 46.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -138.2 126.29 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.13 17.15 6.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.41 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.94 -11.42 55.97 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.922 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -96.09 129.03 43.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 t -93.45 131.67 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -113.0 151.01 31.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.623 ' HA ' HD23 ' A' ' 118' ' ' LEU . 31.7 ttm180 -116.56 132.22 56.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.962 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 17.1 p90 -141.24 159.89 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.464 ' HG3' HD21 ' A' ' 84' ' ' LEU . 1.9 ttm -128.17 145.74 50.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 29' ' ' ILE . 16.3 mt -120.2 111.54 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -123.49 173.3 8.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.69 134.52 24.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 145.52 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.648 ' CD2' HD12 ' A' ' 184' ' ' LEU . 48.6 m-85 -109.27 166.38 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.28 -100.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.503 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 m -125.41 127.61 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.887 ' OD1' HD22 ' A' ' 184' ' ' LEU . 2.1 m-20 -56.67 159.56 3.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -65.65 -20.16 66.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.492 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.581 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 2.4 mt-30 -51.09 -32.74 23.34 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 121.062 0.458 . . . . 0.0 110.335 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -30.89 51.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.132 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 138' ' ' LEU . 30.6 mt -76.69 -25.16 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 147' ' ' LYS . 12.1 t80 -77.88 -45.32 24.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.552 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -29.59 62.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.31 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -99.67 9.06 43.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.018 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.24 49.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.143 0.497 . . . . 0.0 110.02 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 258' ' ' HIS . 0.1 OUTLIER 62.55 21.4 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.132 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -120.74 161.1 22.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.668 ' HE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -146.41 143.39 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 144.39 37.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HG2' HD21 ' A' ' 255' ' ' LEU . 6.6 mtm-85 -56.4 -26.35 52.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -73.85 -41.95 61.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.668 HG21 ' HE1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -62.83 -45.72 91.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 251' ' ' MET . 39.8 t -62.21 -54.09 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.251 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 328' ' ' LEU . 97.7 mt -57.32 -48.13 79.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.31 -50.71 70.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.644 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.52 -41.01 96.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 324' ' ' LEU . 66.3 m -55.62 -41.26 73.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.67 -49.2 76.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.427 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -47.24 86.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.763 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 178' ' ' ILE . 15.5 mt -64.99 -37.61 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 165' ' ' LEU . 6.9 mt -58.14 -37.8 75.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.94 -31.96 70.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.4 mt -74.42 -45.54 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.782 HD21 HD11 ' A' ' 178' ' ' ILE . 15.8 mt -60.02 -45.37 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 2.6 mt-10 -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.788 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.843 ' CE2' HD21 ' A' ' 108' ' ' LEU . 25.3 t80 -75.22 -48.99 20.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.871 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 27.0 pt -74.04 -38.8 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.666 ' CD2' HG12 ' A' ' 174' ' ' VAL . 18.2 t-80 -68.73 -25.18 64.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -98.0 -1.34 42.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.306 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.26 -58.38 1.9 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.717 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 204' ' ' TYR . 0.5 OUTLIER 168.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.473 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 86' ' ' PHE . 64.9 m-85 -159.51 126.37 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 0.0 110.996 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.666 HG12 ' CD2' ' A' ' 169' ' ' HIS . 30.4 m -132.55 147.5 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.433 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 38.7 t-80 77.79 47.07 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -58.81 -18.41 39.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.861 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 195' ' ' LEU . 7.2 t70 74.52 97.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.838 0.351 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.782 HD11 HD21 ' A' ' 165' ' ' LEU . 3.9 mp -97.32 114.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.759 ' O ' HD12 ' A' ' 183' ' ' LEU . 4.7 tmtm? -148.02 179.44 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.581 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -83.72 0.75 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -115.21 2.16 14.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.476 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.802 ' O ' HG22 ' A' ' 196' ' ' VAL . 20.0 m-20 -125.51 -7.49 6.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.556 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.29 113.61 26.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.113 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.887 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -119.04 148.0 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.191 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 141' ' ' ILE . 40.5 mt -86.69 148.53 25.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.212 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.72 127.48 31.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.58 -41.5 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.777 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -77.24 -23.64 51.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.822 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.09 61.67 12.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.57 114.86 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.651 2.234 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -177.49 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.405 ' NE2' ' CG ' ' A' ' 107' ' ' TYR . 3.2 mt-30 -131.2 177.26 7.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.795 HG21 HD21 ' A' ' 138' ' ' LEU . 9.9 p -121.08 147.33 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.44 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 3.6 m-85 -113.62 150.6 32.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 178' ' ' ILE . 30.1 tp -104.14 117.61 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 182' ' ' ASN . 9.2 m -92.17 -179.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.57 93.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -117.72 -49.82 2.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.706 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 82' ' ' THR . . . -59.06 -21.06 52.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -84.86 3.61 37.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.473 0.178 . . . . 0.0 111.421 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 174' ' ' VAL . . . -92.5 -109.61 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 174' ' ' VAL . 46.0 t80 -146.32 118.13 8.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 110.435 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -90.25 77.79 6.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.317 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 172' ' ' GLU . 8.3 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.183 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 228' ' ' THR . 0.6 OUTLIER -158.49 133.9 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.925 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.901 HG23 HD22 ' A' ' 265' ' ' LEU . 7.1 tp -65.63 -13.41 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.443 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.95 -51.03 25.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.742 0.306 . . . . 0.0 111.348 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -145.56 31.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.224 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 225' ' ' ILE . 12.9 t -56.87 116.52 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.319 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 t -57.47 163.31 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mt -60.76 -37.73 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.34 -31.32 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.06 -36.5 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.22 -32.16 73.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -92.2 12.95 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.263 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.39 24.07 55.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.611 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 28.8 t -67.87 136.42 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 238' ' ' PRO . . . -68.98 -62.45 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 237' ' ' ALA . 21.5 Cg_endo -61.2 125.6 17.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.508 2.138 . . . . 0.0 112.353 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.6 OUTLIER -164.95 121.16 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -127.51 -44.25 1.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -8.21 55.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.51 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.61 -49.71 71.35 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.2 p30 -60.36 -34.44 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.374 . . . . 0.0 111.054 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.415 ' CD1' HD13 ' A' ' 309' ' ' LEU . 77.0 mt -78.03 -33.42 51.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.03 -37.28 87.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -65.29 -45.76 92.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.773 HD23 ' OH ' ' A' ' 302' ' ' TYR . 29.2 tp -62.0 -37.23 84.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.87 -43.78 97.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.606 ' HA ' HD12 ' A' ' 252' ' ' ILE . 28.6 m-85 -78.52 -25.65 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 254' ' ' TRP . 6.0 m -56.65 -38.41 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.279 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.413 ' CG ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -69.85 -48.96 56.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.086 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.912 ' O ' HG22 ' A' ' 256' ' ' THR . 5.0 mt -59.59 -51.74 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.178 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.593 ' HB3' HD21 ' A' ' 259' ' ' LEU . 1.1 pt20 -63.55 -28.61 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 20.7 m0 -82.35 -28.49 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.267 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 151' ' ' ARG . 82.8 mt -86.75 -41.68 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 252' ' ' ILE . 15.0 t -96.23 0.56 51.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.498 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.8 97.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.499 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 147' ' ' LYS . 5.1 m-70 64.16 166.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.903 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -132.29 162.44 56.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.7 Cg_endo -67.44 64.19 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.361 2.041 . . . . 0.0 112.433 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.903 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 2.3 p90 177.19 -36.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.169 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.6 tt0 -88.14 10.71 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.536 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.89 -48.13 82.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.9 t-20 -130.54 -29.22 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.387 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.901 HD22 HG23 ' A' ' 225' ' ' ILE . 85.9 mt 71.97 11.64 6.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -14.37 54.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.418 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.467 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -136.89 87.4 19.56 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.104 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 24.7 Cg_exo -63.01 -10.61 21.17 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.68 2.253 . . . . 0.0 112.484 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -49.81 -50.22 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.331 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.4 p90 -81.12 -26.17 36.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 225' ' ' ILE . 50.5 t -61.62 -40.89 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.044 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -75.55 -45.06 40.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.06 -46.97 84.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 59.1 m -58.56 -43.59 89.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -41.7 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.582 HG23 ' NH1' ' A' ' 279' ' ' ARG . 20.3 mt -77.47 -28.98 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.376 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -81.36 -52.17 7.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.608 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 285' ' ' LEU . 4.9 m-85 -64.0 -40.57 96.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.642 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.582 ' NH1' HG23 ' A' ' 276' ' ' ILE . 0.2 OUTLIER -52.1 -26.57 11.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.939 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -113.83 17.76 17.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.34 35.57 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.717 HD13 ' CB ' ' A' ' 303' ' ' MET . 20.5 mt -47.24 -48.61 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.53 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.78 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.196 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 252' ' ' ILE . 0.8 OUTLIER -68.57 -37.82 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.424 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.546 ' HG2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -65.06 -40.22 94.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.725 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -23.3 42.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -82.66 -54.03 5.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.205 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.3 m -79.25 -41.21 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.415 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.29 149.75 39.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -48.65 20.73 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.526 2.151 . . . . 0.0 112.267 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.46 31.1 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -30.84 23.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -170.58 119.59 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm 59.44 97.75 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 -167.47 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.253 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.16 11.49 69.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.878 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 71.0 10.41 6.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.686 0.243 . . . . 0.0 111.341 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.534 HG22 ' CG ' ' A' ' 303' ' ' MET . 37.4 mm -79.59 -45.79 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.788 0.328 . . . . 0.0 110.824 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 286' ' ' MET . . . -44.86 -43.32 8.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.449 ' CB ' HG23 ' A' ' 323' ' ' ILE . 61.3 mttt -60.24 -43.99 95.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.533 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.864 ' O ' HG23 ' A' ' 306' ' ' VAL . 43.2 t80 -68.53 -39.41 81.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.717 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.6 mtp -68.43 -37.29 80.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.342 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.04 -50.22 74.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 2.2 p -59.08 -41.26 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 302' ' ' TYR . 18.0 t -65.19 -24.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.121 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -77.24 -39.77 47.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.222 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -17.41 56.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.091 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.704 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.824 0.26 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 17.7 tp -118.84 -1.26 11.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.398 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 166' ' ' GLU . 79.8 m-85 -57.58 -32.37 67.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.857 0.361 . . . . 0.0 111.003 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.0 -37.63 87.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -46.04 63.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.838 ' HA ' HD12 ' A' ' 323' ' ' ILE . 36.3 mt -54.87 -45.59 74.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -32.41 65.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -38.19 45.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 320' ' ' LEU . 56.9 mt -54.81 -44.49 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' A' ' 158' ' ' SER . 38.4 mt -75.4 -49.94 17.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -54.42 -49.84 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.361 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -53.4 -39.44 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -26.56 70.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.923 HD12 HD23 ' A' ' 325' ' ' LEU . 17.1 mt -65.2 -40.5 94.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -74.46 -27.28 60.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.86 -27.42 68.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.46 -28.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.62 5.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 33.6 t -90.9 152.64 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.72 91.7 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.72 145.9 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -91.49 123.56 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.95 -27.2 7.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.592 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -82.45 143.07 31.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 36' ' ' GLU . 23.6 mt -100.43 142.42 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.8 pt -113.7 154.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 62.2 m -95.51 140.98 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -97.16 -162.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.109 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.94 -42.12 40.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 109.811 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -79.36 -0.05 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.5 mtpt 84.61 29.04 0.06 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 6.0 mttt -74.49 -179.86 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.576 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.7 mt-10 -128.32 79.63 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.409 ' HB2' HG13 ' A' ' 29' ' ' ILE . 31.0 m95 -74.78 143.24 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.756 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 126.6 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG2' HG23 ' A' ' 29' ' ' ILE . 22.9 t -75.87 147.18 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -105.98 -151.77 19.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.706 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 25' ' ' VAL . 3.8 mt -87.01 157.47 54.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 111.018 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.27 144.74 92.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.596 2.197 . . . . 0.0 112.282 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.1 pt -142.22 -42.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.222 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.547 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -91.99 112.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.305 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.57 169.56 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.8 mt -73.49 158.15 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.619 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -121.07 150.91 40.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.349 . . . . 0.0 111.338 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -137.77 157.57 46.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -97.06 30.8 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.51 104.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -137.77 -65.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -103.69 -178.19 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.97 -34.58 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -142.94 159.23 42.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 5.9 t -89.88 160.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 62' ' ' VAL . . . 130.51 46.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.538 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -163.66 -45.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -143.61 67.85 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -117.74 80.09 13.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' CB ' ' HE2' ' A' ' 188' ' ' LYS . 86.8 Cg_endo -82.82 48.27 2.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.748 2.299 . . . . 0.0 112.699 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.885 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 2.2 m -149.81 153.31 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.815 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 133' ' ' ARG . 23.4 m -130.15 144.85 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.044 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG12 ' A' ' 130' ' ' ILE . 7.3 p -135.75 124.81 39.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -104.4 123.38 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.499 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 128' ' ' PHE . 5.0 t -113.07 135.17 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.466 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -141.21 150.62 59.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.579 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.51 118.87 5.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.495 2.13 . . . . 0.0 112.209 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -55.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t0 61.58 98.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.02 94.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.06 151.33 20.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.28 35.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.486 2.124 . . . . 0.0 112.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 84' ' ' LEU . 15.8 tp -64.77 -37.64 88.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.7 -41.31 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 7.3 p -72.84 -32.22 65.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.03 -40.73 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.808 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -61.51 -51.65 67.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -57.72 -43.75 85.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.6 t80 -63.67 -31.61 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.3 m-85 -71.65 -60.29 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.66 -17.89 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.375 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -47.37 60.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.23 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.91 -37.41 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.871 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -54.99 -21.21 11.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 123.12 8.55 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.993 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.92 -25.64 12.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.556 2.171 . . . . 0.0 112.466 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.91 -35.92 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -79.4 -39.76 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.833 HG22 HD11 ' A' ' 100' ' ' ILE . 34.0 mt -65.42 -57.61 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -32.15 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.178 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' THR . 53.0 mttt -76.15 -32.93 59.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -77.16 -38.21 52.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.833 HD11 HG22 ' A' ' 96' ' ' ILE . 18.2 mt -69.69 -37.5 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.13 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -74.94 -27.78 60.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.254 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 98' ' ' LYS . 22.6 p -84.36 -34.02 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.335 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -2.24 24.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 58.61 31.05 20.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.637 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 100' ' ' ILE . 56.9 mt -51.59 -25.64 7.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tptp 78.52 -55.6 0.47 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 108' ' ' LEU . 19.9 t80 -152.79 163.51 39.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 167' ' ' TYR . 3.4 tp -139.85 -168.02 2.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.38 28.4 2.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.433 HG13 ' HD2' ' A' ' 111' ' ' PRO . 25.0 t -101.92 136.49 19.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.588 0.232 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.733 ' HG3' HG12 ' A' ' 196' ' ' VAL . 18.0 Cg_endo -59.48 151.82 66.1 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.608 2.206 . . . . 0.0 112.291 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.8 115.53 23.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -92.5 115.35 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -92.84 -40.46 10.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.745 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.17 -175.98 46.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.405 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.6 t -137.92 165.89 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.666 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.34 177.2 28.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.583 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.487 HD21 ' NE ' ' A' ' 127' ' ' ARG . 2.3 mp -147.83 159.86 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 111.019 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -141.89 141.74 33.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -111.41 130.29 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -138.23 126.26 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.79 23.86 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.9 10.66 61.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.819 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.15 159.2 15.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.17 122.19 46.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.406 ' O ' HD23 ' A' ' 118' ' ' LEU . 16.1 m-85 -114.23 141.43 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.487 ' NE ' HD21 ' A' ' 118' ' ' LEU . 3.0 ttm180 -126.9 126.72 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.806 ' CE1' HD12 ' A' ' 29' ' ' ILE . 35.1 p90 -136.26 161.73 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.683 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.0 tmm? -128.06 145.83 50.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.645 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 70' ' ' VAL . 13.9 mt -121.52 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -132.36 173.29 11.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.8 139.58 26.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.081 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HG3' HG13 ' A' ' 69' ' ' VAL . 7.0 ttt180 -71.84 151.5 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -115.48 167.4 10.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.39 -64.07 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 p -154.33 156.71 37.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.466 ' CG ' HD22 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -77.77 153.25 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.711 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.4 mm? -60.78 -25.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.734 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.722 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 11.2 tt0 -70.33 -44.37 68.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -60.77 -28.53 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 138' ' ' LEU . 35.5 mt -74.56 -28.33 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 t80 -57.28 -46.28 83.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.58 -25.97 67.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.078 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.09 -17.36 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.475 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.2 m120 -94.95 -3.04 49.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 98.78 43.15 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.043 0.537 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 59.79 20.35 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 5.8 mtp180 -169.89 128.04 0.9 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.928 0.394 . . . . 0.0 111.141 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.788 ' CD1' HG21 ' A' ' 153' ' ' THR . 1.1 m-85 -81.26 -175.45 5.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -115.76 169.34 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' HD21 ' A' ' 255' ' ' LEU . 25.1 mtm180 -57.91 -29.9 65.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.788 HG21 ' CD1' ' A' ' 149' ' ' PHE . 23.6 m -60.84 -55.31 34.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.86 HG21 ' HG ' ' A' ' 255' ' ' LEU . 34.9 t -56.75 -52.37 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.579 ' HB3' HD21 ' A' ' 328' ' ' LEU . 23.3 mt -59.27 -41.27 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -64.82 -44.38 90.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.67 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 161' ' ' ILE . 32.5 mt -70.73 -32.73 70.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.56 ' CB ' HD13 ' A' ' 324' ' ' LEU . 1.4 t -62.85 -41.18 99.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 325' ' ' LEU . 11.3 mt -72.36 -33.67 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -70.56 -49.49 47.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.3 mt -61.32 -41.9 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.971 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.674 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.5 mt -60.26 -40.9 91.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.711 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.69 -32.92 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.526 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 161' ' ' ILE . 10.6 mt -79.74 -40.18 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.707 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 162' ' ' LEU . 22.9 mt -55.85 -38.76 70.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.85 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -32.67 74.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 108' ' ' LEU . 80.3 t80 -74.09 -52.51 12.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.778 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 165' ' ' LEU . 8.0 pt -67.66 -27.16 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.271 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 165' ' ' LEU . 1.3 m-70 -80.33 -32.29 37.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.595 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.97 -17.01 62.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -104.36 5.98 34.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.024 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 73.52 46.28 0.22 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.385 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.453 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.1 m-85 -137.06 129.12 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 202' ' ' TYR . 19.3 m -112.17 164.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 195' ' ' LEU . 3.5 t60 -120.01 -66.02 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.28 43.93 93.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -162.84 36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.905 0.383 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.8 mt -74.7 114.24 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -177.92 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.054 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.722 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -80.07 -2.57 44.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.594 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.6 t -106.37 0.05 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.107 0.479 . . . . 0.0 110.57 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.76 -11.24 7.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.074 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.4 mt -108.32 113.77 27.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.616 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 137' ' ' ASP . 1.7 mt -116.99 168.38 10.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.856 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.619 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.9 mt -106.56 149.48 27.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.95 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 0.7 OUTLIER -89.51 142.96 27.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 109.941 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.1 -26.7 5.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.4 ' HE2' ' CB ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -55.62 -25.23 37.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.2 -58.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.425 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HB2' ' CB ' ' A' ' 186' ' ' ASN . 96.0 Cg_exo -37.45 -60.43 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.026 2.484 . . . . 0.0 113.538 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 0.5 OUTLIER 82.32 -4.45 1.43 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.51 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -89.57 -166.88 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.0 p -109.93 145.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 7.8 m-85 -124.38 156.95 36.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.857 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.521 ' HG ' ' CE1' ' A' ' 175' ' ' HIS . 14.9 tp -105.4 115.93 31.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.625 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.0 m -130.97 170.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.2 t70 56.17 88.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.1 m-85 -81.8 -33.88 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.624 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 63.5 14.47 54.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.797 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.26 -49.69 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 46.81 87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.411 ' HB3' ' CG2' ' A' ' 174' ' ' VAL . 0.2 OUTLIER -117.16 135.82 53.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 15.3 ttp-105 -103.49 50.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 69.1 p -150.97 -176.46 5.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.887 HG23 HD22 ' A' ' 265' ' ' LEU . 2.0 tp -148.45 27.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -102.45 -28.25 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.676 ' HB3' HG23 ' A' ' 246' ' ' ILE . 82.5 m-85 -148.93 30.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.3 m -68.65 122.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.4 t -69.88 169.56 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.46 -32.07 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -33.51 60.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -74.0 -31.66 63.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -25.55 65.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 12.87 16.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.321 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.21 69.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.81 152.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.34 . . . . 0.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.03 109.41 16.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.29 177.44 4.54 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.384 2.056 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.6 m -150.55 -59.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -47.27 1.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -59.2 -29.67 67.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -64.99 -49.66 61.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.698 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 p30 -70.6 -42.03 71.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.24 -31.69 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -39.88 78.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 243' ' ' ASP . 9.2 mt -66.7 -35.97 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' OH ' ' A' ' 302' ' ' TYR . 33.3 tp -70.8 -38.84 73.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -63.93 -35.77 92.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.54 -25.8 45.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 111.022 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 10.4 m -65.02 -32.92 74.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.035 0.445 . . . . 0.0 110.468 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.615 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -59.01 -52.69 64.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.055 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.64 HG12 HD13 ' A' ' 285' ' ' LEU . 4.1 mp -68.32 -28.67 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.714 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -75.34 -41.84 55.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 111.473 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.407 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 40.8 m0 -82.27 -24.89 34.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.788 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.86 ' HG ' HG21 ' A' ' 154' ' ' VAL . 72.2 mt -93.16 -37.37 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 289' ' ' CYS . 3.1 m -96.12 -12.68 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 75.04 87.8 0.25 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 64.98 158.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 110.683 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.4 OUTLIER -132.63 160.34 68.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 37.5 Cg_endo -65.92 66.06 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.549 2.166 . . . . 0.0 112.85 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.7 p90 178.34 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.288 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.741 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -98.53 21.99 10.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.214 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -56.09 9.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 69.4 m-20 -125.96 -27.09 3.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.887 HD22 HG23 ' A' ' 225' ' ' ILE . 69.2 mt 70.19 12.74 7.7 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.02 -14.83 43.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.118 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.449 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.9 m-20 -134.33 98.32 14.03 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.03 17.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.698 2.265 . . . . 0.0 112.83 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -80.09 -46.95 15.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.7 p90 -79.27 -26.73 42.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 261' ' ' TRP . 26.7 t -61.43 -37.79 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.189 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.543 ' O ' HD12 ' A' ' 276' ' ' ILE . 5.3 ttp-105 -75.51 -45.54 37.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.237 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -67.19 -37.91 84.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.1 m -68.3 -43.41 77.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -52.42 64.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 272' ' ' ARG . 7.1 mt -60.38 -33.27 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.561 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -81.05 -49.57 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.23 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -62.8 -36.78 84.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -54.2 -29.63 46.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.877 0.37 . . . . 0.0 110.645 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.0 19.52 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.39 41.58 2.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.816 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 303' ' ' MET . 23.5 mt -53.17 -38.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.7 64.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -40.76 85.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.028 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.64 HD13 HG12 ' A' ' 252' ' ' ILE . 3.6 pp -75.54 -28.43 59.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -45.09 91.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.93 -27.4 33.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.373 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -82.76 -33.06 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.691 0.281 . . . . 0.0 111.334 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 256' ' ' THR . 59.4 m -93.7 -41.24 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.21 154.69 37.48 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.63 151.67 18.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.714 2.276 . . . . 0.0 112.327 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.13 -35.68 13.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -71.66 -46.36 59.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -68.15 149.15 49.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.05 147.68 88.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.98 166.91 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.624 2.216 . . . . 0.0 112.156 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -104.99 25.14 26.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.577 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 68.53 13.6 8.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.689 0.28 . . . . 0.0 111.301 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.529 HG22 ' CG ' ' A' ' 303' ' ' MET . 36.4 mm -79.25 -45.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.527 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.63 -43.78 17.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.287 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.4 OUTLIER -59.08 -41.71 88.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.392 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.677 ' HA ' HD13 ' A' ' 323' ' ' ILE . 10.7 t80 -71.46 -43.17 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.514 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.758 ' CB ' HD13 ' A' ' 282' ' ' ILE . 3.8 mtp -61.04 -41.28 96.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.597 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.11 -50.35 74.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.685 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.867 ' O ' HD12 ' A' ' 309' ' ' LEU . 41.9 m -58.45 -33.58 69.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.498 HG21 ' CE1' ' A' ' 302' ' ' TYR . 71.1 t -79.37 -24.46 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.8 -38.61 21.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.683 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 7.7 mt -107.48 -28.34 9.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.497 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 305' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 111.144 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.268 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 316' ' ' LEU . 11.0 mt -103.08 31.22 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -68.48 -29.63 68.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -46.54 85.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -73.83 -43.64 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.8 mt -56.49 -40.57 75.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.56 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.0 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.84 -38.02 76.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 320' ' ' LEU . 54.1 mt -55.96 -48.27 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.321 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 158' ' ' SER . 7.4 mt -80.78 -21.29 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.482 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.75 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.7 tt -81.53 -49.69 10.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.15 -37.31 74.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.98 -27.82 57.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.542 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 159' ' ' LEU . 12.0 mt -68.79 -39.08 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -30.14 69.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.01 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.43 HD11 ' OG ' ' A' ' 333' ' ' SER . 12.0 pt -105.77 -29.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.46 27.25 3.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.43 ' OG ' HD11 ' A' ' 331' ' ' ILE . 2.3 p -114.49 34.04 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.943 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -71.81 89.78 1.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 89.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -101.9 114.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.65 -25.99 11.37 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.04 147.39 29.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD11 ' HD3' ' A' ' 38' ' ' LYS . 20.9 mm -102.29 135.84 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.891 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 13.4 pt -119.84 148.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -95.55 141.46 29.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' CB ' ' HB2' ' A' ' 35' ' ' LYS . 4.1 t70 -83.41 -142.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.27 56.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.1 34.6 24.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.901 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -152.85 19.06 0.6 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' CE2' ' A' ' 37' ' ' TRP . 2.0 mmtt -163.94 175.1 10.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.445 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -151.24 90.44 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 7.3 m95 -94.87 139.96 30.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.209 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD3' HD11 ' A' ' 28' ' ' ILE . 8.7 ttpt -93.14 135.0 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -87.39 138.78 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.67 -118.65 4.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.551 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.4 154.59 47.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.948 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.59 170.69 5.28 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.544 2.163 . . . . 0.0 112.275 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.5 pt -143.9 36.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.562 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.415 HG23 ' HG3' ' A' ' 71' ' ' LYS . 19.0 mt -114.68 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -146.35 172.06 14.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.955 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 69' ' ' VAL . 31.5 mt -77.33 156.33 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -125.67 142.41 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.41 159.72 38.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.1 mtm -99.31 38.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.62 87.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -64.13 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -175.08 -51.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -111.14 -46.55 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.45 178.98 4.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' CE ' ' A' ' 38' ' ' LYS . 21.5 t -94.98 122.64 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.42 -151.56 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.574 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.63 31.34 5.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 80.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.54 137.01 19.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.27 33.25 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.842 2.361 . . . . 0.0 112.775 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -149.82 148.25 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 53' ' ' LEU . 20.5 m -134.86 144.87 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 7.4 p -134.89 132.94 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.557 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 51' ' ' ILE . 1.9 mttp -109.37 120.78 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.844 HG22 ' CB ' ' A' ' 128' ' ' PHE . 14.7 t -113.19 149.07 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.363 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.759 ' HG3' HD23 ' A' ' 80' ' ' LEU . 1.1 mm-40 -133.2 149.86 73.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.679 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 80.32 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.168 . . . . 0.0 112.388 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.1 t 57.04 -168.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 61.39 165.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -124.29 130.81 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.78 -111.45 0.26 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.05 -36.62 85.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.759 HD23 ' HG3' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -67.64 -45.72 74.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -45.79 72.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 p -58.63 -44.17 89.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 2.3 tt0 -68.67 -38.83 80.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' HE2' ' A' ' 129' ' ' MET . 1.9 mt -67.98 -46.57 70.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -56.34 -40.82 75.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.5 t80 -79.66 -29.88 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.743 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -67.71 -52.67 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.434 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -19.61 59.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.437 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -66.33 -47.52 73.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.674 0.273 . . . . 0.0 111.298 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.1 -35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -59.28 -16.99 24.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 125.01 26.88 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.517 0.199 . . . . 0.0 110.84 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.87 -24.89 14.46 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.488 2.125 . . . . 0.0 112.614 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -44.46 91.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.43 -43.77 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 ' CD1' ' A' ' 100' ' ' ILE . 30.0 mt -54.83 -57.6 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.409 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.45 -40.77 62.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.153 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -57.0 -39.65 75.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -77.32 -44.53 29.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.459 ' CD1' HG22 ' A' ' 96' ' ' ILE . 59.6 mt -62.7 -38.8 82.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.63 60.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.414 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -80.52 -36.93 32.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.495 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -105.42 -3.34 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 mttt 58.33 29.31 17.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.857 0.36 . . . . 0.0 110.724 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.49 HD13 HD13 ' A' ' 108' ' ' LEU . 49.9 mt -47.76 -40.41 20.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.206 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' H ' HG23 ' A' ' 100' ' ' ILE . 4.0 tmtp? 69.07 7.81 6.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 68.6 t80 174.62 161.83 0.2 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.751 0.31 . . . . 0.0 110.498 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 167' ' ' TYR . 9.3 tp -153.56 -60.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.07 -0.26 21.02 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.044 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 111' ' ' PRO . 26.7 t -83.33 136.17 43.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.78 0.29 . . . . 0.0 110.929 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 110' ' ' VAL . 15.3 Cg_endo -57.41 143.05 95.11 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.313 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 115.68 26.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -90.42 134.47 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -111.97 -40.83 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.86 -174.5 46.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.824 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.2 t -136.86 153.19 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -131.48 168.29 22.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.28 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 127' ' ' ARG . 52.3 mt -147.93 134.47 19.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 0.0 110.748 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -139.32 135.74 34.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -108.24 135.63 49.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 126.3 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.85 18.3 5.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.38 57.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.895 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -96.04 129.02 43.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.819 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.8 130.31 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.72 136.38 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.809 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -115.25 125.12 52.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.891 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.9 p90 -134.73 159.35 41.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.709 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.561 ' HE2' ' HG ' ' A' ' 84' ' ' LEU . 1.7 ttm -128.06 141.92 51.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.402 HG12 ' CG2' ' A' ' 70' ' ' VAL . 9.3 mt -111.94 111.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.04 173.41 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.73 136.91 21.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -56.94 172.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.235 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CE2' HG11 ' A' ' 196' ' ' VAL . 31.5 m-85 -150.17 162.06 41.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.645 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.6 -84.53 1.58 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.449 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 m -149.68 127.36 11.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.823 0.344 . . . . 0.0 110.719 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.832 ' OD1' HD22 ' A' ' 184' ' ' LEU . 4.9 m-20 -49.0 159.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -69.29 -21.31 63.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.773 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 1.7 pt20 -51.9 -34.13 39.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.379 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -29.63 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.652 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 1.031 HD11 HD11 ' A' ' 185' ' ' LEU . 62.4 mt -73.92 -29.82 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.571 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -59.58 -50.03 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.04 -27.48 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.07 66.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.366 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -97.9 14.96 25.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 87.5 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.95 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.453 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.7 123.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 7.4 m-85 -59.58 -174.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.5 m -119.14 153.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.571 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -54.75 -27.3 40.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 331' ' ' ILE . 10.7 mtpp -74.88 -42.39 57.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -44.3 53.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.243 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 150' ' ' SER . 59.6 t -55.82 -53.92 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 297' ' ' GLY . 13.5 mt -58.43 -46.93 85.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.966 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -52.85 56.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.992 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.5 -40.1 85.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.636 ' HA ' HD12 ' A' ' 161' ' ' ILE . 52.8 p -59.18 -36.8 75.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.674 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.768 HD21 ' HG2' ' A' ' 321' ' ' ARG . 1.5 tm? -67.94 -44.12 77.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.16 95.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 158' ' ' SER . 10.0 mt -64.3 -36.99 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.551 ' CD1' HD12 ' A' ' 324' ' ' LEU . 11.5 mt -61.58 -38.59 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.49 -41.22 93.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.1 mt -74.89 -41.94 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 168' ' ' ILE . 11.2 mt -56.88 -40.51 76.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HG3' ' CG ' ' A' ' 317' ' ' TYR . 10.6 tt0 -64.96 -37.9 89.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.752 ' CD1' HD21 ' A' ' 108' ' ' LEU . 89.9 t80 -66.41 -53.44 35.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 165' ' ' LEU . 5.3 pt -65.48 -27.04 40.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.42 ' N ' HG13 ' A' ' 168' ' ' ILE . 14.8 m-70 -76.48 -39.84 52.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.498 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.91 -12.32 61.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.62 4.25 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.765 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 70.69 47.09 0.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 126.74 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.682 HG13 ' CD1' ' A' ' 204' ' ' TYR . 27.2 m -133.01 169.27 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.603 ' NE2' HD21 ' A' ' 195' ' ' LEU . 31.6 p-80 -162.37 -47.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.16 59.67 8.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.44 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.77 29.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 161' ' ' ILE . 12.3 mt -64.54 105.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 14.1 tptm -149.84 168.33 24.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.773 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -69.39 0.03 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.065 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 -4.07 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.571 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -124.96 -5.77 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.356 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.885 ' C ' HD23 ' A' ' 184' ' ' LEU . 12.6 mt -108.22 113.51 26.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.244 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -121.14 149.75 42.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -178.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 141' ' ' ILE . 10.3 mt -90.36 149.19 22.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.65 130.54 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.687 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -66.77 -67.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -21.3 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -119.56 67.28 10.17 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.83 97.31 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.1 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -172.5 -38.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.213 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -116.15 174.36 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 138' ' ' LEU . 7.9 p -133.05 136.56 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 3.4 m-85 -106.91 156.88 18.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.2 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.603 HD21 ' NE2' ' A' ' 175' ' ' HIS . 18.8 tp -104.06 115.87 31.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 184' ' ' LEU . 27.8 m -115.37 156.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 56.04 93.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.496 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 5.0 m-85 -79.27 -12.87 59.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 57.01 25.2 53.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -176.5 -62.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.703 0.287 . . . . 0.0 111.014 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 86' ' ' PHE . . . 43.88 82.91 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -142.08 149.01 39.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -82.79 94.34 7.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.682 ' CD1' HG13 ' A' ' 174' ' ' VAL . 35.4 p90 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.725 -0.15 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -91.34 -46.95 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tp -178.11 38.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.197 0.523 . . . . 0.0 110.522 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -94.66 64.85 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.269 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.554 ' HB3' HG23 ' A' ' 246' ' ' ILE . 53.3 m-85 75.29 32.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -72.78 153.89 40.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.3 m -95.88 157.49 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.76 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -59.66 -30.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -48.73 55.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.0 -33.42 74.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -72.58 -26.1 61.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.83 12.82 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.375 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.52 59.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.591 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 124.85 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 111.041 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.15 118.91 33.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 55.0 Cg_exo -51.97 101.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.403 2.069 . . . . 0.0 112.298 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.8 m -60.68 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.11 -51.51 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.58 ' HB3' HD22 ' A' ' 309' ' ' LEU . 18.0 ptt180 -62.78 -23.91 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.49 -49.55 72.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.692 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 -31.04 63.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.61 HD13 HD11 ' A' ' 320' ' ' LEU . 30.6 mt -72.18 -36.09 69.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.67 -29.89 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 227' ' ' PHE . 42.0 mt -72.39 -42.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.541 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.5 tp -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -62.42 -39.15 97.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.314 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.5 -25.88 45.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -34.57 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.108 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -49.43 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 248' ' ' GLY . 4.0 mt -65.32 -30.26 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.688 ' HB2' HD21 ' A' ' 259' ' ' LEU . 17.6 tm0? -80.04 -37.4 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.4 m0 -82.22 -39.35 23.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.06 -45.39 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.076 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.404 HG21 ' HB3' ' A' ' 289' ' ' CYS . 10.4 p -96.14 0.55 51.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.41 97.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.475 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 m80 65.0 155.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -134.52 172.54 7.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.474 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 61.5 Cg_endo -73.49 58.11 3.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.373 2.049 . . . . 0.0 112.589 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.989 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.1 p90 -180.0 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.306 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -99.04 20.62 13.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 178.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -55.12 23.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.948 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.1 OUTLIER -127.68 -25.27 3.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.452 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.637 HD22 HG23 ' A' ' 225' ' ' ILE . 53.5 mt 69.34 12.74 8.41 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -88.25 -15.48 35.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.083 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.471 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 4.0 t0 -135.12 97.46 13.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 20.73 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.625 2.216 . . . . 0.0 112.944 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -44.85 22.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.789 0.328 . . . . 0.0 110.764 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.0 p90 -83.87 -26.62 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.015 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.746 ' CG1' HD11 ' A' ' 225' ' ' ILE . 16.3 t -61.76 -37.06 77.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -72.11 -44.36 63.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.35 -37.37 77.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.069 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.3 p -72.01 -38.12 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.253 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.512 ' CD ' HG12 ' A' ' 271' ' ' VAL . 0.2 OUTLIER -61.54 -47.53 85.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.14 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 230' ' ' ILE . 28.7 mm -70.29 -29.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.408 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -48.74 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.501 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.6 m-85 -67.33 -40.56 85.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.76 ' HE ' HD13 ' A' ' 230' ' ' ILE . 6.8 tmm_? -50.68 -27.79 7.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.839 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -118.3 22.84 11.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.11 44.04 2.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.987 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 303' ' ' MET . 22.7 mt -53.32 -38.24 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.01 64.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -40.69 86.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 4.2 pp -76.44 -28.34 56.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.408 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 0.0 OUTLIER -66.69 -37.93 85.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.501 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.84 -31.09 28.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -82.68 -49.6 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.093 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' A' ' 256' ' ' THR . 53.4 m -72.06 -41.33 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.47 134.87 22.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.95 165.3 32.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.68 -29.43 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -38.34 75.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -74.49 -177.35 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.25 142.33 25.75 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.55 142.02 61.15 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 155' ' ' LEU . . . -99.1 24.35 32.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.624 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 64.16 17.1 10.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.714 0.292 . . . . 0.0 111.193 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.474 HG22 ' CG ' ' A' ' 303' ' ' MET . 32.2 mm -79.54 -51.99 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.5 -41.91 14.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.307 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -41.77 96.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 306' ' ' VAL . 50.3 t80 -72.05 -44.41 63.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.808 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.721 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.9 mtp -58.26 -39.76 80.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.662 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -65.76 -43.76 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.984 HG21 HD11 ' A' ' 323' ' ' ILE . 0.7 OUTLIER -65.95 -34.54 78.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 302' ' ' TYR . 67.9 t -78.75 -24.39 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.98 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.058 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 pp -102.17 -24.7 13.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.723 ' O ' HD22 ' A' ' 316' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.162 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.779 0.241 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.723 HD22 ' O ' ' A' ' 309' ' ' LEU . 11.2 tp -98.74 29.01 3.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' GLU . 63.1 m-85 -62.66 -30.02 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.52 -45.57 79.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -45.18 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.858 ' HA ' HD12 ' A' ' 323' ' ' ILE . 89.0 mt -56.13 -50.25 71.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.768 ' HG2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -53.72 -50.96 64.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -54.43 -42.35 70.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 305' ' ' THR . 42.6 mt -54.22 -46.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.564 HD13 ' OG ' ' A' ' 158' ' ' SER . 87.4 mt -81.19 -37.26 28.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.839 HD23 HD12 ' A' ' 328' ' ' LEU . 0.4 OUTLIER -63.17 -49.75 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -54.09 -43.57 70.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.035 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.12 67.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.839 HD12 HD23 ' A' ' 325' ' ' LEU . 11.4 mt -59.19 -24.74 63.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.719 0.295 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 18.8 mttm -76.38 -33.94 58.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.37 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.93 -18.72 55.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.039 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 152' ' ' LYS . 1.2 pt -117.07 -34.77 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -116.23 -25.0 3.66 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.347 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 5.4 t 69.71 72.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.84 125.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.85 138.74 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -79.29 113.05 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.75 13.83 15.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.3 161.13 14.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.623 HD13 ' HG3' ' A' ' 38' ' ' LYS . 20.5 mm -112.39 131.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 9.3 pt -119.84 125.55 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.767 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 t -95.55 141.31 29.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.548 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 13.7 m-20 -90.4 -161.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.57 63.06 0.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.9 31.3 18.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.214 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.8 -33.58 8.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.641 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.87 -158.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.28 93.04 1.94 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.737 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -78.08 155.26 30.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.4 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HG3' HD13 ' A' ' 28' ' ' ILE . 4.8 tttm -100.16 117.78 35.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 29' ' ' ILE . 17.4 t -73.01 143.49 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -118.06 -111.07 2.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.598 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.5 mt -96.11 154.37 38.86 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.704 0.288 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 -27.35 52.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 69' ' ' VAL . 46.5 pt 42.48 31.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.49 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.641 0.257 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mt -129.15 137.61 56.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 0.0 111.325 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -146.43 167.87 22.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 68' ' ' CYS . 6.0 mt -89.09 149.55 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.95 146.92 45.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 t70 -137.54 152.23 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtp -96.48 37.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.31 30.12 19.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.95 179.46 6.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.02 171.87 12.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.16 174.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 t -81.41 157.36 25.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.3 130.87 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.15 -90.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.574 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -99.14 30.52 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.05 -44.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 55' ' ' ASP . . . -105.61 88.66 2.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.92 80.91 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 53' ' ' LEU . 73.3 m -149.71 148.19 28.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.552 HG13 ' CG ' ' A' ' 133' ' ' ARG . 5.4 m -119.68 155.37 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG23 HD13 ' A' ' 130' ' ' ILE . 11.8 p -148.13 126.95 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.034 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 116.22 28.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.682 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.882 HG22 ' CB ' ' A' ' 128' ' ' PHE . 21.6 t -122.46 137.63 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 80' ' ' LEU . 2.2 mt-10 -128.69 147.22 63.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.46 83.5 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.89 -63.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.243 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -46.48 131.28 11.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -140.36 80.08 1.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.52 -76.17 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.45 -28.18 32.67 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.616 2.211 . . . . 0.0 112.299 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.698 ' HG ' HD23 ' A' ' 84' ' ' LEU . 9.3 tp -73.08 -33.27 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -30.62 70.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 p -76.13 -37.98 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 59.8 tt0 -74.41 -39.11 62.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.2 mm? -62.5 -52.47 63.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 11.3 t80 -71.03 -45.83 63.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.993 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 5.7 m-85 -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.461 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.43 -48.04 36.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.645 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -87.75 -47.52 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.701 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -77.49 -50.23 13.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.886 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.51 32.32 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.708 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.04 125.91 89.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.48 -28.2 84.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.44 2.094 . . . . 0.0 112.444 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.35 -32.89 43.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.176 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -79.22 -52.65 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.286 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.746 HD11 ' HA ' ' A' ' 91' ' ' ALA . 50.6 mt -56.71 -52.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.6 -50.6 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -64.66 -42.58 95.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -58.53 -54.2 49.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.93 -36.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -75.11 -27.81 59.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.316 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -78.78 -38.74 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.499 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.71 -2.42 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.335 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.12 30.44 18.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 110.643 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.1 mt -50.15 -31.12 12.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.92 -56.62 0.54 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.29 151.46 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.682 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.2 tp -128.92 -66.88 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 138.09 -14.37 3.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.908 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.11 125.29 77.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.629 0.215 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.31 152.76 7.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 112.249 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -80.19 115.48 19.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 13.3 t80 -93.24 115.76 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -91.8 -40.98 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.224 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.79 -174.63 46.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.76 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 p -131.03 158.05 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.02 179.45 20.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.353 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -147.99 158.85 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.961 0.41 . . . . 0.0 111.314 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.62 114.61 11.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.602 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -91.4 142.26 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 123' ' ' GLY . 4.0 tttt -130.57 157.53 42.46 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.98 51.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.632 0.253 . . . . 0.0 111.428 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' LYS . . . 144.2 -18.27 2.11 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.897 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -126.4 142.96 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.68 138.29 46.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.477 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.556 ' O ' HD23 ' A' ' 118' ' ' LEU . 2.7 m-85 -125.7 134.64 51.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.959 0.409 . . . . 0.0 111.334 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -124.13 138.26 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.467 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.882 ' CB ' HG22 ' A' ' 72' ' ' VAL . 23.2 p90 -147.03 168.73 20.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.275 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.789 ' HB2' HD21 ' A' ' 84' ' ' LEU . 7.1 tmm? -136.67 146.44 45.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.656 HD13 HG23 ' A' ' 70' ' ' VAL . 11.6 mm -96.0 135.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -143.49 165.28 27.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.69 130.09 41.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.552 ' CG ' HG13 ' A' ' 69' ' ' VAL . 3.6 ttt-85 -57.73 143.06 43.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -113.14 166.89 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.79 -83.2 1.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -133.92 127.01 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.667 ' CG ' HD22 ' A' ' 184' ' ' LEU . 3.0 m-20 -55.35 155.75 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 1.9 mm? -60.08 -23.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.619 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -65.43 -42.91 91.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.134 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -61.5 -29.89 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.894 HD11 HD11 ' A' ' 185' ' ' LEU . 26.4 mt -75.39 -28.54 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 10.3 t80 -59.53 -49.37 78.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -28.01 67.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.24 -23.1 65.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.326 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 5.7 m-20 -96.4 15.63 20.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.166 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.71 46.4 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.52 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.2 19.45 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 33.3 mtt180 -147.14 -179.09 6.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 153' ' ' THR . 0.1 OUTLIER -132.84 144.59 50.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 p -81.91 155.38 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.36 68.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -71.8 -36.06 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 149' ' ' PHE . 1.7 m -72.75 -42.26 64.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' A' ' 251' ' ' MET . 47.6 t -66.05 -54.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.81 ' HB3' HD21 ' A' ' 328' ' ' LEU . 71.8 mt -54.89 -47.15 74.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.665 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.485 HD22 HG11 ' A' ' 193' ' ' VAL . 17.4 mt -66.17 -41.17 90.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.596 ' CB ' HD13 ' A' ' 324' ' ' LEU . 60.0 m -54.56 -42.4 70.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.699 HD22 ' HG2' ' A' ' 321' ' ' ARG . 88.8 mt -66.49 -39.61 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.459 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -64.97 -46.34 81.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.726 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.85 -34.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.765 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.3 mt -62.34 -35.89 80.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.17 -42.26 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 ' HA3' ' A' ' 109' ' ' GLY . 11.9 mt -71.41 -34.78 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.75 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 162' ' ' LEU . 23.3 mt -58.77 -39.05 79.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.68 -37.23 79.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -66.78 -54.85 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.713 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 43.5 pt -63.12 -27.28 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -77.9 -38.35 45.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.459 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -10.9 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.981 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.51 4.8 26.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.821 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 1.2 mp0 71.5 48.93 0.31 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -139.68 139.05 36.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 204' ' ' TYR . 12.3 m -137.92 169.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 1.4 p80 -147.13 -54.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.497 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 70.28 31.98 68.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.376 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -136.74 81.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.3 mt -115.61 117.85 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -159.42 -176.6 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.619 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.78 1.91 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.479 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.08 1.4 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 110.329 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -124.82 -12.94 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.287 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 5.5 mt -108.48 123.32 48.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.98 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -127.9 160.96 30.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.894 HD11 HD11 ' A' ' 141' ' ' ILE . 22.4 mt -95.04 149.34 21.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.022 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.7 132.58 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.443 ' CD2' ' CD ' ' A' ' 133' ' ' ARG . 22.3 t80 -68.58 -61.83 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.418 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -63.15 -18.51 63.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.24 75.26 74.87 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.55 89.92 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.536 2.157 . . . . 0.0 112.066 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.95 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.107 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.54 149.86 23.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.9 p -112.45 147.99 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.124 0.488 . . . . 0.0 110.736 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 24.7 m-85 -126.47 157.32 38.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.974 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 26.2 tp -103.32 115.83 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.458 HG21 ' CD1' ' A' ' 184' ' ' LEU . 5.2 t -103.56 137.38 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.16 130.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.724 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.5 m-85 -103.02 7.95 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.195 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 80.99 -55.25 4.78 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.17 -32.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.579 0.228 . . . . 0.0 111.53 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.29 94.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.746 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.539 ' O ' HG22 ' A' ' 174' ' ' VAL . 68.1 t80 -126.29 149.06 49.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -98.82 78.18 2.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.768 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.68 ' CD1' HG13 ' A' ' 174' ' ' VAL . 42.2 p90 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.3 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -169.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 265' ' ' LEU . 20.3 tt -139.13 31.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.031 0.443 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HB3' HD11 ' A' ' 265' ' ' LEU . 0.1 OUTLIER -94.63 21.88 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.709 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 179' ' ' LYS . 0.5 OUTLIER 168.58 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.638 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.2 p -60.01 150.14 30.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -177.71 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.442 HD13 HH21 ' A' ' 279' ' ' ARG . 1.3 mp -65.96 -35.43 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.409 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -57.66 -29.89 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.07 77.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -33.57 76.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -86.12 4.4 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.393 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.84 -2.33 83.71 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.884 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.409 HG11 ' OD2' ' A' ' 231' ' ' ASP . 15.9 t -63.77 133.73 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.844 0.354 . . . . 0.0 111.094 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.4 150.13 89.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HG2' ' CB ' ' A' ' 174' ' ' VAL . 37.6 Cg_endo -65.92 -35.01 36.97 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.518 2.146 . . . . 0.0 112.234 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 204' ' ' TYR . 21.1 t 67.62 -69.62 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.6 ttp-105 -166.18 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -71.73 -32.77 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.5 96.25 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.779 ' HA ' HD12 ' A' ' 246' ' ' ILE . 6.4 m-20 -65.31 -43.34 91.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 320' ' ' LEU . 39.9 mt -64.24 -38.51 91.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 306' ' ' VAL . 2.5 tt0 -59.8 -31.02 69.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.0 mt -75.9 -42.38 39.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.67 HD23 ' OH ' ' A' ' 302' ' ' TYR . 18.6 tp -58.77 -46.27 87.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.684 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 252' ' ' ILE . . . -55.77 -25.42 44.12 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.88 -31.53 45.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 97.2 m -54.22 -48.73 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.794 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.63 -30.54 71.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 285' ' ' LEU . 28.9 mm -66.28 -45.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.201 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.488 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.0 OUTLIER -80.01 -27.37 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.512 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.488 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 17.2 m0 -76.99 -32.66 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.434 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.15 -35.51 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 289' ' ' CYS . 1.8 m -96.27 0.59 51.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.599 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.35 96.29 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.332 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 33.4 m80 61.74 154.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.95 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -121.68 164.26 25.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.823 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 60.0 Cg_endo -72.62 57.64 3.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.641 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.95 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.8 p90 179.35 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' A' ' 259' ' ' LEU . 14.9 tt0 -92.47 13.44 19.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.553 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -59.4 5.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 4.6 m-80 -129.95 -26.17 2.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.417 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.771 HD11 ' HB3' ' A' ' 226' ' ' GLU . 83.6 mt 72.75 11.19 5.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -16.22 49.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.222 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -132.16 99.97 15.9 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.791 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.95 12.07 2.78 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -49.98 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.9 p90 -79.92 -26.23 40.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 15.1 t -60.67 -45.73 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 276' ' ' ILE . 0.6 OUTLIER -74.37 -31.96 62.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.039 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.13 -47.79 33.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.174 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.407 ' HB3' ' CE2' ' A' ' 278' ' ' TYR . 1.5 m -66.84 -35.99 81.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -64.77 -49.62 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.201 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 272' ' ' ARG . 21.7 mt -66.91 -30.14 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -52.05 7.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.597 ' CD1' HD12 ' A' ' 285' ' ' LEU . 10.7 m-85 -56.68 -31.96 64.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.442 HH21 HD13 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -59.08 -27.86 65.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.66 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -130.07 30.29 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -150.19 38.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.763 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.2 mt -52.98 -49.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.03 -49.6 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.3 p -65.33 -31.6 72.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.277 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.597 HD12 ' CD1' ' A' ' 278' ' ' TYR . 1.4 tt -68.7 -38.42 80.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.488 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' PHE . 0.0 OUTLIER -65.42 -38.16 89.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.809 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -25.68 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -82.75 -54.9 4.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.403 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.472 ' O ' HG23 ' A' ' 256' ' ' THR . 0.1 OUTLIER -68.84 -41.3 78.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' MET . 19.4 m-85 -102.26 152.74 38.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -51.03 -61.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.663 2.242 . . . . 0.0 112.462 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -146.53 -45.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.013 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 63.62 56.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -65.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.744 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -62.42 -56.55 29.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 295' ' ' LYS . 18.6 Cg_endo -60.08 -164.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.4 2.066 . . . . 0.0 112.235 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 135.14 37.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.543 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.557 ' HG3' HD11 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -87.75 -33.86 18.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.495 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.757 HD12 ' HG3' ' A' ' 251' ' ' MET . 20.2 mm -74.68 -46.61 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.27 -45.69 17.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -61.71 -38.82 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.489 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.88 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.0 t80 -70.05 -43.36 71.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.873 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.763 ' CB ' HD13 ' A' ' 282' ' ' ILE . 4.5 mtp -65.51 -37.2 86.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -51.38 70.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.617 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.43 HG21 HD11 ' A' ' 323' ' ' ILE . 82.3 p -60.96 -34.72 75.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 302' ' ' TYR . 39.6 t -73.36 -24.66 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.191 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -76.67 -31.89 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.4 mt -104.33 -10.9 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.065 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 N--CA 1.466 -0.119 0 CA-C-O 120.765 0.236 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 316' ' ' LEU . 1.3 pt? -144.87 53.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -56.04 -32.81 64.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -63.27 -34.34 77.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 316' ' ' LEU . 2.8 t30 -70.82 -44.38 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 323' ' ' ILE . 68.1 mt -56.27 -45.43 80.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.699 ' HG2' HD22 ' A' ' 159' ' ' LEU . 13.8 ttt180 -58.45 -47.56 83.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -39.42 81.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 320' ' ' LEU . 33.7 mt -57.12 -44.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.6 HD22 HD23 ' A' ' 155' ' ' LEU . 53.8 mt -78.28 -48.21 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -60.4 -49.86 75.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -58.52 -40.36 82.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.77 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.08 -29.29 59.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.399 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.1 mt -65.01 -39.47 93.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -30.72 69.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.1 pt -106.59 27.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.18 38.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.6 164.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -176.76 37.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.814 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.615 ' OD2' HD12 ' A' ' 328' ' ' LEU . 8.7 m-20 -78.31 85.13 4.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 65.03 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 25.8 71.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.593 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.77 137.56 41.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 36' ' ' GLU . 11.4 mt -105.18 141.29 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.934 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.7 pt -119.91 154.61 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.2 m -95.49 139.47 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.675 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 17.0 p-10 -98.3 -149.81 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.0 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -38.09 18.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.402 . . . . 0.0 110.324 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.99 -0.12 33.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.837 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER 85.02 16.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.289 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.77 173.52 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.611 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -122.69 78.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 110.532 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.46 128.56 37.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -88.21 124.02 33.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 24' ' ' ALA . 21.2 t -81.53 122.65 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.14 -121.56 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD23 ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -116.52 164.56 17.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.696 ' HD2' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -71.07 118.43 5.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.542 2.161 . . . . 0.0 112.279 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 53' ' ' LEU . 1.6 pt -107.02 30.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 6.4 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.7 mp -88.69 104.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.678 ' O ' HG12 ' A' ' 70' ' ' VAL . 23.3 m-85 -129.55 163.59 25.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 43' ' ' ILE . 50.4 mt -73.29 165.91 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -138.5 152.46 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.273 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -136.34 159.74 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.29 29.85 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 t30 58.97 -168.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t 61.56 45.27 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -169.03 126.33 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.988 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.39 116.11 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m 60.75 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 21.8 t -59.24 -57.36 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -151.37 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.551 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 m -100.84 37.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.02 30.67 5.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -85.72 119.55 72.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -87.5 30.17 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.797 2.331 . . . . 0.0 112.927 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.76 148.13 28.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.77 HG13 ' CG ' ' A' ' 133' ' ' ARG . 2.8 m -119.12 153.88 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 52' ' ' TYR . 6.7 p -137.67 134.59 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -121.58 116.76 25.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.68 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.859 HG22 ' CB ' ' A' ' 128' ' ' PHE . 7.8 t -113.37 149.54 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -137.57 136.19 20.03 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.892 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 32.6 Cg_exo -57.93 82.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.514 2.143 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 53.62 29.67 9.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.9 120.77 33.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.61 41.52 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.1 -79.09 1.43 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.09 -43.41 2.4 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.538 2.159 . . . . 0.0 112.35 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HG ' HD23 ' A' ' 84' ' ' LEU . 24.9 tp -60.13 -30.1 69.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.46 -32.3 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.7 p -77.76 -31.7 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -68.33 -46.58 69.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.1 mm? -66.01 -45.82 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -60.35 -29.67 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.876 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.5 m-85 -65.9 -60.3 2.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -17.84 64.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.773 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -18.99 60.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.59 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -62.22 -15.28 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -47.95 130.2 11.88 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.0 -24.32 19.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -79.32 -33.2 43.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.4 -42.51 25.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.8 mt -65.72 -55.26 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -50.76 -31.94 18.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -34.67 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.28 -46.06 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 105' ' ' LEU . 41.5 mm -64.48 -36.52 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.238 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -75.01 -27.72 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -76.65 -38.8 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.342 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -105.46 -3.73 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.254 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 100' ' ' ILE . 16.7 tttt 60.09 30.9 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 100' ' ' ILE . 43.8 mt -49.93 -32.08 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.253 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -55.91 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.98 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -142.21 138.59 31.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.758 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.739 HD21 ' CG ' ' A' ' 167' ' ' TYR . 13.2 tp -114.68 -66.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 132.46 -7.21 5.3 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.822 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.7 t -71.66 136.0 83.38 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.666 0.233 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.5 142.58 80.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.59 2.193 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.97 121.72 26.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -98.7 131.36 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -110.39 -40.83 4.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.065 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.97 -174.58 46.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.655 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -132.97 164.05 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -149.24 174.65 28.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.275 -0.965 . . . . 0.0 113.168 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 127' ' ' ARG . 3.3 mt -145.23 145.15 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.716 0.293 . . . . 0.0 110.741 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -121.81 135.8 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -113.65 121.44 44.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -138.2 126.24 22.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 55.93 20.6 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.364 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.98 -4.99 61.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.903 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -96.04 129.08 43.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 110.776 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.4 t -100.44 122.99 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -105.81 143.59 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.755 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.644 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -107.31 129.27 54.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.934 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.2 p90 -141.52 159.24 42.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.442 ' HB2' HD21 ' A' ' 84' ' ' LEU . 8.1 tmm? -128.13 147.59 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 29' ' ' ILE . 20.2 mt -123.32 112.76 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 111.377 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -121.96 173.3 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.94 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.99 149.66 2.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.77 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.51 168.09 13.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 184' ' ' LEU . 80.6 m-85 -141.46 160.82 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.808 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.77 -94.57 0.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.96 130.69 55.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.827 ' OD1' HD22 ' A' ' 184' ' ' LEU . 6.0 m-20 -57.67 159.83 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.734 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -59.4 -31.01 68.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.585 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -59.44 -45.14 92.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.387 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.49 70.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.378 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 138' ' ' LEU . 10.9 mt -80.17 -26.94 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.454 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 16.3 t80 -66.88 -50.84 61.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -29.31 68.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.572 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.5 -24.7 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.084 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-80 -94.47 15.66 17.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.84 45.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.14 19.71 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.326 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 23.9 mtm180 -145.17 -175.63 4.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.1 OUTLIER -141.93 171.17 14.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 153' ' ' THR . 3.4 m -97.08 157.64 15.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.585 ' HA ' HD21 ' A' ' 255' ' ' LEU . 7.5 mtm-85 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -72.54 -42.62 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 150' ' ' SER . 18.6 p -60.75 -43.63 97.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' A' ' 251' ' ' MET . 38.7 t -65.89 -49.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 331' ' ' ILE . 33.2 mt -60.52 -47.28 86.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -59.83 -46.78 88.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.498 HD22 HG11 ' A' ' 193' ' ' VAL . 27.6 mt -69.97 -43.54 71.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD13 ' A' ' 324' ' ' LEU . 51.2 p -54.4 -34.42 61.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.4 mt -74.71 -41.41 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -45.74 77.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.688 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.4 mt -63.65 -34.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.762 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.507 HD11 ' HE2' ' A' ' 302' ' ' TYR . 9.7 mt -64.38 -40.19 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -38.27 84.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.52 -39.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 47.7 mt -59.11 -45.07 91.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.591 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -66.7 -33.95 76.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.658 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.739 ' CG ' HD21 ' A' ' 108' ' ' LEU . 60.6 t80 -65.51 -51.85 57.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.618 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.0 pt -72.28 -27.28 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.537 ' CE1' HG12 ' A' ' 174' ' ' VAL . 1.5 m-70 -76.16 -32.48 59.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -16.93 62.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.38 3.61 40.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.818 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 78.08 45.36 0.07 Allowed 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.088 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -134.31 142.31 47.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.507 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.586 HG22 ' HD1' ' A' ' 204' ' ' TYR . 28.9 m -142.22 138.88 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.138 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.91 -67.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 81.31 36.54 20.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.626 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.87 -89.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.96 -0.141 . . . . 0.0 110.919 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.0 mp 41.38 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.832 0.349 . . . . 0.0 111.718 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 24.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.297 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . 65.96 9.86 6.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.65 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.8 p -113.63 1.48 14.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.47 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.2 m120 -134.71 4.76 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.146 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 1.9 mt -108.48 117.71 34.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.719 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.827 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -126.78 146.66 50.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.347 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 141' ' ' ILE . 21.9 mt -89.84 149.66 22.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.84 128.01 34.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.446 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 19.7 t80 -71.0 -58.82 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -21.6 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.603 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -129.24 71.08 82.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 86.25 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.52 2.147 . . . . 0.0 112.126 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -177.98 37.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -178.15 172.37 1.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.388 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.505 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.1 p -132.64 147.63 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.391 . . . . 0.0 110.693 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 22.6 m-85 -127.27 156.88 41.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.986 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 183' ' ' LEU . 10.8 tp -103.93 115.83 31.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.514 HG21 HD11 ' A' ' 184' ' ' LEU . 16.6 m -107.41 179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.32 108.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.709 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 15.8 m-85 -117.39 28.18 8.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 200' ' ' LEU . . . -54.01 -28.74 41.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.966 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 199' ' ' GLY . 10.9 mp -115.63 11.67 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 110.947 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -100.24 68.38 1.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.239 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -126.21 149.37 49.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.253 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 39.5 ttp180 -54.26 96.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.586 ' HD1' HG22 ' A' ' 174' ' ' VAL . 44.6 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -140.96 -178.34 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.798 HG12 HG11 ' A' ' 271' ' ' VAL . 8.7 tt -133.74 10.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.347 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 265' ' ' LEU . 27.4 tt0 -67.74 -13.67 62.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.313 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.493 ' HB3' HG23 ' A' ' 246' ' ' ILE . 8.5 m-85 -165.14 29.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.68 130.45 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.54 -47.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.236 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.0 mt -57.03 -59.27 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.153 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.65 -28.18 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.17 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -57.4 -27.61 62.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.299 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.689 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.0 OUTLIER -101.53 1.87 38.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.341 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.52 21.1 40.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.686 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 234' ' ' ASN . 26.4 t -80.51 158.5 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 111.086 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.484 ' N ' HG12 ' A' ' 236' ' ' VAL . . . -80.72 130.65 63.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.44 74.51 3.68 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 204' ' ' TYR . 0.6 OUTLIER -77.39 73.31 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.003 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 73.25 -57.62 0.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.334 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -58.94 -28.49 66.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -80.21 -33.97 30.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.528 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.9 -44.65 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.88 -44.4 86.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.299 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.28 -29.32 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 227' ' ' PHE . 73.0 mt -76.02 -37.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.758 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.8 tp -66.44 -36.28 82.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.23 -28.02 72.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.41 -25.93 46.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 62.7 m -66.62 -32.84 74.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.011 0.434 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.677 ' HA ' HG11 ' A' ' 154' ' ' VAL . 1.1 mmm -60.24 -52.59 64.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.174 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -74.17 -38.55 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.625 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.567 ' HB2' HD21 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -64.71 -39.95 94.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.219 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 38.5 m0 -82.28 -32.34 29.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.504 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 151' ' ' ARG . 56.9 mt -83.58 -37.37 23.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 111.475 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.9 m -96.21 -9.25 30.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.499 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.1 94.35 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.444 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 18.8 m80 62.28 150.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 253' ' ' GLN . 0.3 OUTLIER -111.24 158.49 35.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.69 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.457 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 45.2 Cg_endo -68.32 61.94 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.557 2.171 . . . . 0.0 112.413 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.631 ' HB2' HG22 ' A' ' 271' ' ' VAL . 4.8 p90 175.64 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.463 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.9 tt0 -88.61 10.91 18.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.34 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.3 -47.61 81.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -131.97 -28.32 1.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.399 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.607 HD22 HG23 ' A' ' 225' ' ' ILE . 67.5 mt 71.55 11.29 6.52 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -16.25 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.278 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -131.23 100.75 16.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.94 13.38 2.36 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.638 2.225 . . . . 0.0 112.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -73.73 -46.66 44.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.5 p90 -83.92 -26.44 29.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.798 HG11 HG12 ' A' ' 225' ' ' ILE . 28.7 t -63.03 -39.59 85.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.092 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -52.62 10.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.312 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 75.2 m -56.21 -40.22 73.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.331 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.6 -44.67 93.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 27.9 mm -71.1 -33.08 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.734 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -81.08 -52.17 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -61.99 -35.42 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.024 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -26.5 42.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.359 . . . . 0.0 110.751 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -118.28 20.6 13.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -142.52 45.34 1.62 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.083 0.468 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' CB ' ' A' ' 303' ' ' MET . 26.7 mt -50.45 -40.17 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.65 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.174 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.96 -38.37 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.1 pp -74.01 -39.69 63.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.478 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 8.5 mtt -69.0 -44.29 73.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -39.02 92.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.91 -24.87 32.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.889 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 75.9 m -92.02 -41.35 10.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.66 0.267 . . . . 0.0 111.713 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.74 155.27 58.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.45 179.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.634 2.223 . . . . 0.0 112.278 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -111.25 67.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.67 88.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.9 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 61.41 153.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -93.26 121.7 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.15 -61.91 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.54 -24.53 30.26 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.02 -64.37 0.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.465 HG23 ' HG3' ' A' ' 251' ' ' MET . 25.8 mm -72.96 -43.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.02 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.51 -42.16 10.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.506 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.49 93.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 306' ' ' VAL . 25.6 t80 -69.51 -40.07 77.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.727 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.9 mtp -68.31 -38.6 81.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.68 -45.36 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.76 ' HB ' HD21 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -64.98 -32.88 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.389 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.904 ' HA ' HD12 ' A' ' 309' ' ' LEU . 36.5 t -77.24 -24.88 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -37.72 42.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.164 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.53 -14.54 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.363 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.894 0.289 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.76 HD21 ' HB ' ' A' ' 305' ' ' THR . 0.3 OUTLIER -80.27 -22.28 41.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.086 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.43 ' CG ' ' HG2' ' A' ' 166' ' ' GLU . 34.0 m-85 -52.84 -39.43 62.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 111.047 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.63 -36.48 78.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.0 -45.89 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 323' ' ' ILE . 35.9 mt -56.47 -38.24 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.032 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -43.62 88.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.34 -35.54 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 320' ' ' LEU . 70.9 mt -58.35 -47.12 88.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.025 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.789 HD13 ' OG ' ' A' ' 158' ' ' SER . 47.4 mt -73.64 -51.63 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -56.34 -49.71 73.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.192 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.53 -39.89 74.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -28.14 72.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.722 HD12 HD23 ' A' ' 325' ' ' LEU . 81.3 mt -60.05 -32.52 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -66.88 -30.2 70.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.87 -18.89 55.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.532 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 331' ' ' ILE . 1.3 pp -143.8 84.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 111.333 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 127.23 -33.9 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.704 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.38 101.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.6 mttm 61.71 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 328' ' ' LEU . 0.8 OUTLIER -128.82 115.79 18.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.892 0.377 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.19 110.49 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.82 25.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.554 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 28' ' ' ILE . 2.2 mt-10 -55.62 177.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 27' ' ' GLU . 28.1 mm -130.41 131.31 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 28.9 pt -118.41 154.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.1 t -95.54 138.49 33.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.977 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -95.2 -160.92 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -77.18 -43.8 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 109.967 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.84 -2.2 35.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER 87.31 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' THR . 11.4 mtpt -74.13 178.19 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.64 77.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' HB2' HG13 ' A' ' 29' ' ' ILE . 67.2 m95 -72.75 141.76 48.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 127.88 46.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.974 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 40' ' ' GLY . 31.7 t -92.83 158.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 39' ' ' VAL . . . -123.91 -125.13 2.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.555 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.81 164.03 37.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.473 ' O ' HG23 ' A' ' 43' ' ' ILE . 65.3 Cg_exo -51.28 -180.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.544 2.162 . . . . 0.0 112.387 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 53' ' ' LEU . 15.0 pt -157.37 -43.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.215 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 43' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 1.9 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.947 0.403 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.07 115.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 15.4 m-85 -140.17 165.2 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 43' ' ' ILE . 4.0 mt -70.97 156.71 39.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.15 159.39 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.075 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.12 155.63 40.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.3 ptm -101.07 38.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.92 111.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -175.22 3.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 p -64.93 -45.45 85.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -179.04 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.24 -175.68 5.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.47 146.29 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' HD13 ' A' ' 53' ' ' LEU . . . 170.02 -89.37 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -89.45 -30.35 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.98 53.26 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.48 96.31 41.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.52 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.691 2.261 . . . . 0.0 113.025 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.1 m -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 133' ' ' ARG . 16.2 m -119.33 158.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.727 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HG12 ' A' ' 130' ' ' ILE . 7.8 p -140.34 129.9 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -111.1 123.61 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.451 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 128' ' ' PHE . 18.0 t -113.13 141.69 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.472 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.38 133.79 24.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.605 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 88.12 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.439 2.093 . . . . 0.0 112.326 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m 54.44 -171.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 60.42 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -135.36 -178.22 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.18 -82.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.43 -41.64 6.31 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.62 2.213 . . . . 0.0 112.374 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.718 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.0 tp -65.46 -30.64 71.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -32.72 72.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.421 HG21 ' CA ' ' A' ' 200' ' ' LEU . 1.4 m -78.37 -43.34 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.6 tt0 -64.07 -46.36 84.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.718 HD23 ' HG ' ' A' ' 80' ' ' LEU . 2.7 mm? -61.6 -51.15 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -51.9 66.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 198' ' ' TYR . 15.5 t80 -63.99 -33.73 76.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-85 -72.47 -46.23 55.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -27.17 65.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.7 -47.45 8.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' A' ' 171' ' ' HIS . . . -103.06 -33.68 9.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -91.96 26.87 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.9 133.74 65.36 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.33 -32.84 89.95 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -37.11 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.157 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -58.01 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.795 HD11 ' HA ' ' A' ' 91' ' ' ALA . 54.3 mt -53.27 -49.38 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.56 -43.34 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 111.089 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 102' ' ' THR . 0.2 OUTLIER -70.76 -28.6 64.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -51.06 11.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.703 HG23 ' C ' ' A' ' 105' ' ' LEU . 27.0 mm -57.2 -37.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.257 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -74.86 -27.8 60.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.402 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' LYS . 15.4 p -82.15 -38.77 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -1.63 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.456 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 32.84 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.703 ' C ' HG23 ' A' ' 100' ' ' ILE . 11.8 mt -83.2 58.94 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.58 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.92 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.653 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.18 122.05 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.91 0.386 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 167' ' ' TYR . 12.6 tp -121.86 159.77 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.558 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.47 17.09 57.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.86 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.19 127.12 43.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.594 0.197 . . . . 0.0 111.072 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.05 141.15 48.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.281 1.987 . . . . 0.0 112.283 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.47 115.43 22.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -96.88 127.63 43.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.706 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 114' ' ' TRP . 7.2 m95 -103.04 -40.81 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -177.68 46.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.595 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -135.32 161.79 34.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.607 0.241 . . . . 0.0 110.545 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -153.79 -179.42 29.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.647 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 127' ' ' ARG . 3.3 mp -145.32 159.83 42.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.037 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -132.11 141.7 49.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.831 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.43 125.29 47.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 126.2 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 51.89 23.82 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.89 21.24 40.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.58 159.33 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.769 0.318 . . . . 0.0 110.71 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m -112.74 120.5 41.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -118.18 121.34 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.788 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 118' ' ' LEU . 3.7 mtt180 -107.77 129.28 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.54 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 24.0 p90 -140.04 160.3 40.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 111.235 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.653 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.6 tmm? -128.16 140.03 52.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.401 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.403 HG12 ' CG2' ' A' ' 70' ' ' VAL . 12.9 mt -110.63 111.82 37.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.453 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -127.82 173.22 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.27 141.68 45.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 69' ' ' VAL . 60.4 ttt-85 -73.81 161.92 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.418 ' CD2' HD12 ' A' ' 184' ' ' LEU . 79.1 m-85 -130.96 170.38 14.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.97 -52.16 1.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.6 m -157.93 171.89 19.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -98.82 153.73 18.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.2 mm? -60.03 -33.47 72.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.728 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -61.73 -46.52 89.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.848 0.356 . . . . 0.0 110.282 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -58.71 -28.57 65.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' ' 138' ' ' LEU . 35.1 mt -75.32 -26.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -58.13 -47.65 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.683 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.28 -26.74 68.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.791 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.85 -20.93 61.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 17.0 m120 -94.57 4.19 54.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 85.32 45.86 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.043 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 19.77 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.273 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -162.99 117.43 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.56 -172.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -121.43 158.08 29.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.738 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -34.1 73.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.669 ' CB ' HD13 ' A' ' 331' ' ' ILE . 10.6 pttt -74.71 -37.74 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.7 m -73.7 -40.75 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 150' ' ' SER . 38.5 t -68.04 -44.51 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.542 HD11 ' HG2' ' A' ' 298' ' ' GLU . 22.9 mt -58.33 -54.26 49.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -56.99 -46.99 81.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 193' ' ' VAL . 39.0 mt -65.76 -38.41 88.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.431 ' CB ' HD13 ' A' ' 324' ' ' LEU . 66.3 m -56.87 -34.11 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.708 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 321' ' ' ARG . 9.7 mt -73.31 -45.5 55.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -61.73 -45.07 95.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.791 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.74 ' HA ' HD12 ' A' ' 164' ' ' ILE . 18.3 mt -65.83 -33.04 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.932 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.534 HD23 HD12 ' A' ' 165' ' ' LEU . 11.0 mt -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -40.62 91.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 161' ' ' ILE . 4.0 mt -67.94 -42.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.551 HD22 ' OD2' ' A' ' 243' ' ' ASP . 89.6 mt -55.12 -43.77 74.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.973 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 317' ' ' TYR . 2.1 tt0 -66.0 -37.3 85.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.799 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.489 ' CG ' HD21 ' A' ' 108' ' ' LEU . 79.1 t80 -70.82 -54.66 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.81 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.42 HD13 ' HE2' ' A' ' 198' ' ' TYR . 38.1 pt -59.01 -27.6 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.174 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.51 ' CE1' HG12 ' A' ' 174' ' ' VAL . 2.2 m80 -69.05 -44.17 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.19 -14.45 61.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -99.03 2.87 46.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 72.89 43.05 0.44 Allowed 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.094 0.473 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.727 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 0.7 OUTLIER -140.88 110.38 6.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 204' ' ' TYR . 19.3 m -131.16 139.48 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.619 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -175.76 160.26 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.534 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.842 ' HA3' HD13 ' A' ' 246' ' ' ILE . . . -109.43 71.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.612 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 30.98 2.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.642 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mt -100.74 94.49 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -152.65 24.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.27 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.728 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 68.2 8.21 6.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.806 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -110.48 0.24 17.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -141.65 7.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.791 ' C ' HD23 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -108.66 114.45 28.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.048 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -124.75 148.16 48.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 141' ' ' ILE . 6.6 mt -95.03 149.25 21.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.949 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 1.0 OUTLIER -89.38 132.37 35.0 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.111 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -122.21 -31.38 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -24.29 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.796 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.528 ' CB ' ' HD3' ' A' ' 190' ' ' PRO . 0.5 OUTLIER -166.16 -57.86 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.772 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 189' ' ' ASN . 24.3 Cg_exo -61.25 -133.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.306 2.004 . . . . 0.0 112.376 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 186' ' ' ASN . 0.2 OUTLIER 171.92 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.247 -0.283 . . . . 0.0 111.72 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 1.2 mt-30 -85.95 -169.13 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -109.58 147.94 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 11.0 m-85 -129.5 151.42 50.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.035 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.747 HD23 ' CZ ' ' A' ' 198' ' ' TYR . 14.2 tp -104.04 115.97 31.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.508 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.3 131.88 60.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 20.0 t0 62.61 124.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.747 ' CZ ' HD23 ' A' ' 195' ' ' LEU . 10.1 m-85 -105.45 14.85 28.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.201 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.611 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 83.08 -55.28 5.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.626 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 199' ' ' GLY . 6.8 mp -139.18 -42.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.649 0.261 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 173' ' ' TYR . . . 64.17 101.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.688 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.825 ' CZ ' ' HB1' ' A' ' 237' ' ' ALA . 44.4 t80 -115.73 148.99 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.983 0.42 . . . . 0.0 111.017 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -95.57 78.21 3.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 174' ' ' VAL . 7.8 p90 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.524 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 226' ' ' GLU . 0.2 OUTLIER 60.79 65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.916 0.388 . . . . 0.0 110.88 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.92 HG23 HD22 ' A' ' 265' ' ' LEU . 6.2 tp -60.63 -18.46 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 224' ' ' THR . 1.6 pt-20 -59.92 -30.86 69.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.547 ' HB3' HG23 ' A' ' 246' ' ' ILE . 24.8 m-85 -149.25 34.87 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.305 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.705 HG22 HD12 ' A' ' 225' ' ' ILE . 12.6 t -81.51 116.83 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.303 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 m -64.85 153.43 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.62 -30.45 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 -40.28 74.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.88 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.53 -25.52 64.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.4 7.56 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 78.56 23.42 64.96 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.714 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.72 128.19 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.825 ' HB1' ' CZ ' ' A' ' 202' ' ' TYR . . . -82.7 -53.71 0.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 40.6 Cg_exo -56.88 94.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.466 2.111 . . . . 0.0 112.225 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 m -106.48 120.07 40.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.427 ' HG3' ' CD2' ' A' ' 204' ' ' TYR . 7.8 mtm105 -125.61 -47.8 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.44 -14.12 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.52 -49.68 71.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.692 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD2' HD22 ' A' ' 165' ' ' LEU . 1.5 m-20 -54.53 -38.99 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 320' ' ' LEU . 57.8 mt -74.44 -42.55 58.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.79 -35.13 72.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.842 HD13 ' HA3' ' A' ' 176' ' ' GLY . 11.7 mt -70.18 -44.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.504 HD23 ' OH ' ' A' ' 302' ' ' TYR . 23.8 tp -59.43 -41.47 89.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -60.57 -31.37 74.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.177 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -78.33 -25.72 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 67.2 m -68.03 -32.92 73.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.768 ' O ' HD12 ' A' ' 255' ' ' LEU . 1.7 mmm -58.54 -53.48 57.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.198 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.7 mp -76.93 -39.86 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.754 ' HB2' HD21 ' A' ' 259' ' ' LEU . 1.3 tm0? -59.28 -40.15 85.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.534 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 26.3 m0 -82.43 -46.17 13.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 251' ' ' MET . 6.9 mt -72.89 -25.87 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.8 m -104.5 0.67 29.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.3 88.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.374 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.5 m170 62.9 163.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.859 HD22 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -131.45 164.26 43.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.713 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.72 62.54 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.419 2.079 . . . . 0.0 112.407 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.859 ' CZ2' HD22 ' A' ' 259' ' ' LEU . 4.0 p90 177.24 -37.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.154 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.3 tt0 -91.88 12.58 21.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.316 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.76 -53.76 54.25 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.3 m-20 -131.38 -29.1 1.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.367 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.92 HD22 HG23 ' A' ' 225' ' ' ILE . 54.6 mt 73.89 9.87 4.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -77.02 -16.03 59.42 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.161 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.46 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.7 m-20 -136.21 99.89 10.79 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.799 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.12 16.63 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.647 2.231 . . . . 0.0 112.768 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -79.95 -44.93 19.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.347 . . . . 0.0 110.775 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 3.4 p90 -80.55 -26.21 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 261' ' ' TRP . 27.6 t -62.96 -38.08 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.261 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -75.65 -47.32 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.114 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -52.17 62.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.33 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.6 m -55.52 -39.44 70.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.361 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.56 -44.88 96.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.356 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.5 mt -70.71 -31.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.595 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -81.06 -45.5 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 0.0 111.466 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.2 m-85 -70.85 -34.13 71.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.54 -31.39 62.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.365 . . . . 0.0 110.667 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.31 16.87 23.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.952 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -139.73 44.45 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.753 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.803 HD13 ' CB ' ' A' ' 303' ' ' MET . 30.5 mt -50.58 -39.1 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.89 -27.85 61.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -38.36 27.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.6 pp -73.25 -39.36 65.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.419 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 10.6 mtt -71.16 -38.28 72.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.2 -41.22 97.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -24.81 33.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.3 m -89.78 -41.16 12.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.575 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.17 150.76 37.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.89 178.88 4.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.209 . . . . 0.0 112.291 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.87 30.66 4.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -88.57 -32.2 18.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -134.86 169.64 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.82 138.82 19.9 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 50.5 Cg_exo -53.51 121.24 9.14 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.317 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -147.98 -54.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.542 ' HG2' HD11 ' A' ' 155' ' ' LEU . 5.7 mp0 -62.93 -61.57 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.91 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 251' ' ' MET . 18.0 mm -76.02 -43.34 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.07 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -46.07 -47.92 17.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -59.31 -37.74 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.865 ' O ' HG23 ' A' ' 306' ' ' VAL . 85.6 t80 -72.11 -40.68 67.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.761 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.803 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.5 mtp -68.3 -41.06 81.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.632 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.4 -47.55 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 3.3 p -60.64 -36.52 78.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 302' ' ' TYR . 26.1 t -74.89 -24.72 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.022 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -30.94 54.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.52 -8.77 18.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.727 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.191 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 CA-C-O 120.828 0.262 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.17 25.73 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 166' ' ' GLU . 86.7 m-85 -64.75 -34.19 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.35 -30.9 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.05 -46.01 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.946 ' HA ' HD12 ' A' ' 323' ' ' ILE . 62.1 mt -57.88 -48.86 78.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.426 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -57.95 -30.64 66.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.05 -41.34 35.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 320' ' ' LEU . 17.4 mt -54.62 -41.38 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 162' ' ' LEU . 96.0 mt -75.8 -49.8 17.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.08 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.702 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -58.02 -49.92 75.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.192 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -58.51 -42.27 87.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.01 56.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.456 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 325' ' ' LEU . 25.2 mt -62.67 -28.76 70.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.732 0.301 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 4.0 mtmt -67.7 -28.54 67.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 298' ' ' GLU . . . -77.89 -18.69 55.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.666 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 152' ' ' LYS . 1.4 pp -114.12 16.95 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 108.27 43.22 1.29 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.251 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 17.7 m 58.76 177.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.218 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HB2' HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -79.64 145.79 32.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.885 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.35 162.68 11.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.699 HG22 ' HG ' ' A' ' 41' ' ' LEU . 17.0 t -68.12 120.75 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.16 -24.78 29.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.6 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.16 153.52 14.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 36' ' ' GLU . 34.8 mt -123.05 140.11 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 25.8 pt -119.64 154.67 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 6.7 p -95.38 141.33 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.21 -161.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.64 -37.4 36.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.759 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -83.2 4.5 26.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.3 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 77.19 30.0 0.55 Allowed 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 1.4 mtpp -76.17 175.82 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.032 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HB2' HG21 ' A' ' 28' ' ' ILE . 7.9 pt-20 -122.32 77.34 1.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 0.0 110.678 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HB2' HG13 ' A' ' 29' ' ' ILE . 78.7 m95 -71.89 128.3 35.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.972 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -86.42 127.97 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.05 125.21 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.42 -125.6 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.555 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 25' ' ' VAL . 5.0 mp -117.76 156.92 49.26 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.99 131.35 19.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.586 2.191 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.85 -36.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.555 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.878 0.37 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 71' ' ' LYS . 23.4 mm -96.86 122.97 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.096 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -145.91 168.28 21.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 133' ' ' ARG . 19.3 mt -82.26 154.81 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.35 157.79 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -138.23 154.86 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.56 51.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 60.51 101.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.99 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -121.81 179.43 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 144.49 32.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 67.5 -72.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.11 -169.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 55' ' ' ASP . 21.2 t -98.89 94.48 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.0 -91.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.532 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.94 30.44 4.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.33 65.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.7 94.48 48.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.76 36.46 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.286 2.657 . . . . 0.0 112.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.72 148.24 29.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.57 144.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.059 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.5 p -134.4 123.62 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' HD12 ' A' ' 51' ' ' ILE . 12.2 mttp -105.44 124.22 49.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG22 ' CB ' ' A' ' 128' ' ' PHE . 15.9 t -113.96 141.62 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.07 150.62 59.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.66 86.0 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.517 2.145 . . . . 0.0 112.215 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.6 -71.5 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -161.37 99.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.55 -26.26 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.6 -154.65 7.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.597 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.27 24.84 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.301 2.667 . . . . 0.0 112.687 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.77 -42.29 92.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.14 -44.11 95.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -67.22 -34.34 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.34 -42.91 74.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.5 mm? -57.57 -52.08 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -46.07 78.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.54 -30.74 67.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.621 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -67.56 -46.98 71.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.083 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 1.1 tt0 -79.88 -17.61 52.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.552 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -47.64 60.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.757 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 -34.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -53.95 -20.8 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 40.1 mtpt -47.46 138.29 8.76 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.659 0.266 . . . . 0.0 111.035 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.7 -18.31 47.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.496 2.131 . . . . 0.0 112.393 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.34 -35.9 40.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -79.3 -45.77 19.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 100' ' ' ILE . 62.2 mt -61.05 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -55.45 -33.68 63.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -38.98 63.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -68.95 -42.07 77.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 96' ' ' ILE . 27.3 mt -65.51 -37.5 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.042 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.79 60.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.4 m -80.97 -37.73 28.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.514 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.43 -3.51 20.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.43 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 59.96 31.85 20.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 110.657 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 100' ' ' ILE . 13.2 mt -52.4 -28.45 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mttm 76.33 -56.13 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -145.79 154.27 41.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 167' ' ' TYR . 1.5 tp -127.55 -72.88 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.612 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 127.31 1.03 6.77 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.007 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 164' ' ' ILE . 33.5 t -76.2 128.5 82.64 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.843 0.321 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.81 143.0 9.79 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -84.25 116.88 23.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.709 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -111.99 -40.68 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.94 -175.95 46.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.95 162.1 35.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.675 0.274 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.15 -175.05 21.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.65 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -145.26 158.9 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -131.84 133.85 45.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -107.79 122.6 47.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 126.22 22.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 57.73 19.51 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.275 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.29 -0.15 61.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.897 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 129.09 47.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -96.14 131.62 42.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.63 148.88 39.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -111.4 125.27 53.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.948 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 10.8 p90 -132.24 160.23 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.847 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -128.12 142.64 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 mt -116.24 116.76 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.299 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -128.88 173.16 10.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.36 144.57 20.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.049 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.574 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -59.18 179.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.992 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -151.69 145.47 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.73 -107.87 0.82 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -113.4 130.25 56.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.802 ' OD1' HD22 ' A' ' 184' ' ' LEU . 19.9 m-20 -57.76 155.91 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.5 mm? -61.04 -23.14 65.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.733 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.7 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 8.8 pt20 -68.61 -42.0 78.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.904 0.383 . . . . 0.0 110.409 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -62.8 -35.36 79.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.039 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 138' ' ' LEU . 5.2 mt -78.28 -28.52 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 254' ' ' TRP . 48.4 t80 -61.16 -52.43 64.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.8 -30.42 56.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.96 -16.44 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.637 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -87.81 -2.93 58.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.135 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 95.74 41.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.063 0.545 . . . . 0.0 110.327 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 61.53 19.13 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.541 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -167.04 125.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.129 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.493 ' CD1' HG21 ' A' ' 153' ' ' THR . 0.3 OUTLIER -81.78 -176.88 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 154' ' ' VAL . 17.9 p -113.95 -176.91 3.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -71.8 -33.9 68.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -65.9 -48.08 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.493 HG21 ' CD1' ' A' ' 149' ' ' PHE . 14.3 p -63.44 -40.22 96.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 150' ' ' SER . 47.6 t -70.78 -53.82 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.848 ' HB3' HD21 ' A' ' 328' ' ' LEU . 94.4 mt -57.21 -46.91 82.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -52.8 61.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.555 HD22 HG11 ' A' ' 193' ' ' VAL . 16.6 mt -62.28 -37.01 83.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.772 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 247' ' ' LEU . 38.5 m -58.13 -37.94 75.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 324' ' ' LEU . 35.0 mt -67.58 -48.01 68.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.91 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 178' ' ' ILE . 11.9 mt -62.75 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.5 mt -64.84 -35.08 79.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.62 -38.3 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.612 HD11 ' HA3' ' A' ' 109' ' ' GLY . 33.4 mt -74.54 -42.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 162' ' ' LEU . 6.9 mt -56.29 -43.13 78.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 32.1 tt0 -66.93 -32.78 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.8 ' CG ' HD21 ' A' ' 108' ' ' LEU . 88.9 t80 -68.22 -50.32 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.554 HD13 ' NE2' ' A' ' 175' ' ' HIS . 26.0 pt -73.41 -27.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 174' ' ' VAL . 3.6 m-70 -68.46 -32.37 72.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.299 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.98 -17.1 62.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.51 4.74 38.94 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CG ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 77.1 5.34 3.25 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.488 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 203' ' ' ARG . 4.6 m-85 -94.24 132.77 38.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.723 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 204' ' ' TYR . 30.4 m -142.37 139.06 29.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.071 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.554 ' NE2' HD13 ' A' ' 168' ' ' ILE . 3.0 p80 -115.67 -40.91 3.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.346 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 59.32 19.11 45.55 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.632 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.07 61.35 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 161' ' ' ILE . 3.9 mp -94.51 102.56 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.657 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 183' ' ' LEU . 6.2 mtmm -146.68 -175.48 4.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.687 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.7 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -84.75 3.08 39.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.6 p -106.15 -2.82 22.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.05 -2.89 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.351 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.76 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.1 mt -108.32 122.68 47.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.802 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.2 OUTLIER -131.64 160.63 34.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.76 0.314 . . . . 0.0 110.999 -178.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.5 147.08 23.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 111.194 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.6 OUTLIER -60.98 131.64 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -78.12 -53.72 7.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.77 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.843 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.15 71.81 18.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.969 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.65 101.91 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.16 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -178.0 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -113.24 159.11 19.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.555 HG11 HD22 ' A' ' 157' ' ' LEU . 3.3 p -110.21 148.29 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.99 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.548 ' CE1' ' ND2' ' A' ' 186' ' ' ASN . 13.0 m-85 -125.95 157.63 37.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.008 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.453 HD23 ' HE1' ' A' ' 198' ' ' TYR . 34.3 tp -103.32 115.97 31.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 184' ' ' LEU . 2.3 t -118.18 157.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 54.52 103.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.601 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 48.7 m-85 -97.91 -64.31 1.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.678 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 95.31 -37.66 3.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 199' ' ' GLY . 7.3 mp -128.74 22.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.601 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -78.39 60.97 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.166 0.508 . . . . 0.0 110.536 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -124.33 149.03 47.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.193 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -55.49 97.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.968 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' HG22 ' A' ' 174' ' ' VAL . 47.6 p90 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 -63.28 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -161.65 -44.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HG2' HD13 ' A' ' 225' ' ' ILE . 14.3 mm-40 -159.26 27.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.405 ' CE2' ' HD3' ' A' ' 179' ' ' LYS . 2.7 t80 -94.63 23.8 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -141.86 -72.85 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.519 ' H ' HG23 ' A' ' 228' ' ' THR . 0.9 OUTLIER -167.99 150.32 5.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.347 . . . . 0.0 111.035 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.23 -31.57 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.5 -31.46 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.22 -30.24 63.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -75.66 -29.33 59.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.08 12.91 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.461 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.45 26.31 74.38 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.534 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.63 144.63 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -58.17 145.13 74.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.83 -36.28 18.86 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.414 2.076 . . . . 0.0 112.23 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.6 m 59.55 33.77 22.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -56.14 0.65 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.555 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -21.76 56.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.145 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -59.03 -32.1 70.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 165' ' ' LEU . 2.5 t0 -78.68 -29.23 45.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.79 HD13 HD11 ' A' ' 320' ' ' LEU . 18.8 mt -73.84 -29.77 62.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.011 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.3 -31.98 62.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.428 HD13 ' HA2' ' A' ' 176' ' ' GLY . 2.6 mp -76.1 -38.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 158' ' ' SER . 55.2 tp -73.92 -31.23 62.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.64 -47.69 80.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.559 ' HA ' HD12 ' A' ' 252' ' ' ILE . 51.3 m-85 -78.49 -25.88 45.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 -41.44 70.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.139 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.426 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -60.27 -48.63 80.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.8 ' O ' HG22 ' A' ' 256' ' ' THR . 2.9 mt -66.37 -28.48 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.037 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.635 ' HB2' HD21 ' A' ' 259' ' ' LEU . 12.7 tm0? -80.1 -36.86 34.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.475 ' CD1' ' CE1' ' A' ' 142' ' ' TYR . 20.8 m0 -82.38 -29.89 30.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.426 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.2 mt -67.21 -47.09 71.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.392 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 252' ' ' ILE . 6.1 t -98.71 -23.35 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.327 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.442 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 101.79 14.99 27.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.817 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 166.62 170.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.851 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -133.6 159.56 72.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 261' ' ' TRP . 15.7 Cg_exo -68.33 59.97 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.748 2.299 . . . . 0.0 112.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.851 ' CH2' HD22 ' A' ' 259' ' ' LEU . 16.2 p90 177.34 -42.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.106 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -95.63 17.2 15.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.529 179.172 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -58.33 -51.61 69.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.5 t-20 -130.51 -25.92 2.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 77.2 mt 70.03 13.7 7.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.239 0.543 . . . . 0.0 109.611 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -89.81 -14.99 33.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.253 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.477 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 0.5 OUTLIER -134.98 88.61 26.47 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.93 -8.09 22.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.614 2.209 . . . . 0.0 112.664 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -54.56 -50.07 68.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.751 0.31 . . . . 0.0 111.189 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 5.7 p90 -81.73 -26.18 34.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 225' ' ' ILE . 59.4 t -60.06 -44.33 94.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.473 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -68.89 -42.27 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -36.55 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.1 m -65.61 -43.67 88.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.9 OUTLIER -62.93 -44.58 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.69 -29.68 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.435 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -49.82 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.403 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 13.2 m-85 -64.5 -39.94 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.468 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -26.33 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.28 19.07 15.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -143.81 49.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 303' ' ' MET . 16.6 mt -54.11 -35.22 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.348 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.82 -29.79 62.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 111.067 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.9 pp -73.9 -29.69 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.413 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 4.9 mmt -64.85 -47.47 77.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.01 -20.93 44.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -82.7 -50.86 8.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.694 0.283 . . . . 0.0 111.399 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.87 -41.13 30.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.334 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.63 98.92 16.04 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.084 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.92 84.72 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.474 2.116 . . . . 0.0 112.046 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.6 97.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.642 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 56.18 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -161.84 -51.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -151.16 104.74 2.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 -49.1 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.367 2.045 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.62 30.22 0.03 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER 68.39 7.92 6.29 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.737 0.268 . . . . 0.0 111.664 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.624 HG22 ' CG ' ' A' ' 303' ' ' MET . 28.8 mm -79.57 -46.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.413 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.25 -35.81 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.523 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 323' ' ' ILE . 15.1 mmtp -68.48 -41.49 80.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 306' ' ' VAL . 11.5 t80 -72.11 -34.32 68.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.748 ' CB ' HD13 ' A' ' 282' ' ' ILE . 65.3 mmm -71.78 -48.22 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 305' ' ' THR . 21.4 pt-20 -56.28 -41.41 75.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 309' ' ' LEU . 12.1 m -64.44 -42.19 96.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 302' ' ' TYR . 41.2 t -69.55 -24.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.144 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -71.65 -37.29 70.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 73.7 mt -97.53 -13.53 21.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.607 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.745 HD21 ' HA ' ' A' ' 316' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.952 0.313 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.745 ' HA ' HD21 ' A' ' 309' ' ' LEU . 5.3 tt -127.93 -74.86 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.646 ' N ' HD23 ' A' ' 316' ' ' LEU . 35.2 m-85 -70.68 -38.03 73.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.84 -46.58 84.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.066 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -73.33 -45.94 52.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 323' ' ' ILE . 52.1 mt -58.76 -51.84 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.66 -42.03 70.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -62.36 -46.76 87.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 320' ' ' LEU . 13.9 mt -51.03 -47.28 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.624 HD22 HD23 ' A' ' 155' ' ' LEU . 52.6 mt -71.54 -48.88 45.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.025 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.31 -49.97 72.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.372 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -39.09 79.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.805 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.01 -33.25 68.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 155' ' ' LEU . 11.3 mt -67.98 -38.6 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.42 -30.78 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -30.86 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.17 26.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.83 25.94 38.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.728 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 m -91.92 158.34 16.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 179.12 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.7 102.27 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.53 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.89 -28.82 12.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.51 149.51 49.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.864 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 36' ' ' GLU . 33.6 mt -117.61 136.85 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.95 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 30.0 pt -111.67 154.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -95.3 141.38 28.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -160.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.094 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.21 -42.97 29.77 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.073 0.463 . . . . 0.0 109.971 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -82.22 2.14 33.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.707 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 23.5 tttp 87.6 28.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -69.51 176.52 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.231 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.529 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.4 mp0 -127.86 78.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.898 0.38 . . . . 0.0 110.589 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' HE3' ' HB1' ' A' ' 54' ' ' ALA . 34.7 m95 -76.39 131.39 39.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -92.43 124.38 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.4 t -75.45 142.34 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -134.58 8.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.74 161.82 22.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' ILE . 51.7 Cg_exo -54.43 173.69 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.521 2.147 . . . . 0.0 112.322 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 42' ' ' PRO . 10.5 pt -160.08 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.71 118.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -146.37 171.97 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 7.4 mt -77.29 156.91 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . . . -115.45 147.62 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.2 t0 -138.46 159.61 41.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -118.68 72.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.659 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 64.43 -77.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 59.15 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -80.13 60.76 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.59 148.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 m 59.48 170.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 55' ' ' ASP . 36.1 t -118.1 -53.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.45 -169.94 30.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.528 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 t -103.59 39.99 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -156.37 82.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -120.97 137.61 26.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -87.99 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.985 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 77.2 m -149.7 148.29 29.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.565 HG13 ' CG ' ' A' ' 133' ' ' ARG . 28.6 m -128.74 144.88 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 130' ' ' ILE . 8.0 p -131.57 124.38 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HD2' HD13 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -109.55 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.638 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 128' ' ' PHE . 4.7 t -113.41 144.3 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.15 140.7 21.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.36 109.31 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.507 2.138 . . . . 0.0 112.314 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.71 178.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -87.17 -171.25 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.84 113.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.4 -168.12 30.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.416 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 -44.49 46.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 112.251 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' A' ' 84' ' ' LEU . 13.6 tp -70.12 -30.08 67.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -60.87 -36.78 80.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.2 p -70.63 -36.66 73.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -70.73 -48.4 54.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.2 mm? -58.26 -43.07 87.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -49.9 75.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' CD2' ' A' ' 198' ' ' TYR . 29.8 t80 -70.43 -39.63 74.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.575 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -54.86 -42.97 72.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -77.26 -17.78 58.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.372 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -82.64 -26.77 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.378 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.58 ' HB1' ' HE2' ' A' ' 167' ' ' TYR . . . -139.88 -44.62 0.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.664 0.268 . . . . 0.0 111.719 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -66.04 -11.63 49.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.778 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -47.22 133.62 9.39 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.527 0.203 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.3 -30.57 26.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.538 2.159 . . . . 0.0 112.632 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -31.33 42.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.58 -40.56 66.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 91' ' ' ALA . 24.0 mm -67.3 -57.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -53.49 -27.15 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.301 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -73.96 -55.99 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.03 -47.24 78.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.812 HG23 ' H ' ' A' ' 106' ' ' LYS . 36.3 mm -56.9 -43.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -75.17 -27.64 59.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.1 m -78.79 -38.81 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.612 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -4.72 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.459 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 100' ' ' ILE . 6.8 mttm 59.64 26.96 16.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 108' ' ' LEU . 3.5 mt -54.24 -47.13 72.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.812 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER 59.22 36.18 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.913 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -176.84 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp 71.96 -63.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.34 12.46 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.823 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 108' ' ' LEU . 24.0 t -81.08 138.97 49.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.56 0.219 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HD2' ' CG1' ' A' ' 110' ' ' VAL . 84.6 Cg_exo -46.42 146.38 5.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 112.399 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 115.52 23.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.289 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.2 127.85 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.565 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -112.33 -40.89 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.82 174.9 41.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.606 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.92 173.33 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.417 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.444 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -156.94 178.0 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.764 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 126' ' ' TYR . 1.7 mp -147.93 159.87 43.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 116.57 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.69 124.38 36.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.26 126.29 22.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.4 t30 59.67 17.27 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.535 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.44 56.57 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.916 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 129.03 43.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.819 0.342 . . . . 0.0 110.682 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.3 t -91.15 124.32 35.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.044 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.489 ' O ' HD23 ' A' ' 118' ' ' LEU . 4.2 m-85 -97.73 147.74 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -125.1 125.13 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.95 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 16.5 p90 -138.28 163.11 32.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.756 ' HB2' HD21 ' A' ' 84' ' ' LEU . 9.4 tmm? -128.1 148.62 50.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.709 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 HG12 HG23 ' A' ' 70' ' ' VAL . 19.8 mt -123.39 112.74 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.249 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -123.08 173.27 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -54.19 142.67 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.089 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.565 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -80.26 156.31 26.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -120.36 155.42 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.06 -80.14 1.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -131.65 131.19 42.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -58.87 159.78 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -62.12 -23.91 66.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.626 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -64.27 -42.05 96.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -64.02 -29.7 70.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.298 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 185' ' ' LEU . 12.0 mt -81.5 -29.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 254' ' ' TRP . 18.2 t80 -70.92 -48.89 51.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.806 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.38 -29.81 65.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.44 -24.75 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.578 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -95.2 16.16 17.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.14 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 84.04 46.94 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.153 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.67 20.12 11.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.249 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.13 176.8 8.38 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.93 -169.3 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -116.65 145.2 43.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -30.43 65.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -71.18 -36.43 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.17 -41.12 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 251' ' ' MET . 45.3 t -55.91 -54.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.834 HD12 HD11 ' A' ' 331' ' ' ILE . 61.5 mt -64.18 -37.23 86.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.47 -44.71 74.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.733 HD22 HG11 ' A' ' 193' ' ' VAL . 34.4 mt -71.04 -47.81 56.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.597 ' HA ' HD12 ' A' ' 161' ' ' ILE . 43.8 p -53.38 -37.61 62.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.637 HD11 ' HG ' ' A' ' 325' ' ' LEU . 1.7 mt -68.17 -48.13 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.665 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -38.4 82.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.9 mt -68.57 -37.39 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 165' ' ' LEU . 12.1 mt -60.8 -36.96 80.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -37.94 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.496 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 110' ' ' VAL . 19.0 mt -75.18 -39.0 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 162' ' ' LEU . 46.2 mt -59.32 -43.08 92.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.607 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.0 -34.9 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.592 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.58 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 88.2 t80 -67.84 -52.49 36.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.5 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.1 pt -67.19 -29.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.995 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -75.09 -34.23 61.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.418 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.95 -16.89 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.44 40.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 77.49 43.9 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.69 140.34 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 31.0 m -126.07 138.92 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 45.6 t-80 -159.48 92.48 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.897 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.661 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -93.64 38.61 3.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.284 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 t0 -97.39 34.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.483 HG12 HG21 ' A' ' 161' ' ' ILE . 3.8 mp -74.39 114.46 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.924 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -160.38 -179.12 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.21 -2.09 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.412 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.4 m -107.28 -0.62 22.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.498 ' O ' HG22 ' A' ' 196' ' ' VAL . 73.7 m-80 -127.5 -5.21 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.783 ' C ' HD23 ' A' ' 184' ' ' LEU . 13.0 mt -108.49 118.69 37.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.062 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -126.07 156.68 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.233 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 141' ' ' ILE . 6.5 mt -99.11 149.65 22.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -73.47 135.63 44.11 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.836 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.455 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 9.0 t80 -71.48 -68.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 -15.13 23.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.746 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.59 ' CB ' ' HD2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -76.5 -168.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 189' ' ' ASN . 39.9 Cg_exo -39.85 -27.38 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.563 2.175 . . . . 0.0 113.913 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 1.1 t70 88.08 5.03 0.25 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.663 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -72.82 -167.58 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 157' ' ' LEU . 2.5 p -109.96 147.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.163 0.506 . . . . 0.0 111.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 15.7 m-85 -131.41 157.25 43.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.559 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 58.0 tp -103.62 115.79 31.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.679 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 182' ' ' ASN . 28.4 m -105.67 -175.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.421 ' OD1' HG23 ' A' ' 196' ' ' VAL . 4.1 m-20 60.85 98.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.628 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.89 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 13.1 m-85 -109.87 30.53 6.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -53.72 -24.67 26.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.254 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -114.15 -4.27 13.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.538 0.209 . . . . 0.0 111.064 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.89 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -77.12 59.39 1.71 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 110.689 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.49 149.05 52.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -53.11 93.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.067 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.3 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 228' ' ' THR . 33.3 p -59.95 -176.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 0.0 110.772 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.706 HG12 HG11 ' A' ' 271' ' ' VAL . 7.3 tt -101.11 -21.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' A' ' 265' ' ' LEU . 15.0 pt-20 -52.71 -22.96 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 246' ' ' ILE . 63.1 m-85 -142.53 30.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.322 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.405 HG21 HG13 ' A' ' 225' ' ' ILE . 13.4 t -85.6 146.59 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.95 159.0 19.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.5 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.49 -42.98 82.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.29 66.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.196 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.84 -25.56 63.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.318 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -96.33 0.12 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.45 58.57 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.706 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.73 122.59 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.83 158.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 55.6 Cg_endo -69.9 -171.23 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.6 2.2 . . . . 0.0 112.299 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.06 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -73.95 -54.18 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -83.36 -16.89 44.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.84 92.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.902 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.8 p30 -58.61 -28.79 65.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.309 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 320' ' ' LEU . 70.3 mt -76.6 -34.81 58.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -32.35 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 243' ' ' ASP . 13.4 mt -66.65 -44.81 89.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.02 -36.56 83.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.521 ' O ' ' HE1' ' A' ' 303' ' ' MET . . . -59.21 -47.32 91.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.428 ' HA ' HD12 ' A' ' 252' ' ' ILE . 38.6 m-85 -78.58 -25.69 45.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.297 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -39.06 72.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.03 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.644 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -64.25 -50.04 69.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.892 ' O ' HG22 ' A' ' 256' ' ' THR . 3.4 mt -65.74 -29.21 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.981 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.447 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -68.92 -47.55 65.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.447 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 16.2 m0 -82.34 -26.88 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.405 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 290' ' ' PHE . 11.5 mt -67.05 -49.34 65.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.386 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 252' ' ' ILE . 13.1 t -101.53 -11.48 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 92.75 108.07 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.306 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 25.8 p80 48.18 -175.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.9 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -135.02 154.61 79.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 48.8 Cg_endo -68.77 61.62 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.098 . . . . 0.0 112.166 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.9 ' CH2' HD22 ' A' ' 259' ' ' LEU . 8.4 p90 177.45 -36.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.676 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -89.26 14.44 11.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.535 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.11 -42.12 97.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.33 -29.33 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.277 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 226' ' ' GLU . 87.7 mt 69.59 13.65 8.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -88.19 -14.94 37.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.361 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.0 94.73 14.16 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 59.9 Cg_endo -72.01 -4.43 15.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.545 2.163 . . . . 0.0 112.643 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -53.21 -49.95 65.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.581 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.2 p90 -83.6 -26.07 30.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.008 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.706 HG11 HG12 ' A' ' 225' ' ' ILE . 61.4 t -59.84 -44.38 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -75.51 -36.88 60.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.296 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.84 -43.24 80.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.285 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -36.57 84.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.413 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -66.4 -50.33 63.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.212 -179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.93 -28.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.352 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.483 ' HG3' ' ND2' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -72.36 -52.13 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.184 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.963 ' CD1' HD12 ' A' ' 285' ' ' LEU . 4.4 m-85 -57.99 -37.03 73.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.77 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -55.52 -26.99 46.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 28.63 5.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.74 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 277' ' ' ARG . 37.0 m-80 -146.64 41.58 1.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.761 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 4.2 mm -53.73 -45.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -70.36 -39.55 74.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -70.94 -29.54 65.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.963 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.3 tt -67.38 -50.89 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.565 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.1 mmt -62.03 -36.82 82.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -19.96 61.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -46.48 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.455 ' SG ' HG21 ' A' ' 256' ' ' THR . 4.7 m -93.69 -41.18 9.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.383 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 255' ' ' LEU . 16.6 m-85 -99.11 107.28 43.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.934 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.66 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.454 2.102 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.59 -25.18 38.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.2 -49.88 70.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.69 104.86 17.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -66.36 139.35 96.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.17 -174.09 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.541 2.161 . . . . 0.0 112.26 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 138.77 -43.05 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.322 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -74.74 -70.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.656 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.603 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.8 mm -79.57 -49.72 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.993 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.565 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -44.62 -31.31 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.651 ' HG2' HG23 ' A' ' 323' ' ' ILE . 14.1 ttpt -76.68 -36.46 57.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.619 ' CE2' HD22 ' A' ' 320' ' ' LEU . 17.9 t80 -76.15 -34.3 59.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.603 ' CG ' HG22 ' A' ' 299' ' ' ILE . 56.5 mmm -74.16 -42.13 60.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 305' ' ' THR . 11.7 pt-20 -64.11 -40.74 96.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.669 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.646 HG21 HD11 ' A' ' 323' ' ' ILE . 1.7 p -66.8 -36.05 81.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.676 ' HA ' HD12 ' A' ' 309' ' ' LEU . 74.4 t -79.64 -24.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -32.93 41.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.22 -25.24 10.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.853 0.272 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 319' ' ' ASN . 0.1 OUTLIER -96.39 22.99 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.06 -35.84 81.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.16 -37.05 84.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.631 ' HB3' HD23 ' A' ' 316' ' ' LEU . 4.1 t-20 -77.33 -45.43 26.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 323' ' ' ILE . 56.4 mt -51.04 -43.25 60.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -57.62 -35.74 70.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -35.45 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 301' ' ' LYS . 73.9 mt -55.86 -51.49 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.553 HD13 ' OG ' ' A' ' 158' ' ' SER . 73.5 mt -66.36 -48.9 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.001 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.637 ' HG ' HD11 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -54.76 -49.94 69.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.363 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.6 -40.28 86.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.14 65.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 155' ' ' LEU . 47.1 mt -61.08 -34.96 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -59.74 -31.47 69.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.24 48.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.834 HD11 HD12 ' A' ' 155' ' ' LEU . 1.4 pp -143.77 84.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.412 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.29 -42.69 1.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.724 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 t 65.31 87.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 61.0 156.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -75.53 153.44 37.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.995 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 41' ' ' LEU . 21.4 t 66.02 104.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.62 37.16 31.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.623 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -136.34 152.13 50.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.787 HD11 ' HE3' ' A' ' 38' ' ' LYS . 17.2 mm -116.98 139.21 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.469 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.7 pt -119.74 154.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 34.6 m -95.55 141.33 29.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.996 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 1.1 t70 -93.77 -160.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.03 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.4 ttm -77.67 -41.69 37.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.86 0.15 36.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.589 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 3.1 mttp 87.24 27.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -70.34 179.25 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.06 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.16 79.59 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.469 ' HB2' HG13 ' A' ' 29' ' ' ILE . 69.6 m95 -73.49 137.66 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.907 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD11 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -91.66 134.49 34.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.012 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.89 143.72 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.02 -130.64 7.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -102.51 159.13 30.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.914 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.57 111.18 2.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.533 2.155 . . . . 0.0 112.063 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG12 ' A' ' 69' ' ' VAL . 13.4 pt -106.43 -37.9 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 3.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.37 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 3.6 mp -98.9 136.68 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.387 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.517 ' O ' HG12 ' A' ' 70' ' ' VAL . 19.6 m-85 -140.45 170.3 16.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.663 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.22 152.45 42.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -127.08 153.93 45.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.318 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -143.8 150.45 38.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.789 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 mtm -99.45 45.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 59.84 -177.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 m 61.28 45.15 9.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -163.51 -43.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 69.93 -66.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -87.62 86.97 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.48 88.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.85 36.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.3 p -147.55 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -155.44 80.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.21 71.58 3.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 86.28 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.7 t -148.83 148.13 29.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 HD11 ' A' ' 43' ' ' ILE . 6.1 m -128.27 153.47 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.048 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 52' ' ' TYR . 5.4 p -142.79 119.37 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -103.65 117.42 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 128' ' ' PHE . 11.8 t -118.95 152.05 21.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -139.08 135.77 17.69 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.636 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 83.4 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.303 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.23 -171.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.09 156.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -78.99 177.6 8.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.47 -162.87 29.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.23 32.78 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.708 2.272 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -60.61 -30.84 70.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.41 -37.15 86.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.019 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -33.13 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.7 -40.9 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 129' ' ' MET . 1.4 mt -76.91 -37.62 55.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -59.56 -40.3 86.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 8.5 t80 -82.83 -29.81 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -64.4 -51.91 60.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.122 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.59 -17.3 61.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.434 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.67 -47.51 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -120.07 -22.61 6.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.5 23.8 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -73.16 113.18 19.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.37 -33.31 36.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.454 2.102 . . . . 0.0 112.591 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.68 -39.01 77.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.32 -47.27 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.314 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.2 mt -57.58 -57.54 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.44 62.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -64.39 -47.42 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -60.3 -55.05 38.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.254 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 105' ' ' LEU . 70.0 mt -56.33 -36.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.01 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -74.96 -27.7 60.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.8 m -81.75 -36.61 28.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -2.54 26.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.81 30.77 20.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.676 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 100' ' ' ILE . 29.7 mt -49.57 -31.7 11.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.54 -55.57 0.52 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.83 129.11 13.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.895 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp -99.22 -66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.74 9.5 6.91 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.064 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.8 138.78 27.76 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.826 0.313 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 71.9 Cg_exo -50.8 151.41 11.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.525 2.15 . . . . 0.0 112.406 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.08 115.58 27.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -99.78 126.96 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.562 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -105.95 -40.87 5.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 111.028 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 -174.72 46.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.597 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 p -134.86 159.42 41.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.77 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -138.59 173.37 22.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.828 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 117' ' ' GLY . 3.0 mt -148.04 158.07 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.3 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -145.83 138.61 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.74 123.84 48.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.678 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -138.26 126.23 22.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.22 22.68 2.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.414 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.11 3.51 63.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.719 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -96.08 128.92 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.5 m -89.39 125.82 35.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.09 125.9 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.76 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.91 125.21 51.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.899 ' CB ' HG22 ' A' ' 72' ' ' VAL . 14.6 p90 -140.31 165.72 26.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 111.407 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.436 ' HG3' HD21 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -131.89 147.14 52.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.49 HG22 ' SG ' ' A' ' 68' ' ' CYS . 16.9 mt -123.28 111.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 111.4 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -126.66 173.46 9.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.975 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.98 144.82 3.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HG3' HG13 ' A' ' 69' ' ' VAL . 69.4 ttt-85 -88.42 -25.56 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.566 ' CD2' HD12 ' A' ' 184' ' ' LEU . 80.7 m-85 65.08 178.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.02 -108.15 1.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.59 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -107.02 127.85 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.545 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.3 p30 -58.26 157.65 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 0.9 OUTLIER -60.83 -23.6 65.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.693 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.1 OUTLIER -61.57 -41.03 96.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.97 0.414 . . . . 0.0 110.084 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -34.99 79.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.405 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.526 HG22 ' CE1' ' A' ' 149' ' ' PHE . 3.1 mt -81.35 -25.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 11.9 t80 -67.71 -53.62 26.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -29.46 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.706 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.27 -20.29 62.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.311 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.0 m-20 -98.93 18.17 17.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.18 47.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 63.0 19.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.474 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -147.21 -173.97 4.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -130.96 -169.11 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.778 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 154' ' ' VAL . 37.9 t -113.25 150.24 32.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HA ' HD21 ' A' ' 255' ' ' LEU . 2.5 ttm-85 -59.25 -31.49 69.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -40.98 60.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 150' ' ' SER . 44.6 p -65.47 -43.3 90.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 150' ' ' SER . 29.5 t -59.88 -52.31 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 328' ' ' LEU . 12.6 mt -63.11 -48.04 80.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -59.91 -50.4 73.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 193' ' ' VAL . 13.4 mt -59.68 -40.26 87.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.731 ' HB2' HD13 ' A' ' 324' ' ' LEU . 64.7 m -56.03 -40.93 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.9 -48.04 78.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -47.42 85.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 164' ' ' ILE . 27.1 mt -66.59 -35.09 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.8 mt -58.79 -39.87 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.759 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.47 -32.03 72.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 161' ' ' ILE . 16.4 mt -77.11 -43.33 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 178' ' ' ILE . 75.3 mt -58.52 -39.33 79.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -71.15 -31.39 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.672 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.93 -54.74 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.8 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.2 pt -60.11 -30.11 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.25 -37.28 74.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 110.36 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -16.89 62.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.565 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 2.1 t60 -101.68 6.12 41.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.965 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 77.88 46.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.07 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.51 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 47.2 m-85 -141.54 119.42 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.584 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.93 164.19 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.675 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.06 50.23 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.43 -18.18 49.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.866 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 69.1 79.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 110.846 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.656 ' CG2' HD11 ' A' ' 183' ' ' LEU . 4.0 mp -86.06 115.36 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -155.94 172.87 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.824 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.693 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.81 -2.76 34.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.549 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.22 2.1 16.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.844 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -127.95 -6.76 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.363 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.802 ' O ' HD23 ' A' ' 184' ' ' LEU . 11.0 mt -108.63 127.51 54.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.946 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -134.49 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.123 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.487 HD23 ' HB ' ' A' ' 193' ' ' VAL . 40.9 mt -87.82 149.47 24.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.43 130.31 42.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -82.76 -50.79 8.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -21.07 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -148.3 77.78 9.68 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.74 88.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.78 35.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 174.84 149.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 157' ' ' LEU . 4.9 p -109.97 147.95 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.104 0.478 . . . . 0.0 111.025 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 4.6 m-85 -117.09 156.86 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -105.63 115.86 30.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.691 HG21 HD11 ' A' ' 184' ' ' LEU . 5.6 m -124.2 162.11 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.107 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.28 70.91 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 201' ' ' ALA . 12.8 m-85 -73.23 -60.39 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 92.51 -33.55 4.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.361 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.08 21.29 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.021 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 198' ' ' TYR . . . -83.35 59.15 4.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.06 0.457 . . . . 0.0 110.615 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.81 149.33 50.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.133 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -58.6 99.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 54.4 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.495 -179.696 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.5 m -92.6 -71.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.9 tp -176.74 30.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -102.75 67.57 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.346 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 226' ' ' GLU . 34.3 m-85 72.26 41.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.645 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -102.34 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.785 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -79.99 145.9 32.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.717 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -58.13 -30.8 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.01 -31.31 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.27 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -61.9 -25.61 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -85.01 5.96 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.512 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.28 -2.26 85.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.903 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.97 178.76 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.771 0.319 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -145.22 132.02 9.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 51.8 Cg_exo -53.99 -24.18 31.19 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.356 2.038 . . . . 0.0 112.409 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.7 t 61.65 35.67 16.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -179.57 -76.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -72.21 -15.84 61.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.374 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.57 92.71 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.585 ' CG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -78.51 -26.99 46.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.959 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.524 ' HB2' HG13 ' A' ' 306' ' ' VAL . 29.1 mt -78.23 -34.05 49.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -39.87 85.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.454 HG23 ' HB3' ' A' ' 227' ' ' PHE . 11.2 mt -65.01 -34.88 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.794 HD23 ' OH ' ' A' ' 302' ' ' TYR . 44.6 tp -77.93 -36.17 49.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.28 -29.02 73.85 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.475 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.62 -27.55 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 26.9 m -60.6 -45.83 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.66 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -48.58 -51.14 29.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.663 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -71.67 -51.44 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.573 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.739 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.3 tm0? -56.7 -36.04 69.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -82.38 -49.92 9.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 151' ' ' ARG . 85.6 mt -67.05 -36.28 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.5 m -96.12 -15.38 22.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 68.96 94.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.313 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.7 m80 62.93 140.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.396 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.97 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -122.49 168.84 10.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 55.2 Cg_endo -70.04 59.95 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.45 2.1 . . . . 0.0 112.72 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.97 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.4 p90 177.92 -41.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.6 OUTLIER -95.35 17.68 13.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.346 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.21 -57.34 11.83 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 57.2 t30 -129.12 -26.27 2.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.335 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 225' ' ' ILE . 66.0 mt 70.96 11.95 7.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -85.23 -16.5 40.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.163 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.487 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.7 OUTLIER -133.13 100.43 14.22 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.734 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.15 19.2 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.74 2.293 . . . . 0.0 112.86 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -77.95 -46.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.9 p90 -83.76 -26.71 29.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.821 ' CG1' HD11 ' A' ' 225' ' ' ILE . 18.3 t -65.62 -45.2 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.218 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.42 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -39.9 64.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 47.9 m -66.61 -38.29 86.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.159 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.536 ' CD ' HG12 ' A' ' 271' ' ' VAL . 1.0 OUTLIER -65.29 -51.14 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.071 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.42 -37.34 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -81.18 -50.5 9.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.2 m-85 -59.43 -40.89 88.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.717 ' HE ' HD13 ' A' ' 230' ' ' ILE . 10.0 ttm105 -51.7 -29.43 18.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.04 25.68 9.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -137.6 41.83 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 303' ' ' MET . 28.4 mt -49.58 -39.91 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.84 -34.64 64.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.988 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.47 -43.27 63.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 285' ' ' LEU . 3.5 pp -71.33 -33.2 69.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.449 ' N ' HD12 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -61.99 -50.93 70.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.2 -27.85 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -32.89 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 111.237 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 252' ' ' ILE . 60.8 m -93.71 -41.18 9.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.467 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -94.0 144.66 28.47 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.738 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 176.45 6.81 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.489 2.126 . . . . 0.0 112.285 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -98.62 30.45 3.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -41.15 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -131.67 150.11 52.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 143.19 74.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.53 137.49 25.38 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.478 2.119 . . . . 0.0 112.293 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.93 -41.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.56 -67.87 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.538 HG23 ' HG3' ' A' ' 251' ' ' MET . 29.1 mm -75.66 -41.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -47.23 -45.97 23.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.332 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -61.76 -35.65 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.585 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.794 ' OH ' HD23 ' A' ' 247' ' ' LEU . 21.1 t80 -73.81 -35.88 64.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.721 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.744 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.2 mtp -70.3 -45.26 66.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.35 77.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 309' ' ' LEU . 1.9 m -62.27 -33.53 74.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 302' ' ' TYR . 91.0 t -79.64 -23.96 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.423 ' HB3' HD22 ' A' ' 308' ' ' LEU . 0.1 OUTLIER -83.64 -34.01 25.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.649 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 307' ' ' LYS . 3.9 mm? -113.73 -30.45 6.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.268 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 305' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.313 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.837 ' HA ' HD21 ' A' ' 309' ' ' LEU . 50.3 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.691 0.205 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.5 tp 74.86 57.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 15.5 m-85 -70.34 -30.9 67.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -58.55 -47.59 83.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -46.75 72.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 323' ' ' ILE . 53.7 mt -55.64 -40.7 72.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -46.59 86.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -40.25 90.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 320' ' ' LEU . 67.4 mt -57.85 -42.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 158' ' ' SER . 35.4 mt -78.56 -51.55 9.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -58.25 -49.92 75.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.48 -38.99 86.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.974 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.89 -27.92 65.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 155' ' ' LEU . 14.2 mt -62.31 -38.03 87.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -29.89 70.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.52 77.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.0 pt -99.59 24.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.257 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.36 26.55 37.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.658 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.29 164.56 24.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 146.01 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -127.69 129.48 47.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.877 0.37 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.66 128.16 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.18 57.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.572 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.92 153.3 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' A' ' 36' ' ' GLU . 26.1 mt -115.22 137.15 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.8 pt -119.85 154.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.18 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.2 p -95.57 141.57 28.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.743 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -98.62 -162.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.044 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -37.52 27.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.5 -1.81 43.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 6.4 mttp 86.12 29.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' THR . 5.2 mttp -78.23 177.62 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.188 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HB3' HG21 ' A' ' 28' ' ' ILE . 74.7 mm-40 -129.3 80.44 1.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.405 ' HB2' HG13 ' A' ' 29' ' ' ILE . 73.4 m95 -77.46 131.41 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -89.9 118.24 29.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 53' ' ' LEU . 19.9 t -89.55 141.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -107.19 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -127.31 165.87 26.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 43' ' ' ILE . 31.2 Cg_exo -59.37 178.03 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.64 2.227 . . . . 0.0 112.285 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.496 HG21 HD21 ' A' ' 53' ' ' LEU . 23.3 pt -156.08 30.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.409 0.147 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.413 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 53.3 mt -142.4 135.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 29.3 m-85 -143.4 156.31 44.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.483 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 69' ' ' VAL . 92.4 mt -74.85 157.5 34.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.26 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -140.79 159.72 41.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.4 ptp -101.01 37.85 1.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t30 59.99 30.58 20.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -85.19 -72.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 m -117.18 144.77 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.46 160.86 30.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m 60.5 95.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.507 ' O ' HG12 ' A' ' 62' ' ' VAL . 20.9 t -92.83 47.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -113.05 -27.35 3.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.86 38.13 4.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.63 -59.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 52.63 74.35 0.79 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.144 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 62' ' ' VAL . 61.3 Cg_endo -73.57 -27.29 13.09 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.596 2.198 . . . . 0.0 112.618 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.2 m -149.86 165.31 32.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 133' ' ' ARG . 4.4 m -127.41 152.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 130' ' ' ILE . 7.7 p -142.2 141.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 35.0 mtpt -111.01 123.88 51.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.761 HG22 ' HB3' ' A' ' 128' ' ' PHE . 25.5 t -120.23 136.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.531 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.13 120.6 8.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.685 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.91 91.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.526 2.151 . . . . 0.0 112.472 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p 49.72 83.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.76 118.29 27.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.3 -85.52 0.12 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.36 -49.06 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.552 2.168 . . . . 0.0 112.306 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 84' ' ' LEU . 21.1 tp -76.12 -31.1 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -68.59 -31.19 70.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -45.42 63.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' CD ' HD12 ' A' ' 80' ' ' LEU . 12.5 pt-20 -69.68 -42.21 74.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.4 mm? -54.78 -48.48 72.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.67 -39.67 92.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -57.34 -53.9 52.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -75.31 -17.64 60.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.379 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -83.1 -47.46 11.63 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.89 -23.88 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.642 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -93.92 25.28 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -73.32 131.08 83.38 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.651 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.26 -29.01 89.21 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.488 2.125 . . . . 0.0 112.381 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.33 -31.96 43.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -49.96 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 91' ' ' ALA . 65.7 mt -59.94 -46.48 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -51.8 -48.35 63.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.179 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -38.96 92.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -53.22 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 46.6 mt -64.37 -26.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -75.12 -27.55 59.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -39.21 35.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.88 11.81 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER 70.37 2.03 3.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.657 HD13 HD13 ' A' ' 108' ' ' LEU . 4.5 mt 44.71 28.39 0.33 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.388 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 48.8 36.61 8.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.8 t80 71.34 114.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.757 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG23 ' A' ' 110' ' ' VAL . 6.3 tp -101.79 125.53 48.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -92.38 20.72 42.1 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.753 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.732 HG23 ' HG ' ' A' ' 108' ' ' LEU . 27.7 t -78.17 133.42 64.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.534 0.207 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HB3' HG12 ' A' ' 196' ' ' VAL . 9.3 Cg_endo -51.02 145.64 24.42 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.638 2.225 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 126.23 32.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.14 134.07 43.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -111.52 -40.7 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -176.31 46.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.91 155.01 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -134.53 175.49 20.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.044 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.1 mt -147.91 154.71 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -145.81 141.74 28.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 m-20 -121.34 126.66 50.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.449 ' HE3' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.26 126.39 22.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.15 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 56.33 19.89 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.31 9.26 58.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.836 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 2.1 mtmt -96.07 159.3 15.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 83.2 p -112.58 118.45 35.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.078 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.743 ' O ' HD23 ' A' ' 118' ' ' LEU . 13.0 m-85 -110.44 129.07 55.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.668 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.712 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -123.23 125.08 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.711 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.7 p90 -134.53 159.59 40.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 3.6 tmm? -130.02 141.7 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.018 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 70' ' ' VAL . 5.5 mt -110.16 125.24 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.76 173.35 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.868 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.94 137.39 39.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB3' HG13 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -85.12 -25.61 27.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.717 ' CE2' HG11 ' A' ' 196' ' ' VAL . 59.8 m-85 64.71 -170.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -107.41 -104.28 2.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.665 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 m -97.14 157.71 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.663 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.2 m-20 -92.81 157.0 16.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -63.71 -30.14 71.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.427 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 5.2 pt20 -57.28 -42.81 82.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.668 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -64.65 -25.92 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.631 HD12 HD13 ' A' ' 138' ' ' LEU . 14.5 mt -72.63 -28.95 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.0 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -58.04 -46.26 85.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.18 -31.27 65.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.91 -21.45 65.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.409 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -93.95 -0.22 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.9 43.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 61.54 19.97 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.488 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -162.1 107.87 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -58.27 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.9 m -111.79 161.63 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.774 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.69 -31.55 72.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -70.99 -50.39 34.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -59.19 -50.66 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.16 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 150' ' ' SER . 46.7 t -56.19 -52.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.318 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 328' ' ' LEU . 64.5 mt -59.52 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.258 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -46.03 90.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.599 HD22 HG11 ' A' ' 193' ' ' VAL . 29.9 mt -69.07 -35.35 76.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.824 ' OG ' HD13 ' A' ' 324' ' ' LEU . 12.8 p -57.91 -36.37 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 321' ' ' ARG . 16.6 mt -72.5 -47.23 50.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.494 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -49.52 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.77 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.08 -37.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 165' ' ' LEU . 7.6 mt -58.96 -36.47 74.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -38.04 84.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 109' ' ' GLY . 16.9 mt -74.79 -38.47 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 162' ' ' LEU . 61.5 mt -58.16 -48.22 80.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -68.12 -38.93 82.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.548 ' CE1' HD11 ' A' ' 105' ' ' LEU . 90.6 t80 -59.7 -41.42 90.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.591 HD11 ' CE1' ' A' ' 175' ' ' HIS . 28.2 pt -81.67 -27.19 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.112 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -75.93 -29.99 58.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.425 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.77 -17.1 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.22 6.24 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 72.04 47.16 0.31 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.886 0.374 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 11.1 m-85 -132.05 132.83 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.99 169.31 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.788 ' CD2' HD21 ' A' ' 195' ' ' LEU . 11.4 p-80 -151.68 -51.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.754 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 55.83 53.12 44.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.66 30.17 5.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.104 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 183' ' ' LEU . 2.8 mt -87.29 105.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.26 29.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.427 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 67.11 11.05 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.87 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 m -117.13 5.97 12.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 196' ' ' VAL . 8.9 m120 -138.49 2.89 2.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.594 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.906 ' O ' HD23 ' A' ' 184' ' ' LEU . 5.3 mt -109.59 130.2 55.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.098 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.1 mt -137.53 147.54 45.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.094 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.624 HD23 ' HB ' ' A' ' 193' ' ' VAL . 24.8 mt -86.47 145.87 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 111.528 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.465 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -63.3 125.87 25.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.83 -49.46 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -58.1 -24.4 58.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.659 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.35 81.14 2.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.15 109.73 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.584 2.189 . . . . 0.0 112.291 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -144.55 -45.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -157.86 -167.7 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 138' ' ' LEU . 7.6 p -109.75 148.1 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 9.2 m-85 -119.21 156.96 28.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.388 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.788 HD21 ' CD2' ' A' ' 175' ' ' HIS . 18.3 tp -106.61 115.77 30.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.428 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.717 HG11 ' CE2' ' A' ' 134' ' ' PHE . 30.5 m -126.95 167.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.296 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.7 t70 53.65 57.68 5.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.007 0.432 . . . . 0.0 110.707 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 51.6 m-85 -59.68 -51.55 69.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.071 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.81 -35.83 4.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.94 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.56 31.65 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.503 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -71.82 59.44 0.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.76 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -138.48 148.97 44.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.064 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.428 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 19.4 mtm105 -56.52 101.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 46.0 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.172 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.5 p -87.87 178.09 6.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.576 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.7 tt -116.16 -26.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -24.62 4.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.472 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 246' ' ' ILE . 11.1 m-85 -144.41 38.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.07 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 225' ' ' ILE . 10.2 t -83.99 138.9 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.8 t -91.8 148.29 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 279' ' ' ARG . 15.0 mt -57.34 -51.16 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.188 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.83 -43.91 86.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -72.39 -28.11 62.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.233 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -68.71 -28.04 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.585 ' HB3' HG23 ' A' ' 236' ' ' VAL . 2.2 t30 -91.64 12.86 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.08 23.29 63.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.747 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.654 HG12 ' HD2' ' A' ' 238' ' ' PRO . 14.3 t -77.81 119.52 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -57.67 -57.4 25.66 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.2 Cg_exo -52.43 89.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.407 2.072 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 t -138.14 160.99 37.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -178.79 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.118 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.41 -42.76 93.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.569 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.559 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -59.19 -35.21 73.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.774 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.506 HD21 ' HE1' ' A' ' 317' ' ' TYR . 15.5 mt -80.5 -34.49 35.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.98 -39.37 89.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.717 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 227' ' ' PHE . 8.5 mt -62.9 -47.93 90.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.4 tp -64.79 -33.94 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.397 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.3 95.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 34.0 m-85 -78.57 -25.84 45.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.88 -34.45 65.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.583 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -46.57 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.769 HD13 HD11 ' A' ' 285' ' ' LEU . 9.0 mt -63.57 -38.63 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HB3' HD11 ' A' ' 259' ' ' LEU . 1.5 pp0? -75.17 -31.06 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -82.38 -40.71 20.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.99 -31.19 56.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.98 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.3 m -103.07 0.51 32.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.412 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.71 95.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.519 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 61.12 161.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.956 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -133.0 168.74 16.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.865 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.6 Cg_exo -68.44 59.14 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.863 2.375 . . . . 0.0 112.515 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.956 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.0 p90 179.15 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.445 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 4.1 tt0 -84.48 5.63 26.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.23 -54.1 49.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.4 m120 -130.05 -27.53 2.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 78.5 mt 71.26 12.62 6.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.27 -15.38 38.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.468 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -130.03 92.16 37.35 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.18 -4.12 13.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.883 2.389 . . . . 0.0 112.662 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -55.34 -50.34 69.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.277 . . . . 0.0 111.079 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.7 p90 -84.09 -26.03 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 261' ' ' TRP . 40.8 t -62.49 -43.04 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.298 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -75.52 -40.81 56.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -48.08 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -45.31 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.185 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -58.74 -42.87 89.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.483 ' HA ' HD11 ' A' ' 230' ' ' ILE . 17.3 mt -72.56 -29.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -75.41 -52.1 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -60.47 -39.46 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.633 ' HG3' HD12 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -60.13 -26.18 66.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.948 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -120.2 23.78 10.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -160.66 53.43 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.074 0.464 . . . . 0.0 110.744 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 2.6 mm -48.52 -41.79 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.339 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -64.26 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.513 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.2 p -70.38 -31.98 69.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.769 HD11 HD13 ' A' ' 252' ' ' ILE . 1.2 tt -66.41 -51.4 57.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.467 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 21.5 mmt -62.14 -34.63 76.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -82.79 -33.34 27.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.313 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -54.85 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.467 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' HG21 ' A' ' 252' ' ' ILE . 85.7 m -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.286 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 290' ' ' PHE . 3.7 m-85 -108.36 146.29 33.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 -172.42 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.43 30.87 3.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 -35.28 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.68 91.66 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.79 108.02 1.06 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.23 127.21 23.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.468 2.112 . . . . 0.0 112.256 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -124.1 -40.51 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -47.5 85.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.696 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.2 mm -76.79 -48.74 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.467 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.32 -44.72 8.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.615 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -63.58 -43.22 97.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.382 . . . . 0.0 110.814 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.883 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.5 t80 -69.59 -43.5 72.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.018 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.696 ' CG ' HG22 ' A' ' 299' ' ' ILE . 69.1 mmm -66.54 -39.02 88.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.764 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.83 -40.36 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.273 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -32.34 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 302' ' ' TYR . 14.0 t -71.91 -24.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.096 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -75.7 -37.45 59.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.71 -12.49 22.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 320' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.968 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 309' ' ' LEU . 19.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.85 0.271 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.591 ' H ' HD21 ' A' ' 309' ' ' LEU . 2.3 mp -142.87 42.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.506 ' HE1' HD21 ' A' ' 244' ' ' LEU . 20.1 m-85 -57.06 -36.16 70.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.021 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -69.2 -33.88 74.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.74 -47.42 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.817 ' HA ' HD12 ' A' ' 323' ' ' ILE . 25.9 mt -53.29 -44.37 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 159' ' ' LEU . 4.7 ttt180 -59.15 -32.65 70.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.987 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.97 -30.47 55.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 320' ' ' LEU . 57.9 mt -63.98 -50.01 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.824 HD13 ' OG ' ' A' ' 158' ' ' SER . 8.4 mt -79.96 -26.65 39.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.593 ' HB2' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.58 -48.89 10.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.733 0.301 . . . . 0.0 111.107 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.76 -34.29 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.6 56.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.583 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.732 HD21 ' HB3' ' A' ' 155' ' ' LEU . 29.4 mt -57.23 -32.55 66.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -70.08 -29.62 66.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.63 63.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.8 -28.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.215 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.11 22.92 5.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m -97.67 164.52 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -138.63 111.85 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.81 92.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.957 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 58.1 m -60.97 168.59 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.791 0.329 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 6.6 t -155.75 150.0 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -72.28 139.12 27.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.2 m 60.51 -177.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.5 p -75.47 -31.35 60.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 133.95 68.14 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.453 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt -117.39 91.08 36.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.679 0.276 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.67 157.98 3.18 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.396 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -77.57 -64.83 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 t 69.1 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -148.03 157.08 43.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.42 -37.53 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.0 140.33 43.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -101.32 -39.16 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.4 30.88 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 161.31 24.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.448 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.37 88.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -144.64 -64.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.2 m 68.25 -68.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m 59.99 172.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.97 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.82 -50.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -79.67 110.1 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.91 -45.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -169.32 103.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mt -69.64 -179.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.19 166.94 22.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.41 -32.65 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -88.4 -78.63 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.759 ' CE2' HG21 ' A' ' 29' ' ' ILE . 6.5 m-85 -121.41 98.28 5.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.97 -168.59 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.146 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 40' ' ' GLY . 17.9 t -101.54 108.44 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -35.8 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.508 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 150.34 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG12 ' CG ' ' A' ' 38' ' ' LYS . 18.6 mt -103.25 142.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.759 HG21 ' CE2' ' A' ' 23' ' ' PHE . 11.8 pt -116.76 143.44 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 36' ' ' GLU . 11.8 p -102.33 141.76 34.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.137 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 10.3 m-20 -83.03 -144.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.88 56.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 109.698 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.46 35.6 26.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.571 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -139.33 -8.46 1.3 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.36 177.75 9.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.157 0.503 . . . . 0.0 111.692 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' HG22 ' A' ' 30' ' ' THR . 7.7 mt-10 -155.25 92.73 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 9.2 m95 -96.64 144.83 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.408 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -89.35 125.81 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.852 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.32 131.81 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -106.0 -121.04 4.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.477 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.86 154.61 44.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.709 0.29 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.32 175.19 7.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.516 2.144 . . . . 0.0 112.335 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 pt -141.61 30.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.48 115.7 2.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -110.77 158.87 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.53 -94.72 0.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.473 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.6 52.31 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -121.2 -69.13 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.01 -92.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.576 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.61 91.65 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -85.19 124.08 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.605 ' O ' HG12 ' A' ' 70' ' ' VAL . 68.5 m-85 -146.29 153.3 40.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.44 135.93 36.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.05 137.67 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.624 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 25.3 t0 -124.39 151.18 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.6 ttp -89.81 52.83 2.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -149.47 148.23 29.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.41 34.74 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.43 176.33 7.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.72 134.93 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t 63.42 125.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.38 -52.74 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.3 -133.94 52.09 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.65 29.71 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -105.68 31.98 4.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . -137.82 99.3 9.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.04 42.5 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.709 2.273 . . . . 0.0 112.66 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -149.93 150.28 31.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 110.779 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 131' ' ' MET . 15.8 m -122.02 146.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.855 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 52' ' ' TYR . 7.5 p -131.95 131.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.599 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -105.39 121.09 43.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.215 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.635 HG11 ' CE1' ' A' ' 23' ' ' PHE . 2.8 t -113.12 152.02 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -140.71 136.26 16.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.68 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 112.375 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.3 t 62.28 122.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -171.51 159.9 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.88 75.0 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 82' ' ' THR . . . 179.82 -75.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.46 -61.91 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.64 ' HG ' HD23 ' A' ' 84' ' ' LEU . 6.3 tp -60.48 -33.18 72.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.58 -31.93 72.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 78' ' ' GLY . 22.3 p -75.07 -41.61 58.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.8 -38.48 64.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.5 mm? -64.24 -51.68 62.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -56.78 -51.81 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 198' ' ' TYR . 19.6 t80 -64.27 -29.79 70.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.2 m-85 -69.57 -50.7 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -25.38 64.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -87.67 -47.43 8.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -88.84 19.41 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' CD ' ' HB2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -77.59 114.12 38.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.467 0.175 . . . . 0.0 110.649 179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.25 -26.19 7.93 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.503 2.136 . . . . 0.0 112.636 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.402 ' HB2' ' CD ' ' A' ' 92' ' ' LYS . 8.2 mm-40 -75.4 -40.44 57.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -79.33 -43.43 23.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 51.2 mt -61.25 -52.87 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -42.28 64.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -43.23 67.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.964 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -53.89 37.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 96' ' ' ILE . 40.2 mt -56.66 -34.23 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -74.88 -27.7 60.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 m -71.62 -38.53 70.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -6.53 19.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.983 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.19 27.66 16.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.45 ' CD1' HD13 ' A' ' 108' ' ' LEU . 59.7 mt -51.83 -32.52 32.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.1 tttt 46.74 40.91 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.658 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 25.1 t80 -176.86 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.347 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 96' ' ' ILE . 13.4 tp 59.96 158.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.725 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 164' ' ' ILE . . . -110.66 32.98 6.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.624 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.879 HG21 ' CE2' ' A' ' 167' ' ' TYR . 23.3 t -112.6 126.6 28.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.529 0.204 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.69 161.8 23.63 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.305 2.003 . . . . 0.0 112.025 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 115.43 27.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.06 131.95 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 9.3 m95 -109.89 -40.91 4.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -175.03 46.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.762 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -135.4 162.0 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.82 174.49 24.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.5 mt -147.84 150.61 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.064 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 121.85 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.42 127.86 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -138.29 126.16 22.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.97 20.84 4.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.68 62.07 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.792 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -96.13 129.86 43.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.784 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.64 118.77 30.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.084 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.454 ' O ' HD23 ' A' ' 118' ' ' LEU . 10.0 m-85 -101.42 122.56 43.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -106.51 130.89 54.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.442 ' CZ ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 p90 -140.27 168.62 19.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.104 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.681 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.8 tmm? -142.73 138.96 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 130' ' ' ILE . 1.5 mp -94.09 141.8 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -122.09 164.21 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.658 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.83 -69.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -148.09 -78.24 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 184' ' ' LEU . 1.4 m-85 64.19 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.916 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -117.8 -101.66 2.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.615 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.8 t -102.02 166.33 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.856 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.583 ' HB3' HD22 ' A' ' 184' ' ' LEU . 13.1 p30 -97.95 161.68 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.962 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -58.53 -25.14 62.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.56 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.56 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -55.46 -37.95 68.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.82 70.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 185' ' ' LEU . 14.1 mt -76.35 -26.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.424 ' HA ' ' CE1' ' A' ' 149' ' ' PHE . 36.3 t80 -56.21 -44.74 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.09 -30.35 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.24 -14.09 62.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.511 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -94.6 -1.0 54.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.248 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 92.56 44.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.962 0.505 . . . . 0.0 110.395 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.75 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.591 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -170.72 121.46 0.58 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.918 0.39 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 254' ' ' TRP . 8.6 m-85 -61.33 177.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.521 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.6 t -113.41 160.69 18.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.788 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -36.95 74.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -70.69 -48.8 52.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 340' ' ' ASP . 76.7 p -58.69 -56.2 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.168 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.556 HG21 ' HG ' ' A' ' 255' ' ' LEU . 48.9 t -54.35 -53.5 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 155' ' ' LEU . 15.2 mt -57.54 -45.67 84.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.993 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -65.67 -52.9 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.81 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.783 HD11 HD21 ' A' ' 341' ' ' LEU . 5.7 mt -62.53 -34.06 76.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.743 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.562 ' HB3' HD13 ' A' ' 324' ' ' LEU . 34.1 m -58.83 -46.41 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 325' ' ' LEU . 86.2 mt -61.8 -43.81 98.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -34.02 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.838 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.4 mt -78.96 -36.62 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.149 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.593 HD13 ' HA ' ' A' ' 321' ' ' ARG . 3.4 mt -55.35 -44.12 75.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -26.44 68.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.453 HG12 ' HA3' ' A' ' 109' ' ' GLY . 5.0 mt -72.74 -46.55 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 243' ' ' ASP . 28.3 mt -59.85 -27.29 66.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -30.37 60.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.879 ' CE2' HG21 ' A' ' 110' ' ' VAL . 91.1 t80 -77.15 -56.09 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.436 HG21 ' CE1' ' A' ' 198' ' ' TYR . 41.6 pt -55.13 -29.35 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -42.37 90.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -16.87 61.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 89' ' ' ARG . 0.6 OUTLIER -98.11 2.24 48.41 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.177 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 74.75 40.25 0.39 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.941 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -138.01 127.28 24.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.695 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 202' ' ' TYR . 14.9 m -142.26 169.34 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.391 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.682 ' NE2' HG23 ' A' ' 228' ' ' THR . 1.9 t-160 67.54 43.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.46 -17.17 52.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.678 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.73 82.31 0.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.0 110.993 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.689 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mp -82.04 108.49 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 8.2 tttt -149.32 -176.5 5.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -84.69 -0.26 52.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.417 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.63 5.72 12.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.324 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.759 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.1 m-80 -125.12 -11.07 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.328 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.9 mt -108.32 125.62 51.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.949 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.754 HD23 ' C ' ' A' ' 183' ' ' LEU . 1.2 mt -129.58 154.53 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.354 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 1.058 HD11 HD11 ' A' ' 141' ' ' ILE . 6.1 mt -100.07 149.2 23.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.8 133.37 55.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 133' ' ' ARG . 23.5 t80 -75.25 -66.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.808 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -22.75 41.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.836 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.87 80.94 41.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 101.74 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.565 2.177 . . . . 0.0 112.199 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.486 ' O ' HD12 ' A' ' 339' ' ' LEU . 10.5 t70 -177.5 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.496 ' HA ' HD12 ' A' ' 339' ' ' LEU . 8.6 mp0 -108.22 164.03 12.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.78 HG21 HD21 ' A' ' 138' ' ' LEU . 10.8 p -132.05 147.79 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 1.4 m-85 -123.14 156.73 34.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.709 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 178' ' ' ILE . 26.1 tp -107.28 115.93 31.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.696 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 182' ' ' ASN . 12.4 m -86.86 179.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.254 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.47 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 26.3 m-85 -145.47 -57.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -58.43 -23.69 54.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.696 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.56 33.87 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 175' ' ' HIS . . . -131.08 -90.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.053 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -146.16 118.87 8.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.752 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -94.82 47.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.44 94.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.4 m 58.52 163.91 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.96 -167.66 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.543 2.162 . . . . 0.0 112.329 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -106.12 -46.0 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.76 77.15 0.39 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.91 125.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -37.99 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -76.4 126.41 30.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -67.42 -54.47 20.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.68 154.17 42.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -145.28 -56.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.56 54.02 3.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -155.74 102.91 2.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.46 71.37 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.376 2.05 . . . . 0.0 112.249 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -149.68 -46.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -31.11 66.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.94 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 19.7 t -102.11 -68.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 56.89 36.09 27.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.0 111.58 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 59.49 -149.29 40.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 225' ' ' ILE . 1.3 t -127.75 -52.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.722 0.296 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.619 HG12 HG11 ' A' ' 271' ' ' VAL . 2.1 tt -179.09 38.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.53 63.03 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.504 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.428 ' CE1' ' HG3' ' A' ' 262' ' ' GLU . 30.3 m-85 76.34 29.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.745 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 ' NE2' ' A' ' 175' ' ' HIS . 31.0 m -83.72 145.2 28.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 8.2 t -59.24 141.28 54.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mt -61.01 -37.22 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -43.88 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -59.12 -30.44 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.9 -32.0 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.729 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -96.17 12.84 29.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.298 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 55.79 28.7 53.12 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.5 t -90.79 110.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.56 151.88 0.1 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.79 154.86 8.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.531 2.154 . . . . 0.0 112.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 174' ' ' VAL . 1.3 t -100.55 123.57 44.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 mtm105 -144.87 -50.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -17.66 60.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.31 -33.65 66.01 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.544 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.759 ' HB3' HD22 ' A' ' 165' ' ' LEU . 2.8 m-20 -60.39 -33.12 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.639 HD21 ' CE1' ' A' ' 317' ' ' TYR . 10.4 mt -80.66 -31.59 36.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.841 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.52 -40.91 93.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 243' ' ' ASP . 5.2 mt -61.21 -41.29 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.033 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.437 HD23 ' OH ' ' A' ' 302' ' ' TYR . 54.5 tp -70.37 -39.71 74.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -59.36 -45.86 94.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.545 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -78.61 -25.62 45.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.458 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.83 -41.41 82.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.411 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.0 -48.19 81.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.4 mp -65.77 -31.72 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.295 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.425 ' CB ' HD11 ' A' ' 259' ' ' LEU . 2.6 tm0? -70.4 -43.61 69.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.011 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 15.1 m0 -82.23 -42.91 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.556 ' HG ' HG21 ' A' ' 154' ' ' VAL . 25.5 mt -67.08 -36.82 82.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.27 -21.43 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.32 88.94 0.27 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 62.41 144.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.873 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.15 165.77 33.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 41.3 Cg_endo -67.99 64.41 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.43 2.087 . . . . 0.0 112.607 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.873 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -178.9 -40.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.888 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -113.11 25.35 11.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.356 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -58.54 6.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.7 m120 -129.1 -25.87 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.327 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.574 HD22 HG23 ' A' ' 225' ' ' ILE . 41.9 mt 74.33 11.11 4.19 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -85.12 -15.83 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.597 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.472 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 4.4 m-20 -133.89 74.72 68.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 49.1 Cg_exo -56.04 -16.12 15.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.882 2.388 . . . . 0.0 112.982 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -49.99 -50.44 47.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.476 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.9 p90 -84.13 -27.05 28.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.383 . . . . 0.0 110.785 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 225' ' ' ILE . 18.3 t -60.69 -35.49 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.55 -44.15 44.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.22 -47.62 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -64.4 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -46.76 78.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.6 mt -68.65 -34.7 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -50.72 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -61.89 -37.06 83.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -54.58 -29.33 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -116.75 22.28 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -136.23 40.3 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.734 HD13 ' CB ' ' A' ' 303' ' ' MET . 27.9 mt -49.26 -40.05 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.5 64.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -35.98 66.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 286' ' ' MET . 2.7 pp -80.02 -41.58 25.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 15.0 ttm -63.0 -32.98 74.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.762 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.27 -32.59 33.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -82.79 -27.15 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.289 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.6 m -93.55 -41.28 9.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.349 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -107.57 160.39 26.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.13 167.66 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.63 37.93 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -113.09 33.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 60.72 30.33 19.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -80.09 -50.77 1.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 295' ' ' LYS . 42.2 Cg_exo -56.86 -162.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.515 2.144 . . . . 0.0 112.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.39 -45.64 1.13 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -44.64 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 303' ' ' MET . 29.6 mm -77.24 -46.76 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.055 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.723 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -44.87 -49.57 10.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.526 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.8 OUTLIER -58.87 -40.35 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.663 ' O ' HG23 ' A' ' 306' ' ' VAL . 14.5 t80 -69.88 -42.62 73.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.1 mtp -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.317 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.03 -50.35 74.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.556 HG23 HD23 ' A' ' 316' ' ' LEU . 73.6 m -57.48 -37.79 73.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 302' ' ' TYR . 31.6 t -72.3 -24.75 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -31.9 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.376 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.48 -12.98 23.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -57.95 87.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -170.84 -43.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.37 23.95 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.0 m -117.18 -8.96 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.359 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.78 -71.42 0.1 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.835 0.35 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.64 138.63 82.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.694 ' O ' HD21 ' A' ' 309' ' ' LEU . 52.7 Cg_exo -54.86 -23.64 35.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.512 2.141 . . . . 0.0 112.422 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 305' ' ' THR . 1.5 tp 63.2 32.28 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.639 ' CE1' HD21 ' A' ' 244' ' ' LEU . 3.2 m-85 -66.05 -42.08 89.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -58.5 -32.91 69.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -77.4 -47.45 19.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.778 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.6 mt -55.19 -43.02 74.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.593 ' HA ' HD13 ' A' ' 162' ' ' LEU . 1.8 ttt180 -58.55 -37.82 76.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.02 -33.36 73.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 320' ' ' LEU . 64.9 mt -61.38 -49.43 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 302' ' ' TYR . 12.2 mt -80.51 -23.63 39.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.317 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.868 ' HA ' HD11 ' A' ' 159' ' ' LEU . 7.3 tt -82.44 -35.15 27.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.905 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -68.76 -42.51 77.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.21 -26.52 56.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.556 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.697 HD11 ' CD1' ' A' ' 159' ' ' LEU . 28.1 mt -53.84 -29.7 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.21 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.245 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.8 pt -97.51 24.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.33 40.74 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.632 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.9 t -89.62 178.51 6.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 151.89 30.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.51 89.48 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -115.68 -66.04 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 174.26 40.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -121.22 146.04 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 341' ' ' LEU . 10.3 mt -110.68 -12.21 14.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.17 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.507 ' HB3' HG22 ' A' ' 153' ' ' THR . 1.8 t0 64.02 20.03 12.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.697 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 141' ' ' ILE . 14.9 mt -98.53 29.08 3.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 m -64.8 -44.19 90.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 16.4 m 42.12 61.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.636 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 21.4 t 66.37 91.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.91 35.2 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.67 118.52 36.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 142.98 -96.9 0.19 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.467 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 113.03 28.6 3.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.2 tp -171.41 85.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.86 137.5 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.13 -61.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 60.26 159.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 59.0 p -70.76 104.25 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 354' ' ' ILE . 3.9 tt -160.65 53.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.025 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 43.0 p -129.72 86.49 2.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.63 165.03 12.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -75.91 110.27 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 65.6 mtp85 -95.66 172.04 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.73 177.35 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -151.6 -69.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.58 -174.81 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.32 131.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.54 120.53 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -92.78 178.68 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.3 m -91.53 -32.29 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.11 155.3 31.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.58 130.64 7.17 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.45 51.78 3.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.5 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -105.48 -28.91 5.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 9.3 p -170.01 144.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -173.34 -48.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -166.31 120.26 1.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.7 t -120.64 88.18 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -75.76 178.05 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.08 118.94 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.2 m -92.72 -51.16 5.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -93.86 162.17 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.7 p -150.86 130.5 13.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.66 119.18 38.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.16 105.41 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.844 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.91 97.26 9.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -160.52 179.12 8.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -150.04 31.2 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 9.8 pt -145.16 142.03 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.29 -49.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.4 m -73.91 145.13 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -93.0 48.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 58.0 m -140.0 -66.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 60.17 105.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 17.7 p -86.43 -178.61 6.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.82 111.46 5.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -140.58 162.53 35.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 14.4 mtp85 60.57 -177.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.07 116.55 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -75.26 94.81 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.9 mttt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.907 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 23.5 p -108.2 154.58 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.1 m 60.59 -179.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -129.6 167.37 21.49 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.79 -54.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.1 m 60.4 81.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 119.55 145.04 7.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm -62.57 134.29 95.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.598 0.237 . . . . 0.0 110.781 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.18 166.39 1.05 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.392 2.062 . . . . 0.0 112.364 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.28 164.21 38.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.49 138.62 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -62.53 109.51 1.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.77 33.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.07 -40.92 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -107.71 89.58 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.66 -173.33 2.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.18 28.13 3.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 60.1 94.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -109.34 -31.7 7.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.4 m -96.5 170.76 8.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -105.98 -34.1 7.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.0 145.73 32.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -141.12 160.31 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -92.21 86.53 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -159.0 113.74 2.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 mt 60.32 109.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.98 119.42 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -50.03 75.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.985 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.1 80.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.734 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 3.3 m-85 -59.44 96.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.05 -169.57 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.12 114.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.85 -26.43 5.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -76.17 134.54 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.001 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 36' ' ' GLU . 37.9 mt -105.28 145.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.764 HD12 ' CE1' ' A' ' 128' ' ' PHE . 25.2 pt -119.5 154.49 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.263 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 68.4 p -97.93 141.27 31.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.0 -162.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.94 -41.95 34.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 109.775 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.35 -2.21 33.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.653 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 86.96 27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -72.79 177.41 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.141 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 28' ' ' ILE . 31.0 mt-10 -128.77 79.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.873 0.368 . . . . 0.0 110.597 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 80.4 m95 -73.19 128.65 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.94 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -91.9 119.18 31.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 23' ' ' PHE . 21.4 t -73.62 150.39 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.45 -116.28 2.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 41' ' ' LEU . 4.0 mm? -105.03 158.85 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.733 0.302 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 56.2 Cg_endo -70.48 155.1 64.25 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.559 2.173 . . . . 0.0 112.373 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 HG22 ' A' ' 51' ' ' ILE . 7.2 pt -145.63 31.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.65 -42.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 62.9 169.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.74 165.97 41.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.04 34.68 4.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.79 82.33 1.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.86 112.62 2.1 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.9 m -91.2 59.99 4.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG22 HG13 ' A' ' 43' ' ' ILE . 2.2 mt -85.43 106.92 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 23' ' ' PHE . 70.6 m-85 -131.37 171.33 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.978 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 151.41 23.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.43 153.28 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.672 ' CB ' HG13 ' A' ' 62' ' ' VAL . 28.5 t70 -146.79 140.8 26.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.6 ttp -85.17 57.39 4.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -59.83 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 m 59.39 31.95 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 m -139.83 -66.83 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -176.45 134.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.97 167.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.672 HG13 ' CB ' ' A' ' 55' ' ' ASP . 33.0 t -105.92 -31.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.19 -116.36 3.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -160.87 31.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -138.66 -77.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.89 77.56 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.54 48.87 2.92 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.715 2.276 . . . . 0.0 112.716 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.69 170.14 19.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 131' ' ' MET . 15.6 m -143.1 146.04 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 130' ' ' ILE . 11.5 p -139.21 118.78 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CG ' HG12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -105.18 121.94 44.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 2.8 t -113.14 151.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' HG3' HD22 ' A' ' 80' ' ' LEU . 11.5 mt-10 -141.21 122.25 8.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.19 96.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.336 2.024 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.75 178.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.89 79.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -135.98 32.06 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.26 -178.52 28.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.38 10.99 3.43 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.791 2.327 . . . . 0.0 112.97 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.428 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.5 tp -60.96 -32.96 72.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.43 -39.21 92.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 72.1 p -69.72 -32.05 70.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 198' ' ' TYR . 11.7 tp10 -75.79 -40.5 55.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.6 mm? -65.46 -42.54 92.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -62.08 -51.7 66.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 168' ' ' ILE . 16.7 t80 -59.1 -40.05 84.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.967 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.0 m-85 -56.32 -60.06 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.357 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.07 -17.65 63.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -75.87 -47.53 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.97 -25.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.967 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -88.74 23.63 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -76.73 138.54 66.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.536 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.22 -27.8 58.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.513 2.142 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -79.45 -47.36 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.5 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.6 mt -55.84 -45.68 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -48.65 -38.24 20.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -74.2 -35.15 63.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.672 HG23 ' H ' ' A' ' 106' ' ' LYS . 40.9 mm -66.55 -41.46 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -74.92 -27.6 60.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.59 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' LYS . 25.2 p -84.37 -28.47 26.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.351 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.4 ' CB ' ' HG ' ' A' ' 105' ' ' LEU . 2.5 mmt180 -107.11 -7.23 16.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.844 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm 58.7 21.83 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.802 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 108' ' ' LEU . 41.8 mt -54.69 -41.56 70.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.986 0.422 . . . . 0.0 110.755 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.672 ' H ' HG23 ' A' ' 100' ' ' ILE . 11.5 mtpt 52.35 27.08 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.562 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -177.57 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.691 0.281 . . . . 0.0 111.381 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 105' ' ' LEU . 14.1 tp 69.92 -65.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.824 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.92 1.55 10.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.98 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.524 HG23 ' HG ' ' A' ' 108' ' ' LEU . 22.4 t -89.8 138.65 27.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 111.069 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.83 153.22 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.24 115.62 28.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.22 121.78 36.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -103.86 -40.67 6.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.05 -176.78 46.48 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.66 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -132.58 178.71 6.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -163.36 173.24 39.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.423 HD23 ' HG2' ' A' ' 127' ' ' ARG . 1.1 mt -137.06 159.92 40.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.726 0.298 . . . . 0.0 110.746 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -144.32 119.43 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.023 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.71 124.62 49.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.15 126.2 22.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 55.43 20.83 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.422 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.57 -3.55 61.26 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.903 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -96.14 129.09 43.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -89.07 140.78 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -125.75 123.56 39.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.423 ' HG2' HD23 ' A' ' 118' ' ' LEU . 10.7 mtp85 -102.56 125.13 49.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.764 ' CE1' HD12 ' A' ' 29' ' ' ILE . 23.9 p90 -140.43 162.47 35.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.626 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -131.41 147.18 52.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 70' ' ' VAL . 9.1 mm -98.73 119.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.9 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -120.54 171.94 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.081 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -71.28 145.88 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -64.32 134.17 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.577 ' CE2' HG11 ' A' ' 196' ' ' VAL . 72.9 m-85 -110.17 154.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.722 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -85.39 -107.84 0.69 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.368 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 m -111.24 118.71 36.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.831 0.348 . . . . 0.0 110.672 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -51.22 160.98 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.658 HD13 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -66.53 -21.7 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.679 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.769 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -65.24 -44.7 87.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.027 0.441 . . . . 0.0 109.813 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.88 66.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.191 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.801 ' CD1' HD13 ' A' ' 341' ' ' LEU . 13.8 mt -74.81 -25.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -62.41 -49.03 77.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.521 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.85 -31.11 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.75 -25.43 67.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.587 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -108.95 10.4 26.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.01 52.71 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.047 0.451 . . . . 0.0 110.454 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 23.6 mtpt 61.14 19.66 10.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.588 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -136.15 -175.56 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.045 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -137.13 -172.71 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.01 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.0 m -119.12 149.74 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -57.82 -30.57 65.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.432 ' HB3' HD12 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -74.89 -34.83 62.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -48.38 35.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG21 ' HG ' ' A' ' 255' ' ' LEU . 59.4 t -60.08 -54.19 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 16.5 mt -58.87 -49.7 76.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -59.86 -51.27 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 193' ' ' VAL . 15.4 mt -59.91 -33.42 71.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.519 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 247' ' ' LEU . 0.1 OUTLIER -58.99 -45.57 90.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.69 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 325' ' ' LEU . 58.2 mt -61.74 -45.78 92.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HG3' HD21 ' A' ' 339' ' ' LEU . 16.4 mmp_? -61.75 -48.79 79.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.781 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HG12 ' A' ' 178' ' ' ILE . 11.9 mt -65.18 -40.21 88.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 324' ' ' LEU . 7.4 mt -58.07 -33.47 69.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.21 -32.7 72.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.788 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.74 -44.54 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 178' ' ' ILE . 72.2 mt -55.45 -40.44 71.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.67 -38.46 91.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.067 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.672 ' CE2' HD21 ' A' ' 108' ' ' LEU . 80.5 t80 -66.56 -52.05 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 175' ' ' HIS . 38.0 pt -62.37 -27.16 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -80.71 -34.48 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -16.75 62.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.676 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 2.44 49.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.428 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 12.9 mt-10 78.09 43.48 0.09 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.851 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.3 122.21 15.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.846 HG13 ' CD1' ' A' ' 204' ' ' TYR . 18.8 m -121.92 142.8 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.209 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.505 ' CE1' ' CD1' ' A' ' 198' ' ' TYR . 0.5 OUTLIER 177.74 82.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.82 79.57 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.817 ' OD1' HD21 ' A' ' 195' ' ' LEU . 17.1 p-10 -103.07 22.46 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.649 0.261 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.622 HG12 HG21 ' A' ' 161' ' ' ILE . 3.0 mp -64.1 91.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 171.69 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.769 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.86 -6.31 51.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.538 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.71 1.79 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -123.87 -9.61 7.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.102 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.63 128.83 55.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.4 mt -135.46 149.15 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.756 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.779 HD21 HD11 ' A' ' 341' ' ' LEU . 50.2 mt -86.52 147.83 25.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.281 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -65.8 125.75 26.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -94.95 -42.81 8.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -30.25 66.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.467 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -141.22 69.24 27.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.432 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.51 108.3 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.5 -45.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.082 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 339' ' ' LEU . 9.3 mt-30 -149.62 -166.52 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 111.205 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.9 p -109.91 148.24 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 14.4 m-85 -116.85 156.93 26.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.351 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.817 HD21 ' OD1' ' A' ' 177' ' ' ASP . 22.3 tp -109.14 115.84 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 134' ' ' PHE . 13.1 m -118.5 145.93 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.15 100.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.252 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.505 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 2.9 m-85 -86.65 -20.27 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 65.21 14.64 59.71 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -146.61 -66.35 0.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.38 87.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.295 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -131.0 149.01 52.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -95.82 82.82 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.846 ' CD1' HG13 ' A' ' 174' ' ' VAL . 41.5 p90 -44.87 -29.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.612 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.5 t -103.54 88.98 1.94 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.627 ' HG2' HG13 ' A' ' 209' ' ' VAL . 53.8 Cg_endo -69.01 -167.11 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.633 2.222 . . . . 0.0 112.284 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.66 30.52 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.34 99.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.513 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.627 HG13 ' HG2' ' A' ' 206' ' ' PRO . 6.2 m -138.46 138.95 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.64 27.49 5.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 56.48 78.17 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.047 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -158.82 83.92 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 131.01 16.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.96 91.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.551 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.0 OUTLIER 60.86 79.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.97 107.22 40.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.85 97.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.558 2.172 . . . . 0.0 112.469 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -127.12 30.31 5.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 61.14 35.01 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 62.1 m 63.22 121.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -62.51 -44.48 96.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.408 ' CB ' ' HB1' ' A' ' 232' ' ' ALA . 5.2 t70 -119.26 103.36 9.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.63 -168.44 0.61 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 226' ' ' GLU . 2.0 m 61.29 162.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.894 HG23 HD22 ' A' ' 265' ' ' LEU . 3.7 tp -130.13 15.87 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.499 ' HA ' HD21 ' A' ' 265' ' ' LEU . 43.8 tt0 -74.55 -34.82 63.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 226' ' ' GLU . 73.0 m-85 -157.59 30.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -76.11 132.62 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 172.25 10.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -53.6 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -42.26 90.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.408 ' HB1' ' CB ' ' A' ' 222' ' ' ASP . . . -63.26 -32.79 74.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.216 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.5 -36.53 84.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.724 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -101.67 12.98 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.392 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.31 31.45 59.55 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.801 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.7 t -90.6 113.28 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.106 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.05 154.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.78 158.68 56.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.578 2.186 . . . . 0.0 112.254 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.57 ' O ' HG11 ' A' ' 174' ' ' VAL . 18.9 m -67.22 113.09 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -134.59 -57.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -87.58 -24.87 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.6 -32.11 64.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.563 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -38.12 74.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.444 HD12 ' CD1' ' A' ' 309' ' ' LEU . 57.9 mt -80.6 -33.48 35.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.57 -37.81 79.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.44 -39.67 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.875 HD23 ' OH ' ' A' ' 302' ' ' TYR . 49.6 tp -64.36 -45.43 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.42 92.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.439 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 25.4 m-85 -78.81 -25.7 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.67 -43.25 84.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.279 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.41 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.17 -49.62 76.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.019 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.538 HD11 ' SD ' ' A' ' 303' ' ' MET . 3.6 mt -63.99 -28.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.364 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.2 tm0? -80.12 -40.19 27.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.002 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 36.2 m0 -82.29 -30.85 30.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.439 ' HG ' HG21 ' A' ' 154' ' ' VAL . 28.9 mt -79.79 -44.04 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.05 0.62 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.449 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.71 97.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.5 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 64.07 154.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 1.008 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -137.77 171.28 8.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.56 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 45.3 Cg_endo -68.89 61.73 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.411 2.074 . . . . 0.0 112.633 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 1.008 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.6 p90 178.12 -37.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -98.09 22.23 9.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.437 179.205 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.82 -55.83 6.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -132.22 -26.41 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.482 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.894 HD22 HG23 ' A' ' 225' ' ' ILE . 66.0 mt 71.93 12.27 6.11 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.208 0.528 . . . . 0.0 109.69 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -84.77 -14.43 48.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.456 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -134.92 101.24 11.61 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.52 19.27 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.724 2.283 . . . . 0.0 112.724 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -45.67 17.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -82.09 -26.46 33.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.617 HG11 ' CD1' ' A' ' 225' ' ' ILE . 11.3 t -61.72 -44.22 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -71.47 -44.34 64.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -66.51 -41.25 89.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 278' ' ' TYR . 75.5 m -63.17 -40.5 97.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -61.98 -45.91 91.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.044 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.5 mt -70.88 -46.08 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -59.59 -51.61 69.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.834 ' CD1' HD12 ' A' ' 285' ' ' LEU . 16.3 m-85 -60.43 -31.87 70.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -59.43 -33.26 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.407 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.19 23.07 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.868 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -139.16 37.91 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.609 HG21 ' CG ' ' A' ' 304' ' ' GLU . 7.0 mm -47.09 -43.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -47.74 36.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.073 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.7 -33.61 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.2 tt -64.33 -43.63 94.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 3.5 mmt -65.48 -32.52 74.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.984 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.75 -27.03 31.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.139 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -54.84 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.34 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 252' ' ' ILE . 68.2 m -76.42 -41.22 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.52 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.84 158.71 34.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 177.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.612 2.208 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -108.01 -66.24 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -59.69 -35.12 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -60.27 143.52 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -63.8 148.86 94.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.11 158.83 55.23 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -94.2 20.84 45.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.568 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.35 9.2 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.526 0.203 . . . . 0.0 111.402 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.704 HG22 ' CG ' ' A' ' 303' ' ' MET . 34.2 mm -79.52 -40.76 21.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.446 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -48.04 -45.77 32.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.312 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -59.85 -39.77 86.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.63 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.875 ' OH ' HD23 ' A' ' 247' ' ' LEU . 70.4 t80 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.704 ' CG ' HG22 ' A' ' 299' ' ' ILE . 1.4 mtp -64.73 -45.72 85.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.595 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.609 ' CG ' HG21 ' A' ' 282' ' ' ILE . 2.1 mt-10 -58.13 -51.89 67.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.846 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.7 p -58.07 -53.59 56.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 302' ' ' TYR . 61.1 t -56.32 -24.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.154 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -43.1 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.78 -11.98 60.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.689 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.546 HD23 ' HG2' ' A' ' 314' ' ' LYS . 15.9 mt -48.85 131.7 18.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.222 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.13 165.86 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.789 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.95 30.9 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.5 t -128.42 -44.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.49 -75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.546 ' HG2' HD23 ' A' ' 309' ' ' LEU . 9.2 tptt 58.9 64.51 3.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.47 88.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.345 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.8 tp -140.13 17.64 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -60.07 -31.63 70.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.75 -46.48 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.779 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.49 -40.2 90.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.906 ' HA ' HD12 ' A' ' 323' ' ' ILE . 34.6 mt -55.55 -48.15 75.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.476 ' HG2' HD22 ' A' ' 159' ' ' LEU . 7.7 ttm105 -57.46 -34.56 69.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.876 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -38.52 71.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 320' ' ' LEU . 37.5 mt -57.07 -47.91 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 158' ' ' SER . 30.6 mt -79.78 -22.0 43.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.462 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 325' ' ' LEU . 7.2 tt -82.68 -40.49 20.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.688 0.28 . . . . 0.0 111.109 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.92 -39.42 90.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.94 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -60.32 -26.34 63.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.5 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 69.9 mt -48.44 -27.99 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -81.28 -31.08 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.73 -26.35 65.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.297 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 151' ' ' ARG . 10.6 pt -106.97 22.75 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 53.25 45.69 64.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.738 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.7 t -118.33 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.57 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.959 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.79 133.85 51.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -164.89 -60.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -176.89 35.33 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.546 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 136.43 33.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER 179.17 -24.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.69 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -51.96 -23.57 5.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.801 HD13 ' CD1' ' A' ' 141' ' ' ILE . 1.0 OUTLIER 70.88 10.95 7.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.282 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.6 t 56.69 86.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.808 0.337 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 343' ' ' VAL . 5.6 m -152.16 88.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 35.4 m 43.31 31.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.587 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.09 -44.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -60.35 -31.44 70.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 82.02 46.5 6.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.519 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -83.08 58.74 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.75 -33.11 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 351' ' ' ALA . 0.4 OUTLIER -62.02 157.78 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.431 ' HB2' ' HE2' ' A' ' 350' ' ' LYS . . . 59.49 78.53 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.039 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.12 -179.44 7.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 353' ' ' THR . 9.4 t -110.66 108.83 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.63 134.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 60.9 p -127.52 -46.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 162.77 22.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.85 19.98 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.65 -74.7 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 178.67 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.22 78.84 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.88 -173.58 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 1.3 pt -98.39 30.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -117.21 31.58 6.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -146.46 145.17 30.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.96 -67.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -118.14 -176.67 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.777 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -128.23 86.59 57.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.03 -38.85 6.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.574 2.183 . . . . 0.0 112.24 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 70.6 137.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 370' ' ' VAL . 10.1 m -130.5 104.16 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.31 118.21 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.72 -69.59 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.956 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 3.8 m -93.23 147.77 22.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -118.85 -66.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -164.01 157.01 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -58.87 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.11 136.51 42.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.08 -62.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.68 89.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -45.46 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -81.69 176.34 9.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.961 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.52 -38.55 71.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 58.02 -171.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.055 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 8.0 mt 69.47 -64.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.93 40.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 1.4 m -117.96 -39.9 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -75.21 90.06 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.7 p -147.28 31.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.18 137.66 19.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 43.9 p -97.87 -176.64 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.8 146.99 4.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 -55.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -161.27 102.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.4 139.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.9 127.44 55.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.942 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 57.8 p -62.54 132.52 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 17.8 m -145.71 132.66 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -109.74 122.8 6.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.545 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 4.2 p -79.72 95.83 6.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.2 t -71.15 -54.41 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 92.13 -62.27 2.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.41 148.04 39.32 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.71 116.78 4.84 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.537 2.158 . . . . 0.0 112.34 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.87 123.98 26.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 m -111.71 179.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -105.13 87.74 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.19 88.27 7.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.04 70.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.61 127.21 54.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 123.96 34.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.059 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.71 130.96 50.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.507 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.58 78.78 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 126.83 29.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.9 t -97.71 107.88 20.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -102.18 120.41 40.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.7 92.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.038 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -110.17 160.16 16.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -125.99 113.46 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -104.38 31.03 4.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.57 -176.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.32 123.85 29.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.95 -40.19 87.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -139.4 -80.31 0.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.865 ' CE2' HG21 ' A' ' 29' ' ' ILE . 8.4 m-85 -126.29 134.01 51.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.849 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.44 -178.37 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.67 127.1 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.98 22.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -58.87 139.84 56.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' A' ' 38' ' ' LYS . 21.7 mm -100.34 136.39 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.865 HG21 ' CE2' ' A' ' 23' ' ' PHE . 4.2 pt -117.89 154.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.088 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 3.1 t -101.81 136.94 40.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -93.77 -164.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -41.37 43.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -75.25 -6.63 50.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.429 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 4.2 tttp 89.59 27.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -75.16 178.36 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.154 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.63 79.6 1.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.39 . . . . 0.0 110.591 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.452 ' HB2' HG13 ' A' ' 29' ' ' ILE . 80.5 m95 -76.51 136.73 39.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.952 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -96.88 129.14 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 23' ' ' PHE . 21.6 t -85.95 128.54 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.7 -122.58 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 53' ' ' LEU . 3.9 mm? -100.57 154.42 37.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 61.4 Cg_endo -73.1 105.49 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.615 2.21 . . . . 0.0 112.362 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -98.54 -28.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.99 -100.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.558 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.75 78.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.841 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.95 28.82 5.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.89 -42.79 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.507 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -56.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 110.936 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.34 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -160.39 90.67 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -111.83 137.53 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 23' ' ' PHE . 44.2 m-85 -143.74 172.22 13.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.804 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 66' ' ' ALA . 25.2 mt -69.65 158.26 35.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.68 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -124.45 152.37 43.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.48 156.79 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.4 ptp -97.47 26.42 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.29 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 p -134.45 35.74 3.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.6 30.91 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -131.26 179.07 6.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -99.13 29.89 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' A' ' 38' ' ' LYS . 24.0 t 68.3 -68.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.51 179.03 21.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.559 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -92.54 48.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.482 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -158.38 -69.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.695 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . 63.27 139.32 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.93 -4.74 13.51 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.667 2.245 . . . . 0.0 112.816 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 11.8 m -149.65 157.11 42.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.564 HG13 ' CB ' ' A' ' 133' ' ' ARG . 29.7 m -120.27 144.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 HD13 ' A' ' 130' ' ' ILE . 11.4 p -119.39 121.11 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -98.07 116.19 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.608 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 11.9 t -113.07 139.32 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.309 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 136.52 15.96 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.686 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.51 96.6 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.389 2.059 . . . . 0.0 112.317 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 t 179.63 177.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.24 -42.58 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.12 95.28 2.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.05 -147.98 5.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.488 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.16 -23.09 39.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.528 2.152 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.545 HD23 ' HG3' ' A' ' 127' ' ' ARG . 8.4 tp -60.1 -33.2 71.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -42.14 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.8 p -70.88 -30.15 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -75.02 -42.31 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.3 mm? -59.2 -51.49 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -59.54 -46.21 89.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 198' ' ' TYR . 12.2 t80 -54.67 -50.68 67.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.674 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 24.7 m-85 -59.81 -41.48 91.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.415 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -79.95 -17.79 52.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -47.41 69.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.486 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB1' ' CE1' ' A' ' 171' ' ' HIS . . . -145.03 -32.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -53.86 -21.8 8.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -51.34 125.26 25.53 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 -25.4 15.34 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.491 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.4 -44.01 92.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.131 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.28 -43.13 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.282 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.753 HG22 HD11 ' A' ' 100' ' ' ILE . 30.2 mt -58.42 -48.34 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -52.28 -39.53 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.043 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -75.33 -29.2 59.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -76.62 -43.98 36.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.753 HD11 HG22 ' A' ' 96' ' ' ILE . 34.5 mt -65.85 -37.47 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.8 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' LYS . 16.6 p -82.02 -36.99 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.433 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.71 -2.5 24.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.4 mttm 59.51 31.34 20.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 100' ' ' ILE . 11.7 mt -49.39 -30.88 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.68 -55.6 0.51 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.026 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CD1' ' OE1' ' A' ' 192' ' ' GLN . 6.8 t80 -150.68 139.8 21.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.979 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' A' ' 167' ' ' TYR . 9.5 tp -119.72 162.19 19.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.61 19.14 42.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.97 125.25 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 149.13 37.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.369 2.046 . . . . 0.0 112.262 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.4 115.88 25.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -86.9 129.61 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.721 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 114' ' ' TRP . 6.7 m95 -107.58 -40.91 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.77 -174.66 46.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.1 p -132.86 169.0 17.39 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -158.96 175.84 35.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.977 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.83 150.83 36.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -141.17 141.61 34.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.61 136.07 54.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -138.27 126.27 22.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.29 18.59 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.322 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 10.39 54.72 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.861 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -96.21 159.37 14.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 110.711 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.5 m -111.34 123.11 49.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.492 ' O ' HD23 ' A' ' 118' ' ' LEU . 12.9 m-85 -122.12 136.5 54.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.793 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.545 ' HG3' HD23 ' A' ' 80' ' ' LEU . 15.5 tpt180 -117.95 125.12 49.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.806 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CB ' HG22 ' A' ' 72' ' ' VAL . 29.5 p90 -133.16 165.84 23.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.454 ' HB2' HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -134.65 144.77 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 70' ' ' VAL . 7.2 mm -101.53 111.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.2 173.06 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.141 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.35 127.69 32.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.564 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.65 176.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 184' ' ' LEU . 54.9 m-85 -147.42 175.82 10.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.663 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.21 -81.67 1.6 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.461 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.6 t -149.58 130.51 14.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.837 0.351 . . . . 0.0 110.582 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.16 165.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.713 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.693 HD22 HD12 ' A' ' 141' ' ' ILE . 2.8 mt -77.34 -14.07 59.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.675 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.43 -33.25 29.86 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.05 0.453 . . . . 0.0 109.932 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -75.83 -31.3 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.824 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.755 HG21 HD22 ' A' ' 341' ' ' LEU . 12.2 mt -68.93 -26.74 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 24.1 t80 -71.17 -43.92 66.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -29.9 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.4 67.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.219 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-20 -96.32 21.03 9.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.039 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.41 47.92 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 10.2 tttt 64.7 18.2 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.25 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 13.7 mtp85 -138.01 -170.67 2.84 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.002 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.2 OUTLIER -137.55 -166.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.675 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 m -129.35 151.7 49.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -62.22 -30.7 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -30.99 62.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -51.24 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 150' ' ' SER . 21.9 t -60.33 -48.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.3 mt -59.58 -43.87 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.727 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -68.47 -54.5 16.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 341' ' ' LEU . 11.6 mt -60.19 -42.47 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.699 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.695 ' OG ' HD11 ' A' ' 247' ' ' LEU . 16.1 m -55.58 -42.47 74.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.8 mt -60.02 -49.72 76.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.589 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 21.4 mmt-85 -60.72 -42.0 96.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.817 ' HA ' HD12 ' A' ' 164' ' ' ILE . 17.8 mt -65.19 -36.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.642 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.0 mt -60.23 -39.71 87.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.535 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -34.61 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 161' ' ' ILE . 9.7 mt -74.54 -42.87 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 243' ' ' ASP . 11.4 mt -54.34 -32.24 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.802 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' CD2' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -73.66 -32.79 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.578 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.619 ' CD2' HD21 ' A' ' 108' ' ' LEU . 57.1 t80 -70.91 -49.89 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 165' ' ' LEU . 34.2 pt -63.23 -27.71 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.529 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -72.8 -40.47 65.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 -14.77 62.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.644 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 57.5 m-70 -101.42 2.86 39.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.152 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 76.34 43.37 0.15 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 111.0 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.99 129.08 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.877 HG21 ' HG3' ' A' ' 240' ' ' ARG . 28.9 m -142.2 169.44 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.1 m170 65.23 48.83 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.39 -10.86 54.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.897 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 76.08 69.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.984 0.421 . . . . 0.0 111.026 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.661 HD11 HD21 ' A' ' 165' ' ' LEU . 2.4 mp -73.97 98.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 183' ' ' LEU . 23.6 mttp -144.38 -179.55 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.675 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -82.32 -0.61 46.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.436 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.29 -3.38 18.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 110.833 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.577 ' O ' HG22 ' A' ' 196' ' ' VAL . 35.2 m-20 -126.16 -2.15 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 179' ' ' LYS . 9.4 mt -108.36 113.56 26.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.997 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.813 ' C ' HG23 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -122.82 144.71 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.45 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.851 HD23 ' HB ' ' A' ' 193' ' ' VAL . 1.3 mt -90.48 149.0 22.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.349 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 9.9 m-20 -67.89 126.18 28.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -86.9 -60.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.417 ' HB2' ' NH1' ' A' ' 133' ' ' ARG . 10.4 mmtt -63.79 -30.83 71.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -130.34 71.71 82.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.2 97.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.551 2.167 . . . . 0.0 112.057 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.19 -53.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 339' ' ' LEU . 1.4 mt-30 -150.86 -177.42 5.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 185' ' ' LEU . 7.4 p -110.0 141.28 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.681 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.409 ' CE1' ' OD1' ' A' ' 186' ' ' ASN . 3.3 m-85 -106.97 153.8 22.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.125 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.6 tp -105.99 116.14 31.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 182' ' ' ASN . 7.6 m -88.57 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 198' ' ' TYR . 1.2 t70 63.76 129.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.425 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 30.1 m-85 -162.56 -44.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -55.89 -25.81 46.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.704 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 222' ' ' ASP . 0.3 OUTLIER -97.07 33.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 111.096 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.59 -110.29 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.19 119.38 8.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.809 0.337 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.66 49.49 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.417 ' CE2' ' NH2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER 54.74 83.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.5 t 63.93 133.41 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.806 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.39 -31.82 10.92 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.502 2.134 . . . . 0.0 112.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -121.61 -65.84 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.66 -41.88 1.84 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.465 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 210' ' ' HIS . 30.9 m -61.05 -42.9 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 111.116 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.445 ' N ' HG23 ' A' ' 209' ' ' VAL . 10.0 p80 -95.35 151.84 18.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 -26.18 9.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.05 174.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.571 ' HB2' HG13 ' A' ' 236' ' ' VAL . 53.9 p90 -68.05 -175.78 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.24 -47.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.966 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.557 ' O ' HG22 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -92.0 174.54 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.016 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.86 166.12 16.1 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.56 71.35 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.501 2.134 . . . . 0.0 112.288 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.68 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -59.9 2.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 18.2 m 63.57 135.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -60.63 3.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.442 ' HB2' HD21 ' A' ' 200' ' ' LEU . 33.0 t0 -153.73 -58.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.91 -159.68 1.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.2 p -154.39 -46.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.769 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tt -174.56 36.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HA ' HD13 ' A' ' 265' ' ' LEU . 7.5 pt-20 -95.99 62.85 2.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 226' ' ' GLU . 12.6 t80 70.98 31.97 2.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 41.7 p -100.15 179.75 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 160.16 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.29 -40.29 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -78.13 -28.65 48.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.18 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -58.07 -39.79 79.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -97.02 -5.63 37.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 83.58 -2.7 86.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.718 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 213' ' ' TYR . 3.5 t -78.23 157.77 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.807 0.336 . . . . 0.0 111.167 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -164.99 78.33 1.34 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.45 10.66 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.73 2.287 . . . . 0.0 112.878 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.0 p -153.61 163.24 40.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.877 ' HG3' HG21 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -113.88 -11.83 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.94 -13.48 61.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.315 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.36 -25.93 55.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.607 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.663 ' HB3' HD22 ' A' ' 165' ' ' LEU . 0.8 OUTLIER -55.69 -31.86 62.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.977 0.418 . . . . 0.0 110.838 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 320' ' ' LEU . 21.3 mt -80.58 -30.45 36.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.39 -32.56 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 29.3 mt -69.59 -37.55 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.186 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.739 HD23 ' OH ' ' A' ' 302' ' ' TYR . 40.7 tp -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.83 -41.75 94.23 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.34 -29.03 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -37.18 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.593 ' SD ' HD12 ' A' ' 299' ' ' ILE . 1.8 mtt -68.35 -39.7 81.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.716 HG22 HD23 ' A' ' 259' ' ' LEU . 7.4 mm -62.25 -39.32 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.15 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.836 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.8 tm0? -80.27 -34.97 36.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -76.41 -48.12 20.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.414 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.46 -36.21 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.55 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -96.39 -13.92 22.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.573 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.55 94.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.261 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.0 146.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 110.653 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.924 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.91 166.15 29.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.212 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.01 62.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.953 2.435 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.924 ' CH2' HD22 ' A' ' 259' ' ' LEU . 0.7 OUTLIER -178.54 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 261' ' ' TRP . 1.8 tt0 -108.94 18.22 20.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.069 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -66.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.82 -27.34 3.07 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.428 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 225' ' ' ILE . 19.8 mt 77.18 7.94 2.91 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -16.42 61.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.47 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 33.4 t70 -145.06 91.19 5.99 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 38.5 Cg_endo -66.71 -7.28 17.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.685 2.256 . . . . 0.0 112.841 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.84 -50.11 69.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 110.965 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.47 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 5.5 p90 -83.88 -26.22 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.769 ' CG1' HD11 ' A' ' 225' ' ' ILE . 25.9 t -60.38 -40.85 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -48.67 23.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.975 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -61.6 -35.16 77.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.071 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 m -72.09 -33.7 68.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -70.2 -49.73 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.046 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.4 mm -61.15 -36.59 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -75.54 -52.12 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -55.4 -35.09 64.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -29.69 65.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 22.68 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -137.94 43.57 2.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.7 mt -55.48 -37.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.18 64.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 5.4 t -71.12 -42.79 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.5 pp -65.23 -31.46 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.79 0.329 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mmt -66.81 -49.36 66.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -68.68 -31.4 70.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.247 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -53.76 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.102 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.466 ' O ' HG23 ' A' ' 256' ' ' THR . 81.0 m -66.15 -41.16 90.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.155 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.0 146.19 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 -166.86 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.51 45.28 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -45.73 19.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -149.87 167.15 27.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -86.78 156.57 55.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.86 118.41 5.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.593 2.195 . . . . 0.0 112.192 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -157.69 -49.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.67 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.69 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.0 mm -79.43 -41.69 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.227 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.57 -42.36 7.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.869 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -67.23 -38.71 85.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 110.58 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.739 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.0 t80 -70.5 -44.52 67.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.716 ' CB ' HD13 ' A' ' 282' ' ' ILE . 47.2 mmm -68.73 -31.93 71.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.84 -43.07 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.328 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.881 ' O ' HD12 ' A' ' 309' ' ' LEU . 5.5 p -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 302' ' ' TYR . 79.5 t -79.45 -24.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -36.68 23.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.738 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.1 -27.89 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.54 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER 47.6 -167.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.124 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.667 ' HB2' HD11 ' A' ' 316' ' ' LEU . 8.6 t70 -106.79 54.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 56.94 25.9 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 4.4 m 56.19 25.66 9.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -54.04 7.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 316' ' ' LEU . 1.1 mmmm -136.51 155.42 76.97 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.72 132.15 29.8 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.464 2.11 . . . . 0.0 112.223 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 310' ' ' ASP . 7.7 mp -97.06 29.23 3.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 166' ' ' GLU . 4.1 m-85 -66.53 -29.7 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -40.53 67.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -42.76 48.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.878 ' HA ' HD12 ' A' ' 323' ' ' ILE . 39.3 mt -58.27 -41.38 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.458 ' CG ' HD22 ' A' ' 159' ' ' LEU . 15.0 ttp180 -57.28 -47.36 81.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -39.13 80.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 320' ' ' LEU . 52.0 mt -57.37 -46.42 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.055 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 155' ' ' LEU . 37.4 mt -75.99 -50.36 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.611 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -53.73 -49.89 67.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -56.29 -42.35 77.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.995 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.94 -29.71 65.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 155' ' ' LEU . 19.7 mt -64.75 -35.02 79.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.2 66.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.247 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.49 32.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.1 70.14 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.85 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.61 101.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 39.23 3.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 325' ' ' LEU . 6.5 p-10 -90.44 70.1 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.9 -44.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 174.94 39.05 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.342 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -79.88 121.19 25.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER -162.63 -9.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.204 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 341' ' ' LEU . 5.6 m-20 -60.5 -30.74 69.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 157' ' ' LEU . 1.1 mt 70.81 -52.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 18.3 t 65.89 101.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 344' ' ' VAL . 19.0 m -130.19 -44.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 343' ' ' VAL . 30.2 t -111.9 -46.51 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.79 150.87 28.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -157.41 -55.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.9 62.44 0.29 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.463 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -132.26 53.64 0.8 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mt -130.97 83.16 2.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -160.45 -71.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.851 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -151.41 155.33 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 85.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.75 123.24 44.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 355' ' ' THR . 29.3 mt 63.8 158.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 354' ' ' ILE . 19.4 m 61.12 163.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 355' ' ' THR . 1.9 tttt -125.38 134.41 52.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.58 50.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.78 93.64 4.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 155.73 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -131.64 93.54 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -160.37 153.39 21.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.4 mp -106.53 -55.1 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -167.24 106.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.32 129.66 18.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 149.66 43.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -88.16 136.05 33.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.12 86.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.74 111.0 2.9 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.558 2.172 . . . . 0.0 112.271 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -120.52 179.88 16.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 371' ' ' GLU . 11.1 p -171.34 -44.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.085 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLU . . . . . 0.469 ' N ' HG13 ' A' ' 370' ' ' VAL . 0.7 OUTLIER -109.39 -53.36 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.26 32.81 20.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 15.7 p -138.99 -65.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.54 136.56 43.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -178.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.9 m 61.24 171.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -82.78 -64.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.5 m -110.8 -66.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -143.62 -57.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 44.9 m -99.04 -61.38 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -153.03 -58.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.28 126.91 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -150.26 110.91 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 384' ' ' ILE . 20.1 mt -107.03 31.03 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.67 169.15 11.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -65.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 387' ' ' ARG . 15.4 mtm105 -126.81 -53.92 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.37 171.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -152.77 160.32 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 391' ' ' ARG . 2.2 m -90.1 169.5 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 390' ' ' THR . 29.1 mtm180 64.15 39.26 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -101.72 -34.42 9.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -109.23 158.47 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.809 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 395' ' ' GLN . 12.9 m -136.43 -47.1 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.443 ' N ' HG23 ' A' ' 394' ' ' VAL . 8.5 mt-30 -94.35 131.97 39.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.1 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.901 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 1.3 m 60.38 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 8.1 m -169.51 132.81 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -138.62 -44.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.3 m -70.12 -40.25 74.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -150.28 127.08 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 177.8 98.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -178.57 -61.61 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.253 . . . . 0.0 110.934 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 47.5 Cg_endo -68.59 117.53 5.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.498 2.132 . . . . 0.0 112.294 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.8 ttt-85 -164.73 149.19 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.78 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.03 149.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -70.59 164.72 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -175.56 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.0 121.45 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.18 156.77 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.962 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.95 -175.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.028 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.99 139.02 6.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.533 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.07 30.14 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -61.02 115.13 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.9 m -143.57 92.83 2.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.21 105.45 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.78 169.11 4.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 -178.65 3.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.525 ' HE ' HD21 ' A' ' 19' ' ' LEU . 4.8 ttt180 -137.94 86.4 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.28 140.06 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -172.25 97.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -149.2 157.22 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -125.69 -57.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -96.42 -60.12 1.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' HD2' HG21 ' A' ' 39' ' ' VAL . 10.2 p90 -166.04 107.09 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -134.1 -53.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 41' ' ' LEU . 15.0 t -129.44 117.36 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.71 30.0 27.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -132.54 139.1 47.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.734 0.302 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.641 HG21 ' HB3' ' A' ' 36' ' ' GLU . 35.2 mt -103.71 140.09 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.928 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.7 pt -119.86 154.55 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.6 p -95.65 136.92 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 37' ' ' TRP . 21.7 p-10 -94.54 -148.29 0.27 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.985 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -85.67 -37.91 18.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.242 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.39 2.34 32.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.856 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.2 mmpt? 83.08 15.47 0.34 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -63.15 169.89 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -118.21 76.13 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.018 0.437 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 31' ' ' ASP . 44.5 m95 -67.11 142.67 57.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.787 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 62' ' ' VAL . 23.2 mttm -105.46 132.66 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 ' HD2' ' A' ' 23' ' ' PHE . 17.0 t -89.8 130.02 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -77.56 -106.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.858 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.638 ' HA ' HG22 ' A' ' 25' ' ' VAL . 2.3 mt -121.99 162.25 38.18 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 38.4 Cg_endo -66.78 140.38 55.58 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.666 2.244 . . . . 0.0 112.29 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.694 HG13 HG22 ' A' ' 51' ' ' ILE . 6.5 pt -142.57 30.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.75 141.58 3.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -115.89 144.02 44.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.69 93.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.26 -66.07 2.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.436 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.45 -76.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.79 0.328 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 52' ' ' TYR . . . -109.71 -79.35 1.08 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.742 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER 78.34 -55.71 0.48 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 111.177 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 50' ' ' CYS . 19.7 mm -135.63 127.4 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.361 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 70' ' ' VAL . 14.2 m-85 -146.43 145.8 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' H ' ' A' ' 41' ' ' LEU . 81.0 mt -71.82 136.55 47.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.352 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -114.55 157.22 23.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.507 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 145.99 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.673 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ptm -98.2 40.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.8 t30 58.72 35.86 24.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -65.8 -67.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.43 -170.14 1.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -76.65 -38.82 53.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.85 131.84 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 47.7 t -74.32 -29.1 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.88 65.41 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -179.25 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 110.767 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 76.07 1.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -114.94 89.95 21.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.88 42.36 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.871 2.381 . . . . 0.0 112.807 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -149.71 157.13 42.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.733 HG13 ' HG2' ' A' ' 133' ' ' ARG . 4.8 m -132.05 144.9 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 52' ' ' TYR . 11.2 p -127.41 129.82 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.316 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -94.7 117.48 30.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.199 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 21.4 t -113.2 125.31 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 111.55 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -141.16 146.98 45.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 114.89 3.85 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -60.2 124.16 19.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.12 -73.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -79.36 -32.79 43.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.14 48.42 3.57 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.783 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' THR . 38.5 Cg_endo -67.7 -51.36 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.266 1.977 . . . . 0.0 111.643 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.1 tp -77.93 -21.44 51.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.821 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.78 -33.9 50.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.441 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 79' ' ' PRO . 1.8 t -74.68 -35.36 62.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -73.1 -35.29 66.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 mm? -72.67 -36.2 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -63.97 -47.98 78.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 10.2 t80 -72.0 -35.7 69.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.727 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 1.7 m-85 -56.85 -50.47 72.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -74.98 -17.47 60.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.44 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -47.73 14.64 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -126.36 -19.64 4.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.727 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -92.61 21.4 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 113.25 35.08 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.57 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.76 -29.55 3.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 0.0 112.749 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -71.93 -39.38 69.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.83 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' A' ' 100' ' ' ILE . 50.1 mt -67.53 -49.78 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -29.66 61.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -78.8 -38.16 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -71.14 -42.69 68.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.025 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.6 mt -69.68 -36.43 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.84 60.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 98' ' ' LYS . 35.8 p -84.37 -30.28 25.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.342 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -4.16 17.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 100' ' ' ILE . 3.0 mtmp? 56.59 30.91 18.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.531 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.606 ' HB2' HG23 ' A' ' 100' ' ' ILE . 78.7 mt -45.56 -84.65 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.593 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER 175.16 -62.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.755 0.312 . . . . 0.0 110.984 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -169.13 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 108' ' ' LEU . 4.2 tp 75.34 146.44 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.76 10.23 68.56 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.995 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.97 115.45 44.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.783 0.291 . . . . 0.0 110.939 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 141.07 8.42 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.484 2.123 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 122.26 26.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.42 131.36 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.4 -40.99 3.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.618 0.247 . . . . 0.0 111.551 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.75 171.64 38.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.804 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -132.66 164.48 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.603 0.239 . . . . 0.0 110.643 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -162.01 179.75 37.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.979 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.45 159.68 42.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.715 0.293 . . . . 0.0 110.77 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -144.53 141.65 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.957 0.408 . . . . 0.0 111.108 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.41 129.24 54.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 126.35 22.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.921 0.391 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 55.47 20.9 3.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.72 -0.18 64.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.85 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -96.23 151.15 19.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.759 0.314 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.6 p -101.26 127.33 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.203 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.831 ' O ' HD23 ' A' ' 118' ' ' LEU . 21.6 m-85 -113.57 147.9 37.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.635 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -124.34 125.17 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.77 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.928 ' CE1' HD12 ' A' ' 29' ' ' ILE . 20.7 p90 -135.29 162.45 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.503 ' HG3' HD11 ' A' ' 84' ' ' LEU . 16.0 tmm? -144.94 140.26 28.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.026 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.453 HG13 ' HB ' ' A' ' 70' ' ' VAL . 2.7 mp -99.11 129.82 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -133.31 173.06 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -55.75 138.19 48.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.733 ' HG2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -62.85 170.46 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -145.73 157.5 43.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.98 -74.69 1.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.5 p -148.53 135.1 19.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.82 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -57.31 152.48 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.841 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -57.24 -23.19 46.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.8 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 45.3 tt0 -63.75 -38.56 91.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.154 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -36.48 81.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 1.062 HD13 HD22 ' A' ' 341' ' ' LEU . 8.8 mt -73.85 -25.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.714 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 254' ' ' TRP . 13.1 t80 -76.42 -51.89 10.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.32 -29.99 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.58 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.45 63.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.21 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -96.16 19.77 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.002 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 80.97 48.01 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt 63.37 19.19 11.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.302 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 20.7 mtp180 -131.91 -178.58 4.95 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.868 ' CE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -139.06 -167.81 2.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.688 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.08 144.46 47.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.45 -31.27 63.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 331' ' ' ILE . 3.2 mtmt -74.93 -43.91 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.868 HG21 ' CE1' ' A' ' 149' ' ' PHE . 58.6 m -58.45 -51.82 68.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.22 -46.0 88.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.438 HD22 ' OE2' ' A' ' 298' ' ' GLU . 40.9 mt -65.3 -48.29 73.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -41.97 95.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 341' ' ' LEU . 23.7 mt -70.32 -38.98 75.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 324' ' ' LEU . 91.6 p -59.43 -34.55 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.787 HD12 HD11 ' A' ' 328' ' ' LEU . 13.0 mt -70.8 -46.77 62.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.466 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.626 ' HG3' HD23 ' A' ' 339' ' ' LEU . 14.9 mmt85 -61.32 -44.72 96.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.628 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.7 mt -64.85 -42.18 94.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.698 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 158' ' ' SER . 2.8 mt -55.52 -35.93 66.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -36.93 79.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.603 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 161' ' ' ILE . 5.1 mt -79.54 -38.71 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 162' ' ' LEU . 89.6 mt -58.17 -48.22 80.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -31.09 72.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -72.2 -47.91 47.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.829 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.47 -27.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -76.6 -33.43 58.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.357 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -15.86 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -102.39 3.11 37.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.867 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 74.17 45.24 0.21 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.891 0.377 . . . . 0.0 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -133.08 124.9 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 204' ' ' TYR . 28.3 m -132.2 165.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.067 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.585 ' O ' HD22 ' A' ' 200' ' ' LEU . 10.4 p-80 -150.37 -51.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.237 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.09 24.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.605 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.67 -80.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.584 0.23 . . . . 0.0 110.795 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.0 mt 44.57 95.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 183' ' ' LEU . 5.6 tttt -147.99 174.84 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.8 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -77.09 -1.0 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.593 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.8 t -111.97 1.94 16.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 0.0 110.551 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -123.4 -12.07 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.194 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 179' ' ' LYS . 4.5 mt -108.36 125.19 51.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.908 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 196' ' ' VAL . 0.9 OUTLIER -130.86 156.55 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 111.351 -178.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 141' ' ' ILE . 27.3 mt -90.31 149.84 22.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.05 129.68 40.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.942 0.401 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -73.07 -60.21 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -61.01 -20.84 62.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.534 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -136.52 78.23 44.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.54 80.46 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.534 2.156 . . . . 0.0 112.14 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.36 37.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.06 143.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 157' ' ' LEU . 4.0 p -109.95 147.99 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.162 0.506 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 8.4 m-85 -126.12 156.89 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.652 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 183' ' ' LEU . 39.5 tp -104.01 115.9 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.659 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.77 HG21 HD11 ' A' ' 184' ' ' LEU . 30.9 m -113.76 142.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.1 t70 55.77 84.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -59.05 -21.05 58.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.119 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.713 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 71.49 9.06 68.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.758 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.6 OUTLIER -153.61 -58.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.734 0.302 . . . . 0.0 110.818 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.533 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 43.93 76.24 0.09 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -116.72 148.97 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -103.1 69.71 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.697 ' CD1' HG13 ' A' ' 174' ' ' VAL . 17.0 p90 -50.12 -43.16 51.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.11 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.91 -34.68 46.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.575 2.183 . . . . 0.0 112.277 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.23 34.63 4.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.44 -90.17 1.82 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.425 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.536 HG12 ' HG3' ' A' ' 211' ' ' LYS . 24.2 t -66.0 -29.78 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 63.74 34.72 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.536 ' HG3' HG12 ' A' ' 209' ' ' VAL . 14.5 mttm -77.21 166.66 22.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.44 -66.12 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.25 145.19 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -62.95 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER 60.04 96.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -163.24 72.78 1.94 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 100.84 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.568 2.178 . . . . 0.0 112.282 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.47 -70.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -56.63 10.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 76.9 m 60.76 94.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.808 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 45.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.473 ' HB3' ' HB1' ' A' ' 232' ' ' ALA . 1.8 m-20 -120.27 92.97 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 90.62 -134.11 12.16 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.505 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 -67.22 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.76 HD13 ' HG2' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -159.19 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.76 ' HG2' HD13 ' A' ' 225' ' ' ILE . 5.4 mm-40 -159.48 26.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 227' ' ' PHE . 37.7 t80 -95.07 24.32 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.622 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -142.43 -76.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.993 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.522 ' H ' HG23 ' A' ' 228' ' ' THR . 7.7 t -157.86 163.51 37.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.908 0.385 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.39 -30.51 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.628 ' OD1' HG21 ' A' ' 236' ' ' VAL . 19.3 t70 -64.29 -39.47 93.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 222' ' ' ASP . . . -67.49 -29.64 69.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.72 -25.48 61.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -88.92 12.87 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.475 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.98 28.13 72.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.642 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.628 HG21 ' OD1' ' A' ' 231' ' ' ASP . 22.0 t -88.44 129.29 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.691 0.282 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -76.98 -54.29 1.6 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.0 Cg_exo -54.39 88.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.449 2.099 . . . . 0.0 112.194 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.19 80.77 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -101.8 -24.81 14.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -17.76 41.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.236 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 246' ' ' ILE . . . -61.63 -30.31 74.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.78 -36.79 58.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 110.972 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.58 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 62.2 mt -80.74 -35.0 33.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -57.3 -43.71 83.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 242' ' ' GLY . 3.3 mt -59.9 -42.1 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.804 HD23 ' OH ' ' A' ' 302' ' ' TYR . 30.7 tp -61.1 -30.85 70.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -70.69 -37.36 67.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.366 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.412 ' CZ ' ' HE2' ' A' ' 275' ' ' LYS . 34.5 m-85 -78.55 -26.17 45.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.297 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.283 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.583 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -64.4 -51.07 65.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.189 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.6 mt -63.73 -33.53 62.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -80.02 -33.74 38.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 30.8 m0 -82.28 -48.74 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.415 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -70.93 -36.82 72.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.598 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 289' ' ' CYS . 0.5 OUTLIER -96.14 0.53 51.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.772 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 57.75 94.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.519 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 45.8 m80 63.52 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -132.97 168.52 17.53 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 59.2 Cg_endo -72.61 60.0 3.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.527 2.151 . . . . 0.0 112.534 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.3 p90 178.15 -39.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.9 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -107.45 20.35 19.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.47 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.22 -62.29 1.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -128.57 -26.46 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.283 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 27.9 mt 75.53 10.2 3.5 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.08 0.466 . . . . 0.0 109.756 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -80.91 -16.45 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.11 81.81 37.69 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 33.4 Cg_exo -59.89 -14.77 29.11 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.791 2.328 . . . . 0.0 112.534 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.85 -50.45 45.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.254 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 6.0 p90 -84.04 -26.85 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.767 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 225' ' ' ILE . 39.5 t -60.62 -39.02 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.229 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -73.1 -45.28 58.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 276' ' ' ILE . 19.8 t70 -69.94 -42.73 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.6 t -60.74 -46.17 91.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 279' ' ' ARG . 0.0 OUTLIER -58.75 -51.61 69.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 273' ' ' ASP . 14.0 mt -53.12 -37.66 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.534 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.02 7.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.328 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 285' ' ' LEU . 9.8 m-85 -57.91 -36.98 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 275' ' ' LYS . 0.0 OUTLIER -55.77 -30.62 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 0.0 110.695 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.35 28.12 7.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 284' ' ' SER . 4.1 m120 -136.13 45.1 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.682 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.8 mt -50.43 -36.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.238 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 281' ' ' ASN . 0.3 OUTLIER -78.92 -42.25 27.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.96 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 285' ' ' LEU . 3.0 pp -68.7 -28.47 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.743 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.434 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.9 mmt -72.66 -51.62 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -24.82 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.336 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -48.3 11.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 111.179 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.501 ' HB3' HG21 ' A' ' 256' ' ' THR . 96.8 m -83.16 -41.25 18.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -104.18 153.45 38.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 -170.0 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.562 2.175 . . . . 0.0 112.349 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.05 -43.69 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.13 94.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.08 69.52 0.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 96.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.24 -34.42 21.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.261 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.83 78.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.935 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.438 ' OE2' HD22 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.83 -57.1 14.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.874 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.583 HD12 ' SD ' ' A' ' 251' ' ' MET . 27.1 mm -69.04 -35.31 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.434 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -52.21 -46.09 65.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -61.24 -37.47 83.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.859 ' O ' HG23 ' A' ' 306' ' ' VAL . 46.4 t80 -71.3 -36.17 71.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.682 ' CB ' HD13 ' A' ' 282' ' ' ILE . 0.6 OUTLIER -69.67 -38.06 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.587 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.53 -49.4 76.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.604 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.468 HG21 HD11 ' A' ' 323' ' ' ILE . 0.6 OUTLIER -59.39 -39.69 84.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.712 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 302' ' ' TYR . 22.5 t -73.82 -24.37 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.261 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -79.67 -43.16 23.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.32 -14.4 61.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.814 HD12 ' HA ' ' A' ' 306' ' ' VAL . 6.7 mt -52.56 93.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.74 -171.02 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.016 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.55 79.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 3.8 m 57.77 22.09 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.593 ' OE2' HD22 ' A' ' 309' ' ' LEU . 1.1 tm-20 53.22 97.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -85.87 127.39 62.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.2 95.0 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.372 2.048 . . . . 0.0 112.38 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 24.8 mt -108.95 31.41 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.58 ' CZ ' HD21 ' A' ' 244' ' ' LEU . 15.0 m-85 -61.64 -31.45 71.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -38.79 92.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -76.62 -44.33 34.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.764 ' HA ' HD12 ' A' ' 323' ' ' ILE . 84.4 mt -54.67 -42.18 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.525 ' HG2' HD22 ' A' ' 159' ' ' LEU . 3.4 tmt_? -58.54 -33.32 69.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.44 -32.84 58.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 320' ' ' LEU . 60.1 mt -61.16 -46.96 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.66 HD13 ' OG ' ' A' ' 158' ' ' SER . 41.0 mt -81.17 -23.81 37.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.384 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.613 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.53 -44.39 15.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.184 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.85 -29.11 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -75.36 -26.45 65.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.746 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.787 HD11 HD12 ' A' ' 159' ' ' LEU . 40.9 mt -51.65 -35.22 41.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -29.95 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.27 -30.58 71.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.7 HD12 ' HG2' ' A' ' 152' ' ' LYS . 14.5 pt -97.97 28.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.265 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.35 91.71 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.614 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 m -137.5 164.85 27.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -154.61 154.12 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.54 91.0 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -118.69 35.73 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.85 46.89 21.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 126.01 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.912 HD13 HD12 ' A' ' 341' ' ' LEU . 0.1 OUTLIER -97.74 16.4 20.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.255 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 3.9 t70 56.51 33.54 22.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.039 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 1.062 HD22 HD13 ' A' ' 141' ' ' ILE . 15.7 mt -96.47 62.2 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 67.5 m -58.85 -51.85 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.73 ' HB ' HG23 ' A' ' 141' ' ' ILE . 5.3 p 42.76 68.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.608 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 343' ' ' VAL . 34.5 m 43.69 41.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.698 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 59.67 -176.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.36 -63.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 168.1 89.68 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -123.19 -40.05 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.51 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -41.44 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -143.87 172.99 12.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -170.88 106.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -97.74 166.19 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 60.4 p -130.48 151.72 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.2 pp -77.81 161.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.191 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 1.9 t -164.62 73.06 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -39.24 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -91.76 91.28 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.45 134.6 35.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 132.04 55.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.83 109.52 16.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -105.71 164.16 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 362' ' ' ILE . 3.4 mp -58.89 95.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.37 -35.36 6.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -128.56 103.52 7.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 60.3 m -118.64 -57.5 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 -53.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 60.21 101.48 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.3 -26.81 35.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.432 2.088 . . . . 0.0 112.26 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -102.11 75.27 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 24.8 m -85.89 145.85 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 111.173 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -177.03 -40.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -99.87 34.29 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 62.9 p -136.03 31.66 2.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.79 174.07 7.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -94.0 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.7 t 61.07 83.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.59 158.99 43.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.41 104.51 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.92 -55.94 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.72 156.69 22.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.505 ' HG2' HD11 ' A' ' 384' ' ' ILE . 10.5 tt0 -65.73 131.69 46.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -141.04 138.99 34.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 60.07 87.69 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.505 HD11 ' HG2' ' A' ' 381' ' ' GLU . 26.4 mt -112.18 -35.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 118.53 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.6 m -124.15 121.67 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -118.18 104.89 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 24.7 m -152.52 -46.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.15 175.46 7.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 9.3 t -116.8 159.71 21.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.66 146.97 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -85.92 178.95 7.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -137.67 150.59 47.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 394' ' ' VAL . 11.4 p -64.83 120.13 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.09 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 65.19 -77.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.929 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 2.7 m -147.85 169.23 20.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 12.0 p -151.03 141.63 22.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -169.8 150.64 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 4.1 p -76.42 131.37 39.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.1 169.39 24.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.71 174.49 50.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt 62.4 148.94 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.0 151.45 20.67 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 112.217 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -104.12 130.98 51.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.987 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.8 137.97 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.04 -35.15 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -178.46 139.18 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.091 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.99 -71.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.97 95.42 4.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.804 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.15 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.2 67.52 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -40.81 35.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 61.6 154.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.0 m -161.01 152.39 19.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -86.87 107.42 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.65 133.46 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -137.98 117.82 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mmt-85 -155.42 139.62 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -165.36 -66.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 mt -155.28 168.08 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.19 86.3 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -66.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.752 ' CE2' HG21 ' A' ' 29' ' ' ILE . 26.2 p90 -130.67 119.73 22.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.92 119.18 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.308 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 64.56 110.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.239 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.13 -21.65 42.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.896 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -95.18 147.48 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.09 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 36' ' ' GLU . 17.9 mt -113.88 142.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.896 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 24.9 pt -118.34 154.41 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.419 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 9.4 p -95.88 141.55 29.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.922 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -161.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.18 -39.91 24.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -78.8 -2.82 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.654 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 1.6 tttt 88.51 29.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' THR . 7.2 tttp -77.13 176.41 8.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.365 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB2' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -127.71 79.07 1.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.442 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.407 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.0 m95 -74.53 134.75 42.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.09 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -102.42 127.02 49.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 ' HD2' ' A' ' 23' ' ' PHE . 17.4 t -77.7 117.64 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.051 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -63.23 -105.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -122.53 159.42 52.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.868 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.526 ' HD2' HD23 ' A' ' 41' ' ' LEU . 55.6 Cg_endo -70.05 151.97 67.62 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.174 . . . . 0.0 112.334 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -145.68 30.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.167 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.75 163.24 32.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.544 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -172.0 83.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.42 49.91 1.01 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.59 -63.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -129.92 -57.15 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.95 -100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.424 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 7.7 m -134.53 80.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.743 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.431 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.4 mp -93.74 113.51 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.052 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 9.3 m-85 -135.93 172.29 13.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -78.11 158.78 28.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.04 137.96 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.201 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -143.38 157.77 44.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 46.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -82.81 128.52 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 p -115.86 -39.04 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -93.03 -66.71 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.29 173.06 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.27 144.79 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 63' ' ' GLY . 21.5 t -66.45 155.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -175.62 82.88 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.473 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.2 30.67 20.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.12 31.38 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.61 48.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.07 45.69 1.95 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.572 2.181 . . . . 0.0 112.713 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.8 148.21 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.46 144.89 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.7 p -125.45 119.94 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 118.15 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.398 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.641 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 2.8 t -113.1 135.78 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.336 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.2 143.37 30.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.674 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.58 117.61 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.421 2.08 . . . . 0.0 112.307 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -71.58 109.78 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -157.32 -75.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -76.39 -27.65 56.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.33 46.12 4.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.878 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 43.6 Cg_endo -70.14 -53.19 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.234 1.956 . . . . 0.0 111.651 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 tp -71.37 -23.92 61.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.71 -29.2 62.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.68 -39.69 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.86 -32.51 74.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -69.28 -45.61 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.669 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -57.49 -40.07 77.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.599 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 64.3 t80 -72.16 -36.88 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -70.6 -41.19 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.32 -35.95 81.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.17 14.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.797 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -99.64 -49.58 4.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.847 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -76.61 2.82 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -55.93 121.14 38.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.52 0.2 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.27 -26.94 21.65 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.36 2.04 . . . . 0.0 112.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -79.34 -43.61 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -51.63 51.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.022 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.847 HD11 ' HA ' ' A' ' 91' ' ' ALA . 45.3 mt -57.12 -52.42 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.134 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.76 -31.96 7.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.97 -46.45 29.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.62 ' CG1' HG22 ' A' ' 96' ' ' ILE . 47.4 mm -56.04 -37.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -74.99 -27.76 60.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.1 m -74.61 -38.78 62.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.442 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -107.27 -3.5 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 55.44 24.88 7.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 108' ' ' LEU . 6.0 mt -52.22 -39.55 60.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.567 ' H ' HG23 ' A' ' 100' ' ' ILE . 7.7 ttmt 50.54 41.21 25.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 192' ' ' GLN . 36.7 t80 -177.38 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 105' ' ' LEU . 13.6 tp 60.87 155.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.622 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 164' ' ' ILE . . . -83.87 -3.81 89.07 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.1 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' A' ' 167' ' ' TYR . 43.2 t -77.98 114.3 40.7 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.685 0.242 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.64 151.87 4.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.391 2.061 . . . . 0.0 112.371 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.3 115.49 19.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -92.9 126.03 37.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.454 ' N ' ' CD1' ' A' ' 114' ' ' TRP . 6.0 m95 -103.45 -40.82 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.76 -178.29 45.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.558 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 84' ' ' LEU . 2.6 p -135.57 159.47 41.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -145.45 -177.78 20.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.931 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 159.84 41.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -136.47 137.5 40.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 15.7 p-10 -118.05 125.54 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -138.23 126.14 22.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.09 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.38 21.33 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.491 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.3 57.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.985 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.4 mmtp -96.2 159.41 14.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.5 m -114.51 124.09 51.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.0 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.27 140.41 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -121.54 127.94 51.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.598 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.896 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.5 p90 -140.2 161.09 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.251 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.694 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.3 ttm -128.05 142.36 51.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 29' ' ' ILE . 19.5 mt -118.62 111.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.413 . . . . 0.0 111.336 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -125.46 173.27 9.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.34 132.5 20.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.99 143.16 55.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CD2' HD12 ' A' ' 184' ' ' LEU . 42.6 m-85 -111.34 179.91 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.76 -98.63 2.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.553 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.6 p -125.85 128.18 47.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.703 ' HB3' HD22 ' A' ' 184' ' ' LEU . 11.9 p30 -56.25 164.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.851 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -69.16 -21.36 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.549 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.638 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.91 -35.04 44.11 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.901 0.382 . . . . 0.0 110.429 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -77.83 -25.58 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.356 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.757 HD13 HD22 ' A' ' 341' ' ' LEU . 44.6 mt -73.94 -27.52 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.975 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -57.15 -45.65 83.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.695 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -27.99 60.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.31 -26.2 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -92.79 5.64 50.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.332 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.11 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.128 0.49 . . . . 0.0 110.671 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.07 16.33 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.722 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 145' ' ' ASN . 7.2 ptm180 -161.39 116.35 2.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 1.8 m-85 -57.34 174.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -106.8 158.44 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.626 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -59.2 -32.45 69.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -71.68 -47.78 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -58.28 -55.19 38.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.315 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.781 HG11 ' HB3' ' A' ' 251' ' ' MET . 61.7 t -54.91 -52.69 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.392 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.5 mt -56.52 -46.85 80.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.272 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -52.03 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.876 HD11 HD21 ' A' ' 341' ' ' LEU . 9.3 mt -59.8 -44.25 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.604 ' OG ' HD13 ' A' ' 324' ' ' LEU . 27.2 p -54.66 -45.02 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.733 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 321' ' ' ARG . 10.4 mt -63.05 -43.75 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.358 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -44.51 97.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.477 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.91 -33.48 63.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.676 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 165' ' ' LEU . 10.6 mt -60.9 -38.63 86.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.537 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -32.91 71.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.332 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.416 ' CD1' ' HA3' ' A' ' 109' ' ' GLY . 18.7 mt -78.21 -35.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.376 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 162' ' ' LEU . 15.9 mt -58.15 -48.17 81.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.577 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -31.68 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 110' ' ' VAL . 85.1 t80 -64.1 -42.97 96.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -81.13 -27.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.243 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.41 -29.57 57.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.81 -17.03 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.423 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -106.87 8.45 30.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.688 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 68.88 49.16 0.69 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.27 138.85 46.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 239' ' ' SER . 14.4 m -130.68 169.31 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.497 ' CD2' HD21 ' A' ' 195' ' ' LEU . 6.0 p-80 -154.11 -44.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 111.279 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.31 52.79 49.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.625 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.42 -85.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.59 0.233 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 mt 45.99 91.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 183' ' ' LEU . 19.1 tttt -147.11 170.96 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.821 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -76.36 -1.99 29.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.647 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.19 -0.99 17.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.426 . . . . 0.0 110.435 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -121.5 -8.31 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.351 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.847 ' C ' HD23 ' A' ' 184' ' ' LEU . 8.5 mt -108.43 115.34 29.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.279 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.11 146.43 47.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.211 -178.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 141' ' ' ILE . 31.0 mt -86.39 148.9 25.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.18 124.42 23.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.88 -53.82 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -59.66 -30.14 68.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -143.39 79.14 14.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.641 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.72 108.23 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.634 2.222 . . . . 0.0 112.224 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -56.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -149.94 -167.74 2.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.851 HG21 HD21 ' A' ' 138' ' ' LEU . 6.3 p -110.02 147.39 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 32.1 m-85 -113.22 156.89 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.139 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 175' ' ' HIS . 43.0 tp -104.05 115.83 31.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' A' ' 134' ' ' PHE . 14.9 m -122.17 165.83 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.51 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.658 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.555 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 9.0 m-85 -98.59 -50.66 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 90.64 -47.52 3.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.135 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 221' ' ' HIS . 6.1 mp -118.04 34.87 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.489 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.599 ' HB1' ' CD1' ' A' ' 86' ' ' PHE . . . -77.93 59.65 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -137.06 149.09 47.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.025 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -59.82 101.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 206' ' ' PRO . 42.1 p90 -59.51 -28.04 66.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 13.6 t 61.42 95.98 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.018 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.411 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 52.4 Cg_exo -52.47 -177.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.521 2.148 . . . . 0.0 112.217 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -111.27 -31.88 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.34 -44.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.63 172.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -114.52 31.3 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -69.73 158.62 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.42 32.64 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.0 108.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.974 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.07 -68.57 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.719 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 59.23 161.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' A' ' 217' ' ' PRO . 0.1 OUTLIER -165.15 -64.59 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 216' ' ' ASP . 69.3 Cg_endo -74.34 -168.04 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.415 2.076 . . . . 0.0 112.183 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.82 -40.24 7.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -170.68 43.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.24 134.69 0.43 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.7 ' O ' HD21 ' A' ' 200' ' ' LEU . 2.7 t60 -164.91 -49.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.984 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.412 ' HB2' ' HB1' ' A' ' 232' ' ' ALA . 0.1 OUTLIER -97.98 31.56 2.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.47 -106.02 2.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.587 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 228' ' ' THR . 0.6 OUTLIER -135.11 176.81 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.019 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 265' ' ' LEU . 16.9 tt -93.14 13.83 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -92.46 25.03 3.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.798 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 226' ' ' GLU . 0.4 OUTLIER 174.94 -28.15 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 224' ' ' THR . 16.7 p -81.15 161.72 23.94 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -167.84 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 276' ' ' ILE . 30.2 mt -73.75 -55.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.3 -31.18 65.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 222' ' ' ASP . . . -73.86 -28.38 61.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.404 ' CE1' ' HB ' ' A' ' 225' ' ' ILE . 15.6 t60 -61.56 -51.44 68.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.016 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 236' ' ' VAL . 17.0 m-80 -91.74 12.92 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.421 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.21 15.35 58.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.818 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 234' ' ' ASN . 14.5 t -64.38 141.48 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.22 162.64 0.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 -164.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.682 ' O ' HG11 ' A' ' 174' ' ' VAL . 12.2 p -139.56 104.16 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -158.0 -53.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -28.2 61.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.4 -33.64 66.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 246' ' ' ILE . 34.3 m-20 -56.56 -30.42 63.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.77 HD13 HD11 ' A' ' 320' ' ' LEU . 52.4 mt -80.64 -36.56 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.89 -35.3 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 243' ' ' ASP . 12.0 mt -62.87 -41.52 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.876 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.3 tp -64.19 -50.61 67.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.717 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.81 -27.95 51.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.458 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.93 -33.19 45.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 0.0 110.79 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.429 ' HB3' ' CE3' ' A' ' 254' ' ' TRP . 69.2 m -53.15 -51.63 61.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.046 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.781 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -57.37 -30.58 64.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.624 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.653 HG22 HD23 ' A' ' 259' ' ' LEU . 20.8 mm -69.18 -44.24 80.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.994 0.426 . . . . 0.0 110.737 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.705 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.4 tm0? -80.03 -27.18 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.108 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 2.9 m0 -81.59 -54.38 5.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.38 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 151' ' ' ARG . 43.9 mt -70.32 -35.13 73.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.528 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.25 -13.92 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.538 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.9 97.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.184 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 253' ' ' GLN . 0.1 OUTLIER 66.0 141.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.654 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.966 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -116.64 159.25 41.12 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 14.3 Cg_exo -69.04 59.49 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.839 2.359 . . . . 0.0 112.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.966 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.3 p90 179.13 -38.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.241 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.409 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.1 tt0 -95.99 24.67 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.076 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.59 -57.39 3.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.816 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -125.95 -29.96 3.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.717 HD11 ' CG2' ' A' ' 225' ' ' ILE . 0.3 OUTLIER 73.49 11.67 4.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -15.61 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.449 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.462 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 1.8 m-20 -132.94 103.96 12.88 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.5 17.4 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.722 2.282 . . . . 0.0 112.826 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -79.99 -50.1 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -77.42 -26.04 51.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 5.2 t -60.69 -45.75 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -47.69 25.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -39.16 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -72.74 -39.63 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -49.91 75.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.436 HG13 HD11 ' A' ' 230' ' ' ILE . 5.1 mt -63.97 -44.65 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -52.04 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.8 m-85 -59.03 -33.94 71.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -59.18 -31.14 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 23.65 11.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -147.79 45.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.784 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.5 mt -54.84 -41.24 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.08 67.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -41.52 61.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 282' ' ' ILE . 1.0 OUTLIER -70.77 -38.33 73.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 2.5 ttm -67.53 -33.09 74.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -75.56 -37.69 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.44 25.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.043 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.38 -34.39 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.004 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 8.9 m-85 -127.9 79.91 72.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.969 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 111.4 3.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.554 2.169 . . . . 0.0 112.359 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -128.54 -46.37 1.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -173.84 -62.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -177.01 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.13 127.88 59.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 53.1 Cg_exo -55.12 -168.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.77 -89.91 1.5 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.428 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -125.6 -39.97 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 111.037 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.722 HG22 ' CG ' ' A' ' 303' ' ' MET . 35.3 mm -54.87 -41.43 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -44.4 -30.57 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.5 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.25 -42.26 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.876 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.3 t80 -67.57 -37.72 83.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.784 ' CB ' HD13 ' A' ' 282' ' ' ILE . 62.9 mmm -71.77 -30.0 65.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.96 -50.34 68.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -41.65 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 302' ' ' TYR . 27.8 t -69.93 -24.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.106 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -80.43 -29.94 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.64 -11.91 20.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.584 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.832 ' HG ' HD22 ' A' ' 316' ' ' LEU . 0.2 OUTLIER -54.63 91.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.86 -160.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.57 29.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 p -95.94 -33.94 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.7 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.697 ' HB3' HD11 ' A' ' 316' ' ' LEU . 0.5 OUTLIER -118.44 -163.33 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 316' ' ' LEU . 12.3 mmtm -151.54 -66.98 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 60.8 Cg_endo -72.3 64.01 3.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.31 2.006 . . . . 0.0 112.217 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.832 HD22 ' HG ' ' A' ' 309' ' ' LEU . 4.0 mp -92.17 -23.87 19.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.513 ' CD2' HD21 ' A' ' 244' ' ' LEU . 76.0 m-85 -53.92 -30.28 45.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.97 -36.58 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.9 -37.3 67.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.92 ' HA ' HD12 ' A' ' 323' ' ' ILE . 55.5 mt -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.57 ' HG3' HD22 ' A' ' 159' ' ' LEU . 1.5 ttm-85 -59.34 -46.62 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -40.71 82.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.92 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.6 mt -58.06 -46.81 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.604 HD13 ' OG ' ' A' ' 158' ' ' SER . 40.8 mt -73.68 -51.63 15.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.984 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.28 -49.87 68.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.32 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -58.78 -39.97 82.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.001 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.12 -31.93 70.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.585 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.5 mt -63.02 -41.73 99.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.55 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.75 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.0 pt -101.45 27.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.188 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.04 28.08 52.81 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.583 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 18.1 t -102.33 156.79 17.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -174.61 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.67 100.42 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.4 -26.42 10.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.71 1.83 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.426 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.6 148.02 28.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.865 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 58.2 mt -91.78 12.75 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.318 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.85 25.3 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.797 0.332 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.876 HD21 HD11 ' A' ' 157' ' ' LEU . 34.8 mt -72.71 -43.08 63.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.4 68.33 0.61 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.72 30.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.09 -36.78 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.45 142.28 37.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -78.43 -38.87 40.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 123.27 -139.01 11.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 176.83 107.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.446 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 349' ' ' LEU . 3.7 mm? -73.59 86.55 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -72.84 93.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.3 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.74 103.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 1.4 m -116.62 31.65 6.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -142.06 31.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.179 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 68.4 p -71.96 -34.24 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -115.4 111.16 20.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.1 146.61 24.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.87 -41.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -130.8 131.04 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -128.53 150.78 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -123.29 27.84 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.48 146.94 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.025 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 60.24 177.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.41 109.09 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.832 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -72.4 -28.5 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.045 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -58.3 -68.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.31 93.74 19.69 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.73 -59.81 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -160.49 -152.0 6.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.544 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 370' ' ' VAL . 15.7 m -130.32 105.23 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 59.8 31.11 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -105.21 133.79 49.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.5 p -108.83 -46.1 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.24 -178.17 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.6 175.12 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.0 m 60.3 162.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -78.23 146.17 35.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 76.5 p -72.76 -59.55 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.23 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 7.9 m -107.14 122.38 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.65 127.31 55.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -150.41 -49.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.36 115.37 23.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.44 138.48 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -139.05 120.83 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -90.81 137.95 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 39.61 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.47 163.81 12.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 60.35 170.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.9 m 60.26 31.44 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.62 -59.28 3.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.1 -43.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.01 150.39 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 395' ' ' GLN . 7.4 p 179.53 -34.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.768 ' HG2' HG13 ' A' ' 394' ' ' VAL . 13.9 pt20 -173.78 90.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 13.3 tttt . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.928 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.569 -0.212 . . . . 0.0 112.569 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 1.4 m -65.36 135.9 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 69.6 m -137.82 92.71 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -88.17 170.38 39.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.505 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 23.5 p -162.05 111.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.68 172.61 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -178.34 -95.86 0.1 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.0 131.64 23.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.62 0.248 . . . . 0.0 110.778 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.59 151.37 46.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.508 2.139 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -138.21 177.21 8.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.01 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -134.65 97.47 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.66 33.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 173.5 12.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -107.73 88.86 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.35 30.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.39 -178.15 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.36 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.889 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.13 113.8 12.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 t -161.39 110.72 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.003 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.78 23.29 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.96 -168.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.836 0.35 . . . . 0.0 111.221 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 155.73 42.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -135.59 31.34 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.638 ' HB2' HD12 ' A' ' 19' ' ' LEU . 74.9 m-70 -75.56 -67.62 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.667 HD22 ' HA3' ' A' ' 47' ' ' GLY . 2.9 mp -111.62 162.55 15.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.828 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.09 137.51 9.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.59 156.02 38.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -178.02 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' CE1' HG21 ' A' ' 72' ' ' VAL . 5.3 t80 -93.13 44.38 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' C ' HG23 ' A' ' 25' ' ' VAL . . . -177.5 145.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 41' ' ' LEU . 1.0 OUTLIER 64.75 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.495 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.43 -25.44 22.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.975 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -83.39 136.13 34.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.196 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 38' ' ' LYS . 11.0 mm -100.42 144.27 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.718 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 128' ' ' PHE . 34.1 pt -119.76 151.3 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -95.81 141.4 29.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.806 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.08 -163.53 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.099 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -41.0 35.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 109.792 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -76.69 -5.01 46.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.531 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 89.65 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.9 mttp -77.21 -177.66 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.207 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.8 mm-40 -132.76 81.78 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 110.697 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -75.26 136.93 40.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.932 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' HD12 ' A' ' 28' ' ' ILE . 3.4 mttm -94.1 118.68 31.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -72.73 144.17 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.91 -117.42 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.787 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.677 ' HA ' HG22 ' A' ' 25' ' ' VAL . 3.1 mt -113.27 164.61 15.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 111.021 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 33.9 Cg_endo -64.6 141.86 74.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.598 2.199 . . . . 0.0 112.251 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 ' HG ' ' A' ' 53' ' ' LEU . 13.0 pt -153.76 79.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.28 97.23 0.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.565 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 59.62 96.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 68.12 1.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.667 ' HA3' HD22 ' A' ' 19' ' ' LEU . . . -133.81 -97.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.592 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -81.6 -69.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 52' ' ' TYR . . . -170.33 -102.51 0.16 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.472 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.879 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.5 OUTLIER 79.09 -56.1 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.647 0.26 . . . . 0.0 111.118 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 50' ' ' CYS . 3.9 mp -141.59 130.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 m-85 -146.46 150.15 35.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 41' ' ' LEU . 24.4 mt -70.75 158.8 35.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.342 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.583 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -132.69 154.39 50.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.0 111.38 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -149.14 132.0 16.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.9 mtp -83.62 57.01 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.95 -177.67 5.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.0 p -175.65 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.4 p -79.28 -66.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.21 -69.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -161.21 160.38 29.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.425 HG23 ' HD3' ' A' ' 38' ' ' LYS . 21.5 t -90.58 139.95 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.061 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.89 -123.61 4.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.35 31.05 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.86 42.04 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.583 ' HB1' ' O ' ' A' ' 54' ' ' ALA . . . -109.16 92.34 10.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.001 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.14 49.97 3.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.633 2.222 . . . . 0.0 112.753 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 59.6 m -149.86 148.19 28.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 133' ' ' ARG . 16.5 m -124.51 144.96 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 3.8 p -132.17 122.39 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.878 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -96.95 116.33 29.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.682 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.519 HG21 ' CE1' ' A' ' 23' ' ' PHE . 9.3 t -113.13 133.8 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.39 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.17 150.65 59.41 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.728 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.07 101.21 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.277 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 m 60.36 173.43 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.04 151.41 43.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.31 -55.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' THR . . . 163.44 -68.58 0.22 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.464 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.07 -36.09 64.32 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.352 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.17 -39.83 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.63 -40.44 91.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 21.8 p -68.64 -31.8 71.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 38.3 tt0 -73.82 -47.66 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.7 mm? -58.46 -48.08 81.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -45.03 92.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.443 ' CE2' ' CB ' ' A' ' 90' ' ' ALA . 16.7 t80 -71.91 -44.74 63.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.718 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -57.07 -29.8 63.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.493 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -80.0 -45.57 18.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.074 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -87.39 -47.62 8.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 86' ' ' PHE . . . -81.34 -46.47 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.782 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -94.71 33.17 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.593 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -72.03 123.73 89.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.605 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.58 -25.34 79.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.398 2.065 . . . . 0.0 112.249 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.39 -36.01 39.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.6 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 60.2 mt -56.7 -56.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.304 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -37.95 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -74.47 -43.84 54.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.32 -51.91 65.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' A' ' 105' ' ' LEU . 66.8 mt -60.31 -37.1 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -27.65 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 64.6 m -83.48 -30.92 26.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.23 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HD3' HD21 ' A' ' 105' ' ' LEU . 3.5 ttt-85 -105.95 -4.36 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.018 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.43 28.42 15.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 100' ' ' ILE . 66.6 mt -48.93 -39.41 26.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER 75.41 -1.75 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.62 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 75.6 t80 174.19 162.46 0.19 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 110.461 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.7 tp -147.42 -66.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 130.65 -14.65 5.52 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.7 126.86 88.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.612 0.206 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.49 148.23 20.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.483 2.122 . . . . 0.0 112.193 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -83.99 115.57 22.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.046 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 39.1 t80 -97.48 125.05 41.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -100.82 -40.7 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.86 -176.53 46.36 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.625 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -134.88 154.53 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -137.67 171.07 23.42 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.84 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 127' ' ' ARG . 5.9 mt -142.39 157.25 44.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.702 0.287 . . . . 0.0 110.623 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -145.96 141.56 27.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -115.92 125.33 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 126.27 22.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 60.44 17.05 6.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.51 -6.35 59.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.872 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -96.17 129.57 43.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.9 t -92.38 130.94 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.03 151.48 29.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.748 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -129.93 125.65 35.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.631 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 29' ' ' ILE . 31.0 p90 -133.56 163.76 28.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.665 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.1 ttm -127.98 140.74 51.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.033 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 29' ' ' ILE . 13.7 mt -120.77 111.69 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.44 . . . . 0.0 111.549 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -123.42 173.43 8.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.718 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 15.7 t0 -55.85 138.28 48.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HG3' HG13 ' A' ' 69' ' ' VAL . 52.1 ttt180 -68.89 154.6 41.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.5 ' CD2' HD12 ' A' ' 184' ' ' LEU . 73.3 m-85 -119.32 161.84 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.2 -73.91 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 m -146.56 138.25 24.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.556 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -60.01 152.45 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.715 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 30.3 tp60 -70.95 -41.73 70.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -65.55 -26.96 68.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.79 HD13 HD22 ' A' ' 341' ' ' LEU . 29.1 mt -75.83 -29.77 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 46.8 t80 -54.24 -47.66 71.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.835 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.05 -25.57 68.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.715 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.719 ' HB1' HG12 ' A' ' 344' ' ' VAL . . . -75.73 -19.25 59.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 4.1 m-80 -91.0 5.59 48.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.233 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.55 43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.268 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.6 tttt 62.04 18.7 10.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 1.4 ptt85 -165.49 126.21 1.88 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.3 158.53 30.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -93.07 160.51 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -28.9 68.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 45.5 p -68.01 -44.07 77.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.733 HG21 ' HG ' ' A' ' 255' ' ' LEU . 47.7 t -57.87 -54.03 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.291 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.733 ' HB3' HD21 ' A' ' 328' ' ' LEU . 74.5 mt -61.78 -45.3 94.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.622 ' OE1' HD13 ' A' ' 328' ' ' LEU . 8.8 tp60 -58.58 -44.0 89.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.714 HD23 HD22 ' A' ' 339' ' ' LEU . 42.6 mt -73.33 -37.17 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.6 m -58.25 -41.41 84.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 325' ' ' LEU . 12.7 mt -70.71 -43.79 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.77 88.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' LEU . 7.3 mt -71.29 -33.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.2 mt -64.56 -40.21 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -36.29 80.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.0 mt -73.65 -40.24 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' A' ' 162' ' ' LEU . 21.3 mt -56.22 -33.06 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.69 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 -29.34 59.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -72.02 -52.51 16.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.615 HG21 ' OH ' ' A' ' 198' ' ' TYR . 48.4 pt -64.75 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -40.16 88.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.326 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.02 -12.31 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.75 4.49 25.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.943 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 66.17 46.92 1.97 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.875 0.369 . . . . 0.0 110.706 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -135.34 120.11 18.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 204' ' ' TYR . 3.0 m -124.58 169.08 16.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.008 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 175' ' ' HIS . 3.8 p80 -149.82 -52.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 68.95 37.52 83.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.53 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.3 -81.22 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 183' ' ' LEU . 2.4 mp 47.4 93.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.399 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 174.84 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.019 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -78.23 -3.96 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.3 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.6 t -108.54 0.32 20.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.642 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -125.33 -9.55 6.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.326 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.872 ' C ' HD23 ' A' ' 184' ' ' LEU . 54.9 mt -108.28 117.66 34.73 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.872 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.67 161.45 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.921 0.391 . . . . 0.0 111.492 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.0 mt -92.8 149.82 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.07 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.81 129.91 41.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.416 ' CG ' ' HD3' ' A' ' 133' ' ' ARG . 60.4 t80 -71.77 -62.81 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.591 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -19.95 63.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.653 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -134.34 76.8 61.65 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 78.04 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.437 2.091 . . . . 0.0 111.963 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -179.62 36.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.8 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.648 ' HA ' HD11 ' A' ' 339' ' ' LEU . 0.5 OUTLIER -174.12 145.79 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.264 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.668 HG11 HD22 ' A' ' 157' ' ' LEU . 2.4 p -109.98 147.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 110.888 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 10.8 m-85 -126.25 157.59 37.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 34.0 tp -103.12 115.79 31.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.889 0.376 . . . . 0.0 110.607 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.77 141.32 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.182 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 57.54 106.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.615 ' OH ' HG21 ' A' ' 168' ' ' ILE . 3.4 m-30 -75.48 -24.09 56.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.658 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 93.76 -24.7 24.92 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.553 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 199' ' ' GLY . 5.0 mp -150.78 -44.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 45.93 87.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.095 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.574 ' O ' HG22 ' A' ' 174' ' ' VAL . 30.5 t80 -143.84 148.77 35.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 202' ' ' TYR . 15.2 mtm105 -74.11 98.49 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 174' ' ' VAL . 43.0 p90 -50.59 -26.28 5.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.359 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.4 p -98.23 97.68 4.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.24 -52.75 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.414 2.076 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -144.07 30.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.8 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.12 133.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -144.54 33.19 1.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 155.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.94 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.22 159.75 19.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 213' ' ' TYR . 0.7 OUTLIER -147.74 -45.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.835 ' HA ' HG13 ' A' ' 236' ' ' VAL . 38.0 mtmt 60.13 46.24 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -161.46 139.08 9.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.41 106.34 0.64 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.97 -32.75 96.02 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.459 2.106 . . . . 0.0 112.178 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -161.72 30.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.3 ttt85 60.77 68.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -72.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 63.5 m170 57.16 96.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -112.45 135.01 53.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 69.34 145.1 0.19 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.0 p -59.61 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.3 tp -163.9 27.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.196 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.24 -35.36 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -152.23 32.34 0.53 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.705 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 39.9 p -65.54 128.74 37.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.021 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.6 m -89.88 146.57 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.834 HD11 ' HG3' ' A' ' 275' ' ' LYS . 3.0 mp -57.81 -35.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.71 -30.53 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -75.3 -39.2 59.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -44.3 92.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -92.83 0.57 57.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.87 7.9 62.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.945 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.835 HG13 ' HA ' ' A' ' 214' ' ' LYS . 38.9 t -62.2 127.87 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.65 154.27 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.21 -166.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.55 2.167 . . . . 0.0 112.255 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -96.96 28.46 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -90.86 -53.02 4.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -25.44 62.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.873 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -65.05 -37.76 94.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.05 -40.59 89.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.489 HD12 HD11 ' A' ' 309' ' ' LEU . 48.7 mt -67.0 -35.93 81.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.784 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -62.95 -42.55 99.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.9 mt -65.2 -39.9 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.499 HD23 ' OH ' ' A' ' 302' ' ' TYR . 32.5 tp -65.76 -39.54 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.77 -44.93 96.55 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.379 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.63 -25.7 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.91 -43.33 86.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.252 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.678 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.28 -50.1 74.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 mt -64.19 -26.55 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.66 ' HB2' HD11 ' A' ' 259' ' ' LEU . 12.4 tm0? -71.07 -45.2 64.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.401 ' CD1' ' OE1' ' A' ' 253' ' ' GLN . 18.5 m0 -82.19 -41.09 20.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.733 ' HG ' HG21 ' A' ' 154' ' ' VAL . 21.0 mt -67.04 -39.21 86.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -0.57 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 57.49 96.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 55.6 m80 62.54 144.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -122.35 164.65 24.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.466 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.93 63.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.421 2.08 . . . . 0.0 112.519 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.838 ' CH2' HD22 ' A' ' 259' ' ' LEU . 7.6 p90 176.41 -38.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.108 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.9 tt0 -95.55 18.47 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.289 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -55.93 15.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 93.6 m-20 -126.99 -27.36 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.6 mt 70.67 12.4 7.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -85.19 -15.3 44.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.175 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.46 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 2.1 m-20 -132.56 100.52 14.95 Favored Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.93 15.02 2.05 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.616 2.211 . . . . 0.0 112.857 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -78.54 -49.77 12.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.1 p90 -77.13 -26.47 53.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 225' ' ' ILE . 12.5 t -60.71 -37.53 76.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.56 ' NH1' HD11 ' A' ' 276' ' ' ILE . 12.3 ttt-85 -75.52 -44.94 41.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.068 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.15 -49.67 63.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.235 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.9 m -58.58 -41.98 86.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.834 ' HG3' HD11 ' A' ' 230' ' ' ILE . 10.8 tptt -62.35 -41.5 98.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.144 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.56 HD11 ' NH1' ' A' ' 272' ' ' ARG . 11.3 mt -75.1 -29.09 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.01 16.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -69.98 -40.13 75.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.388 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -52.58 -27.52 17.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.02 15.33 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.21 45.76 2.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.708 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.1 mt -51.7 -36.5 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.336 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.13 63.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.574 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 9.9 t -68.37 -40.36 81.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.34 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.5 pp -76.01 -28.41 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.331 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 4.0 mmt -67.61 -38.42 83.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.751 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -82.7 -31.58 28.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -82.66 -51.59 7.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.07 -41.13 67.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -115.68 151.97 46.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.009 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 131.89 17.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.629 2.219 . . . . 0.0 112.281 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.02 43.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -107.13 -55.91 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -162.1 -176.45 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 60.82 87.16 0.14 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.59 144.16 44.04 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.608 2.205 . . . . 0.0 112.377 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.453 ' O ' HD11 ' A' ' 155' ' ' LEU . . . -96.86 -18.08 30.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.709 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.14 10.61 6.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.362 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.538 HG22 ' CG ' ' A' ' 303' ' ' MET . 43.3 mm -79.41 -46.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.13 -45.27 11.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.446 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.575 ' HB2' HG23 ' A' ' 323' ' ' ILE . 69.1 mttt -59.63 -42.76 93.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.52 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 306' ' ' VAL . 72.7 t80 -70.17 -36.79 74.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.612 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.708 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.6 mtp -67.39 -42.47 83.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.579 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.48 -48.39 80.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -37.78 80.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.692 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 302' ' ' TYR . 40.6 t -71.08 -25.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -43.12 15.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 110.217 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -14.31 62.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.545 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 306' ' ' VAL . 8.7 mt -47.35 114.09 0.81 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.231 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.51 144.53 51.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.759 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -93.3 46.33 1.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.3 m -157.65 -47.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -176.33 116.2 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -176.73 72.15 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 132.24 20.02 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 112.23 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' A' ' 320' ' ' LEU . 1.4 pp -155.41 30.55 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.041 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -57.53 -37.05 72.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.22 -40.69 94.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.741 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.62 -42.88 99.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.562 ' HG ' HD12 ' A' ' 316' ' ' LEU . 79.4 mt -56.18 -45.38 79.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -56.34 -46.45 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.38 91.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 301' ' ' LYS . 97.2 mt -53.07 -42.22 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 155' ' ' LEU . 61.1 mt -81.06 -51.51 8.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.089 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -56.03 -49.77 72.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.43 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.91 -46.16 71.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.71 -28.13 56.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 155' ' ' LEU . 7.2 mt -69.16 -24.74 64.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.715 0.293 . . . . 0.0 111.071 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 1.2 mmtm -69.76 -33.47 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.02 -18.85 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.143 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.52 -34.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -122.07 -24.44 2.25 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.279 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 3.0 t 71.43 65.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 74.61 103.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 164.02 26.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -176.37 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -91.55 46.55 2.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.54 137.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.714 HD22 HD23 ' A' ' 157' ' ' LEU . 70.2 mt -100.5 -3.56 30.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 63.39 17.62 10.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.676 0.274 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.79 HD22 HD13 ' A' ' 141' ' ' ILE . 15.8 mt -73.49 -61.44 1.83 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.7 t 77.89 -55.28 0.51 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.156 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.546 HG22 HG23 ' A' ' 141' ' ' ILE . 6.4 t 58.31 73.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.065 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.719 HG12 ' HB1' ' A' ' 144' ' ' ALA . 10.0 p -61.35 -28.48 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -106.34 81.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.62 -44.28 28.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 141.76 -94.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -127.01 -162.63 11.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.41 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 350' ' ' LYS . 3.8 tt -127.76 158.9 36.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.571 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.7 mttt -66.2 115.25 5.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.12 54.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -99.05 31.43 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 28.2 p -115.77 177.78 4.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 9.6 mt 59.64 75.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.0 m -149.51 136.3 19.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 80.72 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -130.68 88.66 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.0 56.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -166.08 93.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -125.49 -50.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -66.86 117.48 9.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.99 117.68 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -87.37 -46.75 9.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.09 170.16 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.951 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.2 m -126.78 129.52 48.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 60.43 96.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.31 125.6 33.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.84 124.34 15.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.418 2.078 . . . . 0.0 112.21 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.29 -71.02 0.94 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.539 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.15 145.18 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.135 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -131.37 154.18 48.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.59 86.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 76.2 p -120.03 136.76 54.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.42 -176.64 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 60.06 89.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.2 p -103.64 132.81 49.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.29 108.14 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.0 m -127.83 75.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -171.82 -176.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.784 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 33.6 p -99.9 177.54 5.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.49 91.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.02 132.87 43.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -133.66 179.57 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 30.1 mt 63.54 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 60.25 31.95 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.0 p -133.5 104.18 6.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 159.73 37.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 28.7 t -162.91 89.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.47 166.3 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 m -147.12 81.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.963 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -74.78 123.61 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -149.91 -51.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -71.44 166.88 20.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.2 m -139.98 117.97 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -108.11 -61.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 6.3 m -88.61 -53.47 4.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 75.6 m -137.61 118.51 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -124.3 36.29 2.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.82 155.6 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 2.5 m -96.82 39.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -177.12 -121.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HB3' HG12 ' A' ' 4' ' ' VAL . 3.7 mtm -169.54 73.7 0.69 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 110.867 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.83 -25.46 27.33 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.539 2.159 . . . . 0.0 112.344 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -60.6 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.048 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' A' ' 1' ' ' MET . 11.6 p -69.26 145.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -146.38 -47.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.6 -169.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.4 -48.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.43 129.78 54.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.04 -44.64 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.02 167.06 42.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -164.8 95.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 151.63 49.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -106.35 -66.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 m -142.94 -173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 173.8 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -154.67 -49.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -131.43 127.59 37.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.751 ' C ' HD22 ' A' ' 19' ' ' LEU . 61.9 m80 -105.24 30.66 5.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD22 ' C ' ' A' ' 18' ' ' HIS . 3.9 mm? -133.35 -178.66 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.43 -70.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -97.6 177.7 5.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.44 -51.69 2.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 3.6 m-85 -62.69 113.91 3.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.83 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.85 -171.57 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.051 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 110.6 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.93 -27.61 6.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.495 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 135.19 51.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 36' ' ' GLU . 15.7 mt -100.66 143.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.897 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 18.4 pt -119.7 154.99 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 34' ' ' LYS . 1.4 m -94.98 135.45 36.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -160.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.248 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.1 -38.74 51.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.73 3.66 28.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.235 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.9 mttp 76.03 32.43 0.63 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.5 mtpp -77.34 171.87 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.065 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 28' ' ' ILE . 22.3 mt-10 -111.88 73.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.49 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HB2' HG13 ' A' ' 29' ' ' ILE . 26.7 m95 -66.7 145.87 55.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.959 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -100.8 132.39 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 29' ' ' ILE . 25.4 t -88.9 123.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 62' ' ' VAL . . . -75.07 -127.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.551 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.27 159.39 70.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.85 128.2 18.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.167 . . . . 0.0 112.299 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -109.72 -30.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.48 42.57 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.439 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -84.1 99.98 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 -101.12 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.571 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.93 73.75 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CE1' ' NZ ' ' A' ' 71' ' ' LYS . 93.7 m-85 -101.98 -37.72 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.97 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.37 -72.8 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -122.69 73.98 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.961 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.415 HD12 ' HG2' ' A' ' 71' ' ' LYS . 21.5 mm -87.61 114.8 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 59.0 m-85 -146.32 158.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 69' ' ' VAL . 69.0 mt -72.66 163.69 27.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -136.57 157.51 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.733 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.8 t70 -149.29 154.01 38.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 43.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.955 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 60.2 -175.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t 60.47 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.56 68.88 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 59.7 -174.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.7 p -86.06 85.13 7.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 55' ' ' ASP . 20.0 t 68.95 -67.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.24 -156.12 21.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.7 -30.03 8.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.36 53.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.1 113.55 31.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.55 25.85 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.93 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.68 148.34 29.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.959 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 53' ' ' LEU . 27.5 m -129.63 156.89 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.6 p -140.19 122.88 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' NZ ' ' CE1' ' A' ' 48' ' ' PHE . 2.4 mttm -106.4 121.93 45.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' A' ' 128' ' ' PHE . 3.3 t -113.16 146.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.22 136.75 16.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.731 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.33 89.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.364 2.043 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 59.61 172.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.7 81.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.04 -29.34 6.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.15 -165.9 22.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.65 29.29 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.936 2.424 . . . . 0.0 112.808 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.543 HD23 ' HD3' ' A' ' 127' ' ' ARG . 12.3 tp -77.91 -31.88 51.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -67.01 -42.46 84.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 201' ' ' ALA . 11.4 t -69.17 -28.62 66.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.956 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -40.4 69.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.65 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.1 mm? -63.69 -44.54 93.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.04 92.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.46 -43.04 95.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.892 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.4 m-85 -60.07 -44.41 94.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -79.83 -17.6 52.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.382 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -65.35 -47.8 75.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.784 0.326 . . . . 0.0 111.046 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.68 33.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.255 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -119.44 -10.68 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 163.84 0.44 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.696 0.284 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.44 -19.39 43.59 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.614 2.209 . . . . 0.0 112.493 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -75.62 -39.74 57.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -79.34 -42.09 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.486 HD12 ' HB ' ' A' ' 110' ' ' VAL . 28.0 mm -58.36 -48.78 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -70.2 -49.58 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.174 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -58.15 -51.7 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.08 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 108' ' ' LEU . 27.9 mt -61.41 -35.72 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -75.07 -27.84 60.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.29 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -82.38 -37.76 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.468 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -104.8 -1.2 26.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 58.33 31.24 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.763 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HB2' HG23 ' A' ' 100' ' ' ILE . 51.2 mt -51.28 -26.84 7.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.215 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.0 tttt 58.2 94.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.1 t80 63.87 132.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 100' ' ' ILE . 11.4 tp -125.54 163.71 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.6 10.05 66.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.923 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.579 HG21 ' CD2' ' A' ' 167' ' ' TYR . 23.2 t -92.74 123.43 61.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.757 0.278 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 146.38 49.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.075 . . . . 0.0 112.248 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -89.34 119.83 30.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -74.93 123.65 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.81 -40.61 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.47 46.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.704 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -145.52 163.39 34.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.66 -174.98 35.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.707 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -145.5 159.84 42.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -133.38 141.7 48.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.33 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 126.34 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.63 18.46 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.53 20.67 36.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.626 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 0.3 OUTLIER -121.13 128.94 53.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.17 130.87 37.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 124' ' ' LYS . 9.8 m-85 -120.26 143.46 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.543 ' HD3' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -107.04 133.14 52.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.897 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.3 p90 -137.88 163.68 30.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.687 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.7 ttm -129.46 136.33 49.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.423 HG21 ' CZ3' ' A' ' 37' ' ' TRP . 17.6 mt -109.2 119.27 58.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.42 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -134.01 173.23 11.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.795 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.74 145.24 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.208 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -73.4 160.64 31.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 184' ' ' LEU . 92.5 m-85 -132.3 154.92 49.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.98 -99.31 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.342 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.58 125.28 47.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.6 p30 -53.5 158.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -63.79 -21.66 66.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.724 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -61.53 -40.5 94.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 0.0 109.981 178.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.726 ' CD1' HD13 ' A' ' 341' ' ' LEU . 3.1 mt -73.13 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -67.37 -49.02 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.57 -28.58 59.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.873 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.19 -23.63 66.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -98.75 20.89 12.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.77 48.66 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.243 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt 63.37 18.97 11.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.311 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 -176.16 4.52 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.452 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -128.14 -176.0 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.908 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -117.26 135.33 53.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.829 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.768 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -57.48 -26.57 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -42.44 64.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.3 p -74.83 -35.58 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.745 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 150' ' ' SER . 42.4 t -57.68 -53.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.971 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.669 HD23 HD22 ' A' ' 324' ' ' LEU . 52.7 mt -63.87 -44.31 93.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.777 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.429 HE22 HD22 ' A' ' 339' ' ' LEU . 1.4 tm0? -62.17 -45.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.576 HD11 ' CD2' ' A' ' 341' ' ' LEU . 13.6 mt -70.15 -37.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.737 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.1 m -56.55 -37.33 70.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 328' ' ' LEU . 11.4 mt -73.96 -46.77 41.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.07 -46.19 90.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 178' ' ' ILE . 11.4 mt -66.54 -34.43 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.757 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.6 mt -60.03 -36.76 77.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.98 -40.1 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.56 HD21 HD11 ' A' ' 178' ' ' ILE . 82.3 mt -58.04 -42.02 84.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.653 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.69 -45.11 95.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CD2' HG21 ' A' ' 110' ' ' VAL . 60.8 t80 -60.26 -53.01 62.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.3 pt -66.99 -27.17 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.408 ' CD2' ' OH ' ' A' ' 204' ' ' TYR . 8.2 t-160 -78.07 -36.5 48.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.645 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -16.98 62.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -94.57 -1.03 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 75.85 37.71 0.38 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.16 116.03 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.726 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.9 m -112.04 141.82 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.266 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 198' ' ' TYR . 0.8 OUTLIER -179.36 66.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.645 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.641 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -63.1 79.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.661 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -106.35 26.83 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 183' ' ' LEU . 3.3 mp -59.76 103.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.022 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -143.4 170.14 16.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.895 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -77.3 -3.35 39.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.282 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.8 t -112.62 2.26 16.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.658 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -126.53 -5.41 6.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.098 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 184' ' ' LEU . 10.9 mt -108.44 127.55 54.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -136.94 150.08 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.908 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 341' ' ' LEU . 13.8 mt -86.67 149.41 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.256 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.49 127.99 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.746 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.459 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 23.9 t80 -86.47 -43.67 12.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.544 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -20.73 62.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -149.6 71.0 9.76 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.616 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.06 91.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.735 2.29 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.45 31.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.57 155.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.014 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 138' ' ' LEU . 3.7 p -109.94 148.16 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 5.3 m-85 -119.66 156.9 29.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 35.9 tp -106.9 115.8 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 184' ' ' LEU . 24.2 m -115.95 141.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.371 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.45 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.023 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 175' ' ' HIS . 5.2 m-85 -90.22 -19.18 24.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.39 23.29 73.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.373 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 mp -156.32 -68.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 45.67 88.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -137.4 149.11 46.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.998 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.4 81.19 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.713 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.726 ' CD1' HG13 ' A' ' 174' ' ' VAL . 13.3 p90 -46.17 -40.44 11.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.421 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.64 106.77 0.7 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 152.62 21.36 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.493 2.128 . . . . 0.0 112.335 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -35.35 5.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.39 29.47 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.42 141.49 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.31 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -97.16 33.6 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.93 158.17 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -130.02 135.34 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.425 ' CZ ' HG11 ' A' ' 236' ' ' VAL . 1.4 t80 61.38 96.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -87.41 -60.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.426 ' HA ' HG22 ' A' ' 236' ' ' VAL . 1.1 tt0 58.95 96.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -175.09 96.06 0.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.17 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -159.64 -45.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -31.45 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 64.9 m 60.57 -178.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.53 34.95 2.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.74 -178.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.974 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.25 -9.0 17.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.789 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 225' ' ' ILE . 67.0 m 61.74 -90.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.623 0.212 . . . . 0.0 110.77 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.567 HD11 ' CG1' ' A' ' 271' ' ' VAL . 5.9 tp -179.15 35.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.53 -45.19 13.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -157.57 35.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 118.48 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 176.29 8.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 276' ' ' ILE . 3.6 mt -61.83 -31.77 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -74.49 -41.6 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -27.69 66.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -94.79 -17.33 22.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.207 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.32 24.93 10.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 215' ' ' GLU . 22.4 t -89.36 145.18 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -119.08 -61.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 50.3 Cg_exo -55.89 107.33 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.223 1.949 . . . . 0.0 112.299 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.23 -52.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 77.44 -2.82 2.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.768 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -89.55 -23.1 22.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.72 0.295 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.5 -49.74 70.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.701 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.11 -33.44 73.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 320' ' ' LEU . 25.8 mt -80.55 -33.06 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.15 -38.79 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 176' ' ' GLY . 17.4 mt -63.59 -43.95 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.25 -33.51 75.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.511 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.11 -41.83 99.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 252' ' ' ILE . 61.2 m-85 -78.52 -25.69 45.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 111.342 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 3.6 m -56.74 -39.99 74.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.372 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.476 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -68.87 -48.81 62.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.249 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 285' ' ' LEU . 6.1 mt -57.33 -33.45 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.398 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.566 ' HB2' HD21 ' A' ' 259' ' ' LEU . 7.9 tt0 -80.03 -42.7 23.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 0.0 110.928 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.4 m0 -74.1 -24.27 59.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.37 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 151' ' ' ARG . 5.3 mt -96.47 -35.86 10.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.59 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 m -96.2 -14.25 22.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.82 92.27 0.41 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 38.4 m80 61.52 153.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.337 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.882 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -125.21 162.63 42.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.509 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.65 62.13 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 112.424 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.882 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 6.8 p90 176.42 -38.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.468 ' HA ' HD21 ' A' ' 265' ' ' LEU . 1.2 tm-20 -94.26 18.93 10.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.155 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.19 -55.54 13.65 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.5 -28.72 2.26 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.444 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 225' ' ' ILE . 48.0 mt 73.51 10.73 4.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -79.08 -15.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.215 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.473 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.4 m-20 -135.94 101.26 10.54 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.04 16.45 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.674 2.249 . . . . 0.0 112.873 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -79.52 -49.78 11.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.8 p90 -75.83 -29.33 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.567 ' CG1' HD11 ' A' ' 225' ' ' ILE . 6.9 t -62.16 -36.44 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -75.47 -49.3 19.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.19 -35.53 78.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 53.8 m -67.23 -46.14 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.176 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.36 -40.92 96.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 230' ' ' ILE . 12.2 mt -68.24 -35.03 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -81.18 -50.17 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.4 m-85 -58.36 -40.36 82.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.49 -35.44 63.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.744 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -102.83 16.57 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.143 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.93 46.63 1.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.855 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.74 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.6 mt -53.42 -35.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.92 -26.22 60.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.217 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 29.5 t -72.98 -42.55 63.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.502 HD13 HD13 ' A' ' 252' ' ' ILE . 3.2 pp -77.49 -30.79 53.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 7.2 mmt -66.14 -38.65 88.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.639 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -29.79 28.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -82.87 -53.48 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 65.3 m -74.12 -41.19 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 286' ' ' MET . 50.4 m-85 -112.05 152.12 44.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.832 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.57 -46.31 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 54.88 27.83 9.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.43 -31.82 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -106.6 -75.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.021 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.45 110.26 9.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 176.46 6.66 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.378 2.052 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.26 4.85 38.21 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.826 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.06 14.94 5.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 111.297 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.476 HD12 ' SD ' ' A' ' 251' ' ' MET . 30.2 mm -79.44 -43.69 23.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.738 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -49.75 -43.91 48.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.212 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HD2' HG23 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -60.46 -38.58 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.777 ' HA ' HD13 ' A' ' 323' ' ' ILE . 11.2 t80 -71.25 -45.52 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.74 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.3 mtp -61.38 -41.81 97.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -45.52 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.691 ' O ' HD12 ' A' ' 309' ' ' LEU . 33.2 m -62.26 -29.6 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.566 ' HA ' HD12 ' A' ' 309' ' ' LEU . 84.3 t -79.39 -24.0 12.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.343 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 -35.98 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 10.6 tp -110.64 -29.99 7.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.276 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 1.143 HD21 HD22 ' A' ' 316' ' ' LEU . 0.7 OUTLIER 52.36 178.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -158.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.81 59.15 3.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.7 p 65.5 44.82 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.749 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -100.79 148.5 24.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.443 ' HB2' ' HD3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER -81.46 -48.55 1.02 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 314' ' ' LYS . 85.8 Cg_endo -82.01 77.38 3.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.358 2.039 . . . . 0.0 112.639 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 1.143 HD22 HD21 ' A' ' 309' ' ' LEU . 0.5 OUTLIER -91.62 0.23 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.358 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 244' ' ' LEU . 72.9 m-85 -60.72 -30.14 69.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.132 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -39.46 78.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -82.08 -35.98 28.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 323' ' ' ILE . 59.2 mt -57.53 -50.73 72.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.056 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.422 ' HA ' HD21 ' A' ' 159' ' ' LEU . 8.4 ptm180 -56.08 -45.48 79.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.147 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -40.75 79.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.1 mt -58.35 -47.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.669 HD22 HD23 ' A' ' 155' ' ' LEU . 72.4 mt -72.69 -50.85 22.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.011 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -53.01 -49.84 65.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.382 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 -39.33 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.7 71.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 325' ' ' LEU . 13.4 mt -66.73 -38.87 87.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.936 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -61.2 -27.07 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.81 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.9 pt -117.93 20.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.538 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 49.9 43.35 39.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.752 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.1 m -97.95 36.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.05 144.06 45.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.37 114.48 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -167.65 42.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 114.94 28.86 2.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.565 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -126.64 134.37 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER 178.84 -26.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.587 ' O ' HD12 ' A' ' 341' ' ' LEU . 0.7 OUTLIER -53.36 -22.81 8.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.645 0.26 . . . . 0.0 111.528 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.726 HD13 ' CD1' ' A' ' 141' ' ' ILE . 1.2 mp 74.63 24.8 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.763 0.316 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 32.5 t 54.99 33.1 19.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.259 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 340' ' ' ASP . 18.8 m -79.52 -25.33 12.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.35 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 t 67.67 86.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.52 146.38 28.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.13 -59.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 145.34 -44.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.446 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 165.79 -117.36 0.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.35 119.18 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -132.78 -46.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.62 87.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -89.19 -31.56 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 40.6 p -76.03 165.88 24.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 20.0 pt -114.76 -36.07 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 77.8 p -80.23 131.59 35.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -127.01 160.74 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.15 -69.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.05 -179.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.89 89.41 3.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -115.28 -51.71 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.51 127.98 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.56 153.68 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -143.08 77.61 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 59.97 31.31 20.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 99.3 p -113.22 168.95 9.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -140.4 177.42 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.78 88.84 14.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.48 136.04 48.05 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.552 2.168 . . . . 0.0 112.347 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -92.89 -125.88 3.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.7 147.58 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -150.76 37.93 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 61.32 178.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.3 m -150.56 -62.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.9 103.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -145.07 108.27 4.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.2 m -160.8 50.47 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 60.47 105.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 379' ' ' GLN . 1.5 m -86.01 169.91 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLN . . . . . 0.443 ' H ' HG22 ' A' ' 378' ' ' THR . 24.8 mt-30 -76.07 94.35 3.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 8.4 t -81.57 126.43 31.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.49 144.86 31.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -96.81 166.72 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 60.61 178.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.82 126.22 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.51 151.55 41.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.2 p -109.96 89.1 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.66 92.85 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.9 p -117.37 -177.63 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -60.38 144.65 50.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 14.0 p -114.94 -62.94 1.53 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.939 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 61.25 154.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.76 93.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -104.11 124.73 49.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.32 81.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.139 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.14 33.19 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 22.4 t 60.59 -170.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.8 m -123.96 134.82 53.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -156.38 -54.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.27 143.27 31.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.8 m -162.01 110.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -179.86 36.23 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 1.5 mpp? -76.51 -60.92 0.83 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 59.2 Cg_endo -72.31 162.84 40.44 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.153 . . . . 0.0 112.35 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -119.5 -66.39 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.67 -40.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.174 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.39 110.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 85.37 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.67 -174.14 2.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -90.14 108.65 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.86 -31.15 12.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.76 161.39 10.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.12 132.79 25.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.859 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -87.6 95.69 10.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 p -171.42 -178.03 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 t -160.86 139.25 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.0 -44.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -69.56 140.77 53.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.18 31.29 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -131.74 147.69 52.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.52 173.57 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.26 177.7 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.32 -67.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 61.32 90.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.853 ' CE2' HG21 ' A' ' 29' ' ' ILE . 2.9 m-85 -80.58 104.57 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.6 -179.9 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HA2' ' A' ' 40' ' ' GLY . 3.4 m -59.12 145.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.76 -25.29 28.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -112.5 133.56 54.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.012 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mt -100.38 147.86 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.925 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 46.6 pt -116.77 154.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 111.457 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -97.64 141.61 30.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.743 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.34 -162.66 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -36.3 32.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -84.95 5.06 30.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.299 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 11.5 mmtm 79.63 31.36 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.884 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' THR . 9.7 mttp -75.14 177.0 6.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.957 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 80.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.513 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 91.6 m95 -80.1 137.64 36.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.976 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -93.86 119.81 33.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG11 ' C ' ' A' ' 23' ' ' PHE . 40.1 t -71.09 149.6 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -125.03 -146.37 6.8 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.579 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 159.19 31.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.26 168.24 18.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.57 2.18 . . . . 0.0 112.332 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -137.6 79.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.12 -173.62 23.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.479 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.85 105.28 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.758 0.313 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.04 58.56 1.98 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.456 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.714 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -63.44 -107.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.545 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -164.75 -45.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.52 -95.19 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 13.1 m -132.45 66.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 71' ' ' LYS . 8.4 mt -82.27 104.57 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 23' ' ' PHE . 18.8 m-85 -143.6 162.82 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 8.0 mt -78.49 158.41 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -139.03 159.05 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.6 159.64 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.96 41.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.71 82.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 t -114.96 -38.23 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.1 t -127.6 -172.78 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.73 -49.34 75.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 156.84 45.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.68 99.82 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.17 -105.77 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 53.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -165.58 38.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -68.67 142.75 94.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.73 8.79 4.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.692 2.261 . . . . 0.0 113.023 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.2 m -149.69 148.24 29.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.873 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.2 m -120.94 144.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 130' ' ' ILE . 8.9 p -127.27 128.2 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.298 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.72 120.63 39.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.662 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.763 HG22 ' CB ' ' A' ' 128' ' ' PHE . 3.1 t -113.22 152.07 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.939 0.399 . . . . 0.0 111.421 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HB3' ' CB ' ' A' ' 76' ' ' ASP . 7.1 mt-10 -135.85 126.24 16.64 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.56 87.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.478 2.119 . . . . 0.0 112.428 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t 48.97 33.29 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.275 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 2.1 t70 -89.89 161.73 15.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -155.42 145.22 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.82 ' O ' HG23 ' A' ' 82' ' ' THR . . . 135.04 -75.4 0.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -44.59 1.98 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.593 2.195 . . . . 0.0 112.263 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.425 ' HG ' HD23 ' A' ' 84' ' ' LEU . 5.1 tp -77.89 -37.78 47.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -58.52 -29.39 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.012 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 78' ' ' GLY . 67.1 p -75.77 -28.55 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.71 -42.81 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.886 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.4 mm? -68.71 -32.75 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -71.03 -51.78 23.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 73.5 t80 -67.0 -40.81 87.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.946 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.94 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-30 -57.13 -45.12 83.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 73.6 mt-30 -79.89 -17.67 52.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -47.6 19.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.97 -29.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -71.41 3.46 3.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 11.1 mtpt -52.57 159.54 1.65 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.745 0.307 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.22 -32.82 12.32 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.478 2.119 . . . . 0.0 112.288 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.57 -30.02 41.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -75.89 -54.04 7.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.399 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 100' ' ' ILE . 70.5 mt -57.71 -53.23 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.359 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -51.35 -35.66 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.205 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -36.09 78.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -77.08 -42.49 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.7 mt -65.51 -33.17 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -27.67 60.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.1 m -72.6 -36.77 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -5.42 19.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.34 29.68 19.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.886 0.374 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 100' ' ' ILE . 21.7 mt -50.89 -33.52 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.237 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 76.83 -55.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 138.67 50.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.493 HD21 ' CD1' ' A' ' 167' ' ' TYR . 11.0 tp -120.62 -66.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 131.98 -9.83 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.98 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.35 131.05 66.66 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.709 0.255 . . . . 0.0 111.175 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.13 147.56 26.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.273 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -87.33 115.51 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -88.31 126.46 35.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -105.74 -40.72 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.96 -174.62 46.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.623 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -136.58 162.76 32.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -142.46 174.43 23.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.824 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 127' ' ' ARG . 32.2 mt -148.08 159.83 43.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 110.945 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.64 122.1 11.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.028 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.85 118.47 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.22 126.32 22.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.23 20.58 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.527 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.36 -1.3 60.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.94 129.0 43.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.762 0.315 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t -96.22 123.05 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.25 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -106.71 121.28 44.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.488 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.687 ' HA ' HD23 ' A' ' 118' ' ' LEU . 43.5 mtp85 -106.35 125.08 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.4 p90 -139.81 158.76 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.886 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.4 tmm? -128.05 147.21 50.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.647 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.447 HG12 HG23 ' A' ' 70' ' ' VAL . 20.5 mt -121.34 112.73 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.102 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.97 173.41 7.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.169 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.19 148.74 4.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.873 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.9 tpt180 -65.38 155.69 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -128.58 160.01 33.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.29 -110.29 2.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.555 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 p -107.98 125.79 51.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.762 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.743 ' OD1' HD22 ' A' ' 184' ' ' LEU . 10.1 m-20 -58.65 160.34 5.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.813 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.792 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -65.77 -24.35 66.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.591 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 1.2 mt-30 -63.71 -44.29 94.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 110.15 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -60.71 -30.68 70.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.26 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.839 HD13 HD22 ' A' ' 341' ' ' LEU . 40.1 mt -72.87 -25.2 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.762 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 147' ' ' LYS . 76.7 t80 -67.75 -48.85 65.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.619 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.59 -27.96 58.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.741 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.02 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 77.7 m-20 -97.51 -1.8 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.263 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.7 45.34 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.166 0.507 . . . . 0.0 110.345 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 51.7 mttt 61.33 20.91 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.396 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -135.11 107.86 7.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 142' ' ' TYR . 2.0 m-85 -77.93 -172.93 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 154' ' ' VAL . 23.0 t -116.9 150.37 38.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -60.43 -29.4 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.648 ' HG2' HD12 ' A' ' 331' ' ' ILE . 17.3 mtmt -73.81 -43.75 57.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.683 ' CG2' HD23 ' A' ' 341' ' ' LEU . 1.5 m -61.3 -52.04 66.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.43 HG21 ' HG ' ' A' ' 255' ' ' LEU . 46.1 t -54.84 -54.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 328' ' ' LEU . 49.0 mt -62.47 -47.87 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.52 -43.12 93.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.68 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.645 HD22 HG11 ' A' ' 193' ' ' VAL . 22.4 mt -69.1 -35.27 76.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.591 ' OG ' HD21 ' A' ' 247' ' ' LEU . 0.5 OUTLIER -57.32 -42.24 81.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 325' ' ' LEU . 90.5 mt -70.06 -43.19 71.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.726 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -64.27 -49.27 72.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 164' ' ' ILE . 14.2 mt -66.36 -36.23 76.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.54 -36.03 77.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -35.86 74.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.78 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 161' ' ' ILE . 7.0 mt -76.89 -37.3 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.39 -41.85 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.15 -30.96 68.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.696 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.493 ' CD1' HD21 ' A' ' 108' ' ' LEU . 48.5 t80 -70.93 -53.35 15.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.467 HD11 ' CE1' ' A' ' 175' ' ' HIS . 12.1 pt -66.67 -27.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.407 ' N ' HG13 ' A' ' 168' ' ' ILE . 12.3 m170 -75.21 -32.85 61.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.92 -16.96 62.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.58 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -100.47 3.2 42.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 67.71 42.44 2.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.422 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 0.3 OUTLIER -131.64 127.48 37.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.06 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.795 HG11 ' HB3' ' A' ' 239' ' ' SER . 3.7 m -113.57 169.21 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.066 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.709 ' CD2' HD21 ' A' ' 195' ' ' LEU . 18.7 p-80 -147.42 -50.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 53.42 52.83 38.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.646 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.58 28.98 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.253 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.82 106.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.719 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.497 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -153.55 -177.76 6.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.591 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -81.7 -0.08 41.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.293 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 p -109.11 1.23 20.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.44 -6.65 4.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.519 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 184' ' ' LEU . 17.9 mt -108.59 127.98 54.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -134.97 156.82 48.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.164 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.679 HD11 HD13 ' A' ' 341' ' ' LEU . 23.9 mt -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.307 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.26 130.32 42.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 133' ' ' ARG . 6.1 t80 -75.01 -54.41 7.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -21.3 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.506 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -135.89 73.68 59.32 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 102.0 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.526 2.151 . . . . 0.0 112.147 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -177.44 -35.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.844 ' HA ' HD11 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -116.28 -176.77 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -132.56 148.12 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 6.3 m-85 -121.06 156.94 31.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.142 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.709 HD21 ' CD2' ' A' ' 175' ' ' HIS . 60.4 tp -106.62 115.88 30.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.34 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 184' ' ' LEU . 11.1 m -106.64 143.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.58 104.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 175' ' ' HIS . 5.8 m-30 -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.697 ' C ' HD22 ' A' ' 200' ' ' LEU . . . 88.98 -50.66 3.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.398 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 199' ' ' GLY . 2.9 mm? -118.61 -38.72 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.665 0.269 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.37 82.09 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.252 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -118.86 148.96 42.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.422 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 11.0 mtp180 -102.39 70.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.687 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.781 ' CD1' HG13 ' A' ' 174' ' ' VAL . 43.6 p90 -50.85 -48.36 60.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.26 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 77.3 m 58.0 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.405 ' HD3' ' CE2' ' A' ' 204' ' ' TYR . 53.7 Cg_exo -52.15 106.43 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.519 2.146 . . . . 0.0 112.305 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -141.44 83.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 109.58 81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.37 31.15 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.0 -35.97 7.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -87.39 -171.22 3.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -142.44 140.51 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.12 89.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.739 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -127.45 33.3 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -50.61 174.64 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.418 ' CB ' ' CD ' ' A' ' 217' ' ' PRO . 0.3 OUTLIER -178.92 -61.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 216' ' ' ASP . 48.6 Cg_endo -68.78 178.57 3.85 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.41 2.073 . . . . 0.0 112.255 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.38 -41.47 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 40.01 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -37.86 74.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -80.0 -64.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.682 ' HB3' HD11 ' A' ' 200' ' ' LEU . 0.4 OUTLIER 59.59 -168.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.814 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 200' ' ' LEU . . . 116.24 -112.45 2.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -147.47 146.3 29.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.892 HG23 HD22 ' A' ' 265' ' ' LEU . 6.9 tp -68.01 -11.13 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.804 ' HG3' HD11 ' A' ' 265' ' ' LEU . 1.0 OUTLIER -52.47 -36.75 55.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.408 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 62.9 m-85 -157.42 33.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.25 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.727 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -66.53 139.92 57.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.786 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 0.3 OUTLIER -84.6 131.83 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 275' ' ' LYS . 2.6 mt -59.31 -58.85 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.61 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -62.41 -44.19 97.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -57.07 -45.18 83.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -61.82 -27.84 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.632 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.6 t-20 -90.07 -0.1 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.393 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.16 87.2 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.002 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 234' ' ' ASN . 21.2 t -54.13 107.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.56 165.94 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.718 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 36.1 Cg_endo -65.24 148.08 88.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.795 ' HB3' HG11 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -59.46 109.7 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.25 -47.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -67.21 -30.41 70.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.61 91.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.82 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 m-20 -57.16 -32.68 66.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 110.982 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.764 HD21 ' CE2' ' A' ' 317' ' ' TYR . 84.0 mt -80.57 -37.4 31.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -61.71 -37.72 85.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -61.93 -49.28 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.667 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.5 tp -64.8 -40.73 95.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.97 92.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -78.67 -25.88 44.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.15 -39.97 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -50.0 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.761 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.96 -30.56 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.3 tt0 -80.05 -39.94 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.07 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -82.23 -25.8 33.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.381 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 154' ' ' VAL . 16.6 mt -91.22 -44.68 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.223 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.23 0.61 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 65.36 100.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.3 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 3.8 p80 55.67 165.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.888 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -135.38 168.46 17.5 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.507 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 43.2 Cg_endo -68.33 63.33 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.379 2.053 . . . . 0.0 112.457 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.888 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 3.8 p90 175.19 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.013 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -95.21 19.78 10.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.47 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -57.67 4.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 87.0 m-20 -126.91 -26.02 3.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.343 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.892 HD22 HG23 ' A' ' 225' ' ' ILE . 48.4 mt 71.3 12.41 6.72 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.106 0.479 . . . . 0.0 109.822 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -12.89 49.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.196 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 271' ' ' VAL . 29.4 m-20 -124.06 79.63 58.42 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.92 -11.12 29.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.767 2.311 . . . . 0.0 112.597 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -47.65 22.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.069 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -75.3 -26.15 58.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.884 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 261' ' ' TRP . 77.8 t -57.78 -35.22 50.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.591 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -75.59 -41.69 53.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -40.48 82.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.079 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 67.1 m -75.44 -29.93 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.807 ' HB3' HD11 ' A' ' 230' ' ' ILE . 11.6 mmtp -73.54 -45.9 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.069 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.02 -38.57 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -65.12 -52.0 57.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.524 ' CG ' HD12 ' A' ' 285' ' ' LEU . 13.0 m-85 -62.05 -35.12 77.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.444 ' HD3' HD12 ' A' ' 230' ' ' ILE . 0.4 OUTLIER -57.33 -29.28 63.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -118.9 24.0 11.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -140.34 42.52 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 303' ' ' MET . 6.4 mm -47.6 -41.07 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.39 63.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.97 68.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.524 HD12 ' CG ' ' A' ' 278' ' ' TYR . 5.0 tt -64.76 -51.16 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.707 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.574 ' HG3' ' HB2' ' A' ' 300' ' ' ALA . 10.4 mmt -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.734 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.4 -26.54 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -82.76 -52.87 6.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.075 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.92 -41.17 37.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.57 87.38 7.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.41 76.2 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.441 2.094 . . . . 0.0 112.253 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -172.42 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.24 58.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.66 -68.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 296' ' ' PRO . 1.4 mtpp -152.27 101.19 2.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 19.1 Cg_endo -60.2 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.224 1.95 . . . . 0.0 111.975 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -174.86 28.82 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.595 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 68.16 7.01 5.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.502 0.191 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.662 HG22 ' CG ' ' A' ' 303' ' ' MET . 24.3 mm -79.8 -45.7 22.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 110.963 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 286' ' ' MET . . . -44.51 -46.74 9.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.585 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -43.06 89.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.768 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.879 ' CE2' HD11 ' A' ' 324' ' ' LEU . 18.4 t80 -70.56 -46.47 63.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.662 ' CG ' HG22 ' A' ' 299' ' ' ILE . 62.6 mmm -66.06 -37.71 86.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.748 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -42.36 98.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.564 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 42.2 m -67.65 -31.74 71.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 309' ' ' LEU . 66.3 t -79.35 -24.4 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.195 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.33 -40.74 58.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.11 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 310' ' ' ASP . 0.1 OUTLIER -102.79 -27.11 12.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.6 mp 57.23 -82.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 308' ' ' LEU . 12.6 m-20 -166.89 39.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.966 0.413 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.3 t80 61.24 39.99 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m 60.4 31.52 20.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.36 101.86 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.65 139.61 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.31 179.06 6.2 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.596 2.197 . . . . 0.0 112.308 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 319' ' ' ASN . 0.9 OUTLIER -151.01 41.24 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.764 ' CE2' HD21 ' A' ' 244' ' ' LEU . 11.3 m-85 -59.16 -30.09 67.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.75 -47.91 83.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.894 ' HB2' HD22 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -63.67 -35.01 79.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.976 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.922 ' HA ' HD12 ' A' ' 323' ' ' ILE . 57.9 mt -59.57 -42.12 91.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -63.12 -36.39 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.97 73.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 320' ' ' LEU . 20.8 mt -66.26 -49.24 77.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.879 HD11 ' CE2' ' A' ' 302' ' ' TYR . 5.8 mt -76.2 -24.54 54.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.261 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.768 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.6 tt -82.64 -44.75 15.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -59.47 -37.1 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.37 76.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.53 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 159' ' ' LEU . 13.2 mt -59.98 -41.2 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -27.69 61.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.14 -26.29 62.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.31 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.648 HD12 ' HG2' ' A' ' 152' ' ' LYS . 27.7 pt -106.3 -27.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.221 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.21 7.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -65.45 0.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.829 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.91 108.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.442 ' OD2' HD12 ' A' ' 328' ' ' LEU . 5.8 m-20 -70.08 89.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.64 100.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 132.66 -45.45 1.13 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.44 -175.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.307 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' A' ' 192' ' ' GLN . 11.3 mt -104.21 9.9 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.429 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.39 28.02 10.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.692 0.282 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.839 HD22 HD13 ' A' ' 141' ' ' ILE . 32.8 mt -61.06 -33.1 72.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.988 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.2 t 61.1 98.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.862 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.517 HG11 HG12 ' A' ' 141' ' ' ILE . 11.0 m -147.27 86.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 344' ' ' VAL . 18.5 t -92.67 46.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 62.57 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.81 104.18 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.73 164.32 13.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.02 -144.24 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.584 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 350' ' ' LYS . 0.5 OUTLIER -73.06 157.1 37.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.47 ' N ' HD23 ' A' ' 349' ' ' LEU . 0.2 OUTLIER -147.8 129.47 15.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -103.06 179.79 4.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -158.29 149.99 21.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 1.1 m -140.95 137.61 33.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 354' ' ' ILE . 19.0 tt -83.6 114.67 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 43.8 p -143.81 31.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -102.76 151.69 22.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -83.31 167.18 17.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -170.0 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -157.46 133.07 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -157.76 165.44 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.6 145.5 55.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.8 pt -146.18 144.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -115.42 -75.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.84 176.0 7.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.8 t -98.48 86.49 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.32 84.57 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -109.1 158.65 33.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.94 -175.0 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.227 . . . . 0.0 112.228 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 87.54 61.05 1.57 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.475 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 371' ' ' GLU . 15.3 m -138.06 -46.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 370' ' ' VAL . 0.7 OUTLIER -104.51 113.93 27.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -83.1 77.94 9.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.1 t -123.54 79.67 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -138.46 168.04 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 60.33 83.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.5 m 60.64 31.19 20.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.34 149.66 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.6 p -141.19 -46.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.95 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 4.6 m 67.74 39.71 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.89 -48.53 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 59.15 177.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -140.14 105.86 5.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 384' ' ' ILE . 0.9 OUTLIER -76.71 62.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.005 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -123.27 -41.1 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.7 m 63.09 106.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.1 ttm105 -91.46 125.43 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 4.1 p -157.17 82.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.58 160.08 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.8 t -82.77 133.75 35.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.58 -46.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.69 -42.87 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.985 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 61.73 152.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.67 159.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -140.1 -48.29 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.0 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.894 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 6.8 p -82.85 -61.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.3 m -93.94 93.71 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -172.64 120.93 0.84 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.5 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -68.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.8 p -73.98 168.45 19.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 111.12 52.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -178.87 -60.97 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 1' ' ' MET . 37.3 Cg_endo -65.85 78.13 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.391 2.061 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -94.29 173.69 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.95 -43.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -146.35 141.37 27.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -173.7 -70.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.69 127.88 48.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.04 159.21 5.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.51 -50.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.19 123.65 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -71.17 -42.4 69.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.78 7.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.09 82.49 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.9 p -95.7 -28.63 14.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 63.3 160.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE2' HD11 ' A' ' 19' ' ' LEU . 3.7 mmpt? -125.27 149.7 47.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -119.18 -58.2 1.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -164.13 -58.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.559 HD11 ' HE2' ' A' ' 16' ' ' LYS . 1.8 mt 60.46 31.68 20.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.89 77.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.26 -70.25 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -152.73 -66.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.593 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 5.4 m-85 -117.44 152.06 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . . . -147.31 -176.0 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.84 143.64 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.82 26.36 69.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.548 ' O ' HD13 ' A' ' 28' ' ' ILE . 14.8 mm-40 -92.1 170.53 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.548 HD13 ' O ' ' A' ' 27' ' ' GLU . 26.7 mm -126.28 126.26 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.228 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.962 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 36.3 pt -116.87 154.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 t -95.56 141.48 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.916 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -160.81 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.04 -39.12 26.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.156 0.503 . . . . 0.0 109.895 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -84.42 2.83 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 7.4 mttt 86.08 30.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.47 178.62 5.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -130.63 80.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.2 m95 -78.19 144.93 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.004 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG2' HD13 ' A' ' 28' ' ' ILE . 11.5 mtpp -97.28 148.22 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.58 127.64 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.81 -143.13 12.23 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.54 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.47 152.55 39.34 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.45 165.96 2.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.294 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.769 HG13 HG22 ' A' ' 51' ' ' ILE . 14.3 pt -154.42 29.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.48 -163.69 24.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.393 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.17 171.25 9.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.95 68.38 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.531 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.17 28.03 0.89 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.55 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -138.82 -56.06 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.81 -103.25 0.16 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 97.9 m -143.76 84.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.769 HG22 HG13 ' A' ' 43' ' ' ILE . 28.9 mm -92.56 83.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -119.93 172.1 7.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.4 165.88 19.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -130.75 150.22 52.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' CB ' HG22 ' A' ' 62' ' ' VAL . 26.1 t0 -139.89 157.06 46.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.5 57.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.92 94.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.25 -172.16 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -75.65 -38.88 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.74 -68.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -155.48 161.86 40.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 66' ' ' ALA . 21.6 t -74.76 114.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.96 -69.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -119.06 32.03 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.72 87.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -167.62 80.9 0.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.11 49.55 3.17 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.708 2.272 . . . . 0.0 112.642 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.2 m -149.79 148.23 28.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 43' ' ' ILE . 16.9 m -122.96 144.98 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 130' ' ' ILE . 8.0 p -132.94 129.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.156 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.54 124.09 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.665 HG22 ' CB ' ' A' ' 128' ' ' PHE . 2.6 t -113.15 139.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -141.15 144.0 33.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.705 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.92 109.09 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.484 2.122 . . . . 0.0 112.289 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 t -57.83 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.21 -49.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -167.46 110.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.5 39.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.563 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HG3' HD12 ' A' ' 200' ' ' LEU . 71.6 Cg_endo -77.14 -0.77 10.93 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.634 2.222 . . . . 0.0 112.729 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.91 -41.97 92.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -48.92 73.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.502 HG22 ' HA2' ' A' ' 199' ' ' GLY . 6.6 m -75.08 -36.47 61.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.63 -53.04 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HG3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -62.71 -35.6 80.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.871 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 51.1 t80 -65.15 -37.97 89.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.941 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.0 m-85 -55.87 -53.33 58.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -17.35 53.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.605 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.31 -47.56 12.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -128.19 -24.11 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -90.6 23.05 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -70.91 130.08 88.84 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.81 -24.72 76.95 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.459 2.106 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.43 -35.8 39.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.965 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -79.38 -50.24 11.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 91' ' ' ALA . 48.8 mt -62.58 -57.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -50.18 -55.33 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.359 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -31.37 63.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -77.32 -49.71 14.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 106' ' ' LYS . 22.2 mt -75.04 -23.26 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.876 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -27.36 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.626 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.9 p -77.98 -11.05 59.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.358 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 78.18 13.87 1.55 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -83.36 -14.53 52.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.449 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 105' ' ' LEU . 5.0 mt -111.28 -51.46 2.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 100' ' ' ILE . 1.0 OUTLIER 76.14 -56.55 0.58 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CG ' ' NE2' ' A' ' 192' ' ' GLN . 41.1 t80 -145.33 145.03 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 167' ' ' TYR . 11.1 tp -126.12 -43.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 95.41 -7.69 68.89 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.741 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' HG ' ' A' ' 108' ' ' LEU . 35.6 t -78.04 136.64 61.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.72 0.26 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 110' ' ' VAL . 20.1 Cg_endo -60.61 143.46 99.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.457 2.105 . . . . 0.0 112.239 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -84.96 115.65 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.455 ' CE1' HD21 ' A' ' 84' ' ' LEU . 40.0 t80 -89.03 126.76 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -103.48 -40.63 6.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.01 -178.37 45.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.614 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.1 t -132.62 161.15 34.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.64 0.257 . . . . 0.0 110.523 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.05 170.65 30.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.802 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 127' ' ' ARG . 1.8 mt -137.91 159.14 42.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.782 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.77 125.16 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.019 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 130.78 46.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -138.2 126.29 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.13 17.15 6.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.41 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.94 -11.42 55.97 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.922 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -96.09 129.03 43.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 t -93.45 131.67 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -113.0 151.01 31.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.623 ' HA ' HD23 ' A' ' 118' ' ' LEU . 31.7 ttm180 -116.56 132.22 56.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.962 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 17.1 p90 -141.24 159.89 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.464 ' HG3' HD21 ' A' ' 84' ' ' LEU . 1.9 ttm -128.17 145.74 50.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 29' ' ' ILE . 16.3 mt -120.2 111.54 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -123.49 173.3 8.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.69 134.52 24.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 145.52 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.648 ' CD2' HD12 ' A' ' 184' ' ' LEU . 48.6 m-85 -109.27 166.38 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.28 -100.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.503 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 m -125.41 127.61 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.887 ' OD1' HD22 ' A' ' 184' ' ' LEU . 2.1 m-20 -56.67 159.56 3.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -65.65 -20.16 66.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.492 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.581 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 2.4 mt-30 -51.09 -32.74 23.34 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 121.062 0.458 . . . . 0.0 110.335 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -30.89 51.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.132 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 138' ' ' LEU . 30.6 mt -76.69 -25.16 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 147' ' ' LYS . 12.1 t80 -77.88 -45.32 24.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.552 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -29.59 62.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.31 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -99.67 9.06 43.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.018 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.24 49.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.143 0.497 . . . . 0.0 110.02 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 258' ' ' HIS . 0.1 OUTLIER 62.55 21.4 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.132 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -120.74 161.1 22.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.668 ' HE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -146.41 143.39 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 144.39 37.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HG2' HD21 ' A' ' 255' ' ' LEU . 6.6 mtm-85 -56.4 -26.35 52.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -73.85 -41.95 61.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.668 HG21 ' HE1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -62.83 -45.72 91.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 251' ' ' MET . 39.8 t -62.21 -54.09 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.251 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 328' ' ' LEU . 97.7 mt -57.32 -48.13 79.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.31 -50.71 70.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.644 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.832 HD11 HD21 ' A' ' 341' ' ' LEU . 18.4 mt -61.52 -41.01 96.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 324' ' ' LEU . 66.3 m -55.62 -41.26 73.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.67 -49.2 76.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.427 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.466 ' HD3' HD23 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -61.76 -47.24 86.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.763 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 178' ' ' ILE . 15.5 mt -64.99 -37.61 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 165' ' ' LEU . 6.9 mt -58.14 -37.8 75.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.94 -31.96 70.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.4 mt -74.42 -45.54 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.782 HD21 HD11 ' A' ' 178' ' ' ILE . 15.8 mt -60.02 -45.37 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 2.6 mt-10 -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.788 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.843 ' CE2' HD21 ' A' ' 108' ' ' LEU . 25.3 t80 -75.22 -48.99 20.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.871 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 27.0 pt -74.04 -38.8 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.666 ' CD2' HG12 ' A' ' 174' ' ' VAL . 18.2 t-80 -68.73 -25.18 64.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -98.0 -1.34 42.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.306 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.26 -58.38 1.9 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.717 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 204' ' ' TYR . 0.5 OUTLIER 168.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.473 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 86' ' ' PHE . 64.9 m-85 -159.51 126.37 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 0.0 110.996 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.666 HG12 ' CD2' ' A' ' 169' ' ' HIS . 30.4 m -132.55 147.5 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.433 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 38.7 t-80 77.79 47.07 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -58.81 -18.41 39.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.861 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 195' ' ' LEU . 7.2 t70 74.52 97.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.838 0.351 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.782 HD11 HD21 ' A' ' 165' ' ' LEU . 3.9 mp -97.32 114.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.759 ' O ' HD12 ' A' ' 183' ' ' LEU . 4.7 tmtm? -148.02 179.44 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.581 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -83.72 0.75 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -115.21 2.16 14.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.476 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.802 ' O ' HG22 ' A' ' 196' ' ' VAL . 20.0 m-20 -125.51 -7.49 6.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.556 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.29 113.61 26.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.113 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.887 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -119.04 148.0 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.191 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 141' ' ' ILE . 40.5 mt -86.69 148.53 25.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.212 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.72 127.48 31.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.58 -41.5 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.777 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -77.24 -23.64 51.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.822 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.09 61.67 12.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.57 114.86 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.651 2.234 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -177.49 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.815 ' HA ' HD11 ' A' ' 339' ' ' LEU . 3.2 mt-30 -131.2 177.26 7.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.795 HG21 HD21 ' A' ' 138' ' ' LEU . 9.9 p -121.08 147.33 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.44 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 3.6 m-85 -113.62 150.6 32.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 178' ' ' ILE . 30.1 tp -104.14 117.61 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 182' ' ' ASN . 9.2 m -92.17 -179.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.57 93.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -117.72 -49.82 2.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.706 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 82' ' ' THR . . . -59.06 -21.06 52.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -84.86 3.61 37.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.473 0.178 . . . . 0.0 111.421 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 174' ' ' VAL . . . -92.5 -109.61 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 174' ' ' VAL . 46.0 t80 -146.32 118.13 8.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 110.435 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 12.9 ptt180 -90.25 77.79 6.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.317 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 172' ' ' GLU . 8.3 p90 -72.2 1.14 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.183 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.9 OUTLIER -42.59 -48.66 13.1 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 203' ' ' ARG . 22.9 Cg_exo -64.85 159.68 44.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.606 2.204 . . . . 0.0 112.37 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -87.45 -37.3 17.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.734 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.32 79.23 0.13 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.78 -53.23 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 0.0 110.983 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -108.65 149.06 29.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 61.07 90.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.1 -65.29 1.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -82.84 148.15 27.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -131.94 -68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.503 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.5 OUTLIER 60.71 39.58 17.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.766 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -100.45 97.32 6.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.9 82.63 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.426 2.084 . . . . 0.0 112.285 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -142.78 37.56 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 61.93 47.33 6.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 5.5 t -79.66 -51.04 9.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.67 82.88 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -101.93 -35.68 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.71 -75.06 1.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.545 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 228' ' ' THR . 0.6 OUTLIER -158.49 133.9 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.925 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.901 HG23 HD22 ' A' ' 265' ' ' LEU . 7.1 tp -65.63 -13.41 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.443 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.95 -51.03 25.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.742 0.306 . . . . 0.0 111.348 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -145.56 31.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.224 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 225' ' ' ILE . 12.9 t -56.87 116.52 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.319 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 t -57.47 163.31 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mt -60.76 -37.73 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.34 -31.32 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.06 -36.5 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.22 -32.16 73.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -92.2 12.95 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.263 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.39 24.07 55.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.611 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 215' ' ' GLU . 28.8 t -67.87 136.42 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 238' ' ' PRO . . . -68.98 -62.45 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 237' ' ' ALA . 21.5 Cg_endo -61.2 125.6 17.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.508 2.138 . . . . 0.0 112.353 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.6 OUTLIER -164.95 121.16 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -127.51 -44.25 1.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -8.21 55.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.51 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.61 -49.71 71.35 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.2 p30 -60.36 -34.44 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.374 . . . . 0.0 111.054 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.415 ' CD1' HD13 ' A' ' 309' ' ' LEU . 77.0 mt -78.03 -33.42 51.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.03 -37.28 87.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -65.29 -45.76 92.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.773 HD23 ' OH ' ' A' ' 302' ' ' TYR . 29.2 tp -62.0 -37.23 84.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.87 -43.78 97.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.606 ' HA ' HD12 ' A' ' 252' ' ' ILE . 28.6 m-85 -78.52 -25.65 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 254' ' ' TRP . 6.0 m -56.65 -38.41 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.279 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.413 ' CG ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -69.85 -48.96 56.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.086 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.912 ' O ' HG22 ' A' ' 256' ' ' THR . 5.0 mt -59.59 -51.74 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.178 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.593 ' HB3' HD21 ' A' ' 259' ' ' LEU . 1.1 pt20 -63.55 -28.61 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 20.7 m0 -82.35 -28.49 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.267 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 151' ' ' ARG . 82.8 mt -86.75 -41.68 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 252' ' ' ILE . 15.0 t -96.23 0.56 51.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.498 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.8 97.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.499 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 147' ' ' LYS . 5.1 m-70 64.16 166.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.903 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -132.29 162.44 56.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.7 Cg_endo -67.44 64.19 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.361 2.041 . . . . 0.0 112.433 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.903 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 2.3 p90 177.19 -36.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.169 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.6 tt0 -88.14 10.71 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.536 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.89 -48.13 82.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.9 t-20 -130.54 -29.22 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.387 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.901 HD22 HG23 ' A' ' 225' ' ' ILE . 85.9 mt 71.97 11.64 6.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -14.37 54.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.418 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.467 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -136.89 87.4 19.56 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.104 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 24.7 Cg_exo -63.01 -10.61 21.17 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.68 2.253 . . . . 0.0 112.484 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -49.81 -50.22 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.331 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.4 p90 -81.12 -26.17 36.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 225' ' ' ILE . 50.5 t -61.62 -40.89 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.044 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -75.55 -45.06 40.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.06 -46.97 84.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 59.1 m -58.56 -43.59 89.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -41.7 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.582 HG23 ' NH1' ' A' ' 279' ' ' ARG . 20.3 mt -77.47 -28.98 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.376 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -81.36 -52.17 7.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.608 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 285' ' ' LEU . 4.9 m-85 -64.0 -40.57 96.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.642 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.582 ' NH1' HG23 ' A' ' 276' ' ' ILE . 0.2 OUTLIER -52.1 -26.57 11.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.939 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -113.83 17.76 17.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.34 35.57 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.717 HD13 ' CB ' ' A' ' 303' ' ' MET . 20.5 mt -47.24 -48.61 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.53 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.78 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.196 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 252' ' ' ILE . 0.8 OUTLIER -68.57 -37.82 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.424 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.546 ' HG2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -65.06 -40.22 94.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.725 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -23.3 42.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -82.66 -54.03 5.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.205 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.3 m -79.25 -41.21 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.415 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.29 149.75 39.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -48.65 20.73 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.526 2.151 . . . . 0.0 112.267 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.46 31.1 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -30.84 23.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -170.58 119.59 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm 59.44 97.75 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 -167.47 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.253 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.16 11.49 69.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.878 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 71.0 10.41 6.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.686 0.243 . . . . 0.0 111.341 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.534 HG22 ' CG ' ' A' ' 303' ' ' MET . 37.4 mm -79.59 -45.79 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.788 0.328 . . . . 0.0 110.824 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 286' ' ' MET . . . -44.86 -43.32 8.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.449 ' CB ' HG23 ' A' ' 323' ' ' ILE . 61.3 mttt -60.24 -43.99 95.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.533 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.864 ' O ' HG23 ' A' ' 306' ' ' VAL . 43.2 t80 -68.53 -39.41 81.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.717 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.6 mtp -68.43 -37.29 80.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.342 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.04 -50.22 74.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 2.2 p -59.08 -41.26 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 302' ' ' TYR . 18.0 t -65.19 -24.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.121 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -77.24 -39.77 47.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.222 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -17.41 56.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.091 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.8 OUTLIER -69.59 115.43 8.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.704 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -141.71 -48.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.184 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -166.03 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.272 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 25.1 p -84.79 8.22 17.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -126.77 36.17 4.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.408 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 6.4 mtpp -59.05 -60.99 8.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.8 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 73.4 Cg_endo -74.73 60.62 5.26 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.541 2.161 . . . . 0.0 112.274 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 17.7 tp -118.84 -1.26 11.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.398 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 166' ' ' GLU . 79.8 m-85 -57.58 -32.37 67.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.857 0.361 . . . . 0.0 111.003 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.0 -37.63 87.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -46.04 63.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.838 ' HA ' HD12 ' A' ' 323' ' ' ILE . 36.3 mt -54.87 -45.59 74.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -32.41 65.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -38.19 45.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 320' ' ' LEU . 56.9 mt -54.81 -44.49 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' A' ' 158' ' ' SER . 38.4 mt -75.4 -49.94 17.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -54.42 -49.84 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.361 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -53.4 -39.44 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -26.56 70.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.923 HD12 HD23 ' A' ' 325' ' ' LEU . 17.1 mt -65.2 -40.5 94.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -74.46 -27.28 60.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.86 -27.42 68.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.46 -28.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.62 5.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 33.6 t -90.9 152.64 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.72 91.7 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.72 145.9 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.43 32.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.49 0.46 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -82.3 157.83 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.815 HD11 ' HA ' ' A' ' 192' ' ' GLN . 2.3 mt -97.4 16.18 20.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 153' ' ' THR . 0.5 OUTLIER 56.96 39.94 29.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.207 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.832 HD21 HD11 ' A' ' 157' ' ' LEU . 66.5 mt -83.94 -43.19 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.1 m 58.35 96.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.001 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.627 HG11 HG12 ' A' ' 141' ' ' ILE . 5.6 m -149.67 71.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 18.4 t 60.22 60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 59.86 166.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -124.5 -46.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -76.63 153.92 43.08 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 109.58 -158.33 14.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.2 mt -139.21 -47.84 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 153.88 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -92.41 -48.29 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.046 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.2 tttt 60.12 30.92 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 353' ' ' THR . 6.8 m -161.53 31.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.972 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 354' ' ' ILE . 0.5 OUTLIER -143.2 112.7 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 85.45 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 63.92 -78.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.026 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 -44.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.965 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -176.38 -64.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 140.04 29.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.83 -43.77 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.12 146.04 50.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.821 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.2 tt -109.67 141.85 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -129.83 112.23 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.13 109.41 5.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 4.0 m -73.31 150.02 42.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -70.24 92.63 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -89.32 152.06 47.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.27 136.34 31.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.312 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -178.14 53.51 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.526 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.789 HG23 ' HG3' ' A' ' 371' ' ' GLU . 27.7 m -73.74 -31.38 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.128 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLU . . . . . 0.789 ' HG3' HG23 ' A' ' 370' ' ' VAL . 26.8 mt-10 -100.25 161.27 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 60.29 -179.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.8 p -128.8 121.37 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -76.57 -52.85 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.966 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.16 145.18 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.04 177.97 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.53 98.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 3.4 m 60.0 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -158.26 103.85 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 p -96.35 155.19 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -145.71 -47.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -114.67 151.42 33.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -157.4 108.58 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.614 HD11 ' O ' ' A' ' 386' ' ' THR . 0.0 OUTLIER -169.68 124.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLN . . . . . 0.584 ' N ' HD13 ' A' ' 384' ' ' ILE . 14.5 mt-30 -118.5 -41.17 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' THR . . . . . 0.614 ' O ' HD11 ' A' ' 384' ' ' ILE . 81.4 p -81.73 123.84 29.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -135.16 174.06 11.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 30.0 m 60.75 95.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 60.35 -176.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.35 36.01 20.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.66 90.86 5.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -171.04 125.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.89 133.69 51.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.35 157.71 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 -47.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 71.3 m -60.31 164.35 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.03 -179.67 5.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 117.38 -160.87 13.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.4 m -127.14 -64.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 69.2 m -126.7 136.31 52.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -169.82 59.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.505 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 60.22 90.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.245 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.35 167.28 24.36 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.512 2.141 . . . . 0.0 112.295 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -119.21 107.97 14.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 4' ' ' VAL . 14.3 p -106.5 116.01 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.4 tttp 59.9 88.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 -52.71 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.74 -68.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -106.91 160.29 15.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.84 150.38 25.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.29 -132.32 4.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.55 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -85.01 120.09 26.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -105.12 103.57 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.9 p -104.22 170.33 7.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.8 p -80.32 -69.31 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.9 30.78 20.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.091 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -148.45 153.07 38.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 60.15 68.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.1 107.94 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -138.28 -46.45 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.29 166.98 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -86.05 -77.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.779 ' CE2' HG21 ' A' ' 29' ' ' ILE . 5.9 m-85 -115.01 75.95 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.09 -169.66 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -91.49 123.56 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.95 -27.2 7.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.592 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -82.45 143.07 31.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 36' ' ' GLU . 23.6 mt -100.43 142.42 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.8 pt -113.7 154.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 62.2 m -95.51 140.98 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -97.16 -162.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.109 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.94 -42.12 40.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 109.811 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -79.36 -0.05 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.5 mtpt 84.61 29.04 0.06 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 6.0 mttt -74.49 -179.86 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.576 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.7 mt-10 -128.32 79.63 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.409 ' HB2' HG13 ' A' ' 29' ' ' ILE . 31.0 m95 -74.78 143.24 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.756 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 126.6 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG2' HG23 ' A' ' 29' ' ' ILE . 22.9 t -75.87 147.18 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -105.98 -151.77 19.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.706 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 25' ' ' VAL . 3.8 mt -87.01 157.47 54.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 111.018 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.27 144.74 92.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.596 2.197 . . . . 0.0 112.282 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.1 pt -142.22 -42.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.222 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.3 -104.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.547 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -71.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.56 -70.12 0.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.531 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -66.69 2.28 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -96.19 42.06 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.83 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 51' ' ' ILE . . . 165.73 87.99 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.429 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.23 57.98 4.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 110.813 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.525 HD12 ' C ' ' A' ' 49' ' ' GLY . 3.9 mp -91.99 112.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.305 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.57 169.56 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.8 mt -73.49 158.15 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.619 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -121.07 150.91 40.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.349 . . . . 0.0 111.338 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -137.77 157.57 46.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -97.06 30.8 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.51 104.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -137.77 -65.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -103.69 -178.19 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.97 -34.58 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -142.94 159.23 42.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 5.9 t -89.88 160.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 62' ' ' VAL . . . 130.51 46.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.538 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -163.66 -45.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -143.61 67.85 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -117.74 80.09 13.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' CB ' ' HE2' ' A' ' 188' ' ' LYS . 86.8 Cg_endo -82.82 48.27 2.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.748 2.299 . . . . 0.0 112.699 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.885 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 2.2 m -149.81 153.31 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.815 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 133' ' ' ARG . 23.4 m -130.15 144.85 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.044 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG12 ' A' ' 130' ' ' ILE . 7.3 p -135.75 124.81 39.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -104.4 123.38 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.499 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 23' ' ' PHE . 5.0 t -113.07 135.17 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.466 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -141.21 150.62 59.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.579 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.51 118.87 5.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.495 2.13 . . . . 0.0 112.209 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -55.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t0 61.58 98.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.02 94.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.06 151.33 20.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.28 35.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.486 2.124 . . . . 0.0 112.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 84' ' ' LEU . 15.8 tp -64.77 -37.64 88.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.7 -41.31 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 7.3 p -72.84 -32.22 65.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.03 -40.73 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.808 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -61.51 -51.65 67.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -57.72 -43.75 85.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.6 t80 -63.67 -31.61 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.3 m-85 -71.65 -60.29 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.66 -17.89 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.375 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -47.37 60.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.23 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.91 -37.41 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.871 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -54.99 -21.21 11.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 123.12 8.55 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.993 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.92 -25.64 12.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.556 2.171 . . . . 0.0 112.466 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.91 -35.92 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -79.4 -39.76 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.833 HG22 HD11 ' A' ' 100' ' ' ILE . 34.0 mt -65.42 -57.61 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -32.15 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.178 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' THR . 53.0 mttt -76.15 -32.93 59.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -77.16 -38.21 52.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.833 HD11 HG22 ' A' ' 96' ' ' ILE . 18.2 mt -69.69 -37.5 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.13 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -74.94 -27.78 60.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.254 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 98' ' ' LYS . 22.6 p -84.36 -34.02 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.335 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -2.24 24.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 58.61 31.05 20.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.637 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 100' ' ' ILE . 56.9 mt -51.59 -25.64 7.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tptp 78.52 -55.6 0.47 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 108' ' ' LEU . 19.9 t80 -152.79 163.51 39.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 167' ' ' TYR . 3.4 tp -139.85 -168.02 2.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.38 28.4 2.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.433 HG13 ' HD2' ' A' ' 111' ' ' PRO . 25.0 t -101.92 136.49 19.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.588 0.232 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.733 ' HG3' HG12 ' A' ' 196' ' ' VAL . 18.0 Cg_endo -59.48 151.82 66.1 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.608 2.206 . . . . 0.0 112.291 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.8 115.53 23.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -92.5 115.35 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -92.84 -40.46 10.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.745 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.17 -175.98 46.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.405 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.6 t -137.92 165.89 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.666 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.34 177.2 28.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.583 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.487 HD21 ' NE ' ' A' ' 127' ' ' ARG . 2.3 mp -147.83 159.86 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 111.019 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -141.89 141.74 33.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -111.41 130.29 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -138.23 126.26 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.79 23.86 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.9 10.66 61.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.819 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.15 159.2 15.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.17 122.19 46.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.406 ' O ' HD23 ' A' ' 118' ' ' LEU . 16.1 m-85 -114.23 141.43 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.487 ' NE ' HD21 ' A' ' 118' ' ' LEU . 3.0 ttm180 -126.9 126.72 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.806 ' CE1' HD12 ' A' ' 29' ' ' ILE . 35.1 p90 -136.26 161.73 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.683 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.0 tmm? -128.06 145.83 50.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.645 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 70' ' ' VAL . 13.9 mt -121.52 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -132.36 173.29 11.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.8 139.58 26.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.081 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HG3' HG13 ' A' ' 69' ' ' VAL . 7.0 ttt180 -71.84 151.5 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -115.48 167.4 10.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.39 -64.07 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 p -154.33 156.71 37.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.466 ' CG ' HD22 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -77.77 153.25 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.711 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.4 mm? -60.78 -25.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.734 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.722 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 11.2 tt0 -70.33 -44.37 68.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -60.77 -28.53 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 138' ' ' LEU . 35.5 mt -74.56 -28.33 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 t80 -57.28 -46.28 83.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.58 -25.97 67.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.078 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 345' ' ' GLU . . . -77.09 -17.36 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.475 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.2 m120 -94.95 -3.04 49.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 98.78 43.15 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.043 0.537 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 59.79 20.35 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 5.8 mtp180 -169.89 128.04 0.9 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.928 0.394 . . . . 0.0 111.141 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.788 ' CD1' HG21 ' A' ' 153' ' ' THR . 1.1 m-85 -81.26 -175.45 5.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -115.76 169.34 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' HD21 ' A' ' 255' ' ' LEU . 25.1 mtm180 -57.91 -29.9 65.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.788 HG21 ' CD1' ' A' ' 149' ' ' PHE . 23.6 m -60.84 -55.31 34.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.86 HG21 ' HG ' ' A' ' 255' ' ' LEU . 34.9 t -56.75 -52.37 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.579 ' HB3' HD21 ' A' ' 328' ' ' LEU . 23.3 mt -59.27 -41.27 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -64.82 -44.38 90.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.67 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 341' ' ' LEU . 32.5 mt -70.73 -32.73 70.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.56 ' CB ' HD13 ' A' ' 324' ' ' LEU . 1.4 t -62.85 -41.18 99.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 325' ' ' LEU . 11.3 mt -72.36 -33.67 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -70.56 -49.49 47.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.3 mt -61.32 -41.9 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.971 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.674 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.5 mt -60.26 -40.9 91.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.711 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.69 -32.92 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.526 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 161' ' ' ILE . 10.6 mt -79.74 -40.18 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.707 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 162' ' ' LEU . 22.9 mt -55.85 -38.76 70.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.85 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -32.67 74.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 108' ' ' LEU . 80.3 t80 -74.09 -52.51 12.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.778 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 165' ' ' LEU . 8.0 pt -67.66 -27.16 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.271 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 165' ' ' LEU . 1.3 m-70 -80.33 -32.29 37.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.595 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.97 -17.01 62.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -104.36 5.98 34.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.024 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 73.52 46.28 0.22 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.385 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.453 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.1 m-85 -137.06 129.12 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 202' ' ' TYR . 19.3 m -112.17 164.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 195' ' ' LEU . 3.5 t60 -120.01 -66.02 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.28 43.93 93.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -162.84 36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.905 0.383 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.8 mt -74.7 114.24 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -177.92 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.054 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.722 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -80.07 -2.57 44.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.594 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.6 t -106.37 0.05 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.107 0.479 . . . . 0.0 110.57 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.76 -11.24 7.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.074 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.4 mt -108.32 113.77 27.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.616 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 137' ' ' ASP . 1.7 mt -116.99 168.38 10.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.856 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.619 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.9 mt -106.56 149.48 27.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.95 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 0.7 OUTLIER -89.51 142.96 27.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 109.941 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.1 -26.7 5.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.4 ' HE2' ' CB ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -55.62 -25.23 37.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.2 -58.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.425 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HB2' ' CB ' ' A' ' 186' ' ' ASN . 96.0 Cg_exo -37.45 -60.43 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.026 2.484 . . . . 0.0 113.538 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 0.5 OUTLIER 82.32 -4.45 1.43 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.51 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.631 ' HA ' HD11 ' A' ' 339' ' ' LEU . 0.5 OUTLIER -89.57 -166.88 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.0 p -109.93 145.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 7.8 m-85 -124.38 156.95 36.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.857 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.521 ' HG ' ' CE1' ' A' ' 175' ' ' HIS . 14.9 tp -105.4 115.93 31.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.625 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.0 m -130.97 170.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.2 t70 56.17 88.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.1 m-85 -81.8 -33.88 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.624 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 63.5 14.47 54.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.797 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.26 -49.69 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 46.81 87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.411 ' HB3' ' CG2' ' A' ' 174' ' ' VAL . 0.2 OUTLIER -117.16 135.82 53.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 15.3 ttp-105 -103.49 50.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 52.77 24.88 3.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 52.65 89.17 0.1 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.08 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.48 -38.27 63.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.562 2.175 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.1 86.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.36 52.91 0.61 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t 61.31 93.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.79 0.329 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -74.08 77.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -135.08 76.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.5 157.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -166.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.563 ' HA ' HG22 ' A' ' 236' ' ' VAL . 10.7 mmtt 58.13 93.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -73.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -177.71 83.43 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.92 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.541 2.161 . . . . 0.0 112.267 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.89 -60.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -124.16 30.99 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 16.1 m 59.24 -177.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -113.43 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.75 144.81 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -95.82 36.06 4.02 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.485 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 69.1 p -150.97 -176.46 5.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.887 HG23 HD22 ' A' ' 265' ' ' LEU . 2.0 tp -148.45 27.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -102.45 -28.25 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.676 ' HB3' HG23 ' A' ' 246' ' ' ILE . 82.5 m-85 -148.93 30.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.3 m -68.65 122.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.4 t -69.88 169.56 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.46 -32.07 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -33.51 60.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -74.0 -31.66 63.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -25.55 65.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 12.87 16.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.321 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.21 69.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 214' ' ' LYS . 22.1 t -88.81 152.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.34 . . . . 0.0 111.119 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.03 109.41 16.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.29 177.44 4.54 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.384 2.056 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.6 m -150.55 -59.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -47.27 1.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -59.2 -29.67 67.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -64.99 -49.66 61.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.698 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 p30 -70.6 -42.03 71.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.24 -31.69 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -39.88 78.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 243' ' ' ASP . 9.2 mt -66.7 -35.97 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' OH ' ' A' ' 302' ' ' TYR . 33.3 tp -70.8 -38.84 73.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -63.93 -35.77 92.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.54 -25.8 45.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 111.022 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 10.4 m -65.02 -32.92 74.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.035 0.445 . . . . 0.0 110.468 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.615 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -59.01 -52.69 64.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.055 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.64 HG12 HD13 ' A' ' 285' ' ' LEU . 4.1 mp -68.32 -28.67 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.714 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -75.34 -41.84 55.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 111.473 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.407 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 40.8 m0 -82.27 -24.89 34.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.788 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.86 ' HG ' HG21 ' A' ' 154' ' ' VAL . 72.2 mt -93.16 -37.37 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 289' ' ' CYS . 3.1 m -96.12 -12.68 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 75.04 87.8 0.25 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 64.98 158.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 110.683 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.4 OUTLIER -132.63 160.34 68.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 37.5 Cg_endo -65.92 66.06 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.549 2.166 . . . . 0.0 112.85 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.7 p90 178.34 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.288 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.741 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -98.53 21.99 10.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.214 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -56.09 9.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 69.4 m-20 -125.96 -27.09 3.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.887 HD22 HG23 ' A' ' 225' ' ' ILE . 69.2 mt 70.19 12.74 7.7 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.02 -14.83 43.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.118 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.449 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.9 m-20 -134.33 98.32 14.03 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.03 17.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.698 2.265 . . . . 0.0 112.83 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -80.09 -46.95 15.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.7 p90 -79.27 -26.73 42.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 261' ' ' TRP . 26.7 t -61.43 -37.79 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.189 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.543 ' O ' HD12 ' A' ' 276' ' ' ILE . 5.3 ttp-105 -75.51 -45.54 37.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.237 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -67.19 -37.91 84.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.1 m -68.3 -43.41 77.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -52.42 64.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 272' ' ' ARG . 7.1 mt -60.38 -33.27 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.561 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -81.05 -49.57 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.23 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -62.8 -36.78 84.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -54.2 -29.63 46.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.877 0.37 . . . . 0.0 110.645 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.0 19.52 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.39 41.58 2.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.816 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 303' ' ' MET . 23.5 mt -53.17 -38.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.7 64.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -40.76 85.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.028 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.64 HD13 HG12 ' A' ' 252' ' ' ILE . 3.6 pp -75.54 -28.43 59.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -45.09 91.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.93 -27.4 33.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.373 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -82.76 -33.06 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.691 0.281 . . . . 0.0 111.334 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 256' ' ' THR . 59.4 m -93.7 -41.24 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.21 154.69 37.48 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.63 151.67 18.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.714 2.276 . . . . 0.0 112.327 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.13 -35.68 13.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -71.66 -46.36 59.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -68.15 149.15 49.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.05 147.68 88.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.98 166.91 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.624 2.216 . . . . 0.0 112.156 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -104.99 25.14 26.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.577 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 68.53 13.6 8.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.689 0.28 . . . . 0.0 111.301 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.529 HG22 ' CG ' ' A' ' 303' ' ' MET . 36.4 mm -79.25 -45.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.527 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.63 -43.78 17.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.287 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.4 OUTLIER -59.08 -41.71 88.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.392 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.677 ' HA ' HD13 ' A' ' 323' ' ' ILE . 10.7 t80 -71.46 -43.17 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.514 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.758 ' CB ' HD13 ' A' ' 282' ' ' ILE . 3.8 mtp -61.04 -41.28 96.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.597 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.11 -50.35 74.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.685 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.867 ' O ' HD12 ' A' ' 309' ' ' LEU . 41.9 m -58.45 -33.58 69.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.498 HG21 ' CE1' ' A' ' 302' ' ' TYR . 71.1 t -79.37 -24.46 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.8 -38.61 21.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.683 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 7.7 mt -107.48 -28.34 9.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.497 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 305' ' ' THR . 0.9 OUTLIER 48.99 -167.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 111.144 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.492 ' HB2' HD11 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -97.32 174.95 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.968 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -92.86 -64.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.45 29.24 6.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -148.17 85.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 315' ' ' PRO . 2.5 mmmp? -59.37 -58.77 17.03 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 38.1 Cg_endo -66.21 91.09 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.412 2.074 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 310' ' ' ASP . 11.0 mt -103.08 31.22 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -68.48 -29.63 68.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -46.54 85.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -73.83 -43.64 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.8 mt -56.49 -40.57 75.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.56 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.0 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.84 -38.02 76.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 320' ' ' LEU . 54.1 mt -55.96 -48.27 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.321 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 158' ' ' SER . 7.4 mt -80.78 -21.29 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.482 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.75 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.7 tt -81.53 -49.69 10.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.15 -37.31 74.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.98 -27.82 57.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.542 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 159' ' ' LEU . 12.0 mt -68.79 -39.08 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -30.14 69.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.01 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.43 HD11 ' OG ' ' A' ' 333' ' ' SER . 12.0 pt -105.77 -29.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.46 27.25 3.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.43 ' OG ' HD11 ' A' ' 331' ' ' ILE . 2.3 p -114.49 34.04 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.943 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -71.81 89.78 1.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 89.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.93 -31.25 7.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.2 27.35 4.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 157.24 37.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.631 HD11 ' HA ' ' A' ' 192' ' ' GLN . 0.3 OUTLIER -100.32 23.62 9.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.026 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 4.2 t70 60.75 28.38 18.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -139.43 76.3 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.998 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 35.8 p -69.73 -28.2 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.703 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.6 t 64.55 90.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.89 30.77 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.49 ' HB2' ' HB1' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -134.95 129.36 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.78 151.74 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.66 -91.27 2.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 148.93 -110.81 0.5 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 tp -114.76 99.72 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.914 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.457 ' HE2' HG21 ' A' ' 353' ' ' THR . 1.2 tptm -151.06 101.95 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -127.15 -57.24 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -134.71 123.36 23.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.457 HG21 ' HE2' ' A' ' 350' ' ' LYS . 65.3 p -139.68 -60.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 5.3 pt -72.34 78.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.05 144.84 24.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -82.14 149.37 28.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -81.57 85.03 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 141.52 57.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 32.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.6 99.8 6.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.49 158.99 28.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.2 mm -95.0 144.6 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.79 31.87 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.1 31.21 4.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.0 m -108.94 113.36 26.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.11 34.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' A' ' 368' ' ' PRO . 0.9 OUTLIER -75.98 -52.91 2.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 368' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 367' ' ' GLU . 52.0 Cg_exo -52.59 98.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.578 2.186 . . . . 0.0 112.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -75.22 178.03 47.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.464 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 373' ' ' THR . 9.7 m -140.11 149.08 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -77.85 -28.85 50.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.61 -63.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 370' ' ' VAL . 0.2 OUTLIER -139.97 173.73 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 373' ' ' THR . 1.6 mt-10 -141.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.0 155.89 23.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -34.1 9.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 378' ' ' THR . 7.8 t30 -133.94 138.33 45.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 377' ' ' ASN . 1.0 OUTLIER -159.03 127.24 5.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -129.31 130.19 45.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.4 t -151.36 158.87 44.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -150.73 154.08 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -162.93 -61.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -165.28 -44.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.02 170.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -170.84 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 43.7 p -140.91 -174.1 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -84.7 126.57 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 13.9 m -91.05 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.44 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.5 114.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -152.01 -55.7 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 159.0 24.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 161.71 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.3 m -93.42 -31.63 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -92.38 81.99 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 96.0 p -151.65 166.79 30.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 24.0 t -110.41 157.6 19.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 67.69 103.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 85.1 p -74.22 98.75 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 12.2 t -146.16 -49.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -72.1 -28.48 68.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.22 157.31 56.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.3 158.75 56.38 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.522 2.148 . . . . 0.0 112.333 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.11 97.93 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t 62.43 117.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -54.34 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.09 -74.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -172.32 -46.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.67 35.47 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.93 69.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.41 43.29 1.69 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -155.04 174.73 14.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -167.01 177.83 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -113.7 102.46 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 t -113.16 149.94 32.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.66 -58.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -33.71 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -67.34 116.33 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -98.01 150.4 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.36 20.69 10.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 52.1 87.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 0.0 111.256 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 60.81 -165.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.813 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 63.71 99.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.782 ' HB3' HG11 ' A' ' 39' ' ' VAL . 3.6 m-30 -59.53 92.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -171.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -101.9 114.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.65 -25.99 11.37 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.04 147.39 29.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD11 ' HD3' ' A' ' 38' ' ' LYS . 20.9 mm -102.29 135.84 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.891 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 13.4 pt -119.84 148.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -95.55 141.46 29.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' CB ' ' HB2' ' A' ' 35' ' ' LYS . 4.1 t70 -83.41 -142.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.27 56.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.1 34.6 24.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.901 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -152.85 19.06 0.6 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' CE2' ' A' ' 37' ' ' TRP . 2.0 mmtt -163.94 175.1 10.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.445 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -151.24 90.44 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 7.3 m95 -94.87 139.96 30.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.209 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD3' HD11 ' A' ' 28' ' ' ILE . 8.7 ttpt -93.14 135.0 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.782 HG11 ' HB3' ' A' ' 23' ' ' PHE . 19.5 t -87.39 138.78 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.67 -118.65 4.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.551 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.4 154.59 47.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.948 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.59 170.69 5.28 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.544 2.163 . . . . 0.0 112.275 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.5 pt -143.9 36.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.34 148.62 7.11 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.562 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -109.12 134.46 51.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.21 -121.91 0.95 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.501 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.07 66.32 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.454 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -104.41 -51.37 3.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.29 -88.38 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.97 94.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.415 HG23 ' HG3' ' A' ' 71' ' ' LYS . 19.0 mt -114.68 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 23' ' ' PHE . 19.5 m-85 -146.35 172.06 14.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 69' ' ' VAL . 31.5 mt -77.33 156.33 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -125.67 142.41 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.41 159.72 38.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.1 mtm -99.31 38.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.62 87.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -64.13 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -175.08 -51.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -111.14 -46.55 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.45 178.98 4.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' CE ' ' A' ' 38' ' ' LYS . 21.5 t -94.98 122.64 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.42 -151.56 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.574 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.63 31.34 5.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 80.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.54 137.01 19.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.27 33.25 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.842 2.361 . . . . 0.0 112.775 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -149.82 148.25 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 53' ' ' LEU . 20.5 m -134.86 144.87 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 7.4 p -134.89 132.94 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.557 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 51' ' ' ILE . 1.9 mttp -109.37 120.78 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.844 HG22 ' CB ' ' A' ' 128' ' ' PHE . 14.7 t -113.19 149.07 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.363 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.759 ' HG3' HD23 ' A' ' 80' ' ' LEU . 1.1 mm-40 -133.2 149.86 73.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.679 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 80.32 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.168 . . . . 0.0 112.388 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.1 t 57.04 -168.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 61.39 165.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -124.29 130.81 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.78 -111.45 0.26 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.05 -36.62 85.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.759 HD23 ' HG3' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -67.64 -45.72 74.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -45.79 72.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 p -58.63 -44.17 89.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 2.3 tt0 -68.67 -38.83 80.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' HE2' ' A' ' 129' ' ' MET . 1.9 mt -67.98 -46.57 70.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -56.34 -40.82 75.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.5 t80 -79.66 -29.88 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.743 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -67.71 -52.67 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.434 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -19.61 59.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.437 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -66.33 -47.52 73.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.674 0.273 . . . . 0.0 111.298 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.1 -35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -59.28 -16.99 24.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 125.01 26.88 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.517 0.199 . . . . 0.0 110.84 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.87 -24.89 14.46 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.488 2.125 . . . . 0.0 112.614 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -44.46 91.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.43 -43.77 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 ' CD1' ' A' ' 100' ' ' ILE . 30.0 mt -54.83 -57.6 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.409 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.45 -40.77 62.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.153 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -57.0 -39.65 75.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -77.32 -44.53 29.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.459 ' CD1' HG22 ' A' ' 96' ' ' ILE . 59.6 mt -62.7 -38.8 82.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.63 60.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.414 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -80.52 -36.93 32.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.495 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -105.42 -3.34 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 mttt 58.33 29.31 17.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.857 0.36 . . . . 0.0 110.724 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.49 HD13 HD13 ' A' ' 108' ' ' LEU . 49.9 mt -47.76 -40.41 20.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.206 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' H ' HG23 ' A' ' 100' ' ' ILE . 4.0 tmtp? 69.07 7.81 6.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 68.6 t80 174.62 161.83 0.2 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.751 0.31 . . . . 0.0 110.498 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 167' ' ' TYR . 9.3 tp -153.56 -60.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.07 -0.26 21.02 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.044 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 111' ' ' PRO . 26.7 t -83.33 136.17 43.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.78 0.29 . . . . 0.0 110.929 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 110' ' ' VAL . 15.3 Cg_endo -57.41 143.05 95.11 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.313 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 115.68 26.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -90.42 134.47 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -111.97 -40.83 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.86 -174.5 46.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.824 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.2 t -136.86 153.19 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -131.48 168.29 22.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.28 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 127' ' ' ARG . 52.3 mt -147.93 134.47 19.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 0.0 110.748 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -139.32 135.74 34.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -108.24 135.63 49.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 126.3 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.85 18.3 5.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.38 57.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.895 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -96.04 129.02 43.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.819 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.8 130.31 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.72 136.38 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.809 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -115.25 125.12 52.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.891 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.9 p90 -134.73 159.35 41.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.709 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.561 ' HE2' ' HG ' ' A' ' 84' ' ' LEU . 1.7 ttm -128.06 141.92 51.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.402 HG12 ' CG2' ' A' ' 70' ' ' VAL . 9.3 mt -111.94 111.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.04 173.41 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.73 136.91 21.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -56.94 172.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.235 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CE2' HG11 ' A' ' 196' ' ' VAL . 31.5 m-85 -150.17 162.06 41.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.645 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.6 -84.53 1.58 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.449 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 m -149.68 127.36 11.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.823 0.344 . . . . 0.0 110.719 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.832 ' OD1' HD22 ' A' ' 184' ' ' LEU . 4.9 m-20 -49.0 159.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -69.29 -21.31 63.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.773 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 1.7 pt20 -51.9 -34.13 39.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.379 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -29.63 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.652 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 1.031 HD11 HD11 ' A' ' 185' ' ' LEU . 62.4 mt -73.92 -29.82 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.571 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -59.58 -50.03 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.04 -27.48 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.07 66.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.366 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -97.9 14.96 25.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 87.5 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.95 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.453 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.7 123.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 7.4 m-85 -59.58 -174.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.5 m -119.14 153.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.571 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -54.75 -27.3 40.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 331' ' ' ILE . 10.7 mtpp -74.88 -42.39 57.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 339' ' ' LEU . 0.2 OUTLIER -74.23 -44.3 53.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.243 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 150' ' ' SER . 59.6 t -55.82 -53.92 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 297' ' ' GLY . 13.5 mt -58.43 -46.93 85.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.966 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 338' ' ' LYS . 0.1 OUTLIER -64.37 -52.85 56.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.992 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.552 HD11 HD21 ' A' ' 341' ' ' LEU . 11.6 mt -59.5 -40.1 85.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.636 ' HA ' HD12 ' A' ' 161' ' ' ILE . 52.8 p -59.18 -36.8 75.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.674 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.768 HD21 ' HG2' ' A' ' 321' ' ' ARG . 1.5 tm? -67.94 -44.12 77.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.776 ' HD2' HD21 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -60.4 -42.16 95.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.761 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 158' ' ' SER . 10.0 mt -64.3 -36.99 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.551 ' CD1' HD12 ' A' ' 324' ' ' LEU . 11.5 mt -61.58 -38.59 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.49 -41.22 93.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.1 mt -74.89 -41.94 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 168' ' ' ILE . 11.2 mt -56.88 -40.51 76.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HG3' ' CG ' ' A' ' 317' ' ' TYR . 10.6 tt0 -64.96 -37.9 89.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.752 ' CD1' HD21 ' A' ' 108' ' ' LEU . 89.9 t80 -66.41 -53.44 35.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 165' ' ' LEU . 5.3 pt -65.48 -27.04 40.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.42 ' N ' HG13 ' A' ' 168' ' ' ILE . 14.8 m-70 -76.48 -39.84 52.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.498 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.91 -12.32 61.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.62 4.25 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.765 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 70.69 47.09 0.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 126.74 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.682 HG13 ' CD1' ' A' ' 204' ' ' TYR . 27.2 m -133.01 169.27 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.603 ' NE2' HD21 ' A' ' 195' ' ' LEU . 31.6 p-80 -162.37 -47.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.16 59.67 8.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.44 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.77 29.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 161' ' ' ILE . 12.3 mt -64.54 105.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 14.1 tptm -149.84 168.33 24.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.773 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -69.39 0.03 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.065 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 -4.07 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.571 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -124.96 -5.77 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.356 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.885 ' C ' HD23 ' A' ' 184' ' ' LEU . 12.6 mt -108.22 113.51 26.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.244 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -121.14 149.75 42.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -178.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 141' ' ' ILE . 10.3 mt -90.36 149.19 22.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.65 130.54 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.687 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -66.77 -67.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -21.3 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -119.56 67.28 10.17 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.83 97.31 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.1 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.503 ' O ' HD12 ' A' ' 339' ' ' LEU . 1.9 p30 -172.5 -38.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.213 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -116.15 174.36 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 138' ' ' LEU . 7.9 p -133.05 136.56 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 3.4 m-85 -106.91 156.88 18.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.2 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.603 HD21 ' NE2' ' A' ' 175' ' ' HIS . 18.8 tp -104.06 115.87 31.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 184' ' ' LEU . 27.8 m -115.37 156.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 56.04 93.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.496 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 5.0 m-85 -79.27 -12.87 59.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 57.01 25.2 53.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -176.5 -62.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.703 0.287 . . . . 0.0 111.014 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 86' ' ' PHE . . . 43.88 82.91 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -142.08 149.01 39.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -82.79 94.34 7.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.682 ' CD1' HG13 ' A' ' 174' ' ' VAL . 35.4 p90 -48.24 -46.32 35.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.66 87.72 6.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.979 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.0 -38.51 69.61 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.559 2.173 . . . . 0.0 112.266 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -173.07 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.92 -55.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.472 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.0 t 69.04 -67.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -160.71 -50.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.969 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -127.11 -179.05 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -120.75 -41.68 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.471 ' CE1' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -94.98 153.39 17.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -60.68 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.709 ' H ' HG22 ' A' ' 236' ' ' VAL . 10.5 mt-10 60.67 40.98 15.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.88 86.15 24.36 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.31 133.0 21.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.554 2.169 . . . . 0.0 112.325 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -177.68 -44.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -99.42 -22.2 15.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 19.6 m 61.67 30.87 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.528 ' CB ' ' HB1' ' A' ' 232' ' ' ALA . 7.7 t60 58.96 46.46 13.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.976 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 221' ' ' HIS . 54.3 m-20 65.94 -68.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' HIS . . . -49.79 150.42 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.725 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -91.34 -46.95 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tp -178.11 38.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.197 0.523 . . . . 0.0 110.522 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -94.66 64.85 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.269 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.554 ' HB3' HG23 ' A' ' 246' ' ' ILE . 53.3 m-85 75.29 32.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -72.78 153.89 40.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.3 m -95.88 157.49 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.76 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -59.66 -30.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -48.73 55.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.0 -33.42 74.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -72.58 -26.1 61.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.83 12.82 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.375 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.52 59.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.591 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 215' ' ' GLU . 25.9 t -118.25 124.85 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.15 118.91 33.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 55.0 Cg_exo -51.97 101.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.403 2.069 . . . . 0.0 112.298 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.8 m -60.68 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.11 -51.51 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.58 ' HB3' HD22 ' A' ' 309' ' ' LEU . 18.0 ptt180 -62.78 -23.91 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.49 -49.55 72.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.692 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 -31.04 63.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.61 HD13 HD11 ' A' ' 320' ' ' LEU . 30.6 mt -72.18 -36.09 69.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.67 -29.89 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 227' ' ' PHE . 42.0 mt -72.39 -42.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.541 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.5 tp -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -62.42 -39.15 97.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.314 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.5 -25.88 45.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -34.57 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.108 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -49.43 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 248' ' ' GLY . 4.0 mt -65.32 -30.26 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.688 ' HB2' HD21 ' A' ' 259' ' ' LEU . 17.6 tm0? -80.04 -37.4 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.4 m0 -82.22 -39.35 23.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.06 -45.39 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.076 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.404 HG21 ' HB3' ' A' ' 289' ' ' CYS . 10.4 p -96.14 0.55 51.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.41 97.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.475 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 m80 65.0 155.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -134.52 172.54 7.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.474 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 61.5 Cg_endo -73.49 58.11 3.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.373 2.049 . . . . 0.0 112.589 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.989 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.1 p90 -180.0 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.306 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -99.04 20.62 13.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 178.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -55.12 23.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.948 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.1 OUTLIER -127.68 -25.27 3.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.452 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.637 HD22 HG23 ' A' ' 225' ' ' ILE . 53.5 mt 69.34 12.74 8.41 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -88.25 -15.48 35.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.083 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.471 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 4.0 t0 -135.12 97.46 13.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 20.73 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.625 2.216 . . . . 0.0 112.944 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -44.85 22.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.789 0.328 . . . . 0.0 110.764 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.0 p90 -83.87 -26.62 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.015 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.746 ' CG1' HD11 ' A' ' 225' ' ' ILE . 16.3 t -61.76 -37.06 77.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -72.11 -44.36 63.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.35 -37.37 77.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.069 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.3 p -72.01 -38.12 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.253 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.512 ' CD ' HG12 ' A' ' 271' ' ' VAL . 0.2 OUTLIER -61.54 -47.53 85.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.14 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 230' ' ' ILE . 28.7 mm -70.29 -29.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.408 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -48.74 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.501 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.6 m-85 -67.33 -40.56 85.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.76 ' HE ' HD13 ' A' ' 230' ' ' ILE . 6.8 tmm_? -50.68 -27.79 7.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.839 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -118.3 22.84 11.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.11 44.04 2.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.987 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 303' ' ' MET . 22.7 mt -53.32 -38.24 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.01 64.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -40.69 86.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 4.2 pp -76.44 -28.34 56.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.408 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 0.0 OUTLIER -66.69 -37.93 85.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.501 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.84 -31.09 28.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -82.68 -49.6 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.093 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' A' ' 256' ' ' THR . 53.4 m -72.06 -41.33 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.47 134.87 22.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.95 165.3 32.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.68 -29.43 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -38.34 75.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -74.49 -177.35 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.25 142.33 25.75 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.55 142.02 61.15 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 155' ' ' LEU . . . -99.1 24.35 32.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.624 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 64.16 17.1 10.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.714 0.292 . . . . 0.0 111.193 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.474 HG22 ' CG ' ' A' ' 303' ' ' MET . 32.2 mm -79.54 -51.99 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.5 -41.91 14.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.307 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -41.77 96.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 306' ' ' VAL . 50.3 t80 -72.05 -44.41 63.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.808 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.721 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.9 mtp -58.26 -39.76 80.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.662 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -65.76 -43.76 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.984 HG21 HD11 ' A' ' 323' ' ' ILE . 0.7 OUTLIER -65.95 -34.54 78.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 302' ' ' TYR . 67.9 t -78.75 -24.39 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.98 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.058 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 310' ' ' ASP . 3.6 pp -102.17 -24.7 13.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.723 ' O ' HD22 ' A' ' 316' ' ' LEU . 1.1 mp 58.41 -80.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.162 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.7 ' OD1' HD13 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -145.42 170.99 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.794 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -87.33 -33.55 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.1 p -114.46 27.29 9.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.47 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.62 165.45 15.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.84 108.25 2.05 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.279 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.723 HD22 ' O ' ' A' ' 309' ' ' LEU . 11.2 tp -98.74 29.01 3.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' GLU . 63.1 m-85 -62.66 -30.02 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.52 -45.57 79.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -45.18 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.858 ' HA ' HD12 ' A' ' 323' ' ' ILE . 89.0 mt -56.13 -50.25 71.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.768 ' HG2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -53.72 -50.96 64.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -54.43 -42.35 70.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 305' ' ' THR . 42.6 mt -54.22 -46.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.564 HD13 ' OG ' ' A' ' 158' ' ' SER . 87.4 mt -81.19 -37.26 28.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.839 HD23 HD12 ' A' ' 328' ' ' LEU . 0.4 OUTLIER -63.17 -49.75 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -54.09 -43.57 70.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.035 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.12 67.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.839 HD12 HD23 ' A' ' 325' ' ' LEU . 11.4 mt -59.19 -24.74 63.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.719 0.295 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 18.8 mttm -76.38 -33.94 58.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.37 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.93 -18.72 55.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.039 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 152' ' ' LYS . 1.2 pt -117.07 -34.77 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -116.23 -25.0 3.66 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.347 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 5.4 t 69.71 72.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.84 125.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.85 138.74 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.38 38.52 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.26 54.57 26.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.416 ' O ' ' NE2' ' A' ' 156' ' ' GLN . 0.2 OUTLIER -174.26 116.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.776 HD21 ' HD2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -99.0 31.2 3.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER 56.93 27.76 13.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.871 HD22 HD13 ' A' ' 141' ' ' ILE . 19.8 mt -98.49 35.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.4 ' C ' HG22 ' A' ' 343' ' ' VAL . 11.2 m -59.67 -52.8 63.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.4 HG22 ' C ' ' A' ' 342' ' ' SER . 17.5 m 42.31 58.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.8 m 41.62 77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.797 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 84.07 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -158.89 155.16 27.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.71 168.05 12.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 173.54 -125.53 1.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 62.8 mt 60.68 97.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -109.79 -47.08 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -135.12 -177.25 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -146.5 -55.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.0 -62.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 354' ' ' ILE . 2.9 pp -133.05 176.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.7 m -136.13 105.85 6.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.57 114.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -76.97 -177.69 4.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 61.41 172.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 -47.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -93.31 151.57 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -89.34 156.39 18.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.4 mt -59.93 90.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -161.78 31.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.46 121.9 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.6 t -137.29 -46.27 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt 63.26 95.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -125.22 139.72 34.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.53 84.48 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.431 2.087 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -141.85 -44.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.574 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 21.5 t 66.1 90.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.92 156.14 34.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.72 -54.99 2.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 39.8 p -88.69 170.03 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -154.63 -66.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.444 ' HA ' ' CE3' ' A' ' 375' ' ' TRP . 0.0 OUTLIER -118.57 -165.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.0 p -175.81 171.68 2.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -116.87 -59.0 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 379' ' ' GLN . 0.2 OUTLIER -98.26 -177.93 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLN . . . . . 0.47 ' H ' HG22 ' A' ' 378' ' ' THR . 3.3 mt-30 -64.06 85.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.67 123.02 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.81 134.51 39.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.46 79.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -151.73 69.29 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.588 HD11 HG23 ' A' ' 386' ' ' THR . 8.7 tp -134.46 145.45 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 46.21 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' THR . . . . . 0.588 HG23 HD11 ' A' ' 384' ' ' ILE . 20.0 p -89.3 128.27 35.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -126.44 -44.97 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.0 m -105.17 148.22 27.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 390' ' ' THR . 0.0 OUTLIER -178.46 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.2 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 390' ' ' THR . . . . . 0.41 ' N ' ' HG2' ' A' ' 389' ' ' ARG . 4.1 t -94.8 -40.88 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -174.47 137.05 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -87.0 -53.19 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 148.99 51.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 395' ' ' GLN . 21.5 t -87.51 157.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.461 ' N ' HG12 ' A' ' 394' ' ' VAL . 1.6 tt0 60.81 33.53 20.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.556 -0.217 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 4.3 m -154.03 -62.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 49.3 m -83.97 113.78 21.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.29 41.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.523 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.99 130.2 53.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.72 142.06 27.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 136.34 44.39 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.522 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt -111.05 165.94 11.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.24 -34.01 22.81 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -161.7 129.89 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.68 31.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 147.26 25.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.11 176.89 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.28 121.11 3.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.49 169.18 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.85 -31.31 11.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.33 -160.75 12.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.53 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -119.77 -44.62 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.87 159.8 42.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 t -143.51 128.0 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -168.53 150.69 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.18 165.21 9.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.14 -47.57 5.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.1 115.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 62.42 117.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.1 100.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.28 -57.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -179.84 6.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -131.5 -54.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.883 ' CE2' HG21 ' A' ' 72' ' ' VAL . 3.9 m-85 -76.08 97.16 3.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.01 -176.72 3.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -79.29 113.05 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.75 13.83 15.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.3 161.13 14.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.623 HD13 ' HG3' ' A' ' 38' ' ' LYS . 20.5 mm -112.39 131.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 23' ' ' PHE . 9.3 pt -119.84 125.55 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.767 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 t -95.55 141.31 29.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.548 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 13.7 m-20 -90.4 -161.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.57 63.06 0.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.9 31.3 18.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.214 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.8 -33.58 8.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.641 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.87 -158.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.28 93.04 1.94 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.737 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -78.08 155.26 30.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.4 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HG3' HD13 ' A' ' 28' ' ' ILE . 4.8 tttm -100.16 117.78 35.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 29' ' ' ILE . 17.4 t -73.01 143.49 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -118.06 -111.07 2.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.598 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.5 mt -96.11 154.37 38.86 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.704 0.288 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 -27.35 52.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 69' ' ' VAL . 46.5 pt 42.48 31.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -179.11 111.81 0.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.77 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.12 -65.69 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.28 -103.7 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.537 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -68.88 -30.49 69.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 52' ' ' TYR . . . 170.7 -85.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.437 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 78.18 -55.3 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.257 . . . . 0.0 111.2 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mt -129.15 137.61 56.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 0.0 111.325 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 62.4 m-85 -146.43 167.87 22.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 68' ' ' CYS . 6.0 mt -89.09 149.55 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.95 146.92 45.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 t70 -137.54 152.23 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtp -96.48 37.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.31 30.12 19.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.95 179.46 6.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.02 171.87 12.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.16 174.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 t -81.41 157.36 25.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.3 130.87 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.15 -90.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.574 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -99.14 30.52 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.05 -44.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 55' ' ' ASP . . . -105.61 88.66 2.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.92 80.91 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 53' ' ' LEU . 73.3 m -149.71 148.19 28.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.552 HG13 ' CG ' ' A' ' 133' ' ' ARG . 5.4 m -119.68 155.37 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG23 HD13 ' A' ' 130' ' ' ILE . 11.8 p -148.13 126.95 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.034 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 116.22 28.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.682 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.883 HG21 ' CE2' ' A' ' 23' ' ' PHE . 21.6 t -122.46 137.63 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 80' ' ' LEU . 2.2 mt-10 -128.69 147.22 63.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.46 83.5 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.89 -63.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.243 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -46.48 131.28 11.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -140.36 80.08 1.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.52 -76.17 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.45 -28.18 32.67 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.616 2.211 . . . . 0.0 112.299 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.698 ' HG ' HD23 ' A' ' 84' ' ' LEU . 9.3 tp -73.08 -33.27 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -30.62 70.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 p -76.13 -37.98 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 59.8 tt0 -74.41 -39.11 62.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.2 mm? -62.5 -52.47 63.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 11.3 t80 -71.03 -45.83 63.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.993 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 5.7 m-85 -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.461 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.43 -48.04 36.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.645 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -87.75 -47.52 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.701 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -77.49 -50.23 13.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.886 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.51 32.32 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.708 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.04 125.91 89.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.48 -28.2 84.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.44 2.094 . . . . 0.0 112.444 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.35 -32.89 43.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.176 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -79.22 -52.65 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.286 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.746 HD11 ' HA ' ' A' ' 91' ' ' ALA . 50.6 mt -56.71 -52.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.6 -50.6 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -64.66 -42.58 95.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -58.53 -54.2 49.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.93 -36.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -75.11 -27.81 59.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.316 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -78.78 -38.74 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.499 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.71 -2.42 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.335 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.12 30.44 18.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 110.643 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.1 mt -50.15 -31.12 12.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.92 -56.62 0.54 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.29 151.46 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.682 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.2 tp -128.92 -66.88 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 138.09 -14.37 3.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.908 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.11 125.29 77.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.629 0.215 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.31 152.76 7.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 112.249 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -80.19 115.48 19.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 13.3 t80 -93.24 115.76 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -91.8 -40.98 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.224 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.79 -174.63 46.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.76 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 p -131.03 158.05 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.02 179.45 20.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.353 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -147.99 158.85 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.961 0.41 . . . . 0.0 111.314 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.62 114.61 11.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.602 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -91.4 142.26 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 123' ' ' GLY . 4.0 tttt -130.57 157.53 42.46 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.98 51.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.632 0.253 . . . . 0.0 111.428 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' LYS . . . 144.2 -18.27 2.11 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.897 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -126.4 142.96 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.68 138.29 46.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.477 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.556 ' O ' HD23 ' A' ' 118' ' ' LEU . 2.7 m-85 -125.7 134.64 51.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.959 0.409 . . . . 0.0 111.334 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -124.13 138.26 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.467 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.882 ' CB ' HG22 ' A' ' 72' ' ' VAL . 23.2 p90 -147.03 168.73 20.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.275 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.789 ' HB2' HD21 ' A' ' 84' ' ' LEU . 7.1 tmm? -136.67 146.44 45.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.656 HD13 HG23 ' A' ' 70' ' ' VAL . 11.6 mm -96.0 135.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -143.49 165.28 27.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.69 130.09 41.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.552 ' CG ' HG13 ' A' ' 69' ' ' VAL . 3.6 ttt-85 -57.73 143.06 43.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -113.14 166.89 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.79 -83.2 1.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -133.92 127.01 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.667 ' CG ' HD22 ' A' ' 184' ' ' LEU . 3.0 m-20 -55.35 155.75 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 1.9 mm? -60.08 -23.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.619 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -65.43 -42.91 91.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.134 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -61.5 -29.89 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.894 HD11 HD11 ' A' ' 185' ' ' LEU . 26.4 mt -75.39 -28.54 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 10.3 t80 -59.53 -49.37 78.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -28.01 67.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.24 -23.1 65.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.326 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 5.7 m-20 -96.4 15.63 20.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.166 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.71 46.4 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.52 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.2 19.45 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 33.3 mtt180 -147.14 -179.09 6.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 153' ' ' THR . 0.1 OUTLIER -132.84 144.59 50.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 p -81.91 155.38 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.36 68.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -71.8 -36.06 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.555 ' CG2' HD23 ' A' ' 341' ' ' LEU . 1.7 m -72.75 -42.26 64.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' A' ' 251' ' ' MET . 47.6 t -66.05 -54.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.81 ' HB3' HD21 ' A' ' 328' ' ' LEU . 71.8 mt -54.89 -47.15 74.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.665 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.593 HD21 HD21 ' A' ' 341' ' ' LEU . 17.4 mt -66.17 -41.17 90.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.596 ' CB ' HD13 ' A' ' 324' ' ' LEU . 60.0 m -54.56 -42.4 70.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.699 HD22 ' HG2' ' A' ' 321' ' ' ARG . 88.8 mt -66.49 -39.61 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.459 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -64.97 -46.34 81.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.726 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.85 -34.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.765 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.3 mt -62.34 -35.89 80.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.17 -42.26 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 ' HA3' ' A' ' 109' ' ' GLY . 11.9 mt -71.41 -34.78 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.75 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 162' ' ' LEU . 23.3 mt -58.77 -39.05 79.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.68 -37.23 79.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -66.78 -54.85 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.713 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 43.5 pt -63.12 -27.28 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -77.9 -38.35 45.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.459 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -10.9 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.981 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.51 4.8 26.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.821 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 1.2 mp0 71.5 48.93 0.31 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -139.68 139.05 36.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 204' ' ' TYR . 12.3 m -137.92 169.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 1.4 p80 -147.13 -54.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.497 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 70.28 31.98 68.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.376 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -136.74 81.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.3 mt -115.61 117.85 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -159.42 -176.6 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.619 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.78 1.91 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.479 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.08 1.4 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 110.329 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -124.82 -12.94 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.287 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 5.5 mt -108.48 123.32 48.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.98 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -127.9 160.96 30.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.894 HD11 HD11 ' A' ' 141' ' ' ILE . 22.4 mt -95.04 149.34 21.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.022 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.7 132.58 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.443 ' CD2' ' CD ' ' A' ' 133' ' ' ARG . 22.3 t80 -68.58 -61.83 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.418 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -63.15 -18.51 63.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.24 75.26 74.87 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.55 89.92 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.536 2.157 . . . . 0.0 112.066 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.95 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.107 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.471 ' HA ' HD11 ' A' ' 339' ' ' LEU . 35.5 mt-30 -102.54 149.86 23.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.9 p -112.45 147.99 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.124 0.488 . . . . 0.0 110.736 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 24.7 m-85 -126.47 157.32 38.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.974 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 26.2 tp -103.32 115.83 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.458 HG21 ' CD1' ' A' ' 184' ' ' LEU . 5.2 t -103.56 137.38 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.16 130.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.724 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.5 m-85 -103.02 7.95 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.195 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 80.99 -55.25 4.78 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.17 -32.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.579 0.228 . . . . 0.0 111.53 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.29 94.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.746 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.539 ' O ' HG22 ' A' ' 174' ' ' VAL . 68.1 t80 -126.29 149.06 49.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -98.82 78.18 2.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.768 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.68 ' CD1' HG13 ' A' ' 174' ' ' VAL . 42.2 p90 -46.5 -46.59 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.3 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 48.8 t -74.12 127.02 88.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 -171.45 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.478 2.119 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.29 -43.14 17.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.16 -75.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.68 114.01 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.173 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.31 -69.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -177.66 132.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -175.38 4.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 216' ' ' ASP . 2.7 t80 -107.94 -77.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? 44.35 92.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.772 0.32 . . . . 0.0 111.537 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.671 ' HA ' HG22 ' A' ' 236' ' ' VAL . 22.6 mm-40 61.24 117.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.044 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 213' ' ' TYR . 1.0 OUTLIER -169.31 82.53 0.66 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.66 84.92 0.62 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.551 2.167 . . . . 0.0 112.288 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.78 23.63 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.5 56.92 6.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.965 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.17 -66.23 1.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 237' ' ' ALA . 12.4 m170 -98.57 34.61 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -67.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.771 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 58.83 -133.39 52.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.704 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -169.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 265' ' ' LEU . 20.3 tt -139.13 31.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.031 0.443 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HB3' HD11 ' A' ' 265' ' ' LEU . 0.1 OUTLIER -94.63 21.88 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.709 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 179' ' ' LYS . 0.5 OUTLIER 168.58 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.638 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.2 p -60.01 150.14 30.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -177.71 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.442 HD13 HH21 ' A' ' 279' ' ' ARG . 1.3 mp -65.96 -35.43 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.409 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -57.66 -29.89 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.07 77.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -33.57 76.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -86.12 4.4 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.393 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.84 -2.33 83.71 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.884 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 215' ' ' GLU . 15.9 t -63.77 133.73 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.844 0.354 . . . . 0.0 111.094 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 221' ' ' HIS . . . -73.4 150.13 89.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HG2' ' CB ' ' A' ' 174' ' ' VAL . 37.6 Cg_endo -65.92 -35.01 36.97 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.518 2.146 . . . . 0.0 112.234 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 204' ' ' TYR . 21.1 t 67.62 -69.62 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.6 ttp-105 -166.18 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -71.73 -32.77 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.5 96.25 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.779 ' HA ' HD12 ' A' ' 246' ' ' ILE . 6.4 m-20 -65.31 -43.34 91.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 320' ' ' LEU . 39.9 mt -64.24 -38.51 91.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 306' ' ' VAL . 2.5 tt0 -59.8 -31.02 69.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.0 mt -75.9 -42.38 39.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.67 HD23 ' OH ' ' A' ' 302' ' ' TYR . 18.6 tp -58.77 -46.27 87.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.684 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 252' ' ' ILE . . . -55.77 -25.42 44.12 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.88 -31.53 45.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 97.2 m -54.22 -48.73 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.794 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.63 -30.54 71.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 285' ' ' LEU . 28.9 mm -66.28 -45.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.201 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.488 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.0 OUTLIER -80.01 -27.37 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.512 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.488 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 17.2 m0 -76.99 -32.66 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.434 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.15 -35.51 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 289' ' ' CYS . 1.8 m -96.27 0.59 51.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.599 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.35 96.29 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.332 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 33.4 m80 61.74 154.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.95 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -121.68 164.26 25.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.823 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 60.0 Cg_endo -72.62 57.64 3.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.641 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.95 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.8 p90 179.35 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' A' ' 259' ' ' LEU . 14.9 tt0 -92.47 13.44 19.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.553 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -59.4 5.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 4.6 m-80 -129.95 -26.17 2.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.417 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.771 HD11 ' HB3' ' A' ' 226' ' ' GLU . 83.6 mt 72.75 11.19 5.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -16.22 49.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.222 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -132.16 99.97 15.9 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.791 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.95 12.07 2.78 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -49.98 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.9 p90 -79.92 -26.23 40.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 15.1 t -60.67 -45.73 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 276' ' ' ILE . 0.6 OUTLIER -74.37 -31.96 62.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.039 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.13 -47.79 33.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.174 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.407 ' HB3' ' CE2' ' A' ' 278' ' ' TYR . 1.5 m -66.84 -35.99 81.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -64.77 -49.62 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.201 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 272' ' ' ARG . 21.7 mt -66.91 -30.14 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -52.05 7.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.597 ' CD1' HD12 ' A' ' 285' ' ' LEU . 10.7 m-85 -56.68 -31.96 64.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.442 HH21 HD13 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -59.08 -27.86 65.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.66 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -130.07 30.29 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -150.19 38.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.763 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.2 mt -52.98 -49.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.03 -49.6 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.3 p -65.33 -31.6 72.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.277 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.597 HD12 ' CD1' ' A' ' 278' ' ' TYR . 1.4 tt -68.7 -38.42 80.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.488 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' PHE . 0.0 OUTLIER -65.42 -38.16 89.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.809 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -25.68 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -82.75 -54.9 4.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.403 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.472 ' O ' HG23 ' A' ' 256' ' ' THR . 0.1 OUTLIER -68.84 -41.3 78.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' MET . 19.4 m-85 -102.26 152.74 38.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -51.03 -61.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.663 2.242 . . . . 0.0 112.462 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -146.53 -45.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.013 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 63.62 56.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -65.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.744 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -62.42 -56.55 29.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 295' ' ' LYS . 18.6 Cg_endo -60.08 -164.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.4 2.066 . . . . 0.0 112.235 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 135.14 37.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.543 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.557 ' HG3' HD11 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -87.75 -33.86 18.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.495 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.757 HD12 ' HG3' ' A' ' 251' ' ' MET . 20.2 mm -74.68 -46.61 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.27 -45.69 17.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -61.71 -38.82 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.489 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.88 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.0 t80 -70.05 -43.36 71.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.873 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.763 ' CB ' HD13 ' A' ' 282' ' ' ILE . 4.5 mtp -65.51 -37.2 86.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -51.38 70.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.617 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.43 HG21 HD11 ' A' ' 323' ' ' ILE . 82.3 p -60.96 -34.72 75.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 302' ' ' TYR . 39.6 t -73.36 -24.66 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.191 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -76.67 -31.89 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.4 mt -104.33 -10.9 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -53.12 136.09 36.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.065 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.37 162.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.25 20.77 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 3.5 m -164.99 -49.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 110.805 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 -170.08 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 165.13 14.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.05 142.27 27.83 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.627 2.218 . . . . 0.0 112.262 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 316' ' ' LEU . 1.3 pt? -144.87 53.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -56.04 -32.81 64.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -63.27 -34.34 77.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 316' ' ' LEU . 2.8 t30 -70.82 -44.38 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 323' ' ' ILE . 68.1 mt -56.27 -45.43 80.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.699 ' HG2' HD22 ' A' ' 159' ' ' LEU . 13.8 ttt180 -58.45 -47.56 83.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -39.42 81.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 320' ' ' LEU . 33.7 mt -57.12 -44.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.6 HD22 HD23 ' A' ' 155' ' ' LEU . 53.8 mt -78.28 -48.21 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -60.4 -49.86 75.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -58.52 -40.36 82.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.77 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.08 -29.29 59.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.399 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.1 mt -65.01 -39.47 93.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -30.72 69.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.1 pt -106.59 27.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.18 38.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.6 164.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -176.76 37.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.814 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.615 ' OD2' HD12 ' A' ' 328' ' ' LEU . 8.7 m-20 -78.31 85.13 4.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -109.14 -29.22 8.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 137.04 43.46 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.2 -177.22 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 193' ' ' VAL . 12.9 mt -113.14 -9.99 13.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.415 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.03 29.86 0.76 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.616 ' HB2' HD13 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -139.01 68.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.804 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 341' ' ' LEU . 2.4 t 66.35 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 344' ' ' VAL . 6.2 m -149.67 83.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.39 174.76 10.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -137.79 -50.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 76.08 169.58 28.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -152.81 -175.58 24.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.16 31.3 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -104.73 106.03 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.79 90.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.51 107.25 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 2.6 p -151.54 35.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 27.2 mm 59.85 105.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 63.4 p -94.78 -34.43 12.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.17 144.49 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -138.1 -60.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.746 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.93 132.45 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -96.95 168.55 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -168.7 -49.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.77 94.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.7 tp -149.41 138.62 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.37 -47.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -105.36 141.74 36.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.7 p -171.68 -57.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -96.77 -32.1 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.72 124.4 81.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.16 -169.21 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.435 2.09 . . . . 0.0 112.372 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -153.33 160.49 29.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.507 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.44 92.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.84 114.32 28.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.97 -32.64 9.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.4 p -71.86 179.92 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 62.92 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 62.48 118.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.983 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.8 t -94.08 47.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -157.35 103.12 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.7 m 61.15 163.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -83.46 139.56 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 7.1 p -143.93 76.73 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -125.86 -44.8 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 134.0 35.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -119.76 149.85 41.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 384' ' ' ILE . 3.6 mp -80.71 -48.56 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLN . . . . . 0.66 ' O ' HG23 ' A' ' 386' ' ' THR . 36.2 mt-30 60.05 31.18 20.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 385' ' ' GLN . 1.0 OUTLIER -166.67 94.26 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.07 133.61 51.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.6 m -139.22 94.12 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.36 103.39 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.56 -46.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.44 162.59 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.32 132.08 10.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.69 -179.65 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.76 122.95 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.197 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -93.2 84.02 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.869 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 64.5 m -60.8 138.13 58.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.5 m -86.38 132.63 33.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -166.69 174.36 42.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.3 m -106.61 163.7 12.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 29.1 t -118.15 95.14 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 147.96 64.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.88 111.7 13.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.55 101.8 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.476 2.117 . . . . 0.0 112.321 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -85.76 176.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 4' ' ' VAL . 11.2 p -138.59 59.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.68 -70.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.6 165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.88 31.96 6.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.039 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.02 29.84 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.06 36.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.97 -116.47 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 133.31 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.897 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -129.74 153.02 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.988 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -153.61 127.77 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.35 84.63 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.61 89.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -165.52 138.77 4.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -86.8 157.35 19.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -145.87 123.37 11.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tt -136.5 129.96 31.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.01 -53.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 24' ' ' ALA . 7.9 pt-20 -132.49 164.35 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -64.85 -72.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.853 ' CE2' HG21 ' A' ' 29' ' ' ILE . 52.8 p90 -154.47 120.03 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -171.67 138.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.108 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 65.03 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 25.8 71.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.593 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.77 137.56 41.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 36' ' ' GLU . 11.4 mt -105.18 141.29 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.934 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.7 pt -119.91 154.61 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.2 m -95.49 139.47 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.675 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 17.0 p-10 -98.3 -149.81 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.0 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -38.09 18.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.402 . . . . 0.0 110.324 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.99 -0.12 33.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.837 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER 85.02 16.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.289 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.77 173.52 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.611 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -122.69 78.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 110.532 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.46 128.56 37.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -88.21 124.02 33.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 23' ' ' PHE . 21.2 t -81.53 122.65 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.14 -121.56 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD23 ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -116.52 164.56 17.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.696 ' HD2' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -71.07 118.43 5.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.542 2.161 . . . . 0.0 112.279 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 53' ' ' LEU . 1.6 pt -107.02 30.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.68 137.57 2.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -59.11 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.19 108.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.76 -48.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -152.08 -64.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 -75.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.482 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 6.4 m -136.93 80.61 1.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.7 mp -88.69 104.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.678 ' O ' HG12 ' A' ' 70' ' ' VAL . 23.3 m-85 -129.55 163.59 25.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 43' ' ' ILE . 50.4 mt -73.29 165.91 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -138.5 152.46 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.273 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -136.34 159.74 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.29 29.85 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 t30 58.97 -168.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t 61.56 45.27 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -169.03 126.33 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.988 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.39 116.11 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m 60.75 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 21.8 t -59.24 -57.36 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -151.37 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.551 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 m -100.84 37.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.02 30.67 5.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -85.72 119.55 72.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -87.5 30.17 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.797 2.331 . . . . 0.0 112.927 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.76 148.13 28.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.77 HG13 ' CG ' ' A' ' 133' ' ' ARG . 2.8 m -119.12 153.88 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 52' ' ' TYR . 6.7 p -137.67 134.59 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -121.58 116.76 25.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.68 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.859 HG22 ' CB ' ' A' ' 128' ' ' PHE . 7.8 t -113.37 149.54 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -137.57 136.19 20.03 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.892 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 32.6 Cg_exo -57.93 82.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.514 2.143 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 53.62 29.67 9.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.9 120.77 33.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.61 41.52 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.1 -79.09 1.43 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.09 -43.41 2.4 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.538 2.159 . . . . 0.0 112.35 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HG ' HD23 ' A' ' 84' ' ' LEU . 24.9 tp -60.13 -30.1 69.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.46 -32.3 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.7 p -77.76 -31.7 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -68.33 -46.58 69.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.1 mm? -66.01 -45.82 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -60.35 -29.67 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.876 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.5 m-85 -65.9 -60.3 2.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -17.84 64.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.773 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -18.99 60.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.59 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -62.22 -15.28 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -47.95 130.2 11.88 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.0 -24.32 19.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -79.32 -33.2 43.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.4 -42.51 25.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.8 mt -65.72 -55.26 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -50.76 -31.94 18.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -34.67 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.28 -46.06 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 105' ' ' LEU . 41.5 mm -64.48 -36.52 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.238 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -75.01 -27.72 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -76.65 -38.8 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.342 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -105.46 -3.73 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.254 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 100' ' ' ILE . 16.7 tttt 60.09 30.9 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 100' ' ' ILE . 43.8 mt -49.93 -32.08 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.253 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -55.91 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.98 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -142.21 138.59 31.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.758 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.739 HD21 ' CG ' ' A' ' 167' ' ' TYR . 13.2 tp -114.68 -66.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 132.46 -7.21 5.3 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.822 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.7 t -71.66 136.0 83.38 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.666 0.233 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.5 142.58 80.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.59 2.193 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.97 121.72 26.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -98.7 131.36 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -110.39 -40.83 4.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.065 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.97 -174.58 46.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.655 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -132.97 164.05 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -149.24 174.65 28.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.275 -0.965 . . . . 0.0 113.168 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 127' ' ' ARG . 3.3 mt -145.23 145.15 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.716 0.293 . . . . 0.0 110.741 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -121.81 135.8 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -113.65 121.44 44.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -138.2 126.24 22.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 55.93 20.6 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.364 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.98 -4.99 61.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.903 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -96.04 129.08 43.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 110.776 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.4 t -100.44 122.99 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -105.81 143.59 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.755 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.644 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -107.31 129.27 54.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.934 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.2 p90 -141.52 159.24 42.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.442 ' HB2' HD21 ' A' ' 84' ' ' LEU . 8.1 tmm? -128.13 147.59 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 29' ' ' ILE . 20.2 mt -123.32 112.76 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 111.377 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -121.96 173.3 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.94 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.99 149.66 2.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.77 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.51 168.09 13.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 184' ' ' LEU . 80.6 m-85 -141.46 160.82 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.808 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.77 -94.57 0.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.96 130.69 55.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.827 ' OD1' HD22 ' A' ' 184' ' ' LEU . 6.0 m-20 -57.67 159.83 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.734 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -59.4 -31.01 68.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.585 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -59.44 -45.14 92.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.387 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.49 70.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.378 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.751 HD13 HD22 ' A' ' 341' ' ' LEU . 10.9 mt -80.17 -26.94 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.454 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 16.3 t80 -66.88 -50.84 61.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -29.31 68.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.572 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.753 ' HB1' HG23 ' A' ' 344' ' ' VAL . . . -61.5 -24.7 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.084 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-80 -94.47 15.66 17.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.84 45.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.14 19.71 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.326 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 23.9 mtm180 -145.17 -175.63 4.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.1 OUTLIER -141.93 171.17 14.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 153' ' ' THR . 3.4 m -97.08 157.64 15.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.585 ' HA ' HD21 ' A' ' 255' ' ' LEU . 7.5 mtm-85 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -72.54 -42.62 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.944 HG22 ' HB2' ' A' ' 340' ' ' ASP . 18.6 p -60.75 -43.63 97.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' A' ' 251' ' ' MET . 38.7 t -65.89 -49.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 331' ' ' ILE . 33.2 mt -60.52 -47.28 86.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -59.83 -46.78 88.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.498 HD22 HG11 ' A' ' 193' ' ' VAL . 27.6 mt -69.97 -43.54 71.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD13 ' A' ' 324' ' ' LEU . 51.2 p -54.4 -34.42 61.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.4 mt -74.71 -41.41 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -45.74 77.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.688 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.4 mt -63.65 -34.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.762 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.507 HD11 ' HE2' ' A' ' 302' ' ' TYR . 9.7 mt -64.38 -40.19 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -38.27 84.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.52 -39.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 47.7 mt -59.11 -45.07 91.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.591 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -66.7 -33.95 76.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.658 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.739 ' CG ' HD21 ' A' ' 108' ' ' LEU . 60.6 t80 -65.51 -51.85 57.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.618 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.0 pt -72.28 -27.28 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.537 ' CE1' HG12 ' A' ' 174' ' ' VAL . 1.5 m-70 -76.16 -32.48 59.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -16.93 62.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -101.38 3.61 40.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.818 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 78.08 45.36 0.07 Allowed 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.088 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -134.31 142.31 47.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.507 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.586 HG22 ' HD1' ' A' ' 204' ' ' TYR . 28.9 m -142.22 138.88 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.138 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.91 -67.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 81.31 36.54 20.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.626 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.87 -89.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.96 -0.141 . . . . 0.0 110.919 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.0 mp 41.38 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.832 0.349 . . . . 0.0 111.718 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 24.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.297 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . 65.96 9.86 6.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.65 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.8 p -113.63 1.48 14.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.47 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.2 m120 -134.71 4.76 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.146 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 1.9 mt -108.48 117.71 34.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.719 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.827 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -126.78 146.66 50.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.347 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 341' ' ' LEU . 21.9 mt -89.84 149.66 22.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.84 128.01 34.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.446 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 19.7 t80 -71.0 -58.82 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -21.6 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.603 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -129.24 71.08 82.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 86.25 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.52 2.147 . . . . 0.0 112.126 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -177.98 37.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -178.15 172.37 1.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.388 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.505 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.1 p -132.64 147.63 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.391 . . . . 0.0 110.693 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 22.6 m-85 -127.27 156.88 41.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.986 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 183' ' ' LEU . 10.8 tp -103.93 115.83 31.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.514 HG21 HD11 ' A' ' 184' ' ' LEU . 16.6 m -107.41 179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.32 108.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.709 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 15.8 m-85 -117.39 28.18 8.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 200' ' ' LEU . . . -54.01 -28.74 41.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.966 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 199' ' ' GLY . 10.9 mp -115.63 11.67 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 110.947 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -100.24 68.38 1.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.239 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -126.21 149.37 49.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.253 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 39.5 ttp180 -54.26 96.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.586 ' HD1' HG22 ' A' ' 174' ' ' VAL . 44.6 p90 -60.39 -47.94 83.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 107.32 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.945 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 204' ' ' TYR . 72.5 Cg_endo -78.8 -47.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.336 2.024 . . . . 0.0 112.303 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 176.99 -37.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 102.28 23.14 9.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 209' ' ' VAL . 9.7 m -149.45 97.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.298 . . . . 0.0 111.048 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 26.6 m170 62.36 -80.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -168.59 156.38 7.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.932 0.396 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -148.65 131.55 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 171.44 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.91 66.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.634 ' HG2' ' HB2' ' A' ' 237' ' ' ALA . 11.7 tp10 -64.54 -43.69 93.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 5.3 t0 -104.23 121.87 46.02 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 23.3 Cg_exo -64.49 -10.94 26.14 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.554 2.169 . . . . 0.0 112.894 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -93.28 5.43 51.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.582 0.23 . . . . 0.0 111.218 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 53.91 24.3 4.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.745 0.307 . . . . 0.0 110.981 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 1.8 t -163.8 128.76 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.35 87.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.413 ' CB ' ' HB1' ' A' ' 232' ' ' ALA . 5.6 p30 -150.47 179.69 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -122.55 -38.81 0.57 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -140.96 -178.34 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.798 HG12 HG11 ' A' ' 271' ' ' VAL . 8.7 tt -133.74 10.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.347 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 265' ' ' LEU . 27.4 tt0 -67.74 -13.67 62.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.313 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.493 ' HB3' HG23 ' A' ' 246' ' ' ILE . 8.5 m-85 -165.14 29.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.68 130.45 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.54 -47.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.236 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.0 mt -57.03 -59.27 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.153 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.65 -28.18 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.413 ' HB1' ' CB ' ' A' ' 222' ' ' ASP . . . -71.34 -49.17 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.623 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -57.4 -27.61 62.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.299 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.689 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.0 OUTLIER -101.53 1.87 38.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.341 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.52 21.1 40.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.686 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 234' ' ' ASN . 26.4 t -80.51 158.5 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 111.086 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.634 ' HB2' ' HG2' ' A' ' 215' ' ' GLU . . . -80.72 130.65 63.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.44 74.51 3.68 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 204' ' ' TYR . 0.6 OUTLIER -77.39 73.31 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.003 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 73.25 -57.62 0.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.334 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -58.94 -28.49 66.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -80.21 -33.97 30.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.528 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.9 -44.65 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.88 -44.4 86.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.299 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.28 -29.32 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 227' ' ' PHE . 73.0 mt -76.02 -37.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.758 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.8 tp -66.44 -36.28 82.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.23 -28.02 72.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.41 -25.93 46.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 62.7 m -66.62 -32.84 74.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.011 0.434 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.677 ' HA ' HG11 ' A' ' 154' ' ' VAL . 1.1 mmm -60.24 -52.59 64.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.174 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -74.17 -38.55 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.625 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.567 ' HB2' HD21 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -64.71 -39.95 94.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.219 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 38.5 m0 -82.28 -32.34 29.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.504 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 151' ' ' ARG . 56.9 mt -83.58 -37.37 23.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 111.475 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.9 m -96.21 -9.25 30.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.499 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.1 94.35 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.444 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 18.8 m80 62.28 150.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 253' ' ' GLN . 0.3 OUTLIER -111.24 158.49 35.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.69 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.457 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 45.2 Cg_endo -68.32 61.94 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.557 2.171 . . . . 0.0 112.413 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.631 ' HB2' HG22 ' A' ' 271' ' ' VAL . 4.8 p90 175.64 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.463 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.9 tt0 -88.61 10.91 18.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.34 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.3 -47.61 81.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -131.97 -28.32 1.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.399 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.607 HD22 HG23 ' A' ' 225' ' ' ILE . 67.5 mt 71.55 11.29 6.52 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -16.25 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.278 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -131.23 100.75 16.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.94 13.38 2.36 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.638 2.225 . . . . 0.0 112.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -73.73 -46.66 44.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.5 p90 -83.92 -26.44 29.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.798 HG11 HG12 ' A' ' 225' ' ' ILE . 28.7 t -63.03 -39.59 85.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.092 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -52.62 10.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.312 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 75.2 m -56.21 -40.22 73.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.331 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.6 -44.67 93.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 27.9 mm -71.1 -33.08 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.734 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -81.08 -52.17 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -61.99 -35.42 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.024 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -26.5 42.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.359 . . . . 0.0 110.751 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -118.28 20.6 13.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -142.52 45.34 1.62 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.083 0.468 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' CB ' ' A' ' 303' ' ' MET . 26.7 mt -50.45 -40.17 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.65 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.174 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.96 -38.37 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.1 pp -74.01 -39.69 63.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.478 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 8.5 mtt -69.0 -44.29 73.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -39.02 92.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.91 -24.87 32.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.889 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 75.9 m -92.02 -41.35 10.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.66 0.267 . . . . 0.0 111.713 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.74 155.27 58.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.45 179.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.634 2.223 . . . . 0.0 112.278 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -111.25 67.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.67 88.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.9 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 61.41 153.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -93.26 121.7 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.15 -61.91 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.54 -24.53 30.26 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.02 -64.37 0.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.465 HG23 ' HG3' ' A' ' 251' ' ' MET . 25.8 mm -72.96 -43.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.02 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.51 -42.16 10.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.506 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.49 93.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 306' ' ' VAL . 25.6 t80 -69.51 -40.07 77.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.727 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.9 mtp -68.31 -38.6 81.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.68 -45.36 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.76 ' HB ' HD21 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -64.98 -32.88 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.389 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.904 ' HA ' HD12 ' A' ' 309' ' ' LEU . 36.5 t -77.24 -24.88 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -37.72 42.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.164 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.53 -14.54 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.363 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -51.27 96.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.9 88.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.24 30.43 20.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.95 -32.99 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.923 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.566 ' HB3' HD12 ' A' ' 316' ' ' LEU . 2.5 tt0 -172.17 104.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.405 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 9.0 mttm -58.88 -60.54 10.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 59.4 Cg_endo -71.84 62.27 3.1 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.464 2.109 . . . . 0.0 112.384 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.76 HD21 ' HB ' ' A' ' 305' ' ' THR . 0.3 OUTLIER -80.27 -22.28 41.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.086 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.43 ' CG ' ' HG2' ' A' ' 166' ' ' GLU . 34.0 m-85 -52.84 -39.43 62.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 111.047 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.63 -36.48 78.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.0 -45.89 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 323' ' ' ILE . 35.9 mt -56.47 -38.24 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.032 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -43.62 88.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.34 -35.54 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 320' ' ' LEU . 70.9 mt -58.35 -47.12 88.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.025 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.789 HD13 ' OG ' ' A' ' 158' ' ' SER . 47.4 mt -73.64 -51.63 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -56.34 -49.71 73.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.192 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.53 -39.89 74.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -28.14 72.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.722 HD12 HD23 ' A' ' 325' ' ' LEU . 81.3 mt -60.05 -32.52 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -66.88 -30.2 70.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.87 -18.89 55.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.532 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 331' ' ' ILE . 1.3 pp -143.8 84.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 111.333 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 127.23 -33.9 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.704 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.38 101.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.6 mttm 61.71 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 328' ' ' LEU . 0.8 OUTLIER -128.82 115.79 18.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -170.21 37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -152.54 -43.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -106.86 132.24 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 192' ' ' GLN . 27.3 mt -96.91 -4.41 40.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.359 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.944 ' HB2' HG22 ' A' ' 153' ' ' THR . 3.9 m-20 62.12 19.55 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.769 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 141' ' ' ILE . 15.2 mt -93.29 48.3 1.31 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 110.637 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.465 ' C ' HG23 ' A' ' 343' ' ' VAL . 0.4 OUTLIER -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.997 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 141' ' ' ILE . 2.2 t 68.3 28.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.753 HG23 ' HB1' ' A' ' 144' ' ' ALA . 21.9 t 58.38 75.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.96 82.9 4.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.75 89.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.817 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -136.39 48.63 0.91 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.519 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -82.33 128.28 8.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.33 174.78 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 0.0 110.846 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -107.34 128.04 54.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -158.27 -47.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.63 169.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.7 t -101.83 160.87 14.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.8 pt -66.85 153.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 9.5 t -162.83 152.99 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.85 105.66 1.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -130.41 36.18 3.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 61.15 105.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -118.57 102.48 8.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -95.13 -179.02 4.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -130.65 -172.88 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.07 102.82 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.54 164.43 30.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 89.11 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 -42.1 2.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.99 53.43 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.94 133.31 21.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.777 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.41 -172.05 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.487 2.125 . . . . 0.0 112.377 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 170.55 -142.33 7.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.06 179.08 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.0 66.27 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.38 104.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.5 t -156.34 170.39 22.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -162.25 140.95 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -47.29 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.81 163.85 20.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -108.96 -26.83 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.4 m 64.16 83.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -155.31 90.11 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -63.46 1.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -79.73 172.21 14.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.02 127.98 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.39 -43.31 12.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.77 108.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -61.79 137.99 58.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.65 88.09 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.12 -67.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 -174.09 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.42 -60.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 m -132.3 125.17 30.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.48 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.966 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -99.08 -36.76 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 108.36 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.26 143.22 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 94.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 45.8 t -140.01 -60.69 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.332 . . . . 0.0 110.937 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.76 85.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 128.71 -172.87 19.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.5 m -128.07 101.66 6.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.7 m -112.21 154.3 25.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 176.15 -87.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 104.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.582 0.23 . . . . 0.0 110.851 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.85 165.7 27.01 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.405 2.07 . . . . 0.0 112.24 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -120.24 -67.14 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.82 147.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.163 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -116.89 -39.08 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 34.09 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.68 152.64 51.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -138.28 22.61 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.37 100.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.277 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.78 93.33 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.588 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -164.92 123.12 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.11 91.55 6.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.928 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -62.89 93.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -91.99 144.85 25.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.21 138.21 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.018 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -149.26 127.62 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -74.86 -178.37 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.7 175.98 9.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.39 77.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.58 -167.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.057 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -106.55 -53.09 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.468 ' NE2' ' HG3' ' A' ' 121' ' ' LYS . 1.1 tp60 -83.0 -72.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' CE2' HG21 ' A' ' 72' ' ' VAL . 6.5 m-85 -118.27 108.11 14.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.83 -178.83 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.19 110.49 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.82 25.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.554 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 28' ' ' ILE . 2.2 mt-10 -55.62 177.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 27' ' ' GLU . 28.1 mm -130.41 131.31 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 28.9 pt -118.41 154.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.1 t -95.54 138.49 33.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.977 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -95.2 -160.92 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -77.18 -43.8 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 109.967 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.84 -2.2 35.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER 87.31 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' THR . 11.4 mtpt -74.13 178.19 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.64 77.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' HB2' HG13 ' A' ' 29' ' ' ILE . 67.2 m95 -72.75 141.76 48.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 127.88 46.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.974 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 23' ' ' PHE . 31.7 t -92.83 158.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 39' ' ' VAL . . . -123.91 -125.13 2.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.555 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.81 164.03 37.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.473 ' O ' HG23 ' A' ' 43' ' ' ILE . 65.3 Cg_exo -51.28 -180.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.544 2.162 . . . . 0.0 112.387 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 53' ' ' LEU . 15.0 pt -157.37 -43.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.215 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -145.89 177.21 24.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.503 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -108.11 44.61 1.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -72.69 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.6 -152.19 28.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.543 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.93 32.37 1.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.41 -103.66 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 1.9 m -142.48 71.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.07 115.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 15.4 m-85 -140.17 165.2 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 43' ' ' ILE . 4.0 mt -70.97 156.71 39.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.15 159.39 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.075 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.12 155.63 40.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.3 ptm -101.07 38.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.92 111.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -175.22 3.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 p -64.93 -45.45 85.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -179.04 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.24 -175.68 5.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.47 146.29 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' HD13 ' A' ' 53' ' ' LEU . . . 170.02 -89.37 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -89.45 -30.35 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.98 53.26 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.48 96.31 41.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.52 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.691 2.261 . . . . 0.0 113.025 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.1 m -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 133' ' ' ARG . 16.2 m -119.33 158.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.727 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HG12 ' A' ' 130' ' ' ILE . 7.8 p -140.34 129.9 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -111.1 123.61 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.451 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 128' ' ' PHE . 18.0 t -113.13 141.69 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.472 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.38 133.79 24.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.605 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 88.12 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.439 2.093 . . . . 0.0 112.326 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m 54.44 -171.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 60.42 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -135.36 -178.22 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.18 -82.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.43 -41.64 6.31 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.62 2.213 . . . . 0.0 112.374 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.718 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.0 tp -65.46 -30.64 71.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -32.72 72.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.421 HG21 ' CA ' ' A' ' 200' ' ' LEU . 1.4 m -78.37 -43.34 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.6 tt0 -64.07 -46.36 84.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.718 HD23 ' HG ' ' A' ' 80' ' ' LEU . 2.7 mm? -61.6 -51.15 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -51.9 66.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 198' ' ' TYR . 15.5 t80 -63.99 -33.73 76.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-85 -72.47 -46.23 55.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -27.17 65.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.7 -47.45 8.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' A' ' 171' ' ' HIS . . . -103.06 -33.68 9.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -91.96 26.87 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.9 133.74 65.36 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.33 -32.84 89.95 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -37.11 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.157 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -58.01 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.795 HD11 ' HA ' ' A' ' 91' ' ' ALA . 54.3 mt -53.27 -49.38 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.56 -43.34 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 111.089 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 102' ' ' THR . 0.2 OUTLIER -70.76 -28.6 64.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -51.06 11.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.703 HG23 ' C ' ' A' ' 105' ' ' LEU . 27.0 mm -57.2 -37.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.257 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -74.86 -27.8 60.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.402 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' LYS . 15.4 p -82.15 -38.77 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -1.63 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.456 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 32.84 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.703 ' C ' HG23 ' A' ' 100' ' ' ILE . 11.8 mt -83.2 58.94 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.58 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.92 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.653 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.18 122.05 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.91 0.386 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 167' ' ' TYR . 12.6 tp -121.86 159.77 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.558 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.47 17.09 57.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.86 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.19 127.12 43.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.594 0.197 . . . . 0.0 111.072 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.05 141.15 48.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.281 1.987 . . . . 0.0 112.283 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.47 115.43 22.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -96.88 127.63 43.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.706 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 7.2 m95 -103.04 -40.81 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -177.68 46.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.595 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -135.32 161.79 34.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.607 0.241 . . . . 0.0 110.545 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -153.79 -179.42 29.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.647 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 127' ' ' ARG . 3.3 mp -145.32 159.83 42.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.037 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -132.11 141.7 49.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.831 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.43 125.29 47.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.468 ' HG3' ' NE2' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -138.12 126.2 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.909 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 51.89 23.82 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.89 21.24 40.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.58 159.33 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.769 0.318 . . . . 0.0 110.71 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m -112.74 120.5 41.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -118.18 121.34 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.788 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 118' ' ' LEU . 3.7 mtt180 -107.77 129.28 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.54 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 24.0 p90 -140.04 160.3 40.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 111.235 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.653 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.6 tmm? -128.16 140.03 52.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.401 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.403 HG12 ' CG2' ' A' ' 70' ' ' VAL . 12.9 mt -110.63 111.82 37.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.453 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -127.82 173.22 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.27 141.68 45.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 69' ' ' VAL . 60.4 ttt-85 -73.81 161.92 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.418 ' CD2' HD12 ' A' ' 184' ' ' LEU . 79.1 m-85 -130.96 170.38 14.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.97 -52.16 1.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.6 m -157.93 171.89 19.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -98.82 153.73 18.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.2 mm? -60.03 -33.47 72.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.728 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -61.73 -46.52 89.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.848 0.356 . . . . 0.0 110.282 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -58.71 -28.57 65.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 1.055 HD13 HD22 ' A' ' 341' ' ' LEU . 35.1 mt -75.32 -26.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -58.13 -47.65 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.683 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.28 -26.74 68.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.791 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 343' ' ' VAL . . . -72.85 -20.93 61.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 17.0 m120 -94.57 4.19 54.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 85.32 45.86 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.043 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 19.77 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.273 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -162.99 117.43 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.56 -172.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -121.43 158.08 29.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.738 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -34.1 73.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.669 ' CB ' HD13 ' A' ' 331' ' ' ILE . 10.6 pttt -74.71 -37.74 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 339' ' ' LEU . 1.7 m -73.7 -40.75 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 150' ' ' SER . 38.5 t -68.04 -44.51 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.542 HD11 ' HG2' ' A' ' 298' ' ' GLU . 22.9 mt -58.33 -54.26 49.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -56.99 -46.99 81.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 1.028 HD23 HD22 ' A' ' 339' ' ' LEU . 39.0 mt -65.76 -38.41 88.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.431 ' CB ' HD13 ' A' ' 324' ' ' LEU . 66.3 m -56.87 -34.11 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.708 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 321' ' ' ARG . 9.7 mt -73.31 -45.5 55.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.686 ' HG3' HD21 ' A' ' 339' ' ' LEU . 23.6 mmm180 -61.73 -45.07 95.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.791 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.74 ' HA ' HD12 ' A' ' 164' ' ' ILE . 18.3 mt -65.83 -33.04 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.932 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.534 HD23 HD12 ' A' ' 165' ' ' LEU . 11.0 mt -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -40.62 91.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 161' ' ' ILE . 4.0 mt -67.94 -42.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.551 HD22 ' OD2' ' A' ' 243' ' ' ASP . 89.6 mt -55.12 -43.77 74.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.973 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 317' ' ' TYR . 2.1 tt0 -66.0 -37.3 85.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.799 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.489 ' CG ' HD21 ' A' ' 108' ' ' LEU . 79.1 t80 -70.82 -54.66 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.81 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.42 HD13 ' HE2' ' A' ' 198' ' ' TYR . 38.1 pt -59.01 -27.6 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.174 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.51 ' CE1' HG12 ' A' ' 174' ' ' VAL . 2.2 m80 -69.05 -44.17 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.19 -14.45 61.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -99.03 2.87 46.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 72.89 43.05 0.44 Allowed 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.094 0.473 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.727 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 0.7 OUTLIER -140.88 110.38 6.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 204' ' ' TYR . 19.3 m -131.16 139.48 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.619 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -175.76 160.26 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.534 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.842 ' HA3' HD13 ' A' ' 246' ' ' ILE . . . -109.43 71.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.612 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 30.98 2.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.642 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mt -100.74 94.49 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -152.65 24.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.27 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.728 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 68.2 8.21 6.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.806 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -110.48 0.24 17.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -141.65 7.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.791 ' C ' HD23 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -108.66 114.45 28.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.048 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -124.75 148.16 48.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 141' ' ' ILE . 6.6 mt -95.03 149.25 21.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.949 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 1.0 OUTLIER -89.38 132.37 35.0 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.111 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -122.21 -31.38 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -24.29 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.796 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.528 ' CB ' ' HD3' ' A' ' 190' ' ' PRO . 0.5 OUTLIER -166.16 -57.86 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.772 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 189' ' ' ASN . 24.3 Cg_exo -61.25 -133.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.306 2.004 . . . . 0.0 112.376 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 186' ' ' ASN . 0.2 OUTLIER 171.92 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.247 -0.283 . . . . 0.0 111.72 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 1.2 mt-30 -85.95 -169.13 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -109.58 147.94 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 11.0 m-85 -129.5 151.42 50.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.035 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.747 HD23 ' CZ ' ' A' ' 198' ' ' TYR . 14.2 tp -104.04 115.97 31.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.508 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.3 131.88 60.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 20.0 t0 62.61 124.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.747 ' CZ ' HD23 ' A' ' 195' ' ' LEU . 10.1 m-85 -105.45 14.85 28.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.201 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.611 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 83.08 -55.28 5.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.626 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 199' ' ' GLY . 6.8 mp -139.18 -42.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.649 0.261 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 173' ' ' TYR . . . 64.17 101.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.688 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.825 ' CZ ' ' HB1' ' A' ' 237' ' ' ALA . 44.4 t80 -115.73 148.99 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.983 0.42 . . . . 0.0 111.017 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -95.57 78.21 3.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 174' ' ' VAL . 7.8 p90 -44.53 -34.47 2.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.524 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.84 136.48 85.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.78 171.14 18.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.445 2.097 . . . . 0.0 112.262 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.95 -40.45 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.84 44.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.93 -61.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -112.86 135.25 53.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.985 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -102.4 37.86 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.9 -168.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 215' ' ' GLU . 1.1 p90 -98.36 -177.87 3.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -54.04 4.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 213' ' ' TYR . 7.3 tt0 62.94 102.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' N ' ' HD3' ' A' ' 217' ' ' PRO . 4.3 t0 57.98 62.99 4.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 216' ' ' ASP . 32.1 Cg_exo -58.2 -59.81 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.49 2.127 . . . . 0.0 112.147 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.22 -46.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.851 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -169.54 69.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 98.6 m 60.02 165.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -133.79 -54.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.45 143.98 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -100.96 -134.07 8.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.567 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 226' ' ' GLU . 0.2 OUTLIER 60.79 65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.916 0.388 . . . . 0.0 110.88 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.92 HG23 HD22 ' A' ' 265' ' ' LEU . 6.2 tp -60.63 -18.46 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 224' ' ' THR . 1.6 pt-20 -59.92 -30.86 69.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.547 ' HB3' HG23 ' A' ' 246' ' ' ILE . 24.8 m-85 -149.25 34.87 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.305 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.705 HG22 HD12 ' A' ' 225' ' ' ILE . 12.6 t -81.51 116.83 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.303 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 m -64.85 153.43 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.62 -30.45 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 -40.28 74.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.88 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.53 -25.52 64.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.4 7.56 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 78.56 23.42 64.96 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.714 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.72 128.19 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.825 ' HB1' ' CZ ' ' A' ' 202' ' ' TYR . . . -82.7 -53.71 0.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 40.6 Cg_exo -56.88 94.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.466 2.111 . . . . 0.0 112.225 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 m -106.48 120.07 40.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.427 ' HG3' ' CD2' ' A' ' 204' ' ' TYR . 7.8 mtm105 -125.61 -47.8 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.44 -14.12 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.52 -49.68 71.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.692 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD2' HD22 ' A' ' 165' ' ' LEU . 1.5 m-20 -54.53 -38.99 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 320' ' ' LEU . 57.8 mt -74.44 -42.55 58.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.79 -35.13 72.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.842 HD13 ' HA3' ' A' ' 176' ' ' GLY . 11.7 mt -70.18 -44.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.504 HD23 ' OH ' ' A' ' 302' ' ' TYR . 23.8 tp -59.43 -41.47 89.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -60.57 -31.37 74.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.177 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -78.33 -25.72 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 67.2 m -68.03 -32.92 73.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.768 ' O ' HD12 ' A' ' 255' ' ' LEU . 1.7 mmm -58.54 -53.48 57.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.198 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.7 mp -76.93 -39.86 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.754 ' HB2' HD21 ' A' ' 259' ' ' LEU . 1.3 tm0? -59.28 -40.15 85.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.534 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 26.3 m0 -82.43 -46.17 13.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 251' ' ' MET . 6.9 mt -72.89 -25.87 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.8 m -104.5 0.67 29.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.3 88.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.374 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.5 m170 62.9 163.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.859 HD22 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -131.45 164.26 43.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.713 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.72 62.54 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.419 2.079 . . . . 0.0 112.407 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.859 ' CZ2' HD22 ' A' ' 259' ' ' LEU . 4.0 p90 177.24 -37.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.154 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.3 tt0 -91.88 12.58 21.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.316 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.76 -53.76 54.25 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.3 m-20 -131.38 -29.1 1.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.367 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.92 HD22 HG23 ' A' ' 225' ' ' ILE . 54.6 mt 73.89 9.87 4.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -77.02 -16.03 59.42 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.161 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.46 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.7 m-20 -136.21 99.89 10.79 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.799 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.12 16.63 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.647 2.231 . . . . 0.0 112.768 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -79.95 -44.93 19.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.347 . . . . 0.0 110.775 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 3.4 p90 -80.55 -26.21 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 261' ' ' TRP . 27.6 t -62.96 -38.08 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.261 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -75.65 -47.32 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.114 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -52.17 62.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.33 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.6 m -55.52 -39.44 70.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.361 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.56 -44.88 96.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.356 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.5 mt -70.71 -31.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.595 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -81.06 -45.5 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 0.0 111.466 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.2 m-85 -70.85 -34.13 71.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.54 -31.39 62.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.365 . . . . 0.0 110.667 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.31 16.87 23.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.952 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -139.73 44.45 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.753 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.803 HD13 ' CB ' ' A' ' 303' ' ' MET . 30.5 mt -50.58 -39.1 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.89 -27.85 61.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -38.36 27.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 285' ' ' LEU . 1.6 pp -73.25 -39.36 65.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.419 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 10.6 mtt -71.16 -38.28 72.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.2 -41.22 97.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -24.81 33.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.3 m -89.78 -41.16 12.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.575 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.17 150.76 37.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.89 178.88 4.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.209 . . . . 0.0 112.291 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.87 30.66 4.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -88.57 -32.2 18.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -134.86 169.64 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.82 138.82 19.9 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 50.5 Cg_exo -53.51 121.24 9.14 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.317 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -147.98 -54.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.542 ' HG2' HD11 ' A' ' 155' ' ' LEU . 5.7 mp0 -62.93 -61.57 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.91 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 251' ' ' MET . 18.0 mm -76.02 -43.34 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.07 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -46.07 -47.92 17.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -59.31 -37.74 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.865 ' O ' HG23 ' A' ' 306' ' ' VAL . 85.6 t80 -72.11 -40.68 67.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.761 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.803 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.5 mtp -68.3 -41.06 81.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.632 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.4 -47.55 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 3.3 p -60.64 -36.52 78.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 302' ' ' TYR . 26.1 t -74.89 -24.72 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.022 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -30.94 54.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.52 -8.77 18.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.727 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -47.44 157.71 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.191 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 178.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 16.1 t80 77.56 -56.05 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.5 t -108.53 -39.47 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.77 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.46 112.81 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.41 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 0.0 OUTLIER -73.33 -61.28 1.48 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 58.1 Cg_endo -71.32 111.88 3.2 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.113 . . . . 0.0 112.39 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.17 25.73 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 166' ' ' GLU . 86.7 m-85 -64.75 -34.19 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.35 -30.9 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.05 -46.01 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.946 ' HA ' HD12 ' A' ' 323' ' ' ILE . 62.1 mt -57.88 -48.86 78.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.426 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -57.95 -30.64 66.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.05 -41.34 35.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 320' ' ' LEU . 17.4 mt -54.62 -41.38 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 162' ' ' LEU . 96.0 mt -75.8 -49.8 17.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.08 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.702 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -58.02 -49.92 75.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.192 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -58.51 -42.27 87.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.01 56.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.456 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 325' ' ' LEU . 25.2 mt -62.67 -28.76 70.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.732 0.301 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 4.0 mtmt -67.7 -28.54 67.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 298' ' ' GLU . . . -77.89 -18.69 55.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.666 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 152' ' ' LYS . 1.4 pp -114.12 16.95 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 108.27 43.22 1.29 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.251 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 17.7 m 58.76 177.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.218 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HB2' HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -79.64 145.79 32.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.885 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.35 162.68 11.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.52 -65.6 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -148.2 28.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.88 140.33 32.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.028 HD22 HD23 ' A' ' 157' ' ' LEU . 0.7 OUTLIER -98.55 28.25 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 62.89 28.83 16.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.208 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 141' ' ' ILE . 8.0 mt -99.86 40.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.741 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 11.0 p -61.41 -38.68 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.602 ' CG1' HG23 ' A' ' 141' ' ' ILE . 6.3 m 41.82 76.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.677 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 345' ' ' GLU . 12.6 m -135.14 -47.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 344' ' ' VAL . 2.4 mp0 -78.99 157.64 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.83 139.72 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 161.42 -94.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 93.13 -157.87 23.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.75 143.1 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.91 92.63 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.07 -163.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.51 18.97 9.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.4 m 56.08 101.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 355' ' ' THR . 2.7 tt -178.33 -43.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.457 ' N ' HG23 ' A' ' 354' ' ' ILE . 20.9 p -131.13 70.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.49 139.06 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 9.2 tttt 61.12 156.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -146.32 102.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.3 134.61 52.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.967 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -159.99 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 362' ' ' ILE . 4.2 mt-10 -156.33 151.12 26.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 361' ' ' GLU . 22.5 mm -138.05 96.84 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.83 176.35 7.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.74 151.93 20.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.23 -29.36 7.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.67 167.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.039 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -107.12 87.15 2.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.33 62.12 3.46 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 0.0 112.3 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -136.36 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 370' ' ' VAL . 10.6 p -116.7 55.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.06 134.0 48.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -171.38 -65.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.7 m -112.5 142.47 45.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.0 153.76 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -108.24 126.27 52.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.41 -175.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -142.16 135.08 28.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 2.7 p -131.83 159.86 37.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.43 175.2 6.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.955 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.5 p -130.58 136.6 49.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 146.86 29.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -105.06 97.06 6.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.54 -170.21 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.073 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.59 -28.97 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -159.5 104.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 1.6 p -100.71 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -109.17 -68.62 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 10.8 t 60.75 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.88 118.11 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.3 t -115.46 -38.94 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -106.97 131.02 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -81.4 -178.29 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.01 115.3 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.7 m -82.4 137.09 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -107.05 142.86 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.92 77.35 1.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.0 p -145.41 175.98 9.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 116.9 150.31 9.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.75 -35.65 26.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.8 t -145.07 -54.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -146.89 -170.92 15.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.409 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt -118.16 136.61 23.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.16 -45.42 41.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -96.14 -172.89 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 5' ' ' LYS . 12.3 p -172.04 -41.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -71.45 71.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.67 153.57 38.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.35 -52.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -119.56 122.78 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.89 -43.71 4.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.73 50.99 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.499 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 130.99 38.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 154.01 37.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -152.55 160.28 43.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -140.29 35.2 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.07 33.43 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -94.66 115.08 27.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.22 91.5 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -157.11 167.04 31.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -129.43 -62.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.85 80.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.42 85.91 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -123.55 -74.98 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 29' ' ' ILE . 3.8 m-85 -82.53 113.6 20.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 177.62 7.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.699 HG22 ' HG ' ' A' ' 41' ' ' LEU . 17.0 t -68.12 120.75 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.16 -24.78 29.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.6 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.16 153.52 14.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 36' ' ' GLU . 34.8 mt -123.05 140.11 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 25.8 pt -119.64 154.67 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 6.7 p -95.38 141.33 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.21 -161.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.64 -37.4 36.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.759 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -83.2 4.5 26.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.3 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 77.19 30.0 0.55 Allowed 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 1.4 mtpp -76.17 175.82 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.032 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HB2' HG21 ' A' ' 28' ' ' ILE . 7.9 pt-20 -122.32 77.34 1.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 0.0 110.678 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HB2' HG13 ' A' ' 29' ' ' ILE . 78.7 m95 -71.89 128.3 35.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.972 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -86.42 127.97 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.05 125.21 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.42 -125.6 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.555 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 25' ' ' VAL . 5.0 mp -117.76 156.92 49.26 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.99 131.35 19.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.586 2.191 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.424 HD12 ' NE2' ' A' ' 45' ' ' GLN . 23.6 pt -104.85 -36.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.9 101.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' NE2' HD12 ' A' ' 43' ' ' ILE . 2.6 mp0 -105.58 -44.19 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.28 -42.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.9 94.12 1.68 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.422 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.9 -65.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.23 -85.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -149.47 87.44 1.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 71' ' ' LYS . 23.4 mm -96.86 122.97 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.096 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 61.2 m-85 -145.91 168.28 21.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 133' ' ' ARG . 19.3 mt -82.26 154.81 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.35 157.79 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -138.23 154.86 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.56 51.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 60.51 101.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.99 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -121.81 179.43 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 144.49 32.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 67.5 -72.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.11 -169.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 55' ' ' ASP . 21.2 t -98.89 94.48 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.0 -91.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.532 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.94 30.44 4.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.33 65.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.7 94.48 48.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.76 36.46 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.286 2.657 . . . . 0.0 112.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.72 148.24 29.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.57 144.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.059 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.5 p -134.4 123.62 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' HD12 ' A' ' 51' ' ' ILE . 12.2 mttp -105.44 124.22 49.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG22 ' CB ' ' A' ' 128' ' ' PHE . 15.9 t -113.96 141.62 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.07 150.62 59.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.66 86.0 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.517 2.145 . . . . 0.0 112.215 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.6 -71.5 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -161.37 99.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.55 -26.26 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.6 -154.65 7.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.597 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.27 24.84 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.301 2.667 . . . . 0.0 112.687 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.77 -42.29 92.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.14 -44.11 95.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -67.22 -34.34 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.34 -42.91 74.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.5 mm? -57.57 -52.08 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -46.07 78.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.54 -30.74 67.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.621 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -67.56 -46.98 71.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.083 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 1.1 tt0 -79.88 -17.61 52.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.552 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -47.64 60.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.757 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 -34.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -53.95 -20.8 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 40.1 mtpt -47.46 138.29 8.76 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.659 0.266 . . . . 0.0 111.035 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.7 -18.31 47.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.496 2.131 . . . . 0.0 112.393 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.34 -35.9 40.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -79.3 -45.77 19.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 100' ' ' ILE . 62.2 mt -61.05 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -55.45 -33.68 63.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -38.98 63.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -68.95 -42.07 77.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 96' ' ' ILE . 27.3 mt -65.51 -37.5 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.042 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.79 60.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.4 m -80.97 -37.73 28.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.514 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.43 -3.51 20.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.43 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 59.96 31.85 20.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 110.657 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 100' ' ' ILE . 13.2 mt -52.4 -28.45 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mttm 76.33 -56.13 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -145.79 154.27 41.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 167' ' ' TYR . 1.5 tp -127.55 -72.88 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.612 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 127.31 1.03 6.77 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.007 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 164' ' ' ILE . 33.5 t -76.2 128.5 82.64 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.843 0.321 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.81 143.0 9.79 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -84.25 116.88 23.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.709 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -111.99 -40.68 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.94 -175.95 46.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.95 162.1 35.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.675 0.274 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.15 -175.05 21.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.65 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -145.26 158.9 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -131.84 133.85 45.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -107.79 122.6 47.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 126.22 22.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 57.73 19.51 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.275 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.29 -0.15 61.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.897 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 129.09 47.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -96.14 131.62 42.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.63 148.88 39.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -111.4 125.27 53.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.948 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 10.8 p90 -132.24 160.23 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.847 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -128.12 142.64 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 mt -116.24 116.76 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.299 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -128.88 173.16 10.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.36 144.57 20.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.049 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.574 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -59.18 179.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.992 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -151.69 145.47 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.73 -107.87 0.82 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -113.4 130.25 56.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.802 ' OD1' HD22 ' A' ' 184' ' ' LEU . 19.9 m-20 -57.76 155.91 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.5 mm? -61.04 -23.14 65.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.733 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.7 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 8.8 pt20 -68.61 -42.0 78.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.904 0.383 . . . . 0.0 110.409 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -62.8 -35.36 79.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.039 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.897 HG21 ' HB2' ' A' ' 341' ' ' LEU . 5.2 mt -78.28 -28.52 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 254' ' ' TRP . 48.4 t80 -61.16 -52.43 64.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.8 -30.42 56.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.96 -16.44 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.637 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -87.81 -2.93 58.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.135 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 95.74 41.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.063 0.545 . . . . 0.0 110.327 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 61.53 19.13 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.541 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -167.04 125.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.129 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.493 ' CD1' HG21 ' A' ' 153' ' ' THR . 0.3 OUTLIER -81.78 -176.88 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 154' ' ' VAL . 17.9 p -113.95 -176.91 3.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -71.8 -33.9 68.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -65.9 -48.08 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 340' ' ' ASP . 14.3 p -63.44 -40.22 96.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 150' ' ' SER . 47.6 t -70.78 -53.82 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.848 ' HB3' HD21 ' A' ' 328' ' ' LEU . 94.4 mt -57.21 -46.91 82.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -52.8 61.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.555 HD22 HG11 ' A' ' 193' ' ' VAL . 16.6 mt -62.28 -37.01 83.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.772 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 247' ' ' LEU . 38.5 m -58.13 -37.94 75.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 324' ' ' LEU . 35.0 mt -67.58 -48.01 68.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.91 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 178' ' ' ILE . 11.9 mt -62.75 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.5 mt -64.84 -35.08 79.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.62 -38.3 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.612 HD11 ' HA3' ' A' ' 109' ' ' GLY . 33.4 mt -74.54 -42.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 162' ' ' LEU . 6.9 mt -56.29 -43.13 78.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 32.1 tt0 -66.93 -32.78 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.8 ' CG ' HD21 ' A' ' 108' ' ' LEU . 88.9 t80 -68.22 -50.32 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.554 HD13 ' NE2' ' A' ' 175' ' ' HIS . 26.0 pt -73.41 -27.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 174' ' ' VAL . 3.6 m-70 -68.46 -32.37 72.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.299 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.98 -17.1 62.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.51 4.74 38.94 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CG ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 77.1 5.34 3.25 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.488 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 203' ' ' ARG . 4.6 m-85 -94.24 132.77 38.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.723 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 204' ' ' TYR . 30.4 m -142.37 139.06 29.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.071 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.554 ' NE2' HD13 ' A' ' 168' ' ' ILE . 3.0 p80 -115.67 -40.91 3.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.346 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 59.32 19.11 45.55 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.632 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.07 61.35 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 161' ' ' ILE . 3.9 mp -94.51 102.56 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.657 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 183' ' ' LEU . 6.2 mtmm -146.68 -175.48 4.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.687 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.7 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -84.75 3.08 39.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.6 p -106.15 -2.82 22.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.05 -2.89 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.351 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.76 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.1 mt -108.32 122.68 47.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.802 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.2 OUTLIER -131.64 160.63 34.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.76 0.314 . . . . 0.0 110.999 -178.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.5 147.08 23.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 111.194 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.6 OUTLIER -60.98 131.64 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -78.12 -53.72 7.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.77 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.843 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.15 71.81 18.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.969 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.65 101.91 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.16 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -178.0 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.596 ' CA ' HD11 ' A' ' 339' ' ' LEU . 50.5 mm-40 -113.24 159.11 19.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.555 HG11 HD22 ' A' ' 157' ' ' LEU . 3.3 p -110.21 148.29 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.99 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.548 ' CE1' ' ND2' ' A' ' 186' ' ' ASN . 13.0 m-85 -125.95 157.63 37.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.008 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.453 HD23 ' HE1' ' A' ' 198' ' ' TYR . 34.3 tp -103.32 115.97 31.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 184' ' ' LEU . 2.3 t -118.18 157.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 54.52 103.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.601 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 48.7 m-85 -97.91 -64.31 1.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.678 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 95.31 -37.66 3.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 199' ' ' GLY . 7.3 mp -128.74 22.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.601 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -78.39 60.97 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.166 0.508 . . . . 0.0 110.536 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -124.33 149.03 47.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.193 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -55.49 97.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.968 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' HG22 ' A' ' 174' ' ' VAL . 47.6 p90 -57.73 -29.76 65.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.76 75.29 78.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.79 -62.99 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.587 2.191 . . . . 0.0 112.414 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.88 90.47 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.62 -44.79 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.397 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.78 83.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.07 167.37 10.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.61 -30.99 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -129.86 -72.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.512 ' HB2' HG13 ' A' ' 236' ' ' VAL . 21.5 p90 -174.62 -178.34 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -98.93 -66.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.41 53.69 2.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -145.3 154.82 54.02 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.08 172.37 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.632 2.221 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.32 -55.19 0.48 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -10.78 60.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 56.7 m -52.57 134.24 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -151.07 87.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.72 163.43 15.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.05 -92.97 1.11 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.521 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 -63.28 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -161.65 -44.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HG2' HD13 ' A' ' 225' ' ' ILE . 14.3 mm-40 -159.26 27.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.405 ' CE2' ' HD3' ' A' ' 179' ' ' LYS . 2.7 t80 -94.63 23.8 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -141.86 -72.85 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.519 ' H ' HG23 ' A' ' 228' ' ' THR . 0.9 OUTLIER -167.99 150.32 5.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.347 . . . . 0.0 111.035 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.23 -31.57 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.5 -31.46 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.22 -30.24 63.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -75.66 -29.33 59.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.08 12.91 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.461 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.45 26.31 74.38 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.534 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 213' ' ' TYR . 20.1 t -95.63 144.63 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 111.036 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -58.17 145.13 74.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.83 -36.28 18.86 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.414 2.076 . . . . 0.0 112.23 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.6 m 59.55 33.77 22.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -56.14 0.65 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.555 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -21.76 56.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.145 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -59.03 -32.1 70.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 165' ' ' LEU . 2.5 t0 -78.68 -29.23 45.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.79 HD13 HD11 ' A' ' 320' ' ' LEU . 18.8 mt -73.84 -29.77 62.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.011 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.3 -31.98 62.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.428 HD13 ' HA2' ' A' ' 176' ' ' GLY . 2.6 mp -76.1 -38.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 158' ' ' SER . 55.2 tp -73.92 -31.23 62.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.64 -47.69 80.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.559 ' HA ' HD12 ' A' ' 252' ' ' ILE . 51.3 m-85 -78.49 -25.88 45.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 -41.44 70.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.139 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.426 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -60.27 -48.63 80.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.8 ' O ' HG22 ' A' ' 256' ' ' THR . 2.9 mt -66.37 -28.48 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.037 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.635 ' HB2' HD21 ' A' ' 259' ' ' LEU . 12.7 tm0? -80.1 -36.86 34.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.475 ' CD1' ' CE1' ' A' ' 142' ' ' TYR . 20.8 m0 -82.38 -29.89 30.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.426 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.2 mt -67.21 -47.09 71.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.392 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 252' ' ' ILE . 6.1 t -98.71 -23.35 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.327 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.442 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 101.79 14.99 27.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.817 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 166.62 170.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.851 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -133.6 159.56 72.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 261' ' ' TRP . 15.7 Cg_exo -68.33 59.97 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.748 2.299 . . . . 0.0 112.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.851 ' CH2' HD22 ' A' ' 259' ' ' LEU . 16.2 p90 177.34 -42.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.106 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -95.63 17.2 15.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.529 179.172 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -58.33 -51.61 69.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.5 t-20 -130.51 -25.92 2.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 77.2 mt 70.03 13.7 7.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.239 0.543 . . . . 0.0 109.611 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -89.81 -14.99 33.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.253 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.477 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 0.5 OUTLIER -134.98 88.61 26.47 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.93 -8.09 22.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.614 2.209 . . . . 0.0 112.664 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -54.56 -50.07 68.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.751 0.31 . . . . 0.0 111.189 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 5.7 p90 -81.73 -26.18 34.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 225' ' ' ILE . 59.4 t -60.06 -44.33 94.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.473 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -68.89 -42.27 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -36.55 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.1 m -65.61 -43.67 88.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.9 OUTLIER -62.93 -44.58 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.69 -29.68 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.435 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -49.82 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.403 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 13.2 m-85 -64.5 -39.94 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.468 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -26.33 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.28 19.07 15.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -143.81 49.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 303' ' ' MET . 16.6 mt -54.11 -35.22 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.348 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.82 -29.79 62.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 111.067 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.9 pp -73.9 -29.69 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.413 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 4.9 mmt -64.85 -47.47 77.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.01 -20.93 44.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -82.7 -50.86 8.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.694 0.283 . . . . 0.0 111.399 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.87 -41.13 30.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.334 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.63 98.92 16.04 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.084 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.92 84.72 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.474 2.116 . . . . 0.0 112.046 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.6 97.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.642 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 56.18 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -161.84 -51.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -151.16 104.74 2.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 -49.1 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.367 2.045 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.62 30.22 0.03 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER 68.39 7.92 6.29 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.737 0.268 . . . . 0.0 111.664 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.624 HG22 ' CG ' ' A' ' 303' ' ' MET . 28.8 mm -79.57 -46.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.413 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.25 -35.81 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.523 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 323' ' ' ILE . 15.1 mmtp -68.48 -41.49 80.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 306' ' ' VAL . 11.5 t80 -72.11 -34.32 68.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.748 ' CB ' HD13 ' A' ' 282' ' ' ILE . 65.3 mmm -71.78 -48.22 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 305' ' ' THR . 21.4 pt-20 -56.28 -41.41 75.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 309' ' ' LEU . 12.1 m -64.44 -42.19 96.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 302' ' ' TYR . 41.2 t -69.55 -24.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.144 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -71.65 -37.29 70.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 73.7 mt -97.53 -13.53 21.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.607 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.745 HD21 ' HA ' ' A' ' 316' ' ' LEU . 0.2 OUTLIER -63.16 120.46 11.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.91 -175.59 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.39 -19.65 56.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 16.6 p -95.57 30.68 2.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -141.3 113.26 7.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.854 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 315' ' ' PRO . 15.3 mttp -64.97 -56.45 20.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.285 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 40.1 Cg_endo -67.13 113.24 2.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.34 2.027 . . . . 0.0 112.567 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.745 ' HA ' HD21 ' A' ' 309' ' ' LEU . 5.3 tt -127.93 -74.86 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.646 ' N ' HD23 ' A' ' 316' ' ' LEU . 35.2 m-85 -70.68 -38.03 73.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.84 -46.58 84.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.066 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -73.33 -45.94 52.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 323' ' ' ILE . 52.1 mt -58.76 -51.84 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.66 -42.03 70.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -62.36 -46.76 87.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 320' ' ' LEU . 13.9 mt -51.03 -47.28 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.624 HD22 HD23 ' A' ' 155' ' ' LEU . 52.6 mt -71.54 -48.88 45.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.025 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.31 -49.97 72.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.372 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -39.09 79.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.805 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.01 -33.25 68.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 155' ' ' LEU . 11.3 mt -67.98 -38.6 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.42 -30.78 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -30.86 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.17 26.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.83 25.94 38.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.728 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 m -91.92 158.34 16.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 179.12 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.7 102.27 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.02 -28.5 12.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 163.99 -28.79 0.23 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.457 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -96.21 157.09 16.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.596 HD11 ' CA ' ' A' ' 192' ' ' GLN . 0.8 OUTLIER -98.73 32.53 2.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.771 ' HB3' HG22 ' A' ' 153' ' ' THR . 1.7 m-20 62.9 23.22 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.028 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.897 ' HB2' HG21 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -140.14 77.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.957 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.479 ' C ' HG23 ' A' ' 343' ' ' VAL . 84.2 p -67.96 -25.53 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.951 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.628 HG22 HG12 ' A' ' 141' ' ' ILE . 2.6 t 71.73 95.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m -87.16 -35.01 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.72 131.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -125.44 174.2 8.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 156.79 -169.39 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 162.23 -159.58 31.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.2 tt -127.28 138.49 53.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -96.33 129.63 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -138.59 129.23 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -65.98 178.73 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 61.0 p -121.27 -45.12 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 3.8 tt -122.04 147.86 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.21 -70.63 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -159.81 129.88 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 -67.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 57.24 94.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.74 178.13 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -127.29 178.96 5.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.66 119.13 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.4 HG22 ' HG3' ' A' ' 364' ' ' GLU . 3.2 mt -83.66 105.11 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.27 114.51 23.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.4 ' HG3' HG22 ' A' ' 362' ' ' ILE . 35.8 mt-10 -131.88 31.27 4.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.3 m -150.06 125.62 10.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -79.95 100.06 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -111.9 155.42 43.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.15 155.51 8.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.315 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.86 -45.13 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.27 138.17 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -86.71 95.4 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -91.93 -71.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.9 m -148.18 114.71 5.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.81 175.02 7.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 60.81 168.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 107.45 19.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -159.85 165.45 32.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 3.5 t -160.85 59.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.46 134.59 11.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.827 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.62 140.84 40.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.42 133.3 38.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.34 36.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -88.8 -67.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 23.6 mt 59.84 94.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.1 112.44 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.94 -59.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 60.2 104.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.1 m -124.97 38.59 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -112.16 144.93 40.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 177.28 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 394' ' ' VAL . 0.2 OUTLIER 60.77 -167.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.01 37.55 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.07 43.07 11.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 391' ' ' ARG . 28.2 t -119.46 123.56 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 60.16 36.11 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 6.0 tttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.928 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 3.2 m -64.8 161.54 17.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.813 0.339 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.2 m -103.97 176.99 4.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -78.15 -35.26 34.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 9.8 m 60.87 94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.5 t -130.34 -48.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -128.03 -46.33 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.427 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mtp -154.81 145.25 15.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.13 156.84 9.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.457 2.105 . . . . 0.0 112.255 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 60.45 110.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.45 94.4 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -81.7 145.59 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.95 -51.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.052 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.63 -68.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 60.73 98.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.24 114.9 16.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.35 -166.96 24.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.553 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.68 99.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -84.6 124.25 31.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -150.17 -52.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.97 87.74 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.6 79.72 6.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -160.35 138.3 9.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.58 -175.33 5.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -107.29 118.25 36.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mt -94.25 170.46 9.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.4 -70.4 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.04 111.51 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -73.74 -31.49 63.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.826 ' CE2' HG21 ' A' ' 29' ' ' ILE . 23.2 m-85 -75.65 63.81 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.731 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.16 -176.56 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.211 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.53 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.89 -28.82 12.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.51 149.51 49.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.864 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 36' ' ' GLU . 33.6 mt -117.61 136.85 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.95 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 30.0 pt -111.67 154.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -95.3 141.38 28.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -160.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.094 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.21 -42.97 29.77 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.073 0.463 . . . . 0.0 109.971 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -82.22 2.14 33.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.707 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 23.5 tttp 87.6 28.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -69.51 176.52 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.231 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.529 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.4 mp0 -127.86 78.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.898 0.38 . . . . 0.0 110.589 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' HE3' ' HB1' ' A' ' 54' ' ' ALA . 34.7 m95 -76.39 131.39 39.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -92.43 124.38 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.4 t -75.45 142.34 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -134.58 8.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.74 161.82 22.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' ILE . 51.7 Cg_exo -54.43 173.69 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.521 2.147 . . . . 0.0 112.322 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 42' ' ' PRO . 10.5 pt -160.08 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.04 -131.92 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -158.73 113.1 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.19 -69.43 2.81 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.54 141.34 2.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -96.84 -48.98 5.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.23 -96.67 2.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.71 79.63 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.71 118.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 23' ' ' PHE . 22.4 m-85 -146.37 171.97 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 7.4 mt -77.29 156.91 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . . . -115.45 147.62 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.2 t0 -138.46 159.61 41.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -118.68 72.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.659 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 64.43 -77.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 59.15 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -80.13 60.76 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.59 148.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 m 59.48 170.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 55' ' ' ASP . 36.1 t -118.1 -53.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.45 -169.94 30.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.528 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 t -103.59 39.99 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -156.37 82.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -120.97 137.61 26.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -87.99 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.985 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 77.2 m -149.7 148.29 29.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.565 HG13 ' CG ' ' A' ' 133' ' ' ARG . 28.6 m -128.74 144.88 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 130' ' ' ILE . 8.0 p -131.57 124.38 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HD2' HD13 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -109.55 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.638 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 128' ' ' PHE . 4.7 t -113.41 144.3 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.15 140.7 21.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.36 109.31 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.507 2.138 . . . . 0.0 112.314 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.71 178.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -87.17 -171.25 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.84 113.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.4 -168.12 30.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.416 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 -44.49 46.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 112.251 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' A' ' 84' ' ' LEU . 13.6 tp -70.12 -30.08 67.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -60.87 -36.78 80.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.2 p -70.63 -36.66 73.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -70.73 -48.4 54.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.2 mm? -58.26 -43.07 87.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -49.9 75.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' CD2' ' A' ' 198' ' ' TYR . 29.8 t80 -70.43 -39.63 74.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.575 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -54.86 -42.97 72.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -77.26 -17.78 58.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.372 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -82.64 -26.77 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.378 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.58 ' HB1' ' HE2' ' A' ' 167' ' ' TYR . . . -139.88 -44.62 0.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.664 0.268 . . . . 0.0 111.719 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -66.04 -11.63 49.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.778 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -47.22 133.62 9.39 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.527 0.203 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.3 -30.57 26.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.538 2.159 . . . . 0.0 112.632 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -31.33 42.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.58 -40.56 66.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 91' ' ' ALA . 24.0 mm -67.3 -57.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -53.49 -27.15 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.301 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -73.96 -55.99 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.03 -47.24 78.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.812 HG23 ' H ' ' A' ' 106' ' ' LYS . 36.3 mm -56.9 -43.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -75.17 -27.64 59.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.1 m -78.79 -38.81 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.612 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -4.72 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.459 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 100' ' ' ILE . 6.8 mttm 59.64 26.96 16.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 108' ' ' LEU . 3.5 mt -54.24 -47.13 72.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.812 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER 59.22 36.18 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.913 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -176.84 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp 71.96 -63.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.34 12.46 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.823 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 108' ' ' LEU . 24.0 t -81.08 138.97 49.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.56 0.219 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HD2' ' CG1' ' A' ' 110' ' ' VAL . 84.6 Cg_exo -46.42 146.38 5.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 112.399 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 115.52 23.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.289 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.2 127.85 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.565 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -112.33 -40.89 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.82 174.9 41.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.606 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.92 173.33 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.417 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.444 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -156.94 178.0 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.764 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 126' ' ' TYR . 1.7 mp -147.93 159.87 43.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 116.57 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.69 124.38 36.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.26 126.29 22.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.4 t30 59.67 17.27 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.535 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.44 56.57 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.916 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 129.03 43.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.819 0.342 . . . . 0.0 110.682 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.3 t -91.15 124.32 35.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.044 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.489 ' O ' HD23 ' A' ' 118' ' ' LEU . 4.2 m-85 -97.73 147.74 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -125.1 125.13 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.95 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 16.5 p90 -138.28 163.11 32.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.756 ' HB2' HD21 ' A' ' 84' ' ' LEU . 9.4 tmm? -128.1 148.62 50.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.709 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 HG12 HG23 ' A' ' 70' ' ' VAL . 19.8 mt -123.39 112.74 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.249 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -123.08 173.27 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -54.19 142.67 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.089 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.565 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -80.26 156.31 26.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -120.36 155.42 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.06 -80.14 1.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -131.65 131.19 42.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -58.87 159.78 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -62.12 -23.91 66.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.626 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -64.27 -42.05 96.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -64.02 -29.7 70.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.298 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 185' ' ' LEU . 12.0 mt -81.5 -29.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 254' ' ' TRP . 18.2 t80 -70.92 -48.89 51.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.806 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.38 -29.81 65.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.44 -24.75 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.578 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -95.2 16.16 17.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.14 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 84.04 46.94 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.153 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.67 20.12 11.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.249 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.13 176.8 8.38 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.93 -169.3 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -116.65 145.2 43.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -30.43 65.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -71.18 -36.43 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 339' ' ' LEU . 0.2 OUTLIER -73.17 -41.12 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 251' ' ' MET . 45.3 t -55.91 -54.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.834 HD12 HD11 ' A' ' 331' ' ' ILE . 61.5 mt -64.18 -37.23 86.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.47 -44.71 74.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.792 HD23 HD22 ' A' ' 339' ' ' LEU . 34.4 mt -71.04 -47.81 56.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.597 ' HA ' HD12 ' A' ' 161' ' ' ILE . 43.8 p -53.38 -37.61 62.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.637 HD11 ' HG ' ' A' ' 325' ' ' LEU . 1.7 mt -68.17 -48.13 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.665 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -38.4 82.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.9 mt -68.57 -37.39 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 165' ' ' LEU . 12.1 mt -60.8 -36.96 80.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -37.94 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.496 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 110' ' ' VAL . 19.0 mt -75.18 -39.0 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 162' ' ' LEU . 46.2 mt -59.32 -43.08 92.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.607 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.0 -34.9 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.592 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.58 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 88.2 t80 -67.84 -52.49 36.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.5 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.1 pt -67.19 -29.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.995 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -75.09 -34.23 61.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.418 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.95 -16.89 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.44 40.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 77.49 43.9 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.69 140.34 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 31.0 m -126.07 138.92 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 45.6 t-80 -159.48 92.48 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.897 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.661 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -93.64 38.61 3.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.284 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 t0 -97.39 34.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.483 HG12 HG21 ' A' ' 161' ' ' ILE . 3.8 mp -74.39 114.46 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.924 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -160.38 -179.12 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.21 -2.09 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.412 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.4 m -107.28 -0.62 22.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.498 ' O ' HG22 ' A' ' 196' ' ' VAL . 73.7 m-80 -127.5 -5.21 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.783 ' C ' HD23 ' A' ' 184' ' ' LEU . 13.0 mt -108.49 118.69 37.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.062 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -126.07 156.68 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.233 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 141' ' ' ILE . 6.5 mt -99.11 149.65 22.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -73.47 135.63 44.11 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.836 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.455 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 9.0 t80 -71.48 -68.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 -15.13 23.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.746 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.59 ' CB ' ' HD2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -76.5 -168.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 189' ' ' ASN . 39.9 Cg_exo -39.85 -27.38 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.563 2.175 . . . . 0.0 113.913 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 1.1 t70 88.08 5.03 0.25 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.663 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -72.82 -167.58 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 157' ' ' LEU . 2.5 p -109.96 147.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.163 0.506 . . . . 0.0 111.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 15.7 m-85 -131.41 157.25 43.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.559 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 58.0 tp -103.62 115.79 31.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.679 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 182' ' ' ASN . 28.4 m -105.67 -175.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.421 ' OD1' HG23 ' A' ' 196' ' ' VAL . 4.1 m-20 60.85 98.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.628 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.89 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 13.1 m-85 -109.87 30.53 6.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -53.72 -24.67 26.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.254 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -114.15 -4.27 13.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.538 0.209 . . . . 0.0 111.064 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.89 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -77.12 59.39 1.71 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 110.689 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.49 149.05 52.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -53.11 93.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.067 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -60.0 -35.82 75.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.3 m 63.39 125.97 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.38 170.49 19.12 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.312 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -129.14 -55.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -80.33 -51.45 4.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.55 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.425 HG12 ' ND1' ' A' ' 210' ' ' HIS . 18.2 t 69.06 -66.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.24 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.425 ' ND1' HG12 ' A' ' 209' ' ' VAL . 67.4 m80 -112.18 30.78 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -121.37 146.11 47.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 147.75 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 61.09 160.15 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -172.23 35.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.026 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.48 81.31 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -97.34 -56.61 0.19 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.198 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.451 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 54.4 Cg_exo -52.24 -173.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.508 2.139 . . . . 0.0 112.347 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.17 70.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.96 47.58 17.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.006 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.52 89.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -69.45 -55.93 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.64 -70.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.018 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -58.95 171.96 4.45 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.687 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 228' ' ' THR . 33.3 p -59.95 -176.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 0.0 110.772 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.706 HG12 HG11 ' A' ' 271' ' ' VAL . 7.3 tt -101.11 -21.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' A' ' 265' ' ' LEU . 15.0 pt-20 -52.71 -22.96 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 246' ' ' ILE . 63.1 m-85 -142.53 30.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.322 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.405 HG21 HG13 ' A' ' 225' ' ' ILE . 13.4 t -85.6 146.59 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.95 159.0 19.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.5 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.49 -42.98 82.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.29 66.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.196 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.84 -25.56 63.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.318 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -96.33 0.12 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' A' ' 217' ' ' PRO . . . 89.44 -15.45 58.57 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.706 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.73 122.59 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.83 158.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 55.6 Cg_endo -69.9 -171.23 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.6 2.2 . . . . 0.0 112.299 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.06 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -73.95 -54.18 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -83.36 -16.89 44.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.84 92.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.902 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.8 p30 -58.61 -28.79 65.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.309 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 320' ' ' LEU . 70.3 mt -76.6 -34.81 58.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -32.35 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 243' ' ' ASP . 13.4 mt -66.65 -44.81 89.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.02 -36.56 83.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.521 ' O ' ' HE1' ' A' ' 303' ' ' MET . . . -59.21 -47.32 91.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.428 ' HA ' HD12 ' A' ' 252' ' ' ILE . 38.6 m-85 -78.58 -25.69 45.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.297 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -39.06 72.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.03 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.644 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -64.25 -50.04 69.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.892 ' O ' HG22 ' A' ' 256' ' ' THR . 3.4 mt -65.74 -29.21 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.981 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.447 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -68.92 -47.55 65.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.447 ' CD1' ' NE2' ' A' ' 253' ' ' GLN . 16.2 m0 -82.34 -26.88 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.405 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 290' ' ' PHE . 11.5 mt -67.05 -49.34 65.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.386 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 252' ' ' ILE . 13.1 t -101.53 -11.48 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 92.75 108.07 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.306 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 25.8 p80 48.18 -175.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.9 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -135.02 154.61 79.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 48.8 Cg_endo -68.77 61.62 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.098 . . . . 0.0 112.166 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.9 ' CH2' HD22 ' A' ' 259' ' ' LEU . 8.4 p90 177.45 -36.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.676 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -89.26 14.44 11.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.535 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.11 -42.12 97.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.33 -29.33 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.277 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 226' ' ' GLU . 87.7 mt 69.59 13.65 8.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -88.19 -14.94 37.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.361 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.0 94.73 14.16 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 59.9 Cg_endo -72.01 -4.43 15.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.545 2.163 . . . . 0.0 112.643 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -53.21 -49.95 65.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.581 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.2 p90 -83.6 -26.07 30.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.008 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.706 HG11 HG12 ' A' ' 225' ' ' ILE . 61.4 t -59.84 -44.38 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -75.51 -36.88 60.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.296 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.84 -43.24 80.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.285 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -36.57 84.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.413 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -66.4 -50.33 63.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.212 -179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.93 -28.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.352 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.483 ' HG3' ' ND2' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -72.36 -52.13 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.184 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.963 ' CD1' HD12 ' A' ' 285' ' ' LEU . 4.4 m-85 -57.99 -37.03 73.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.77 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -55.52 -26.99 46.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 28.63 5.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.74 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 277' ' ' ARG . 37.0 m-80 -146.64 41.58 1.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.761 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 4.2 mm -53.73 -45.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -70.36 -39.55 74.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -70.94 -29.54 65.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.963 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.3 tt -67.38 -50.89 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.565 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.1 mmt -62.03 -36.82 82.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -19.96 61.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -46.48 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.455 ' SG ' HG21 ' A' ' 256' ' ' THR . 4.7 m -93.69 -41.18 9.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.383 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 255' ' ' LEU . 16.6 m-85 -99.11 107.28 43.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.934 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.66 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.454 2.102 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.59 -25.18 38.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.2 -49.88 70.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.69 104.86 17.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -66.36 139.35 96.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.17 -174.09 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.541 2.161 . . . . 0.0 112.26 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 138.77 -43.05 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.322 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -74.74 -70.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.656 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.603 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.8 mm -79.57 -49.72 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.993 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.565 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -44.62 -31.31 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.651 ' HG2' HG23 ' A' ' 323' ' ' ILE . 14.1 ttpt -76.68 -36.46 57.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.619 ' CE2' HD22 ' A' ' 320' ' ' LEU . 17.9 t80 -76.15 -34.3 59.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.603 ' CG ' HG22 ' A' ' 299' ' ' ILE . 56.5 mmm -74.16 -42.13 60.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 305' ' ' THR . 11.7 pt-20 -64.11 -40.74 96.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.669 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.646 HG21 HD11 ' A' ' 323' ' ' ILE . 1.7 p -66.8 -36.05 81.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.676 ' HA ' HD12 ' A' ' 309' ' ' LEU . 74.4 t -79.64 -24.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -32.93 41.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.22 -25.24 10.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER 47.78 -165.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.119 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.604 ' HB2' HD12 ' A' ' 316' ' ' LEU . 0.2 OUTLIER -96.05 39.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.976 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.89 29.72 19.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.82 30.75 20.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -88.17 -40.79 13.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.57 166.27 16.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.771 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.46 129.31 22.25 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.13 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 319' ' ' ASN . 0.1 OUTLIER -96.39 22.99 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.06 -35.84 81.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.16 -37.05 84.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.631 ' HB3' HD23 ' A' ' 316' ' ' LEU . 4.1 t-20 -77.33 -45.43 26.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 323' ' ' ILE . 56.4 mt -51.04 -43.25 60.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -57.62 -35.74 70.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -35.45 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 301' ' ' LYS . 73.9 mt -55.86 -51.49 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.553 HD13 ' OG ' ' A' ' 158' ' ' SER . 73.5 mt -66.36 -48.9 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.001 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.637 ' HG ' HD11 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -54.76 -49.94 69.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.363 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.6 -40.28 86.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.14 65.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 155' ' ' LEU . 47.1 mt -61.08 -34.96 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -59.74 -31.47 69.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.24 48.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.834 HD11 HD12 ' A' ' 155' ' ' LEU . 1.4 pp -143.77 84.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.412 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.29 -42.69 1.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.724 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 t 65.31 87.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 61.0 156.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -75.53 153.44 37.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -107.49 -28.76 9.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.77 42.07 0.23 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.382 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -168.92 160.49 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.792 HD22 HD23 ' A' ' 157' ' ' LEU . 5.6 mt -91.19 10.48 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.333 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 2.3 t70 58.29 21.57 8.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.159 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.905 HD22 HD13 ' A' ' 141' ' ' ILE . 27.2 mt -71.39 -73.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 110.563 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.3 m 77.16 -54.55 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.64 HG22 HG12 ' A' ' 141' ' ' ILE . 4.9 t 70.1 30.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.016 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 344' ' ' VAL . 18.6 t 59.79 36.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 62.26 149.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.531 ' OD1' HD22 ' A' ' 349' ' ' LEU . 1.4 m-20 -154.95 -169.5 3.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 110.24 78.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.415 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.671 ' C ' HD12 ' A' ' 349' ' ' LEU . . . 81.71 71.9 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 348' ' ' GLY . 9.3 mp -122.25 105.38 10.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.335 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -64.0 94.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.95 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.85 8.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -72.43 173.02 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.0 m -159.12 83.51 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 355' ' ' THR . 1.7 pp -109.17 -28.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 354' ' ' ILE . 9.4 t 50.55 175.33 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.456 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.51 160.19 4.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.979 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 174.13 14.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -135.69 157.54 46.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -128.56 -52.77 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -97.01 133.66 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -115.21 106.97 14.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -179.51 -36.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.78 -58.47 3.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.257 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -87.42 143.34 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.8 m -97.54 166.9 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.68 168.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 155.57 36.22 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.4 130.88 24.86 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.581 2.187 . . . . 0.0 112.255 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 140.79 174.85 14.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 151.04 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 111.175 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.32 99.33 3.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 60.47 88.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.1 m -84.58 -37.57 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.65 98.75 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -63.81 170.5 3.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 18.8 p -162.53 162.03 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -106.42 -179.73 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 1.7 t -145.94 -47.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -113.28 -58.97 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.3 t -84.93 150.91 24.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.9 115.08 8.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.42 100.62 7.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -115.51 159.99 20.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 17.5 mt -130.75 134.08 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -177.5 5.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 81.0 p -83.47 146.36 28.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 125.47 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.2 m 60.52 89.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.04 133.94 54.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 42.7 m -62.5 114.5 3.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -95.89 152.17 18.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 117.23 6.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 147.68 47.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 396' ' ' LYS . 20.6 t -112.64 127.63 69.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -98.46 28.72 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.607 ' H ' HG12 ' A' ' 394' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.043 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 13.3 p 58.62 32.3 22.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.6 t -82.74 89.05 6.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -138.89 -87.92 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.3 176.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 62.4 m -107.28 149.96 27.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -175.85 -135.25 2.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.57 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.5 139.32 14.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.654 0.264 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.58 133.93 48.28 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.517 2.145 . . . . 0.0 112.22 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 124.77 23.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.17 155.97 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 30.54 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.25 153.73 18.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 60.68 -173.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -151.12 111.91 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.6 118.33 26.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.02 -68.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.457 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.03 -169.83 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.7 132.29 21.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t 60.48 32.09 20.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.6 p -87.78 -66.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.57 92.23 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -157.79 88.17 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -106.1 -33.01 8.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -74.46 -176.77 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -127.15 88.27 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.26 -61.91 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.18 -171.6 3.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 62.67 75.66 0.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.753 ' HZ ' HG21 ' A' ' 72' ' ' VAL . 50.2 p90 -65.59 127.86 33.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -166.76 122.73 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 41' ' ' LEU . 21.4 t 66.02 104.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.62 37.16 31.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.623 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -136.34 152.13 50.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.787 HD11 ' HE3' ' A' ' 38' ' ' LYS . 17.2 mm -116.98 139.21 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 23' ' ' PHE . 4.7 pt -119.74 154.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 34.6 m -95.55 141.33 29.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.996 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 1.1 t70 -93.77 -160.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.03 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.4 ttm -77.67 -41.69 37.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.86 0.15 36.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.589 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 3.1 mttp 87.24 27.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -70.34 179.25 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.06 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.16 79.59 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.469 ' HB2' HG13 ' A' ' 29' ' ' ILE . 69.6 m95 -73.49 137.66 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.907 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD11 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -91.66 134.49 34.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.012 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.737 HG21 ' HD2' ' A' ' 23' ' ' PHE . 25.0 t -94.89 143.72 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.02 -130.64 7.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -102.51 159.13 30.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.914 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.57 111.18 2.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.533 2.155 . . . . 0.0 112.063 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG12 ' A' ' 69' ' ' VAL . 13.4 pt -106.43 -37.9 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.43 179.03 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -171.75 -42.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.9 97.06 1.72 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.37 -152.71 7.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.64 32.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 -98.08 0.15 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 3.6 p -179.01 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 3.6 mp -98.9 136.68 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.387 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.517 ' O ' HG12 ' A' ' 70' ' ' VAL . 19.6 m-85 -140.45 170.3 16.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.663 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.22 152.45 42.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -127.08 153.93 45.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.318 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -143.8 150.45 38.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.789 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 mtm -99.45 45.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 59.84 -177.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 m 61.28 45.15 9.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -163.51 -43.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 69.93 -66.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -87.62 86.97 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.48 88.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.85 36.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.3 p -147.55 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -155.44 80.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.21 71.58 3.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 86.28 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.7 t -148.83 148.13 29.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 HD11 ' A' ' 43' ' ' ILE . 6.1 m -128.27 153.47 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.048 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 52' ' ' TYR . 5.4 p -142.79 119.37 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -103.65 117.42 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 128' ' ' PHE . 11.8 t -118.95 152.05 21.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -139.08 135.77 17.69 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.636 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 83.4 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.303 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.23 -171.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.09 156.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -78.99 177.6 8.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.47 -162.87 29.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.23 32.78 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.708 2.272 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -60.61 -30.84 70.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.41 -37.15 86.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.019 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -33.13 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.7 -40.9 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 129' ' ' MET . 1.4 mt -76.91 -37.62 55.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -59.56 -40.3 86.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 8.5 t80 -82.83 -29.81 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -64.4 -51.91 60.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.122 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.59 -17.3 61.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.434 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.67 -47.51 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -120.07 -22.61 6.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.5 23.8 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -73.16 113.18 19.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.37 -33.31 36.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.454 2.102 . . . . 0.0 112.591 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.68 -39.01 77.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.32 -47.27 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.314 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.2 mt -57.58 -57.54 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.44 62.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -64.39 -47.42 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -60.3 -55.05 38.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.254 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 105' ' ' LEU . 70.0 mt -56.33 -36.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.01 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -74.96 -27.7 60.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.8 m -81.75 -36.61 28.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -2.54 26.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.81 30.77 20.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.676 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 100' ' ' ILE . 29.7 mt -49.57 -31.7 11.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.54 -55.57 0.52 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.83 129.11 13.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.895 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp -99.22 -66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.74 9.5 6.91 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.064 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.8 138.78 27.76 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.826 0.313 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 71.9 Cg_exo -50.8 151.41 11.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.525 2.15 . . . . 0.0 112.406 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.08 115.58 27.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -99.78 126.96 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.562 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -105.95 -40.87 5.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 111.028 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 -174.72 46.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.597 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 p -134.86 159.42 41.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.77 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -138.59 173.37 22.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.828 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 117' ' ' GLY . 3.0 mt -148.04 158.07 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.3 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -145.83 138.61 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.74 123.84 48.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.678 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -138.26 126.23 22.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.22 22.68 2.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.414 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.11 3.51 63.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.719 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -96.08 128.92 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.5 m -89.39 125.82 35.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.09 125.9 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.76 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.91 125.21 51.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.899 ' CB ' HG22 ' A' ' 72' ' ' VAL . 14.6 p90 -140.31 165.72 26.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 111.407 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.436 ' HG3' HD21 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -131.89 147.14 52.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.49 HG22 ' SG ' ' A' ' 68' ' ' CYS . 16.9 mt -123.28 111.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 111.4 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -126.66 173.46 9.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.975 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.98 144.82 3.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HG3' HG13 ' A' ' 69' ' ' VAL . 69.4 ttt-85 -88.42 -25.56 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.566 ' CD2' HD12 ' A' ' 184' ' ' LEU . 80.7 m-85 65.08 178.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.02 -108.15 1.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.59 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -107.02 127.85 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.545 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.3 p30 -58.26 157.65 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 0.9 OUTLIER -60.83 -23.6 65.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.693 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.1 OUTLIER -61.57 -41.03 96.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.97 0.414 . . . . 0.0 110.084 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -34.99 79.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.405 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.526 HG22 ' CE1' ' A' ' 149' ' ' PHE . 3.1 mt -81.35 -25.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 11.9 t80 -67.71 -53.62 26.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -29.46 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.706 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.27 -20.29 62.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.311 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.0 m-20 -98.93 18.17 17.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.18 47.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 63.0 19.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.474 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -147.21 -173.97 4.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -130.96 -169.11 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.778 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 154' ' ' VAL . 37.9 t -113.25 150.24 32.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HA ' HD21 ' A' ' 255' ' ' LEU . 2.5 ttm-85 -59.25 -31.49 69.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -40.98 60.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 150' ' ' SER . 44.6 p -65.47 -43.3 90.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 150' ' ' SER . 29.5 t -59.88 -52.31 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 328' ' ' LEU . 12.6 mt -63.11 -48.04 80.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -59.91 -50.4 73.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 193' ' ' VAL . 13.4 mt -59.68 -40.26 87.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.731 ' HB2' HD13 ' A' ' 324' ' ' LEU . 64.7 m -56.03 -40.93 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.9 -48.04 78.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -47.42 85.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 164' ' ' ILE . 27.1 mt -66.59 -35.09 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.8 mt -58.79 -39.87 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.759 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.47 -32.03 72.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 161' ' ' ILE . 16.4 mt -77.11 -43.33 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 178' ' ' ILE . 75.3 mt -58.52 -39.33 79.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -71.15 -31.39 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.672 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.93 -54.74 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.8 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.2 pt -60.11 -30.11 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.25 -37.28 74.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 110.36 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -16.89 62.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.565 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 2.1 t60 -101.68 6.12 41.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.965 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 77.88 46.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.07 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.51 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 47.2 m-85 -141.54 119.42 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.584 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.93 164.19 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.675 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.06 50.23 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.43 -18.18 49.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.866 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 69.1 79.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 110.846 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.656 ' CG2' HD11 ' A' ' 183' ' ' LEU . 4.0 mp -86.06 115.36 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -155.94 172.87 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.824 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.693 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.81 -2.76 34.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.549 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.22 2.1 16.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.844 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -127.95 -6.76 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.363 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.802 ' O ' HD23 ' A' ' 184' ' ' LEU . 11.0 mt -108.63 127.51 54.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.946 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -134.49 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.123 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 341' ' ' LEU . 40.9 mt -87.82 149.47 24.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.43 130.31 42.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -82.76 -50.79 8.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -21.07 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -148.3 77.78 9.68 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.74 88.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.78 35.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.412 ' HA ' ' HG ' ' A' ' 339' ' ' LEU . 1.1 mm-40 174.84 149.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 157' ' ' LEU . 4.9 p -109.97 147.95 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.104 0.478 . . . . 0.0 111.025 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 4.6 m-85 -117.09 156.86 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -105.63 115.86 30.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.691 HG21 HD11 ' A' ' 184' ' ' LEU . 5.6 m -124.2 162.11 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.107 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.28 70.91 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 201' ' ' ALA . 12.8 m-85 -73.23 -60.39 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 92.51 -33.55 4.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.361 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.08 21.29 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.021 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 198' ' ' TYR . . . -83.35 59.15 4.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.06 0.457 . . . . 0.0 110.615 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.81 149.33 50.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.133 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -58.6 99.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 205' ' ' CYS . 54.4 p90 -54.9 -47.79 73.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.411 ' N ' ' CD2' ' A' ' 204' ' ' TYR . 8.9 p -67.13 134.64 93.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.203 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.38 -72.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.477 2.118 . . . . 0.0 112.243 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -142.73 -71.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.74 -89.22 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 212' ' ' GLU . 21.8 t 60.33 159.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.486 ' N ' HG12 ' A' ' 209' ' ' VAL . 0.9 OUTLIER -152.47 -51.59 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -129.07 36.44 4.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.598 ' HB2' HG13 ' A' ' 209' ' ' VAL . 32.3 mt-10 -116.52 -48.54 2.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.438 ' C ' ' HG2' ' A' ' 214' ' ' LYS . 0.6 OUTLIER -71.86 -152.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.751 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 213' ' ' TYR . 19.4 ptmt 45.09 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.002 0.43 . . . . 0.0 111.231 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.523 ' HA ' HG21 ' A' ' 236' ' ' VAL . 3.0 tm-20 76.24 87.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.851 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.62 89.75 0.29 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.806 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.53 141.92 32.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.518 2.145 . . . . 0.0 112.42 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -132.23 -70.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 30.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 1.7 m 56.49 103.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.987 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -72.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.33 164.22 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.003 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.24 110.55 3.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.5 m -92.6 -71.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.9 tp -176.74 30.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -102.75 67.57 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.346 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 226' ' ' GLU . 34.3 m-85 72.26 41.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.645 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -102.34 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.785 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -79.99 145.9 32.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.717 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -58.13 -30.8 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.01 -31.31 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.27 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -61.9 -25.61 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -85.01 5.96 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.512 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.28 -2.26 85.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.903 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 215' ' ' GLU . 9.0 m -111.97 178.76 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.771 0.319 . . . . 0.0 111.065 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -145.22 132.02 9.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 51.8 Cg_exo -53.99 -24.18 31.19 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.356 2.038 . . . . 0.0 112.409 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.7 t 61.65 35.67 16.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -179.57 -76.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -72.21 -15.84 61.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.374 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.57 92.71 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.585 ' CG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -78.51 -26.99 46.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.959 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.524 ' HB2' HG13 ' A' ' 306' ' ' VAL . 29.1 mt -78.23 -34.05 49.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -39.87 85.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.454 HG23 ' HB3' ' A' ' 227' ' ' PHE . 11.2 mt -65.01 -34.88 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.794 HD23 ' OH ' ' A' ' 302' ' ' TYR . 44.6 tp -77.93 -36.17 49.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.28 -29.02 73.85 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.475 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.62 -27.55 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 26.9 m -60.6 -45.83 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.66 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -48.58 -51.14 29.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.663 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -71.67 -51.44 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.573 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.739 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.3 tm0? -56.7 -36.04 69.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -82.38 -49.92 9.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 151' ' ' ARG . 85.6 mt -67.05 -36.28 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.5 m -96.12 -15.38 22.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 68.96 94.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.313 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.7 m80 62.93 140.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.396 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.97 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -122.49 168.84 10.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 55.2 Cg_endo -70.04 59.95 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.45 2.1 . . . . 0.0 112.72 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.97 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.4 p90 177.92 -41.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.6 OUTLIER -95.35 17.68 13.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.346 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.21 -57.34 11.83 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 57.2 t30 -129.12 -26.27 2.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.335 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 225' ' ' ILE . 66.0 mt 70.96 11.95 7.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -85.23 -16.5 40.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.163 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.487 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.7 OUTLIER -133.13 100.43 14.22 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.734 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.15 19.2 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.74 2.293 . . . . 0.0 112.86 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -77.95 -46.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.9 p90 -83.76 -26.71 29.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.821 ' CG1' HD11 ' A' ' 225' ' ' ILE . 18.3 t -65.62 -45.2 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.218 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.42 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -39.9 64.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 47.9 m -66.61 -38.29 86.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.159 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.536 ' CD ' HG12 ' A' ' 271' ' ' VAL . 1.0 OUTLIER -65.29 -51.14 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.071 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.42 -37.34 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -81.18 -50.5 9.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.2 m-85 -59.43 -40.89 88.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.717 ' HE ' HD13 ' A' ' 230' ' ' ILE . 10.0 ttm105 -51.7 -29.43 18.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.04 25.68 9.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -137.6 41.83 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 303' ' ' MET . 28.4 mt -49.58 -39.91 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.84 -34.64 64.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.988 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.47 -43.27 63.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 285' ' ' LEU . 3.5 pp -71.33 -33.2 69.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.449 ' N ' HD12 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -61.99 -50.93 70.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.2 -27.85 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -32.89 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 111.237 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 252' ' ' ILE . 60.8 m -93.71 -41.18 9.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.467 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -94.0 144.66 28.47 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.738 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 176.45 6.81 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.489 2.126 . . . . 0.0 112.285 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -98.62 30.45 3.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -41.15 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -131.67 150.11 52.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 143.19 74.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.53 137.49 25.38 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.478 2.119 . . . . 0.0 112.293 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.93 -41.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.56 -67.87 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.538 HG23 ' HG3' ' A' ' 251' ' ' MET . 29.1 mm -75.66 -41.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -47.23 -45.97 23.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.332 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -61.76 -35.65 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.585 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.794 ' OH ' HD23 ' A' ' 247' ' ' LEU . 21.1 t80 -73.81 -35.88 64.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.721 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.744 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.2 mtp -70.3 -45.26 66.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.35 77.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 309' ' ' LEU . 1.9 m -62.27 -33.53 74.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 302' ' ' TYR . 91.0 t -79.64 -23.96 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.423 ' HB3' HD22 ' A' ' 308' ' ' LEU . 0.1 OUTLIER -83.64 -34.01 25.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.649 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 307' ' ' LYS . 3.9 mm? -113.73 -30.45 6.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.268 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 305' ' ' THR . 0.5 OUTLIER 44.87 -165.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.313 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.79 160.32 30.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.76 84.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 28.5 m -159.49 73.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -152.01 -173.54 4.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.8 0.49 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.837 ' HA ' HD21 ' A' ' 309' ' ' LEU . 50.3 Cg_exo -53.69 -21.86 21.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.613 2.209 . . . . 0.0 112.443 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.5 tp 74.86 57.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 15.5 m-85 -70.34 -30.9 67.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -58.55 -47.59 83.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -46.75 72.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 323' ' ' ILE . 53.7 mt -55.64 -40.7 72.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -46.59 86.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -40.25 90.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 320' ' ' LEU . 67.4 mt -57.85 -42.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 158' ' ' SER . 35.4 mt -78.56 -51.55 9.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -58.25 -49.92 75.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.48 -38.99 86.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.974 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.89 -27.92 65.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 155' ' ' LEU . 14.2 mt -62.31 -38.03 87.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -29.89 70.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.52 77.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.0 pt -99.59 24.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.257 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.36 26.55 37.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.658 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.29 164.56 24.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 146.01 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -127.69 129.48 47.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.62 -55.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -159.58 27.22 0.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -93.69 146.6 23.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.811 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.655 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.3 OUTLIER -176.31 0.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.107 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.728 ' O ' HD12 ' A' ' 341' ' ' LEU . 12.2 t70 -63.3 -20.46 65.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.81 HD11 HD21 ' A' ' 185' ' ' LEU . 0.5 OUTLIER 70.85 8.73 6.64 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.434 ' C ' HG23 ' A' ' 343' ' ' VAL . 7.1 m 73.23 -56.07 0.66 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.772 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 342' ' ' SER . 4.4 t 76.28 -54.27 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.369 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 6.3 m -151.72 31.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.229 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -37.57 16.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -87.28 146.38 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 155.04 -85.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -109.73 151.32 17.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.27 -71.31 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.26 98.83 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.0 166.03 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -165.96 -62.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 356' ' ' LYS . 9.7 m -144.76 118.28 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.874 HG23 HG22 ' A' ' 355' ' ' THR . 1.3 tt -71.27 -41.52 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.874 HG22 HG23 ' A' ' 354' ' ' ILE . 4.4 t -160.05 106.03 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.431 ' HB2' HG21 ' A' ' 353' ' ' THR . 4.8 ttpm? -90.06 159.99 16.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -145.1 125.31 13.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.83 87.79 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.82 30.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 62.74 -79.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.002 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -69.34 112.47 5.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 362' ' ' ILE . 17.3 tt -89.81 70.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.61 178.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 59.99 91.93 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 32.2 t -123.75 159.74 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -136.87 163.62 30.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -132.31 136.89 28.81 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.33 91.7 1.04 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.484 2.123 . . . . 0.0 112.339 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 135.98 49.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.576 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 370' ' ' VAL . 15.1 t -130.2 29.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.766 0.317 . . . . 0.0 111.111 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.74 145.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.83 150.91 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 170.39 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -120.29 -41.75 2.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 7.0 m0 61.43 31.6 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.4 t -82.94 146.89 28.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.17 172.75 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.802 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 43.6 p -94.02 166.74 12.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.07 96.81 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.94 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 6.5 t -73.77 123.44 24.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -87.82 -40.05 14.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 60.21 100.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -144.35 167.35 22.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.59 153.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.94 -49.47 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 38.4 m -77.4 126.1 30.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -145.59 -56.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.2 m -97.16 142.97 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -166.82 114.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 p -147.47 168.18 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.96 -51.22 4.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.09 167.5 19.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -126.09 130.46 51.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.88 105.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.159 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.01 114.94 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.842 -179.978 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 10.2 t 60.52 32.11 20.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.963 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -118.35 -51.11 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 161.57 112.53 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 71.3 m -154.12 -52.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 14.5 m -79.49 -171.31 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 157.34 -166.34 33.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.421 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 81.42 9.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 0.0 110.973 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.99 55.56 5.66 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.615 2.21 . . . . 0.0 112.521 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.5 ' HD2' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER 175.62 123.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.5 HG23 ' HD2' ' A' ' 3' ' ' ARG . 21.2 t 63.74 139.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -82.77 83.56 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.62 15.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.02 78.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -166.69 118.75 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.55 86.77 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.33 -46.55 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 91.79 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -126.07 94.93 4.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.4 -175.48 5.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 152.15 38.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.23 97.66 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -159.61 149.2 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.42 100.78 12.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.98 31.74 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 126.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -104.36 -41.32 5.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.09 -51.53 66.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.973 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 72' ' ' VAL . 7.4 m-85 -121.14 113.63 20.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.95 -178.38 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.66 128.16 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.18 57.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.572 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.92 153.3 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' A' ' 36' ' ' GLU . 26.1 mt -115.22 137.15 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.8 pt -119.85 154.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.18 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.2 p -95.57 141.57 28.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.743 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -98.62 -162.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.044 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -37.52 27.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.5 -1.81 43.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 6.4 mttp 86.12 29.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' THR . 5.2 mttp -78.23 177.62 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.188 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HB3' HG21 ' A' ' 28' ' ' ILE . 74.7 mm-40 -129.3 80.44 1.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.405 ' HB2' HG13 ' A' ' 29' ' ' ILE . 73.4 m95 -77.46 131.41 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -89.9 118.24 29.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 53' ' ' LEU . 19.9 t -89.55 141.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -107.19 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -127.31 165.87 26.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 43' ' ' ILE . 31.2 Cg_exo -59.37 178.03 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.64 2.227 . . . . 0.0 112.285 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.496 HG21 HD21 ' A' ' 53' ' ' LEU . 23.3 pt -156.08 30.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.06 93.73 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 61.34 106.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.82 155.9 15.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.46 -86.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.84 61.95 1.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 74' ' ' PRO . . . 110.67 113.22 3.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.335 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 40.6 t -177.78 -89.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.409 0.147 . . . . 0.0 110.882 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.413 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 53.3 mt -142.4 135.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 29.3 m-85 -143.4 156.31 44.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.483 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 69' ' ' VAL . 92.4 mt -74.85 157.5 34.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.26 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -140.79 159.72 41.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.4 ptp -101.01 37.85 1.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t30 59.99 30.58 20.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -85.19 -72.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 m -117.18 144.77 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.46 160.86 30.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m 60.5 95.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.507 ' O ' HG12 ' A' ' 62' ' ' VAL . 20.9 t -92.83 47.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -113.05 -27.35 3.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.86 38.13 4.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.63 -59.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 52.63 74.35 0.79 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.144 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 62' ' ' VAL . 61.3 Cg_endo -73.57 -27.29 13.09 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.596 2.198 . . . . 0.0 112.618 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.2 m -149.86 165.31 32.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 133' ' ' ARG . 4.4 m -127.41 152.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 130' ' ' ILE . 7.7 p -142.2 141.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 35.0 mtpt -111.01 123.88 51.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.761 HG22 ' HB3' ' A' ' 128' ' ' PHE . 25.5 t -120.23 136.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.531 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.13 120.6 8.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.685 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 49' ' ' GLY . 71.0 Cg_exo -50.91 91.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.526 2.151 . . . . 0.0 112.472 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p 49.72 83.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.76 118.29 27.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.3 -85.52 0.12 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.36 -49.06 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.552 2.168 . . . . 0.0 112.306 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 84' ' ' LEU . 21.1 tp -76.12 -31.1 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -68.59 -31.19 70.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -45.42 63.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' CD ' HD12 ' A' ' 80' ' ' LEU . 12.5 pt-20 -69.68 -42.21 74.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.4 mm? -54.78 -48.48 72.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.67 -39.67 92.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -57.34 -53.9 52.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -75.31 -17.64 60.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.379 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -83.1 -47.46 11.63 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.89 -23.88 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.642 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -93.92 25.28 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -73.32 131.08 83.38 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.651 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.26 -29.01 89.21 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.488 2.125 . . . . 0.0 112.381 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.33 -31.96 43.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -49.96 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 91' ' ' ALA . 65.7 mt -59.94 -46.48 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -51.8 -48.35 63.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.179 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -38.96 92.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -53.22 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 46.6 mt -64.37 -26.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -75.12 -27.55 59.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -39.21 35.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.88 11.81 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER 70.37 2.03 3.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.657 HD13 HD13 ' A' ' 108' ' ' LEU . 4.5 mt 44.71 28.39 0.33 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.388 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 48.8 36.61 8.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.8 t80 71.34 114.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.757 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG23 ' A' ' 110' ' ' VAL . 6.3 tp -101.79 125.53 48.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -92.38 20.72 42.1 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.753 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.732 HG23 ' HG ' ' A' ' 108' ' ' LEU . 27.7 t -78.17 133.42 64.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.534 0.207 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HB3' HG12 ' A' ' 196' ' ' VAL . 9.3 Cg_endo -51.02 145.64 24.42 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.638 2.225 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 126.23 32.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.14 134.07 43.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -111.52 -40.7 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -176.31 46.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.91 155.01 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -134.53 175.49 20.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.044 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.1 mt -147.91 154.71 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -145.81 141.74 28.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 m-20 -121.34 126.66 50.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.449 ' HE3' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.26 126.39 22.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.15 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 56.33 19.89 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.31 9.26 58.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.836 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 2.1 mtmt -96.07 159.3 15.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 83.2 p -112.58 118.45 35.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.078 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.743 ' O ' HD23 ' A' ' 118' ' ' LEU . 13.0 m-85 -110.44 129.07 55.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.668 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.712 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -123.23 125.08 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.711 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.7 p90 -134.53 159.59 40.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 3.6 tmm? -130.02 141.7 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.018 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 70' ' ' VAL . 5.5 mt -110.16 125.24 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.76 173.35 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.868 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.94 137.39 39.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB3' HG13 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -85.12 -25.61 27.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.717 ' CE2' HG11 ' A' ' 196' ' ' VAL . 59.8 m-85 64.71 -170.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -107.41 -104.28 2.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.665 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 m -97.14 157.71 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.663 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.2 m-20 -92.81 157.0 16.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -63.71 -30.14 71.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.427 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 5.2 pt20 -57.28 -42.81 82.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.668 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -64.65 -25.92 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.76 ' CD1' HD13 ' A' ' 341' ' ' LEU . 14.5 mt -72.63 -28.95 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.0 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -58.04 -46.26 85.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.18 -31.27 65.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 343' ' ' VAL . . . -67.91 -21.45 65.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.409 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -93.95 -0.22 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.9 43.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 61.54 19.97 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.488 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -162.1 107.87 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -58.27 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.9 m -111.79 161.63 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.774 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.69 -31.55 72.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -70.99 -50.39 34.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -59.19 -50.66 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.16 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 150' ' ' SER . 46.7 t -56.19 -52.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.318 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 328' ' ' LEU . 64.5 mt -59.52 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.258 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -46.03 90.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.649 HD11 HD21 ' A' ' 341' ' ' LEU . 29.9 mt -69.07 -35.35 76.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.824 ' OG ' HD13 ' A' ' 324' ' ' LEU . 12.8 p -57.91 -36.37 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 321' ' ' ARG . 16.6 mt -72.5 -47.23 50.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.494 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -49.52 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.77 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.08 -37.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 165' ' ' LEU . 7.6 mt -58.96 -36.47 74.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -38.04 84.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 109' ' ' GLY . 16.9 mt -74.79 -38.47 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 162' ' ' LEU . 61.5 mt -58.16 -48.22 80.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -68.12 -38.93 82.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.548 ' CE1' HD11 ' A' ' 105' ' ' LEU . 90.6 t80 -59.7 -41.42 90.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.591 HD11 ' CE1' ' A' ' 175' ' ' HIS . 28.2 pt -81.67 -27.19 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.112 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -75.93 -29.99 58.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.425 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.77 -17.1 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.22 6.24 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 72.04 47.16 0.31 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.886 0.374 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 11.1 m-85 -132.05 132.83 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.99 169.31 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.788 ' CD2' HD21 ' A' ' 195' ' ' LEU . 11.4 p-80 -151.68 -51.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.754 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 55.83 53.12 44.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.66 30.17 5.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.104 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 183' ' ' LEU . 2.8 mt -87.29 105.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.26 29.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.427 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 67.11 11.05 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.87 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 m -117.13 5.97 12.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 196' ' ' VAL . 8.9 m120 -138.49 2.89 2.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.594 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.906 ' O ' HD23 ' A' ' 184' ' ' LEU . 5.3 mt -109.59 130.2 55.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.098 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.1 mt -137.53 147.54 45.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.094 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.686 HD21 HD11 ' A' ' 341' ' ' LEU . 24.8 mt -86.47 145.87 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 111.528 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.465 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -63.3 125.87 25.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.83 -49.46 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -58.1 -24.4 58.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.659 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.35 81.14 2.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.15 109.73 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.584 2.189 . . . . 0.0 112.291 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -144.55 -45.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -157.86 -167.7 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 138' ' ' LEU . 7.6 p -109.75 148.1 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 9.2 m-85 -119.21 156.96 28.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.388 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.788 HD21 ' CD2' ' A' ' 175' ' ' HIS . 18.3 tp -106.61 115.77 30.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.428 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.717 HG11 ' CE2' ' A' ' 134' ' ' PHE . 30.5 m -126.95 167.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.296 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.7 t70 53.65 57.68 5.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.007 0.432 . . . . 0.0 110.707 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 51.6 m-85 -59.68 -51.55 69.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.071 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.81 -35.83 4.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.94 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.56 31.65 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.503 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -71.82 59.44 0.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.76 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -138.48 148.97 44.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.064 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.428 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 19.4 mtm105 -56.52 101.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -58.68 -23.41 59.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.172 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 15.4 t -104.68 103.29 39.49 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.943 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.488 ' HB2' HG13 ' A' ' 209' ' ' VAL . 54.7 Cg_exo -52.1 176.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.439 2.093 . . . . 0.0 112.398 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.92 -34.81 3.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.85 14.53 58.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.062 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 206' ' ' PRO . 12.6 m -84.6 171.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -137.82 -50.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -66.65 140.43 57.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.05 155.88 26.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.63 147.87 31.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.27 94.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.62 106.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -171.46 84.97 0.48 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 94.54 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.586 2.191 . . . . 0.0 112.337 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 20.84 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 53.71 47.25 24.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.084 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 58.0 m -91.71 -38.45 12.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.47 ' CD2' ' HB1' ' A' ' 232' ' ' ALA . 7.2 t60 -64.91 -45.97 83.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.47 172.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 122.51 -164.12 15.65 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.5 p -87.87 178.09 6.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.576 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.7 tt -116.16 -26.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -24.62 4.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.472 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 246' ' ' ILE . 11.1 m-85 -144.41 38.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.07 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 225' ' ' ILE . 10.2 t -83.99 138.9 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.8 t -91.8 148.29 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 279' ' ' ARG . 15.0 mt -57.34 -51.16 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.188 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.83 -43.91 86.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.47 ' HB1' ' CD2' ' A' ' 221' ' ' HIS . . . -72.39 -28.11 62.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.233 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -68.71 -28.04 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.585 ' HB3' HG23 ' A' ' 236' ' ' VAL . 2.2 t30 -91.64 12.86 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.08 23.29 63.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.747 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.654 HG12 ' HD2' ' A' ' 238' ' ' PRO . 14.3 t -77.81 119.52 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -57.67 -57.4 25.66 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.2 Cg_exo -52.43 89.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.407 2.072 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 t -138.14 160.99 37.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -178.79 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.118 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.41 -42.76 93.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.569 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.559 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -59.19 -35.21 73.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.774 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.506 HD21 ' HE1' ' A' ' 317' ' ' TYR . 15.5 mt -80.5 -34.49 35.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.98 -39.37 89.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.717 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 227' ' ' PHE . 8.5 mt -62.9 -47.93 90.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.4 tp -64.79 -33.94 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.397 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.3 95.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 34.0 m-85 -78.57 -25.84 45.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.88 -34.45 65.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.583 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -46.57 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.769 HD13 HD11 ' A' ' 285' ' ' LEU . 9.0 mt -63.57 -38.63 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HB3' HD11 ' A' ' 259' ' ' LEU . 1.5 pp0? -75.17 -31.06 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -82.38 -40.71 20.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.99 -31.19 56.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.98 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.3 m -103.07 0.51 32.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.412 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.71 95.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.519 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 61.12 161.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.956 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -133.0 168.74 16.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.865 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.6 Cg_exo -68.44 59.14 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.863 2.375 . . . . 0.0 112.515 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.956 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.0 p90 179.15 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.445 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 4.1 tt0 -84.48 5.63 26.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.23 -54.1 49.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.4 m120 -130.05 -27.53 2.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 78.5 mt 71.26 12.62 6.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.27 -15.38 38.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.468 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -130.03 92.16 37.35 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.18 -4.12 13.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.883 2.389 . . . . 0.0 112.662 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -55.34 -50.34 69.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.277 . . . . 0.0 111.079 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.7 p90 -84.09 -26.03 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 261' ' ' TRP . 40.8 t -62.49 -43.04 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.298 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -75.52 -40.81 56.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -48.08 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -45.31 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.185 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -58.74 -42.87 89.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.483 ' HA ' HD11 ' A' ' 230' ' ' ILE . 17.3 mt -72.56 -29.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -75.41 -52.1 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -60.47 -39.46 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.633 ' HG3' HD12 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -60.13 -26.18 66.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.948 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -120.2 23.78 10.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -160.66 53.43 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.074 0.464 . . . . 0.0 110.744 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 2.6 mm -48.52 -41.79 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.339 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -64.26 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.513 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.2 p -70.38 -31.98 69.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.769 HD11 HD13 ' A' ' 252' ' ' ILE . 1.2 tt -66.41 -51.4 57.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.467 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 21.5 mmt -62.14 -34.63 76.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -82.79 -33.34 27.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.313 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -54.85 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.467 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' HG21 ' A' ' 252' ' ' ILE . 85.7 m -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.286 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 290' ' ' PHE . 3.7 m-85 -108.36 146.29 33.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 -172.42 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.43 30.87 3.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 -35.28 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.68 91.66 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.79 108.02 1.06 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.23 127.21 23.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.468 2.112 . . . . 0.0 112.256 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -124.1 -40.51 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -47.5 85.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.696 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.2 mm -76.79 -48.74 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.467 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.32 -44.72 8.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.615 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -63.58 -43.22 97.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.382 . . . . 0.0 110.814 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.883 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.5 t80 -69.59 -43.5 72.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.018 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.696 ' CG ' HG22 ' A' ' 299' ' ' ILE . 69.1 mmm -66.54 -39.02 88.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.764 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.83 -40.36 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.273 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -32.34 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 302' ' ' TYR . 14.0 t -71.91 -24.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.096 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -75.7 -37.45 59.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.71 -12.49 22.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 320' ' ' LEU . 0.3 OUTLIER -52.86 140.86 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.968 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.58 -58.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.72 -48.49 15.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.45 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -55.3 -58.39 7.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.497 ' H ' HG23 ' A' ' 312' ' ' THR . 0.9 OUTLIER 179.84 -67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -117.85 156.47 49.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 309' ' ' LEU . 19.0 Cg_endo -60.15 -178.19 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.276 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.591 ' H ' HD21 ' A' ' 309' ' ' LEU . 2.3 mp -142.87 42.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.506 ' HE1' HD21 ' A' ' 244' ' ' LEU . 20.1 m-85 -57.06 -36.16 70.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.021 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -69.2 -33.88 74.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.74 -47.42 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.817 ' HA ' HD12 ' A' ' 323' ' ' ILE . 25.9 mt -53.29 -44.37 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 159' ' ' LEU . 4.7 ttt180 -59.15 -32.65 70.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.987 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.97 -30.47 55.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 320' ' ' LEU . 57.9 mt -63.98 -50.01 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.824 HD13 ' OG ' ' A' ' 158' ' ' SER . 8.4 mt -79.96 -26.65 39.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.593 ' HB2' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.58 -48.89 10.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.733 0.301 . . . . 0.0 111.107 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.76 -34.29 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.6 56.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.583 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.732 HD21 ' HB3' ' A' ' 155' ' ' LEU . 29.4 mt -57.23 -32.55 66.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -70.08 -29.62 66.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.63 63.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.8 -28.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.215 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.11 22.92 5.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m -97.67 164.52 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -138.63 111.85 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.81 92.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.97 -74.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.957 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -134.4 22.94 3.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.692 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.81 135.62 41.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.709 0.29 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER 177.76 -15.31 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.53 -24.49 8.22 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.653 0.263 . . . . 0.0 111.542 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.76 HD13 ' CD1' ' A' ' 141' ' ' ILE . 0.9 OUTLIER 67.75 12.29 8.78 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.419 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.1 m 51.46 83.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.888 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 343' ' ' VAL . 15.2 m -151.74 88.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 14.6 m -83.6 56.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.57 31.65 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -143.54 85.52 1.84 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.12 73.48 1.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 137.52 102.41 0.6 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.408 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.3 pt? -109.91 -30.45 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -92.84 132.79 36.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -149.18 176.97 10.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -177.88 3.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 353' ' ' THR . 4.4 t -150.82 80.69 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.74 151.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.066 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 1.3 t -120.03 -41.93 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -104.68 116.74 32.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -31.84 15.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.66 176.9 8.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.67 93.92 5.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.97 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.37 145.74 32.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.569 ' O ' HD13 ' A' ' 362' ' ' ILE . 0.5 OUTLIER -96.41 96.67 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 361' ' ' GLU . 25.1 mm -133.43 131.84 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 31.42 5.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.437 ' H ' HG22 ' A' ' 362' ' ' ILE . 0.8 OUTLIER -105.52 74.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 30.9 t -110.4 -28.93 8.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 63.44 116.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -107.48 99.67 29.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.71 -49.02 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.475 2.117 . . . . 0.0 112.358 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 100.38 -160.53 19.1 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 16.9 m -152.25 149.37 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.132 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 44.83 39.34 3.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.395 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.71 116.65 33.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 4.9 m 60.19 83.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -112.67 135.44 53.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -144.31 165.53 27.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.12 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -85.36 -49.18 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 17.6 m 60.71 95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -168.48 162.45 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 67.4 p -77.52 122.19 24.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 93.68 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.33 95.61 3.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -160.7 174.88 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 384' ' ' ILE . 3.5 tp -119.74 114.74 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.39 144.59 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.95 95.15 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.44 80.65 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.778 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 37.0 m 61.11 179.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.3 ttm-85 -159.29 -48.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.2 t -160.24 -45.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -69.69 116.23 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -34.09 64.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -128.33 104.51 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.57 126.58 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -147.97 -49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 8.7 mttm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.917 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 40' ' ' GLY . 17.9 t -101.54 108.44 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -35.8 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.508 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 150.34 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG12 ' CG ' ' A' ' 38' ' ' LYS . 18.6 mt -103.25 142.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 11.8 pt -116.76 143.44 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 36' ' ' GLU . 11.8 p -102.33 141.76 34.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.137 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 10.3 m-20 -83.03 -144.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.88 56.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 109.698 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.46 35.6 26.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.571 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -139.33 -8.46 1.3 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.36 177.75 9.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.157 0.503 . . . . 0.0 111.692 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' HG22 ' A' ' 30' ' ' THR . 7.7 mt-10 -155.25 92.73 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 9.2 m95 -96.64 144.83 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.408 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -89.35 125.81 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.852 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.32 131.81 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -106.0 -121.04 4.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.477 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.86 154.61 44.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.709 0.29 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.32 175.19 7.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.516 2.144 . . . . 0.0 112.335 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 pt -141.61 30.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -85.19 124.08 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.605 ' O ' HG12 ' A' ' 70' ' ' VAL . 68.5 m-85 -146.29 153.3 40.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.44 135.93 36.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.05 137.67 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.624 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 25.3 t0 -124.39 151.18 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.6 ttp -89.81 52.83 2.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -149.47 148.23 29.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.41 34.74 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.43 176.33 7.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.72 134.93 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t 63.42 125.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.38 -52.74 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.3 -133.94 52.09 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.65 29.71 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -105.68 31.98 4.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . -137.82 99.3 9.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.04 42.5 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.709 2.273 . . . . 0.0 112.66 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -149.93 150.28 31.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 110.779 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 131' ' ' MET . 15.8 m -122.02 146.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.855 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 52' ' ' TYR . 7.5 p -131.95 131.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.599 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -105.39 121.09 43.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.215 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 128' ' ' PHE . 2.8 t -113.12 152.02 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -140.71 136.26 16.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.68 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 112.375 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.3 t 62.28 122.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -171.51 159.9 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.88 75.0 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 82' ' ' THR . . . 179.82 -75.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.46 -61.91 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.64 ' HG ' HD23 ' A' ' 84' ' ' LEU . 6.3 tp -60.48 -33.18 72.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.58 -31.93 72.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 78' ' ' GLY . 22.3 p -75.07 -41.61 58.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.8 -38.48 64.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.5 mm? -64.24 -51.68 62.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -56.78 -51.81 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 198' ' ' TYR . 19.6 t80 -64.27 -29.79 70.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.2 m-85 -69.57 -50.7 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -25.38 64.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -87.67 -47.43 8.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -88.84 19.41 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' CD ' ' HB2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -77.59 114.12 38.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.467 0.175 . . . . 0.0 110.649 179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.25 -26.19 7.93 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.503 2.136 . . . . 0.0 112.636 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.402 ' HB2' ' CD ' ' A' ' 92' ' ' LYS . 8.2 mm-40 -75.4 -40.44 57.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -79.33 -43.43 23.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 51.2 mt -61.25 -52.87 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -42.28 64.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -43.23 67.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.964 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -53.89 37.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 96' ' ' ILE . 40.2 mt -56.66 -34.23 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -74.88 -27.7 60.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 m -71.62 -38.53 70.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -6.53 19.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.983 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.19 27.66 16.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.45 ' CD1' HD13 ' A' ' 108' ' ' LEU . 59.7 mt -51.83 -32.52 32.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.1 tttt 46.74 40.91 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.658 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 25.1 t80 -176.86 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.347 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 96' ' ' ILE . 13.4 tp 59.96 158.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.725 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 164' ' ' ILE . . . -110.66 32.98 6.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.624 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.879 HG21 ' CE2' ' A' ' 167' ' ' TYR . 23.3 t -112.6 126.6 28.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.529 0.204 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.69 161.8 23.63 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.305 2.003 . . . . 0.0 112.025 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 115.43 27.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.06 131.95 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 9.3 m95 -109.89 -40.91 4.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -175.03 46.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.762 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -135.4 162.0 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.82 174.49 24.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.5 mt -147.84 150.61 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.064 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 121.85 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.42 127.86 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -138.29 126.16 22.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.97 20.84 4.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.68 62.07 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.792 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -96.13 129.86 43.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.784 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.64 118.77 30.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.084 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.454 ' O ' HD23 ' A' ' 118' ' ' LEU . 10.0 m-85 -101.42 122.56 43.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -106.51 130.89 54.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.442 ' CZ ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 p90 -140.27 168.62 19.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.104 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.681 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.8 tmm? -142.73 138.96 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 130' ' ' ILE . 1.5 mp -94.09 141.8 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -122.09 164.21 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.658 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.83 -69.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -148.09 -78.24 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 184' ' ' LEU . 1.4 m-85 64.19 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.916 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -117.8 -101.66 2.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.615 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.8 t -102.02 166.33 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.856 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.583 ' HB3' HD22 ' A' ' 184' ' ' LEU . 13.1 p30 -97.95 161.68 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.962 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -58.53 -25.14 62.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.56 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.56 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -55.46 -37.95 68.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.82 70.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 185' ' ' LEU . 14.1 mt -76.35 -26.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.424 ' HA ' ' CE1' ' A' ' 149' ' ' PHE . 36.3 t80 -56.21 -44.74 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.09 -30.35 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.24 -14.09 62.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.511 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -94.6 -1.0 54.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.248 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 92.56 44.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.962 0.505 . . . . 0.0 110.395 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.75 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.591 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -170.72 121.46 0.58 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.918 0.39 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 254' ' ' TRP . 8.6 m-85 -61.33 177.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.521 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.6 t -113.41 160.69 18.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.788 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -36.95 74.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -70.69 -48.8 52.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.7 p -58.69 -56.2 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.168 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.556 HG21 ' HG ' ' A' ' 255' ' ' LEU . 48.9 t -54.35 -53.5 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 155' ' ' LEU . 15.2 mt -57.54 -45.67 84.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.993 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -65.67 -52.9 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.81 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' A' ' 193' ' ' VAL . 5.7 mt -62.53 -34.06 76.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.743 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.562 ' HB3' HD13 ' A' ' 324' ' ' LEU . 34.1 m -58.83 -46.41 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 325' ' ' LEU . 86.2 mt -61.8 -43.81 98.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -34.02 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.838 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.4 mt -78.96 -36.62 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.149 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.593 HD13 ' HA ' ' A' ' 321' ' ' ARG . 3.4 mt -55.35 -44.12 75.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -26.44 68.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.453 HG12 ' HA3' ' A' ' 109' ' ' GLY . 5.0 mt -72.74 -46.55 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 243' ' ' ASP . 28.3 mt -59.85 -27.29 66.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -30.37 60.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.879 ' CE2' HG21 ' A' ' 110' ' ' VAL . 91.1 t80 -77.15 -56.09 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.436 HG21 ' CE1' ' A' ' 198' ' ' TYR . 41.6 pt -55.13 -29.35 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -42.37 90.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -16.87 61.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 89' ' ' ARG . 0.6 OUTLIER -98.11 2.24 48.41 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.177 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 74.75 40.25 0.39 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.941 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -138.01 127.28 24.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.695 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 202' ' ' TYR . 14.9 m -142.26 169.34 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.391 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.682 ' NE2' HG23 ' A' ' 228' ' ' THR . 1.9 t-160 67.54 43.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.46 -17.17 52.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.678 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.73 82.31 0.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.0 110.993 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.689 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mp -82.04 108.49 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 8.2 tttt -149.32 -176.5 5.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -84.69 -0.26 52.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.417 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.63 5.72 12.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.324 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.759 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.1 m-80 -125.12 -11.07 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.328 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.9 mt -108.32 125.62 51.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.949 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.754 HD23 ' C ' ' A' ' 183' ' ' LEU . 1.2 mt -129.58 154.53 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.354 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 1.058 HD11 HD11 ' A' ' 141' ' ' ILE . 6.1 mt -100.07 149.2 23.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.8 133.37 55.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 133' ' ' ARG . 23.5 t80 -75.25 -66.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.808 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -22.75 41.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.836 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.87 80.94 41.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 101.74 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.565 2.177 . . . . 0.0 112.199 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -177.5 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.417 ' HB3' ' CE2' ' A' ' 107' ' ' TYR . 8.6 mp0 -108.22 164.03 12.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.78 HG21 HD21 ' A' ' 138' ' ' LEU . 10.8 p -132.05 147.79 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 1.4 m-85 -123.14 156.73 34.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.709 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 178' ' ' ILE . 26.1 tp -107.28 115.93 31.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.696 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 182' ' ' ASN . 12.4 m -86.86 179.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.254 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.47 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 26.3 m-85 -145.47 -57.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -58.43 -23.69 54.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.696 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.56 33.87 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 175' ' ' HIS . . . -131.08 -90.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.053 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -146.16 118.87 8.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.752 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -94.82 47.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 225' ' ' ILE . 1.3 t -127.75 -52.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.722 0.296 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.619 HG12 HG11 ' A' ' 271' ' ' VAL . 2.1 tt -179.09 38.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.53 63.03 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.504 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.428 ' CE1' ' HG3' ' A' ' 262' ' ' GLU . 30.3 m-85 76.34 29.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.745 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 ' NE2' ' A' ' 175' ' ' HIS . 31.0 m -83.72 145.2 28.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 8.2 t -59.24 141.28 54.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mt -61.01 -37.22 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -43.88 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -59.12 -30.44 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -72.9 -32.0 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.729 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -96.17 12.84 29.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.298 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 55.79 28.7 53.12 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.5 t -90.79 110.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.56 151.88 0.1 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.79 154.86 8.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.531 2.154 . . . . 0.0 112.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 174' ' ' VAL . 1.3 t -100.55 123.57 44.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 mtm105 -144.87 -50.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -17.66 60.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.31 -33.65 66.01 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.544 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.759 ' HB3' HD22 ' A' ' 165' ' ' LEU . 2.8 m-20 -60.39 -33.12 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.639 HD21 ' CE1' ' A' ' 317' ' ' TYR . 10.4 mt -80.66 -31.59 36.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.841 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.52 -40.91 93.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 243' ' ' ASP . 5.2 mt -61.21 -41.29 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.033 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.437 HD23 ' OH ' ' A' ' 302' ' ' TYR . 54.5 tp -70.37 -39.71 74.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -59.36 -45.86 94.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.545 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -78.61 -25.62 45.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.458 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.83 -41.41 82.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.411 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.0 -48.19 81.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.4 mp -65.77 -31.72 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.295 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.425 ' CB ' HD11 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -70.4 -43.61 69.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.011 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 15.1 m0 -82.23 -42.91 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.556 ' HG ' HG21 ' A' ' 154' ' ' VAL . 25.5 mt -67.08 -36.82 82.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.27 -21.43 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.32 88.94 0.27 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 8.6 m170 62.41 144.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.873 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.15 165.77 33.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 41.3 Cg_endo -67.99 64.41 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.43 2.087 . . . . 0.0 112.607 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.873 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -178.9 -40.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.888 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -113.11 25.35 11.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.356 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -58.54 6.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.7 m120 -129.1 -25.87 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.327 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.574 HD22 HG23 ' A' ' 225' ' ' ILE . 41.9 mt 74.33 11.11 4.19 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -85.12 -15.83 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.597 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.472 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 4.4 m-20 -133.89 74.72 68.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 49.1 Cg_exo -56.04 -16.12 15.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.882 2.388 . . . . 0.0 112.982 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -49.99 -50.44 47.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.476 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.9 p90 -84.13 -27.05 28.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.383 . . . . 0.0 110.785 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 225' ' ' ILE . 18.3 t -60.69 -35.49 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.55 -44.15 44.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.22 -47.62 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -64.4 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -46.76 78.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.6 mt -68.65 -34.7 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -50.72 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -61.89 -37.06 83.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -54.58 -29.33 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -116.75 22.28 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -136.23 40.3 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.734 HD13 ' CB ' ' A' ' 303' ' ' MET . 27.9 mt -49.26 -40.05 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.5 64.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -35.98 66.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 286' ' ' MET . 2.7 pp -80.02 -41.58 25.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 15.0 ttm -63.0 -32.98 74.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.762 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.27 -32.59 33.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -82.79 -27.15 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.289 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.6 m -93.55 -41.28 9.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.349 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -107.57 160.39 26.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.13 167.66 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.63 37.93 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -113.09 33.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 60.72 30.33 19.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -80.09 -50.77 1.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 295' ' ' LYS . 42.2 Cg_exo -56.86 -162.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.515 2.144 . . . . 0.0 112.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.39 -45.64 1.13 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -44.64 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 303' ' ' MET . 29.6 mm -77.24 -46.76 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.055 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.723 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -44.87 -49.57 10.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.526 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.8 OUTLIER -58.87 -40.35 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.663 ' O ' HG23 ' A' ' 306' ' ' VAL . 14.5 t80 -69.88 -42.62 73.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.1 mtp -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.317 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.03 -50.35 74.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.556 HG23 HD23 ' A' ' 316' ' ' LEU . 73.6 m -57.48 -37.79 73.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 302' ' ' TYR . 31.6 t -72.3 -24.75 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -31.9 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.376 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.48 -12.98 23.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.694 ' O ' HD21 ' A' ' 309' ' ' LEU . 52.7 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.777 0.24 . . . . 0.0 112.422 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 305' ' ' THR . 1.5 tp 63.2 32.28 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.639 ' CE1' HD21 ' A' ' 244' ' ' LEU . 3.2 m-85 -66.05 -42.08 89.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -58.5 -32.91 69.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -77.4 -47.45 19.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.778 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.6 mt -55.19 -43.02 74.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.593 ' HA ' HD13 ' A' ' 162' ' ' LEU . 1.8 ttt180 -58.55 -37.82 76.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.02 -33.36 73.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 320' ' ' LEU . 64.9 mt -61.38 -49.43 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 302' ' ' TYR . 12.2 mt -80.51 -23.63 39.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.317 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.868 ' HA ' HD11 ' A' ' 159' ' ' LEU . 7.3 tt -82.44 -35.15 27.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.905 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -68.76 -42.51 77.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.21 -26.52 56.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.556 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.697 HD11 ' CD1' ' A' ' 159' ' ' LEU . 28.1 mt -53.84 -29.7 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.21 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.245 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.8 pt -97.51 24.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.33 40.74 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.632 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.9 t -89.62 178.51 6.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 151.89 30.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.51 89.48 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.77 0.319 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.12 114.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.85 -26.43 5.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -76.17 134.54 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.001 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 36' ' ' GLU . 37.9 mt -105.28 145.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.764 HD12 ' CE1' ' A' ' 128' ' ' PHE . 25.2 pt -119.5 154.49 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.263 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 68.4 p -97.93 141.27 31.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.0 -162.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.94 -41.95 34.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 109.775 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.35 -2.21 33.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.653 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 86.96 27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -72.79 177.41 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.141 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 28' ' ' ILE . 31.0 mt-10 -128.77 79.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.873 0.368 . . . . 0.0 110.597 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 80.4 m95 -73.19 128.65 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.94 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -91.9 119.18 31.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.62 150.39 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.45 -116.28 2.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 41' ' ' LEU . 4.0 mm? -105.03 158.85 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.733 0.302 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 56.2 Cg_endo -70.48 155.1 64.25 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.559 2.173 . . . . 0.0 112.373 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 HG22 ' A' ' 51' ' ' ILE . 7.2 pt -145.63 31.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.9 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.465 HG22 HG13 ' A' ' 43' ' ' ILE . 2.2 mt -85.43 106.92 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 70.6 m-85 -131.37 171.33 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.978 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 151.41 23.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.43 153.28 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.672 ' CB ' HG13 ' A' ' 62' ' ' VAL . 28.5 t70 -146.79 140.8 26.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.6 ttp -85.17 57.39 4.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -59.83 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 m 59.39 31.95 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 m -139.83 -66.83 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -176.45 134.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.97 167.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.672 HG13 ' CB ' ' A' ' 55' ' ' ASP . 33.0 t -105.92 -31.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.19 -116.36 3.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -160.87 31.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -138.66 -77.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.89 77.56 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.54 48.87 2.92 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.715 2.276 . . . . 0.0 112.716 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.69 170.14 19.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.41 HG13 ' HA ' ' A' ' 133' ' ' ARG . 15.6 m -143.1 146.04 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 130' ' ' ILE . 11.5 p -139.21 118.78 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CG ' HG12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -105.18 121.94 44.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.685 HG22 ' CB ' ' A' ' 128' ' ' PHE . 2.8 t -113.14 151.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' HG3' HD22 ' A' ' 80' ' ' LEU . 11.5 mt-10 -141.21 122.25 8.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.19 96.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.336 2.024 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.75 178.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.89 79.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -135.98 32.06 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.26 -178.52 28.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.38 10.99 3.43 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.791 2.327 . . . . 0.0 112.97 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.428 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.5 tp -60.96 -32.96 72.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.43 -39.21 92.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 72.1 p -69.72 -32.05 70.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 198' ' ' TYR . 11.7 tp10 -75.79 -40.5 55.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.6 mm? -65.46 -42.54 92.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -62.08 -51.7 66.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 168' ' ' ILE . 16.7 t80 -59.1 -40.05 84.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.967 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.0 m-85 -56.32 -60.06 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.357 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.07 -17.65 63.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -75.87 -47.53 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.97 -25.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.967 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -88.74 23.63 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -76.73 138.54 66.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.536 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.22 -27.8 58.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.513 2.142 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -79.45 -47.36 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.5 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.6 mt -55.84 -45.68 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -48.65 -38.24 20.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -74.2 -35.15 63.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.672 HG23 ' H ' ' A' ' 106' ' ' LYS . 40.9 mm -66.55 -41.46 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -74.92 -27.6 60.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.59 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' LYS . 25.2 p -84.37 -28.47 26.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.351 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.4 ' CB ' ' HG ' ' A' ' 105' ' ' LEU . 2.5 mmt180 -107.11 -7.23 16.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.844 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm 58.7 21.83 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.802 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 108' ' ' LEU . 41.8 mt -54.69 -41.56 70.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.986 0.422 . . . . 0.0 110.755 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.672 ' H ' HG23 ' A' ' 100' ' ' ILE . 11.5 mtpt 52.35 27.08 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.562 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -177.57 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.691 0.281 . . . . 0.0 111.381 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 105' ' ' LEU . 14.1 tp 69.92 -65.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.824 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.92 1.55 10.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.98 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.524 HG23 ' HG ' ' A' ' 108' ' ' LEU . 22.4 t -89.8 138.65 27.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 111.069 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.83 153.22 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.24 115.62 28.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.22 121.78 36.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -103.86 -40.67 6.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.05 -176.78 46.48 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.66 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -132.58 178.71 6.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -163.36 173.24 39.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.423 HD23 ' HG2' ' A' ' 127' ' ' ARG . 1.1 mt -137.06 159.92 40.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.726 0.298 . . . . 0.0 110.746 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.47 ' CD2' HG22 ' A' ' 29' ' ' ILE . 1.3 t-80 -144.32 119.43 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.71 124.62 49.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.15 126.2 22.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.0 t30 55.43 20.83 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.422 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.57 -3.55 61.26 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.903 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -96.14 129.09 43.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -89.07 140.78 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -125.75 123.56 39.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.423 ' HG2' HD23 ' A' ' 118' ' ' LEU . 10.7 mtp85 -102.56 125.13 49.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.764 ' CE1' HD12 ' A' ' 29' ' ' ILE . 23.9 p90 -140.43 162.47 35.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.626 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -131.41 147.18 52.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 70' ' ' VAL . 9.1 mm -98.73 119.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.9 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -120.54 171.94 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.081 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -71.28 145.88 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -64.32 134.17 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.577 ' CE2' HG11 ' A' ' 196' ' ' VAL . 72.9 m-85 -110.17 154.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.722 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -85.39 -107.84 0.69 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.368 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 m -111.24 118.71 36.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.831 0.348 . . . . 0.0 110.672 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -51.22 160.98 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.658 HD13 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -66.53 -21.7 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.679 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.769 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -65.24 -44.7 87.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.027 0.441 . . . . 0.0 109.813 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.88 66.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.191 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.658 HD12 HD13 ' A' ' 138' ' ' LEU . 13.8 mt -74.81 -25.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -62.41 -49.03 77.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.521 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.85 -31.11 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.75 -25.43 67.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.587 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.5 m-20 -108.95 10.4 26.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.01 52.71 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.047 0.451 . . . . 0.0 110.454 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 23.6 mtpt 61.14 19.66 10.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.588 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -136.15 -175.56 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.045 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -137.13 -172.71 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.01 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.0 m -119.12 149.74 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -57.82 -30.57 65.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.432 ' HB3' HD12 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -74.89 -34.83 62.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -48.38 35.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG21 ' HG ' ' A' ' 255' ' ' LEU . 59.4 t -60.08 -54.19 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 16.5 mt -58.87 -49.7 76.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -59.86 -51.27 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 193' ' ' VAL . 15.4 mt -59.91 -33.42 71.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.519 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 247' ' ' LEU . 0.1 OUTLIER -58.99 -45.57 90.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.69 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 325' ' ' LEU . 58.2 mt -61.74 -45.78 92.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.75 -48.79 79.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.781 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HG12 ' A' ' 178' ' ' ILE . 11.9 mt -65.18 -40.21 88.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 324' ' ' LEU . 7.4 mt -58.07 -33.47 69.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.21 -32.7 72.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.788 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.74 -44.54 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 178' ' ' ILE . 72.2 mt -55.45 -40.44 71.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.67 -38.46 91.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.067 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.672 ' CE2' HD21 ' A' ' 108' ' ' LEU . 80.5 t80 -66.56 -52.05 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 175' ' ' HIS . 38.0 pt -62.37 -27.16 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.71 -34.48 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -16.75 62.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.676 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 2.44 49.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.428 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 12.9 mt-10 78.09 43.48 0.09 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.851 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.3 122.21 15.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.846 HG13 ' CD1' ' A' ' 204' ' ' TYR . 18.8 m -121.92 142.8 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.209 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.505 ' CE1' ' CD1' ' A' ' 198' ' ' TYR . 0.5 OUTLIER 177.74 82.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.82 79.57 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.817 ' OD1' HD21 ' A' ' 195' ' ' LEU . 17.1 p-10 -103.07 22.46 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.649 0.261 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.622 HG12 HG21 ' A' ' 161' ' ' ILE . 3.0 mp -64.1 91.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 171.69 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.769 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.86 -6.31 51.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.538 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.71 1.79 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -123.87 -9.61 7.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.102 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.63 128.83 55.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.4 mt -135.46 149.15 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.756 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 193' ' ' VAL . 50.2 mt -86.52 147.83 25.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.281 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -65.8 125.75 26.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -94.95 -42.81 8.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -30.25 66.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.467 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -141.22 69.24 27.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.432 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.51 108.3 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.5 -45.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.082 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -149.62 -166.52 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 111.205 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.9 p -109.91 148.24 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 14.4 m-85 -116.85 156.93 26.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.351 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.817 HD21 ' OD1' ' A' ' 177' ' ' ASP . 22.3 tp -109.14 115.84 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 134' ' ' PHE . 13.1 m -118.5 145.93 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.15 100.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.252 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.505 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 2.9 m-85 -86.65 -20.27 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 65.21 14.64 59.71 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -146.61 -66.35 0.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.38 87.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.295 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -131.0 149.01 52.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -95.82 82.82 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.846 ' CD1' HG13 ' A' ' 174' ' ' VAL . 41.5 p90 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.612 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 226' ' ' GLU . 2.0 m 61.29 162.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.894 HG23 HD22 ' A' ' 265' ' ' LEU . 3.7 tp -130.13 15.87 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.499 ' HA ' HD21 ' A' ' 265' ' ' LEU . 43.8 tt0 -74.55 -34.82 63.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 226' ' ' GLU . 73.0 m-85 -157.59 30.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -76.11 132.62 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 172.25 10.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -53.6 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -42.26 90.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.26 -32.79 74.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.216 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.5 -36.53 84.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.724 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -101.67 12.98 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.392 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.31 31.45 59.55 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.801 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.7 t -90.6 113.28 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.106 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.05 154.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.78 158.68 56.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.578 2.186 . . . . 0.0 112.254 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.57 ' O ' HG11 ' A' ' 174' ' ' VAL . 18.9 m -67.22 113.09 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -134.59 -57.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -87.58 -24.87 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.6 -32.11 64.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.563 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -38.12 74.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.444 HD12 ' CD1' ' A' ' 309' ' ' LEU . 57.9 mt -80.6 -33.48 35.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.57 -37.81 79.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.44 -39.67 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.875 HD23 ' OH ' ' A' ' 302' ' ' TYR . 49.6 tp -64.36 -45.43 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.42 92.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.439 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 25.4 m-85 -78.81 -25.7 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.67 -43.25 84.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.279 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.41 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.17 -49.62 76.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.019 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.538 HD11 ' SD ' ' A' ' 303' ' ' MET . 3.6 mt -63.99 -28.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.364 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 259' ' ' LEU . 9.0 tm0? -80.12 -40.19 27.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.002 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 36.2 m0 -82.29 -30.85 30.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.439 ' HG ' HG21 ' A' ' 154' ' ' VAL . 28.9 mt -79.79 -44.04 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.05 0.62 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.449 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.71 97.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.5 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 64.07 154.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 1.008 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -137.77 171.28 8.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.56 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 45.3 Cg_endo -68.89 61.73 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.411 2.074 . . . . 0.0 112.633 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 1.008 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.6 p90 178.12 -37.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -98.09 22.23 9.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.437 179.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.82 -55.83 6.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -132.22 -26.41 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.482 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.894 HD22 HG23 ' A' ' 225' ' ' ILE . 66.0 mt 71.93 12.27 6.11 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.208 0.528 . . . . 0.0 109.69 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -84.77 -14.43 48.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.456 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -134.92 101.24 11.61 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.52 19.27 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.724 2.283 . . . . 0.0 112.724 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -45.67 17.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -82.09 -26.46 33.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.617 HG11 ' CD1' ' A' ' 225' ' ' ILE . 11.3 t -61.72 -44.22 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -71.47 -44.34 64.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -66.51 -41.25 89.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 278' ' ' TYR . 75.5 m -63.17 -40.5 97.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -61.98 -45.91 91.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.044 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.5 mt -70.88 -46.08 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -59.59 -51.61 69.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.834 ' CD1' HD12 ' A' ' 285' ' ' LEU . 16.3 m-85 -60.43 -31.87 70.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -59.43 -33.26 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.407 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.19 23.07 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.868 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -139.16 37.91 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.609 HG21 ' CG ' ' A' ' 304' ' ' GLU . 7.0 mm -47.09 -43.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -47.74 36.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.073 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.7 -33.61 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.2 tt -64.33 -43.63 94.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 3.5 mmt -65.48 -32.52 74.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.984 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.75 -27.03 31.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.139 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -54.84 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.34 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 252' ' ' ILE . 68.2 m -76.42 -41.22 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.52 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.84 158.71 34.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 177.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.612 2.208 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -108.01 -66.24 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -59.69 -35.12 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -60.27 143.52 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -63.8 148.86 94.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.11 158.83 55.23 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -94.2 20.84 45.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.568 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.35 9.2 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.526 0.203 . . . . 0.0 111.402 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.704 HG22 ' CG ' ' A' ' 303' ' ' MET . 34.2 mm -79.52 -40.76 21.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.446 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -48.04 -45.77 32.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.312 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -59.85 -39.77 86.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.63 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.875 ' OH ' HD23 ' A' ' 247' ' ' LEU . 70.4 t80 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.704 ' CG ' HG22 ' A' ' 299' ' ' ILE . 1.4 mtp -64.73 -45.72 85.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.595 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.609 ' CG ' HG21 ' A' ' 282' ' ' ILE . 2.1 mt-10 -58.13 -51.89 67.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.846 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.7 p -58.07 -53.59 56.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 302' ' ' TYR . 61.1 t -56.32 -24.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.154 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -43.1 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.78 -11.98 60.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.689 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' A' ' 244' ' ' LEU . 15.9 mt . . . . . 0 C--O 1.232 0.148 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.222 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.784 0.244 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.8 tp -140.13 17.64 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -60.07 -31.63 70.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.75 -46.48 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.779 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.49 -40.2 90.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.906 ' HA ' HD12 ' A' ' 323' ' ' ILE . 34.6 mt -55.55 -48.15 75.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.476 ' HG2' HD22 ' A' ' 159' ' ' LEU . 7.7 ttm105 -57.46 -34.56 69.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.876 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -38.52 71.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 320' ' ' LEU . 37.5 mt -57.07 -47.91 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 158' ' ' SER . 30.6 mt -79.78 -22.0 43.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.462 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.634 ' O ' HD23 ' A' ' 325' ' ' LEU . 7.2 tt -82.68 -40.49 20.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.688 0.28 . . . . 0.0 111.109 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.92 -39.42 90.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.94 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -60.32 -26.34 63.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.5 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 69.9 mt -48.44 -27.99 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -81.28 -31.08 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.73 -26.35 65.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.297 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 151' ' ' ARG . 10.6 pt -106.97 22.75 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 53.25 45.69 64.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.738 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.7 t -118.33 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.57 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.959 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.79 133.85 51.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.67 127.1 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.98 22.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -58.87 139.84 56.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' A' ' 38' ' ' LYS . 21.7 mm -100.34 136.39 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.2 pt -117.89 154.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.088 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 3.1 t -101.81 136.94 40.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -93.77 -164.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -41.37 43.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -75.25 -6.63 50.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.429 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 4.2 tttp 89.59 27.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -75.16 178.36 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.154 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.63 79.6 1.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.39 . . . . 0.0 110.591 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.452 ' HB2' HG13 ' A' ' 29' ' ' ILE . 80.5 m95 -76.51 136.73 39.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.952 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -96.88 129.14 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.95 128.54 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.7 -122.58 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 53' ' ' LEU . 3.9 mm? -100.57 154.42 37.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 61.4 Cg_endo -73.1 105.49 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.615 2.21 . . . . 0.0 112.362 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -98.54 -28.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.558 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -111.83 137.53 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 44.2 m-85 -143.74 172.22 13.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.804 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 66' ' ' ALA . 25.2 mt -69.65 158.26 35.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.68 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -124.45 152.37 43.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.48 156.79 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.4 ptp -97.47 26.42 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.29 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 p -134.45 35.74 3.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.6 30.91 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -131.26 179.07 6.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -99.13 29.89 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' A' ' 38' ' ' LYS . 24.0 t 68.3 -68.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.51 179.03 21.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.559 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -92.54 48.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.482 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -158.38 -69.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.695 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . 63.27 139.32 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.93 -4.74 13.51 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.667 2.245 . . . . 0.0 112.816 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 11.8 m -149.65 157.11 42.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.564 HG13 ' CB ' ' A' ' 133' ' ' ARG . 29.7 m -120.27 144.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 HD13 ' A' ' 130' ' ' ILE . 11.4 p -119.39 121.11 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -98.07 116.19 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.496 HG22 ' CB ' ' A' ' 128' ' ' PHE . 11.9 t -113.07 139.32 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.309 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 136.52 15.96 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.686 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.51 96.6 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.389 2.059 . . . . 0.0 112.317 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 t 179.63 177.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.24 -42.58 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.12 95.28 2.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.05 -147.98 5.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.488 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.16 -23.09 39.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.528 2.152 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.545 HD23 ' HG3' ' A' ' 127' ' ' ARG . 8.4 tp -60.1 -33.2 71.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -42.14 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.8 p -70.88 -30.15 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -75.02 -42.31 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.3 mm? -59.2 -51.49 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -59.54 -46.21 89.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 198' ' ' TYR . 12.2 t80 -54.67 -50.68 67.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.674 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 24.7 m-85 -59.81 -41.48 91.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.415 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -79.95 -17.79 52.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -47.41 69.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.486 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB1' ' CE1' ' A' ' 171' ' ' HIS . . . -145.03 -32.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -53.86 -21.8 8.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -51.34 125.26 25.53 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 -25.4 15.34 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.491 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.4 -44.01 92.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.131 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.28 -43.13 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.282 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.753 HG22 HD11 ' A' ' 100' ' ' ILE . 30.2 mt -58.42 -48.34 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -52.28 -39.53 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.043 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -75.33 -29.2 59.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -76.62 -43.98 36.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.753 HD11 HG22 ' A' ' 96' ' ' ILE . 34.5 mt -65.85 -37.47 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.8 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' LYS . 16.6 p -82.02 -36.99 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.433 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.71 -2.5 24.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.4 mttm 59.51 31.34 20.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 100' ' ' ILE . 11.7 mt -49.39 -30.88 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.68 -55.6 0.51 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.026 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CD1' ' OE1' ' A' ' 192' ' ' GLN . 6.8 t80 -150.68 139.8 21.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.979 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' A' ' 167' ' ' TYR . 9.5 tp -119.72 162.19 19.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.61 19.14 42.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.97 125.25 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 149.13 37.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.369 2.046 . . . . 0.0 112.262 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.4 115.88 25.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -86.9 129.61 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.721 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.7 m95 -107.58 -40.91 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.77 -174.66 46.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.1 p -132.86 169.0 17.39 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -158.96 175.84 35.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.977 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.83 150.83 36.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -141.17 141.61 34.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.61 136.07 54.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -138.27 126.27 22.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.29 18.59 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.322 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 10.39 54.72 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.861 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -96.21 159.37 14.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 110.711 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.5 m -111.34 123.11 49.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.492 ' O ' HD23 ' A' ' 118' ' ' LEU . 12.9 m-85 -122.12 136.5 54.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.793 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.545 ' HG3' HD23 ' A' ' 80' ' ' LEU . 15.5 tpt180 -117.95 125.12 49.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.806 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CB ' HG22 ' A' ' 72' ' ' VAL . 29.5 p90 -133.16 165.84 23.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.454 ' HB2' HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -134.65 144.77 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 70' ' ' VAL . 7.2 mm -101.53 111.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.2 173.06 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.141 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.35 127.69 32.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.564 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.65 176.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 184' ' ' LEU . 54.9 m-85 -147.42 175.82 10.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.663 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.21 -81.67 1.6 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.461 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.6 t -149.58 130.51 14.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.837 0.351 . . . . 0.0 110.582 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.16 165.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.713 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.693 HD22 HD12 ' A' ' 141' ' ' ILE . 2.8 mt -77.34 -14.07 59.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.675 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.43 -33.25 29.86 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.05 0.453 . . . . 0.0 109.932 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -75.83 -31.3 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.824 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.693 HD12 HD22 ' A' ' 138' ' ' LEU . 12.2 mt -68.93 -26.74 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 24.1 t80 -71.17 -43.92 66.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -29.9 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.4 67.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.219 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-20 -96.32 21.03 9.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.039 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.41 47.92 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 10.2 tttt 64.7 18.2 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.25 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 13.7 mtp85 -138.01 -170.67 2.84 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.002 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.2 OUTLIER -137.55 -166.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.675 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 m -129.35 151.7 49.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -62.22 -30.7 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -30.99 62.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -51.24 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 150' ' ' SER . 21.9 t -60.33 -48.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.3 mt -59.58 -43.87 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.727 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -68.47 -54.5 16.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.19 -42.47 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.695 ' OG ' HD11 ' A' ' 247' ' ' LEU . 16.1 m -55.58 -42.47 74.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.8 mt -60.02 -49.72 76.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.589 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 21.4 mmt-85 -60.72 -42.0 96.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.817 ' HA ' HD12 ' A' ' 164' ' ' ILE . 17.8 mt -65.19 -36.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.642 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.0 mt -60.23 -39.71 87.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.535 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -34.61 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 161' ' ' ILE . 9.7 mt -74.54 -42.87 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 243' ' ' ASP . 11.4 mt -54.34 -32.24 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.802 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' CD2' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -73.66 -32.79 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.578 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.619 ' CD2' HD21 ' A' ' 108' ' ' LEU . 57.1 t80 -70.91 -49.89 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 165' ' ' LEU . 34.2 pt -63.23 -27.71 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.529 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -72.8 -40.47 65.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 -14.77 62.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.644 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 57.5 m-70 -101.42 2.86 39.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.152 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 76.34 43.37 0.15 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 111.0 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.99 129.08 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.877 HG21 ' HG3' ' A' ' 240' ' ' ARG . 28.9 m -142.2 169.44 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.1 m170 65.23 48.83 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.39 -10.86 54.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.897 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 76.08 69.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.984 0.421 . . . . 0.0 111.026 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.661 HD11 HD21 ' A' ' 165' ' ' LEU . 2.4 mp -73.97 98.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 183' ' ' LEU . 23.6 mttp -144.38 -179.55 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.675 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -82.32 -0.61 46.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.436 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.29 -3.38 18.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 110.833 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.577 ' O ' HG22 ' A' ' 196' ' ' VAL . 35.2 m-20 -126.16 -2.15 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 179' ' ' LYS . 9.4 mt -108.36 113.56 26.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.997 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.813 ' C ' HG23 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -122.82 144.71 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.45 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.851 HD23 ' HB ' ' A' ' 193' ' ' VAL . 1.3 mt -90.48 149.0 22.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.349 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 9.9 m-20 -67.89 126.18 28.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -86.9 -60.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.417 ' HB2' ' NH1' ' A' ' 133' ' ' ARG . 10.4 mmtt -63.79 -30.83 71.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -130.34 71.71 82.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.2 97.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.551 2.167 . . . . 0.0 112.057 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.19 -53.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 107' ' ' TYR . 1.4 mt-30 -150.86 -177.42 5.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 185' ' ' LEU . 7.4 p -110.0 141.28 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.681 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.409 ' CE1' ' OD1' ' A' ' 186' ' ' ASN . 3.3 m-85 -106.97 153.8 22.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.125 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.6 tp -105.99 116.14 31.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 182' ' ' ASN . 7.6 m -88.57 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 198' ' ' TYR . 1.2 t70 63.76 129.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.425 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 30.1 m-85 -162.56 -44.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -55.89 -25.81 46.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.704 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.07 33.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 111.096 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.59 -110.29 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.19 119.38 8.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.809 0.337 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.66 49.49 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.417 ' CE2' ' NH2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.2 p -154.39 -46.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.769 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tt -174.56 36.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HA ' HD13 ' A' ' 265' ' ' LEU . 7.5 pt-20 -95.99 62.85 2.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 226' ' ' GLU . 12.6 t80 70.98 31.97 2.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 41.7 p -100.15 179.75 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 160.16 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.29 -40.29 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -78.13 -28.65 48.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.18 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -58.07 -39.79 79.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -97.02 -5.63 37.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 83.58 -2.7 86.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.718 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.23 157.77 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.807 0.336 . . . . 0.0 111.167 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -164.99 78.33 1.34 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.45 10.66 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.73 2.287 . . . . 0.0 112.878 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.0 p -153.61 163.24 40.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.877 ' HG3' HG21 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -113.88 -11.83 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.94 -13.48 61.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.315 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.36 -25.93 55.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.607 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.663 ' HB3' HD22 ' A' ' 165' ' ' LEU . 0.8 OUTLIER -55.69 -31.86 62.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.977 0.418 . . . . 0.0 110.838 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 320' ' ' LEU . 21.3 mt -80.58 -30.45 36.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.39 -32.56 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 29.3 mt -69.59 -37.55 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.186 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.739 HD23 ' OH ' ' A' ' 302' ' ' TYR . 40.7 tp -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.83 -41.75 94.23 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.34 -29.03 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -37.18 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.593 ' SD ' HD12 ' A' ' 299' ' ' ILE . 1.8 mtt -68.35 -39.7 81.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.716 HG22 HD23 ' A' ' 259' ' ' LEU . 7.4 mm -62.25 -39.32 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.15 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.836 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.8 tm0? -80.27 -34.97 36.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -76.41 -48.12 20.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.414 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.46 -36.21 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.55 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -96.39 -13.92 22.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.573 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.55 94.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.261 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.0 146.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 110.653 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.924 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.91 166.15 29.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.212 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.01 62.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.953 2.435 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.924 ' CH2' HD22 ' A' ' 259' ' ' LEU . 0.7 OUTLIER -178.54 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 261' ' ' TRP . 1.8 tt0 -108.94 18.22 20.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.069 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -66.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.82 -27.34 3.07 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.428 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 225' ' ' ILE . 19.8 mt 77.18 7.94 2.91 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -16.42 61.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.47 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 33.4 t70 -145.06 91.19 5.99 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 38.5 Cg_endo -66.71 -7.28 17.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.685 2.256 . . . . 0.0 112.841 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.84 -50.11 69.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 110.965 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.47 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 5.5 p90 -83.88 -26.22 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.769 ' CG1' HD11 ' A' ' 225' ' ' ILE . 25.9 t -60.38 -40.85 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -48.67 23.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.975 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -61.6 -35.16 77.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.071 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 m -72.09 -33.7 68.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -70.2 -49.73 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.046 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.4 mm -61.15 -36.59 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -75.54 -52.12 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -55.4 -35.09 64.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -29.69 65.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 22.68 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.94 43.57 2.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.7 mt -55.48 -37.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.18 64.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 5.4 t -71.12 -42.79 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.5 pp -65.23 -31.46 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.79 0.329 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mmt -66.81 -49.36 66.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -68.68 -31.4 70.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.247 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -53.76 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.102 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.466 ' O ' HG23 ' A' ' 256' ' ' THR . 81.0 m -66.15 -41.16 90.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.155 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.0 146.19 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 -166.86 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.51 45.28 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -45.73 19.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -149.87 167.15 27.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -86.78 156.57 55.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.86 118.41 5.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.593 2.195 . . . . 0.0 112.192 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -157.69 -49.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.67 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.69 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.0 mm -79.43 -41.69 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.227 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.57 -42.36 7.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.869 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -67.23 -38.71 85.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 110.58 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.739 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.0 t80 -70.5 -44.52 67.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.716 ' CB ' HD13 ' A' ' 282' ' ' ILE . 47.2 mmm -68.73 -31.93 71.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.84 -43.07 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.328 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.881 ' O ' HD12 ' A' ' 309' ' ' LEU . 5.5 p -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 302' ' ' TYR . 79.5 t -79.45 -24.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -36.68 23.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.738 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.1 -27.89 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.54 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.124 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.871 0.28 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.06 29.23 3.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 166' ' ' GLU . 4.1 m-85 -66.53 -29.7 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -40.53 67.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -42.76 48.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.878 ' HA ' HD12 ' A' ' 323' ' ' ILE . 39.3 mt -58.27 -41.38 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.458 ' CG ' HD22 ' A' ' 159' ' ' LEU . 15.0 ttp180 -57.28 -47.36 81.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -39.13 80.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 320' ' ' LEU . 52.0 mt -57.37 -46.42 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.055 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 155' ' ' LEU . 37.4 mt -75.99 -50.36 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.611 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -53.73 -49.89 67.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -56.29 -42.35 77.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.995 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.94 -29.71 65.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 155' ' ' LEU . 19.7 mt -64.75 -35.02 79.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.2 66.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.247 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.49 32.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.1 70.14 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.85 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.61 101.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 39.23 3.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 325' ' ' LEU . 6.5 p-10 -90.44 70.1 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' O ' HG12 ' A' ' 39' ' ' VAL . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.812 0.339 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 41' ' ' LEU . 15.0 t -129.44 117.36 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.71 30.0 27.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -132.54 139.1 47.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.734 0.302 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.641 HG21 ' HB3' ' A' ' 36' ' ' GLU . 35.2 mt -103.71 140.09 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.928 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.7 pt -119.86 154.55 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.6 p -95.65 136.92 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 37' ' ' TRP . 21.7 p-10 -94.54 -148.29 0.27 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.985 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -85.67 -37.91 18.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.242 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.39 2.34 32.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.856 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.2 mmpt? 83.08 15.47 0.34 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -63.15 169.89 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -118.21 76.13 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.018 0.437 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 31' ' ' ASP . 44.5 m95 -67.11 142.67 57.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.787 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 62' ' ' VAL . 23.2 mttm -105.46 132.66 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 24' ' ' ALA . 17.0 t -89.8 130.02 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.429 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -77.56 -106.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.858 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.638 ' HA ' HG22 ' A' ' 25' ' ' VAL . 2.3 mt -121.99 162.25 38.18 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 38.4 Cg_endo -66.78 140.38 55.58 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.666 2.244 . . . . 0.0 112.29 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.694 HG13 HG22 ' A' ' 51' ' ' ILE . 6.5 pt -142.57 30.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.742 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.686 0.279 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 50' ' ' CYS . 19.7 mm -135.63 127.4 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.361 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 70' ' ' VAL . 14.2 m-85 -146.43 145.8 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' H ' ' A' ' 41' ' ' LEU . 81.0 mt -71.82 136.55 47.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.352 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -114.55 157.22 23.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.507 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 145.99 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.673 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ptm -98.2 40.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.8 t30 58.72 35.86 24.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -65.8 -67.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.43 -170.14 1.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -76.65 -38.82 53.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.85 131.84 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 47.7 t -74.32 -29.1 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.88 65.41 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -179.25 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 110.767 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 76.07 1.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -114.94 89.95 21.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.88 42.36 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.871 2.381 . . . . 0.0 112.807 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -149.71 157.13 42.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.733 HG13 ' HG2' ' A' ' 133' ' ' ARG . 4.8 m -132.05 144.9 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 52' ' ' TYR . 11.2 p -127.41 129.82 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.316 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -94.7 117.48 30.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.199 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.2 125.31 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 111.55 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -141.16 146.98 45.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 114.89 3.85 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -60.2 124.16 19.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.12 -73.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -79.36 -32.79 43.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.14 48.42 3.57 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.783 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' THR . 38.5 Cg_endo -67.7 -51.36 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.266 1.977 . . . . 0.0 111.643 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.1 tp -77.93 -21.44 51.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.821 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.78 -33.9 50.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.441 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 79' ' ' PRO . 1.8 t -74.68 -35.36 62.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -73.1 -35.29 66.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 mm? -72.67 -36.2 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -63.97 -47.98 78.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 173' ' ' TYR . 10.2 t80 -72.0 -35.7 69.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.727 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 1.7 m-85 -56.85 -50.47 72.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -74.98 -17.47 60.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.44 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -47.73 14.64 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -126.36 -19.64 4.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.727 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -92.61 21.4 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 113.25 35.08 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.57 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.76 -29.55 3.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 0.0 112.749 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -71.93 -39.38 69.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.83 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' A' ' 100' ' ' ILE . 50.1 mt -67.53 -49.78 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -29.66 61.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -78.8 -38.16 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -71.14 -42.69 68.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.025 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.6 mt -69.68 -36.43 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.84 60.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 98' ' ' LYS . 35.8 p -84.37 -30.28 25.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.342 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -4.16 17.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 100' ' ' ILE . 3.0 mtmp? 56.59 30.91 18.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.531 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.606 ' HB2' HG23 ' A' ' 100' ' ' ILE . 78.7 mt -45.56 -84.65 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.593 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER 175.16 -62.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.755 0.312 . . . . 0.0 110.984 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -169.13 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 108' ' ' LEU . 4.2 tp 75.34 146.44 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.76 10.23 68.56 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.995 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.97 115.45 44.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.783 0.291 . . . . 0.0 110.939 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 141.07 8.42 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.484 2.123 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 122.26 26.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.42 131.36 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.4 -40.99 3.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.618 0.247 . . . . 0.0 111.551 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.75 171.64 38.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.804 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -132.66 164.48 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.603 0.239 . . . . 0.0 110.643 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -162.01 179.75 37.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.979 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.45 159.68 42.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.715 0.293 . . . . 0.0 110.77 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -144.53 141.65 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.957 0.408 . . . . 0.0 111.108 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.41 129.24 54.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 126.35 22.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.921 0.391 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 55.47 20.9 3.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.72 -0.18 64.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.85 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -96.23 151.15 19.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.759 0.314 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.6 p -101.26 127.33 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.203 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.831 ' O ' HD23 ' A' ' 118' ' ' LEU . 21.6 m-85 -113.57 147.9 37.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.635 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -124.34 125.17 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.77 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.928 ' CE1' HD12 ' A' ' 29' ' ' ILE . 20.7 p90 -135.29 162.45 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.503 ' HG3' HD11 ' A' ' 84' ' ' LEU . 16.0 tmm? -144.94 140.26 28.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.026 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.453 HG13 ' HB ' ' A' ' 70' ' ' VAL . 2.7 mp -99.11 129.82 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -133.31 173.06 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -55.75 138.19 48.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.733 ' HG2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -62.85 170.46 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -145.73 157.5 43.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.98 -74.69 1.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.5 p -148.53 135.1 19.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.82 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -57.31 152.48 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.841 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -57.24 -23.19 46.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.8 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 45.3 tt0 -63.75 -38.56 91.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.154 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -36.48 81.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.841 HD12 ' HA ' ' A' ' 138' ' ' LEU . 8.8 mt -73.85 -25.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.714 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 254' ' ' TRP . 13.1 t80 -76.42 -51.89 10.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.32 -29.99 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.58 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.45 63.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.21 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -96.16 19.77 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.002 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 80.97 48.01 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt 63.37 19.19 11.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.302 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 20.7 mtp180 -131.91 -178.58 4.95 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.868 ' CE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -139.06 -167.81 2.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.688 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.08 144.46 47.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.45 -31.27 63.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 331' ' ' ILE . 3.2 mtmt -74.93 -43.91 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.868 HG21 ' CE1' ' A' ' 149' ' ' PHE . 58.6 m -58.45 -51.82 68.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.22 -46.0 88.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.438 HD22 ' OE2' ' A' ' 298' ' ' GLU . 40.9 mt -65.3 -48.29 73.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -41.97 95.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.677 HD22 HG11 ' A' ' 193' ' ' VAL . 23.7 mt -70.32 -38.98 75.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 324' ' ' LEU . 91.6 p -59.43 -34.55 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.787 HD12 HD11 ' A' ' 328' ' ' LEU . 13.0 mt -70.8 -46.77 62.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.466 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -61.32 -44.72 96.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.7 mt -64.85 -42.18 94.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.698 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 158' ' ' SER . 2.8 mt -55.52 -35.93 66.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -36.93 79.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.603 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 161' ' ' ILE . 5.1 mt -79.54 -38.71 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 162' ' ' LEU . 89.6 mt -58.17 -48.22 80.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -31.09 72.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -72.2 -47.91 47.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.829 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.47 -27.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -76.6 -33.43 58.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.357 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -15.86 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -102.39 3.11 37.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.867 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 74.17 45.24 0.21 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.891 0.377 . . . . 0.0 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -133.08 124.9 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 204' ' ' TYR . 28.3 m -132.2 165.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.067 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.585 ' O ' HD22 ' A' ' 200' ' ' LEU . 10.4 p-80 -150.37 -51.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.237 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.09 24.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.605 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.67 -80.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.584 0.23 . . . . 0.0 110.795 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.0 mt 44.57 95.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 183' ' ' LEU . 5.6 tttt -147.99 174.84 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.8 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -77.09 -1.0 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.593 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.8 t -111.97 1.94 16.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 0.0 110.551 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -123.4 -12.07 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.194 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 179' ' ' LYS . 4.5 mt -108.36 125.19 51.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.908 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 196' ' ' VAL . 0.9 OUTLIER -130.86 156.55 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 111.351 -178.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 141' ' ' ILE . 27.3 mt -90.31 149.84 22.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.05 129.68 40.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.942 0.401 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -73.07 -60.21 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -61.01 -20.84 62.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.534 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -136.52 78.23 44.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.54 80.46 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.534 2.156 . . . . 0.0 112.14 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.36 37.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.06 143.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 157' ' ' LEU . 4.0 p -109.95 147.99 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.162 0.506 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 8.4 m-85 -126.12 156.89 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.652 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 183' ' ' LEU . 39.5 tp -104.01 115.9 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.659 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.77 HG21 HD11 ' A' ' 184' ' ' LEU . 30.9 m -113.76 142.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.1 t70 55.77 84.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -59.05 -21.05 58.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.119 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.713 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 71.49 9.06 68.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.758 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.6 OUTLIER -153.61 -58.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.734 0.302 . . . . 0.0 110.818 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.533 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 43.93 76.24 0.09 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -116.72 148.97 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -103.1 69.71 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.697 ' CD1' HG13 ' A' ' 174' ' ' VAL . 17.0 p90 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 -67.22 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.76 HD13 ' HG2' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -159.19 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.76 ' HG2' HD13 ' A' ' 225' ' ' ILE . 5.4 mm-40 -159.48 26.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 227' ' ' PHE . 37.7 t80 -95.07 24.32 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.622 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -142.43 -76.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.993 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.522 ' H ' HG23 ' A' ' 228' ' ' THR . 7.7 t -157.86 163.51 37.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.908 0.385 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.39 -30.51 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.628 ' OD1' HG21 ' A' ' 236' ' ' VAL . 19.3 t70 -64.29 -39.47 93.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -67.49 -29.64 69.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.72 -25.48 61.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -88.92 12.87 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.475 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.98 28.13 72.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.642 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.628 HG21 ' OD1' ' A' ' 231' ' ' ASP . 22.0 t -88.44 129.29 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.691 0.282 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -76.98 -54.29 1.6 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.0 Cg_exo -54.39 88.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.449 2.099 . . . . 0.0 112.194 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.19 80.77 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -101.8 -24.81 14.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -17.76 41.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.236 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 246' ' ' ILE . . . -61.63 -30.31 74.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.78 -36.79 58.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 110.972 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.58 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 62.2 mt -80.74 -35.0 33.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -57.3 -43.71 83.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 242' ' ' GLY . 3.3 mt -59.9 -42.1 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.804 HD23 ' OH ' ' A' ' 302' ' ' TYR . 30.7 tp -61.1 -30.85 70.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -70.69 -37.36 67.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.366 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.412 ' CZ ' ' HE2' ' A' ' 275' ' ' LYS . 34.5 m-85 -78.55 -26.17 45.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.297 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.283 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.583 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -64.4 -51.07 65.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.189 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.6 mt -63.73 -33.53 62.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -80.02 -33.74 38.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 30.8 m0 -82.28 -48.74 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.415 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -70.93 -36.82 72.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.598 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 289' ' ' CYS . 0.5 OUTLIER -96.14 0.53 51.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.772 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 57.75 94.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.519 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 45.8 m80 63.52 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -132.97 168.52 17.53 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 59.2 Cg_endo -72.61 60.0 3.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.527 2.151 . . . . 0.0 112.534 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.3 p90 178.15 -39.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.9 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -107.45 20.35 19.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.47 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.22 -62.29 1.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -128.57 -26.46 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.283 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 27.9 mt 75.53 10.2 3.5 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.08 0.466 . . . . 0.0 109.756 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -80.91 -16.45 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.11 81.81 37.69 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 33.4 Cg_exo -59.89 -14.77 29.11 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.791 2.328 . . . . 0.0 112.534 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.85 -50.45 45.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.254 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 6.0 p90 -84.04 -26.85 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.767 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 225' ' ' ILE . 39.5 t -60.62 -39.02 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.229 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -73.1 -45.28 58.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 276' ' ' ILE . 19.8 t70 -69.94 -42.73 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.6 t -60.74 -46.17 91.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 279' ' ' ARG . 0.0 OUTLIER -58.75 -51.61 69.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 273' ' ' ASP . 14.0 mt -53.12 -37.66 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.534 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.02 7.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.328 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 285' ' ' LEU . 9.8 m-85 -57.91 -36.98 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 275' ' ' LYS . 0.0 OUTLIER -55.77 -30.62 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 0.0 110.695 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.35 28.12 7.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 284' ' ' SER . 4.1 m120 -136.13 45.1 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.682 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.8 mt -50.43 -36.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.238 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 281' ' ' ASN . 0.3 OUTLIER -78.92 -42.25 27.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.96 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 285' ' ' LEU . 3.0 pp -68.7 -28.47 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.743 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.434 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.9 mmt -72.66 -51.62 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -24.82 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.336 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -48.3 11.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 111.179 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.501 ' HB3' HG21 ' A' ' 256' ' ' THR . 96.8 m -83.16 -41.25 18.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -104.18 153.45 38.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 -170.0 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.562 2.175 . . . . 0.0 112.349 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.05 -43.69 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.13 94.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.08 69.52 0.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 96.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.24 -34.42 21.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.261 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.83 78.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.935 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.438 ' OE2' HD22 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.83 -57.1 14.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.874 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.583 HD12 ' SD ' ' A' ' 251' ' ' MET . 27.1 mm -69.04 -35.31 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.434 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -52.21 -46.09 65.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -61.24 -37.47 83.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.859 ' O ' HG23 ' A' ' 306' ' ' VAL . 46.4 t80 -71.3 -36.17 71.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.682 ' CB ' HD13 ' A' ' 282' ' ' ILE . 0.6 OUTLIER -69.67 -38.06 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.587 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.53 -49.4 76.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.604 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.468 HG21 HD11 ' A' ' 323' ' ' ILE . 0.6 OUTLIER -59.39 -39.69 84.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.712 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 302' ' ' TYR . 22.5 t -73.82 -24.37 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.261 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -79.67 -43.16 23.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.32 -14.4 61.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.814 HD12 ' HA ' ' A' ' 306' ' ' VAL . 6.7 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.853 0.272 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 24.8 mt -108.95 31.41 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.58 ' CZ ' HD21 ' A' ' 244' ' ' LEU . 15.0 m-85 -61.64 -31.45 71.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -38.79 92.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -76.62 -44.33 34.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.764 ' HA ' HD12 ' A' ' 323' ' ' ILE . 84.4 mt -54.67 -42.18 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.525 ' HG2' HD22 ' A' ' 159' ' ' LEU . 3.4 tmt_? -58.54 -33.32 69.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.44 -32.84 58.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 320' ' ' LEU . 60.1 mt -61.16 -46.96 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.66 HD13 ' OG ' ' A' ' 158' ' ' SER . 41.0 mt -81.17 -23.81 37.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.384 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.613 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.53 -44.39 15.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.184 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.85 -29.11 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -75.36 -26.45 65.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.746 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.787 HD11 HD12 ' A' ' 159' ' ' LEU . 40.9 mt -51.65 -35.22 41.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -29.95 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.27 -30.58 71.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.7 HD12 ' HG2' ' A' ' 152' ' ' LYS . 14.5 pt -97.97 28.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.265 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.35 91.71 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.614 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 m -137.5 164.85 27.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -154.61 154.12 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.54 91.0 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 64.56 110.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.239 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.13 -21.65 42.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.896 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -95.18 147.48 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.09 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 36' ' ' GLU . 17.9 mt -113.88 142.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.896 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 24.9 pt -118.34 154.41 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.419 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 9.4 p -95.88 141.55 29.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.922 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -161.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.18 -39.91 24.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -78.8 -2.82 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.654 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 1.6 tttt 88.51 29.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' THR . 7.2 tttp -77.13 176.41 8.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.365 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB2' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -127.71 79.07 1.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.442 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.407 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.0 m95 -74.53 134.75 42.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.09 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -102.42 127.02 49.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -77.7 117.64 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -63.23 -105.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -122.53 159.42 52.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.868 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.526 ' HD2' HD23 ' A' ' 41' ' ' LEU . 55.6 Cg_endo -70.05 151.97 67.62 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.174 . . . . 0.0 112.334 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -145.68 30.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.167 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.544 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 7.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.431 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.4 mp -93.74 113.51 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.052 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 9.3 m-85 -135.93 172.29 13.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -78.11 158.78 28.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.04 137.96 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.201 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -143.38 157.77 44.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 46.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -82.81 128.52 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 p -115.86 -39.04 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -93.03 -66.71 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.29 173.06 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.27 144.79 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 63' ' ' GLY . 21.5 t -66.45 155.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -175.62 82.88 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.473 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.2 30.67 20.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.12 31.38 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.61 48.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.07 45.69 1.95 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.572 2.181 . . . . 0.0 112.713 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.8 148.21 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.46 144.89 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.7 p -125.45 119.94 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 118.15 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.398 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' A' ' 128' ' ' PHE . 2.8 t -113.1 135.78 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.336 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.2 143.37 30.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.674 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.58 117.61 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.421 2.08 . . . . 0.0 112.307 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -71.58 109.78 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -157.32 -75.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -76.39 -27.65 56.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.33 46.12 4.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.878 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 43.6 Cg_endo -70.14 -53.19 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.234 1.956 . . . . 0.0 111.651 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 tp -71.37 -23.92 61.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.71 -29.2 62.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.68 -39.69 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.86 -32.51 74.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -69.28 -45.61 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.669 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -57.49 -40.07 77.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.599 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 64.3 t80 -72.16 -36.88 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -70.6 -41.19 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.32 -35.95 81.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.17 14.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.797 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -99.64 -49.58 4.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.847 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -76.61 2.82 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -55.93 121.14 38.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.52 0.2 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.27 -26.94 21.65 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.36 2.04 . . . . 0.0 112.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -79.34 -43.61 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -51.63 51.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.022 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.847 HD11 ' HA ' ' A' ' 91' ' ' ALA . 45.3 mt -57.12 -52.42 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.134 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.76 -31.96 7.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.97 -46.45 29.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.62 ' CG1' HG22 ' A' ' 96' ' ' ILE . 47.4 mm -56.04 -37.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -74.99 -27.76 60.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.1 m -74.61 -38.78 62.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.442 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -107.27 -3.5 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 55.44 24.88 7.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 108' ' ' LEU . 6.0 mt -52.22 -39.55 60.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.567 ' H ' HG23 ' A' ' 100' ' ' ILE . 7.7 ttmt 50.54 41.21 25.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 192' ' ' GLN . 36.7 t80 -177.38 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 105' ' ' LEU . 13.6 tp 60.87 155.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.622 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 164' ' ' ILE . . . -83.87 -3.81 89.07 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.1 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' A' ' 167' ' ' TYR . 43.2 t -77.98 114.3 40.7 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.685 0.242 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.64 151.87 4.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.391 2.061 . . . . 0.0 112.371 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.3 115.49 19.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -92.9 126.03 37.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.0 m95 -103.45 -40.82 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.76 -178.29 45.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.558 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 84' ' ' LEU . 2.6 p -135.57 159.47 41.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -145.45 -177.78 20.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.931 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 159.84 41.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -136.47 137.5 40.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 15.7 p-10 -118.05 125.54 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -138.23 126.14 22.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.09 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.38 21.33 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.491 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.3 57.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.985 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.4 mmtp -96.2 159.41 14.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.5 m -114.51 124.09 51.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.0 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.27 140.41 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -121.54 127.94 51.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.598 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.896 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.5 p90 -140.2 161.09 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.251 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.694 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.3 ttm -128.05 142.36 51.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 29' ' ' ILE . 19.5 mt -118.62 111.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.413 . . . . 0.0 111.336 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -125.46 173.27 9.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.34 132.5 20.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.99 143.16 55.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CD2' HD12 ' A' ' 184' ' ' LEU . 42.6 m-85 -111.34 179.91 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.76 -98.63 2.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.553 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.6 p -125.85 128.18 47.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.703 ' HB3' HD22 ' A' ' 184' ' ' LEU . 11.9 p30 -56.25 164.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.851 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -69.16 -21.36 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.549 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.638 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.91 -35.04 44.11 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.901 0.382 . . . . 0.0 110.429 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -77.83 -25.58 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.356 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 138' ' ' LEU . 44.6 mt -73.94 -27.52 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.975 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -57.15 -45.65 83.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.695 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -27.99 60.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.31 -26.2 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -92.79 5.64 50.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.332 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.11 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.128 0.49 . . . . 0.0 110.671 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.07 16.33 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.722 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 145' ' ' ASN . 7.2 ptm180 -161.39 116.35 2.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 1.8 m-85 -57.34 174.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -106.8 158.44 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.626 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -59.2 -32.45 69.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -71.68 -47.78 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -58.28 -55.19 38.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.315 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.781 HG11 ' HB3' ' A' ' 251' ' ' MET . 61.7 t -54.91 -52.69 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.392 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.5 mt -56.52 -46.85 80.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.272 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -52.03 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.8 -44.25 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.604 ' OG ' HD13 ' A' ' 324' ' ' LEU . 27.2 p -54.66 -45.02 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.733 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 321' ' ' ARG . 10.4 mt -63.05 -43.75 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.358 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -44.51 97.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.477 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.91 -33.48 63.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.676 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 165' ' ' LEU . 10.6 mt -60.9 -38.63 86.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.537 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -32.91 71.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.332 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.416 ' CD1' ' HA3' ' A' ' 109' ' ' GLY . 18.7 mt -78.21 -35.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.376 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 162' ' ' LEU . 15.9 mt -58.15 -48.17 81.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.577 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -31.68 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 110' ' ' VAL . 85.1 t80 -64.1 -42.97 96.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.487 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 36.0 pt -81.13 -27.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.243 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.41 -29.57 57.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.81 -17.03 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.423 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -106.87 8.45 30.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.688 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 68.88 49.16 0.69 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.27 138.85 46.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 239' ' ' SER . 14.4 m -130.68 169.31 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.508 ' CE1' HD21 ' A' ' 195' ' ' LEU . 1.5 p80 -154.11 -44.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 111.279 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.31 52.79 49.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.625 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.42 -85.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.59 0.233 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 mt 45.99 91.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 183' ' ' LEU . 19.1 tttt -147.11 170.96 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.821 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -76.36 -1.99 29.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.647 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.19 -0.99 17.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.426 . . . . 0.0 110.435 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -121.5 -8.31 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.351 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.847 ' C ' HD23 ' A' ' 184' ' ' LEU . 8.5 mt -108.43 115.34 29.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.279 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.11 146.43 47.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.211 -178.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 141' ' ' ILE . 31.0 mt -86.39 148.9 25.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.18 124.42 23.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.88 -53.82 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -59.66 -30.14 68.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -143.39 79.14 14.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.641 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.72 108.23 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.634 2.222 . . . . 0.0 112.224 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -56.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -149.94 -167.74 2.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.851 HG21 HD21 ' A' ' 138' ' ' LEU . 6.3 p -110.02 147.39 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 32.1 m-85 -113.22 156.89 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.139 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 175' ' ' HIS . 43.0 tp -104.05 115.83 31.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' A' ' 134' ' ' PHE . 14.9 m -122.17 165.83 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.51 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.658 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.555 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 9.0 m-85 -98.59 -50.66 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 90.64 -47.52 3.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.135 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.04 34.87 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.489 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.599 ' HB1' ' CD1' ' A' ' 86' ' ' PHE . . . -77.93 59.65 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -137.06 149.09 47.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.025 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -59.82 101.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.1 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 179.86 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 228' ' ' THR . 0.6 OUTLIER -135.11 176.81 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.019 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 265' ' ' LEU . 16.9 tt -93.14 13.83 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -92.46 25.03 3.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.798 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 226' ' ' GLU . 0.4 OUTLIER 174.94 -28.15 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 224' ' ' THR . 16.7 p -81.15 161.72 23.94 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -167.84 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 276' ' ' ILE . 30.2 mt -73.75 -55.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.3 -31.18 65.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.86 -28.38 61.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.404 ' CE1' ' HB ' ' A' ' 225' ' ' ILE . 15.6 t60 -61.56 -51.44 68.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.016 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 236' ' ' VAL . 17.0 m-80 -91.74 12.92 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.421 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.21 15.35 58.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.818 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 234' ' ' ASN . 14.5 t -64.38 141.48 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.22 162.64 0.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 -164.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.682 ' O ' HG11 ' A' ' 174' ' ' VAL . 12.2 p -139.56 104.16 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -158.0 -53.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -28.2 61.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.4 -33.64 66.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 246' ' ' ILE . 34.3 m-20 -56.56 -30.42 63.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.77 HD13 HD11 ' A' ' 320' ' ' LEU . 52.4 mt -80.64 -36.56 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.89 -35.3 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 243' ' ' ASP . 12.0 mt -62.87 -41.52 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.876 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.3 tp -64.19 -50.61 67.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.717 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.81 -27.95 51.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.458 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.93 -33.19 45.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 0.0 110.79 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.429 ' HB3' ' CE3' ' A' ' 254' ' ' TRP . 69.2 m -53.15 -51.63 61.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.046 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.781 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -57.37 -30.58 64.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.624 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.653 HG22 HD23 ' A' ' 259' ' ' LEU . 20.8 mm -69.18 -44.24 80.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.994 0.426 . . . . 0.0 110.737 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.705 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.4 tm0? -80.03 -27.18 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.108 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 2.9 m0 -81.59 -54.38 5.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.38 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 151' ' ' ARG . 43.9 mt -70.32 -35.13 73.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.528 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.25 -13.92 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.538 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.9 97.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.184 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 253' ' ' GLN . 0.1 OUTLIER 66.0 141.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.654 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.966 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -116.64 159.25 41.12 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 14.3 Cg_exo -69.04 59.49 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.839 2.359 . . . . 0.0 112.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.966 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.3 p90 179.13 -38.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.241 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.409 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.1 tt0 -95.99 24.67 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.076 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.59 -57.39 3.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.816 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -125.95 -29.96 3.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.717 HD11 ' CG2' ' A' ' 225' ' ' ILE . 0.3 OUTLIER 73.49 11.67 4.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -15.61 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.449 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.462 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 1.8 m-20 -132.94 103.96 12.88 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.5 17.4 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.722 2.282 . . . . 0.0 112.826 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -79.99 -50.1 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -77.42 -26.04 51.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 5.2 t -60.69 -45.75 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -47.69 25.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -39.16 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -72.74 -39.63 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -49.91 75.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.436 HG13 HD11 ' A' ' 230' ' ' ILE . 5.1 mt -63.97 -44.65 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -52.04 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.8 m-85 -59.03 -33.94 71.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -59.18 -31.14 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 23.65 11.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -147.79 45.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.784 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.5 mt -54.84 -41.24 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.08 67.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -41.52 61.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 282' ' ' ILE . 1.0 OUTLIER -70.77 -38.33 73.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 2.5 ttm -67.53 -33.09 74.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -75.56 -37.69 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.44 25.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.043 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.38 -34.39 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.004 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 8.9 m-85 -127.9 79.91 72.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.969 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 111.4 3.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.554 2.169 . . . . 0.0 112.359 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -128.54 -46.37 1.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -173.84 -62.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -177.01 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.13 127.88 59.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 53.1 Cg_exo -55.12 -168.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.77 -89.91 1.5 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.428 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -125.6 -39.97 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 111.037 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.722 HG22 ' CG ' ' A' ' 303' ' ' MET . 35.3 mm -54.87 -41.43 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -44.4 -30.57 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.5 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.25 -42.26 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.876 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.3 t80 -67.57 -37.72 83.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.784 ' CB ' HD13 ' A' ' 282' ' ' ILE . 62.9 mmm -71.77 -30.0 65.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.96 -50.34 68.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -41.65 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 302' ' ' TYR . 27.8 t -69.93 -24.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.106 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -80.43 -29.94 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.64 -11.91 20.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.584 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.832 ' HG ' HD22 ' A' ' 316' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.292 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.832 HD22 ' HG ' ' A' ' 309' ' ' LEU . 4.0 mp -92.17 -23.87 19.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.513 ' CD2' HD21 ' A' ' 244' ' ' LEU . 76.0 m-85 -53.92 -30.28 45.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.97 -36.58 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.9 -37.3 67.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.92 ' HA ' HD12 ' A' ' 323' ' ' ILE . 55.5 mt -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.57 ' HG3' HD22 ' A' ' 159' ' ' LEU . 1.5 ttm-85 -59.34 -46.62 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -40.71 82.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.92 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.6 mt -58.06 -46.81 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.604 HD13 ' OG ' ' A' ' 158' ' ' SER . 40.8 mt -73.68 -51.63 15.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.984 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.28 -49.87 68.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.32 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -58.78 -39.97 82.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.001 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.12 -31.93 70.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.585 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.5 mt -63.02 -41.73 99.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.55 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.75 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.0 pt -101.45 27.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.188 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.04 28.08 52.81 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.583 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 18.1 t -102.33 156.79 17.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -174.61 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.67 100.42 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' C ' HG23 ' A' ' 25' ' ' VAL . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 41' ' ' LEU . 1.0 OUTLIER 64.75 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.495 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.43 -25.44 22.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.975 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -83.39 136.13 34.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.196 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 38' ' ' LYS . 11.0 mm -100.42 144.27 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.718 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 128' ' ' PHE . 34.1 pt -119.76 151.3 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -95.81 141.4 29.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.806 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.08 -163.53 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.099 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -41.0 35.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 109.792 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -76.69 -5.01 46.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.531 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 89.65 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.9 mttp -77.21 -177.66 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.207 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.8 mm-40 -132.76 81.78 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 110.697 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -75.26 136.93 40.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.932 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' HD12 ' A' ' 28' ' ' ILE . 3.4 mttm -94.1 118.68 31.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -72.73 144.17 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.91 -117.42 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.787 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.677 ' HA ' HG22 ' A' ' 25' ' ' VAL . 3.1 mt -113.27 164.61 15.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 111.021 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 33.9 Cg_endo -64.6 141.86 74.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.598 2.199 . . . . 0.0 112.251 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 ' HG ' ' A' ' 53' ' ' LEU . 13.0 pt -153.76 79.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.565 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.879 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.647 0.26 . . . . 0.0 111.118 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 50' ' ' CYS . 3.9 mp -141.59 130.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 m-85 -146.46 150.15 35.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 41' ' ' LEU . 24.4 mt -70.75 158.8 35.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.342 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.583 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -132.69 154.39 50.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.0 111.38 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -149.14 132.0 16.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.9 mtp -83.62 57.01 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.95 -177.67 5.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.0 p -175.65 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.4 p -79.28 -66.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.21 -69.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -161.21 160.38 29.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.425 HG23 ' HD3' ' A' ' 38' ' ' LYS . 21.5 t -90.58 139.95 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.061 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.89 -123.61 4.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.35 31.05 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.86 42.04 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.583 ' HB1' ' O ' ' A' ' 54' ' ' ALA . . . -109.16 92.34 10.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.001 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.14 49.97 3.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.633 2.222 . . . . 0.0 112.753 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 59.6 m -149.86 148.19 28.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 133' ' ' ARG . 16.5 m -124.51 144.96 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 3.8 p -132.17 122.39 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.878 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -96.95 116.33 29.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.682 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 128' ' ' PHE . 9.3 t -113.13 133.8 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.39 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.17 150.65 59.41 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.728 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.07 101.21 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.277 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 m 60.36 173.43 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.04 151.41 43.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.31 -55.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' THR . . . 163.44 -68.58 0.22 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.464 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.07 -36.09 64.32 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.352 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.17 -39.83 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.63 -40.44 91.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 21.8 p -68.64 -31.8 71.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 38.3 tt0 -73.82 -47.66 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.7 mm? -58.46 -48.08 81.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -45.03 92.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.443 ' CE2' ' CB ' ' A' ' 90' ' ' ALA . 16.7 t80 -71.91 -44.74 63.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.718 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -57.07 -29.8 63.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.493 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -80.0 -45.57 18.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.074 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -87.39 -47.62 8.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 86' ' ' PHE . . . -81.34 -46.47 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.782 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -94.71 33.17 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.593 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -72.03 123.73 89.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.605 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.58 -25.34 79.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.398 2.065 . . . . 0.0 112.249 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.39 -36.01 39.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.6 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 60.2 mt -56.7 -56.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.304 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -37.95 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -74.47 -43.84 54.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.32 -51.91 65.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' A' ' 105' ' ' LEU . 66.8 mt -60.31 -37.1 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -27.65 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 64.6 m -83.48 -30.92 26.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.23 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HD3' HD21 ' A' ' 105' ' ' LEU . 3.5 ttt-85 -105.95 -4.36 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.018 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.43 28.42 15.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 100' ' ' ILE . 66.6 mt -48.93 -39.41 26.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER 75.41 -1.75 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.62 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 75.6 t80 174.19 162.46 0.19 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 110.461 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.7 tp -147.42 -66.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 130.65 -14.65 5.52 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.7 126.86 88.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.612 0.206 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.49 148.23 20.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.483 2.122 . . . . 0.0 112.193 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -83.99 115.57 22.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.046 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 39.1 t80 -97.48 125.05 41.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -100.82 -40.7 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.86 -176.53 46.36 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.625 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -134.88 154.53 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -137.67 171.07 23.42 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.84 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 127' ' ' ARG . 5.9 mt -142.39 157.25 44.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.702 0.287 . . . . 0.0 110.623 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -145.96 141.56 27.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -115.92 125.33 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 126.27 22.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 60.44 17.05 6.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.51 -6.35 59.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.872 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -96.17 129.57 43.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.9 t -92.38 130.94 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.03 151.48 29.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.748 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -129.93 125.65 35.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.631 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 29' ' ' ILE . 31.0 p90 -133.56 163.76 28.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.665 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.1 ttm -127.98 140.74 51.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.033 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 29' ' ' ILE . 13.7 mt -120.77 111.69 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.44 . . . . 0.0 111.549 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -123.42 173.43 8.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.718 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 15.7 t0 -55.85 138.28 48.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HG3' HG13 ' A' ' 69' ' ' VAL . 52.1 ttt180 -68.89 154.6 41.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.5 ' CD2' HD12 ' A' ' 184' ' ' LEU . 73.3 m-85 -119.32 161.84 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.2 -73.91 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 m -146.56 138.25 24.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.556 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -60.01 152.45 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.715 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 30.3 tp60 -70.95 -41.73 70.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -65.55 -26.96 68.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 138' ' ' LEU . 29.1 mt -75.83 -29.77 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 46.8 t80 -54.24 -47.66 71.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.835 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.05 -25.57 68.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.715 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.73 -19.25 59.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 4.1 m-80 -91.0 5.59 48.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.233 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.55 43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.268 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.6 tttt 62.04 18.7 10.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 1.4 ptt85 -165.49 126.21 1.88 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.3 158.53 30.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -93.07 160.51 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -28.9 68.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 45.5 p -68.01 -44.07 77.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.733 HG21 ' HG ' ' A' ' 255' ' ' LEU . 47.7 t -57.87 -54.03 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.291 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.733 ' HB3' HD21 ' A' ' 328' ' ' LEU . 74.5 mt -61.78 -45.3 94.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.622 ' OE1' HD13 ' A' ' 328' ' ' LEU . 8.8 tp60 -58.58 -44.0 89.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.668 HD22 HG11 ' A' ' 193' ' ' VAL . 42.6 mt -73.33 -37.17 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.6 m -58.25 -41.41 84.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 325' ' ' LEU . 12.7 mt -70.71 -43.79 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.77 88.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' LEU . 7.3 mt -71.29 -33.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.2 mt -64.56 -40.21 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -36.29 80.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.0 mt -73.65 -40.24 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' A' ' 162' ' ' LEU . 21.3 mt -56.22 -33.06 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.69 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 -29.34 59.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -72.02 -52.51 16.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.615 HG21 ' OH ' ' A' ' 198' ' ' TYR . 48.4 pt -64.75 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -40.16 88.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.326 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.02 -12.31 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.75 4.49 25.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.943 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 66.17 46.92 1.97 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.875 0.369 . . . . 0.0 110.706 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -135.34 120.11 18.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 204' ' ' TYR . 3.0 m -124.58 169.08 16.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.008 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 12.6 p-80 -149.82 -52.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 68.95 37.52 83.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.53 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.3 -81.22 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 183' ' ' LEU . 2.4 mp 47.4 93.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.399 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 174.84 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.019 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -78.23 -3.96 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.3 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.6 t -108.54 0.32 20.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.642 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -125.33 -9.55 6.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.326 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.872 ' C ' HD23 ' A' ' 184' ' ' LEU . 54.9 mt -108.28 117.66 34.73 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.872 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.67 161.45 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.921 0.391 . . . . 0.0 111.492 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.0 mt -92.8 149.82 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.07 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.81 129.91 41.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.416 ' CG ' ' HD3' ' A' ' 133' ' ' ARG . 60.4 t80 -71.77 -62.81 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.591 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -19.95 63.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.653 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -134.34 76.8 61.65 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 78.04 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.437 2.091 . . . . 0.0 111.963 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -179.62 36.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.8 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 107' ' ' TYR . 1.0 OUTLIER -174.12 145.79 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.264 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.668 HG11 HD22 ' A' ' 157' ' ' LEU . 2.4 p -109.98 147.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 110.888 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 10.8 m-85 -126.25 157.59 37.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 34.0 tp -103.12 115.79 31.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.889 0.376 . . . . 0.0 110.607 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.77 141.32 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.182 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 57.54 106.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.615 ' OH ' HG21 ' A' ' 168' ' ' ILE . 3.4 m-30 -75.48 -24.09 56.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.658 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 93.76 -24.7 24.92 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.553 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 199' ' ' GLY . 5.0 mp -150.78 -44.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 45.93 87.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.095 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.574 ' O ' HG22 ' A' ' 174' ' ' VAL . 30.5 t80 -143.84 148.77 35.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 202' ' ' TYR . 15.2 mtm105 -74.11 98.49 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 174' ' ' VAL . 43.0 p90 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.0 p -59.61 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.3 tp -163.9 27.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.196 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.24 -35.36 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -152.23 32.34 0.53 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.705 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 39.9 p -65.54 128.74 37.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.021 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.6 m -89.88 146.57 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.834 HD11 ' HG3' ' A' ' 275' ' ' LYS . 3.0 mp -57.81 -35.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.71 -30.53 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -75.3 -39.2 59.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -44.3 92.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -92.83 0.57 57.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.87 7.9 62.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.945 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.2 127.87 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.65 154.27 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.21 -166.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.55 2.167 . . . . 0.0 112.255 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -96.96 28.46 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -90.86 -53.02 4.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -25.44 62.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.873 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -65.05 -37.76 94.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.05 -40.59 89.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.489 HD12 HD11 ' A' ' 309' ' ' LEU . 48.7 mt -67.0 -35.93 81.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.784 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -62.95 -42.55 99.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.9 mt -65.2 -39.9 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.499 HD23 ' OH ' ' A' ' 302' ' ' TYR . 32.5 tp -65.76 -39.54 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.77 -44.93 96.55 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.379 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.63 -25.7 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.91 -43.33 86.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.252 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.678 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.28 -50.1 74.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 mt -64.19 -26.55 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.66 ' HB2' HD11 ' A' ' 259' ' ' LEU . 12.4 tm0? -71.07 -45.2 64.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.401 ' CD1' ' OE1' ' A' ' 253' ' ' GLN . 18.5 m0 -82.19 -41.09 20.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.733 ' HG ' HG21 ' A' ' 154' ' ' VAL . 21.0 mt -67.04 -39.21 86.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -0.57 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 57.49 96.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 55.6 m80 62.54 144.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -122.35 164.65 24.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.466 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.93 63.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.421 2.08 . . . . 0.0 112.519 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.838 ' CH2' HD22 ' A' ' 259' ' ' LEU . 7.6 p90 176.41 -38.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.108 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.9 tt0 -95.55 18.47 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.289 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -55.93 15.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 93.6 m-20 -126.99 -27.36 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.6 mt 70.67 12.4 7.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -85.19 -15.3 44.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.175 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.46 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 2.1 m-20 -132.56 100.52 14.95 Favored Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.93 15.02 2.05 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.616 2.211 . . . . 0.0 112.857 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -78.54 -49.77 12.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.1 p90 -77.13 -26.47 53.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 225' ' ' ILE . 12.5 t -60.71 -37.53 76.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.56 ' NH1' HD11 ' A' ' 276' ' ' ILE . 12.3 ttt-85 -75.52 -44.94 41.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.068 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.15 -49.67 63.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.235 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.9 m -58.58 -41.98 86.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.834 ' HG3' HD11 ' A' ' 230' ' ' ILE . 10.8 tptt -62.35 -41.5 98.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.144 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.56 HD11 ' NH1' ' A' ' 272' ' ' ARG . 11.3 mt -75.1 -29.09 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.01 16.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -69.98 -40.13 75.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.388 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -52.58 -27.52 17.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.02 15.33 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 0.0 OUTLIER -138.21 45.76 2.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.708 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.1 mt -51.7 -36.5 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.336 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.13 63.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.574 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.416 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 9.9 t -68.37 -40.36 81.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.34 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.5 pp -76.01 -28.41 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.331 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 4.0 mmt -67.61 -38.42 83.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.751 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -82.7 -31.58 28.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -82.66 -51.59 7.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.07 -41.13 67.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -115.68 151.97 46.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.009 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 131.89 17.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.629 2.219 . . . . 0.0 112.281 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.02 43.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -107.13 -55.91 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -162.1 -176.45 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 60.82 87.16 0.14 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.59 144.16 44.04 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.608 2.205 . . . . 0.0 112.377 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.453 ' O ' HD11 ' A' ' 155' ' ' LEU . . . -96.86 -18.08 30.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.709 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.14 10.61 6.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.362 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.538 HG22 ' CG ' ' A' ' 303' ' ' MET . 43.3 mm -79.41 -46.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.13 -45.27 11.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.446 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.575 ' HB2' HG23 ' A' ' 323' ' ' ILE . 69.1 mttt -59.63 -42.76 93.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.52 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 306' ' ' VAL . 72.7 t80 -70.17 -36.79 74.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.612 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.708 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.6 mtp -67.39 -42.47 83.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.579 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.48 -48.39 80.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -37.78 80.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.692 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 302' ' ' TYR . 40.6 t -71.08 -25.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -43.12 15.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 110.217 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -14.31 62.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.545 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 306' ' ' VAL . 8.7 mt . . . . . 0 N--CA 1.462 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.231 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.465 -0.197 0 CA-C-O 120.736 0.223 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' A' ' 320' ' ' LEU . 1.4 pp -155.41 30.55 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.041 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -57.53 -37.05 72.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.22 -40.69 94.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.741 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.62 -42.88 99.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.562 ' HG ' HD12 ' A' ' 316' ' ' LEU . 79.4 mt -56.18 -45.38 79.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -56.34 -46.45 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.38 91.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 301' ' ' LYS . 97.2 mt -53.07 -42.22 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 155' ' ' LEU . 61.1 mt -81.06 -51.51 8.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.089 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -56.03 -49.77 72.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.43 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.91 -46.16 71.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.71 -28.13 56.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 155' ' ' LEU . 7.2 mt -69.16 -24.74 64.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.715 0.293 . . . . 0.0 111.071 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 1.2 mmtm -69.76 -33.47 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.02 -18.85 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.143 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.52 -34.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -122.07 -24.44 2.25 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.279 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 3.0 t 71.43 65.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 74.61 103.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 164.02 26.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.834 0.35 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 110.6 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.93 -27.61 6.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.495 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 135.19 51.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 36' ' ' GLU . 15.7 mt -100.66 143.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.897 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 18.4 pt -119.7 154.99 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 34' ' ' LYS . 1.4 m -94.98 135.45 36.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -160.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.248 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.1 -38.74 51.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.73 3.66 28.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.235 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.9 mttp 76.03 32.43 0.63 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.5 mtpp -77.34 171.87 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.065 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 28' ' ' ILE . 22.3 mt-10 -111.88 73.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.49 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HB2' HG13 ' A' ' 29' ' ' ILE . 26.7 m95 -66.7 145.87 55.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.959 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -100.8 132.39 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 29' ' ' ILE . 25.4 t -88.9 123.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 62' ' ' VAL . . . -75.07 -127.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.551 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.27 159.39 70.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.85 128.2 18.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.167 . . . . 0.0 112.299 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -109.72 -30.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.439 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.349 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.415 HD12 ' HG2' ' A' ' 71' ' ' LYS . 21.5 mm -87.61 114.8 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -146.32 158.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.934 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 69' ' ' VAL . 69.0 mt -72.66 163.69 27.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -136.57 157.51 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.733 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.8 t70 -149.29 154.01 38.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 43.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.955 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 60.2 -175.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t 60.47 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.56 68.88 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 59.7 -174.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.7 p -86.06 85.13 7.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 55' ' ' ASP . 20.0 t 68.95 -67.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.24 -156.12 21.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.7 -30.03 8.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.36 53.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.1 113.55 31.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.55 25.85 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.93 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.68 148.34 29.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.959 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 53' ' ' LEU . 27.5 m -129.63 156.89 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.6 p -140.19 122.88 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HG2' HD12 ' A' ' 51' ' ' ILE . 2.4 mttm -106.4 121.93 45.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' A' ' 128' ' ' PHE . 3.3 t -113.16 146.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.22 136.75 16.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.731 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.33 89.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.364 2.043 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 59.61 172.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.7 81.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.04 -29.34 6.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.15 -165.9 22.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.65 29.29 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.936 2.424 . . . . 0.0 112.808 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.543 HD23 ' HD3' ' A' ' 127' ' ' ARG . 12.3 tp -77.91 -31.88 51.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -67.01 -42.46 84.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 201' ' ' ALA . 11.4 t -69.17 -28.62 66.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.956 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -40.4 69.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.65 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.1 mm? -63.69 -44.54 93.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.04 92.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.46 -43.04 95.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.892 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.4 m-85 -60.07 -44.41 94.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -79.83 -17.6 52.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.382 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -65.35 -47.8 75.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.784 0.326 . . . . 0.0 111.046 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.68 33.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.255 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -119.44 -10.68 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 163.84 0.44 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.696 0.284 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.44 -19.39 43.59 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.614 2.209 . . . . 0.0 112.493 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -75.62 -39.74 57.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -79.34 -42.09 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.486 HD12 ' HB ' ' A' ' 110' ' ' VAL . 28.0 mm -58.36 -48.78 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -70.2 -49.58 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.174 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -58.15 -51.7 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.08 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 108' ' ' LEU . 27.9 mt -61.41 -35.72 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -75.07 -27.84 60.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.29 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -82.38 -37.76 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.468 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -104.8 -1.2 26.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 58.33 31.24 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.763 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HB2' HG23 ' A' ' 100' ' ' ILE . 51.2 mt -51.28 -26.84 7.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.215 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.0 tttt 58.2 94.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.1 t80 63.87 132.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 100' ' ' ILE . 11.4 tp -125.54 163.71 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.6 10.05 66.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.923 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.579 HG21 ' CD2' ' A' ' 167' ' ' TYR . 23.2 t -92.74 123.43 61.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.757 0.278 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 146.38 49.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.075 . . . . 0.0 112.248 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -89.34 119.83 30.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -74.93 123.65 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.81 -40.61 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.47 46.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.704 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -145.52 163.39 34.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.66 -174.98 35.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.707 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -145.5 159.84 42.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -133.38 141.7 48.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.33 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 126.34 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.63 18.46 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.53 20.67 36.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.626 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 0.3 OUTLIER -121.13 128.94 53.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.17 130.87 37.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 124' ' ' LYS . 9.8 m-85 -120.26 143.46 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.543 ' HD3' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -107.04 133.14 52.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.897 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.3 p90 -137.88 163.68 30.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.687 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.7 ttm -129.46 136.33 49.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.423 HG21 ' CZ3' ' A' ' 37' ' ' TRP . 17.6 mt -109.2 119.27 58.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.42 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -134.01 173.23 11.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.795 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.74 145.24 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.208 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -73.4 160.64 31.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 184' ' ' LEU . 92.5 m-85 -132.3 154.92 49.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.98 -99.31 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.342 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.58 125.28 47.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.6 p30 -53.5 158.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -63.79 -21.66 66.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.724 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -61.53 -40.5 94.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 0.0 109.981 178.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 138' ' ' LEU . 3.1 mt -73.13 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -67.37 -49.02 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.57 -28.58 59.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.873 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.19 -23.63 66.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -98.75 20.89 12.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.77 48.66 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.243 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt 63.37 18.97 11.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.311 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 -176.16 4.52 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.452 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -128.14 -176.0 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.908 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -117.26 135.33 53.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.829 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.768 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -57.48 -26.57 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -42.44 64.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.3 p -74.83 -35.58 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.745 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 150' ' ' SER . 42.4 t -57.68 -53.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.971 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.669 HD23 HD22 ' A' ' 324' ' ' LEU . 52.7 mt -63.87 -44.31 93.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.777 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -62.17 -45.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.692 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 193' ' ' VAL . 13.6 mt -70.15 -37.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.737 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.1 m -56.55 -37.33 70.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 328' ' ' LEU . 11.4 mt -73.96 -46.77 41.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.07 -46.19 90.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 178' ' ' ILE . 11.4 mt -66.54 -34.43 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.757 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.6 mt -60.03 -36.76 77.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.98 -40.1 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.56 HD21 HD11 ' A' ' 178' ' ' ILE . 82.3 mt -58.04 -42.02 84.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.653 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.69 -45.11 95.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CD2' HG21 ' A' ' 110' ' ' VAL . 60.8 t80 -60.26 -53.01 62.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.3 pt -66.99 -27.17 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.408 ' CD2' ' OH ' ' A' ' 204' ' ' TYR . 8.2 t-160 -78.07 -36.5 48.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.645 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -16.98 62.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -94.57 -1.03 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 75.85 37.71 0.38 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.16 116.03 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.726 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.9 m -112.04 141.82 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.266 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 198' ' ' TYR . 0.8 OUTLIER -179.36 66.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.645 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.641 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -63.1 79.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.661 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -106.35 26.83 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 183' ' ' LEU . 3.3 mp -59.76 103.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.022 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -143.4 170.14 16.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.895 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -77.3 -3.35 39.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.282 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.8 t -112.62 2.26 16.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.658 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -126.53 -5.41 6.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.098 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 184' ' ' LEU . 10.9 mt -108.44 127.55 54.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -136.94 150.08 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.908 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 193' ' ' VAL . 13.8 mt -86.67 149.41 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.256 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.5 OUTLIER -67.49 127.99 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.746 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.459 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 23.9 t80 -86.47 -43.67 12.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.544 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -20.73 62.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -149.6 71.0 9.76 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.616 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.06 91.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.735 2.29 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.45 31.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.57 155.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.014 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 138' ' ' LEU . 3.7 p -109.94 148.16 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 5.3 m-85 -119.66 156.9 29.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 35.9 tp -106.9 115.8 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 184' ' ' LEU . 24.2 m -115.95 141.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.371 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.45 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.023 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 175' ' ' HIS . 5.2 m-85 -90.22 -19.18 24.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.39 23.29 73.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.373 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 mp -156.32 -68.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 45.67 88.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -137.4 149.11 46.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.998 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.4 81.19 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.713 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.726 ' CD1' HG13 ' A' ' 174' ' ' VAL . 13.3 p90 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.421 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.789 -0.125 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 225' ' ' ILE . 67.0 m 61.74 -90.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.623 0.212 . . . . 0.0 110.77 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.567 HD11 ' CG1' ' A' ' 271' ' ' VAL . 5.9 tp -179.15 35.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.53 -45.19 13.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -157.57 35.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 118.48 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 176.29 8.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 276' ' ' ILE . 3.6 mt -61.83 -31.77 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -74.49 -41.6 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -27.69 66.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -94.79 -17.33 22.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.207 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.32 24.93 10.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.4 t -89.36 145.18 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -119.08 -61.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 50.3 Cg_exo -55.89 107.33 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.223 1.949 . . . . 0.0 112.299 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.23 -52.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 77.44 -2.82 2.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.768 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -89.55 -23.1 22.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.72 0.295 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.5 -49.74 70.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.701 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.11 -33.44 73.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 320' ' ' LEU . 25.8 mt -80.55 -33.06 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.15 -38.79 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 176' ' ' GLY . 17.4 mt -63.59 -43.95 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.25 -33.51 75.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.511 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.11 -41.83 99.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 252' ' ' ILE . 61.2 m-85 -78.52 -25.69 45.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 111.342 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 3.6 m -56.74 -39.99 74.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.372 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.476 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -68.87 -48.81 62.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.249 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 285' ' ' LEU . 6.1 mt -57.33 -33.45 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.398 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.566 ' HB2' HD21 ' A' ' 259' ' ' LEU . 7.9 tt0 -80.03 -42.7 23.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 0.0 110.928 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.4 m0 -74.1 -24.27 59.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.37 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 151' ' ' ARG . 5.3 mt -96.47 -35.86 10.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.59 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 m -96.2 -14.25 22.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.82 92.27 0.41 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 38.4 m80 61.52 153.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.337 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.882 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -125.21 162.63 42.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.509 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.65 62.13 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 112.424 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.882 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 6.8 p90 176.42 -38.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.468 ' HA ' HD21 ' A' ' 265' ' ' LEU . 1.2 tm-20 -94.26 18.93 10.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.155 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.19 -55.54 13.65 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.5 -28.72 2.26 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.444 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 225' ' ' ILE . 48.0 mt 73.51 10.73 4.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -79.08 -15.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.215 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.473 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.4 m-20 -135.94 101.26 10.54 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.04 16.45 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.674 2.249 . . . . 0.0 112.873 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -79.52 -49.78 11.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.8 p90 -75.83 -29.33 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.567 ' CG1' HD11 ' A' ' 225' ' ' ILE . 6.9 t -62.16 -36.44 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -75.47 -49.3 19.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.19 -35.53 78.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 53.8 m -67.23 -46.14 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.176 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.36 -40.92 96.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 230' ' ' ILE . 12.2 mt -68.24 -35.03 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -81.18 -50.17 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.4 m-85 -58.36 -40.36 82.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.49 -35.44 63.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.744 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -102.83 16.57 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.143 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.93 46.63 1.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.855 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.74 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.6 mt -53.42 -35.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.92 -26.22 60.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.217 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 29.5 t -72.98 -42.55 63.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.502 HD13 HD13 ' A' ' 252' ' ' ILE . 3.2 pp -77.49 -30.79 53.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 7.2 mmt -66.14 -38.65 88.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.639 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -29.79 28.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -82.87 -53.48 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 65.3 m -74.12 -41.19 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 286' ' ' MET . 50.4 m-85 -112.05 152.12 44.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.832 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.57 -46.31 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 54.88 27.83 9.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.43 -31.82 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -106.6 -75.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.021 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.45 110.26 9.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 176.46 6.66 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.378 2.052 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.26 4.85 38.21 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.826 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.06 14.94 5.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 111.297 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.476 HD12 ' SD ' ' A' ' 251' ' ' MET . 30.2 mm -79.44 -43.69 23.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.738 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -49.75 -43.91 48.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.212 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HD2' HG23 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -60.46 -38.58 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.777 ' HA ' HD13 ' A' ' 323' ' ' ILE . 11.2 t80 -71.25 -45.52 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.74 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.3 mtp -61.38 -41.81 97.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -45.52 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.691 ' O ' HD12 ' A' ' 309' ' ' LEU . 33.2 m -62.26 -29.6 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.566 ' HA ' HD12 ' A' ' 309' ' ' LEU . 84.3 t -79.39 -24.0 12.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.343 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 -35.98 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 10.6 tp -110.64 -29.99 7.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.276 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 1.143 HD21 HD22 ' A' ' 316' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 CA-C-O 120.8 0.25 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 1.143 HD22 HD21 ' A' ' 309' ' ' LEU . 0.5 OUTLIER -91.62 0.23 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.358 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 244' ' ' LEU . 72.9 m-85 -60.72 -30.14 69.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.132 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -39.46 78.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -82.08 -35.98 28.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 323' ' ' ILE . 59.2 mt -57.53 -50.73 72.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.056 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.422 ' HA ' HD21 ' A' ' 159' ' ' LEU . 8.4 ptm180 -56.08 -45.48 79.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.147 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -40.75 79.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.1 mt -58.35 -47.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.669 HD22 HD23 ' A' ' 155' ' ' LEU . 72.4 mt -72.69 -50.85 22.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.011 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -53.01 -49.84 65.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.382 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -55.11 -39.33 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.7 71.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 325' ' ' LEU . 13.4 mt -66.73 -38.87 87.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.936 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -61.2 -27.07 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.81 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.9 pt -117.93 20.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.538 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 49.9 43.35 39.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.752 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.1 m -97.95 36.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.05 144.06 45.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.37 114.48 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HA2' ' A' ' 40' ' ' GLY . 3.4 m -59.12 145.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.76 -25.29 28.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -112.5 133.56 54.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.012 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mt -100.38 147.86 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.925 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 46.6 pt -116.77 154.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 111.457 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -97.64 141.61 30.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.743 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.34 -162.66 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -36.3 32.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -84.95 5.06 30.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.299 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 11.5 mmtm 79.63 31.36 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.884 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' THR . 9.7 mttp -75.14 177.0 6.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.957 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 80.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.513 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 91.6 m95 -80.1 137.64 36.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.976 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -93.86 119.81 33.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.09 149.6 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -125.03 -146.37 6.8 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.579 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 159.19 31.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.26 168.24 18.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.57 2.18 . . . . 0.0 112.332 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -137.6 79.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.479 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 13.1 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 71' ' ' LYS . 8.4 mt -82.27 104.57 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -143.6 162.82 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 8.0 mt -78.49 158.41 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -139.03 159.05 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.6 159.64 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.96 41.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.71 82.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 t -114.96 -38.23 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.1 t -127.6 -172.78 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.73 -49.34 75.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 156.84 45.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.68 99.82 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.17 -105.77 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 53.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -165.58 38.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -68.67 142.75 94.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.73 8.79 4.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.692 2.261 . . . . 0.0 113.023 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.2 m -149.69 148.24 29.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.873 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.2 m -120.94 144.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 130' ' ' ILE . 8.9 p -127.27 128.2 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.298 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.72 120.63 39.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.662 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.763 HG22 ' CB ' ' A' ' 128' ' ' PHE . 3.1 t -113.22 152.07 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.939 0.399 . . . . 0.0 111.421 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HB3' ' CB ' ' A' ' 76' ' ' ASP . 7.1 mt-10 -135.85 126.24 16.64 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.56 87.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.478 2.119 . . . . 0.0 112.428 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t 48.97 33.29 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.275 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 2.1 t70 -89.89 161.73 15.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -155.42 145.22 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.82 ' O ' HG23 ' A' ' 82' ' ' THR . . . 135.04 -75.4 0.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -44.59 1.98 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.593 2.195 . . . . 0.0 112.263 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.425 ' HG ' HD23 ' A' ' 84' ' ' LEU . 5.1 tp -77.89 -37.78 47.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -58.52 -29.39 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.012 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 78' ' ' GLY . 67.1 p -75.77 -28.55 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.71 -42.81 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.886 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.4 mm? -68.71 -32.75 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -71.03 -51.78 23.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 73.5 t80 -67.0 -40.81 87.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.946 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.94 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-30 -57.13 -45.12 83.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 73.6 mt-30 -79.89 -17.67 52.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -47.6 19.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.97 -29.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -71.41 3.46 3.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 11.1 mtpt -52.57 159.54 1.65 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.745 0.307 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.22 -32.82 12.32 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.478 2.119 . . . . 0.0 112.288 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.57 -30.02 41.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -75.89 -54.04 7.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.399 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 100' ' ' ILE . 70.5 mt -57.71 -53.23 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.359 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -51.35 -35.66 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.205 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -36.09 78.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -77.08 -42.49 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.7 mt -65.51 -33.17 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -27.67 60.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.1 m -72.6 -36.77 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -5.42 19.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.34 29.68 19.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.886 0.374 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 100' ' ' ILE . 21.7 mt -50.89 -33.52 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.237 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 76.83 -55.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 138.67 50.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.493 HD21 ' CD1' ' A' ' 167' ' ' TYR . 11.0 tp -120.62 -66.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 131.98 -9.83 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.98 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.35 131.05 66.66 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.709 0.255 . . . . 0.0 111.175 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.13 147.56 26.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.273 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -87.33 115.51 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -88.31 126.46 35.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -105.74 -40.72 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.96 -174.62 46.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.623 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -136.58 162.76 32.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -142.46 174.43 23.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.824 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 127' ' ' ARG . 32.2 mt -148.08 159.83 43.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 110.945 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.64 122.1 11.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.028 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.85 118.47 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.22 126.32 22.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.23 20.58 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.527 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.36 -1.3 60.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.94 129.0 43.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.762 0.315 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t -96.22 123.05 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.25 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -106.71 121.28 44.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.488 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.687 ' HA ' HD23 ' A' ' 118' ' ' LEU . 43.5 mtp85 -106.35 125.08 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.4 p90 -139.81 158.76 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.886 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.4 tmm? -128.05 147.21 50.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.647 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.447 HG12 HG23 ' A' ' 70' ' ' VAL . 20.5 mt -121.34 112.73 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.102 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.97 173.41 7.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.169 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.19 148.74 4.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.873 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.9 tpt180 -65.38 155.69 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -128.58 160.01 33.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.29 -110.29 2.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.555 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 p -107.98 125.79 51.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.762 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.743 ' OD1' HD22 ' A' ' 184' ' ' LEU . 10.1 m-20 -58.65 160.34 5.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.813 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.792 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -65.77 -24.35 66.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.591 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 1.2 mt-30 -63.71 -44.29 94.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 110.15 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -60.71 -30.68 70.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.26 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 138' ' ' LEU . 40.1 mt -72.87 -25.2 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.762 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 147' ' ' LYS . 76.7 t80 -67.75 -48.85 65.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.619 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.59 -27.96 58.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.741 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.02 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 77.7 m-20 -97.51 -1.8 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.263 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.7 45.34 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.166 0.507 . . . . 0.0 110.345 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 51.7 mttt 61.33 20.91 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.396 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -135.11 107.86 7.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 142' ' ' TYR . 2.0 m-85 -77.93 -172.93 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 154' ' ' VAL . 23.0 t -116.9 150.37 38.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -60.43 -29.4 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.648 ' HG2' HD12 ' A' ' 331' ' ' ILE . 17.3 mtmt -73.81 -43.75 57.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -61.3 -52.04 66.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.43 HG21 ' HG ' ' A' ' 255' ' ' LEU . 46.1 t -54.84 -54.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 328' ' ' LEU . 49.0 mt -62.47 -47.87 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -43.12 93.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.68 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.645 HD22 HG11 ' A' ' 193' ' ' VAL . 22.4 mt -69.1 -35.27 76.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.591 ' OG ' HD21 ' A' ' 247' ' ' LEU . 0.5 OUTLIER -57.32 -42.24 81.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 325' ' ' LEU . 90.5 mt -70.06 -43.19 71.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.726 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -64.27 -49.27 72.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 164' ' ' ILE . 14.2 mt -66.36 -36.23 76.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.54 -36.03 77.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -35.86 74.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.78 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 161' ' ' ILE . 7.0 mt -76.89 -37.3 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.39 -41.85 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.15 -30.96 68.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.696 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.493 ' CD1' HD21 ' A' ' 108' ' ' LEU . 48.5 t80 -70.93 -53.35 15.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.467 HD11 ' CE1' ' A' ' 175' ' ' HIS . 12.1 pt -66.67 -27.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.407 ' N ' HG13 ' A' ' 168' ' ' ILE . 6.6 m-70 -75.21 -32.85 61.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.92 -16.96 62.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.58 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -100.47 3.2 42.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 67.71 42.44 2.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.422 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 0.3 OUTLIER -131.64 127.48 37.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.06 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.795 HG11 ' HB3' ' A' ' 239' ' ' SER . 3.7 m -113.57 169.21 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.066 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.709 ' CD2' HD21 ' A' ' 195' ' ' LEU . 18.7 p-80 -147.42 -50.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 53.42 52.83 38.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.646 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.58 28.98 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.253 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.82 106.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.719 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.497 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -153.55 -177.76 6.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.591 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -81.7 -0.08 41.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.293 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 p -109.11 1.23 20.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.44 -6.65 4.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.519 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 184' ' ' LEU . 17.9 mt -108.59 127.98 54.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -134.97 156.82 48.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.164 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.9 mt -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.307 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.456 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.3 OUTLIER -67.26 130.32 42.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 133' ' ' ARG . 6.1 t80 -75.01 -54.41 7.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -21.3 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.506 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -135.89 73.68 59.32 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 102.0 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.526 2.151 . . . . 0.0 112.147 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -177.44 -35.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -176.77 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -132.56 148.12 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.456 ' CE1' ' ND2' ' A' ' 186' ' ' ASN . 6.3 m-85 -121.06 156.94 31.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.142 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.709 HD21 ' CD2' ' A' ' 175' ' ' HIS . 60.4 tp -106.62 115.88 30.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.34 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 184' ' ' LEU . 11.1 m -106.64 143.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.58 104.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 175' ' ' HIS . 5.8 m-30 -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.697 ' C ' HD22 ' A' ' 200' ' ' LEU . . . 88.98 -50.66 3.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.398 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 199' ' ' GLY . 2.9 mm? -118.61 -38.72 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.665 0.269 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.37 82.09 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.252 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -118.86 148.96 42.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.422 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 11.0 mtp180 -102.39 70.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.687 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.781 ' CD1' HG13 ' A' ' 174' ' ' VAL . 43.6 p90 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.26 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 200' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -147.47 146.3 29.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.892 HG23 HD22 ' A' ' 265' ' ' LEU . 6.9 tp -68.01 -11.13 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.804 ' HG3' HD11 ' A' ' 265' ' ' LEU . 1.0 OUTLIER -52.47 -36.75 55.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.408 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 62.9 m-85 -157.42 33.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.25 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.727 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -66.53 139.92 57.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.786 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 0.3 OUTLIER -84.6 131.83 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 275' ' ' LYS . 2.6 mt -59.31 -58.85 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.61 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -62.41 -44.19 97.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -57.07 -45.18 83.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -61.82 -27.84 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.632 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.6 t-20 -90.07 -0.1 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.393 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.16 87.2 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.002 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 234' ' ' ASN . 21.2 t -54.13 107.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.56 165.94 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.718 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 36.1 Cg_endo -65.24 148.08 88.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.795 ' HB3' HG11 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -59.46 109.7 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.25 -47.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -67.21 -30.41 70.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.61 91.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.82 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 m-20 -57.16 -32.68 66.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 110.982 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.764 HD21 ' CE2' ' A' ' 317' ' ' TYR . 84.0 mt -80.57 -37.4 31.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -61.71 -37.72 85.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -61.93 -49.28 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.667 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.5 tp -64.8 -40.73 95.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.97 92.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -78.67 -25.88 44.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.15 -39.97 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -50.0 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.761 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.96 -30.56 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.3 tt0 -80.05 -39.94 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.07 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -82.23 -25.8 33.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.381 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 154' ' ' VAL . 16.6 mt -91.22 -44.68 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.223 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.23 0.61 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 65.36 100.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.3 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 3.8 p80 55.67 165.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.888 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -135.38 168.46 17.5 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.507 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 43.2 Cg_endo -68.33 63.33 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.379 2.053 . . . . 0.0 112.457 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.888 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 3.8 p90 175.19 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.013 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -95.21 19.78 10.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.47 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -57.67 4.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 87.0 m-20 -126.91 -26.02 3.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.343 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.892 HD22 HG23 ' A' ' 225' ' ' ILE . 48.4 mt 71.3 12.41 6.72 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.106 0.479 . . . . 0.0 109.822 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -12.89 49.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.196 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 271' ' ' VAL . 29.4 m-20 -124.06 79.63 58.42 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.92 -11.12 29.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.767 2.311 . . . . 0.0 112.597 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -47.65 22.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.069 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -75.3 -26.15 58.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.884 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 261' ' ' TRP . 77.8 t -57.78 -35.22 50.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.591 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -75.59 -41.69 53.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -40.48 82.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.079 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 67.1 m -75.44 -29.93 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.807 ' HB3' HD11 ' A' ' 230' ' ' ILE . 11.6 mmtp -73.54 -45.9 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.069 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.02 -38.57 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -65.12 -52.0 57.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.524 ' CG ' HD12 ' A' ' 285' ' ' LEU . 13.0 m-85 -62.05 -35.12 77.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.444 ' HD3' HD12 ' A' ' 230' ' ' ILE . 0.4 OUTLIER -57.33 -29.28 63.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -118.9 24.0 11.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -140.34 42.52 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 303' ' ' MET . 6.4 mm -47.6 -41.07 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.39 63.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.97 68.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.524 HD12 ' CG ' ' A' ' 278' ' ' TYR . 5.0 tt -64.76 -51.16 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.707 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.574 ' HG3' ' HB2' ' A' ' 300' ' ' ALA . 10.4 mmt -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.734 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.4 -26.54 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -82.76 -52.87 6.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.075 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.92 -41.17 37.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.57 87.38 7.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.41 76.2 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.441 2.094 . . . . 0.0 112.253 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -172.42 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.24 58.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.66 -68.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 296' ' ' PRO . 1.4 mtpp -152.27 101.19 2.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 19.1 Cg_endo -60.2 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.224 1.95 . . . . 0.0 111.975 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -174.86 28.82 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.595 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 68.16 7.01 5.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.502 0.191 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.662 HG22 ' CG ' ' A' ' 303' ' ' MET . 24.3 mm -79.8 -45.7 22.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 110.963 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 286' ' ' MET . . . -44.51 -46.74 9.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.585 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -43.06 89.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.768 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.879 ' CE2' HD11 ' A' ' 324' ' ' LEU . 18.4 t80 -70.56 -46.47 63.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.662 ' CG ' HG22 ' A' ' 299' ' ' ILE . 62.6 mmm -66.06 -37.71 86.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.748 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -42.36 98.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.564 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 42.2 m -67.65 -31.74 71.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 309' ' ' LEU . 66.3 t -79.35 -24.4 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.195 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.33 -40.74 58.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.11 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.79 -27.11 12.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.6 mp . . . . . 0 N--CA 1.462 0.159 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.888 0.287 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 319' ' ' ASN . 0.9 OUTLIER -151.01 41.24 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.764 ' CE2' HD21 ' A' ' 244' ' ' LEU . 11.3 m-85 -59.16 -30.09 67.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.75 -47.91 83.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.894 ' HB2' HD22 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -63.67 -35.01 79.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.976 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.922 ' HA ' HD12 ' A' ' 323' ' ' ILE . 57.9 mt -59.57 -42.12 91.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -63.12 -36.39 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.97 73.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 320' ' ' LEU . 20.8 mt -66.26 -49.24 77.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.879 HD11 ' CE2' ' A' ' 302' ' ' TYR . 5.8 mt -76.2 -24.54 54.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.261 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.768 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.6 tt -82.64 -44.75 15.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -59.47 -37.1 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.37 76.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.53 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 159' ' ' LEU . 13.2 mt -59.98 -41.2 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -27.69 61.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.14 -26.29 62.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.31 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.648 HD12 ' HG2' ' A' ' 152' ' ' LYS . 27.7 pt -106.3 -27.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.221 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.21 7.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -65.45 0.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.829 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.91 108.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.442 ' OD2' HD12 ' A' ' 328' ' ' LEU . 5.8 m-20 -70.08 89.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.84 143.64 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.82 26.36 69.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.548 ' O ' HD13 ' A' ' 28' ' ' ILE . 14.8 mm-40 -92.1 170.53 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.548 HD13 ' O ' ' A' ' 27' ' ' GLU . 26.7 mm -126.28 126.26 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.228 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.962 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 36.3 pt -116.87 154.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 t -95.56 141.48 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.916 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -160.81 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.04 -39.12 26.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.156 0.503 . . . . 0.0 109.895 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -84.42 2.83 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 7.4 mttt 86.08 30.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.47 178.62 5.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -130.63 80.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.2 m95 -78.19 144.93 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.004 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG2' HD13 ' A' ' 28' ' ' ILE . 11.5 mtpp -97.28 148.22 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.58 127.64 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.81 -143.13 12.23 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.54 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.47 152.55 39.34 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.45 165.96 2.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.294 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.769 HG13 HG22 ' A' ' 51' ' ' ILE . 14.3 pt -154.42 29.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.393 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 97.9 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.769 HG22 HG13 ' A' ' 43' ' ' ILE . 28.9 mm -92.56 83.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -119.93 172.1 7.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.4 165.88 19.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -130.75 150.22 52.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.417 ' CB ' HG22 ' A' ' 62' ' ' VAL . 26.1 t0 -139.89 157.06 46.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.5 57.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.92 94.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.25 -172.16 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -75.65 -38.88 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.74 -68.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -155.48 161.86 40.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 66' ' ' ALA . 21.6 t -74.76 114.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.96 -69.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -119.06 32.03 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.72 87.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -167.62 80.9 0.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.11 49.55 3.17 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.708 2.272 . . . . 0.0 112.642 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.2 m -149.79 148.23 28.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 43' ' ' ILE . 16.9 m -122.96 144.98 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 130' ' ' ILE . 8.0 p -132.94 129.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.156 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.54 124.09 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.665 HG22 ' CB ' ' A' ' 128' ' ' PHE . 2.6 t -113.15 139.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -141.15 144.0 33.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.705 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.92 109.09 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.484 2.122 . . . . 0.0 112.289 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 t -57.83 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.21 -49.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -167.46 110.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.5 39.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.563 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HG3' HD12 ' A' ' 200' ' ' LEU . 71.6 Cg_endo -77.14 -0.77 10.93 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.634 2.222 . . . . 0.0 112.729 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.91 -41.97 92.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -48.92 73.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.502 HG22 ' HA2' ' A' ' 199' ' ' GLY . 6.6 m -75.08 -36.47 61.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.63 -53.04 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HG3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -62.71 -35.6 80.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.871 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 51.1 t80 -65.15 -37.97 89.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.941 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.0 m-85 -55.87 -53.33 58.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -17.35 53.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.605 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.31 -47.56 12.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -128.19 -24.11 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -90.6 23.05 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -70.91 130.08 88.84 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.81 -24.72 76.95 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.459 2.106 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.43 -35.8 39.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.965 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -79.38 -50.24 11.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 91' ' ' ALA . 48.8 mt -62.58 -57.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -50.18 -55.33 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.359 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -31.37 63.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -77.32 -49.71 14.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 106' ' ' LYS . 22.2 mt -75.04 -23.26 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.876 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -27.36 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.626 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.9 p -77.98 -11.05 59.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.358 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 78.18 13.87 1.55 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -83.36 -14.53 52.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.449 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 105' ' ' LEU . 5.0 mt -111.28 -51.46 2.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 100' ' ' ILE . 1.0 OUTLIER 76.14 -56.55 0.58 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CG ' ' NE2' ' A' ' 192' ' ' GLN . 41.1 t80 -145.33 145.03 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 167' ' ' TYR . 11.1 tp -126.12 -43.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 95.41 -7.69 68.89 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.741 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' HG ' ' A' ' 108' ' ' LEU . 35.6 t -78.04 136.64 61.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.72 0.26 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 110' ' ' VAL . 20.1 Cg_endo -60.61 143.46 99.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.457 2.105 . . . . 0.0 112.239 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -84.96 115.65 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.455 ' CE1' HD21 ' A' ' 84' ' ' LEU . 40.0 t80 -89.03 126.76 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -103.48 -40.63 6.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.01 -178.37 45.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.614 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.1 t -132.62 161.15 34.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.64 0.257 . . . . 0.0 110.523 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.05 170.65 30.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.802 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 127' ' ' ARG . 1.8 mt -137.91 159.14 42.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.782 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.77 125.16 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.019 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 130.78 46.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -138.2 126.29 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.13 17.15 6.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.41 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.94 -11.42 55.97 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.922 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -96.09 129.03 43.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 t -93.45 131.67 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -113.0 151.01 31.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.623 ' HA ' HD23 ' A' ' 118' ' ' LEU . 31.7 ttm180 -116.56 132.22 56.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.962 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 17.1 p90 -141.24 159.89 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.464 ' HG3' HD21 ' A' ' 84' ' ' LEU . 1.9 ttm -128.17 145.74 50.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 29' ' ' ILE . 16.3 mt -120.2 111.54 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -123.49 173.3 8.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.69 134.52 24.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 145.52 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.648 ' CD2' HD12 ' A' ' 184' ' ' LEU . 48.6 m-85 -109.27 166.38 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.28 -100.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.503 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 m -125.41 127.61 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.887 ' OD1' HD22 ' A' ' 184' ' ' LEU . 2.1 m-20 -56.67 159.56 3.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -65.65 -20.16 66.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.492 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.581 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 2.4 mt-30 -51.09 -32.74 23.34 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 121.062 0.458 . . . . 0.0 110.335 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -30.89 51.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.132 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 138' ' ' LEU . 30.6 mt -76.69 -25.16 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 147' ' ' LYS . 12.1 t80 -77.88 -45.32 24.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.552 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -29.59 62.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.31 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -99.67 9.06 43.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.018 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.24 49.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.143 0.497 . . . . 0.0 110.02 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 258' ' ' HIS . 0.1 OUTLIER 62.55 21.4 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.132 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -120.74 161.1 22.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.668 ' HE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -146.41 143.39 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 144.39 37.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HG2' HD21 ' A' ' 255' ' ' LEU . 6.6 mtm-85 -56.4 -26.35 52.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -73.85 -41.95 61.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.668 HG21 ' HE1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -62.83 -45.72 91.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 251' ' ' MET . 39.8 t -62.21 -54.09 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.251 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 328' ' ' LEU . 97.7 mt -57.32 -48.13 79.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.31 -50.71 70.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.644 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.52 -41.01 96.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 324' ' ' LEU . 66.3 m -55.62 -41.26 73.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.67 -49.2 76.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.427 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -47.24 86.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.763 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 178' ' ' ILE . 15.5 mt -64.99 -37.61 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 165' ' ' LEU . 6.9 mt -58.14 -37.8 75.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.94 -31.96 70.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.4 mt -74.42 -45.54 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.782 HD21 HD11 ' A' ' 178' ' ' ILE . 15.8 mt -60.02 -45.37 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 2.6 mt-10 -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.788 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.843 ' CE2' HD21 ' A' ' 108' ' ' LEU . 25.3 t80 -75.22 -48.99 20.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.871 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 27.0 pt -74.04 -38.8 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.666 ' CD2' HG12 ' A' ' 174' ' ' VAL . 18.2 t-80 -68.73 -25.18 64.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -98.0 -1.34 42.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.306 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.26 -58.38 1.9 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.717 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 204' ' ' TYR . 0.5 OUTLIER 168.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.473 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 86' ' ' PHE . 64.9 m-85 -159.51 126.37 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 0.0 110.996 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.666 HG12 ' CD2' ' A' ' 169' ' ' HIS . 30.4 m -132.55 147.5 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.433 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.596 ' CE1' HD11 ' A' ' 246' ' ' ILE . 37.7 t60 77.79 47.07 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -58.81 -18.41 39.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.861 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 195' ' ' LEU . 7.2 t70 74.52 97.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.838 0.351 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.782 HD11 HD21 ' A' ' 165' ' ' LEU . 3.9 mp -97.32 114.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.759 ' O ' HD12 ' A' ' 183' ' ' LEU . 4.7 tmtm? -148.02 179.44 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.581 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -83.72 0.75 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -115.21 2.16 14.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.476 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.802 ' O ' HG22 ' A' ' 196' ' ' VAL . 20.0 m-20 -125.51 -7.49 6.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.556 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.29 113.61 26.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.113 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.887 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -119.04 148.0 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.191 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 141' ' ' ILE . 40.5 mt -86.69 148.53 25.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.212 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.72 127.48 31.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.58 -41.5 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.777 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -77.24 -23.64 51.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.822 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.09 61.67 12.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.57 114.86 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.651 2.234 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -177.49 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.405 ' NE2' ' CG ' ' A' ' 107' ' ' TYR . 3.2 mt-30 -131.2 177.26 7.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.795 HG21 HD21 ' A' ' 138' ' ' LEU . 9.9 p -121.08 147.33 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.44 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 3.6 m-85 -113.62 150.6 32.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 178' ' ' ILE . 30.1 tp -104.14 117.61 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 182' ' ' ASN . 9.2 m -92.17 -179.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.57 93.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -117.72 -49.82 2.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.706 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 82' ' ' THR . . . -59.06 -21.06 52.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -84.86 3.61 37.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.473 0.178 . . . . 0.0 111.421 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 174' ' ' VAL . . . -92.5 -109.61 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 174' ' ' VAL . 46.0 t80 -146.32 118.13 8.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 110.435 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -90.25 77.79 6.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.317 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 172' ' ' GLU . 8.3 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.183 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 228' ' ' THR . 0.6 OUTLIER -158.49 133.9 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.925 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.901 HG23 HD22 ' A' ' 265' ' ' LEU . 7.1 tp -65.63 -13.41 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.443 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.95 -51.03 25.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.742 0.306 . . . . 0.0 111.348 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -145.56 31.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.224 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 225' ' ' ILE . 12.9 t -56.87 116.52 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.319 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 t -57.47 163.31 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mt -60.76 -37.73 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.34 -31.32 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.06 -36.5 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.22 -32.16 73.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -92.2 12.95 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.263 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.39 24.07 55.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.611 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 28.8 t -67.87 136.42 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 238' ' ' PRO . . . -68.98 -62.45 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 237' ' ' ALA . 21.5 Cg_endo -61.2 125.6 17.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.508 2.138 . . . . 0.0 112.353 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.6 OUTLIER -164.95 121.16 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -127.51 -44.25 1.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -8.21 55.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.51 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.61 -49.71 71.35 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.2 p30 -60.36 -34.44 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.374 . . . . 0.0 111.054 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.415 ' CD1' HD13 ' A' ' 309' ' ' LEU . 77.0 mt -78.03 -33.42 51.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.03 -37.28 87.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -65.29 -45.76 92.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.773 HD23 ' OH ' ' A' ' 302' ' ' TYR . 29.2 tp -62.0 -37.23 84.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.87 -43.78 97.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.606 ' HA ' HD12 ' A' ' 252' ' ' ILE . 28.6 m-85 -78.52 -25.65 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 254' ' ' TRP . 6.0 m -56.65 -38.41 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.279 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.413 ' CG ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -69.85 -48.96 56.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.086 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.912 ' O ' HG22 ' A' ' 256' ' ' THR . 5.0 mt -59.59 -51.74 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.178 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.593 ' HB3' HD21 ' A' ' 259' ' ' LEU . 1.1 pt20 -63.55 -28.61 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 20.7 m0 -82.35 -28.49 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.267 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 151' ' ' ARG . 82.8 mt -86.75 -41.68 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 252' ' ' ILE . 15.0 t -96.23 0.56 51.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.498 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.8 97.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.499 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 147' ' ' LYS . 5.1 m-70 64.16 166.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.903 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -132.29 162.44 56.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.7 Cg_endo -67.44 64.19 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.361 2.041 . . . . 0.0 112.433 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.903 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 2.3 p90 177.19 -36.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.169 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.6 tt0 -88.14 10.71 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.536 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.89 -48.13 82.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.9 t-20 -130.54 -29.22 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.387 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.901 HD22 HG23 ' A' ' 225' ' ' ILE . 85.9 mt 71.97 11.64 6.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -14.37 54.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.418 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.467 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -136.89 87.4 19.56 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.104 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 24.7 Cg_exo -63.01 -10.61 21.17 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.68 2.253 . . . . 0.0 112.484 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -49.81 -50.22 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.331 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.4 p90 -81.12 -26.17 36.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 225' ' ' ILE . 50.5 t -61.62 -40.89 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.044 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -75.55 -45.06 40.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.06 -46.97 84.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 59.1 m -58.56 -43.59 89.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -41.7 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.582 HG23 ' NH1' ' A' ' 279' ' ' ARG . 20.3 mt -77.47 -28.98 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.376 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -81.36 -52.17 7.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.608 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 285' ' ' LEU . 4.9 m-85 -64.0 -40.57 96.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.642 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.582 ' NH1' HG23 ' A' ' 276' ' ' ILE . 0.2 OUTLIER -52.1 -26.57 11.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.939 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -113.83 17.76 17.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.34 35.57 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.717 HD13 ' CB ' ' A' ' 303' ' ' MET . 20.5 mt -47.24 -48.61 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.53 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.78 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.196 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 252' ' ' ILE . 0.8 OUTLIER -68.57 -37.82 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.424 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.546 ' HG2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -65.06 -40.22 94.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.725 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -23.3 42.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -82.66 -54.03 5.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.205 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.3 m -79.25 -41.21 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.415 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.29 149.75 39.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -48.65 20.73 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.526 2.151 . . . . 0.0 112.267 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.46 31.1 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -30.84 23.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -170.58 119.59 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm 59.44 97.75 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 -167.47 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.253 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.16 11.49 69.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.878 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 71.0 10.41 6.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.686 0.243 . . . . 0.0 111.341 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.534 HG22 ' CG ' ' A' ' 303' ' ' MET . 37.4 mm -79.59 -45.79 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.788 0.328 . . . . 0.0 110.824 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 286' ' ' MET . . . -44.86 -43.32 8.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.449 ' CB ' HG23 ' A' ' 323' ' ' ILE . 61.3 mttt -60.24 -43.99 95.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.533 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.864 ' O ' HG23 ' A' ' 306' ' ' VAL . 43.2 t80 -68.53 -39.41 81.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.717 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.6 mtp -68.43 -37.29 80.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.342 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.04 -50.22 74.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 2.2 p -59.08 -41.26 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 302' ' ' TYR . 18.0 t -65.19 -24.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.121 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -77.24 -39.77 47.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.222 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -17.41 56.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.091 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.704 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.824 0.26 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 17.7 tp -118.84 -1.26 11.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.398 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 166' ' ' GLU . 79.8 m-85 -57.58 -32.37 67.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.857 0.361 . . . . 0.0 111.003 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.0 -37.63 87.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -46.04 63.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.838 ' HA ' HD12 ' A' ' 323' ' ' ILE . 36.3 mt -54.87 -45.59 74.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -32.41 65.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -38.19 45.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 320' ' ' LEU . 56.9 mt -54.81 -44.49 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' A' ' 158' ' ' SER . 38.4 mt -75.4 -49.94 17.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -54.42 -49.84 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.361 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -53.4 -39.44 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -26.56 70.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.923 HD12 HD23 ' A' ' 325' ' ' LEU . 17.1 mt -65.2 -40.5 94.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -74.46 -27.28 60.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.86 -27.42 68.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.46 -28.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.62 5.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 33.6 t -90.9 152.64 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.72 91.7 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.72 145.9 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -91.49 123.56 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.95 -27.2 7.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.592 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -82.45 143.07 31.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 36' ' ' GLU . 23.6 mt -100.43 142.42 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.8 pt -113.7 154.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 62.2 m -95.51 140.98 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -97.16 -162.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.109 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.94 -42.12 40.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 109.811 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -79.36 -0.05 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.5 mtpt 84.61 29.04 0.06 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 6.0 mttt -74.49 -179.86 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.576 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.7 mt-10 -128.32 79.63 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.409 ' HB2' HG13 ' A' ' 29' ' ' ILE . 31.0 m95 -74.78 143.24 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.756 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 126.6 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG2' HG23 ' A' ' 29' ' ' ILE . 22.9 t -75.87 147.18 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -105.98 -151.77 19.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.706 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 25' ' ' VAL . 3.8 mt -87.01 157.47 54.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 111.018 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.27 144.74 92.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.596 2.197 . . . . 0.0 112.282 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.1 pt -142.22 -42.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.222 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.547 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -91.99 112.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.305 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.57 169.56 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.8 mt -73.49 158.15 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.619 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -121.07 150.91 40.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.349 . . . . 0.0 111.338 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -137.77 157.57 46.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -97.06 30.8 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.51 104.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -137.77 -65.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -103.69 -178.19 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.97 -34.58 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -142.94 159.23 42.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 5.9 t -89.88 160.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 62' ' ' VAL . . . 130.51 46.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.538 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -163.66 -45.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -143.61 67.85 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -117.74 80.09 13.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' CB ' ' HE2' ' A' ' 188' ' ' LYS . 86.8 Cg_endo -82.82 48.27 2.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.748 2.299 . . . . 0.0 112.699 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.885 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 2.2 m -149.81 153.31 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.815 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 133' ' ' ARG . 23.4 m -130.15 144.85 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.044 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG12 ' A' ' 130' ' ' ILE . 7.3 p -135.75 124.81 39.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -104.4 123.38 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.499 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 128' ' ' PHE . 5.0 t -113.07 135.17 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.466 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -141.21 150.62 59.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.579 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.51 118.87 5.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.495 2.13 . . . . 0.0 112.209 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -55.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t0 61.58 98.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.02 94.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.06 151.33 20.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.28 35.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.486 2.124 . . . . 0.0 112.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 84' ' ' LEU . 15.8 tp -64.77 -37.64 88.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.7 -41.31 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 7.3 p -72.84 -32.22 65.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.03 -40.73 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.808 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -61.51 -51.65 67.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -57.72 -43.75 85.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.6 t80 -63.67 -31.61 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.3 m-85 -71.65 -60.29 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.66 -17.89 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.375 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -47.37 60.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.23 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.91 -37.41 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.871 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -54.99 -21.21 11.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 123.12 8.55 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.993 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.92 -25.64 12.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.556 2.171 . . . . 0.0 112.466 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.91 -35.92 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -79.4 -39.76 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.833 HG22 HD11 ' A' ' 100' ' ' ILE . 34.0 mt -65.42 -57.61 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -32.15 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.178 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' THR . 53.0 mttt -76.15 -32.93 59.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -77.16 -38.21 52.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.833 HD11 HG22 ' A' ' 96' ' ' ILE . 18.2 mt -69.69 -37.5 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.13 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -74.94 -27.78 60.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.254 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 98' ' ' LYS . 22.6 p -84.36 -34.02 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.335 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -2.24 24.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 58.61 31.05 20.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.637 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 100' ' ' ILE . 56.9 mt -51.59 -25.64 7.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tptp 78.52 -55.6 0.47 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 108' ' ' LEU . 19.9 t80 -152.79 163.51 39.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 167' ' ' TYR . 3.4 tp -139.85 -168.02 2.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.38 28.4 2.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.433 HG13 ' HD2' ' A' ' 111' ' ' PRO . 25.0 t -101.92 136.49 19.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.588 0.232 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.733 ' HG3' HG12 ' A' ' 196' ' ' VAL . 18.0 Cg_endo -59.48 151.82 66.1 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.608 2.206 . . . . 0.0 112.291 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.8 115.53 23.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -92.5 115.35 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -92.84 -40.46 10.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.745 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.17 -175.98 46.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.405 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.6 t -137.92 165.89 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.666 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.34 177.2 28.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.583 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.487 HD21 ' NE ' ' A' ' 127' ' ' ARG . 2.3 mp -147.83 159.86 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 111.019 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -141.89 141.74 33.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -111.41 130.29 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -138.23 126.26 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.79 23.86 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.9 10.66 61.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.819 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.15 159.2 15.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.17 122.19 46.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.406 ' O ' HD23 ' A' ' 118' ' ' LEU . 16.1 m-85 -114.23 141.43 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.487 ' NE ' HD21 ' A' ' 118' ' ' LEU . 3.0 ttm180 -126.9 126.72 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.806 ' CE1' HD12 ' A' ' 29' ' ' ILE . 35.1 p90 -136.26 161.73 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.683 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.0 tmm? -128.06 145.83 50.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.645 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 70' ' ' VAL . 13.9 mt -121.52 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -132.36 173.29 11.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.8 139.58 26.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.081 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HG3' HG13 ' A' ' 69' ' ' VAL . 7.0 ttt180 -71.84 151.5 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -115.48 167.4 10.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.39 -64.07 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 p -154.33 156.71 37.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.466 ' CG ' HD22 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -77.77 153.25 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.711 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.4 mm? -60.78 -25.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.734 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.722 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 11.2 tt0 -70.33 -44.37 68.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -60.77 -28.53 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 138' ' ' LEU . 35.5 mt -74.56 -28.33 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 t80 -57.28 -46.28 83.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.58 -25.97 67.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.078 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.09 -17.36 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.475 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.2 m120 -94.95 -3.04 49.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 98.78 43.15 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.043 0.537 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 59.79 20.35 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 5.8 mtp180 -169.89 128.04 0.9 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.928 0.394 . . . . 0.0 111.141 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.788 ' CD1' HG21 ' A' ' 153' ' ' THR . 1.1 m-85 -81.26 -175.45 5.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -115.76 169.34 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' HD21 ' A' ' 255' ' ' LEU . 25.1 mtm180 -57.91 -29.9 65.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.788 HG21 ' CD1' ' A' ' 149' ' ' PHE . 23.6 m -60.84 -55.31 34.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.86 HG21 ' HG ' ' A' ' 255' ' ' LEU . 34.9 t -56.75 -52.37 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.579 ' HB3' HD21 ' A' ' 328' ' ' LEU . 23.3 mt -59.27 -41.27 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -64.82 -44.38 90.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.67 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 161' ' ' ILE . 32.5 mt -70.73 -32.73 70.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.56 ' CB ' HD13 ' A' ' 324' ' ' LEU . 1.4 t -62.85 -41.18 99.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 325' ' ' LEU . 11.3 mt -72.36 -33.67 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -70.56 -49.49 47.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.3 mt -61.32 -41.9 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.971 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.674 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.5 mt -60.26 -40.9 91.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.711 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.69 -32.92 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.526 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 161' ' ' ILE . 10.6 mt -79.74 -40.18 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.707 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 162' ' ' LEU . 22.9 mt -55.85 -38.76 70.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.85 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -32.67 74.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 108' ' ' LEU . 80.3 t80 -74.09 -52.51 12.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.778 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 165' ' ' LEU . 8.0 pt -67.66 -27.16 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.271 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 165' ' ' LEU . 1.3 m-70 -80.33 -32.29 37.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.595 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.97 -17.01 62.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -104.36 5.98 34.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.024 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 73.52 46.28 0.22 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.385 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.453 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.1 m-85 -137.06 129.12 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 202' ' ' TYR . 19.3 m -112.17 164.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.491 ' CD2' ' CE1' ' A' ' 198' ' ' TYR . 12.5 t-80 -120.01 -66.02 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.28 43.93 93.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -162.84 36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.905 0.383 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.8 mt -74.7 114.24 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -177.92 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.054 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.722 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -80.07 -2.57 44.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.594 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.6 t -106.37 0.05 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.107 0.479 . . . . 0.0 110.57 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.76 -11.24 7.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.074 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.4 mt -108.32 113.77 27.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.616 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 137' ' ' ASP . 1.7 mt -116.99 168.38 10.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.856 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.619 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.9 mt -106.56 149.48 27.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.95 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 0.3 OUTLIER -89.51 142.96 27.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 109.941 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.1 -26.7 5.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.4 ' HE2' ' CB ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -55.62 -25.23 37.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 174.2 -58.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.425 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HB2' ' CB ' ' A' ' 186' ' ' ASN . 96.0 Cg_exo -37.45 -60.43 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.026 2.484 . . . . 0.0 113.538 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 0.5 OUTLIER 82.32 -4.45 1.43 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.51 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -89.57 -166.88 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.0 p -109.93 145.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 7.8 m-85 -124.38 156.95 36.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.857 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.471 HD21 ' CD2' ' A' ' 175' ' ' HIS . 14.9 tp -105.4 115.93 31.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.625 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.0 m -130.97 170.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.2 t70 56.17 88.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.1 m-85 -81.8 -33.88 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.624 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 63.5 14.47 54.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.797 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.26 -49.69 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 46.81 87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.411 ' HB3' ' CG2' ' A' ' 174' ' ' VAL . 0.2 OUTLIER -117.16 135.82 53.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 15.3 ttp-105 -103.49 50.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 69.1 p -150.97 -176.46 5.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.887 HG23 HD22 ' A' ' 265' ' ' LEU . 2.0 tp -148.45 27.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -102.45 -28.25 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.676 ' HB3' HG23 ' A' ' 246' ' ' ILE . 82.5 m-85 -148.93 30.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.3 m -68.65 122.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.4 t -69.88 169.56 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.46 -32.07 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -33.51 60.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -74.0 -31.66 63.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -25.55 65.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 12.87 16.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.321 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.21 69.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.81 152.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.34 . . . . 0.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.03 109.41 16.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.29 177.44 4.54 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.384 2.056 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.6 m -150.55 -59.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -47.27 1.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -59.2 -29.67 67.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -64.99 -49.66 61.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.698 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 p30 -70.6 -42.03 71.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.24 -31.69 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -39.88 78.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 243' ' ' ASP . 9.2 mt -66.7 -35.97 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' OH ' ' A' ' 302' ' ' TYR . 33.3 tp -70.8 -38.84 73.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -63.93 -35.77 92.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.54 -25.8 45.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 111.022 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 10.4 m -65.02 -32.92 74.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.035 0.445 . . . . 0.0 110.468 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.615 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -59.01 -52.69 64.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.055 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.64 HG12 HD13 ' A' ' 285' ' ' LEU . 4.1 mp -68.32 -28.67 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.714 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -75.34 -41.84 55.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 111.473 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.407 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 40.8 m0 -82.27 -24.89 34.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.788 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.86 ' HG ' HG21 ' A' ' 154' ' ' VAL . 72.2 mt -93.16 -37.37 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 289' ' ' CYS . 3.1 m -96.12 -12.68 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 75.04 87.8 0.25 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.5 m170 64.98 158.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.4 OUTLIER -132.63 160.34 68.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 37.5 Cg_endo -65.92 66.06 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.549 2.166 . . . . 0.0 112.85 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.7 p90 178.34 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.288 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.741 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -98.53 21.99 10.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.214 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -56.09 9.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 69.4 m-20 -125.96 -27.09 3.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.887 HD22 HG23 ' A' ' 225' ' ' ILE . 69.2 mt 70.19 12.74 7.7 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.02 -14.83 43.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.118 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.449 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.9 m-20 -134.33 98.32 14.03 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.03 17.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.698 2.265 . . . . 0.0 112.83 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -80.09 -46.95 15.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.7 p90 -79.27 -26.73 42.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 261' ' ' TRP . 26.7 t -61.43 -37.79 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.189 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.543 ' O ' HD12 ' A' ' 276' ' ' ILE . 5.3 ttp-105 -75.51 -45.54 37.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.237 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -67.19 -37.91 84.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.1 m -68.3 -43.41 77.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -52.42 64.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 272' ' ' ARG . 7.1 mt -60.38 -33.27 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.561 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -81.05 -49.57 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.23 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -62.8 -36.78 84.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -54.2 -29.63 46.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.877 0.37 . . . . 0.0 110.645 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.0 19.52 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -136.39 41.58 2.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.816 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 303' ' ' MET . 23.5 mt -53.17 -38.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.7 64.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -40.76 85.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.028 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.64 HD13 HG12 ' A' ' 252' ' ' ILE . 3.6 pp -75.54 -28.43 59.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -45.09 91.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.93 -27.4 33.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.373 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -82.76 -33.06 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.691 0.281 . . . . 0.0 111.334 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 256' ' ' THR . 59.4 m -93.7 -41.24 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.21 154.69 37.48 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.63 151.67 18.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.714 2.276 . . . . 0.0 112.327 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.13 -35.68 13.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -71.66 -46.36 59.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -68.15 149.15 49.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.05 147.68 88.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.98 166.91 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.624 2.216 . . . . 0.0 112.156 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -104.99 25.14 26.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.577 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 68.53 13.6 8.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.689 0.28 . . . . 0.0 111.301 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.529 HG22 ' CG ' ' A' ' 303' ' ' MET . 36.4 mm -79.25 -45.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.527 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.63 -43.78 17.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.287 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.4 OUTLIER -59.08 -41.71 88.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.392 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.677 ' HA ' HD13 ' A' ' 323' ' ' ILE . 10.7 t80 -71.46 -43.17 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.514 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.758 ' CB ' HD13 ' A' ' 282' ' ' ILE . 3.8 mtp -61.04 -41.28 96.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.597 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.11 -50.35 74.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.685 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.867 ' O ' HD12 ' A' ' 309' ' ' LEU . 41.9 m -58.45 -33.58 69.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.498 HG21 ' CE1' ' A' ' 302' ' ' TYR . 71.1 t -79.37 -24.46 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.8 -38.61 21.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.683 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 7.7 mt -107.48 -28.34 9.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.497 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 305' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 111.144 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.268 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 316' ' ' LEU . 11.0 mt -103.08 31.22 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -68.48 -29.63 68.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -46.54 85.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -73.83 -43.64 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.8 mt -56.49 -40.57 75.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.56 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.0 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.84 -38.02 76.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 320' ' ' LEU . 54.1 mt -55.96 -48.27 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.321 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 158' ' ' SER . 7.4 mt -80.78 -21.29 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.482 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.75 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.7 tt -81.53 -49.69 10.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.15 -37.31 74.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.98 -27.82 57.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.542 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 159' ' ' LEU . 12.0 mt -68.79 -39.08 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -30.14 69.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.01 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.43 HD11 ' OG ' ' A' ' 333' ' ' SER . 12.0 pt -105.77 -29.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.46 27.25 3.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.43 ' OG ' HD11 ' A' ' 331' ' ' ILE . 2.3 p -114.49 34.04 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.943 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -71.81 89.78 1.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 89.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -101.9 114.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.65 -25.99 11.37 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.04 147.39 29.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD11 ' HD3' ' A' ' 38' ' ' LYS . 20.9 mm -102.29 135.84 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.891 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 13.4 pt -119.84 148.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -95.55 141.46 29.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' CB ' ' HB2' ' A' ' 35' ' ' LYS . 4.1 t70 -83.41 -142.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.27 56.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.1 34.6 24.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.901 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -152.85 19.06 0.6 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' CE2' ' A' ' 37' ' ' TRP . 2.0 mmtt -163.94 175.1 10.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.445 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -151.24 90.44 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 7.3 m95 -94.87 139.96 30.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.209 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD3' HD11 ' A' ' 28' ' ' ILE . 8.7 ttpt -93.14 135.0 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -87.39 138.78 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.67 -118.65 4.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.551 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.4 154.59 47.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.948 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.59 170.69 5.28 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.544 2.163 . . . . 0.0 112.275 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.5 pt -143.9 36.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.562 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.415 HG23 ' HG3' ' A' ' 71' ' ' LYS . 19.0 mt -114.68 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -146.35 172.06 14.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.955 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 69' ' ' VAL . 31.5 mt -77.33 156.33 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -125.67 142.41 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.41 159.72 38.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.1 mtm -99.31 38.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.62 87.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -64.13 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -175.08 -51.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -111.14 -46.55 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.45 178.98 4.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' CE ' ' A' ' 38' ' ' LYS . 21.5 t -94.98 122.64 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.42 -151.56 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.574 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.63 31.34 5.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 80.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.54 137.01 19.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.27 33.25 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.842 2.361 . . . . 0.0 112.775 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -149.82 148.25 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 53' ' ' LEU . 20.5 m -134.86 144.87 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 7.4 p -134.89 132.94 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.557 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 51' ' ' ILE . 1.9 mttp -109.37 120.78 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.844 HG22 ' CB ' ' A' ' 128' ' ' PHE . 14.7 t -113.19 149.07 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.363 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.759 ' HG3' HD23 ' A' ' 80' ' ' LEU . 1.1 mm-40 -133.2 149.86 73.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.679 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 80.32 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.168 . . . . 0.0 112.388 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.1 t 57.04 -168.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 61.39 165.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -124.29 130.81 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.78 -111.45 0.26 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.05 -36.62 85.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.759 HD23 ' HG3' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -67.64 -45.72 74.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -45.79 72.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 p -58.63 -44.17 89.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 2.3 tt0 -68.67 -38.83 80.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' HE2' ' A' ' 129' ' ' MET . 1.9 mt -67.98 -46.57 70.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -56.34 -40.82 75.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.5 t80 -79.66 -29.88 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.743 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -67.71 -52.67 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.434 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -19.61 59.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.437 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -66.33 -47.52 73.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.674 0.273 . . . . 0.0 111.298 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.1 -35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -59.28 -16.99 24.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 125.01 26.88 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.517 0.199 . . . . 0.0 110.84 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.87 -24.89 14.46 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.488 2.125 . . . . 0.0 112.614 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -44.46 91.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.43 -43.77 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 ' CD1' ' A' ' 100' ' ' ILE . 30.0 mt -54.83 -57.6 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.409 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.45 -40.77 62.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.153 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -57.0 -39.65 75.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -77.32 -44.53 29.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.459 ' CD1' HG22 ' A' ' 96' ' ' ILE . 59.6 mt -62.7 -38.8 82.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.63 60.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.414 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -80.52 -36.93 32.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.495 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -105.42 -3.34 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 mttt 58.33 29.31 17.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.857 0.36 . . . . 0.0 110.724 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.49 HD13 HD13 ' A' ' 108' ' ' LEU . 49.9 mt -47.76 -40.41 20.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.206 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' H ' HG23 ' A' ' 100' ' ' ILE . 4.0 tmtp? 69.07 7.81 6.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 68.6 t80 174.62 161.83 0.2 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.751 0.31 . . . . 0.0 110.498 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 167' ' ' TYR . 9.3 tp -153.56 -60.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.07 -0.26 21.02 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.044 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 111' ' ' PRO . 26.7 t -83.33 136.17 43.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.78 0.29 . . . . 0.0 110.929 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 110' ' ' VAL . 15.3 Cg_endo -57.41 143.05 95.11 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.313 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 115.68 26.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -90.42 134.47 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -111.97 -40.83 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.86 -174.5 46.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.824 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.2 t -136.86 153.19 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -131.48 168.29 22.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.28 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 127' ' ' ARG . 52.3 mt -147.93 134.47 19.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 0.0 110.748 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -139.32 135.74 34.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -108.24 135.63 49.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 126.3 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.85 18.3 5.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.38 57.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.895 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -96.04 129.02 43.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.819 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.8 130.31 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.72 136.38 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.809 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -115.25 125.12 52.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.891 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.9 p90 -134.73 159.35 41.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.709 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.561 ' HE2' ' HG ' ' A' ' 84' ' ' LEU . 1.7 ttm -128.06 141.92 51.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.402 HG12 ' CG2' ' A' ' 70' ' ' VAL . 9.3 mt -111.94 111.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.04 173.41 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.73 136.91 21.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -56.94 172.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.235 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CE2' HG11 ' A' ' 196' ' ' VAL . 31.5 m-85 -150.17 162.06 41.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.645 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.6 -84.53 1.58 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.449 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 m -149.68 127.36 11.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.823 0.344 . . . . 0.0 110.719 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.832 ' OD1' HD22 ' A' ' 184' ' ' LEU . 4.9 m-20 -49.0 159.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -69.29 -21.31 63.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.773 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 1.7 pt20 -51.9 -34.13 39.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.379 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -29.63 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.652 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 1.031 HD11 HD11 ' A' ' 185' ' ' LEU . 62.4 mt -73.92 -29.82 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.571 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -59.58 -50.03 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.04 -27.48 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.07 66.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.366 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -97.9 14.96 25.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 87.5 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.95 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.453 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.7 123.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 7.4 m-85 -59.58 -174.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.5 m -119.14 153.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.571 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -54.75 -27.3 40.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 331' ' ' ILE . 10.7 mtpp -74.88 -42.39 57.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 -44.3 53.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.243 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 150' ' ' SER . 59.6 t -55.82 -53.92 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 297' ' ' GLY . 13.5 mt -58.43 -46.93 85.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.966 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -52.85 56.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.992 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.5 -40.1 85.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.636 ' HA ' HD12 ' A' ' 161' ' ' ILE . 52.8 p -59.18 -36.8 75.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.674 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.768 HD21 ' HG2' ' A' ' 321' ' ' ARG . 1.5 tm? -67.94 -44.12 77.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.16 95.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 158' ' ' SER . 10.0 mt -64.3 -36.99 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.551 ' CD1' HD12 ' A' ' 324' ' ' LEU . 11.5 mt -61.58 -38.59 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.49 -41.22 93.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.1 mt -74.89 -41.94 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 168' ' ' ILE . 11.2 mt -56.88 -40.51 76.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HG3' ' CG ' ' A' ' 317' ' ' TYR . 10.6 tt0 -64.96 -37.9 89.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.752 ' CD1' HD21 ' A' ' 108' ' ' LEU . 89.9 t80 -66.41 -53.44 35.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 165' ' ' LEU . 5.3 pt -65.48 -27.04 40.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.42 ' N ' HG13 ' A' ' 168' ' ' ILE . 14.8 m-70 -76.48 -39.84 52.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.498 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.91 -12.32 61.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.62 4.25 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.765 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 70.69 47.09 0.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 126.74 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.682 HG13 ' CD1' ' A' ' 204' ' ' TYR . 27.2 m -133.01 169.27 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.603 ' NE2' HD21 ' A' ' 195' ' ' LEU . 31.6 p-80 -162.37 -47.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.16 59.67 8.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.44 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.77 29.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 161' ' ' ILE . 12.3 mt -64.54 105.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 14.1 tptm -149.84 168.33 24.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.773 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -69.39 0.03 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.065 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 -4.07 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.571 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -124.96 -5.77 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.356 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.885 ' C ' HD23 ' A' ' 184' ' ' LEU . 12.6 mt -108.22 113.51 26.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.244 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -121.14 149.75 42.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -178.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 141' ' ' ILE . 10.3 mt -90.36 149.19 22.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.65 130.54 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.687 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -66.77 -67.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -21.3 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -119.56 67.28 10.17 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.83 97.31 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.1 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -172.5 -38.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.213 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -116.15 174.36 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 138' ' ' LEU . 7.9 p -133.05 136.56 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 3.4 m-85 -106.91 156.88 18.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.2 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.603 HD21 ' NE2' ' A' ' 175' ' ' HIS . 18.8 tp -104.06 115.87 31.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 184' ' ' LEU . 27.8 m -115.37 156.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 56.04 93.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.496 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 5.0 m-85 -79.27 -12.87 59.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 57.01 25.2 53.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -176.5 -62.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.703 0.287 . . . . 0.0 111.014 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 86' ' ' PHE . . . 43.88 82.91 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -142.08 149.01 39.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -82.79 94.34 7.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.682 ' CD1' HG13 ' A' ' 174' ' ' VAL . 35.4 p90 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.725 -0.15 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -91.34 -46.95 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tp -178.11 38.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.197 0.523 . . . . 0.0 110.522 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -94.66 64.85 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.269 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.554 ' HB3' HG23 ' A' ' 246' ' ' ILE . 53.3 m-85 75.29 32.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -72.78 153.89 40.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.3 m -95.88 157.49 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.76 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -59.66 -30.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -48.73 55.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.0 -33.42 74.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.58 -26.1 61.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.83 12.82 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.375 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.52 59.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.591 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 124.85 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 111.041 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.15 118.91 33.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 55.0 Cg_exo -51.97 101.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.403 2.069 . . . . 0.0 112.298 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.8 m -60.68 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.11 -51.51 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.58 ' HB3' HD22 ' A' ' 309' ' ' LEU . 18.0 ptt180 -62.78 -23.91 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.49 -49.55 72.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.692 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 -31.04 63.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.61 HD13 HD11 ' A' ' 320' ' ' LEU . 30.6 mt -72.18 -36.09 69.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.67 -29.89 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 227' ' ' PHE . 42.0 mt -72.39 -42.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.541 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.5 tp -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -62.42 -39.15 97.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.314 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.5 -25.88 45.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -34.57 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.108 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -49.43 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 248' ' ' GLY . 4.0 mt -65.32 -30.26 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.688 ' HB2' HD21 ' A' ' 259' ' ' LEU . 17.6 tm0? -80.04 -37.4 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.4 m0 -82.22 -39.35 23.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.06 -45.39 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.076 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.404 HG21 ' HB3' ' A' ' 289' ' ' CYS . 10.4 p -96.14 0.55 51.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.41 97.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.475 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 m80 65.0 155.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -134.52 172.54 7.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.474 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 61.5 Cg_endo -73.49 58.11 3.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.373 2.049 . . . . 0.0 112.589 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.989 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.1 p90 -180.0 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.306 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -99.04 20.62 13.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 178.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -55.12 23.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.948 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.1 OUTLIER -127.68 -25.27 3.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.452 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.637 HD22 HG23 ' A' ' 225' ' ' ILE . 53.5 mt 69.34 12.74 8.41 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -88.25 -15.48 35.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.083 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.471 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 4.0 t0 -135.12 97.46 13.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 20.73 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.625 2.216 . . . . 0.0 112.944 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -44.85 22.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.789 0.328 . . . . 0.0 110.764 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.0 p90 -83.87 -26.62 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.015 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.746 ' CG1' HD11 ' A' ' 225' ' ' ILE . 16.3 t -61.76 -37.06 77.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -72.11 -44.36 63.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.35 -37.37 77.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.069 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.3 p -72.01 -38.12 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.253 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.512 ' CD ' HG12 ' A' ' 271' ' ' VAL . 0.2 OUTLIER -61.54 -47.53 85.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.14 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 230' ' ' ILE . 28.7 mm -70.29 -29.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.408 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -48.74 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.501 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.6 m-85 -67.33 -40.56 85.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.76 ' HE ' HD13 ' A' ' 230' ' ' ILE . 6.8 tmm_? -50.68 -27.79 7.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.839 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -118.3 22.84 11.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.11 44.04 2.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.987 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 303' ' ' MET . 22.7 mt -53.32 -38.24 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.01 64.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -40.69 86.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 4.2 pp -76.44 -28.34 56.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.408 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 0.0 OUTLIER -66.69 -37.93 85.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.501 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.84 -31.09 28.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -82.68 -49.6 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.093 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' A' ' 256' ' ' THR . 53.4 m -72.06 -41.33 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.47 134.87 22.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.95 165.3 32.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.68 -29.43 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -38.34 75.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -74.49 -177.35 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.25 142.33 25.75 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.55 142.02 61.15 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 155' ' ' LEU . . . -99.1 24.35 32.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.624 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 64.16 17.1 10.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.714 0.292 . . . . 0.0 111.193 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.474 HG22 ' CG ' ' A' ' 303' ' ' MET . 32.2 mm -79.54 -51.99 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.5 -41.91 14.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.307 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -41.77 96.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 306' ' ' VAL . 50.3 t80 -72.05 -44.41 63.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.808 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.721 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.9 mtp -58.26 -39.76 80.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.662 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -65.76 -43.76 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.984 HG21 HD11 ' A' ' 323' ' ' ILE . 0.7 OUTLIER -65.95 -34.54 78.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 302' ' ' TYR . 67.9 t -78.75 -24.39 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.98 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.058 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 pp -102.17 -24.7 13.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.723 ' O ' HD22 ' A' ' 316' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.162 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.779 0.241 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.723 HD22 ' O ' ' A' ' 309' ' ' LEU . 11.2 tp -98.74 29.01 3.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' GLU . 63.1 m-85 -62.66 -30.02 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.52 -45.57 79.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -45.18 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.858 ' HA ' HD12 ' A' ' 323' ' ' ILE . 89.0 mt -56.13 -50.25 71.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.768 ' HG2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -53.72 -50.96 64.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -54.43 -42.35 70.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 305' ' ' THR . 42.6 mt -54.22 -46.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.564 HD13 ' OG ' ' A' ' 158' ' ' SER . 87.4 mt -81.19 -37.26 28.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.839 HD23 HD12 ' A' ' 328' ' ' LEU . 0.4 OUTLIER -63.17 -49.75 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -54.09 -43.57 70.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.035 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.12 67.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.839 HD12 HD23 ' A' ' 325' ' ' LEU . 11.4 mt -59.19 -24.74 63.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.719 0.295 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 18.8 mttm -76.38 -33.94 58.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.37 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.93 -18.72 55.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.039 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 152' ' ' LYS . 1.2 pt -117.07 -34.77 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -116.23 -25.0 3.66 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.347 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 5.4 t 69.71 72.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.84 125.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.85 138.74 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -79.29 113.05 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.75 13.83 15.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.3 161.13 14.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.623 HD13 ' HG3' ' A' ' 38' ' ' LYS . 20.5 mm -112.39 131.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 9.3 pt -119.84 125.55 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.767 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 t -95.55 141.31 29.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.548 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 13.7 m-20 -90.4 -161.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.57 63.06 0.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.9 31.3 18.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.214 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.8 -33.58 8.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.641 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.87 -158.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.28 93.04 1.94 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.737 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -78.08 155.26 30.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.4 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HG3' HD13 ' A' ' 28' ' ' ILE . 4.8 tttm -100.16 117.78 35.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 29' ' ' ILE . 17.4 t -73.01 143.49 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -118.06 -111.07 2.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.598 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.5 mt -96.11 154.37 38.86 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.704 0.288 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 -27.35 52.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 69' ' ' VAL . 46.5 pt 42.48 31.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.49 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.641 0.257 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mt -129.15 137.61 56.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 0.0 111.325 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -146.43 167.87 22.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 68' ' ' CYS . 6.0 mt -89.09 149.55 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.95 146.92 45.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 t70 -137.54 152.23 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtp -96.48 37.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.31 30.12 19.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.95 179.46 6.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.02 171.87 12.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.16 174.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 t -81.41 157.36 25.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.3 130.87 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.15 -90.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.574 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -99.14 30.52 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.05 -44.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 55' ' ' ASP . . . -105.61 88.66 2.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.92 80.91 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 53' ' ' LEU . 73.3 m -149.71 148.19 28.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.552 HG13 ' CG ' ' A' ' 133' ' ' ARG . 5.4 m -119.68 155.37 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG23 HD13 ' A' ' 130' ' ' ILE . 11.8 p -148.13 126.95 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.034 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 116.22 28.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.682 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.882 HG22 ' CB ' ' A' ' 128' ' ' PHE . 21.6 t -122.46 137.63 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 80' ' ' LEU . 2.2 mt-10 -128.69 147.22 63.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.46 83.5 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.89 -63.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.243 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -46.48 131.28 11.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -140.36 80.08 1.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.52 -76.17 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.45 -28.18 32.67 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.616 2.211 . . . . 0.0 112.299 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.698 ' HG ' HD23 ' A' ' 84' ' ' LEU . 9.3 tp -73.08 -33.27 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -30.62 70.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 p -76.13 -37.98 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 59.8 tt0 -74.41 -39.11 62.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.2 mm? -62.5 -52.47 63.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 11.3 t80 -71.03 -45.83 63.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.993 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 5.7 m-85 -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.461 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.43 -48.04 36.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.645 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -87.75 -47.52 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.701 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -77.49 -50.23 13.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.886 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.51 32.32 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.708 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.04 125.91 89.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.48 -28.2 84.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.44 2.094 . . . . 0.0 112.444 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.35 -32.89 43.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.176 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -79.22 -52.65 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.286 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.746 HD11 ' HA ' ' A' ' 91' ' ' ALA . 50.6 mt -56.71 -52.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.6 -50.6 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -64.66 -42.58 95.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -58.53 -54.2 49.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.93 -36.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -75.11 -27.81 59.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.316 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -78.78 -38.74 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.499 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.71 -2.42 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.335 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.12 30.44 18.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 110.643 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.1 mt -50.15 -31.12 12.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.92 -56.62 0.54 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.29 151.46 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.682 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.2 tp -128.92 -66.88 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 138.09 -14.37 3.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.908 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.11 125.29 77.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.629 0.215 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.31 152.76 7.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 112.249 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -80.19 115.48 19.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 13.3 t80 -93.24 115.76 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -91.8 -40.98 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.224 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.79 -174.63 46.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.76 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 p -131.03 158.05 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.02 179.45 20.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.353 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -147.99 158.85 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.961 0.41 . . . . 0.0 111.314 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.62 114.61 11.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.602 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -91.4 142.26 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 123' ' ' GLY . 4.0 tttt -130.57 157.53 42.46 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.98 51.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.632 0.253 . . . . 0.0 111.428 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' LYS . . . 144.2 -18.27 2.11 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.897 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -126.4 142.96 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.68 138.29 46.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.477 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.556 ' O ' HD23 ' A' ' 118' ' ' LEU . 2.7 m-85 -125.7 134.64 51.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.959 0.409 . . . . 0.0 111.334 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -124.13 138.26 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.467 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.882 ' CB ' HG22 ' A' ' 72' ' ' VAL . 23.2 p90 -147.03 168.73 20.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.275 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.789 ' HB2' HD21 ' A' ' 84' ' ' LEU . 7.1 tmm? -136.67 146.44 45.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.656 HD13 HG23 ' A' ' 70' ' ' VAL . 11.6 mm -96.0 135.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -143.49 165.28 27.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.69 130.09 41.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.552 ' CG ' HG13 ' A' ' 69' ' ' VAL . 3.6 ttt-85 -57.73 143.06 43.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -113.14 166.89 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.79 -83.2 1.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -133.92 127.01 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.667 ' CG ' HD22 ' A' ' 184' ' ' LEU . 3.0 m-20 -55.35 155.75 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 1.9 mm? -60.08 -23.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.619 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -65.43 -42.91 91.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.134 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -61.5 -29.89 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.894 HD11 HD11 ' A' ' 185' ' ' LEU . 26.4 mt -75.39 -28.54 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 10.3 t80 -59.53 -49.37 78.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -28.01 67.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.24 -23.1 65.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.326 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 5.7 m-20 -96.4 15.63 20.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.166 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.71 46.4 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.52 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.2 19.45 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 33.3 mtt180 -147.14 -179.09 6.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 153' ' ' THR . 0.1 OUTLIER -132.84 144.59 50.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 p -81.91 155.38 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.36 68.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -71.8 -36.06 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 149' ' ' PHE . 1.7 m -72.75 -42.26 64.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' A' ' 251' ' ' MET . 47.6 t -66.05 -54.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.81 ' HB3' HD21 ' A' ' 328' ' ' LEU . 71.8 mt -54.89 -47.15 74.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.665 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.485 HD22 HG11 ' A' ' 193' ' ' VAL . 17.4 mt -66.17 -41.17 90.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.596 ' CB ' HD13 ' A' ' 324' ' ' LEU . 60.0 m -54.56 -42.4 70.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.699 HD22 ' HG2' ' A' ' 321' ' ' ARG . 88.8 mt -66.49 -39.61 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.459 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -64.97 -46.34 81.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.726 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.85 -34.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.765 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.3 mt -62.34 -35.89 80.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.17 -42.26 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 ' HA3' ' A' ' 109' ' ' GLY . 11.9 mt -71.41 -34.78 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.75 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 162' ' ' LEU . 23.3 mt -58.77 -39.05 79.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.68 -37.23 79.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -66.78 -54.85 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.713 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 43.5 pt -63.12 -27.28 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -77.9 -38.35 45.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.459 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -10.9 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.981 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.51 4.8 26.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.821 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 1.2 mp0 71.5 48.93 0.31 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -139.68 139.05 36.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 204' ' ' TYR . 12.3 m -137.92 169.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 1.4 p80 -147.13 -54.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.497 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 70.28 31.98 68.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.376 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -136.74 81.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.3 mt -115.61 117.85 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -159.42 -176.6 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.619 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.78 1.91 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.479 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.08 1.4 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 110.329 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -124.82 -12.94 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.287 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 5.5 mt -108.48 123.32 48.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.98 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -127.9 160.96 30.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.894 HD11 HD11 ' A' ' 141' ' ' ILE . 22.4 mt -95.04 149.34 21.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.022 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.7 132.58 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.443 ' CD2' ' CD ' ' A' ' 133' ' ' ARG . 22.3 t80 -68.58 -61.83 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.418 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -63.15 -18.51 63.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.24 75.26 74.87 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.55 89.92 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.536 2.157 . . . . 0.0 112.066 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.95 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.107 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.54 149.86 23.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.9 p -112.45 147.99 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.124 0.488 . . . . 0.0 110.736 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 24.7 m-85 -126.47 157.32 38.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.974 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 26.2 tp -103.32 115.83 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.458 HG21 ' CD1' ' A' ' 184' ' ' LEU . 5.2 t -103.56 137.38 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.16 130.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.724 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.5 m-85 -103.02 7.95 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.195 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 80.99 -55.25 4.78 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.17 -32.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.579 0.228 . . . . 0.0 111.53 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.29 94.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.746 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.539 ' O ' HG22 ' A' ' 174' ' ' VAL . 68.1 t80 -126.29 149.06 49.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -98.82 78.18 2.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.768 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.68 ' CD1' HG13 ' A' ' 174' ' ' VAL . 42.2 p90 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.3 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -169.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 265' ' ' LEU . 20.3 tt -139.13 31.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.031 0.443 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HB3' HD11 ' A' ' 265' ' ' LEU . 0.1 OUTLIER -94.63 21.88 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.709 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 179' ' ' LYS . 0.5 OUTLIER 168.58 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.638 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.2 p -60.01 150.14 30.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -177.71 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.442 HD13 HH21 ' A' ' 279' ' ' ARG . 1.3 mp -65.96 -35.43 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.409 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -57.66 -29.89 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.07 77.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -33.57 76.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -86.12 4.4 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.393 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.84 -2.33 83.71 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.884 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.409 HG11 ' OD2' ' A' ' 231' ' ' ASP . 15.9 t -63.77 133.73 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.844 0.354 . . . . 0.0 111.094 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.4 150.13 89.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HG2' ' CB ' ' A' ' 174' ' ' VAL . 37.6 Cg_endo -65.92 -35.01 36.97 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.518 2.146 . . . . 0.0 112.234 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 204' ' ' TYR . 21.1 t 67.62 -69.62 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.6 ttp-105 -166.18 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -71.73 -32.77 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.5 96.25 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.779 ' HA ' HD12 ' A' ' 246' ' ' ILE . 6.4 m-20 -65.31 -43.34 91.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 320' ' ' LEU . 39.9 mt -64.24 -38.51 91.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 306' ' ' VAL . 2.5 tt0 -59.8 -31.02 69.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.0 mt -75.9 -42.38 39.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.67 HD23 ' OH ' ' A' ' 302' ' ' TYR . 18.6 tp -58.77 -46.27 87.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.684 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 252' ' ' ILE . . . -55.77 -25.42 44.12 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.88 -31.53 45.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 97.2 m -54.22 -48.73 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.794 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.63 -30.54 71.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 285' ' ' LEU . 28.9 mm -66.28 -45.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.201 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HB3' ' CG ' ' A' ' 259' ' ' LEU . 0.0 OUTLIER -80.01 -27.37 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.512 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.433 ' CE3' HG13 ' A' ' 154' ' ' VAL . 17.2 m0 -76.99 -32.66 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.434 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.15 -35.51 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 289' ' ' CYS . 1.8 m -96.27 0.59 51.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.599 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.35 96.29 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.332 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 33.4 m80 61.74 154.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.95 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -121.68 164.26 25.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.823 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 60.0 Cg_endo -72.62 57.64 3.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.641 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.95 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.8 p90 179.35 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' A' ' 259' ' ' LEU . 14.9 tt0 -92.47 13.44 19.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.553 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -59.4 5.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 4.6 m-80 -129.95 -26.17 2.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.417 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.771 HD11 ' HB3' ' A' ' 226' ' ' GLU . 83.6 mt 72.75 11.19 5.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -16.22 49.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.222 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -132.16 99.97 15.9 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.791 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.95 12.07 2.78 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -49.98 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.9 p90 -79.92 -26.23 40.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 15.1 t -60.67 -45.73 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 276' ' ' ILE . 0.6 OUTLIER -74.37 -31.96 62.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.039 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.13 -47.79 33.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.174 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.407 ' HB3' ' CE2' ' A' ' 278' ' ' TYR . 1.5 m -66.84 -35.99 81.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -64.77 -49.62 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.201 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 272' ' ' ARG . 21.7 mt -66.91 -30.14 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -52.05 7.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.597 ' CD1' HD12 ' A' ' 285' ' ' LEU . 10.7 m-85 -56.68 -31.96 64.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.442 HH21 HD13 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -59.08 -27.86 65.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.66 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -130.07 30.29 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -150.19 38.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.763 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.2 mt -52.98 -49.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.03 -49.6 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.3 p -65.33 -31.6 72.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.277 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.597 HD12 ' CD1' ' A' ' 278' ' ' TYR . 1.4 tt -68.7 -38.42 80.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.488 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' PHE . 0.0 OUTLIER -65.42 -38.16 89.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.809 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -25.68 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -82.75 -54.9 4.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.403 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.472 ' O ' HG23 ' A' ' 256' ' ' THR . 0.1 OUTLIER -68.84 -41.3 78.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' MET . 19.4 m-85 -102.26 152.74 38.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -51.03 -61.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.663 2.242 . . . . 0.0 112.462 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -146.53 -45.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.013 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 63.62 56.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -65.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.744 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -62.42 -56.55 29.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 295' ' ' LYS . 18.6 Cg_endo -60.08 -164.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.4 2.066 . . . . 0.0 112.235 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 135.14 37.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.543 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.557 ' HG3' HD11 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -87.75 -33.86 18.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.495 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.757 HD12 ' HG3' ' A' ' 251' ' ' MET . 20.2 mm -74.68 -46.61 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.27 -45.69 17.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -61.71 -38.82 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.489 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.88 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.0 t80 -70.05 -43.36 71.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.873 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.763 ' CB ' HD13 ' A' ' 282' ' ' ILE . 4.5 mtp -65.51 -37.2 86.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -51.38 70.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.617 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.43 HG21 HD11 ' A' ' 323' ' ' ILE . 82.3 p -60.96 -34.72 75.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 302' ' ' TYR . 39.6 t -73.36 -24.66 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.191 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -76.67 -31.89 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.4 mt -104.33 -10.9 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.065 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 N--CA 1.466 -0.119 0 CA-C-O 120.765 0.236 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 316' ' ' LEU . 1.3 pt? -144.87 53.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -56.04 -32.81 64.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -63.27 -34.34 77.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 316' ' ' LEU . 2.8 t30 -70.82 -44.38 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 323' ' ' ILE . 68.1 mt -56.27 -45.43 80.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.699 ' HG2' HD22 ' A' ' 159' ' ' LEU . 13.8 ttt180 -58.45 -47.56 83.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -39.42 81.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 320' ' ' LEU . 33.7 mt -57.12 -44.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.6 HD22 HD23 ' A' ' 155' ' ' LEU . 53.8 mt -78.28 -48.21 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -60.4 -49.86 75.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -58.52 -40.36 82.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.77 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.08 -29.29 59.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.399 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.1 mt -65.01 -39.47 93.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -30.72 69.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.1 pt -106.59 27.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.18 38.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.6 164.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -176.76 37.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.814 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.615 ' OD2' HD12 ' A' ' 328' ' ' LEU . 8.7 m-20 -78.31 85.13 4.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 65.03 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 25.8 71.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.593 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.77 137.56 41.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 36' ' ' GLU . 11.4 mt -105.18 141.29 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.934 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.7 pt -119.91 154.61 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.2 m -95.49 139.47 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.675 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 17.0 p-10 -98.3 -149.81 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.0 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -38.09 18.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.402 . . . . 0.0 110.324 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.99 -0.12 33.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.837 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER 85.02 16.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.289 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.77 173.52 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.611 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -122.69 78.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 110.532 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.46 128.56 37.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -88.21 124.02 33.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 24' ' ' ALA . 21.2 t -81.53 122.65 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.14 -121.56 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD23 ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -116.52 164.56 17.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.696 ' HD2' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -71.07 118.43 5.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.542 2.161 . . . . 0.0 112.279 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 53' ' ' LEU . 1.6 pt -107.02 30.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 6.4 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.7 mp -88.69 104.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.678 ' O ' HG12 ' A' ' 70' ' ' VAL . 23.3 m-85 -129.55 163.59 25.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 43' ' ' ILE . 50.4 mt -73.29 165.91 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -138.5 152.46 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.273 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -136.34 159.74 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.29 29.85 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 t30 58.97 -168.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t 61.56 45.27 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -169.03 126.33 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.988 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.39 116.11 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m 60.75 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 21.8 t -59.24 -57.36 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -151.37 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.551 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 m -100.84 37.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.02 30.67 5.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -85.72 119.55 72.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -87.5 30.17 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.797 2.331 . . . . 0.0 112.927 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.76 148.13 28.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.77 HG13 ' CG ' ' A' ' 133' ' ' ARG . 2.8 m -119.12 153.88 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 52' ' ' TYR . 6.7 p -137.67 134.59 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -121.58 116.76 25.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.68 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.859 HG22 ' CB ' ' A' ' 128' ' ' PHE . 7.8 t -113.37 149.54 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -137.57 136.19 20.03 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.892 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 32.6 Cg_exo -57.93 82.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.514 2.143 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 53.62 29.67 9.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.9 120.77 33.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.61 41.52 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.1 -79.09 1.43 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.09 -43.41 2.4 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.538 2.159 . . . . 0.0 112.35 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HG ' HD23 ' A' ' 84' ' ' LEU . 24.9 tp -60.13 -30.1 69.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.46 -32.3 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.7 p -77.76 -31.7 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -68.33 -46.58 69.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.1 mm? -66.01 -45.82 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -60.35 -29.67 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.876 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.5 m-85 -65.9 -60.3 2.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -17.84 64.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.773 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -18.99 60.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.59 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -62.22 -15.28 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -47.95 130.2 11.88 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.0 -24.32 19.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -79.32 -33.2 43.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.4 -42.51 25.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.8 mt -65.72 -55.26 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -50.76 -31.94 18.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -34.67 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.28 -46.06 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 105' ' ' LEU . 41.5 mm -64.48 -36.52 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.238 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -75.01 -27.72 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -76.65 -38.8 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.342 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -105.46 -3.73 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.254 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 100' ' ' ILE . 16.7 tttt 60.09 30.9 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 100' ' ' ILE . 43.8 mt -49.93 -32.08 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.253 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -55.91 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.98 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -142.21 138.59 31.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.758 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.739 HD21 ' CG ' ' A' ' 167' ' ' TYR . 13.2 tp -114.68 -66.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 132.46 -7.21 5.3 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.822 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.7 t -71.66 136.0 83.38 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.666 0.233 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.5 142.58 80.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.59 2.193 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.97 121.72 26.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -98.7 131.36 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -110.39 -40.83 4.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.065 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.97 -174.58 46.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.655 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -132.97 164.05 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -149.24 174.65 28.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.275 -0.965 . . . . 0.0 113.168 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 127' ' ' ARG . 3.3 mt -145.23 145.15 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.716 0.293 . . . . 0.0 110.741 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -121.81 135.8 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -113.65 121.44 44.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -138.2 126.24 22.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 55.93 20.6 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.364 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.98 -4.99 61.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.903 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -96.04 129.08 43.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 110.776 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.4 t -100.44 122.99 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -105.81 143.59 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.755 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.644 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -107.31 129.27 54.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.934 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.2 p90 -141.52 159.24 42.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.442 ' HB2' HD21 ' A' ' 84' ' ' LEU . 8.1 tmm? -128.13 147.59 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 29' ' ' ILE . 20.2 mt -123.32 112.76 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 111.377 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -121.96 173.3 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.94 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.99 149.66 2.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.77 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.51 168.09 13.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 184' ' ' LEU . 80.6 m-85 -141.46 160.82 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.808 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.77 -94.57 0.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.96 130.69 55.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.827 ' OD1' HD22 ' A' ' 184' ' ' LEU . 6.0 m-20 -57.67 159.83 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.734 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -59.4 -31.01 68.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.585 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -59.44 -45.14 92.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.387 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.49 70.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.378 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 138' ' ' LEU . 10.9 mt -80.17 -26.94 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.454 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 16.3 t80 -66.88 -50.84 61.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -29.31 68.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.572 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.5 -24.7 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.084 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-80 -94.47 15.66 17.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.84 45.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.14 19.71 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.326 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 23.9 mtm180 -145.17 -175.63 4.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.1 OUTLIER -141.93 171.17 14.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 153' ' ' THR . 3.4 m -97.08 157.64 15.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.585 ' HA ' HD21 ' A' ' 255' ' ' LEU . 7.5 mtm-85 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -72.54 -42.62 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 150' ' ' SER . 18.6 p -60.75 -43.63 97.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' A' ' 251' ' ' MET . 38.7 t -65.89 -49.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 331' ' ' ILE . 33.2 mt -60.52 -47.28 86.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -59.83 -46.78 88.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.498 HD22 HG11 ' A' ' 193' ' ' VAL . 27.6 mt -69.97 -43.54 71.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD13 ' A' ' 324' ' ' LEU . 51.2 p -54.4 -34.42 61.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.4 mt -74.71 -41.41 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -45.74 77.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.688 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.4 mt -63.65 -34.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.762 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.507 HD11 ' HE2' ' A' ' 302' ' ' TYR . 9.7 mt -64.38 -40.19 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -38.27 84.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.52 -39.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 47.7 mt -59.11 -45.07 91.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.591 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -66.7 -33.95 76.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.658 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.739 ' CG ' HD21 ' A' ' 108' ' ' LEU . 60.6 t80 -65.51 -51.85 57.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.618 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.0 pt -72.28 -27.28 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.537 ' CE1' HG12 ' A' ' 174' ' ' VAL . 1.5 m-70 -76.16 -32.48 59.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -16.93 62.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -101.38 3.61 40.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.818 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 78.08 45.36 0.07 Allowed 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.088 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -134.31 142.31 47.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.507 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.586 HG22 ' HD1' ' A' ' 204' ' ' TYR . 28.9 m -142.22 138.88 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.138 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.91 -67.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 81.31 36.54 20.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.626 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.87 -89.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.96 -0.141 . . . . 0.0 110.919 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.0 mp 41.38 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.832 0.349 . . . . 0.0 111.718 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 24.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.297 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . 65.96 9.86 6.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.65 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.8 p -113.63 1.48 14.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.47 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.2 m120 -134.71 4.76 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.146 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 1.9 mt -108.48 117.71 34.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.719 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.827 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -126.78 146.66 50.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.347 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 141' ' ' ILE . 21.9 mt -89.84 149.66 22.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.84 128.01 34.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.446 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 19.7 t80 -71.0 -58.82 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -21.6 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.603 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -129.24 71.08 82.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 86.25 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.52 2.147 . . . . 0.0 112.126 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -177.98 37.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -178.15 172.37 1.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.388 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.505 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.1 p -132.64 147.63 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.391 . . . . 0.0 110.693 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 22.6 m-85 -127.27 156.88 41.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.986 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 183' ' ' LEU . 10.8 tp -103.93 115.83 31.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.514 HG21 HD11 ' A' ' 184' ' ' LEU . 16.6 m -107.41 179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.32 108.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.709 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 15.8 m-85 -117.39 28.18 8.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 200' ' ' LEU . . . -54.01 -28.74 41.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.966 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 199' ' ' GLY . 10.9 mp -115.63 11.67 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 110.947 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -100.24 68.38 1.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.239 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -126.21 149.37 49.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.253 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 39.5 ttp180 -54.26 96.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.586 ' HD1' HG22 ' A' ' 174' ' ' VAL . 44.6 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -140.96 -178.34 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.798 HG12 HG11 ' A' ' 271' ' ' VAL . 8.7 tt -133.74 10.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.347 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 265' ' ' LEU . 27.4 tt0 -67.74 -13.67 62.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.313 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.493 ' HB3' HG23 ' A' ' 246' ' ' ILE . 8.5 m-85 -165.14 29.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.68 130.45 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.54 -47.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.236 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.0 mt -57.03 -59.27 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.153 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.65 -28.18 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.17 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -57.4 -27.61 62.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.299 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.689 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.0 OUTLIER -101.53 1.87 38.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.341 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.52 21.1 40.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.686 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 234' ' ' ASN . 26.4 t -80.51 158.5 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 111.086 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.484 ' N ' HG12 ' A' ' 236' ' ' VAL . . . -80.72 130.65 63.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.44 74.51 3.68 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 204' ' ' TYR . 0.6 OUTLIER -77.39 73.31 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.003 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 73.25 -57.62 0.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.334 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -58.94 -28.49 66.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -80.21 -33.97 30.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.528 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.9 -44.65 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.88 -44.4 86.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.299 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.28 -29.32 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 227' ' ' PHE . 73.0 mt -76.02 -37.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.758 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.8 tp -66.44 -36.28 82.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.23 -28.02 72.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.41 -25.93 46.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 62.7 m -66.62 -32.84 74.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.011 0.434 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.677 ' HA ' HG11 ' A' ' 154' ' ' VAL . 1.1 mmm -60.24 -52.59 64.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.174 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -74.17 -38.55 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.625 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.567 ' HB2' HD21 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -64.71 -39.95 94.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.219 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 38.5 m0 -82.28 -32.34 29.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.504 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 151' ' ' ARG . 56.9 mt -83.58 -37.37 23.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 111.475 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.9 m -96.21 -9.25 30.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.499 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.1 94.35 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.444 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 18.8 m80 62.28 150.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 253' ' ' GLN . 0.3 OUTLIER -111.24 158.49 35.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.69 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.457 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 45.2 Cg_endo -68.32 61.94 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.557 2.171 . . . . 0.0 112.413 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.631 ' HB2' HG22 ' A' ' 271' ' ' VAL . 4.8 p90 175.64 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.463 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.9 tt0 -88.61 10.91 18.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.34 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.3 -47.61 81.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -131.97 -28.32 1.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.399 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.607 HD22 HG23 ' A' ' 225' ' ' ILE . 67.5 mt 71.55 11.29 6.52 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -16.25 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.278 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -131.23 100.75 16.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.94 13.38 2.36 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.638 2.225 . . . . 0.0 112.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -73.73 -46.66 44.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.5 p90 -83.92 -26.44 29.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.798 HG11 HG12 ' A' ' 225' ' ' ILE . 28.7 t -63.03 -39.59 85.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.092 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -52.62 10.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.312 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 75.2 m -56.21 -40.22 73.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.331 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.6 -44.67 93.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 27.9 mm -71.1 -33.08 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.734 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -81.08 -52.17 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -61.99 -35.42 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.024 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -26.5 42.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.359 . . . . 0.0 110.751 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -118.28 20.6 13.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -142.52 45.34 1.62 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.083 0.468 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' CB ' ' A' ' 303' ' ' MET . 26.7 mt -50.45 -40.17 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.65 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.174 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.96 -38.37 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.1 pp -74.01 -39.69 63.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.478 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 8.5 mtt -69.0 -44.29 73.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -39.02 92.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.91 -24.87 32.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.889 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 75.9 m -92.02 -41.35 10.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.66 0.267 . . . . 0.0 111.713 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.74 155.27 58.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.45 179.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.634 2.223 . . . . 0.0 112.278 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -111.25 67.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.67 88.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.9 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 61.41 153.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -93.26 121.7 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.15 -61.91 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.54 -24.53 30.26 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.02 -64.37 0.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.465 HG23 ' HG3' ' A' ' 251' ' ' MET . 25.8 mm -72.96 -43.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.02 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.51 -42.16 10.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.506 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.49 93.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 306' ' ' VAL . 25.6 t80 -69.51 -40.07 77.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.727 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.9 mtp -68.31 -38.6 81.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.68 -45.36 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.76 ' HB ' HD21 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -64.98 -32.88 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.389 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.904 ' HA ' HD12 ' A' ' 309' ' ' LEU . 36.5 t -77.24 -24.88 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -37.72 42.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.164 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.53 -14.54 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.363 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.894 0.289 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.76 HD21 ' HB ' ' A' ' 305' ' ' THR . 0.3 OUTLIER -80.27 -22.28 41.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.086 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.43 ' CG ' ' HG2' ' A' ' 166' ' ' GLU . 34.0 m-85 -52.84 -39.43 62.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 111.047 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.63 -36.48 78.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.0 -45.89 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 323' ' ' ILE . 35.9 mt -56.47 -38.24 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.032 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -43.62 88.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.34 -35.54 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 320' ' ' LEU . 70.9 mt -58.35 -47.12 88.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.025 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.789 HD13 ' OG ' ' A' ' 158' ' ' SER . 47.4 mt -73.64 -51.63 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -56.34 -49.71 73.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.192 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.53 -39.89 74.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -28.14 72.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.722 HD12 HD23 ' A' ' 325' ' ' LEU . 81.3 mt -60.05 -32.52 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -66.88 -30.2 70.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.87 -18.89 55.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.532 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 331' ' ' ILE . 1.3 pp -143.8 84.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 111.333 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 127.23 -33.9 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.704 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.38 101.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.6 mttm 61.71 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 328' ' ' LEU . 0.8 OUTLIER -128.82 115.79 18.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.892 0.377 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.19 110.49 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.82 25.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.554 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 28' ' ' ILE . 2.2 mt-10 -55.62 177.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 27' ' ' GLU . 28.1 mm -130.41 131.31 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 28.9 pt -118.41 154.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.1 t -95.54 138.49 33.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.977 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -95.2 -160.92 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -77.18 -43.8 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 109.967 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.84 -2.2 35.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER 87.31 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' THR . 11.4 mtpt -74.13 178.19 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.64 77.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' HB2' HG13 ' A' ' 29' ' ' ILE . 67.2 m95 -72.75 141.76 48.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 127.88 46.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.974 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 40' ' ' GLY . 31.7 t -92.83 158.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 39' ' ' VAL . . . -123.91 -125.13 2.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.555 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.81 164.03 37.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.473 ' O ' HG23 ' A' ' 43' ' ' ILE . 65.3 Cg_exo -51.28 -180.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.544 2.162 . . . . 0.0 112.387 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 53' ' ' LEU . 15.0 pt -157.37 -43.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.215 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 43' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 1.9 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.947 0.403 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.07 115.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 15.4 m-85 -140.17 165.2 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 43' ' ' ILE . 4.0 mt -70.97 156.71 39.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.15 159.39 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.075 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.12 155.63 40.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.3 ptm -101.07 38.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.92 111.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -175.22 3.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 p -64.93 -45.45 85.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -179.04 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.24 -175.68 5.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.47 146.29 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' HD13 ' A' ' 53' ' ' LEU . . . 170.02 -89.37 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -89.45 -30.35 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.98 53.26 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.48 96.31 41.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.52 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.691 2.261 . . . . 0.0 113.025 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.1 m -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 133' ' ' ARG . 16.2 m -119.33 158.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.727 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HG12 ' A' ' 130' ' ' ILE . 7.8 p -140.34 129.9 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -111.1 123.61 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.451 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 128' ' ' PHE . 18.0 t -113.13 141.69 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.472 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.38 133.79 24.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.605 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 88.12 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.439 2.093 . . . . 0.0 112.326 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m 54.44 -171.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 60.42 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -135.36 -178.22 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.18 -82.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.43 -41.64 6.31 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.62 2.213 . . . . 0.0 112.374 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.718 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.0 tp -65.46 -30.64 71.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -32.72 72.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.421 HG21 ' CA ' ' A' ' 200' ' ' LEU . 1.4 m -78.37 -43.34 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.6 tt0 -64.07 -46.36 84.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.718 HD23 ' HG ' ' A' ' 80' ' ' LEU . 2.7 mm? -61.6 -51.15 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -51.9 66.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 198' ' ' TYR . 15.5 t80 -63.99 -33.73 76.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-85 -72.47 -46.23 55.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -27.17 65.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.7 -47.45 8.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' A' ' 171' ' ' HIS . . . -103.06 -33.68 9.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -91.96 26.87 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.9 133.74 65.36 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.33 -32.84 89.95 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -37.11 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.157 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -58.01 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.795 HD11 ' HA ' ' A' ' 91' ' ' ALA . 54.3 mt -53.27 -49.38 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.56 -43.34 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 111.089 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 102' ' ' THR . 0.2 OUTLIER -70.76 -28.6 64.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -51.06 11.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.703 HG23 ' C ' ' A' ' 105' ' ' LEU . 27.0 mm -57.2 -37.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.257 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -74.86 -27.8 60.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.402 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' LYS . 15.4 p -82.15 -38.77 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -1.63 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.456 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 32.84 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.703 ' C ' HG23 ' A' ' 100' ' ' ILE . 11.8 mt -83.2 58.94 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.58 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.92 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.653 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.18 122.05 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.91 0.386 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 167' ' ' TYR . 12.6 tp -121.86 159.77 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.558 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.47 17.09 57.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.86 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.19 127.12 43.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.594 0.197 . . . . 0.0 111.072 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.05 141.15 48.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.281 1.987 . . . . 0.0 112.283 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.47 115.43 22.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -96.88 127.63 43.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.706 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 7.2 m95 -103.04 -40.81 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -177.68 46.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.595 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -135.32 161.79 34.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.607 0.241 . . . . 0.0 110.545 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -153.79 -179.42 29.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.647 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 127' ' ' ARG . 3.3 mp -145.32 159.83 42.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.037 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -132.11 141.7 49.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.831 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.43 125.29 47.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 126.2 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 51.89 23.82 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.89 21.24 40.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.58 159.33 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.769 0.318 . . . . 0.0 110.71 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m -112.74 120.5 41.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -118.18 121.34 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.788 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 118' ' ' LEU . 3.7 mtt180 -107.77 129.28 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.54 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 24.0 p90 -140.04 160.3 40.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 111.235 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.653 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.6 tmm? -128.16 140.03 52.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.401 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.403 HG12 ' CG2' ' A' ' 70' ' ' VAL . 12.9 mt -110.63 111.82 37.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.453 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -127.82 173.22 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.27 141.68 45.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 69' ' ' VAL . 60.4 ttt-85 -73.81 161.92 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.418 ' CD2' HD12 ' A' ' 184' ' ' LEU . 79.1 m-85 -130.96 170.38 14.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.97 -52.16 1.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.6 m -157.93 171.89 19.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -98.82 153.73 18.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.2 mm? -60.03 -33.47 72.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.728 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -61.73 -46.52 89.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.848 0.356 . . . . 0.0 110.282 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -58.71 -28.57 65.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' ' 138' ' ' LEU . 35.1 mt -75.32 -26.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -58.13 -47.65 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.683 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.28 -26.74 68.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.791 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.85 -20.93 61.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 17.0 m120 -94.57 4.19 54.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 85.32 45.86 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.043 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 19.77 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.273 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -162.99 117.43 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.56 -172.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -121.43 158.08 29.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.738 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -34.1 73.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.669 ' CB ' HD13 ' A' ' 331' ' ' ILE . 10.6 pttt -74.71 -37.74 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.7 m -73.7 -40.75 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 150' ' ' SER . 38.5 t -68.04 -44.51 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.542 HD11 ' HG2' ' A' ' 298' ' ' GLU . 22.9 mt -58.33 -54.26 49.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -56.99 -46.99 81.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 193' ' ' VAL . 39.0 mt -65.76 -38.41 88.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.431 ' CB ' HD13 ' A' ' 324' ' ' LEU . 66.3 m -56.87 -34.11 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.708 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 321' ' ' ARG . 9.7 mt -73.31 -45.5 55.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -61.73 -45.07 95.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.791 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.74 ' HA ' HD12 ' A' ' 164' ' ' ILE . 18.3 mt -65.83 -33.04 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.932 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.534 HD23 HD12 ' A' ' 165' ' ' LEU . 11.0 mt -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -40.62 91.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 161' ' ' ILE . 4.0 mt -67.94 -42.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.551 HD22 ' OD2' ' A' ' 243' ' ' ASP . 89.6 mt -55.12 -43.77 74.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.973 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 317' ' ' TYR . 2.1 tt0 -66.0 -37.3 85.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.799 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.489 ' CG ' HD21 ' A' ' 108' ' ' LEU . 79.1 t80 -70.82 -54.66 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.81 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.42 HD13 ' HE2' ' A' ' 198' ' ' TYR . 38.1 pt -59.01 -27.6 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.174 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.51 ' CE1' HG12 ' A' ' 174' ' ' VAL . 2.2 m80 -69.05 -44.17 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.19 -14.45 61.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -99.03 2.87 46.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 72.89 43.05 0.44 Allowed 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.094 0.473 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.727 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 0.7 OUTLIER -140.88 110.38 6.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 204' ' ' TYR . 19.3 m -131.16 139.48 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.619 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.417 ' CD2' ' O ' ' A' ' 198' ' ' TYR . 2.0 t60 -175.76 160.26 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.534 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.842 ' HA3' HD13 ' A' ' 246' ' ' ILE . . . -109.43 71.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.612 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 30.98 2.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.642 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mt -100.74 94.49 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -152.65 24.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.27 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.728 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 68.2 8.21 6.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.806 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -110.48 0.24 17.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -141.65 7.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.791 ' C ' HD23 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -108.66 114.45 28.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.048 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -124.75 148.16 48.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 141' ' ' ILE . 6.6 mt -95.03 149.25 21.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.949 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 1.0 OUTLIER -89.38 132.37 35.0 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.111 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -122.21 -31.38 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -24.29 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.796 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.528 ' CB ' ' HD3' ' A' ' 190' ' ' PRO . 0.7 OUTLIER -166.16 -57.86 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.772 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 189' ' ' ASN . 24.3 Cg_exo -61.25 -133.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.306 2.004 . . . . 0.0 112.376 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 186' ' ' ASN . 0.2 OUTLIER 171.92 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.247 -0.283 . . . . 0.0 111.72 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 1.2 mt-30 -85.95 -169.13 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -109.58 147.94 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 11.0 m-85 -129.5 151.42 50.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.035 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.747 HD23 ' CZ ' ' A' ' 198' ' ' TYR . 14.2 tp -104.04 115.97 31.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.508 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.3 131.88 60.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 20.0 t0 62.61 124.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.747 ' CZ ' HD23 ' A' ' 195' ' ' LEU . 10.1 m-85 -105.45 14.85 28.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.201 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.611 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 83.08 -55.28 5.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.626 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 199' ' ' GLY . 6.8 mp -139.18 -42.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.649 0.261 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 173' ' ' TYR . . . 64.17 101.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.688 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.825 ' CZ ' ' HB1' ' A' ' 237' ' ' ALA . 44.4 t80 -115.73 148.99 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.983 0.42 . . . . 0.0 111.017 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -95.57 78.21 3.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 174' ' ' VAL . 7.8 p90 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.524 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 226' ' ' GLU . 0.2 OUTLIER 60.79 65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.916 0.388 . . . . 0.0 110.88 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.92 HG23 HD22 ' A' ' 265' ' ' LEU . 6.2 tp -60.63 -18.46 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 224' ' ' THR . 1.6 pt-20 -59.92 -30.86 69.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.547 ' HB3' HG23 ' A' ' 246' ' ' ILE . 24.8 m-85 -149.25 34.87 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.305 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.705 HG22 HD12 ' A' ' 225' ' ' ILE . 12.6 t -81.51 116.83 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.303 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 m -64.85 153.43 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.62 -30.45 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 -40.28 74.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.88 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.53 -25.52 64.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.4 7.56 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 78.56 23.42 64.96 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.714 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.72 128.19 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.825 ' HB1' ' CZ ' ' A' ' 202' ' ' TYR . . . -82.7 -53.71 0.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 40.6 Cg_exo -56.88 94.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.466 2.111 . . . . 0.0 112.225 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 m -106.48 120.07 40.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.427 ' HG3' ' CD2' ' A' ' 204' ' ' TYR . 7.8 mtm105 -125.61 -47.8 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.44 -14.12 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.52 -49.68 71.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.692 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD2' HD22 ' A' ' 165' ' ' LEU . 1.5 m-20 -54.53 -38.99 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 320' ' ' LEU . 57.8 mt -74.44 -42.55 58.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.79 -35.13 72.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.842 HD13 ' HA3' ' A' ' 176' ' ' GLY . 11.7 mt -70.18 -44.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.504 HD23 ' OH ' ' A' ' 302' ' ' TYR . 23.8 tp -59.43 -41.47 89.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -60.57 -31.37 74.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.177 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -78.33 -25.72 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 67.2 m -68.03 -32.92 73.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.768 ' O ' HD12 ' A' ' 255' ' ' LEU . 1.7 mmm -58.54 -53.48 57.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.198 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.7 mp -76.93 -39.86 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.754 ' HB2' HD21 ' A' ' 259' ' ' LEU . 14.6 tm0? -59.28 -40.15 85.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -82.43 -46.17 13.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 251' ' ' MET . 6.9 mt -72.89 -25.87 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.8 m -104.5 0.67 29.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.3 88.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.374 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.5 m170 62.9 163.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.859 HD22 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -131.45 164.26 43.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.713 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.72 62.54 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.419 2.079 . . . . 0.0 112.407 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.859 ' CZ2' HD22 ' A' ' 259' ' ' LEU . 4.0 p90 177.24 -37.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.154 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.3 tt0 -91.88 12.58 21.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.316 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.76 -53.76 54.25 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.3 m-20 -131.38 -29.1 1.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.367 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.92 HD22 HG23 ' A' ' 225' ' ' ILE . 54.6 mt 73.89 9.87 4.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -77.02 -16.03 59.42 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.161 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.46 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.7 m-20 -136.21 99.89 10.79 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.799 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.12 16.63 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.647 2.231 . . . . 0.0 112.768 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -79.95 -44.93 19.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.347 . . . . 0.0 110.775 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 3.4 p90 -80.55 -26.21 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 261' ' ' TRP . 27.6 t -62.96 -38.08 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.261 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -75.65 -47.32 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.114 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -52.17 62.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.33 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.6 m -55.52 -39.44 70.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.361 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.56 -44.88 96.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.356 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.5 mt -70.71 -31.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.595 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -81.06 -45.5 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 0.0 111.466 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.2 m-85 -70.85 -34.13 71.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.54 -31.39 62.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.365 . . . . 0.0 110.667 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.31 16.87 23.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.952 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -139.73 44.45 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.753 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.803 HD13 ' CB ' ' A' ' 303' ' ' MET . 30.5 mt -50.58 -39.1 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.89 -27.85 61.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -38.36 27.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.6 pp -73.25 -39.36 65.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.419 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 10.6 mtt -71.16 -38.28 72.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.2 -41.22 97.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -24.81 33.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.3 m -89.78 -41.16 12.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.575 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.17 150.76 37.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.89 178.88 4.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.209 . . . . 0.0 112.291 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.87 30.66 4.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -88.57 -32.2 18.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -134.86 169.64 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.82 138.82 19.9 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 50.5 Cg_exo -53.51 121.24 9.14 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.317 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -147.98 -54.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.542 ' HG2' HD11 ' A' ' 155' ' ' LEU . 5.7 mp0 -62.93 -61.57 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.91 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 251' ' ' MET . 18.0 mm -76.02 -43.34 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.07 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -46.07 -47.92 17.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -59.31 -37.74 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.865 ' O ' HG23 ' A' ' 306' ' ' VAL . 85.6 t80 -72.11 -40.68 67.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.761 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.803 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.5 mtp -68.3 -41.06 81.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.632 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.4 -47.55 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 3.3 p -60.64 -36.52 78.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 302' ' ' TYR . 26.1 t -74.89 -24.72 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.022 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -30.94 54.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.52 -8.77 18.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.727 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.191 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 CA-C-O 120.828 0.262 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.17 25.73 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 166' ' ' GLU . 86.7 m-85 -64.75 -34.19 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.35 -30.9 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.05 -46.01 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.946 ' HA ' HD12 ' A' ' 323' ' ' ILE . 62.1 mt -57.88 -48.86 78.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.426 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -57.95 -30.64 66.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.05 -41.34 35.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 320' ' ' LEU . 17.4 mt -54.62 -41.38 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 162' ' ' LEU . 96.0 mt -75.8 -49.8 17.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.08 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.702 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -58.02 -49.92 75.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.192 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -58.51 -42.27 87.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.01 56.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.456 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 325' ' ' LEU . 25.2 mt -62.67 -28.76 70.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.732 0.301 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 4.0 mtmt -67.7 -28.54 67.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 298' ' ' GLU . . . -77.89 -18.69 55.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.666 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 152' ' ' LYS . 1.4 pp -114.12 16.95 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 108.27 43.22 1.29 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.251 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 17.7 m 58.76 177.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.218 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HB2' HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -79.64 145.79 32.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.885 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.35 162.68 11.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.699 HG22 ' HG ' ' A' ' 41' ' ' LEU . 17.0 t -68.12 120.75 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.16 -24.78 29.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.6 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.16 153.52 14.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 36' ' ' GLU . 34.8 mt -123.05 140.11 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 25.8 pt -119.64 154.67 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 6.7 p -95.38 141.33 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.21 -161.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.64 -37.4 36.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.759 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -83.2 4.5 26.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.3 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 77.19 30.0 0.55 Allowed 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 1.4 mtpp -76.17 175.82 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.032 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HB2' HG21 ' A' ' 28' ' ' ILE . 7.9 pt-20 -122.32 77.34 1.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 0.0 110.678 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HB2' HG13 ' A' ' 29' ' ' ILE . 78.7 m95 -71.89 128.3 35.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.972 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -86.42 127.97 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.05 125.21 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.42 -125.6 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.555 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 25' ' ' VAL . 5.0 mp -117.76 156.92 49.26 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.99 131.35 19.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.586 2.191 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 pt -104.85 -36.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.555 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.878 0.37 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 71' ' ' LYS . 23.4 mm -96.86 122.97 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.096 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -145.91 168.28 21.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 133' ' ' ARG . 19.3 mt -82.26 154.81 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.35 157.79 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -138.23 154.86 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.56 51.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 60.51 101.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.99 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -121.81 179.43 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 144.49 32.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 67.5 -72.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.11 -169.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 55' ' ' ASP . 21.2 t -98.89 94.48 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.0 -91.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.532 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.94 30.44 4.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.33 65.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.7 94.48 48.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.76 36.46 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.286 2.657 . . . . 0.0 112.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.72 148.24 29.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.57 144.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.059 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.5 p -134.4 123.62 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' HD12 ' A' ' 51' ' ' ILE . 12.2 mttp -105.44 124.22 49.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG22 ' CB ' ' A' ' 128' ' ' PHE . 15.9 t -113.96 141.62 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.07 150.62 59.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.66 86.0 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.517 2.145 . . . . 0.0 112.215 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.6 -71.5 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -161.37 99.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -110.55 -26.26 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.6 -154.65 7.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.597 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.27 24.84 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.301 2.667 . . . . 0.0 112.687 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.77 -42.29 92.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.14 -44.11 95.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -67.22 -34.34 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.34 -42.91 74.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.5 mm? -57.57 -52.08 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -46.07 78.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.54 -30.74 67.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.621 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -67.56 -46.98 71.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.083 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 1.1 tt0 -79.88 -17.61 52.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.552 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -47.64 60.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.757 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 -34.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -53.95 -20.8 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 40.1 mtpt -47.46 138.29 8.76 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.659 0.266 . . . . 0.0 111.035 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.7 -18.31 47.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.496 2.131 . . . . 0.0 112.393 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.34 -35.9 40.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -79.3 -45.77 19.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 100' ' ' ILE . 62.2 mt -61.05 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -55.45 -33.68 63.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -38.98 63.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -68.95 -42.07 77.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 96' ' ' ILE . 27.3 mt -65.51 -37.5 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.042 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.79 60.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.4 m -80.97 -37.73 28.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.514 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.43 -3.51 20.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.43 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 59.96 31.85 20.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 110.657 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 100' ' ' ILE . 13.2 mt -52.4 -28.45 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mttm 76.33 -56.13 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -145.79 154.27 41.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 167' ' ' TYR . 1.5 tp -127.55 -72.88 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.612 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 127.31 1.03 6.77 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.007 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 164' ' ' ILE . 33.5 t -76.2 128.5 82.64 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.843 0.321 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.81 143.0 9.79 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -84.25 116.88 23.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.709 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -111.99 -40.68 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.94 -175.95 46.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.95 162.1 35.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.675 0.274 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.15 -175.05 21.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.65 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -145.26 158.9 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -131.84 133.85 45.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -107.79 122.6 47.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 126.22 22.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 57.73 19.51 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.275 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.29 -0.15 61.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.897 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 129.09 47.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -96.14 131.62 42.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.63 148.88 39.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -111.4 125.27 53.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.948 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 10.8 p90 -132.24 160.23 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.847 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -128.12 142.64 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 mt -116.24 116.76 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.299 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -128.88 173.16 10.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.36 144.57 20.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.049 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.574 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -59.18 179.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.992 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -151.69 145.47 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.73 -107.87 0.82 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -113.4 130.25 56.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.802 ' OD1' HD22 ' A' ' 184' ' ' LEU . 19.9 m-20 -57.76 155.91 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.5 mm? -61.04 -23.14 65.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.733 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.7 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 20.4 pt20 -68.61 -42.0 78.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.904 0.383 . . . . 0.0 110.409 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -62.8 -35.36 79.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.039 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 138' ' ' LEU . 5.2 mt -78.28 -28.52 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 254' ' ' TRP . 48.4 t80 -61.16 -52.43 64.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.8 -30.42 56.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.96 -16.44 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.637 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -87.81 -2.93 58.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.135 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 95.74 41.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.063 0.545 . . . . 0.0 110.327 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 61.53 19.13 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.541 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -167.04 125.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.129 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.493 ' CD1' HG21 ' A' ' 153' ' ' THR . 0.3 OUTLIER -81.78 -176.88 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 154' ' ' VAL . 17.9 p -113.95 -176.91 3.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -71.8 -33.9 68.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -65.9 -48.08 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.493 HG21 ' CD1' ' A' ' 149' ' ' PHE . 14.3 p -63.44 -40.22 96.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 150' ' ' SER . 47.6 t -70.78 -53.82 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.848 ' HB3' HD21 ' A' ' 328' ' ' LEU . 94.4 mt -57.21 -46.91 82.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -52.8 61.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.555 HD22 HG11 ' A' ' 193' ' ' VAL . 16.6 mt -62.28 -37.01 83.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.772 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 247' ' ' LEU . 38.5 m -58.13 -37.94 75.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 324' ' ' LEU . 35.0 mt -67.58 -48.01 68.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.91 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 178' ' ' ILE . 11.9 mt -62.75 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.5 mt -64.84 -35.08 79.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.62 -38.3 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.612 HD11 ' HA3' ' A' ' 109' ' ' GLY . 33.4 mt -74.54 -42.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 162' ' ' LEU . 6.9 mt -56.29 -43.13 78.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 32.1 tt0 -66.93 -32.78 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.8 ' CG ' HD21 ' A' ' 108' ' ' LEU . 88.9 t80 -68.22 -50.32 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.554 HD13 ' NE2' ' A' ' 175' ' ' HIS . 26.0 pt -73.41 -27.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 174' ' ' VAL . 3.6 m-70 -68.46 -32.37 72.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.299 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.98 -17.1 62.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.51 4.74 38.94 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CG ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 77.1 5.34 3.25 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.488 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 203' ' ' ARG . 4.6 m-85 -94.24 132.77 38.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.723 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 204' ' ' TYR . 30.4 m -142.37 139.06 29.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.071 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.554 ' NE2' HD13 ' A' ' 168' ' ' ILE . 3.0 p80 -115.67 -40.91 3.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.346 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 59.32 19.11 45.55 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.632 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.07 61.35 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 161' ' ' ILE . 3.9 mp -94.51 102.56 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.657 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 183' ' ' LEU . 6.2 mtmm -146.68 -175.48 4.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.687 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.7 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -84.75 3.08 39.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.6 p -106.15 -2.82 22.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.05 -2.89 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.351 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.76 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.1 mt -108.32 122.68 47.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.802 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.2 OUTLIER -131.64 160.63 34.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.76 0.314 . . . . 0.0 110.999 -178.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.5 147.08 23.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 111.194 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.406 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 0.2 OUTLIER -60.98 131.64 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -78.12 -53.72 7.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.77 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.843 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.15 71.81 18.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.969 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.65 101.91 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.16 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -178.0 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -113.24 159.11 19.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.555 HG11 HD22 ' A' ' 157' ' ' LEU . 3.3 p -110.21 148.29 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.99 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 13.0 m-85 -125.95 157.63 37.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.008 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.453 HD23 ' HE1' ' A' ' 198' ' ' TYR . 34.3 tp -103.32 115.97 31.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 184' ' ' LEU . 2.3 t -118.18 157.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 54.52 103.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.601 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 48.7 m-85 -97.91 -64.31 1.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.678 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 95.31 -37.66 3.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 199' ' ' GLY . 7.3 mp -128.74 22.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.601 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -78.39 60.97 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.166 0.508 . . . . 0.0 110.536 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -124.33 149.03 47.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.193 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -55.49 97.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.968 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' HG22 ' A' ' 174' ' ' VAL . 47.6 p90 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 -63.28 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -161.65 -44.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HG2' HD13 ' A' ' 225' ' ' ILE . 14.3 mm-40 -159.26 27.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.405 ' CE2' ' HD3' ' A' ' 179' ' ' LYS . 2.7 t80 -94.63 23.8 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -141.86 -72.85 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.519 ' H ' HG23 ' A' ' 228' ' ' THR . 0.9 OUTLIER -167.99 150.32 5.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.347 . . . . 0.0 111.035 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.23 -31.57 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.5 -31.46 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.22 -30.24 63.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -75.66 -29.33 59.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.08 12.91 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.461 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.45 26.31 74.38 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.534 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.63 144.63 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 111.036 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -58.17 145.13 74.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.83 -36.28 18.86 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.414 2.076 . . . . 0.0 112.23 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.6 m 59.55 33.77 22.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -56.14 0.65 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.555 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -21.76 56.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.145 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -59.03 -32.1 70.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 165' ' ' LEU . 2.5 t0 -78.68 -29.23 45.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.79 HD13 HD11 ' A' ' 320' ' ' LEU . 18.8 mt -73.84 -29.77 62.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.011 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.3 -31.98 62.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.428 HD13 ' HA2' ' A' ' 176' ' ' GLY . 2.6 mp -76.1 -38.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 158' ' ' SER . 55.2 tp -73.92 -31.23 62.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.64 -47.69 80.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.559 ' HA ' HD12 ' A' ' 252' ' ' ILE . 51.3 m-85 -78.49 -25.88 45.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 -41.44 70.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.139 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.426 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -60.27 -48.63 80.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.8 ' O ' HG22 ' A' ' 256' ' ' THR . 2.9 mt -66.37 -28.48 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.037 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.635 ' HB2' HD21 ' A' ' 259' ' ' LEU . 12.7 tm0? -80.1 -36.86 34.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.475 ' CD1' ' CE1' ' A' ' 142' ' ' TYR . 20.8 m0 -82.38 -29.89 30.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.426 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.2 mt -67.21 -47.09 71.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.392 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 252' ' ' ILE . 6.1 t -98.71 -23.35 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.327 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.442 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 101.79 14.99 27.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.817 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 166.62 170.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.851 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -133.6 159.56 72.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 261' ' ' TRP . 15.7 Cg_exo -68.33 59.97 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.748 2.299 . . . . 0.0 112.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.851 ' CH2' HD22 ' A' ' 259' ' ' LEU . 16.2 p90 177.34 -42.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.106 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -95.63 17.2 15.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.529 179.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -58.33 -51.61 69.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.5 t-20 -130.51 -25.92 2.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 77.2 mt 70.03 13.7 7.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.239 0.543 . . . . 0.0 109.611 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -89.81 -14.99 33.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.253 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.477 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 0.5 OUTLIER -134.98 88.61 26.47 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.93 -8.09 22.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.614 2.209 . . . . 0.0 112.664 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -54.56 -50.07 68.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.751 0.31 . . . . 0.0 111.189 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 5.7 p90 -81.73 -26.18 34.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 225' ' ' ILE . 59.4 t -60.06 -44.33 94.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.473 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -68.89 -42.27 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -36.55 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.1 m -65.61 -43.67 88.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.9 OUTLIER -62.93 -44.58 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.69 -29.68 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.435 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -49.82 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.403 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 13.2 m-85 -64.5 -39.94 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.468 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -26.33 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.28 19.07 15.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -143.81 49.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 303' ' ' MET . 16.6 mt -54.11 -35.22 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.348 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.82 -29.79 62.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 111.067 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.9 pp -73.9 -29.69 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.413 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 4.9 mmt -64.85 -47.47 77.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.01 -20.93 44.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -82.7 -50.86 8.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.694 0.283 . . . . 0.0 111.399 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.87 -41.13 30.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.334 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.63 98.92 16.04 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.084 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.92 84.72 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.474 2.116 . . . . 0.0 112.046 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.6 97.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.642 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 56.18 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -161.84 -51.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -151.16 104.74 2.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 -49.1 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.367 2.045 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.62 30.22 0.03 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER 68.39 7.92 6.29 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.737 0.268 . . . . 0.0 111.664 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.624 HG22 ' CG ' ' A' ' 303' ' ' MET . 28.8 mm -79.57 -46.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.413 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.25 -35.81 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.523 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 323' ' ' ILE . 15.1 mmtp -68.48 -41.49 80.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 306' ' ' VAL . 11.5 t80 -72.11 -34.32 68.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.748 ' CB ' HD13 ' A' ' 282' ' ' ILE . 65.3 mmm -71.78 -48.22 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 305' ' ' THR . 21.4 pt-20 -56.28 -41.41 75.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 309' ' ' LEU . 12.1 m -64.44 -42.19 96.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 302' ' ' TYR . 41.2 t -69.55 -24.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.144 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -71.65 -37.29 70.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 73.7 mt -97.53 -13.53 21.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.607 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.745 HD21 ' HA ' ' A' ' 316' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.952 0.313 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.745 ' HA ' HD21 ' A' ' 309' ' ' LEU . 5.3 tt -127.93 -74.86 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.646 ' N ' HD23 ' A' ' 316' ' ' LEU . 35.2 m-85 -70.68 -38.03 73.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.84 -46.58 84.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.066 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.433 HD22 HD11 ' A' ' 323' ' ' ILE . 3.3 t30 -73.33 -45.94 52.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 323' ' ' ILE . 52.1 mt -58.76 -51.84 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.66 -42.03 70.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -62.36 -46.76 87.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 320' ' ' LEU . 13.9 mt -51.03 -47.28 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.624 HD22 HD23 ' A' ' 155' ' ' LEU . 52.6 mt -71.54 -48.88 45.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.025 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.31 -49.97 72.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.372 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -39.09 79.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.805 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.01 -33.25 68.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 155' ' ' LEU . 11.3 mt -67.98 -38.6 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.42 -30.78 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -30.86 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.17 26.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.83 25.94 38.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.728 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 m -91.92 158.34 16.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 179.12 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.7 102.27 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.53 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.89 -28.82 12.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.51 149.51 49.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.864 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 36' ' ' GLU . 33.6 mt -117.61 136.85 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.95 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 30.0 pt -111.67 154.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -95.3 141.38 28.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -160.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.094 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.21 -42.97 29.77 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.073 0.463 . . . . 0.0 109.971 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -82.22 2.14 33.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.707 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 23.5 tttp 87.6 28.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -69.51 176.52 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.231 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.529 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.4 mp0 -127.86 78.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.898 0.38 . . . . 0.0 110.589 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' HE3' ' HB1' ' A' ' 54' ' ' ALA . 34.7 m95 -76.39 131.39 39.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -92.43 124.38 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.4 t -75.45 142.34 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -134.58 8.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.74 161.82 22.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' ILE . 51.7 Cg_exo -54.43 173.69 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.521 2.147 . . . . 0.0 112.322 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 42' ' ' PRO . 10.5 pt -160.08 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.71 118.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -146.37 171.97 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 7.4 mt -77.29 156.91 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . . . -115.45 147.62 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.2 t0 -138.46 159.61 41.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -118.68 72.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.659 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 64.43 -77.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 59.15 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -80.13 60.76 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.59 148.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 m 59.48 170.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 55' ' ' ASP . 36.1 t -118.1 -53.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.45 -169.94 30.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.528 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 t -103.59 39.99 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -156.37 82.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -120.97 137.61 26.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -87.99 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.985 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 77.2 m -149.7 148.29 29.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.565 HG13 ' CG ' ' A' ' 133' ' ' ARG . 28.6 m -128.74 144.88 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 130' ' ' ILE . 8.0 p -131.57 124.38 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HD2' HD13 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -109.55 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.638 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 128' ' ' PHE . 4.7 t -113.41 144.3 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.15 140.7 21.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.36 109.31 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.507 2.138 . . . . 0.0 112.314 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.71 178.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -87.17 -171.25 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.84 113.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.4 -168.12 30.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.416 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 -44.49 46.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 112.251 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' A' ' 84' ' ' LEU . 13.6 tp -70.12 -30.08 67.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -60.87 -36.78 80.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.2 p -70.63 -36.66 73.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -70.73 -48.4 54.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.2 mm? -58.26 -43.07 87.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -49.9 75.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' CD2' ' A' ' 198' ' ' TYR . 29.8 t80 -70.43 -39.63 74.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.575 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -54.86 -42.97 72.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -77.26 -17.78 58.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.372 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -82.64 -26.77 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.378 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.58 ' HB1' ' HE2' ' A' ' 167' ' ' TYR . . . -139.88 -44.62 0.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.664 0.268 . . . . 0.0 111.719 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -66.04 -11.63 49.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.778 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -47.22 133.62 9.39 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.527 0.203 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.3 -30.57 26.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.538 2.159 . . . . 0.0 112.632 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -31.33 42.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.58 -40.56 66.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 91' ' ' ALA . 24.0 mm -67.3 -57.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -53.49 -27.15 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.301 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -73.96 -55.99 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.03 -47.24 78.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.812 HG23 ' H ' ' A' ' 106' ' ' LYS . 36.3 mm -56.9 -43.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -75.17 -27.64 59.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.1 m -78.79 -38.81 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.612 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -4.72 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.459 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 100' ' ' ILE . 6.8 mttm 59.64 26.96 16.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 108' ' ' LEU . 3.5 mt -54.24 -47.13 72.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.812 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER 59.22 36.18 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.913 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -176.84 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp 71.96 -63.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.34 12.46 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.823 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 108' ' ' LEU . 24.0 t -81.08 138.97 49.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.56 0.219 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HD2' ' CG1' ' A' ' 110' ' ' VAL . 84.6 Cg_exo -46.42 146.38 5.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 112.399 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 115.52 23.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.289 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.2 127.85 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.565 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -112.33 -40.89 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.82 174.9 41.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.606 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.92 173.33 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.417 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.444 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -156.94 178.0 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.764 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 126' ' ' TYR . 1.7 mp -147.93 159.87 43.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 116.57 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.69 124.38 36.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.26 126.29 22.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.4 t30 59.67 17.27 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.535 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.44 56.57 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.916 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 129.03 43.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.819 0.342 . . . . 0.0 110.682 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.3 t -91.15 124.32 35.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.044 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.489 ' O ' HD23 ' A' ' 118' ' ' LEU . 4.2 m-85 -97.73 147.74 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -125.1 125.13 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.95 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 16.5 p90 -138.28 163.11 32.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.756 ' HB2' HD21 ' A' ' 84' ' ' LEU . 9.4 tmm? -128.1 148.62 50.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.709 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 HG12 HG23 ' A' ' 70' ' ' VAL . 19.8 mt -123.39 112.74 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.249 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -123.08 173.27 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -54.19 142.67 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.089 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.565 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -80.26 156.31 26.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -120.36 155.42 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.06 -80.14 1.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -131.65 131.19 42.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -58.87 159.78 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -62.12 -23.91 66.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.626 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -64.27 -42.05 96.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -64.02 -29.7 70.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.298 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 185' ' ' LEU . 12.0 mt -81.5 -29.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 254' ' ' TRP . 18.2 t80 -70.92 -48.89 51.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.806 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.38 -29.81 65.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.44 -24.75 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.578 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -95.2 16.16 17.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.14 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 84.04 46.94 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.153 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.67 20.12 11.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.249 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.13 176.8 8.38 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.93 -169.3 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -116.65 145.2 43.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -30.43 65.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -71.18 -36.43 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.17 -41.12 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 251' ' ' MET . 45.3 t -55.91 -54.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.834 HD12 HD11 ' A' ' 331' ' ' ILE . 61.5 mt -64.18 -37.23 86.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.47 -44.71 74.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.733 HD22 HG11 ' A' ' 193' ' ' VAL . 34.4 mt -71.04 -47.81 56.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.597 ' HA ' HD12 ' A' ' 161' ' ' ILE . 43.8 p -53.38 -37.61 62.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.637 HD11 ' HG ' ' A' ' 325' ' ' LEU . 1.7 mt -68.17 -48.13 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.665 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -38.4 82.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.9 mt -68.57 -37.39 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 165' ' ' LEU . 12.1 mt -60.8 -36.96 80.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -37.94 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.496 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 110' ' ' VAL . 19.0 mt -75.18 -39.0 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 162' ' ' LEU . 46.2 mt -59.32 -43.08 92.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.607 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.0 -34.9 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.592 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.58 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 88.2 t80 -67.84 -52.49 36.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.5 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.1 pt -67.19 -29.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.995 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -75.09 -34.23 61.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.418 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.95 -16.89 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.44 40.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 77.49 43.9 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.69 140.34 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 31.0 m -126.07 138.92 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 45.6 t-80 -159.48 92.48 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.897 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.661 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -93.64 38.61 3.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.284 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 t0 -97.39 34.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.483 HG12 HG21 ' A' ' 161' ' ' ILE . 3.8 mp -74.39 114.46 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.924 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -160.38 -179.12 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.21 -2.09 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.412 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.4 m -107.28 -0.62 22.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.498 ' O ' HG22 ' A' ' 196' ' ' VAL . 73.7 m-80 -127.5 -5.21 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.783 ' C ' HD23 ' A' ' 184' ' ' LEU . 13.0 mt -108.49 118.69 37.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.062 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -126.07 156.68 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 141' ' ' ILE . 6.5 mt -99.11 149.65 22.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 191' ' ' ASP . 14.0 m-20 -73.47 135.63 44.11 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.836 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.455 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 9.0 t80 -71.48 -68.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 -15.13 23.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.746 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.59 ' CB ' ' HD2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -76.5 -168.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 189' ' ' ASN . 39.9 Cg_exo -39.85 -27.38 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.563 2.175 . . . . 0.0 113.913 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 1.1 t70 88.08 5.03 0.25 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.663 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -72.82 -167.58 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 157' ' ' LEU . 2.5 p -109.96 147.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.163 0.506 . . . . 0.0 111.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 15.7 m-85 -131.41 157.25 43.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.559 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 58.0 tp -103.62 115.79 31.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.679 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 182' ' ' ASN . 28.4 m -105.67 -175.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.421 ' OD1' HG23 ' A' ' 196' ' ' VAL . 4.1 m-20 60.85 98.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.628 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.89 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 13.1 m-85 -109.87 30.53 6.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -53.72 -24.67 26.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.254 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -114.15 -4.27 13.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.538 0.209 . . . . 0.0 111.064 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.89 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -77.12 59.39 1.71 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 110.689 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.49 149.05 52.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -53.11 93.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.067 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.3 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 228' ' ' THR . 33.3 p -59.95 -176.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 0.0 110.772 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.706 HG12 HG11 ' A' ' 271' ' ' VAL . 7.3 tt -101.11 -21.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' A' ' 265' ' ' LEU . 15.0 pt-20 -52.71 -22.96 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 246' ' ' ILE . 63.1 m-85 -142.53 30.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.322 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.405 HG21 HG13 ' A' ' 225' ' ' ILE . 13.4 t -85.6 146.59 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.95 159.0 19.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.5 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.49 -42.98 82.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.29 66.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.196 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.84 -25.56 63.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.318 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -96.33 0.12 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.45 58.57 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.706 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.73 122.59 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.83 158.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 55.6 Cg_endo -69.9 -171.23 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.6 2.2 . . . . 0.0 112.299 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.06 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -73.95 -54.18 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -83.36 -16.89 44.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.84 92.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.902 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.8 p30 -58.61 -28.79 65.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.309 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 320' ' ' LEU . 70.3 mt -76.6 -34.81 58.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -32.35 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 243' ' ' ASP . 13.4 mt -66.65 -44.81 89.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.02 -36.56 83.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.521 ' O ' ' HE1' ' A' ' 303' ' ' MET . . . -59.21 -47.32 91.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.428 ' HA ' HD12 ' A' ' 252' ' ' ILE . 38.6 m-85 -78.58 -25.69 45.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.297 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -39.06 72.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.03 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.644 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -64.25 -50.04 69.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.892 ' O ' HG22 ' A' ' 256' ' ' THR . 3.4 mt -65.74 -29.21 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.981 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.447 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -68.92 -47.55 65.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.447 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 16.2 m0 -82.34 -26.88 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.405 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 290' ' ' PHE . 11.5 mt -67.05 -49.34 65.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.386 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 252' ' ' ILE . 13.1 t -101.53 -11.48 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 92.75 108.07 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.306 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 25.8 p80 48.18 -175.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.9 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -135.02 154.61 79.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 48.8 Cg_endo -68.77 61.62 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.098 . . . . 0.0 112.166 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.9 ' CH2' HD22 ' A' ' 259' ' ' LEU . 8.4 p90 177.45 -36.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.676 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -89.26 14.44 11.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.535 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.11 -42.12 97.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -129.33 -29.33 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.277 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 226' ' ' GLU . 87.7 mt 69.59 13.65 8.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -88.19 -14.94 37.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.361 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.0 94.73 14.16 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 59.9 Cg_endo -72.01 -4.43 15.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.545 2.163 . . . . 0.0 112.643 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -53.21 -49.95 65.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.581 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.2 p90 -83.6 -26.07 30.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.008 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.706 HG11 HG12 ' A' ' 225' ' ' ILE . 61.4 t -59.84 -44.38 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -75.51 -36.88 60.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.296 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.84 -43.24 80.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.285 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -36.57 84.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.413 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -66.4 -50.33 63.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.212 -179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.93 -28.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.352 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -52.13 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.184 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.963 ' CD1' HD12 ' A' ' 285' ' ' LEU . 4.4 m-85 -57.99 -37.03 73.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.77 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -55.52 -26.99 46.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 28.63 5.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.74 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -146.64 41.58 1.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 4.2 mm -53.73 -45.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -70.36 -39.55 74.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -70.94 -29.54 65.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.963 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.3 tt -67.38 -50.89 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.565 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.1 mmt -62.03 -36.82 82.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -19.96 61.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -46.48 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.455 ' SG ' HG21 ' A' ' 256' ' ' THR . 4.7 m -93.69 -41.18 9.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.383 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 255' ' ' LEU . 16.6 m-85 -99.11 107.28 43.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.934 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.66 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.454 2.102 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.59 -25.18 38.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.2 -49.88 70.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.69 104.86 17.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -66.36 139.35 96.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.17 -174.09 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.541 2.161 . . . . 0.0 112.26 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 138.77 -43.05 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.322 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -74.74 -70.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.656 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.603 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.8 mm -79.57 -49.72 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.993 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.565 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -44.62 -31.31 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.651 ' HG2' HG23 ' A' ' 323' ' ' ILE . 14.1 ttpt -76.68 -36.46 57.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.619 ' CE2' HD22 ' A' ' 320' ' ' LEU . 17.9 t80 -76.15 -34.3 59.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.603 ' CG ' HG22 ' A' ' 299' ' ' ILE . 56.5 mmm -74.16 -42.13 60.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 305' ' ' THR . 11.7 pt-20 -64.11 -40.74 96.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.669 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.646 HG21 HD11 ' A' ' 323' ' ' ILE . 1.7 p -66.8 -36.05 81.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.676 ' HA ' HD12 ' A' ' 309' ' ' LEU . 74.4 t -79.64 -24.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -32.93 41.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.22 -25.24 10.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.853 0.272 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 319' ' ' ASN . 0.1 OUTLIER -96.39 22.99 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.06 -35.84 81.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.16 -37.05 84.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.631 ' HB3' HD23 ' A' ' 316' ' ' LEU . 4.1 t-20 -77.33 -45.43 26.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 323' ' ' ILE . 56.4 mt -51.04 -43.25 60.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -57.62 -35.74 70.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -35.45 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 301' ' ' LYS . 73.9 mt -55.86 -51.49 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.553 HD13 ' OG ' ' A' ' 158' ' ' SER . 73.5 mt -66.36 -48.9 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.001 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.637 ' HG ' HD11 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -54.76 -49.94 69.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.363 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.6 -40.28 86.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.14 65.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 155' ' ' LEU . 47.1 mt -61.08 -34.96 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -59.74 -31.47 69.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.24 48.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.834 HD11 HD12 ' A' ' 155' ' ' LEU . 1.4 pp -143.77 84.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.412 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.29 -42.69 1.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.724 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 t 65.31 87.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 61.0 156.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -75.53 153.44 37.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.995 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 41' ' ' LEU . 21.4 t 66.02 104.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.62 37.16 31.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.623 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -136.34 152.13 50.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.787 HD11 ' HE3' ' A' ' 38' ' ' LYS . 17.2 mm -116.98 139.21 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.469 HG13 ' HB2' ' A' ' 37' ' ' TRP . 4.7 pt -119.74 154.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 34.6 m -95.55 141.33 29.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.996 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 1.1 t70 -93.77 -160.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.03 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.4 ttm -77.67 -41.69 37.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.86 0.15 36.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.589 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 3.1 mttp 87.24 27.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -70.34 179.25 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.06 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.16 79.59 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.469 ' HB2' HG13 ' A' ' 29' ' ' ILE . 69.6 m95 -73.49 137.66 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.907 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD11 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -91.66 134.49 34.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.012 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.89 143.72 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.02 -130.64 7.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -102.51 159.13 30.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.914 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.57 111.18 2.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.533 2.155 . . . . 0.0 112.063 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG12 ' A' ' 69' ' ' VAL . 13.4 pt -106.43 -37.9 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 3.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.37 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 3.6 mp -98.9 136.68 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.387 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.517 ' O ' HG12 ' A' ' 70' ' ' VAL . 19.6 m-85 -140.45 170.3 16.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.663 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.22 152.45 42.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -127.08 153.93 45.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.318 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -143.8 150.45 38.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.789 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 mtm -99.45 45.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m120 59.84 -177.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 m 61.28 45.15 9.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -163.51 -43.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 69.93 -66.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -87.62 86.97 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.48 88.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.85 36.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.3 p -147.55 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -155.44 80.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.21 71.58 3.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 86.28 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.7 t -148.83 148.13 29.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 HD11 ' A' ' 43' ' ' ILE . 6.1 m -128.27 153.47 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.048 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 52' ' ' TYR . 5.4 p -142.79 119.37 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -103.65 117.42 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 128' ' ' PHE . 11.8 t -118.95 152.05 21.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -139.08 135.77 17.69 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.636 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 83.4 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.303 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.23 -171.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.09 156.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -78.99 177.6 8.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.47 -162.87 29.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.23 32.78 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.708 2.272 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -60.61 -30.84 70.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.41 -37.15 86.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.019 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -33.13 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.7 -40.9 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 129' ' ' MET . 1.4 mt -76.91 -37.62 55.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -59.56 -40.3 86.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 8.5 t80 -82.83 -29.81 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -64.4 -51.91 60.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.122 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.59 -17.3 61.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.434 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.67 -47.51 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -120.07 -22.61 6.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.5 23.8 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -73.16 113.18 19.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.37 -33.31 36.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.454 2.102 . . . . 0.0 112.591 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.68 -39.01 77.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.32 -47.27 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.314 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.2 mt -57.58 -57.54 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.44 62.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -64.39 -47.42 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -60.3 -55.05 38.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.254 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 105' ' ' LEU . 70.0 mt -56.33 -36.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.01 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -74.96 -27.7 60.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.8 m -81.75 -36.61 28.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -2.54 26.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.81 30.77 20.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.676 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 100' ' ' ILE . 29.7 mt -49.57 -31.7 11.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.54 -55.57 0.52 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.83 129.11 13.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.895 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp -99.22 -66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.74 9.5 6.91 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.064 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.8 138.78 27.76 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.826 0.313 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 71.9 Cg_exo -50.8 151.41 11.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.525 2.15 . . . . 0.0 112.406 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.08 115.58 27.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -99.78 126.96 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.562 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -105.95 -40.87 5.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 111.028 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 -174.72 46.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.597 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 p -134.86 159.42 41.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.77 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -138.59 173.37 22.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.828 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 117' ' ' GLY . 3.0 mt -148.04 158.07 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.3 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -145.83 138.61 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.74 123.84 48.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.678 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -138.26 126.23 22.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.22 22.68 2.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.414 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.11 3.51 63.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.719 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -96.08 128.92 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.5 m -89.39 125.82 35.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.09 125.9 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.76 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.91 125.21 51.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.899 ' CB ' HG22 ' A' ' 72' ' ' VAL . 14.6 p90 -140.31 165.72 26.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 111.407 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.436 ' HG3' HD21 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -131.89 147.14 52.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.49 HG22 ' SG ' ' A' ' 68' ' ' CYS . 16.9 mt -123.28 111.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 111.4 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -126.66 173.46 9.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.975 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.98 144.82 3.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HG3' HG13 ' A' ' 69' ' ' VAL . 69.4 ttt-85 -88.42 -25.56 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.566 ' CD2' HD12 ' A' ' 184' ' ' LEU . 80.7 m-85 65.08 178.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.02 -108.15 1.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.59 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -107.02 127.85 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.545 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.3 p30 -58.26 157.65 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 0.9 OUTLIER -60.83 -23.6 65.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.693 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.1 OUTLIER -61.57 -41.03 96.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.97 0.414 . . . . 0.0 110.084 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -34.99 79.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.405 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.526 HG22 ' CE1' ' A' ' 149' ' ' PHE . 3.1 mt -81.35 -25.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 11.9 t80 -67.71 -53.62 26.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -29.46 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.706 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.27 -20.29 62.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.311 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.0 m-20 -98.93 18.17 17.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.18 47.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 63.0 19.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.474 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -147.21 -173.97 4.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -130.96 -169.11 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.778 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 154' ' ' VAL . 37.9 t -113.25 150.24 32.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HA ' HD21 ' A' ' 255' ' ' LEU . 2.5 ttm-85 -59.25 -31.49 69.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -40.98 60.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 150' ' ' SER . 44.6 p -65.47 -43.3 90.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 150' ' ' SER . 29.5 t -59.88 -52.31 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 328' ' ' LEU . 12.6 mt -63.11 -48.04 80.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -59.91 -50.4 73.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 193' ' ' VAL . 13.4 mt -59.68 -40.26 87.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.731 ' HB2' HD13 ' A' ' 324' ' ' LEU . 64.7 m -56.03 -40.93 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.9 -48.04 78.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -47.42 85.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 164' ' ' ILE . 27.1 mt -66.59 -35.09 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.8 mt -58.79 -39.87 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.759 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.47 -32.03 72.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 161' ' ' ILE . 16.4 mt -77.11 -43.33 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 178' ' ' ILE . 75.3 mt -58.52 -39.33 79.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -71.15 -31.39 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.672 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.93 -54.74 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.8 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.2 pt -60.11 -30.11 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.25 -37.28 74.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 110.36 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -16.89 62.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.565 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 2.1 t60 -101.68 6.12 41.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.965 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 77.88 46.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.07 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.51 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 47.2 m-85 -141.54 119.42 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.584 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.93 164.19 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.675 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.06 50.23 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.43 -18.18 49.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.866 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 69.1 79.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 110.846 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.656 ' CG2' HD11 ' A' ' 183' ' ' LEU . 4.0 mp -86.06 115.36 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -155.94 172.87 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.824 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.693 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.81 -2.76 34.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.549 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.22 2.1 16.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.844 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -127.95 -6.76 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.363 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.802 ' O ' HD23 ' A' ' 184' ' ' LEU . 11.0 mt -108.63 127.51 54.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.946 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -134.49 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.123 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.487 HD23 ' HB ' ' A' ' 193' ' ' VAL . 40.9 mt -87.82 149.47 24.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.43 130.31 42.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -82.76 -50.79 8.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -21.07 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -148.3 77.78 9.68 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.74 88.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.78 35.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 174.84 149.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 157' ' ' LEU . 4.9 p -109.97 147.95 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.104 0.478 . . . . 0.0 111.025 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 4.6 m-85 -117.09 156.86 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -105.63 115.86 30.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.691 HG21 HD11 ' A' ' 184' ' ' LEU . 5.6 m -124.2 162.11 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.107 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.28 70.91 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 201' ' ' ALA . 12.8 m-85 -73.23 -60.39 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 92.51 -33.55 4.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.361 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.08 21.29 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.021 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 198' ' ' TYR . . . -83.35 59.15 4.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.06 0.457 . . . . 0.0 110.615 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.81 149.33 50.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.133 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -58.6 99.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 54.4 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.495 -179.696 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.5 m -92.6 -71.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.9 tp -176.74 30.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -102.75 67.57 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.346 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 226' ' ' GLU . 34.3 m-85 72.26 41.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.645 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -102.34 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.785 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -79.99 145.9 32.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.717 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -58.13 -30.8 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.01 -31.31 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.27 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -61.9 -25.61 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -85.01 5.96 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.512 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.28 -2.26 85.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.903 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.97 178.76 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.771 0.319 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -145.22 132.02 9.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 51.8 Cg_exo -53.99 -24.18 31.19 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.356 2.038 . . . . 0.0 112.409 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.7 t 61.65 35.67 16.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -179.57 -76.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -72.21 -15.84 61.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.374 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.57 92.71 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.585 ' CG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -78.51 -26.99 46.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.959 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.524 ' HB2' HG13 ' A' ' 306' ' ' VAL . 29.1 mt -78.23 -34.05 49.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -39.87 85.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.454 HG23 ' HB3' ' A' ' 227' ' ' PHE . 11.2 mt -65.01 -34.88 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.794 HD23 ' OH ' ' A' ' 302' ' ' TYR . 44.6 tp -77.93 -36.17 49.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.28 -29.02 73.85 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.475 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.62 -27.55 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 26.9 m -60.6 -45.83 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.66 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -48.58 -51.14 29.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.663 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -71.67 -51.44 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.573 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.739 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.3 tm0? -56.7 -36.04 69.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -82.38 -49.92 9.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 151' ' ' ARG . 85.6 mt -67.05 -36.28 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.5 m -96.12 -15.38 22.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 68.96 94.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.313 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.7 m80 62.93 140.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.396 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.97 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -122.49 168.84 10.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 55.2 Cg_endo -70.04 59.95 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.45 2.1 . . . . 0.0 112.72 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.97 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.4 p90 177.92 -41.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.6 OUTLIER -95.35 17.68 13.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.346 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.21 -57.34 11.83 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 57.2 t30 -129.12 -26.27 2.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.335 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 225' ' ' ILE . 66.0 mt 70.96 11.95 7.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -85.23 -16.5 40.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.163 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.487 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.7 OUTLIER -133.13 100.43 14.22 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.734 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.15 19.2 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.74 2.293 . . . . 0.0 112.86 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -77.95 -46.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.9 p90 -83.76 -26.71 29.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.821 ' CG1' HD11 ' A' ' 225' ' ' ILE . 18.3 t -65.62 -45.2 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.218 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.42 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -39.9 64.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 47.9 m -66.61 -38.29 86.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.159 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.536 ' CD ' HG12 ' A' ' 271' ' ' VAL . 1.0 OUTLIER -65.29 -51.14 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.071 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.42 -37.34 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -81.18 -50.5 9.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.2 m-85 -59.43 -40.89 88.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.717 ' HE ' HD13 ' A' ' 230' ' ' ILE . 10.0 ttm105 -51.7 -29.43 18.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.04 25.68 9.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -137.6 41.83 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 303' ' ' MET . 28.4 mt -49.58 -39.91 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.84 -34.64 64.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.988 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.47 -43.27 63.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 285' ' ' LEU . 3.5 pp -71.33 -33.2 69.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.449 ' N ' HD12 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -61.99 -50.93 70.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.2 -27.85 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -32.89 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 111.237 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 252' ' ' ILE . 60.8 m -93.71 -41.18 9.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.467 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -94.0 144.66 28.47 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.738 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 176.45 6.81 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.489 2.126 . . . . 0.0 112.285 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -98.62 30.45 3.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -41.15 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -131.67 150.11 52.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 143.19 74.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.53 137.49 25.38 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.478 2.119 . . . . 0.0 112.293 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.93 -41.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.56 -67.87 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.538 HG23 ' HG3' ' A' ' 251' ' ' MET . 29.1 mm -75.66 -41.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -47.23 -45.97 23.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.332 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -61.76 -35.65 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.585 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.794 ' OH ' HD23 ' A' ' 247' ' ' LEU . 21.1 t80 -73.81 -35.88 64.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.721 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.744 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.2 mtp -70.3 -45.26 66.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.35 77.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 309' ' ' LEU . 1.9 m -62.27 -33.53 74.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 302' ' ' TYR . 91.0 t -79.64 -23.96 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.423 ' HB3' HD22 ' A' ' 308' ' ' LEU . 0.1 OUTLIER -83.64 -34.01 25.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.649 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 307' ' ' LYS . 3.9 mm? -113.73 -30.45 6.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.268 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 305' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.313 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.837 ' HA ' HD21 ' A' ' 309' ' ' LEU . 50.3 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.691 0.205 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.5 tp 74.86 57.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 15.5 m-85 -70.34 -30.9 67.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -58.55 -47.59 83.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -46.75 72.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 323' ' ' ILE . 53.7 mt -55.64 -40.7 72.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -46.59 86.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -40.25 90.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 320' ' ' LEU . 67.4 mt -57.85 -42.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 158' ' ' SER . 35.4 mt -78.56 -51.55 9.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -58.25 -49.92 75.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.48 -38.99 86.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.974 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.89 -27.92 65.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.551 HD12 HD23 ' A' ' 325' ' ' LEU . 14.2 mt -62.31 -38.03 87.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -29.89 70.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.52 77.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.0 pt -99.59 24.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.257 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.36 26.55 37.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.658 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.29 164.56 24.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 146.01 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -127.69 129.48 47.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.877 0.37 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.66 128.16 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.18 57.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.572 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.92 153.3 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' A' ' 36' ' ' GLU . 26.1 mt -115.22 137.15 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.8 pt -119.85 154.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.18 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.2 p -95.57 141.57 28.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.743 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -98.62 -162.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.044 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -37.52 27.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.5 -1.81 43.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 6.4 mttp 86.12 29.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' THR . 5.2 mttp -78.23 177.62 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.188 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HB3' HG21 ' A' ' 28' ' ' ILE . 74.7 mm-40 -129.3 80.44 1.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.405 ' HB2' HG13 ' A' ' 29' ' ' ILE . 73.4 m95 -77.46 131.41 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -89.9 118.24 29.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 53' ' ' LEU . 19.9 t -89.55 141.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -107.19 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -127.31 165.87 26.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 43' ' ' ILE . 31.2 Cg_exo -59.37 178.03 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.64 2.227 . . . . 0.0 112.285 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.496 HG21 HD21 ' A' ' 53' ' ' LEU . 23.3 pt -156.08 30.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.409 0.147 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.413 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 53.3 mt -142.4 135.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 29.3 m-85 -143.4 156.31 44.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.483 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 69' ' ' VAL . 92.4 mt -74.85 157.5 34.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.26 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -140.79 159.72 41.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.4 ptp -101.01 37.85 1.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t30 59.99 30.58 20.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -85.19 -72.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 m -117.18 144.77 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.46 160.86 30.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m 60.5 95.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.507 ' O ' HG12 ' A' ' 62' ' ' VAL . 20.9 t -92.83 47.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -113.05 -27.35 3.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.86 38.13 4.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.63 -59.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 52.63 74.35 0.79 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.144 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 62' ' ' VAL . 61.3 Cg_endo -73.57 -27.29 13.09 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.596 2.198 . . . . 0.0 112.618 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.2 m -149.86 165.31 32.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 133' ' ' ARG . 4.4 m -127.41 152.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 130' ' ' ILE . 7.7 p -142.2 141.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 35.0 mtpt -111.01 123.88 51.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.761 HG22 ' HB3' ' A' ' 128' ' ' PHE . 25.5 t -120.23 136.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.531 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.13 120.6 8.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.685 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.91 91.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.526 2.151 . . . . 0.0 112.472 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p 49.72 83.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.76 118.29 27.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.3 -85.52 0.12 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.36 -49.06 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.552 2.168 . . . . 0.0 112.306 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 84' ' ' LEU . 21.1 tp -76.12 -31.1 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -68.59 -31.19 70.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -45.42 63.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' CD ' HD12 ' A' ' 80' ' ' LEU . 12.5 pt-20 -69.68 -42.21 74.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.4 mm? -54.78 -48.48 72.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.67 -39.67 92.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -57.34 -53.9 52.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -75.31 -17.64 60.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.379 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -83.1 -47.46 11.63 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.89 -23.88 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.642 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -93.92 25.28 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -73.32 131.08 83.38 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.651 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.26 -29.01 89.21 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.488 2.125 . . . . 0.0 112.381 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.33 -31.96 43.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -49.96 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 91' ' ' ALA . 65.7 mt -59.94 -46.48 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -51.8 -48.35 63.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.179 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -38.96 92.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -53.22 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 46.6 mt -64.37 -26.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -75.12 -27.55 59.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -39.21 35.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.88 11.81 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER 70.37 2.03 3.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.657 HD13 HD13 ' A' ' 108' ' ' LEU . 4.5 mt 44.71 28.39 0.33 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.388 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 48.8 36.61 8.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.8 t80 71.34 114.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.757 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG23 ' A' ' 110' ' ' VAL . 6.3 tp -101.79 125.53 48.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -92.38 20.72 42.1 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.753 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.732 HG23 ' HG ' ' A' ' 108' ' ' LEU . 27.7 t -78.17 133.42 64.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.534 0.207 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HB3' HG12 ' A' ' 196' ' ' VAL . 9.3 Cg_endo -51.02 145.64 24.42 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.638 2.225 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 126.23 32.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.14 134.07 43.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -111.52 -40.7 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -176.31 46.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.91 155.01 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -134.53 175.49 20.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.044 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.1 mt -147.91 154.71 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -145.81 141.74 28.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 m-20 -121.34 126.66 50.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.449 ' HE3' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.26 126.39 22.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.15 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 56.33 19.89 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.31 9.26 58.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.836 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 2.1 mtmt -96.07 159.3 15.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 83.2 p -112.58 118.45 35.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.078 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.743 ' O ' HD23 ' A' ' 118' ' ' LEU . 13.0 m-85 -110.44 129.07 55.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.668 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.712 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -123.23 125.08 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.711 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.7 p90 -134.53 159.59 40.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 3.6 tmm? -130.02 141.7 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.018 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 70' ' ' VAL . 5.5 mt -110.16 125.24 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.76 173.35 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.868 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.94 137.39 39.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB3' HG13 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -85.12 -25.61 27.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.717 ' CE2' HG11 ' A' ' 196' ' ' VAL . 59.8 m-85 64.71 -170.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -107.41 -104.28 2.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.665 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 m -97.14 157.71 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.663 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.2 m-20 -92.81 157.0 16.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -63.71 -30.14 71.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.427 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 5.2 pt20 -57.28 -42.81 82.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.668 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -64.65 -25.92 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.631 HD12 HD13 ' A' ' 138' ' ' LEU . 14.5 mt -72.63 -28.95 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.0 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -58.04 -46.26 85.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.18 -31.27 65.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.91 -21.45 65.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.409 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -93.95 -0.22 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.9 43.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 61.54 19.97 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.488 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -162.1 107.87 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -58.27 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.9 m -111.79 161.63 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.774 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.69 -31.55 72.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -70.99 -50.39 34.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -59.19 -50.66 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.16 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 150' ' ' SER . 46.7 t -56.19 -52.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.318 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 328' ' ' LEU . 64.5 mt -59.52 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.258 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -46.03 90.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.599 HD22 HG11 ' A' ' 193' ' ' VAL . 29.9 mt -69.07 -35.35 76.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.824 ' OG ' HD13 ' A' ' 324' ' ' LEU . 12.8 p -57.91 -36.37 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 321' ' ' ARG . 16.6 mt -72.5 -47.23 50.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.494 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -49.52 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.77 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.08 -37.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 165' ' ' LEU . 7.6 mt -58.96 -36.47 74.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -38.04 84.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 109' ' ' GLY . 16.9 mt -74.79 -38.47 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 162' ' ' LEU . 61.5 mt -58.16 -48.22 80.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -68.12 -38.93 82.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.548 ' CE1' HD11 ' A' ' 105' ' ' LEU . 90.6 t80 -59.7 -41.42 90.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.591 HD11 ' CE1' ' A' ' 175' ' ' HIS . 28.2 pt -81.67 -27.19 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.112 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -75.93 -29.99 58.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.425 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.77 -17.1 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.22 6.24 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 72.04 47.16 0.31 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.886 0.374 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 11.1 m-85 -132.05 132.83 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.99 169.31 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.788 ' CD2' HD21 ' A' ' 195' ' ' LEU . 11.4 p-80 -151.68 -51.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.754 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 55.83 53.12 44.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.66 30.17 5.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.104 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 183' ' ' LEU . 2.8 mt -87.29 105.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.26 29.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.427 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 67.11 11.05 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.87 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 m -117.13 5.97 12.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 196' ' ' VAL . 8.9 m120 -138.49 2.89 2.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.594 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.906 ' O ' HD23 ' A' ' 184' ' ' LEU . 5.3 mt -109.59 130.2 55.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.098 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.1 mt -137.53 147.54 45.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.094 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.624 HD23 ' HB ' ' A' ' 193' ' ' VAL . 24.8 mt -86.47 145.87 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 111.528 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 125.87 25.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.83 -49.46 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -58.1 -24.4 58.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.659 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.35 81.14 2.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.15 109.73 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.584 2.189 . . . . 0.0 112.291 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -144.55 -45.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -157.86 -167.7 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 138' ' ' LEU . 7.6 p -109.75 148.1 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 9.2 m-85 -119.21 156.96 28.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.388 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.788 HD21 ' CD2' ' A' ' 175' ' ' HIS . 18.3 tp -106.61 115.77 30.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.428 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.717 HG11 ' CE2' ' A' ' 134' ' ' PHE . 30.5 m -126.95 167.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.296 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.7 t70 53.65 57.68 5.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.007 0.432 . . . . 0.0 110.707 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 51.6 m-85 -59.68 -51.55 69.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.071 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.81 -35.83 4.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.94 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.56 31.65 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.503 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -71.82 59.44 0.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.76 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -138.48 148.97 44.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.064 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.428 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 19.4 mtm105 -56.52 101.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 46.0 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.172 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.5 p -87.87 178.09 6.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.576 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.7 tt -116.16 -26.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -24.62 4.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.472 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 246' ' ' ILE . 11.1 m-85 -144.41 38.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.07 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 225' ' ' ILE . 10.2 t -83.99 138.9 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.8 t -91.8 148.29 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 279' ' ' ARG . 15.0 mt -57.34 -51.16 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.188 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.83 -43.91 86.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -72.39 -28.11 62.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.233 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -68.71 -28.04 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.585 ' HB3' HG23 ' A' ' 236' ' ' VAL . 2.2 t30 -91.64 12.86 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.08 23.29 63.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.747 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.654 HG12 ' HD2' ' A' ' 238' ' ' PRO . 14.3 t -77.81 119.52 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -57.67 -57.4 25.66 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.2 Cg_exo -52.43 89.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.407 2.072 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 t -138.14 160.99 37.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -178.79 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.118 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.41 -42.76 93.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.569 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.559 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -59.19 -35.21 73.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.774 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.506 HD21 ' HE1' ' A' ' 317' ' ' TYR . 15.5 mt -80.5 -34.49 35.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.98 -39.37 89.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.717 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 227' ' ' PHE . 8.5 mt -62.9 -47.93 90.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.4 tp -64.79 -33.94 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.397 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.3 95.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 34.0 m-85 -78.57 -25.84 45.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.88 -34.45 65.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.583 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -46.57 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.769 HD13 HD11 ' A' ' 285' ' ' LEU . 9.0 mt -63.57 -38.63 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HB3' HD11 ' A' ' 259' ' ' LEU . 1.5 pp0? -75.17 -31.06 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -82.38 -40.71 20.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.99 -31.19 56.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.98 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.3 m -103.07 0.51 32.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.412 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.71 95.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.519 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 61.12 161.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.956 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -133.0 168.74 16.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.865 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.6 Cg_exo -68.44 59.14 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.863 2.375 . . . . 0.0 112.515 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.956 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.0 p90 179.15 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.445 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 4.1 tt0 -84.48 5.63 26.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.23 -54.1 49.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.4 m120 -130.05 -27.53 2.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 78.5 mt 71.26 12.62 6.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.27 -15.38 38.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.468 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -130.03 92.16 37.35 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.18 -4.12 13.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.883 2.389 . . . . 0.0 112.662 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -55.34 -50.34 69.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.277 . . . . 0.0 111.079 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.7 p90 -84.09 -26.03 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 261' ' ' TRP . 40.8 t -62.49 -43.04 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.298 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -75.52 -40.81 56.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -48.08 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -45.31 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.185 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -58.74 -42.87 89.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.483 ' HA ' HD11 ' A' ' 230' ' ' ILE . 17.3 mt -72.56 -29.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -75.41 -52.1 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -60.47 -39.46 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.633 ' HG3' HD12 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -60.13 -26.18 66.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.948 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -120.2 23.78 10.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.66 53.43 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.074 0.464 . . . . 0.0 110.744 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 2.6 mm -48.52 -41.79 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.339 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -64.26 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.513 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.2 p -70.38 -31.98 69.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.769 HD11 HD13 ' A' ' 252' ' ' ILE . 1.2 tt -66.41 -51.4 57.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.467 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 21.5 mmt -62.14 -34.63 76.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -82.79 -33.34 27.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.313 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -54.85 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.467 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' HG21 ' A' ' 252' ' ' ILE . 85.7 m -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.286 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 290' ' ' PHE . 3.7 m-85 -108.36 146.29 33.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 -172.42 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.43 30.87 3.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 -35.28 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.68 91.66 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.79 108.02 1.06 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.23 127.21 23.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.468 2.112 . . . . 0.0 112.256 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -124.1 -40.51 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -47.5 85.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.696 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.2 mm -76.79 -48.74 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.467 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.32 -44.72 8.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.615 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -63.58 -43.22 97.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.382 . . . . 0.0 110.814 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.883 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.5 t80 -69.59 -43.5 72.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.018 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.696 ' CG ' HG22 ' A' ' 299' ' ' ILE . 69.1 mmm -66.54 -39.02 88.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.764 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.83 -40.36 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.273 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -32.34 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 302' ' ' TYR . 14.0 t -71.91 -24.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.096 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -75.7 -37.45 59.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.71 -12.49 22.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 320' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.968 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 309' ' ' LEU . 19.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.85 0.271 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.591 ' H ' HD21 ' A' ' 309' ' ' LEU . 2.3 mp -142.87 42.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.506 ' HE1' HD21 ' A' ' 244' ' ' LEU . 20.1 m-85 -57.06 -36.16 70.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.021 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -69.2 -33.88 74.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.74 -47.42 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.817 ' HA ' HD12 ' A' ' 323' ' ' ILE . 25.9 mt -53.29 -44.37 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 159' ' ' LEU . 4.7 ttt180 -59.15 -32.65 70.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.987 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.97 -30.47 55.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 320' ' ' LEU . 57.9 mt -63.98 -50.01 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.824 HD13 ' OG ' ' A' ' 158' ' ' SER . 8.4 mt -79.96 -26.65 39.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.593 ' HB2' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.58 -48.89 10.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.733 0.301 . . . . 0.0 111.107 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.76 -34.29 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.6 56.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.583 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.732 HD21 ' HB3' ' A' ' 155' ' ' LEU . 29.4 mt -57.23 -32.55 66.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -70.08 -29.62 66.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.63 63.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.8 -28.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.215 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.11 22.92 5.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m -97.67 164.52 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -138.63 111.85 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.81 92.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.957 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 58.1 m -60.97 168.59 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.791 0.329 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 6.6 t -155.75 150.0 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -72.28 139.12 27.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.2 m 60.51 -177.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.5 p -75.47 -31.35 60.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 133.95 68.14 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.453 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt -117.39 91.08 36.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.679 0.276 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.67 157.98 3.18 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.396 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -77.57 -64.83 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 t 69.1 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -148.03 157.08 43.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.42 -37.53 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.0 140.33 43.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -101.32 -39.16 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.4 30.88 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 161.31 24.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.448 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.37 88.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -144.64 -64.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.2 m 68.25 -68.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m 59.99 172.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.97 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.82 -50.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -79.67 110.1 14.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.91 -45.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -169.32 103.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mt -69.64 -179.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.19 166.94 22.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.41 -32.65 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -88.4 -78.63 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.759 ' CE2' HG21 ' A' ' 29' ' ' ILE . 6.5 m-85 -121.41 98.28 5.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.97 -168.59 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.146 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 40' ' ' GLY . 17.9 t -101.54 108.44 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -35.8 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.508 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 150.34 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.936 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG12 ' CG ' ' A' ' 38' ' ' LYS . 18.6 mt -103.25 142.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.759 HG21 ' CE2' ' A' ' 23' ' ' PHE . 11.8 pt -116.76 143.44 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 36' ' ' GLU . 11.8 p -102.33 141.76 34.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.137 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 10.3 m-20 -83.03 -144.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.88 56.24 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 109.698 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.46 35.6 26.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.571 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -139.33 -8.46 1.3 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.36 177.75 9.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.157 0.503 . . . . 0.0 111.692 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' HG22 ' A' ' 30' ' ' THR . 7.7 mt-10 -155.25 92.73 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 9.2 m95 -96.64 144.83 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.408 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -89.35 125.81 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.852 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.32 131.81 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -106.0 -121.04 4.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.477 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.86 154.61 44.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.709 0.29 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.32 175.19 7.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.516 2.144 . . . . 0.0 112.335 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.0 pt -141.61 30.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.48 115.7 2.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -110.77 158.87 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.53 -94.72 0.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.473 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.6 52.31 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -121.2 -69.13 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.01 -92.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.576 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.61 91.65 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -85.19 124.08 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.605 ' O ' HG12 ' A' ' 70' ' ' VAL . 68.5 m-85 -146.29 153.3 40.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.44 135.93 36.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.05 137.67 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.624 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 25.3 t0 -124.39 151.18 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 10.6 ttp -89.81 52.83 2.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -149.47 148.23 29.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.41 34.74 3.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.43 176.33 7.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.72 134.93 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t 63.42 125.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.38 -52.74 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.3 -133.94 52.09 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.65 29.71 3.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -105.68 31.98 4.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . . . -137.82 99.3 9.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.04 42.5 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.709 2.273 . . . . 0.0 112.66 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -149.93 150.28 31.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 110.779 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 131' ' ' MET . 15.8 m -122.02 146.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.855 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 52' ' ' TYR . 7.5 p -131.95 131.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.599 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -105.39 121.09 43.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.215 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.635 HG11 ' CE1' ' A' ' 23' ' ' PHE . 2.8 t -113.12 152.02 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -140.71 136.26 16.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.68 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.418 2.079 . . . . 0.0 112.375 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.3 t 62.28 122.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -171.51 159.9 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.88 75.0 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 82' ' ' THR . . . 179.82 -75.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.525 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.46 -61.91 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.64 ' HG ' HD23 ' A' ' 84' ' ' LEU . 6.3 tp -60.48 -33.18 72.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.58 -31.93 72.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 78' ' ' GLY . 22.3 p -75.07 -41.61 58.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.8 -38.48 64.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.5 mm? -64.24 -51.68 62.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -56.78 -51.81 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 198' ' ' TYR . 19.6 t80 -64.27 -29.79 70.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.2 m-85 -69.57 -50.7 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -25.38 64.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -87.67 -47.43 8.68 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.97 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -88.84 19.41 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' CD ' ' HB2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -77.59 114.12 38.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.467 0.175 . . . . 0.0 110.649 179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.25 -26.19 7.93 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.503 2.136 . . . . 0.0 112.636 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.402 ' HB2' ' CD ' ' A' ' 92' ' ' LYS . 8.2 mm-40 -75.4 -40.44 57.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.811 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -79.33 -43.43 23.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 51.2 mt -61.25 -52.87 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -42.28 64.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.124 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -43.23 67.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.964 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -53.89 37.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 96' ' ' ILE . 40.2 mt -56.66 -34.23 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -74.88 -27.7 60.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 m -71.62 -38.53 70.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -6.53 19.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.983 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.19 27.66 16.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.45 ' CD1' HD13 ' A' ' 108' ' ' LEU . 59.7 mt -51.83 -32.52 32.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.1 tttt 46.74 40.91 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.658 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 25.1 t80 -176.86 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.347 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 96' ' ' ILE . 13.4 tp 59.96 158.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.725 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 164' ' ' ILE . . . -110.66 32.98 6.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.624 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.879 HG21 ' CE2' ' A' ' 167' ' ' TYR . 23.3 t -112.6 126.6 28.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.529 0.204 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.69 161.8 23.63 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.305 2.003 . . . . 0.0 112.025 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 115.43 27.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.06 131.95 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 9.3 m95 -109.89 -40.91 4.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.09 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -175.03 46.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.762 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -135.4 162.0 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.82 174.49 24.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.5 mt -147.84 150.61 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.064 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 121.85 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.42 127.86 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -138.29 126.16 22.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.97 20.84 4.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.68 62.07 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.792 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -96.13 129.86 43.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.784 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.64 118.77 30.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.084 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.454 ' O ' HD23 ' A' ' 118' ' ' LEU . 10.0 m-85 -101.42 122.56 43.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -106.51 130.89 54.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.442 ' CZ ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 p90 -140.27 168.62 19.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.104 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.681 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.8 tmm? -142.73 138.96 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 130' ' ' ILE . 1.5 mp -94.09 141.8 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -122.09 164.21 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.658 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.83 -69.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -148.09 -78.24 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 184' ' ' LEU . 1.4 m-85 64.19 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.916 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -117.8 -101.66 2.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.615 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.8 t -102.02 166.33 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.856 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.583 ' HB3' HD22 ' A' ' 184' ' ' LEU . 13.1 p30 -97.95 161.68 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.962 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -58.53 -25.14 62.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.56 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.56 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -55.46 -37.95 68.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.82 70.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 185' ' ' LEU . 14.1 mt -76.35 -26.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.85 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.424 ' HA ' ' CE1' ' A' ' 149' ' ' PHE . 36.3 t80 -56.21 -44.74 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.09 -30.35 63.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.24 -14.09 62.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.511 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -94.6 -1.0 54.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.248 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 92.56 44.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.962 0.505 . . . . 0.0 110.395 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.75 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.591 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -170.72 121.46 0.58 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.918 0.39 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 254' ' ' TRP . 8.6 m-85 -61.33 177.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.521 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.6 t -113.41 160.69 18.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.788 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -36.95 74.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -70.69 -48.8 52.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 340' ' ' ASP . 76.7 p -58.69 -56.2 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.168 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.556 HG21 ' HG ' ' A' ' 255' ' ' LEU . 48.9 t -54.35 -53.5 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 155' ' ' LEU . 15.2 mt -57.54 -45.67 84.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.993 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -65.67 -52.9 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.81 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.783 HD11 HD21 ' A' ' 341' ' ' LEU . 5.7 mt -62.53 -34.06 76.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.743 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.562 ' HB3' HD13 ' A' ' 324' ' ' LEU . 34.1 m -58.83 -46.41 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 325' ' ' LEU . 86.2 mt -61.8 -43.81 98.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -34.02 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.838 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.4 mt -78.96 -36.62 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.149 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.593 HD13 ' HA ' ' A' ' 321' ' ' ARG . 3.4 mt -55.35 -44.12 75.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -26.44 68.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.453 HG12 ' HA3' ' A' ' 109' ' ' GLY . 5.0 mt -72.74 -46.55 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 243' ' ' ASP . 28.3 mt -59.85 -27.29 66.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -30.37 60.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.879 ' CE2' HG21 ' A' ' 110' ' ' VAL . 91.1 t80 -77.15 -56.09 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.436 HG21 ' CE1' ' A' ' 198' ' ' TYR . 41.6 pt -55.13 -29.35 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -42.37 90.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -16.87 61.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 89' ' ' ARG . 0.6 OUTLIER -98.11 2.24 48.41 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.177 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 74.75 40.25 0.39 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.941 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -138.01 127.28 24.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.695 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 202' ' ' TYR . 14.9 m -142.26 169.34 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.391 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.682 ' NE2' HG23 ' A' ' 228' ' ' THR . 1.9 t-160 67.54 43.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.46 -17.17 52.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.678 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.73 82.31 0.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.0 110.993 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.689 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mp -82.04 108.49 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 8.2 tttt -149.32 -176.5 5.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -84.69 -0.26 52.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.417 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.63 5.72 12.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.324 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.759 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.1 m-80 -125.12 -11.07 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.328 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.9 mt -108.32 125.62 51.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.949 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.754 HD23 ' C ' ' A' ' 183' ' ' LEU . 1.2 mt -129.58 154.53 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.354 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 1.058 HD11 HD11 ' A' ' 141' ' ' ILE . 6.1 mt -100.07 149.2 23.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -61.8 133.37 55.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.483 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 133' ' ' ARG . 23.5 t80 -75.25 -66.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.808 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -22.75 41.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.836 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.87 80.94 41.4 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.15 101.74 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.565 2.177 . . . . 0.0 112.199 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.486 ' O ' HD12 ' A' ' 339' ' ' LEU . 10.5 t70 -177.5 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.496 ' HA ' HD12 ' A' ' 339' ' ' LEU . 8.6 mp0 -108.22 164.03 12.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.78 HG21 HD21 ' A' ' 138' ' ' LEU . 10.8 p -132.05 147.79 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 1.4 m-85 -123.14 156.73 34.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.709 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 178' ' ' ILE . 26.1 tp -107.28 115.93 31.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.696 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 182' ' ' ASN . 12.4 m -86.86 179.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.254 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.47 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 26.3 m-85 -145.47 -57.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -58.43 -23.69 54.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.696 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.56 33.87 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 175' ' ' HIS . . . -131.08 -90.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.053 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.587 ' HB3' HG23 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -146.16 118.87 8.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.752 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -94.82 47.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.44 94.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.4 m 58.52 163.91 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.035 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.96 -167.66 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.543 2.162 . . . . 0.0 112.329 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -106.12 -46.0 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.76 77.15 0.39 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.91 125.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -37.99 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -76.4 126.41 30.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -67.42 -54.47 20.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.68 154.17 42.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -145.28 -56.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.56 54.02 3.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -155.74 102.91 2.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.46 71.37 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.376 2.05 . . . . 0.0 112.249 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -149.68 -46.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -31.11 66.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.94 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 19.7 t -102.11 -68.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 56.89 36.09 27.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.0 111.58 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 59.49 -149.29 40.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 225' ' ' ILE . 1.3 t -127.75 -52.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.722 0.296 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.619 HG12 HG11 ' A' ' 271' ' ' VAL . 2.1 tt -179.09 38.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.489 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.53 63.03 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.504 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.428 ' CE1' ' HG3' ' A' ' 262' ' ' GLU . 30.3 m-85 76.34 29.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.745 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 ' NE2' ' A' ' 175' ' ' HIS . 31.0 m -83.72 145.2 28.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 8.2 t -59.24 141.28 54.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mt -61.01 -37.22 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -43.88 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -59.12 -30.44 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -72.9 -32.0 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.729 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -96.17 12.84 29.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.298 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 55.79 28.7 53.12 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.5 t -90.79 110.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.56 151.88 0.1 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.79 154.86 8.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.531 2.154 . . . . 0.0 112.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 174' ' ' VAL . 1.3 t -100.55 123.57 44.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 mtm105 -144.87 -50.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -17.66 60.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.31 -33.65 66.01 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.544 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.759 ' HB3' HD22 ' A' ' 165' ' ' LEU . 2.8 m-20 -60.39 -33.12 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.639 HD21 ' CE1' ' A' ' 317' ' ' TYR . 10.4 mt -80.66 -31.59 36.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.841 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.52 -40.91 93.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 243' ' ' ASP . 5.2 mt -61.21 -41.29 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.033 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.437 HD23 ' OH ' ' A' ' 302' ' ' TYR . 54.5 tp -70.37 -39.71 74.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -59.36 -45.86 94.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.545 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -78.61 -25.62 45.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.458 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.83 -41.41 82.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.411 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.0 -48.19 81.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.4 mp -65.77 -31.72 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.295 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.425 ' CB ' HD11 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -70.4 -43.61 69.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.011 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 15.1 m0 -82.23 -42.91 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.556 ' HG ' HG21 ' A' ' 154' ' ' VAL . 25.5 mt -67.08 -36.82 82.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.27 -21.43 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.32 88.94 0.27 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 8.6 m170 62.41 144.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.873 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.15 165.77 33.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 41.3 Cg_endo -67.99 64.41 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.43 2.087 . . . . 0.0 112.607 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.873 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -178.9 -40.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.888 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -113.11 25.35 11.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.356 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -58.54 6.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.7 m120 -129.1 -25.87 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.327 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.574 HD22 HG23 ' A' ' 225' ' ' ILE . 41.9 mt 74.33 11.11 4.19 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -85.12 -15.83 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.597 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.472 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 4.4 m-20 -133.89 74.72 68.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 49.1 Cg_exo -56.04 -16.12 15.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.882 2.388 . . . . 0.0 112.982 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -49.99 -50.44 47.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.476 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.9 p90 -84.13 -27.05 28.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.383 . . . . 0.0 110.785 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 225' ' ' ILE . 18.3 t -60.69 -35.49 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.55 -44.15 44.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.22 -47.62 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 34.8 p -64.4 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -46.76 78.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 20.6 mt -68.65 -34.7 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -50.72 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -61.89 -37.06 83.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -54.58 -29.33 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.782 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -116.75 22.28 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.879 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -136.23 40.3 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.734 HD13 ' CB ' ' A' ' 303' ' ' MET . 27.9 mt -49.26 -40.05 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.5 64.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -35.98 66.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 286' ' ' MET . 2.7 pp -80.02 -41.58 25.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 15.0 ttm -63.0 -32.98 74.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.762 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.27 -32.59 33.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -82.79 -27.15 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.289 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.6 m -93.55 -41.28 9.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.349 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -107.57 160.39 26.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.13 167.66 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.63 37.93 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -113.09 33.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 60.72 30.33 19.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -80.09 -50.77 1.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 295' ' ' LYS . 42.2 Cg_exo -56.86 -162.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.515 2.144 . . . . 0.0 112.238 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.39 -45.64 1.13 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -44.64 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 303' ' ' MET . 29.6 mm -77.24 -46.76 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.055 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.723 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -44.87 -49.57 10.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.526 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.8 OUTLIER -58.87 -40.35 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.663 ' O ' HG23 ' A' ' 306' ' ' VAL . 14.5 t80 -69.88 -42.62 73.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.1 mtp -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.317 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.03 -50.35 74.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.556 HG23 HD23 ' A' ' 316' ' ' LEU . 73.6 m -57.48 -37.79 73.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 302' ' ' TYR . 31.6 t -72.3 -24.75 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -31.9 39.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.376 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.48 -12.98 23.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -57.95 87.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -170.84 -43.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.37 23.95 7.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.0 m -117.18 -8.96 11.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.359 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.78 -71.42 0.1 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.835 0.35 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.64 138.63 82.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.694 ' O ' HD21 ' A' ' 309' ' ' LEU . 52.7 Cg_exo -54.86 -23.64 35.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.512 2.141 . . . . 0.0 112.422 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 305' ' ' THR . 1.5 tp 63.2 32.28 15.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.639 ' CE1' HD21 ' A' ' 244' ' ' LEU . 3.2 m-85 -66.05 -42.08 89.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -58.5 -32.91 69.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -77.4 -47.45 19.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.778 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.6 mt -55.19 -43.02 74.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.593 ' HA ' HD13 ' A' ' 162' ' ' LEU . 1.8 ttt180 -58.55 -37.82 76.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.02 -33.36 73.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 320' ' ' LEU . 64.9 mt -61.38 -49.43 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 302' ' ' TYR . 12.2 mt -80.51 -23.63 39.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.317 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.868 ' HA ' HD11 ' A' ' 159' ' ' LEU . 7.3 tt -82.44 -35.15 27.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.905 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -68.76 -42.51 77.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.21 -26.52 56.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.556 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.697 HD11 ' CD1' ' A' ' 159' ' ' LEU . 28.1 mt -53.84 -29.7 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.21 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.245 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.8 pt -97.51 24.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.256 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.92 26.33 40.74 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.632 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.9 t -89.62 178.51 6.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.66 151.89 30.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.51 89.48 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -115.68 -66.04 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 174.26 40.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -121.22 146.04 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 341' ' ' LEU . 10.3 mt -110.68 -12.21 14.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.17 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.507 ' HB3' HG22 ' A' ' 153' ' ' THR . 1.8 t0 64.02 20.03 12.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.697 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 141' ' ' ILE . 14.9 mt -98.53 29.08 3.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 m -64.8 -44.19 90.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 16.4 m 42.12 61.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.636 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 21.4 t 66.37 91.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.91 35.2 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.67 118.52 36.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 142.98 -96.9 0.19 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.467 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 113.03 28.6 3.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.2 tp -171.41 85.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.86 137.5 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.13 -61.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 60.26 159.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 59.0 p -70.76 104.25 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 354' ' ' ILE . 3.9 tt -160.65 53.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.025 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 43.0 p -129.72 86.49 2.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.63 165.03 12.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -75.91 110.27 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 65.6 mtp85 -95.66 172.04 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.73 177.35 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -151.6 -69.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.58 -174.81 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.32 131.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.54 120.53 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -92.78 178.68 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.3 m -91.53 -32.29 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.11 155.3 31.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.58 130.64 7.17 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.45 51.78 3.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.5 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -105.48 -28.91 5.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 9.3 p -170.01 144.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -173.34 -48.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -166.31 120.26 1.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.7 t -120.64 88.18 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -75.76 178.05 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.08 118.94 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.2 m -92.72 -51.16 5.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -93.86 162.17 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.7 p -150.86 130.5 13.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.66 119.18 38.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.16 105.41 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.844 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.91 97.26 9.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -160.52 179.12 8.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -150.04 31.2 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 9.8 pt -145.16 142.03 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.29 -49.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.4 m -73.91 145.13 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -93.0 48.23 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 58.0 m -140.0 -66.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 60.17 105.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 17.7 p -86.43 -178.61 6.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.82 111.46 5.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -140.58 162.53 35.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 14.4 mtp85 60.57 -177.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.07 116.55 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -75.26 94.81 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 5.9 mttt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.907 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 23.5 p -108.2 154.58 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.1 m 60.59 -179.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -129.6 167.37 21.49 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.79 -54.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.1 m 60.4 81.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 119.55 145.04 7.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm -62.57 134.29 95.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.598 0.237 . . . . 0.0 110.781 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.18 166.39 1.05 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.392 2.062 . . . . 0.0 112.364 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.28 164.21 38.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.49 138.62 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -62.53 109.51 1.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.77 33.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.07 -40.92 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -107.71 89.58 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.66 -173.33 2.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.18 28.13 3.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 60.1 94.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -109.34 -31.7 7.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.4 m -96.5 170.76 8.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -105.98 -34.1 7.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.0 145.73 32.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -141.12 160.31 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -92.21 86.53 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -159.0 113.74 2.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.596 HD11 HD22 ' A' ' 122' ' ' ASN . 2.6 mt 60.32 109.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.98 119.42 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -50.03 75.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.985 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.1 80.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.734 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 3.3 m-85 -59.44 96.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.05 -169.57 1.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.12 114.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.186 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.85 -26.43 5.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -76.17 134.54 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.001 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 36' ' ' GLU . 37.9 mt -105.28 145.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.764 HD12 ' CE1' ' A' ' 128' ' ' PHE . 25.2 pt -119.5 154.49 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.263 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 68.4 p -97.93 141.27 31.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.0 -162.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.94 -41.95 34.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 109.775 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.35 -2.21 33.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.653 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 86.96 27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.811 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -72.79 177.41 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.141 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 28' ' ' ILE . 31.0 mt-10 -128.77 79.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.873 0.368 . . . . 0.0 110.597 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 80.4 m95 -73.19 128.65 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.94 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -91.9 119.18 31.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 23' ' ' PHE . 21.4 t -73.62 150.39 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.45 -116.28 2.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 4.0 mm? -105.03 158.85 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.733 0.302 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 56.2 Cg_endo -70.48 155.1 64.25 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.559 2.173 . . . . 0.0 112.373 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 HG22 ' A' ' 51' ' ' ILE . 7.2 pt -145.63 31.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.047 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.65 -42.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 62.9 169.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.74 165.97 41.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.04 34.68 4.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.79 82.33 1.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.86 112.62 2.1 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.9 m -91.2 59.99 4.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG22 HG13 ' A' ' 43' ' ' ILE . 2.2 mt -85.43 106.92 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.173 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 23' ' ' PHE . 70.6 m-85 -131.37 171.33 13.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.978 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 151.41 23.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.43 153.28 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.672 ' CB ' HG13 ' A' ' 62' ' ' VAL . 28.5 t70 -146.79 140.8 26.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.6 ttp -85.17 57.39 4.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.58 -59.83 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.9 m 59.39 31.95 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 m -139.83 -66.83 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -176.45 134.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.97 167.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.672 HG13 ' CB ' ' A' ' 55' ' ' ASP . 33.0 t -105.92 -31.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.19 -116.36 3.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -160.87 31.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -138.66 -77.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.89 77.56 0.4 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.54 48.87 2.92 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.715 2.276 . . . . 0.0 112.716 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.69 170.14 19.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 131' ' ' MET . 15.6 m -143.1 146.04 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 130' ' ' ILE . 11.5 p -139.21 118.78 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.228 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CG ' HG12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -105.18 121.94 44.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 2.8 t -113.14 151.52 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' HG3' HD22 ' A' ' 80' ' ' LEU . 11.5 mt-10 -141.21 122.25 8.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.19 96.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.336 2.024 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.75 178.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.89 79.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -135.98 32.06 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.26 -178.52 28.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.38 10.99 3.43 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.791 2.327 . . . . 0.0 112.97 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.428 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.5 tp -60.96 -32.96 72.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.43 -39.21 92.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 72.1 p -69.72 -32.05 70.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 198' ' ' TYR . 11.7 tp10 -75.79 -40.5 55.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.6 mm? -65.46 -42.54 92.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -62.08 -51.7 66.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 168' ' ' ILE . 16.7 t80 -59.1 -40.05 84.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.967 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.0 m-85 -56.32 -60.06 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.357 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.07 -17.65 63.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -75.87 -47.53 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.97 -25.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.967 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -88.74 23.63 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -76.73 138.54 66.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.536 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.22 -27.8 58.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.513 2.142 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -79.45 -47.36 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.5 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.6 mt -55.84 -45.68 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -48.65 -38.24 20.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.083 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -74.2 -35.15 63.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.672 HG23 ' H ' ' A' ' 106' ' ' LYS . 40.9 mm -66.55 -41.46 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -74.92 -27.6 60.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.59 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' LYS . 25.2 p -84.37 -28.47 26.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.351 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.4 ' CB ' ' HG ' ' A' ' 105' ' ' LEU . 2.5 mmt180 -107.11 -7.23 16.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.844 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mmtm 58.7 21.83 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.802 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 108' ' ' LEU . 41.8 mt -54.69 -41.56 70.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.986 0.422 . . . . 0.0 110.755 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.672 ' H ' HG23 ' A' ' 100' ' ' ILE . 11.5 mtpt 52.35 27.08 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.562 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -177.57 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.691 0.281 . . . . 0.0 111.381 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 105' ' ' LEU . 14.1 tp 69.92 -65.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.824 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.92 1.55 10.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.98 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.524 HG23 ' HG ' ' A' ' 108' ' ' LEU . 22.4 t -89.8 138.65 27.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 111.069 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.83 153.22 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.24 115.62 28.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.22 121.78 36.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -103.86 -40.67 6.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.05 -176.78 46.48 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.66 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -132.58 178.71 6.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -163.36 173.24 39.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.423 HD23 ' HG2' ' A' ' 127' ' ' ARG . 1.1 mt -137.06 159.92 40.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.726 0.298 . . . . 0.0 110.746 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.47 ' CD2' HG22 ' A' ' 29' ' ' ILE . 1.3 t-80 -144.32 119.43 10.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.71 124.62 49.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.15 126.2 22.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.596 HD22 HD11 ' A' ' 19' ' ' LEU . 19.0 t30 55.43 20.83 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.422 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.57 -3.55 61.26 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.903 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -96.14 129.09 43.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -89.07 140.78 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -125.75 123.56 39.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.423 ' HG2' HD23 ' A' ' 118' ' ' LEU . 10.7 mtp85 -102.56 125.13 49.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.764 ' CE1' HD12 ' A' ' 29' ' ' ILE . 23.9 p90 -140.43 162.47 35.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.908 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.626 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -131.41 147.18 52.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 70' ' ' VAL . 9.1 mm -98.73 119.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.9 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -120.54 171.94 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.081 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -71.28 145.88 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -64.32 134.17 54.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.939 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.577 ' CE2' HG11 ' A' ' 196' ' ' VAL . 72.9 m-85 -110.17 154.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.722 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -85.39 -107.84 0.69 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.368 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 m -111.24 118.71 36.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.831 0.348 . . . . 0.0 110.672 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -51.22 160.98 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.658 HD13 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -66.53 -21.7 66.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.679 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.769 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -65.24 -44.7 87.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.027 0.441 . . . . 0.0 109.813 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.88 66.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.191 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.801 ' CD1' HD13 ' A' ' 341' ' ' LEU . 13.8 mt -74.81 -25.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 147' ' ' LYS . 0.6 OUTLIER -62.41 -49.03 77.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.521 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.85 -31.11 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.75 -25.43 67.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.587 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.5 m-20 -108.95 10.4 26.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.308 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.01 52.71 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.047 0.451 . . . . 0.0 110.454 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 23.6 mtpt 61.14 19.66 10.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.588 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -136.15 -175.56 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.045 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.437 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.2 OUTLIER -137.13 -172.71 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.01 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.0 m -119.12 149.74 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.458 ' HB3' HG21 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -57.82 -30.57 65.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.432 ' HB3' HD12 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -74.89 -34.83 62.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -48.38 35.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG21 ' HG ' ' A' ' 255' ' ' LEU . 59.4 t -60.08 -54.19 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 328' ' ' LEU . 16.5 mt -58.87 -49.7 76.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -59.86 -51.27 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 193' ' ' VAL . 15.4 mt -59.91 -33.42 71.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.519 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 247' ' ' LEU . 0.1 OUTLIER -58.99 -45.57 90.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.69 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 325' ' ' LEU . 58.2 mt -61.74 -45.78 92.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HG3' HD21 ' A' ' 339' ' ' LEU . 16.4 mmp_? -61.75 -48.79 79.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.781 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HG12 ' A' ' 178' ' ' ILE . 11.9 mt -65.18 -40.21 88.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 324' ' ' LEU . 7.4 mt -58.07 -33.47 69.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.21 -32.7 72.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.788 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.74 -44.54 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 178' ' ' ILE . 72.2 mt -55.45 -40.44 71.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.67 -38.46 91.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.067 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.672 ' CE2' HD21 ' A' ' 108' ' ' LEU . 80.5 t80 -66.56 -52.05 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 175' ' ' HIS . 38.0 pt -62.37 -27.16 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.374 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.71 -34.48 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -16.75 62.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.676 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 2.44 49.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.428 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 12.9 mt-10 78.09 43.48 0.09 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.851 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.3 122.21 15.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.846 HG13 ' CD1' ' A' ' 204' ' ' TYR . 18.8 m -121.92 142.8 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.209 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.505 ' CE1' ' CD1' ' A' ' 198' ' ' TYR . 0.5 OUTLIER 177.74 82.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.82 79.57 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.817 ' OD1' HD21 ' A' ' 195' ' ' LEU . 17.1 p-10 -103.07 22.46 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.649 0.261 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.622 HG12 HG21 ' A' ' 161' ' ' ILE . 3.0 mp -64.1 91.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 171.69 13.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.769 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.86 -6.31 51.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.538 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.71 1.79 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -123.87 -9.61 7.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.102 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.63 128.83 55.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.4 mt -135.46 149.15 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.756 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.779 HD21 HD11 ' A' ' 341' ' ' LEU . 50.2 mt -86.52 147.83 25.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.281 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -65.8 125.75 26.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -94.95 -42.81 8.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -30.25 66.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.467 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -141.22 69.24 27.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.432 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.51 108.3 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.5 -45.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.082 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 339' ' ' LEU . 40.6 mt-30 -149.62 -166.52 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 111.205 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.9 p -109.91 148.24 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 14.4 m-85 -116.85 156.93 26.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.351 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.817 HD21 ' OD1' ' A' ' 177' ' ' ASP . 22.3 tp -109.14 115.84 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 184' ' ' LEU . 13.1 m -118.5 145.93 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.47 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.15 100.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.252 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.505 ' CD1' ' CE1' ' A' ' 175' ' ' HIS . 2.9 m-85 -86.65 -20.27 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 65.21 14.64 59.71 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -146.61 -66.35 0.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.38 87.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.295 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -131.0 149.01 52.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -95.82 82.82 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.846 ' CD1' HG13 ' A' ' 174' ' ' VAL . 41.5 p90 -44.87 -29.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.612 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.5 t -103.54 88.98 1.94 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.627 ' HG2' HG13 ' A' ' 209' ' ' VAL . 53.8 Cg_endo -69.01 -167.11 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.633 2.222 . . . . 0.0 112.284 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.66 30.52 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.34 99.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.513 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.627 HG13 ' HG2' ' A' ' 206' ' ' PRO . 6.2 m -138.46 138.95 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.64 27.49 5.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 56.48 78.17 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.047 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -158.82 83.92 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 131.01 16.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.96 91.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.551 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.0 OUTLIER 60.86 79.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.97 107.22 40.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.85 97.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.558 2.172 . . . . 0.0 112.469 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -127.12 30.31 5.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 61.14 35.01 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 62.1 m 63.22 121.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.448 ' CD2' ' HA ' ' A' ' 238' ' ' PRO . 0.7 OUTLIER -62.51 -44.48 96.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.408 ' CB ' ' HB1' ' A' ' 232' ' ' ALA . 5.2 t70 -119.26 103.36 9.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.63 -168.44 0.61 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 226' ' ' GLU . 2.0 m 61.29 162.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.894 HG23 HD22 ' A' ' 265' ' ' LEU . 3.7 tp -130.13 15.87 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.499 ' HA ' HD21 ' A' ' 265' ' ' LEU . 43.8 tt0 -74.55 -34.82 63.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 226' ' ' GLU . 73.0 m-85 -157.59 30.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -76.11 132.62 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.82 172.25 10.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -53.6 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -42.26 90.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.408 ' HB1' ' CB ' ' A' ' 222' ' ' ASP . . . -63.26 -32.79 74.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.216 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.5 -36.53 84.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.724 ' HB3' HG23 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -101.67 12.98 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.392 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.31 31.45 59.55 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.801 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 234' ' ' ASN . 38.7 t -90.6 113.28 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.106 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.05 154.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.448 ' HA ' ' CD2' ' A' ' 221' ' ' HIS . 48.5 Cg_endo -68.78 158.68 56.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.578 2.186 . . . . 0.0 112.254 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.57 ' O ' HG11 ' A' ' 174' ' ' VAL . 18.9 m -67.22 113.09 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -134.59 -57.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -87.58 -24.87 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.6 -32.11 64.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.563 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -38.12 74.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.444 HD12 ' CD1' ' A' ' 309' ' ' LEU . 57.9 mt -80.6 -33.48 35.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.57 -37.81 79.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.44 -39.67 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.875 HD23 ' OH ' ' A' ' 302' ' ' TYR . 49.6 tp -64.36 -45.43 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.42 92.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.439 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 25.4 m-85 -78.81 -25.7 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.67 -43.25 84.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.279 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.41 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.17 -49.62 76.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.019 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.538 HD11 ' SD ' ' A' ' 303' ' ' MET . 3.6 mt -63.99 -28.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.364 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.668 ' HB2' HD11 ' A' ' 259' ' ' LEU . 9.0 tm0? -80.12 -40.19 27.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.002 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 36.2 m0 -82.29 -30.85 30.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.439 ' HG ' HG21 ' A' ' 154' ' ' VAL . 28.9 mt -79.79 -44.04 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.05 0.62 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.449 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.71 97.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.5 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 64.07 154.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 1.008 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -137.77 171.28 8.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.56 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 45.3 Cg_endo -68.89 61.73 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.411 2.074 . . . . 0.0 112.633 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 1.008 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.6 p90 178.12 -37.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -98.09 22.23 9.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.437 179.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.82 -55.83 6.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.958 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -132.22 -26.41 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.482 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.894 HD22 HG23 ' A' ' 225' ' ' ILE . 66.0 mt 71.93 12.27 6.11 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.208 0.528 . . . . 0.0 109.69 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -84.77 -14.43 48.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.273 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.456 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -134.92 101.24 11.61 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.52 19.27 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.724 2.283 . . . . 0.0 112.724 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -45.67 17.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -82.09 -26.46 33.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.617 HG11 ' CD1' ' A' ' 225' ' ' ILE . 11.3 t -61.72 -44.22 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -71.47 -44.34 64.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -66.51 -41.25 89.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.981 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 278' ' ' TYR . 75.5 m -63.17 -40.5 97.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -61.98 -45.91 91.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.044 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 11.5 mt -70.88 -46.08 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -59.59 -51.61 69.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.834 ' CD1' HD12 ' A' ' 285' ' ' LEU . 16.3 m-85 -60.43 -31.87 70.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -59.43 -33.26 71.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.407 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.19 23.07 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.868 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -139.16 37.91 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.609 HG21 ' CG ' ' A' ' 304' ' ' GLU . 7.0 mm -47.09 -43.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.8 -47.74 36.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.073 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.7 -33.61 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.834 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.2 tt -64.33 -43.63 94.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 3.5 mmt -65.48 -32.52 74.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.984 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.75 -27.03 31.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.139 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -54.84 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.34 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 252' ' ' ILE . 68.2 m -76.42 -41.22 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.52 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.84 158.71 34.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 177.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.612 2.208 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -108.01 -66.24 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -59.69 -35.12 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -60.27 143.52 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -63.8 148.86 94.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.11 158.83 55.23 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -94.2 20.84 45.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.568 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.35 9.2 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.526 0.203 . . . . 0.0 111.402 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.704 HG22 ' CG ' ' A' ' 303' ' ' MET . 34.2 mm -79.52 -40.76 21.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.446 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -48.04 -45.77 32.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.312 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -59.85 -39.77 86.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.63 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.875 ' OH ' HD23 ' A' ' 247' ' ' LEU . 70.4 t80 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.704 ' CG ' HG22 ' A' ' 299' ' ' ILE . 1.4 mtp -64.73 -45.72 85.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.595 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.609 ' CG ' HG21 ' A' ' 282' ' ' ILE . 2.1 mt-10 -58.13 -51.89 67.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.846 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.7 p -58.07 -53.59 56.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 302' ' ' TYR . 61.1 t -56.32 -24.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.154 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -43.1 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.286 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.78 -11.98 60.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.689 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.546 HD23 ' HG2' ' A' ' 314' ' ' LYS . 15.9 mt -48.85 131.7 18.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.222 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.13 165.86 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.789 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.95 30.9 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.5 t -128.42 -44.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.49 -75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.546 ' HG2' HD23 ' A' ' 309' ' ' LEU . 9.2 tptt 58.9 64.51 3.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.47 88.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.345 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 2.8 tp -140.13 17.64 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -60.07 -31.63 70.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.75 -46.48 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.779 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.49 -40.2 90.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.906 ' HA ' HD12 ' A' ' 323' ' ' ILE . 34.6 mt -55.55 -48.15 75.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.476 ' HG2' HD22 ' A' ' 159' ' ' LEU . 7.7 ttm105 -57.46 -34.56 69.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.876 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -38.52 71.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 320' ' ' LEU . 37.5 mt -57.07 -47.91 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 158' ' ' SER . 30.6 mt -79.78 -22.0 43.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.462 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.634 ' O ' HD23 ' A' ' 325' ' ' LEU . 7.2 tt -82.68 -40.49 20.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.688 0.28 . . . . 0.0 111.109 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.92 -39.42 90.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.94 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -60.32 -26.34 63.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.5 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 155' ' ' LEU . 69.9 mt -48.44 -27.99 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -81.28 -31.08 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.73 -26.35 65.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.297 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.458 HG21 ' HB3' ' A' ' 151' ' ' ARG . 10.6 pt -106.97 22.75 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 53.25 45.69 64.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.738 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.7 t -118.33 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.57 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.959 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.79 133.85 51.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -164.89 -60.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -176.89 35.33 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.546 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 136.43 33.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.701 0.286 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER 179.17 -24.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.69 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -51.96 -23.57 5.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.801 HD13 ' CD1' ' A' ' 141' ' ' ILE . 1.0 OUTLIER 70.88 10.95 7.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.282 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.6 t 56.69 86.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.808 0.337 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 343' ' ' VAL . 5.6 m -152.16 88.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 343' ' ' VAL . 35.4 m 43.31 31.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.587 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.09 -44.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -60.35 -31.44 70.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 82.02 46.5 6.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.519 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -83.08 58.74 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.75 -33.11 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 351' ' ' ALA . 0.4 OUTLIER -62.02 157.78 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.431 ' HB2' ' HE2' ' A' ' 350' ' ' LYS . . . 59.49 78.53 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.039 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.12 -179.44 7.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 353' ' ' THR . 9.4 t -110.66 108.83 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.63 134.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 60.9 p -127.52 -46.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 162.77 22.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.85 19.98 19.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.65 -74.7 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 178.67 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.22 78.84 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.88 -173.58 2.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 1.3 pt -98.39 30.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -117.21 31.58 6.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -146.46 145.17 30.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.96 -67.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -118.14 -176.67 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.777 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -128.23 86.59 57.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.03 -38.85 6.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.574 2.183 . . . . 0.0 112.24 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 70.6 137.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 370' ' ' VAL . 10.1 m -130.5 104.16 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.31 118.21 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.72 -69.59 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.956 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 3.8 m -93.23 147.77 22.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -118.85 -66.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -164.01 157.01 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -58.87 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -103.11 136.51 42.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.08 -62.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.68 89.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -45.46 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -81.69 176.34 9.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.961 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.52 -38.55 71.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 58.02 -171.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.055 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 8.0 mt 69.47 -64.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.93 40.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 1.4 m -117.96 -39.9 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -75.21 90.06 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.7 p -147.28 31.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.18 137.66 19.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 43.9 p -97.87 -176.64 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.8 146.99 4.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 -55.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -161.27 102.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.4 139.04 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.9 127.44 55.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.942 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 57.8 p -62.54 132.52 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 17.8 m -145.71 132.66 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -109.74 122.8 6.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.545 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 4.2 p -79.72 95.83 6.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.2 t -71.15 -54.41 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 92.13 -62.27 2.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.41 148.04 39.32 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.71 116.78 4.84 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.537 2.158 . . . . 0.0 112.34 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.87 123.98 26.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 m -111.71 179.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -105.13 87.74 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.19 88.27 7.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.04 70.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.61 127.21 54.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 123.96 34.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.059 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.71 130.96 50.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.507 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.58 78.78 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 126.83 29.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.9 t -97.71 107.88 20.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -102.18 120.41 40.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.7 92.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.038 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -110.17 160.16 16.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -125.99 113.46 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -104.38 31.03 4.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.57 -176.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.32 123.85 29.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.95 -40.19 87.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -139.4 -80.31 0.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.865 ' CE2' HG21 ' A' ' 29' ' ' ILE . 8.4 m-85 -126.29 134.01 51.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.849 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.44 -178.37 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.67 127.1 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.98 22.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -58.87 139.84 56.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' A' ' 38' ' ' LYS . 21.7 mm -100.34 136.39 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.865 HG21 ' CE2' ' A' ' 23' ' ' PHE . 4.2 pt -117.89 154.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.088 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 3.1 t -101.81 136.94 40.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -93.77 -164.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -41.37 43.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -75.25 -6.63 50.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.429 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 4.2 tttp 89.59 27.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.6 OUTLIER -75.16 178.36 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.154 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.63 79.6 1.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.39 . . . . 0.0 110.591 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.452 ' HB2' HG13 ' A' ' 29' ' ' ILE . 80.5 m95 -76.51 136.73 39.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.952 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -96.88 129.14 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 23' ' ' PHE . 21.6 t -85.95 128.54 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.7 -122.58 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 53' ' ' LEU . 3.9 mm? -100.57 154.42 37.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 61.4 Cg_endo -73.1 105.49 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.615 2.21 . . . . 0.0 112.362 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -98.54 -28.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.99 -100.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.558 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.75 78.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.841 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.95 28.82 5.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.89 -42.79 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.507 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 -56.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 110.936 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.34 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -160.39 90.67 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -111.83 137.53 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 23' ' ' PHE . 44.2 m-85 -143.74 172.22 13.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.804 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 66' ' ' ALA . 25.2 mt -69.65 158.26 35.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.68 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -124.45 152.37 43.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.48 156.79 43.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.4 ptp -97.47 26.42 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.29 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 p -134.45 35.74 3.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.6 30.91 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -131.26 179.07 6.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -99.13 29.89 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' A' ' 38' ' ' LYS . 24.0 t 68.3 -68.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.51 179.03 21.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.559 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -92.54 48.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.482 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -158.38 -69.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.695 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . 63.27 139.32 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.93 -4.74 13.51 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.667 2.245 . . . . 0.0 112.816 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 11.8 m -149.65 157.11 42.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.564 HG13 ' CB ' ' A' ' 133' ' ' ARG . 29.7 m -120.27 144.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 HD13 ' A' ' 130' ' ' ILE . 11.4 p -119.39 121.11 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -98.07 116.19 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.608 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 11.9 t -113.07 139.32 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.309 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 136.52 15.96 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.686 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.51 96.6 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.389 2.059 . . . . 0.0 112.317 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 t 179.63 177.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.24 -42.58 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.12 95.28 2.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.05 -147.98 5.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.488 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.16 -23.09 39.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.528 2.152 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.545 HD23 ' HG3' ' A' ' 127' ' ' ARG . 8.4 tp -60.1 -33.2 71.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -42.14 78.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.8 p -70.88 -30.15 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -75.02 -42.31 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.3 mm? -59.2 -51.49 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -59.54 -46.21 89.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 198' ' ' TYR . 12.2 t80 -54.67 -50.68 67.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.674 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 24.7 m-85 -59.81 -41.48 91.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.415 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -79.95 -17.79 52.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -47.41 69.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.486 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.644 ' HB1' ' CE1' ' A' ' 171' ' ' HIS . . . -145.03 -32.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -53.86 -21.8 8.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -51.34 125.26 25.53 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 -25.4 15.34 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.491 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.4 -44.01 92.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.131 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.28 -43.13 24.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.282 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.753 HG22 HD11 ' A' ' 100' ' ' ILE . 30.2 mt -58.42 -48.34 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -52.28 -39.53 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.043 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' THR . 0.1 OUTLIER -75.33 -29.2 59.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -76.62 -43.98 36.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.753 HD11 HG22 ' A' ' 96' ' ' ILE . 34.5 mt -65.85 -37.47 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.8 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' LYS . 16.6 p -82.02 -36.99 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.433 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.71 -2.5 24.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.4 mttm 59.51 31.34 20.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 100' ' ' ILE . 11.7 mt -49.39 -30.88 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.68 -55.6 0.51 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.026 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CD1' ' OE1' ' A' ' 192' ' ' GLN . 6.8 t80 -150.68 139.8 21.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.979 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' A' ' 167' ' ' TYR . 9.5 tp -119.72 162.19 19.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.61 19.14 42.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.97 125.25 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 149.13 37.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.369 2.046 . . . . 0.0 112.262 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.4 115.88 25.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -86.9 129.61 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.721 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.7 m95 -107.58 -40.91 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.77 -174.66 46.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.1 p -132.86 169.0 17.39 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -158.96 175.84 35.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.977 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.83 150.83 36.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -141.17 141.61 34.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.983 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.61 136.07 54.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -138.27 126.27 22.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.29 18.59 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.322 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 10.39 54.72 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.861 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -96.21 159.37 14.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 110.711 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.5 m -111.34 123.11 49.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.492 ' O ' HD23 ' A' ' 118' ' ' LEU . 12.9 m-85 -122.12 136.5 54.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.793 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.545 ' HG3' HD23 ' A' ' 80' ' ' LEU . 15.5 tpt180 -117.95 125.12 49.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.806 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CB ' HG22 ' A' ' 72' ' ' VAL . 29.5 p90 -133.16 165.84 23.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.454 ' HB2' HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -134.65 144.77 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.211 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 70' ' ' VAL . 7.2 mm -101.53 111.64 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.2 173.06 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.141 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.35 127.69 32.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.564 ' CB ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.65 176.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 184' ' ' LEU . 54.9 m-85 -147.42 175.82 10.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.663 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.21 -81.67 1.6 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.461 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.6 t -149.58 130.51 14.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.837 0.351 . . . . 0.0 110.582 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.16 165.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.713 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.693 HD22 HD12 ' A' ' 141' ' ' ILE . 2.8 mt -77.34 -14.07 59.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.675 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.43 -33.25 29.86 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.05 0.453 . . . . 0.0 109.932 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -75.83 -31.3 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.824 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.755 HG21 HD22 ' A' ' 341' ' ' LEU . 12.2 mt -68.93 -26.74 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 24.1 t80 -71.17 -43.92 66.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -29.9 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.4 67.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.219 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-20 -96.32 21.03 9.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.039 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.41 47.92 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.401 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 10.2 tttt 64.7 18.2 11.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.25 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 13.7 mtp85 -138.01 -170.67 2.84 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.002 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.2 OUTLIER -137.55 -166.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.675 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 m -129.35 151.7 49.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -62.22 -30.7 71.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -30.99 62.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -51.24 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 150' ' ' SER . 21.9 t -60.33 -48.89 86.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.3 mt -59.58 -43.87 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.727 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 tp60 -68.47 -54.5 16.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 341' ' ' LEU . 11.6 mt -60.19 -42.47 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.699 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.695 ' OG ' HD11 ' A' ' 247' ' ' LEU . 16.1 m -55.58 -42.47 74.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.8 mt -60.02 -49.72 76.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.589 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 21.4 mmt-85 -60.72 -42.0 96.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.817 ' HA ' HD12 ' A' ' 164' ' ' ILE . 17.8 mt -65.19 -36.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.642 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.0 mt -60.23 -39.71 87.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.535 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -34.61 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 161' ' ' ILE . 9.7 mt -74.54 -42.87 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 243' ' ' ASP . 11.4 mt -54.34 -32.24 56.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.802 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' CD2' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -73.66 -32.79 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.578 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.619 ' CD2' HD21 ' A' ' 108' ' ' LEU . 57.1 t80 -70.91 -49.89 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 165' ' ' LEU . 34.2 pt -63.23 -27.71 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.529 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -72.8 -40.47 65.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 -14.77 62.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.644 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 57.5 m-70 -101.42 2.86 39.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.152 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 76.34 43.37 0.15 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 111.0 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.99 129.08 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.877 HG21 ' HG3' ' A' ' 240' ' ' ARG . 28.9 m -142.2 169.44 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.1 m170 65.23 48.83 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.39 -10.86 54.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.897 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 76.08 69.33 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.984 0.421 . . . . 0.0 111.026 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.661 HD11 HD21 ' A' ' 165' ' ' LEU . 2.4 mp -73.97 98.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 183' ' ' LEU . 23.6 mttp -144.38 -179.55 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.675 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -82.32 -0.61 46.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.436 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.29 -3.38 18.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 110.833 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.577 ' O ' HG22 ' A' ' 196' ' ' VAL . 35.2 m-20 -126.16 -2.15 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 179' ' ' LYS . 9.4 mt -108.36 113.56 26.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.997 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.813 ' C ' HG23 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -122.82 144.71 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.45 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.851 HD23 ' HB ' ' A' ' 193' ' ' VAL . 1.3 mt -90.48 149.0 22.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.349 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 9.9 m-20 -67.89 126.18 28.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -86.9 -60.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.417 ' HB2' ' NH1' ' A' ' 133' ' ' ARG . 10.4 mmtt -63.79 -30.83 71.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -130.34 71.71 82.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.2 97.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.551 2.167 . . . . 0.0 112.057 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.19 -53.33 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 339' ' ' LEU . 1.4 mt-30 -150.86 -177.42 5.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 185' ' ' LEU . 7.4 p -110.0 141.28 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.681 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.409 ' CE1' ' OD1' ' A' ' 186' ' ' ASN . 3.3 m-85 -106.97 153.8 22.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.125 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.6 tp -105.99 116.14 31.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 182' ' ' ASN . 7.6 m -88.57 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 198' ' ' TYR . 1.2 t70 63.76 129.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.425 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 30.1 m-85 -162.56 -44.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -55.89 -25.81 46.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.704 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 222' ' ' ASP . 0.3 OUTLIER -97.07 33.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 111.096 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.59 -110.29 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.19 119.38 8.88 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.809 0.337 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.66 49.49 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.417 ' CE2' ' NH2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER 54.74 83.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.5 t 63.93 133.41 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.806 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.39 -31.82 10.92 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.502 2.134 . . . . 0.0 112.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -121.61 -65.84 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.66 -41.88 1.84 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.465 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 210' ' ' HIS . 30.9 m -61.05 -42.9 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.37 . . . . 0.0 111.116 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.445 ' N ' HG23 ' A' ' 209' ' ' VAL . 10.0 p80 -95.35 151.84 18.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 -26.18 9.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.05 174.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.571 ' HB2' HG13 ' A' ' 236' ' ' VAL . 53.9 p90 -68.05 -175.78 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.24 -47.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.966 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.557 ' O ' HG22 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -92.0 174.54 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.016 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.86 166.12 16.1 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.56 71.35 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.501 2.134 . . . . 0.0 112.288 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.68 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -59.9 2.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 18.2 m 63.57 135.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -60.63 3.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.442 ' HB2' HD21 ' A' ' 200' ' ' LEU . 33.0 t0 -153.73 -58.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.91 -159.68 1.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.2 p -154.39 -46.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.769 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tt -174.56 36.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HA ' HD13 ' A' ' 265' ' ' LEU . 7.5 pt-20 -95.99 62.85 2.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 226' ' ' GLU . 12.6 t80 70.98 31.97 2.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 41.7 p -100.15 179.75 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 160.16 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.29 -40.29 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -78.13 -28.65 48.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.18 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -58.07 -39.79 79.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -97.02 -5.63 37.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 83.58 -2.7 86.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.718 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 213' ' ' TYR . 3.5 t -78.23 157.77 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.807 0.336 . . . . 0.0 111.167 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -164.99 78.33 1.34 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.45 10.66 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.73 2.287 . . . . 0.0 112.878 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.0 p -153.61 163.24 40.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.877 ' HG3' HG21 ' A' ' 174' ' ' VAL . 0.0 OUTLIER -113.88 -11.83 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.94 -13.48 61.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.315 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.36 -25.93 55.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.607 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.663 ' HB3' HD22 ' A' ' 165' ' ' LEU . 0.8 OUTLIER -55.69 -31.86 62.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.977 0.418 . . . . 0.0 110.838 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 320' ' ' LEU . 21.3 mt -80.58 -30.45 36.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.922 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.39 -32.56 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 29.3 mt -69.59 -37.55 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.186 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.739 HD23 ' OH ' ' A' ' 302' ' ' TYR . 40.7 tp -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.83 -41.75 94.23 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -71.34 -29.03 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -37.18 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.593 ' SD ' HD12 ' A' ' 299' ' ' ILE . 1.8 mtt -68.35 -39.7 81.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.716 HG22 HD23 ' A' ' 259' ' ' LEU . 7.4 mm -62.25 -39.32 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.15 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.836 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.8 tm0? -80.27 -34.97 36.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -76.41 -48.12 20.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.414 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 75.2 mt -73.46 -36.21 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.55 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -96.39 -13.92 22.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.573 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.55 94.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.261 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.0 146.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 110.653 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.924 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -136.91 166.15 29.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.212 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.01 62.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.953 2.435 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.924 ' CH2' HD22 ' A' ' 259' ' ' LEU . 0.7 OUTLIER -178.54 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 261' ' ' TRP . 1.8 tt0 -108.94 18.22 20.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.069 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -66.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.82 -27.34 3.07 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.428 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 225' ' ' ILE . 19.8 mt 77.18 7.94 2.91 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -16.42 61.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.47 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 33.4 t70 -145.06 91.19 5.99 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 38.5 Cg_endo -66.71 -7.28 17.71 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.685 2.256 . . . . 0.0 112.841 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.84 -50.11 69.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 110.965 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.47 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 5.5 p90 -83.88 -26.22 29.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.769 ' CG1' HD11 ' A' ' 225' ' ' ILE . 25.9 t -60.38 -40.85 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -48.67 23.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.975 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -61.6 -35.16 77.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.071 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 m -72.09 -33.7 68.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -70.2 -49.73 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.046 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.4 mm -61.15 -36.59 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -75.54 -52.12 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -55.4 -35.09 64.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -29.69 65.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.25 22.68 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.94 43.57 2.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.7 mt -55.48 -37.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.18 64.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 5.4 t -71.12 -42.79 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.5 pp -65.23 -31.46 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.79 0.329 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mmt -66.81 -49.36 66.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.716 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -68.68 -31.4 70.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.247 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -53.76 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.102 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.466 ' O ' HG23 ' A' ' 256' ' ' THR . 81.0 m -66.15 -41.16 90.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.155 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.0 146.19 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 -166.86 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.51 45.28 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -45.73 19.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -149.87 167.15 27.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -86.78 156.57 55.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.86 118.41 5.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.593 2.195 . . . . 0.0 112.192 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -157.69 -49.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.67 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.69 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.0 mm -79.43 -41.69 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.227 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -44.57 -42.36 7.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.869 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -67.23 -38.71 85.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.379 . . . . 0.0 110.58 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.739 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.0 t80 -70.5 -44.52 67.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.716 ' CB ' HD13 ' A' ' 282' ' ' ILE . 47.2 mmm -68.73 -31.93 71.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.84 -43.07 94.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.328 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.881 ' O ' HD12 ' A' ' 309' ' ' LEU . 5.5 p -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.624 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 302' ' ' TYR . 79.5 t -79.45 -24.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -36.68 23.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.738 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.1 -27.89 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.54 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 305' ' ' THR . 0.7 OUTLIER 47.6 -167.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.124 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.667 ' HB2' HD11 ' A' ' 316' ' ' LEU . 8.6 t70 -106.79 54.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 56.94 25.9 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 4.4 m 56.19 25.66 9.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -54.04 7.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 316' ' ' LEU . 1.1 mmmm -136.51 155.42 76.97 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.72 132.15 29.8 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.464 2.11 . . . . 0.0 112.223 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 310' ' ' ASP . 7.7 mp -97.06 29.23 3.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 166' ' ' GLU . 4.1 m-85 -66.53 -29.7 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -40.53 67.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -42.76 48.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.878 ' HA ' HD12 ' A' ' 323' ' ' ILE . 39.3 mt -58.27 -41.38 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.458 ' CG ' HD22 ' A' ' 159' ' ' LEU . 15.0 ttp180 -57.28 -47.36 81.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -39.13 80.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 320' ' ' LEU . 52.0 mt -57.37 -46.42 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.055 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 155' ' ' LEU . 37.4 mt -75.99 -50.36 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.611 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -53.73 -49.89 67.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -56.29 -42.35 77.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.995 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.94 -29.71 65.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 155' ' ' LEU . 19.7 mt -64.75 -35.02 79.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.2 66.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.247 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.49 32.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.1 70.14 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.85 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.61 101.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 39.23 3.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 325' ' ' LEU . 6.5 p-10 -90.44 70.1 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.9 -44.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 174.94 39.05 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.342 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -79.88 121.19 25.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER -162.63 -9.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.204 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 341' ' ' LEU . 5.6 m-20 -60.5 -30.74 69.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 157' ' ' LEU . 1.1 mt 70.81 -52.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 18.3 t 65.89 101.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 344' ' ' VAL . 19.0 m -130.19 -44.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 343' ' ' VAL . 30.2 t -111.9 -46.51 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.79 150.87 28.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -157.41 -55.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.9 62.44 0.29 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.463 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -132.26 53.64 0.8 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mt -130.97 83.16 2.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -160.45 -71.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.851 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -151.41 155.33 38.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 85.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.75 123.24 44.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 355' ' ' THR . 29.3 mt 63.8 158.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 354' ' ' ILE . 19.4 m 61.12 163.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 355' ' ' THR . 1.9 tttt -125.38 134.41 52.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -114.58 50.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.78 93.64 4.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 155.73 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -131.64 93.54 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -160.37 153.39 21.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.4 mp -106.53 -55.1 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -167.24 106.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.32 129.66 18.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 149.66 43.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -88.16 136.05 33.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.12 86.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.74 111.0 2.9 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.558 2.172 . . . . 0.0 112.271 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -120.52 179.88 16.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 371' ' ' GLU . 11.1 p -171.34 -44.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.085 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . 0.469 ' N ' HG13 ' A' ' 370' ' ' VAL . 0.7 OUTLIER -109.39 -53.36 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.26 32.81 20.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 15.7 p -138.99 -65.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.54 136.56 43.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -178.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.9 m 61.24 171.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -82.78 -64.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.5 m -110.8 -66.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -143.62 -57.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 44.9 m -99.04 -61.38 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -153.03 -58.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.28 126.91 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -150.26 110.91 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 384' ' ' ILE . 20.1 mt -107.03 31.03 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.67 169.15 11.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -65.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 387' ' ' ARG . 15.4 mtm105 -126.81 -53.92 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.37 171.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -152.77 160.32 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 391' ' ' ARG . 2.2 m -90.1 169.5 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 390' ' ' THR . 29.1 mtm180 64.15 39.26 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -101.72 -34.42 9.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -109.23 158.47 17.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.809 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 395' ' ' GLN . 12.9 m -136.43 -47.1 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.443 ' N ' HG23 ' A' ' 394' ' ' VAL . 8.5 mt-30 -94.35 131.97 39.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.1 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.901 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 1.3 m 60.38 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 8.1 m -169.51 132.81 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -138.62 -44.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.3 m -70.12 -40.25 74.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -150.28 127.08 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 177.8 98.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -178.57 -61.61 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.253 . . . . 0.0 110.934 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 47.5 Cg_endo -68.59 117.53 5.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.498 2.132 . . . . 0.0 112.294 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.8 ttt-85 -164.73 149.19 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.78 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.03 149.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -70.59 164.72 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -175.56 -42.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.0 121.45 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.18 156.77 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.962 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.95 -175.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.028 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.99 139.02 6.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.533 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.07 30.14 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -61.02 115.13 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.9 m -143.57 92.83 2.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.21 105.45 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.78 169.11 4.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 -178.65 3.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.525 ' HE ' HD21 ' A' ' 19' ' ' LEU . 4.8 ttt180 -137.94 86.4 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.28 140.06 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -172.25 97.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -149.2 157.22 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -125.69 -57.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -96.42 -60.12 1.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' HD2' HG21 ' A' ' 39' ' ' VAL . 10.2 p90 -166.04 107.09 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -134.1 -53.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 41' ' ' LEU . 15.0 t -129.44 117.36 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.71 30.0 27.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -132.54 139.1 47.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.734 0.302 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.641 HG21 ' HB3' ' A' ' 36' ' ' GLU . 35.2 mt -103.71 140.09 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.928 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.7 pt -119.86 154.55 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.6 p -95.65 136.92 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 37' ' ' TRP . 21.7 p-10 -94.54 -148.29 0.27 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.985 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -85.67 -37.91 18.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.242 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.39 2.34 32.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.856 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.2 mmpt? 83.08 15.47 0.34 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -63.15 169.89 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -118.21 76.13 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.018 0.437 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 31' ' ' ASP . 44.5 m95 -67.11 142.67 57.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.787 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 62' ' ' VAL . 23.2 mttm -105.46 132.66 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 ' HD2' ' A' ' 23' ' ' PHE . 17.0 t -89.8 130.02 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -77.56 -106.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.858 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.638 ' HA ' HG22 ' A' ' 25' ' ' VAL . 2.3 mt -121.99 162.25 38.18 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.754 0.311 . . . . 0.0 110.995 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 38.4 Cg_endo -66.78 140.38 55.58 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.666 2.244 . . . . 0.0 112.29 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.694 HG13 HG22 ' A' ' 51' ' ' ILE . 6.5 pt -142.57 30.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.75 141.58 3.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -115.89 144.02 44.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.69 93.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.393 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.26 -66.07 2.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.436 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.45 -76.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.79 0.328 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 52' ' ' TYR . . . -109.71 -79.35 1.08 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.742 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER 78.34 -55.71 0.48 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 111.177 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 50' ' ' CYS . 19.7 mm -135.63 127.4 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.361 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 70' ' ' VAL . 14.2 m-85 -146.43 145.8 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' H ' ' A' ' 41' ' ' LEU . 81.0 mt -71.82 136.55 47.07 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.352 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -114.55 157.22 23.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.507 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.36 145.99 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.673 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ptm -98.2 40.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.8 t30 58.72 35.86 24.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -65.8 -67.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.43 -170.14 1.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -76.65 -38.82 53.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.85 131.84 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 47.7 t -74.32 -29.1 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.88 65.41 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -179.25 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 110.767 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 76.07 1.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -114.94 89.95 21.28 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.88 42.36 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.871 2.381 . . . . 0.0 112.807 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -149.71 157.13 42.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.733 HG13 ' HG2' ' A' ' 133' ' ' ARG . 4.8 m -132.05 144.9 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 52' ' ' TYR . 11.2 p -127.41 129.82 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.316 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -94.7 117.48 30.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.199 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 21.4 t -113.2 125.31 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 111.55 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -141.16 146.98 45.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 114.89 3.85 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -60.2 124.16 19.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.12 -73.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -79.36 -32.79 43.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.14 48.42 3.57 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.783 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 82' ' ' THR . 38.5 Cg_endo -67.7 -51.36 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.266 1.977 . . . . 0.0 111.643 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.1 tp -77.93 -21.44 51.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.821 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.78 -33.9 50.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.441 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 79' ' ' PRO . 1.8 t -74.68 -35.36 62.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -73.1 -35.29 66.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 mm? -72.67 -36.2 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -63.97 -47.98 78.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 173' ' ' TYR . 10.2 t80 -72.0 -35.7 69.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.727 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 1.7 m-85 -56.85 -50.47 72.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -74.98 -17.47 60.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.44 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -47.73 14.64 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -126.36 -19.64 4.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.727 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -92.61 21.4 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 113.25 35.08 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.57 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.76 -29.55 3.6 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 0.0 112.749 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -71.93 -39.38 69.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.83 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' A' ' 100' ' ' ILE . 50.1 mt -67.53 -49.78 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -29.66 61.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -78.8 -38.16 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -71.14 -42.69 68.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.025 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.6 mt -69.68 -36.43 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.84 60.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 98' ' ' LYS . 35.8 p -84.37 -30.28 25.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.342 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -4.16 17.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 100' ' ' ILE . 3.0 mtmp? 56.59 30.91 18.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.531 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.606 ' HB2' HG23 ' A' ' 100' ' ' ILE . 78.7 mt -45.56 -84.65 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.593 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER 175.16 -62.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.755 0.312 . . . . 0.0 110.984 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -169.13 -37.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 108' ' ' LEU . 4.2 tp 75.34 146.44 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.76 10.23 68.56 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.995 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.97 115.45 44.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.783 0.291 . . . . 0.0 110.939 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 141.07 8.42 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.484 2.123 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 122.26 26.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.42 131.36 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.4 -40.99 3.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.618 0.247 . . . . 0.0 111.551 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.75 171.64 38.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.804 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -132.66 164.48 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.603 0.239 . . . . 0.0 110.643 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -162.01 179.75 37.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.979 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -145.45 159.68 42.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.715 0.293 . . . . 0.0 110.77 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -144.53 141.65 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.957 0.408 . . . . 0.0 111.108 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.41 129.24 54.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 126.35 22.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.921 0.391 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 55.47 20.9 3.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.72 -0.18 64.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.85 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -96.23 151.15 19.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.759 0.314 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.6 p -101.26 127.33 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.203 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.831 ' O ' HD23 ' A' ' 118' ' ' LEU . 21.6 m-85 -113.57 147.9 37.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.635 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -124.34 125.17 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.77 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.928 ' CE1' HD12 ' A' ' 29' ' ' ILE . 20.7 p90 -135.29 162.45 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.231 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.503 ' HG3' HD11 ' A' ' 84' ' ' LEU . 16.0 tmm? -144.94 140.26 28.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.026 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.453 HG13 ' HB ' ' A' ' 70' ' ' VAL . 2.7 mp -99.11 129.82 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -133.31 173.06 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -55.75 138.19 48.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.733 ' HG2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -62.85 170.46 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -145.73 157.5 43.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.98 -74.69 1.24 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.5 p -148.53 135.1 19.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.82 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -57.31 152.48 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.841 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -57.24 -23.19 46.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.8 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 45.3 tt0 -63.75 -38.56 91.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.154 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -36.48 81.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.34 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 1.062 HD13 HD22 ' A' ' 341' ' ' LEU . 8.8 mt -73.85 -25.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.714 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 254' ' ' TRP . 13.1 t80 -76.42 -51.89 10.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.32 -29.99 70.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.58 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.45 63.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.21 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -96.16 19.77 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.002 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 80.97 48.01 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt 63.37 19.19 11.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.302 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 20.7 mtp180 -131.91 -178.58 4.95 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.868 ' CE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -139.06 -167.81 2.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.688 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.08 144.46 47.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.45 -31.27 63.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 331' ' ' ILE . 3.2 mtmt -74.93 -43.91 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.868 HG21 ' CE1' ' A' ' 149' ' ' PHE . 58.6 m -58.45 -51.82 68.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.5 t -58.22 -46.0 88.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.115 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.438 HD22 ' OE2' ' A' ' 298' ' ' GLU . 40.9 mt -65.3 -48.29 73.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -41.97 95.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.67 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 341' ' ' LEU . 23.7 mt -70.32 -38.98 75.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 324' ' ' LEU . 91.6 p -59.43 -34.55 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.787 HD12 HD11 ' A' ' 328' ' ' LEU . 13.0 mt -70.8 -46.77 62.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.466 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.626 ' HG3' HD23 ' A' ' 339' ' ' LEU . 14.9 mmt85 -61.32 -44.72 96.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.628 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.7 mt -64.85 -42.18 94.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.698 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 158' ' ' SER . 2.8 mt -55.52 -35.93 66.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -36.93 79.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.603 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 161' ' ' ILE . 5.1 mt -79.54 -38.71 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 162' ' ' LEU . 89.6 mt -58.17 -48.22 80.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.821 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -31.09 72.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -72.2 -47.91 47.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.829 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.47 -27.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -76.6 -33.43 58.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.357 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -15.86 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -102.39 3.11 37.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.867 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 74.17 45.24 0.21 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.891 0.377 . . . . 0.0 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -133.08 124.9 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 204' ' ' TYR . 28.3 m -132.2 165.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.067 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.585 ' O ' HD22 ' A' ' 200' ' ' LEU . 10.4 p-80 -150.37 -51.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.237 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.09 24.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.605 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.67 -80.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.584 0.23 . . . . 0.0 110.795 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.0 mt 44.57 95.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 183' ' ' LEU . 5.6 tttt -147.99 174.84 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.8 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -77.09 -1.0 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.593 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.8 t -111.97 1.94 16.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 0.0 110.551 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -123.4 -12.07 7.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.194 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 179' ' ' LYS . 4.5 mt -108.36 125.19 51.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.908 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 196' ' ' VAL . 0.9 OUTLIER -130.86 156.55 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 111.351 -178.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 141' ' ' ILE . 27.3 mt -90.31 149.84 22.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.05 129.68 40.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.942 0.401 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -73.07 -60.21 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -61.01 -20.84 62.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.534 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -136.52 78.23 44.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.54 80.46 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.534 2.156 . . . . 0.0 112.14 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.36 37.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.06 143.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 157' ' ' LEU . 4.0 p -109.95 147.99 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.162 0.506 . . . . 0.0 111.272 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 8.4 m-85 -126.12 156.89 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.652 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 183' ' ' LEU . 39.5 tp -104.01 115.9 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.659 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.77 HG21 HD11 ' A' ' 184' ' ' LEU . 30.9 m -113.76 142.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.1 t70 55.77 84.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -59.05 -21.05 58.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.119 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.713 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 71.49 9.06 68.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.758 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.6 OUTLIER -153.61 -58.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.734 0.302 . . . . 0.0 110.818 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.533 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 43.93 76.24 0.09 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -116.72 148.97 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -103.1 69.71 1.04 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.697 ' CD1' HG13 ' A' ' 174' ' ' VAL . 17.0 p90 -50.12 -43.16 51.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.11 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.91 -34.68 46.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.575 2.183 . . . . 0.0 112.277 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.23 34.63 4.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.44 -90.17 1.82 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.425 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.536 HG12 ' HG3' ' A' ' 211' ' ' LYS . 24.2 t -66.0 -29.78 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 63.74 34.72 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.536 ' HG3' HG12 ' A' ' 209' ' ' VAL . 14.5 mttm -77.21 166.66 22.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.44 -66.12 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.897 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.25 145.19 32.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -62.95 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER 60.04 96.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -163.24 72.78 1.94 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 100.84 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.568 2.178 . . . . 0.0 112.282 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.47 -70.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -56.63 10.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 76.9 m 60.76 94.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.808 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 45.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.473 ' HB3' ' HB1' ' A' ' 232' ' ' ALA . 1.8 m-20 -120.27 92.97 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 90.62 -134.11 12.16 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.505 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 -67.22 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.76 HD13 ' HG2' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -159.19 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.76 ' HG2' HD13 ' A' ' 225' ' ' ILE . 5.4 mm-40 -159.48 26.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.028 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 227' ' ' PHE . 37.7 t80 -95.07 24.32 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.622 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -142.43 -76.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.993 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.522 ' H ' HG23 ' A' ' 228' ' ' THR . 7.7 t -157.86 163.51 37.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.908 0.385 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.39 -30.51 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.628 ' OD1' HG21 ' A' ' 236' ' ' VAL . 19.3 t70 -64.29 -39.47 93.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 222' ' ' ASP . . . -67.49 -29.64 69.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.72 -25.48 61.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -88.92 12.87 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.475 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.98 28.13 72.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.642 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.628 HG21 ' OD1' ' A' ' 231' ' ' ASP . 22.0 t -88.44 129.29 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.691 0.282 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -76.98 -54.29 1.6 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.0 Cg_exo -54.39 88.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.449 2.099 . . . . 0.0 112.194 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.19 80.77 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -101.8 -24.81 14.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -17.76 41.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.236 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 246' ' ' ILE . . . -61.63 -30.31 74.37 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.78 -36.79 58.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 110.972 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.58 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 62.2 mt -80.74 -35.0 33.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -57.3 -43.71 83.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 242' ' ' GLY . 3.3 mt -59.9 -42.1 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.804 HD23 ' OH ' ' A' ' 302' ' ' TYR . 30.7 tp -61.1 -30.85 70.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -70.69 -37.36 67.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.366 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.412 ' CZ ' ' HE2' ' A' ' 275' ' ' LYS . 34.5 m-85 -78.55 -26.17 45.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.297 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.283 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.583 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -64.4 -51.07 65.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.189 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.6 mt -63.73 -33.53 62.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -80.02 -33.74 38.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 30.8 m0 -82.28 -48.74 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.415 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -70.93 -36.82 72.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.598 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 289' ' ' CYS . 0.5 OUTLIER -96.14 0.53 51.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.772 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 57.75 94.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.519 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 45.8 m80 63.52 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -132.97 168.52 17.53 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 59.2 Cg_endo -72.61 60.0 3.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.527 2.151 . . . . 0.0 112.534 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 259' ' ' LEU . 1.3 p90 178.15 -39.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.9 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -107.45 20.35 19.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.47 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.22 -62.29 1.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -128.57 -26.46 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.283 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 27.9 mt 75.53 10.2 3.5 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.08 0.466 . . . . 0.0 109.756 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -80.91 -16.45 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.515 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.11 81.81 37.69 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 33.4 Cg_exo -59.89 -14.77 29.11 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.791 2.328 . . . . 0.0 112.534 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.85 -50.45 45.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.254 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 6.0 p90 -84.04 -26.85 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.767 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 225' ' ' ILE . 39.5 t -60.62 -39.02 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.229 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -73.1 -45.28 58.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 276' ' ' ILE . 19.8 t70 -69.94 -42.73 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.104 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.6 t -60.74 -46.17 91.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 279' ' ' ARG . 0.0 OUTLIER -58.75 -51.61 69.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 273' ' ' ASP . 14.0 mt -53.12 -37.66 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.534 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.02 7.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.328 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 285' ' ' LEU . 9.8 m-85 -57.91 -36.98 73.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 275' ' ' LYS . 0.0 OUTLIER -55.77 -30.62 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 0.0 110.695 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.35 28.12 7.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 284' ' ' SER . 4.1 m120 -136.13 45.1 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.682 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.8 mt -50.43 -36.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.238 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 281' ' ' ASN . 0.3 OUTLIER -78.92 -42.25 27.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.96 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 285' ' ' LEU . 3.0 pp -68.7 -28.47 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.743 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.434 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.9 mmt -72.66 -51.62 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -24.82 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.336 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -48.3 11.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 111.179 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.501 ' HB3' HG21 ' A' ' 256' ' ' THR . 96.8 m -83.16 -41.25 18.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -104.18 153.45 38.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 -170.0 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.562 2.175 . . . . 0.0 112.349 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.05 -43.69 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.13 94.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -105.08 69.52 0.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 96.9 5.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.24 -34.42 21.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.261 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.83 78.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.935 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.438 ' OE2' HD22 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.83 -57.1 14.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.874 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.583 HD12 ' SD ' ' A' ' 251' ' ' MET . 27.1 mm -69.04 -35.31 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.434 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -52.21 -46.09 65.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -61.24 -37.47 83.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.859 ' O ' HG23 ' A' ' 306' ' ' VAL . 46.4 t80 -71.3 -36.17 71.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.682 ' CB ' HD13 ' A' ' 282' ' ' ILE . 0.6 OUTLIER -69.67 -38.06 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.587 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.53 -49.4 76.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.604 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.468 HG21 HD11 ' A' ' 323' ' ' ILE . 0.6 OUTLIER -59.39 -39.69 84.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.712 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 302' ' ' TYR . 22.5 t -73.82 -24.37 19.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.261 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -79.67 -43.16 23.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.32 -14.4 61.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.454 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.814 HD12 ' HA ' ' A' ' 306' ' ' VAL . 6.7 mt -52.56 93.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.74 -171.02 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.016 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.55 79.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 3.8 m 57.77 22.09 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.593 ' OE2' HD22 ' A' ' 309' ' ' LEU . 1.1 tm-20 53.22 97.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -85.87 127.39 62.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.2 95.0 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.372 2.048 . . . . 0.0 112.38 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 24.8 mt -108.95 31.41 5.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.58 ' CZ ' HD21 ' A' ' 244' ' ' LEU . 15.0 m-85 -61.64 -31.45 71.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -38.79 92.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -76.62 -44.33 34.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.764 ' HA ' HD12 ' A' ' 323' ' ' ILE . 84.4 mt -54.67 -42.18 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.525 ' HG2' HD22 ' A' ' 159' ' ' LEU . 3.4 tmt_? -58.54 -33.32 69.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.44 -32.84 58.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 320' ' ' LEU . 60.1 mt -61.16 -46.96 95.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.66 HD13 ' OG ' ' A' ' 158' ' ' SER . 41.0 mt -81.17 -23.81 37.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.384 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.613 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.53 -44.39 15.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.184 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.85 -29.11 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -75.36 -26.45 65.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.746 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.787 HD11 HD12 ' A' ' 159' ' ' LEU . 40.9 mt -51.65 -35.22 41.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -29.95 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.27 -30.58 71.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.7 HD12 ' HG2' ' A' ' 152' ' ' LYS . 14.5 pt -97.97 28.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.265 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.72 43.35 91.71 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.614 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 m -137.5 164.85 27.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -154.61 154.12 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.54 91.0 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -118.69 35.73 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.85 46.89 21.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.99 126.01 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.912 HD13 HD12 ' A' ' 341' ' ' LEU . 0.1 OUTLIER -97.74 16.4 20.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.255 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 3.9 t70 56.51 33.54 22.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.039 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 1.062 HD22 HD13 ' A' ' 141' ' ' ILE . 15.7 mt -96.47 62.2 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.688 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 67.5 m -58.85 -51.85 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.73 ' HB ' HG23 ' A' ' 141' ' ' ILE . 5.3 p 42.76 68.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.608 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 343' ' ' VAL . 34.5 m 43.69 41.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.698 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 59.67 -176.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.36 -63.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 168.1 89.68 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -123.19 -40.05 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.51 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 -41.44 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -143.87 172.99 12.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -170.88 106.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -97.74 166.19 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 60.4 p -130.48 151.72 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.2 pp -77.81 161.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.191 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 1.9 t -164.62 73.06 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -39.24 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -91.76 91.28 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.45 134.6 35.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 132.04 55.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.83 109.52 16.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -105.71 164.16 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 362' ' ' ILE . 3.4 mp -58.89 95.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.37 -35.36 6.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -128.56 103.52 7.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 60.3 m -118.64 -57.5 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 -53.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 60.21 101.48 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.3 -26.81 35.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.432 2.088 . . . . 0.0 112.26 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -102.11 75.27 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 24.8 m -85.89 145.85 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 111.173 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -177.03 -40.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -99.87 34.29 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 62.9 p -136.03 31.66 2.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.79 174.07 7.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -94.0 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.7 t 61.07 83.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -141.59 158.99 43.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.41 104.51 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.92 -55.94 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.72 156.69 22.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.505 ' HG2' HD11 ' A' ' 384' ' ' ILE . 10.5 tt0 -65.73 131.69 46.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -141.04 138.99 34.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 60.07 87.69 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.505 HD11 ' HG2' ' A' ' 381' ' ' GLU . 26.4 mt -112.18 -35.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.33 118.53 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.6 m -124.15 121.67 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -118.18 104.89 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 24.7 m -152.52 -46.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.15 175.46 7.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 9.3 t -116.8 159.71 21.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.66 146.97 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -85.92 178.95 7.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -137.67 150.59 47.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 394' ' ' VAL . 11.4 p -64.83 120.13 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.09 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 65.19 -77.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.929 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 2.7 m -147.85 169.23 20.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 12.0 p -151.03 141.63 22.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -169.8 150.64 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 4.1 p -76.42 131.37 39.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.1 169.39 24.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.71 174.49 50.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt 62.4 148.94 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.761 0.315 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.0 151.45 20.67 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.525 2.15 . . . . 0.0 112.217 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -104.12 130.98 51.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.987 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.8 137.97 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.04 -35.15 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -178.46 139.18 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.091 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.99 -71.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.97 95.42 4.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.804 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.15 -44.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.2 67.52 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -40.81 35.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 61.6 154.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.0 m -161.01 152.39 19.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -86.87 107.42 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.65 133.46 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -137.98 117.82 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mmt-85 -155.42 139.62 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -165.36 -66.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 mt -155.28 168.08 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.19 86.3 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -66.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.752 ' CE2' HG21 ' A' ' 29' ' ' ILE . 26.2 p90 -130.67 119.73 22.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.92 119.18 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.308 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 64.56 110.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.239 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.13 -21.65 42.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.896 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -95.18 147.48 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.09 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 36' ' ' GLU . 17.9 mt -113.88 142.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.896 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 24.9 pt -118.34 154.41 20.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.419 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 9.4 p -95.88 141.55 29.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.922 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -161.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.18 -39.91 24.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -78.8 -2.82 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.654 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 1.6 tttt 88.51 29.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' THR . 7.2 tttp -77.13 176.41 8.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.365 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB2' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -127.71 79.07 1.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.442 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.407 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.0 m95 -74.53 134.75 42.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.09 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -102.42 127.02 49.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 ' HD2' ' A' ' 23' ' ' PHE . 17.4 t -77.7 117.64 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.051 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -63.23 -105.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -122.53 159.42 52.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.868 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.526 ' HD2' HD23 ' A' ' 41' ' ' LEU . 55.6 Cg_endo -70.05 151.97 67.62 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.174 . . . . 0.0 112.334 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -145.68 30.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.167 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.75 163.24 32.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.544 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -172.0 83.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.42 49.91 1.01 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.59 -63.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -129.92 -57.15 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.95 -100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.424 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 7.7 m -134.53 80.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.743 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.431 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.4 mp -93.74 113.51 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.052 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 9.3 m-85 -135.93 172.29 13.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.0 mt -78.11 158.78 28.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.04 137.96 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.201 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -143.38 157.77 44.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 46.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -82.81 128.52 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 p -115.86 -39.04 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -93.03 -66.71 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.29 173.06 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.27 144.79 31.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 63' ' ' GLY . 21.5 t -66.45 155.58 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -175.62 82.88 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.473 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.2 30.67 20.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.12 31.38 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.61 48.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.07 45.69 1.95 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.572 2.181 . . . . 0.0 112.713 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.8 148.21 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.46 144.89 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.7 p -125.45 119.94 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 118.15 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.398 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.641 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 2.8 t -113.1 135.78 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.336 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.2 143.37 30.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.674 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.58 117.61 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.421 2.08 . . . . 0.0 112.307 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -71.58 109.78 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -157.32 -75.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -76.39 -27.65 56.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 90.33 46.12 4.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.878 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 43.6 Cg_endo -70.14 -53.19 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.234 1.956 . . . . 0.0 111.651 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.0 tp -71.37 -23.92 61.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.71 -29.2 62.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -70.68 -39.69 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.86 -32.51 74.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -69.28 -45.61 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.669 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -57.49 -40.07 77.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.599 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 64.3 t80 -72.16 -36.88 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -70.6 -41.19 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.32 -35.95 81.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.17 14.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.797 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -99.64 -49.58 4.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.847 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -76.61 2.82 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -55.93 121.14 38.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.52 0.2 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.27 -26.94 21.65 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.36 2.04 . . . . 0.0 112.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -79.34 -43.61 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -51.63 51.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.022 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.847 HD11 ' HA ' ' A' ' 91' ' ' ALA . 45.3 mt -57.12 -52.42 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.134 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.76 -31.96 7.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.97 -46.45 29.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.62 ' CG1' HG22 ' A' ' 96' ' ' ILE . 47.4 mm -56.04 -37.03 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -74.99 -27.76 60.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.1 m -74.61 -38.78 62.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.442 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -107.27 -3.5 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 55.44 24.88 7.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 108' ' ' LEU . 6.0 mt -52.22 -39.55 60.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.567 ' H ' HG23 ' A' ' 100' ' ' ILE . 7.7 ttmt 50.54 41.21 25.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 192' ' ' GLN . 36.7 t80 -177.38 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 105' ' ' LEU . 13.6 tp 60.87 155.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.622 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 164' ' ' ILE . . . -83.87 -3.81 89.07 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.1 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' A' ' 167' ' ' TYR . 43.2 t -77.98 114.3 40.7 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.685 0.242 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.64 151.87 4.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.391 2.061 . . . . 0.0 112.371 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.3 115.49 19.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -92.9 126.03 37.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 6.0 m95 -103.45 -40.82 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.76 -178.29 45.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.558 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 84' ' ' LEU . 2.6 p -135.57 159.47 41.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -145.45 -177.78 20.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.931 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 159.84 41.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -136.47 137.5 40.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 15.7 p-10 -118.05 125.54 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -138.23 126.14 22.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.09 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.38 21.33 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.491 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.3 57.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.985 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.4 mmtp -96.2 159.41 14.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.5 m -114.51 124.09 51.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.0 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -117.27 140.41 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -121.54 127.94 51.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.598 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.896 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.5 p90 -140.2 161.09 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.251 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.694 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.3 ttm -128.05 142.36 51.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.37 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 29' ' ' ILE . 19.5 mt -118.62 111.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.413 . . . . 0.0 111.336 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -125.46 173.27 9.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.34 132.5 20.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.99 143.16 55.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CD2' HD12 ' A' ' 184' ' ' LEU . 42.6 m-85 -111.34 179.91 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.76 -98.63 2.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.553 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 75.6 p -125.85 128.18 47.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.703 ' HB3' HD22 ' A' ' 184' ' ' LEU . 11.9 p30 -56.25 164.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.851 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -69.16 -21.36 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.549 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.638 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -51.91 -35.04 44.11 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.901 0.382 . . . . 0.0 110.429 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -77.83 -25.58 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.356 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.757 HD13 HD22 ' A' ' 341' ' ' LEU . 44.6 mt -73.94 -27.52 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.975 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -57.15 -45.65 83.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.695 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -27.99 60.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.31 -26.2 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -92.79 5.64 50.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.332 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.11 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.128 0.49 . . . . 0.0 110.671 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.07 16.33 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.722 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 145' ' ' ASN . 7.2 ptm180 -161.39 116.35 2.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 1.8 m-85 -57.34 174.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -106.8 158.44 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.626 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -59.2 -32.45 69.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -71.68 -47.78 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -58.28 -55.19 38.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.315 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.781 HG11 ' HB3' ' A' ' 251' ' ' MET . 61.7 t -54.91 -52.69 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.392 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 328' ' ' LEU . 52.5 mt -56.52 -46.85 80.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.272 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -52.03 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.876 HD11 HD21 ' A' ' 341' ' ' LEU . 9.3 mt -59.8 -44.25 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.604 ' OG ' HD13 ' A' ' 324' ' ' LEU . 27.2 p -54.66 -45.02 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.733 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 321' ' ' ARG . 10.4 mt -63.05 -43.75 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.358 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -44.51 97.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.477 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.91 -33.48 63.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.676 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 165' ' ' LEU . 10.6 mt -60.9 -38.63 86.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.537 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -32.91 71.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.332 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.416 ' CD1' ' HA3' ' A' ' 109' ' ' GLY . 18.7 mt -78.21 -35.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.376 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 162' ' ' LEU . 15.9 mt -58.15 -48.17 81.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.577 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -31.68 71.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 110' ' ' VAL . 85.1 t80 -64.1 -42.97 96.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.487 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 36.0 pt -81.13 -27.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.243 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.41 -29.57 57.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.81 -17.03 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.423 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -106.87 8.45 30.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.688 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 68.88 49.16 0.69 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.27 138.85 46.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.03 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 239' ' ' SER . 14.4 m -130.68 169.31 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.508 ' CE1' HD21 ' A' ' 195' ' ' LEU . 1.5 p80 -154.11 -44.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 111.279 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.31 52.79 49.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.625 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.42 -85.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.59 0.233 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 mt 45.99 91.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 183' ' ' LEU . 19.1 tttt -147.11 170.96 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.821 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -76.36 -1.99 29.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.647 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.19 -0.99 17.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.426 . . . . 0.0 110.435 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -121.5 -8.31 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.351 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.847 ' C ' HD23 ' A' ' 184' ' ' LEU . 8.5 mt -108.43 115.34 29.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.279 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.11 146.43 47.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.211 -178.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 141' ' ' ILE . 31.0 mt -86.39 148.9 25.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.18 124.42 23.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -92.88 -53.82 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -59.66 -30.14 68.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -143.39 79.14 14.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.641 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.72 108.23 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.634 2.222 . . . . 0.0 112.224 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -56.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -149.94 -167.74 2.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.851 HG21 HD21 ' A' ' 138' ' ' LEU . 6.3 p -110.02 147.39 14.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 32.1 m-85 -113.22 156.89 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.139 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 175' ' ' HIS . 43.0 tp -104.05 115.83 31.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' A' ' 134' ' ' PHE . 14.9 m -122.17 165.83 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.51 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.658 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.555 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 9.0 m-85 -98.59 -50.66 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 90.64 -47.52 3.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.135 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 221' ' ' HIS . 6.1 mp -118.04 34.87 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.489 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.599 ' HB1' ' CD1' ' A' ' 86' ' ' PHE . . . -77.93 59.65 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -137.06 149.09 47.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.025 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -59.82 101.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 206' ' ' PRO . 42.1 p90 -59.51 -28.04 66.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 13.6 t 61.42 95.98 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.018 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.411 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 52.4 Cg_exo -52.47 -177.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.521 2.148 . . . . 0.0 112.217 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -111.27 -31.88 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.34 -44.74 1.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.63 172.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -114.52 31.3 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -69.73 158.62 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.42 32.64 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.0 108.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.974 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.07 -68.57 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.719 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 59.23 161.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' A' ' 217' ' ' PRO . 0.1 OUTLIER -165.15 -64.59 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 216' ' ' ASP . 69.3 Cg_endo -74.34 -168.04 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.415 2.076 . . . . 0.0 112.183 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.82 -40.24 7.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -170.68 43.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.24 134.69 0.43 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.7 ' O ' HD21 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -164.91 -49.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.984 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.412 ' HB2' ' HB1' ' A' ' 232' ' ' ALA . 0.1 OUTLIER -97.98 31.56 2.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.47 -106.02 2.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.587 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 228' ' ' THR . 0.6 OUTLIER -135.11 176.81 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.019 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 265' ' ' LEU . 16.9 tt -93.14 13.83 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -92.46 25.03 3.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.798 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 226' ' ' GLU . 0.4 OUTLIER 174.94 -28.15 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 224' ' ' THR . 16.7 p -81.15 161.72 23.94 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -167.84 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 276' ' ' ILE . 30.2 mt -73.75 -55.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.3 -31.18 65.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 222' ' ' ASP . . . -73.86 -28.38 61.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.404 ' CE1' ' HB ' ' A' ' 225' ' ' ILE . 15.6 t60 -61.56 -51.44 68.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.016 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 236' ' ' VAL . 17.0 m-80 -91.74 12.92 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.421 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.21 15.35 58.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.818 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 234' ' ' ASN . 14.5 t -64.38 141.48 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 60.22 162.64 0.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 -164.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.682 ' O ' HG11 ' A' ' 174' ' ' VAL . 12.2 p -139.56 104.16 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -158.0 -53.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -28.2 61.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.4 -33.64 66.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 246' ' ' ILE . 34.3 m-20 -56.56 -30.42 63.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 0.0 110.968 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.77 HD13 HD11 ' A' ' 320' ' ' LEU . 52.4 mt -80.64 -36.56 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.89 -35.3 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 243' ' ' ASP . 12.0 mt -62.87 -41.52 92.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.876 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.3 tp -64.19 -50.61 67.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.717 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -55.81 -27.95 51.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.458 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.93 -33.19 45.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.882 0.372 . . . . 0.0 110.79 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.429 ' HB3' ' CE3' ' A' ' 254' ' ' TRP . 69.2 m -53.15 -51.63 61.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.046 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.781 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -57.37 -30.58 64.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.624 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.653 HG22 HD23 ' A' ' 259' ' ' LEU . 20.8 mm -69.18 -44.24 80.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.994 0.426 . . . . 0.0 110.737 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.705 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.4 tm0? -80.03 -27.18 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.108 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 2.9 m0 -81.59 -54.38 5.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.38 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 151' ' ' ARG . 43.9 mt -70.32 -35.13 73.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.528 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.25 -13.92 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.538 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.9 97.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.184 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 253' ' ' GLN . 0.1 OUTLIER 66.0 141.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.654 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.966 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -116.64 159.25 41.12 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 14.3 Cg_exo -69.04 59.49 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.839 2.359 . . . . 0.0 112.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.966 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.3 p90 179.13 -38.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.241 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.409 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.1 tt0 -95.99 24.67 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.076 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.59 -57.39 3.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.816 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -125.95 -29.96 3.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.717 HD11 ' CG2' ' A' ' 225' ' ' ILE . 0.3 OUTLIER 73.49 11.67 4.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -15.61 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.449 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.462 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 1.8 m-20 -132.94 103.96 12.88 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.5 17.4 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.722 2.282 . . . . 0.0 112.826 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -79.99 -50.1 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.1 p90 -77.42 -26.04 51.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 5.2 t -60.69 -45.75 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -47.69 25.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -39.16 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -72.74 -39.63 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -49.91 75.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.436 HG13 HD11 ' A' ' 230' ' ' ILE . 5.1 mt -63.97 -44.65 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -52.04 44.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.8 m-85 -59.03 -33.94 71.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -59.18 -31.14 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 23.65 11.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -147.79 45.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.784 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.5 mt -54.84 -41.24 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.08 67.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -41.52 61.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 282' ' ' ILE . 1.0 OUTLIER -70.77 -38.33 73.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 2.5 ttm -67.53 -33.09 74.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -75.56 -37.69 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.44 25.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.043 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.38 -34.39 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.004 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 8.9 m-85 -127.9 79.91 72.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.969 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 111.4 3.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.554 2.169 . . . . 0.0 112.359 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -128.54 -46.37 1.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -173.84 -62.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -177.01 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.13 127.88 59.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 53.1 Cg_exo -55.12 -168.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.77 -89.91 1.5 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.428 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -125.6 -39.97 2.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 0.0 111.037 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.722 HG22 ' CG ' ' A' ' 303' ' ' MET . 35.3 mm -54.87 -41.43 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -44.4 -30.57 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.5 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -78.25 -42.26 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.484 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.876 ' OH ' HD23 ' A' ' 247' ' ' LEU . 11.3 t80 -67.57 -37.72 83.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.784 ' CB ' HD13 ' A' ' 282' ' ' ILE . 62.9 mmm -71.77 -30.0 65.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.96 -50.34 68.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -41.65 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 302' ' ' TYR . 27.8 t -69.93 -24.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.106 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -80.43 -29.94 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.64 -11.91 20.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.584 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.832 ' HG ' HD22 ' A' ' 316' ' ' LEU . 0.2 OUTLIER -54.63 91.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.86 -160.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.799 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.57 29.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 p -95.94 -33.94 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.7 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.697 ' HB3' HD11 ' A' ' 316' ' ' LEU . 0.5 OUTLIER -118.44 -163.33 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 316' ' ' LEU . 12.3 mmtm -151.54 -66.98 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 60.8 Cg_endo -72.3 64.01 3.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.31 2.006 . . . . 0.0 112.217 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.832 HD22 ' HG ' ' A' ' 309' ' ' LEU . 4.0 mp -92.17 -23.87 19.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.513 ' CD2' HD21 ' A' ' 244' ' ' LEU . 76.0 m-85 -53.92 -30.28 45.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.97 -36.58 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.9 -37.3 67.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.92 ' HA ' HD12 ' A' ' 323' ' ' ILE . 55.5 mt -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.57 ' HG3' HD22 ' A' ' 159' ' ' LEU . 1.5 ttm-85 -59.34 -46.62 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -40.71 82.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.92 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.6 mt -58.06 -46.81 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.604 HD13 ' OG ' ' A' ' 158' ' ' SER . 40.8 mt -73.68 -51.63 15.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.984 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.28 -49.87 68.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.32 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -58.78 -39.97 82.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.001 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.12 -31.93 70.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.585 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.5 mt -63.02 -41.73 99.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.55 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.75 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.0 pt -101.45 27.08 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.188 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 56.04 28.08 52.81 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.583 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 18.1 t -102.33 156.79 17.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -174.61 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.67 100.42 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.4 -26.42 10.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.71 1.83 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.426 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.6 148.02 28.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.865 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 58.2 mt -91.78 12.75 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.318 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.85 25.3 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.797 0.332 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.876 HD21 HD11 ' A' ' 157' ' ' LEU . 34.8 mt -72.71 -43.08 63.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.4 68.33 0.61 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.72 30.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.09 -36.78 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.45 142.28 37.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -78.43 -38.87 40.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 123.27 -139.01 11.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 176.83 107.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.446 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 349' ' ' LEU . 3.7 mm? -73.59 86.55 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -72.84 93.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.3 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.74 103.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 1.4 m -116.62 31.65 6.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -142.06 31.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.179 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 68.4 p -71.96 -34.24 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -115.4 111.16 20.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.1 146.61 24.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.87 -41.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -130.8 131.04 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -128.53 150.78 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -123.29 27.84 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.48 146.94 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.025 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 60.24 177.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.41 109.09 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.832 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -72.4 -28.5 63.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.045 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -58.3 -68.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.31 93.74 19.69 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.73 -59.81 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -160.49 -152.0 6.41 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.544 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 370' ' ' VAL . 15.7 m -130.32 105.23 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 59.8 31.11 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -105.21 133.79 49.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.5 p -108.83 -46.1 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.24 -178.17 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.6 175.12 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.0 m 60.3 162.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -78.23 146.17 35.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 76.5 p -72.76 -59.55 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.23 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 7.9 m -107.14 122.38 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.65 127.31 55.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -150.41 -49.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -86.36 115.37 23.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.144 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.44 138.48 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -139.05 120.83 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -90.81 137.95 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 39.61 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.47 163.81 12.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 60.35 170.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 3.9 m 60.26 31.44 20.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.62 -59.28 3.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.1 -43.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.01 150.39 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 395' ' ' GLN . 7.4 p 179.53 -34.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.768 ' HG2' HG13 ' A' ' 394' ' ' VAL . 13.9 pt20 -173.78 90.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 13.3 tttt . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.928 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.569 -0.212 . . . . 0.0 112.569 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 1.4 m -65.36 135.9 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 69.6 m -137.82 92.71 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -88.17 170.38 39.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.505 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 23.5 p -162.05 111.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.68 172.61 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -178.34 -95.86 0.1 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.0 131.64 23.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.62 0.248 . . . . 0.0 110.778 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.59 151.37 46.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.508 2.139 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -138.21 177.21 8.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.01 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -134.65 97.47 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.66 33.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 173.5 12.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -107.73 88.86 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.35 30.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.39 -178.15 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.36 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.889 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.13 113.8 12.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 t -161.39 110.72 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.003 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.78 23.29 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.96 -168.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.836 0.35 . . . . 0.0 111.221 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 155.73 42.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -135.59 31.34 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.638 ' HB2' HD12 ' A' ' 19' ' ' LEU . 74.9 m-70 -75.56 -67.62 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.667 HD22 ' HA3' ' A' ' 47' ' ' GLY . 2.9 mp -111.62 162.55 15.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.828 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.09 137.51 9.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.59 156.02 38.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -178.02 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' CE1' HG21 ' A' ' 72' ' ' VAL . 5.3 t80 -93.13 44.38 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' C ' HG23 ' A' ' 25' ' ' VAL . . . -177.5 145.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 41' ' ' LEU . 1.0 OUTLIER 64.75 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.495 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.43 -25.44 22.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.975 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -83.39 136.13 34.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.196 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 38' ' ' LYS . 11.0 mm -100.42 144.27 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.718 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 128' ' ' PHE . 34.1 pt -119.76 151.3 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -95.81 141.4 29.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.806 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -96.08 -163.53 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.099 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -41.0 35.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 109.792 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -76.69 -5.01 46.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.531 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 89.65 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.9 mttp -77.21 -177.66 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.207 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.8 mm-40 -132.76 81.78 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 110.697 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -75.26 136.93 40.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.932 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HG3' HD12 ' A' ' 28' ' ' ILE . 3.4 mttm -94.1 118.68 31.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -72.73 144.17 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.91 -117.42 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.787 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.677 ' HA ' HG22 ' A' ' 25' ' ' VAL . 3.1 mt -113.27 164.61 15.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 111.021 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 41' ' ' LEU . 33.9 Cg_endo -64.6 141.86 74.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.598 2.199 . . . . 0.0 112.251 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 ' HG ' ' A' ' 53' ' ' LEU . 13.0 pt -153.76 79.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.28 97.23 0.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.565 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 59.62 96.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 68.12 1.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.667 ' HA3' HD22 ' A' ' 19' ' ' LEU . . . -133.81 -97.82 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.592 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -81.6 -69.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 52' ' ' TYR . . . -170.33 -102.51 0.16 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.472 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.879 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.5 OUTLIER 79.09 -56.1 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.647 0.26 . . . . 0.0 111.118 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 50' ' ' CYS . 3.9 mp -141.59 130.81 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.294 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 m-85 -146.46 150.15 35.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 41' ' ' LEU . 24.4 mt -70.75 158.8 35.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.342 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.583 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -132.69 154.39 50.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.0 111.38 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -149.14 132.0 16.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.9 mtp -83.62 57.01 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.95 -177.67 5.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.0 p -175.65 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.4 p -79.28 -66.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -125.21 -69.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 p -161.21 160.38 29.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.425 HG23 ' HD3' ' A' ' 38' ' ' LYS . 21.5 t -90.58 139.95 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.061 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.89 -123.61 4.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.35 31.05 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.86 42.04 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.583 ' HB1' ' O ' ' A' ' 54' ' ' ALA . . . -109.16 92.34 10.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.001 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.14 49.97 3.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.633 2.222 . . . . 0.0 112.753 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 59.6 m -149.86 148.19 28.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 133' ' ' ARG . 16.5 m -124.51 144.96 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 3.8 p -132.17 122.39 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.878 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -96.95 116.33 29.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.682 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.519 HG21 ' CE1' ' A' ' 23' ' ' PHE . 9.3 t -113.13 133.8 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.39 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.17 150.65 59.41 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.728 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.07 101.21 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.277 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 m 60.36 173.43 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.04 151.41 43.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.31 -55.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' THR . . . 163.44 -68.58 0.22 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.464 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.07 -36.09 64.32 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.352 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.17 -39.83 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.63 -40.44 91.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 21.8 p -68.64 -31.8 71.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 38.3 tt0 -73.82 -47.66 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.7 mm? -58.46 -48.08 81.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -45.03 92.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.443 ' CE2' ' CB ' ' A' ' 90' ' ' ALA . 16.7 t80 -71.91 -44.74 63.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.718 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.3 m-85 -57.07 -29.8 63.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.493 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -80.0 -45.57 18.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.074 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -87.39 -47.62 8.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 86' ' ' PHE . . . -81.34 -46.47 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.782 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -94.71 33.17 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.593 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -72.03 123.73 89.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.605 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.58 -25.34 79.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.398 2.065 . . . . 0.0 112.249 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.39 -36.01 39.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -53.6 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.852 HD11 ' HA ' ' A' ' 91' ' ' ALA . 60.2 mt -56.7 -56.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.304 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -37.95 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -74.47 -43.84 54.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.32 -51.91 65.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' A' ' 105' ' ' LEU . 66.8 mt -60.31 -37.1 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -27.65 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 64.6 m -83.48 -30.92 26.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.23 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HD3' HD21 ' A' ' 105' ' ' LEU . 3.5 ttt-85 -105.95 -4.36 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.018 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.43 28.42 15.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 100' ' ' ILE . 66.6 mt -48.93 -39.41 26.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER 75.41 -1.75 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.62 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 75.6 t80 174.19 162.46 0.19 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 110.461 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.7 tp -147.42 -66.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 130.65 -14.65 5.52 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.7 126.86 88.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.612 0.206 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.49 148.23 20.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.483 2.122 . . . . 0.0 112.193 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -83.99 115.57 22.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.046 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 39.1 t80 -97.48 125.05 41.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.629 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -100.82 -40.7 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.86 -176.53 46.36 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.625 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -134.88 154.53 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -137.67 171.07 23.42 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.84 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 127' ' ' ARG . 5.9 mt -142.39 157.25 44.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.702 0.287 . . . . 0.0 110.623 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -145.96 141.56 27.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -115.92 125.33 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 126.27 22.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 60.44 17.05 6.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.51 -6.35 59.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.872 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -96.17 129.57 43.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.9 t -92.38 130.94 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.03 151.48 29.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.748 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -129.93 125.65 35.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.631 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 29' ' ' ILE . 31.0 p90 -133.56 163.76 28.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.453 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.665 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.1 ttm -127.98 140.74 51.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.033 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 29' ' ' ILE . 13.7 mt -120.77 111.69 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.44 . . . . 0.0 111.549 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -123.42 173.43 8.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.718 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 15.7 t0 -55.85 138.28 48.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HG3' HG13 ' A' ' 69' ' ' VAL . 52.1 ttt180 -68.89 154.6 41.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.5 ' CD2' HD12 ' A' ' 184' ' ' LEU . 73.3 m-85 -119.32 161.84 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.2 -73.91 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 m -146.56 138.25 24.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.744 0.307 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.556 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -60.01 152.45 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.715 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 30.3 tp60 -70.95 -41.73 70.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -65.55 -26.96 68.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.79 HD13 HD22 ' A' ' 341' ' ' LEU . 29.1 mt -75.83 -29.77 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.792 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 46.8 t80 -54.24 -47.66 71.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.835 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.05 -25.57 68.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.715 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.719 ' HB1' HG12 ' A' ' 344' ' ' VAL . . . -75.73 -19.25 59.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 4.1 m-80 -91.0 5.59 48.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.233 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.55 43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.268 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.6 tttt 62.04 18.7 10.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 1.4 ptt85 -165.49 126.21 1.88 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.3 158.53 30.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -93.07 160.51 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -28.9 68.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 45.5 p -68.01 -44.07 77.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.733 HG21 ' HG ' ' A' ' 255' ' ' LEU . 47.7 t -57.87 -54.03 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.291 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.733 ' HB3' HD21 ' A' ' 328' ' ' LEU . 74.5 mt -61.78 -45.3 94.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.622 ' OE1' HD13 ' A' ' 328' ' ' LEU . 8.8 tp60 -58.58 -44.0 89.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.714 HD23 HD22 ' A' ' 339' ' ' LEU . 42.6 mt -73.33 -37.17 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.6 m -58.25 -41.41 84.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 325' ' ' LEU . 12.7 mt -70.71 -43.79 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.77 88.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' LEU . 7.3 mt -71.29 -33.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.2 mt -64.56 -40.21 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -36.29 80.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.0 mt -73.65 -40.24 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' A' ' 162' ' ' LEU . 21.3 mt -56.22 -33.06 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.69 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 -29.34 59.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -72.02 -52.51 16.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.615 HG21 ' OH ' ' A' ' 198' ' ' TYR . 48.4 pt -64.75 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -40.16 88.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.326 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.02 -12.31 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.75 4.49 25.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.943 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 66.17 46.92 1.97 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.875 0.369 . . . . 0.0 110.706 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -135.34 120.11 18.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 204' ' ' TYR . 3.0 m -124.58 169.08 16.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.008 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 12.6 p-80 -149.82 -52.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 68.95 37.52 83.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.53 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.3 -81.22 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 183' ' ' LEU . 2.4 mp 47.4 93.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.399 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 174.84 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.019 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -78.23 -3.96 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.3 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.6 t -108.54 0.32 20.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.642 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -125.33 -9.55 6.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.326 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.872 ' C ' HD23 ' A' ' 184' ' ' LEU . 54.9 mt -108.28 117.66 34.73 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.75 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.872 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -122.67 161.45 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.921 0.391 . . . . 0.0 111.492 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.0 mt -92.8 149.82 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.07 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.81 129.91 41.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.416 ' CG ' ' HD3' ' A' ' 133' ' ' ARG . 60.4 t80 -71.77 -62.81 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.591 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -19.95 63.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.653 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -134.34 76.8 61.65 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 78.04 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.437 2.091 . . . . 0.0 111.963 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -179.62 36.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.8 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.648 ' HA ' HD11 ' A' ' 339' ' ' LEU . 1.0 OUTLIER -174.12 145.79 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.264 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.668 HG11 HD22 ' A' ' 157' ' ' LEU . 2.4 p -109.98 147.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 110.888 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 10.8 m-85 -126.25 157.59 37.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 34.0 tp -103.12 115.79 31.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.889 0.376 . . . . 0.0 110.607 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.77 141.32 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.182 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.5 t70 57.54 106.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.615 ' OH ' HG21 ' A' ' 168' ' ' ILE . 3.4 m-30 -75.48 -24.09 56.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.019 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.658 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 93.76 -24.7 24.92 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.553 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 199' ' ' GLY . 5.0 mp -150.78 -44.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 45.93 87.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.095 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.574 ' O ' HG22 ' A' ' 174' ' ' VAL . 30.5 t80 -143.84 148.77 35.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 202' ' ' TYR . 15.2 mtm105 -74.11 98.49 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 174' ' ' VAL . 43.0 p90 -50.59 -26.28 5.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.359 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.4 p -98.23 97.68 4.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.24 -52.75 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.414 2.076 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -144.07 30.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.8 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.12 133.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.097 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -144.54 33.19 1.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 155.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.94 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.22 159.75 19.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 213' ' ' TYR . 0.7 OUTLIER -147.74 -45.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.835 ' HA ' HG13 ' A' ' 236' ' ' VAL . 38.0 mtmt 60.13 46.24 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -161.46 139.08 9.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.41 106.34 0.64 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.97 -32.75 96.02 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.459 2.106 . . . . 0.0 112.178 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -161.72 30.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.3 ttt85 60.77 68.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -72.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 63.5 m170 57.16 96.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -112.45 135.01 53.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 69.34 145.1 0.19 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.0 p -59.61 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.749 0.309 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.3 tp -163.9 27.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.196 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.24 -35.36 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -152.23 32.34 0.53 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.705 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 39.9 p -65.54 128.74 37.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.021 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.6 m -89.88 146.57 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.834 HD11 ' HG3' ' A' ' 275' ' ' LYS . 3.0 mp -57.81 -35.56 51.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -73.71 -30.53 62.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -75.3 -39.2 59.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -44.3 92.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -92.83 0.57 57.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.87 7.9 62.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.945 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.835 HG13 ' HA ' ' A' ' 214' ' ' LYS . 38.9 t -62.2 127.87 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 61.65 154.27 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.21 -166.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.55 2.167 . . . . 0.0 112.255 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -96.96 28.46 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -90.86 -53.02 4.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -25.44 62.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.873 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -65.05 -37.76 94.58 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.452 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.05 -40.59 89.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.489 HD12 HD11 ' A' ' 309' ' ' LEU . 48.7 mt -67.0 -35.93 81.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.784 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -62.95 -42.55 99.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.9 mt -65.2 -39.9 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.499 HD23 ' OH ' ' A' ' 302' ' ' TYR . 32.5 tp -65.76 -39.54 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.739 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.77 -44.93 96.55 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.379 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.63 -25.7 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.7 m -57.91 -43.33 86.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.252 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.678 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -61.28 -50.1 74.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 mt -64.19 -26.55 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.66 ' HB2' HD11 ' A' ' 259' ' ' LEU . 12.4 tm0? -71.07 -45.2 64.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.401 ' CD1' ' OE1' ' A' ' 253' ' ' GLN . 18.5 m0 -82.19 -41.09 20.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.733 ' HG ' HG21 ' A' ' 154' ' ' VAL . 21.0 mt -67.04 -39.21 86.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -0.57 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 57.49 96.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 55.6 m80 62.54 144.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -122.35 164.65 24.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.466 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.93 63.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.421 2.08 . . . . 0.0 112.519 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.838 ' CH2' HD22 ' A' ' 259' ' ' LEU . 7.6 p90 176.41 -38.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.108 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.9 tt0 -95.55 18.47 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.289 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -55.93 15.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 93.6 m-20 -126.99 -27.36 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 67.6 mt 70.67 12.4 7.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -85.19 -15.3 44.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.175 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.46 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 2.1 m-20 -132.56 100.52 14.95 Favored Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.93 15.02 2.05 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.616 2.211 . . . . 0.0 112.857 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -78.54 -49.77 12.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.1 p90 -77.13 -26.47 53.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 225' ' ' ILE . 12.5 t -60.71 -37.53 76.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.56 ' NH1' HD11 ' A' ' 276' ' ' ILE . 12.3 ttt-85 -75.52 -44.94 41.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.068 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.15 -49.67 63.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.235 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.9 m -58.58 -41.98 86.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.834 ' HG3' HD11 ' A' ' 230' ' ' ILE . 10.8 tptt -62.35 -41.5 98.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.144 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.56 HD11 ' NH1' ' A' ' 272' ' ' ARG . 11.3 mt -75.1 -29.09 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.01 16.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -69.98 -40.13 75.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.388 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -52.58 -27.52 17.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.02 15.33 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.106 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 0.0 OUTLIER -138.21 45.76 2.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.708 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.1 mt -51.7 -36.5 18.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.336 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.13 63.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.574 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.416 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 9.9 t -68.37 -40.36 81.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.34 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.5 pp -76.01 -28.41 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.331 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 4.0 mmt -67.61 -38.42 83.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.751 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -82.7 -31.58 28.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -82.66 -51.59 7.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.07 -41.13 67.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -115.68 151.97 46.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.009 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 131.89 17.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.629 2.219 . . . . 0.0 112.281 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.02 43.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -107.13 -55.91 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -162.1 -176.45 5.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 60.82 87.16 0.14 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.59 144.16 44.04 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.608 2.205 . . . . 0.0 112.377 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.453 ' O ' HD11 ' A' ' 155' ' ' LEU . . . -96.86 -18.08 30.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.709 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.14 10.61 6.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.362 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.538 HG22 ' CG ' ' A' ' 303' ' ' MET . 43.3 mm -79.41 -46.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.13 -45.27 11.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.446 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.575 ' HB2' HG23 ' A' ' 323' ' ' ILE . 69.1 mttt -59.63 -42.76 93.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.52 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 306' ' ' VAL . 72.7 t80 -70.17 -36.79 74.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.612 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.708 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.6 mtp -67.39 -42.47 83.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.579 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.48 -48.39 80.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -37.78 80.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.692 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 302' ' ' TYR . 40.6 t -71.08 -25.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.65 -43.12 15.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 110.217 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -14.31 62.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.545 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 306' ' ' VAL . 8.7 mt -47.35 114.09 0.81 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.231 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.51 144.53 51.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.759 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -93.3 46.33 1.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.3 m -157.65 -47.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -176.33 116.2 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -176.73 72.15 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 132.24 20.02 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 112.23 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' A' ' 320' ' ' LEU . 1.4 pp -155.41 30.55 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.041 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -57.53 -37.05 72.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.22 -40.69 94.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.741 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.62 -42.88 99.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.562 ' HG ' HD12 ' A' ' 316' ' ' LEU . 79.4 mt -56.18 -45.38 79.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -56.34 -46.45 79.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.802 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.38 91.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.743 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 301' ' ' LYS . 97.2 mt -53.07 -42.22 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 155' ' ' LEU . 61.1 mt -81.06 -51.51 8.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.089 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -56.03 -49.77 72.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.43 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.91 -46.16 71.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.71 -28.13 56.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.464 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 155' ' ' LEU . 7.2 mt -69.16 -24.74 64.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.715 0.293 . . . . 0.0 111.071 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 1.2 mmtm -69.76 -33.47 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -78.02 -18.85 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.143 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.52 -34.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -122.07 -24.44 2.25 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.279 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 3.0 t 71.43 65.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 0.0 110.832 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 74.61 103.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 164.02 26.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -176.37 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -91.55 46.55 2.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.54 137.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.714 HD22 HD23 ' A' ' 157' ' ' LEU . 70.2 mt -100.5 -3.56 30.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 63.39 17.62 10.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.676 0.274 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.79 HD22 HD13 ' A' ' 141' ' ' ILE . 15.8 mt -73.49 -61.44 1.83 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.7 t 77.89 -55.28 0.51 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.156 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.546 HG22 HG23 ' A' ' 141' ' ' ILE . 6.4 t 58.31 73.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.065 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.719 HG12 ' HB1' ' A' ' 144' ' ' ALA . 10.0 p -61.35 -28.48 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -106.34 81.78 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.62 -44.28 28.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 141.76 -94.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -127.01 -162.63 11.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.41 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 350' ' ' LYS . 3.8 tt -127.76 158.9 36.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.571 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.7 mttt -66.2 115.25 5.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.12 54.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -99.05 31.43 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 28.2 p -115.77 177.78 4.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 9.6 mt 59.64 75.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.071 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.0 m -149.51 136.3 19.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 80.72 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -130.68 88.66 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.0 56.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -166.08 93.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -125.49 -50.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -66.86 117.48 9.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.99 117.68 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -87.37 -46.75 9.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.09 170.16 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.951 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.2 m -126.78 129.52 48.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 60.43 96.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.31 125.6 33.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.84 124.34 15.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.418 2.078 . . . . 0.0 112.21 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.29 -71.02 0.94 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.539 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.15 145.18 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.135 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -131.37 154.18 48.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.59 86.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 76.2 p -120.03 136.76 54.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.42 -176.64 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 60.06 89.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.2 p -103.64 132.81 49.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.29 108.14 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.0 m -127.83 75.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -171.82 -176.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.784 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 33.6 p -99.9 177.54 5.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.49 91.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -73.02 132.87 43.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -133.66 179.57 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 30.1 mt 63.54 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 60.25 31.95 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.0 p -133.5 104.18 6.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 159.73 37.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 28.7 t -162.91 89.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.47 166.3 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 4.2 m -147.12 81.46 1.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.963 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -74.78 123.61 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -149.91 -51.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -71.44 166.88 20.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.2 m -139.98 117.97 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -108.11 -61.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 6.3 m -88.61 -53.47 4.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 75.6 m -137.61 118.51 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -124.3 36.29 2.96 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.82 155.6 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 2.5 m -96.82 39.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -177.12 -121.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HB3' HG12 ' A' ' 4' ' ' VAL . 3.7 mtm -169.54 73.7 0.69 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 110.867 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.83 -25.46 27.33 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.539 2.159 . . . . 0.0 112.344 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -60.6 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.048 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' A' ' 1' ' ' MET . 11.6 p -69.26 145.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -146.38 -47.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.6 -169.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.4 -48.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.43 129.78 54.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.04 -44.64 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.02 167.06 42.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -164.8 95.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 151.63 49.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -106.35 -66.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 m -142.94 -173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 173.8 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -154.67 -49.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -131.43 127.59 37.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.751 ' C ' HD22 ' A' ' 19' ' ' LEU . 61.9 m80 -105.24 30.66 5.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD22 ' C ' ' A' ' 18' ' ' HIS . 3.9 mm? -133.35 -178.66 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.43 -70.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -97.6 177.7 5.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.44 -51.69 2.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 3.6 m-85 -62.69 113.91 3.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.83 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.85 -171.57 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.051 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 110.6 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.93 -27.61 6.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.495 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 135.19 51.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 36' ' ' GLU . 15.7 mt -100.66 143.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.079 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.897 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 18.4 pt -119.7 154.99 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 34' ' ' LYS . 1.4 m -94.98 135.45 36.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -160.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.248 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.1 -38.74 51.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -82.73 3.66 28.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.235 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.9 mttp 76.03 32.43 0.63 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.5 mtpp -77.34 171.87 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.065 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 28' ' ' ILE . 22.3 mt-10 -111.88 73.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.49 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HB2' HG13 ' A' ' 29' ' ' ILE . 26.7 m95 -66.7 145.87 55.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.959 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -100.8 132.39 46.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 29' ' ' ILE . 25.4 t -88.9 123.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.689 ' CA ' HG11 ' A' ' 62' ' ' VAL . . . -75.07 -127.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.551 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.27 159.39 70.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.85 128.2 18.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.167 . . . . 0.0 112.299 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.0 pt -109.72 -30.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.48 42.57 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.439 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.1 99.98 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 -101.12 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.571 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.93 73.75 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CE1' ' NZ ' ' A' ' 71' ' ' LYS . 93.7 m-85 -101.98 -37.72 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.884 0.373 . . . . 0.0 110.97 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.37 -72.8 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -122.69 73.98 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.961 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.415 HD12 ' HG2' ' A' ' 71' ' ' LYS . 21.5 mm -87.61 114.8 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 59.0 m-85 -146.32 158.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 69' ' ' VAL . 69.0 mt -72.66 163.69 27.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -136.57 157.51 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.733 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.8 t70 -149.29 154.01 38.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 43.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.955 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 60.2 -175.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t 60.47 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.56 68.88 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 59.7 -174.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.7 p -86.06 85.13 7.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 55' ' ' ASP . 20.0 t 68.95 -67.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.24 -156.12 21.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.7 -30.03 8.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.36 53.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.1 113.55 31.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.55 25.85 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.93 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.68 148.34 29.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.959 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 53' ' ' LEU . 27.5 m -129.63 156.89 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.6 p -140.19 122.88 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' NZ ' ' CE1' ' A' ' 48' ' ' PHE . 2.4 mttm -106.4 121.93 45.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' A' ' 128' ' ' PHE . 3.3 t -113.16 146.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.235 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.22 136.75 16.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.731 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.33 89.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.364 2.043 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 59.61 172.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.7 81.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.04 -29.34 6.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.15 -165.9 22.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.65 29.29 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.936 2.424 . . . . 0.0 112.808 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.543 HD23 ' HD3' ' A' ' 127' ' ' ARG . 12.3 tp -77.91 -31.88 51.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -67.01 -42.46 84.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 201' ' ' ALA . 11.4 t -69.17 -28.62 66.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.956 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -40.4 69.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.65 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.1 mm? -63.69 -44.54 93.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.04 92.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.46 -43.04 95.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.892 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.4 m-85 -60.07 -44.41 94.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -79.83 -17.6 52.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.382 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -65.35 -47.8 75.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.784 0.326 . . . . 0.0 111.046 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.68 33.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.255 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -119.44 -10.68 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 163.84 0.44 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.696 0.284 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.44 -19.39 43.59 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.614 2.209 . . . . 0.0 112.493 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -75.62 -39.74 57.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -79.34 -42.09 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.486 HD12 ' HB ' ' A' ' 110' ' ' VAL . 28.0 mm -58.36 -48.78 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -70.2 -49.58 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.174 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -58.15 -51.7 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.08 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 108' ' ' LEU . 27.9 mt -61.41 -35.72 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -75.07 -27.84 60.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.29 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -82.38 -37.76 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.468 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -104.8 -1.2 26.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 58.33 31.24 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.763 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HB2' HG23 ' A' ' 100' ' ' ILE . 51.2 mt -51.28 -26.84 7.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.215 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.0 tttt 58.2 94.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.1 t80 63.87 132.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 100' ' ' ILE . 11.4 tp -125.54 163.71 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.6 10.05 66.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.923 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.579 HG21 ' CD2' ' A' ' 167' ' ' TYR . 23.2 t -92.74 123.43 61.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.757 0.278 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 146.38 49.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.075 . . . . 0.0 112.248 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -89.34 119.83 30.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -74.93 123.65 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -104.81 -40.61 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.47 46.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.704 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -145.52 163.39 34.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.66 -174.98 35.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.707 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -145.5 159.84 42.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -133.38 141.7 48.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.33 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 126.34 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.63 18.46 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.53 20.67 36.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.626 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 0.3 OUTLIER -121.13 128.94 53.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.779 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.17 130.87 37.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 124' ' ' LYS . 9.8 m-85 -120.26 143.46 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.543 ' HD3' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -107.04 133.14 52.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.897 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.3 p90 -137.88 163.68 30.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.687 ' HB2' HD21 ' A' ' 84' ' ' LEU . 2.7 ttm -129.46 136.33 49.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.423 HG21 ' CZ3' ' A' ' 37' ' ' TRP . 17.6 mt -109.2 119.27 58.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.42 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -134.01 173.23 11.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.795 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.74 145.24 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.208 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' NH1' ' CE2' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -73.4 160.64 31.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 184' ' ' LEU . 92.5 m-85 -132.3 154.92 49.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.98 -99.31 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.342 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.58 125.28 47.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.6 p30 -53.5 158.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HA ' HD12 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -63.79 -21.66 66.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.724 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -61.53 -40.5 94.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 0.0 109.981 178.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.726 ' CD1' HD13 ' A' ' 341' ' ' LEU . 3.1 mt -73.13 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -67.37 -49.02 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.57 -28.58 59.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.873 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.19 -23.63 66.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -98.75 20.89 12.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 81.77 48.66 0.02 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.243 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt 63.37 18.97 11.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.311 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 -176.16 4.52 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.452 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -128.14 -176.0 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.908 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -117.26 135.33 53.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.829 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.768 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -57.48 -26.57 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -42.44 64.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.3 p -74.83 -35.58 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.745 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 150' ' ' SER . 42.4 t -57.68 -53.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.971 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.669 HD23 HD22 ' A' ' 324' ' ' LEU . 52.7 mt -63.87 -44.31 93.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.777 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.429 HE22 HD22 ' A' ' 339' ' ' LEU . 1.4 tm0? -62.17 -45.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.576 HD11 ' CD2' ' A' ' 341' ' ' LEU . 13.6 mt -70.15 -37.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.737 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 324' ' ' LEU . 58.1 m -56.55 -37.33 70.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 328' ' ' LEU . 11.4 mt -73.96 -46.77 41.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.07 -46.19 90.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 178' ' ' ILE . 11.4 mt -66.54 -34.43 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.757 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.6 mt -60.03 -36.76 77.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.487 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 mt -71.98 -40.1 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.56 HD21 HD11 ' A' ' 178' ' ' ILE . 82.3 mt -58.04 -42.02 84.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.653 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.69 -45.11 95.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CD2' HG21 ' A' ' 110' ' ' VAL . 60.8 t80 -60.26 -53.01 62.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.3 pt -66.99 -27.17 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.21 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.408 ' CD2' ' OH ' ' A' ' 204' ' ' TYR . 8.2 t-160 -78.07 -36.5 48.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.645 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -16.98 62.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -94.57 -1.03 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 75.85 37.71 0.38 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.16 116.03 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.726 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.9 m -112.04 141.82 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.266 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 198' ' ' TYR . 0.8 OUTLIER -179.36 66.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.645 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.641 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -63.1 79.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.661 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -106.35 26.83 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 183' ' ' LEU . 3.3 mp -59.76 103.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.022 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -143.4 170.14 16.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.895 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -77.3 -3.35 39.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.282 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.8 t -112.62 2.26 16.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.658 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -126.53 -5.41 6.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.098 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 184' ' ' LEU . 10.9 mt -108.44 127.55 54.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -136.94 150.08 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.908 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 341' ' ' LEU . 13.8 mt -86.67 149.41 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.256 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.5 OUTLIER -67.49 127.99 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.746 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.459 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 23.9 t80 -86.47 -43.67 12.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.544 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -20.73 62.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -149.6 71.0 9.76 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.616 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.06 91.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.735 2.29 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.45 31.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.57 155.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.014 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 138' ' ' LEU . 3.7 p -109.94 148.16 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 5.3 m-85 -119.66 156.9 29.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 35.9 tp -106.9 115.8 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.59 HG21 HD11 ' A' ' 184' ' ' LEU . 24.2 m -115.95 141.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.371 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.45 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.023 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 175' ' ' HIS . 5.2 m-85 -90.22 -19.18 24.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 67.39 23.29 73.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.373 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 mp -156.32 -68.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 82' ' ' THR . . . 45.67 88.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -137.4 149.11 46.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.998 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.4 81.19 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.713 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.726 ' CD1' HG13 ' A' ' 174' ' ' VAL . 13.3 p90 -46.17 -40.44 11.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.421 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.64 106.77 0.7 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 152.62 21.36 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.493 2.128 . . . . 0.0 112.335 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -35.35 5.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -160.39 29.47 0.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.42 141.49 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.31 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -97.16 33.6 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.93 158.17 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -130.02 135.34 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.425 ' CZ ' HG11 ' A' ' 236' ' ' VAL . 1.4 t80 61.38 96.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -87.41 -60.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.426 ' HA ' HG22 ' A' ' 236' ' ' VAL . 1.1 tt0 58.95 96.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -175.09 96.06 0.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.17 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.528 2.152 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -159.64 -45.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -31.45 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 64.9 m 60.57 -178.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.53 34.95 2.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.74 -178.32 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.974 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.25 -9.0 17.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.789 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 225' ' ' ILE . 67.0 m 61.74 -90.35 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.623 0.212 . . . . 0.0 110.77 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.567 HD11 ' CG1' ' A' ' 271' ' ' VAL . 5.9 tp -179.15 35.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.89 0.376 . . . . 0.0 111.195 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.53 -45.19 13.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -157.57 35.77 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 118.48 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 176.29 8.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 276' ' ' ILE . 3.6 mt -61.83 -31.77 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -74.49 -41.6 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -27.69 66.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -94.79 -17.33 22.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.207 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.32 24.93 10.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 215' ' ' GLU . 22.4 t -89.36 145.18 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -119.08 -61.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 50.3 Cg_exo -55.89 107.33 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.223 1.949 . . . . 0.0 112.299 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.23 -52.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.816 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 77.44 -2.82 2.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.768 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -89.55 -23.1 22.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.72 0.295 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.5 -49.74 70.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.701 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.11 -33.44 73.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 320' ' ' LEU . 25.8 mt -80.55 -33.06 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.15 -38.79 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 176' ' ' GLY . 17.4 mt -63.59 -43.95 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.25 -33.51 75.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.511 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -63.11 -41.83 99.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 252' ' ' ILE . 61.2 m-85 -78.52 -25.69 45.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 111.342 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 3.6 m -56.74 -39.99 74.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.372 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.476 ' SD ' HD12 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -68.87 -48.81 62.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.249 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 285' ' ' LEU . 6.1 mt -57.33 -33.45 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.398 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.566 ' HB2' HD21 ' A' ' 259' ' ' LEU . 7.9 tt0 -80.03 -42.7 23.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.976 0.417 . . . . 0.0 110.928 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.4 m0 -74.1 -24.27 59.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.37 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 151' ' ' ARG . 5.3 mt -96.47 -35.86 10.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.59 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 m -96.2 -14.25 22.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.499 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.82 92.27 0.41 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 38.4 m80 61.52 153.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.337 . . . . 0.0 111.159 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.882 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -125.21 162.63 42.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.509 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.65 62.13 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 112.424 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.882 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 6.8 p90 176.42 -38.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.031 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.468 ' HA ' HD21 ' A' ' 265' ' ' LEU . 1.2 tm-20 -94.26 18.93 10.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.155 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.19 -55.54 13.65 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.6 OUTLIER -129.5 -28.72 2.26 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.444 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 225' ' ' ILE . 48.0 mt 73.51 10.73 4.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -79.08 -15.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.215 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.473 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.4 m-20 -135.94 101.26 10.54 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.777 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.04 16.45 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.674 2.249 . . . . 0.0 112.873 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -79.52 -49.78 11.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 4.8 p90 -75.83 -29.33 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.567 ' CG1' HD11 ' A' ' 225' ' ' ILE . 6.9 t -62.16 -36.44 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -75.47 -49.3 19.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.09 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.19 -35.53 78.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 53.8 m -67.23 -46.14 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.176 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -61.36 -40.92 96.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.37 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.412 ' HA ' HD11 ' A' ' 230' ' ' ILE . 12.2 mt -68.24 -35.03 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -81.18 -50.17 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.4 m-85 -58.36 -40.36 82.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.49 -35.44 63.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.744 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -102.83 16.57 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.143 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.93 46.63 1.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.855 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.74 HD13 ' CB ' ' A' ' 303' ' ' MET . 18.6 mt -53.42 -35.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.92 -26.22 60.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.217 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 29.5 t -72.98 -42.55 63.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.764 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.502 HD13 HD13 ' A' ' 252' ' ' ILE . 3.2 pp -77.49 -30.79 53.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 300' ' ' ALA . 7.2 mmt -66.14 -38.65 88.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.639 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -29.79 28.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -82.87 -53.48 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 65.3 m -74.12 -41.19 61.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.342 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 286' ' ' MET . 50.4 m-85 -112.05 152.12 44.09 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.832 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.57 -46.31 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 54.88 27.83 9.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.43 -31.82 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -106.6 -75.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.021 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.45 110.26 9.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 176.46 6.66 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.378 2.052 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.26 4.85 38.21 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.826 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.06 14.94 5.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 111.297 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.476 HD12 ' SD ' ' A' ' 251' ' ' MET . 30.2 mm -79.44 -43.69 23.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.738 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 286' ' ' MET . . . -49.75 -43.91 48.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.212 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HD2' HG23 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -60.46 -38.58 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.777 ' HA ' HD13 ' A' ' 323' ' ' ILE . 11.2 t80 -71.25 -45.52 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.74 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.3 mtp -61.38 -41.81 97.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -45.52 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.691 ' O ' HD12 ' A' ' 309' ' ' LEU . 33.2 m -62.26 -29.6 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.566 ' HA ' HD12 ' A' ' 309' ' ' LEU . 84.3 t -79.39 -24.0 12.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.343 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 -35.98 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 10.6 tp -110.64 -29.99 7.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.276 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 1.143 HD21 HD22 ' A' ' 316' ' ' LEU . 0.7 OUTLIER 52.36 178.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -158.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.81 59.15 3.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.7 p 65.5 44.82 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.749 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -100.79 148.5 24.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.443 ' HB2' ' HD3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER -81.46 -48.55 1.02 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 314' ' ' LYS . 85.8 Cg_endo -82.01 77.38 3.86 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.358 2.039 . . . . 0.0 112.639 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 1.143 HD22 HD21 ' A' ' 309' ' ' LEU . 0.5 OUTLIER -91.62 0.23 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.358 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 244' ' ' LEU . 72.9 m-85 -60.72 -30.14 69.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.132 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -39.46 78.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -82.08 -35.98 28.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 323' ' ' ILE . 59.2 mt -57.53 -50.73 72.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.056 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.422 ' HA ' HD21 ' A' ' 159' ' ' LEU . 8.4 ptm180 -56.08 -45.48 79.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.147 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -40.75 79.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 320' ' ' LEU . 18.1 mt -58.35 -47.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.669 HD22 HD23 ' A' ' 155' ' ' LEU . 72.4 mt -72.69 -50.85 22.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.011 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -53.01 -49.84 65.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.382 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -55.11 -39.33 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.47 -26.7 71.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.604 HD12 HD23 ' A' ' 325' ' ' LEU . 13.4 mt -66.73 -38.87 87.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.936 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -61.2 -27.07 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.81 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.9 pt -117.93 20.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.538 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 49.9 43.35 39.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.752 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.1 m -97.95 36.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.05 144.06 45.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.37 114.48 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -167.65 42.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 114.94 28.86 2.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.565 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -126.64 134.37 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.727 0.299 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER 178.84 -26.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.587 ' O ' HD12 ' A' ' 341' ' ' LEU . 0.7 OUTLIER -53.36 -22.81 8.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.645 0.26 . . . . 0.0 111.528 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.726 HD13 ' CD1' ' A' ' 141' ' ' ILE . 1.2 mp 74.63 24.8 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.763 0.316 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 32.5 t 54.99 33.1 19.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.259 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 340' ' ' ASP . 18.8 m -79.52 -25.33 12.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.35 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 t 67.67 86.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.52 146.38 28.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.13 -59.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 145.34 -44.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.446 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 165.79 -117.36 0.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.35 119.18 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -132.78 -46.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.62 87.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -89.19 -31.56 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 40.6 p -76.03 165.88 24.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 20.0 pt -114.76 -36.07 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 77.8 p -80.23 131.59 35.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -127.01 160.74 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.15 -69.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.05 -179.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.89 89.41 3.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -115.28 -51.71 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.51 127.98 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.56 153.68 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -143.08 77.61 1.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 59.97 31.31 20.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 99.3 p -113.22 168.95 9.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -140.4 177.42 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.78 88.84 14.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.48 136.04 48.05 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.552 2.168 . . . . 0.0 112.347 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -92.89 -125.88 3.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.7 147.58 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -150.76 37.93 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 61.32 178.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.3 m -150.56 -62.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.9 103.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -145.07 108.27 4.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.2 m -160.8 50.47 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 60.47 105.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 379' ' ' GLN . 1.5 m -86.01 169.91 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . 0.443 ' H ' HG22 ' A' ' 378' ' ' THR . 24.8 mt-30 -76.07 94.35 3.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 8.4 t -81.57 126.43 31.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.49 144.86 31.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -96.81 166.72 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . 60.61 178.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.82 126.22 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.51 151.55 41.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.2 p -109.96 89.1 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.66 92.85 8.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.9 p -117.37 -177.63 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -60.38 144.65 50.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 14.0 p -114.94 -62.94 1.53 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.939 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 61.25 154.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.76 93.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -104.11 124.73 49.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.32 81.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.139 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.14 33.19 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 22.4 t 60.59 -170.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.8 m -123.96 134.82 53.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -156.38 -54.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.27 143.27 31.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.8 m -162.01 110.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -179.86 36.23 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 1.5 mpp? -76.51 -60.92 0.83 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 59.2 Cg_endo -72.31 162.84 40.44 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.153 . . . . 0.0 112.35 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -119.5 -66.39 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.67 -40.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.174 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.39 110.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 85.37 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.67 -174.14 2.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -90.14 108.65 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.86 -31.15 12.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.76 161.39 10.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.12 132.79 25.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.859 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -87.6 95.69 10.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 p -171.42 -178.03 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 t -160.86 139.25 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.0 -44.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -69.56 140.77 53.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.18 31.29 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -131.74 147.69 52.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.52 173.57 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.26 177.7 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.32 -67.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 61.32 90.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.853 ' CE2' HG21 ' A' ' 29' ' ' ILE . 2.9 m-85 -80.58 104.57 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.6 -179.9 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HA2' ' A' ' 40' ' ' GLY . 3.4 m -59.12 145.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.76 -25.29 28.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -112.5 133.56 54.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.012 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mt -100.38 147.86 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.925 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 46.6 pt -116.77 154.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 111.457 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -97.64 141.61 30.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.743 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.34 -162.66 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -36.3 32.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -84.95 5.06 30.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.299 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 11.5 mmtm 79.63 31.36 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.884 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' THR . 9.7 mttp -75.14 177.0 6.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.957 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 80.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.513 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 91.6 m95 -80.1 137.64 36.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.976 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -93.86 119.81 33.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG11 ' C ' ' A' ' 23' ' ' PHE . 40.1 t -71.09 149.6 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -125.03 -146.37 6.8 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.579 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 159.19 31.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.658 0.266 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.26 168.24 18.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.57 2.18 . . . . 0.0 112.332 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -137.6 79.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.12 -173.62 23.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.479 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.85 105.28 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.758 0.313 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.04 58.56 1.98 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.456 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.714 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -63.44 -107.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.545 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -164.75 -45.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.52 -95.19 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 13.1 m -132.45 66.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 71' ' ' LYS . 8.4 mt -82.27 104.57 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 23' ' ' PHE . 18.8 m-85 -143.6 162.82 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 8.0 mt -78.49 158.41 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -139.03 159.05 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.6 159.64 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.96 41.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.71 82.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 t -114.96 -38.23 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.1 t -127.6 -172.78 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -62.73 -49.34 75.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 156.84 45.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.68 99.82 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.17 -105.77 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 53.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -165.58 38.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -68.67 142.75 94.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.73 8.79 4.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.692 2.261 . . . . 0.0 113.023 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 75.2 m -149.69 148.24 29.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.873 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.2 m -120.94 144.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 130' ' ' ILE . 8.9 p -127.27 128.2 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.298 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.72 120.63 39.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.662 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.763 HG22 ' CB ' ' A' ' 128' ' ' PHE . 3.1 t -113.22 152.07 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.939 0.399 . . . . 0.0 111.421 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HB3' ' CB ' ' A' ' 76' ' ' ASP . 7.1 mt-10 -135.85 126.24 16.64 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.56 87.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.478 2.119 . . . . 0.0 112.428 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t 48.97 33.29 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.275 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 2.1 t70 -89.89 161.73 15.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -155.42 145.22 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.82 ' O ' HG23 ' A' ' 82' ' ' THR . . . 135.04 -75.4 0.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -44.59 1.98 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.593 2.195 . . . . 0.0 112.263 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.425 ' HG ' HD23 ' A' ' 84' ' ' LEU . 5.1 tp -77.89 -37.78 47.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -58.52 -29.39 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.012 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 78' ' ' GLY . 67.1 p -75.77 -28.55 58.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.71 -42.81 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.886 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.4 mm? -68.71 -32.75 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -71.03 -51.78 23.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 73.5 t80 -67.0 -40.81 87.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.946 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.94 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-30 -57.13 -45.12 83.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 73.6 mt-30 -79.89 -17.67 52.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -47.6 19.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.97 -29.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -71.41 3.46 3.77 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 11.1 mtpt -52.57 159.54 1.65 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.745 0.307 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.22 -32.82 12.32 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.478 2.119 . . . . 0.0 112.288 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.57 -30.02 41.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -75.89 -54.04 7.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.399 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 100' ' ' ILE . 70.5 mt -57.71 -53.23 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.359 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -51.35 -35.66 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.205 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -36.09 78.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -77.08 -42.49 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 105' ' ' LEU . 60.7 mt -65.51 -33.17 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -27.67 60.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.1 m -72.6 -36.77 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -5.42 19.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.34 29.68 19.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.886 0.374 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 100' ' ' ILE . 21.7 mt -50.89 -33.52 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.237 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 76.83 -55.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 138.67 50.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.493 HD21 ' CD1' ' A' ' 167' ' ' TYR . 11.0 tp -120.62 -66.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 131.98 -9.83 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.98 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.35 131.05 66.66 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.709 0.255 . . . . 0.0 111.175 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.13 147.56 26.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.273 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -87.33 115.51 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -88.31 126.46 35.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -105.74 -40.72 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.96 -174.62 46.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.623 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -136.58 162.76 32.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -142.46 174.43 23.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.824 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 127' ' ' ARG . 32.2 mt -148.08 159.83 43.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 110.945 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.64 122.1 11.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.028 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.85 118.47 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.22 126.32 22.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 55.23 20.58 3.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.527 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.36 -1.3 60.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.94 129.0 43.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.762 0.315 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t -96.22 123.05 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.25 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -106.71 121.28 44.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.488 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.687 ' HA ' HD23 ' A' ' 118' ' ' LEU . 43.5 mtp85 -106.35 125.08 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.4 p90 -139.81 158.76 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.886 ' HB2' HD21 ' A' ' 84' ' ' LEU . 5.4 tmm? -128.05 147.21 50.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.647 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.447 HG12 HG23 ' A' ' 70' ' ' VAL . 20.5 mt -121.34 112.73 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.102 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.97 173.41 7.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.169 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.19 148.74 4.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.873 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.9 tpt180 -65.38 155.69 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -128.58 160.01 33.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.707 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.29 -110.29 2.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.555 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.2 p -107.98 125.79 51.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.762 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.743 ' OD1' HD22 ' A' ' 184' ' ' LEU . 10.1 m-20 -58.65 160.34 5.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.813 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.792 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.2 mm? -65.77 -24.35 66.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.591 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 1.2 mt-30 -63.71 -44.29 94.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 110.15 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -60.71 -30.68 70.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.26 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.839 HD13 HD22 ' A' ' 341' ' ' LEU . 40.1 mt -72.87 -25.2 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.762 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 147' ' ' LYS . 76.7 t80 -67.75 -48.85 65.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.619 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.59 -27.96 58.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.741 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.02 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 77.7 m-20 -97.51 -1.8 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.263 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.7 45.34 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.166 0.507 . . . . 0.0 110.345 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 51.7 mttt 61.33 20.91 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.396 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -135.11 107.86 7.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 142' ' ' TYR . 2.0 m-85 -77.93 -172.93 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 154' ' ' VAL . 23.0 t -116.9 150.37 38.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -60.43 -29.4 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.648 ' HG2' HD12 ' A' ' 331' ' ' ILE . 17.3 mtmt -73.81 -43.75 57.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.683 ' CG2' HD23 ' A' ' 341' ' ' LEU . 1.5 m -61.3 -52.04 66.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.43 HG21 ' HG ' ' A' ' 255' ' ' LEU . 46.1 t -54.84 -54.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 328' ' ' LEU . 49.0 mt -62.47 -47.87 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -43.12 93.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.68 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.645 HD22 HG11 ' A' ' 193' ' ' VAL . 22.4 mt -69.1 -35.27 76.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.77 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.591 ' OG ' HD21 ' A' ' 247' ' ' LEU . 0.5 OUTLIER -57.32 -42.24 81.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 325' ' ' LEU . 90.5 mt -70.06 -43.19 71.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.726 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -64.27 -49.27 72.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.75 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 164' ' ' ILE . 14.2 mt -66.36 -36.23 76.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.54 -36.03 77.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -35.86 74.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.78 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 161' ' ' ILE . 7.0 mt -76.89 -37.3 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.39 -41.85 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.15 -30.96 68.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.696 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.493 ' CD1' HD21 ' A' ' 108' ' ' LEU . 48.5 t80 -70.93 -53.35 15.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.467 HD11 ' CE1' ' A' ' 175' ' ' HIS . 12.1 pt -66.67 -27.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.407 ' N ' HG13 ' A' ' 168' ' ' ILE . 6.6 m-70 -75.21 -32.85 61.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.92 -16.96 62.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.58 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -100.47 3.2 42.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 67.71 42.44 2.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.422 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 0.3 OUTLIER -131.64 127.48 37.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.06 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.795 HG11 ' HB3' ' A' ' 239' ' ' SER . 3.7 m -113.57 169.21 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.066 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.709 ' CD2' HD21 ' A' ' 195' ' ' LEU . 18.7 p-80 -147.42 -50.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 53.42 52.83 38.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.646 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.58 28.98 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.253 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.82 106.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.719 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.497 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -153.55 -177.76 6.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.591 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -81.7 -0.08 41.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.293 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 p -109.11 1.23 20.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.44 -6.65 4.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.519 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 184' ' ' LEU . 17.9 mt -108.59 127.98 54.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.103 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -134.97 156.82 48.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.164 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.679 HD11 HD13 ' A' ' 341' ' ' LEU . 23.9 mt -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.307 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.456 ' ND2' ' CE1' ' A' ' 194' ' ' TYR . 0.3 OUTLIER -67.26 130.32 42.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 133' ' ' ARG . 6.1 t80 -75.01 -54.41 7.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -21.3 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.506 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -135.89 73.68 59.32 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 102.0 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.526 2.151 . . . . 0.0 112.147 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -177.44 -35.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.844 ' HA ' HD11 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -116.28 -176.77 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -132.56 148.12 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.456 ' CE1' ' ND2' ' A' ' 186' ' ' ASN . 6.3 m-85 -121.06 156.94 31.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.142 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.709 HD21 ' CD2' ' A' ' 175' ' ' HIS . 60.4 tp -106.62 115.88 30.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.34 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 184' ' ' LEU . 11.1 m -106.64 143.39 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.58 104.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 175' ' ' HIS . 5.8 m-30 -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.697 ' C ' HD22 ' A' ' 200' ' ' LEU . . . 88.98 -50.66 3.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.398 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 199' ' ' GLY . 2.9 mm? -118.61 -38.72 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.665 0.269 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 44.37 82.09 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.252 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -118.86 148.96 42.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.422 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 11.0 mtp180 -102.39 70.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.687 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.781 ' CD1' HG13 ' A' ' 174' ' ' VAL . 43.6 p90 -50.85 -48.36 60.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.26 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 77.3 m 58.0 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.405 ' HD3' ' CE2' ' A' ' 204' ' ' TYR . 53.7 Cg_exo -52.15 106.43 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.519 2.146 . . . . 0.0 112.305 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -141.44 83.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 109.58 81.04 1.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.37 31.15 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.0 -35.97 7.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -87.39 -171.22 3.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -142.44 140.51 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.12 89.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.739 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -127.45 33.3 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -50.61 174.64 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.418 ' CB ' ' CD ' ' A' ' 217' ' ' PRO . 0.3 OUTLIER -178.92 -61.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 216' ' ' ASP . 48.6 Cg_endo -68.78 178.57 3.85 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.41 2.073 . . . . 0.0 112.255 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.38 -41.47 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 40.01 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -37.86 74.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.464 ' CD2' ' HB1' ' A' ' 232' ' ' ALA . 5.6 t-80 -80.0 -64.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.682 ' HB3' HD11 ' A' ' 200' ' ' LEU . 0.4 OUTLIER 59.59 -168.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.814 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 200' ' ' LEU . . . 116.24 -112.45 2.59 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.3 p -147.47 146.3 29.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.892 HG23 HD22 ' A' ' 265' ' ' LEU . 6.9 tp -68.01 -11.13 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.804 ' HG3' HD11 ' A' ' 265' ' ' LEU . 1.0 OUTLIER -52.47 -36.75 55.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.408 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 179' ' ' LYS . 62.9 m-85 -157.42 33.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.25 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.727 HG22 HD12 ' A' ' 225' ' ' ILE . 10.0 t -66.53 139.92 57.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 110.786 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 232' ' ' ALA . 0.3 OUTLIER -84.6 131.83 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 275' ' ' LYS . 2.6 mt -59.31 -58.85 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.61 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -62.41 -44.19 97.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 229' ' ' SER . . . -57.07 -45.18 83.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -61.82 -27.84 69.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.632 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.6 t-20 -90.07 -0.1 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.393 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.16 87.2 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.002 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 234' ' ' ASN . 21.2 t -54.13 107.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.56 165.94 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.718 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 36.1 Cg_endo -65.24 148.08 88.43 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.795 ' HB3' HG11 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -59.46 109.7 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.25 -47.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -67.21 -30.41 70.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.61 91.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.82 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 m-20 -57.16 -32.68 66.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 0.0 110.982 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.764 HD21 ' CE2' ' A' ' 317' ' ' TYR . 84.0 mt -80.57 -37.4 31.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -61.71 -37.72 85.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -61.93 -49.28 84.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.667 HD23 ' OH ' ' A' ' 302' ' ' TYR . 27.5 tp -64.8 -40.73 95.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.97 92.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -78.67 -25.88 44.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 111.304 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.15 -39.97 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -50.0 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.761 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.96 -30.56 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 259' ' ' LEU . 2.3 tt0 -80.05 -39.94 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.07 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -82.23 -25.8 33.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.381 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 154' ' ' VAL . 16.6 mt -91.22 -44.68 9.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.223 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 m -96.23 0.61 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 65.36 100.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.3 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 3.8 p80 55.67 165.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.888 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -135.38 168.46 17.5 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.507 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 43.2 Cg_endo -68.33 63.33 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.379 2.053 . . . . 0.0 112.457 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.888 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 3.8 p90 175.19 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.013 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -95.21 19.78 10.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.47 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -57.67 4.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 87.0 m-20 -126.91 -26.02 3.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.343 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.892 HD22 HG23 ' A' ' 225' ' ' ILE . 48.4 mt 71.3 12.41 6.72 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.106 0.479 . . . . 0.0 109.822 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -12.89 49.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.196 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 271' ' ' VAL . 29.4 m-20 -124.06 79.63 58.42 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.92 -11.12 29.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.767 2.311 . . . . 0.0 112.597 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -47.65 22.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.069 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -75.3 -26.15 58.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.884 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 261' ' ' TRP . 77.8 t -57.78 -35.22 50.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.591 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -75.59 -41.69 53.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -40.48 82.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.079 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 67.1 m -75.44 -29.93 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.807 ' HB3' HD11 ' A' ' 230' ' ' ILE . 11.6 mmtp -73.54 -45.9 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.069 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.02 -38.57 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -65.12 -52.0 57.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.011 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.524 ' CG ' HD12 ' A' ' 285' ' ' LEU . 13.0 m-85 -62.05 -35.12 77.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.444 ' HD3' HD12 ' A' ' 230' ' ' ILE . 0.4 OUTLIER -57.33 -29.28 63.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -118.9 24.0 11.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -140.34 42.52 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 303' ' ' MET . 6.4 mm -47.6 -41.07 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.39 63.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.97 68.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.524 HD12 ' CG ' ' A' ' 278' ' ' TYR . 5.0 tt -64.76 -51.16 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.707 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.574 ' HG3' ' HB2' ' A' ' 300' ' ' ALA . 10.4 mmt -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.734 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.4 -26.54 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -82.76 -52.87 6.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.075 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 35.2 m -77.92 -41.17 37.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.57 87.38 7.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.41 76.2 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.441 2.094 . . . . 0.0 112.253 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -172.42 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.24 58.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.66 -68.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 296' ' ' PRO . 1.4 mtpp -152.27 101.19 2.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 19.1 Cg_endo -60.2 -72.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.224 1.95 . . . . 0.0 111.975 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -174.86 28.82 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.595 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 68.16 7.01 5.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.502 0.191 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.662 HG22 ' CG ' ' A' ' 303' ' ' MET . 24.3 mm -79.8 -45.7 22.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 110.963 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.574 ' HB2' ' HG3' ' A' ' 286' ' ' MET . . . -44.51 -46.74 9.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.585 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -43.06 89.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.768 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.879 ' CE2' HD11 ' A' ' 324' ' ' LEU . 18.4 t80 -70.56 -46.47 63.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.662 ' CG ' HG22 ' A' ' 299' ' ' ILE . 62.6 mmm -66.06 -37.71 86.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.748 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -42.36 98.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.564 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 309' ' ' LEU . 42.2 m -67.65 -31.74 71.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 309' ' ' LEU . 66.3 t -79.35 -24.4 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.195 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.33 -40.74 58.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.11 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 310' ' ' ASP . 0.1 OUTLIER -102.79 -27.11 12.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.6 mp 57.23 -82.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 308' ' ' LEU . 12.6 m-20 -166.89 39.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.966 0.413 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.3 t80 61.24 39.99 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m 60.4 31.52 20.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.36 101.86 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.65 139.61 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.31 179.06 6.2 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.596 2.197 . . . . 0.0 112.308 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 319' ' ' ASN . 0.9 OUTLIER -151.01 41.24 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.764 ' CE2' HD21 ' A' ' 244' ' ' LEU . 11.3 m-85 -59.16 -30.09 67.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.75 -47.91 83.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.894 ' HB2' HD22 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -63.67 -35.01 79.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.976 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.922 ' HA ' HD12 ' A' ' 323' ' ' ILE . 57.9 mt -59.57 -42.12 91.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -63.12 -36.39 83.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.97 73.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 320' ' ' LEU . 20.8 mt -66.26 -49.24 77.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.254 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.879 HD11 ' CE2' ' A' ' 302' ' ' TYR . 5.8 mt -76.2 -24.54 54.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.261 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.768 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.6 tt -82.64 -44.75 15.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -59.47 -37.1 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.37 76.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.53 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 159' ' ' LEU . 13.2 mt -59.98 -41.2 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -27.69 61.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.14 -26.29 62.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.31 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.648 HD12 ' HG2' ' A' ' 152' ' ' LYS . 27.7 pt -106.3 -27.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.221 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.21 7.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -65.45 0.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.829 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.91 108.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.442 ' OD2' HD12 ' A' ' 328' ' ' LEU . 5.8 m-20 -70.08 89.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.64 100.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 132.66 -45.45 1.13 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.44 -175.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.746 0.307 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' A' ' 192' ' ' GLN . 11.3 mt -104.21 9.9 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.429 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.39 28.02 10.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.692 0.282 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.839 HD22 HD13 ' A' ' 141' ' ' ILE . 32.8 mt -61.06 -33.1 72.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.988 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.2 t 61.1 98.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.862 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.517 HG11 HG12 ' A' ' 141' ' ' ILE . 11.0 m -147.27 86.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 344' ' ' VAL . 18.5 t -92.67 46.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 62.57 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.81 104.18 4.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.73 164.32 13.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.02 -144.24 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.584 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 350' ' ' LYS . 0.5 OUTLIER -73.06 157.1 37.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.47 ' N ' HD23 ' A' ' 349' ' ' LEU . 0.2 OUTLIER -147.8 129.47 15.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -103.06 179.79 4.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -158.29 149.99 21.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 1.1 m -140.95 137.61 33.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 354' ' ' ILE . 19.0 tt -83.6 114.67 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 43.8 p -143.81 31.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -102.76 151.69 22.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -83.31 167.18 17.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -170.0 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -157.46 133.07 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -157.76 165.44 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.6 145.5 55.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.8 pt -146.18 144.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -115.42 -75.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.84 176.0 7.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.8 t -98.48 86.49 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.32 84.57 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -109.1 158.65 33.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.94 -175.0 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.227 . . . . 0.0 112.228 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 87.54 61.05 1.57 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.475 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 371' ' ' GLU . 15.3 m -138.06 -46.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 370' ' ' VAL . 0.7 OUTLIER -104.51 113.93 27.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -83.1 77.94 9.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.1 t -123.54 79.67 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -138.46 168.04 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 60.33 83.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.5 m 60.64 31.19 20.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.34 149.66 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.6 p -141.19 -46.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.95 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 4.6 m 67.74 39.71 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.89 -48.53 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 59.15 177.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -140.14 105.86 5.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 384' ' ' ILE . 0.9 OUTLIER -76.71 62.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.005 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -123.27 -41.1 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.7 m 63.09 106.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.1 ttm105 -91.46 125.43 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 4.1 p -157.17 82.09 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.58 160.08 18.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.8 t -82.77 133.75 35.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.58 -46.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.69 -42.87 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.985 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 61.73 152.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.67 159.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -140.1 -48.29 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 30.0 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.894 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 6.8 p -82.85 -61.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.3 m -93.94 93.71 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -172.64 120.93 0.84 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.5 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -68.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.8 p -73.98 168.45 19.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 111.12 52.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -178.87 -60.97 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 1' ' ' MET . 37.3 Cg_endo -65.85 78.13 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.391 2.061 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -94.29 173.69 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.95 -43.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -146.35 141.37 27.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -173.7 -70.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.69 127.88 48.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.04 159.21 5.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.51 -50.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.19 123.65 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -71.17 -42.4 69.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.78 7.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.09 82.49 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.9 p -95.7 -28.63 14.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 63.3 160.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HE2' HD11 ' A' ' 19' ' ' LEU . 3.7 mmpt? -125.27 149.7 47.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -119.18 -58.2 1.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -164.13 -58.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.559 HD11 ' HE2' ' A' ' 16' ' ' LYS . 1.8 mt 60.46 31.68 20.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.89 77.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.26 -70.25 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -152.73 -66.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.593 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 5.4 m-85 -117.44 152.06 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . . . -147.31 -176.0 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.84 143.64 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.82 26.36 69.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.53 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.548 ' O ' HD13 ' A' ' 28' ' ' ILE . 14.8 mm-40 -92.1 170.53 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.548 HD13 ' O ' ' A' ' 27' ' ' GLU . 26.7 mm -126.28 126.26 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.228 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.962 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 36.3 pt -116.87 154.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 t -95.56 141.48 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.916 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -160.81 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.04 -39.12 26.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.156 0.503 . . . . 0.0 109.895 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -84.42 2.83 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 7.4 mttt 86.08 30.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -74.47 178.62 5.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -130.63 80.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 44.2 m95 -78.19 144.93 35.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.004 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG2' HD13 ' A' ' 28' ' ' ILE . 11.5 mtpp -97.28 148.22 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.58 127.64 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.81 -143.13 12.23 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.54 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.47 152.55 39.34 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.45 165.96 2.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.551 2.167 . . . . 0.0 112.294 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.769 HG13 HG22 ' A' ' 51' ' ' ILE . 14.3 pt -154.42 29.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.48 -163.69 24.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.393 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.17 171.25 9.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.95 68.38 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.531 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.17 28.03 0.89 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.55 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -138.82 -56.06 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.81 -103.25 0.16 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 97.9 m -143.76 84.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.769 HG22 HG13 ' A' ' 43' ' ' ILE . 28.9 mm -92.56 83.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -119.93 172.1 7.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.4 165.88 19.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . -130.75 150.22 52.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' CB ' HG22 ' A' ' 62' ' ' VAL . 26.1 t0 -139.89 157.06 46.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.5 57.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.92 94.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.25 -172.16 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -75.65 -38.88 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.74 -68.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -155.48 161.86 40.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 66' ' ' ALA . 21.6 t -74.76 114.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.96 -69.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -119.06 32.03 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.72 87.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -167.62 80.9 0.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.11 49.55 3.17 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.708 2.272 . . . . 0.0 112.642 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 86.2 m -149.79 148.23 28.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 43' ' ' ILE . 16.9 m -122.96 144.98 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 130' ' ' ILE . 8.0 p -132.94 129.84 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.156 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.54 124.09 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.665 HG22 ' CB ' ' A' ' 128' ' ' PHE . 2.6 t -113.15 139.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -141.15 144.0 33.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.705 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.92 109.09 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.484 2.122 . . . . 0.0 112.289 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 t -57.83 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.21 -49.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -167.46 110.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.5 39.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.563 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HG3' HD12 ' A' ' 200' ' ' LEU . 71.6 Cg_endo -77.14 -0.77 10.93 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.634 2.222 . . . . 0.0 112.729 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.91 -41.97 92.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -48.92 73.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.502 HG22 ' HA2' ' A' ' 199' ' ' GLY . 6.6 m -75.08 -36.47 61.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -63.63 -53.04 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HG3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -62.71 -35.6 80.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -46.91 76.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.56 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.871 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 51.1 t80 -65.15 -37.97 89.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.941 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 4.0 m-85 -55.87 -53.33 58.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -17.35 53.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.605 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.31 -47.56 12.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -128.19 -24.11 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -90.6 23.05 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -70.91 130.08 88.84 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.81 -24.72 76.95 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.459 2.106 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.43 -35.8 39.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.965 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -79.38 -50.24 11.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 91' ' ' ALA . 48.8 mt -62.58 -57.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -50.18 -55.33 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.359 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -31.37 63.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -77.32 -49.71 14.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 106' ' ' LYS . 22.2 mt -75.04 -23.26 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.876 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -27.36 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.626 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.9 p -77.98 -11.05 59.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.358 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 78.18 13.87 1.55 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -83.36 -14.53 52.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.449 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 105' ' ' LEU . 5.0 mt -111.28 -51.46 2.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 100' ' ' ILE . 1.0 OUTLIER 76.14 -56.55 0.58 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' CG ' ' NE2' ' A' ' 192' ' ' GLN . 41.1 t80 -145.33 145.03 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 167' ' ' TYR . 11.1 tp -126.12 -43.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.02 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 95.41 -7.69 68.89 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.741 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' HG ' ' A' ' 108' ' ' LEU . 35.6 t -78.04 136.64 61.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.72 0.26 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 110' ' ' VAL . 20.1 Cg_endo -60.61 143.46 99.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.457 2.105 . . . . 0.0 112.239 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -84.96 115.65 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.455 ' CE1' HD21 ' A' ' 84' ' ' LEU . 40.0 t80 -89.03 126.76 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -103.48 -40.63 6.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.01 -178.37 45.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.614 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.1 t -132.62 161.15 34.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.64 0.257 . . . . 0.0 110.523 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.05 170.65 30.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.802 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 127' ' ' ARG . 1.8 mt -137.91 159.14 42.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 110.782 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.77 125.16 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.019 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 130.78 46.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -138.2 126.29 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.13 17.15 6.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.41 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.94 -11.42 55.97 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.922 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -96.09 129.03 43.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 t -93.45 131.67 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -113.0 151.01 31.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.623 ' HA ' HD23 ' A' ' 118' ' ' LEU . 31.7 ttm180 -116.56 132.22 56.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.962 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 17.1 p90 -141.24 159.89 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.464 ' HG3' HD21 ' A' ' 84' ' ' LEU . 1.9 ttm -128.17 145.74 50.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 29' ' ' ILE . 16.3 mt -120.2 111.54 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -123.49 173.3 8.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.69 134.52 24.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 145.52 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.648 ' CD2' HD12 ' A' ' 184' ' ' LEU . 48.6 m-85 -109.27 166.38 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.28 -100.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.503 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 m -125.41 127.61 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.887 ' OD1' HD22 ' A' ' 184' ' ' LEU . 2.1 m-20 -56.67 159.56 3.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.795 HD21 HG21 ' A' ' 193' ' ' VAL . 0.3 OUTLIER -65.65 -20.16 66.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.492 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.581 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 2.4 mt-30 -51.09 -32.74 23.34 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 121.062 0.458 . . . . 0.0 110.335 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -30.89 51.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.132 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 138' ' ' LEU . 30.6 mt -76.69 -25.16 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 147' ' ' LYS . 12.1 t80 -77.88 -45.32 24.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.552 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -29.59 62.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.31 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -99.67 9.06 43.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.018 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 79.24 49.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.143 0.497 . . . . 0.0 110.02 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 258' ' ' HIS . 0.1 OUTLIER 62.55 21.4 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.132 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -120.74 161.1 22.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.668 ' HE1' HG21 ' A' ' 153' ' ' THR . 0.1 OUTLIER -146.41 143.39 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 144.39 37.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HG2' HD21 ' A' ' 255' ' ' LEU . 6.6 mtm-85 -56.4 -26.35 52.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -73.85 -41.95 61.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.668 HG21 ' HE1' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -62.83 -45.72 91.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 251' ' ' MET . 39.8 t -62.21 -54.09 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.251 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.811 ' HB3' HD21 ' A' ' 328' ' ' LEU . 97.7 mt -57.32 -48.13 79.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.31 -50.71 70.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.644 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.832 HD11 HD21 ' A' ' 341' ' ' LEU . 18.4 mt -61.52 -41.01 96.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.507 ' HB2' HD13 ' A' ' 324' ' ' LEU . 66.3 m -55.62 -41.26 73.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.67 -49.2 76.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.427 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.466 ' HD3' HD23 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -61.76 -47.24 86.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.763 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 178' ' ' ILE . 15.5 mt -64.99 -37.61 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 165' ' ' LEU . 6.9 mt -58.14 -37.8 75.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.655 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.94 -31.96 70.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.4 mt -74.42 -45.54 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.782 HD21 HD11 ' A' ' 178' ' ' ILE . 15.8 mt -60.02 -45.37 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 2.6 mt-10 -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.788 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.843 ' CE2' HD21 ' A' ' 108' ' ' LEU . 25.3 t80 -75.22 -48.99 20.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.871 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 27.0 pt -74.04 -38.8 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.666 ' CD2' HG12 ' A' ' 174' ' ' VAL . 18.2 t-80 -68.73 -25.18 64.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -98.0 -1.34 42.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.306 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.26 -58.38 1.9 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.717 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 204' ' ' TYR . 0.5 OUTLIER 168.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.473 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 86' ' ' PHE . 64.9 m-85 -159.51 126.37 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 0.0 110.996 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.666 HG12 ' CD2' ' A' ' 169' ' ' HIS . 30.4 m -132.55 147.5 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.433 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.596 ' CE1' HD11 ' A' ' 246' ' ' ILE . 37.7 t60 77.79 47.07 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -58.81 -18.41 39.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.861 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.44 ' O ' HD11 ' A' ' 195' ' ' LEU . 7.2 t70 74.52 97.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.838 0.351 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.782 HD11 HD21 ' A' ' 165' ' ' LEU . 3.9 mp -97.32 114.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.759 ' O ' HD12 ' A' ' 183' ' ' LEU . 4.7 tmtm? -148.02 179.44 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.581 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -83.72 0.75 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -115.21 2.16 14.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.476 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.802 ' O ' HG22 ' A' ' 196' ' ' VAL . 20.0 m-20 -125.51 -7.49 6.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.556 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 184' ' ' LEU . 9.6 mt -108.29 113.61 26.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.113 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.887 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.3 OUTLIER -119.04 148.0 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.191 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 141' ' ' ILE . 40.5 mt -86.69 148.53 25.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.212 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.72 127.48 31.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.58 -41.5 12.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.777 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -77.24 -23.64 51.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.822 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.09 61.67 12.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.57 114.86 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.651 2.234 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -177.49 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.815 ' HA ' HD11 ' A' ' 339' ' ' LEU . 3.2 mt-30 -131.2 177.26 7.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.795 HG21 HD21 ' A' ' 138' ' ' LEU . 9.9 p -121.08 147.33 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.974 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.44 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 3.6 m-85 -113.62 150.6 32.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 178' ' ' ILE . 30.1 tp -104.14 117.61 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 182' ' ' ASN . 9.2 m -92.17 -179.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.57 93.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -117.72 -49.82 2.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.706 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' A' ' 82' ' ' THR . . . -59.06 -21.06 52.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -84.86 3.61 37.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.473 0.178 . . . . 0.0 111.421 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 174' ' ' VAL . . . -92.5 -109.61 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 174' ' ' VAL . 46.0 t80 -146.32 118.13 8.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.846 0.355 . . . . 0.0 110.435 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 12.9 ptt180 -90.25 77.79 6.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.317 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 172' ' ' GLU . 8.3 p90 -72.2 1.14 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.183 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.9 OUTLIER -42.59 -48.66 13.1 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 203' ' ' ARG . 22.9 Cg_exo -64.85 159.68 44.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.606 2.204 . . . . 0.0 112.37 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -87.45 -37.3 17.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.734 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.32 79.23 0.13 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.78 -53.23 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 0.0 110.983 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -108.65 149.06 29.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 61.07 90.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.1 -65.29 1.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -82.84 148.15 27.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -131.94 -68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.503 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.5 OUTLIER 60.71 39.58 17.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.766 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -100.45 97.32 6.28 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.9 82.63 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.426 2.084 . . . . 0.0 112.285 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -142.78 37.56 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 61.93 47.33 6.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 5.5 t -79.66 -51.04 9.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.67 82.88 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -101.93 -35.68 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.71 -75.06 1.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.545 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 228' ' ' THR . 0.6 OUTLIER -158.49 133.9 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.925 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.901 HG23 HD22 ' A' ' 265' ' ' LEU . 7.1 tp -65.63 -13.41 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.443 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.95 -51.03 25.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.742 0.306 . . . . 0.0 111.348 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -145.56 31.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.224 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 225' ' ' ILE . 12.9 t -56.87 116.52 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.771 0.319 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.4 t -57.47 163.31 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mt -60.76 -37.73 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.34 -31.32 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.06 -36.5 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.22 -32.16 73.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -92.2 12.95 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.263 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.39 24.07 55.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.611 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 215' ' ' GLU . 28.8 t -67.87 136.42 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 238' ' ' PRO . . . -68.98 -62.45 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 237' ' ' ALA . 21.5 Cg_endo -61.2 125.6 17.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.508 2.138 . . . . 0.0 112.353 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.6 OUTLIER -164.95 121.16 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.849 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -127.51 -44.25 1.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -8.21 55.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.51 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.61 -49.71 71.35 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.2 p30 -60.36 -34.44 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.374 . . . . 0.0 111.054 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.415 ' CD1' HD13 ' A' ' 309' ' ' LEU . 77.0 mt -78.03 -33.42 51.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.03 -37.28 87.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 243' ' ' ASP . 6.1 mt -65.29 -45.76 92.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.773 HD23 ' OH ' ' A' ' 302' ' ' TYR . 29.2 tp -62.0 -37.23 84.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.87 -43.78 97.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.606 ' HA ' HD12 ' A' ' 252' ' ' ILE . 28.6 m-85 -78.52 -25.65 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 254' ' ' TRP . 6.0 m -56.65 -38.41 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.279 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.413 ' CG ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -69.85 -48.96 56.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.086 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.912 ' O ' HG22 ' A' ' 256' ' ' THR . 5.0 mt -59.59 -51.74 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.178 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.593 ' HB3' HD21 ' A' ' 259' ' ' LEU . 1.1 pt20 -63.55 -28.61 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 20.7 m0 -82.35 -28.49 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.267 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 151' ' ' ARG . 82.8 mt -86.75 -41.68 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 252' ' ' ILE . 15.0 t -96.23 0.56 51.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.498 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.8 97.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.499 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 147' ' ' LYS . 5.1 m-70 64.16 166.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.903 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 0.2 OUTLIER -132.29 162.44 56.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.7 Cg_endo -67.44 64.19 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.361 2.041 . . . . 0.0 112.433 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.903 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 2.3 p90 177.19 -36.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.169 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 1.6 tt0 -88.14 10.71 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.536 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.89 -48.13 82.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 3.9 t-20 -130.54 -29.22 1.99 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.387 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.901 HD22 HG23 ' A' ' 225' ' ' ILE . 85.9 mt 71.97 11.64 6.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -14.37 54.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.418 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.467 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -136.89 87.4 19.56 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.104 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 24.7 Cg_exo -63.01 -10.61 21.17 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.68 2.253 . . . . 0.0 112.484 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -49.81 -50.22 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.331 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.4 p90 -81.12 -26.17 36.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 225' ' ' ILE . 50.5 t -61.62 -40.89 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.044 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -75.55 -45.06 40.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.06 -46.97 84.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 59.1 m -58.56 -43.59 89.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -41.7 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.582 HG23 ' NH1' ' A' ' 279' ' ' ARG . 20.3 mt -77.47 -28.98 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.376 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -81.36 -52.17 7.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.608 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 285' ' ' LEU . 4.9 m-85 -64.0 -40.57 96.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.642 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.582 ' NH1' HG23 ' A' ' 276' ' ' ILE . 0.2 OUTLIER -52.1 -26.57 11.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.939 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -113.83 17.76 17.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.34 35.57 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.717 HD13 ' CB ' ' A' ' 303' ' ' MET . 20.5 mt -47.24 -48.61 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.53 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.78 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.196 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 252' ' ' ILE . 0.8 OUTLIER -68.57 -37.82 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.424 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.546 ' HG2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -65.06 -40.22 94.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.725 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -23.3 42.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -82.66 -54.03 5.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.205 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 96.3 m -79.25 -41.21 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.415 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.29 149.75 39.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -48.65 20.73 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.526 2.151 . . . . 0.0 112.267 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.46 31.1 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -30.84 23.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -170.58 119.59 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm 59.44 97.75 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 -167.47 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.253 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.16 11.49 69.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.878 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 71.0 10.41 6.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.686 0.243 . . . . 0.0 111.341 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.534 HG22 ' CG ' ' A' ' 303' ' ' MET . 37.4 mm -79.59 -45.79 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.788 0.328 . . . . 0.0 110.824 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 286' ' ' MET . . . -44.86 -43.32 8.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.449 ' CB ' HG23 ' A' ' 323' ' ' ILE . 61.3 mttt -60.24 -43.99 95.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.533 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.864 ' O ' HG23 ' A' ' 306' ' ' VAL . 43.2 t80 -68.53 -39.41 81.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.717 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.6 mtp -68.43 -37.29 80.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.342 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.04 -50.22 74.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 2.2 p -59.08 -41.26 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 302' ' ' TYR . 18.0 t -65.19 -24.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.121 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -77.24 -39.77 47.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.222 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -17.41 56.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.091 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.8 OUTLIER -69.59 115.43 8.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.704 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -141.71 -48.51 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.184 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -166.03 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.272 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 25.1 p -84.79 8.22 17.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -126.77 36.17 4.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.408 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 6.4 mtpp -59.05 -60.99 8.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.8 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 73.4 Cg_endo -74.73 60.62 5.26 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.541 2.161 . . . . 0.0 112.274 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 17.7 tp -118.84 -1.26 11.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.398 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 166' ' ' GLU . 79.8 m-85 -57.58 -32.37 67.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.857 0.361 . . . . 0.0 111.003 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.0 -37.63 87.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -46.04 63.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.838 ' HA ' HD12 ' A' ' 323' ' ' ILE . 36.3 mt -54.87 -45.59 74.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -32.41 65.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -38.19 45.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 320' ' ' LEU . 56.9 mt -54.81 -44.49 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' A' ' 158' ' ' SER . 38.4 mt -75.4 -49.94 17.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -54.42 -49.84 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.361 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -53.4 -39.44 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -26.56 70.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.923 HD12 HD23 ' A' ' 325' ' ' LEU . 17.1 mt -65.2 -40.5 94.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 17.8 pttt -74.46 -27.28 60.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.86 -27.42 68.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 22.5 pt -101.46 -28.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.62 5.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 33.6 t -90.9 152.64 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.72 91.7 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.72 145.9 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.43 32.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.49 0.46 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -82.3 157.83 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.815 HD11 ' HA ' ' A' ' 192' ' ' GLN . 2.3 mt -97.4 16.18 20.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 153' ' ' THR . 0.5 OUTLIER 56.96 39.94 29.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.207 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.832 HD21 HD11 ' A' ' 157' ' ' LEU . 66.5 mt -83.94 -43.19 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.1 m 58.35 96.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.001 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.627 HG11 HG12 ' A' ' 141' ' ' ILE . 5.6 m -149.67 71.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 18.4 t 60.22 60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 59.86 166.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -124.5 -46.3 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -76.63 153.92 43.08 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 109.58 -158.33 14.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.2 mt -139.21 -47.84 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 153.88 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -92.41 -48.29 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.046 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.2 tttt 60.12 30.92 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 353' ' ' THR . 6.8 m -161.53 31.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.972 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 354' ' ' ILE . 0.5 OUTLIER -143.2 112.7 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 85.45 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 63.92 -78.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.026 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 -44.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.965 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -176.38 -64.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 140.04 29.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.83 -43.77 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.12 146.04 50.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.821 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.2 tt -109.67 141.85 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -129.83 112.23 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.13 109.41 5.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 4.0 m -73.31 150.02 42.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -70.24 92.63 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -89.32 152.06 47.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.27 136.34 31.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.553 2.169 . . . . 0.0 112.312 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -178.14 53.51 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.526 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.789 HG23 ' HG3' ' A' ' 371' ' ' GLU . 27.7 m -73.74 -31.38 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.128 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . 0.789 ' HG3' HG23 ' A' ' 370' ' ' VAL . 26.8 mt-10 -100.25 161.27 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 60.29 -179.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.8 p -128.8 121.37 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -76.57 -52.85 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.966 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.16 145.18 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.04 177.97 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -157.53 98.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 3.4 m 60.0 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -158.26 103.85 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 p -96.35 155.19 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -145.71 -47.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -114.67 151.42 33.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -157.4 108.58 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.614 HD11 ' O ' ' A' ' 386' ' ' THR . 0.0 OUTLIER -169.68 124.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . 0.584 ' N ' HD13 ' A' ' 384' ' ' ILE . 14.5 mt-30 -118.5 -41.17 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . 0.614 ' O ' HD11 ' A' ' 384' ' ' ILE . 81.4 p -81.73 123.84 29.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -135.16 174.06 11.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 30.0 m 60.75 95.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 60.35 -176.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.35 36.01 20.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.66 90.86 5.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -171.04 125.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.89 133.69 51.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.35 157.71 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 -47.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 71.3 m -60.31 164.35 4.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.03 -179.67 5.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 117.38 -160.87 13.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.4 m -127.14 -64.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 69.2 m -126.7 136.31 52.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -169.82 59.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.505 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 60.22 90.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.245 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.35 167.28 24.36 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.512 2.141 . . . . 0.0 112.295 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -119.21 107.97 14.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 4' ' ' VAL . 14.3 p -106.5 116.01 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.4 tttp 59.9 88.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 -52.71 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.74 -68.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -106.91 160.29 15.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.84 150.38 25.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.29 -132.32 4.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.55 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -85.01 120.09 26.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -105.12 103.57 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.9 p -104.22 170.33 7.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.8 p -80.32 -69.31 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.9 30.78 20.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.091 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -148.45 153.07 38.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 60.15 68.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.1 107.94 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -138.28 -46.45 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.29 166.98 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -86.05 -77.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.779 ' CE2' HG21 ' A' ' 29' ' ' ILE . 5.9 m-85 -115.01 75.95 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.09 -169.66 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -91.49 123.56 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.95 -27.2 7.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.592 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -82.45 143.07 31.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 36' ' ' GLU . 23.6 mt -100.43 142.42 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 128' ' ' PHE . 30.8 pt -113.7 154.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 62.2 m -95.51 140.98 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.9 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -97.16 -162.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.109 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.94 -42.12 40.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 109.811 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -79.36 -0.05 31.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 8.5 mtpt 84.61 29.04 0.06 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 6.0 mttt -74.49 -179.86 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.576 ' HB3' HG21 ' A' ' 28' ' ' ILE . 6.7 mt-10 -128.32 79.63 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.409 ' HB2' HG13 ' A' ' 29' ' ' ILE . 31.0 m95 -74.78 143.24 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.756 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 126.6 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG2' HG23 ' A' ' 29' ' ' ILE . 22.9 t -75.87 147.18 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -105.98 -151.77 19.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.706 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 25' ' ' VAL . 3.8 mt -87.01 157.47 54.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 111.018 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.27 144.74 92.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.596 2.197 . . . . 0.0 112.282 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.1 pt -142.22 -42.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.222 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.3 -104.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.547 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -71.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.56 -70.12 0.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.531 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -66.69 2.28 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -96.19 42.06 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.83 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 51' ' ' ILE . . . 165.73 87.99 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.429 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.23 57.98 4.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 110.813 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.525 HD12 ' C ' ' A' ' 49' ' ' GLY . 3.9 mp -91.99 112.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.305 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.57 169.56 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.8 mt -73.49 158.15 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.619 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -121.07 150.91 40.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.349 . . . . 0.0 111.338 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -137.77 157.57 46.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -97.06 30.8 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.51 104.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -137.77 -65.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -103.69 -178.19 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.97 -34.58 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -142.94 159.23 42.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 5.9 t -89.88 160.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 62' ' ' VAL . . . 130.51 46.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.538 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -163.66 -45.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -143.61 67.85 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 62' ' ' VAL . . . -117.74 80.09 13.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' CB ' ' HE2' ' A' ' 188' ' ' LYS . 86.8 Cg_endo -82.82 48.27 2.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.748 2.299 . . . . 0.0 112.699 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.885 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 2.2 m -149.81 153.31 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.815 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 133' ' ' ARG . 23.4 m -130.15 144.85 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.044 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG12 ' A' ' 130' ' ' ILE . 7.3 p -135.75 124.81 39.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -104.4 123.38 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.499 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 23' ' ' PHE . 5.0 t -113.07 135.17 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.466 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -141.21 150.62 59.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.579 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.51 118.87 5.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.495 2.13 . . . . 0.0 112.209 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -55.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t0 61.58 98.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.02 94.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.06 151.33 20.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.28 35.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.486 2.124 . . . . 0.0 112.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 84' ' ' LEU . 15.8 tp -64.77 -37.64 88.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.7 -41.31 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 201' ' ' ALA . 7.3 p -72.84 -32.22 65.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.03 -40.73 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.808 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 129' ' ' MET . 2.8 mm? -61.51 -51.65 67.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -57.72 -43.75 85.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.502 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.6 t80 -63.67 -31.61 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.3 m-85 -71.65 -60.29 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.66 -17.89 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.375 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -47.37 60.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.23 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.91 -37.41 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.871 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -54.99 -21.21 11.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 123.12 8.55 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.993 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.92 -25.64 12.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.556 2.171 . . . . 0.0 112.466 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.91 -35.92 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -79.4 -39.76 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.833 HG22 HD11 ' A' ' 100' ' ' ILE . 34.0 mt -65.42 -57.61 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -32.15 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.178 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' THR . 53.0 mttt -76.15 -32.93 59.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -77.16 -38.21 52.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.833 HD11 HG22 ' A' ' 96' ' ' ILE . 18.2 mt -69.69 -37.5 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.13 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -74.94 -27.78 60.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.254 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 98' ' ' LYS . 22.6 p -84.36 -34.02 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.335 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -2.24 24.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 58.61 31.05 20.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.637 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 100' ' ' ILE . 56.9 mt -51.59 -25.64 7.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.308 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tptp 78.52 -55.6 0.47 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 108' ' ' LEU . 19.9 t80 -152.79 163.51 39.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 167' ' ' TYR . 3.4 tp -139.85 -168.02 2.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.38 28.4 2.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.433 HG13 ' HD2' ' A' ' 111' ' ' PRO . 25.0 t -101.92 136.49 19.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.588 0.232 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.733 ' HG3' HG12 ' A' ' 196' ' ' VAL . 18.0 Cg_endo -59.48 151.82 66.1 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.608 2.206 . . . . 0.0 112.291 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.8 115.53 23.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -92.5 115.35 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -92.84 -40.46 10.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.745 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 174.17 -175.98 46.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.405 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.6 t -137.92 165.89 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.666 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.34 177.2 28.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.583 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.487 HD21 ' NE ' ' A' ' 127' ' ' ARG . 2.3 mp -147.83 159.86 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 111.019 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -141.89 141.74 33.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -111.41 130.29 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -138.23 126.26 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.86 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.79 23.86 2.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.9 10.66 61.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.819 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.15 159.2 15.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.17 122.19 46.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.406 ' O ' HD23 ' A' ' 118' ' ' LEU . 16.1 m-85 -114.23 141.43 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.487 ' NE ' HD21 ' A' ' 118' ' ' LEU . 3.0 ttm180 -126.9 126.72 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.806 ' CE1' HD12 ' A' ' 29' ' ' ILE . 35.1 p90 -136.26 161.73 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.683 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.0 tmm? -128.06 145.83 50.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.645 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 70' ' ' VAL . 13.9 mt -121.52 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -132.36 173.29 11.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.8 139.58 26.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.081 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HG3' HG13 ' A' ' 69' ' ' VAL . 7.0 ttt180 -71.84 151.5 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -115.48 167.4 10.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.39 -64.07 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 p -154.33 156.71 37.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.466 ' CG ' HD22 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -77.77 153.25 33.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.711 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.4 mm? -60.78 -25.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.734 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.722 ' CA ' ' HB1' ' A' ' 180' ' ' ALA . 11.2 tt0 -70.33 -44.37 68.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -60.77 -28.53 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 138' ' ' LEU . 35.5 mt -74.56 -28.33 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 t80 -57.28 -46.28 83.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.58 -25.97 67.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.078 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 345' ' ' GLU . . . -77.09 -17.36 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.475 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.2 m120 -94.95 -3.04 49.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 98.78 43.15 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.043 0.537 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 59.79 20.35 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 142' ' ' TYR . 5.8 mtp180 -169.89 128.04 0.9 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.928 0.394 . . . . 0.0 111.141 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.788 ' CD1' HG21 ' A' ' 153' ' ' THR . 1.1 m-85 -81.26 -175.45 5.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -115.76 169.34 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' HA ' HD21 ' A' ' 255' ' ' LEU . 25.1 mtm180 -57.91 -29.9 65.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.788 HG21 ' CD1' ' A' ' 149' ' ' PHE . 23.6 m -60.84 -55.31 34.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.86 HG21 ' HG ' ' A' ' 255' ' ' LEU . 34.9 t -56.75 -52.37 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.579 ' HB3' HD21 ' A' ' 328' ' ' LEU . 23.3 mt -59.27 -41.27 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -64.82 -44.38 90.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.67 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 341' ' ' LEU . 32.5 mt -70.73 -32.73 70.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.56 ' CB ' HD13 ' A' ' 324' ' ' LEU . 1.4 t -62.85 -41.18 99.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.75 HD11 ' HA ' ' A' ' 325' ' ' LEU . 11.3 mt -72.36 -33.67 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -70.56 -49.49 47.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 164' ' ' ILE . 7.3 mt -61.32 -41.9 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.971 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.674 ' HA ' HD12 ' A' ' 165' ' ' LEU . 13.5 mt -60.26 -40.9 91.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.711 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.69 -32.92 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.526 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 161' ' ' ILE . 10.6 mt -79.74 -40.18 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.707 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 162' ' ' LEU . 22.9 mt -55.85 -38.76 70.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.85 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -32.67 74.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 108' ' ' LEU . 80.3 t80 -74.09 -52.51 12.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.778 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 165' ' ' LEU . 8.0 pt -67.66 -27.16 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.271 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 165' ' ' LEU . 1.3 m-70 -80.33 -32.29 37.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.595 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.97 -17.01 62.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -104.36 5.98 34.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.024 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 73.52 46.28 0.22 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.385 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.453 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.1 m-85 -137.06 129.12 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 202' ' ' TYR . 19.3 m -112.17 164.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.491 ' CD2' ' CE1' ' A' ' 198' ' ' TYR . 12.5 t-80 -120.01 -66.02 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 57.28 43.93 93.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -162.84 36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.905 0.383 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.8 mt -74.7 114.24 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 -177.92 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.054 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.722 ' HB1' ' CA ' ' A' ' 139' ' ' GLN . . . -80.07 -2.57 44.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.594 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.6 t -106.37 0.05 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.107 0.479 . . . . 0.0 110.57 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.76 -11.24 7.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.074 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.4 mt -108.32 113.77 27.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.616 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 137' ' ' ASP . 1.7 mt -116.99 168.38 10.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.856 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.619 HD11 ' CD1' ' A' ' 141' ' ' ILE . 49.9 mt -106.56 149.48 27.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.95 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 0.3 OUTLIER -89.51 142.96 27.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 109.941 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.1 -26.7 5.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.4 ' HE2' ' CB ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -55.62 -25.23 37.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 174.2 -58.93 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.425 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HB2' ' CB ' ' A' ' 186' ' ' ASN . 96.0 Cg_exo -37.45 -60.43 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.026 2.484 . . . . 0.0 113.538 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 0.5 OUTLIER 82.32 -4.45 1.43 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.51 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.631 ' HA ' HD11 ' A' ' 339' ' ' LEU . 0.5 OUTLIER -89.57 -166.88 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.0 p -109.93 145.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 7.8 m-85 -124.38 156.95 36.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.857 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.471 HD21 ' CD2' ' A' ' 175' ' ' HIS . 14.9 tp -105.4 115.93 31.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.625 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.0 m -130.97 170.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.2 t70 56.17 88.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.502 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.1 m-85 -81.8 -33.88 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.624 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 63.5 14.47 54.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.797 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.26 -49.69 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . 46.81 87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.411 ' HB3' ' CG2' ' A' ' 174' ' ' VAL . 0.2 OUTLIER -117.16 135.82 53.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 15.3 ttp-105 -103.49 50.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 52.77 24.88 3.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 52.65 89.17 0.1 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.08 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.48 -38.27 63.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.562 2.175 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.1 86.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.36 52.91 0.61 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t 61.31 93.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.79 0.329 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -74.08 77.62 1.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -135.08 76.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.5 157.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -166.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.563 ' HA ' HG22 ' A' ' 236' ' ' VAL . 10.7 mmtt 58.13 93.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -73.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -177.71 83.43 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.92 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.541 2.161 . . . . 0.0 112.267 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.89 -60.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -124.16 30.99 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 16.1 m 59.24 -177.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -113.43 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.75 144.81 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -95.82 36.06 4.02 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.485 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 69.1 p -150.97 -176.46 5.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.887 HG23 HD22 ' A' ' 265' ' ' LEU . 2.0 tp -148.45 27.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -102.45 -28.25 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.676 ' HB3' HG23 ' A' ' 246' ' ' ILE . 82.5 m-85 -148.93 30.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.3 m -68.65 122.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 40.4 t -69.88 169.56 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.46 -32.07 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -33.51 60.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -74.0 -31.66 63.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -25.55 65.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 12.87 16.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.321 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.21 69.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 214' ' ' LYS . 22.1 t -88.81 152.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.34 . . . . 0.0 111.119 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.03 109.41 16.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.29 177.44 4.54 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.384 2.056 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.6 m -150.55 -59.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -47.27 1.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -59.2 -29.67 67.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -64.99 -49.66 61.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.698 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.5 p30 -70.6 -42.03 71.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.24 -31.69 71.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -39.88 78.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 243' ' ' ASP . 9.2 mt -66.7 -35.97 76.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' OH ' ' A' ' 302' ' ' TYR . 33.3 tp -70.8 -38.84 73.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -63.93 -35.77 92.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.54 -25.8 45.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 111.022 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 10.4 m -65.02 -32.92 74.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.035 0.445 . . . . 0.0 110.468 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.615 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -59.01 -52.69 64.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.055 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.64 HG12 HD13 ' A' ' 285' ' ' LEU . 4.1 mp -68.32 -28.67 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.714 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -75.34 -41.84 55.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 111.473 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.407 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 40.8 m0 -82.27 -24.89 34.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.788 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.86 ' HG ' HG21 ' A' ' 154' ' ' VAL . 72.2 mt -93.16 -37.37 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 289' ' ' CYS . 3.1 m -96.12 -12.68 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 75.04 87.8 0.25 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.5 m170 64.98 158.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.4 OUTLIER -132.63 160.34 68.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 37.5 Cg_endo -65.92 66.06 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.549 2.166 . . . . 0.0 112.85 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.7 p90 178.34 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.288 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.741 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -98.53 21.99 10.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.214 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -56.09 9.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 69.4 m-20 -125.96 -27.09 3.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.887 HD22 HG23 ' A' ' 225' ' ' ILE . 69.2 mt 70.19 12.74 7.7 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.02 -14.83 43.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.118 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.449 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.9 m-20 -134.33 98.32 14.03 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.03 17.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.698 2.265 . . . . 0.0 112.83 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -80.09 -46.95 15.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.456 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 4.7 p90 -79.27 -26.73 42.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 261' ' ' TRP . 26.7 t -61.43 -37.79 78.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.189 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.543 ' O ' HD12 ' A' ' 276' ' ' ILE . 5.3 ttp-105 -75.51 -45.54 37.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.237 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -67.19 -37.91 84.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 4.1 m -68.3 -43.41 77.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -52.42 64.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 272' ' ' ARG . 7.1 mt -60.38 -33.27 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.561 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -81.05 -49.57 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.23 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 3.5 m-85 -62.8 -36.78 84.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -54.2 -29.63 46.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.877 0.37 . . . . 0.0 110.645 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.0 19.52 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -136.39 41.58 2.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.816 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 303' ' ' MET . 23.5 mt -53.17 -38.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.7 64.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -40.76 85.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.028 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.64 HD13 HG12 ' A' ' 252' ' ' ILE . 3.6 pp -75.54 -28.43 59.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.84 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -45.09 91.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.93 -27.4 33.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.373 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -82.76 -33.06 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.691 0.281 . . . . 0.0 111.334 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 256' ' ' THR . 59.4 m -93.7 -41.24 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.55 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.21 154.69 37.48 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.63 151.67 18.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.714 2.276 . . . . 0.0 112.327 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.13 -35.68 13.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -71.66 -46.36 59.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -68.15 149.15 49.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.05 147.68 88.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.98 166.91 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.624 2.216 . . . . 0.0 112.156 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -104.99 25.14 26.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.577 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 68.53 13.6 8.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.689 0.28 . . . . 0.0 111.301 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.529 HG22 ' CG ' ' A' ' 303' ' ' MET . 36.4 mm -79.25 -45.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.527 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.63 -43.78 17.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.287 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.4 OUTLIER -59.08 -41.71 88.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.392 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.677 ' HA ' HD13 ' A' ' 323' ' ' ILE . 10.7 t80 -71.46 -43.17 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.514 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.758 ' CB ' HD13 ' A' ' 282' ' ' ILE . 3.8 mtp -61.04 -41.28 96.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.597 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.11 -50.35 74.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.685 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.867 ' O ' HD12 ' A' ' 309' ' ' LEU . 41.9 m -58.45 -33.58 69.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.498 HG21 ' CE1' ' A' ' 302' ' ' TYR . 71.1 t -79.37 -24.46 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.8 -38.61 21.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.683 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 7.7 mt -107.48 -28.34 9.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.497 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 305' ' ' THR . 0.9 OUTLIER 48.99 -167.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.761 0.315 . . . . 0.0 111.144 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.492 ' HB2' HD11 ' A' ' 316' ' ' LEU . 0.1 OUTLIER -97.32 174.95 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.968 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -92.86 -64.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.45 29.24 6.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -148.17 85.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 315' ' ' PRO . 2.5 mmmp? -59.37 -58.77 17.03 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 38.1 Cg_endo -66.21 91.09 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.412 2.074 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 310' ' ' ASP . 11.0 mt -103.08 31.22 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -68.48 -29.63 68.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -46.54 85.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -73.83 -43.64 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 323' ' ' ILE . 61.8 mt -56.49 -40.57 75.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.56 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.0 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.84 -38.02 76.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 320' ' ' LEU . 54.1 mt -55.96 -48.27 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.321 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 158' ' ' SER . 7.4 mt -80.78 -21.29 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.482 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.75 ' HA ' HD11 ' A' ' 159' ' ' LEU . 6.7 tt -81.53 -49.69 10.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.15 -37.31 74.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -56.98 -27.82 57.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.542 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 159' ' ' LEU . 12.0 mt -68.79 -39.08 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -30.14 69.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.01 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.43 HD11 ' OG ' ' A' ' 333' ' ' SER . 12.0 pt -105.77 -29.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.46 27.25 3.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.43 ' OG ' HD11 ' A' ' 331' ' ' ILE . 2.3 p -114.49 34.04 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.943 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -71.81 89.78 1.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 89.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.93 -31.25 7.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.2 27.35 4.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 157.24 37.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.631 HD11 ' HA ' ' A' ' 192' ' ' GLN . 0.3 OUTLIER -100.32 23.62 9.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.026 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 4.2 t70 60.75 28.38 18.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -139.43 76.3 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.998 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 35.8 p -69.73 -28.2 65.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.703 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.6 t 64.55 90.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.89 30.77 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.49 ' HB2' ' HB1' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -134.95 129.36 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -69.78 151.74 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.66 -91.27 2.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 148.93 -110.81 0.5 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 tp -114.76 99.72 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.914 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.457 ' HE2' HG21 ' A' ' 353' ' ' THR . 1.2 tptm -151.06 101.95 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -127.15 -57.24 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -134.71 123.36 23.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.457 HG21 ' HE2' ' A' ' 350' ' ' LYS . 65.3 p -139.68 -60.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 5.3 pt -72.34 78.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.05 144.84 24.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -82.14 149.37 28.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -81.57 85.03 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 141.52 57.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 32.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.6 99.8 6.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.49 158.99 28.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.2 mm -95.0 144.6 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.79 31.87 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.1 31.21 4.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.0 m -108.94 113.36 26.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.11 34.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' A' ' 368' ' ' PRO . 0.9 OUTLIER -75.98 -52.91 2.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 367' ' ' GLU . 52.0 Cg_exo -52.59 98.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.578 2.186 . . . . 0.0 112.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -75.22 178.03 47.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.464 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 373' ' ' THR . 9.7 m -140.11 149.08 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -77.85 -28.85 50.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.61 -63.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 370' ' ' VAL . 0.2 OUTLIER -139.97 173.73 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 373' ' ' THR . 1.6 mt-10 -141.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.0 155.89 23.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -34.1 9.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 378' ' ' THR . 7.8 t30 -133.94 138.33 45.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 377' ' ' ASN . 1.0 OUTLIER -159.03 127.24 5.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -129.31 130.19 45.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.4 t -151.36 158.87 44.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -150.73 154.08 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -162.93 -61.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -165.28 -44.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.02 170.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -170.84 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 43.7 p -140.91 -174.1 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -84.7 126.57 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 13.9 m -91.05 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.44 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.5 114.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -152.01 -55.7 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 159.0 24.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 161.71 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.3 m -93.42 -31.63 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -92.38 81.99 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 96.0 p -151.65 166.79 30.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 24.0 t -110.41 157.6 19.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 67.69 103.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 85.1 p -74.22 98.75 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.31 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 12.2 t -146.16 -49.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -72.1 -28.48 68.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.22 157.31 56.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.3 158.75 56.38 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.522 2.148 . . . . 0.0 112.333 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.11 97.93 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t 62.43 117.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -54.34 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.09 -74.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -172.32 -46.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.67 35.47 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.93 69.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.41 43.29 1.69 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -155.04 174.73 14.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -167.01 177.83 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -113.7 102.46 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 t -113.16 149.94 32.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.66 -58.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -33.71 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -67.34 116.33 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -98.01 150.4 21.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.36 20.69 10.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 52.1 87.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 0.0 111.256 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 60.81 -165.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.813 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 63.71 99.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.782 ' HB3' HG11 ' A' ' 39' ' ' VAL . 3.6 m-30 -59.53 92.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -171.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -101.9 114.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.65 -25.99 11.37 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.04 147.39 29.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD11 ' HD3' ' A' ' 38' ' ' LYS . 20.9 mm -102.29 135.84 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.891 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 13.4 pt -119.84 148.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -95.55 141.46 29.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.071 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' CB ' ' HB2' ' A' ' 35' ' ' LYS . 4.1 t70 -83.41 -142.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.27 56.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.1 34.6 24.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.901 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -152.85 19.06 0.6 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' CE2' ' A' ' 37' ' ' TRP . 2.0 mmtt -163.94 175.1 10.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.445 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -151.24 90.44 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 7.3 m95 -94.87 139.96 30.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.209 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HD3' HD11 ' A' ' 28' ' ' ILE . 8.7 ttpt -93.14 135.0 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.782 HG11 ' HB3' ' A' ' 23' ' ' PHE . 19.5 t -87.39 138.78 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.67 -118.65 4.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.551 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.4 154.59 47.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.948 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.59 170.69 5.28 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.544 2.163 . . . . 0.0 112.275 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.5 pt -143.9 36.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.34 148.62 7.11 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.562 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -109.12 134.46 51.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.21 -121.91 0.95 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.501 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.07 66.32 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.454 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -104.41 -51.37 3.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.29 -88.38 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.97 94.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.415 HG23 ' HG3' ' A' ' 71' ' ' LYS . 19.0 mt -114.68 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 23' ' ' PHE . 19.5 m-85 -146.35 172.06 14.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 HG12 ' A' ' 69' ' ' VAL . 31.5 mt -77.33 156.33 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -125.67 142.41 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.41 159.72 38.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.1 mtm -99.31 38.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.62 87.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -64.13 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -175.08 -51.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -111.14 -46.55 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.45 178.98 4.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.427 HG23 ' CE ' ' A' ' 38' ' ' LYS . 21.5 t -94.98 122.64 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.42 -151.56 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.574 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.63 31.34 5.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 80.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.54 137.01 19.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.27 33.25 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.842 2.361 . . . . 0.0 112.775 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -149.82 148.25 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.489 HG12 HD23 ' A' ' 53' ' ' LEU . 20.5 m -134.86 144.87 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 128' ' ' PHE . 7.4 p -134.89 132.94 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.557 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 51' ' ' ILE . 1.9 mttp -109.37 120.78 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.844 HG22 ' CB ' ' A' ' 128' ' ' PHE . 14.7 t -113.19 149.07 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 0.0 111.363 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.759 ' HG3' HD23 ' A' ' 80' ' ' LEU . 1.1 mm-40 -133.2 149.86 73.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.679 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 80.32 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.551 2.168 . . . . 0.0 112.388 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.1 t 57.04 -168.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 61.39 165.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -124.29 130.81 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.78 -111.45 0.26 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.05 -36.62 85.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.759 HD23 ' HG3' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -67.64 -45.72 74.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -45.79 72.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 p -58.63 -44.17 89.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 2.3 tt0 -68.67 -38.83 80.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' HE2' ' A' ' 129' ' ' MET . 1.9 mt -67.98 -46.57 70.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -56.34 -40.82 75.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 10.5 t80 -79.66 -29.88 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.743 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -67.71 -52.67 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.434 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -19.61 59.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.437 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -66.33 -47.52 73.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.674 0.273 . . . . 0.0 111.298 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.1 -35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -59.28 -16.99 24.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 125.01 26.88 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.517 0.199 . . . . 0.0 110.84 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.87 -24.89 14.46 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.488 2.125 . . . . 0.0 112.614 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -44.46 91.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.43 -43.77 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 ' CD1' ' A' ' 100' ' ' ILE . 30.0 mt -54.83 -57.6 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.409 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.45 -40.77 62.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.153 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -57.0 -39.65 75.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -77.32 -44.53 29.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.459 ' CD1' HG22 ' A' ' 96' ' ' ILE . 59.6 mt -62.7 -38.8 82.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -27.63 60.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.414 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -80.52 -36.93 32.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.495 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -105.42 -3.34 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 mttt 58.33 29.31 17.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.857 0.36 . . . . 0.0 110.724 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.49 HD13 HD13 ' A' ' 108' ' ' LEU . 49.9 mt -47.76 -40.41 20.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.206 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' H ' HG23 ' A' ' 100' ' ' ILE . 4.0 tmtp? 69.07 7.81 6.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 68.6 t80 174.62 161.83 0.2 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.751 0.31 . . . . 0.0 110.498 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 167' ' ' TYR . 9.3 tp -153.56 -60.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.07 -0.26 21.02 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.044 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 111' ' ' PRO . 26.7 t -83.33 136.17 43.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.78 0.29 . . . . 0.0 110.929 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 110' ' ' VAL . 15.3 Cg_endo -57.41 143.05 95.11 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.313 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 115.68 26.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -90.42 134.47 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -111.97 -40.83 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.86 -174.5 46.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.824 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.2 t -136.86 153.19 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -131.48 168.29 22.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.28 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 127' ' ' ARG . 52.3 mt -147.93 134.47 19.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 0.0 110.748 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -139.32 135.74 34.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -108.24 135.63 49.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 126.3 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.85 18.3 5.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.38 57.82 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.895 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -96.04 129.02 43.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.819 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.8 130.31 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.72 136.38 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.809 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -115.25 125.12 52.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.891 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 12.9 p90 -134.73 159.35 41.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.709 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.561 ' HE2' ' HG ' ' A' ' 84' ' ' LEU . 1.7 ttm -128.06 141.92 51.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.402 HG12 ' CG2' ' A' ' 70' ' ' VAL . 9.3 mt -111.94 111.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.04 173.41 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.73 136.91 21.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.463 ' HA ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -56.94 172.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.235 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CE2' HG11 ' A' ' 196' ' ' VAL . 31.5 m-85 -150.17 162.06 41.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.645 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.6 -84.53 1.58 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.449 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.8 m -149.68 127.36 11.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.823 0.344 . . . . 0.0 110.719 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.832 ' OD1' HD22 ' A' ' 184' ' ' LEU . 4.9 m-20 -49.0 159.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -69.29 -21.31 63.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.773 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 1.7 pt20 -51.9 -34.13 39.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.379 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -29.63 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.652 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 1.031 HD11 HD11 ' A' ' 185' ' ' LEU . 62.4 mt -73.92 -29.82 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.571 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -59.58 -50.03 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -74.04 -27.48 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.07 66.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.366 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -97.9 14.96 25.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.242 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 87.5 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 19.95 10.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.453 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.7 123.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 7.4 m-85 -59.58 -174.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.5 m -119.14 153.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.571 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -54.75 -27.3 40.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 331' ' ' ILE . 10.7 mtpp -74.88 -42.39 57.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 339' ' ' LEU . 0.2 OUTLIER -74.23 -44.3 53.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.243 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 150' ' ' SER . 59.6 t -55.82 -53.92 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 297' ' ' GLY . 13.5 mt -58.43 -46.93 85.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.966 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -52.85 56.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.992 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.552 HD11 HD21 ' A' ' 341' ' ' LEU . 11.6 mt -59.5 -40.1 85.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.636 ' HA ' HD12 ' A' ' 161' ' ' ILE . 52.8 p -59.18 -36.8 75.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.674 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.768 HD21 ' HG2' ' A' ' 321' ' ' ARG . 1.5 tm? -67.94 -44.12 77.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.776 ' HD2' HD21 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -60.4 -42.16 95.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.761 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 158' ' ' SER . 10.0 mt -64.3 -36.99 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.551 ' CD1' HD12 ' A' ' 324' ' ' LEU . 11.5 mt -61.58 -38.59 88.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.49 -41.22 93.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 31.1 mt -74.89 -41.94 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 168' ' ' ILE . 11.2 mt -56.88 -40.51 76.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HG3' ' CG ' ' A' ' 317' ' ' TYR . 10.6 tt0 -64.96 -37.9 89.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.752 ' CD1' HD21 ' A' ' 108' ' ' LEU . 89.9 t80 -66.41 -53.44 35.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 165' ' ' LEU . 5.3 pt -65.48 -27.04 40.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.42 ' N ' HG13 ' A' ' 168' ' ' ILE . 14.8 m-70 -76.48 -39.84 52.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.498 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.91 -12.32 61.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.62 4.25 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.765 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 70.69 47.09 0.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.06 126.74 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.682 HG13 ' CD1' ' A' ' 204' ' ' TYR . 27.2 m -133.01 169.27 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.603 ' NE2' HD21 ' A' ' 195' ' ' LEU . 31.6 p-80 -162.37 -47.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.16 59.67 8.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.44 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.77 29.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 161' ' ' ILE . 12.3 mt -64.54 105.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 227' ' ' PHE . 14.1 tptm -149.84 168.33 24.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.773 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -69.39 0.03 5.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.065 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 -4.07 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.571 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -124.96 -5.77 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.356 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.885 ' C ' HD23 ' A' ' 184' ' ' LEU . 12.6 mt -108.22 113.51 26.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.244 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -121.14 149.75 42.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -178.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 141' ' ' ILE . 10.3 mt -90.36 149.19 22.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.65 130.54 46.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.687 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -66.77 -67.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -21.3 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -119.56 67.28 10.17 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.83 97.31 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.508 2.139 . . . . 0.0 112.1 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.503 ' O ' HD12 ' A' ' 339' ' ' LEU . 1.9 p30 -172.5 -38.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.213 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -116.15 174.36 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 138' ' ' LEU . 7.9 p -133.05 136.56 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 3.4 m-85 -106.91 156.88 18.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.2 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.603 HD21 ' NE2' ' A' ' 175' ' ' HIS . 18.8 tp -104.06 115.87 31.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 184' ' ' LEU . 27.8 m -115.37 156.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 56.04 93.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.496 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 5.0 m-85 -79.27 -12.87 59.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 57.01 25.2 53.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -176.5 -62.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.703 0.287 . . . . 0.0 111.014 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 86' ' ' PHE . . . 43.88 82.91 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.325 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -142.08 149.01 39.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -82.79 94.34 7.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.682 ' CD1' HG13 ' A' ' 174' ' ' VAL . 35.4 p90 -48.24 -46.32 35.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.3 t -145.66 87.72 6.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.979 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.0 -38.51 69.61 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.559 2.173 . . . . 0.0 112.266 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -173.07 -43.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.92 -55.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.472 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.0 t 69.04 -67.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -160.71 -50.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.969 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -127.11 -179.05 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -120.75 -41.68 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.471 ' CE1' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -94.98 153.39 17.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -60.68 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.709 ' H ' HG22 ' A' ' 236' ' ' VAL . 10.5 mt-10 60.67 40.98 15.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.88 86.15 24.36 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.31 133.0 21.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.554 2.169 . . . . 0.0 112.325 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -177.68 -44.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -99.42 -22.2 15.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 19.6 m 61.67 30.87 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.528 ' CB ' ' HB1' ' A' ' 232' ' ' ALA . 7.7 t60 58.96 46.46 13.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.976 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 221' ' ' HIS . 54.3 m-20 65.94 -68.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' HIS . . . -49.79 150.42 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.725 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 p -91.34 -46.95 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.2 tp -178.11 38.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.197 0.523 . . . . 0.0 110.522 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -94.66 64.85 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.269 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.554 ' HB3' HG23 ' A' ' 246' ' ' ILE . 53.3 m-85 75.29 32.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -72.78 153.89 40.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.3 m -95.88 157.49 15.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.76 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -59.66 -30.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -48.73 55.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.0 -33.42 74.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.58 -26.1 61.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.83 12.82 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.375 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.52 59.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.591 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 215' ' ' GLU . 25.9 t -118.25 124.85 73.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.15 118.91 33.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 55.0 Cg_exo -51.97 101.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.403 2.069 . . . . 0.0 112.298 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.8 m -60.68 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.11 -51.51 0.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.58 ' HB3' HD22 ' A' ' 309' ' ' LEU . 18.0 ptt180 -62.78 -23.91 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.49 -49.55 72.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.692 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 -31.04 63.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.61 HD13 HD11 ' A' ' 320' ' ' LEU . 30.6 mt -72.18 -36.09 69.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.67 -29.89 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 227' ' ' PHE . 42.0 mt -72.39 -42.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.541 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.5 tp -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.677 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -62.42 -39.15 97.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.314 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.5 -25.88 45.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -34.57 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.108 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -49.43 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 248' ' ' GLY . 4.0 mt -65.32 -30.26 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.189 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.688 ' HB2' HD21 ' A' ' 259' ' ' LEU . 17.6 tm0? -80.04 -37.4 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.4 m0 -82.22 -39.35 23.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.06 -45.39 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.076 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.404 HG21 ' HB3' ' A' ' 289' ' ' CYS . 10.4 p -96.14 0.55 51.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.41 97.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.475 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 m80 65.0 155.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -134.52 172.54 7.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.474 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 61.5 Cg_endo -73.49 58.11 3.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.373 2.049 . . . . 0.0 112.589 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.989 ' CH2' HD22 ' A' ' 259' ' ' LEU . 3.1 p90 -180.0 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.306 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -99.04 20.62 13.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 178.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -55.12 23.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.948 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.1 OUTLIER -127.68 -25.27 3.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.452 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.637 HD22 HG23 ' A' ' 225' ' ' ILE . 53.5 mt 69.34 12.74 8.41 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -88.25 -15.48 35.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.083 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.471 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 4.0 t0 -135.12 97.46 13.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 20.73 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.625 2.216 . . . . 0.0 112.944 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -44.85 22.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.789 0.328 . . . . 0.0 110.764 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.0 p90 -83.87 -26.62 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.015 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.746 ' CG1' HD11 ' A' ' 225' ' ' ILE . 16.3 t -61.76 -37.06 77.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -72.11 -44.36 63.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.35 -37.37 77.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.069 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 28.3 p -72.01 -38.12 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.253 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.512 ' CD ' HG12 ' A' ' 271' ' ' VAL . 0.2 OUTLIER -61.54 -47.53 85.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.14 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 230' ' ' ILE . 28.7 mm -70.29 -29.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.408 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -48.74 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.501 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.6 m-85 -67.33 -40.56 85.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.76 ' HE ' HD13 ' A' ' 230' ' ' ILE . 6.8 tmm_? -50.68 -27.79 7.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.839 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -118.3 22.84 11.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -138.11 44.04 2.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.987 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 303' ' ' MET . 22.7 mt -53.32 -38.24 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.01 64.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.084 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -40.69 86.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.033 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 4.2 pp -76.44 -28.34 56.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.408 ' HE1' ' HG3' ' A' ' 303' ' ' MET . 0.0 OUTLIER -66.69 -37.93 85.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.501 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.84 -31.09 28.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -82.68 -49.6 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.093 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' A' ' 256' ' ' THR . 53.4 m -72.06 -41.33 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -114.47 134.87 22.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.95 165.3 32.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.68 -29.43 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -38.34 75.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -74.49 -177.35 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.25 142.33 25.75 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.55 142.02 61.15 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 155' ' ' LEU . . . -99.1 24.35 32.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.624 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 64.16 17.1 10.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.714 0.292 . . . . 0.0 111.193 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.474 HG22 ' CG ' ' A' ' 303' ' ' MET . 32.2 mm -79.54 -51.99 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.5 -41.91 14.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.307 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -41.77 96.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 306' ' ' VAL . 50.3 t80 -72.05 -44.41 63.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.808 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.721 ' CB ' HD13 ' A' ' 282' ' ' ILE . 1.9 mtp -58.26 -39.76 80.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.662 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -65.76 -43.76 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.57 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.984 HG21 HD11 ' A' ' 323' ' ' ILE . 0.7 OUTLIER -65.95 -34.54 78.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 302' ' ' TYR . 67.9 t -78.75 -24.39 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.98 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.058 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 310' ' ' ASP . 3.6 pp -102.17 -24.7 13.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.723 ' O ' HD22 ' A' ' 316' ' ' LEU . 1.1 mp 58.41 -80.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.162 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.7 ' OD1' HD13 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -145.42 170.99 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.794 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -87.33 -33.55 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.1 p -114.46 27.29 9.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.47 102.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.62 165.45 15.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.84 108.25 2.05 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.279 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.723 HD22 ' O ' ' A' ' 309' ' ' LEU . 11.2 tp -98.74 29.01 3.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' GLU . 63.1 m-85 -62.66 -30.02 71.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.52 -45.57 79.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -45.18 60.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.858 ' HA ' HD12 ' A' ' 323' ' ' ILE . 89.0 mt -56.13 -50.25 71.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.768 ' HG2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -53.72 -50.96 64.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -54.43 -42.35 70.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 305' ' ' THR . 42.6 mt -54.22 -46.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.564 HD13 ' OG ' ' A' ' 158' ' ' SER . 87.4 mt -81.19 -37.26 28.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.839 HD23 HD12 ' A' ' 328' ' ' LEU . 0.4 OUTLIER -63.17 -49.75 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -54.09 -43.57 70.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.035 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.12 67.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.839 HD12 HD23 ' A' ' 325' ' ' LEU . 11.4 mt -59.19 -24.74 63.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.719 0.295 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 18.8 mttm -76.38 -33.94 58.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.37 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.93 -18.72 55.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.039 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 152' ' ' LYS . 1.2 pt -117.07 -34.77 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -116.23 -25.0 3.66 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.347 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 5.4 t 69.71 72.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.84 125.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.85 138.74 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.38 38.52 4.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.26 54.57 26.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.26 116.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.776 HD21 ' HD2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -99.0 31.2 3.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER 56.93 27.76 13.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.871 HD22 HD13 ' A' ' 141' ' ' ILE . 19.8 mt -98.49 35.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.823 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.4 ' C ' HG22 ' A' ' 343' ' ' VAL . 11.2 m -59.67 -52.8 63.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.4 HG22 ' C ' ' A' ' 342' ' ' SER . 17.5 m 42.31 58.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.8 m 41.62 77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.797 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 84.07 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -158.89 155.16 27.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.71 168.05 12.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 173.54 -125.53 1.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 62.8 mt 60.68 97.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -109.79 -47.08 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -135.12 -177.25 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -146.5 -55.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.0 -62.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 354' ' ' ILE . 2.9 pp -133.05 176.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.7 m -136.13 105.85 6.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.57 114.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -76.97 -177.69 4.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 61.41 172.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 -47.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -93.31 151.57 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -89.34 156.39 18.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.4 mt -59.93 90.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -161.78 31.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.46 121.9 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.6 t -137.29 -46.27 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt 63.26 95.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -125.22 139.72 34.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.53 84.48 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.431 2.087 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -141.85 -44.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.574 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 21.5 t 66.1 90.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.92 156.14 34.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.72 -54.99 2.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 39.8 p -88.69 170.03 11.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -154.63 -66.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.444 ' CE3' ' HA ' ' A' ' 375' ' ' TRP . 0.0 OUTLIER -118.57 -165.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 56.0 p -175.81 171.68 2.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -116.87 -59.0 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 379' ' ' GLN . 0.2 OUTLIER -98.26 -177.93 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . 0.47 ' H ' HG22 ' A' ' 378' ' ' THR . 3.3 mt-30 -64.06 85.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.67 123.02 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.81 134.51 39.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.46 79.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -151.73 69.29 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.588 HD11 HG23 ' A' ' 386' ' ' THR . 8.7 tp -134.46 145.45 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.93 46.21 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . 0.588 HG23 HD11 ' A' ' 384' ' ' ILE . 20.0 p -89.3 128.27 35.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -126.44 -44.97 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.0 m -105.17 148.22 27.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 390' ' ' THR . 0.0 OUTLIER -178.46 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.2 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . 0.41 ' N ' ' HG2' ' A' ' 389' ' ' ARG . 4.1 t -94.8 -40.88 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -174.47 137.05 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -87.0 -53.19 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 148.99 51.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 395' ' ' GLN . 21.5 t -87.51 157.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.461 ' N ' HG12 ' A' ' 394' ' ' VAL . 1.6 tt0 60.81 33.53 20.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.556 -0.217 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 4.3 m -154.03 -62.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 49.3 m -83.97 113.78 21.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.29 41.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.523 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.99 130.2 53.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.72 142.06 27.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 136.34 44.39 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.522 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt -111.05 165.94 11.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.72 0.295 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.24 -34.01 22.81 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -161.7 129.89 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.68 31.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 147.26 25.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.11 176.89 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.28 121.11 3.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.49 169.18 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.85 -31.31 11.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.33 -160.75 12.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.53 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -119.77 -44.62 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.87 159.8 42.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 t -143.51 128.0 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -168.53 150.69 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.18 165.21 9.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.14 -47.57 5.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.1 115.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 62.42 117.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.1 100.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.28 -57.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -179.84 6.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -131.5 -54.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.883 ' CE2' HG21 ' A' ' 72' ' ' VAL . 3.9 m-85 -76.08 97.16 3.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.01 -176.72 3.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 40' ' ' GLY . 21.6 t -79.29 113.05 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.75 13.83 15.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.3 161.13 14.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.623 HD13 ' HG3' ' A' ' 38' ' ' LYS . 20.5 mm -112.39 131.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 23' ' ' PHE . 9.3 pt -119.84 125.55 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.767 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.9 t -95.55 141.31 29.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.548 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 13.7 m-20 -90.4 -161.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.022 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.57 63.06 0.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.9 31.3 18.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.214 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.8 -33.58 8.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.641 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.87 -158.07 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.28 93.04 1.94 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.737 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -78.08 155.26 30.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.4 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HG3' HD13 ' A' ' 28' ' ' ILE . 4.8 tttm -100.16 117.78 35.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.763 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 29' ' ' ILE . 17.4 t -73.01 143.49 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -118.06 -111.07 2.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.598 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.5 mt -96.11 154.37 38.86 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.704 0.288 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 -27.35 52.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 69' ' ' VAL . 46.5 pt 42.48 31.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -179.11 111.81 0.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.77 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.12 -65.69 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.28 -103.7 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.537 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -68.88 -30.49 69.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 52' ' ' TYR . . . 170.7 -85.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.437 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 78.18 -55.3 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.641 0.257 . . . . 0.0 111.2 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mt -129.15 137.61 56.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 0.0 111.325 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 62.4 m-85 -146.43 167.87 22.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 68' ' ' CYS . 6.0 mt -89.09 149.55 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.95 146.92 45.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 9.0 t70 -137.54 152.23 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mtp -96.48 37.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.31 30.12 19.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.95 179.46 6.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.02 171.87 12.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.16 174.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 t -81.41 157.36 25.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.3 130.87 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.15 -90.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.574 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -99.14 30.52 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.05 -44.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 55' ' ' ASP . . . -105.61 88.66 2.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.92 80.91 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 53' ' ' LEU . 73.3 m -149.71 148.19 28.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.552 HG13 ' CG ' ' A' ' 133' ' ' ARG . 5.4 m -119.68 155.37 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG23 HD13 ' A' ' 130' ' ' ILE . 11.8 p -148.13 126.95 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.034 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.68 116.22 28.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.682 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.883 HG21 ' CE2' ' A' ' 23' ' ' PHE . 21.6 t -122.46 137.63 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 80' ' ' LEU . 2.2 mt-10 -128.69 147.22 63.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.46 83.5 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.89 -63.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.243 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -46.48 131.28 11.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -140.36 80.08 1.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.52 -76.17 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.45 -28.18 32.67 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.616 2.211 . . . . 0.0 112.299 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.698 ' HG ' HD23 ' A' ' 84' ' ' LEU . 9.3 tp -73.08 -33.27 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -30.62 70.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 p -76.13 -37.98 57.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG2' ' CD1' ' A' ' 87' ' ' TYR . 59.8 tt0 -74.41 -39.11 62.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.2 mm? -62.5 -52.47 63.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 198' ' ' TYR . 11.3 t80 -71.03 -45.83 63.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.993 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 5.7 m-85 -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.461 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.43 -48.04 36.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.645 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -87.75 -47.52 8.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.701 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -77.49 -50.23 13.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.886 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.51 32.32 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.708 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.04 125.91 89.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.48 -28.2 84.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.44 2.094 . . . . 0.0 112.444 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.35 -32.89 43.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.176 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -79.22 -52.65 7.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.286 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.746 HD11 ' HA ' ' A' ' 91' ' ' ALA . 50.6 mt -56.71 -52.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.6 -50.6 62.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -64.66 -42.58 95.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -58.53 -54.2 49.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.93 -36.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -75.11 -27.81 59.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.316 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -78.78 -38.74 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.499 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.71 -2.42 21.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.335 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.12 30.44 18.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 110.643 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.1 mt -50.15 -31.12 12.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.261 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.92 -56.62 0.54 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.29 151.46 49.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.682 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 108' ' ' LEU . 11.2 tp -128.92 -66.88 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 138.09 -14.37 3.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.908 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.11 125.29 77.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.629 0.215 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.31 152.76 7.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 112.249 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -80.19 115.48 19.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.129 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CE1' ' HA2' ' A' ' 115' ' ' GLY . 13.3 t80 -93.24 115.76 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -91.8 -40.98 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.224 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 113' ' ' TYR . . . 173.79 -174.63 46.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.76 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 p -131.03 158.05 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 31' ' ' ASP . . . -143.02 179.45 20.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.353 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -147.99 158.85 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.961 0.41 . . . . 0.0 111.314 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.62 114.61 11.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.602 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -91.4 142.26 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 123' ' ' GLY . 4.0 tttt -130.57 157.53 42.46 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.98 51.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.632 0.253 . . . . 0.0 111.428 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 121' ' ' LYS . . . 144.2 -18.27 2.11 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.897 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -126.4 142.96 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.68 138.29 46.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.477 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.556 ' O ' HD23 ' A' ' 118' ' ' LEU . 2.7 m-85 -125.7 134.64 51.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.959 0.409 . . . . 0.0 111.334 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -124.13 138.26 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.467 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.882 ' CB ' HG22 ' A' ' 72' ' ' VAL . 23.2 p90 -147.03 168.73 20.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.275 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.789 ' HB2' HD21 ' A' ' 84' ' ' LEU . 7.1 tmm? -136.67 146.44 45.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.656 HD13 HG23 ' A' ' 70' ' ' VAL . 11.6 mm -96.0 135.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -143.49 165.28 27.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.69 130.09 41.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.552 ' CG ' HG13 ' A' ' 69' ' ' VAL . 3.6 ttt-85 -57.73 143.06 43.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -113.14 166.89 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.79 -83.2 1.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -133.92 127.01 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.667 ' CG ' HD22 ' A' ' 184' ' ' LEU . 3.0 m-20 -55.35 155.75 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 1.9 mm? -60.08 -23.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.619 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.7 OUTLIER -65.43 -42.91 91.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.134 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -61.5 -29.89 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.894 HD11 HD11 ' A' ' 185' ' ' LEU . 26.4 mt -75.39 -28.54 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 10.3 t80 -59.53 -49.37 78.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -28.01 67.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.749 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.24 -23.1 65.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.326 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 5.7 m-20 -96.4 15.63 20.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.166 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 88.71 46.4 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.52 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.2 19.45 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 33.3 mtt180 -147.14 -179.09 6.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 153' ' ' THR . 0.1 OUTLIER -132.84 144.59 50.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 p -81.91 155.38 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.36 68.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -71.8 -36.06 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.555 ' CG2' HD23 ' A' ' 341' ' ' LEU . 1.7 m -72.75 -42.26 64.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' A' ' 251' ' ' MET . 47.6 t -66.05 -54.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.81 ' HB3' HD21 ' A' ' 328' ' ' LEU . 71.8 mt -54.89 -47.15 74.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.665 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.593 HD21 HD21 ' A' ' 341' ' ' LEU . 17.4 mt -66.17 -41.17 90.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.596 ' CB ' HD13 ' A' ' 324' ' ' LEU . 60.0 m -54.56 -42.4 70.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.699 HD22 ' HG2' ' A' ' 321' ' ' ARG . 88.8 mt -66.49 -39.61 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.459 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -64.97 -46.34 81.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.726 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.85 -34.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.765 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.3 mt -62.34 -35.89 80.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.17 -42.26 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 ' HA3' ' A' ' 109' ' ' GLY . 11.9 mt -71.41 -34.78 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.75 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 162' ' ' LEU . 23.3 mt -58.77 -39.05 79.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.68 -37.23 79.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -66.78 -54.85 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.713 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 175' ' ' HIS . 43.5 pt -63.12 -27.28 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -77.9 -38.35 45.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.459 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -10.9 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.981 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.51 4.8 26.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.821 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 1.2 mp0 71.5 48.93 0.31 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.835 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -139.68 139.05 36.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 204' ' ' TYR . 12.3 m -137.92 169.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 1.4 p80 -147.13 -54.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.497 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 70.28 31.98 68.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.376 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -136.74 81.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.3 mt -115.61 117.85 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -159.42 -176.6 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.619 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.78 1.91 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.479 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.08 1.4 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 110.329 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -124.82 -12.94 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.287 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 5.5 mt -108.48 123.32 48.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.98 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -127.9 160.96 30.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.894 HD11 HD11 ' A' ' 141' ' ' ILE . 22.4 mt -95.04 149.34 21.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.022 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.7 132.58 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.443 ' CD2' ' CD ' ' A' ' 133' ' ' ARG . 22.3 t80 -68.58 -61.83 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.418 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -63.15 -18.51 63.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.24 75.26 74.87 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.55 89.92 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.536 2.157 . . . . 0.0 112.066 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.95 -34.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.107 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.471 ' HA ' HD11 ' A' ' 339' ' ' LEU . 35.5 mt-30 -102.54 149.86 23.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.9 p -112.45 147.99 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.124 0.488 . . . . 0.0 110.736 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 24.7 m-85 -126.47 157.32 38.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.974 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 26.2 tp -103.32 115.83 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.458 HG21 ' CD1' ' A' ' 184' ' ' LEU . 5.2 t -103.56 137.38 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.16 130.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.724 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 86' ' ' PHE . 3.5 m-85 -103.02 7.95 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.195 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 80.99 -55.25 4.78 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.17 -32.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.579 0.228 . . . . 0.0 111.53 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.29 94.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 110.746 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.539 ' O ' HG22 ' A' ' 174' ' ' VAL . 68.1 t80 -126.29 149.06 49.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -98.82 78.18 2.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.768 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.68 ' CD1' HG13 ' A' ' 174' ' ' VAL . 42.2 p90 -46.5 -46.59 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.3 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 48.8 t -74.12 127.02 88.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 -171.45 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.478 2.119 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.29 -43.14 17.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.16 -75.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.68 114.01 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 111.173 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.31 -69.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -177.66 132.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -175.38 4.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 216' ' ' ASP . 2.7 t80 -107.94 -77.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? 44.35 92.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.772 0.32 . . . . 0.0 111.537 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.671 ' HA ' HG22 ' A' ' 236' ' ' VAL . 22.6 mm-40 61.24 117.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.044 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 213' ' ' TYR . 1.0 OUTLIER -169.31 82.53 0.66 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.66 84.92 0.62 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.551 2.167 . . . . 0.0 112.288 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.78 23.63 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.5 56.92 6.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.965 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.17 -66.23 1.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 237' ' ' ALA . 12.4 m170 -98.57 34.61 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -67.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.771 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 58.83 -133.39 52.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.704 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -169.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 265' ' ' LEU . 20.3 tt -139.13 31.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.031 0.443 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HB3' HD11 ' A' ' 265' ' ' LEU . 0.1 OUTLIER -94.63 21.88 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.709 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 179' ' ' LYS . 0.5 OUTLIER 168.58 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.638 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.2 p -60.01 150.14 30.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -177.71 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.985 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.442 HD13 HH21 ' A' ' 279' ' ' ARG . 1.3 mp -65.96 -35.43 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.409 ' OD2' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -57.66 -29.89 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.07 77.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -33.57 76.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -86.12 4.4 38.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.393 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.84 -2.33 83.71 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.884 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 215' ' ' GLU . 15.9 t -63.77 133.73 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.844 0.354 . . . . 0.0 111.094 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 221' ' ' HIS . . . -73.4 150.13 89.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HG2' ' CB ' ' A' ' 174' ' ' VAL . 37.6 Cg_endo -65.92 -35.01 36.97 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.518 2.146 . . . . 0.0 112.234 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 204' ' ' TYR . 21.1 t 67.62 -69.62 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.6 ttp-105 -166.18 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -71.73 -32.77 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.5 96.25 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.779 ' HA ' HD12 ' A' ' 246' ' ' ILE . 6.4 m-20 -65.31 -43.34 91.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 320' ' ' LEU . 39.9 mt -64.24 -38.51 91.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 306' ' ' VAL . 2.5 tt0 -59.8 -31.02 69.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 243' ' ' ASP . 7.0 mt -75.9 -42.38 39.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.67 HD23 ' OH ' ' A' ' 302' ' ' TYR . 18.6 tp -58.77 -46.27 87.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.684 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 252' ' ' ILE . . . -55.77 -25.42 44.12 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.547 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.88 -31.53 45.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 97.2 m -54.22 -48.73 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.794 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -62.63 -30.54 71.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 285' ' ' LEU . 28.9 mm -66.28 -45.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.201 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HB3' ' CG ' ' A' ' 259' ' ' LEU . 0.0 OUTLIER -80.01 -27.37 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.512 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.433 ' CE3' HG13 ' A' ' 154' ' ' VAL . 17.2 m0 -76.99 -32.66 57.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.434 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.15 -35.51 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 289' ' ' CYS . 1.8 m -96.27 0.59 51.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.599 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.35 96.29 0.01 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.332 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 33.4 m80 61.74 154.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.95 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -121.68 164.26 25.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.823 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 60.0 Cg_endo -72.62 57.64 3.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.641 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.95 ' CH2' HD22 ' A' ' 259' ' ' LEU . 5.8 p90 179.35 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' A' ' 259' ' ' LEU . 14.9 tt0 -92.47 13.44 19.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.553 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -59.4 5.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 4.6 m-80 -129.95 -26.17 2.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.417 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.771 HD11 ' HB3' ' A' ' 226' ' ' GLU . 83.6 mt 72.75 11.19 5.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -16.22 49.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.222 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.454 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.4 OUTLIER -132.16 99.97 15.9 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.791 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.95 12.07 2.78 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -49.98 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 3.9 p90 -79.92 -26.23 40.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 15.1 t -60.67 -45.73 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.52 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 276' ' ' ILE . 0.6 OUTLIER -74.37 -31.96 62.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.039 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.13 -47.79 33.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.174 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.407 ' HB3' ' CE2' ' A' ' 278' ' ' TYR . 1.5 m -66.84 -35.99 81.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -64.77 -49.62 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.201 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 272' ' ' ARG . 21.7 mt -66.91 -30.14 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -52.05 7.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.597 ' CD1' HD12 ' A' ' 285' ' ' LEU . 10.7 m-85 -56.68 -31.96 64.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.442 HH21 HD13 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -59.08 -27.86 65.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.66 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -130.07 30.29 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -150.19 38.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.763 HD13 ' CB ' ' A' ' 303' ' ' MET . 21.2 mt -52.98 -49.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.03 -49.6 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.3 p -65.33 -31.6 72.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.277 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.597 HD12 ' CD1' ' A' ' 278' ' ' TYR . 1.4 tt -68.7 -38.42 80.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.488 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' PHE . 0.0 OUTLIER -65.42 -38.16 89.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.809 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -25.68 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -82.75 -54.9 4.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.403 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.472 ' O ' HG23 ' A' ' 256' ' ' THR . 0.1 OUTLIER -68.84 -41.3 78.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' MET . 19.4 m-85 -102.26 152.74 38.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -51.03 -61.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.663 2.242 . . . . 0.0 112.462 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -146.53 -45.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.013 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 63.62 56.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -65.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.744 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 296' ' ' PRO . 0.0 OUTLIER -62.42 -56.55 29.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 295' ' ' LYS . 18.6 Cg_endo -60.08 -164.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.4 2.066 . . . . 0.0 112.235 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 135.14 37.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.543 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.557 ' HG3' HD11 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -87.75 -33.86 18.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.495 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.757 HD12 ' HG3' ' A' ' 251' ' ' MET . 20.2 mm -74.68 -46.61 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.631 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -46.27 -45.69 17.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -61.71 -38.82 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.489 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.88 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.0 t80 -70.05 -43.36 71.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.873 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.763 ' CB ' HD13 ' A' ' 282' ' ' ILE . 4.5 mtp -65.51 -37.2 86.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -51.38 70.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.617 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.43 HG21 HD11 ' A' ' 323' ' ' ILE . 82.3 p -60.96 -34.72 75.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 302' ' ' TYR . 39.6 t -73.36 -24.66 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.191 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -76.67 -31.89 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 6.4 mt -104.33 -10.9 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -53.12 136.09 36.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.065 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.37 162.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.25 20.77 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 3.5 m -164.99 -49.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 110.805 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 -170.08 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.971 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 165.13 14.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.05 142.27 27.83 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.627 2.218 . . . . 0.0 112.262 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 316' ' ' LEU . 1.3 pt? -144.87 53.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -56.04 -32.81 64.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -63.27 -34.34 77.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 316' ' ' LEU . 2.8 t30 -70.82 -44.38 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 323' ' ' ILE . 68.1 mt -56.27 -45.43 80.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.699 ' HG2' HD22 ' A' ' 159' ' ' LEU . 13.8 ttt180 -58.45 -47.56 83.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -39.42 81.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 320' ' ' LEU . 33.7 mt -57.12 -44.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.6 HD22 HD23 ' A' ' 155' ' ' LEU . 53.8 mt -78.28 -48.21 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -60.4 -49.86 75.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -58.52 -40.36 82.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.77 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.08 -29.29 59.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.399 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 155' ' ' LEU . 15.1 mt -65.01 -39.47 93.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -30.72 69.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.1 pt -106.59 27.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.18 38.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.6 164.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -176.76 37.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.814 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.615 ' OD2' HD12 ' A' ' 328' ' ' LEU . 8.7 m-20 -78.31 85.13 4.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -109.14 -29.22 8.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 137.04 43.46 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.2 -177.22 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 193' ' ' VAL . 12.9 mt -113.14 -9.99 13.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.415 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.03 29.86 0.76 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.616 ' HB2' HD13 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -139.01 68.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.804 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 341' ' ' LEU . 2.4 t 66.35 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 344' ' ' VAL . 6.2 m -149.67 83.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.39 174.76 10.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -137.79 -50.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 76.08 169.58 28.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -152.81 -175.58 24.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.16 31.3 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -104.73 106.03 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.79 90.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.51 107.25 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 2.6 p -151.54 35.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 27.2 mm 59.85 105.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 63.4 p -94.78 -34.43 12.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.17 144.49 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -138.1 -60.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.746 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.93 132.45 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -96.95 168.55 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -168.7 -49.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.77 94.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.7 tp -149.41 138.62 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.37 -47.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -105.36 141.74 36.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.7 p -171.68 -57.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -96.77 -32.1 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.72 124.4 81.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.16 -169.21 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.435 2.09 . . . . 0.0 112.372 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -153.33 160.49 29.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.507 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.44 92.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.84 114.32 28.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.97 -32.64 9.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.4 p -71.86 179.92 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 62.92 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 62.48 118.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.983 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.8 t -94.08 47.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -157.35 103.12 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.7 m 61.15 163.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -83.46 139.56 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 7.1 p -143.93 76.73 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -125.86 -44.8 1.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 134.0 35.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -119.76 149.85 41.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 384' ' ' ILE . 3.6 mp -80.71 -48.56 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . 0.66 ' O ' HG23 ' A' ' 386' ' ' THR . 36.2 mt-30 60.05 31.18 20.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 385' ' ' GLN . 1.0 OUTLIER -166.67 94.26 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.07 133.61 51.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.6 m -139.22 94.12 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.36 103.39 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.56 -46.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.44 162.59 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.32 132.08 10.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.69 -179.65 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.76 122.95 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.197 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -93.2 84.02 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.869 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 64.5 m -60.8 138.13 58.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.5 m -86.38 132.63 33.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -166.69 174.36 42.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.538 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.3 m -106.61 163.7 12.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 29.1 t -118.15 95.14 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 147.96 64.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.88 111.7 13.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.55 101.8 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.476 2.117 . . . . 0.0 112.321 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -85.76 176.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 4' ' ' VAL . 11.2 p -138.59 59.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.68 -70.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.6 165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.88 31.96 6.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.039 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.02 29.84 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.06 36.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.97 -116.47 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 133.31 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.897 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -129.74 153.02 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.988 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -153.61 127.77 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.35 84.63 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.61 89.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -165.52 138.77 4.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -86.8 157.35 19.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -145.87 123.37 11.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tt -136.5 129.96 31.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.01 -53.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 24' ' ' ALA . 7.9 pt-20 -132.49 164.35 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -64.85 -72.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.853 ' CE2' HG21 ' A' ' 29' ' ' ILE . 52.8 p90 -154.47 120.03 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -171.67 138.76 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.108 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 41' ' ' LEU . 3.0 t 65.03 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 25.8 71.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.593 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.77 137.56 41.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 36' ' ' GLU . 11.4 mt -105.18 141.29 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.934 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.7 pt -119.91 154.61 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.2 m -95.49 139.47 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.675 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 17.0 p-10 -98.3 -149.81 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.0 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -38.09 18.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.943 0.402 . . . . 0.0 110.324 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -79.99 -0.12 33.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.837 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER 85.02 16.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.289 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.77 173.52 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.611 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -122.69 78.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 110.532 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.46 128.56 37.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -88.21 124.02 33.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 23' ' ' PHE . 21.2 t -81.53 122.65 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.14 -121.56 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD23 ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -116.52 164.56 17.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.696 ' HD2' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -71.07 118.43 5.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.542 2.161 . . . . 0.0 112.279 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 53' ' ' LEU . 1.6 pt -107.02 30.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.68 137.57 2.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -59.11 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.19 108.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.76 -48.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -152.08 -64.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 -75.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.482 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 6.4 m -136.93 80.61 1.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.7 mp -88.69 104.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.678 ' O ' HG12 ' A' ' 70' ' ' VAL . 23.3 m-85 -129.55 163.59 25.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 43' ' ' ILE . 50.4 mt -73.29 165.91 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -138.5 152.46 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.273 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -136.34 159.74 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.29 29.85 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 t30 58.97 -168.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t 61.56 45.27 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -169.03 126.33 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.988 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.39 116.11 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m 60.75 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 21.8 t -59.24 -57.36 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -151.37 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.551 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 m -100.84 37.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.02 30.67 5.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -85.72 119.55 72.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -87.5 30.17 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.797 2.331 . . . . 0.0 112.927 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -149.76 148.13 28.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.77 HG13 ' CG ' ' A' ' 133' ' ' ARG . 2.8 m -119.12 153.88 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 52' ' ' TYR . 6.7 p -137.67 134.59 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -121.58 116.76 25.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.68 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.859 HG22 ' CB ' ' A' ' 128' ' ' PHE . 7.8 t -113.37 149.54 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -137.57 136.19 20.03 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.892 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 32.6 Cg_exo -57.93 82.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.514 2.143 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 53.62 29.67 9.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.9 120.77 33.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.61 41.52 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.1 -79.09 1.43 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.09 -43.41 2.4 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.538 2.159 . . . . 0.0 112.35 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HG ' HD23 ' A' ' 84' ' ' LEU . 24.9 tp -60.13 -30.1 69.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.46 -32.3 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.7 p -77.76 -31.7 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -68.33 -46.58 69.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 129' ' ' MET . 4.1 mm? -66.01 -45.82 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -60.35 -29.67 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.876 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.5 m-85 -65.9 -60.3 2.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.66 -17.84 64.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.773 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -18.99 60.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.59 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . . . -62.22 -15.28 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -47.95 130.2 11.88 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.0 -24.32 19.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -79.32 -33.2 43.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.4 -42.51 25.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.8 mt -65.72 -55.26 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -50.76 -31.94 18.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -34.67 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.28 -46.06 24.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 105' ' ' LEU . 41.5 mm -64.48 -36.52 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.238 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -75.01 -27.72 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.254 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -76.65 -38.8 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.342 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -105.46 -3.73 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.254 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 100' ' ' ILE . 16.7 tttt 60.09 30.9 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 100' ' ' ILE . 43.8 mt -49.93 -32.08 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.253 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -55.91 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.98 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -142.21 138.59 31.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.758 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.739 HD21 ' CG ' ' A' ' 167' ' ' TYR . 13.2 tp -114.68 -66.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' TYR . . . 132.46 -7.21 5.3 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.822 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.7 t -71.66 136.0 83.38 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.666 0.233 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.5 142.58 80.61 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.59 2.193 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.97 121.72 26.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -98.7 131.36 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -110.39 -40.83 4.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.065 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.97 -174.58 46.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.655 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -132.97 164.05 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -149.24 174.65 28.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.275 -0.965 . . . . 0.0 113.168 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 127' ' ' ARG . 3.3 mt -145.23 145.15 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.716 0.293 . . . . 0.0 110.741 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -121.81 135.8 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -113.65 121.44 44.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -138.2 126.24 22.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.982 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 55.93 20.6 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.364 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.98 -4.99 61.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.903 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -96.04 129.08 43.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.348 . . . . 0.0 110.776 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.4 t -100.44 122.99 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -105.81 143.59 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.755 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.644 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -107.31 129.27 54.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.934 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 11.2 p90 -141.52 159.24 42.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.442 ' HB2' HD21 ' A' ' 84' ' ' LEU . 8.1 tmm? -128.13 147.59 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 29' ' ' ILE . 20.2 mt -123.32 112.76 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.978 0.418 . . . . 0.0 111.377 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -121.96 173.3 7.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.94 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.99 149.66 2.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.77 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.51 168.09 13.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 184' ' ' LEU . 80.6 m-85 -141.46 160.82 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.808 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.77 -94.57 0.72 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.96 130.69 55.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.827 ' OD1' HD22 ' A' ' 184' ' ' LEU . 6.0 m-20 -57.67 159.83 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.734 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -59.4 -31.01 68.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.585 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -59.44 -45.14 92.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.387 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.49 70.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.378 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.751 HD13 HD22 ' A' ' 341' ' ' LEU . 10.9 mt -80.17 -26.94 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.454 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 16.3 t80 -66.88 -50.84 61.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -29.31 68.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.572 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.753 ' HB1' HG23 ' A' ' 344' ' ' VAL . . . -61.5 -24.7 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.084 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.1 m-80 -94.47 15.66 17.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.84 45.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.14 19.71 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.326 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 23.9 mtm180 -145.17 -175.63 4.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 0.1 OUTLIER -141.93 171.17 14.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 153' ' ' THR . 3.4 m -97.08 157.64 15.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.585 ' HA ' HD21 ' A' ' 255' ' ' LEU . 7.5 mtm-85 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -72.54 -42.62 64.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.944 HG22 ' HB2' ' A' ' 340' ' ' ASP . 18.6 p -60.75 -43.63 97.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' A' ' 251' ' ' MET . 38.7 t -65.89 -49.86 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 331' ' ' ILE . 33.2 mt -60.52 -47.28 86.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -59.83 -46.78 88.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.498 HD22 HG11 ' A' ' 193' ' ' VAL . 27.6 mt -69.97 -43.54 71.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD13 ' A' ' 324' ' ' LEU . 51.2 p -54.4 -34.42 61.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 159' ' ' LEU . 10.4 mt -74.71 -41.41 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -45.74 77.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.688 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.4 mt -63.65 -34.43 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.762 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.507 HD11 ' HE2' ' A' ' 302' ' ' TYR . 9.7 mt -64.38 -40.19 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -38.27 84.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.52 -39.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 169' ' ' HIS . 47.7 mt -59.11 -45.07 91.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.591 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -66.7 -33.95 76.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.658 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.739 ' CG ' HD21 ' A' ' 108' ' ' LEU . 60.6 t80 -65.51 -51.85 57.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.618 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 43.0 pt -72.28 -27.28 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.537 ' CE1' HG12 ' A' ' 174' ' ' VAL . 1.5 m-70 -76.16 -32.48 59.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -16.93 62.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -101.38 3.61 40.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.818 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 78.08 45.36 0.07 Allowed 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.088 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -134.31 142.31 47.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.507 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.586 HG22 ' HD1' ' A' ' 204' ' ' TYR . 28.9 m -142.22 138.88 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.138 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.91 -67.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 81.31 36.54 20.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.626 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.87 -89.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.96 -0.141 . . . . 0.0 110.919 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.0 mp 41.38 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.832 0.349 . . . . 0.0 111.718 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 24.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.297 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . 65.96 9.86 6.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.65 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.8 p -113.63 1.48 14.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.47 ' O ' HG22 ' A' ' 196' ' ' VAL . 2.2 m120 -134.71 4.76 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.146 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 184' ' ' LEU . 1.9 mt -108.48 117.71 34.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.719 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.827 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -126.78 146.66 50.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.876 0.37 . . . . 0.0 111.347 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 341' ' ' LEU . 21.9 mt -89.84 149.66 22.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.84 128.01 34.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.446 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 19.7 t80 -71.0 -58.82 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -21.6 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.603 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -129.24 71.08 82.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 86.25 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.52 2.147 . . . . 0.0 112.126 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -177.98 37.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -178.15 172.37 1.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.388 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.505 ' CG2' HD21 ' A' ' 138' ' ' LEU . 2.1 p -132.64 147.63 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.92 0.391 . . . . 0.0 110.693 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 22.6 m-85 -127.27 156.88 41.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.986 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 183' ' ' LEU . 10.8 tp -103.93 115.83 31.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.514 HG21 HD11 ' A' ' 184' ' ' LEU . 16.6 m -107.41 179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.32 108.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.709 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 15.8 m-85 -117.39 28.18 8.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.719 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 200' ' ' LEU . . . -54.01 -28.74 41.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.966 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 199' ' ' GLY . 10.9 mp -115.63 11.67 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 110.947 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -100.24 68.38 1.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.239 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -126.21 149.37 49.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.253 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 39.5 ttp180 -54.26 96.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.586 ' HD1' HG22 ' A' ' 174' ' ' VAL . 44.6 p90 -60.39 -47.94 83.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 107.32 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.945 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 204' ' ' TYR . 72.5 Cg_endo -78.8 -47.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.336 2.024 . . . . 0.0 112.303 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 176.99 -37.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 102.28 23.14 9.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 209' ' ' VAL . 9.7 m -149.45 97.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.298 . . . . 0.0 111.048 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 26.6 m170 62.36 -80.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -168.59 156.38 7.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.932 0.396 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -148.65 131.55 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 171.44 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.91 66.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.634 ' HG2' ' HB2' ' A' ' 237' ' ' ALA . 11.7 tp10 -64.54 -43.69 93.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 5.3 t0 -104.23 121.87 46.02 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 23.3 Cg_exo -64.49 -10.94 26.14 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.554 2.169 . . . . 0.0 112.894 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -93.28 5.43 51.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.582 0.23 . . . . 0.0 111.218 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 53.91 24.3 4.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.745 0.307 . . . . 0.0 110.981 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 1.8 t -163.8 128.76 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -171.35 87.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.413 ' CB ' ' HB1' ' A' ' 232' ' ' ALA . 5.6 p30 -150.47 179.69 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -122.55 -38.81 0.57 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.1 p -140.96 -178.34 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.798 HG12 HG11 ' A' ' 271' ' ' VAL . 8.7 tt -133.74 10.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.347 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 265' ' ' LEU . 27.4 tt0 -67.74 -13.67 62.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.313 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.493 ' HB3' HG23 ' A' ' 246' ' ' ILE . 8.5 m-85 -165.14 29.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.025 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.68 130.45 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.753 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.54 -47.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.236 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 26.0 mt -57.03 -59.27 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.153 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.65 -28.18 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.413 ' HB1' ' CB ' ' A' ' 222' ' ' ASP . . . -71.34 -49.17 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.623 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -57.4 -27.61 62.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.299 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.689 ' HB3' HG23 ' A' ' 236' ' ' VAL . 1.0 OUTLIER -101.53 1.87 38.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.341 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.52 21.1 40.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.686 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 234' ' ' ASN . 26.4 t -80.51 158.5 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 111.086 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.634 ' HB2' ' HG2' ' A' ' 215' ' ' GLU . . . -80.72 130.65 63.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.44 74.51 3.68 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 204' ' ' TYR . 0.6 OUTLIER -77.39 73.31 3.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.003 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 73.25 -57.62 0.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.334 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -58.94 -28.49 66.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -80.21 -33.97 30.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.528 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.9 -44.65 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.88 -44.4 86.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.299 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.28 -29.32 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 227' ' ' PHE . 73.0 mt -76.02 -37.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.758 HD23 ' OH ' ' A' ' 302' ' ' TYR . 41.8 tp -66.44 -36.28 82.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.709 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.23 -28.02 72.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.41 -25.93 46.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 254' ' ' TRP . 62.7 m -66.62 -32.84 74.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.011 0.434 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.677 ' HA ' HG11 ' A' ' 154' ' ' VAL . 1.1 mmm -60.24 -52.59 64.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.174 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -74.17 -38.55 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.625 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.567 ' HB2' HD21 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -64.71 -39.95 94.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.219 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 38.5 m0 -82.28 -32.34 29.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.504 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 151' ' ' ARG . 56.9 mt -83.58 -37.37 23.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 111.475 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.9 m -96.21 -9.25 30.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.499 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.1 94.35 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.444 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 18.8 m80 62.28 150.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 253' ' ' GLN . 0.3 OUTLIER -111.24 158.49 35.91 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.69 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.457 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 45.2 Cg_endo -68.32 61.94 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.557 2.171 . . . . 0.0 112.413 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.631 ' HB2' HG22 ' A' ' 271' ' ' VAL . 4.8 p90 175.64 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.463 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.9 tt0 -88.61 10.91 18.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.34 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.3 -47.61 81.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -131.97 -28.32 1.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.399 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.607 HD22 HG23 ' A' ' 225' ' ' ILE . 67.5 mt 71.55 11.29 6.52 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -16.25 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.278 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -131.23 100.75 16.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.94 13.38 2.36 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.638 2.225 . . . . 0.0 112.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -73.73 -46.66 44.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.755 0.312 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.5 p90 -83.92 -26.44 29.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.798 HG11 HG12 ' A' ' 225' ' ' ILE . 28.7 t -63.03 -39.59 85.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.092 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -52.62 10.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.312 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 75.2 m -56.21 -40.22 73.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.331 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.6 -44.67 93.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 27.9 mm -71.1 -33.08 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.734 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -81.08 -52.17 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 6.8 m-85 -61.99 -35.42 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.024 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -26.5 42.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.359 . . . . 0.0 110.751 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -118.28 20.6 13.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -142.52 45.34 1.62 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.083 0.468 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' CB ' ' A' ' 303' ' ' MET . 26.7 mt -50.45 -40.17 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.026 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.65 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.174 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.96 -38.37 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 285' ' ' LEU . 1.1 pp -74.01 -39.69 63.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.478 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 8.5 mtt -69.0 -44.29 73.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -39.02 92.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.91 -24.87 32.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.889 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 75.9 m -92.02 -41.35 10.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.66 0.267 . . . . 0.0 111.713 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.74 155.27 58.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.968 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.45 179.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.634 2.223 . . . . 0.0 112.278 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -111.25 67.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.67 88.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.9 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 61.41 153.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -93.26 121.7 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.15 -61.91 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.54 -24.53 30.26 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.02 -64.37 0.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.465 HG23 ' HG3' ' A' ' 251' ' ' MET . 25.8 mm -72.96 -43.08 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.02 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -45.51 -42.16 10.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.506 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.49 93.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.737 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 306' ' ' VAL . 25.6 t80 -69.51 -40.07 77.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.727 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.9 mtp -68.31 -38.6 81.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.68 -45.36 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.76 ' HB ' HD21 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -64.98 -32.88 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.389 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.904 ' HA ' HD12 ' A' ' 309' ' ' LEU . 36.5 t -77.24 -24.88 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -37.72 42.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.164 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.53 -14.54 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.363 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -51.27 96.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.9 88.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.24 30.43 20.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.95 -32.99 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.923 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.566 ' HB3' HD12 ' A' ' 316' ' ' LEU . 2.5 tt0 -172.17 104.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.405 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 9.0 mttm -58.88 -60.54 10.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 59.4 Cg_endo -71.84 62.27 3.1 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.464 2.109 . . . . 0.0 112.384 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.76 HD21 ' HB ' ' A' ' 305' ' ' THR . 0.3 OUTLIER -80.27 -22.28 41.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.086 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.43 ' CG ' ' HG2' ' A' ' 166' ' ' GLU . 34.0 m-85 -52.84 -39.43 62.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 111.047 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.63 -36.48 78.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.0 -45.89 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 323' ' ' ILE . 35.9 mt -56.47 -38.24 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.032 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -43.62 88.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.34 -35.54 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 320' ' ' LEU . 70.9 mt -58.35 -47.12 88.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.025 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.789 HD13 ' OG ' ' A' ' 158' ' ' SER . 47.4 mt -73.64 -51.63 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -56.34 -49.71 73.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.192 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.53 -39.89 74.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.17 -28.14 72.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.722 HD12 HD23 ' A' ' 325' ' ' LEU . 81.3 mt -60.05 -32.52 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -66.88 -30.2 70.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.87 -18.89 55.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.532 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 331' ' ' ILE . 1.3 pp -143.8 84.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 111.333 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 127.23 -33.9 3.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.704 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.38 101.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 16.6 mttm 61.71 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 328' ' ' LEU . 0.8 OUTLIER -128.82 115.79 18.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -170.21 37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -152.54 -43.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -106.86 132.24 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 192' ' ' GLN . 27.3 mt -96.91 -4.41 40.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.359 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.944 ' HB2' HG22 ' A' ' 153' ' ' THR . 3.9 m-20 62.12 19.55 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.769 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 141' ' ' ILE . 15.2 mt -93.29 48.3 1.31 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 110.637 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.465 ' C ' HG23 ' A' ' 343' ' ' VAL . 0.4 OUTLIER -59.3 -40.5 86.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.997 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 141' ' ' ILE . 2.2 t 68.3 28.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.753 HG23 ' HB1' ' A' ' 144' ' ' ALA . 21.9 t 58.38 75.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.96 82.9 4.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.75 89.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.817 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -136.39 48.63 0.91 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.519 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -82.33 128.28 8.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.33 174.78 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 0.0 110.846 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -107.34 128.04 54.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -158.27 -47.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.63 169.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.7 t -101.83 160.87 14.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 2.8 pt -66.85 153.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 9.5 t -162.83 152.99 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.85 105.66 1.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -130.41 36.18 3.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 61.15 105.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -118.57 102.48 8.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -95.13 -179.02 4.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -130.65 -172.88 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.07 102.82 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.54 164.43 30.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 89.11 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 -42.1 2.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.99 53.43 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.94 133.31 21.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.777 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.41 -172.05 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.487 2.125 . . . . 0.0 112.377 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 170.55 -142.33 7.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.06 179.08 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.0 66.27 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.38 104.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.5 t -156.34 170.39 22.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -162.25 140.95 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -47.29 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.81 163.85 20.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -108.96 -26.83 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.4 m 64.16 83.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -155.31 90.11 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -63.46 1.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -79.73 172.21 14.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.02 127.98 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.39 -43.31 12.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.77 108.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -61.79 137.99 58.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.65 88.09 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.12 -67.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 -174.09 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.42 -60.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.5 m -132.3 125.17 30.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.48 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.966 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -99.08 -36.76 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 108.36 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.26 143.22 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 94.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 45.8 t -140.01 -60.69 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.332 . . . . 0.0 110.937 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.76 85.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 128.71 -172.87 19.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 1.5 m -128.07 101.66 6.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.7 m -112.21 154.3 25.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 176.15 -87.81 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 104.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.582 0.23 . . . . 0.0 110.851 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.85 165.7 27.01 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.405 2.07 . . . . 0.0 112.24 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -120.24 -67.14 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.82 147.74 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.163 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -116.89 -39.08 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 34.09 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.68 152.64 51.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.051 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -138.28 22.61 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 54.37 100.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.277 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.78 93.33 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.588 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -164.92 123.12 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.11 91.55 6.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.928 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -62.89 93.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -91.99 144.85 25.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.21 138.21 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.018 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -149.26 127.62 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -74.86 -178.37 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.7 175.98 9.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.39 77.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.58 -167.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.057 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -106.55 -53.09 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.0 -72.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' CE2' HG21 ' A' ' 72' ' ' VAL . 6.5 m-85 -118.27 108.11 14.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.83 -178.83 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.19 110.49 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.3 -20.82 25.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.554 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 28' ' ' ILE . 2.2 mt-10 -55.62 177.18 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 27' ' ' GLU . 28.1 mm -130.41 131.31 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 28.9 pt -118.41 154.59 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 2.1 t -95.54 138.49 33.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.977 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -95.2 -160.92 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 mmt -77.18 -43.8 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 109.967 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -77.84 -2.2 35.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.651 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER 87.31 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' THR . 11.4 mtpt -74.13 178.19 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.64 77.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' HB2' HG13 ' A' ' 29' ' ' ILE . 67.2 m95 -72.75 141.76 48.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 127.88 46.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.974 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 23' ' ' PHE . 31.7 t -92.83 158.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 39' ' ' VAL . . . -123.91 -125.13 2.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.555 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.81 164.03 37.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.473 ' O ' HG23 ' A' ' 43' ' ' ILE . 65.3 Cg_exo -51.28 -180.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.544 2.162 . . . . 0.0 112.387 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 53' ' ' LEU . 15.0 pt -157.37 -43.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.215 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -145.89 177.21 24.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.503 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -108.11 44.61 1.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -72.69 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.442 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.6 -152.19 28.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.543 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.93 32.37 1.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.41 -103.66 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 1.9 m -142.48 71.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.07 115.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 50' ' ' CYS . 15.4 m-85 -140.17 165.2 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 43' ' ' ILE . 4.0 mt -70.97 156.71 39.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.15 159.39 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.075 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.12 155.63 40.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.3 ptm -101.07 38.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.92 111.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -175.22 3.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 p -64.93 -45.45 85.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -179.04 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.24 -175.68 5.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.47 146.29 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' HD13 ' A' ' 53' ' ' LEU . . . 170.02 -89.37 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -89.45 -30.35 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.98 53.26 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.48 96.31 41.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.52 14.56 2.35 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.691 2.261 . . . . 0.0 113.025 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.1 m -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 133' ' ' ARG . 16.2 m -119.33 158.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.727 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HG12 ' A' ' 130' ' ' ILE . 7.8 p -140.34 129.9 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 111.377 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -111.1 123.61 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.451 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 128' ' ' PHE . 18.0 t -113.13 141.69 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.472 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.38 133.79 24.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.605 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 88.12 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.439 2.093 . . . . 0.0 112.326 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m 54.44 -171.59 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 60.42 158.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -135.36 -178.22 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.18 -82.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.43 -41.64 6.31 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.62 2.213 . . . . 0.0 112.374 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.718 ' HG ' HD23 ' A' ' 84' ' ' LEU . 11.0 tp -65.46 -30.64 71.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -32.72 72.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.421 HG21 ' CA ' ' A' ' 200' ' ' LEU . 1.4 m -78.37 -43.34 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.6 tt0 -64.07 -46.36 84.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.718 HD23 ' HG ' ' A' ' 80' ' ' LEU . 2.7 mm? -61.6 -51.15 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -51.9 66.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 198' ' ' TYR . 15.5 t80 -63.99 -33.73 76.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 3.4 m-85 -72.47 -46.23 55.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -27.17 65.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.7 -47.45 8.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' A' ' 171' ' ' HIS . . . -103.06 -33.68 9.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -91.96 26.87 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.9 133.74 65.36 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.33 -32.84 89.95 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -37.11 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.157 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -58.01 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.795 HD11 ' HA ' ' A' ' 91' ' ' ALA . 54.3 mt -53.27 -49.38 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.56 -43.34 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 111.089 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 102' ' ' THR . 0.2 OUTLIER -70.76 -28.6 64.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -51.06 11.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.703 HG23 ' C ' ' A' ' 105' ' ' LEU . 27.0 mm -57.2 -37.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.257 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -74.86 -27.8 60.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.402 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' LYS . 15.4 p -82.15 -38.77 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -1.63 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.456 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 32.84 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.703 ' C ' HG23 ' A' ' 100' ' ' ILE . 11.8 mt -83.2 58.94 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.58 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.92 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.653 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.18 122.05 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.91 0.386 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 167' ' ' TYR . 12.6 tp -121.86 159.77 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.558 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.47 17.09 57.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.86 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -95.19 127.12 43.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.594 0.197 . . . . 0.0 111.072 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.05 141.15 48.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.281 1.987 . . . . 0.0 112.283 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.47 115.43 22.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -96.88 127.63 43.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.706 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 114' ' ' TRP . 7.2 m95 -103.04 -40.81 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -177.68 46.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.595 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -135.32 161.79 34.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.607 0.241 . . . . 0.0 110.545 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -153.79 -179.42 29.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.647 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 127' ' ' ARG . 3.3 mp -145.32 159.83 42.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.037 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -132.11 141.7 49.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.831 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.43 125.29 47.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 126.2 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 51.89 23.82 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.89 21.24 40.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.468 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.58 159.33 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.769 0.318 . . . . 0.0 110.71 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m -112.74 120.5 41.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -118.18 121.34 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.788 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 118' ' ' LEU . 3.7 mtt180 -107.77 129.28 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.54 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 24.0 p90 -140.04 160.3 40.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 111.235 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.653 ' HB2' HD21 ' A' ' 84' ' ' LEU . 3.6 tmm? -128.16 140.03 52.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.401 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.403 HG12 ' CG2' ' A' ' 70' ' ' VAL . 12.9 mt -110.63 111.82 37.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.453 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -127.82 173.22 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.27 141.68 45.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 69' ' ' VAL . 60.4 ttt-85 -73.81 161.92 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.418 ' CD2' HD12 ' A' ' 184' ' ' LEU . 79.1 m-85 -130.96 170.38 14.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.97 -52.16 1.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.6 m -157.93 171.89 19.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -98.82 153.73 18.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.2 mm? -60.03 -33.47 72.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.728 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -61.73 -46.52 89.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.848 0.356 . . . . 0.0 110.282 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -58.71 -28.57 65.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 1.055 HD13 HD22 ' A' ' 341' ' ' LEU . 35.1 mt -75.32 -26.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.692 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -58.13 -47.65 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.683 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.28 -26.74 68.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.791 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 343' ' ' VAL . . . -72.85 -20.93 61.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 17.0 m120 -94.57 4.19 54.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 85.32 45.86 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.043 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 19.77 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.273 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -162.99 117.43 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.56 -172.16 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -121.43 158.08 29.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.738 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -34.1 73.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.669 ' CB ' HD13 ' A' ' 331' ' ' ILE . 10.6 pttt -74.71 -37.74 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 339' ' ' LEU . 1.7 m -73.7 -40.75 63.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 150' ' ' SER . 38.5 t -68.04 -44.51 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.542 HD11 ' HG2' ' A' ' 298' ' ' GLU . 22.9 mt -58.33 -54.26 49.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -56.99 -46.99 81.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 1.028 HD23 HD22 ' A' ' 339' ' ' LEU . 39.0 mt -65.76 -38.41 88.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.431 ' CB ' HD13 ' A' ' 324' ' ' LEU . 66.3 m -56.87 -34.11 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.708 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 321' ' ' ARG . 9.7 mt -73.31 -45.5 55.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.686 ' HG3' HD21 ' A' ' 339' ' ' LEU . 23.6 mmm180 -61.73 -45.07 95.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.791 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.74 ' HA ' HD12 ' A' ' 164' ' ' ILE . 18.3 mt -65.83 -33.04 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.932 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.534 HD23 HD12 ' A' ' 165' ' ' LEU . 11.0 mt -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -40.62 91.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 161' ' ' ILE . 4.0 mt -67.94 -42.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.551 HD22 ' OD2' ' A' ' 243' ' ' ASP . 89.6 mt -55.12 -43.77 74.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.973 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 317' ' ' TYR . 2.1 tt0 -66.0 -37.3 85.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.799 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.489 ' CG ' HD21 ' A' ' 108' ' ' LEU . 79.1 t80 -70.82 -54.66 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.81 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.42 HD13 ' HE2' ' A' ' 198' ' ' TYR . 38.1 pt -59.01 -27.6 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.174 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.51 ' CE1' HG12 ' A' ' 174' ' ' VAL . 2.2 m80 -69.05 -44.17 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.19 -14.45 61.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -99.03 2.87 46.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 72.89 43.05 0.44 Allowed 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.094 0.473 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.727 ' CD1' ' HB1' ' A' ' 201' ' ' ALA . 0.7 OUTLIER -140.88 110.38 6.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 204' ' ' TYR . 19.3 m -131.16 139.48 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.619 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.417 ' CD2' ' O ' ' A' ' 198' ' ' TYR . 2.0 t60 -175.76 160.26 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.534 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.842 ' HA3' HD13 ' A' ' 246' ' ' ILE . . . -109.43 71.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.612 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 30.98 2.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.642 HG23 HD11 ' A' ' 183' ' ' LEU . 3.6 mt -100.74 94.49 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -152.65 24.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.27 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.728 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 68.2 8.21 6.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.806 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -110.48 0.24 17.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -141.65 7.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.791 ' C ' HD23 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -108.66 114.45 28.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.048 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.791 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -124.75 148.16 48.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 141' ' ' ILE . 6.6 mt -95.03 149.25 21.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.949 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 190' ' ' PRO . 1.0 OUTLIER -89.38 132.37 35.0 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.111 179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -122.21 -31.38 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -24.29 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.796 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.528 ' CB ' ' HD3' ' A' ' 190' ' ' PRO . 0.7 OUTLIER -166.16 -57.86 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.772 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 189' ' ' ASN . 24.3 Cg_exo -61.25 -133.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.306 2.004 . . . . 0.0 112.376 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 186' ' ' ASN . 0.2 OUTLIER 171.92 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.247 -0.283 . . . . 0.0 111.72 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 1.2 mt-30 -85.95 -169.13 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 157' ' ' LEU . 3.5 p -109.58 147.94 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 11.0 m-85 -129.5 151.42 50.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.035 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.747 HD23 ' CZ ' ' A' ' 198' ' ' TYR . 14.2 tp -104.04 115.97 31.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.508 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.3 131.88 60.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 20.0 t0 62.61 124.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.747 ' CZ ' HD23 ' A' ' 195' ' ' LEU . 10.1 m-85 -105.45 14.85 28.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.201 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.611 ' C ' HD12 ' A' ' 200' ' ' LEU . . . 83.08 -55.28 5.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.626 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 199' ' ' GLY . 6.8 mp -139.18 -42.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.649 0.261 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 173' ' ' TYR . . . 64.17 101.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.688 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.825 ' CZ ' ' HB1' ' A' ' 237' ' ' ALA . 44.4 t80 -115.73 148.99 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.983 0.42 . . . . 0.0 111.017 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -95.57 78.21 3.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.681 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 174' ' ' VAL . 7.8 p90 -44.53 -34.47 2.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.524 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.84 136.48 85.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.78 171.14 18.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.445 2.097 . . . . 0.0 112.262 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.95 -40.45 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.84 44.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.93 -61.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.14 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -112.86 135.25 53.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.985 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -102.4 37.86 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.9 -168.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 215' ' ' GLU . 1.1 p90 -98.36 -177.87 3.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -54.04 4.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 213' ' ' TYR . 7.3 tt0 62.94 102.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' N ' ' HD3' ' A' ' 217' ' ' PRO . 4.3 t0 57.98 62.99 4.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 216' ' ' ASP . 32.1 Cg_exo -58.2 -59.81 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.49 2.127 . . . . 0.0 112.147 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.22 -46.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.851 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -169.54 69.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 98.6 m 60.02 165.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -133.79 -54.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.45 143.98 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -100.96 -134.07 8.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.567 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 226' ' ' GLU . 0.2 OUTLIER 60.79 65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.916 0.388 . . . . 0.0 110.88 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.92 HG23 HD22 ' A' ' 265' ' ' LEU . 6.2 tp -60.63 -18.46 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 224' ' ' THR . 1.6 pt-20 -59.92 -30.86 69.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.547 ' HB3' HG23 ' A' ' 246' ' ' ILE . 24.8 m-85 -149.25 34.87 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.305 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.705 HG22 HD12 ' A' ' 225' ' ' ILE . 12.6 t -81.51 116.83 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.303 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.2 m -64.85 153.43 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.62 -30.45 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.27 -40.28 74.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.88 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.53 -25.52 64.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.4 7.56 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 78.56 23.42 64.96 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.714 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.72 128.19 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.825 ' HB1' ' CZ ' ' A' ' 202' ' ' TYR . . . -82.7 -53.71 0.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 40.6 Cg_exo -56.88 94.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.466 2.111 . . . . 0.0 112.225 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 m -106.48 120.07 40.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.427 ' HG3' ' CD2' ' A' ' 204' ' ' TYR . 7.8 mtm105 -125.61 -47.8 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.44 -14.12 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.52 -49.68 71.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.692 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD2' HD22 ' A' ' 165' ' ' LEU . 1.5 m-20 -54.53 -38.99 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 320' ' ' LEU . 57.8 mt -74.44 -42.55 58.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.79 -35.13 72.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.842 HD13 ' HA3' ' A' ' 176' ' ' GLY . 11.7 mt -70.18 -44.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.504 HD23 ' OH ' ' A' ' 302' ' ' TYR . 23.8 tp -59.43 -41.47 89.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -60.57 -31.37 74.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.177 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -78.33 -25.72 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 67.2 m -68.03 -32.92 73.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.768 ' O ' HD12 ' A' ' 255' ' ' LEU . 1.7 mmm -58.54 -53.48 57.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.198 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 248' ' ' GLY . 2.7 mp -76.93 -39.86 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.754 ' HB2' HD21 ' A' ' 259' ' ' LEU . 14.6 tm0? -59.28 -40.15 85.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.022 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -82.43 -46.17 13.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 251' ' ' MET . 6.9 mt -72.89 -25.87 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.8 m -104.5 0.67 29.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.3 88.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.374 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.5 m170 62.9 163.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.859 HD22 ' CZ2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -131.45 164.26 43.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.713 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 49.1 Cg_endo -68.72 62.54 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.419 2.079 . . . . 0.0 112.407 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.859 ' CZ2' HD22 ' A' ' 259' ' ' LEU . 4.0 p90 177.24 -37.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.154 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 2.3 tt0 -91.88 12.58 21.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.316 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.76 -53.76 54.25 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.3 m-20 -131.38 -29.1 1.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.367 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.92 HD22 HG23 ' A' ' 225' ' ' ILE . 54.6 mt 73.89 9.87 4.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -77.02 -16.03 59.42 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.161 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.46 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 2.7 m-20 -136.21 99.89 10.79 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.799 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.12 16.63 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.647 2.231 . . . . 0.0 112.768 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -79.95 -44.93 19.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.83 0.347 . . . . 0.0 110.775 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 3.4 p90 -80.55 -26.21 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 261' ' ' TRP . 27.6 t -62.96 -38.08 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.261 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -75.65 -47.32 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.114 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -52.17 62.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.33 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.6 m -55.52 -39.44 70.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.361 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.56 -44.88 96.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.356 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.5 mt -70.71 -31.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.595 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -81.06 -45.5 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 0.0 111.466 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 5.2 m-85 -70.85 -34.13 71.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.54 -31.39 62.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.365 . . . . 0.0 110.667 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.31 16.87 23.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.952 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -139.73 44.45 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.753 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.803 HD13 ' CB ' ' A' ' 303' ' ' MET . 30.5 mt -50.58 -39.1 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.89 -27.85 61.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -38.36 27.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 285' ' ' LEU . 1.6 pp -73.25 -39.36 65.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.419 ' HE3' ' HG3' ' A' ' 303' ' ' MET . 10.6 mtt -71.16 -38.28 72.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.2 -41.22 97.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -24.81 33.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 66.3 m -89.78 -41.16 12.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.575 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.17 150.76 37.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.89 178.88 4.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.209 . . . . 0.0 112.291 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.87 30.66 4.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -88.57 -32.2 18.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -134.86 169.64 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.785 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.82 138.82 19.9 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 50.5 Cg_exo -53.51 121.24 9.14 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.317 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -147.98 -54.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.542 ' HG2' HD11 ' A' ' 155' ' ' LEU . 5.7 mp0 -62.93 -61.57 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.91 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 251' ' ' MET . 18.0 mm -76.02 -43.34 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.07 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 296' ' ' PRO . . . -46.07 -47.92 17.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -59.31 -37.74 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.802 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.865 ' O ' HG23 ' A' ' 306' ' ' VAL . 85.6 t80 -72.11 -40.68 67.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.761 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.803 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.5 mtp -68.3 -41.06 81.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.632 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.4 -47.55 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.594 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 3.3 p -60.64 -36.52 78.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 302' ' ' TYR . 26.1 t -74.89 -24.72 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.022 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -30.94 54.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.52 -8.77 18.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.727 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -47.44 157.71 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.191 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 178.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 16.1 t80 77.56 -56.05 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.5 t -108.53 -39.47 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.77 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.46 112.81 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.41 ' CB ' ' CD ' ' A' ' 315' ' ' PRO . 0.0 OUTLIER -73.33 -61.28 1.48 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.886 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 314' ' ' LYS . 58.1 Cg_endo -71.32 111.88 3.2 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.113 . . . . 0.0 112.39 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.17 25.73 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 166' ' ' GLU . 86.7 m-85 -64.75 -34.19 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.942 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.35 -30.9 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.05 -46.01 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.946 ' HA ' HD12 ' A' ' 323' ' ' ILE . 62.1 mt -57.88 -48.86 78.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.426 ' O ' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -57.95 -30.64 66.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.05 -41.34 35.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 320' ' ' LEU . 17.4 mt -54.62 -41.38 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 162' ' ' LEU . 96.0 mt -75.8 -49.8 17.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.08 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.702 HD23 HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -58.02 -49.92 75.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.192 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -58.51 -42.27 87.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.01 56.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.456 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 325' ' ' LEU . 25.2 mt -62.67 -28.76 70.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.732 0.301 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 333' ' ' SER . 4.0 mtmt -67.7 -28.54 67.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 298' ' ' GLU . . . -77.89 -18.69 55.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.666 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 152' ' ' LYS . 1.4 pp -114.12 16.95 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 108.27 43.22 1.29 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.251 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 17.7 m 58.76 177.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.218 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HB2' HD12 ' A' ' 328' ' ' LEU . 0.7 OUTLIER -79.64 145.79 32.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.885 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.35 162.68 11.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.52 -65.6 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -148.2 28.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.88 140.33 32.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.028 HD22 HD23 ' A' ' 157' ' ' LEU . 0.7 OUTLIER -98.55 28.25 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 62.89 28.83 16.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.208 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 141' ' ' ILE . 8.0 mt -99.86 40.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.741 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 11.0 p -61.41 -38.68 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.602 ' CG1' HG23 ' A' ' 141' ' ' ILE . 6.3 m 41.82 76.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.677 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 345' ' ' GLU . 12.6 m -135.14 -47.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 344' ' ' VAL . 2.4 mp0 -78.99 157.64 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.83 139.72 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 161.42 -94.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 93.13 -157.87 23.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.75 143.1 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.91 92.63 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.07 -163.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.51 18.97 9.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.4 m 56.08 101.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 355' ' ' THR . 2.7 tt -178.33 -43.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.457 ' N ' HG23 ' A' ' 354' ' ' ILE . 20.9 p -131.13 70.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.49 139.06 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 9.2 tttt 61.12 156.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -146.32 102.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.3 134.61 52.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.967 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -159.99 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 362' ' ' ILE . 4.2 mt-10 -156.33 151.12 26.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 361' ' ' GLU . 22.5 mm -138.05 96.84 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.83 176.35 7.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.74 151.93 20.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.23 -29.36 7.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.068 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.67 167.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.039 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -107.12 87.15 2.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.33 62.12 3.46 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 0.0 112.3 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -136.36 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 370' ' ' VAL . 10.6 p -116.7 55.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.06 134.0 48.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -171.38 -65.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 2.7 m -112.5 142.47 45.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.0 153.76 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -108.24 126.27 52.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.41 -175.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -142.16 135.08 28.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 2.7 p -131.83 159.86 37.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.43 175.2 6.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.955 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.5 p -130.58 136.6 49.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 146.86 29.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -105.06 97.06 6.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -107.54 -170.21 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.073 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.59 -28.97 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -159.5 104.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 1.6 p -100.71 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -109.17 -68.62 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 10.8 t 60.75 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.88 118.11 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.3 t -115.46 -38.94 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -106.97 131.02 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -81.4 -178.29 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.01 115.3 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.7 m -82.4 137.09 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -107.05 142.86 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.92 77.35 1.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 3.0 p -145.41 175.98 9.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 116.9 150.31 9.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.75 -35.65 26.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.8 t -145.07 -54.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -146.89 -170.92 15.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.409 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt -118.16 136.61 23.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.16 -45.42 41.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -96.14 -172.89 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 5' ' ' LYS . 12.3 p -172.04 -41.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -71.45 71.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.67 153.57 38.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.35 -52.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -119.56 122.78 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.89 -43.71 4.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.73 50.99 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.499 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 130.99 38.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 154.01 37.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -152.55 160.28 43.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.855 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -140.29 35.2 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.07 33.43 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -94.66 115.08 27.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.22 91.5 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -157.11 167.04 31.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -129.43 -62.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.85 80.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.42 85.91 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -123.55 -74.98 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 29' ' ' ILE . 3.8 m-85 -82.53 113.6 20.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 177.62 7.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.699 HG22 ' HG ' ' A' ' 41' ' ' LEU . 17.0 t -68.12 120.75 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.129 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.16 -24.78 29.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.6 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.16 153.52 14.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.953 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' A' ' 36' ' ' GLU . 34.8 mt -123.05 140.11 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 25.8 pt -119.64 154.67 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 6.7 p -95.38 141.33 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.21 -161.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.64 -37.4 36.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.759 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . . . -83.2 4.5 26.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.3 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER 77.19 30.0 0.55 Allowed 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 1.4 mtpp -76.17 175.82 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.032 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HB2' HG21 ' A' ' 28' ' ' ILE . 7.9 pt-20 -122.32 77.34 1.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 0.0 110.678 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HB2' HG13 ' A' ' 29' ' ' ILE . 78.7 m95 -71.89 128.3 35.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.972 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -86.42 127.97 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.05 125.21 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.42 -125.6 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.555 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 25' ' ' VAL . 5.0 mp -117.76 156.92 49.26 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.99 131.35 19.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.586 2.191 . . . . 0.0 112.352 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.424 HD12 ' NE2' ' A' ' 45' ' ' GLN . 23.6 pt -104.85 -36.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.9 101.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.555 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' NE2' HD12 ' A' ' 43' ' ' ILE . 2.6 mp0 -105.58 -44.19 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.28 -42.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.9 94.12 1.68 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.422 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.9 -65.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.23 -85.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -149.47 87.44 1.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 71' ' ' LYS . 23.4 mm -96.86 122.97 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.096 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 61.2 m-85 -145.91 168.28 21.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 133' ' ' ARG . 19.3 mt -82.26 154.81 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.35 157.79 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -138.23 154.86 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.56 51.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 60.51 101.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.99 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -121.81 179.43 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 144.49 32.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 67.5 -72.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.11 -169.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 55' ' ' ASP . 21.2 t -98.89 94.48 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.0 -91.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.532 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.94 30.44 4.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.33 65.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.7 94.48 48.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.76 36.46 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.286 2.657 . . . . 0.0 112.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.72 148.24 29.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.57 144.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.059 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.5 p -134.4 123.62 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HG2' HD12 ' A' ' 51' ' ' ILE . 12.2 mttp -105.44 124.22 49.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG22 ' CB ' ' A' ' 128' ' ' PHE . 15.9 t -113.96 141.62 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.07 150.62 59.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.66 86.0 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.517 2.145 . . . . 0.0 112.215 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.6 -71.5 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -161.37 99.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -110.55 -26.26 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.6 -154.65 7.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.597 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.27 24.84 0.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.301 2.667 . . . . 0.0 112.687 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.77 -42.29 92.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.14 -44.11 95.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -67.22 -34.34 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.34 -42.91 74.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 129' ' ' MET . 1.5 mm? -57.57 -52.08 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -46.07 78.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.54 -30.74 67.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.621 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -67.56 -46.98 71.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.083 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' HA ' ' CG ' ' A' ' 92' ' ' LYS . 1.1 tt0 -79.88 -17.61 52.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.552 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -47.64 60.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.757 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.61 -34.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -53.95 -20.8 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 88' ' ' GLN . 40.1 mtpt -47.46 138.29 8.76 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.659 0.266 . . . . 0.0 111.035 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.7 -18.31 47.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.496 2.131 . . . . 0.0 112.393 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.34 -35.9 40.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -79.3 -45.77 19.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 100' ' ' ILE . 62.2 mt -61.05 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -55.45 -33.68 63.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -38.98 63.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -68.95 -42.07 77.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 96' ' ' ILE . 27.3 mt -65.51 -37.5 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.042 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -27.79 60.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.4 m -80.97 -37.73 28.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.514 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.43 -3.51 20.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.43 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 59.96 31.85 20.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 110.657 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 100' ' ' ILE . 13.2 mt -52.4 -28.45 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mttm 76.33 -56.13 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -145.79 154.27 41.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.807 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 167' ' ' TYR . 1.5 tp -127.55 -72.88 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.612 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . 127.31 1.03 6.77 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.007 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 164' ' ' ILE . 33.5 t -76.2 128.5 82.64 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.843 0.321 . . . . 0.0 110.915 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.81 143.0 9.79 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -84.25 116.88 23.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.709 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -111.99 -40.68 4.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.94 -175.95 46.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.95 162.1 35.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.675 0.274 . . . . 0.0 110.632 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -150.15 -175.05 21.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.65 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mp -145.26 158.9 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -131.84 133.85 45.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -107.79 122.6 47.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 126.22 22.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 57.73 19.51 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.275 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.29 -0.15 61.72 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.897 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 129.09 47.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -96.14 131.62 42.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -115.63 148.88 39.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -111.4 125.27 53.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.948 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 10.8 p90 -132.24 160.23 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.847 ' HB2' HD21 ' A' ' 84' ' ' LEU . 1.5 ttm -128.12 142.64 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 mt -116.24 116.76 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.299 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -128.88 173.16 10.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.84 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.36 144.57 20.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.049 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.574 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -59.18 179.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.992 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -151.69 145.47 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.73 -107.87 0.82 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -113.4 130.25 56.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.802 ' OD1' HD22 ' A' ' 184' ' ' LEU . 19.9 m-20 -57.76 155.91 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 141' ' ' ILE . 1.5 mm? -61.04 -23.14 65.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.733 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.7 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 20.4 pt20 -68.61 -42.0 78.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.904 0.383 . . . . 0.0 110.409 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -62.8 -35.36 79.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.039 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.897 HG21 ' HB2' ' A' ' 341' ' ' LEU . 5.2 mt -78.28 -28.52 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 254' ' ' TRP . 48.4 t80 -61.16 -52.43 64.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.8 -30.42 56.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.96 -16.44 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.637 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -87.81 -2.93 58.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.135 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 95.74 41.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.063 0.545 . . . . 0.0 110.327 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 61.53 19.13 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.541 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -167.04 125.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.129 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.493 ' CD1' HG21 ' A' ' 153' ' ' THR . 0.3 OUTLIER -81.78 -176.88 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 154' ' ' VAL . 17.9 p -113.95 -176.91 3.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -71.8 -33.9 68.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -65.9 -48.08 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 340' ' ' ASP . 14.3 p -63.44 -40.22 96.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 150' ' ' SER . 47.6 t -70.78 -53.82 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.848 ' HB3' HD21 ' A' ' 328' ' ' LEU . 94.4 mt -57.21 -46.91 82.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -52.8 61.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.555 HD22 HG11 ' A' ' 193' ' ' VAL . 16.6 mt -62.28 -37.01 83.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.772 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 247' ' ' LEU . 38.5 m -58.13 -37.94 75.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 324' ' ' LEU . 35.0 mt -67.58 -48.01 68.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.91 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 178' ' ' ILE . 11.9 mt -62.75 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 165' ' ' LEU . 18.5 mt -64.84 -35.08 79.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.62 -38.3 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.612 HD11 ' HA3' ' A' ' 109' ' ' GLY . 33.4 mt -74.54 -42.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 162' ' ' LEU . 6.9 mt -56.29 -43.13 78.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HG3' ' CD2' ' A' ' 317' ' ' TYR . 32.1 tt0 -66.93 -32.78 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.8 ' CG ' HD21 ' A' ' 108' ' ' LEU . 88.9 t80 -68.22 -50.32 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.554 HD13 ' NE2' ' A' ' 175' ' ' HIS . 26.0 pt -73.41 -27.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 174' ' ' VAL . 3.6 m-70 -68.46 -32.37 72.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.299 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.98 -17.1 62.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.51 4.74 38.94 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CG ' ' A' ' 203' ' ' ARG . 0.4 OUTLIER 77.1 5.34 3.25 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.488 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 203' ' ' ARG . 4.6 m-85 -94.24 132.77 38.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.723 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 204' ' ' TYR . 30.4 m -142.37 139.06 29.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.071 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.554 ' NE2' HD13 ' A' ' 168' ' ' ILE . 3.0 p80 -115.67 -40.91 3.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.346 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 59.32 19.11 45.55 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.632 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.07 61.35 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 161' ' ' ILE . 3.9 mp -94.51 102.56 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.657 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 183' ' ' LEU . 6.2 mtmm -146.68 -175.48 4.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.687 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.7 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -84.75 3.08 39.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.6 p -106.15 -2.82 22.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -130.05 -2.89 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.351 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.76 ' C ' HD23 ' A' ' 184' ' ' LEU . 3.1 mt -108.32 122.68 47.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.802 HD22 ' OD1' ' A' ' 137' ' ' ASP . 0.2 OUTLIER -131.64 160.63 34.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.76 0.314 . . . . 0.0 110.999 -178.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.5 147.08 23.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 111.194 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.406 ' OD1' ' CE1' ' A' ' 194' ' ' TYR . 0.2 OUTLIER -60.98 131.64 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -78.12 -53.72 7.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.77 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.843 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.15 71.81 18.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.969 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.65 101.91 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.16 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -178.0 -37.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.596 ' CA ' HD11 ' A' ' 339' ' ' LEU . 50.5 mm-40 -113.24 159.11 19.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.555 HG11 HD22 ' A' ' 157' ' ' LEU . 3.3 p -110.21 148.29 13.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.99 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 13.0 m-85 -125.95 157.63 37.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.008 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.453 HD23 ' HE1' ' A' ' 198' ' ' TYR . 34.3 tp -103.32 115.97 31.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 184' ' ' LEU . 2.3 t -118.18 157.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 54.52 103.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.601 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 48.7 m-85 -97.91 -64.31 1.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.678 ' O ' HD12 ' A' ' 200' ' ' LEU . . . 95.31 -37.66 3.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 199' ' ' GLY . 7.3 mp -128.74 22.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.601 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -78.39 60.97 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.166 0.508 . . . . 0.0 110.536 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -124.33 149.03 47.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.193 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -55.49 97.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.968 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' HG22 ' A' ' 174' ' ' VAL . 47.6 p90 -57.73 -29.76 65.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.76 75.29 78.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.79 -62.99 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.587 2.191 . . . . 0.0 112.414 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.88 90.47 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.62 -44.79 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.397 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.78 83.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.07 167.37 10.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.61 -30.99 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -129.86 -72.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.512 ' HB2' HG13 ' A' ' 236' ' ' VAL . 21.5 p90 -174.62 -178.34 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -98.93 -66.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.41 53.69 2.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -145.3 154.82 54.02 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.08 172.37 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.632 2.221 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.32 -55.19 0.48 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -10.78 60.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.396 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 56.7 m -52.57 134.24 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.07 87.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -115.72 163.43 15.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.05 -92.97 1.11 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.521 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 -63.28 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -161.65 -44.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.771 ' HG2' HD13 ' A' ' 225' ' ' ILE . 14.3 mm-40 -159.26 27.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.405 ' CE2' ' HD3' ' A' ' 179' ' ' LYS . 2.7 t80 -94.63 23.8 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -141.86 -72.85 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.519 ' H ' HG23 ' A' ' 228' ' ' THR . 0.9 OUTLIER -167.99 150.32 5.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.347 . . . . 0.0 111.035 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.23 -31.57 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.5 -31.46 72.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -73.22 -30.24 63.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.264 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -75.66 -29.33 59.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.08 12.91 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.461 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.45 26.31 74.38 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.534 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 213' ' ' TYR . 20.1 t -95.63 144.63 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 111.036 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -58.17 145.13 74.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.83 -36.28 18.86 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.414 2.076 . . . . 0.0 112.23 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.6 m 59.55 33.77 22.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -56.14 0.65 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.555 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -21.76 56.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.145 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -59.03 -32.1 70.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.518 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 165' ' ' LEU . 2.5 t0 -78.68 -29.23 45.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.155 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.79 HD13 HD11 ' A' ' 320' ' ' LEU . 18.8 mt -73.84 -29.77 62.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.011 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.3 -31.98 62.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.428 HD13 ' HA2' ' A' ' 176' ' ' GLY . 2.6 mp -76.1 -38.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 158' ' ' SER . 55.2 tp -73.92 -31.23 62.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.64 -47.69 80.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.559 ' HA ' HD12 ' A' ' 252' ' ' ILE . 51.3 m-85 -78.49 -25.88 45.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 -41.44 70.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.139 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.426 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -60.27 -48.63 80.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.8 ' O ' HG22 ' A' ' 256' ' ' THR . 2.9 mt -66.37 -28.48 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.037 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.635 ' HB2' HD21 ' A' ' 259' ' ' LEU . 12.7 tm0? -80.1 -36.86 34.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.475 ' CD1' ' CE1' ' A' ' 142' ' ' TYR . 20.8 m0 -82.38 -29.89 30.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.426 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.2 mt -67.21 -47.09 71.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.392 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 252' ' ' ILE . 6.1 t -98.71 -23.35 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.327 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.442 ' HA2' ' OH ' ' A' ' 142' ' ' TYR . . . 101.79 14.99 27.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.817 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 166.62 170.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.851 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.3 OUTLIER -133.6 159.56 72.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 261' ' ' TRP . 15.7 Cg_exo -68.33 59.97 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.748 2.299 . . . . 0.0 112.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.851 ' CH2' HD22 ' A' ' 259' ' ' LEU . 16.2 p90 177.34 -42.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.106 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.9 OUTLIER -95.63 17.2 15.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.529 179.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -58.33 -51.61 69.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 2.5 t-20 -130.51 -25.92 2.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 77.2 mt 70.03 13.7 7.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.239 0.543 . . . . 0.0 109.611 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -89.81 -14.99 33.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.253 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.477 ' CB ' ' CE2' ' A' ' 270' ' ' TYR . 0.5 OUTLIER -134.98 88.61 26.47 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.93 -8.09 22.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.614 2.209 . . . . 0.0 112.664 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -54.56 -50.07 68.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.751 0.31 . . . . 0.0 111.189 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.477 ' CE2' ' CB ' ' A' ' 267' ' ' ASP . 5.7 p90 -81.73 -26.18 34.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 225' ' ' ILE . 59.4 t -60.06 -44.33 94.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.473 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -68.89 -42.27 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 0.0 110.964 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -36.55 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.1 m -65.61 -43.67 88.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.9 OUTLIER -62.93 -44.58 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.69 -29.68 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.435 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -49.82 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.403 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 13.2 m-85 -64.5 -39.94 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.468 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -26.33 12.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.28 19.07 15.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -143.81 49.32 1.39 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.748 HD13 ' CB ' ' A' ' 303' ' ' MET . 16.6 mt -54.11 -35.22 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.348 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.82 -29.79 62.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 111.067 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 278' ' ' TYR . 2.9 pp -73.9 -29.69 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.413 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 4.9 mmt -64.85 -47.47 77.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.01 -20.93 44.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -82.7 -50.86 8.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.694 0.283 . . . . 0.0 111.399 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.87 -41.13 30.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.334 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.63 98.92 16.04 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.084 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.92 84.72 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.474 2.116 . . . . 0.0 112.046 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.6 97.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.642 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 56.18 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -161.84 -51.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -151.16 104.74 2.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 -49.1 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.367 2.045 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.62 30.22 0.03 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER 68.39 7.92 6.29 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.737 0.268 . . . . 0.0 111.664 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.624 HG22 ' CG ' ' A' ' 303' ' ' MET . 28.8 mm -79.57 -46.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 110.742 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.413 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.25 -35.81 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.523 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 323' ' ' ILE . 15.1 mmtp -68.48 -41.49 80.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 306' ' ' VAL . 11.5 t80 -72.11 -34.32 68.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.748 ' CB ' HD13 ' A' ' 282' ' ' ILE . 65.3 mmm -71.78 -48.22 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 305' ' ' THR . 21.4 pt-20 -56.28 -41.41 75.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 309' ' ' LEU . 12.1 m -64.44 -42.19 96.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 302' ' ' TYR . 41.2 t -69.55 -24.39 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.144 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -71.65 -37.29 70.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 73.7 mt -97.53 -13.53 21.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.607 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.745 HD21 ' HA ' ' A' ' 316' ' ' LEU . 0.2 OUTLIER -63.16 120.46 11.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.91 -175.59 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.39 -19.65 56.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 16.6 p -95.57 30.68 2.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -141.3 113.26 7.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.854 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 315' ' ' PRO . 15.3 mttp -64.97 -56.45 20.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.285 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 40.1 Cg_endo -67.13 113.24 2.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.34 2.027 . . . . 0.0 112.567 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.745 ' HA ' HD21 ' A' ' 309' ' ' LEU . 5.3 tt -127.93 -74.86 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.646 ' N ' HD23 ' A' ' 316' ' ' LEU . 35.2 m-85 -70.68 -38.03 73.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.84 -46.58 84.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.066 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.433 HD22 HD11 ' A' ' 323' ' ' ILE . 3.3 t30 -73.33 -45.94 52.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 323' ' ' ILE . 52.1 mt -58.76 -51.84 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.66 -42.03 70.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -62.36 -46.76 87.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 320' ' ' LEU . 13.9 mt -51.03 -47.28 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.624 HD22 HD23 ' A' ' 155' ' ' LEU . 52.6 mt -71.54 -48.88 45.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.025 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.31 -49.97 72.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.372 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -39.09 79.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.805 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.01 -33.25 68.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 155' ' ' LEU . 11.3 mt -67.98 -38.6 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.42 -30.78 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -30.86 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.17 26.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.83 25.94 38.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.728 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 m -91.92 158.34 16.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 179.12 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.7 102.27 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.02 -28.5 12.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.95 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 163.99 -28.79 0.23 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.457 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -96.21 157.09 16.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.596 HD11 ' CA ' ' A' ' 192' ' ' GLN . 0.8 OUTLIER -98.73 32.53 2.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.771 ' HB3' HG22 ' A' ' 153' ' ' THR . 1.7 m-20 62.9 23.22 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.028 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.897 ' HB2' HG21 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -140.14 77.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.957 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.479 ' C ' HG23 ' A' ' 343' ' ' VAL . 84.2 p -67.96 -25.53 65.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.951 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.628 HG22 HG12 ' A' ' 141' ' ' ILE . 2.6 t 71.73 95.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m -87.16 -35.01 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.72 131.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.44 174.2 8.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 156.79 -169.39 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 162.23 -159.58 31.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.2 tt -127.28 138.49 53.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -96.33 129.63 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -138.59 129.23 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -65.98 178.73 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 61.0 p -121.27 -45.12 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 3.8 tt -122.04 147.86 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.21 -70.63 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -159.81 129.88 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 -67.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 57.24 94.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.74 178.13 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -127.29 178.96 5.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.66 119.13 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.4 HG22 ' HG3' ' A' ' 364' ' ' GLU . 3.2 mt -83.66 105.11 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.27 114.51 23.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.4 ' HG3' HG22 ' A' ' 362' ' ' ILE . 35.8 mt-10 -131.88 31.27 4.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.3 m -150.06 125.62 10.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -79.95 100.06 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -111.9 155.42 43.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.15 155.51 8.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.315 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.86 -45.13 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.27 138.17 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -86.71 95.4 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -91.93 -71.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.9 m -148.18 114.71 5.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.81 175.02 7.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 60.81 168.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 107.45 19.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -159.85 165.45 32.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 3.5 t -160.85 59.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.46 134.59 11.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.827 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.62 140.84 40.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.42 133.3 38.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.34 36.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -88.8 -67.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 23.6 mt 59.84 94.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.1 112.44 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.94 -59.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 60.2 104.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.1 m -124.97 38.59 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -112.16 144.93 40.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 177.28 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 394' ' ' VAL . 0.2 OUTLIER 60.77 -167.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.01 37.55 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.07 43.07 11.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 391' ' ' ARG . 28.2 t -119.46 123.56 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 60.16 36.11 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 6.0 tttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.928 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 3.2 m -64.8 161.54 17.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.813 0.339 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.2 m -103.97 176.99 4.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -78.15 -35.26 34.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 9.8 m 60.87 94.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.5 t -130.34 -48.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -128.03 -46.33 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.427 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mtp -154.81 145.25 15.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.13 156.84 9.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.457 2.105 . . . . 0.0 112.255 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 60.45 110.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.45 94.4 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -81.7 145.59 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.95 -51.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.052 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.63 -68.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.102 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 60.73 98.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.24 114.9 16.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.35 -166.96 24.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.553 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.68 99.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -84.6 124.25 31.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -150.17 -52.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.97 87.74 6.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.6 79.72 6.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -160.35 138.3 9.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.58 -175.33 5.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -107.29 118.25 36.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mt -94.25 170.46 9.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.4 -70.4 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.04 111.51 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -73.74 -31.49 63.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.826 ' CE2' HG21 ' A' ' 29' ' ' ILE . 23.2 m-85 -75.65 63.81 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.731 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.16 -176.56 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.211 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.53 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.89 -28.82 12.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.51 149.51 49.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.864 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 36' ' ' GLU . 33.6 mt -117.61 136.85 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.95 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 30.0 pt -111.67 154.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -95.3 141.38 28.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -160.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.094 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.21 -42.97 29.77 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.073 0.463 . . . . 0.0 109.971 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -82.22 2.14 33.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.707 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 23.5 tttp 87.6 28.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -69.51 176.52 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.231 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.529 ' HB3' HG21 ' A' ' 28' ' ' ILE . 4.4 mp0 -127.86 78.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.898 0.38 . . . . 0.0 110.589 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' HE3' ' HB1' ' A' ' 54' ' ' ALA . 34.7 m95 -76.39 131.39 39.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -92.43 124.38 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.4 t -75.45 142.34 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -134.58 8.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.74 161.82 22.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.581 ' O ' HG23 ' A' ' 43' ' ' ILE . 51.7 Cg_exo -54.43 173.69 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.521 2.147 . . . . 0.0 112.322 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 42' ' ' PRO . 10.5 pt -160.08 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.04 -131.92 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -158.73 113.1 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.19 -69.43 2.81 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.54 141.34 2.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -96.84 -48.98 5.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.23 -96.67 2.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.71 79.63 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.71 118.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 23' ' ' PHE . 22.4 m-85 -146.37 171.97 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 7.4 mt -77.29 156.91 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . . . -115.45 147.62 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HB2' HG13 ' A' ' 62' ' ' VAL . 6.2 t0 -138.46 159.61 41.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.9 mmt -118.68 72.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.659 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 64.43 -77.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 59.15 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -80.13 60.76 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.59 148.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 m 59.48 170.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 55' ' ' ASP . 36.1 t -118.1 -53.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.45 -169.94 30.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.528 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 t -103.59 39.99 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -156.37 82.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -120.97 137.61 26.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -87.99 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.985 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 77.2 m -149.7 148.29 29.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.565 HG13 ' CG ' ' A' ' 133' ' ' ARG . 28.6 m -128.74 144.88 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 130' ' ' ILE . 8.0 p -131.57 124.38 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HD2' HD13 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -109.55 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.638 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 128' ' ' PHE . 4.7 t -113.41 144.3 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.15 140.7 21.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.36 109.31 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.507 2.138 . . . . 0.0 112.314 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.71 178.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -87.17 -171.25 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.84 113.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.4 -168.12 30.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.416 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 -44.49 46.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 112.251 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' A' ' 84' ' ' LEU . 13.6 tp -70.12 -30.08 67.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -60.87 -36.78 80.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 58.2 p -70.63 -36.66 73.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -70.73 -48.4 54.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 129' ' ' MET . 3.2 mm? -58.26 -43.07 87.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -49.9 75.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' CD2' ' A' ' 198' ' ' TYR . 29.8 t80 -70.43 -39.63 74.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.575 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -54.86 -42.97 72.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -77.26 -17.78 58.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.372 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -82.64 -26.77 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.378 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.58 ' HB1' ' HE2' ' A' ' 167' ' ' TYR . . . -139.88 -44.62 0.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.664 0.268 . . . . 0.0 111.719 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -66.04 -11.63 49.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.778 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -47.22 133.62 9.39 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 120.527 0.203 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.3 -30.57 26.82 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.538 2.159 . . . . 0.0 112.632 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -31.33 42.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.58 -40.56 66.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.031 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 91' ' ' ALA . 24.0 mm -67.3 -57.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -53.49 -27.15 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.301 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -73.96 -55.99 5.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.03 -47.24 78.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.812 HG23 ' H ' ' A' ' 106' ' ' LYS . 36.3 mm -56.9 -43.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.254 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -75.17 -27.64 59.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.1 m -78.79 -38.81 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.612 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -4.72 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.459 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 100' ' ' ILE . 6.8 mttm 59.64 26.96 16.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 108' ' ' LEU . 3.5 mt -54.24 -47.13 72.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.993 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.812 ' H ' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER 59.22 36.18 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.913 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -176.84 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.692 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp 71.96 -63.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.34 12.46 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.823 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 108' ' ' LEU . 24.0 t -81.08 138.97 49.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.56 0.219 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HD2' ' CG1' ' A' ' 110' ' ' VAL . 84.6 Cg_exo -46.42 146.38 5.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 112.399 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 115.52 23.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.289 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.2 127.85 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.565 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 35.9 m95 -112.33 -40.89 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.82 174.9 41.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.606 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.92 173.33 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.417 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.444 ' HA3' ' CZ ' ' A' ' 128' ' ' PHE . . . -156.94 178.0 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.764 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 126' ' ' TYR . 1.7 mp -147.93 159.87 43.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 116.57 9.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.69 124.38 36.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.26 126.29 22.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.4 t30 59.67 17.27 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.535 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.44 56.57 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.916 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.03 129.03 43.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.819 0.342 . . . . 0.0 110.682 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.3 t -91.15 124.32 35.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.044 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.489 ' O ' HD23 ' A' ' 118' ' ' LEU . 4.2 m-85 -97.73 147.74 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -125.1 125.13 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.95 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 16.5 p90 -138.28 163.11 32.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.756 ' HB2' HD21 ' A' ' 84' ' ' LEU . 9.4 tmm? -128.1 148.62 50.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.709 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 HG12 HG23 ' A' ' 70' ' ' VAL . 19.8 mt -123.39 112.74 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.249 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -123.08 173.27 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -54.19 142.67 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.089 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.565 ' CG ' HG13 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -80.26 156.31 26.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -120.36 155.42 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.06 -80.14 1.16 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -131.65 131.19 42.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.49 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.9 p30 -58.87 159.78 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' A' ' 141' ' ' ILE . 2.6 mm? -62.12 -23.91 66.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.626 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -64.27 -42.05 96.63 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -64.02 -29.7 70.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.298 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 185' ' ' LEU . 12.0 mt -81.5 -29.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 254' ' ' TRP . 18.2 t80 -70.92 -48.89 51.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.806 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.38 -29.81 65.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.44 -24.75 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.261 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.578 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 m-80 -95.2 16.16 17.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.14 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 84.04 46.94 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.153 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.67 20.12 11.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.249 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.13 176.8 8.38 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.029 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.93 -169.3 2.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -116.65 145.2 43.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -30.43 65.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -71.18 -36.43 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 339' ' ' LEU . 0.2 OUTLIER -73.17 -41.12 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 251' ' ' MET . 45.3 t -55.91 -54.18 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.384 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.834 HD12 HD11 ' A' ' 331' ' ' ILE . 61.5 mt -64.18 -37.23 86.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.47 -44.71 74.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.792 HD23 HD22 ' A' ' 339' ' ' LEU . 34.4 mt -71.04 -47.81 56.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.597 ' HA ' HD12 ' A' ' 161' ' ' ILE . 43.8 p -53.38 -37.61 62.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.637 HD11 ' HG ' ' A' ' 325' ' ' LEU . 1.7 mt -68.17 -48.13 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.665 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -38.4 82.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 158' ' ' SER . 7.9 mt -68.57 -37.39 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 165' ' ' LEU . 12.1 mt -60.8 -36.96 80.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -37.94 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.496 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 110' ' ' VAL . 19.0 mt -75.18 -39.0 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 162' ' ' LEU . 46.2 mt -59.32 -43.08 92.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.607 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.0 -34.9 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.592 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.58 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 88.2 t80 -67.84 -52.49 36.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.5 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.1 pt -67.19 -29.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.995 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -75.09 -34.23 61.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.418 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.95 -16.89 62.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.44 40.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 77.49 43.9 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.955 0.407 . . . . 0.0 111.033 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.69 140.34 48.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 31.0 m -126.07 138.92 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 45.6 t-80 -159.48 92.48 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.897 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.661 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -93.64 38.61 3.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.284 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 t0 -97.39 34.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.483 HG12 HG21 ' A' ' 161' ' ' ILE . 3.8 mp -74.39 114.46 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.924 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -160.38 -179.12 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . -80.21 -2.09 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.412 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.4 m -107.28 -0.62 22.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.498 ' O ' HG22 ' A' ' 196' ' ' VAL . 73.7 m-80 -127.5 -5.21 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.783 ' C ' HD23 ' A' ' 184' ' ' LEU . 13.0 mt -108.49 118.69 37.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.062 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -126.07 156.68 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 141' ' ' ILE . 6.5 mt -99.11 149.65 22.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 191' ' ' ASP . 14.0 m-20 -73.47 135.63 44.11 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.836 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.455 ' CE2' ' NH1' ' A' ' 133' ' ' ARG . 9.0 t80 -71.48 -68.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 -15.13 23.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.746 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.59 ' CB ' ' HD2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -76.5 -168.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 189' ' ' ASN . 39.9 Cg_exo -39.85 -27.38 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.563 2.175 . . . . 0.0 113.913 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 190' ' ' PRO . 1.1 t70 88.08 5.03 0.25 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.622 0.249 . . . . 0.0 111.139 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.663 ' O ' ' HA ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -72.82 -167.58 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 157' ' ' LEU . 2.5 p -109.96 147.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.163 0.506 . . . . 0.0 111.082 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 15.7 m-85 -131.41 157.25 43.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.559 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 58.0 tp -103.62 115.79 31.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.679 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 182' ' ' ASN . 28.4 m -105.67 -175.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.421 ' OD1' HG23 ' A' ' 196' ' ' VAL . 4.1 m-20 60.85 98.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.628 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.89 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . 13.1 m-85 -109.87 30.53 6.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -53.72 -24.67 26.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.254 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mp -114.15 -4.27 13.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.538 0.209 . . . . 0.0 111.064 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.89 ' HB3' ' HB3' ' A' ' 198' ' ' TYR . . . -77.12 59.39 1.71 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 110.689 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.49 149.05 52.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -53.11 93.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.067 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -60.0 -35.82 75.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 1.3 m 63.39 125.97 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.38 170.49 19.12 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.312 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -129.14 -55.29 1.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -80.33 -51.45 4.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.55 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.425 HG12 ' ND1' ' A' ' 210' ' ' HIS . 18.2 t 69.06 -66.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.24 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.425 ' ND1' HG12 ' A' ' 209' ' ' VAL . 67.4 m80 -112.18 30.78 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -121.37 146.11 47.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 147.75 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 61.09 160.15 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -172.23 35.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.026 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.48 81.31 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -97.34 -56.61 0.19 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.198 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.451 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 54.4 Cg_exo -52.24 -173.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.508 2.139 . . . . 0.0 112.347 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.17 70.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.96 47.58 17.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.006 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.52 89.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -69.45 -55.93 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.64 -70.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.018 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -58.95 171.96 4.45 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.687 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 228' ' ' THR . 33.3 p -59.95 -176.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 0.0 110.772 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.706 HG12 HG11 ' A' ' 271' ' ' VAL . 7.3 tt -101.11 -21.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' A' ' 265' ' ' LEU . 15.0 pt-20 -52.71 -22.96 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 246' ' ' ILE . 63.1 m-85 -142.53 30.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.322 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.405 HG21 HG13 ' A' ' 225' ' ' ILE . 13.4 t -85.6 146.59 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.95 159.0 19.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.805 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 5.7 mt -61.5 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.49 -42.98 82.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.29 66.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.196 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.84 -25.56 63.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.318 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -96.33 0.12 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' A' ' 217' ' ' PRO . . . 89.44 -15.45 58.57 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.706 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.73 122.59 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 238' ' ' PRO . . . 60.83 158.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 237' ' ' ALA . 55.6 Cg_endo -69.9 -171.23 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.6 2.2 . . . . 0.0 112.299 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.06 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -73.95 -54.18 8.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -83.36 -16.89 44.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.84 92.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.902 ' HA ' HD12 ' A' ' 246' ' ' ILE . 1.8 p30 -58.61 -28.79 65.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.309 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 320' ' ' LEU . 70.3 mt -76.6 -34.81 58.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.819 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -32.35 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 243' ' ' ASP . 13.4 mt -66.65 -44.81 89.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.02 -36.56 83.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.521 ' O ' ' HE1' ' A' ' 303' ' ' MET . . . -59.21 -47.32 91.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.428 ' HA ' HD12 ' A' ' 252' ' ' ILE . 38.6 m-85 -78.58 -25.69 45.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.297 . . . . 0.0 111.123 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -39.06 72.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.03 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.644 ' HB3' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -64.25 -50.04 69.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.892 ' O ' HG22 ' A' ' 256' ' ' THR . 3.4 mt -65.74 -29.21 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.981 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.447 ' NE2' ' CD1' ' A' ' 254' ' ' TRP . 0.6 OUTLIER -68.92 -47.55 65.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.447 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 16.2 m0 -82.34 -26.88 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.405 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 290' ' ' PHE . 11.5 mt -67.05 -49.34 65.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.386 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 252' ' ' ILE . 13.1 t -101.53 -11.48 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 258' ' ' HIS . . . 92.75 108.07 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.306 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 257' ' ' GLY . 25.8 p80 48.18 -175.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.9 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.5 OUTLIER -135.02 154.61 79.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.592 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 48.8 Cg_endo -68.77 61.62 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.448 2.098 . . . . 0.0 112.166 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.9 ' CH2' HD22 ' A' ' 259' ' ' LEU . 8.4 p90 177.45 -36.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.676 ' HG2' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -89.26 14.44 11.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.535 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.11 -42.12 97.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -129.33 -29.33 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.277 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 226' ' ' GLU . 87.7 mt 69.59 13.65 8.25 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -88.19 -14.94 37.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.361 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 270' ' ' TYR . 0.1 OUTLIER -136.0 94.73 14.16 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 59.9 Cg_endo -72.01 -4.43 15.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.545 2.163 . . . . 0.0 112.643 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -53.21 -49.95 65.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.581 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.2 p90 -83.6 -26.07 30.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.008 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.706 HG11 HG12 ' A' ' 225' ' ' ILE . 61.4 t -59.84 -44.38 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -75.51 -36.88 60.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.296 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -67.84 -43.24 80.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.285 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -36.57 84.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.413 ' HE2' ' CE2' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -66.4 -50.33 63.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.212 -179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 34.0 mt -61.93 -28.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.352 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -52.13 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.184 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.963 ' CD1' HD12 ' A' ' 285' ' ' LEU . 4.4 m-85 -57.99 -37.03 73.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.77 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -55.52 -26.99 46.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 28.63 5.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.74 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -146.64 41.58 1.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 4.2 mm -53.73 -45.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -70.36 -39.55 74.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -70.94 -29.54 65.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.963 HD12 ' CD1' ' A' ' 278' ' ' TYR . 5.3 tt -67.38 -50.89 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.565 ' HE1' ' N ' ' A' ' 300' ' ' ALA . 3.1 mmt -62.03 -36.82 82.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -19.96 61.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -46.48 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.455 ' SG ' HG21 ' A' ' 256' ' ' THR . 4.7 m -93.69 -41.18 9.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.383 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 255' ' ' LEU . 16.6 m-85 -99.11 107.28 43.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.934 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -51.66 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.454 2.102 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.59 -25.18 38.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.2 -49.88 70.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.69 104.86 17.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -66.36 139.35 96.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.17 -174.09 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.541 2.161 . . . . 0.0 112.26 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 138.77 -43.05 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.322 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -74.74 -70.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.656 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.603 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.8 mm -79.57 -49.72 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.993 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.565 ' N ' ' HE1' ' A' ' 286' ' ' MET . . . -44.62 -31.31 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.651 ' HG2' HG23 ' A' ' 323' ' ' ILE . 14.1 ttpt -76.68 -36.46 57.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 110.595 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.619 ' CE2' HD22 ' A' ' 320' ' ' LEU . 17.9 t80 -76.15 -34.3 59.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.603 ' CG ' HG22 ' A' ' 299' ' ' ILE . 56.5 mmm -74.16 -42.13 60.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 305' ' ' THR . 11.7 pt-20 -64.11 -40.74 96.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.669 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.646 HG21 HD11 ' A' ' 323' ' ' ILE . 1.7 p -66.8 -36.05 81.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.676 ' HA ' HD12 ' A' ' 309' ' ' LEU . 74.4 t -79.64 -24.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -32.93 41.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.22 -25.24 10.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER 47.78 -165.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.119 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.604 ' HB2' HD12 ' A' ' 316' ' ' LEU . 0.2 OUTLIER -96.05 39.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.976 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.89 29.72 19.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.82 30.75 20.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -88.17 -40.79 13.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.57 166.27 16.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.771 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.46 129.31 22.25 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.13 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 319' ' ' ASN . 0.1 OUTLIER -96.39 22.99 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.06 -35.84 81.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.16 -37.05 84.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.631 ' HB3' HD23 ' A' ' 316' ' ' LEU . 4.1 t-20 -77.33 -45.43 26.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 323' ' ' ILE . 56.4 mt -51.04 -43.25 60.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -57.62 -35.74 70.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -35.45 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 301' ' ' LYS . 73.9 mt -55.86 -51.49 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.553 HD13 ' OG ' ' A' ' 158' ' ' SER . 73.5 mt -66.36 -48.9 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.001 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.637 ' HG ' HD11 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -54.76 -49.94 69.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.363 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.6 -40.28 86.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.14 65.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 155' ' ' LEU . 47.1 mt -61.08 -34.96 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -59.74 -31.47 69.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -77.89 -24.24 48.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.441 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.834 HD11 HD12 ' A' ' 155' ' ' LEU . 1.4 pp -143.77 84.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.412 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.29 -42.69 1.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.724 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 t 65.31 87.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 61.0 156.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -75.53 153.44 37.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -107.49 -28.76 9.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.77 42.07 0.23 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.382 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -168.92 160.49 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.792 HD22 HD23 ' A' ' 157' ' ' LEU . 5.6 mt -91.19 10.48 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.333 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 2.3 t70 58.29 21.57 8.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.159 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.905 HD22 HD13 ' A' ' 141' ' ' ILE . 27.2 mt -71.39 -73.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 110.563 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.3 m 77.16 -54.55 0.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.64 HG22 HG12 ' A' ' 141' ' ' ILE . 4.9 t 70.1 30.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.016 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 344' ' ' VAL . 18.6 t 59.79 36.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 62.26 149.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.681 ' ND2' HD22 ' A' ' 349' ' ' LEU . 0.2 OUTLIER -154.95 -169.5 3.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 110.24 78.34 0.99 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.415 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.671 ' C ' HD12 ' A' ' 349' ' ' LEU . . . 81.71 71.9 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.681 HD22 ' ND2' ' A' ' 346' ' ' ASN . 9.3 mp -122.25 105.38 10.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.335 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -64.0 94.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.95 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.85 8.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -72.43 173.02 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.0 m -159.12 83.51 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 355' ' ' THR . 1.7 pp -109.17 -28.8 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 354' ' ' ILE . 9.4 t 50.55 175.33 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.456 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.51 160.19 4.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.979 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 174.13 14.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -135.69 157.54 46.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -128.56 -52.77 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -97.01 133.66 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -115.21 106.97 14.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -179.51 -36.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.78 -58.47 3.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.257 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -87.42 143.34 27.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.8 m -97.54 166.9 11.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.68 168.41 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 155.57 36.22 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.4 130.88 24.86 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.581 2.187 . . . . 0.0 112.255 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 140.79 174.85 14.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 151.04 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 111.175 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.32 99.33 3.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 60.47 88.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 1.1 m -84.58 -37.57 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.65 98.75 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -63.81 170.5 3.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 18.8 p -162.53 162.03 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -106.42 -179.73 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 1.7 t -145.94 -47.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -113.28 -58.97 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 3.3 t -84.93 150.91 24.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.9 115.08 8.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.42 100.62 7.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -115.51 159.99 20.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 17.5 mt -130.75 134.08 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -177.5 5.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 81.0 p -83.47 146.36 28.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 125.47 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.2 m 60.52 89.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.04 133.94 54.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 42.7 m -62.5 114.5 3.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -95.89 152.17 18.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 117.23 6.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 147.68 47.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 396' ' ' LYS . 20.6 t -112.64 127.63 69.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -98.46 28.72 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.607 ' H ' HG12 ' A' ' 394' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.043 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 13.3 p 58.62 32.3 22.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.6 t -82.74 89.05 6.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . -138.89 -87.92 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.3 176.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 62.4 m -107.28 149.96 27.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -175.85 -135.25 2.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.57 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -146.5 139.32 14.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.654 0.264 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.58 133.93 48.28 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.517 2.145 . . . . 0.0 112.22 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 124.77 23.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.17 155.97 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 30.54 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.25 153.73 18.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 60.68 -173.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -151.12 111.91 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.6 118.33 26.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.02 -68.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.457 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.03 -169.83 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.7 132.29 21.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t 60.48 32.09 20.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.6 p -87.78 -66.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.57 92.23 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -157.79 88.17 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -106.1 -33.01 8.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -74.46 -176.77 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -127.15 88.27 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.26 -61.91 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.18 -171.6 3.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 62.67 75.66 0.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.753 ' HZ ' HG21 ' A' ' 72' ' ' VAL . 50.2 p90 -65.59 127.86 33.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -166.76 122.73 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 41' ' ' LEU . 21.4 t 66.02 104.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.62 37.16 31.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.623 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -136.34 152.13 50.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.787 HD11 ' HE3' ' A' ' 38' ' ' LYS . 17.2 mm -116.98 139.21 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 23' ' ' PHE . 4.7 pt -119.74 154.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 34.6 m -95.55 141.33 29.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.996 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 1.1 t70 -93.77 -160.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.03 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.4 ttm -77.67 -41.69 37.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.86 0.15 36.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.589 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 3.1 mttp 87.24 27.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -70.34 179.25 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.06 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.16 79.59 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.469 ' HB2' HG13 ' A' ' 29' ' ' ILE . 69.6 m95 -73.49 137.66 44.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.907 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD11 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -91.66 134.49 34.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.012 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.737 HG21 ' HD2' ' A' ' 23' ' ' PHE . 25.0 t -94.89 143.72 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.02 -130.64 7.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -102.51 159.13 30.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.914 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.57 111.18 2.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.533 2.155 . . . . 0.0 112.063 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG12 ' A' ' 69' ' ' VAL . 13.4 pt -106.43 -37.9 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.43 179.03 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -171.75 -42.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.9 97.06 1.72 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.37 -152.71 7.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.64 32.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 -98.08 0.15 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 3.6 p -179.01 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 3.6 mp -98.9 136.68 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.387 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.517 ' O ' HG12 ' A' ' 70' ' ' VAL . 19.6 m-85 -140.45 170.3 16.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.663 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.22 152.45 42.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . . . -127.08 153.93 45.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.318 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -143.8 150.45 38.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.789 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 mtm -99.45 45.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m120 59.84 -177.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 m 61.28 45.15 9.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -163.51 -43.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 69.93 -66.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -87.62 86.97 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.48 88.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.85 36.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.3 p -147.55 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -155.44 80.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.21 71.58 3.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 86.28 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 1.7 t -148.83 148.13 29.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.711 HG12 HD11 ' A' ' 43' ' ' ILE . 6.1 m -128.27 153.47 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.048 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 52' ' ' TYR . 5.4 p -142.79 119.37 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -103.65 117.42 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 128' ' ' PHE . 11.8 t -118.95 152.05 21.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -139.08 135.77 17.69 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.636 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.44 83.4 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.303 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.23 -171.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.09 156.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -78.99 177.6 8.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.47 -162.87 29.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -22.23 32.78 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.708 2.272 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -60.61 -30.84 70.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.004 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.41 -37.15 86.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.019 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -33.13 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.7 -40.9 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 129' ' ' MET . 1.4 mt -76.91 -37.62 55.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -59.56 -40.3 86.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 8.5 t80 -82.83 -29.81 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.1 m-85 -64.4 -51.91 60.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.122 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.59 -17.3 61.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.434 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.67 -47.51 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . . . -120.07 -22.61 6.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -92.5 23.8 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -73.16 113.18 19.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.536 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.37 -33.31 36.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.454 2.102 . . . . 0.0 112.591 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.68 -39.01 77.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -79.32 -47.27 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.314 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 91' ' ' ALA . 64.2 mt -57.58 -57.54 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.24 -46.44 62.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -64.39 -47.42 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.209 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -60.3 -55.05 38.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.254 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 105' ' ' LEU . 70.0 mt -56.33 -36.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.01 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -74.96 -27.7 60.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.8 m -81.75 -36.61 28.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -2.54 26.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.81 30.77 20.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.676 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 100' ' ' ILE . 29.7 mt -49.57 -31.7 11.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.54 -55.57 0.52 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.83 129.11 13.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.895 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 105' ' ' LEU . 12.4 tp -99.22 -66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.74 9.5 6.91 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.064 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.8 138.78 27.76 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.826 0.313 . . . . 0.0 111.02 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 71.9 Cg_exo -50.8 151.41 11.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.525 2.15 . . . . 0.0 112.406 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.08 115.58 27.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -99.78 126.96 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.562 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -105.95 -40.87 5.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.34 . . . . 0.0 111.028 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 -174.72 46.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.597 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 p -134.86 159.42 41.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.77 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -138.59 173.37 22.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.828 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 117' ' ' GLY . 3.0 mt -148.04 158.07 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.3 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -145.83 138.61 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.74 123.84 48.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.678 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -138.26 126.23 22.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.22 22.68 2.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.414 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.11 3.51 63.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.719 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -96.08 128.92 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.5 m -89.39 125.82 35.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.09 125.9 54.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.76 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.91 125.21 51.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.899 ' CB ' HG22 ' A' ' 72' ' ' VAL . 14.6 p90 -140.31 165.72 26.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 111.407 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.436 ' HG3' HD21 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -131.89 147.14 52.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.49 HG22 ' SG ' ' A' ' 68' ' ' CYS . 16.9 mt -123.28 111.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 111.4 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.415 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -126.66 173.46 9.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.975 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.98 144.82 3.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HG3' HG13 ' A' ' 69' ' ' VAL . 69.4 ttt-85 -88.42 -25.56 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.566 ' CD2' HD12 ' A' ' 184' ' ' LEU . 80.7 m-85 65.08 178.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.67 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.02 -108.15 1.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.59 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -107.02 127.85 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.545 ' HB3' HD22 ' A' ' 184' ' ' LEU . 1.3 p30 -58.26 157.65 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 193' ' ' VAL . 0.9 OUTLIER -60.83 -23.6 65.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.693 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 0.1 OUTLIER -61.57 -41.03 96.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.97 0.414 . . . . 0.0 110.084 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -34.99 79.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.405 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.526 HG22 ' CE1' ' A' ' 149' ' ' PHE . 3.1 mt -81.35 -25.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 148' ' ' ARG . 11.9 t80 -67.71 -53.62 26.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -29.46 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.706 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.27 -20.29 62.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.311 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.0 m-20 -98.93 18.17 17.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.156 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 86.18 47.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt 63.0 19.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.474 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -147.21 -173.97 4.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -130.96 -169.11 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.778 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 154' ' ' VAL . 37.9 t -113.25 150.24 32.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HA ' HD21 ' A' ' 255' ' ' LEU . 2.5 ttm-85 -59.25 -31.49 69.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -40.98 60.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 150' ' ' SER . 44.6 p -65.47 -43.3 90.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 150' ' ' SER . 29.5 t -59.88 -52.31 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 328' ' ' LEU . 12.6 mt -63.11 -48.04 80.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -59.91 -50.4 73.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 193' ' ' VAL . 13.4 mt -59.68 -40.26 87.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.731 ' HB2' HD13 ' A' ' 324' ' ' LEU . 64.7 m -56.03 -40.93 74.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.9 -48.04 78.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -47.42 85.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 164' ' ' ILE . 27.1 mt -66.59 -35.09 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.8 mt -58.79 -39.87 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.759 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.47 -32.03 72.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.698 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 161' ' ' ILE . 16.4 mt -77.11 -43.33 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.929 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 178' ' ' ILE . 75.3 mt -58.52 -39.33 79.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -71.15 -31.39 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.672 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.93 -54.74 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.8 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 ' HZ ' ' A' ' 86' ' ' PHE . 43.2 pt -60.11 -30.11 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.25 -37.28 74.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 110.36 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -16.89 62.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.565 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 2.1 t60 -101.68 6.12 41.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.965 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 77.88 46.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.07 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.51 ' CD2' ' CE1' ' A' ' 86' ' ' PHE . 47.2 m-85 -141.54 119.42 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.584 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.93 164.19 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.675 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.06 50.23 0.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -60.43 -18.18 49.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.866 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 69.1 79.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 110.846 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.656 ' CG2' HD11 ' A' ' 183' ' ' LEU . 4.0 mp -86.06 115.36 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.219 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -155.94 172.87 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.824 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.693 ' HB1' ' HA ' ' A' ' 139' ' ' GLN . . . -76.81 -2.76 34.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.549 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.22 2.1 16.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.844 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -127.95 -6.76 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.363 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.802 ' O ' HD23 ' A' ' 184' ' ' LEU . 11.0 mt -108.63 127.51 54.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.946 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -134.49 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 111.123 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 341' ' ' LEU . 40.9 mt -87.82 149.47 24.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.114 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.43 130.31 42.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -82.76 -50.79 8.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -21.07 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -148.3 77.78 9.68 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.74 88.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.78 35.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.412 ' HA ' ' HG ' ' A' ' 339' ' ' LEU . 1.1 mm-40 174.84 149.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 157' ' ' LEU . 4.9 p -109.97 147.95 13.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.104 0.478 . . . . 0.0 111.025 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 4.6 m-85 -117.09 156.86 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -105.63 115.86 30.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.691 HG21 HD11 ' A' ' 184' ' ' LEU . 5.6 m -124.2 162.11 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.107 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.28 70.91 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 201' ' ' ALA . 12.8 m-85 -73.23 -60.39 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 92.51 -33.55 4.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.361 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.08 21.29 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.021 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 198' ' ' TYR . . . -83.35 59.15 4.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.06 0.457 . . . . 0.0 110.615 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.81 149.33 50.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.133 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -58.6 99.49 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 205' ' ' CYS . 54.4 p90 -54.9 -47.79 73.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.495 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.411 ' N ' ' CD2' ' A' ' 204' ' ' TYR . 8.9 p -67.13 134.64 93.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.203 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.38 -72.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.477 2.118 . . . . 0.0 112.243 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -142.73 -71.5 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.74 -89.22 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 212' ' ' GLU . 21.8 t 60.33 159.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.486 ' N ' HG12 ' A' ' 209' ' ' VAL . 0.9 OUTLIER -152.47 -51.59 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -129.07 36.44 4.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.598 ' HB2' HG13 ' A' ' 209' ' ' VAL . 32.3 mt-10 -116.52 -48.54 2.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.438 ' C ' ' HG2' ' A' ' 214' ' ' LYS . 0.6 OUTLIER -71.86 -152.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.751 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 213' ' ' TYR . 19.4 ptmt 45.09 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.002 0.43 . . . . 0.0 111.231 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.523 ' HA ' HG21 ' A' ' 236' ' ' VAL . 3.0 tm-20 76.24 87.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.851 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.62 89.75 0.29 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.806 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.53 141.92 32.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.518 2.145 . . . . 0.0 112.42 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -132.23 -70.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 30.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 1.7 m 56.49 103.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.987 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -72.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.33 164.22 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.003 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.24 110.55 3.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.5 m -92.6 -71.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.821 HD11 ' CG1' ' A' ' 271' ' ' VAL . 1.9 tp -176.74 30.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -102.75 67.57 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.346 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 226' ' ' GLU . 34.3 m-85 72.26 41.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.645 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.8 t -102.34 154.45 19.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.785 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -79.99 145.9 32.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.717 HD13 ' HE ' ' A' ' 279' ' ' ARG . 3.6 mp -58.13 -30.8 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.01 -31.31 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.27 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -61.9 -25.61 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -85.01 5.96 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.512 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.28 -2.26 85.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.903 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 215' ' ' GLU . 9.0 m -111.97 178.76 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.771 0.319 . . . . 0.0 111.065 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -145.22 132.02 9.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 51.8 Cg_exo -53.99 -24.18 31.19 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.356 2.038 . . . . 0.0 112.409 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.7 t 61.65 35.67 16.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -179.57 -76.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -72.21 -15.84 61.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.374 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.57 92.71 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.585 ' CG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -78.51 -26.99 46.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.794 0.331 . . . . 0.0 110.959 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.524 ' HB2' HG13 ' A' ' 306' ' ' VAL . 29.1 mt -78.23 -34.05 49.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -39.87 85.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.454 HG23 ' HB3' ' A' ' 227' ' ' PHE . 11.2 mt -65.01 -34.88 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.794 HD23 ' OH ' ' A' ' 302' ' ' TYR . 44.6 tp -77.93 -36.17 49.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 252' ' ' ILE . . . -64.28 -29.02 73.85 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.475 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.62 -27.55 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 26.9 m -60.6 -45.83 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.66 ' HA ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -48.58 -51.14 29.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.663 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 248' ' ' GLY . 3.2 mp -71.67 -51.44 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.573 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.739 ' HB2' HD11 ' A' ' 259' ' ' LEU . 1.3 tm0? -56.7 -36.04 69.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.198 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -82.38 -49.92 9.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 151' ' ' ARG . 85.6 mt -67.05 -36.28 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.5 m -96.12 -15.38 22.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 68.96 94.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.313 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.7 m80 62.93 140.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.396 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.97 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -122.49 168.84 10.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 55.2 Cg_endo -70.04 59.95 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.45 2.1 . . . . 0.0 112.72 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.97 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.4 p90 177.92 -41.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 0.6 OUTLIER -95.35 17.68 13.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.346 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.21 -57.34 11.83 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 57.2 t30 -129.12 -26.27 2.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.335 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 225' ' ' ILE . 66.0 mt 70.96 11.95 7.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -85.23 -16.5 40.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.163 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.487 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.7 OUTLIER -133.13 100.43 14.22 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.734 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.15 19.2 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.74 2.293 . . . . 0.0 112.86 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -77.95 -46.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 267' ' ' ASP . 2.9 p90 -83.76 -26.71 29.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.821 ' CG1' HD11 ' A' ' 225' ' ' ILE . 18.3 t -65.62 -45.2 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.218 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.42 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -39.9 64.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 47.9 m -66.61 -38.29 86.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.159 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.536 ' CD ' HG12 ' A' ' 271' ' ' VAL . 1.0 OUTLIER -65.29 -51.14 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.071 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.42 -37.34 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -81.18 -50.5 9.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 285' ' ' LEU . 7.2 m-85 -59.43 -40.89 88.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.717 ' HE ' HD13 ' A' ' 230' ' ' ILE . 10.0 ttm105 -51.7 -29.43 18.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.04 25.68 9.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -137.6 41.83 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 303' ' ' MET . 28.4 mt -49.58 -39.91 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -73.84 -34.64 64.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.988 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.47 -43.27 63.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 285' ' ' LEU . 3.5 pp -71.33 -33.2 69.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.449 ' N ' HD12 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -61.99 -50.93 70.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -71.2 -27.85 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.36 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -32.89 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 111.237 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 252' ' ' ILE . 60.8 m -93.71 -41.18 9.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.467 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -94.0 144.66 28.47 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.738 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.83 176.45 6.81 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.489 2.126 . . . . 0.0 112.285 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -98.62 30.45 3.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -41.15 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -131.67 150.11 52.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 143.19 74.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.53 137.49 25.38 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.478 2.119 . . . . 0.0 112.293 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.93 -41.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.56 -67.87 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.538 HG23 ' HG3' ' A' ' 251' ' ' MET . 29.1 mm -75.66 -41.18 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -47.23 -45.97 23.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.332 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -61.76 -35.65 78.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.585 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.794 ' OH ' HD23 ' A' ' 247' ' ' LEU . 21.1 t80 -73.81 -35.88 64.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.721 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.744 ' CB ' HD13 ' A' ' 282' ' ' ILE . 2.2 mtp -70.3 -45.26 66.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.35 77.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 309' ' ' LEU . 1.9 m -62.27 -33.53 74.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.713 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 302' ' ' TYR . 91.0 t -79.64 -23.96 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.423 ' HB3' HD22 ' A' ' 308' ' ' LEU . 0.1 OUTLIER -83.64 -34.01 25.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.649 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 307' ' ' LYS . 3.9 mm? -113.73 -30.45 6.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.268 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 305' ' ' THR . 0.5 OUTLIER 44.87 -165.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.313 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.79 160.32 30.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.76 84.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 28.5 m -159.49 73.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -152.01 -173.54 4.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.8 0.49 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.837 ' HA ' HD21 ' A' ' 309' ' ' LEU . 50.3 Cg_exo -53.69 -21.86 21.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.613 2.209 . . . . 0.0 112.443 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 13.5 tp 74.86 57.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 315' ' ' PRO . 15.5 m-85 -70.34 -30.9 67.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -58.55 -47.59 83.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -46.75 72.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 323' ' ' ILE . 53.7 mt -55.64 -40.7 72.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 -46.59 86.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -40.25 90.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 320' ' ' LEU . 67.4 mt -57.85 -42.68 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.163 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 158' ' ' SER . 35.4 mt -78.56 -51.55 9.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 328' ' ' LEU . 0.6 OUTLIER -58.25 -49.92 75.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.48 -38.99 86.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.974 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.89 -27.92 65.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.551 HD12 HD23 ' A' ' 325' ' ' LEU . 14.2 mt -62.31 -38.03 87.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -29.89 70.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.52 77.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.0 pt -99.59 24.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.257 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 54.36 26.55 37.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.658 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.29 164.56 24.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 146.01 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -127.69 129.48 47.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.62 -55.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -159.58 27.22 0.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -93.69 146.6 23.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.811 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.655 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.3 OUTLIER -176.31 0.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.107 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.728 ' O ' HD12 ' A' ' 341' ' ' LEU . 12.2 t70 -63.3 -20.46 65.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.81 HD11 HD21 ' A' ' 185' ' ' LEU . 0.5 OUTLIER 70.85 8.73 6.64 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.434 ' C ' HG23 ' A' ' 343' ' ' VAL . 7.1 m 73.23 -56.07 0.66 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.772 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 342' ' ' SER . 4.4 t 76.28 -54.27 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.369 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 6.3 m -151.72 31.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.229 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -37.57 16.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -87.28 146.38 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 155.04 -85.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -109.73 151.32 17.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.27 -71.31 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.26 98.83 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.0 166.03 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -165.96 -62.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 356' ' ' LYS . 9.7 m -144.76 118.28 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.874 HG23 HG22 ' A' ' 355' ' ' THR . 1.3 tt -71.27 -41.52 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.874 HG22 HG23 ' A' ' 354' ' ' ILE . 4.4 t -160.05 106.03 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.431 ' HB2' HG21 ' A' ' 353' ' ' THR . 4.8 ttpm? -90.06 159.99 16.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -145.1 125.31 13.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.83 87.79 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.82 30.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 62.74 -79.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.002 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -69.34 112.47 5.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.581 ' O ' HG23 ' A' ' 362' ' ' ILE . 17.3 tt -89.81 70.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.61 178.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 59.99 91.93 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 32.2 t -123.75 159.74 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -136.87 163.62 30.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -132.31 136.89 28.81 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.33 91.7 1.04 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.484 2.123 . . . . 0.0 112.339 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 135.98 49.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.576 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 370' ' ' VAL . 15.1 t -130.2 29.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.766 0.317 . . . . 0.0 111.111 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.74 145.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.83 150.91 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 170.39 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -120.29 -41.75 2.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 7.0 m0 61.43 31.6 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.4 t -82.94 146.89 28.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.17 172.75 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.802 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 43.6 p -94.02 166.74 12.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.07 96.81 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.94 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 6.5 t -73.77 123.44 24.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -87.82 -40.05 14.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 60.21 100.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -144.35 167.35 22.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.59 153.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.94 -49.47 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 38.4 m -77.4 126.1 30.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -145.59 -56.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.2 m -97.16 142.97 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -166.82 114.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 1.4 p -147.47 168.18 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -97.96 -51.22 4.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.09 167.5 19.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -126.09 130.46 51.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.88 105.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.159 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.01 114.94 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.842 -179.978 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -5' ' ' SER . . . . . . . . . . . . . 10.2 t 60.52 32.11 20.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.963 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -118.35 -51.11 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . 161.57 112.53 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 71.3 m -154.12 -52.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 14.5 m -79.49 -171.31 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 157.34 -166.34 33.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.421 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 81.42 9.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 0.0 110.973 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.99 55.56 5.66 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.615 2.21 . . . . 0.0 112.521 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.5 ' HD2' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER 175.62 123.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.5 HG23 ' HD2' ' A' ' 3' ' ' ARG . 21.2 t 63.74 139.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -82.77 83.56 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.62 15.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.02 78.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -166.69 118.75 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.55 86.77 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.33 -46.55 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.45 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 91.79 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -126.07 94.93 4.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.96 149.79 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.4 -175.48 5.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 152.15 38.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.23 97.66 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -159.61 149.2 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.42 100.78 12.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.98 31.74 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 126.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -104.36 -41.32 5.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.09 -51.53 66.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.973 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 72' ' ' VAL . 7.4 m-85 -121.14 113.63 20.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.95 -178.38 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.66 128.16 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.18 57.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.572 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.92 153.3 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' A' ' 36' ' ' GLU . 26.1 mt -115.22 137.15 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 48.8 pt -119.85 154.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.18 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 74.2 p -95.57 141.57 28.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.743 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -98.62 -162.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.044 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -37.52 27.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' LYS . . . -80.5 -1.81 43.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.534 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' ALA . 6.4 mttp 86.12 29.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' THR . 5.2 mttp -78.23 177.62 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.188 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HB3' HG21 ' A' ' 28' ' ' ILE . 74.7 mm-40 -129.3 80.44 1.97 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.405 ' HB2' HG13 ' A' ' 29' ' ' ILE . 73.4 m95 -77.46 131.41 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -89.9 118.24 29.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 53' ' ' LEU . 19.9 t -89.55 141.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.21 -107.19 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -127.31 165.87 26.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 43' ' ' ILE . 31.2 Cg_exo -59.37 178.03 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.64 2.227 . . . . 0.0 112.285 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.496 HG21 HD21 ' A' ' 53' ' ' LEU . 23.3 pt -156.08 30.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.06 93.73 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 61.34 106.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.82 155.9 15.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.46 -86.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.84 61.95 1.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 74' ' ' PRO . . . 110.67 113.22 3.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.335 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 40.6 t -177.78 -89.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.409 0.147 . . . . 0.0 110.882 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.413 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 53.3 mt -142.4 135.52 27.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 23' ' ' PHE . 29.3 m-85 -143.4 156.31 44.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.483 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 69' ' ' VAL . 92.4 mt -74.85 157.5 34.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.14 159.26 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -140.79 159.72 41.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.4 ptp -101.01 37.85 1.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t30 59.99 30.58 20.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.918 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -85.19 -72.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 m -117.18 144.77 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.46 160.86 30.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m 60.5 95.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.507 ' O ' HG12 ' A' ' 62' ' ' VAL . 20.9 t -92.83 47.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -113.05 -27.35 3.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.86 38.13 4.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.63 -59.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 52.63 74.35 0.79 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.144 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 62' ' ' VAL . 61.3 Cg_endo -73.57 -27.29 13.09 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.596 2.198 . . . . 0.0 112.618 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.2 m -149.86 165.31 32.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 133' ' ' ARG . 4.4 m -127.41 152.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 130' ' ' ILE . 7.7 p -142.2 141.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.572 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 35.0 mtpt -111.01 123.88 51.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.761 HG22 ' HB3' ' A' ' 128' ' ' PHE . 25.5 t -120.23 136.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.531 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.13 120.6 8.34 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.685 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 49' ' ' GLY . 71.0 Cg_exo -50.91 91.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.526 2.151 . . . . 0.0 112.472 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p 49.72 83.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.76 118.29 27.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.3 -85.52 0.12 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.36 -49.06 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.552 2.168 . . . . 0.0 112.306 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 84' ' ' LEU . 21.1 tp -76.12 -31.1 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -68.59 -31.19 70.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -45.42 63.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' CD ' HD12 ' A' ' 80' ' ' LEU . 12.5 pt-20 -69.68 -42.21 74.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 80' ' ' LEU . 1.4 mm? -54.78 -48.48 72.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.67 -39.67 92.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 2.6 m-85 -57.34 -53.9 52.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -75.31 -17.64 60.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.379 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -83.1 -47.46 11.63 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.89 -23.88 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.642 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -93.92 25.28 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.694 0.283 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -73.32 131.08 83.38 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.651 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.26 -29.01 89.21 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.488 2.125 . . . . 0.0 112.381 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.33 -31.96 43.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -49.96 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 91' ' ' ALA . 65.7 mt -59.94 -46.48 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -51.8 -48.35 63.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.179 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -38.96 92.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -53.22 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 46.6 mt -64.37 -26.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -75.12 -27.55 59.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -39.21 35.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.88 11.81 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER 70.37 2.03 3.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.657 HD13 HD13 ' A' ' 108' ' ' LEU . 4.5 mt 44.71 28.39 0.33 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.74 0.305 . . . . 0.0 111.388 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 48.8 36.61 8.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 2.8 t80 71.34 114.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.757 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG23 ' A' ' 110' ' ' VAL . 6.3 tp -101.79 125.53 48.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -92.38 20.72 42.1 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.753 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.732 HG23 ' HG ' ' A' ' 108' ' ' LEU . 27.7 t -78.17 133.42 64.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.534 0.207 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HB3' HG12 ' A' ' 196' ' ' VAL . 9.3 Cg_endo -51.02 145.64 24.42 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.638 2.225 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 126.23 32.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.14 134.07 43.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -111.52 -40.7 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.88 -176.31 46.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.91 155.01 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 128' ' ' PHE . . . -134.53 175.49 20.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.044 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 126' ' ' TYR . 2.1 mt -147.91 154.71 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -145.81 141.74 28.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 m-20 -121.34 126.66 50.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.449 ' HE3' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.26 126.39 22.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.15 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 56.33 19.89 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.31 9.26 58.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.836 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 2.1 mtmt -96.07 159.3 15.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 83.2 p -112.58 118.45 35.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.078 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.743 ' O ' HD23 ' A' ' 118' ' ' LEU . 13.0 m-85 -110.44 129.07 55.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.668 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.712 ' HG3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -123.23 125.08 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.711 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' A' ' 29' ' ' ILE . 23.7 p90 -134.53 159.59 40.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 3.6 tmm? -130.02 141.7 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.018 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 70' ' ' VAL . 5.5 mt -110.16 125.24 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.76 173.35 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.868 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.94 137.39 39.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB3' HG13 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -85.12 -25.61 27.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.717 ' CE2' HG11 ' A' ' 196' ' ' VAL . 59.8 m-85 64.71 -170.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -107.41 -104.28 2.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.665 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 m -97.14 157.71 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.663 ' CG ' HD22 ' A' ' 184' ' ' LEU . 1.2 m-20 -92.81 157.0 16.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -63.71 -30.14 71.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.427 ' N ' ' HB1' ' A' ' 180' ' ' ALA . 5.2 pt20 -57.28 -42.81 82.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.668 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -64.65 -25.92 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.76 ' CD1' HD13 ' A' ' 341' ' ' LEU . 14.5 mt -72.63 -28.95 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.0 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -58.04 -46.26 85.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.18 -31.27 65.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 343' ' ' VAL . . . -67.91 -21.45 65.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.409 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 1.0 OUTLIER -93.95 -0.22 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ASN . . . 90.9 43.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 61.54 19.97 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.488 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -162.1 107.87 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.087 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -58.27 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.9 m -111.79 161.63 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.774 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.69 -31.55 72.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -70.99 -50.39 34.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -59.19 -50.66 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.16 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 150' ' ' SER . 46.7 t -56.19 -52.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.318 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 328' ' ' LEU . 64.5 mt -59.52 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.258 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -46.03 90.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.649 HD11 HD21 ' A' ' 341' ' ' LEU . 29.9 mt -69.07 -35.35 76.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.824 ' OG ' HD13 ' A' ' 324' ' ' LEU . 12.8 p -57.91 -36.37 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 321' ' ' ARG . 16.6 mt -72.5 -47.23 50.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.494 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -49.52 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.77 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.08 -37.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 165' ' ' LEU . 7.6 mt -58.96 -36.47 74.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.667 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -38.04 84.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 109' ' ' GLY . 16.9 mt -74.79 -38.47 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 162' ' ' LEU . 61.5 mt -58.16 -48.22 80.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -68.12 -38.93 82.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.548 ' CE1' HD11 ' A' ' 105' ' ' LEU . 90.6 t80 -59.7 -41.42 90.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.591 HD11 ' CE1' ' A' ' 175' ' ' HIS . 28.2 pt -81.67 -27.19 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.112 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -75.93 -29.99 58.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.425 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.77 -17.1 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.22 6.24 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 72.04 47.16 0.31 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.886 0.374 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 203' ' ' ARG . 11.1 m-85 -132.05 132.83 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.99 169.31 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.788 ' CD2' HD21 ' A' ' 195' ' ' LEU . 11.4 p-80 -151.68 -51.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.317 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.754 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . 55.83 53.12 44.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.66 30.17 5.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.104 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 183' ' ' LEU . 2.8 mt -87.29 105.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.26 29.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.427 ' HB1' ' N ' ' A' ' 139' ' ' GLN . . . 67.11 11.05 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.87 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 m -117.13 5.97 12.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 196' ' ' VAL . 8.9 m120 -138.49 2.89 2.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.594 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.906 ' O ' HD23 ' A' ' 184' ' ' LEU . 5.3 mt -109.59 130.2 55.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.098 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 183' ' ' LEU . 1.1 mt -137.53 147.54 45.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.094 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.686 HD21 HD11 ' A' ' 341' ' ' LEU . 24.8 mt -86.47 145.87 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 111.528 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 125.87 25.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.83 -49.46 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -58.1 -24.4 58.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.659 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.35 81.14 2.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.15 109.73 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.584 2.189 . . . . 0.0 112.291 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -144.55 -45.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -157.86 -167.7 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 138' ' ' LEU . 7.6 p -109.75 148.1 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 9.2 m-85 -119.21 156.96 28.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.388 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.788 HD21 ' CD2' ' A' ' 175' ' ' HIS . 18.3 tp -106.61 115.77 30.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.428 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.717 HG11 ' CE2' ' A' ' 134' ' ' PHE . 30.5 m -126.95 167.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.296 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.7 t70 53.65 57.68 5.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.007 0.432 . . . . 0.0 110.707 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 201' ' ' ALA . 51.6 m-85 -59.68 -51.55 69.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.071 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 93.81 -35.83 4.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.94 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.56 31.65 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.503 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 198' ' ' TYR . . . -71.82 59.44 0.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.76 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -138.48 148.97 44.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.064 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.428 ' HG3' ' CE1' ' A' ' 173' ' ' TYR . 19.4 mtm105 -56.52 101.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -58.68 -23.41 59.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.172 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 15.4 t -104.68 103.29 39.49 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.943 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.488 ' HB2' HG13 ' A' ' 209' ' ' VAL . 54.7 Cg_exo -52.1 176.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.439 2.093 . . . . 0.0 112.398 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.92 -34.81 3.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -87.85 14.53 58.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.062 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 206' ' ' PRO . 12.6 m -84.6 171.76 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -137.82 -50.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -66.65 140.43 57.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.05 155.88 26.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.63 147.87 31.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.27 94.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 61.62 106.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -171.46 84.97 0.48 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 94.54 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.586 2.191 . . . . 0.0 112.337 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 20.84 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 53.71 47.25 24.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.084 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 58.0 m -91.71 -38.45 12.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.47 ' CD2' ' HB1' ' A' ' 232' ' ' ALA . 7.2 t60 -64.91 -45.97 83.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.47 172.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 122.51 -164.12 15.65 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.5 p -87.87 178.09 6.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.576 ' CD1' HG11 ' A' ' 271' ' ' VAL . 2.7 tt -116.16 -26.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -24.62 4.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.472 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 246' ' ' ILE . 11.1 m-85 -144.41 38.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.07 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 225' ' ' ILE . 10.2 t -83.99 138.9 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.8 t -91.8 148.29 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 279' ' ' ARG . 15.0 mt -57.34 -51.16 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.188 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.83 -43.91 86.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.47 ' HB1' ' CD2' ' A' ' 221' ' ' HIS . . . -72.39 -28.11 62.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.233 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -68.71 -28.04 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.585 ' HB3' HG23 ' A' ' 236' ' ' VAL . 2.2 t30 -91.64 12.86 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.44 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.08 23.29 63.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.747 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.654 HG12 ' HD2' ' A' ' 238' ' ' PRO . 14.3 t -77.81 119.52 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.856 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -57.67 -57.4 25.66 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 52.2 Cg_exo -52.43 89.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.407 2.072 . . . . 0.0 112.165 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 t -138.14 160.99 37.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -178.79 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.118 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -57.41 -42.76 93.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.569 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.559 ' HA ' HD12 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -59.19 -35.21 73.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.774 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.506 HD21 ' HE1' ' A' ' 317' ' ' TYR . 15.5 mt -80.5 -34.49 35.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.98 -39.37 89.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.717 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 227' ' ' PHE . 8.5 mt -62.9 -47.93 90.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.4 tp -64.79 -33.94 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.397 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.3 95.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.348 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 275' ' ' LYS . 34.0 m-85 -78.57 -25.84 45.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.88 -34.45 65.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.583 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -46.57 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.769 HD13 HD11 ' A' ' 285' ' ' LEU . 9.0 mt -63.57 -38.63 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HB3' HD11 ' A' ' 259' ' ' LEU . 1.5 pp0? -75.17 -31.06 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -82.38 -40.71 20.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.039 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.99 -31.19 56.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.98 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.3 m -103.07 0.51 32.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.412 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.71 95.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.519 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 61.12 161.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.956 HD22 ' CH2' ' A' ' 261' ' ' TRP . 0.1 OUTLIER -133.0 168.74 16.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.865 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 261' ' ' TRP . 15.6 Cg_exo -68.44 59.14 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.863 2.375 . . . . 0.0 112.515 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.956 ' CH2' HD22 ' A' ' 259' ' ' LEU . 2.0 p90 179.15 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.445 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 261' ' ' TRP . 4.1 tt0 -84.48 5.63 26.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.539 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.23 -54.1 49.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 1.4 m120 -130.05 -27.53 2.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 78.5 mt 71.26 12.62 6.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.27 -15.38 38.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.468 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 270' ' ' TYR . 0.2 OUTLIER -130.03 92.16 37.35 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.18 -4.12 13.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.883 2.389 . . . . 0.0 112.662 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -55.34 -50.34 69.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.277 . . . . 0.0 111.079 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 261' ' ' TRP . 1.7 p90 -84.09 -26.03 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 261' ' ' TRP . 40.8 t -62.49 -43.04 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.298 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -75.52 -40.81 56.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -48.08 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -45.31 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.185 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -58.74 -42.87 89.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.483 ' HA ' HD11 ' A' ' 230' ' ' ILE . 17.3 mt -72.56 -29.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -75.41 -52.1 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -60.47 -39.46 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.633 ' HG3' HD12 ' A' ' 230' ' ' ILE . 0.1 OUTLIER -60.13 -26.18 66.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.948 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -120.2 23.78 10.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.66 53.43 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.074 0.464 . . . . 0.0 110.744 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 303' ' ' MET . 2.6 mm -48.52 -41.79 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.339 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -64.26 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.513 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.2 p -70.38 -31.98 69.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.769 HD11 HD13 ' A' ' 252' ' ' ILE . 1.2 tt -66.41 -51.4 57.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.467 ' HE3' ' N ' ' A' ' 300' ' ' ALA . 21.5 mmt -62.14 -34.63 76.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -82.79 -33.34 27.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.313 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -54.85 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.467 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' HG21 ' A' ' 252' ' ' ILE . 85.7 m -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.286 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 290' ' ' PHE . 3.7 m-85 -108.36 146.29 33.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 -172.42 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 112.347 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.43 30.87 3.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 -35.28 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.68 91.66 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.79 108.02 1.06 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.23 127.21 23.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.468 2.112 . . . . 0.0 112.256 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -124.1 -40.51 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.11 -47.5 85.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.696 HG22 ' CG ' ' A' ' 303' ' ' MET . 19.2 mm -76.79 -48.74 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.467 ' N ' ' HE3' ' A' ' 286' ' ' MET . . . -44.32 -44.72 8.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.615 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -63.58 -43.22 97.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.382 . . . . 0.0 110.814 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.883 ' O ' HG23 ' A' ' 306' ' ' VAL . 18.5 t80 -69.59 -43.5 72.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.018 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.696 ' CG ' HG22 ' A' ' 299' ' ' ILE . 69.1 mmm -66.54 -39.02 88.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.764 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.83 -40.36 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.273 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -32.34 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 302' ' ' TYR . 14.0 t -71.91 -24.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.096 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -75.7 -37.45 59.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.71 -12.49 22.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 320' ' ' LEU . 0.3 OUTLIER -52.86 140.86 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.968 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.58 -58.9 0.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -45.72 -48.49 15.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.45 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -55.3 -58.39 7.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.497 ' H ' HG23 ' A' ' 312' ' ' THR . 0.9 OUTLIER 179.84 -67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -117.85 156.47 49.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 309' ' ' LEU . 19.0 Cg_endo -60.15 -178.19 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.54 2.16 . . . . 0.0 112.276 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.591 ' H ' HD21 ' A' ' 309' ' ' LEU . 2.3 mp -142.87 42.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.506 ' HE1' HD21 ' A' ' 244' ' ' LEU . 20.1 m-85 -57.06 -36.16 70.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.021 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -69.2 -33.88 74.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.74 -47.42 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.817 ' HA ' HD12 ' A' ' 323' ' ' ILE . 25.9 mt -53.29 -44.37 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 159' ' ' LEU . 4.7 ttt180 -59.15 -32.65 70.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.987 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.97 -30.47 55.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 320' ' ' LEU . 57.9 mt -63.98 -50.01 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.343 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.824 HD13 ' OG ' ' A' ' 158' ' ' SER . 8.4 mt -79.96 -26.65 39.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.593 ' HB2' HD11 ' A' ' 159' ' ' LEU . 6.9 tt -82.58 -48.89 10.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.733 0.301 . . . . 0.0 111.107 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.76 -34.29 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.6 56.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.583 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.732 HD21 ' HB3' ' A' ' 155' ' ' LEU . 29.4 mt -57.23 -32.55 66.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -70.08 -29.62 66.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.63 63.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.8 -28.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.215 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.11 22.92 5.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m -97.67 164.52 12.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -138.63 111.85 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.81 92.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.97 -74.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.957 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -134.4 22.94 3.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.692 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.81 135.62 41.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.709 0.29 . . . . 0.0 110.733 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 339' ' ' LEU . 0.2 OUTLIER 177.76 -15.31 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.53 -24.49 8.22 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.653 0.263 . . . . 0.0 111.542 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.76 HD13 ' CD1' ' A' ' 141' ' ' ILE . 0.9 OUTLIER 67.75 12.29 8.78 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.419 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.1 m 51.46 83.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.888 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 343' ' ' VAL . 15.2 m -151.74 88.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 14.6 m -83.6 56.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.57 31.65 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -143.54 85.52 1.84 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.12 73.48 1.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 137.52 102.41 0.6 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.408 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 349' ' ' LEU . 1.3 pt? -109.91 -30.45 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -92.84 132.79 36.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -149.18 176.97 10.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -177.88 3.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 353' ' ' THR . 4.4 t -150.82 80.69 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.74 151.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.066 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 1.3 t -120.03 -41.93 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -104.68 116.74 32.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -31.84 15.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.66 176.9 8.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.67 93.92 5.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.97 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.37 145.74 32.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.569 ' O ' HD13 ' A' ' 362' ' ' ILE . 0.5 OUTLIER -96.41 96.67 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 361' ' ' GLU . 25.1 mm -133.43 131.84 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 31.42 5.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.437 ' H ' HG22 ' A' ' 362' ' ' ILE . 0.8 OUTLIER -105.52 74.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 30.9 t -110.4 -28.93 8.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 63.44 116.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -107.48 99.67 29.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.71 -49.02 18.04 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.475 2.117 . . . . 0.0 112.358 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 100.38 -160.53 19.1 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' VAL . . . . . . . . . . . . . 16.9 m -152.25 149.37 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.132 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 44.83 39.34 3.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.395 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.71 116.65 33.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 4.9 m 60.19 83.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -112.67 135.44 53.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -144.31 165.53 27.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.12 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -85.36 -49.18 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 17.6 m 60.71 95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -168.48 162.45 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 67.4 p -77.52 122.19 24.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 93.68 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -138.33 95.61 3.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -160.7 174.88 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 384' ' ' ILE . 3.5 tp -119.74 114.74 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.39 144.59 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.95 95.15 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.44 80.65 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.778 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 37.0 m 61.11 179.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.3 ttm-85 -159.29 -48.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' THR . . . . . . . . . . . . . 2.2 t -160.24 -45.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -69.69 116.23 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -34.09 64.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -128.33 104.51 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.57 126.58 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -147.97 -49.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 8.7 mttm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.917 179.991 . . . . . . . . 0 0 . 1 stop_ save_